data_2luo_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2luo _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.434 ' HB3' ' O ' ' A' ' 36' ' ' ASP . 56.9 Cg_endo . . . . . 0 N--CA 1.457 -0.64 0 CA-C-O 121.732 0.638 . . . . 1.0 113.642 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.753 HD13 ' HB3' ' A' ' 84' ' ' ASP . 0.2 OUTLIER -68.44 -177.89 1.01 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.623 -1.171 . . . . 1.0 109.522 178.078 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.694 ' HA ' ' O ' ' A' ' 39' ' ' ARG . 2.4 t-160 -156.84 87.7 1.01 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.924 -0.398 . . . . 1.0 109.924 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.773 HG11 HD11 ' A' ' 85' ' ' LEU . 2.5 t -97.15 104.68 16.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.473 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.586 ' HA ' ' O ' ' A' ' 41' ' ' THR . 12.7 t -107.99 115.58 30.39 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.163 0.506 . . . . 1.0 110.453 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.529 ' HD1' ' HB ' ' A' ' 87' ' ' VAL . 0.7 OUTLIER -84.56 131.75 34.59 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.438 -178.009 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.619 HG23 HD12 ' A' ' 97' ' ' LEU . 43.6 t -116.19 112.58 40.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.223 0.535 . . . . 1.0 111.891 -176.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.654 ' HB2' HD22 ' A' ' 89' ' ' LEU . 17.7 t -141.65 165.8 26.49 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.934 -0.575 . . . . 1.0 109.689 177.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.65 HG23 ' HE2' ' A' ' 93' ' ' HIS . 1.2 p -73.47 101.6 3.56 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.959 0.409 . . . . 1.0 110.782 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.928 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 120.68 -43.34 1.55 Allowed Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.859 -0.686 . . . . 1.0 111.863 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.641 ' ND2' ' H ' ' A' ' 74' ' ' ALA . 59.0 t30 60.2 25.82 15.22 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 122.169 0.985 . . . . 1.0 110.883 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.6 pt -126.54 0.66 4.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 115.602 -0.726 . . . . 1.0 111.15 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 23.1 m -120.6 -88.79 0.62 Allowed 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.439 -0.504 . . . . 1.0 111.916 -176.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.1 ttm105 -71.94 -40.42 68.72 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.282 0.475 . . . . 1.0 112.282 -174.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.421 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 24.5 m -58.47 -58.34 19.79 Favored Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 111.846 0.313 . . . . 1.0 111.846 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.499 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 40.2 Cg_endo -64.49 -20.99 66.37 Favored 'Trans proline' 0 C--N 1.357 0.978 0 C-N-CA 122.035 1.823 . . . . 1.0 112.166 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.669 ' HB3' HD11 ' A' ' 142' ' ' ILE . 41.9 mmm -62.97 -54.45 38.14 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.625 -0.261 . . . . 1.0 110.499 177.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.445 ' HA ' ' HB2' ' A' ' 24' ' ' MET . . . -71.84 -27.83 63.16 Favored 'General case' 0 CA--C 1.509 -0.624 0 C-N-CA 120.461 -0.496 . . . . 1.0 110.076 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.684 ' O ' ' HB1' ' A' ' 26' ' ' ALA . 15.8 tt0 -50.47 -53.47 29.48 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-N 114.741 -1.118 . . . . 1.0 109.852 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.793 ' HB3' ' HG2' ' A' ' 68' ' ' PRO . 0.1 OUTLIER -82.78 -27.32 31.07 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.165 -0.925 . . . . 1.0 110.22 -175.958 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.743 ' HB3' HD12 ' A' ' 146' ' ' LEU . 7.9 mmm -62.87 -75.61 0.07 Allowed 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 112.993 0.738 . . . . 1.0 112.993 -176.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.828 ' HB3' HD21 ' A' ' 146' ' ' LEU . 19.8 p90 -78.04 -29.92 49.61 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 119.958 -0.697 . . . . 1.0 111.219 -175.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.684 ' HB1' ' O ' ' A' ' 22' ' ' GLU . . . -63.37 -38.15 90.02 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 119.413 -0.915 . . . . 1.0 110.57 179.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.65 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -63.36 -40.75 98.13 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.94 -0.763 . . . . 1.0 108.94 177.098 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.586 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 79.4 mt-30 -59.83 -41.88 92.32 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-N 115.85 -0.613 . . . . 1.0 110.679 176.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.655 ' HG ' ' O ' ' A' ' 25' ' ' PHE . 80.2 mt -55.89 -61.41 2.39 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.682 -0.69 . . . . 1.0 110.257 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.531 ' HB3' ' HA3' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -59.07 -33.56 70.95 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.793 -0.363 . . . . 1.0 111.374 178.553 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -63.37 -25.54 68.34 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.21 0.448 . . . . 1.0 112.21 176.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.583 ' HD3' HD13 ' A' ' 34' ' ' LEU . 8.3 ptm85 -98.6 -21.29 16.54 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 120.05 -0.66 . . . . 1.0 110.104 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.27 33.17 1.83 Allowed Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 114.991 -1.004 . . . . 1.0 112.437 177.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.583 HD13 ' HD3' ' A' ' 32' ' ' ARG . 36.1 mt -127.14 6.47 6.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.982 0.391 . . . . 1.0 110.709 -178.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.531 ' HA3' ' HB3' ' A' ' 30' ' ' ARG . . . -54.21 -35.84 55.87 Favored Glycine 0 CA--C 1.52 0.374 0 C-N-CA 121.27 -0.49 . . . . 1.0 113.573 -177.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.607 ' HA ' ' NH1' ' A' ' 39' ' ' ARG . 2.8 m-20 -92.29 -14.02 29.48 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.97 0.414 . . . . 1.0 110.925 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.83 -17.93 49.13 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.875 -0.602 . . . . 1.0 111.2 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.68 HG22 ' HB3' ' A' ' 5' ' ' LEU . 0.4 OUTLIER -144.64 124.3 7.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.39 0.614 . . . . 1.0 111.055 179.436 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.694 ' O ' ' HA ' ' A' ' 6' ' ' HIS . 25.8 mmt180 -95.66 101.45 13.15 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.634 -0.712 . . . . 1.0 110.948 -178.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.633 HG13 ' HB2' ' A' ' 26' ' ' ALA . 1.6 m -89.03 136.61 23.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 109.035 -0.728 . . . . 1.0 109.035 178.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.586 ' O ' ' HA ' ' A' ' 8' ' ' THR . 31.7 p -146.6 -176.11 5.05 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.045 -0.98 . . . . 1.0 109.742 -175.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.419 ' HB3' ' HD2' ' A' ' 9' ' ' PHE . 49.2 p -158.76 160.66 36.56 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.153 -0.619 . . . . 1.0 111.253 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.613 ' HB3' ' CD2' ' A' ' 80' ' ' HIS . . . -162.68 161.88 26.66 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.315 0.579 . . . . 1.0 111.582 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -124.33 138.53 11.31 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 111.096 -0.802 . . . . 1.0 111.096 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.511 HG23 HD11 ' A' ' 96' ' ' LEU . 33.7 p -74.36 -24.0 59.09 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 111.962 0.356 . . . . 1.0 111.962 -176.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.583 ' HA3' ' CZ3' ' A' ' 48' ' ' TRP . . . -110.76 9.39 29.97 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.533 -0.841 . . . . 1.0 113.083 -178.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 42.67 37.35 1.0 Allowed 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 113.885 1.068 . . . . 1.0 113.885 177.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.928 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 1.5 m-90 -44.81 -70.41 0.1 Allowed 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.559 0.695 . . . . 1.0 112.369 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.665 ' O ' ' HB2' ' A' ' 52' ' ' SER . 6.8 m-70 -109.65 43.73 1.28 Allowed 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.1 -0.954 . . . . 1.0 111.057 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.42 HG22 ' HA ' ' A' ' 74' ' ' ALA . 14.8 p -62.54 129.74 26.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 C-N-CA 120.425 -0.51 . . . . 1.0 110.169 178.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.14 -13.5 66.88 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 121.109 -0.567 . . . . 1.0 111.684 -176.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.665 ' HB2' ' O ' ' A' ' 49' ' ' HIS . 0.4 OUTLIER -80.0 -162.26 0.42 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.174 0.511 . . . . 1.0 110.669 179.58 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 33.7 t -126.45 175.94 7.52 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.291 -1.003 . . . . 1.0 108.291 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.06 141.06 47.21 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.955 0.407 . . . . 1.0 111.374 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.48 ' OD1' ' HG2' ' A' ' 57' ' ' ARG . 13.2 t70 -61.05 141.15 57.61 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.285 -0.87 . . . . 1.0 111.436 -177.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -46.24 -37.8 7.67 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.727 -1.124 . . . . 1.0 113.555 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.671 ' O ' HG23 ' A' ' 61' ' ' VAL . 14.9 ptp180 -69.95 -45.31 67.73 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 122.276 -0.265 . . . . 1.0 110.897 -176.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.0 -31.62 68.19 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.485 -178.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.64 -43.43 98.82 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.893 -0.594 . . . . 1.0 110.046 178.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.41 -42.4 97.65 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.786 -0.721 . . . . 1.0 111.486 177.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.671 HG23 ' O ' ' A' ' 57' ' ' ARG . 61.3 t -58.05 -58.53 6.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-O 120.975 0.417 . . . . 1.0 111.273 179.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.718 ' HB2' HG23 ' A' ' 69' ' ' THR . 90.1 mt -59.04 -51.21 71.02 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.061 -0.518 . . . . 1.0 111.662 -178.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -60.87 -29.27 69.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.482 -0.326 . . . . 1.0 110.894 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.19 -31.48 71.91 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.225 0.536 . . . . 1.0 110.546 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -99.42 1.89 44.63 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.492 -0.776 . . . . 1.0 111.505 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.97 16.26 56.41 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 121.045 -0.597 . . . . 1.0 113.213 177.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -92.08 149.58 38.96 Favored Pre-proline 0 C--N 1.322 -0.627 0 C-N-CA 122.083 0.153 . . . . 1.0 111.082 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.793 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 49.6 Cg_endo -68.89 158.23 58.72 Favored 'Trans proline' 0 CA--C 1.511 -0.634 0 C-N-CA 122.519 2.146 . . . . 1.0 110.36 176.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.718 HG23 ' HB2' ' A' ' 62' ' ' LEU . 58.1 p -134.53 3.53 3.31 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 119.562 -0.855 . . . . 1.0 112.65 -176.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -79.85 135.65 36.5 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.762 -0.375 . . . . 1.0 110.429 -179.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -175.58 153.99 1.54 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.698 -0.683 . . . . 1.0 109.251 -176.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -123.3 116.72 23.79 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.208 -1.034 . . . . 1.0 108.208 177.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.493 ' HB2' ' O ' ' A' ' 49' ' ' HIS . . . -61.3 139.02 58.24 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.259 0.552 . . . . 1.0 111.895 -176.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.641 ' H ' ' ND2' ' A' ' 14' ' ' ASN . . . -130.88 161.23 32.3 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.427 -0.806 . . . . 1.0 109.942 178.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -98.1 161.41 13.73 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.943 -0.762 . . . . 1.0 108.943 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.529 HG12 HD21 ' A' ' 97' ' ' LEU . 94.0 t -67.44 102.72 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.398 0.618 . . . . 1.0 110.388 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.548 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -120.79 -170.87 14.23 Favored Glycine 0 N--CA 1.443 -0.882 0 CA-C-N 115.046 -0.979 . . . . 1.0 111.824 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 88.4 m -55.92 -54.12 48.52 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.758 0.651 . . . . 1.0 112.758 -178.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.564 ' HG2' ' N ' ' A' ' 80' ' ' HIS . 0.6 OUTLIER -56.43 -31.36 63.84 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.893 -0.594 . . . . 1.0 111.089 -178.167 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.613 ' CD2' ' HB3' ' A' ' 43' ' ' ALA . 79.1 m80 -76.32 -42.36 45.4 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.6 -0.727 . . . . 1.0 110.064 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 23.2 mt -66.21 -19.77 65.93 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.476 178.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -84.77 -5.33 59.32 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.871 -0.604 . . . . 1.0 110.998 -178.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.561 ' HB3' ' O ' ' A' ' 6' ' ' HIS . . . -60.8 157.85 14.14 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.071 -0.513 . . . . 1.0 111.644 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.753 ' HB3' HD13 ' A' ' 5' ' ' LEU . 29.9 t70 -82.69 -16.57 47.67 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 115.915 -0.584 . . . . 1.0 109.807 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.773 HD11 HG11 ' A' ' 7' ' ' VAL . 0.4 OUTLIER -154.61 115.82 4.05 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.334 -0.848 . . . . 1.0 109.059 -176.581 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.579 HD23 HG21 ' A' ' 102' ' ' VAL . 5.4 mp -106.74 106.81 17.52 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-N 115.479 -0.782 . . . . 1.0 109.853 177.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.561 HG12 HD22 ' A' ' 110' ' ' LEU . 52.3 t -85.14 92.26 3.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 114.896 -1.047 . . . . 1.0 110.869 -176.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.27 147.54 32.49 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.514 -0.766 . . . . 1.0 110.98 179.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.654 HD22 ' HB2' ' A' ' 11' ' ' CYS . 2.9 mm? -103.73 -4.85 23.14 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.273 0.558 . . . . 1.0 110.49 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.456 ' CG ' ' H ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -155.37 153.37 30.35 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.71 -0.677 . . . . 1.0 111.223 178.538 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 25.4 ptt180 -50.19 -32.09 15.44 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 114.903 -1.044 . . . . 1.0 112.998 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.704 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 5.9 m-20 -76.3 -48.46 20.03 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.288 -0.264 . . . . 1.0 110.288 -176.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.65 ' HE2' HG23 ' A' ' 12' ' ' THR . 14.2 m170 -55.14 -48.46 73.65 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.73 -0.47 . . . . 1.0 109.73 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.451 ' HA ' HG22 ' A' ' 107' ' ' VAL . . . -59.3 -43.45 92.6 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.028 0.442 . . . . 1.0 110.849 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 9.8 ttt-85 -59.67 -45.51 91.84 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 115.408 -0.815 . . . . 1.0 111.66 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.761 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 56.0 mt -63.86 -49.49 72.55 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 115.902 -0.59 . . . . 1.0 110.028 -175.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.642 ' HG ' ' O ' ' A' ' 93' ' ' HIS . 22.6 mt -52.77 -57.83 8.86 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.668 -0.696 . . . . 1.0 111.368 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.573 ' HA ' ' HB ' ' A' ' 102' ' ' VAL . 9.4 ptt180 -60.42 -43.21 96.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.11 -0.496 . . . . 1.0 111.878 -176.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.639 ' HG3' ' O ' ' A' ' 96' ' ' LEU . 1.3 pp0? -68.33 -23.31 64.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.911 0.386 . . . . 1.0 110.287 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.761 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 11.4 mt -79.2 -13.43 59.71 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.87 -0.605 . . . . 1.0 112.194 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 148.4 -22.87 1.37 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.067 -1.063 . . . . 1.0 112.773 -178.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.914 HG12 ' H ' ' A' ' 103' ' ' GLU . 3.3 t -75.6 -156.09 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.123 0.487 . . . . 1.0 110.119 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.914 ' H ' HG12 ' A' ' 102' ' ' VAL . 9.3 pt-20 -170.44 163.84 8.57 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.755 -1.202 . . . . 1.0 107.755 -177.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.751 ' HA ' HG11 ' A' ' 107' ' ' VAL . . . -65.83 -22.14 66.53 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.754 0.311 . . . . 1.0 111.213 -176.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.462 ' HB1' ' HG3' ' A' ' 103' ' ' GLU . . . -58.52 -37.8 76.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.295 0.569 . . . . 1.0 109.947 174.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.676 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 10.5 mtt180 -96.21 -45.33 6.89 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 115.193 -0.912 . . . . 1.0 110.778 -177.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.751 HG11 ' HA ' ' A' ' 104' ' ' ALA . 8.2 p -79.07 124.8 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-O 121.289 0.566 . . . . 1.0 110.49 -176.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.529 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 10.6 mmm180 -140.85 147.92 39.71 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.285 -0.635 . . . . 1.0 109.285 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.445 ' HE2' ' HB3' ' A' ' 109' ' ' MET . 83.1 mmm -78.88 140.24 38.16 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.451 -0.34 . . . . 1.0 110.375 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.561 HD22 HG12 ' A' ' 87' ' ' VAL . 3.0 tm? -58.45 -51.69 68.77 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 122.973 0.171 . . . . 1.0 111.262 -179.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 46.1 ttm-85 -71.26 -14.51 62.25 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 120.278 -0.569 . . . . 1.0 110.442 -178.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.436 ' HB2' ' HB2' ' A' ' 109' ' ' MET . 42.2 t -73.62 -9.51 58.75 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.71 -0.396 . . . . 1.0 110.423 179.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.536 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 97.2 m-85 -91.02 -22.68 20.66 Favored 'General case' 0 C--N 1.341 0.213 0 N-CA-C 109.782 -0.451 . . . . 1.0 109.782 175.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.5 t0 . . . . . 0 C--N 1.331 -0.237 0 CA-C-N 115.22 -0.9 . . . . 1.0 111.019 -178.435 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 . . . . . 0 C--O 1.233 0.204 0 CA-C-O 120.96 0.409 . . . . 1.0 110.806 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -61.58 -51.56 68.04 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.659 -0.7 . . . . 1.0 110.126 178.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.951 ' HA ' HG21 ' A' ' 141' ' ' VAL . 71.9 t -59.85 -41.15 84.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.758 -0.655 . . . . 1.0 110.346 178.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.518 ' HB2' HG11 ' A' ' 61' ' ' VAL . 49.8 t80 -54.65 -43.6 72.51 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.185 -0.916 . . . . 1.0 109.418 176.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.513 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -63.94 -41.86 97.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.595 -0.729 . . . . 1.0 110.798 178.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.951 HG21 ' HA ' ' A' ' 138' ' ' VAL . 5.6 t -53.83 -53.1 29.22 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 CA-C-O 121.841 0.829 . . . . 1.0 110.031 177.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.669 HD11 ' HB3' ' A' ' 20' ' ' MET . 6.8 mt -64.97 -50.94 72.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 114.649 -1.16 . . . . 1.0 112.085 -177.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.534 ' HB3' ' HE2' ' A' ' 24' ' ' MET . 10.3 pt-20 -57.33 -30.87 65.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.677 0.275 . . . . 1.0 110.533 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.9 t -73.49 -29.62 62.62 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-O 121.2 0.524 . . . . 1.0 110.164 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.505 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -86.7 -24.12 25.31 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-N 116.018 -0.537 . . . . 1.0 112.128 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.828 HD21 ' HB3' ' A' ' 25' ' ' PHE . 14.4 mt -55.15 -36.42 45.14 Favored Pre-proline 0 CA--C 1.545 0.769 0 N-CA-C 112.745 0.646 . . . . 1.0 112.745 -177.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 56.9 Cg_endo -70.22 -10.59 28.53 Favored 'Trans proline' 0 C--N 1.363 1.299 0 C-N-CA 122.63 2.22 . . . . 1.0 112.09 176.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -106.07 -33.74 3.39 Favored Glycine 0 N--CA 1.449 -0.492 0 N-CA-C 110.372 -1.091 . . . . 1.0 110.372 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.466 ' O ' HG13 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -73.02 -39.23 66.17 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.0 -1.111 . . . . 1.0 108.0 178.369 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . 0.519 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 0.2 OUTLIER -52.97 -58.4 7.11 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 114.801 -1.091 . . . . 1.0 110.834 175.293 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -56.92 -39.83 75.22 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.766 -1.106 . . . . 1.0 111.304 -174.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . 0.746 ' HZ3' HD12 ' A' ' 5' ' ' LEU . 22.3 t90 -65.18 -55.75 16.8 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.602 -0.726 . . . . 1.0 110.875 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.466 HG13 ' O ' ' A' ' 149' ' ' LEU . 6.5 m -61.35 -41.97 91.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.888 -0.412 . . . . 1.0 109.888 -178.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.425 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 3.3 m-20 -60.19 -51.26 70.35 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-O 120.96 0.41 . . . . 1.0 110.855 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 7.1 pt-20 -63.4 -38.35 90.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.95 -177.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.52 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 5.5 mmt85 -73.81 -43.02 60.08 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.701 -0.681 . . . . 1.0 110.802 -176.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.427 HD12 ' C ' ' A' ' 157' ' ' LEU . 4.0 pp . . . . . 0 C--N 1.322 -0.596 0 CA-C-N 116.017 -0.538 . . . . 1.0 109.998 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.436 ' HB2' ' HG2' ' A' ' 39' ' ' ARG . 17.8 Cg_endo . . . . . 0 N--CA 1.461 -0.385 0 CA-C-O 121.091 0.371 . . . . 1.0 112.915 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.794 ' HB3' HG23 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -65.38 175.92 1.57 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.599 -0.728 . . . . 1.0 109.684 179.67 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.772 ' H ' HD12 ' A' ' 5' ' ' LEU . 0.5 OUTLIER -153.75 100.28 2.37 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.883 -0.414 . . . . 1.0 109.883 179.175 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.662 HG11 HD13 ' A' ' 85' ' ' LEU . 1.8 t -103.6 116.84 48.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 107.983 -1.118 . . . . 1.0 107.983 178.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.604 ' CG2' ' HG ' ' A' ' 86' ' ' LEU . 15.1 t -119.77 114.31 21.95 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 120.589 -0.444 . . . . 1.0 110.81 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.763 ' HZ ' ' HE1' ' A' ' 25' ' ' PHE . 0.4 OUTLIER -84.35 131.41 34.7 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 120.398 -0.521 . . . . 1.0 110.177 -179.619 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.595 HG22 HD13 ' A' ' 97' ' ' LEU . 30.1 t -113.66 118.42 58.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 116.284 -0.416 . . . . 1.0 111.365 -176.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.408 ' HB2' HD22 ' A' ' 89' ' ' LEU . 46.2 t -148.65 146.8 28.34 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.996 -0.372 . . . . 1.0 109.996 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.54 93.27 1.19 Allowed 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 121.115 0.483 . . . . 1.0 110.394 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 148.08 -37.99 1.06 Allowed Glycine 0 N--CA 1.441 -1.01 0 CA-C-N 115.183 -0.917 . . . . 1.0 111.088 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.987 HD21 ' HB1' ' A' ' 73' ' ' ALA . 1.4 p-10 48.47 24.43 0.74 Allowed 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.063 0.945 . . . . 1.0 112.864 178.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.449 HG12 ' HB2' ' A' ' 49' ' ' HIS . 1.3 pt -148.23 47.2 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.451 0 CA-C-N 115.574 -0.739 . . . . 1.0 110.625 178.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.453 ' HA ' ' OD1' ' A' ' 55' ' ' ASP . 53.2 t -161.68 -84.56 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.535 -0.757 . . . . 1.0 109.599 173.082 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 27.4 mmt85 -59.79 -57.16 14.12 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.795 -0.639 . . . . 1.0 112.002 -178.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 1.093 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 6.2 m -52.11 -58.35 11.72 Favored Pre-proline 0 CA--C 1.546 0.825 0 CA-C-N 115.085 -0.961 . . . . 1.0 112.55 -177.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.646 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 37.3 Cg_endo -63.45 -27.82 70.71 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 121.985 1.79 . . . . 1.0 112.909 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.46 ' HB3' HD12 ' A' ' 142' ' ' ILE . 45.5 mmm -59.28 -57.31 13.58 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.295 -0.261 . . . . 1.0 110.295 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.538 ' O ' ' HD1' ' A' ' 25' ' ' PHE . . . -71.37 -32.16 68.16 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 115.885 -0.598 . . . . 1.0 110.507 -178.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.574 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 15.0 tt0 -49.79 -52.72 29.95 Favored 'General case' 0 C--O 1.216 -0.69 0 O-C-N 124.198 0.936 . . . . 1.0 109.917 -178.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.955 ' HE3' ' HB2' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -86.63 -22.33 26.24 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 119.592 -0.843 . . . . 1.0 110.9 -176.919 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.51 ' HE1' HD12 ' A' ' 146' ' ' LEU . 88.7 mtp -64.21 -75.16 0.09 Allowed 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.384 0.513 . . . . 1.0 112.384 -179.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.763 ' HE1' ' HZ ' ' A' ' 9' ' ' PHE . 0.8 OUTLIER -78.43 -28.29 46.72 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 119.754 -0.778 . . . . 1.0 111.613 -175.452 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.574 ' HB3' ' O ' ' A' ' 22' ' ' GLU . . . -64.54 -38.73 92.04 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 119.387 -0.925 . . . . 1.0 110.473 178.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.6 ' HG3' ' N ' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -64.75 -37.45 87.63 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.825 -0.806 . . . . 1.0 108.825 177.789 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.6 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 78.5 mt-30 -60.05 -43.01 95.68 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-N 115.967 -0.56 . . . . 1.0 109.897 175.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 25' ' ' PHE . 93.2 mt -56.02 -59.01 5.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.74 -0.664 . . . . 1.0 110.767 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.484 ' HG2' ' O ' ' A' ' 27' ' ' GLN . 0.2 OUTLIER -60.58 -34.27 73.94 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.372 -0.531 . . . . 1.0 111.349 178.463 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.8 m170 -59.42 -30.09 68.23 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 111.994 0.368 . . . . 1.0 111.994 176.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.463 ' HG2' ' O ' ' A' ' 28' ' ' GLN . 5.8 ptp180 -95.41 -19.25 20.05 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 119.501 -0.88 . . . . 1.0 110.261 179.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 107.42 38.44 2.09 Favored Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.238 -0.892 . . . . 1.0 112.339 177.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 25.2 mt -129.54 0.02 4.98 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 122.554 -0.38 . . . . 1.0 110.258 -178.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.441 ' H ' ' HA ' ' A' ' 30' ' ' ARG . . . -54.26 -28.41 42.72 Favored Glycine 0 CA--C 1.519 0.337 0 CA-C-N 116.028 -0.533 . . . . 1.0 113.837 -178.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.508 ' HA ' ' NH1' ' A' ' 39' ' ' ARG . 5.1 t70 -89.45 -24.88 21.75 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-O 121.54 0.686 . . . . 1.0 109.739 178.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -77.59 -19.38 55.7 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 114.716 -1.129 . . . . 1.0 111.438 -174.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.794 HG23 ' HB3' ' A' ' 5' ' ' LEU . 0.4 OUTLIER -145.05 124.24 6.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.964 -0.562 . . . . 1.0 109.889 179.81 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.508 ' NH1' ' HA ' ' A' ' 36' ' ' ASP . 29.1 mmt180 -90.16 137.44 32.34 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 109.291 -0.633 . . . . 1.0 109.291 -178.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 80.8 t -124.78 126.88 72.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 N-CA-C 109.425 -0.583 . . . . 1.0 109.425 -178.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.438 ' O ' ' HA ' ' A' ' 8' ' ' THR . 31.5 p -139.51 -178.11 5.24 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.175 -0.921 . . . . 1.0 110.557 -174.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 1.093 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 87.9 p -159.01 159.61 34.97 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.987 -0.551 . . . . 1.0 109.987 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.455 ' HA ' ' O ' ' A' ' 74' ' ' ALA . . . -164.44 166.17 20.8 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 121.32 0.581 . . . . 1.0 111.462 -178.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -124.58 138.96 11.47 Favored Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 110.789 -0.924 . . . . 1.0 110.789 177.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.566 HG21 HD12 ' A' ' 96' ' ' LEU . 28.3 p -71.79 -21.9 61.65 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.96 0.409 . . . . 1.0 110.977 -178.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -107.17 2.2 35.16 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 120.789 -0.72 . . . . 1.0 113.217 -177.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.481 ' HB3' ' HB2' ' A' ' 75' ' ' GLN . 3.1 p-10 44.23 35.99 1.41 Allowed 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 113.324 0.861 . . . . 1.0 113.324 178.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -43.87 -74.65 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.715 0.769 . . . . 1.0 112.453 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.449 ' HB2' HG12 ' A' ' 15' ' ' ILE . 79.0 m-70 -106.25 42.57 1.25 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.043 -0.98 . . . . 1.0 110.686 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.418 HG23 ' HA ' ' A' ' 74' ' ' ALA . 14.5 p -60.32 134.94 25.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.429 178.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.55 -13.63 60.03 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.885 -0.674 . . . . 1.0 112.303 -178.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.8 t -79.79 -162.67 0.45 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.163 0.506 . . . . 1.0 109.928 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 15.5 t -119.56 174.91 6.11 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.931 -0.766 . . . . 1.0 108.931 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.424 ' HB1' ' HB3' ' A' ' 71' ' ' HIS . . . -62.71 147.02 50.89 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.34 0.59 . . . . 1.0 111.485 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.608 ' OD2' ' HG3' ' A' ' 57' ' ' ARG . 9.8 p-10 -60.79 138.91 58.07 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.958 -1.019 . . . . 1.0 112.885 -178.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -48.6 -36.52 15.86 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 114.704 -1.134 . . . . 1.0 112.596 178.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.608 ' HG3' ' OD2' ' A' ' 55' ' ' ASP . 8.2 ptt180 -70.65 -44.23 67.54 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 122.298 0.239 . . . . 1.0 111.095 -178.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.34 -38.59 78.22 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 109.222 -0.658 . . . . 1.0 109.222 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.06 -44.9 94.38 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.604 -0.725 . . . . 1.0 109.984 178.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.411 ' O ' ' HG2' ' A' ' 63' ' ' ARG . . . -58.06 -44.1 94.83 Favored Glycine 0 N--CA 1.443 -0.882 0 CA-C-N 115.618 -0.719 . . . . 1.0 113.198 178.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.3 m -75.6 -39.24 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-N 117.326 0.563 . . . . 1.0 111.383 -178.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.591 ' HB2' HG21 ' A' ' 69' ' ' THR . 96.6 mt -61.59 -52.14 65.64 Favored 'General case' 0 C--O 1.23 0.044 0 C-N-CA 120.892 -0.323 . . . . 1.0 110.299 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.411 ' HG2' ' O ' ' A' ' 60' ' ' GLY . 6.8 ptm180 -59.63 -30.79 68.96 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.723 -0.671 . . . . 1.0 110.947 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.6 -33.23 74.58 Favored 'General case' 0 C--O 1.226 -0.141 0 CA-C-N 116.354 -0.385 . . . . 1.0 111.297 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.462 ' HB2' ' HD2' ' A' ' 67' ' ' TYR . 98.5 m-70 -96.33 2.51 52.84 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.341 -0.39 . . . . 1.0 111.237 -178.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 90.18 14.34 59.1 Favored Glycine 0 C--N 1.329 0.145 0 CA-C-N 116.005 -0.543 . . . . 1.0 112.536 177.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.462 ' HD2' ' HB2' ' A' ' 65' ' ' HIS . 69.0 m-85 -91.39 149.56 39.78 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-O 120.551 0.215 . . . . 1.0 110.855 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -69.05 153.71 71.76 Favored 'Trans proline' 0 CA--C 1.509 -0.742 0 C-N-CA 122.325 2.017 . . . . 1.0 110.666 177.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.591 HG21 ' HB2' ' A' ' 62' ' ' LEU . 42.3 p -124.74 15.68 8.71 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 121.552 0.691 . . . . 1.0 110.442 -177.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -84.2 120.11 25.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.056 -0.975 . . . . 1.0 110.154 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.955 ' HB2' ' HE3' ' A' ' 23' ' ' LYS . 32.3 t60 -159.11 147.72 18.17 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.761 -0.654 . . . . 1.0 110.587 -177.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.7 tpp180 -125.71 112.57 16.25 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 107.697 -1.223 . . . . 1.0 107.697 175.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.987 ' HB1' HD21 ' A' ' 14' ' ' ASN . . . -59.95 140.17 56.91 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.543 -0.753 . . . . 1.0 111.956 -176.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.455 ' O ' ' HA ' ' A' ' 43' ' ' ALA . . . -135.96 160.6 38.11 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.646 178.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.481 ' HB2' ' HB3' ' A' ' 47' ' ' ASN . 43.5 tt0 -98.68 155.82 17.14 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.767 -0.457 . . . . 1.0 109.767 178.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.466 HG11 HD23 ' A' ' 97' ' ' LEU . 36.5 t -66.48 111.32 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.365 0.603 . . . . 1.0 110.731 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.453 ' H ' ' HD1' ' A' ' 80' ' ' HIS . . . -123.86 -168.3 12.93 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.049 -0.978 . . . . 1.0 111.034 -179.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 80.6 m -55.73 -46.96 77.67 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.711 0.291 . . . . 1.0 111.377 -179.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -60.13 -29.57 68.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.407 -0.36 . . . . 1.0 111.553 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.453 ' HD1' ' H ' ' A' ' 77' ' ' GLY . 77.1 m80 -78.1 -39.26 42.0 Favored 'General case' 0 C--O 1.222 -0.357 0 N-CA-C 109.858 -0.423 . . . . 1.0 109.858 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.672 ' O ' HG23 ' A' ' 102' ' ' VAL . 15.6 mt -70.36 -18.18 63.06 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.308 -0.405 . . . . 1.0 110.451 176.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -88.43 -7.73 56.12 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 120.77 0.319 . . . . 1.0 110.232 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.579 ' HA ' ' HB3' ' A' ' 6' ' ' HIS . . . -59.65 148.01 35.36 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.81 -0.632 . . . . 1.0 109.888 178.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.529 ' HB3' HD12 ' A' ' 5' ' ' LEU . 28.5 t70 -74.44 -16.1 60.88 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.218 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.662 HD13 HG11 ' A' ' 7' ' ' VAL . 0.6 OUTLIER -153.17 116.47 4.64 Favored 'General case' 0 CA--C 1.51 -0.596 0 N-CA-C 109.336 -0.616 . . . . 1.0 109.336 -176.836 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.692 ' HB3' HD11 ' A' ' 97' ' ' LEU . 5.0 mp -106.89 105.52 15.59 Favored 'General case' 0 N--CA 1.426 -1.654 0 CA-C-N 115.489 -0.778 . . . . 1.0 109.782 178.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.612 HG12 HD22 ' A' ' 110' ' ' LEU . 86.6 t -84.63 93.39 3.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 114.554 -1.203 . . . . 1.0 111.263 -175.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.17 145.34 31.06 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.594 -0.73 . . . . 1.0 111.249 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.408 HD22 ' HB2' ' A' ' 11' ' ' CYS . 4.2 mm? -96.53 -11.53 25.32 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.821 -0.627 . . . . 1.0 109.774 178.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.464 ' CG ' ' H ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -148.78 153.62 38.41 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.631 -0.713 . . . . 1.0 110.747 179.859 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -57.96 -26.19 61.97 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.274 -0.876 . . . . 1.0 112.935 -178.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.62 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 82.8 m-20 -77.41 -47.34 20.03 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 110.125 -0.324 . . . . 1.0 110.125 -178.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.647 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 20.6 m170 -53.87 -47.64 70.84 Favored 'General case' 0 CA--C 1.522 -0.106 0 CA-C-N 115.981 -0.554 . . . . 1.0 109.666 177.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.95 -44.42 91.44 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.909 -0.587 . . . . 1.0 110.61 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.652 ' O ' ' HG2' ' A' ' 99' ' ' GLN . 9.8 ttp180 -56.54 -46.13 80.81 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.603 -0.726 . . . . 1.0 111.129 178.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.62 ' HG ' ' O ' ' A' ' 92' ' ' ASN . 42.7 mt -63.39 -47.87 80.22 Favored 'General case' 0 C--O 1.216 -0.696 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.547 -175.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.692 HD11 ' HB3' ' A' ' 86' ' ' LEU . 29.5 mt -53.03 -58.8 5.76 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.784 -0.644 . . . . 1.0 111.413 -177.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.673 ' CA ' HG12 ' A' ' 102' ' ' VAL . 2.2 ptm180 -59.33 -45.25 91.85 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.844 0.683 . . . . 1.0 112.844 -179.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.652 ' HG2' ' O ' ' A' ' 95' ' ' ARG . 7.5 pt20 -68.24 -23.6 64.81 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.165 -0.614 . . . . 1.0 110.49 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.618 HD12 ' O ' ' A' ' 96' ' ' LEU . 6.7 mp -78.98 -17.5 55.29 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 116.267 -0.424 . . . . 1.0 111.817 178.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 152.66 -23.44 0.83 Allowed Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 119.579 -1.296 . . . . 1.0 113.749 -178.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.673 HG12 ' CA ' ' A' ' 98' ' ' ARG . 0.4 OUTLIER -78.45 -163.89 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-N 117.77 0.785 . . . . 1.0 110.166 179.801 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.663 ' N ' HG11 ' A' ' 102' ' ' VAL . 13.1 pt-20 -156.38 165.22 36.99 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 107.736 -1.209 . . . . 1.0 107.736 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.763 ' HA ' HG11 ' A' ' 107' ' ' VAL . . . -61.37 -27.11 68.29 Favored 'General case' 0 C--N 1.316 -0.881 0 O-C-N 123.466 0.479 . . . . 1.0 111.278 -175.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.423 ' HA ' ' NH2' ' A' ' 108' ' ' ARG . . . -58.22 -34.07 70.0 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 120.713 0.292 . . . . 1.0 110.578 177.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.425 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 3.9 mtp180 -97.59 -42.84 7.48 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.955 -0.566 . . . . 1.0 111.343 -178.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.763 HG11 ' HA ' ' A' ' 104' ' ' ALA . 12.6 p -77.88 119.08 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-O 120.95 0.405 . . . . 1.0 110.032 -174.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.521 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 26.8 mmt180 -137.96 149.82 46.48 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 121.695 -0.628 . . . . 1.0 110.583 -178.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.629 ' HB2' ' HB2' ' A' ' 112' ' ' SER . 80.9 mmm -79.06 138.19 37.87 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.015 -0.539 . . . . 1.0 110.214 178.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.612 HD22 HG12 ' A' ' 87' ' ' VAL . 2.9 tm? -57.29 -48.8 78.0 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.037 0.446 . . . . 1.0 111.036 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 6.5 ttt-85 -69.68 -14.61 62.89 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.637 -0.71 . . . . 1.0 110.07 -178.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.629 ' HB2' ' HB2' ' A' ' 109' ' ' MET . 43.9 t -79.12 -8.97 59.41 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.921 -0.581 . . . . 1.0 111.289 -178.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.561 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 91.4 m-85 -91.36 -19.04 23.35 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 120.812 0.339 . . . . 1.0 110.266 176.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 15.8 t0 . . . . . 0 C--N 1.325 -0.491 0 CA-C-N 115.854 -0.612 . . . . 1.0 111.143 -177.456 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 . . . . . 0 N--CA 1.454 -0.261 0 CA-C-O 120.791 0.329 . . . . 1.0 110.864 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.4 ' O ' ' HB2' ' A' ' 140' ' ' ALA . 4.3 tp10 -62.79 -47.5 83.2 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.961 -0.755 . . . . 1.0 108.961 175.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.984 ' HA ' HG22 ' A' ' 141' ' ' VAL . 55.3 t -61.93 -39.91 85.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 114.662 -1.153 . . . . 1.0 109.815 176.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -53.11 -43.45 66.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.965 -1.016 . . . . 1.0 108.912 175.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.648 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -65.14 -41.16 95.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.304 -0.862 . . . . 1.0 111.09 177.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.984 HG22 ' HA ' ' A' ' 138' ' ' VAL . 12.7 t -54.64 -52.55 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 121.841 0.829 . . . . 1.0 110.233 178.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.463 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 7.1 mt -65.81 -50.62 69.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 114.817 -1.083 . . . . 1.0 111.769 -179.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.648 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 11.3 pt-20 -58.91 -29.4 67.03 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 120.812 -0.355 . . . . 1.0 110.349 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 2.1 t -74.17 -27.58 60.89 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 121.114 0.483 . . . . 1.0 109.94 178.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.47 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -86.54 -24.72 25.38 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 115.882 -0.599 . . . . 1.0 111.597 178.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.72 HD21 ' HB3' ' A' ' 25' ' ' PHE . 17.9 mt -54.85 -36.84 49.25 Favored Pre-proline 0 CA--C 1.549 0.942 0 N-CA-C 112.636 0.606 . . . . 1.0 112.636 -178.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 56.2 Cg_endo -70.45 -12.28 31.33 Favored 'Trans proline' 0 C--N 1.368 1.578 0 C-N-CA 122.775 2.317 . . . . 1.0 112.022 177.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.561 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -104.13 -33.68 3.92 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 110.195 -1.162 . . . . 1.0 110.195 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.454 HD12 ' CE2' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -72.51 -39.15 67.82 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 108.267 -1.012 . . . . 1.0 108.267 178.446 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . 0.508 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 0.2 OUTLIER -54.0 -58.86 5.75 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-N 114.52 -1.218 . . . . 1.0 110.845 175.994 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -55.15 -41.78 72.23 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 114.826 -1.079 . . . . 1.0 111.012 -174.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . 0.656 ' HZ3' HD11 ' A' ' 5' ' ' LEU . 18.6 t90 -63.35 -54.94 29.06 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.325 -0.852 . . . . 1.0 110.444 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.451 HG13 ' O ' ' A' ' 149' ' ' LEU . 6.2 m -64.82 -41.25 91.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 120.842 -0.343 . . . . 1.0 110.764 -178.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.44 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 15.3 m-20 -60.03 -49.46 77.59 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 121.269 0.557 . . . . 1.0 110.613 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.456 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 5.7 pt-20 -65.31 -37.27 86.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.612 -0.722 . . . . 1.0 110.739 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.441 ' HG3' ' CH2' ' A' ' 152' ' ' TRP . 10.9 mmt180 -75.07 -39.3 60.95 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.186 -0.461 . . . . 1.0 111.565 -177.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 4.4 pp . . . . . 0 C--N 1.326 -0.43 0 N-CA-C 109.218 -0.66 . . . . 1.0 109.218 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo . . . . . 0 C--O 1.232 0.202 0 CA-C-O 121.145 0.394 . . . . 1.0 113.036 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.835 HD12 ' HZ3' ' A' ' 152' ' ' TRP . 0.2 OUTLIER -69.19 -179.36 1.55 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.659 -0.7 . . . . 1.0 109.831 177.973 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.664 ' H ' HD13 ' A' ' 5' ' ' LEU . 2.5 t-160 -158.45 89.73 0.99 Allowed 'General case' 0 C--N 1.326 -0.444 0 O-C-N 122.145 -0.347 . . . . 1.0 110.066 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.49 HG12 HD11 ' A' ' 85' ' ' LEU . 1.8 t -95.61 109.07 21.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.87 -0.419 . . . . 1.0 109.87 178.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.622 ' CG2' ' HG ' ' A' ' 86' ' ' LEU . 10.5 t -112.89 118.84 36.02 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 120.896 0.379 . . . . 1.0 110.043 177.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.575 ' HD1' ' HB ' ' A' ' 87' ' ' VAL . 1.3 m-85 -86.65 131.27 34.2 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 116.465 -0.334 . . . . 1.0 110.784 -178.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.622 HG22 HD11 ' A' ' 97' ' ' LEU . 21.3 t -115.49 109.61 28.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.852 -0.613 . . . . 1.0 110.964 -177.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.624 ' HB2' HD22 ' A' ' 89' ' ' LEU . 49.8 t -142.38 163.55 32.55 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.587 -0.523 . . . . 1.0 109.587 179.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.564 HG23 ' HE2' ' A' ' 93' ' ' HIS . 0.7 OUTLIER -75.13 100.6 4.3 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.017 0.437 . . . . 1.0 110.89 -179.054 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.836 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 125.0 -44.78 1.22 Allowed Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.935 -0.65 . . . . 1.0 111.831 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 65.7 11.82 7.83 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.278 0.631 . . . . 1.0 111.348 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.422 ' HA ' ' HG3' ' A' ' 19' ' ' PRO . 10.0 pt -120.57 8.74 6.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 O-C-N 121.736 -0.603 . . . . 1.0 111.738 -177.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.544 ' O ' ' HG3' ' A' ' 20' ' ' MET . 6.8 p -126.1 -86.56 0.61 Allowed 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.034 0.383 . . . . 1.0 112.034 -178.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.657 ' HD3' HG12 ' A' ' 138' ' ' VAL . 16.6 tpp180 -66.31 -48.53 70.04 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.981 0.42 . . . . 1.0 111.554 -176.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.614 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 14.2 m -56.55 -57.06 25.86 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 115.667 -0.697 . . . . 1.0 112.8 -178.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.687 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 39.0 Cg_endo -64.26 -27.54 64.0 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 121.806 1.67 . . . . 1.0 112.355 -177.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.619 ' HA ' HD23 ' A' ' 62' ' ' LEU . 66.1 mtp -62.43 -53.53 53.5 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.316 -0.554 . . . . 1.0 110.55 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.456 ' HA ' ' HB2' ' A' ' 24' ' ' MET . . . -70.59 -30.44 67.12 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.588 -0.445 . . . . 1.0 110.526 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.515 ' O ' ' HB1' ' A' ' 26' ' ' ALA . 14.7 tt0 -52.15 -51.79 55.79 Favored 'General case' 0 C--O 1.214 -0.777 0 CA-C-N 115.49 -0.777 . . . . 1.0 109.623 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.902 ' HE3' ' HB2' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -88.49 -21.28 24.25 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 119.674 -0.81 . . . . 1.0 111.228 -176.702 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.53 ' HE3' HD11 ' A' ' 146' ' ' LEU . 83.1 mtp -65.8 -74.47 0.11 Allowed 'General case' 0 C--O 1.237 0.418 0 N-CA-C 112.37 0.508 . . . . 1.0 112.37 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.702 ' HB3' HD23 ' A' ' 146' ' ' LEU . 17.0 p90 -76.17 -30.52 58.13 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 119.707 -0.797 . . . . 1.0 111.481 -175.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.515 ' HB1' ' O ' ' A' ' 22' ' ' GLU . . . -65.11 -35.8 82.26 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 119.17 -1.012 . . . . 1.0 110.893 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.716 ' HA ' ' HD3' ' A' ' 30' ' ' ARG . 0.1 OUTLIER -63.07 -39.34 94.42 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 108.454 -0.943 . . . . 1.0 108.454 177.21 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.616 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 78.9 mt-30 -58.68 -45.81 88.62 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.647 -0.706 . . . . 1.0 109.879 175.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 25' ' ' PHE . 96.7 mt -55.42 -58.85 6.02 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.502 -0.772 . . . . 1.0 110.978 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.716 ' HD3' ' HA ' ' A' ' 27' ' ' GLN . 0.4 OUTLIER -59.24 -36.24 75.11 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.49 -0.484 . . . . 1.0 111.258 179.125 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -63.35 -26.12 68.61 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.581 0.586 . . . . 1.0 112.581 177.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.63 ' HG3' ' HG ' ' A' ' 34' ' ' LEU . 8.3 ptp180 -95.54 -16.9 21.85 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 119.568 -0.853 . . . . 1.0 109.805 177.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 105.56 23.36 7.59 Favored Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 114.99 -1.004 . . . . 1.0 112.053 176.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.63 ' HG ' ' HG3' ' A' ' 32' ' ' ARG . 24.5 mt -111.69 1.5 16.75 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.172 -0.307 . . . . 1.0 110.172 -177.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -54.55 -26.03 37.07 Favored Glycine 0 CA--C 1.522 0.472 0 C-N-CA 121.115 -0.564 . . . . 1.0 113.2 -178.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.598 ' HA ' ' NH1' ' A' ' 39' ' ' ARG . 0.5 OUTLIER -95.98 -22.83 17.15 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 109.467 -0.568 . . . . 1.0 109.467 177.533 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -76.97 -23.28 52.33 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.903 -1.044 . . . . 1.0 111.002 -175.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.819 HG23 ' HB3' ' A' ' 5' ' ' LEU . 0.2 OUTLIER -143.38 122.59 8.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.733 -0.667 . . . . 1.0 109.334 177.911 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.598 ' NH1' ' HA ' ' A' ' 36' ' ' ASP . 30.2 mmt180 -87.18 143.33 27.34 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 109.201 -0.666 . . . . 1.0 109.201 -178.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.432 HG13 ' HB2' ' A' ' 26' ' ' ALA . 54.2 t -131.82 131.53 61.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 109.497 -0.557 . . . . 1.0 109.497 -178.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.501 ' O ' ' HA ' ' A' ' 8' ' ' THR . 43.2 p -145.95 -175.74 4.87 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.344 -0.844 . . . . 1.0 109.972 -174.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.614 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 90.6 p -161.7 166.04 27.24 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.799 -0.36 . . . . 1.0 110.52 178.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.613 ' HB2' ' CD2' ' A' ' 80' ' ' HIS . . . -165.52 169.0 15.97 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.398 0.618 . . . . 1.0 111.543 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -127.24 132.3 7.51 Favored Glycine 0 N--CA 1.44 -1.09 0 CA-C-N 114.924 -1.034 . . . . 1.0 110.937 177.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.566 HG21 HD11 ' A' ' 96' ' ' LEU . 17.8 p -67.75 -26.86 66.34 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.912 0.386 . . . . 1.0 111.707 -177.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -107.25 9.47 39.02 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.847 -0.692 . . . . 1.0 113.207 -177.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 43.5 38.17 1.73 Allowed 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 113.719 1.007 . . . . 1.0 113.719 176.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.836 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 1.1 m-90 -47.07 -74.21 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.514 0.674 . . . . 1.0 112.438 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.531 ' O ' ' HB1' ' A' ' 73' ' ' ALA . 3.8 m-70 -105.54 39.84 1.67 Allowed 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.184 -0.916 . . . . 1.0 111.16 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.8 p -60.17 127.19 19.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 120.377 -0.529 . . . . 1.0 110.068 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.602 ' HA2' ' NE ' ' A' ' 72' ' ' ARG . . . 93.47 -14.28 65.64 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.913 -0.661 . . . . 1.0 111.961 -177.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.514 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 3.1 t -81.4 -158.18 0.21 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.232 0.539 . . . . 1.0 110.034 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 18.7 t -133.28 175.29 9.53 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 115.676 -0.693 . . . . 1.0 109.153 -178.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.96 141.93 43.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.25 0.548 . . . . 1.0 111.85 -178.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.455 ' CG ' ' HG3' ' A' ' 57' ' ' ARG . 56.6 t0 -56.06 129.82 41.47 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.019 -0.991 . . . . 1.0 110.06 178.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -51.51 -29.69 17.58 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.103 0.779 . . . . 1.0 113.103 -179.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.59 ' O ' HG23 ' A' ' 61' ' ' VAL . 0.2 OUTLIER -74.03 -41.89 61.13 Favored 'General case' 0 N--CA 1.461 0.122 0 C-N-CA 120.261 -0.576 . . . . 1.0 110.412 178.602 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.43 -32.41 70.0 Favored 'General case' 0 N--CA 1.46 0.07 0 CA-C-O 120.918 0.39 . . . . 1.0 110.051 178.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.37 -42.42 98.68 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.762 -0.653 . . . . 1.0 110.025 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.43 ' O ' ' HG2' ' A' ' 63' ' ' ARG . . . -64.27 -40.4 97.89 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.563 -0.827 . . . . 1.0 111.217 178.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.59 HG23 ' O ' ' A' ' 57' ' ' ARG . 59.0 t -57.38 -57.47 9.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.091 0.472 . . . . 1.0 110.762 177.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.619 HD23 ' HA ' ' A' ' 20' ' ' MET . 5.7 mp -59.28 -52.28 66.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.972 -0.558 . . . . 1.0 111.109 -178.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 60' ' ' GLY . 5.9 ptm180 -60.08 -26.91 66.55 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.729 -0.669 . . . . 1.0 111.338 -178.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.54 -36.54 73.74 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.124 0.488 . . . . 1.0 110.379 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -93.15 3.82 55.04 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.577 -0.738 . . . . 1.0 111.019 -178.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.35 13.69 63.19 Favored Glycine 0 C--N 1.329 0.178 0 CA-C-N 115.735 -0.666 . . . . 1.0 112.593 176.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.466 ' CD1' ' HA ' ' A' ' 24' ' ' MET . 60.5 m-85 -90.03 147.48 37.3 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 110.258 -0.275 . . . . 1.0 110.258 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.469 ' HG2' ' CB ' ' A' ' 23' ' ' LYS . 56.8 Cg_endo -69.44 159.87 51.99 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.45 2.1 . . . . 1.0 110.572 177.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.0 p -130.38 12.69 5.5 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.541 0.686 . . . . 1.0 109.928 -178.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -70.94 114.35 8.91 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 114.725 -1.125 . . . . 1.0 109.994 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.902 ' HB2' ' HE3' ' A' ' 23' ' ' LYS . 62.5 t60 -160.48 149.83 17.35 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.928 0.394 . . . . 1.0 111.202 -176.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.602 ' NE ' ' HA2' ' A' ' 51' ' ' GLY . 1.4 tmt_? -135.61 112.36 10.13 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.684 -1.228 . . . . 1.0 107.684 175.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.531 ' HB1' ' O ' ' A' ' 49' ' ' HIS . . . -59.71 138.98 57.6 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.895 -1.048 . . . . 1.0 112.724 -174.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -130.06 160.62 33.17 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.249 -0.887 . . . . 1.0 110.354 178.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -97.31 155.16 17.0 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.43 -0.952 . . . . 1.0 108.43 178.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.48 HG11 HD21 ' A' ' 97' ' ' LEU . 19.1 t -68.42 112.59 3.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 120.938 0.399 . . . . 1.0 110.607 -178.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.437 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -122.97 -170.23 13.46 Favored Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 115.373 -0.831 . . . . 1.0 111.5 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 98.2 m -56.45 -44.15 80.22 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 122.388 0.275 . . . . 1.0 111.214 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -59.23 -29.71 67.73 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.972 0.415 . . . . 1.0 111.227 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.613 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 80.1 m80 -78.21 -41.66 33.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.161 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.723 ' HA ' HD21 ' A' ' 86' ' ' LEU . 15.6 mt -68.39 -17.41 64.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.255 0.55 . . . . 1.0 110.669 177.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.61 -4.5 59.18 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 116.167 -0.47 . . . . 1.0 110.539 -178.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.553 ' HB2' ' O ' ' A' ' 6' ' ' HIS . . . -63.41 160.0 17.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.99 -0.55 . . . . 1.0 111.049 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.744 ' HB3' HD13 ' A' ' 5' ' ' LEU . 15.5 t70 -85.29 -13.16 50.56 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.517 -0.549 . . . . 1.0 109.517 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.733 HD12 ' CE3' ' A' ' 152' ' ' TRP . 1.1 tt -157.73 112.2 2.63 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.746 -0.661 . . . . 1.0 109.6 -177.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.723 HD21 ' HA ' ' A' ' 81' ' ' LEU . 5.6 mp -103.84 89.18 3.23 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-N 115.396 -0.82 . . . . 1.0 110.832 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.629 HG21 HD23 ' A' ' 85' ' ' LEU . 54.0 t -66.22 91.34 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 113.816 -1.538 . . . . 1.0 112.05 -179.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.06 147.74 31.34 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.245 -1.343 . . . . 1.0 109.693 177.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.624 HD22 ' HB2' ' A' ' 11' ' ' CYS . 3.7 mm? -100.86 -10.86 20.3 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.308 0.575 . . . . 1.0 109.618 177.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -141.56 151.52 43.28 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.214 -0.903 . . . . 1.0 110.087 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -65.07 -17.35 64.38 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 123.477 0.485 . . . . 1.0 110.089 176.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.633 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 5.3 m-20 -77.83 -50.04 13.09 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.668 -0.697 . . . . 1.0 109.817 178.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.671 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 16.3 m170 -59.26 -42.95 92.39 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.561 -0.533 . . . . 1.0 109.561 178.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.68 -44.48 93.6 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.559 178.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.601 ' O ' ' HG2' ' A' ' 99' ' ' GLN . 0.5 OUTLIER -56.66 -45.26 81.77 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 115.818 -0.628 . . . . 1.0 111.015 178.356 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.683 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 50.9 mt -64.39 -48.3 75.97 Favored 'General case' 0 C--O 1.216 -0.68 0 CA-C-N 115.944 -0.571 . . . . 1.0 110.425 -175.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.671 ' HG ' ' O ' ' A' ' 93' ' ' HIS . 33.2 mt -53.0 -60.16 3.63 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.898 -0.592 . . . . 1.0 111.474 -178.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.706 ' N ' HG12 ' A' ' 102' ' ' VAL . 1.2 ptm180 -59.26 -45.16 91.96 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.843 -0.617 . . . . 1.0 112.381 -179.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.601 ' HG2' ' O ' ' A' ' 95' ' ' ARG . 6.2 pt20 -66.74 -24.69 66.25 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 119.956 -0.698 . . . . 1.0 110.194 178.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.683 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 10.1 mt -80.7 -18.84 46.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.031 -0.531 . . . . 1.0 111.592 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 151.99 -21.27 0.88 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 119.748 -1.215 . . . . 1.0 114.44 -178.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.706 HG12 ' N ' ' A' ' 98' ' ' ARG . 0.3 OUTLIER -76.82 -162.36 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 118.113 0.956 . . . . 1.0 110.662 -179.492 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.764 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 12.3 pt-20 -157.3 160.32 38.43 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 107.703 -1.221 . . . . 1.0 107.703 -179.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.77 ' HA ' HG11 ' A' ' 107' ' ' VAL . . . -61.04 -26.13 67.41 Favored 'General case' 0 C--N 1.322 -0.601 0 O-C-N 123.366 0.416 . . . . 1.0 111.32 -175.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.43 ' HB2' ' HG3' ' A' ' 103' ' ' GLU . . . -57.06 -36.42 70.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.15 0.5 . . . . 1.0 110.533 175.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.764 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 7.9 mtt-85 -98.46 -42.37 7.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.237 -0.892 . . . . 1.0 111.194 -177.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.77 HG11 ' HA ' ' A' ' 104' ' ' ALA . 14.6 p -77.96 115.44 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 120.614 -0.435 . . . . 1.0 110.085 -175.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.612 ' HD2' ' O ' ' A' ' 107' ' ' VAL . 26.9 mmm180 -136.13 148.71 48.35 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 121.68 -0.637 . . . . 1.0 110.7 -178.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.423 ' HE1' ' C ' ' A' ' 89' ' ' LEU . 83.2 mmm -78.92 137.52 37.67 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.615 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.62 HD22 HG12 ' A' ' 87' ' ' VAL . 2.8 tm? -56.02 -52.68 63.36 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 122.455 0.302 . . . . 1.0 111.532 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 25.6 ttt85 -71.22 -16.83 62.52 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.586 -0.445 . . . . 1.0 111.222 -176.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 41.7 t -73.56 -7.63 52.68 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 120.585 -0.446 . . . . 1.0 110.703 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.636 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 83.3 m-85 -87.31 -21.74 25.55 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-O 120.664 0.269 . . . . 1.0 110.765 176.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 16.8 t0 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 115.948 -0.569 . . . . 1.0 111.433 -177.647 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 . . . . . 0 N--CA 1.452 -0.348 0 CA-C-O 120.699 0.285 . . . . 1.0 111.277 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.547 ' O ' HG22 ' A' ' 141' ' ' VAL . 11.1 tp10 -64.34 -48.3 76.08 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 108.073 -1.084 . . . . 1.0 108.073 174.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.657 HG12 ' HD3' ' A' ' 17' ' ' ARG . 57.4 t -56.52 -47.41 81.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 114.482 -1.235 . . . . 1.0 109.766 175.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.476 ' HB2' HG13 ' A' ' 61' ' ' VAL . 69.8 t80 -56.4 -44.12 79.98 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 113.858 -1.519 . . . . 1.0 110.147 178.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.687 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -63.42 -44.97 93.09 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.208 -0.451 . . . . 1.0 111.761 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.547 HG22 ' O ' ' A' ' 137' ' ' GLU . 36.3 t -55.43 -46.59 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.706 0.765 . . . . 1.0 110.005 178.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.448 HD13 ' O ' ' A' ' 138' ' ' VAL . 7.0 mt -69.51 -51.13 44.88 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 115.04 -0.982 . . . . 1.0 111.785 -178.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.687 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 6.2 pt-20 -56.14 -33.88 65.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.537 0.208 . . . . 1.0 110.665 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.8 t -73.33 -27.98 61.81 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.238 0.542 . . . . 1.0 110.124 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.474 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -86.69 -23.99 25.39 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-N 115.869 -0.605 . . . . 1.0 111.823 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.702 HD23 ' HB3' ' A' ' 25' ' ' PHE . 11.9 mt -55.16 -37.89 61.65 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 112.654 0.613 . . . . 1.0 112.654 -178.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 61.5 Cg_endo -70.65 -13.2 32.23 Favored 'Trans proline' 0 C--N 1.359 1.116 0 C-N-CA 122.649 2.232 . . . . 1.0 111.939 177.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.636 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -102.72 -32.35 4.81 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 110.099 -1.2 . . . . 1.0 110.099 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.508 ' O ' HG12 ' A' ' 153' ' ' VAL . 0.4 OUTLIER -73.73 -40.69 63.35 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.396 -0.964 . . . . 1.0 108.396 177.604 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . 0.453 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -55.53 -54.7 40.76 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 114.81 -1.086 . . . . 1.0 110.135 175.667 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -58.94 -42.52 89.96 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.333 -0.849 . . . . 1.0 110.961 -175.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . 0.835 ' HZ3' HD12 ' A' ' 5' ' ' LEU . 23.6 t90 -63.02 -55.28 26.99 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.46 -0.791 . . . . 1.0 110.465 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.508 HG12 ' O ' ' A' ' 149' ' ' LEU . 10.7 m -62.7 -40.69 89.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.816 -0.354 . . . . 1.0 110.587 -177.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.484 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 4.1 m-20 -60.79 -50.93 71.46 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-O 120.838 0.351 . . . . 1.0 110.727 178.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.472 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 6.8 pt-20 -64.11 -36.86 85.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.861 -178.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.469 ' HG3' ' CH2' ' A' ' 152' ' ' TRP . 10.4 mmt180 -73.56 -42.61 61.42 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 116.185 -0.461 . . . . 1.0 111.394 -178.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 4.3 pp . . . . . 0 C--O 1.236 0.356 0 N-CA-C 109.27 -0.641 . . . . 1.0 109.27 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.866 ' HG3' ' HE ' ' A' ' 39' ' ' ARG . 60.0 Cg_endo . . . . . 0 C--O 1.236 0.402 0 N-CA-C 114.298 0.846 . . . . 1.0 114.298 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.852 ' HB3' HG22 ' A' ' 38' ' ' VAL . 0.8 OUTLIER -74.8 -173.31 1.82 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.05 -0.977 . . . . 1.0 110.836 178.146 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.472 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 0.2 OUTLIER -159.15 94.59 1.21 Allowed 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 121.087 -0.245 . . . . 1.0 111.448 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.743 HG13 HD11 ' A' ' 85' ' ' LEU . 2.2 t -95.94 113.48 30.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 108.893 -0.781 . . . . 1.0 108.893 175.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.612 ' CG2' ' HG ' ' A' ' 86' ' ' LEU . 14.5 t -114.15 115.26 27.22 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 120.992 0.425 . . . . 1.0 110.108 178.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.546 ' HD1' ' HB ' ' A' ' 87' ' ' VAL . 2.0 m-85 -81.81 146.77 29.72 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 109.56 -0.533 . . . . 1.0 109.56 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.632 HG21 HD12 ' A' ' 97' ' ' LEU . 42.5 t -130.42 114.0 27.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 121.059 0.457 . . . . 1.0 111.63 -177.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.609 ' SG ' ' HD2' ' A' ' 17' ' ' ARG . 47.9 t -143.93 161.25 39.19 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.821 -0.807 . . . . 1.0 108.821 177.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.88 97.07 3.23 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.269 0.556 . . . . 1.0 111.182 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.668 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 130.96 -44.74 1.18 Allowed Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.457 -0.792 . . . . 1.0 111.249 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.598 ' ND2' ' H ' ' A' ' 74' ' ' ALA . 58.6 t30 59.8 29.16 18.73 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.829 0.824 . . . . 1.0 111.179 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.3 pt -130.91 10.67 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.963 -0.562 . . . . 1.0 111.675 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.662 ' O ' ' HG3' ' A' ' 20' ' ' MET . 12.3 m -125.54 -89.64 0.57 Allowed 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.089 -0.644 . . . . 1.0 111.609 -178.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.609 ' HD2' ' SG ' ' A' ' 11' ' ' CYS . 1.9 ptp85 -74.27 -35.85 63.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.065 -0.516 . . . . 1.0 112.364 -176.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.513 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 16.5 m -58.99 -58.83 16.58 Favored Pre-proline 0 CA--C 1.541 0.602 0 C-N-CA 121.26 -0.176 . . . . 1.0 111.105 179.026 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.733 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 36.6 Cg_endo -61.93 -26.66 79.11 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.051 1.834 . . . . 1.0 111.937 178.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.662 ' HG3' ' O ' ' A' ' 16' ' ' CYS . 63.8 mtp -62.43 -54.57 38.22 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.847 -0.341 . . . . 1.0 111.106 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.405 ' HA ' ' HB2' ' A' ' 24' ' ' MET . . . -70.1 -28.5 65.45 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 120.452 -0.499 . . . . 1.0 109.666 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.605 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 7.4 tt0 -54.32 -51.9 63.24 Favored 'General case' 0 C--O 1.216 -0.672 0 CA-C-N 115.029 -0.987 . . . . 1.0 109.236 178.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.747 ' HB3' ' HG2' ' A' ' 68' ' ' PRO . 0.0 OUTLIER -80.36 -29.9 37.95 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.758 -0.655 . . . . 1.0 110.212 -176.846 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.554 ' HB3' HD12 ' A' ' 146' ' ' LEU . 3.1 mmm -63.33 -76.12 0.07 Allowed 'General case' 0 C--O 1.238 0.458 0 N-CA-C 113.058 0.762 . . . . 1.0 113.058 -176.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.66 ' HB3' HD23 ' A' ' 146' ' ' LEU . 22.6 p90 -76.76 -29.72 56.22 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 119.859 -0.736 . . . . 1.0 111.268 -174.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.605 ' HB3' ' O ' ' A' ' 22' ' ' GLU . . . -65.25 -37.82 88.43 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 119.036 -1.066 . . . . 1.0 111.134 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.646 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -63.2 -40.04 96.34 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.56 -0.904 . . . . 1.0 108.56 177.854 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.584 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 79.1 mt-30 -57.49 -47.71 81.19 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 115.608 -0.724 . . . . 1.0 110.082 176.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.517 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 93.3 mt -53.09 -59.55 4.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.69 -0.686 . . . . 1.0 111.06 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.591 ' HD3' ' HA ' ' A' ' 27' ' ' GLN . 0.1 OUTLIER -59.5 -37.25 77.81 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.484 -0.486 . . . . 1.0 111.275 178.955 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -63.9 -21.32 66.41 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.873 0.694 . . . . 1.0 112.873 178.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.517 ' HG2' ' O ' ' A' ' 29' ' ' LEU . 7.6 ptp180 -99.29 -21.54 16.01 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 119.677 -0.809 . . . . 1.0 110.037 176.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 107.34 42.35 1.51 Allowed Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 115.202 -0.908 . . . . 1.0 111.99 178.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.42 HD12 ' HG3' ' A' ' 32' ' ' ARG . 23.8 mt -135.83 -5.11 2.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.704 0.288 . . . . 1.0 110.372 -178.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.72 -25.19 58.4 Favored Glycine 0 C--N 1.329 0.168 0 C-N-CA 121.361 -0.447 . . . . 1.0 112.619 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.434 ' O ' ' HB3' ' A' ' 4' ' ' PRO . 49.3 m-20 -85.01 -28.92 25.4 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.28 0.562 . . . . 1.0 109.885 177.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.58 -18.56 51.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.09 -0.959 . . . . 1.0 112.015 -177.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.852 HG22 ' HB3' ' A' ' 5' ' ' LEU . 0.8 OUTLIER -144.85 122.85 5.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.255 0.55 . . . . 1.0 110.137 179.133 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.866 ' HE ' ' HG3' ' A' ' 4' ' ' PRO . 9.9 mmt180 -89.16 145.45 25.42 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.802 -0.636 . . . . 1.0 110.071 -178.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 77.5 t -132.55 118.88 36.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.439 0.638 . . . . 1.0 109.869 -178.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' A' ' 8' ' ' THR . 36.7 p -132.87 -174.42 3.47 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 114.279 -1.328 . . . . 1.0 111.365 -175.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.513 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 63.9 p -159.63 161.22 34.99 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.509 -178.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.647 ' HB1' ' CD2' ' A' ' 80' ' ' HIS . . . -162.38 163.09 27.99 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.294 0.569 . . . . 1.0 111.627 -178.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -123.73 131.77 8.17 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 110.863 -0.895 . . . . 1.0 110.863 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.582 HG23 ' CG1' ' A' ' 10' ' ' VAL . 18.0 p -67.72 -26.92 66.39 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.036 0.384 . . . . 1.0 112.036 -177.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -107.26 9.07 38.75 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.73 -0.748 . . . . 1.0 112.904 -177.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 41.02 41.93 1.41 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.834 0.854 . . . . 1.0 113.288 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.668 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 0.9 OUTLIER -50.34 -77.64 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.154 0.502 . . . . 1.0 112.013 179.009 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.416 ' O ' ' HB2' ' A' ' 73' ' ' ALA . 15.8 m-70 -101.97 41.12 1.24 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.907 -0.588 . . . . 1.0 110.919 -179.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.2 p -61.56 127.43 21.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.13 0.491 . . . . 1.0 110.105 178.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.766 ' HA2' ' HD3' ' A' ' 72' ' ' ARG . . . 97.02 -15.43 62.56 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.679 -0.691 . . . . 1.0 112.107 -177.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.0 t -80.27 -159.02 0.2 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.367 0.603 . . . . 1.0 109.926 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 31.7 t -132.91 173.08 11.77 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.359 -0.837 . . . . 1.0 109.01 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.91 139.95 32.23 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.982 0.42 . . . . 1.0 111.3 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.629 ' OD1' ' HG2' ' A' ' 57' ' ' ARG . 11.7 t70 -60.9 139.14 58.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.425 -0.807 . . . . 1.0 110.374 -178.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -48.21 -33.95 9.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.409 -0.814 . . . . 1.0 112.861 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.629 ' HG2' ' OD1' ' A' ' 55' ' ' ASP . 18.8 ptp180 -70.96 -46.07 63.03 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 122.26 -0.275 . . . . 1.0 110.589 -177.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.47 -32.84 68.75 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 116.086 -0.506 . . . . 1.0 109.743 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.99 -46.88 88.96 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.191 -0.67 . . . . 1.0 109.191 176.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.455 ' HA2' ' HD3' ' A' ' 63' ' ' ARG . . . -61.05 -39.69 97.44 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.818 -0.706 . . . . 1.0 111.574 177.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.565 HG22 ' O ' ' A' ' 57' ' ' ARG . 93.3 t -60.55 -60.31 2.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.803 0.335 . . . . 1.0 111.214 177.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.753 ' HB2' HG22 ' A' ' 69' ' ' THR . 81.8 mt -58.17 -51.79 68.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.211 -0.45 . . . . 1.0 111.526 -176.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.455 ' HD3' ' HA2' ' A' ' 60' ' ' GLY . 6.9 ptm180 -59.17 -29.15 67.25 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.315 -0.402 . . . . 1.0 111.191 -179.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.57 -30.63 61.79 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.343 0.592 . . . . 1.0 110.904 -179.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -95.06 3.97 54.25 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.854 -0.612 . . . . 1.0 110.668 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.09 10.61 60.94 Favored Glycine 0 C--N 1.331 0.264 0 CA-C-N 115.694 -0.685 . . . . 1.0 113.312 175.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.406 ' CD1' ' HA ' ' A' ' 24' ' ' MET . 66.5 m-85 -92.08 152.33 42.63 Favored Pre-proline 0 C--N 1.316 -0.871 0 CA-C-O 120.61 0.243 . . . . 1.0 111.543 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.747 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 33.0 Cg_endo -68.07 156.94 63.92 Favored 'Trans proline' 0 CA--C 1.514 -0.496 0 C-N-CA 122.515 2.144 . . . . 1.0 110.737 175.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.753 HG22 ' HB2' ' A' ' 62' ' ' LEU . 63.3 p -132.55 7.89 4.19 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 120.102 -0.639 . . . . 1.0 112.485 -176.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -90.5 133.09 35.29 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.008 0.432 . . . . 1.0 110.851 -178.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.434 ' HB2' ' HE3' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -173.03 150.71 2.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.41 -0.814 . . . . 1.0 109.207 -176.749 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.766 ' HD3' ' HA2' ' A' ' 51' ' ' GLY . 4.1 tmm_? -120.79 115.33 23.07 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.169 -1.049 . . . . 1.0 108.169 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.416 ' HB2' ' O ' ' A' ' 49' ' ' HIS . . . -58.03 137.08 57.16 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.462 0.648 . . . . 1.0 112.307 -175.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.598 ' H ' ' ND2' ' A' ' 14' ' ' ASN . . . -127.81 158.29 38.1 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.41 -0.813 . . . . 1.0 109.913 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -94.89 155.92 16.57 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.916 -0.772 . . . . 1.0 108.916 177.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.524 HG13 ' CD2' ' A' ' 97' ' ' LEU . 22.0 t -67.46 112.56 2.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.236 0.541 . . . . 1.0 110.09 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.545 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -126.24 -167.19 12.39 Favored Glycine 0 N--CA 1.438 -1.178 0 CA-C-N 115.445 -0.798 . . . . 1.0 111.38 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 54.4 m -55.42 -51.68 66.08 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 122.574 0.35 . . . . 1.0 111.931 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.485 ' HG2' ' N ' ' A' ' 80' ' ' HIS . 1.1 pm0 -57.2 -31.92 65.94 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.655 -0.702 . . . . 1.0 111.008 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.647 ' CD2' ' HB1' ' A' ' 43' ' ' ALA . 78.3 m80 -76.74 -41.86 43.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.034 179.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 24.4 mt -67.41 -19.26 65.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.939 -0.573 . . . . 1.0 110.992 177.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -87.38 -6.09 58.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.933 -0.576 . . . . 1.0 111.209 -178.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.472 ' HB2' ' O ' ' A' ' 6' ' ' HIS . . . -59.93 152.96 22.26 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.852 -0.613 . . . . 1.0 111.275 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -76.86 -17.48 58.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.102 0.477 . . . . 1.0 109.965 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.743 HD11 HG13 ' A' ' 7' ' ' VAL . 0.3 OUTLIER -153.26 116.42 4.6 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-N 115.604 -0.725 . . . . 1.0 109.443 -176.722 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.632 HD23 HG21 ' A' ' 102' ' ' VAL . 5.1 mp -106.72 107.3 18.25 Favored 'General case' 0 N--CA 1.422 -1.856 0 CA-C-N 115.774 -0.648 . . . . 1.0 110.01 177.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.546 ' HB ' ' HD1' ' A' ' 9' ' ' PHE . 51.5 t -85.49 93.3 3.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 114.994 -1.003 . . . . 1.0 110.934 -176.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.23 145.78 32.06 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.628 -0.714 . . . . 1.0 110.432 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.492 ' HG ' ' HD3' ' A' ' 17' ' ' ARG . 3.9 mm? -96.67 -12.44 23.84 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.208 0.528 . . . . 1.0 110.604 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.482 ' CG ' ' H ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -151.54 157.66 42.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.625 -0.716 . . . . 1.0 111.193 179.523 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -53.5 -29.68 37.44 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 113.467 0.914 . . . . 1.0 113.467 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.628 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 2.2 m120 -76.59 -48.37 19.43 Favored 'General case' 0 CA--C 1.512 -0.486 0 C-N-CA 120.364 -0.534 . . . . 1.0 110.864 -177.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.696 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 15.7 m170 -56.04 -46.36 78.91 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.838 -0.43 . . . . 1.0 109.838 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.45 -43.13 93.24 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.803 0.335 . . . . 1.0 110.794 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.431 ' O ' ' HG2' ' A' ' 98' ' ' ARG . 13.1 ttt180 -59.76 -44.64 93.76 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 115.845 -0.616 . . . . 1.0 111.629 179.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.742 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 58.5 mt -64.03 -48.98 74.2 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.169 -0.468 . . . . 1.0 110.083 -176.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.696 ' HG ' ' O ' ' A' ' 93' ' ' HIS . 32.7 mt -52.7 -57.12 11.15 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.845 -0.616 . . . . 1.0 111.22 -179.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.526 ' HA ' ' HB ' ' A' ' 102' ' ' VAL . 12.9 ptt180 -61.26 -41.31 96.71 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.216 -0.447 . . . . 1.0 111.832 -176.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.649 ' HG3' ' O ' ' A' ' 96' ' ' LEU . 1.1 pp0? -69.12 -25.32 64.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.993 0.425 . . . . 1.0 110.359 178.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.742 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 14.2 mt -78.53 -13.65 59.73 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.987 -0.551 . . . . 1.0 112.315 -179.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 148.59 -22.73 1.34 Allowed Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 119.995 -1.097 . . . . 1.0 112.935 -178.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.926 HG13 ' H ' ' A' ' 103' ' ' GLU . 3.3 t -76.24 -156.98 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 109.687 -0.486 . . . . 1.0 109.687 178.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.926 ' H ' HG13 ' A' ' 102' ' ' VAL . 16.8 pt-20 -171.18 168.08 6.87 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 107.66 -1.237 . . . . 1.0 107.66 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.725 ' HA ' HG11 ' A' ' 107' ' ' VAL . . . -66.45 -23.93 66.36 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.992 -0.283 . . . . 1.0 111.572 -174.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.04 -37.78 72.25 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.246 0.546 . . . . 1.0 110.509 176.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.741 ' HD2' HG12 ' A' ' 102' ' ' VAL . 15.1 mtt180 -96.11 -45.17 6.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.778 -1.101 . . . . 1.0 110.935 -176.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.725 HG11 ' HA ' ' A' ' 104' ' ' ALA . 8.0 p -79.46 124.78 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-O 121.572 0.701 . . . . 1.0 110.702 -177.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.543 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 21.2 mmm180 -140.52 146.69 38.46 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 -179.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.498 ' HB2' ' HB2' ' A' ' 112' ' ' SER . 82.1 mmm -78.86 137.84 37.86 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.762 -0.654 . . . . 1.0 110.369 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.505 HD22 HG11 ' A' ' 87' ' ' VAL . 3.1 tm? -56.31 -48.7 76.16 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.077 0.465 . . . . 1.0 111.268 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 65.0 ttt180 -69.6 -20.59 63.62 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.98 -0.554 . . . . 1.0 110.303 -177.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.498 ' HB2' ' HB2' ' A' ' 109' ' ' MET . 36.1 t -76.15 -5.41 46.56 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.62 -0.718 . . . . 1.0 110.913 -177.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.55 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 86.9 m-85 -90.68 -22.77 20.98 Favored 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 122.172 -0.33 . . . . 1.0 110.237 175.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 58.6 t0 . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 115.733 -0.667 . . . . 1.0 110.263 -177.767 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 . . . . . 0 N--CA 1.454 -0.229 0 CA-C-O 121.045 0.45 . . . . 1.0 109.853 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.418 ' O ' HG23 ' A' ' 141' ' ' VAL . 71.1 tt0 -67.8 -42.95 80.76 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 108.539 -0.911 . . . . 1.0 108.539 174.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.458 HG12 HD12 ' A' ' 142' ' ' ILE . 76.1 t -58.72 -44.34 89.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 114.514 -1.221 . . . . 1.0 109.583 176.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.49 ' HB2' ' HE2' ' A' ' 20' ' ' MET . 46.5 t80 -54.59 -43.41 72.11 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.444 -1.253 . . . . 1.0 110.257 177.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.429 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -63.9 -42.19 97.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.774 -0.648 . . . . 1.0 110.901 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 137' ' ' GLU . 31.2 t -57.7 -57.02 12.09 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 CA-C-O 121.384 0.611 . . . . 1.0 110.592 178.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.474 ' HA ' HD12 ' A' ' 110' ' ' LEU . 7.0 mt -57.7 -52.07 62.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.21 -0.904 . . . . 1.0 112.388 -177.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.491 ' HG3' ' N ' ' A' ' 144' ' ' SER . 2.2 pt-20 -56.34 -33.06 65.28 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.702 0.287 . . . . 1.0 110.536 -179.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' SER . . . . . 0.491 ' N ' ' HG3' ' A' ' 143' ' ' GLU . 4.0 t -73.52 -27.42 61.35 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.347 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.472 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -88.61 -22.34 23.54 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-N 115.914 -0.585 . . . . 1.0 111.86 179.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.66 HD23 ' HB3' ' A' ' 25' ' ' PHE . 12.5 mt -55.28 -37.31 55.37 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-O 119.212 -0.423 . . . . 1.0 112.117 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 43.3 Cg_endo -68.91 -12.17 33.74 Favored 'Trans proline' 0 C--N 1.365 1.409 0 C-N-CA 122.325 2.017 . . . . 1.0 111.943 176.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.55 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -104.51 -33.8 3.78 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 110.72 -0.952 . . . . 1.0 110.72 178.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.512 HD11 ' CE2' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -73.46 -39.62 64.79 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.348 -0.982 . . . . 1.0 108.348 178.93 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . 0.51 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 0.2 OUTLIER -54.12 -55.01 31.76 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-N 115.136 -0.938 . . . . 1.0 110.628 175.347 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -56.29 -42.26 77.24 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.716 -1.129 . . . . 1.0 111.193 -175.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . 0.654 ' HZ3' HD21 ' A' ' 5' ' ' LEU . 22.1 t90 -64.97 -54.85 24.1 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.346 -0.843 . . . . 1.0 110.613 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.453 HG12 ' O ' ' A' ' 149' ' ' LEU . 6.4 m -62.21 -41.17 90.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 120.587 -0.445 . . . . 1.0 110.069 -178.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -60.19 -49.51 77.36 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-O 121.013 0.435 . . . . 1.0 110.792 178.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.529 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 11.8 pt-20 -63.61 -39.57 94.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.691 -0.686 . . . . 1.0 110.399 -178.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.508 ' HG3' ' CH2' ' A' ' 152' ' ' TRP . 15.6 mmt85 -74.59 -42.37 58.8 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.863 -0.608 . . . . 1.0 111.528 -175.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.409 HD12 ' C ' ' A' ' 157' ' ' LEU . 4.0 pp . . . . . 0 C--N 1.325 -0.487 0 CA-C-O 121.285 0.564 . . . . 1.0 109.576 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.624 ' HB2' ' HG2' ' A' ' 39' ' ' ARG . 18.9 Cg_endo . . . . . 0 N--CA 1.46 -0.443 0 N-CA-C 113.886 0.687 . . . . 1.0 113.886 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.543 ' HB3' HG12 ' A' ' 38' ' ' VAL . 0.4 OUTLIER -71.1 -173.85 0.89 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.287 -1.324 . . . . 1.0 110.347 179.173 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.56 ' HB3' ' H ' ' A' ' 84' ' ' ASP . 1.5 t-160 -155.2 102.52 2.3 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 110.043 -0.355 . . . . 1.0 110.043 -178.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.624 HG11 HD11 ' A' ' 85' ' ' LEU . 2.1 t -106.53 112.48 39.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 108.125 -1.065 . . . . 1.0 108.125 177.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.522 HG21 ' HG ' ' A' ' 86' ' ' LEU . 9.0 t -114.58 114.11 25.29 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.033 0.444 . . . . 1.0 110.479 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.577 ' HD1' ' HB ' ' A' ' 87' ' ' VAL . 0.9 OUTLIER -83.87 134.83 34.68 Favored 'General case' 0 CA--C 1.511 -0.526 0 O-C-N 121.857 -0.527 . . . . 1.0 110.259 -179.541 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.535 ' CG1' HG23 ' A' ' 45' ' ' THR . 48.8 t -119.69 115.61 48.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-O 121.227 0.537 . . . . 1.0 111.453 -177.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 37.4 t -140.49 163.15 33.6 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.527 -0.76 . . . . 1.0 109.297 178.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.15 84.94 3.63 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.167 0.508 . . . . 1.0 111.23 -177.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.684 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 141.84 -39.14 1.42 Allowed Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.443 -0.799 . . . . 1.0 111.952 179.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 62.71 16.47 8.98 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.817 0.818 . . . . 1.0 111.347 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.432 ' O ' ' HB3' ' A' ' 55' ' ' ASP . 1.8 pt -131.44 32.87 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 O-C-N 121.827 -0.546 . . . . 1.0 110.553 -178.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.785 ' O ' ' HG3' ' A' ' 20' ' ' MET . 35.6 m -147.97 -88.21 0.09 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.915 -0.402 . . . . 1.0 109.915 175.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.41 -51.29 68.11 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.257 0.466 . . . . 1.0 112.257 -177.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.853 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 14.3 m -54.19 -58.99 11.21 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 115.99 -0.55 . . . . 1.0 112.369 -177.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.632 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 33.2 Cg_endo -61.62 -26.6 80.54 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 121.898 1.732 . . . . 1.0 112.705 -178.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.785 ' HG3' ' O ' ' A' ' 16' ' ' CYS . 72.9 mtp -60.43 -54.84 40.76 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.751 -0.38 . . . . 1.0 110.524 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.516 ' HA ' ' HB2' ' A' ' 24' ' ' MET . . . -74.75 -27.53 60.39 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.582 -0.447 . . . . 1.0 110.763 -178.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.46 ' HA ' ' CE2' ' A' ' 9' ' ' PHE . 18.1 tt0 -52.37 -53.36 45.82 Favored 'General case' 0 C--O 1.217 -0.634 0 O-C-N 124.064 0.852 . . . . 1.0 110.09 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.929 ' HE3' ' HB2' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -86.71 -22.35 26.08 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.43 -0.805 . . . . 1.0 110.69 -176.409 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.652 ' HB3' HD12 ' A' ' 146' ' ' LEU . 3.2 mmm -63.73 -76.66 0.06 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.216 0.45 . . . . 1.0 112.216 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.766 ' HB3' HD23 ' A' ' 146' ' ' LEU . 22.6 p90 -76.2 -29.76 57.74 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 119.697 -0.801 . . . . 1.0 111.68 -175.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.54 ' HA ' HD11 ' A' ' 29' ' ' LEU . . . -63.35 -36.62 84.31 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 119.321 -0.952 . . . . 1.0 110.714 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.633 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -65.48 -39.32 91.8 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 108.801 -0.815 . . . . 1.0 108.801 177.218 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.608 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 59.8 mt-30 -60.47 -37.73 81.96 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 121.098 0.475 . . . . 1.0 110.395 177.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.564 HD13 ' HB ' ' A' ' 38' ' ' VAL . 95.9 mt -57.01 -62.63 1.61 Allowed 'General case' 0 C--O 1.223 -0.308 0 CA-C-N 115.724 -0.671 . . . . 1.0 110.555 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.47 ' HB3' ' HA3' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -59.3 -31.01 68.74 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.154 -0.618 . . . . 1.0 111.548 179.099 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -59.88 -33.73 72.22 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.929 0.395 . . . . 1.0 111.213 176.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.557 ' HD3' HD12 ' A' ' 34' ' ' LEU . 11.6 ptm180 -95.71 -20.68 18.71 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 120.142 -0.623 . . . . 1.0 109.827 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 109.6 36.22 2.11 Favored Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 115.008 -0.996 . . . . 1.0 112.459 177.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.557 HD12 ' HD3' ' A' ' 32' ' ' ARG . 38.9 mt -129.03 4.36 5.31 Favored 'General case' 0 C--N 1.331 -0.239 0 O-C-N 122.275 -0.544 . . . . 1.0 110.174 -179.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.47 ' HA3' ' HB3' ' A' ' 30' ' ' ARG . . . -59.0 -29.53 65.3 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 121.276 -0.488 . . . . 1.0 113.27 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.583 ' HA ' ' NH1' ' A' ' 39' ' ' ARG . 11.8 m-20 -92.71 -17.63 24.0 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.117 0.484 . . . . 1.0 110.254 177.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.89 -24.13 38.51 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.659 -0.701 . . . . 1.0 110.428 178.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.564 ' HB ' HD13 ' A' ' 29' ' ' LEU . 12.0 t -130.94 123.92 55.12 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.446 -179.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.624 ' HG2' ' HB2' ' A' ' 4' ' ' PRO . 22.8 mmt180 -93.82 130.56 39.8 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 109.058 -0.719 . . . . 1.0 109.058 175.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 64.0 t -122.68 117.84 53.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-O 121.528 0.68 . . . . 1.0 109.599 -175.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.502 ' O ' ' HA ' ' A' ' 8' ' ' THR . 57.9 p -130.99 -177.11 4.23 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.379 -1.282 . . . . 1.0 110.322 -175.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.853 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 90.9 p -160.56 165.71 30.32 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.842 -0.343 . . . . 1.0 110.339 179.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.623 ' HB1' ' CD2' ' A' ' 80' ' ' HIS . . . -164.0 166.92 21.07 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 121.365 0.603 . . . . 1.0 111.677 -179.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -124.55 131.92 8.03 Favored Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 110.682 -0.967 . . . . 1.0 110.682 176.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.535 HG23 ' CG1' ' A' ' 10' ' ' VAL . 36.3 p -66.62 -28.87 68.83 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.108 0.41 . . . . 1.0 112.108 -176.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.434 ' HA3' ' CZ3' ' A' ' 48' ' ' TRP . . . -106.53 10.82 42.48 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.618 -0.801 . . . . 1.0 113.598 -175.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 44.87 34.51 1.23 Allowed 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.559 0.948 . . . . 1.0 113.559 177.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.684 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 1.2 m-90 -45.09 -74.87 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.596 0.712 . . . . 1.0 111.984 179.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -107.39 41.17 1.54 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.822 -1.081 . . . . 1.0 111.132 -178.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.9 p -60.64 127.84 20.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.405 178.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.03 -12.62 68.9 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.962 -0.637 . . . . 1.0 112.378 -178.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 t -80.81 -160.19 0.3 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.907 0.384 . . . . 1.0 110.615 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 31.7 t -129.91 170.42 13.95 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.688 -0.486 . . . . 1.0 109.688 -178.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.83 143.2 38.11 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.242 0.544 . . . . 1.0 112.094 -178.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.663 ' OD2' ' HG3' ' A' ' 57' ' ' ARG . 12.8 p-10 -63.54 144.58 56.88 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.71 -1.132 . . . . 1.0 112.655 -177.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -48.69 -43.3 36.93 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.546 -1.206 . . . . 1.0 113.311 178.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.663 ' HG3' ' OD2' ' A' ' 55' ' ' ASP . 4.0 ptp180 -71.49 -40.73 70.04 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 121.135 -0.226 . . . . 1.0 111.471 -175.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.621 ' HB1' ' HG2' ' A' ' 20' ' ' MET . . . -71.04 -35.66 72.05 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.045 0.45 . . . . 1.0 109.834 178.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.85 -42.3 97.6 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.905 -0.589 . . . . 1.0 111.04 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -67.53 -34.73 85.05 Favored Glycine 0 CA--C 1.489 -1.546 0 N-CA-C 110.379 -1.089 . . . . 1.0 110.379 -178.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.543 ' O ' ' HD2' ' A' ' 65' ' ' HIS . 1.1 t -63.07 -54.57 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 CA-C-N 113.557 -1.322 . . . . 1.0 110.882 176.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.684 HD11 ' HG3' ' A' ' 23' ' ' LYS . 89.5 mt -62.39 -51.86 65.88 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.772 0.32 . . . . 1.0 111.152 -177.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -64.83 -23.5 67.26 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.807 -0.633 . . . . 1.0 111.509 -177.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.68 -33.3 70.77 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.2 0.524 . . . . 1.0 110.589 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.543 ' HD2' ' O ' ' A' ' 61' ' ' VAL . 87.7 m-70 -96.12 1.46 52.45 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.713 -0.676 . . . . 1.0 111.063 -178.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 96.22 9.51 56.87 Favored Glycine 0 C--N 1.33 0.221 0 C-N-CA 120.886 -0.674 . . . . 1.0 113.112 176.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.494 ' CD1' ' HA ' ' A' ' 24' ' ' MET . 73.5 m-85 -88.99 149.37 43.21 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-O 120.413 0.149 . . . . 1.0 110.621 -179.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.471 ' HG2' ' CB ' ' A' ' 23' ' ' LYS . 40.9 Cg_endo -69.09 156.31 65.49 Favored 'Trans proline' 0 CA--C 1.51 -0.705 0 C-N-CA 122.252 1.968 . . . . 1.0 110.883 176.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.68 HG21 ' HB2' ' A' ' 62' ' ' LEU . 52.1 p -130.36 13.68 5.56 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.49 0.662 . . . . 1.0 110.443 -177.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -85.03 125.5 32.78 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.988 -1.006 . . . . 1.0 109.15 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.929 ' HB2' ' HE3' ' A' ' 23' ' ' LYS . 19.2 t60 -165.54 154.06 11.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.347 -0.388 . . . . 1.0 110.385 -175.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -133.95 113.85 12.63 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.628 -0.879 . . . . 1.0 108.628 176.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.63 140.27 56.53 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.171 -0.922 . . . . 1.0 112.558 -175.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.454 ' O ' ' HA ' ' A' ' 43' ' ' ALA . . . -134.18 150.74 51.1 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.257 -0.883 . . . . 1.0 109.81 178.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -86.62 155.33 20.48 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.615 -0.513 . . . . 1.0 109.615 176.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.574 HG11 ' CD2' ' A' ' 97' ' ' LEU . 8.8 t -67.41 112.62 2.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.123 0.487 . . . . 1.0 110.212 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.484 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -123.37 -166.92 12.72 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.58 -0.736 . . . . 1.0 111.437 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 44.3 m -57.11 -51.56 68.82 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.125 0.488 . . . . 1.0 111.687 -178.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.445 ' HG2' ' N ' ' A' ' 80' ' ' HIS . 1.4 pm0 -56.39 -31.57 63.97 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.3 -0.864 . . . . 1.0 111.114 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.623 ' CD2' ' HB1' ' A' ' 43' ' ' ALA . 80.1 m80 -75.28 -42.77 54.09 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 116.055 -0.52 . . . . 1.0 110.158 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.549 ' HA ' HD23 ' A' ' 86' ' ' LEU . 21.0 mt -67.69 -18.64 65.0 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.737 -0.665 . . . . 1.0 110.672 178.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.37 -2.9 58.82 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.852 -0.613 . . . . 1.0 110.853 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.549 ' HA ' ' HB3' ' A' ' 6' ' ' HIS . . . -60.23 155.14 18.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.827 -0.624 . . . . 1.0 111.498 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.707 ' HA ' ' NH1' ' A' ' 106' ' ' ARG . 25.0 t70 -79.5 -16.83 55.37 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.335 0.588 . . . . 1.0 109.883 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.624 HD11 HG11 ' A' ' 7' ' ' VAL . 0.5 OUTLIER -155.07 117.64 4.28 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.137 -0.938 . . . . 1.0 108.909 -177.405 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.6 HD22 HG21 ' A' ' 102' ' ' VAL . 5.0 mp -105.52 104.11 13.77 Favored 'General case' 0 N--CA 1.425 -1.704 0 CA-C-N 115.518 -0.765 . . . . 1.0 109.744 178.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.577 ' HB ' ' HD1' ' A' ' 9' ' ' PHE . 72.2 t -84.91 92.59 3.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.202 -0.908 . . . . 1.0 111.272 -176.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.02 146.03 30.86 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.18 -0.918 . . . . 1.0 110.785 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -97.55 -7.63 30.9 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.37 0.605 . . . . 1.0 109.952 178.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.469 ' CG ' ' H ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -152.64 152.97 32.39 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.16 -0.927 . . . . 1.0 110.103 178.335 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 18.7 ptt180 -64.3 -19.72 65.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.573 -0.74 . . . . 1.0 112.749 -176.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.627 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 7.1 m120 -75.62 -48.73 20.97 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.397 -0.594 . . . . 1.0 109.397 178.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.734 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 17.8 m170 -56.29 -47.32 78.89 Favored 'General case' 0 C--N 1.333 -0.124 0 N-CA-C 109.619 -0.512 . . . . 1.0 109.619 177.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.456 ' HA ' HG21 ' A' ' 107' ' ' VAL . . . -58.55 -44.33 89.63 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.308 -0.406 . . . . 1.0 110.961 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.439 ' O ' ' HG2' ' A' ' 98' ' ' ARG . 2.0 ttt85 -59.64 -41.76 91.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.128 -0.487 . . . . 1.0 111.517 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.75 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 50.4 mt -63.91 -49.27 73.32 Favored 'General case' 0 C--O 1.219 -0.52 0 N-CA-C 109.744 -0.465 . . . . 1.0 109.744 -177.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.734 ' HG ' ' O ' ' A' ' 93' ' ' HIS . 27.5 mt -55.78 -55.59 30.58 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.316 -0.856 . . . . 1.0 111.67 -178.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.439 ' HG2' ' O ' ' A' ' 95' ' ' ARG . 20.2 ptt180 -60.97 -43.6 98.56 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.214 -0.448 . . . . 1.0 111.554 -176.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.635 ' HG3' ' O ' ' A' ' 96' ' ' LEU . 1.1 pp0? -69.0 -21.38 64.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.125 0.488 . . . . 1.0 110.239 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.75 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 9.8 mt -78.61 -7.81 57.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.595 -0.729 . . . . 1.0 111.962 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 147.66 -31.13 1.38 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.047 -1.073 . . . . 1.0 113.223 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.711 HG12 ' H ' ' A' ' 103' ' ' GLU . 1.4 t -75.15 -153.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.359 0.6 . . . . 1.0 111.238 -178.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.711 ' H ' HG12 ' A' ' 102' ' ' VAL . 15.5 pt-20 -164.25 164.53 22.45 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.603 -0.888 . . . . 1.0 108.603 -178.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.806 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -67.69 -21.92 65.31 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.571 -0.286 . . . . 1.0 111.542 -175.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.61 -35.88 77.22 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.284 0.564 . . . . 1.0 110.371 175.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.711 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 0.6 OUTLIER -95.09 -44.84 7.48 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 115.201 -0.909 . . . . 1.0 110.364 -177.676 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.806 HG12 ' HA ' ' A' ' 104' ' ' ALA . 8.9 p -78.33 117.29 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-O 121.846 0.832 . . . . 1.0 109.595 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.573 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 29.1 mmm180 -134.43 148.62 50.66 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.662 -0.699 . . . . 1.0 109.915 -177.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 82.6 mmm -78.57 140.29 38.52 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.279 -0.873 . . . . 1.0 110.581 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.552 HD13 ' HA ' ' A' ' 142' ' ' ILE . 3.2 tm? -56.49 -50.47 71.66 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 123.085 0.241 . . . . 1.0 110.93 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 5.6 ttm-85 -70.96 -15.52 62.59 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.691 -0.404 . . . . 1.0 110.854 -178.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 33.5 t -75.26 -2.7 29.33 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 120.97 -0.292 . . . . 1.0 110.31 -179.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.665 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 85.9 m-85 -96.08 -17.77 20.67 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 121.972 -0.455 . . . . 1.0 110.617 175.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.7 t0 . . . . . 0 C--N 1.326 -0.438 0 CA-C-N 115.882 -0.599 . . . . 1.0 110.47 -178.307 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 . . . . . 0 N--CA 1.452 -0.348 0 N-CA-C 109.634 -0.506 . . . . 1.0 109.634 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -65.56 -45.5 83.12 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 109.643 -0.503 . . . . 1.0 109.643 176.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.872 ' HA ' HG13 ' A' ' 141' ' ' VAL . 24.4 t -63.74 -40.39 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-O 121.756 0.788 . . . . 1.0 109.043 177.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -55.94 -42.18 75.77 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.328 -0.851 . . . . 1.0 109.309 175.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.543 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -66.99 -47.96 69.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.489 -0.778 . . . . 1.0 111.711 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.872 HG13 ' HA ' ' A' ' 138' ' ' VAL . 3.6 p -59.54 -43.86 91.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.709 0.766 . . . . 1.0 111.214 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.562 HD13 HG12 ' A' ' 138' ' ' VAL . 13.5 mt -67.13 -51.08 57.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 115.206 -0.906 . . . . 1.0 111.504 178.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.543 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 7.6 pt-20 -56.11 -30.25 61.8 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 109.934 -0.395 . . . . 1.0 109.934 179.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 4.2 t -72.57 -30.32 64.3 Favored 'General case' 0 C--O 1.226 -0.179 0 CA-C-N 115.749 -0.66 . . . . 1.0 110.315 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.46 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -87.84 -22.62 24.35 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-N 116.024 -0.535 . . . . 1.0 111.723 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.766 HD23 ' HB3' ' A' ' 25' ' ' PHE . 9.9 mt -54.77 -38.77 70.54 Favored Pre-proline 0 CA--C 1.545 0.774 0 CA-C-O 119.163 -0.446 . . . . 1.0 112.048 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.588 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 61.7 Cg_endo -71.28 -11.01 28.17 Favored 'Trans proline' 0 C--N 1.365 1.429 0 C-N-CA 122.695 2.264 . . . . 1.0 112.113 177.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.665 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -103.86 -33.32 4.11 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.372 -1.091 . . . . 1.0 110.372 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.479 HD11 ' CE2' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -74.28 -40.38 62.33 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.378 -0.971 . . . . 1.0 108.378 178.372 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . 0.471 ' O ' ' HB2' ' A' ' 154' ' ' ASP . 1.0 OUTLIER -55.71 -52.1 65.05 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 114.716 -1.129 . . . . 1.0 110.966 176.111 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -61.73 -42.35 98.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.755 -0.657 . . . . 1.0 110.962 -176.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . 0.529 ' HZ3' HD22 ' A' ' 5' ' ' LEU . 28.0 t90 -60.98 -57.12 13.95 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.387 -0.824 . . . . 1.0 110.629 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.511 ' HB ' HD21 ' A' ' 5' ' ' LEU . 11.0 m -60.41 -38.49 78.0 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.279 0 N-CA-C 110.088 -0.338 . . . . 1.0 110.088 -178.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.508 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 0.5 OUTLIER -59.53 -56.19 25.07 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.403 0.62 . . . . 1.0 110.815 179.72 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -61.44 -39.81 92.19 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.047 -0.978 . . . . 1.0 110.72 -177.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.429 ' HD3' ' HA ' ' A' ' 156' ' ' ARG . 11.4 mmt85 -72.07 -45.75 59.54 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 115.79 -0.641 . . . . 1.0 110.966 -176.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 3.6 pp . . . . . 0 C--N 1.326 -0.439 0 CA-C-N 115.789 -0.641 . . . . 1.0 109.372 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.454 ' HB2' ' HG2' ' A' ' 39' ' ' ARG . 19.4 Cg_endo . . . . . 0 N--CA 1.458 -0.584 0 CA-C-O 121.112 0.38 . . . . 1.0 112.402 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.773 ' HB3' HG21 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -65.04 177.17 1.05 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.667 -0.697 . . . . 1.0 109.304 -179.213 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.702 ' H ' HD13 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -157.24 90.93 1.14 Allowed 'General case' 0 C--N 1.318 -0.797 0 O-C-N 121.878 -0.514 . . . . 1.0 111.036 -179.134 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.561 HG11 HD13 ' A' ' 85' ' ' LEU . 1.7 t -95.74 109.09 22.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.731 -0.668 . . . . 1.0 109.557 178.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.598 ' CG2' ' HG ' ' A' ' 86' ' ' LEU . 10.1 t -112.56 117.28 31.9 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 109.623 -0.51 . . . . 1.0 109.623 178.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.722 ' HZ ' ' HE1' ' A' ' 25' ' ' PHE . 1.0 OUTLIER -86.3 134.49 33.74 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 120.843 0.354 . . . . 1.0 110.234 -178.919 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.698 HG21 HD12 ' A' ' 97' ' ' LEU . 33.7 t -116.5 113.67 43.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 116.083 -0.508 . . . . 1.0 111.649 -176.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.59 ' HB2' HD22 ' A' ' 89' ' ' LEU . 38.3 t -143.86 160.61 40.47 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.145 -0.48 . . . . 1.0 109.837 178.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.409 HG22 ' CZ3' ' A' ' 48' ' ' TRP . 0.6 OUTLIER -67.39 100.45 0.84 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.205 0.526 . . . . 1.0 111.18 -179.768 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.974 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 117.21 -40.01 2.48 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.513 -0.767 . . . . 1.0 112.18 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.626 ' ND2' ' H ' ' A' ' 74' ' ' ALA . 57.7 t30 60.61 25.72 15.43 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 122.449 1.119 . . . . 1.0 110.392 -177.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.584 ' O ' ' HB3' ' A' ' 55' ' ' ASP . 1.3 pt -134.76 39.02 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 114.908 -1.042 . . . . 1.0 109.658 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.754 ' O ' ' HG3' ' A' ' 20' ' ' MET . 6.9 p -151.38 -89.26 0.06 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.086 -0.507 . . . . 1.0 111.426 177.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 81.3 mtt180 -74.83 -45.1 45.56 Favored 'General case' 0 N--CA 1.464 0.249 0 O-C-N 122.004 -0.435 . . . . 1.0 111.543 -176.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.442 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 20.4 m -53.09 -56.32 24.96 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 116.117 -0.492 . . . . 1.0 111.364 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.442 ' HD3' ' HB2' ' A' ' 18' ' ' SER . 49.4 Cg_endo -67.28 -24.52 43.62 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 121.444 1.43 . . . . 1.0 112.909 -178.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.754 ' HG3' ' O ' ' A' ' 16' ' ' CYS . 63.4 mtp -59.15 -53.35 59.32 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 109.869 -0.419 . . . . 1.0 109.869 178.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.551 ' O ' ' HD1' ' A' ' 25' ' ' PHE . . . -72.77 -31.15 64.68 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 115.379 -0.828 . . . . 1.0 110.68 -177.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.563 ' O ' ' HB1' ' A' ' 26' ' ' ALA . 17.5 tt0 -50.66 -53.46 30.85 Favored 'General case' 0 C--O 1.218 -0.554 0 O-C-N 124.167 0.917 . . . . 1.0 110.162 -178.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.643 ' HZ3' ' HB2' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -84.9 -24.23 28.55 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.497 -0.774 . . . . 1.0 110.902 -176.618 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.511 ' HE2' HD11 ' A' ' 146' ' ' LEU . 85.4 mtp -63.61 -75.66 0.08 Allowed 'General case' 0 C--O 1.237 0.423 0 N-CA-C 112.621 0.6 . . . . 1.0 112.621 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.727 ' HB3' HD23 ' A' ' 146' ' ' LEU . 0.6 OUTLIER -78.62 -28.77 45.65 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.163 -0.615 . . . . 1.0 111.93 -174.885 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.563 ' HB1' ' O ' ' A' ' 22' ' ' GLU . . . -64.71 -38.07 89.75 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 119.346 -0.941 . . . . 1.0 110.389 178.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.641 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -62.92 -38.84 92.57 Favored 'General case' 0 CA--C 1.527 0.061 0 N-CA-C 108.406 -0.961 . . . . 1.0 108.406 177.046 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.638 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 79.4 mt-30 -59.89 -42.88 94.76 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 115.593 -0.73 . . . . 1.0 110.808 176.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 25' ' ' PHE . 96.5 mt -56.17 -60.05 4.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.104 -0.498 . . . . 1.0 111.322 -178.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.29 -34.91 74.42 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.144 -0.623 . . . . 1.0 111.178 178.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -60.76 -29.24 69.29 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 111.96 0.355 . . . . 1.0 111.96 177.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.605 ' HG2' ' O ' ' A' ' 28' ' ' GLN . 6.8 ptp180 -94.72 -21.1 18.98 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.098 -0.641 . . . . 1.0 110.275 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 107.43 40.38 1.78 Allowed Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.175 -0.921 . . . . 1.0 111.962 177.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 25.8 mt -132.32 0.32 3.71 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.965 -0.383 . . . . 1.0 109.965 -178.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.7 -28.91 60.7 Favored Glycine 0 C--N 1.332 0.351 0 CA-C-N 116.035 -0.53 . . . . 1.0 112.855 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -83.35 -25.76 31.14 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.17 0.509 . . . . 1.0 110.321 177.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.41 -23.11 40.6 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.559 -0.746 . . . . 1.0 111.571 -177.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.773 HG21 ' HB3' ' A' ' 5' ' ' LEU . 0.4 OUTLIER -141.33 125.09 16.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.296 0.569 . . . . 1.0 111.241 -179.396 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.454 ' HG2' ' HB2' ' A' ' 4' ' ' PRO . 17.3 mmt180 -88.93 142.43 27.65 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.475 -0.784 . . . . 1.0 108.998 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.4 HG13 ' HB2' ' A' ' 26' ' ' ALA . 77.0 t -129.8 130.13 66.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 109.173 -0.676 . . . . 1.0 109.173 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.496 ' O ' ' HA ' ' A' ' 8' ' ' THR . 37.0 p -143.8 -174.17 4.18 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.782 -1.099 . . . . 1.0 110.487 -174.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.456 ' OG ' ' HE1' ' A' ' 71' ' ' HIS . 65.2 p -160.43 163.03 33.37 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.598 -0.274 . . . . 1.0 110.427 -179.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.649 ' HB1' ' CD2' ' A' ' 80' ' ' HIS . . . -163.34 161.98 24.81 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.278 0.561 . . . . 1.0 111.345 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -123.37 133.42 8.95 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.453 -0.794 . . . . 1.0 111.481 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.492 HG22 ' CG1' ' A' ' 10' ' ' VAL . 17.9 p -71.44 -20.83 62.05 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.688 0.28 . . . . 1.0 111.727 -178.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.454 ' HA3' ' CZ3' ' A' ' 48' ' ' TRP . . . -109.66 5.33 31.09 Favored Glycine 0 C--O 1.226 -0.377 0 C-N-CA 120.603 -0.808 . . . . 1.0 113.026 -178.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.401 ' HB3' ' NE2' ' A' ' 75' ' ' GLN . 3.2 p-10 42.92 34.54 0.62 Allowed 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 113.518 0.933 . . . . 1.0 113.518 178.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.974 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 0.9 OUTLIER -46.83 -72.99 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.298 0.571 . . . . 1.0 112.419 -178.983 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.507 ' HB3' ' HB3' ' A' ' 52' ' ' SER . 3.2 m-70 -106.5 42.66 1.24 Allowed 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.734 -0.666 . . . . 1.0 111.186 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.437 HG21 ' HA ' ' A' ' 74' ' ' ALA . 11.9 p -61.34 126.92 20.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 120.573 -0.451 . . . . 1.0 109.985 178.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.0 -12.59 69.63 Favored Glycine 0 CA--C 1.519 0.303 0 N-CA-C 111.794 -0.523 . . . . 1.0 111.794 -176.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.511 ' O ' ' HD3' ' A' ' 72' ' ' ARG . 1.4 t -83.08 -159.58 0.35 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.149 0.5 . . . . 1.0 109.839 178.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.593 ' HA ' ' O ' ' A' ' 71' ' ' HIS . 25.0 t -131.17 170.38 14.64 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.955 -0.566 . . . . 1.0 109.573 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.643 ' HB2' ' HZ3' ' A' ' 23' ' ' LYS . . . -50.74 145.7 6.65 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 123.758 0.661 . . . . 1.0 111.553 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.677 ' OD1' ' HA ' ' A' ' 16' ' ' CYS . 9.6 p-10 -61.47 144.94 53.35 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.434 -0.803 . . . . 1.0 112.388 -178.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -45.75 -36.32 4.97 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.214 -1.357 . . . . 1.0 113.221 175.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.599 ' O ' HG21 ' A' ' 61' ' ' VAL . 17.1 mtt-85 -71.22 -49.66 41.09 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.843 0.354 . . . . 1.0 111.013 -175.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.65 -29.83 67.39 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.419 -0.81 . . . . 1.0 110.557 -178.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.65 -47.71 84.16 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.701 -0.481 . . . . 1.0 109.701 177.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.36 -38.09 95.7 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.962 -0.637 . . . . 1.0 112.101 178.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.599 HG21 ' O ' ' A' ' 57' ' ' ARG . 99.7 t -64.19 -58.87 5.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.25 0.548 . . . . 1.0 110.826 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.48 ' HB2' HG21 ' A' ' 69' ' ' THR . 8.6 mp -59.79 -48.65 80.84 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.686 -0.688 . . . . 1.0 111.54 -177.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.483 ' HB3' HG22 ' A' ' 69' ' ' THR . 9.9 ptm180 -60.59 -28.54 68.57 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.517 -0.31 . . . . 1.0 111.131 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.34 -33.88 75.1 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.417 0.627 . . . . 1.0 110.053 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -93.74 4.78 53.42 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.228 -0.896 . . . . 1.0 111.536 -178.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.89 16.18 65.98 Favored Glycine 0 N--CA 1.455 -0.093 0 C-N-CA 120.96 -0.638 . . . . 1.0 112.754 177.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -92.44 151.95 41.79 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 110.259 -0.274 . . . . 1.0 110.259 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.476 ' O ' ' HD2' ' A' ' 23' ' ' LYS . 27.8 Cg_endo -66.29 152.1 81.84 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 121.877 1.718 . . . . 1.0 110.155 176.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.483 HG22 ' HB3' ' A' ' 63' ' ' ARG . 66.7 p -131.28 25.61 4.85 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 120.266 -0.574 . . . . 1.0 112.041 -175.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.474 ' C ' ' HZ1' ' A' ' 23' ' ' LYS . 34.2 t70 -110.57 127.02 55.04 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.783 -0.451 . . . . 1.0 109.783 179.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.593 ' O ' ' HA ' ' A' ' 53' ' ' CYS . 0.2 OUTLIER -160.09 139.5 11.04 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.883 -179.61 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.511 ' HD3' ' O ' ' A' ' 52' ' ' SER . 5.1 tpp180 -102.72 114.98 29.67 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.969 -0.56 . . . . 1.0 110.132 178.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 49' ' ' HIS . . . -63.51 138.01 58.35 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.139 -0.482 . . . . 1.0 112.133 -178.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.626 ' H ' ' ND2' ' A' ' 14' ' ' ASN . . . -129.41 163.62 25.43 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.942 -0.572 . . . . 1.0 109.894 176.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.401 ' NE2' ' HB3' ' A' ' 47' ' ' ASN . 16.0 tt0 -98.07 159.41 14.95 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.977 -0.749 . . . . 1.0 108.977 178.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.543 HG13 HD21 ' A' ' 97' ' ' LEU . 47.8 t -70.83 115.26 10.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.936 0.398 . . . . 1.0 110.252 177.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.558 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -128.31 -167.0 12.13 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.723 -0.671 . . . . 1.0 111.697 178.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 30.3 m -57.35 -51.83 67.81 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.973 0.416 . . . . 1.0 111.747 -179.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.467 ' HG2' ' N ' ' A' ' 80' ' ' HIS . 1.6 pm0 -56.21 -31.93 63.95 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.623 -0.717 . . . . 1.0 110.981 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.649 ' CD2' ' HB1' ' A' ' 43' ' ' ALA . 80.0 m80 -74.87 -41.16 60.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.967 -0.561 . . . . 1.0 109.955 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.715 ' HA ' HD21 ' A' ' 86' ' ' LEU . 15.6 mt -68.78 -16.34 63.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.973 0.416 . . . . 1.0 110.238 176.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -87.35 -8.32 56.78 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 120.932 0.396 . . . . 1.0 110.112 -179.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 6' ' ' HIS . . . -59.18 156.16 12.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.86 -0.609 . . . . 1.0 110.774 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.763 ' HA ' ' NH1' ' A' ' 106' ' ' ARG . 3.0 t70 -82.35 -12.47 57.93 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.902 0.382 . . . . 1.0 110.153 -178.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.713 HD11 ' CE3' ' A' ' 152' ' ' TRP . 1.1 tt -158.0 115.26 2.94 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.81 -0.632 . . . . 1.0 109.539 -178.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.715 HD21 ' HA ' ' A' ' 81' ' ' LEU . 5.2 mp -107.08 87.64 2.55 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 115.669 -0.696 . . . . 1.0 110.802 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.617 HG12 HD21 ' A' ' 110' ' ' LEU . 76.7 t -66.01 92.91 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 113.886 -1.507 . . . . 1.0 112.521 -178.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.69 149.86 31.08 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.993 -1.003 . . . . 1.0 111.093 177.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.59 HD22 ' HB2' ' A' ' 11' ' ' CYS . 3.9 mm? -98.7 -5.69 31.04 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.971 179.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.59 ' HA ' ' HE2' ' A' ' 109' ' ' MET . 17.9 p30 -159.09 166.43 31.62 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.506 0.67 . . . . 1.0 111.368 174.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 9.1 ptt180 -62.63 -18.98 63.32 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.11 -1.404 . . . . 1.0 112.305 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.61 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 5.9 m-20 -78.48 -53.24 7.45 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.749 0.309 . . . . 1.0 110.623 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.663 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 14.1 m170 -58.84 -44.73 91.02 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.958 -0.565 . . . . 1.0 109.674 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.17 -42.78 91.62 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.002 0.429 . . . . 1.0 110.817 179.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 4.3 ttm180 -57.99 -44.84 87.4 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.37 -0.832 . . . . 1.0 111.281 177.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.679 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 49.4 mt -64.85 -48.45 74.28 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.44 -175.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.698 HD12 HG21 ' A' ' 10' ' ' VAL . 29.0 mt -53.57 -59.77 4.16 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.642 -0.708 . . . . 1.0 111.771 -177.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.7 ' CA ' HG13 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -60.12 -44.33 94.98 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.47 0.545 . . . . 1.0 112.47 -179.308 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.522 ' HG3' ' O ' ' A' ' 96' ' ' LEU . 1.0 OUTLIER -66.56 -23.3 66.19 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.254 -0.578 . . . . 1.0 109.945 179.056 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.679 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 8.9 mt -80.98 -21.75 40.05 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.764 -0.653 . . . . 1.0 111.65 178.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 155.25 -22.72 0.58 Allowed Glycine 0 CA--C 1.521 0.453 0 C-N-CA 119.332 -1.413 . . . . 1.0 114.38 -177.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.7 HG13 ' CA ' ' A' ' 98' ' ' ARG . 0.3 OUTLIER -76.82 -162.09 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 117.836 0.818 . . . . 1.0 110.431 -179.78 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.736 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 16.7 pt-20 -156.37 159.85 39.13 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 107.624 -1.25 . . . . 1.0 107.624 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.733 ' HA ' HG13 ' A' ' 107' ' ' VAL . . . -62.91 -23.65 67.46 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.692 0.282 . . . . 1.0 111.625 -174.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.77 -36.57 74.6 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.376 174.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.763 ' NH1' ' HA ' ' A' ' 84' ' ' ASP . 0.7 OUTLIER -97.25 -42.17 7.93 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 115.323 -0.853 . . . . 1.0 111.063 -177.382 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.733 HG13 ' HA ' ' A' ' 104' ' ' ALA . 14.2 p -79.18 114.69 20.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.113 0.482 . . . . 1.0 109.798 -175.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.613 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 27.3 mmm180 -133.32 148.6 51.91 Favored 'General case' 0 C--N 1.318 -0.777 0 O-C-N 121.521 -0.737 . . . . 1.0 110.314 -177.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.59 ' HE2' ' HA ' ' A' ' 90' ' ' ASP . 74.8 mmm -78.91 138.16 37.97 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.454 -0.794 . . . . 1.0 110.526 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.617 HD21 HG12 ' A' ' 87' ' ' VAL . 3.2 tm? -57.66 -50.67 72.39 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 111.488 0.181 . . . . 1.0 111.488 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.435 ' O ' ' HG2' ' A' ' 111' ' ' ARG . 19.1 ttm180 -69.18 -17.99 63.87 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.661 -0.416 . . . . 1.0 110.227 -178.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.527 ' HB2' ' HB2' ' A' ' 109' ' ' MET . 39.3 t -73.48 -5.66 41.46 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.928 -0.309 . . . . 1.0 111.262 -178.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.643 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 88.6 m-85 -92.99 -18.07 23.15 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 121.073 0.463 . . . . 1.0 110.411 175.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 17.7 t0 . . . . . 0 C--N 1.327 -0.401 0 CA-C-N 115.598 -0.728 . . . . 1.0 111.256 -177.211 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 . . . . . 0 N--CA 1.452 -0.349 0 CA-C-O 120.882 0.372 . . . . 1.0 110.44 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -65.08 -47.96 75.41 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.107 -0.701 . . . . 1.0 109.107 175.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.773 ' HA ' HG21 ' A' ' 141' ' ' VAL . 52.7 t -60.85 -42.41 92.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 115.833 -0.621 . . . . 1.0 109.545 176.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.449 ' HB2' HG12 ' A' ' 61' ' ' VAL . 70.0 t80 -54.56 -43.48 72.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.906 -1.043 . . . . 1.0 109.45 176.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.691 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -64.0 -38.53 91.41 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.516 -0.765 . . . . 1.0 110.737 177.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.773 HG21 ' HA ' ' A' ' 138' ' ' VAL . 13.6 t -58.33 -51.9 65.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-O 121.558 0.694 . . . . 1.0 110.067 177.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.437 ' HA ' HD13 ' A' ' 110' ' ' LEU . 5.8 mt -65.44 -50.96 69.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.177 -0.92 . . . . 1.0 111.89 -179.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.691 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 6.8 pt-20 -55.09 -33.47 62.82 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 110.033 -0.358 . . . . 1.0 110.033 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' SER . . . . . 0.493 ' HB2' ' O ' ' A' ' 140' ' ' ALA . 1.0 OUTLIER -73.5 -27.69 61.51 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.841 -0.618 . . . . 1.0 110.384 -179.694 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.448 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -86.94 -23.91 24.95 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 116.107 -0.497 . . . . 1.0 111.407 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.727 HD23 ' HB3' ' A' ' 25' ' ' PHE . 16.0 mt -55.22 -37.92 62.01 Favored Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 112.276 0.473 . . . . 1.0 112.276 -178.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 60.8 Cg_endo -71.61 -9.75 25.55 Favored 'Trans proline' 0 C--N 1.362 1.288 0 C-N-CA 122.634 2.222 . . . . 1.0 112.147 177.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.643 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -105.14 -30.86 4.6 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 110.317 -1.113 . . . . 1.0 110.317 178.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.553 HD12 ' CE2' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -75.54 -42.12 53.27 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.3 -1.0 . . . . 1.0 108.3 177.424 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . 0.437 ' HE2' ' HB2' ' A' ' 25' ' ' PHE . 9.9 m170 -54.34 -49.76 69.0 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.087 -0.961 . . . . 1.0 110.777 176.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -61.54 -45.98 91.86 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.584 -0.735 . . . . 1.0 110.764 -177.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . 0.713 ' CE3' HD11 ' A' ' 85' ' ' LEU . 27.8 t90 -59.15 -57.02 14.89 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.914 -1.039 . . . . 1.0 110.722 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 15.8 m -58.88 -38.09 70.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.834 -0.346 . . . . 1.0 110.567 -178.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.51 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 9.9 t70 -58.84 -57.38 13.3 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 122.062 0.934 . . . . 1.0 110.897 178.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.435 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 4.5 pt-20 -62.23 -36.9 83.4 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 113.928 -1.487 . . . . 1.0 110.733 -176.118 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.509 ' HG3' ' CH2' ' A' ' 152' ' ' TRP . 3.8 mmt180 -74.72 -44.72 48.52 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.754 -0.657 . . . . 1.0 111.35 -177.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 3.7 pp . . . . . 0 C--N 1.327 -0.396 0 N-CA-C 109.566 -0.531 . . . . 1.0 109.566 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.482 ' HB3' ' O ' ' A' ' 36' ' ' ASP . 49.5 Cg_endo . . . . . 0 N--CA 1.46 -0.449 0 CA-C-O 121.25 0.437 . . . . 1.0 113.174 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.84 ' HB3' HG23 ' A' ' 38' ' ' VAL . 0.9 OUTLIER -73.57 -173.71 1.52 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.411 -0.813 . . . . 1.0 110.879 179.574 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.572 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 1.5 t-160 -158.09 93.93 1.27 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.462 -0.335 . . . . 1.0 111.027 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.781 HG13 HD12 ' A' ' 85' ' ' LEU . 2.3 t -94.28 109.31 21.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.037 -0.727 . . . . 1.0 109.037 176.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.689 ' CG2' ' HG ' ' A' ' 86' ' ' LEU . 12.8 t -112.32 112.98 24.95 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.116 0.484 . . . . 1.0 110.307 178.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.74 ' HZ ' ' HE1' ' A' ' 25' ' ' PHE . 0.9 OUTLIER -82.06 147.1 29.31 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 121.857 -0.527 . . . . 1.0 109.761 179.921 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.641 HG21 HD21 ' A' ' 97' ' ' LEU . 44.3 t -132.74 118.12 32.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.321 0.581 . . . . 1.0 111.634 -176.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.54 ' HB3' HD21 ' A' ' 89' ' ' LEU . 28.7 p -141.29 178.81 7.16 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.524 -0.762 . . . . 1.0 110.092 178.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.501 HG23 ' NE2' ' A' ' 93' ' ' HIS . 0.7 OUTLIER -86.36 86.64 7.34 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.988 0.423 . . . . 1.0 110.971 179.064 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.831 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 135.55 -37.6 1.89 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.656 -0.783 . . . . 1.0 112.077 178.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.464 HD22 ' CB ' ' A' ' 42' ' ' SER . 3.8 t-20 64.01 17.22 10.46 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.59 0.709 . . . . 1.0 111.103 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.0 pt -124.55 11.03 4.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 O-C-N 121.783 -0.573 . . . . 1.0 111.715 -177.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 7.5 p -127.45 -87.36 0.57 Allowed 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 112.112 0.412 . . . . 1.0 112.112 -177.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.68 -44.37 74.17 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 112.323 0.49 . . . . 1.0 112.323 -176.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.712 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 50.9 m -57.37 -58.03 20.92 Favored Pre-proline 0 CA--C 1.538 0.488 0 N-CA-C 112.378 0.51 . . . . 1.0 112.378 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.638 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 49.4 Cg_endo -64.96 -24.48 60.4 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 121.632 1.555 . . . . 1.0 112.071 -177.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.585 ' HB3' HD11 ' A' ' 142' ' ' ILE . 39.9 mmm -61.62 -54.39 43.54 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 121.13 -0.228 . . . . 1.0 110.767 178.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.537 ' O ' ' HD1' ' A' ' 25' ' ' PHE . . . -72.65 -32.02 65.53 Favored 'General case' 0 CA--C 1.507 -0.679 0 C-N-CA 120.615 -0.434 . . . . 1.0 110.124 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.565 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 11.3 tt0 -50.83 -51.79 47.56 Favored 'General case' 0 C--O 1.216 -0.708 0 O-C-N 124.399 1.062 . . . . 1.0 109.988 -178.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.87 ' HB3' ' HG2' ' A' ' 68' ' ' PRO . 0.0 OUTLIER -79.45 -30.33 42.15 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.829 -0.623 . . . . 1.0 110.014 -176.906 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.659 ' HE2' ' HB3' ' A' ' 143' ' ' GLU . 3.2 mmm -62.39 -75.78 0.07 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.436 0.902 . . . . 1.0 113.436 -176.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.74 ' HE1' ' HZ ' ' A' ' 9' ' ' PHE . 0.8 OUTLIER -78.86 -27.81 44.16 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.011 -0.676 . . . . 1.0 111.543 -174.628 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.565 ' HB3' ' O ' ' A' ' 22' ' ' GLU . . . -64.62 -37.16 86.63 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 118.934 -1.106 . . . . 1.0 110.262 177.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.706 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -63.48 -39.44 94.46 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.76 -0.83 . . . . 1.0 108.76 177.417 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.573 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 77.6 mt-30 -59.67 -45.02 93.3 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.982 -0.554 . . . . 1.0 110.39 176.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.602 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 90.8 mt -54.46 -61.38 2.34 Favored 'General case' 0 N--CA 1.461 0.094 0 CA-C-N 115.751 -0.659 . . . . 1.0 111.078 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.6 ' HD3' ' HA ' ' A' ' 27' ' ' GLN . 3.2 ptm180 -58.53 -39.72 80.96 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.211 -0.449 . . . . 1.0 111.47 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -62.27 -22.52 66.07 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 112.176 0.435 . . . . 1.0 112.176 178.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.602 ' HG2' ' O ' ' A' ' 29' ' ' LEU . 5.7 ptm85 -99.89 -17.79 17.44 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 119.346 -0.941 . . . . 1.0 110.158 178.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.17 35.75 2.86 Favored Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 115.016 -0.993 . . . . 1.0 112.077 177.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.501 ' HG ' ' HG3' ' A' ' 32' ' ' ARG . 43.5 mt -126.88 -1.28 6.61 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.739 0.304 . . . . 1.0 110.346 -178.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.32 -28.0 54.12 Favored Glycine 0 N--CA 1.46 0.288 0 CA-C-N 116.027 -0.533 . . . . 1.0 112.897 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.482 ' O ' ' HB3' ' A' ' 4' ' ' PRO . 4.9 m-20 -89.7 -22.36 22.26 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.666 0.27 . . . . 1.0 110.55 177.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.04 -26.33 39.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.033 -0.53 . . . . 1.0 111.497 -179.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.84 HG23 ' HB3' ' A' ' 5' ' ' LEU . 1.1 p -143.83 124.02 8.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.37 0.605 . . . . 1.0 110.198 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.417 ' HE ' ' HG3' ' A' ' 4' ' ' PRO . 17.7 mmt85 -90.17 147.42 23.59 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.287 -0.87 . . . . 1.0 109.704 -178.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 74.7 t -132.64 117.27 30.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.557 0.694 . . . . 1.0 110.584 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.498 ' O ' ' HA ' ' A' ' 8' ' ' THR . 69.8 p -132.23 -174.15 3.36 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.502 -1.226 . . . . 1.0 110.419 -177.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.712 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 93.2 p -160.98 168.91 23.62 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.806 -0.357 . . . . 1.0 110.58 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.576 ' HB1' ' CD2' ' A' ' 80' ' ' HIS . . . -163.96 167.44 20.55 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.186 0.517 . . . . 1.0 111.291 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -125.75 135.74 9.34 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 115.355 -0.839 . . . . 1.0 111.023 176.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.643 HG21 HD13 ' A' ' 96' ' ' LEU . 23.5 p -70.59 -26.47 63.53 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.315 0.487 . . . . 1.0 112.315 -177.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.458 ' HA3' ' CZ3' ' A' ' 48' ' ' TRP . . . -108.11 9.61 36.58 Favored Glycine 0 C--O 1.229 -0.179 0 C-N-CA 120.717 -0.754 . . . . 1.0 112.796 -177.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 42.97 38.87 1.55 Allowed 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.344 0.868 . . . . 1.0 113.344 178.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.831 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 1.1 m-90 -46.38 -75.34 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.326 0.584 . . . . 1.0 112.48 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.483 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 8.1 m-70 -106.42 41.31 1.45 Allowed 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.259 -0.882 . . . . 1.0 111.046 -179.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.528 HG21 ' HA ' ' A' ' 74' ' ' ALA . 15.0 p -61.27 125.01 16.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 120.471 -0.492 . . . . 1.0 110.281 178.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.42 -12.5 66.4 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.903 -0.665 . . . . 1.0 111.763 -177.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.409 ' CB ' ' HB3' ' A' ' 49' ' ' HIS . 2.8 t -81.15 -160.33 0.32 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.228 0.537 . . . . 1.0 110.08 178.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 34.9 t -129.87 171.45 12.72 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.465 -0.788 . . . . 1.0 109.325 -178.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.26 140.85 37.71 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.745 0.307 . . . . 1.0 111.464 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -59.47 141.35 54.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.605 -0.725 . . . . 1.0 111.52 -177.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -51.58 -28.89 15.36 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 113.378 0.881 . . . . 1.0 113.378 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.675 ' O ' HG23 ' A' ' 61' ' ' VAL . 18.9 mtp180 -68.46 -50.61 51.24 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 118.524 0.602 . . . . 1.0 109.506 178.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.21 -32.37 72.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.145 -0.934 . . . . 1.0 110.568 -176.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.85 -46.6 88.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.135 178.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.88 -37.81 95.51 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.667 -0.778 . . . . 1.0 111.843 177.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.675 HG23 ' O ' ' A' ' 57' ' ' ARG . 58.1 t -63.2 -58.95 5.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.21 0.529 . . . . 1.0 111.282 179.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.716 ' HB2' HG23 ' A' ' 69' ' ' THR . 92.3 mt -58.3 -53.16 61.38 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.745 -0.661 . . . . 1.0 111.356 -177.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -59.23 -29.71 67.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.44 -0.346 . . . . 1.0 111.083 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.79 -33.33 73.69 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.231 0.538 . . . . 1.0 111.03 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -98.8 6.37 46.92 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.065 -0.516 . . . . 1.0 111.216 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.23 13.81 63.23 Favored Glycine 0 C--N 1.332 0.323 0 CA-C-N 115.642 -0.708 . . . . 1.0 112.961 176.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -90.59 151.64 44.25 Favored Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 110.554 -0.165 . . . . 1.0 110.554 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.87 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 46.9 Cg_endo -70.2 160.07 50.87 Favored 'Trans proline' 0 CA--C 1.515 -0.428 0 C-N-CA 122.481 2.121 . . . . 1.0 111.111 176.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.716 HG23 ' HB2' ' A' ' 62' ' ' LEU . 65.8 p -134.1 4.11 3.47 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.419 -0.513 . . . . 1.0 111.697 -177.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -74.38 126.75 31.37 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.398 -0.364 . . . . 1.0 110.075 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.861 ' HB2' ' HE3' ' A' ' 23' ' ' LYS . 28.8 t60 -166.28 150.29 7.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.638 -0.256 . . . . 1.0 110.802 -176.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -131.03 110.22 11.07 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.905 -1.146 . . . . 1.0 107.905 177.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 49' ' ' HIS . . . -58.57 139.92 55.06 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.896 -1.047 . . . . 1.0 112.412 -174.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.528 ' HA ' HG21 ' A' ' 50' ' ' VAL . . . -130.81 165.55 22.75 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.789 -0.642 . . . . 1.0 110.478 178.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -101.52 159.31 15.4 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.017 -0.735 . . . . 1.0 109.017 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.538 HG12 HD22 ' A' ' 97' ' ' LEU . 96.5 t -66.87 110.56 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.903 0.383 . . . . 1.0 110.61 179.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.466 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -127.52 -169.43 12.67 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.696 -0.684 . . . . 1.0 112.324 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 99.1 m -54.51 -52.03 63.26 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 123.457 0.703 . . . . 1.0 112.595 -178.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.582 ' HG2' ' N ' ' A' ' 80' ' ' HIS . 0.8 OUTLIER -58.19 -29.84 65.96 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.281 0.562 . . . . 1.0 110.523 -178.204 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.582 ' N ' ' HG2' ' A' ' 79' ' ' GLU . 79.9 m80 -76.59 -42.77 41.34 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.535 -0.757 . . . . 1.0 110.014 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.637 ' O ' HG23 ' A' ' 102' ' ' VAL . 17.3 mt -67.71 -18.85 65.05 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.118 0.485 . . . . 1.0 110.681 177.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.69 -7.92 57.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.936 0.398 . . . . 1.0 110.494 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.572 ' HB2' ' O ' ' A' ' 6' ' ' HIS . . . -60.74 152.69 26.16 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.64 -0.709 . . . . 1.0 111.099 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.455 ' HB3' ' HG ' ' A' ' 5' ' ' LEU . 26.0 t70 -79.47 -15.13 58.3 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.991 -0.55 . . . . 1.0 109.775 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.781 HD12 HG13 ' A' ' 7' ' ' VAL . 0.4 OUTLIER -153.62 117.33 4.7 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 115.573 -0.74 . . . . 1.0 109.862 -177.16 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.689 ' HG ' ' CG2' ' A' ' 8' ' ' THR . 5.0 mp -109.45 105.98 15.55 Favored 'General case' 0 N--CA 1.427 -1.599 0 CA-C-N 115.42 -0.809 . . . . 1.0 109.865 177.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.664 ' HB ' ' HD1' ' A' ' 9' ' ' PHE . 64.7 t -85.43 91.8 3.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.014 -0.994 . . . . 1.0 111.389 -175.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.06 149.92 30.5 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.307 -0.861 . . . . 1.0 110.884 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.54 HD21 ' HB3' ' A' ' 11' ' ' CYS . 3.9 mm? -96.26 -10.55 27.67 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.844 -0.616 . . . . 1.0 110.674 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.536 ' HA ' ' HE2' ' A' ' 109' ' ' MET . 9.7 p30 -156.5 167.89 29.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.463 0.649 . . . . 1.0 111.85 175.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -57.3 -24.61 56.08 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.165 -1.38 . . . . 1.0 112.636 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.611 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 91.1 m-20 -76.43 -53.88 7.51 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.837 0.351 . . . . 1.0 110.656 -176.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.506 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 13.2 m170 -58.94 -42.61 90.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.223 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.55 -43.5 97.18 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.999 0.428 . . . . 1.0 110.586 178.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.443 HH11 ' HD3' ' A' ' 95' ' ' ARG . 5.0 ttm-85 -57.9 -43.62 86.27 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 115.508 -0.769 . . . . 1.0 110.999 177.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.643 HD13 HG21 ' A' ' 45' ' ' THR . 55.6 mt -65.88 -50.51 64.24 Favored 'General case' 0 C--O 1.217 -0.633 0 CA-C-N 115.906 -0.588 . . . . 1.0 110.365 -176.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.641 HD21 HG21 ' A' ' 10' ' ' VAL . 30.5 mt -51.87 -56.1 16.1 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.055 -0.521 . . . . 1.0 111.135 -178.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.706 ' CA ' HG11 ' A' ' 102' ' ' VAL . 14.2 ptt85 -62.37 -43.1 99.61 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.546 0.573 . . . . 1.0 112.546 -178.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.538 ' HG3' ' O ' ' A' ' 96' ' ' LEU . 0.9 OUTLIER -67.36 -26.77 66.64 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.592 -0.443 . . . . 1.0 110.045 179.262 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.508 HD13 ' O ' ' A' ' 96' ' ' LEU . 5.4 mp -76.51 -20.26 57.12 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 116.088 -0.505 . . . . 1.0 111.818 178.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 153.2 -22.38 0.76 Allowed Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 119.465 -1.35 . . . . 1.0 113.927 -177.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.98 HG21 ' HD2' ' A' ' 106' ' ' ARG . 0.4 OUTLIER -76.42 -163.52 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-N 117.633 0.717 . . . . 1.0 110.33 -178.756 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.65 ' N ' HG13 ' A' ' 102' ' ' VAL . 12.7 pt-20 -159.05 162.64 36.66 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 107.369 -1.345 . . . . 1.0 107.369 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.737 ' HA ' HG13 ' A' ' 107' ' ' VAL . . . -62.14 -24.72 67.34 Favored 'General case' 0 C--N 1.322 -0.617 0 O-C-N 123.135 0.272 . . . . 1.0 111.421 -175.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.438 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . . . -56.57 -38.05 71.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.42 0.628 . . . . 1.0 110.06 175.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.98 ' HD2' HG21 ' A' ' 102' ' ' VAL . 20.4 mtt180 -97.65 -43.64 7.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.755 -1.111 . . . . 1.0 111.12 -176.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.737 HG13 ' HA ' ' A' ' 104' ' ' ALA . 10.7 p -79.62 118.79 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-O 121.037 0.446 . . . . 1.0 110.187 -174.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.66 ' HD2' ' O ' ' A' ' 107' ' ' VAL . 19.6 mmm180 -137.37 149.53 47.05 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.386 0.612 . . . . 1.0 111.076 -178.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.536 ' HE2' ' HA ' ' A' ' 90' ' ' ASP . 80.3 mmm -80.25 137.58 36.66 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.185 -0.916 . . . . 1.0 110.692 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.518 HD21 HG11 ' A' ' 87' ' ' VAL . 3.1 tm? -58.71 -49.26 78.26 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.868 0.366 . . . . 1.0 111.09 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -69.42 -16.7 63.55 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.171 -177.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.448 ' HB2' ' HB2' ' A' ' 109' ' ' MET . 37.4 t -78.38 -7.76 57.69 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 116.147 -0.478 . . . . 1.0 111.355 -178.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.506 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 92.4 m-85 -91.15 -21.58 21.1 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 109.821 -0.436 . . . . 1.0 109.821 175.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.7 t0 . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 115.766 -0.652 . . . . 1.0 110.556 -179.576 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 . . . . . 0 N--CA 1.453 -0.312 0 CA-C-O 120.518 0.199 . . . . 1.0 110.959 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -63.19 -50.94 68.32 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.77 -0.456 . . . . 1.0 109.77 177.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.986 ' HA ' HG22 ' A' ' 141' ' ' VAL . 96.1 t -61.27 -40.41 85.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.402 0.62 . . . . 1.0 109.979 178.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.456 ' HB2' HG11 ' A' ' 61' ' ' VAL . 22.9 t80 -53.49 -45.01 69.47 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.865 -1.061 . . . . 1.0 109.459 175.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.602 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -64.19 -40.16 95.5 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.393 -0.821 . . . . 1.0 110.543 177.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.986 HG22 ' HA ' ' A' ' 138' ' ' VAL . 13.9 t -55.44 -53.16 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-O 121.619 0.723 . . . . 1.0 109.908 177.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.585 HD11 ' HB3' ' A' ' 20' ' ' MET . 5.7 mt -63.99 -51.66 66.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 114.945 -1.025 . . . . 1.0 111.812 -178.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.659 ' HB3' ' HE2' ' A' ' 24' ' ' MET . 8.0 pt-20 -57.89 -30.2 65.66 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.74 -0.384 . . . . 1.0 110.397 -179.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 2.4 t -74.87 -26.7 59.85 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 121.253 0.549 . . . . 1.0 110.001 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.476 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -85.88 -25.81 25.97 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-N 115.794 -0.639 . . . . 1.0 111.277 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.681 HD22 ' HB3' ' A' ' 25' ' ' PHE . 16.7 mt -56.17 -36.4 45.72 Favored Pre-proline 0 CA--C 1.547 0.851 0 N-CA-C 112.719 0.637 . . . . 1.0 112.719 -178.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 43.9 Cg_endo -68.02 -14.4 40.92 Favored 'Trans proline' 0 C--N 1.364 1.357 0 C-N-CA 122.59 2.193 . . . . 1.0 111.495 177.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.506 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -103.29 -33.62 4.18 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 114.577 -1.192 . . . . 1.0 110.375 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.476 ' O ' HG13 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -73.19 -41.8 63.43 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 108.416 -0.957 . . . . 1.0 108.416 178.855 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . 0.587 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 0.2 OUTLIER -53.93 -55.87 23.0 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-N 115.067 -0.969 . . . . 1.0 110.506 175.217 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -56.78 -42.92 80.28 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.764 -1.107 . . . . 1.0 110.781 -174.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . 0.701 ' HZ3' HD21 ' A' ' 5' ' ' LEU . 26.2 t90 -62.84 -56.17 19.73 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.181 -0.918 . . . . 1.0 110.286 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.476 HG13 ' O ' ' A' ' 149' ' ' LEU . 9.7 m -60.35 -40.3 83.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.904 -0.318 . . . . 1.0 110.463 -178.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.419 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 1.4 m-20 -60.46 -51.88 67.57 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 123.425 0.453 . . . . 1.0 111.042 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 7.9 pt-20 -63.32 -37.82 88.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.789 -0.641 . . . . 1.0 110.6 -178.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.517 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 10.4 mmt85 -72.84 -46.45 52.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.834 -0.621 . . . . 1.0 111.115 -176.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 4.0 pp . . . . . 0 C--N 1.325 -0.494 0 CA-C-N 115.658 -0.701 . . . . 1.0 109.686 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo . . . . . 0 C--O 1.234 0.306 0 N-CA-C 113.481 0.531 . . . . 1.0 113.481 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.784 ' HB3' HG22 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -66.51 177.84 1.43 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.016 -0.993 . . . . 1.0 109.688 178.417 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.551 ' HB3' ' H ' ' A' ' 84' ' ' ASP . 3.3 t-160 -156.17 90.08 1.18 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 121.98 -0.45 . . . . 1.0 110.493 -179.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.716 HG13 HD13 ' A' ' 85' ' ' LEU . 2.0 t -94.33 113.17 28.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 N-CA-C 109.321 -0.622 . . . . 1.0 109.321 177.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.576 ' CG2' ' HG ' ' A' ' 86' ' ' LEU . 8.5 t -115.31 114.24 24.91 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.03 0.443 . . . . 1.0 110.589 178.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.629 ' HD2' ' HB3' ' A' ' 42' ' ' SER . 1.5 m-85 -84.71 132.83 34.41 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 122.138 -0.351 . . . . 1.0 110.744 -178.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.715 HG23 HD22 ' A' ' 97' ' ' LEU . 32.9 t -118.18 115.64 48.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.293 0.568 . . . . 1.0 111.975 -176.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.606 ' SG ' ' HD2' ' A' ' 17' ' ' ARG . 52.5 t -144.79 159.38 42.96 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.731 -0.668 . . . . 1.0 109.578 178.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -72.02 97.92 1.98 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.939 0.4 . . . . 1.0 110.336 178.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.888 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 127.88 -43.27 1.35 Allowed Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.481 -0.782 . . . . 1.0 111.549 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.417 HD22 ' CB ' ' A' ' 42' ' ' SER . 3.8 t-20 64.66 11.98 7.19 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 121.361 0.6 . . . . 1.0 111.752 179.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.447 ' HA ' ' HG3' ' A' ' 19' ' ' PRO . 7.5 pt -119.61 11.54 6.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 O-C-N 121.69 -0.631 . . . . 1.0 111.395 -178.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.1 p -127.36 -88.31 0.56 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.208 -0.451 . . . . 1.0 112.015 -178.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.606 ' HD2' ' SG ' ' A' ' 11' ' ' CYS . 57.7 mtt85 -63.54 -52.33 61.6 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 120.95 0.405 . . . . 1.0 111.845 -176.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.693 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 14.1 m -53.16 -58.37 12.73 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 115.666 -0.697 . . . . 1.0 112.679 -178.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.502 ' HD3' ' HB2' ' A' ' 18' ' ' SER . 57.7 Cg_endo -67.92 -20.72 44.79 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 121.556 1.504 . . . . 1.0 112.51 -176.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.585 ' HA ' HD12 ' A' ' 62' ' ' LEU . 47.2 mmm -61.89 -54.09 46.75 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 110.221 -0.288 . . . . 1.0 110.221 177.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.468 ' HA ' ' HB2' ' A' ' 24' ' ' MET . . . -74.9 -26.1 59.4 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 116.134 -0.485 . . . . 1.0 110.401 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.498 ' HA ' ' CE2' ' A' ' 9' ' ' PHE . 16.3 tt0 -51.29 -54.56 24.8 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.028 -0.987 . . . . 1.0 109.992 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.661 ' O ' ' HB3' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -85.69 -22.98 27.61 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.267 -0.879 . . . . 1.0 110.383 -176.023 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.67 ' HB3' HD12 ' A' ' 146' ' ' LEU . 6.3 mmm -63.03 -76.12 0.07 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.381 0.61 . . . . 1.0 112.592 -178.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.725 ' HB3' HD21 ' A' ' 146' ' ' LEU . 24.9 p90 -77.13 -29.63 54.77 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 119.864 -0.734 . . . . 1.0 111.546 -175.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.486 ' HB2' HG13 ' A' ' 40' ' ' VAL . . . -64.39 -38.2 90.19 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 119.493 -0.883 . . . . 1.0 110.817 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.936 ' HA ' ' HE ' ' A' ' 30' ' ' ARG . 0.1 OUTLIER -62.53 -39.68 94.34 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.906 -0.776 . . . . 1.0 108.906 177.03 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.606 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 79.2 mt-30 -59.06 -43.78 91.75 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.653 -0.703 . . . . 1.0 110.589 176.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 25' ' ' PHE . 92.5 mt -54.22 -62.68 1.5 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.942 -0.572 . . . . 1.0 111.207 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.936 ' HE ' ' HA ' ' A' ' 27' ' ' GLN . 0.1 OUTLIER -58.93 -34.04 71.27 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 120.559 -0.456 . . . . 1.0 111.466 178.683 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.0 m170 -62.12 -28.63 69.77 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.422 0.527 . . . . 1.0 112.422 177.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.533 ' HG2' ' O ' ' A' ' 28' ' ' GLN . 9.2 ptp180 -95.33 -20.29 19.26 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 119.535 -0.866 . . . . 1.0 110.101 178.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 108.17 39.32 1.84 Allowed Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.034 -0.985 . . . . 1.0 111.992 177.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 25.0 mt -131.03 2.21 4.31 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.567 -0.531 . . . . 1.0 109.567 -178.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -53.75 -35.73 53.27 Favored Glycine 0 C--O 1.226 -0.364 0 CA-C-N 115.545 -0.752 . . . . 1.0 113.35 -178.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.466 ' HA ' ' NH1' ' A' ' 39' ' ' ARG . 0.3 OUTLIER -86.94 -19.17 29.19 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 122.489 -0.418 . . . . 1.0 110.138 -179.86 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.89 -22.13 43.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.878 -0.601 . . . . 1.0 111.373 -177.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.784 HG22 ' HB3' ' A' ' 5' ' ' LEU . 0.4 OUTLIER -143.09 123.62 10.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.064 0.459 . . . . 1.0 110.66 -179.727 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.466 ' NH1' ' HA ' ' A' ' 36' ' ' ASP . 29.0 mmt180 -89.05 144.56 26.06 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.011 -0.541 . . . . 1.0 109.65 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.486 HG13 ' HB2' ' A' ' 26' ' ' ALA . 48.9 t -132.04 122.58 49.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 121.838 0.828 . . . . 1.0 110.234 -177.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.5 ' O ' ' HA ' ' A' ' 8' ' ' THR . 76.8 p -137.13 -176.87 4.53 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.203 -1.362 . . . . 1.0 110.511 -174.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.693 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 88.2 p -160.81 166.35 28.73 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.866 -0.334 . . . . 1.0 110.235 179.043 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.589 ' HB1' ' CD2' ' A' ' 80' ' ' HIS . . . -164.65 168.15 18.38 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.271 0.557 . . . . 1.0 111.353 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -125.83 132.81 8.04 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.26 -0.882 . . . . 1.0 110.997 177.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.572 HG21 ' CG1' ' A' ' 10' ' ' VAL . 26.0 p -68.77 -22.74 64.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.795 0.331 . . . . 1.0 111.831 -177.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.407 ' HA3' ' HZ3' ' A' ' 48' ' ' TRP . . . -112.41 9.11 26.47 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.875 -0.679 . . . . 1.0 113.133 -177.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 43.83 37.34 1.63 Allowed 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 114.156 1.169 . . . . 1.0 114.156 177.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.888 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 1.2 m-90 -45.77 -73.66 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.454 0.645 . . . . 1.0 112.404 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.48 ' O ' ' HB2' ' A' ' 73' ' ' ALA . 12.4 m-70 -106.06 40.84 1.51 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.248 -0.887 . . . . 1.0 111.063 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.0 p -60.18 129.37 22.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 120.65 -0.42 . . . . 1.0 110.375 179.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.25 -13.61 65.91 Favored Glycine 0 C--O 1.227 -0.33 0 C-N-CA 121.033 -0.603 . . . . 1.0 111.87 -177.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.5 t -80.58 -161.12 0.35 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.636 -0.505 . . . . 1.0 109.636 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 33.6 t -126.33 175.18 8.02 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.585 -0.894 . . . . 1.0 108.585 -178.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.14 141.08 47.44 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 123.098 0.248 . . . . 1.0 110.482 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.54 ' OD2' ' HG2' ' A' ' 57' ' ' ARG . 18.6 t70 -62.1 143.42 56.7 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.841 -177.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -46.69 -36.39 7.05 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.973 -1.012 . . . . 1.0 112.819 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.657 ' O ' HG22 ' A' ' 61' ' ' VAL . 19.3 ptp180 -69.69 -47.11 64.35 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 121.033 -0.267 . . . . 1.0 110.686 -176.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.408 ' HB2' ' SD ' ' A' ' 20' ' ' MET . . . -71.49 -31.96 67.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.097 0.475 . . . . 1.0 110.471 -177.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.14 -55.08 38.19 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.112 -0.699 . . . . 1.0 109.112 176.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -58.31 -39.69 93.0 Favored Glycine 0 N--CA 1.441 -1.009 0 CA-C-N 115.853 -0.612 . . . . 1.0 111.924 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.657 HG22 ' O ' ' A' ' 57' ' ' ARG . 98.7 t -58.98 -58.94 4.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.065 0.46 . . . . 1.0 110.992 177.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.605 HD13 ' HG3' ' A' ' 23' ' ' LYS . 87.7 mt -59.77 -52.46 65.36 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.881 -0.6 . . . . 1.0 111.61 -177.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.575 ' HB3' HG23 ' A' ' 69' ' ' THR . 0.0 OUTLIER -61.34 -33.31 73.41 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.727 -178.997 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.71 -32.93 74.13 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.212 0.53 . . . . 1.0 110.667 179.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -95.68 2.39 54.0 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.646 -0.706 . . . . 1.0 111.078 -178.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 94.12 9.51 59.35 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.978 -0.629 . . . . 1.0 113.531 176.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -90.68 152.15 44.62 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 110.061 -0.348 . . . . 1.0 110.061 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.546 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 36.0 Cg_endo -67.31 157.56 61.15 Favored 'Trans proline' 0 CA--C 1.512 -0.609 0 C-N-CA 122.189 1.926 . . . . 1.0 110.756 176.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.575 HG23 ' HB3' ' A' ' 63' ' ' ARG . 63.2 p -130.65 11.46 5.26 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 120.365 -0.534 . . . . 1.0 111.644 -176.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -80.87 133.51 35.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.77 -0.65 . . . . 1.0 110.087 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 51.7 t60 -169.22 152.24 4.93 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.892 0.377 . . . . 1.0 110.659 -176.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.431 ' HD3' ' HA ' ' A' ' 72' ' ' ARG . 9.4 tpp180 -133.93 110.86 10.0 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 108.084 -1.08 . . . . 1.0 108.084 175.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.48 ' HB2' ' O ' ' A' ' 49' ' ' HIS . . . -60.34 137.72 58.09 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.288 -0.869 . . . . 1.0 112.176 -175.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -130.96 160.25 35.08 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.437 -0.801 . . . . 1.0 110.013 178.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -97.43 154.82 17.23 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.026 -0.731 . . . . 1.0 109.026 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.511 HG13 HD23 ' A' ' 97' ' ' LEU . 14.5 t -67.35 113.19 3.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.053 0.454 . . . . 1.0 110.725 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.444 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -124.19 -169.59 13.12 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.128 -0.942 . . . . 1.0 111.538 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 97.9 m -58.51 -44.48 89.48 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 122.275 0.23 . . . . 1.0 111.548 -178.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -60.4 -28.48 68.26 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.937 0.399 . . . . 1.0 111.183 178.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.589 ' CD2' ' HB1' ' A' ' 43' ' ' ALA . 78.8 m80 -77.67 -41.43 38.2 Favored 'General case' 0 C--O 1.223 -0.297 0 N-CA-C 109.763 -0.458 . . . . 1.0 109.763 179.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.658 ' O ' HG23 ' A' ' 102' ' ' VAL . 15.6 mt -69.83 -14.42 62.75 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.6 177.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -88.49 -7.55 56.34 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 120.884 0.373 . . . . 1.0 110.618 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.547 ' HB2' ' O ' ' A' ' 6' ' ' HIS . . . -59.94 150.38 29.0 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.805 -0.634 . . . . 1.0 111.407 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.698 ' HB3' HD12 ' A' ' 5' ' ' LEU . 15.3 t70 -75.4 -15.19 60.48 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.941 -0.392 . . . . 1.0 109.941 178.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.716 HD13 HG13 ' A' ' 7' ' ' VAL . 0.5 OUTLIER -154.66 119.63 4.94 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 109.245 -0.65 . . . . 1.0 109.245 -177.787 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.659 ' HB3' HD11 ' A' ' 97' ' ' LEU . 5.1 mp -109.8 104.74 13.75 Favored 'General case' 0 N--CA 1.426 -1.652 0 CA-C-N 115.531 -0.759 . . . . 1.0 109.735 177.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.582 ' HA ' ' O ' ' A' ' 108' ' ' ARG . 53.6 t -83.79 91.54 2.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 114.924 -1.035 . . . . 1.0 111.115 -176.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.13 145.73 33.57 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.397 -0.82 . . . . 1.0 110.29 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.481 ' HG ' ' CB ' ' A' ' 17' ' ' ARG . 3.9 mm? -99.35 -8.04 25.4 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.026 -0.534 . . . . 1.0 110.361 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.427 ' CG ' ' H ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -151.76 152.48 32.77 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.662 -0.699 . . . . 1.0 110.858 179.15 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -58.16 -24.01 57.37 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.21 0.818 . . . . 1.0 113.21 -177.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.672 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 9.7 m120 -77.1 -48.07 18.76 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.933 -0.395 . . . . 1.0 109.933 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.547 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 11.7 m170 -56.6 -44.24 80.91 Favored 'General case' 0 N--CA 1.461 0.094 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.031 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.65 -45.17 92.81 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.952 178.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.6 ttt180 -59.26 -39.89 84.29 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.11 -0.496 . . . . 1.0 111.152 178.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.697 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 48.7 mt -66.16 -48.87 69.33 Favored 'General case' 0 C--O 1.218 -0.58 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.304 -176.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.715 HD22 HG23 ' A' ' 10' ' ' VAL . 36.2 mt -52.89 -58.39 7.07 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.086 -0.506 . . . . 1.0 111.374 -179.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.775 ' HA ' HG13 ' A' ' 102' ' ' VAL . 1.3 ptt180 -58.34 -44.69 88.83 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.801 -0.636 . . . . 1.0 111.811 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.636 ' HG3' ' O ' ' A' ' 96' ' ' LEU . 1.1 pp0? -67.8 -25.27 65.5 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.043 0.449 . . . . 1.0 109.948 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.697 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 13.2 mt -79.67 -12.6 59.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.668 -0.696 . . . . 1.0 111.612 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 145.99 -22.25 1.77 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 119.863 -1.16 . . . . 1.0 113.935 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.775 HG13 ' HA ' ' A' ' 98' ' ' ARG . 0.4 OUTLIER -75.93 -163.19 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 CA-C-N 117.419 0.609 . . . . 1.0 110.463 -178.813 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.726 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 12.4 pt-20 -155.87 163.11 40.21 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.702 -1.221 . . . . 1.0 107.702 -179.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.782 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -63.03 -24.98 68.17 Favored 'General case' 0 C--N 1.321 -0.664 0 O-C-N 123.186 0.304 . . . . 1.0 111.459 -175.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.2 -36.82 73.67 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.189 0.519 . . . . 1.0 110.042 175.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.726 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 5.5 mtt-85 -97.23 -42.42 7.82 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 115.368 -0.833 . . . . 1.0 111.6 -176.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.782 HG12 ' HA ' ' A' ' 104' ' ' ALA . 11.9 p -77.55 118.68 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 109.354 -0.61 . . . . 1.0 109.354 -175.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.582 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 16.1 mmm180 -138.64 147.31 42.73 Favored 'General case' 0 C--N 1.319 -0.755 0 O-C-N 121.623 -0.673 . . . . 1.0 110.764 -178.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.478 ' HB2' ' HB2' ' A' ' 112' ' ' SER . 77.1 mmm -79.76 137.54 37.03 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.523 -0.762 . . . . 1.0 110.639 179.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.496 HD22 HG13 ' A' ' 87' ' ' VAL . 3.1 tm? -57.5 -49.97 74.56 Favored 'General case' 0 N--CA 1.465 0.303 0 O-C-N 123.16 0.287 . . . . 1.0 111.221 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 46.1 ttt180 -70.29 -17.44 63.09 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.877 -0.329 . . . . 1.0 110.776 -177.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.478 ' HB2' ' HB2' ' A' ' 109' ' ' MET . 33.8 t -75.6 -4.58 40.81 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.984 -0.286 . . . . 1.0 110.969 -178.026 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.602 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 92.1 m-85 -92.26 -16.25 26.38 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 120.878 0.37 . . . . 1.0 110.196 175.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 17.9 t0 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.0 -0.545 . . . . 1.0 110.712 -178.552 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 . . . . . 0 N--CA 1.454 -0.258 0 CA-C-O 120.758 0.313 . . . . 1.0 110.908 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -64.33 -50.73 66.62 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.62 0.724 . . . . 1.0 109.359 176.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 1.047 ' HA ' HG21 ' A' ' 141' ' ' VAL . 92.9 t -61.77 -38.7 81.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.01 -0.995 . . . . 1.0 109.992 177.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.511 ' HB2' ' HE2' ' A' ' 20' ' ' MET . 24.9 t80 -53.52 -42.06 67.02 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.098 -0.955 . . . . 1.0 109.325 175.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.51 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -65.33 -41.3 94.1 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.301 -0.863 . . . . 1.0 110.187 177.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 1.047 HG21 ' HA ' ' A' ' 138' ' ' VAL . 11.9 t -55.52 -52.43 47.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 121.604 0.716 . . . . 1.0 110.139 177.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.558 HD13 ' HB3' ' A' ' 20' ' ' MET . 6.5 mt -63.99 -51.74 65.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 114.954 -1.021 . . . . 1.0 112.055 -178.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.51 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 11.3 pt-20 -56.43 -31.5 63.99 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.862 0.363 . . . . 1.0 110.373 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.4 t -74.5 -28.35 60.95 Favored 'General case' 0 C--O 1.225 -0.206 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.253 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.481 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -86.54 -24.12 25.6 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-N 115.889 -0.596 . . . . 1.0 111.545 179.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.725 HD21 ' HB3' ' A' ' 25' ' ' PHE . 11.8 mt -55.65 -36.9 51.05 Favored Pre-proline 0 CA--C 1.544 0.727 0 N-CA-C 112.577 0.584 . . . . 1.0 112.577 -178.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 55.8 Cg_endo -69.88 -11.6 31.01 Favored 'Trans proline' 0 C--N 1.363 1.332 0 C-N-CA 122.339 2.026 . . . . 1.0 111.854 177.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.602 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -104.85 -33.94 3.64 Favored Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 110.703 -0.959 . . . . 1.0 110.703 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.517 HD11 ' CE2' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -74.21 -41.12 61.89 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.43 -0.952 . . . . 1.0 108.43 178.729 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . 0.503 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 1.2 m-70 -54.29 -55.14 31.23 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 114.933 -1.031 . . . . 1.0 109.926 174.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -57.32 -40.83 78.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.315 -0.857 . . . . 1.0 110.71 -175.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . 0.707 ' HZ3' HD11 ' A' ' 5' ' ' LEU . 27.0 t90 -63.54 -57.54 9.83 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.596 -0.729 . . . . 1.0 110.748 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.409 HG12 ' O ' ' A' ' 149' ' ' LEU . 10.3 m -61.43 -41.17 88.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.803 -0.359 . . . . 1.0 110.195 -178.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.41 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 1.8 m-20 -60.5 -50.72 72.44 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 120.897 0.38 . . . . 1.0 110.42 178.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.545 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 6.3 pt-20 -63.23 -38.13 89.94 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.123 0.487 . . . . 1.0 110.936 -178.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.52 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 4.7 mmt180 -72.58 -45.15 60.54 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.664 -177.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 3.9 pp . . . . . 0 C--N 1.32 -0.704 0 CA-C-N 115.716 -0.675 . . . . 1.0 109.762 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo . . . . . 0 N--CA 1.46 -0.443 0 CA-C-O 121.002 0.334 . . . . 1.0 112.834 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.767 HD12 ' HB3' ' A' ' 84' ' ' ASP . 0.2 OUTLIER -67.13 177.82 1.65 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.532 -0.758 . . . . 1.0 109.384 178.749 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.62 ' O ' ' HB1' ' A' ' 83' ' ' ALA . 3.4 t-160 -157.55 89.32 1.03 Allowed 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.363 -0.606 . . . . 1.0 109.363 -179.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.792 HG12 HD11 ' A' ' 85' ' ' LEU . 2.4 t -95.95 107.38 19.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 109.759 -0.46 . . . . 1.0 109.759 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.598 ' CG2' ' HG ' ' A' ' 86' ' ' LEU . 11.8 t -108.25 114.97 29.26 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.084 0.469 . . . . 1.0 110.943 -179.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.543 ' HA ' ' O ' ' A' ' 87' ' ' VAL . 0.5 OUTLIER -85.76 134.55 33.94 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 122.203 -0.31 . . . . 1.0 110.262 -178.802 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.581 ' CG1' HG21 ' A' ' 45' ' ' THR . 42.4 t -120.66 119.87 60.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-O 121.385 0.612 . . . . 1.0 112.17 -175.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.467 ' HA ' ' CE1' ' A' ' 93' ' ' HIS . 15.4 p -143.68 167.63 21.81 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.214 -0.903 . . . . 1.0 109.453 177.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.98 93.54 3.82 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.417 0.627 . . . . 1.0 111.033 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.745 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 129.68 -37.03 2.24 Favored Glycine 0 N--CA 1.443 -0.855 0 CA-C-N 115.25 -0.886 . . . . 1.0 112.526 178.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.437 HD22 ' CB ' ' A' ' 42' ' ' SER . 3.6 t-20 64.49 19.1 11.69 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.924 0.868 . . . . 1.0 110.703 -179.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.475 ' O ' ' HB3' ' A' ' 55' ' ' ASP . 1.3 pt -135.95 47.38 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 CA-C-N 115.491 -0.777 . . . . 1.0 109.567 -178.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.681 ' O ' ' HG3' ' A' ' 20' ' ' MET . 4.4 p -157.23 -89.3 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.78 -1.1 . . . . 1.0 111.846 175.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.478 ' HD2' ' SG ' ' A' ' 16' ' ' CYS . 0.1 OUTLIER -74.96 -43.1 55.95 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 121.908 -0.495 . . . . 1.0 111.817 -175.569 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.821 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 46.8 m -54.33 -56.6 24.76 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 116.425 -0.352 . . . . 1.0 111.505 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.663 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 49.0 Cg_endo -66.47 -24.22 49.57 Favored 'Trans proline' 0 C--N 1.357 0.995 0 C-N-CA 121.548 1.499 . . . . 1.0 112.387 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.681 ' HG3' ' O ' ' A' ' 16' ' ' CYS . 51.0 mtp -62.94 -56.54 16.31 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.672 -0.411 . . . . 1.0 110.646 177.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.63 -28.02 64.5 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 120.724 -0.39 . . . . 1.0 110.217 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.77 ' O ' ' HB1' ' A' ' 26' ' ' ALA . 14.8 tt0 -51.85 -53.22 42.82 Favored 'General case' 0 C--O 1.214 -0.764 0 CA-C-N 114.74 -1.118 . . . . 1.0 109.614 178.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.911 ' HB3' ' HG2' ' A' ' 68' ' ' PRO . 0.1 OUTLIER -79.43 -32.39 42.81 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.36 -0.837 . . . . 1.0 110.235 -176.089 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.568 ' HB3' HD12 ' A' ' 146' ' ' LEU . 3.5 mmm -61.9 -75.61 0.07 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 113.173 0.805 . . . . 1.0 113.173 -175.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.738 ' HB3' HD22 ' A' ' 146' ' ' LEU . 14.0 p90 -78.44 -29.31 46.95 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 119.828 -0.749 . . . . 1.0 111.484 -174.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.77 ' HB1' ' O ' ' A' ' 22' ' ' GLU . . . -64.12 -36.62 84.62 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 119.146 -1.021 . . . . 1.0 110.461 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.638 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -64.03 -39.32 93.84 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.614 -0.884 . . . . 1.0 108.614 177.062 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.564 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 77.1 mt-30 -60.38 -39.45 87.33 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-N 115.719 -0.673 . . . . 1.0 110.916 176.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.572 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 88.7 mt -59.81 -59.89 4.71 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.756 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.472 ' HA ' ' H ' ' A' ' 35' ' ' GLY . 0.1 OUTLIER -58.96 -36.87 75.54 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.375 -0.53 . . . . 1.0 111.254 178.518 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -65.02 -25.46 67.86 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.382 0.512 . . . . 1.0 112.382 177.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.576 ' HD3' HD13 ' A' ' 34' ' ' LEU . 3.9 ptm180 -93.17 -19.46 21.44 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 119.461 -0.895 . . . . 1.0 109.465 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 110.4 35.02 2.17 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 114.955 -1.02 . . . . 1.0 111.926 177.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.576 HD13 ' HD3' ' A' ' 32' ' ' ARG . 46.9 mt -134.45 5.93 3.5 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 122.59 -0.359 . . . . 1.0 111.006 -177.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.472 ' H ' ' HA ' ' A' ' 30' ' ' ARG . . . -54.83 -29.62 50.75 Favored Glycine 0 C--N 1.33 0.24 0 C-N-CA 121.177 -0.535 . . . . 1.0 113.118 -178.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -94.92 -20.91 19.0 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.632 0.253 . . . . 1.0 110.985 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.48 -23.27 43.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.369 0.604 . . . . 1.0 111.342 -178.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.764 HG21 ' HB3' ' A' ' 5' ' ' LEU . 0.3 OUTLIER -142.44 119.5 6.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.53 -0.545 . . . . 1.0 109.53 178.001 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 16.9 mmt85 -91.13 148.42 22.39 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.618 -0.719 . . . . 1.0 109.295 -178.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.604 HG12 ' HB2' ' A' ' 26' ' ' ALA . 2.0 m -131.54 139.62 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.075 0 N-CA-C 108.391 -0.966 . . . . 1.0 108.391 178.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.493 ' O ' ' HA ' ' A' ' 8' ' ' THR . 21.7 p -146.36 -177.69 5.75 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.287 -0.87 . . . . 1.0 109.808 -175.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.821 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 93.4 p -159.32 163.96 35.23 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 120.613 -0.435 . . . . 1.0 109.982 178.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.557 ' HB3' ' CD2' ' A' ' 80' ' ' HIS . . . -164.38 164.96 22.0 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.452 0.644 . . . . 1.0 111.357 -179.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.462 ' HA2' ' O ' ' A' ' 11' ' ' CYS . . . -122.18 130.05 7.84 Favored Glycine 0 N--CA 1.439 -1.163 0 N-CA-C 110.41 -1.076 . . . . 1.0 110.41 177.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.581 HG21 ' CG1' ' A' ' 10' ' ' VAL . 18.8 p -65.25 -24.16 67.25 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 111.853 0.316 . . . . 1.0 111.853 -177.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -107.66 8.81 37.44 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.809 -0.71 . . . . 1.0 113.353 -177.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 42.96 37.77 1.22 Allowed 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.722 0.809 . . . . 1.0 113.078 179.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.745 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 0.7 OUTLIER -49.2 -76.66 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.524 0.565 . . . . 1.0 112.524 -179.59 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.468 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 36.1 m-70 -103.97 39.65 1.59 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.869 -0.605 . . . . 1.0 111.154 -178.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.499 HG22 ' HA ' ' A' ' 74' ' ' ALA . 11.0 p -59.4 126.31 16.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.019 0.438 . . . . 1.0 110.338 178.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.25 -14.76 62.12 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 121.037 -0.601 . . . . 1.0 111.942 -177.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.461 ' O ' ' HA ' ' A' ' 72' ' ' ARG . 3.8 t -81.61 -161.87 0.47 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.119 0.485 . . . . 1.0 110.138 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 30.2 t -120.84 178.59 4.65 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.737 -0.665 . . . . 1.0 109.289 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.403 ' HB1' ' HB3' ' A' ' 71' ' ' HIS . . . -67.21 146.91 53.71 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.224 0.535 . . . . 1.0 110.499 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.582 ' OD1' ' HA ' ' A' ' 16' ' ' CYS . 9.7 p-10 -64.46 150.69 46.04 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.889 -1.05 . . . . 1.0 113.588 -175.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -44.8 -49.62 10.63 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 113.533 -1.667 . . . . 1.0 114.121 176.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.48 ' HG2' ' OD2' ' A' ' 55' ' ' ASP . 9.6 ptp180 -71.04 -37.38 72.56 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.856 -0.338 . . . . 1.0 111.647 -174.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.452 ' HB1' ' HG2' ' A' ' 20' ' ' MET . . . -70.73 -40.95 72.45 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.906 -0.405 . . . . 1.0 109.906 177.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.5 -47.08 85.54 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.87 -0.604 . . . . 1.0 109.836 179.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -60.17 -46.87 93.44 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.912 -0.661 . . . . 1.0 113.318 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.43 HG11 ' O ' ' A' ' 57' ' ' ARG . 13.3 m -71.85 -38.06 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 CA-C-N 117.8 0.8 . . . . 1.0 111.663 -178.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.557 HD21 ' HG3' ' A' ' 23' ' ' LYS . 4.6 mp -63.9 -52.7 58.71 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 120.489 -0.484 . . . . 1.0 110.361 178.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 63' ' ' ARG . 0.3 OUTLIER -62.44 -27.67 69.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.013 -0.539 . . . . 1.0 111.416 -179.298 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.64 -33.9 69.33 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 120.817 0.341 . . . . 1.0 110.812 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -94.68 3.01 55.58 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.776 -178.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 90.56 13.49 59.66 Favored Glycine 0 CA--C 1.517 0.206 0 CA-C-N 115.697 -0.683 . . . . 1.0 113.257 176.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -90.26 155.4 46.72 Favored Pre-proline 0 C--N 1.318 -0.776 0 CA-C-O 120.45 0.167 . . . . 1.0 110.716 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.911 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 74.5 Cg_endo -72.91 162.24 41.56 Favored 'Trans proline' 0 CA--C 1.512 -0.604 0 C-N-CA 122.43 2.087 . . . . 1.0 110.871 177.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 35.0 p -137.83 10.93 2.89 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 120.043 -0.663 . . . . 1.0 111.228 -178.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -72.53 116.84 13.48 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.666 178.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.832 ' HB2' ' HE3' ' A' ' 23' ' ' LYS . 50.1 t60 -157.85 149.74 21.97 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.918 0.39 . . . . 1.0 111.175 -177.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' A' ' 52' ' ' SER . 4.8 tpt180 -133.66 114.19 13.2 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.785 -1.191 . . . . 1.0 107.785 175.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.468 ' HB3' ' O ' ' A' ' 49' ' ' HIS . . . -59.32 137.81 57.85 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.088 -0.96 . . . . 1.0 112.774 -175.074 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.499 ' HA ' HG22 ' A' ' 50' ' ' VAL . . . -129.65 161.65 30.11 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.213 -0.903 . . . . 1.0 110.078 178.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -97.53 156.73 16.37 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 108.244 -1.021 . . . . 1.0 108.244 178.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.498 HG12 ' CD2' ' A' ' 97' ' ' LEU . 8.1 t -66.91 104.26 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.303 0.573 . . . . 1.0 109.781 178.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.403 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -113.89 -175.09 18.93 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 115.184 -0.917 . . . . 1.0 111.269 -178.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 94.1 m -56.37 -43.36 79.1 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.814 0.34 . . . . 1.0 111.259 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -60.88 -29.76 69.74 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.091 -0.504 . . . . 1.0 111.312 178.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.557 ' CD2' ' HB3' ' A' ' 43' ' ' ALA . 80.0 m80 -78.19 -39.73 39.8 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-O 120.98 0.419 . . . . 1.0 109.875 178.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.518 ' HA ' HD21 ' A' ' 86' ' ' LEU . 33.9 mt -68.65 -18.75 64.34 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.784 -0.644 . . . . 1.0 110.758 178.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.8 -4.8 59.22 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.861 -0.608 . . . . 1.0 110.844 -178.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.62 ' HB1' ' O ' ' A' ' 6' ' ' HIS . . . -59.98 154.22 19.49 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.979 -0.555 . . . . 1.0 111.665 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.767 ' HB3' HD12 ' A' ' 5' ' ' LEU . 10.6 t70 -80.4 -12.08 59.62 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.52 -0.548 . . . . 1.0 109.52 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.792 HD11 HG12 ' A' ' 7' ' ' VAL . 0.4 OUTLIER -156.98 118.09 3.68 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 115.65 -0.705 . . . . 1.0 109.22 -177.615 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.694 ' HB3' HD13 ' A' ' 97' ' ' LEU . 5.1 mp -107.52 105.99 16.16 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-N 115.815 -0.629 . . . . 1.0 109.709 177.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.565 HG11 HD23 ' A' ' 110' ' ' LEU . 48.1 t -86.51 94.88 4.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 114.823 -1.081 . . . . 1.0 111.066 -176.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -82.73 144.67 30.04 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 114.975 -1.012 . . . . 1.0 110.949 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.412 HD13 ' HA ' ' A' ' 89' ' ' LEU . 4.3 mm? -95.04 -13.65 25.01 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.254 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.44 ' CG ' ' H ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -148.74 153.67 38.51 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.724 -0.671 . . . . 1.0 111.542 -178.89 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.405 ' H ' ' HG2' ' A' ' 91' ' ' ARG . 1.7 ptt180 -49.74 -32.2 13.1 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.666 1.186 . . . . 1.0 113.55 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.638 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 76.9 m-20 -77.36 -47.51 19.7 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.751 -0.38 . . . . 1.0 110.672 -177.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.715 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 13.5 m170 -54.52 -48.15 72.27 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.923 -0.399 . . . . 1.0 109.923 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.96 -43.03 91.24 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.073 0.463 . . . . 1.0 110.752 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.673 ' O ' ' HG2' ' A' ' 99' ' ' GLN . 11.5 ttp180 -58.32 -47.56 83.31 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.465 -0.789 . . . . 1.0 111.363 179.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.712 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 48.4 mt -62.16 -49.11 77.15 Favored 'General case' 0 C--O 1.219 -0.533 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.233 -175.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.715 ' HG ' ' O ' ' A' ' 93' ' ' HIS . 32.1 mt -53.42 -58.05 8.49 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.816 -0.629 . . . . 1.0 111.762 -177.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.511 ' HG2' ' O ' ' A' ' 95' ' ' ARG . 22.6 ptt180 -59.41 -44.83 92.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.451 . . . . 1.0 111.578 -176.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.673 ' HG2' ' O ' ' A' ' 95' ' ' ARG . 9.9 pt20 -70.89 -18.65 62.67 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.84 0.353 . . . . 1.0 111.227 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.712 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 5.5 mt -79.58 -8.1 58.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.068 -0.515 . . . . 1.0 111.706 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 146.87 -30.36 1.52 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.029 -1.082 . . . . 1.0 113.011 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.78 HG13 ' H ' ' A' ' 103' ' ' GLU . 2.0 t -73.32 -154.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 121.077 0.465 . . . . 1.0 110.868 -178.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.78 ' H ' HG13 ' A' ' 102' ' ' VAL . 15.6 pt-20 -164.61 165.14 21.31 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.977 -0.749 . . . . 1.0 108.977 -177.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.778 ' HA ' HG13 ' A' ' 107' ' ' VAL . . . -65.01 -24.87 67.63 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 123.409 0.443 . . . . 1.0 111.542 -176.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.5 -35.65 72.57 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.3 0.571 . . . . 1.0 110.254 175.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.689 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 4.7 mtt-85 -96.89 -42.71 7.81 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 115.2 -0.909 . . . . 1.0 111.029 -177.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.778 HG13 ' HA ' ' A' ' 104' ' ' ALA . 7.8 p -80.79 121.7 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-O 121.37 0.605 . . . . 1.0 109.981 -177.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.528 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 12.7 mmm180 -137.97 146.6 43.36 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.39 -0.596 . . . . 1.0 109.39 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.431 ' HB2' ' HB2' ' A' ' 112' ' ' SER . 79.6 mmm -77.81 139.53 39.33 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.837 -0.619 . . . . 1.0 110.234 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.565 HD23 HG11 ' A' ' 87' ' ' VAL . 3.2 tm? -56.04 -48.29 76.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.517 0.198 . . . . 1.0 111.075 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 20.7 ttt85 -71.35 -17.49 62.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.007 0.432 . . . . 1.0 110.498 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.431 ' HB2' ' HB2' ' A' ' 109' ' ' MET . 30.5 t -70.67 -12.26 61.45 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.581 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.45 ' HZ ' HD21 ' A' ' 85' ' ' LEU . 97.6 m-85 -90.8 -25.38 19.96 Favored 'General case' 0 N--CA 1.456 -0.166 0 O-C-N 122.175 -0.328 . . . . 1.0 110.122 176.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 13.1 t0 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 115.51 -0.768 . . . . 1.0 111.756 -177.432 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 . . . . . 0 N--CA 1.45 -0.453 0 CA-C-O 120.528 0.204 . . . . 1.0 111.237 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.404 ' O ' HG23 ' A' ' 141' ' ' VAL . 20.0 tp10 -65.29 -46.76 79.12 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 108.187 -1.042 . . . . 1.0 108.187 174.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 72.3 t -60.08 -44.25 94.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 114.594 -1.185 . . . . 1.0 109.214 175.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -54.01 -42.79 69.47 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.453 -1.249 . . . . 1.0 109.828 176.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.519 ' HA ' ' OE2' ' A' ' 143' ' ' GLU . . . -64.26 -42.07 96.64 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.462 -0.79 . . . . 1.0 111.03 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 137' ' ' GLU . 16.9 t -56.96 -53.77 38.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.503 0.668 . . . . 1.0 110.235 178.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.461 ' HA ' HD11 ' A' ' 110' ' ' LEU . 4.7 mt -60.92 -52.27 63.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.376 -0.829 . . . . 1.0 112.289 -178.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.519 ' OE2' ' HA ' ' A' ' 140' ' ' ALA . 13.2 pt-20 -56.17 -32.18 64.09 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.932 0.396 . . . . 1.0 110.515 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 73.0 m -72.8 -28.9 62.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.574 -0.739 . . . . 1.0 110.939 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.467 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -87.18 -23.5 24.77 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-N 116.215 -0.448 . . . . 1.0 111.712 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.738 HD22 ' HB3' ' A' ' 25' ' ' PHE . 13.4 mt -56.01 -36.66 48.63 Favored Pre-proline 0 CA--C 1.548 0.874 0 N-CA-C 112.417 0.525 . . . . 1.0 112.417 -177.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.619 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 51.1 Cg_endo -69.7 -10.79 29.47 Favored 'Trans proline' 0 C--N 1.366 1.465 0 C-N-CA 122.733 2.288 . . . . 1.0 112.277 177.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -105.24 -32.6 3.95 Favored Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 110.465 -1.054 . . . . 1.0 110.465 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.467 ' O ' HG13 ' A' ' 153' ' ' VAL . 0.4 OUTLIER -74.48 -41.02 61.45 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.664 -0.865 . . . . 1.0 108.664 178.937 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -53.52 -55.38 25.96 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 114.814 -1.085 . . . . 1.0 110.921 175.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -60.75 -40.47 92.56 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.563 -0.744 . . . . 1.0 111.591 -176.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . 0.745 ' HZ3' HD11 ' A' ' 5' ' ' LEU . 29.0 t90 -63.36 -54.6 34.37 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.552 -0.749 . . . . 1.0 110.751 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.467 HG13 ' O ' ' A' ' 149' ' ' LEU . 11.1 m -60.11 -39.19 79.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 C-N-CA 120.84 -0.344 . . . . 1.0 110.075 -179.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.428 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 8.3 m-20 -59.68 -51.74 68.5 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.272 0.558 . . . . 1.0 110.966 178.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.509 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 5.1 pt-20 -63.46 -38.31 90.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.406 -0.815 . . . . 1.0 110.443 -178.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.508 ' HG3' ' CH2' ' A' ' 152' ' ' TRP . 10.9 mmt180 -74.89 -42.72 57.29 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.615 -0.72 . . . . 1.0 111.664 -177.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 4.2 pp . . . . . 0 C--N 1.322 -0.599 0 CA-C-O 121.157 0.503 . . . . 1.0 109.793 179.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.57 ' HB3' ' O ' ' A' ' 36' ' ' ASP . 23.1 Cg_endo . . . . . 0 N--CA 1.464 -0.26 0 N-CA-C 114.046 0.748 . . . . 1.0 114.046 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.838 ' HB3' HG21 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -66.11 177.66 1.34 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.635 -1.166 . . . . 1.0 109.578 178.084 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.573 ' H ' HD12 ' A' ' 5' ' ' LEU . 0.9 OUTLIER -155.51 99.0 2.0 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.763 -0.458 . . . . 1.0 109.763 179.617 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.617 HG12 HD13 ' A' ' 85' ' ' LEU . 2.3 t -104.09 118.27 50.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 108.147 -1.057 . . . . 1.0 108.147 177.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.617 HG22 ' HG ' ' A' ' 86' ' ' LEU . 11.7 t -119.75 113.59 20.86 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.302 0.572 . . . . 1.0 110.352 178.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.653 ' HD1' ' HB ' ' A' ' 87' ' ' VAL . 1.0 OUTLIER -84.51 133.21 34.47 Favored 'General case' 0 CA--C 1.512 -0.487 0 O-C-N 122.024 -0.423 . . . . 1.0 110.258 -178.18 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.557 ' CG1' HG21 ' A' ' 45' ' ' THR . 40.7 t -119.95 119.49 60.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.552 0.691 . . . . 1.0 112.042 -176.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.436 ' HA ' ' CE1' ' A' ' 93' ' ' HIS . 21.7 p -148.32 163.37 37.29 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.221 -0.9 . . . . 1.0 109.963 177.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.96 96.81 5.83 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 120.849 0.357 . . . . 1.0 110.39 177.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.487 ' O ' HG12 ' A' ' 15' ' ' ILE . . . 146.64 -36.62 1.24 Allowed Glycine 0 C--O 1.218 -0.89 0 CA-C-N 115.687 -0.688 . . . . 1.0 112.26 179.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.505 ' OD1' ' HB1' ' A' ' 73' ' ' ALA . 32.2 p30 49.27 18.54 0.26 Allowed 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 125.155 1.382 . . . . 1.0 114.115 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.487 HG12 ' O ' ' A' ' 13' ' ' GLY . 5.8 pt -136.44 2.6 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 112.13 0.419 . . . . 1.0 112.13 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.639 ' O ' ' HG3' ' A' ' 20' ' ' MET . 51.4 t -121.99 -86.79 0.65 Allowed 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.437 -0.505 . . . . 1.0 111.577 -178.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 54.1 mtt85 -59.2 -56.55 20.67 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.063 0.458 . . . . 1.0 112.103 -175.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.901 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 45.3 m -53.19 -59.0 10.21 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 115.552 -0.749 . . . . 1.0 112.497 -177.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -63.19 -25.34 72.52 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 121.954 1.769 . . . . 1.0 113.2 -178.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.639 ' HG3' ' O ' ' A' ' 16' ' ' CYS . 53.4 mtp -61.19 -53.34 58.14 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.778 -0.369 . . . . 1.0 110.3 178.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.423 ' HA ' ' HB2' ' A' ' 24' ' ' MET . . . -72.2 -26.74 62.17 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.265 -0.574 . . . . 1.0 110.178 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.511 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 17.7 tt0 -53.83 -52.1 61.43 Favored 'General case' 0 C--O 1.212 -0.874 0 CA-C-N 115.135 -0.939 . . . . 1.0 109.431 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.67 ' HZ3' ' HB3' ' A' ' 54' ' ' ALA . 0.1 OUTLIER -86.65 -23.03 25.8 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 120.06 -0.656 . . . . 1.0 110.879 -176.431 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.469 ' HB3' HD12 ' A' ' 146' ' ' LEU . 86.0 mtp -64.57 -75.78 0.08 Allowed 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.001 0.429 . . . . 1.0 112.132 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.599 ' HB3' HD13 ' A' ' 146' ' ' LEU . 17.5 p90 -77.04 -30.31 55.59 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 119.883 -0.727 . . . . 1.0 111.51 -175.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.511 ' HB2' ' O ' ' A' ' 22' ' ' GLU . . . -64.39 -36.96 85.84 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 118.951 -1.099 . . . . 1.0 110.991 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.611 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -63.56 -37.53 87.68 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 108.433 -0.951 . . . . 1.0 108.433 176.468 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.581 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 77.9 mt-30 -60.15 -41.07 91.96 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-N 116.022 -0.536 . . . . 1.0 110.187 175.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' A' ' 25' ' ' PHE . 70.7 mt -57.71 -59.69 4.83 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.004 -0.544 . . . . 1.0 110.907 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.52 ' HD3' ' HA ' ' A' ' 27' ' ' GLN . 0.3 OUTLIER -59.37 -34.36 72.31 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.556 -0.457 . . . . 1.0 110.779 178.225 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -63.01 -27.41 69.4 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.693 0.627 . . . . 1.0 112.693 176.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.473 ' HG2' ' O ' ' A' ' 28' ' ' GLN . 6.9 ptp180 -95.9 -15.01 22.68 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.566 0.698 . . . . 1.0 110.109 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.86 39.69 3.07 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 114.913 -1.039 . . . . 1.0 111.49 177.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.413 HD12 ' HG3' ' A' ' 32' ' ' ARG . 31.3 mt -132.32 3.8 3.98 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.987 -0.375 . . . . 1.0 109.987 -178.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.22 -26.93 51.41 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 121.037 -0.602 . . . . 1.0 112.507 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.637 ' HA ' ' NH1' ' A' ' 39' ' ' ARG . 11.9 m-20 -91.32 -21.69 20.91 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.623 0.249 . . . . 1.0 110.796 176.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -81.01 -23.55 38.57 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.338 -178.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.838 HG21 ' HB3' ' A' ' 5' ' ' LEU . 0.7 OUTLIER -142.68 123.91 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-O 121.269 0.557 . . . . 1.0 110.509 179.769 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.637 ' NH1' ' HA ' ' A' ' 36' ' ' ASP . 24.3 mmt180 -92.53 141.33 28.63 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 109.233 -0.655 . . . . 1.0 109.233 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.46 HG13 ' HB3' ' A' ' 26' ' ' ALA . 34.2 t -129.13 125.34 62.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-O 121.445 0.64 . . . . 1.0 109.931 -177.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 8' ' ' THR . 36.5 p -136.79 -177.69 4.85 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.165 -1.379 . . . . 1.0 110.298 -174.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.901 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 66.9 p -161.03 162.94 31.9 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.986 -0.376 . . . . 1.0 109.986 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.568 ' HB3' ' CD2' ' A' ' 80' ' ' HIS . . . -164.59 171.03 15.01 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.556 0.693 . . . . 1.0 111.922 -178.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -128.29 134.05 7.98 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 114.851 -1.068 . . . . 1.0 111.073 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.557 HG21 ' CG1' ' A' ' 10' ' ' VAL . 25.7 p -69.6 -18.13 63.59 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.045 0.45 . . . . 1.0 111.385 -178.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.51 ' HA3' ' CZ3' ' A' ' 48' ' ' TRP . . . -113.8 8.53 23.7 Favored Glycine 0 CA--C 1.521 0.436 0 C-N-CA 120.853 -0.689 . . . . 1.0 113.173 -179.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 44.01 39.19 2.6 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 113.821 1.045 . . . . 1.0 113.821 177.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.51 ' CZ3' ' HA3' ' A' ' 46' ' ' GLY . 1.2 m-90 -43.96 -77.32 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.534 0.683 . . . . 1.0 112.506 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.419 ' O ' ' HB2' ' A' ' 73' ' ' ALA . 24.4 m-70 -106.0 40.53 1.57 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.023 -0.99 . . . . 1.0 111.314 -179.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.426 HG23 ' HA ' ' A' ' 74' ' ' ALA . 12.0 p -58.2 127.63 17.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.853 179.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.6 -14.94 64.16 Favored Glycine 0 C--N 1.329 0.184 0 C-N-CA 121.196 -0.525 . . . . 1.0 112.195 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.6 t -81.56 -162.4 0.51 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.42 0.629 . . . . 1.0 110.356 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 14.0 t -118.89 175.74 5.61 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.703 -0.851 . . . . 1.0 108.703 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.67 ' HB3' ' HZ3' ' A' ' 23' ' ' LYS . . . -60.66 147.43 42.05 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 123.331 0.394 . . . . 1.0 111.525 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.484 ' OD1' ' HG2' ' A' ' 57' ' ' ARG . 11.5 t70 -63.0 142.84 58.23 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.698 -0.683 . . . . 1.0 111.163 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.439 ' HG3' ' N ' ' A' ' 57' ' ' ARG . 5.4 pt-20 -50.02 -37.06 31.2 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 113.522 0.934 . . . . 1.0 113.522 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.484 ' HG2' ' OD1' ' A' ' 55' ' ' ASP . 11.3 ptp180 -71.16 -37.56 72.2 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.039 0.447 . . . . 1.0 110.624 -176.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.52 -37.65 74.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.61 -0.723 . . . . 1.0 109.5 178.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.14 -42.97 99.77 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.743 -0.662 . . . . 1.0 109.281 176.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -58.77 -45.5 94.8 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.566 -0.743 . . . . 1.0 113.359 178.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.443 HG12 ' HG2' ' A' ' 136' ' ' GLU . 35.0 m -73.28 -41.73 57.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 117.569 0.685 . . . . 1.0 111.863 -179.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.7 ' HB2' HG23 ' A' ' 69' ' ' THR . 96.2 mt -60.63 -52.22 66.05 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 120.828 -0.349 . . . . 1.0 110.194 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -59.83 -32.48 70.7 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.101 -0.499 . . . . 1.0 111.079 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.5 -34.81 74.85 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 121.155 0.503 . . . . 1.0 110.877 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -93.33 4.49 53.89 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.897 -179.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.16 16.74 62.23 Favored Glycine 0 C--N 1.331 0.288 0 CA-C-N 115.832 -0.622 . . . . 1.0 112.964 176.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.444 ' HD1' ' HG2' ' A' ' 27' ' ' GLN . 55.3 m-85 -92.45 153.52 42.69 Favored Pre-proline 0 C--N 1.32 -0.686 0 N-CA-C 110.434 -0.21 . . . . 1.0 110.434 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -68.25 156.76 64.57 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.063 1.842 . . . . 1.0 110.509 175.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.7 HG23 ' HB2' ' A' ' 62' ' ' LEU . 72.2 p -130.83 27.73 4.9 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 120.222 -0.591 . . . . 1.0 111.342 -176.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.47 ' C ' ' HZ1' ' A' ' 23' ' ' LYS . 17.5 t0 -104.08 131.87 50.91 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.81 -0.632 . . . . 1.0 110.335 178.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -167.42 148.82 5.62 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.621 -0.718 . . . . 1.0 109.398 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -121.28 113.04 19.37 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 107.972 -1.121 . . . . 1.0 107.972 176.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.505 ' HB1' ' OD1' ' A' ' 14' ' ' ASN . . . -57.84 139.56 53.84 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.557 -0.747 . . . . 1.0 112.272 -175.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.426 ' HA ' HG23 ' A' ' 50' ' ' VAL . . . -132.98 161.95 32.97 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.742 178.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -97.66 156.59 16.47 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 108.134 -1.062 . . . . 1.0 108.134 177.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.588 HG12 ' CD2' ' A' ' 97' ' ' LEU . 14.5 t -66.24 104.69 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.529 0.681 . . . . 1.0 110.232 178.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.4 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -117.57 -171.77 15.67 Favored Glycine 0 N--CA 1.442 -0.962 0 CA-C-N 114.633 -1.167 . . . . 1.0 111.12 -178.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 98.9 m -56.99 -44.42 82.7 Favored 'General case' 0 C--N 1.319 -0.72 0 O-C-N 123.628 0.252 . . . . 1.0 111.3 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -60.71 -29.39 69.31 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.762 0.315 . . . . 1.0 111.216 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.568 ' CD2' ' HB3' ' A' ' 43' ' ' ALA . 79.1 m80 -79.22 -42.15 26.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.422 -0.354 . . . . 1.0 110.179 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.466 ' HA ' HD21 ' A' ' 86' ' ' LEU . 21.4 mt -66.77 -21.43 66.06 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.132 -0.485 . . . . 1.0 110.967 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.25 -5.01 59.28 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.166 -0.47 . . . . 1.0 111.438 -178.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.531 ' HA ' ' HB3' ' A' ' 6' ' ' HIS . . . -59.04 151.58 21.91 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.219 -0.446 . . . . 1.0 111.686 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.698 ' HB3' HD12 ' A' ' 5' ' ' LEU . 28.4 t70 -75.8 -16.26 60.12 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.924 -0.58 . . . . 1.0 109.635 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.617 HD13 HG12 ' A' ' 7' ' ' VAL . 0.4 OUTLIER -156.21 116.56 3.68 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.53 -0.759 . . . . 1.0 109.155 -176.931 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.617 ' HG ' HG22 ' A' ' 8' ' ' THR . 5.4 mp -106.59 106.48 17.02 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-N 115.778 -0.646 . . . . 1.0 109.562 177.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.653 ' HB ' ' HD1' ' A' ' 9' ' ' PHE . 54.9 t -85.18 93.15 3.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.124 -0.944 . . . . 1.0 110.994 -176.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.47 145.45 30.73 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.612 -0.722 . . . . 1.0 110.673 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -96.38 -6.79 36.72 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.845 -0.616 . . . . 1.0 109.973 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.448 ' CG ' ' H ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -154.49 151.0 28.41 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.585 -0.734 . . . . 1.0 110.86 179.749 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 13.7 ptp180 -58.04 -24.08 56.95 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.151 -0.931 . . . . 1.0 112.737 -177.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.681 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 82.3 m-20 -77.01 -47.64 20.12 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.983 -0.377 . . . . 1.0 109.983 -178.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.78 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 15.4 m170 -55.78 -48.26 75.64 Favored 'General case' 0 C--N 1.333 -0.119 0 N-CA-C 109.475 -0.565 . . . . 1.0 109.475 176.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.572 ' HA ' HG21 ' A' ' 107' ' ' VAL . . . -57.68 -42.46 83.65 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.477 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 10.2 ttp180 -58.76 -47.12 85.75 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 115.548 -0.751 . . . . 1.0 111.248 178.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.74 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 52.0 mt -62.89 -50.32 71.34 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.667 -0.697 . . . . 1.0 110.212 -175.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.78 ' HG ' ' O ' ' A' ' 93' ' ' HIS . 22.1 mt -54.71 -57.36 11.81 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.369 -0.832 . . . . 1.0 111.468 -178.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.663 ' HA ' ' HB ' ' A' ' 102' ' ' VAL . 15.9 ptt180 -60.63 -42.83 97.68 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.08 -0.509 . . . . 1.0 111.675 -175.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.592 ' HG3' ' O ' ' A' ' 96' ' ' LEU . 0.9 OUTLIER -67.82 -25.43 65.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.888 0.375 . . . . 1.0 110.191 179.222 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.74 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 11.6 mt -77.13 -12.46 59.95 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.609 0.596 . . . . 1.0 112.609 -178.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 151.52 -26.94 0.96 Allowed Glycine 0 N--CA 1.453 -0.18 0 C-N-CA 120.277 -0.963 . . . . 1.0 112.4 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.892 HG13 ' H ' ' A' ' 103' ' ' GLU . 2.7 t -73.97 -155.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 C-N-CA 123.122 0.569 . . . . 1.0 110.185 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.892 ' H ' HG13 ' A' ' 102' ' ' VAL . 15.4 pt-20 -170.48 164.32 8.54 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 107.883 -1.154 . . . . 1.0 107.883 -178.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.731 ' HA ' HG11 ' A' ' 107' ' ' VAL . . . -67.31 -21.69 65.66 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.771 0.319 . . . . 1.0 110.882 -176.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.5 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . . . -58.31 -38.21 76.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.924 -0.58 . . . . 1.0 109.869 174.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.705 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 31.7 mtt180 -95.36 -45.79 6.98 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 115.182 -0.917 . . . . 1.0 110.333 -177.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.731 HG11 ' HA ' ' A' ' 104' ' ' ALA . 8.9 p -79.6 119.83 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-O 121.634 0.731 . . . . 1.0 110.033 -177.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.558 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 22.4 mmm180 -134.77 145.71 48.66 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.414 -0.587 . . . . 1.0 109.414 -178.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 81.4 mmm -77.35 134.86 38.37 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.829 -0.623 . . . . 1.0 110.389 -178.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.516 HD22 HG11 ' A' ' 87' ' ' VAL . 3.0 tm? -55.33 -48.94 73.42 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.933 0.396 . . . . 1.0 111.066 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 37.8 ttt180 -69.98 -19.02 63.37 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.894 -0.594 . . . . 1.0 110.679 -177.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 41.7 t -77.31 -8.41 57.59 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.95 -178.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.57 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 90.4 m-85 -88.75 -17.62 29.47 Favored 'General case' 0 C--N 1.341 0.21 0 O-C-N 121.858 -0.526 . . . . 1.0 110.235 176.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.5 t0 . . . . . 0 CA--C 1.521 -0.149 0 CA-C-N 115.993 -0.549 . . . . 1.0 110.908 -178.651 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.443 ' HG2' HG12 ' A' ' 61' ' ' VAL . 32.3 mt-10 . . . . . 0 C--O 1.234 0.259 0 CA-C-O 120.871 0.367 . . . . 1.0 110.014 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.511 ' O ' HG23 ' A' ' 141' ' ' VAL . 8.3 tt0 -64.44 -45.05 89.17 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.583 -0.735 . . . . 1.0 109.885 178.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 40.6 t -58.22 -43.34 85.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.405 0.621 . . . . 1.0 110.07 177.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -54.35 -45.65 72.77 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.43 -1.259 . . . . 1.0 110.344 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.578 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -62.3 -41.36 98.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.954 -0.567 . . . . 1.0 111.334 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 137' ' ' GLU . 20.7 t -56.9 -52.58 53.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-O 121.637 0.732 . . . . 1.0 110.855 178.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 6.3 mt -64.11 -49.67 80.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 114.928 -1.033 . . . . 1.0 111.956 -177.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.578 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 7.2 pt-20 -56.99 -30.45 64.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.887 0.375 . . . . 1.0 110.272 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 2.8 t -72.21 -31.28 65.72 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-O 121.233 0.54 . . . . 1.0 110.265 179.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.472 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -86.24 -23.07 26.55 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-N 115.699 -0.682 . . . . 1.0 111.796 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.599 HD13 ' HB3' ' A' ' 25' ' ' PHE . 10.6 mt -54.54 -40.94 86.77 Favored Pre-proline 0 C--N 1.329 -0.305 0 N-CA-C 112.795 0.665 . . . . 1.0 112.795 -178.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.688 ' HA ' ' CD2' ' A' ' 150' ' ' HIS . 69.7 Cg_endo -69.07 -7.27 20.39 Favored 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 122.279 1.986 . . . . 1.0 112.182 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.57 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -108.09 -32.5 3.25 Favored Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 109.903 -1.279 . . . . 1.0 109.903 177.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.558 HD12 ' CE2' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -76.49 -53.33 8.25 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.689 -0.756 . . . . 1.0 109.91 -179.334 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . 0.688 ' CD2' ' HA ' ' A' ' 147' ' ' PRO . 3.7 p80 -56.28 -45.38 80.18 Favored 'General case' 0 C--O 1.216 -0.67 0 CA-C-O 121.469 0.652 . . . . 1.0 110.682 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.407 ' N ' ' CG ' ' A' ' 150' ' ' HIS . 25.9 t70 -57.31 -42.79 82.48 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 114.458 -1.246 . . . . 1.0 110.279 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . 0.741 ' HZ3' HD11 ' A' ' 5' ' ' LEU . 18.1 t90 -62.45 -55.47 27.34 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 114.993 -1.003 . . . . 1.0 110.072 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.55 HG12 HG21 ' A' ' 7' ' ' VAL . 4.0 m -61.95 -40.28 86.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.453 -0.34 . . . . 1.0 110.143 -179.04 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.49 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 67.1 m-20 -59.47 -54.89 41.43 Favored 'General case' 0 C--N 1.338 0.105 0 CA-C-O 121.405 0.621 . . . . 1.0 110.287 178.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.494 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 5.5 pt-20 -60.4 -35.76 76.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.278 -0.874 . . . . 1.0 110.571 -178.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 10.3 mmt180 -74.79 -43.69 53.42 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 115.831 -0.622 . . . . 1.0 111.187 -178.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 4.4 pp . . . . . 0 N--CA 1.464 0.264 0 CA-C-O 121.498 0.666 . . . . 1.0 109.73 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.454 ' HG2' ' HG2' ' A' ' 39' ' ' ARG . 37.3 Cg_endo . . . . . 0 C--O 1.233 0.245 0 N-CA-C 113.601 0.577 . . . . 1.0 113.601 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.775 ' HB3' HG22 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -66.56 177.61 1.51 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.472 -0.786 . . . . 1.0 109.432 177.868 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.738 ' H ' HD13 ' A' ' 5' ' ' LEU . 1.7 t-160 -156.0 90.57 1.22 Allowed 'General case' 0 C--N 1.321 -0.631 0 O-C-N 122.161 -0.337 . . . . 1.0 110.695 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.82 HG13 HD12 ' A' ' 85' ' ' LEU . 2.1 t -96.29 102.88 14.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.031 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.624 ' CG2' HD23 ' A' ' 86' ' ' LEU . 9.6 t -105.8 114.71 29.02 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 121.029 0.442 . . . . 1.0 111.143 -178.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.544 ' HD1' ' HB ' ' A' ' 87' ' ' VAL . 1.1 m-85 -83.42 131.15 35.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.834 0.35 . . . . 1.0 110.361 -179.122 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.686 HG22 HD11 ' A' ' 97' ' ' LEU . 37.3 t -117.59 113.68 43.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.07 -0.514 . . . . 1.0 111.848 -176.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.53 ' HA ' ' CE1' ' A' ' 93' ' ' HIS . 41.8 t -142.7 163.06 33.84 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.048 -0.723 . . . . 1.0 109.048 177.064 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.79 90.89 4.07 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.357 0.599 . . . . 1.0 110.94 -178.03 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.811 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 136.65 -44.0 1.19 Allowed Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.453 -0.794 . . . . 1.0 111.442 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.612 ' ND2' ' H ' ' A' ' 74' ' ' ALA . 59.3 t30 61.57 22.88 13.27 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.843 0.83 . . . . 1.0 111.998 177.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.9 pt -127.41 4.44 3.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 O-C-N 121.63 -0.669 . . . . 1.0 110.956 179.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.746 ' O ' ' HG3' ' A' ' 20' ' ' MET . 5.3 p -121.6 -87.77 0.63 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.91 -0.587 . . . . 1.0 112.429 -177.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.748 HH11 HG23 ' A' ' 138' ' ' VAL . 8.5 mmt180 -71.63 -44.89 63.55 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.297 -0.41 . . . . 1.0 111.52 -174.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.425 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 19.2 m -55.72 -56.18 32.75 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-N 116.163 -0.471 . . . . 1.0 112.192 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.523 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 55.6 Cg_endo -67.01 -19.07 52.14 Favored 'Trans proline' 0 C--N 1.357 1.026 0 C-N-CA 121.633 1.555 . . . . 1.0 112.245 -178.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.746 ' HG3' ' O ' ' A' ' 16' ' ' CYS . 61.3 mtp -62.7 -55.0 30.75 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 120.336 -0.545 . . . . 1.0 109.907 176.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.433 ' HA ' ' HB2' ' A' ' 24' ' ' MET . . . -71.73 -27.9 63.31 Favored 'General case' 0 CA--C 1.512 -0.505 0 C-N-CA 120.37 -0.532 . . . . 1.0 110.617 -179.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.72 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 13.2 tt0 -51.15 -54.08 28.55 Favored 'General case' 0 C--O 1.217 -0.626 0 O-C-N 124.334 1.021 . . . . 1.0 109.73 179.191 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.889 ' HB3' ' HG2' ' A' ' 68' ' ' PRO . 0.4 OUTLIER -81.7 -27.16 34.09 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.239 -0.891 . . . . 1.0 110.311 -176.093 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.638 ' HB3' HD11 ' A' ' 146' ' ' LEU . 6.0 mmm -62.4 -76.76 0.06 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.811 0.671 . . . . 1.0 112.811 -176.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.694 ' HB3' HD21 ' A' ' 146' ' ' LEU . 18.2 p90 -78.2 -28.58 48.08 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 119.945 -0.702 . . . . 1.0 111.051 -174.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.72 ' HB3' ' O ' ' A' ' 22' ' ' GLU . . . -65.18 -38.02 89.18 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 119.208 -0.997 . . . . 1.0 110.922 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.73 ' HA ' ' HD3' ' A' ' 30' ' ' ARG . 0.1 OUTLIER -63.2 -37.7 88.27 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 108.709 -0.849 . . . . 1.0 108.709 177.485 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.598 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 74.9 mt-30 -60.33 -45.37 93.66 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.688 -0.687 . . . . 1.0 110.259 175.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 25' ' ' PHE . 84.9 mt -54.95 -58.47 7.5 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.887 -0.597 . . . . 1.0 111.09 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.73 ' HD3' ' HA ' ' A' ' 27' ' ' GLN . 0.7 OUTLIER -58.93 -38.1 78.21 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.35 -0.386 . . . . 1.0 111.228 179.597 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -62.7 -26.32 68.61 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.543 0.571 . . . . 1.0 112.543 177.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.598 ' HG2' ' O ' ' A' ' 28' ' ' GLN . 7.0 ptp180 -95.26 -18.96 20.4 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 119.406 -0.917 . . . . 1.0 109.917 178.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 107.44 34.95 2.76 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.345 -0.843 . . . . 1.0 112.305 177.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 21.1 mt -126.41 2.36 6.98 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.924 -0.399 . . . . 1.0 109.924 -178.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -53.54 -31.04 43.56 Favored Glycine 0 CA--C 1.521 0.468 0 CA-C-N 116.014 -0.539 . . . . 1.0 113.262 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.654 ' HA ' ' NH1' ' A' ' 39' ' ' ARG . 15.0 m-20 -92.04 -17.85 24.46 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 122.648 -0.325 . . . . 1.0 110.65 177.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.55 -22.73 43.46 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.163 -0.471 . . . . 1.0 111.139 -177.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.775 HG22 ' HB3' ' A' ' 5' ' ' LEU . 0.3 OUTLIER -144.32 123.92 7.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.186 0.517 . . . . 1.0 110.922 -179.749 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.671 ' O ' ' HA ' ' A' ' 6' ' ' HIS . 15.0 mmt180 -95.33 104.82 16.72 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 115.698 -0.683 . . . . 1.0 111.153 -177.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.679 HG12 ' HB1' ' A' ' 26' ' ' ALA . 1.5 m -87.99 137.1 21.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 108.231 -1.026 . . . . 1.0 108.231 176.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.491 ' O ' ' HA ' ' A' ' 8' ' ' THR . 21.5 p -146.76 -177.75 5.82 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.354 -0.839 . . . . 1.0 109.819 -175.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.474 ' OG ' ' HE1' ' A' ' 71' ' ' HIS . 67.1 p -157.14 156.73 33.21 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 120.388 -0.525 . . . . 1.0 111.035 -177.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.522 ' O ' ' HA ' ' A' ' 10' ' ' VAL . . . -161.65 160.68 29.02 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 121.225 0.536 . . . . 1.0 111.061 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 11' ' ' CYS . . . -123.08 133.77 9.19 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 111.351 -0.7 . . . . 1.0 111.351 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.498 HG22 HD13 ' A' ' 96' ' ' LEU . 21.1 p -69.17 -22.57 63.91 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 111.931 0.345 . . . . 1.0 111.931 -177.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -110.46 7.1 30.2 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.866 -0.683 . . . . 1.0 113.111 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 42.87 35.98 0.81 Allowed 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 113.87 1.063 . . . . 1.0 113.87 178.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.811 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 1.0 OUTLIER -44.95 -70.29 0.11 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.422 0.629 . . . . 1.0 112.487 -178.315 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.486 ' O ' ' HB2' ' A' ' 73' ' ' ALA . 24.3 m-70 -110.58 44.08 1.31 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.317 -0.856 . . . . 1.0 111.244 179.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.457 HG21 ' HA ' ' A' ' 74' ' ' ALA . 12.0 p -61.56 129.17 24.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.772 -0.455 . . . . 1.0 109.772 177.055 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.585 ' HA2' ' HD3' ' A' ' 72' ' ' ARG . . . 92.58 -12.15 70.43 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.977 -0.63 . . . . 1.0 111.838 -177.271 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.487 ' O ' ' HA ' ' A' ' 72' ' ' ARG . 2.4 t -81.45 -158.56 0.22 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.357 0.598 . . . . 1.0 109.97 179.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 36.8 t -134.18 170.52 15.56 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 108.719 -0.845 . . . . 1.0 108.719 -178.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.54 140.77 27.39 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.193 0.52 . . . . 1.0 111.816 -178.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -59.35 137.37 58.01 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 114.432 -1.258 . . . . 1.0 110.43 -178.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -51.33 -29.15 14.27 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.315 -0.857 . . . . 1.0 113.109 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.457 ' O ' HG22 ' A' ' 61' ' ' VAL . 30.9 mtt180 -69.63 -50.96 39.27 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.136 0.494 . . . . 1.0 110.267 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.43 -29.32 67.0 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.18 -0.918 . . . . 1.0 110.533 -177.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.27 -44.63 96.92 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.86 -0.609 . . . . 1.0 109.514 176.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.19 -39.67 96.27 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.715 -0.755 . . . . 1.0 111.667 178.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.491 ' O ' ' HD2' ' A' ' 65' ' ' HIS . 78.7 t -60.81 -56.28 18.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 CA-C-O 121.188 0.518 . . . . 1.0 110.957 178.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.775 HD11 ' HG3' ' A' ' 23' ' ' LYS . 70.5 mt -61.04 -50.95 71.24 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.936 -0.574 . . . . 1.0 111.366 -178.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -60.07 -28.24 67.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.419 -0.355 . . . . 1.0 110.675 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.65 -35.67 79.31 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 120.977 0.417 . . . . 1.0 110.818 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.491 ' HD2' ' O ' ' A' ' 61' ' ' VAL . 88.8 m-70 -96.64 4.05 52.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.871 -0.604 . . . . 1.0 111.329 -177.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 90.21 14.99 58.16 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 121.086 -0.578 . . . . 1.0 112.632 177.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.495 ' HD1' ' HG2' ' A' ' 27' ' ' GLN . 69.7 m-85 -89.9 151.05 44.87 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-O 120.44 0.162 . . . . 1.0 110.985 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.889 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 55.3 Cg_endo -68.9 160.58 49.22 Favored 'Trans proline' 0 CA--C 1.511 -0.67 0 C-N-CA 122.571 2.18 . . . . 1.0 110.125 175.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.702 HG22 ' HB2' ' A' ' 62' ' ' LEU . 47.5 p -135.62 -0.43 2.63 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 119.589 -0.844 . . . . 1.0 112.161 -177.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.484 ' O ' ' HE2' ' A' ' 23' ' ' LYS . 48.4 t0 -71.94 134.84 46.22 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.293 -0.632 . . . . 1.0 109.293 -179.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.614 ' HB2' ' HE2' ' A' ' 23' ' ' LYS . 32.7 t60 -169.05 154.81 6.28 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.971 0.415 . . . . 1.0 110.379 -174.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.585 ' HD3' ' HA2' ' A' ' 51' ' ' GLY . 5.0 tmm_? -136.4 108.37 7.15 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 107.468 -1.308 . . . . 1.0 107.468 176.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.486 ' HB2' ' O ' ' A' ' 49' ' ' HIS . . . -58.67 139.99 55.27 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.823 -1.081 . . . . 1.0 112.048 -175.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.612 ' H ' ' ND2' ' A' ' 14' ' ' ASN . . . -130.01 161.54 30.73 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.645 -0.707 . . . . 1.0 109.93 177.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -96.77 159.9 14.67 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.205 -0.665 . . . . 1.0 109.205 179.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.7 t -70.18 110.2 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.158 0.504 . . . . 1.0 110.316 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.564 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -123.95 -170.58 13.34 Favored Glycine 0 N--CA 1.441 -1.006 0 CA-C-N 115.397 -0.819 . . . . 1.0 111.564 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 43.3 m -58.63 -51.71 68.75 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.873 0.368 . . . . 1.0 111.647 -178.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.557 ' HG2' ' N ' ' A' ' 80' ' ' HIS . 0.7 OUTLIER -54.46 -32.74 58.27 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.563 -0.744 . . . . 1.0 111.007 179.789 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.557 ' N ' ' HG2' ' A' ' 79' ' ' GLU . 79.4 m80 -76.87 -40.61 47.0 Favored 'General case' 0 C--O 1.223 -0.321 0 N-CA-C 109.659 -0.497 . . . . 1.0 109.659 178.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.564 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 54.4 mt -65.75 -18.4 65.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.248 0.547 . . . . 1.0 110.539 178.143 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.39 -4.04 59.03 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.872 -0.604 . . . . 1.0 110.697 -178.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.56 ' HB2' ' O ' ' A' ' 6' ' ' HIS . . . -64.13 149.33 47.93 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.807 -0.633 . . . . 1.0 111.4 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.529 ' HB3' HD13 ' A' ' 5' ' ' LEU . 24.7 t70 -73.23 -14.4 61.33 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.07 0.462 . . . . 1.0 109.871 178.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.82 HD12 HG13 ' A' ' 7' ' ' VAL . 0.9 OUTLIER -154.08 120.94 5.59 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.597 -0.729 . . . . 1.0 110.504 -177.735 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 1.013 HD11 HG13 ' A' ' 102' ' ' VAL . 0.3 OUTLIER -105.99 104.33 14.02 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.747 -0.835 . . . . 1.0 108.747 175.158 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.573 HG23 HD23 ' A' ' 85' ' ' LEU . 54.5 t -83.73 92.18 2.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 121.493 0.663 . . . . 1.0 110.551 -178.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.21 146.78 30.3 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.195 -0.912 . . . . 1.0 111.231 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.432 HD22 ' HB2' ' A' ' 11' ' ' CYS . 4.2 mm? -98.18 -13.68 20.76 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 115.689 -0.687 . . . . 1.0 109.741 178.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -139.44 153.55 47.59 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.496 -0.774 . . . . 1.0 109.961 -177.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -62.78 -20.38 64.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.36 0.6 . . . . 1.0 109.819 176.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.623 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 95.1 m-20 -76.49 -51.93 10.78 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.935 -1.029 . . . . 1.0 110.319 -178.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.53 ' CE1' ' HA ' ' A' ' 11' ' ' CYS . 19.0 m170 -58.3 -44.14 88.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.792 -0.64 . . . . 1.0 110.277 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.531 ' HA ' HD13 ' A' ' 97' ' ' LEU . . . -60.54 -42.77 97.19 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.026 0.441 . . . . 1.0 110.473 178.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 5.0 ttp-105 -58.59 -45.56 88.82 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 115.438 -0.801 . . . . 1.0 111.16 178.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.727 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 45.6 mt -63.69 -50.28 69.81 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.343 -176.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.686 HD11 HG22 ' A' ' 10' ' ' VAL . 14.0 mt -52.76 -58.52 6.61 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.936 -0.575 . . . . 1.0 111.835 -177.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 13.0 ptt180 -60.68 -44.8 96.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.281 -0.418 . . . . 1.0 111.922 -176.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.452 ' HG3' ' O ' ' A' ' 96' ' ' LEU . 1.2 pt20 -69.0 -20.18 64.15 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 121.01 0.433 . . . . 1.0 110.595 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.727 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 6.2 mt -79.22 -9.02 59.47 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.622 -0.717 . . . . 1.0 111.798 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 150.96 -32.89 0.96 Allowed Glycine 0 CA--C 1.505 -0.57 0 C-N-CA 119.842 -1.171 . . . . 1.0 113.352 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 1.013 HG13 HD11 ' A' ' 86' ' ' LEU . 0.8 OUTLIER -76.79 -151.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 121.716 0.769 . . . . 1.0 112.056 -176.697 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.626 ' H ' HG12 ' A' ' 102' ' ' VAL . 12.8 pt-20 -162.9 167.42 22.7 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.189 -0.914 . . . . 1.0 108.733 -178.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.756 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -67.23 -22.32 65.7 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.179 -0.464 . . . . 1.0 112.132 -174.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.24 -36.59 73.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.12 0.486 . . . . 1.0 110.687 176.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.579 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 1.0 OUTLIER -96.86 -40.36 8.96 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.207 -0.906 . . . . 1.0 110.805 -177.615 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.756 HG12 ' HA ' ' A' ' 104' ' ' ALA . 13.4 p -79.76 115.2 21.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.574 0.702 . . . . 1.0 110.352 -179.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.53 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 20.5 mmm180 -133.3 145.08 50.12 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.889 -0.596 . . . . 1.0 109.658 -177.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 84.6 mmm -77.52 137.52 38.67 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.947 -0.57 . . . . 1.0 110.543 -179.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.54 HD21 HG11 ' A' ' 87' ' ' VAL . 3.1 tm? -55.27 -49.81 71.11 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.802 0.334 . . . . 1.0 110.567 179.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.468 HH11 ' HG2' ' A' ' 111' ' ' ARG . 11.8 ttt-85 -72.94 -12.87 61.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.321 -0.4 . . . . 1.0 111.419 -176.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 33.3 t -78.81 -8.97 59.28 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 121.15 -0.22 . . . . 1.0 110.855 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.609 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 82.6 m-85 -86.46 -18.27 32.11 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-O 120.975 0.417 . . . . 1.0 110.341 177.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.8 t0 . . . . . 0 C--N 1.327 -0.41 0 CA-C-N 115.33 -0.85 . . . . 1.0 111.046 -179.44 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.43 ' HA ' ' HB3' ' A' ' 139' ' ' PHE . 36.7 mt-10 . . . . . 0 N--CA 1.452 -0.345 0 CA-C-O 120.857 0.361 . . . . 1.0 110.382 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -63.22 -50.22 71.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.029 -0.532 . . . . 1.0 109.878 178.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 1.055 ' HA ' HG21 ' A' ' 141' ' ' VAL . 53.4 t -62.74 -40.16 87.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.663 -0.699 . . . . 1.0 109.857 175.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.524 ' HB2' ' HE1' ' A' ' 20' ' ' MET . 18.3 t80 -54.5 -41.77 69.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.113 -0.949 . . . . 1.0 109.172 175.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.564 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -65.63 -42.37 91.6 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.604 -0.725 . . . . 1.0 110.544 176.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 1.055 HG21 ' HA ' ' A' ' 138' ' ' VAL . 13.8 t -54.15 -52.11 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-O 121.863 0.84 . . . . 1.0 109.715 177.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.535 ' HA ' HD11 ' A' ' 110' ' ' LEU . 7.2 mt -65.29 -51.32 66.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 114.597 -1.183 . . . . 1.0 112.084 -178.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.564 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 8.4 pt-20 -55.29 -34.37 64.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.825 0.345 . . . . 1.0 110.479 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 67.1 m -72.24 -28.96 63.48 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.738 -0.664 . . . . 1.0 110.743 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.461 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -88.48 -22.77 23.48 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.776 -0.647 . . . . 1.0 112.08 179.253 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.694 HD21 ' HB3' ' A' ' 25' ' ' PHE . 12.0 mt -55.65 -37.74 60.3 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 112.266 0.469 . . . . 1.0 112.266 -178.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 60.3 Cg_endo -70.53 -10.31 27.67 Favored 'Trans proline' 0 C--N 1.361 1.204 0 C-N-CA 122.493 2.129 . . . . 1.0 111.832 177.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.609 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -104.67 -32.41 4.18 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 110.572 -1.011 . . . . 1.0 110.572 178.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.473 ' O ' HG12 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -75.63 -41.89 53.03 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.687 -0.857 . . . . 1.0 108.687 179.474 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . 0.442 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 0.5 OUTLIER -54.08 -56.85 14.18 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 114.791 -1.095 . . . . 1.0 110.736 176.787 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -58.55 -40.64 83.58 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.226 -0.897 . . . . 1.0 111.504 -175.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . 0.735 ' HZ3' HD12 ' A' ' 5' ' ' LEU . 31.0 t90 -63.22 -55.23 26.75 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.624 -0.716 . . . . 1.0 110.615 -179.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.513 HG11 HG23 ' A' ' 7' ' ' VAL . 7.2 m -61.65 -40.38 86.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 120.723 -0.391 . . . . 1.0 110.598 -178.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.425 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 13.3 m-20 -59.69 -52.0 67.4 Favored 'General case' 0 CA--C 1.523 -0.084 0 CA-C-O 120.994 0.426 . . . . 1.0 110.721 178.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.578 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 6.2 pt-20 -61.86 -38.84 89.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.586 -0.734 . . . . 1.0 110.296 -178.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.499 ' HG3' ' CH2' ' A' ' 152' ' ' TRP . 20.4 mmt180 -72.11 -46.62 55.97 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.805 -0.634 . . . . 1.0 111.057 -177.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 4.1 pp . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 121.337 0.589 . . . . 1.0 109.591 -179.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.466 ' HB2' ' HG2' ' A' ' 39' ' ' ARG . 35.1 Cg_endo . . . . . 0 C--O 1.235 0.327 0 N-CA-C 113.836 0.668 . . . . 1.0 113.836 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.759 ' HB3' HG22 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -66.17 178.42 1.16 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.75 -1.114 . . . . 1.0 109.319 177.547 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.68 ' H ' HD11 ' A' ' 5' ' ' LEU . 4.0 t-160 -156.8 98.23 1.76 Allowed 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.503 -0.555 . . . . 1.0 109.503 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.703 HG11 HD12 ' A' ' 85' ' ' LEU . 2.1 t -103.18 117.97 49.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 N-CA-C 107.722 -1.214 . . . . 1.0 107.722 177.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.564 HG23 ' HG ' ' A' ' 86' ' ' LEU . 8.3 t -118.54 114.38 22.73 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 120.931 0.396 . . . . 1.0 110.204 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.565 ' HD2' ' HB3' ' A' ' 42' ' ' SER . 2.2 m-85 -82.89 126.07 32.06 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.076 0.465 . . . . 1.0 110.215 -178.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.66 HG23 HD11 ' A' ' 97' ' ' LEU . 35.4 t -110.23 112.01 38.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 CA-C-N 115.74 -0.664 . . . . 1.0 111.631 -176.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.615 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 37.7 t -139.91 161.28 37.96 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.149 -1.056 . . . . 1.0 108.149 177.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.435 HG23 ' HE2' ' A' ' 93' ' ' HIS . 0.5 OUTLIER -66.24 -39.89 89.86 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.217 0.532 . . . . 1.0 109.812 179.248 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.62 ' C ' ' H ' ' A' ' 15' ' ' ILE . . . -104.17 80.4 0.32 Allowed Glycine 0 N--CA 1.435 -1.432 0 CA-C-N 115.187 -0.915 . . . . 1.0 110.856 175.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.6 ' ND2' ' HB3' ' A' ' 73' ' ' ALA . 15.9 p-10 -59.5 17.72 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.74 1.616 . . . . 1.0 112.418 176.1 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.62 ' H ' ' C ' ' A' ' 13' ' ' GLY . 6.7 pt -121.59 -0.81 7.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.177 178.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 22.1 m -116.16 -87.09 0.61 Allowed 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.215 0.45 . . . . 1.0 112.215 -177.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.571 HH21 ' HB3' ' A' ' 89' ' ' LEU . 13.0 mtm-85 -72.38 -46.96 53.02 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 112.391 0.515 . . . . 1.0 112.391 -173.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.715 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 26.4 m -54.46 -58.72 12.71 Favored Pre-proline 0 CA--C 1.537 0.446 0 CA-C-N 116.306 -0.406 . . . . 1.0 111.333 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.437 ' CD ' ' HB2' ' A' ' 18' ' ' SER . 39.3 Cg_endo -63.56 -22.9 70.66 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 121.763 1.642 . . . . 1.0 113.345 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.66 ' HB3' HD11 ' A' ' 142' ' ' ILE . 35.6 mmm -60.97 -53.62 55.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.635 0.255 . . . . 1.0 110.846 178.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.92 -25.63 60.09 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.168 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.457 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 17.9 tt0 -51.92 -54.09 33.47 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 114.761 -1.109 . . . . 1.0 109.819 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.652 ' O ' ' HB3' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -83.51 -26.99 29.7 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.378 -0.828 . . . . 1.0 110.838 -175.753 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.555 ' HB3' HD11 ' A' ' 146' ' ' LEU . 5.6 mmm -60.85 -75.61 0.06 Allowed 'General case' 0 C--O 1.239 0.542 0 CA-C-O 121.453 0.644 . . . . 1.0 112.504 -178.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.665 ' HB3' HD12 ' A' ' 146' ' ' LEU . 22.3 p90 -79.37 -28.83 41.94 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.088 -0.645 . . . . 1.0 111.674 -174.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.457 ' HB2' ' O ' ' A' ' 22' ' ' GLU . . . -64.8 -36.2 83.56 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 119.082 -1.047 . . . . 1.0 110.739 178.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.652 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -63.73 -38.56 91.55 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.666 -0.864 . . . . 1.0 108.666 176.595 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.664 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 78.7 mt-30 -59.24 -44.56 92.35 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 115.608 -0.724 . . . . 1.0 110.499 175.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 25' ' ' PHE . 90.0 mt -54.26 -59.62 4.43 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.887 -0.597 . . . . 1.0 111.239 -179.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.515 ' HD3' ' HA ' ' A' ' 27' ' ' GLN . 1.5 ptm180 -59.31 -34.55 72.45 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.714 -0.394 . . . . 1.0 111.155 178.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -62.27 -28.96 70.08 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.315 0.487 . . . . 1.0 112.315 177.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.664 ' HG2' ' O ' ' A' ' 28' ' ' GLN . 4.8 ptp180 -94.16 -16.0 24.12 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 119.915 -0.714 . . . . 1.0 110.429 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 102.72 38.75 2.89 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.403 -0.817 . . . . 1.0 111.48 177.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 27.3 mt -132.72 1.51 3.66 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 110.088 -0.338 . . . . 1.0 110.088 -178.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.6 -27.29 58.48 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 121.05 -0.595 . . . . 1.0 112.343 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -82.55 -31.27 29.17 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.964 0.411 . . . . 1.0 109.928 177.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -78.94 -16.86 56.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.201 -0.909 . . . . 1.0 112.318 -174.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.759 HG22 ' HB3' ' A' ' 5' ' ' LEU . 0.3 OUTLIER -143.86 126.59 11.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 121.877 -0.515 . . . . 1.0 111.241 -179.998 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.466 ' HG2' ' HB2' ' A' ' 4' ' ' PRO . 7.7 mmt180 -90.46 132.62 35.55 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 108.636 -0.875 . . . . 1.0 108.636 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.402 HG13 ' HB3' ' A' ' 26' ' ' ALA . 68.3 t -124.9 119.41 55.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.264 -0.643 . . . . 1.0 109.264 -179.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' A' ' 8' ' ' THR . 78.0 p -132.49 -175.16 3.66 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.47 -1.241 . . . . 1.0 110.979 -174.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.715 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 87.8 p -158.58 163.39 37.04 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.682 -0.488 . . . . 1.0 109.682 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.558 ' HB1' ' CD2' ' A' ' 80' ' ' HIS . . . -164.93 168.78 17.23 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 121.219 0.533 . . . . 1.0 111.571 -178.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.615 ' HA2' ' O ' ' A' ' 11' ' ' CYS . . . -127.53 132.56 7.55 Favored Glycine 0 N--CA 1.438 -1.174 0 CA-C-N 115.078 -0.965 . . . . 1.0 111.462 178.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.492 HG21 ' CG1' ' A' ' 10' ' ' VAL . 26.9 p -69.47 -23.41 63.64 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.887 0.375 . . . . 1.0 111.325 -178.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.416 ' HA3' ' HZ3' ' A' ' 48' ' ' TRP . . . -112.92 9.1 25.41 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.858 -0.686 . . . . 1.0 112.304 -178.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.476 ' HB3' ' HB2' ' A' ' 75' ' ' GLN . 2.7 p-10 43.64 39.11 2.23 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.991 0.916 . . . . 1.0 113.41 177.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.416 ' HZ3' ' HA3' ' A' ' 46' ' ' GLY . 1.2 m-90 -42.8 -72.54 0.06 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.294 0.568 . . . . 1.0 112.386 -178.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.428 ' O ' ' HB1' ' A' ' 73' ' ' ALA . 75.9 m-70 -112.23 45.72 1.25 Allowed 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.283 -0.872 . . . . 1.0 111.243 178.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.422 HG21 ' HA ' ' A' ' 74' ' ' ALA . 11.6 p -61.78 129.93 25.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.622 -0.717 . . . . 1.0 110.135 177.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.603 ' HA2' ' HD3' ' A' ' 72' ' ' ARG . . . 93.66 -15.31 63.34 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.889 -0.672 . . . . 1.0 112.081 -177.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.4 t -80.06 -161.16 0.33 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.379 0.609 . . . . 1.0 109.914 179.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 35.5 t -127.98 170.62 12.66 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 115.288 -0.869 . . . . 1.0 108.932 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -52.06 136.13 29.99 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 123.338 0.398 . . . . 1.0 111.414 -178.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.697 ' OD1' ' HG2' ' A' ' 57' ' ' ARG . 12.5 t70 -57.17 140.27 50.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.389 -0.823 . . . . 1.0 111.309 -178.114 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -45.78 -37.93 6.57 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.99 -1.004 . . . . 1.0 113.519 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.697 ' HG2' ' OD1' ' A' ' 55' ' ' ASP . 15.3 ptp180 -70.12 -44.52 68.77 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 120.522 -0.471 . . . . 1.0 110.914 -177.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.406 ' HB2' ' SD ' ' A' ' 20' ' ' MET . . . -71.24 -30.91 66.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.035 0.445 . . . . 1.0 110.384 -178.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.02 -45.82 90.54 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.082 177.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.2 -36.87 94.01 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.937 -0.649 . . . . 1.0 111.773 177.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.64 HG22 ' O ' ' A' ' 57' ' ' ARG . 86.9 t -62.06 -59.04 4.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.23 0.538 . . . . 1.0 110.851 178.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.665 ' HB2' HG22 ' A' ' 69' ' ' THR . 96.8 mt -60.16 -50.12 74.95 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.836 -0.62 . . . . 1.0 111.363 -177.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 -59.25 -30.62 68.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.47 -0.332 . . . . 1.0 111.061 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.28 -33.24 73.99 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 121.124 0.488 . . . . 1.0 111.136 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -97.59 5.34 49.61 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.859 -0.61 . . . . 1.0 111.437 -178.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.48 13.44 63.32 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.899 -0.667 . . . . 1.0 112.837 177.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -91.13 148.95 39.01 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-O 120.561 0.22 . . . . 1.0 110.944 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.591 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 48.9 Cg_endo -69.95 158.13 57.73 Favored 'Trans proline' 0 CA--C 1.513 -0.563 0 C-N-CA 122.243 1.962 . . . . 1.0 110.841 176.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.665 HG22 ' HB2' ' A' ' 62' ' ' LEU . 53.1 p -131.3 9.09 4.73 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.341 -0.543 . . . . 1.0 110.803 -178.059 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -73.6 123.77 24.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.463 -0.79 . . . . 1.0 109.536 -178.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.434 ' HE1' ' OG ' ' A' ' 42' ' ' SER . 31.2 t60 -166.07 154.58 11.01 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.973 -175.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.603 ' HD3' ' HA2' ' A' ' 51' ' ' GLY . 2.3 tmm_? -135.8 110.1 8.42 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.048 -1.093 . . . . 1.0 108.048 175.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.6 ' HB3' ' ND2' ' A' ' 14' ' ' ASN . . . -55.7 136.68 50.59 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.621 -1.172 . . . . 1.0 112.527 -175.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.465 ' O ' ' HA ' ' A' ' 43' ' ' ALA . . . -129.45 160.4 33.26 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.822 -0.172 . . . . 1.0 110.743 178.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.476 ' HB2' ' HB3' ' A' ' 47' ' ' ASN . 9.3 tt0 -97.04 153.39 17.95 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.531 -0.914 . . . . 1.0 108.531 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.473 HG11 ' CD2' ' A' ' 97' ' ' LEU . 20.2 t -65.41 109.92 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.424 0.631 . . . . 1.0 110.748 179.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.413 ' H ' ' HD1' ' A' ' 80' ' ' HIS . . . -120.92 -169.67 13.87 Favored Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 115.396 -0.82 . . . . 1.0 111.103 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 53.9 m -58.8 -42.89 90.18 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.52 0.2 . . . . 1.0 110.692 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -57.78 -31.96 67.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.944 0.402 . . . . 1.0 111.303 177.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.558 ' CD2' ' HB1' ' A' ' 43' ' ' ALA . 79.3 m80 -79.22 -41.27 28.66 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-N 116.522 -0.308 . . . . 1.0 110.943 -179.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.652 ' HA ' HD23 ' A' ' 86' ' ' LEU . 16.8 mt -67.95 -19.04 64.93 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.914 0.387 . . . . 1.0 110.127 177.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.13 -5.16 59.26 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.849 0.357 . . . . 1.0 110.388 -178.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.488 ' HA ' ' HB3' ' A' ' 6' ' ' HIS . . . -58.2 153.72 14.53 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.822 -0.626 . . . . 1.0 110.782 178.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.744 ' HB3' HD11 ' A' ' 5' ' ' LEU . 12.1 t70 -79.96 -14.57 58.5 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.902 -0.59 . . . . 1.0 109.546 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.703 HD12 HG11 ' A' ' 7' ' ' VAL . 0.4 OUTLIER -155.69 118.31 4.2 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.342 -0.845 . . . . 1.0 108.842 -178.11 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.652 HD23 ' HA ' ' A' ' 81' ' ' LEU . 5.2 mp -107.93 105.55 15.4 Favored 'General case' 0 N--CA 1.425 -1.683 0 CA-C-O 121.305 0.574 . . . . 1.0 109.806 178.273 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.582 ' HA ' ' O ' ' A' ' 108' ' ' ARG . 55.8 t -84.9 92.59 3.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 114.652 -1.158 . . . . 1.0 111.453 -175.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.79 146.56 33.71 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.566 -0.743 . . . . 1.0 110.758 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.571 ' HB3' HH21 ' A' ' 17' ' ' ARG . 3.9 mm? -100.83 -7.57 23.47 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.459 179.156 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.434 ' CG ' ' H ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -153.97 156.38 37.35 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.994 -0.548 . . . . 1.0 111.282 178.594 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 6.0 ptm85 -55.72 -24.65 35.98 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.479 0.918 . . . . 1.0 113.479 -178.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.646 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 87.8 m-20 -76.79 -51.49 11.27 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 110.186 -0.301 . . . . 1.0 110.186 -178.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.66 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 13.5 m170 -55.27 -46.33 76.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.011 -0.541 . . . . 1.0 110.527 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.85 -43.12 94.83 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.069 0.462 . . . . 1.0 110.713 179.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.69 ' O ' ' HG2' ' A' ' 99' ' ' GLN . 5.9 ttm180 -58.44 -46.49 86.43 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 115.482 -0.781 . . . . 1.0 111.005 177.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.732 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 46.6 mt -62.51 -51.14 68.59 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-N 115.921 -0.581 . . . . 1.0 110.412 -175.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.66 ' HG ' ' O ' ' A' ' 93' ' ' HIS . 40.8 mt -51.22 -58.34 6.42 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.954 -0.566 . . . . 1.0 111.684 -177.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.648 ' CA ' HG11 ' A' ' 102' ' ' VAL . 13.3 ptt180 -58.91 -46.99 86.59 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.015 -0.539 . . . . 1.0 112.258 -179.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.69 ' HG2' ' O ' ' A' ' 95' ' ' ARG . 12.8 pt20 -69.24 -19.39 63.94 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.649 -0.421 . . . . 1.0 110.665 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.732 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 10.8 mt -81.43 -18.96 43.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.969 -0.56 . . . . 1.0 110.963 177.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 153.35 -25.15 0.77 Allowed Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 119.706 -1.235 . . . . 1.0 113.655 -178.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.696 HG13 ' N ' ' A' ' 103' ' ' GLU . 0.4 OUTLIER -76.49 -161.6 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 CA-C-N 117.493 0.646 . . . . 1.0 110.555 -178.44 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.732 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 15.5 pt-20 -159.25 161.89 36.08 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.604 -1.258 . . . . 1.0 107.604 -178.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.78 ' HA ' HG13 ' A' ' 107' ' ' VAL . . . -62.84 -24.51 67.82 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.725 0.298 . . . . 1.0 111.406 -175.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.63 -36.05 73.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.01 -0.541 . . . . 1.0 110.171 174.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.742 ' NH1' ' HA ' ' A' ' 84' ' ' ASP . 1.6 mtt-85 -98.95 -41.37 7.62 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 115.604 -0.726 . . . . 1.0 111.366 -177.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.78 HG13 ' HA ' ' A' ' 104' ' ' ALA . 10.5 p -80.21 120.25 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-O 120.905 0.383 . . . . 1.0 110.015 -175.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.582 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 31.5 mmm180 -138.86 149.18 44.59 Favored 'General case' 0 C--N 1.318 -0.761 0 O-C-N 121.864 -0.522 . . . . 1.0 110.361 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.556 ' HB2' ' HB2' ' A' ' 112' ' ' SER . 83.3 mmm -78.73 136.21 37.35 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.848 -0.614 . . . . 1.0 110.41 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.519 HD23 HG12 ' A' ' 87' ' ' VAL . 2.8 tm? -53.57 -53.8 46.51 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.494 0.188 . . . . 1.0 110.853 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.506 ' O ' ' HB3' ' A' ' 114' ' ' ASP . 5.8 ttt85 -73.88 -9.92 59.14 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.082 -0.647 . . . . 1.0 111.323 -176.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.556 ' HB2' ' HB2' ' A' ' 109' ' ' MET . 41.5 t -75.5 -6.01 48.05 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.775 -0.454 . . . . 1.0 109.775 178.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.558 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 96.9 m-85 -94.74 -12.7 26.68 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.526 0.679 . . . . 1.0 109.402 175.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.506 ' HB3' ' O ' ' A' ' 111' ' ' ARG . 6.0 t0 . . . . . 0 N--CA 1.466 0.368 0 CA-C-N 114.97 -1.014 . . . . 1.0 111.533 -177.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.485 ' HA ' ' HB3' ' A' ' 139' ' ' PHE . 16.2 mt-10 . . . . . 0 N--CA 1.451 -0.398 0 N-CA-C 111.496 0.184 . . . . 1.0 111.496 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 23.4 tp10 -64.42 -47.21 80.0 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 108.54 -0.911 . . . . 1.0 108.54 174.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.944 ' HA ' HG21 ' A' ' 141' ' ' VAL . 95.3 t -61.85 -40.5 87.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.9 -0.591 . . . . 1.0 109.746 176.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.509 ' HB2' HG13 ' A' ' 61' ' ' VAL . 13.5 t80 -52.75 -47.2 67.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.03 -0.986 . . . . 1.0 109.244 174.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.506 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -59.79 -43.06 94.62 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 115.351 -0.841 . . . . 1.0 110.228 177.279 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.944 HG21 ' HA ' ' A' ' 138' ' ' VAL . 8.2 t -54.54 -51.35 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 121.581 0.705 . . . . 1.0 110.505 177.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.66 HD11 ' HB3' ' A' ' 20' ' ' MET . 6.1 mt -66.16 -50.48 68.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 114.99 -1.005 . . . . 1.0 112.07 -178.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.506 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 8.8 pt-20 -56.06 -33.74 65.27 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.926 -0.398 . . . . 1.0 109.926 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' SER . . . . . 0.407 ' HB3' ' OD1' ' A' ' 114' ' ' ASP . 70.7 m -72.48 -28.65 63.04 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.758 -0.655 . . . . 1.0 110.514 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.429 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -87.27 -22.37 25.22 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.172 -0.467 . . . . 1.0 111.85 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.665 HD12 ' HB3' ' A' ' 25' ' ' PHE . 12.8 mt -57.44 -37.47 57.24 Favored Pre-proline 0 CA--C 1.546 0.82 0 N-CA-C 112.656 0.613 . . . . 1.0 112.656 -178.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.622 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 48.0 Cg_endo -68.27 -12.07 33.88 Favored 'Trans proline' 0 C--N 1.365 1.44 0 C-N-CA 122.79 2.326 . . . . 1.0 111.665 177.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.558 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -103.88 -34.93 3.61 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 114.903 -1.044 . . . . 1.0 110.927 178.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.626 HD21 ' CE2' ' A' ' 25' ' ' PHE . 13.4 tp -75.77 -41.0 54.29 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.872 -0.788 . . . . 1.0 108.872 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . 0.568 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 0.2 OUTLIER -53.92 -53.37 53.66 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 115.233 -0.894 . . . . 1.0 110.001 174.845 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -57.68 -43.76 85.32 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.871 -1.059 . . . . 1.0 110.679 -176.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . 0.736 ' HZ3' HD13 ' A' ' 5' ' ' LEU . 20.6 t90 -62.26 -55.78 25.0 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.395 -0.821 . . . . 1.0 110.486 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.447 HG12 HG21 ' A' ' 7' ' ' VAL . 12.6 m -62.02 -43.94 98.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 C-N-CA 120.72 -0.392 . . . . 1.0 111.091 -177.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.418 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 2.9 m-20 -59.81 -49.95 75.72 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 121.149 0.499 . . . . 1.0 110.76 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.522 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 7.0 pt-20 -62.81 -39.23 93.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.626 -0.715 . . . . 1.0 110.554 -178.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.561 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 6.3 mmt85 -73.13 -47.35 44.87 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.871 -0.604 . . . . 1.0 111.13 -175.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 4.2 pp . . . . . 0 C--N 1.326 -0.449 0 CA-C-N 115.7 -0.682 . . . . 1.0 109.985 -178.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.558 ' HB2' ' HG2' ' A' ' 39' ' ' ARG . 26.0 Cg_endo . . . . . 0 N--CA 1.458 -0.592 0 N-CA-C 113.58 0.569 . . . . 1.0 113.58 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.79 ' HB3' HG11 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -68.06 179.4 1.53 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.845 -1.07 . . . . 1.0 109.422 176.087 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.583 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 2.3 t-160 -156.07 87.73 1.07 Allowed 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.878 -0.416 . . . . 1.0 109.878 -179.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.783 HG13 HD12 ' A' ' 85' ' ' LEU . 2.2 t -93.12 108.99 21.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 109.4 -0.593 . . . . 1.0 109.4 178.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.681 ' CG2' HD22 ' A' ' 86' ' ' LEU . 10.0 t -110.76 111.44 22.62 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.949 0.404 . . . . 1.0 110.635 179.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.623 ' HD1' ' HB ' ' A' ' 87' ' ' VAL . 1.3 m-85 -82.22 136.71 35.05 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.705 -0.479 . . . . 1.0 109.705 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.655 HG21 HD21 ' A' ' 97' ' ' LEU . 47.8 t -124.57 115.29 44.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.018 0.437 . . . . 1.0 111.461 -177.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.522 ' HB2' HD21 ' A' ' 89' ' ' LEU . 44.7 t -146.52 153.14 40.05 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.957 -0.565 . . . . 1.0 110.091 178.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -71.31 98.45 1.76 Allowed 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.902 -0.407 . . . . 1.0 109.902 178.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 142.68 -40.59 1.25 Allowed Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 110.623 -0.991 . . . . 1.0 110.623 -178.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 1.004 HD21 ' HB3' ' A' ' 73' ' ' ALA . 1.1 p-10 49.37 23.45 0.86 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.601 1.16 . . . . 1.0 113.228 177.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.7 pt -140.83 9.44 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.288 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.478 177.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.46 ' O ' ' HG2' ' A' ' 20' ' ' MET . 5.1 p -122.41 -87.57 0.63 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.719 -0.673 . . . . 1.0 111.782 -176.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 17' ' ' ARG . 7.3 mmm-85 -67.2 -48.69 67.16 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 121.124 0.488 . . . . 1.0 111.25 -175.32 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.86 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 13.1 m -52.48 -58.28 12.36 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-N 115.063 -0.971 . . . . 1.0 112.396 -179.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.616 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 56.8 Cg_endo -67.06 -23.43 46.29 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 121.842 1.694 . . . . 1.0 112.914 -178.227 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.556 ' HB3' HD13 ' A' ' 142' ' ' ILE . 51.8 mmm -59.65 -57.11 14.36 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.906 -0.405 . . . . 1.0 109.906 178.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.43 ' HB2' ' CG2' ' A' ' 142' ' ' ILE . . . -73.5 -27.15 61.22 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.57 -0.741 . . . . 1.0 110.645 -179.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.514 ' O ' ' HB1' ' A' ' 26' ' ' ALA . 13.0 tt0 -52.82 -52.84 55.4 Favored 'General case' 0 C--O 1.215 -0.737 0 O-C-N 123.907 0.755 . . . . 1.0 109.946 -179.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.948 ' HE3' ' HB2' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -85.09 -25.81 27.33 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.837 -0.619 . . . . 1.0 110.777 -176.462 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.487 ' HB3' HD12 ' A' ' 146' ' ' LEU . 88.1 mtp -63.33 -74.59 0.09 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.564 0.579 . . . . 1.0 112.564 -177.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.706 ' HB3' HD21 ' A' ' 146' ' ' LEU . 17.2 p90 -76.81 -30.7 56.51 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 119.64 -0.824 . . . . 1.0 111.711 -176.003 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.514 ' HB1' ' O ' ' A' ' 22' ' ' GLU . . . -64.61 -37.51 87.82 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 119.284 -0.966 . . . . 1.0 111.172 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.617 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -63.32 -39.09 93.6 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 108.367 -0.975 . . . . 1.0 108.367 176.461 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.573 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 79.7 mt-30 -59.61 -42.49 92.74 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.562 -0.745 . . . . 1.0 110.172 175.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.629 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 88.8 mt -56.34 -61.13 2.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.947 -0.569 . . . . 1.0 110.719 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.479 ' HB3' ' HA3' ' A' ' 35' ' ' GLY . 0.2 OUTLIER -58.92 -35.78 73.66 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.778 -0.369 . . . . 1.0 111.382 178.642 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 3.1 m170 -63.23 -24.89 68.07 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.26 0.467 . . . . 1.0 112.26 177.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.629 ' HG2' ' O ' ' A' ' 29' ' ' LEU . 5.9 ptm85 -100.05 -20.18 16.16 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.442 0.639 . . . . 1.0 110.299 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 110.98 35.02 2.06 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.196 -0.911 . . . . 1.0 112.277 177.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.451 ' HG ' ' HG3' ' A' ' 32' ' ' ARG . 21.6 mt -128.33 3.89 5.72 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.877 -0.416 . . . . 1.0 109.877 -179.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.479 ' HA3' ' HB3' ' A' ' 30' ' ' ARG . . . -59.17 -31.44 69.2 Favored Glycine 0 C--O 1.229 -0.217 0 CA-C-N 115.777 -0.647 . . . . 1.0 113.383 -178.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.421 ' O ' ' HB3' ' A' ' 4' ' ' PRO . 3.3 t0 -86.98 -26.05 24.0 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 109.072 -0.714 . . . . 1.0 109.072 177.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.11 -20.82 47.72 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 114.558 -1.201 . . . . 1.0 110.795 -175.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.79 HG11 ' HB3' ' A' ' 5' ' ' LEU . 37.9 t -133.1 122.68 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 CA-C-N 116.393 -0.367 . . . . 1.0 110.207 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.558 ' HG2' ' HB2' ' A' ' 4' ' ' PRO . 11.9 mmt180 -89.78 133.32 34.76 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.04 -1.096 . . . . 1.0 108.04 175.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.494 HG13 ' HB2' ' A' ' 26' ' ' ALA . 45.5 t -127.53 115.58 40.5 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-O 121.375 0.607 . . . . 1.0 109.985 -178.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.427 ' O ' ' HA ' ' A' ' 8' ' ' THR . 67.3 p -130.53 -175.51 3.67 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.461 -1.245 . . . . 1.0 110.427 -175.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.86 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 85.4 p -159.86 165.08 32.98 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 110.004 -0.369 . . . . 1.0 110.004 178.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.534 ' O ' ' HA ' ' A' ' 10' ' ' VAL . . . -164.57 166.85 19.92 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 120.944 0.402 . . . . 1.0 110.775 -179.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.435 ' HA3' ' OD1' ' A' ' 14' ' ' ASN . . . -125.96 138.96 11.12 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 111.257 -0.737 . . . . 1.0 111.257 177.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.561 HG21 HD12 ' A' ' 96' ' ' LEU . 21.4 p -72.86 -25.21 61.02 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.722 0.296 . . . . 1.0 111.339 -178.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.451 ' HA3' ' HZ3' ' A' ' 48' ' ' TRP . . . -107.85 9.49 37.28 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.97 -0.633 . . . . 1.0 113.34 -177.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 45.43 36.25 2.32 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 113.719 1.007 . . . . 1.0 113.719 176.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.451 ' HZ3' ' HA3' ' A' ' 46' ' ' GLY . 1.2 m-90 -44.53 -78.82 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.592 0.711 . . . . 1.0 112.376 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.4 ' O ' ' HB1' ' A' ' 73' ' ' ALA . 8.2 m-70 -104.87 41.1 1.38 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.06 -0.973 . . . . 1.0 111.325 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.421 HG23 ' HA ' ' A' ' 74' ' ' ALA . 14.0 p -59.77 128.05 20.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.538 -0.301 . . . . 1.0 110.473 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.73 -13.5 67.35 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 121.071 -0.585 . . . . 1.0 112.202 -178.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.8 t -80.77 -161.79 0.42 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.321 0.582 . . . . 1.0 110.015 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 20.2 t -122.87 176.29 6.08 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.103 -1.073 . . . . 1.0 108.103 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.28 140.54 55.91 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.752 0.31 . . . . 1.0 110.56 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.43 ' OD1' ' HG2' ' A' ' 57' ' ' ARG . 9.8 t70 -59.12 140.2 56.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.86 -0.609 . . . . 1.0 111.079 -176.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -47.56 -37.1 11.61 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.485 -0.779 . . . . 1.0 112.873 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.43 ' HG2' ' OD1' ' A' ' 55' ' ' ASP . 11.5 ptp180 -73.83 -39.52 63.98 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 122.06 -0.4 . . . . 1.0 111.159 -177.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.92 -37.35 72.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.196 0.522 . . . . 1.0 110.06 178.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.41 -41.47 98.73 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.684 -0.689 . . . . 1.0 109.617 177.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.92 -48.09 81.64 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 115.687 -0.688 . . . . 1.0 112.679 178.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 23.6 m -72.17 -37.28 59.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 117.469 0.635 . . . . 1.0 111.614 -178.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.477 ' CD2' ' HG3' ' A' ' 23' ' ' LYS . 1.3 mp -62.05 -54.87 35.38 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.877 -0.329 . . . . 1.0 110.185 178.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -60.31 -32.79 71.55 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.862 -0.608 . . . . 1.0 110.911 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.47 -32.25 72.96 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-O 121.144 0.497 . . . . 1.0 111.192 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -98.11 5.85 48.18 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.961 -0.563 . . . . 1.0 111.515 -178.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 90.71 11.98 61.34 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 115.977 -0.556 . . . . 1.0 113.429 175.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.43 ' HD1' ' HG2' ' A' ' 27' ' ' GLN . 54.7 m-85 -92.67 151.01 40.66 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-O 120.624 0.25 . . . . 1.0 111.157 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.632 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 44.6 Cg_endo -70.22 158.93 54.82 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.19 1.926 . . . . 1.0 110.528 175.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 30.6 p -129.98 8.46 5.22 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.728 0.775 . . . . 1.0 109.823 -177.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -73.0 120.2 18.31 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.661 -1.154 . . . . 1.0 110.076 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.948 ' HB2' ' HE3' ' A' ' 23' ' ' LYS . 31.9 t60 -164.81 150.95 10.31 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.433 -0.349 . . . . 1.0 110.596 -175.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -132.29 111.26 11.22 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 108.489 -0.93 . . . . 1.0 108.489 175.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 1.004 ' HB3' HD21 ' A' ' 14' ' ' ASN . . . -59.47 141.53 54.5 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.211 -0.904 . . . . 1.0 112.606 -175.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.421 ' HA ' HG23 ' A' ' 50' ' ' VAL . . . -134.52 165.73 24.53 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.8 -0.637 . . . . 1.0 109.845 177.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -101.64 160.79 14.15 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.156 -0.683 . . . . 1.0 109.156 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 86.5 t -65.45 106.07 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.073 0.463 . . . . 1.0 110.88 179.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.454 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -120.77 -175.08 15.21 Favored Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 115.588 -0.733 . . . . 1.0 111.772 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 77.2 m -57.09 -49.45 75.82 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 122.742 0.417 . . . . 1.0 111.826 -178.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.455 ' HG2' ' N ' ' A' ' 80' ' ' HIS . 3.2 pm0 -57.33 -31.06 65.32 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.11 0.481 . . . . 1.0 111.062 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.455 ' N ' ' HG2' ' A' ' 79' ' ' GLU . 80.3 m80 -76.07 -41.55 50.21 Favored 'General case' 0 C--O 1.222 -0.356 0 CA-C-N 115.871 -0.604 . . . . 1.0 109.824 178.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 40.8 mt -66.1 -19.77 65.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.848 178.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.75 -6.26 59.14 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.92 -178.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.583 ' HB3' ' O ' ' A' ' 6' ' ' HIS . . . -60.33 148.56 36.53 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.399 -0.819 . . . . 1.0 111.756 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.686 ' HB3' HD13 ' A' ' 5' ' ' LEU . 15.5 t70 -74.46 -13.5 60.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.886 -0.597 . . . . 1.0 109.996 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.783 HD12 HG13 ' A' ' 7' ' ' VAL . 0.9 OUTLIER -154.37 122.76 6.1 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.685 -0.689 . . . . 1.0 110.198 -178.525 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.94 HD12 HG12 ' A' ' 102' ' ' VAL . 0.2 OUTLIER -108.15 105.0 14.53 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.904 -0.776 . . . . 1.0 108.904 174.653 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.623 ' HB ' ' HD1' ' A' ' 9' ' ' PHE . 53.7 t -84.31 91.27 2.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.663 0.744 . . . . 1.0 110.803 -178.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.93 147.0 30.49 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.434 -0.803 . . . . 1.0 111.207 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.522 HD21 ' HB2' ' A' ' 11' ' ' CYS . 4.2 mm? -100.79 -5.53 26.17 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.546 -0.752 . . . . 1.0 109.558 178.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -148.04 145.24 28.39 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.068 -0.969 . . . . 1.0 110.277 -178.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -55.6 -26.28 43.03 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.418 0.687 . . . . 1.0 111.191 177.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.677 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 80.3 m-20 -75.21 -49.28 19.89 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.719 -0.673 . . . . 1.0 109.911 -178.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.461 ' HB3' HG11 ' A' ' 10' ' ' VAL . 11.8 m170 -58.19 -43.48 87.56 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 115.808 -0.633 . . . . 1.0 109.369 179.32 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.464 ' HA ' HG23 ' A' ' 107' ' ' VAL . . . -59.67 -47.12 86.88 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.915 -0.584 . . . . 1.0 110.718 178.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 13.2 ttm180 -59.59 -39.53 84.48 Favored 'General case' 0 CA--C 1.521 -0.143 0 CA-C-N 115.792 -0.64 . . . . 1.0 111.405 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.734 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 55.6 mt -66.14 -50.68 63.12 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 116.499 -0.319 . . . . 1.0 110.359 -177.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.655 HD21 HG21 ' A' ' 10' ' ' VAL . 14.2 mt -53.51 -56.35 17.75 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.858 -0.61 . . . . 1.0 111.452 -179.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 13.3 ptt85 -62.46 -43.9 97.7 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.161 -0.472 . . . . 1.0 111.844 -177.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.574 ' HG3' ' O ' ' A' ' 96' ' ' LEU . 0.9 OUTLIER -66.35 -22.22 66.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.378 0.608 . . . . 1.0 110.103 179.536 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.734 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 10.0 mt -77.87 -13.21 59.96 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.348 -0.842 . . . . 1.0 111.761 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 154.62 -33.52 0.69 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.003 -1.094 . . . . 1.0 113.279 -179.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.94 HG12 HD12 ' A' ' 86' ' ' LEU . 0.8 OUTLIER -76.36 -152.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.697 0.761 . . . . 1.0 112.221 -176.969 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.631 ' H ' HG11 ' A' ' 102' ' ' VAL . 11.4 pt-20 -164.72 167.32 19.14 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.449 -0.796 . . . . 1.0 109.125 -177.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.809 ' HA ' HG11 ' A' ' 107' ' ' VAL . . . -67.18 -23.26 65.74 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.231 -0.441 . . . . 1.0 111.81 -175.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.12 -34.76 70.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.361 0.601 . . . . 1.0 110.578 176.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.537 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 8.0 mtp180 -98.83 -40.93 7.87 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 115.475 -0.784 . . . . 1.0 110.825 -178.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.809 HG11 ' HA ' ' A' ' 104' ' ' ALA . 9.3 p -80.2 121.62 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-O 121.719 0.771 . . . . 1.0 110.721 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.515 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 21.1 mmm180 -138.05 150.07 46.59 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.808 -0.633 . . . . 1.0 110.177 -178.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.54 ' HB2' ' HB2' ' A' ' 112' ' ' SER . 81.7 mmm -78.45 138.86 38.68 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.619 -0.719 . . . . 1.0 109.715 178.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.554 HD21 HG12 ' A' ' 87' ' ' VAL . 3.0 tm? -55.68 -49.03 74.05 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.621 0.248 . . . . 1.0 110.765 179.01 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 18.4 ttt85 -71.46 -14.28 62.09 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.87 0.367 . . . . 1.0 110.662 -178.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.54 ' HB2' ' HB2' ' A' ' 109' ' ' MET . 26.4 t -70.88 -14.02 62.24 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.482 -0.326 . . . . 1.0 110.403 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.542 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 98.7 m-85 -90.39 -15.37 31.14 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 120.95 0.405 . . . . 1.0 110.44 177.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 13.5 t0 . . . . . 0 C--N 1.327 -0.382 0 CA-C-N 115.785 -0.643 . . . . 1.0 111.206 -177.045 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 . . . . . 0 N--CA 1.456 -0.168 0 CA-C-O 120.56 0.219 . . . . 1.0 111.34 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -63.6 -48.37 77.64 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.588 -0.893 . . . . 1.0 108.588 175.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.99 ' HA ' HG22 ' A' ' 141' ' ' VAL . 54.6 t -60.85 -41.43 88.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.095 -0.957 . . . . 1.0 109.941 176.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -53.55 -42.17 67.23 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.912 -1.04 . . . . 1.0 109.203 176.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.744 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -66.95 -40.21 87.48 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.278 -0.874 . . . . 1.0 110.635 177.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.99 HG22 ' HA ' ' A' ' 138' ' ' VAL . 10.7 t -55.58 -49.96 70.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.65 0.738 . . . . 1.0 110.167 178.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.556 HD13 ' HB3' ' A' ' 20' ' ' MET . 6.2 mt -67.78 -49.79 66.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 114.996 -1.002 . . . . 1.0 111.825 -178.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.744 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 5.3 pt-20 -57.49 -28.3 63.3 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.905 0.383 . . . . 1.0 110.062 178.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.9 t -75.11 -28.19 60.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.06 177.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.472 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -86.52 -23.71 25.79 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-N 116.246 -0.434 . . . . 1.0 111.644 178.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.706 HD21 ' HB3' ' A' ' 25' ' ' PHE . 14.2 mt -56.83 -35.93 40.97 Favored Pre-proline 0 CA--C 1.546 0.798 0 CA-C-O 118.943 -0.551 . . . . 1.0 112.452 -178.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.616 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 37.6 Cg_endo -67.63 -12.75 36.66 Favored 'Trans proline' 0 C--N 1.365 1.402 0 C-N-CA 122.543 2.162 . . . . 1.0 111.494 177.028 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.542 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -104.52 -34.12 3.68 Favored Glycine 0 N--CA 1.44 -1.065 0 CA-C-N 114.995 -1.002 . . . . 1.0 110.611 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.54 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.4 OUTLIER -75.24 -40.9 58.53 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 108.9 -0.778 . . . . 1.0 108.9 179.318 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . 0.44 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 1.1 m-70 -54.33 -52.87 60.17 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.187 -0.915 . . . . 1.0 110.244 175.137 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -60.01 -44.1 94.78 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.67 -0.695 . . . . 1.0 110.946 -176.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . 0.772 ' HZ3' HD12 ' A' ' 5' ' ' LEU . 26.4 t90 -60.56 -55.23 35.88 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.491 -0.777 . . . . 1.0 110.697 -178.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.417 HG11 ' O ' ' A' ' 149' ' ' LEU . 11.7 m -60.67 -39.71 82.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 121.071 -0.252 . . . . 1.0 110.772 -178.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.526 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 4.6 m-20 -59.49 -54.9 41.23 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.271 0.558 . . . . 1.0 110.975 178.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.488 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 6.6 pt-20 -62.28 -33.95 75.64 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.506 -0.77 . . . . 1.0 110.465 -178.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.562 ' HG3' ' CH2' ' A' ' 152' ' ' TRP . 18.5 mmt-85 -74.38 -42.6 59.03 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.759 -0.655 . . . . 1.0 111.711 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 4.5 pp . . . . . 0 C--N 1.323 -0.552 0 N-CA-C 109.505 -0.554 . . . . 1.0 109.505 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.443 ' HB2' ' HG2' ' A' ' 39' ' ' ARG . 36.4 Cg_endo . . . . . 0 C--O 1.233 0.272 0 CA-C-O 121.396 0.498 . . . . 1.0 112.939 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.784 ' HB3' HG23 ' A' ' 38' ' ' VAL . 0.6 OUTLIER -70.99 -174.18 0.91 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.322 -0.854 . . . . 1.0 110.989 -179.388 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.599 ' HB3' ' HA ' ' A' ' 83' ' ' ALA . 2.7 t-160 -156.51 104.83 2.21 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.468 -0.333 . . . . 1.0 110.659 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.667 HG13 HD13 ' A' ' 85' ' ' LEU . 2.8 t -105.16 119.47 54.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 107.32 -1.363 . . . . 1.0 107.32 175.018 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.555 HG22 ' HG ' ' A' ' 86' ' ' LEU . 8.2 t -121.74 114.01 20.51 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 120.44 -0.504 . . . . 1.0 110.484 179.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.66 ' HD2' ' HB3' ' A' ' 42' ' ' SER . 1.5 m-85 -83.15 127.35 33.53 Favored 'General case' 0 CA--C 1.512 -0.491 0 O-C-N 122.004 -0.435 . . . . 1.0 110.6 -179.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.601 HG21 HD22 ' A' ' 97' ' ' LEU . 23.8 t -111.39 111.76 37.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.008 0.432 . . . . 1.0 111.633 -176.194 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.542 ' HB2' HD22 ' A' ' 89' ' ' LEU . 42.2 t -141.24 155.98 45.95 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.331 179.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.42 92.59 0.61 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.103 0.478 . . . . 1.0 110.776 179.194 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.808 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 132.57 -41.92 1.44 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.791 -0.718 . . . . 1.0 111.869 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.406 HD22 ' CB ' ' A' ' 42' ' ' SER . 3.6 t-20 62.17 18.74 10.35 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.454 0.645 . . . . 1.0 111.766 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.2 pt -127.25 11.8 3.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 O-C-N 121.542 -0.724 . . . . 1.0 112.165 -176.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.715 ' O ' ' HG3' ' A' ' 20' ' ' MET . 80.5 m -126.6 -89.96 0.54 Allowed 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.122 -0.631 . . . . 1.0 111.852 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.405 ' HG3' ' HG ' ' A' ' 89' ' ' LEU . 0.9 OUTLIER -74.4 -30.13 61.82 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.674 0.62 . . . . 1.0 112.674 -175.819 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.641 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 17.2 m -62.46 -58.91 14.58 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 121.04 -0.264 . . . . 1.0 110.841 178.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.724 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 35.2 Cg_endo -62.78 -25.79 74.82 Favored 'Trans proline' 0 C--N 1.357 0.978 0 C-N-CA 122.213 1.942 . . . . 1.0 111.983 179.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.715 ' HG3' ' O ' ' A' ' 16' ' ' CYS . 71.3 mtp -61.85 -52.85 62.44 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.849 -0.34 . . . . 1.0 110.809 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.425 ' HA ' ' HB2' ' A' ' 24' ' ' MET . . . -74.16 -27.17 60.7 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.577 -0.449 . . . . 1.0 110.108 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.575 ' O ' ' HB1' ' A' ' 26' ' ' ALA . 7.9 tt0 -55.88 -49.78 72.44 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 115.159 -0.928 . . . . 1.0 109.302 179.254 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.901 ' HB3' ' HG2' ' A' ' 68' ' ' PRO . 0.0 OUTLIER -80.79 -32.15 35.46 Favored 'General case' 0 C--N 1.32 -0.691 0 O-C-N 121.825 -0.547 . . . . 1.0 110.002 -177.155 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.604 ' HB3' HD11 ' A' ' 146' ' ' LEU . 2.3 mmm -61.56 -76.15 0.06 Allowed 'General case' 0 C--O 1.236 0.362 0 N-CA-C 112.928 0.714 . . . . 1.0 112.928 -176.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.697 ' HB3' HD21 ' A' ' 146' ' ' LEU . 16.5 p90 -76.84 -30.36 56.28 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 119.645 -0.822 . . . . 1.0 111.749 -174.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.575 ' HB1' ' O ' ' A' ' 22' ' ' GLU . . . -63.87 -37.75 88.55 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 119.082 -1.047 . . . . 1.0 110.894 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.676 ' HA ' ' HD3' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -65.82 -37.71 86.99 Favored 'General case' 0 C--N 1.333 -0.13 0 N-CA-C 108.955 -0.758 . . . . 1.0 108.955 177.836 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.537 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 79.3 mt-30 -58.8 -42.09 88.28 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.114 175.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.643 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 85.9 mt -56.02 -60.54 3.34 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.706 -0.679 . . . . 1.0 110.578 179.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.676 ' HD3' ' HA ' ' A' ' 27' ' ' GLN . 0.7 OUTLIER -58.94 -37.69 77.3 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.59 -0.277 . . . . 1.0 111.168 179.254 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -60.93 -25.31 66.69 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.252 0.464 . . . . 1.0 112.252 177.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.643 ' HG2' ' O ' ' A' ' 29' ' ' LEU . 3.6 ptm180 -100.71 -18.94 16.27 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 119.602 -0.839 . . . . 1.0 110.418 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 108.04 36.04 2.43 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.236 -0.893 . . . . 1.0 112.502 176.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.416 HD12 ' HD3' ' A' ' 32' ' ' ARG . 23.2 mt -130.08 -3.62 4.5 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 122.625 -0.338 . . . . 1.0 110.535 -178.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.5 -25.93 61.41 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 121.126 -0.559 . . . . 1.0 112.488 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -80.06 -32.08 39.4 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.511 0.672 . . . . 1.0 109.847 177.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.74 -18.36 51.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.814 -1.085 . . . . 1.0 112.759 -175.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.784 HG23 ' HB3' ' A' ' 5' ' ' LEU . 0.8 OUTLIER -145.02 128.97 12.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.107 0.479 . . . . 1.0 110.869 -178.837 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.443 ' HG2' ' HB2' ' A' ' 4' ' ' PRO . 9.3 mmm180 -94.12 140.75 29.36 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.639 -0.709 . . . . 1.0 110.168 -178.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.441 HG11 ' HB2' ' A' ' 26' ' ' ALA . 77.9 t -127.77 120.0 53.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-O 121.659 0.743 . . . . 1.0 109.633 -178.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.534 ' O ' ' HA ' ' A' ' 8' ' ' THR . 69.3 p -136.05 -174.54 3.7 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.135 -1.393 . . . . 1.0 109.933 -175.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.66 ' HB3' ' HD2' ' A' ' 9' ' ' PHE . 84.4 p -162.69 167.32 23.28 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 116.485 -0.325 . . . . 1.0 110.49 179.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.588 ' HB2' ' CD2' ' A' ' 80' ' ' HIS . . . -162.83 166.7 23.79 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.578 0.704 . . . . 1.0 111.727 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.439 ' HA2' ' O ' ' A' ' 11' ' ' CYS . . . -124.87 131.34 7.74 Favored Glycine 0 N--CA 1.443 -0.86 0 CA-C-N 114.785 -1.098 . . . . 1.0 111.252 178.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.494 HG23 HD11 ' A' ' 96' ' ' LEU . 40.9 p -70.11 -27.49 64.63 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.985 0.421 . . . . 1.0 111.108 -178.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -102.28 5.93 52.85 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 121.069 -0.586 . . . . 1.0 113.161 -176.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 44.19 34.6 1.03 Allowed 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 114.269 1.211 . . . . 1.0 114.269 176.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.808 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 0.9 OUTLIER -46.75 -72.62 0.05 Allowed 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.638 0.732 . . . . 1.0 112.494 -179.846 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.402 ' O ' ' HB1' ' A' ' 73' ' ' ALA . 17.7 m-70 -107.75 42.58 1.32 Allowed 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.045 -0.979 . . . . 1.0 111.016 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.2 p -62.84 128.48 24.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.098 0.475 . . . . 1.0 110.284 178.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.48 -13.56 67.28 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.761 -0.733 . . . . 1.0 111.828 -177.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.4 t -80.66 -158.74 0.2 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.063 0.459 . . . . 1.0 110.036 178.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 21.6 t -131.15 174.69 9.78 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.117 -1.068 . . . . 1.0 108.117 -179.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.2 137.31 47.4 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.713 0.292 . . . . 1.0 111.032 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.719 ' OD1' ' HG2' ' A' ' 57' ' ' ARG . 11.3 t70 -62.66 140.64 58.71 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 115.881 -0.599 . . . . 1.0 110.145 -177.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -51.53 -30.4 20.26 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 113.341 0.867 . . . . 1.0 113.341 -178.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.719 ' HG2' ' OD1' ' A' ' 55' ' ' ASP . 3.9 ptp180 -70.99 -44.4 66.02 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 118.351 0.523 . . . . 1.0 110.769 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.69 -35.82 70.38 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.739 -0.664 . . . . 1.0 109.583 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.84 -44.22 96.73 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.402 -0.817 . . . . 1.0 109.472 177.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.424 ' O ' ' HG2' ' A' ' 63' ' ' ARG . . . -56.75 -45.92 90.33 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.95 -0.643 . . . . 1.0 113.301 178.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.1 m -73.29 -38.62 54.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 117.793 0.797 . . . . 1.0 111.478 -178.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.656 HD21 ' HA ' ' A' ' 20' ' ' MET . 5.6 mp -62.17 -53.29 57.35 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.85 -0.34 . . . . 1.0 110.556 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.424 ' HG2' ' O ' ' A' ' 60' ' ' GLY . 11.6 ptm180 -59.98 -28.37 67.63 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.952 -0.567 . . . . 1.0 111.377 179.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.39 -30.27 65.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.22 0.533 . . . . 1.0 110.738 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -96.83 4.76 51.53 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.872 -0.604 . . . . 1.0 110.526 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.62 13.41 65.18 Favored Glycine 0 C--N 1.331 0.257 0 CA-C-N 115.681 -0.691 . . . . 1.0 113.087 176.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -92.06 150.84 41.18 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-O 120.498 0.19 . . . . 1.0 110.882 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.901 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 39.3 Cg_endo -67.8 155.79 68.51 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.395 2.063 . . . . 1.0 110.612 176.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 57.0 p -130.86 10.74 5.08 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 120.262 -0.575 . . . . 1.0 111.834 -176.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -97.32 136.5 37.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.915 0.388 . . . . 1.0 110.853 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.69 ' HB3' ' HE3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -178.98 162.55 1.26 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.523 -1.288 . . . . 1.0 107.523 177.729 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -121.56 120.82 35.93 Favored 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 119.548 -0.861 . . . . 1.0 108.871 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.402 ' HB1' ' O ' ' A' ' 49' ' ' HIS . . . -60.03 140.67 56.66 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.763 -0.653 . . . . 1.0 111.288 -177.154 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.441 ' O ' ' HA ' ' A' ' 43' ' ' ALA . . . -134.65 151.07 50.77 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.907 -0.588 . . . . 1.0 110.132 179.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -87.57 153.31 21.5 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.644 -0.872 . . . . 1.0 108.644 177.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.544 HG12 HD23 ' A' ' 97' ' ' LEU . 21.7 t -63.91 114.2 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.217 0.532 . . . . 1.0 110.506 -179.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.436 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -125.27 -169.31 12.9 Favored Glycine 0 N--CA 1.442 -0.948 0 CA-C-N 115.129 -0.941 . . . . 1.0 111.279 179.299 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 51.9 m -59.86 -43.72 94.53 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.453 0.168 . . . . 1.0 111.196 -178.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -59.09 -31.34 68.81 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 120.952 0.406 . . . . 1.0 111.249 177.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.588 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 78.6 m80 -76.52 -40.69 49.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.497 -0.32 . . . . 1.0 110.276 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.699 ' HA ' HD23 ' A' ' 86' ' ' LEU . 14.6 mt -70.18 -17.09 63.15 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 120.774 0.321 . . . . 1.0 110.444 177.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.73 -7.09 58.99 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 120.777 0.322 . . . . 1.0 110.223 -179.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.599 ' HA ' ' HB3' ' A' ' 6' ' ' HIS . . . -58.45 149.23 25.62 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.961 -0.563 . . . . 1.0 110.922 178.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.515 ' HA ' ' HE ' ' A' ' 106' ' ' ARG . 32.1 t70 -75.49 -16.19 60.33 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.179 0.514 . . . . 1.0 109.739 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.667 HD13 HG13 ' A' ' 7' ' ' VAL . 0.6 OUTLIER -152.73 117.68 5.13 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.205 -0.907 . . . . 1.0 109.043 -177.688 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.699 HD23 ' HA ' ' A' ' 81' ' ' LEU . 4.9 mp -108.06 104.23 13.62 Favored 'General case' 0 N--CA 1.424 -1.758 0 CA-C-N 115.824 -0.625 . . . . 1.0 109.535 178.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.583 ' HB ' ' HD1' ' A' ' 9' ' ' PHE . 52.9 t -83.32 90.58 2.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.01 -0.996 . . . . 1.0 110.757 -175.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.63 146.06 34.31 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.484 -0.78 . . . . 1.0 110.441 179.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.542 HD22 ' HB2' ' A' ' 11' ' ' CYS . 4.1 mm? -95.33 -8.63 35.24 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.335 0.588 . . . . 1.0 109.592 178.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -151.18 154.61 37.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.451 -0.795 . . . . 1.0 111.18 178.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.441 ' H ' ' HG2' ' A' ' 91' ' ' ARG . 13.5 ptt180 -61.63 -20.02 62.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.42 -0.809 . . . . 1.0 111.523 177.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.652 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 4.2 m-20 -75.2 -51.9 12.22 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.044 -0.725 . . . . 1.0 109.044 179.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.545 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 10.4 m170 -58.32 -44.68 88.76 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.073 -0.967 . . . . 1.0 109.792 178.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.466 ' HA ' HD13 ' A' ' 97' ' ' LEU . . . -60.23 -44.51 95.14 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 116.297 -0.41 . . . . 1.0 111.072 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.645 ' O ' ' HG2' ' A' ' 99' ' ' GLN . 2.4 ttt180 -57.23 -44.8 84.12 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 115.934 -0.575 . . . . 1.0 110.954 178.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.652 ' HG ' ' O ' ' A' ' 92' ' ' ASN . 49.3 mt -63.34 -45.41 91.38 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 116.121 -0.49 . . . . 1.0 110.515 -175.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.612 HD12 ' HB3' ' A' ' 86' ' ' LEU . 31.2 mt -54.52 -61.08 2.54 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.814 -0.63 . . . . 1.0 111.433 -178.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.719 ' N ' HG12 ' A' ' 102' ' ' VAL . 7.3 ptm180 -58.8 -45.19 90.47 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.73 0.641 . . . . 1.0 112.73 -179.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.645 ' HG2' ' O ' ' A' ' 95' ' ' ARG . 6.6 pt20 -66.57 -23.91 66.27 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 119.978 -0.689 . . . . 1.0 109.915 179.061 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.593 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 3.4 mt -81.68 -13.73 57.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.605 -0.725 . . . . 1.0 111.789 178.274 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 150.83 -26.16 1.04 Allowed Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 119.769 -1.205 . . . . 1.0 114.138 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.719 HG12 ' N ' ' A' ' 98' ' ' ARG . 0.3 OUTLIER -77.26 -161.64 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-N 118.026 0.913 . . . . 1.0 111.252 -177.967 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.678 ' N ' HG11 ' A' ' 102' ' ' VAL . 12.9 pt-20 -159.05 164.49 35.39 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.844 -1.169 . . . . 1.0 107.844 -178.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.818 ' HA ' HG11 ' A' ' 107' ' ' VAL . . . -63.48 -24.22 67.73 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 123.354 0.409 . . . . 1.0 111.379 -175.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.94 -34.42 71.73 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.206 176.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.611 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 1.2 mtp85 -102.16 -40.42 6.81 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.653 -0.703 . . . . 1.0 111.541 -177.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.818 HG11 ' HA ' ' A' ' 104' ' ' ALA . 8.6 p -77.13 120.7 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 N-CA-C 109.415 -0.587 . . . . 1.0 109.415 -175.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.573 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 12.0 mmm180 -139.75 145.57 38.43 Favored 'General case' 0 C--N 1.322 -0.604 0 O-C-N 121.762 -0.586 . . . . 1.0 110.358 -178.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.504 ' HB2' ' HB2' ' A' ' 112' ' ' SER . 73.5 mmm -78.67 138.78 38.46 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.917 -0.583 . . . . 1.0 110.56 178.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.519 HD23 HG12 ' A' ' 87' ' ' VAL . 3.0 tm? -57.37 -50.53 72.67 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.668 0.27 . . . . 1.0 111.472 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 14.2 ttt180 -70.06 -17.23 63.23 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.041 0.448 . . . . 1.0 110.624 -177.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.504 ' HB2' ' HB2' ' A' ' 109' ' ' MET . 32.5 t -75.2 -7.65 54.43 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.888 -178.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.558 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 92.4 m-85 -90.56 -17.89 26.19 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 110.287 -0.264 . . . . 1.0 110.287 176.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 27.4 t0 . . . . . 0 N--CA 1.464 0.241 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.799 -178.53 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 . . . . . 0 N--CA 1.456 -0.141 0 CA-C-O 120.594 0.235 . . . . 1.0 111.337 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -63.42 -47.12 83.25 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 109.251 -0.648 . . . . 1.0 109.251 175.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.919 ' HA ' HG11 ' A' ' 141' ' ' VAL . 85.5 t -62.74 -39.83 86.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.576 0.703 . . . . 1.0 109.259 177.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -56.33 -42.22 77.31 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.584 -0.735 . . . . 1.0 109.481 175.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.484 ' O ' ' HG2' ' A' ' 143' ' ' GLU . . . -67.14 -49.14 65.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.047 -0.979 . . . . 1.0 111.32 179.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.919 HG11 ' HA ' ' A' ' 138' ' ' VAL . 2.9 p -58.37 -40.34 77.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.456 0.646 . . . . 1.0 110.779 -178.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.554 HD12 HG11 ' A' ' 138' ' ' VAL . 14.2 mt -70.26 -51.54 37.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 115.187 -0.915 . . . . 1.0 112.228 178.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.515 ' HB3' ' HE1' ' A' ' 24' ' ' MET . 11.6 pt-20 -55.46 -31.18 61.75 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.309 0.576 . . . . 1.0 110.287 179.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 65.9 m -74.97 -27.66 60.26 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.102 -0.954 . . . . 1.0 110.468 179.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.477 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -86.24 -24.68 25.92 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 115.99 -0.55 . . . . 1.0 111.725 178.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.697 HD21 ' HB3' ' A' ' 25' ' ' PHE . 12.7 mt -55.89 -37.28 55.38 Favored Pre-proline 0 CA--C 1.547 0.846 0 N-CA-C 112.468 0.544 . . . . 1.0 112.468 -178.11 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.627 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 38.3 Cg_endo -67.04 -14.04 42.09 Favored 'Trans proline' 0 C--N 1.363 1.311 0 C-N-CA 122.495 2.13 . . . . 1.0 111.908 177.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.558 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -104.19 -34.05 3.79 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.084 -0.962 . . . . 1.0 110.714 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.571 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -73.68 -40.93 63.31 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.889 -0.782 . . . . 1.0 108.889 179.543 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . 0.542 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 0.2 OUTLIER -53.08 -57.04 11.76 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 115.103 -0.953 . . . . 1.0 110.837 175.672 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -57.01 -40.19 76.15 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.727 -1.124 . . . . 1.0 111.069 -174.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . 0.611 ' HZ3' HD21 ' A' ' 5' ' ' LEU . 24.3 t90 -63.22 -58.01 8.59 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.173 -0.922 . . . . 1.0 110.614 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.428 HG12 ' O ' ' A' ' 149' ' ' LEU . 5.7 m -60.73 -40.55 85.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.81 -0.356 . . . . 1.0 110.303 -177.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.409 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 5.8 m-20 -61.17 -49.5 76.93 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.832 0.349 . . . . 1.0 110.904 178.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.517 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 9.3 pt-20 -63.51 -39.39 94.3 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.095 0.474 . . . . 1.0 110.548 -178.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.516 ' HG3' ' CH2' ' A' ' 152' ' ' TRP . 18.4 mmt85 -71.32 -46.73 59.95 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.516 -0.766 . . . . 1.0 110.837 -176.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 4.2 pp . . . . . 0 C--N 1.326 -0.453 0 CA-C-O 121.228 0.537 . . . . 1.0 109.941 -179.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.45 ' HB2' ' HG2' ' A' ' 39' ' ' ARG . 13.0 Cg_endo . . . . . 0 N--CA 1.461 -0.386 0 N-CA-C 114.101 0.769 . . . . 1.0 114.101 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.824 ' HB3' HG21 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -65.19 178.51 0.87 Allowed 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.637 -1.165 . . . . 1.0 108.453 178.608 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.725 ' H ' HD11 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -155.55 100.97 2.14 Favored 'General case' 0 C--N 1.318 -0.803 0 O-C-N 121.549 -0.72 . . . . 1.0 109.585 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.457 HG23 HG12 ' A' ' 153' ' ' VAL . 2.2 t -104.68 116.01 47.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 107.964 -1.125 . . . . 1.0 107.964 178.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.619 HG22 ' HG ' ' A' ' 86' ' ' LEU . 6.3 t -119.06 117.89 29.96 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 120.52 -0.472 . . . . 1.0 109.918 178.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.587 ' HD2' ' HB3' ' A' ' 42' ' ' SER . 1.6 m-85 -85.22 133.19 34.19 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.016 -178.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.621 HG22 HD13 ' A' ' 97' ' ' LEU . 22.5 t -118.04 113.42 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.775 0 CA-C-O 121.123 0.487 . . . . 1.0 111.383 -176.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.669 ' SG ' ' HD3' ' A' ' 17' ' ' ARG . 42.2 t -144.94 160.23 41.66 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.657 -0.701 . . . . 1.0 109.491 178.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.446 HG22 ' NE2' ' A' ' 93' ' ' HIS . 2.7 p -68.56 112.28 5.26 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 120.941 0.401 . . . . 1.0 110.226 178.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.956 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 110.57 -45.16 1.36 Allowed Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.651 -0.785 . . . . 1.0 112.286 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.566 ' ND2' ' H ' ' A' ' 74' ' ' ALA . 57.5 t30 59.66 35.25 22.36 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 122.016 0.912 . . . . 1.0 110.953 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.406 HD13 ' ND1' ' A' ' 49' ' ' HIS . 4.5 pt -130.32 -4.39 2.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 O-C-N 121.682 -0.636 . . . . 1.0 112.483 -179.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.718 ' O ' ' HG3' ' A' ' 20' ' ' MET . 32.7 m -115.43 -89.05 0.57 Allowed 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 119.671 -0.812 . . . . 1.0 111.881 -177.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.94 ' HG3' ' HG ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -70.76 -39.99 72.91 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.821 0.674 . . . . 1.0 112.821 -175.071 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.478 ' HB3' ' HB2' ' A' ' 9' ' ' PHE . 19.4 m -57.58 -57.4 25.59 Favored Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 111.518 0.192 . . . . 1.0 111.518 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.453 ' HD3' ' HB2' ' A' ' 18' ' ' SER . 40.0 Cg_endo -65.15 -23.93 59.68 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 121.886 1.724 . . . . 1.0 112.395 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.718 ' HG3' ' O ' ' A' ' 16' ' ' CYS . 78.0 mtp -61.78 -52.33 64.66 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.111 -0.329 . . . . 1.0 110.111 179.046 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.453 ' HA ' ' HB2' ' A' ' 24' ' ' MET . . . -72.37 -27.56 62.46 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-N 115.632 -0.713 . . . . 1.0 110.138 -178.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.488 ' O ' ' HB1' ' A' ' 26' ' ' ALA . 17.2 tt0 -52.63 -51.99 57.59 Favored 'General case' 0 C--O 1.216 -0.664 0 CA-C-N 114.981 -1.009 . . . . 1.0 109.361 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.687 ' O ' ' HB3' ' A' ' 27' ' ' GLN . 0.1 OUTLIER -88.14 -22.79 23.88 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.815 -1.084 . . . . 1.0 110.99 -175.974 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.516 ' HB3' HD12 ' A' ' 146' ' ' LEU . 89.2 mtp -65.39 -74.97 0.09 Allowed 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.101 0.476 . . . . 1.0 112.246 -179.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.71 ' HB3' HD22 ' A' ' 146' ' ' LEU . 17.9 p90 -75.48 -30.64 59.95 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.003 -0.679 . . . . 1.0 111.601 -175.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.505 ' HA ' HD13 ' A' ' 29' ' ' LEU . . . -64.79 -35.79 82.24 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 119.305 -0.958 . . . . 1.0 110.905 179.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.687 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -63.79 -37.88 89.01 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.402 -0.962 . . . . 1.0 108.402 177.147 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.582 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 77.9 mt-30 -59.5 -45.54 91.39 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 115.519 -0.764 . . . . 1.0 110.351 175.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.505 HD13 ' HA ' ' A' ' 26' ' ' ALA . 81.8 mt -53.3 -62.48 1.63 Allowed 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 115.859 -0.61 . . . . 1.0 111.317 -179.179 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.429 ' HA ' ' H ' ' A' ' 35' ' ' GLY . 0.3 OUTLIER -58.77 -35.48 72.85 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 120.831 -0.348 . . . . 1.0 111.502 179.863 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -62.14 -28.62 69.77 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.139 0.422 . . . . 1.0 112.139 177.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.582 ' HG2' ' O ' ' A' ' 28' ' ' GLN . 7.3 ptp180 -94.71 -20.25 19.69 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 119.452 -0.899 . . . . 1.0 109.949 178.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 110.52 35.52 2.06 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.202 -0.908 . . . . 1.0 112.277 176.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.461 ' HG ' ' HG3' ' A' ' 32' ' ' ARG . 17.9 mt -126.16 1.43 7.16 Favored 'General case' 0 N--CA 1.452 -0.358 0 O-C-N 122.432 -0.452 . . . . 1.0 110.0 -178.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.429 ' H ' ' HA ' ' A' ' 30' ' ' ARG . . . -55.75 -30.2 56.03 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 121.094 -0.574 . . . . 1.0 112.709 -178.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -88.79 -20.77 24.29 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.924 0.392 . . . . 1.0 110.55 178.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.92 -21.54 40.44 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.73 -0.668 . . . . 1.0 111.802 -179.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.824 HG21 ' HB3' ' A' ' 5' ' ' LEU . 0.6 OUTLIER -144.21 125.8 9.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.283 0.563 . . . . 1.0 111.386 -179.727 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.45 ' HG2' ' HB2' ' A' ' 4' ' ' PRO . 11.8 mmt180 -88.33 135.01 33.66 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.693 -0.855 . . . . 1.0 108.693 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.479 HG11 ' HB2' ' A' ' 26' ' ' ALA . 53.9 t -124.76 123.25 65.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.546 0.689 . . . . 1.0 109.385 -178.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.549 ' O ' ' HA ' ' A' ' 8' ' ' THR . 42.8 p -138.54 -175.75 4.23 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.491 -1.231 . . . . 1.0 110.989 -174.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.587 ' HB3' ' HD2' ' A' ' 9' ' ' PHE . 59.6 p -160.13 162.6 34.01 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.397 -0.365 . . . . 1.0 110.135 -178.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.609 ' HB2' ' CD2' ' A' ' 80' ' ' HIS . . . -162.88 163.19 26.5 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.36 0.6 . . . . 1.0 111.636 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.46 ' HA2' ' O ' ' A' ' 11' ' ' CYS . . . -123.23 131.64 8.25 Favored Glycine 0 N--CA 1.442 -0.909 0 N-CA-C 110.778 -0.929 . . . . 1.0 110.778 178.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.499 HG23 ' CG1' ' A' ' 10' ' ' VAL . 23.2 p -69.98 -25.36 63.58 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.805 0.336 . . . . 1.0 111.752 -177.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.512 ' HA3' ' HZ3' ' A' ' 48' ' ' TRP . . . -110.91 9.16 29.64 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 120.851 -0.69 . . . . 1.0 113.409 -176.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 41.98 41.81 2.08 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 114.25 1.204 . . . . 1.0 114.25 176.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.956 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 1.2 m-90 -49.1 -76.02 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.694 0.759 . . . . 1.0 111.903 177.19 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.406 ' ND1' HD13 ' A' ' 15' ' ' ILE . 9.1 m170 -102.39 39.19 1.54 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.178 -0.919 . . . . 1.0 111.04 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.9 p -60.05 128.41 21.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.147 0.499 . . . . 1.0 110.529 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.43 ' HA2' ' HD3' ' A' ' 72' ' ' ARG . . . 93.3 -14.22 65.78 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.944 -0.646 . . . . 1.0 111.99 -177.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.1 t -80.63 -161.12 0.35 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.183 0.516 . . . . 1.0 110.004 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 71' ' ' HIS . 24.8 t -121.39 176.23 5.76 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 108.448 -0.945 . . . . 1.0 108.448 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.499 ' HB2' ' HZ2' ' A' ' 23' ' ' LYS . . . -59.63 143.68 49.86 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.313 -0.403 . . . . 1.0 111.273 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.464 ' OD1' ' HG3' ' A' ' 57' ' ' ARG . 51.6 t0 -49.58 123.93 8.62 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.898 -1.046 . . . . 1.0 110.115 178.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -44.57 -37.02 3.3 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.444 -0.798 . . . . 1.0 112.64 178.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.589 ' O ' HG21 ' A' ' 61' ' ' VAL . 0.2 OUTLIER -73.27 -38.06 66.07 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.095 -0.642 . . . . 1.0 111.178 -179.102 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.11 -36.37 72.12 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.55 0.214 . . . . 1.0 110.472 177.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.47 -41.88 97.92 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.046 177.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.09 -42.3 99.74 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 111.084 -0.807 . . . . 1.0 111.084 176.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.589 HG21 ' O ' ' A' ' 57' ' ' ARG . 85.0 t -59.14 -57.36 11.74 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 CA-C-N 115.273 -0.464 . . . . 1.0 111.127 178.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.643 ' HB2' HG22 ' A' ' 69' ' ' THR . 85.7 mt -59.5 -50.36 74.22 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.227 -0.442 . . . . 1.0 111.504 -177.152 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.665 ' HB3' HG23 ' A' ' 69' ' ' THR . 2.2 ptt180 -63.25 -27.74 69.55 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.727 -0.67 . . . . 1.0 110.823 -178.162 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.86 -29.68 68.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.128 0.49 . . . . 1.0 110.702 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -98.81 4.31 47.58 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.837 -0.619 . . . . 1.0 111.452 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.39 12.39 63.1 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.712 -0.756 . . . . 1.0 112.691 177.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.517 ' HD1' ' HG2' ' A' ' 27' ' ' GLN . 62.3 m-85 -86.96 152.31 53.3 Favored Pre-proline 0 C--N 1.323 -0.574 0 O-C-N 122.756 -0.261 . . . . 1.0 110.409 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.626 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 17.8 Cg_endo -64.81 153.25 78.81 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.295 1.997 . . . . 1.0 110.417 175.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.665 HG23 ' HB3' ' A' ' 63' ' ' ARG . 61.5 p -135.35 28.84 3.36 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 120.232 -0.587 . . . . 1.0 112.336 -176.074 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -104.38 130.47 52.25 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.343 -0.614 . . . . 1.0 109.343 178.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.684 ' HB2' ' HE2' ' A' ' 23' ' ' LYS . 18.7 t60 -164.95 148.34 8.56 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.287 -177.466 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.443 ' HD2' ' C ' ' A' ' 72' ' ' ARG . 6.3 tmm_? -127.41 111.31 13.71 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 107.493 -1.299 . . . . 1.0 107.493 177.342 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.58 134.25 55.97 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.1 -0.955 . . . . 1.0 111.918 -175.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.566 ' H ' ' ND2' ' A' ' 14' ' ' ASN . . . -128.8 147.98 50.84 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.725 -0.67 . . . . 1.0 109.791 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -87.09 155.83 19.97 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.747 -0.464 . . . . 1.0 109.747 176.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.481 HG12 HD21 ' A' ' 97' ' ' LEU . 12.9 t -64.11 112.58 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.488 0.661 . . . . 1.0 111.229 -179.374 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -122.64 -171.75 13.86 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 114.937 -1.029 . . . . 1.0 111.748 179.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 96.6 m -56.41 -44.45 80.35 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 123.704 0.297 . . . . 1.0 111.212 -179.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -60.07 -27.83 67.3 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.873 0.368 . . . . 1.0 110.939 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.609 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 79.6 m80 -79.73 -41.56 26.44 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 116.421 -0.354 . . . . 1.0 110.389 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.639 ' O ' HG21 ' A' ' 102' ' ' VAL . 17.9 mt -67.61 -17.0 64.46 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.241 176.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.76 -8.28 57.5 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.395 -0.366 . . . . 1.0 110.848 -179.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.527 ' HA ' ' HB3' ' A' ' 6' ' ' HIS . . . -60.15 151.17 27.67 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.074 -0.512 . . . . 1.0 111.569 -179.488 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.75 ' HB3' HD11 ' A' ' 5' ' ' LEU . 9.9 t70 -76.13 -14.98 60.16 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.759 -0.655 . . . . 1.0 109.712 179.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.742 HD13 ' CE3' ' A' ' 152' ' ' TRP . 1.2 tt -157.48 116.53 3.28 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.89 -0.595 . . . . 1.0 109.572 -177.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.619 ' HG ' HG22 ' A' ' 8' ' ' THR . 5.3 mp -107.27 88.44 2.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 116.018 -0.537 . . . . 1.0 110.671 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.617 HG22 HD23 ' A' ' 85' ' ' LEU . 70.3 t -66.18 91.02 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 113.801 -1.545 . . . . 1.0 112.363 -179.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.49 146.32 32.77 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.509 -1.223 . . . . 1.0 110.655 177.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.94 ' HG ' ' HG3' ' A' ' 17' ' ' ARG . 4.3 mm? -99.04 -8.47 25.27 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.253 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.441 ' CG ' ' H ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -153.32 155.22 36.07 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.08 -0.509 . . . . 1.0 111.142 -179.843 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -56.91 -27.02 60.25 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.24 -0.891 . . . . 1.0 113.31 -178.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.647 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 7.0 m-20 -75.58 -49.93 17.08 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.977 -0.379 . . . . 1.0 109.977 -178.061 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.661 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 9.9 m170 -55.28 -47.33 75.69 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.73 -0.668 . . . . 1.0 110.295 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.96 -43.96 91.41 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.09 0.471 . . . . 1.0 110.704 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.456 ' O ' ' HG2' ' A' ' 99' ' ' GLN . 17.1 ttt180 -59.4 -44.42 92.82 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.759 -0.655 . . . . 1.0 111.332 178.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.647 ' HG ' ' O ' ' A' ' 92' ' ' ASN . 60.2 mt -62.69 -47.32 84.16 Favored 'General case' 0 C--O 1.215 -0.737 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.425 -176.358 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.661 ' HG ' ' O ' ' A' ' 93' ' ' HIS . 29.5 mt -54.32 -59.46 4.64 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.636 -0.711 . . . . 1.0 111.417 -178.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.683 ' CA ' HG12 ' A' ' 102' ' ' VAL . 16.5 ptt85 -59.7 -44.71 93.56 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.305 0.483 . . . . 1.0 112.305 -178.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' A' ' 95' ' ' ARG . 2.3 pt20 -68.06 -24.63 65.09 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.497 -0.481 . . . . 1.0 109.918 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.641 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 6.1 mt -81.48 -16.14 52.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.718 -0.674 . . . . 1.0 112.037 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 151.06 -23.44 0.99 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 119.873 -1.156 . . . . 1.0 114.184 -178.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.867 HG22 ' HD2' ' A' ' 106' ' ' ARG . 0.4 OUTLIER -76.62 -163.11 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 CA-C-N 117.958 0.879 . . . . 1.0 110.295 -179.091 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.685 ' N ' HG11 ' A' ' 102' ' ' VAL . 14.2 pt-20 -158.11 161.4 37.94 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 107.702 -1.221 . . . . 1.0 107.702 -179.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.772 ' HA ' HG13 ' A' ' 107' ' ' VAL . . . -61.86 -25.02 67.28 Favored 'General case' 0 C--N 1.32 -0.717 0 O-C-N 123.285 0.366 . . . . 1.0 111.273 -175.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.418 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . . . -56.37 -39.31 72.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.318 0.58 . . . . 1.0 110.286 175.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.867 ' HD2' HG22 ' A' ' 102' ' ' VAL . 22.5 mtt180 -96.82 -42.51 7.93 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 115.036 -0.983 . . . . 1.0 111.13 -176.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.772 HG13 ' HA ' ' A' ' 104' ' ' ALA . 11.5 p -78.86 117.75 24.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 120.694 -0.402 . . . . 1.0 110.03 -174.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.612 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 0.1 OUTLIER -138.35 148.44 44.57 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 121.716 -0.615 . . . . 1.0 110.455 -178.97 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 83.9 mmm -80.86 140.53 35.33 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.977 -0.556 . . . . 1.0 111.006 -178.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.555 HD23 HG12 ' A' ' 87' ' ' VAL . 3.1 tm? -59.11 -48.71 80.62 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 111.552 0.204 . . . . 1.0 111.552 -179.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 7.7 ttm180 -69.26 -19.92 63.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.707 0.289 . . . . 1.0 110.528 -178.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 30.4 t -74.26 -7.0 51.2 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.464 -0.335 . . . . 1.0 111.177 -178.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.624 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 87.6 m-85 -92.93 -19.11 21.96 Favored 'General case' 0 C--N 1.34 0.181 0 O-C-N 121.834 -0.541 . . . . 1.0 110.65 177.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 13.6 t0 . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 115.885 -0.598 . . . . 1.0 111.041 -178.58 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 . . . . . 0 N--CA 1.451 -0.384 0 CA-C-O 120.427 0.156 . . . . 1.0 111.182 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.601 ' O ' HG21 ' A' ' 141' ' ' VAL . 2.8 tt0 -63.85 -49.4 72.93 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.794 -0.447 . . . . 1.0 109.794 177.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.436 HG13 HD11 ' A' ' 142' ' ' ILE . 84.3 t -59.05 -44.54 91.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.479 0.657 . . . . 1.0 109.692 177.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -56.7 -40.11 75.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.804 -1.089 . . . . 1.0 110.058 177.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.561 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -67.18 -41.94 85.07 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.246 -0.433 . . . . 1.0 110.746 178.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.601 HG21 ' O ' ' A' ' 137' ' ' GLU . 33.4 t -56.33 -51.06 68.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.645 0.736 . . . . 1.0 110.425 178.212 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.436 HD11 HG13 ' A' ' 138' ' ' VAL . 7.7 mt -65.96 -50.36 70.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 114.782 -1.099 . . . . 1.0 111.588 -178.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.561 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 12.7 pt-20 -57.49 -30.41 65.08 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 121.003 -0.279 . . . . 1.0 110.354 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 2.9 t -74.76 -28.85 60.92 Favored 'General case' 0 C--O 1.226 -0.167 0 CA-C-O 121.155 0.502 . . . . 1.0 110.384 178.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.462 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -86.98 -22.31 25.64 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 116.014 -0.539 . . . . 1.0 111.523 179.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.71 HD22 ' HB3' ' A' ' 25' ' ' PHE . 11.2 mt -55.57 -37.49 57.52 Favored Pre-proline 0 CA--C 1.54 0.569 0 N-CA-C 112.523 0.564 . . . . 1.0 112.523 -179.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 57.1 Cg_endo -70.59 -8.53 23.83 Favored 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 122.495 2.13 . . . . 1.0 112.255 177.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.624 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -108.73 -33.93 2.74 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.214 -1.154 . . . . 1.0 110.214 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.564 HD12 HG21 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -73.44 -43.63 59.93 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.163 -1.051 . . . . 1.0 108.163 178.509 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . 0.658 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 0.2 OUTLIER -54.21 -52.52 61.01 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-N 114.768 -1.106 . . . . 1.0 110.227 174.865 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -57.59 -43.89 84.97 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.324 -1.307 . . . . 1.0 110.89 -175.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . 0.742 ' CE3' HD13 ' A' ' 85' ' ' LEU . 22.9 t90 -63.01 -57.05 12.01 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.095 -0.957 . . . . 1.0 110.414 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.457 HG12 HG23 ' A' ' 7' ' ' VAL . 8.4 m -61.95 -42.09 93.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.776 -0.37 . . . . 1.0 110.566 -177.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -60.33 -51.22 70.45 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.907 0.384 . . . . 1.0 110.777 179.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.523 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 13.8 pt-20 -62.66 -38.76 91.57 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.771 -0.65 . . . . 1.0 110.403 -178.466 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.497 ' HD3' ' HA ' ' A' ' 156' ' ' ARG . 1.8 mmt180 -72.65 -50.66 23.6 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.893 -0.594 . . . . 1.0 111.029 -177.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.1 pp . . . . . 0 C--N 1.322 -0.601 0 CA-C-N 116.069 -0.514 . . . . 1.0 109.885 -178.941 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.572 ' HB3' ' O ' ' A' ' 36' ' ' ASP . 35.0 Cg_endo . . . . . 0 N--CA 1.463 -0.292 0 N-CA-C 113.826 0.664 . . . . 1.0 113.826 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.827 ' HB3' HG22 ' A' ' 38' ' ' VAL . 0.5 OUTLIER -73.21 -172.49 1.12 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.694 -1.139 . . . . 1.0 110.711 -179.303 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.612 ' HB3' ' HA ' ' A' ' 83' ' ' ALA . 0.3 OUTLIER -157.38 94.41 1.38 Allowed 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.897 -0.321 . . . . 1.0 110.881 179.295 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.673 HG13 HD11 ' A' ' 85' ' ' LEU . 2.1 t -96.06 115.62 35.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.876 -0.786 . . . . 1.0 108.876 176.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.586 ' CG2' ' HG ' ' A' ' 86' ' ' LEU . 14.2 t -118.52 115.35 24.42 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 120.92 0.391 . . . . 1.0 110.585 178.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.58 ' HD1' ' HB ' ' A' ' 87' ' ' VAL . 1.0 OUTLIER -83.54 132.42 34.93 Favored 'General case' 0 CA--C 1.511 -0.55 0 O-C-N 122.162 -0.336 . . . . 1.0 110.472 -179.025 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.703 HG23 HD11 ' A' ' 97' ' ' LEU . 44.5 t -115.37 119.98 63.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.221 0.534 . . . . 1.0 111.803 -176.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.52 ' HA ' ' CE1' ' A' ' 93' ' ' HIS . 47.0 t -147.59 164.92 31.95 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.654 -0.703 . . . . 1.0 109.712 178.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.517 HG22 ' HE2' ' A' ' 93' ' ' HIS . 0.6 OUTLIER -74.6 96.22 2.94 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.186 0.517 . . . . 1.0 110.66 179.097 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.954 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 125.04 -39.81 2.01 Favored Glycine 0 N--CA 1.441 -1.01 0 CA-C-N 115.486 -0.779 . . . . 1.0 111.972 179.117 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.478 HD22 ' CB ' ' A' ' 42' ' ' SER . 3.6 t-20 65.05 18.88 11.67 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 122.115 0.96 . . . . 1.0 110.078 -178.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.505 HG12 ' HB2' ' A' ' 49' ' ' HIS . 1.2 pt -134.58 48.43 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-N 115.078 -0.964 . . . . 1.0 110.103 -177.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.739 ' O ' ' HG3' ' A' ' 20' ' ' MET . 4.7 p -157.9 -90.12 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.285 -0.87 . . . . 1.0 111.495 174.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.634 HH11 ' HB3' ' A' ' 89' ' ' LEU . 1.2 mtt180 -70.73 -44.46 66.8 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.986 0.422 . . . . 1.0 111.187 -177.071 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.683 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 15.1 m -54.41 -58.13 15.39 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-N 115.756 -0.657 . . . . 1.0 111.838 -179.364 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.511 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 33.6 Cg_endo -64.1 -24.58 66.24 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 121.68 1.586 . . . . 1.0 112.627 -179.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.739 ' HG3' ' O ' ' A' ' 16' ' ' CYS . 57.6 mtp -62.01 -53.81 50.38 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.902 -0.319 . . . . 1.0 110.607 178.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.429 ' HA ' ' HB2' ' A' ' 24' ' ' MET . . . -74.91 -26.14 59.43 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.488 -178.022 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.472 ' O ' ' HB1' ' A' ' 26' ' ' ALA . 12.5 tt0 -53.84 -51.28 64.06 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.274 -0.876 . . . . 1.0 109.528 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.803 ' HB3' ' HG2' ' A' ' 68' ' ' PRO . 0.2 OUTLIER -80.7 -31.14 36.27 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.549 -0.75 . . . . 1.0 110.451 -177.244 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.63 ' HB3' HD11 ' A' ' 146' ' ' LEU . 6.0 mmm -60.85 -75.49 0.06 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.902 0.704 . . . . 1.0 112.902 -175.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.669 ' O ' ' HG ' ' A' ' 29' ' ' LEU . 19.0 p90 -77.94 -30.77 50.61 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 119.815 -0.754 . . . . 1.0 111.527 -175.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.472 ' HB1' ' O ' ' A' ' 22' ' ' GLU . . . -63.03 -38.23 90.37 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 119.06 -1.056 . . . . 1.0 110.648 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.649 ' HA ' ' HD3' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -65.39 -40.13 93.1 Favored 'General case' 0 C--N 1.339 0.118 0 N-CA-C 108.936 -0.765 . . . . 1.0 108.936 177.504 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.653 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 50.7 mt-30 -61.59 -40.46 94.84 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.751 176.241 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.669 ' HG ' ' O ' ' A' ' 25' ' ' PHE . 83.9 mt -56.73 -57.65 11.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.638 178.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.649 ' HD3' ' HA ' ' A' ' 27' ' ' GLN . 1.6 ptm180 -59.9 -32.28 70.6 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.485 -0.486 . . . . 1.0 111.129 178.051 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -62.27 -32.93 73.7 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 111.967 0.358 . . . . 1.0 111.967 175.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.653 ' HG2' ' O ' ' A' ' 28' ' ' GLN . 4.8 ptp180 -91.94 -17.5 25.08 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.632 0.729 . . . . 1.0 109.706 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.22 33.64 5.1 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 114.911 -1.041 . . . . 1.0 111.435 177.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 33.2 mt -123.42 -0.75 8.69 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.566 -0.531 . . . . 1.0 109.566 -177.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.25 -27.52 60.45 Favored Glycine 0 C--O 1.227 -0.338 0 CA-C-N 115.889 -0.596 . . . . 1.0 112.486 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.572 ' O ' ' HB3' ' A' ' 4' ' ' PRO . 0.9 OUTLIER -86.34 -25.86 25.18 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 109.716 -0.475 . . . . 1.0 109.716 177.549 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -78.42 -21.69 48.85 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.137 -0.938 . . . . 1.0 111.341 -176.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.827 HG22 ' HB3' ' A' ' 5' ' ' LEU . 1.2 p -144.45 126.85 10.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.229 0.538 . . . . 1.0 110.378 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.477 ' HG2' ' HB2' ' A' ' 4' ' ' PRO . 11.0 mmt180 -90.0 144.59 25.78 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.462 -0.79 . . . . 1.0 109.585 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.428 HG11 ' HB2' ' A' ' 26' ' ' ALA . 77.8 t -129.68 127.73 64.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 121.382 0.611 . . . . 1.0 109.93 -178.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.527 ' O ' ' HA ' ' A' ' 8' ' ' THR . 40.0 p -143.89 -175.54 4.63 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.476 -1.238 . . . . 1.0 110.024 -175.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.683 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 86.4 p -161.27 167.03 26.72 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 110.006 -0.368 . . . . 1.0 110.006 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.594 ' HB1' ' CD2' ' A' ' 80' ' ' HIS . . . -163.5 166.41 22.66 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.156 0.503 . . . . 1.0 111.695 -178.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.505 ' HA2' ' O ' ' A' ' 11' ' ' CYS . . . -125.15 137.71 10.56 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.302 -0.863 . . . . 1.0 111.398 178.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.64 HG23 HD12 ' A' ' 96' ' ' LEU . 22.1 p -74.17 -22.93 59.21 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.805 0.303 . . . . 1.0 111.747 -177.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.455 ' HA3' ' CZ3' ' A' ' 48' ' ' TRP . . . -111.31 8.31 28.73 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.668 -0.777 . . . . 1.0 113.03 -178.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.451 ' HB3' ' HB2' ' A' ' 75' ' ' GLN . 2.7 p-10 43.01 37.02 1.0 Allowed 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 113.875 1.065 . . . . 1.0 113.875 177.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.954 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 1.1 m-90 -46.8 -64.4 0.78 Allowed 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.325 0.583 . . . . 1.0 112.532 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.567 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 2.3 m-70 -111.99 39.25 2.44 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.753 -0.658 . . . . 1.0 111.281 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.507 HG22 ' HA ' ' A' ' 74' ' ' ALA . 14.9 p -59.87 126.87 18.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 C-N-CA 120.207 -0.597 . . . . 1.0 110.473 179.056 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.64 -14.17 65.62 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-N 116.032 -0.531 . . . . 1.0 111.948 -177.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.464 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 3.3 t -79.93 -160.72 0.29 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.45 0.643 . . . . 1.0 109.961 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 47.7 t -124.48 175.02 7.41 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 115.445 -0.798 . . . . 1.0 108.971 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.38 147.56 48.06 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.54 0.686 . . . . 1.0 111.49 -178.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.428 ' N ' ' OD1' ' A' ' 55' ' ' ASP . 9.0 p-10 -59.75 137.76 57.96 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.437 -1.256 . . . . 1.0 112.034 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -48.36 -35.25 12.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.672 -1.149 . . . . 1.0 112.785 179.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.426 ' H ' ' HG2' ' A' ' 57' ' ' ARG . 17.3 ptt180 -71.93 -43.69 64.86 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.377 0.132 . . . . 1.0 111.071 -177.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.444 ' O ' ' HG ' ' A' ' 62' ' ' LEU . . . -69.56 -39.13 77.59 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 109.378 -0.601 . . . . 1.0 109.378 178.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.4 -45.53 93.93 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.672 -0.695 . . . . 1.0 109.398 177.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.4 ' O ' ' HG2' ' A' ' 63' ' ' ARG . . . -57.83 -47.21 90.29 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 115.768 -0.651 . . . . 1.0 113.36 178.058 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.6 m -70.34 -39.99 77.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 117.699 0.749 . . . . 1.0 111.045 -178.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.699 HD11 ' HG3' ' A' ' 23' ' ' LYS . 96.0 mt -63.64 -52.56 60.26 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 120.605 -0.438 . . . . 1.0 110.653 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.4 ' HG2' ' O ' ' A' ' 60' ' ' GLY . 4.5 ptm180 -61.13 -30.26 70.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.554 -0.294 . . . . 1.0 110.997 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.99 -33.45 75.6 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 120.946 0.403 . . . . 1.0 110.735 179.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -96.68 3.35 52.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.839 -0.619 . . . . 1.0 110.873 -178.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.41 13.8 62.89 Favored Glycine 0 N--CA 1.452 -0.257 0 CA-C-N 115.962 -0.563 . . . . 1.0 112.906 177.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -89.48 152.8 47.81 Favored Pre-proline 0 C--N 1.322 -0.616 0 N-CA-C 110.571 -0.159 . . . . 1.0 110.571 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.803 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 45.7 Cg_endo -69.8 158.46 56.84 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.182 1.921 . . . . 1.0 110.713 176.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.583 HG23 ' HB2' ' A' ' 62' ' ' LEU . 36.4 p -133.32 4.04 3.68 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 119.856 -0.738 . . . . 1.0 111.807 -177.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.4 ' O ' ' HE2' ' A' ' 23' ' ' LYS . 24.4 t70 -67.74 127.09 31.5 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.976 -0.556 . . . . 1.0 110.099 178.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.514 ' HB2' ' HE2' ' A' ' 23' ' ' LYS . 59.0 t60 -165.39 149.67 8.61 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.951 0.405 . . . . 1.0 111.116 -176.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.458 ' HA ' ' O ' ' A' ' 52' ' ' SER . 0.9 OUTLIER -134.16 112.65 11.29 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.113 -1.069 . . . . 1.0 108.113 175.136 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.567 ' HB3' ' O ' ' A' ' 49' ' ' HIS . . . -61.42 142.53 56.91 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.656 -1.157 . . . . 1.0 112.294 -176.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.507 ' HA ' HG22 ' A' ' 50' ' ' VAL . . . -133.55 161.25 35.11 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.469 -0.787 . . . . 1.0 109.885 178.072 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.451 ' HB2' ' HB3' ' A' ' 47' ' ' ASN . 46.8 tt0 -97.57 160.04 14.56 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.611 -0.885 . . . . 1.0 108.611 178.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.486 HG13 HD22 ' A' ' 97' ' ' LEU . 93.8 t -64.97 102.82 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.353 0.597 . . . . 1.0 110.093 178.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -119.57 -174.94 15.78 Favored Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 114.834 -1.075 . . . . 1.0 111.769 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 93.0 m -57.75 -45.75 85.44 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 111.616 0.228 . . . . 1.0 111.616 -177.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -59.12 -29.65 67.55 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.871 0.367 . . . . 1.0 111.305 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.594 ' CD2' ' HB1' ' A' ' 43' ' ' ALA . 78.2 m80 -78.39 -41.24 33.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.394 -0.366 . . . . 1.0 110.491 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.636 ' O ' HG21 ' A' ' 102' ' ' VAL . 18.2 mt -68.31 -17.28 64.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.404 177.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.87 -8.27 58.17 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.846 0.355 . . . . 1.0 110.487 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.612 ' HA ' ' HB3' ' A' ' 6' ' ' HIS . . . -58.91 151.85 20.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.664 -0.698 . . . . 1.0 111.427 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.6 ' HA ' ' NH1' ' A' ' 106' ' ' ARG . 27.0 t70 -78.73 -14.45 59.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.333 -0.394 . . . . 1.0 109.956 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.673 HD11 HG13 ' A' ' 7' ' ' VAL . 0.5 OUTLIER -155.36 117.33 4.11 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.65 -0.705 . . . . 1.0 109.311 -177.909 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.595 ' HB3' HD12 ' A' ' 97' ' ' LEU . 5.0 mp -107.67 105.94 16.04 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-N 115.622 -0.717 . . . . 1.0 109.897 177.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.58 ' HB ' ' HD1' ' A' ' 9' ' ' PHE . 56.0 t -84.5 92.94 3.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 114.803 -1.09 . . . . 1.0 111.002 -176.094 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.7 141.81 37.6 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.474 -0.785 . . . . 1.0 110.62 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.634 ' HB3' HH11 ' A' ' 17' ' ' ARG . 3.8 mm? -95.82 -8.77 33.32 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.261 0.553 . . . . 1.0 109.82 178.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.475 ' CG ' ' H ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -149.73 151.55 33.83 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.249 -0.887 . . . . 1.0 110.786 -179.939 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -55.16 -29.86 58.67 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.262 -0.881 . . . . 1.0 112.92 -179.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.681 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 43.2 m-80 -75.06 -49.51 19.48 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.614 -0.513 . . . . 1.0 109.614 -176.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.555 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 16.7 m170 -52.44 -46.07 66.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.535 -0.757 . . . . 1.0 110.121 178.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.404 ' HA ' HG23 ' A' ' 107' ' ' VAL . . . -58.85 -46.44 87.74 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.42 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.1 ttm180 -61.47 -39.27 90.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.722 -0.672 . . . . 1.0 111.626 178.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.681 ' HG ' ' O ' ' A' ' 92' ' ' ASN . 36.1 mt -65.85 -47.19 75.77 Favored 'General case' 0 C--O 1.218 -0.594 0 N-CA-C 110.229 -0.285 . . . . 1.0 110.229 -177.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.703 HD11 HG23 ' A' ' 10' ' ' VAL . 31.6 mt -55.14 -58.78 6.27 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.145 -0.48 . . . . 1.0 111.655 -178.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.664 ' HD2' HG11 ' A' ' 107' ' ' VAL . 2.9 ptm180 -60.3 -41.52 93.59 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.826 -0.624 . . . . 1.0 112.473 -178.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.639 ' HG3' ' O ' ' A' ' 96' ' ' LEU . 1.0 OUTLIER -66.8 -27.76 67.83 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.361 -0.607 . . . . 1.0 109.361 178.536 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.656 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 11.1 mt -79.46 -13.44 59.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.537 -0.756 . . . . 1.0 111.769 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 149.36 -25.31 1.23 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 119.907 -1.14 . . . . 1.0 113.678 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.66 HG11 ' H ' ' A' ' 103' ' ' GLU . 0.4 OUTLIER -76.73 -163.02 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-N 117.437 0.619 . . . . 1.0 110.321 -178.615 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.66 ' H ' HG11 ' A' ' 102' ' ' VAL . 12.5 pt-20 -159.97 166.64 29.67 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 108.389 -0.967 . . . . 1.0 108.389 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.777 ' HA ' HG13 ' A' ' 107' ' ' VAL . . . -63.75 -25.23 68.1 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 123.304 0.378 . . . . 1.0 111.686 -174.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.41 -36.19 75.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.112 0.482 . . . . 1.0 110.142 175.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.6 ' NH1' ' HA ' ' A' ' 84' ' ' ASP . 0.8 OUTLIER -98.15 -42.82 7.27 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 115.525 -0.761 . . . . 1.0 111.293 -177.163 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.777 HG13 ' HA ' ' A' ' 104' ' ' ALA . 7.7 p -78.34 118.09 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 N-CA-C 109.266 -0.642 . . . . 1.0 109.266 -176.311 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.541 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 17.7 mmm180 -136.3 147.53 47.51 Favored 'General case' 0 C--N 1.32 -0.703 0 O-C-N 121.633 -0.667 . . . . 1.0 110.352 -178.042 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.413 ' HE2' ' HB3' ' A' ' 109' ' ' MET . 83.0 mmm -78.09 137.45 38.23 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.889 -0.596 . . . . 1.0 110.382 179.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.526 HD22 HG11 ' A' ' 87' ' ' VAL . 3.1 tm? -56.06 -49.09 74.75 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 123.031 0.207 . . . . 1.0 111.239 179.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 21.0 ttt180 -71.87 -11.9 61.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.011 0.434 . . . . 1.0 111.007 -178.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 26.7 t -75.81 -9.67 58.79 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.944 -0.303 . . . . 1.0 110.705 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.558 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 97.3 m-85 -92.41 -19.81 21.68 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.237 0.542 . . . . 1.0 110.366 176.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 20.7 t0 . . . . . 0 C--N 1.325 -0.481 0 CA-C-N 114.945 -1.025 . . . . 1.0 111.685 -177.116 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 . . . . . 0 N--CA 1.454 -0.233 0 CA-C-O 120.862 0.363 . . . . 1.0 110.607 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -64.31 -48.28 76.23 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.543 -0.91 . . . . 1.0 108.543 174.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 1.013 ' HA ' HG23 ' A' ' 141' ' ' VAL . 54.8 t -61.9 -39.74 84.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.225 -0.898 . . . . 1.0 109.648 176.006 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.432 ' HB2' ' HE2' ' A' ' 20' ' ' MET . 46.1 t80 -53.44 -41.4 66.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.203 -0.908 . . . . 1.0 109.107 175.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.674 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -68.28 -39.83 82.01 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.323 -0.853 . . . . 1.0 110.629 177.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 1.013 HG23 ' HA ' ' A' ' 138' ' ' VAL . 15.9 t -55.6 -51.43 58.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-O 121.932 0.872 . . . . 1.0 109.83 177.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.454 HD11 HG13 ' A' ' 138' ' ' VAL . 7.0 mt -65.51 -51.59 61.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 114.755 -1.111 . . . . 1.0 111.775 -178.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.674 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 8.1 pt-20 -55.12 -32.79 62.32 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.839 -0.344 . . . . 1.0 110.29 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 2.3 t -73.64 -30.18 62.79 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.488 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.455 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -86.17 -22.63 26.9 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-N 116.006 -0.543 . . . . 1.0 111.636 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.645 HD23 ' HB3' ' A' ' 25' ' ' PHE . 11.0 mt -54.18 -41.72 90.05 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 112.744 0.646 . . . . 1.0 112.744 -178.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.682 ' HA ' ' CD2' ' A' ' 150' ' ' HIS . 60.3 Cg_endo -68.36 -7.68 20.84 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 122.371 2.048 . . . . 1.0 111.866 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.558 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -108.48 -33.55 2.88 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 110.234 -1.146 . . . . 1.0 110.234 178.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.526 HD12 ' CE2' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -75.14 -54.34 7.31 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.327 -0.62 . . . . 1.0 109.327 -179.797 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . 0.682 ' CD2' ' HA ' ' A' ' 147' ' ' PRO . 2.0 p80 -56.16 -46.81 79.15 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 115.268 -0.878 . . . . 1.0 110.471 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.448 ' N ' ' CG ' ' A' ' 150' ' ' HIS . 2.0 t70 -59.62 -37.94 79.98 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.764 -1.107 . . . . 1.0 110.411 -178.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . 0.772 ' HZ3' HD21 ' A' ' 5' ' ' LEU . 28.2 t90 -64.52 -54.66 28.87 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 115.637 -0.71 . . . . 1.0 109.858 178.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.603 HG21 ' O ' ' A' ' 150' ' ' HIS . 3.5 m -58.77 -37.8 68.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.571 -0.529 . . . . 1.0 109.571 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.448 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 2.7 m-20 -59.44 -56.39 22.61 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 121.487 0.661 . . . . 1.0 110.765 177.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.596 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 6.3 pt-20 -60.63 -37.92 83.06 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 114.901 -1.045 . . . . 1.0 110.369 -177.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.475 ' HA ' ' HD3' ' A' ' 156' ' ' ARG . 1.0 OUTLIER -74.11 -48.67 27.97 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.571 -0.741 . . . . 1.0 111.361 -177.222 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 3.9 pp . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.233 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.563 ' HB2' ' HG2' ' A' ' 39' ' ' ARG . 25.3 Cg_endo . . . . . 0 C--O 1.235 0.338 0 N-CA-C 115.253 1.213 . . . . 1.0 115.253 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.641 HD23 ' HZ3' ' A' ' 152' ' ' TRP . 0.4 OUTLIER -74.3 -173.35 1.67 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 113.487 -1.688 . . . . 1.0 110.024 178.273 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.63 ' HB3' ' H ' ' A' ' 84' ' ' ASP . 3.0 t-160 -156.48 92.14 1.29 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.578 -0.449 . . . . 1.0 110.878 -178.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.743 HG13 HD12 ' A' ' 85' ' ' LEU . 2.9 t -96.1 111.11 25.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.351 -0.611 . . . . 1.0 109.351 177.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.524 ' CG2' ' HG ' ' A' ' 86' ' ' LEU . 9.2 t -112.17 113.88 26.38 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.221 0.534 . . . . 1.0 110.291 179.152 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.566 ' CE2' ' HA ' ' A' ' 22' ' ' GLU . 1.0 OUTLIER -83.43 125.3 31.56 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 122.004 -0.435 . . . . 1.0 110.289 -178.564 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.529 HG23 HD11 ' A' ' 97' ' ' LEU . 37.6 t -112.18 111.12 34.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.802 -0.635 . . . . 1.0 112.161 -176.357 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.576 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 48.3 t -135.73 160.0 39.89 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.043 -1.095 . . . . 1.0 108.043 176.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -64.21 -32.23 73.73 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.334 0.588 . . . . 1.0 109.79 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.562 ' C ' ' H ' ' A' ' 15' ' ' ILE . . . -111.27 84.66 0.37 Allowed Glycine 0 N--CA 1.436 -1.328 0 CA-C-N 115.149 -0.932 . . . . 1.0 110.868 174.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.568 ' ND2' ' HB3' ' A' ' 73' ' ' ALA . 10.5 p-10 -65.0 16.07 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.262 1.425 . . . . 1.0 112.105 178.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.562 ' H ' ' C ' ' A' ' 13' ' ' GLY . 6.9 pt -119.89 -3.34 9.42 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.045 177.447 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 9.2 m -115.13 -87.08 0.59 Allowed 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.679 -0.408 . . . . 1.0 112.041 -176.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.674 ' HG2' ' HG ' ' A' ' 89' ' ' LEU . 15.7 tpp180 -67.45 -50.43 59.24 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.352 -0.385 . . . . 1.0 112.014 -174.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.559 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 33.8 m -54.39 -59.05 11.24 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-N 116.321 -0.4 . . . . 1.0 111.882 -178.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.446 ' HG3' ' HA ' ' A' ' 15' ' ' ILE . 40.6 Cg_endo -63.89 -20.87 68.84 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 121.933 1.755 . . . . 1.0 113.029 -179.087 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.531 ' HB3' HD12 ' A' ' 142' ' ' ILE . 39.5 mmm -61.54 -55.51 30.2 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 110.056 -0.35 . . . . 1.0 110.056 177.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.415 ' HB2' HG23 ' A' ' 142' ' ' ILE . . . -72.24 -26.67 62.1 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 115.81 -0.632 . . . . 1.0 110.416 -179.008 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.76 ' O ' ' HB1' ' A' ' 26' ' ' ALA . 18.1 tt0 -50.7 -54.56 22.14 Favored 'General case' 0 C--O 1.216 -0.686 0 CA-C-N 114.776 -1.102 . . . . 1.0 109.811 179.096 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.726 ' HB3' ' HG2' ' A' ' 68' ' ' PRO . 0.0 OUTLIER -84.15 -26.3 28.97 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.443 -0.799 . . . . 1.0 110.729 -175.803 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.524 ' HB3' HD13 ' A' ' 146' ' ' LEU . 90.9 mtp -63.91 -75.52 0.08 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.644 0.609 . . . . 1.0 112.644 -176.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.722 ' HB3' HD23 ' A' ' 146' ' ' LEU . 18.2 p90 -76.99 -29.57 55.54 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 119.696 -0.801 . . . . 1.0 111.311 -175.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.76 ' HB1' ' O ' ' A' ' 22' ' ' GLU . . . -63.86 -37.0 85.75 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 119.2 -1.0 . . . . 1.0 110.562 179.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.685 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -63.84 -38.42 91.03 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 108.801 -0.814 . . . . 1.0 108.801 177.363 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.52 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 60.7 mt-30 -58.83 -43.84 90.79 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-O 121.149 0.499 . . . . 1.0 110.107 175.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.666 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 95.6 mt -54.84 -61.5 2.27 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.425 -0.807 . . . . 1.0 110.984 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.62 ' HD3' ' HA ' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -59.54 -35.73 74.77 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.763 -0.375 . . . . 1.0 111.565 179.633 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 3.4 m170 -62.83 -27.96 69.68 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 111.934 0.346 . . . . 1.0 111.934 177.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.666 ' HG2' ' O ' ' A' ' 29' ' ' LEU . 4.7 ptm85 -97.13 -22.0 17.01 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 119.796 -0.762 . . . . 1.0 110.291 -179.105 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 112.34 36.16 1.66 Allowed Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.226 -0.897 . . . . 1.0 112.528 177.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.414 HD13 ' HD3' ' A' ' 32' ' ' ARG . 18.9 mt -131.74 7.48 4.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.158 0.504 . . . . 1.0 109.814 -179.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.56 -32.25 77.47 Favored Glycine 0 C--N 1.332 0.321 0 CA-C-N 115.831 -0.622 . . . . 1.0 113.03 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.638 ' HA ' ' NH1' ' A' ' 39' ' ' ARG . 3.2 m-20 -90.29 -15.41 31.28 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.935 0.398 . . . . 1.0 110.179 177.115 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -81.16 -22.7 38.77 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.61 -0.723 . . . . 1.0 110.916 178.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.527 HG11 ' HB3' ' A' ' 5' ' ' LEU . 8.7 t -133.7 123.35 45.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.675 0.274 . . . . 1.0 110.932 -178.456 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.638 ' NH1' ' HA ' ' A' ' 36' ' ' ASP . 24.2 mmt180 -96.92 98.0 9.74 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.157 0.503 . . . . 1.0 110.757 178.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.606 HG23 ' HB2' ' A' ' 26' ' ' ALA . 0.8 OUTLIER -92.25 120.89 42.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-O 122.209 1.005 . . . . 1.0 110.699 179.652 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.486 ' O ' ' HA ' ' A' ' 8' ' ' THR . 82.3 p -131.41 -175.24 3.64 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 113.466 -1.697 . . . . 1.0 110.082 -177.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.559 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 78.3 p -157.82 161.46 38.37 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.797 -0.361 . . . . 1.0 110.57 -178.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.635 ' HA ' ' O ' ' A' ' 74' ' ' ALA . . . -163.48 165.71 23.46 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.283 0.564 . . . . 1.0 111.522 -178.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.576 ' HA2' ' O ' ' A' ' 11' ' ' CYS . . . -126.01 134.07 8.51 Favored Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 115.284 -0.871 . . . . 1.0 111.415 178.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.479 HG21 HD12 ' A' ' 96' ' ' LEU . 26.9 p -71.57 -26.39 62.6 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.827 0.313 . . . . 1.0 111.433 -178.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -107.88 7.8 36.09 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.892 -0.671 . . . . 1.0 112.545 -177.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 43.34 39.8 2.3 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 113.569 0.951 . . . . 1.0 113.569 178.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -44.67 -76.2 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.443 0.639 . . . . 1.0 112.063 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 52.6 m-70 -107.01 44.46 1.06 Allowed 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.278 -0.873 . . . . 1.0 111.162 178.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.0 p -60.06 129.04 22.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.915 -0.584 . . . . 1.0 110.809 178.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.84 -13.42 66.0 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.899 -0.667 . . . . 1.0 112.26 -178.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -82.29 -162.48 0.56 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.009 0.433 . . . . 1.0 109.864 179.058 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 38.4 t -119.36 173.48 6.93 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.239 -0.652 . . . . 1.0 109.239 -179.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.73 135.55 47.06 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.821 0.343 . . . . 1.0 111.61 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.782 ' OD1' ' HG3' ' A' ' 57' ' ' ARG . 15.6 t0 -51.54 134.62 29.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.139 -0.937 . . . . 1.0 111.191 -179.046 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -48.31 -32.1 6.91 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.159 -0.928 . . . . 1.0 113.04 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.782 ' HG3' ' OD1' ' A' ' 55' ' ' ASP . 6.5 mtt180 -68.56 -50.71 49.76 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.254 0.55 . . . . 1.0 109.625 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.5 -32.19 71.98 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.006 -0.997 . . . . 1.0 110.405 -176.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.09 -45.45 94.68 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 109.433 -0.581 . . . . 1.0 109.433 176.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.25 -44.59 95.33 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.927 -0.654 . . . . 1.0 111.76 176.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.616 HG21 ' O ' ' A' ' 57' ' ' ARG . 64.5 t -57.05 -56.51 14.37 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 CA-C-O 121.279 0.561 . . . . 1.0 111.152 178.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.743 ' HB2' HG23 ' A' ' 69' ' ' THR . 88.4 mt -60.13 -52.46 65.25 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.087 -0.506 . . . . 1.0 111.398 -179.271 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -60.59 -28.61 68.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.687 -0.233 . . . . 1.0 110.897 -178.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.49 -34.12 77.22 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-O 121.106 0.479 . . . . 1.0 110.333 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -95.55 4.95 52.68 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.859 -0.61 . . . . 1.0 111.178 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.58 21.52 61.83 Favored Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 116.002 -0.544 . . . . 1.0 112.308 178.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -91.84 150.91 41.58 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.771 -0.214 . . . . 1.0 110.444 178.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.726 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 37.8 Cg_endo -68.41 155.68 68.32 Favored 'Trans proline' 0 CA--C 1.51 -0.687 0 C-N-CA 122.334 2.023 . . . . 1.0 110.162 176.289 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.743 HG23 ' HB2' ' A' ' 62' ' ' LEU . 56.6 p -134.79 7.3 3.49 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 119.778 -0.769 . . . . 1.0 111.709 -177.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.424 ' O ' ' HE2' ' A' ' 23' ' ' LYS . 12.8 t70 -74.49 132.52 41.96 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 108.791 -0.818 . . . . 1.0 108.791 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.44 ' HE1' ' OG ' ' A' ' 42' ' ' SER . 37.2 t60 -170.05 151.12 3.91 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.132 0.491 . . . . 1.0 110.585 -175.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.41 ' HD3' ' HA ' ' A' ' 72' ' ' ARG . 3.2 tpp85 -130.71 109.37 10.57 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 107.818 -1.178 . . . . 1.0 107.818 176.057 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.568 ' HB3' ' ND2' ' A' ' 14' ' ' ASN . . . -56.32 137.45 52.42 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.097 -0.956 . . . . 1.0 112.084 -176.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.635 ' O ' ' HA ' ' A' ' 43' ' ' ALA . . . -133.6 145.41 50.01 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.834 -0.621 . . . . 1.0 109.976 179.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -84.45 154.77 22.57 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.737 -0.468 . . . . 1.0 109.737 177.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.552 HG12 ' CD2' ' A' ' 97' ' ' LEU . 16.6 t -62.39 107.17 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.359 0.599 . . . . 1.0 110.528 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.446 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -115.67 -174.21 17.74 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 115.089 -0.96 . . . . 1.0 110.869 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 68.2 m -57.04 -43.23 81.76 Favored 'General case' 0 C--N 1.319 -0.75 0 O-C-N 123.681 0.283 . . . . 1.0 110.304 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -58.33 -31.26 67.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 1.0 111.536 178.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.558 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 80.2 m80 -79.5 -37.71 36.08 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.834 0.35 . . . . 1.0 110.251 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 41.4 mt -67.97 -19.11 64.92 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.783 -0.644 . . . . 1.0 110.782 177.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.44 -3.39 59.0 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.909 -0.587 . . . . 1.0 110.732 -178.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 6' ' ' HIS . . . -61.81 152.08 32.52 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.948 -0.569 . . . . 1.0 111.646 179.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.63 ' H ' ' HB3' ' A' ' 6' ' ' HIS . 11.4 t70 -79.79 -14.32 58.79 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.071 0.463 . . . . 1.0 109.872 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.743 HD12 HG13 ' A' ' 7' ' ' VAL . 0.3 OUTLIER -154.2 117.06 4.44 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 108.641 -0.874 . . . . 1.0 108.641 -176.818 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.593 ' HB3' HD12 ' A' ' 97' ' ' LEU . 5.3 mp -107.98 106.31 16.5 Favored 'General case' 0 N--CA 1.423 -1.805 0 CA-C-N 115.683 -0.689 . . . . 1.0 109.639 178.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.543 HG12 HD23 ' A' ' 110' ' ' LEU . 55.6 t -85.72 91.71 3.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.204 -0.907 . . . . 1.0 110.542 -176.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.7 149.69 29.63 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.332 -0.849 . . . . 1.0 110.85 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.674 ' HG ' ' HG2' ' A' ' 17' ' ' ARG . 3.7 mm? -106.3 1.18 25.68 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.851 -0.613 . . . . 1.0 109.754 178.157 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -154.0 146.98 24.48 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.464 -0.789 . . . . 1.0 110.519 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 11.4 ptt180 -60.58 -20.65 61.12 Favored 'General case' 0 C--N 1.33 -0.247 0 O-C-N 123.983 0.802 . . . . 1.0 110.946 177.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.717 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 78.9 m-20 -77.63 -47.82 18.36 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.19 -0.67 . . . . 1.0 109.19 178.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.728 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 8.8 m170 -61.26 -47.05 87.8 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 109.508 -0.552 . . . . 1.0 109.508 179.002 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.481 ' HA ' HG21 ' A' ' 107' ' ' VAL . . . -58.12 -42.37 85.62 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.1 -0.5 . . . . 1.0 110.732 179.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.687 ' O ' ' HG2' ' A' ' 99' ' ' GLN . 16.9 ttm180 -60.27 -45.29 93.8 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 115.636 -0.711 . . . . 1.0 111.47 178.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.754 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 50.1 mt -63.23 -49.99 72.01 Favored 'General case' 0 C--O 1.22 -0.475 0 O-C-N 123.52 0.513 . . . . 1.0 109.979 -175.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.728 ' HG ' ' O ' ' A' ' 93' ' ' HIS . 27.3 mt -53.49 -57.74 9.61 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.771 -0.649 . . . . 1.0 111.467 -178.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.553 ' HA ' ' HB ' ' A' ' 102' ' ' VAL . 6.6 ptt180 -60.42 -44.82 95.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.042 -0.526 . . . . 1.0 111.778 -176.385 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.687 ' HG2' ' O ' ' A' ' 95' ' ' ARG . 8.4 pt20 -67.71 -20.82 65.31 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.068 0.461 . . . . 1.0 110.608 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.754 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 8.2 mt -80.08 -8.32 59.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.967 -0.56 . . . . 1.0 111.814 179.403 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 147.5 -28.75 1.48 Allowed Glycine 0 C--N 1.331 0.303 0 C-N-CA 119.786 -1.197 . . . . 1.0 112.955 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.814 HG11 ' H ' ' A' ' 103' ' ' GLU . 2.1 t -73.84 -154.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 C-N-CA 123.036 0.535 . . . . 1.0 110.949 -178.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.814 ' H ' HG11 ' A' ' 102' ' ' VAL . 12.5 pt-20 -168.02 165.7 13.45 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.646 -0.872 . . . . 1.0 108.646 -179.092 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.786 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -65.59 -24.02 66.97 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.676 0.274 . . . . 1.0 111.664 -176.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.7 -36.62 74.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.418 0.628 . . . . 1.0 109.983 175.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.623 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 7.7 mtt-85 -94.92 -45.16 7.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.039 -0.982 . . . . 1.0 110.704 -177.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.786 HG12 ' HA ' ' A' ' 104' ' ' ALA . 7.3 p -79.94 122.6 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-O 121.415 0.626 . . . . 1.0 110.092 -177.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.539 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 7.8 mmm180 -138.12 146.31 42.68 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.079 -0.712 . . . . 1.0 109.079 -178.216 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.427 ' HE3' ' HB3' ' A' ' 109' ' ' MET . 86.5 mmm -79.22 134.95 36.66 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.024 -0.534 . . . . 1.0 110.378 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.543 HD23 HG12 ' A' ' 87' ' ' VAL . 3.2 tm? -56.97 -49.18 76.49 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.671 0.272 . . . . 1.0 111.108 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 16.6 ttm180 -69.52 -21.35 63.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.886 0.374 . . . . 1.0 110.53 -177.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 32.6 t -77.04 -6.04 51.16 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.424 -0.353 . . . . 1.0 111.138 -178.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.556 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 85.6 m-85 -87.44 -19.97 27.28 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.952 -0.388 . . . . 1.0 109.952 175.235 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 61.7 t0 . . . . . 0 C--O 1.233 0.19 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.198 -178.836 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 . . . . . 0 CA--C 1.522 -0.128 0 CA-C-O 120.657 0.265 . . . . 1.0 111.307 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.597 ' O ' HG21 ' A' ' 141' ' ' VAL . 7.9 tp10 -61.22 -47.66 85.06 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 108.7 -0.852 . . . . 1.0 108.7 176.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.628 HG13 ' HD3' ' A' ' 17' ' ' ARG . 75.6 t -56.7 -47.54 82.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 114.419 -1.264 . . . . 1.0 110.084 176.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.49 ' HB2' HG12 ' A' ' 61' ' ' VAL . 52.7 t80 -55.58 -44.56 77.03 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.616 -1.174 . . . . 1.0 110.5 178.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.418 ' O ' ' HG2' ' A' ' 143' ' ' GLU . . . -62.83 -44.69 95.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.991 -0.55 . . . . 1.0 111.518 -179.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.597 HG21 ' O ' ' A' ' 137' ' ' GLU . 21.2 t -56.28 -48.03 80.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.338 0.59 . . . . 1.0 110.584 178.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.531 HD12 ' HB3' ' A' ' 20' ' ' MET . 5.8 mt -67.11 -49.56 71.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 115.413 -0.812 . . . . 1.0 112.127 -178.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.466 ' HA ' ' HG ' ' A' ' 146' ' ' LEU . 11.2 pt-20 -56.19 -32.7 64.61 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.98 0.419 . . . . 1.0 110.451 179.359 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 63.3 m -73.06 -27.4 61.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.902 -0.59 . . . . 1.0 110.612 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.479 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -86.44 -25.09 25.41 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 115.67 -0.696 . . . . 1.0 111.92 178.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.722 HD23 ' HB3' ' A' ' 25' ' ' PHE . 14.9 mt -55.49 -36.69 48.58 Favored Pre-proline 0 CA--C 1.546 0.814 0 N-CA-C 112.745 0.646 . . . . 1.0 112.745 -178.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.621 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 42.1 Cg_endo -68.58 -14.91 40.65 Favored 'Trans proline' 0 C--N 1.359 1.106 0 C-N-CA 122.317 2.011 . . . . 1.0 111.661 176.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.556 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -101.97 -34.12 4.42 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.133 -0.94 . . . . 1.0 110.941 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.488 HD13 HG23 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -72.49 -40.0 67.22 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.18 -1.044 . . . . 1.0 108.18 179.334 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . 0.482 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 0.2 OUTLIER -54.54 -54.28 43.33 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 114.648 -1.16 . . . . 1.0 110.541 175.427 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -57.27 -42.32 81.38 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.125 -0.943 . . . . 1.0 111.445 -175.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . 0.641 ' HZ3' HD23 ' A' ' 5' ' ' LEU . 18.0 t90 -62.27 -57.91 9.67 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.415 -0.811 . . . . 1.0 110.084 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.514 ' HB ' HD22 ' A' ' 5' ' ' LEU . 7.8 m -60.65 -43.82 95.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.675 -177.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.407 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 8.7 m-20 -60.87 -49.55 77.01 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 121.208 0.527 . . . . 1.0 111.015 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.422 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 5.4 pt-20 -64.85 -36.26 83.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.977 -0.556 . . . . 1.0 110.656 -178.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.522 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 0.6 OUTLIER -74.13 -43.41 57.61 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 115.769 -0.65 . . . . 1.0 110.869 -176.985 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 4.2 pp . . . . . 0 C--N 1.324 -0.5 0 CA-C-O 121.124 0.487 . . . . 1.0 109.748 178.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo . . . . . 0 N--CA 1.462 -0.325 0 CA-C-O 120.843 0.268 . . . . 1.0 111.842 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.787 HD13 ' HB3' ' A' ' 84' ' ' ASP . 0.2 OUTLIER -67.02 178.46 1.4 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.456 -0.572 . . . . 1.0 109.456 178.101 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.662 ' HA ' ' O ' ' A' ' 39' ' ' ARG . 2.7 t-160 -156.06 89.48 1.15 Allowed 'General case' 0 C--N 1.321 -0.651 0 O-C-N 122.053 -0.404 . . . . 1.0 109.989 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.714 HG12 HD11 ' A' ' 85' ' ' LEU . 2.1 t -96.51 105.57 17.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.366 -0.379 . . . . 1.0 110.134 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.632 ' CG2' ' HG ' ' A' ' 86' ' ' LEU . 13.0 t -108.65 115.44 30.09 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.079 0.466 . . . . 1.0 110.199 -179.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.568 ' HD1' ' HB ' ' A' ' 87' ' ' VAL . 0.7 OUTLIER -83.74 129.89 34.95 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.793 -0.447 . . . . 1.0 109.793 -178.952 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.71 HG21 HD12 ' A' ' 97' ' ' LEU . 22.0 t -114.38 113.01 42.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.737 -0.665 . . . . 1.0 111.945 -174.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.504 ' HA ' ' CE1' ' A' ' 93' ' ' HIS . 49.2 t -142.78 155.26 44.81 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.359 -0.608 . . . . 1.0 109.359 178.048 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.1 88.66 2.44 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.393 0.616 . . . . 1.0 111.157 -178.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.754 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 140.59 -45.74 0.96 Allowed Glycine 0 N--CA 1.445 -0.754 0 CA-C-N 115.313 -0.858 . . . . 1.0 111.062 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.621 ' ND2' ' H ' ' A' ' 74' ' ' ALA . 61.0 t30 58.63 23.86 11.43 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.674 0.75 . . . . 1.0 112.202 178.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.4 pt -124.51 3.88 4.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 O-C-N 121.616 -0.678 . . . . 1.0 111.494 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.681 ' O ' ' HG3' ' A' ' 20' ' ' MET . 27.9 m -129.4 -84.19 0.56 Allowed 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.597 -0.441 . . . . 1.0 111.064 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.419 ' H ' ' HD3' ' A' ' 17' ' ' ARG . 1.5 mpt_? -61.56 -58.83 6.58 Favored 'General case' 0 C--O 1.243 0.728 0 CA-C-N 116.211 -0.449 . . . . 1.0 111.939 -175.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.0 m -51.49 -58.58 10.32 Favored Pre-proline 0 CA--C 1.54 0.587 0 N-CA-C 112.982 0.734 . . . . 1.0 112.982 -178.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -63.67 -23.57 69.77 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 121.636 1.557 . . . . 1.0 112.495 -177.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.681 ' HG3' ' O ' ' A' ' 16' ' ' CYS . 61.2 mtp -61.98 -51.65 67.21 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.674 -0.41 . . . . 1.0 110.349 179.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.443 ' HA ' ' HB2' ' A' ' 24' ' ' MET . . . -71.58 -29.42 64.69 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.15 -0.62 . . . . 1.0 110.672 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.751 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 22.1 tt0 -53.17 -53.25 53.26 Favored 'General case' 0 C--O 1.219 -0.514 0 O-C-N 124.166 0.916 . . . . 1.0 110.171 -179.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.726 ' O ' ' HB3' ' A' ' 27' ' ' GLN . 0.3 OUTLIER -84.8 -23.11 29.28 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.031 -0.986 . . . . 1.0 110.364 -175.493 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.63 ' HE1' ' HB3' ' A' ' 143' ' ' GLU . 2.2 mmm -65.22 -76.35 0.07 Allowed 'General case' 0 C--O 1.238 0.477 0 N-CA-C 113.076 0.769 . . . . 1.0 113.076 -179.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.757 ' HB3' HD21 ' A' ' 146' ' ' LEU . 18.0 p90 -76.37 -29.38 57.13 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 119.852 -0.739 . . . . 1.0 111.243 -174.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.751 ' HB3' ' O ' ' A' ' 22' ' ' GLU . . . -64.38 -35.73 81.85 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 119.577 -0.849 . . . . 1.0 110.818 178.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.726 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -63.99 -38.82 92.46 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.63 -0.878 . . . . 1.0 108.63 177.175 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.573 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 71.1 mt-30 -61.04 -41.71 97.09 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 115.285 -0.87 . . . . 1.0 110.638 175.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 25' ' ' PHE . 90.1 mt -57.07 -62.01 2.05 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 115.956 -0.566 . . . . 1.0 111.172 -179.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.652 ' HE ' ' HA ' ' A' ' 27' ' ' GLN . 0.1 OUTLIER -58.06 -32.55 68.12 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 120.468 -0.493 . . . . 1.0 111.325 179.582 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -64.11 -28.07 69.52 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.15 0.426 . . . . 1.0 112.15 176.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.58 ' HG3' ' HG ' ' A' ' 34' ' ' LEU . 7.3 ptp180 -95.4 -20.54 19.01 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 121.843 0.83 . . . . 1.0 109.625 178.042 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 108.77 31.93 3.26 Favored Glycine 0 N--CA 1.441 -0.972 0 CA-C-N 114.833 -1.076 . . . . 1.0 112.101 176.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.58 ' HG ' ' HG3' ' A' ' 32' ' ' ARG . 22.7 mt -119.54 0.5 11.03 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 122.434 -0.451 . . . . 1.0 109.959 -178.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -53.9 -32.13 48.11 Favored Glycine 0 C--N 1.331 0.295 0 CA-C-N 115.943 -0.572 . . . . 1.0 113.137 -179.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.763 ' HA ' ' NH1' ' A' ' 39' ' ' ARG . 0.1 OUTLIER -89.52 -20.63 23.59 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-O 121.273 0.559 . . . . 1.0 110.312 178.66 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.89 -25.09 40.73 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.568 -0.742 . . . . 1.0 111.127 -177.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.713 HG22 ' HB3' ' A' ' 5' ' ' LEU . 0.5 OUTLIER -141.16 124.77 16.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.219 0.533 . . . . 1.0 110.826 179.707 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.763 ' NH1' ' HA ' ' A' ' 36' ' ' ASP . 24.6 mmt180 -95.5 106.5 18.58 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.57 -0.741 . . . . 1.0 111.262 -178.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.68 HG12 ' HB1' ' A' ' 26' ' ' ALA . 1.5 m -90.49 137.64 21.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-N 115.884 -0.598 . . . . 1.0 109.396 178.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.513 ' O ' ' HA ' ' A' ' 8' ' ' THR . 24.6 p -146.25 -178.07 5.95 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.063 -0.971 . . . . 1.0 110.009 -175.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.3 p -158.01 157.18 32.49 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.296 -0.562 . . . . 1.0 110.866 -177.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.604 ' HB3' ' CD2' ' A' ' 80' ' ' HIS . . . -163.23 164.51 25.03 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 121.475 0.655 . . . . 1.0 111.64 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' A' ' 11' ' ' CYS . . . -122.63 133.92 9.4 Favored Glycine 0 N--CA 1.441 -0.984 0 CA-C-N 115.06 -0.973 . . . . 1.0 111.046 177.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.52 HG23 ' CG1' ' A' ' 10' ' ' VAL . 12.3 p -69.68 -23.47 63.45 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.834 0.349 . . . . 1.0 111.762 -177.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.432 ' HA3' ' CZ3' ' A' ' 48' ' ' TRP . . . -109.84 8.48 31.79 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.723 -0.751 . . . . 1.0 113.239 -178.315 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 42.11 38.68 1.16 Allowed 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 113.551 0.945 . . . . 1.0 113.551 178.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.754 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 1.2 m-90 -46.9 -74.29 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.347 0.594 . . . . 1.0 112.278 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.445 ' O ' ' HB1' ' A' ' 73' ' ' ALA . 46.5 m-70 -107.07 42.45 1.3 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.314 -0.857 . . . . 1.0 111.349 -179.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.452 HG22 ' HA ' ' A' ' 74' ' ' ALA . 14.6 p -61.58 132.02 26.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.215 178.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.35 -14.53 63.52 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.921 -0.657 . . . . 1.0 112.186 -177.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.49 -158.84 0.28 Allowed 'General case' 0 C--O 1.236 0.391 0 CA-C-O 120.986 0.422 . . . . 1.0 109.959 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.3 t -133.55 173.36 11.59 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.494 -0.558 . . . . 1.0 109.494 -178.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.454 ' HB2' ' HZ3' ' A' ' 23' ' ' LYS . . . -56.67 148.15 20.82 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.015 -0.539 . . . . 1.0 111.507 -178.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.428 ' OD1' ' HG2' ' A' ' 57' ' ' ARG . 15.6 t70 -68.41 145.8 53.79 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.371 -0.831 . . . . 1.0 111.417 -178.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.414 ' HG3' ' N ' ' A' ' 57' ' ' ARG . 6.4 pt-20 -47.58 -37.74 12.97 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.953 -1.021 . . . . 1.0 113.224 178.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.592 ' O ' HG22 ' A' ' 61' ' ' VAL . 19.9 ptp180 -70.68 -44.43 67.02 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 121.136 -0.226 . . . . 1.0 110.777 -176.071 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.15 -30.86 68.13 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.689 -0.486 . . . . 1.0 109.689 -179.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.46 -46.75 84.8 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.635 -0.711 . . . . 1.0 109.504 176.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.439 ' O ' ' HG2' ' A' ' 63' ' ' ARG . . . -62.72 -41.98 99.76 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.843 -0.694 . . . . 1.0 111.927 178.249 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.592 HG22 ' O ' ' A' ' 57' ' ' ARG . 97.5 t -58.23 -59.35 3.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.429 0.633 . . . . 1.0 111.622 178.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.463 ' HB2' HG23 ' A' ' 69' ' ' THR . 10.0 mp -61.72 -48.05 82.51 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.754 -0.657 . . . . 1.0 111.048 -177.155 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.439 ' HG2' ' O ' ' A' ' 60' ' ' GLY . 22.1 ptt180 -58.74 -31.44 68.32 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.611 -0.268 . . . . 1.0 110.888 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.65 -34.24 76.55 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.223 0.535 . . . . 1.0 110.826 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.457 ' HD2' ' O ' ' A' ' 61' ' ' VAL . 90.1 m-70 -96.91 5.55 50.3 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.587 -0.733 . . . . 1.0 110.866 -178.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.85 17.38 63.53 Favored Glycine 0 C--N 1.33 0.236 0 CA-C-N 115.7 -0.682 . . . . 1.0 113.165 176.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.535 ' HD1' ' HG2' ' A' ' 27' ' ' GLN . 71.1 m-85 -88.68 154.89 50.78 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-O 120.501 0.191 . . . . 1.0 110.827 179.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.563 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 21.9 Cg_endo -67.46 151.81 79.54 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.354 2.036 . . . . 1.0 110.123 174.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.463 HG23 ' HB2' ' A' ' 62' ' ' LEU . 67.1 p -132.68 20.15 4.24 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 120.271 -0.572 . . . . 1.0 112.181 -175.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.559 ' C ' ' HZ1' ' A' ' 23' ' ' LYS . 31.3 t70 -113.8 128.2 56.31 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.965 -177.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.573 ' HB3' ' NZ ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -165.76 159.44 16.19 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.429 -0.805 . . . . 1.0 108.923 178.838 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -116.35 120.15 37.94 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.627 -0.879 . . . . 1.0 108.627 178.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.445 ' HB1' ' O ' ' A' ' 49' ' ' HIS . . . -61.03 136.89 58.22 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.833 0.349 . . . . 1.0 111.77 -178.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.621 ' H ' ' ND2' ' A' ' 14' ' ' ASN . . . -127.63 163.54 24.0 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.07 178.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -98.91 157.26 16.43 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.476 -0.935 . . . . 1.0 108.476 178.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.512 HG13 HD21 ' A' ' 97' ' ' LEU . 41.9 t -71.71 111.98 6.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.159 0.504 . . . . 1.0 110.271 179.229 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.45 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -124.43 -165.21 12.13 Favored Glycine 0 N--CA 1.437 -1.275 0 CA-C-N 115.497 -0.774 . . . . 1.0 111.324 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 83.5 m -56.17 -51.2 68.88 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 122.651 0.381 . . . . 1.0 111.877 -179.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.546 ' HG2' ' N ' ' A' ' 80' ' ' HIS . 0.7 OUTLIER -58.15 -29.76 65.83 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.844 -0.616 . . . . 1.0 110.704 -178.589 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.604 ' CD2' ' HB3' ' A' ' 43' ' ' ALA . 79.3 m80 -76.82 -41.61 43.63 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 115.793 -0.64 . . . . 1.0 110.349 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.645 ' O ' HG23 ' A' ' 102' ' ' VAL . 16.6 mt -68.83 -18.67 64.2 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.442 176.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.06 -5.51 59.2 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.185 -178.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.589 ' HB2' ' O ' ' A' ' 6' ' ' HIS . . . -61.34 153.23 27.27 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.534 -0.757 . . . . 1.0 110.764 179.084 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.787 ' HB3' HD13 ' A' ' 5' ' ' LEU . 12.2 t70 -82.46 -11.93 58.18 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.242 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.714 HD11 HG12 ' A' ' 7' ' ' VAL . 0.3 OUTLIER -156.61 114.19 3.2 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 109.283 -0.636 . . . . 1.0 109.283 -178.224 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.632 ' HG ' ' CG2' ' A' ' 8' ' ' THR . 5.1 mp -105.74 106.33 16.78 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 115.407 -0.815 . . . . 1.0 110.069 178.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.589 HG11 HD21 ' A' ' 110' ' ' LEU . 52.6 t -84.79 93.43 3.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 114.772 -1.104 . . . . 1.0 110.856 -176.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.54 143.98 34.34 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.193 -0.912 . . . . 1.0 110.562 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -93.39 -19.24 21.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.494 0.664 . . . . 1.0 109.848 178.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -139.86 154.91 47.42 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.443 -0.799 . . . . 1.0 110.311 -178.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -58.67 -22.32 56.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.889 -0.596 . . . . 1.0 111.619 178.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.635 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 94.5 m-20 -75.41 -52.08 11.59 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.861 -0.609 . . . . 1.0 110.278 -178.194 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.66 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 17.5 m170 -55.92 -45.24 78.77 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.38 -0.827 . . . . 1.0 110.814 -179.23 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.425 ' HA ' HD11 ' A' ' 97' ' ' LEU . . . -59.86 -44.07 94.33 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.107 0.48 . . . . 1.0 110.463 178.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 13.6 ttm180 -58.99 -42.65 90.54 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.317 -0.856 . . . . 1.0 111.522 178.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.666 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 34.9 mt -66.32 -47.16 74.43 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.599 -177.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.71 HD12 HG21 ' A' ' 10' ' ' VAL . 33.1 mt -53.14 -59.84 4.05 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.189 -0.459 . . . . 1.0 111.725 -177.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.673 ' CA ' HG13 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -58.46 -44.25 89.2 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.406 0.521 . . . . 1.0 112.406 -179.66 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.588 ' HG3' ' O ' ' A' ' 96' ' ' LEU . 1.0 OUTLIER -67.25 -24.74 65.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.115 0.483 . . . . 1.0 109.814 179.599 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.666 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 12.5 mt -80.82 -19.46 44.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.456 -0.793 . . . . 1.0 111.896 178.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 152.71 -22.84 0.82 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 119.37 -1.395 . . . . 1.0 114.314 -177.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.673 HG13 ' CA ' ' A' ' 98' ' ' ARG . 0.3 OUTLIER -76.05 -161.92 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-N 117.988 0.894 . . . . 1.0 110.502 -179.096 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.802 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 8.6 pt-20 -158.06 160.27 37.21 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 107.671 -1.233 . . . . 1.0 107.671 -177.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.783 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -60.86 -27.08 67.86 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 123.194 0.309 . . . . 1.0 111.183 -175.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.424 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . . . -57.4 -35.38 69.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.101 0.477 . . . . 1.0 110.706 176.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.802 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 9.4 mtt-85 -99.51 -39.68 8.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.508 -0.769 . . . . 1.0 111.551 -177.15 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.783 HG12 ' HA ' ' A' ' 104' ' ' ALA . 9.3 p -80.06 122.25 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 120.661 -0.416 . . . . 1.0 110.85 -174.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.49 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 14.3 mmm180 -141.56 150.54 42.22 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 121.846 -0.534 . . . . 1.0 111.057 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.419 ' HE3' ' HB3' ' A' ' 109' ' ' MET . 85.7 mmm -80.92 140.0 35.55 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.726 -0.67 . . . . 1.0 110.525 178.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.589 HD21 HG11 ' A' ' 87' ' ' VAL . 3.0 tm? -58.31 -49.73 76.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.588 0.232 . . . . 1.0 111.245 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 47.7 ttt180 -72.03 -15.7 62.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.714 0.292 . . . . 1.0 111.031 -177.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.4 t -72.46 -10.62 60.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.659 -0.246 . . . . 1.0 110.636 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.518 ' HZ ' HD23 ' A' ' 85' ' ' LEU . 95.8 m-85 -89.39 -20.1 24.38 Favored 'General case' 0 C--O 1.233 0.203 0 O-C-N 122.224 -0.297 . . . . 1.0 110.826 177.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 19.8 t0 . . . . . 0 N--CA 1.466 0.325 0 CA-C-N 115.969 -0.559 . . . . 1.0 111.554 -177.133 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 . . . . . 0 N--CA 1.455 -0.183 0 CA-C-O 120.467 0.175 . . . . 1.0 111.176 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -63.76 -51.07 66.52 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.108 0.48 . . . . 1.0 109.823 177.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.838 ' HA ' HG11 ' A' ' 141' ' ' VAL . 21.3 t -63.11 -41.13 91.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.749 0.785 . . . . 1.0 109.335 177.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.456 ' HB2' HG12 ' A' ' 61' ' ' VAL . 66.8 t80 -56.31 -43.22 78.75 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.566 -0.743 . . . . 1.0 109.727 177.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.502 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -66.92 -49.88 64.16 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.389 -0.823 . . . . 1.0 111.871 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.838 HG11 ' HA ' ' A' ' 138' ' ' VAL . 5.6 p -57.2 -43.19 81.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 CA-C-O 121.565 0.698 . . . . 1.0 110.671 -178.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.577 HD11 HG12 ' A' ' 138' ' ' VAL . 16.4 mt -68.46 -53.83 25.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 115.031 -0.986 . . . . 1.0 111.934 178.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.63 ' HB3' ' HE1' ' A' ' 24' ' ' MET . 8.3 pt-20 -57.56 -28.43 63.54 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.513 -0.312 . . . . 1.0 110.372 -179.016 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 3.1 t -73.78 -30.04 62.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.085 0.469 . . . . 1.0 110.265 177.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.474 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -86.57 -23.37 25.83 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 116.187 -0.461 . . . . 1.0 111.904 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.757 HD21 ' HB3' ' A' ' 25' ' ' PHE . 17.5 mt -54.9 -37.56 57.51 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 112.146 0.424 . . . . 1.0 112.146 -178.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.604 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 56.1 Cg_endo -69.58 -9.19 25.53 Favored 'Trans proline' 0 C--N 1.364 1.366 0 C-N-CA 122.413 2.076 . . . . 1.0 112.35 177.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.515 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -106.09 -33.27 3.51 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 110.257 -1.137 . . . . 1.0 110.257 178.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.461 ' O ' HG13 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -73.4 -41.66 63.05 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.814 -0.81 . . . . 1.0 108.814 178.934 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . 0.433 ' O ' ' HB2' ' A' ' 154' ' ' ASP . 2.1 m-70 -54.56 -50.88 66.9 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.134 -0.939 . . . . 1.0 110.628 177.067 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -60.98 -46.28 91.39 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.493 -0.776 . . . . 1.0 111.389 -176.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . 0.758 ' HZ3' HD12 ' A' ' 5' ' ' LEU . 21.1 t90 -59.45 -55.5 33.88 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.164 -0.925 . . . . 1.0 111.033 -177.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.509 HG12 HG22 ' A' ' 7' ' ' VAL . 6.1 m -61.88 -40.15 86.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.44 -177.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.556 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 1.1 t70 -60.03 -56.23 24.19 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 121.562 0.696 . . . . 1.0 110.574 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -63.25 -35.66 81.09 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.894 -1.048 . . . . 1.0 110.922 -176.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 19.5 mmt-85 -72.17 -45.74 59.22 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.743 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.556 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 4.0 pp . . . . . 0 CA--C 1.52 -0.184 0 N-CA-C 109.417 -0.586 . . . . 1.0 109.417 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.695 ' HG3' ' HE ' ' A' ' 39' ' ' ARG . 49.0 Cg_endo . . . . . 0 N--CA 1.462 -0.348 0 N-CA-C 113.541 0.554 . . . . 1.0 113.541 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.794 HD21 ' HZ3' ' A' ' 152' ' ' TRP . 0.6 OUTLIER -75.65 -172.58 1.91 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.155 -0.93 . . . . 1.0 110.662 178.219 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.509 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 0.1 OUTLIER -157.11 92.8 1.28 Allowed 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 121.107 -0.237 . . . . 1.0 111.136 179.641 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.643 HG13 HD13 ' A' ' 85' ' ' LEU . 1.9 t -97.12 115.3 36.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 108.802 -0.814 . . . . 1.0 108.802 176.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.602 ' CG2' ' HG ' ' A' ' 86' ' ' LEU . 7.2 t -116.28 117.58 30.39 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 120.821 0.343 . . . . 1.0 110.239 178.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.603 ' HD2' ' HB3' ' A' ' 42' ' ' SER . 2.0 m-85 -85.52 133.89 34.06 Favored 'General case' 0 CA--C 1.518 -0.276 0 O-C-N 121.974 -0.454 . . . . 1.0 110.883 -179.08 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.659 HG21 HD13 ' A' ' 97' ' ' LEU . 28.8 t -118.07 118.69 59.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.204 0.526 . . . . 1.0 111.497 -177.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.496 ' HA ' ' CE1' ' A' ' 93' ' ' HIS . 33.9 t -146.54 170.82 16.11 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 178.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.798 HG23 ' HE2' ' A' ' 93' ' ' HIS . 0.9 OUTLIER -80.64 92.65 6.01 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.25 0.548 . . . . 1.0 110.856 179.959 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.939 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 129.35 -40.39 1.7 Allowed Glycine 0 N--CA 1.441 -0.97 0 C-N-CA 120.597 -0.811 . . . . 1.0 111.74 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.422 HD22 ' CB ' ' A' ' 42' ' ' SER . 4.2 t-20 64.33 14.62 8.89 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.843 0.83 . . . . 1.0 111.338 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.451 ' HA ' ' HG3' ' A' ' 19' ' ' PRO . 14.5 pt -121.54 4.21 6.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 O-C-N 121.705 -0.622 . . . . 1.0 112.074 -177.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 6.1 p -120.3 -87.55 0.64 Allowed 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.926 -0.309 . . . . 1.0 111.81 -177.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 12.6 mtp180 -72.21 -45.06 61.86 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.29 0.478 . . . . 1.0 112.29 -175.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.529 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 18.5 m -55.01 -56.72 24.82 Favored Pre-proline 0 CA--C 1.541 0.603 0 N-CA-C 112.099 0.407 . . . . 1.0 112.099 179.276 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.47 ' HD3' ' HB2' ' A' ' 18' ' ' SER . 57.6 Cg_endo -68.53 -21.59 39.78 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 121.765 1.644 . . . . 1.0 112.539 -177.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.56 ' HB3' HD13 ' A' ' 142' ' ' ILE . 34.0 mmm -60.82 -53.13 61.06 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.601 -0.272 . . . . 1.0 110.32 177.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.474 ' HA ' ' HB2' ' A' ' 24' ' ' MET . . . -75.26 -25.43 58.03 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.234 -0.586 . . . . 1.0 110.61 -179.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.533 ' HA ' ' HE2' ' A' ' 9' ' ' PHE . 17.8 tt0 -52.31 -53.58 42.5 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 115.489 -0.778 . . . . 1.0 109.94 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.591 ' O ' ' HB3' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -85.88 -23.58 27.0 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.209 -0.905 . . . . 1.0 110.758 -175.787 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.625 ' HB3' HD13 ' A' ' 146' ' ' LEU . 7.0 mmm -61.78 -75.55 0.07 Allowed 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.563 0.579 . . . . 1.0 112.563 -178.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.677 ' HB3' HD11 ' A' ' 146' ' ' LEU . 26.5 p90 -80.65 -28.72 36.79 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.179 -0.608 . . . . 1.0 111.573 -174.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' 22' ' ' GLU . . . -63.65 -38.97 93.11 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 119.237 -0.985 . . . . 1.0 110.261 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.6 ' HA ' ' HD3' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -64.88 -37.65 88.35 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 108.845 -0.798 . . . . 1.0 108.845 177.272 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.602 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 79.1 mt-30 -59.02 -47.59 84.66 Favored 'General case' 0 CA--C 1.522 -0.097 0 CA-C-N 116.433 -0.349 . . . . 1.0 110.413 175.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 25' ' ' PHE . 95.6 mt -52.07 -56.26 15.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.835 -0.62 . . . . 1.0 111.071 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.6 ' HD3' ' HA ' ' A' ' 27' ' ' GLN . 0.1 OUTLIER -61.67 -37.4 83.93 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.647 -0.421 . . . . 1.0 111.797 178.866 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 8.1 m170 -62.82 -23.39 67.24 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.391 0.515 . . . . 1.0 112.391 178.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.602 ' HG2' ' O ' ' A' ' 28' ' ' GLN . 7.9 ptp180 -98.49 -21.52 16.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.48 0.657 . . . . 1.0 110.185 178.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 108.03 39.85 1.78 Allowed Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 115.24 -0.891 . . . . 1.0 112.297 177.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 15.9 mt -137.46 -3.11 1.93 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.034 0.445 . . . . 1.0 109.9 -177.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.414 ' HA3' ' HB3' ' A' ' 30' ' ' ARG . . . -62.82 -23.58 65.65 Favored Glycine 0 C--N 1.332 0.325 0 CA-C-N 115.856 -0.611 . . . . 1.0 112.585 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -83.75 -32.86 25.22 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.272 0.558 . . . . 1.0 109.537 176.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.49 -15.84 55.75 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.45 -0.796 . . . . 1.0 111.334 -178.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.5 t -130.58 121.61 51.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 110.237 -0.282 . . . . 1.0 110.237 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.695 ' HE ' ' HG3' ' A' ' 4' ' ' PRO . 7.2 mmt180 -93.24 134.83 35.04 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 109.873 -0.417 . . . . 1.0 109.873 177.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.447 HG12 ' HB1' ' A' ' 26' ' ' ALA . 55.1 t -129.85 119.72 48.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 121.699 0.761 . . . . 1.0 109.877 -177.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.487 ' O ' ' HA ' ' A' ' 8' ' ' THR . 48.0 p -133.65 -174.12 3.43 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 113.693 -1.594 . . . . 1.0 110.809 -175.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.603 ' HB3' ' HD2' ' A' ' 9' ' ' PHE . 81.8 p -161.82 166.9 25.73 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 120.931 -0.308 . . . . 1.0 110.47 179.136 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.591 ' HB2' ' CD2' ' A' ' 80' ' ' HIS . . . -164.54 169.61 16.88 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.447 0.642 . . . . 1.0 111.728 -179.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -127.85 140.9 12.15 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.266 -0.879 . . . . 1.0 111.028 178.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.479 HG23 HD13 ' A' ' 96' ' ' LEU . 39.9 p -76.7 -23.2 53.15 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.935 0.368 . . . . 1.0 111.829 -177.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.5 ' HA3' ' CZ3' ' A' ' 48' ' ' TRP . . . -112.03 11.91 26.91 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.511 -0.852 . . . . 1.0 113.156 -177.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.416 ' HB3' ' HB2' ' A' ' 75' ' ' GLN . 2.7 p-10 43.11 39.9 2.1 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 113.572 0.953 . . . . 1.0 113.572 178.165 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.939 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 1.3 m-90 -46.84 -77.0 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.531 0.682 . . . . 1.0 112.306 179.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.558 ' O ' ' HB2' ' A' ' 73' ' ' ALA . 11.3 m-70 -105.45 41.77 1.32 Allowed 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.525 -0.761 . . . . 1.0 111.06 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.549 HG22 ' HA ' ' A' ' 74' ' ' ALA . 12.9 p -61.04 125.85 17.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.119 0.485 . . . . 1.0 110.181 178.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.794 ' HA2' ' HD3' ' A' ' 72' ' ' ARG . . . 95.27 -15.23 63.74 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 121.06 -0.591 . . . . 1.0 111.637 -176.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.484 ' CB ' ' HB3' ' A' ' 49' ' ' HIS . 3.3 t -79.58 -159.99 0.23 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.251 0.548 . . . . 1.0 109.746 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 36.1 t -128.14 175.06 8.71 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 109.189 -0.671 . . . . 1.0 109.189 -179.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.57 142.48 39.25 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.87 0.367 . . . . 1.0 111.29 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -62.79 143.62 57.33 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.663 -0.699 . . . . 1.0 112.557 -176.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.566 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 12.2 pt-20 -43.61 -42.32 5.1 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 114.383 -1.28 . . . . 1.0 113.748 178.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.669 ' O ' HG23 ' A' ' 61' ' ' VAL . 10.0 mtt-85 -70.16 -48.4 57.51 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 120.784 0.326 . . . . 1.0 110.462 -176.497 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.38 -31.49 70.89 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.224 -0.898 . . . . 1.0 110.298 -177.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.73 -45.84 84.77 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.66 -0.496 . . . . 1.0 109.66 176.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.07 -39.93 98.62 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.708 -0.758 . . . . 1.0 111.489 178.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 57' ' ' ARG . 88.8 t -58.67 -59.16 4.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-O 121.233 0.54 . . . . 1.0 111.242 178.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.649 ' HB2' HG23 ' A' ' 69' ' ' THR . 96.6 mt -60.4 -50.09 74.99 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.939 -0.573 . . . . 1.0 111.54 -177.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 6.9 ptm85 -61.72 -27.56 68.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.723 -0.217 . . . . 1.0 111.008 -178.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.7 -34.14 76.3 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.453 0.644 . . . . 1.0 110.387 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.42 ' HD2' ' O ' ' A' ' 61' ' ' VAL . 94.1 m-70 -96.41 4.98 51.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.562 -0.744 . . . . 1.0 111.43 -178.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.15 11.48 64.78 Favored Glycine 0 C--N 1.329 0.188 0 C-N-CA 121.026 -0.607 . . . . 1.0 112.743 177.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -89.84 149.75 42.54 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-O 120.691 0.282 . . . . 1.0 110.773 -179.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.428 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 37.6 Cg_endo -67.91 156.14 67.05 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.285 1.99 . . . . 1.0 110.878 177.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.649 HG23 ' HB2' ' A' ' 62' ' ' LEU . 80.4 p -130.85 14.24 5.3 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 120.191 -0.604 . . . . 1.0 111.032 -176.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -77.2 132.66 38.86 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.513 -0.767 . . . . 1.0 109.856 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.41 ' HB2' ' HE2' ' A' ' 23' ' ' LYS . 54.4 t60 -172.17 148.0 2.11 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.038 0.447 . . . . 1.0 110.797 -177.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.794 ' HD3' ' HA2' ' A' ' 51' ' ' GLY . 5.3 tmm_? -131.41 108.45 9.62 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 107.153 -1.425 . . . . 1.0 107.153 176.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.558 ' HB2' ' O ' ' A' ' 49' ' ' HIS . . . -58.73 139.99 55.44 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.071 -0.968 . . . . 1.0 112.474 -174.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.549 ' HA ' HG22 ' A' ' 50' ' ' VAL . . . -134.58 147.16 50.18 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.707 -0.678 . . . . 1.0 110.113 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.416 ' HB2' ' HB3' ' A' ' 47' ' ' ASN . 49.0 tt0 -83.79 153.56 24.03 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 110.116 -0.327 . . . . 1.0 110.116 176.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.573 HG13 HD23 ' A' ' 97' ' ' LEU . 82.0 t -63.56 112.56 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.033 -0.531 . . . . 1.0 110.909 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.425 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -122.4 -171.79 13.94 Favored Glycine 0 N--CA 1.442 -0.915 0 N-CA-C 111.055 -0.818 . . . . 1.0 111.055 178.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 90.8 m -57.88 -44.19 86.52 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.707 0.289 . . . . 1.0 110.935 -179.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -58.97 -29.99 67.6 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.186 -0.461 . . . . 1.0 111.641 178.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.591 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 79.7 m80 -78.66 -39.62 36.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.821 0.343 . . . . 1.0 110.169 179.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.697 ' HA ' HD23 ' A' ' 86' ' ' LEU . 16.2 mt -69.49 -15.19 63.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.112 0.482 . . . . 1.0 110.101 177.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.37 -5.83 59.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.323 -0.399 . . . . 1.0 110.543 -179.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.509 ' HB3' ' O ' ' A' ' 6' ' ' HIS . . . -63.35 154.36 32.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.906 -0.588 . . . . 1.0 110.976 179.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -80.9 -14.78 57.69 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 109.871 -0.418 . . . . 1.0 109.871 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.748 HD11 ' CE3' ' A' ' 152' ' ' TRP . 0.9 OUTLIER -152.72 113.51 4.13 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.484 -0.78 . . . . 1.0 109.73 -177.43 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.697 HD23 ' HA ' ' A' ' 81' ' ' LEU . 5.5 mp -105.72 87.65 2.64 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.534 -0.757 . . . . 1.0 110.951 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.609 HG23 HD23 ' A' ' 85' ' ' LEU . 54.6 t -66.36 92.88 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 113.806 -1.543 . . . . 1.0 112.237 -178.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.06 145.54 32.4 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.393 -1.276 . . . . 1.0 109.917 177.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -98.57 -8.53 26.32 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.955 0.407 . . . . 1.0 110.094 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.443 ' CG ' ' H ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -152.03 153.81 34.74 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.694 -0.685 . . . . 1.0 111.066 179.945 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -55.3 -27.67 48.35 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.251 -0.886 . . . . 1.0 113.104 -178.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.569 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 91.6 m-20 -75.51 -49.97 17.09 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.734 0.302 . . . . 1.0 110.504 -177.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.798 ' HE2' HG23 ' A' ' 12' ' ' THR . 18.2 m170 -53.94 -46.02 71.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.428 179.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.91 -43.94 91.17 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.941 0.4 . . . . 1.0 110.735 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 16.6 ttm180 -61.3 -39.84 91.96 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.722 -0.672 . . . . 1.0 111.602 178.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.569 ' HG ' ' O ' ' A' ' 92' ' ' ASN . 43.9 mt -67.06 -50.74 60.87 Favored 'General case' 0 C--O 1.217 -0.645 0 CA-C-N 116.43 -0.35 . . . . 1.0 110.416 -178.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.659 HD13 HG21 ' A' ' 10' ' ' VAL . 29.2 mt -52.0 -57.45 9.44 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.971 -0.559 . . . . 1.0 111.387 -177.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.739 ' CA ' HG12 ' A' ' 102' ' ' VAL . 9.5 ptt180 -59.75 -44.12 93.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.659 -0.7 . . . . 1.0 112.439 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.531 ' HG3' ' O ' ' A' ' 96' ' ' LEU . 0.9 OUTLIER -67.66 -25.24 65.61 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.394 -0.522 . . . . 1.0 109.895 -179.972 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.445 HD13 ' O ' ' A' ' 96' ' ' LEU . 5.9 mp -77.68 -20.7 53.25 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 116.096 -0.502 . . . . 1.0 111.592 177.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 152.87 -21.15 0.78 Allowed Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 119.477 -1.344 . . . . 1.0 114.216 -178.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.739 HG12 ' CA ' ' A' ' 98' ' ' ARG . 0.3 OUTLIER -76.05 -162.35 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 118.048 0.924 . . . . 1.0 110.313 -179.51 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.734 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 10.7 pt-20 -159.34 160.6 35.23 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 107.753 -1.203 . . . . 1.0 107.753 -177.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.737 ' HA ' HG13 ' A' ' 107' ' ' VAL . . . -62.2 -25.1 67.6 Favored 'General case' 0 C--N 1.316 -0.876 0 O-C-N 123.465 0.478 . . . . 1.0 111.274 -175.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.04 -30.2 67.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.011 0.434 . . . . 1.0 110.546 175.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.734 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 11.5 mtt-85 -105.41 -43.16 5.04 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 115.531 -0.759 . . . . 1.0 111.464 -177.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.737 HG13 ' HA ' ' A' ' 104' ' ' ALA . 11.3 p -78.38 117.93 24.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.497 -0.557 . . . . 1.0 109.497 -174.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.582 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 8.5 mmm180 -139.24 149.79 44.74 Favored 'General case' 0 C--N 1.322 -0.597 0 O-C-N 121.604 -0.685 . . . . 1.0 110.59 -176.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.402 ' HE1' ' HB3' ' A' ' 109' ' ' MET . 87.7 mmm -80.39 131.49 35.62 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.079 -0.51 . . . . 1.0 111.26 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.53 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 2.8 tm? -53.54 -50.54 65.27 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 123.402 0.439 . . . . 1.0 111.028 179.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 43.7 ttt-85 -71.07 -16.67 62.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.308 -0.406 . . . . 1.0 110.956 -176.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 46.8 t -79.81 -2.31 42.75 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 120.706 -0.398 . . . . 1.0 111.034 -179.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.721 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 87.8 m-85 -92.74 -16.61 25.24 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-O 120.914 0.388 . . . . 1.0 109.972 175.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 22.1 t0 . . . . . 0 C--N 1.326 -0.421 0 CA-C-N 115.727 -0.669 . . . . 1.0 111.291 -178.261 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 . . . . . 0 N--CA 1.453 -0.295 0 CA-C-O 120.875 0.369 . . . . 1.0 110.248 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -62.76 -48.77 77.75 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.289 0.566 . . . . 1.0 110.048 178.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.998 ' HA ' HG22 ' A' ' 141' ' ' VAL . 73.5 t -61.51 -40.37 86.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.36 -0.836 . . . . 1.0 110.044 177.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.512 ' HB2' HG11 ' A' ' 61' ' ' VAL . 35.7 t80 -53.65 -42.12 67.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.129 -0.942 . . . . 1.0 109.204 175.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.63 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -67.18 -38.17 84.94 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.343 -0.844 . . . . 1.0 110.599 177.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.998 HG22 ' HA ' ' A' ' 138' ' ' VAL . 13.2 t -56.6 -53.58 39.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.58 0.705 . . . . 1.0 109.986 176.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.56 HD13 ' HB3' ' A' ' 20' ' ' MET . 6.0 mt -62.9 -50.43 79.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 114.883 -1.053 . . . . 1.0 111.842 -178.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.63 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 8.3 pt-20 -55.54 -33.33 63.72 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.628 0.252 . . . . 1.0 110.396 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 2.0 t -74.18 -28.53 61.33 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-O 121.064 0.459 . . . . 1.0 110.327 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.451 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -86.41 -23.3 26.14 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 116.329 -0.396 . . . . 1.0 111.851 179.228 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.677 HD11 ' HB3' ' A' ' 25' ' ' PHE . 11.9 mt -55.45 -38.31 66.5 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 112.37 0.507 . . . . 1.0 112.37 -179.063 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 58.0 Cg_endo -70.81 -10.13 27.12 Favored 'Trans proline' 0 C--N 1.359 1.107 0 C-N-CA 122.56 2.173 . . . . 1.0 112.211 178.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.721 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -105.12 -33.44 3.71 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 110.442 -1.063 . . . . 1.0 110.442 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.578 HD21 ' CE2' ' A' ' 25' ' ' PHE . 13.0 tp -73.86 -37.41 64.79 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.451 -1.314 . . . . 1.0 107.451 177.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . 0.457 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 0.2 OUTLIER -54.24 -51.5 64.29 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 114.549 -1.205 . . . . 1.0 109.57 174.195 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -59.16 -46.65 87.84 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.963 -1.017 . . . . 1.0 111.342 -176.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . 0.794 ' HZ3' HD21 ' A' ' 5' ' ' LEU . 28.7 t90 -63.0 -52.17 64.0 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.49 -0.777 . . . . 1.0 111.056 -178.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.482 HG12 ' O ' ' A' ' 149' ' ' LEU . 12.3 m -61.01 -39.39 82.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 120.545 -0.462 . . . . 1.0 109.919 -179.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.11 -51.54 68.7 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 116.417 -0.356 . . . . 1.0 111.076 177.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.531 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 4.8 pt-20 -60.18 -39.34 86.12 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.256 0.55 . . . . 1.0 110.235 -178.017 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.544 ' HG3' ' CH2' ' A' ' 152' ' ' TRP . 17.3 mmt85 -72.11 -46.24 57.44 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.369 -0.832 . . . . 1.0 111.437 -176.133 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.3 pp . . . . . 0 C--N 1.327 -0.39 0 N-CA-C 109.317 -0.623 . . . . 1.0 109.317 179.331 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.578 ' HB2' ' HG2' ' A' ' 39' ' ' ARG . 11.1 Cg_endo . . . . . 0 C--O 1.236 0.389 0 N-CA-C 114.803 1.039 . . . . 1.0 114.803 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.685 HD23 ' HZ3' ' A' ' 152' ' ' TRP . 0.7 OUTLIER -70.79 -174.14 0.88 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 114.006 -1.452 . . . . 1.0 110.118 179.949 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.657 ' HA ' ' O ' ' A' ' 39' ' ' ARG . 1.4 t-160 -157.54 93.3 1.28 Allowed 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.493 -0.483 . . . . 1.0 111.159 -178.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.717 HG11 HD11 ' A' ' 85' ' ' LEU . 2.5 t -98.27 108.63 22.33 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.454 0 N-CA-C 109.916 -0.402 . . . . 1.0 109.916 177.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' A' ' 41' ' ' THR . 14.7 t -109.88 116.88 32.44 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.143 0.497 . . . . 1.0 110.937 -179.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.564 ' CE2' ' HA ' ' A' ' 22' ' ' GLU . 0.4 OUTLIER -86.95 129.43 34.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.902 0.382 . . . . 1.0 110.653 -179.166 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.627 HG22 HD21 ' A' ' 97' ' ' LEU . 41.2 t -114.14 116.59 53.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.914 -0.585 . . . . 1.0 111.782 -176.206 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.507 ' HA ' ' CE1' ' A' ' 93' ' ' HIS . 45.1 t -145.32 151.9 39.05 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.409 178.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.34 99.71 2.99 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.285 0.564 . . . . 1.0 110.423 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.528 ' O ' HG12 ' A' ' 15' ' ' ILE . . . 140.02 -32.85 2.16 Favored Glycine 0 C--O 1.217 -0.951 0 CA-C-N 115.555 -0.748 . . . . 1.0 111.488 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.581 ' OD1' ' HB3' ' A' ' 73' ' ' ALA . 34.3 p30 48.7 20.98 0.38 Allowed 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 125.268 1.427 . . . . 1.0 113.901 179.198 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.528 HG12 ' O ' ' A' ' 13' ' ' GLY . 5.3 pt -139.46 10.26 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 122.233 -0.292 . . . . 1.0 111.362 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 47.9 t -125.1 -87.34 0.61 Allowed 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.263 -0.575 . . . . 1.0 112.131 -178.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 35.8 mtt180 -71.21 -39.47 71.72 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.23 0.456 . . . . 1.0 112.23 -174.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.891 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 16.5 m -58.29 -58.59 17.8 Favored Pre-proline 0 CA--C 1.543 0.677 0 N-CA-C 111.753 0.279 . . . . 1.0 111.753 179.155 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.619 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 38.1 Cg_endo -63.71 -23.94 69.31 Favored 'Trans proline' 0 C--N 1.358 1.042 0 C-N-CA 122.341 2.027 . . . . 1.0 112.431 178.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.63 ' HB3' HD11 ' A' ' 142' ' ' ILE . 49.0 mmm -59.74 -55.47 33.97 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.228 -0.286 . . . . 1.0 110.228 179.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.454 ' HA ' ' HB2' ' A' ' 24' ' ' MET . . . -75.36 -26.19 58.32 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.238 -0.585 . . . . 1.0 110.522 -179.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.696 ' O ' ' HB1' ' A' ' 26' ' ' ALA . 11.8 tt0 -52.44 -54.3 34.01 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 115.377 -0.828 . . . . 1.0 110.008 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.668 ' HE3' ' HB2' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -84.78 -23.44 29.19 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.362 -0.836 . . . . 1.0 110.576 -175.844 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.595 ' HB3' HD12 ' A' ' 146' ' ' LEU . 5.2 mmm -62.82 -75.74 0.07 Allowed 'General case' 0 C--O 1.237 0.442 0 N-CA-C 112.679 0.622 . . . . 1.0 112.679 -178.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.758 ' HB3' HD21 ' A' ' 146' ' ' LEU . 18.6 p90 -79.06 -28.92 43.22 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 119.848 -0.741 . . . . 1.0 111.251 -174.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.696 ' HB1' ' O ' ' A' ' 22' ' ' GLU . . . -64.06 -37.15 86.38 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 119.486 -0.886 . . . . 1.0 110.661 179.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.615 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -64.54 -38.69 91.87 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.676 -0.861 . . . . 1.0 108.676 176.507 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.565 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 77.8 mt-30 -60.63 -41.56 95.12 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.619 -0.718 . . . . 1.0 110.426 176.07 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.635 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 88.2 mt -57.01 -58.97 5.84 Favored 'General case' 0 C--O 1.225 -0.201 0 CA-C-N 115.774 -0.648 . . . . 1.0 110.89 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.508 ' HD3' ' HA ' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -59.31 -35.37 73.67 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.204 -0.598 . . . . 1.0 111.163 178.654 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -63.33 -26.29 68.7 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.244 0.461 . . . . 1.0 112.244 177.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.635 ' HG2' ' O ' ' A' ' 29' ' ' LEU . 4.0 ptm85 -96.21 -23.37 16.75 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 119.775 -0.77 . . . . 1.0 109.954 178.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 113.47 34.65 1.71 Allowed Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.174 -0.921 . . . . 1.0 112.433 177.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 25.8 mt -129.37 5.08 5.19 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.853 -0.425 . . . . 1.0 109.853 -178.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.429 ' HA3' ' HB3' ' A' ' 30' ' ' ARG . . . -59.39 -31.6 70.54 Favored Glycine 0 C--N 1.332 0.308 0 CA-C-N 115.819 -0.628 . . . . 1.0 112.967 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -88.17 -20.85 25.03 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.864 0.364 . . . . 1.0 110.186 176.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.02 -25.05 40.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.814 -0.63 . . . . 1.0 111.299 -178.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.614 HG12 ' HB3' ' A' ' 5' ' ' LEU . 5.9 t -130.13 126.29 61.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 121.106 -0.238 . . . . 1.0 110.604 -178.337 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.657 ' O ' ' HA ' ' A' ' 6' ' ' HIS . 24.2 mmt180 -99.61 98.89 9.7 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.185 0.517 . . . . 1.0 110.876 177.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.681 HG11 ' HB2' ' A' ' 26' ' ' ALA . 1.5 m -88.45 136.75 22.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 CA-C-N 115.703 -0.68 . . . . 1.0 109.299 178.228 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.525 ' O ' ' HA ' ' A' ' 8' ' ' THR . 28.9 p -146.59 -179.8 7.02 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.117 -0.947 . . . . 1.0 109.756 -175.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.891 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 95.1 p -158.19 161.4 37.83 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.382 -0.527 . . . . 1.0 110.936 -178.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.501 ' HB1' ' CD2' ' A' ' 80' ' ' HIS . . . -165.09 168.37 17.36 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.309 0.576 . . . . 1.0 111.415 -179.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -124.68 132.15 8.08 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 110.805 -0.918 . . . . 1.0 110.805 177.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.577 HG21 ' CG1' ' A' ' 10' ' ' VAL . 20.2 p -66.72 -28.82 68.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.948 0.404 . . . . 1.0 111.446 -176.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -101.64 7.13 55.49 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.653 -0.784 . . . . 1.0 113.059 -176.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 42.85 39.39 1.7 Allowed 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 113.46 0.911 . . . . 1.0 113.46 178.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -47.18 -79.64 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.635 0.731 . . . . 1.0 112.533 178.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -103.79 42.11 1.21 Allowed 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.992 -1.004 . . . . 1.0 111.095 -178.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.4 p -60.53 125.63 17.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.797 -0.638 . . . . 1.0 110.408 178.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.33 -12.76 64.99 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.703 -0.76 . . . . 1.0 111.834 -177.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.33 -161.06 0.38 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.728 -0.471 . . . . 1.0 109.728 178.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 71' ' ' HIS . 30.0 t -127.34 169.45 13.56 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.512 -0.921 . . . . 1.0 108.512 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -51.14 138.96 19.2 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.921 0.391 . . . . 1.0 111.707 -179.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.744 ' OD1' ' HG2' ' A' ' 57' ' ' ARG . 12.1 t70 -62.62 140.97 58.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.585 -0.734 . . . . 1.0 111.05 -176.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -51.06 -33.62 26.45 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.793 1.035 . . . . 1.0 113.793 -178.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.744 ' HG2' ' OD1' ' A' ' 55' ' ' ASP . 9.9 ptm180 -72.63 -41.16 65.81 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 118.958 0.799 . . . . 1.0 110.619 -178.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.15 -38.89 75.57 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.134 0.493 . . . . 1.0 109.955 179.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.13 -42.8 99.2 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.517 -0.765 . . . . 1.0 109.909 178.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -57.82 -45.92 92.97 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.903 -0.665 . . . . 1.0 113.224 178.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 5.8 m -72.88 -39.75 59.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 117.585 0.692 . . . . 1.0 111.414 -178.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.611 ' HB2' HG22 ' A' ' 69' ' ' THR . 94.8 mt -60.92 -55.2 35.81 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 120.774 0.321 . . . . 1.0 110.5 179.063 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -58.59 -33.16 69.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.75 -0.659 . . . . 1.0 110.729 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.95 -34.48 78.08 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.081 0.467 . . . . 1.0 110.932 179.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -95.62 5.68 50.86 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.891 -0.595 . . . . 1.0 111.409 -178.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.91 12.4 66.23 Favored Glycine 0 N--CA 1.452 -0.267 0 CA-C-N 115.589 -0.732 . . . . 1.0 112.575 176.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -91.5 147.88 36.24 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-O 120.625 0.25 . . . . 1.0 110.827 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.518 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 38.1 Cg_endo -69.0 154.85 70.05 Favored 'Trans proline' 0 CA--C 1.508 -0.799 0 C-N-CA 122.529 2.152 . . . . 1.0 110.544 177.106 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.611 HG22 ' HB2' ' A' ' 62' ' ' LEU . 27.9 p -127.85 14.85 6.92 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.226 0.536 . . . . 1.0 110.428 -178.054 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -84.03 119.03 24.45 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.32 -0.855 . . . . 1.0 109.839 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.668 ' HB2' ' HE3' ' A' ' 23' ' ' LYS . 3.5 t60 -162.18 142.58 10.14 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.334 -176.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 -113.69 115.52 27.99 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 107.887 -1.153 . . . . 1.0 107.887 177.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.581 ' HB3' ' OD1' ' A' ' 14' ' ' ASN . . . -60.02 138.44 57.86 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 112.28 0.474 . . . . 1.0 112.28 -177.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -134.74 158.02 45.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.228 178.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -94.09 155.43 17.09 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.385 -0.598 . . . . 1.0 109.385 177.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.487 HG11 ' CD2' ' A' ' 97' ' ' LEU . 5.0 t -69.63 113.31 5.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.559 -0.534 . . . . 1.0 109.559 178.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.5 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -125.31 -166.65 12.38 Favored Glycine 0 N--CA 1.44 -1.061 0 CA-C-N 115.44 -0.8 . . . . 1.0 111.353 -179.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 83.8 m -55.83 -53.31 58.26 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.967 0.413 . . . . 1.0 111.623 -178.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.442 ' HG2' ' N ' ' A' ' 80' ' ' HIS . 1.6 pm0 -56.14 -32.72 64.51 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.415 -0.811 . . . . 1.0 111.287 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.501 ' CD2' ' HB1' ' A' ' 43' ' ' ALA . 78.3 m80 -74.81 -39.73 61.52 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.048 -0.524 . . . . 1.0 109.727 179.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.618 ' HA ' HD21 ' A' ' 86' ' ' LEU . 29.5 mt -69.03 -20.76 64.13 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.89 -0.595 . . . . 1.0 110.997 177.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.41 -4.6 59.21 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.773 -177.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.539 ' HB3' ' O ' ' A' ' 6' ' ' HIS . . . -59.58 153.61 19.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.706 -0.679 . . . . 1.0 111.064 179.234 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.404 ' H ' ' HB3' ' A' ' 6' ' ' HIS . 13.8 t70 -79.4 -16.82 55.58 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.162 0.506 . . . . 1.0 110.036 -179.623 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.717 HD11 HG11 ' A' ' 7' ' ' VAL . 0.3 OUTLIER -152.91 114.12 4.2 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.403 -0.817 . . . . 1.0 109.088 -178.057 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.618 HD21 ' HA ' ' A' ' 81' ' ' LEU . 4.9 mp -104.32 106.48 17.0 Favored 'General case' 0 N--CA 1.424 -1.726 0 CA-C-N 115.322 -0.854 . . . . 1.0 109.724 178.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.643 HG11 HD23 ' A' ' 110' ' ' LEU . 53.9 t -86.67 94.98 4.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 114.926 -1.034 . . . . 1.0 111.242 -177.173 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.92 143.68 31.49 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.501 -0.772 . . . . 1.0 110.805 178.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.502 HD23 ' HB2' ' A' ' 11' ' ' CYS . 4.4 mm? -93.93 -16.29 24.12 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.758 -0.655 . . . . 1.0 109.535 178.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -141.49 152.48 44.22 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.504 -0.771 . . . . 1.0 110.514 -177.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.403 ' H ' ' HG2' ' A' ' 91' ' ' ARG . 9.2 ptt180 -61.15 -21.45 63.77 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.649 0.593 . . . . 1.0 111.238 177.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.681 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 95.4 m-20 -73.84 -50.6 19.61 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 109.644 -0.502 . . . . 1.0 109.644 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.647 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 8.5 m170 -60.16 -43.63 95.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.452 -0.795 . . . . 1.0 109.786 178.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.95 -44.68 94.26 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.164 0.507 . . . . 1.0 110.544 179.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.458 ' O ' ' HG2' ' A' ' 98' ' ' ARG . 0.3 OUTLIER -57.83 -44.07 86.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.38 -0.827 . . . . 1.0 111.225 178.173 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.732 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 50.8 mt -64.69 -49.87 69.21 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 116.279 -0.418 . . . . 1.0 110.49 -177.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.647 ' HG ' ' O ' ' A' ' 93' ' ' HIS . 49.3 mt -51.97 -56.76 12.2 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.947 -0.57 . . . . 1.0 111.641 -178.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.458 ' HG2' ' O ' ' A' ' 95' ' ' ARG . 26.1 ptt85 -59.62 -45.57 91.56 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.138 -0.483 . . . . 1.0 111.729 -176.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.624 ' HG3' ' O ' ' A' ' 96' ' ' LEU . 1.2 pp0? -69.42 -21.55 63.74 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 120.967 0.413 . . . . 1.0 110.857 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.732 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 10.8 mt -78.72 -6.82 56.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.043 -0.526 . . . . 1.0 111.966 -178.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 144.1 -29.31 1.94 Allowed Glycine 0 CA--C 1.506 -0.479 0 C-N-CA 119.828 -1.177 . . . . 1.0 113.021 178.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.762 HG11 ' H ' ' A' ' 103' ' ' GLU . 1.6 t -74.85 -153.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-O 121.541 0.686 . . . . 1.0 110.814 -178.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.762 ' H ' HG11 ' A' ' 102' ' ' VAL . 12.6 pt-20 -163.59 159.45 21.83 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.895 -1.15 . . . . 1.0 107.895 -178.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.45 ' HA ' ' HB ' ' A' ' 107' ' ' VAL . . . -67.71 -17.28 64.51 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.665 -0.414 . . . . 1.0 112.031 -173.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.92 -37.17 76.06 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 173.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.599 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 2.5 mtp85 -94.73 -34.98 12.33 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 114.744 -1.116 . . . . 1.0 110.422 -178.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.563 HG22 ' O ' ' A' ' 103' ' ' GLU . 39.5 t -79.57 114.56 20.57 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.423 -179.106 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.472 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 15.1 mmt180 -135.42 147.37 48.95 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 120.212 -0.595 . . . . 1.0 110.403 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.611 ' HB2' ' HB2' ' A' ' 112' ' ' SER . 77.0 mmm -78.07 139.05 39.06 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.691 -0.686 . . . . 1.0 110.037 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.643 HD23 HG11 ' A' ' 87' ' ' VAL . 2.9 tm? -56.89 -50.18 73.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.602 0.239 . . . . 1.0 110.963 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.09 -12.08 61.04 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.082 0.468 . . . . 1.0 110.747 -177.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.611 ' HB2' ' HB2' ' A' ' 109' ' ' MET . 32.5 t -78.69 -4.86 51.22 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.978 -0.555 . . . . 1.0 111.011 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.566 ' HZ ' HD21 ' A' ' 85' ' ' LEU . 86.4 m-85 -91.8 -21.06 20.87 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.049 0.452 . . . . 1.0 109.873 175.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.6 t0 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 115.303 -0.862 . . . . 1.0 110.533 -179.956 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.413 ' HA ' ' HB3' ' A' ' 139' ' ' PHE . 20.4 mt-10 . . . . . 0 N--CA 1.453 -0.29 0 CA-C-O 120.64 0.257 . . . . 1.0 110.883 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.523 ' O ' HG21 ' A' ' 141' ' ' VAL . 23.5 tp10 -63.99 -49.98 70.36 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.994 -0.743 . . . . 1.0 108.994 175.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.412 ' O ' HD12 ' A' ' 142' ' ' ILE . 87.2 t -59.41 -42.91 89.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.323 -0.853 . . . . 1.0 108.889 175.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.462 ' HD2' ' HE2' ' A' ' 20' ' ' MET . 45.6 t80 -53.9 -43.41 69.67 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.159 -1.382 . . . . 1.0 109.553 175.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.546 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -65.03 -40.86 95.43 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.583 -0.735 . . . . 1.0 110.913 179.012 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.523 HG21 ' O ' ' A' ' 137' ' ' GLU . 21.5 t -56.17 -48.63 78.95 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 CA-C-O 121.868 0.842 . . . . 1.0 109.537 177.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.63 HD11 ' HB3' ' A' ' 20' ' ' MET . 5.3 mt -65.62 -51.88 57.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 114.763 -1.108 . . . . 1.0 111.593 -179.346 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.546 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 8.8 pt-20 -56.09 -33.21 64.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.745 0.307 . . . . 1.0 110.506 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 72.7 m -72.37 -28.44 63.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.889 -0.596 . . . . 1.0 110.927 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.467 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -87.61 -23.86 24.15 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-N 115.838 -0.619 . . . . 1.0 111.801 179.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.758 HD21 ' HB3' ' A' ' 25' ' ' PHE . 13.6 mt -55.86 -37.97 63.02 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 120.562 -0.455 . . . . 1.0 112.033 -177.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . 0.611 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 57.8 Cg_endo -69.73 -9.65 26.65 Favored 'Trans proline' 0 C--N 1.363 1.314 0 C-N-CA 122.666 2.244 . . . . 1.0 112.084 178.223 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.541 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -106.09 -32.28 3.83 Favored Glycine 0 N--CA 1.442 -0.934 0 N-CA-C 109.896 -1.282 . . . . 1.0 109.896 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.468 ' O ' HG12 ' A' ' 153' ' ' VAL . 0.4 OUTLIER -74.96 -39.83 61.11 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.448 -0.945 . . . . 1.0 108.448 178.507 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -54.52 -50.99 66.53 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.364 -0.835 . . . . 1.0 110.578 175.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -60.79 -45.76 93.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.367 -0.833 . . . . 1.0 111.611 -176.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . 0.685 ' HZ3' HD23 ' A' ' 5' ' ' LEU . 22.2 t90 -60.2 -55.24 36.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.136 -0.938 . . . . 1.0 110.695 -177.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.468 HG12 ' O ' ' A' ' 149' ' ' LEU . 5.3 m -61.19 -40.39 85.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.524 -0.307 . . . . 1.0 110.527 -178.047 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.441 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 0.5 OUTLIER -60.95 -53.92 51.32 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.085 0.469 . . . . 1.0 111.104 179.216 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 10.5 pt-20 -61.97 -36.47 81.57 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.698 -0.683 . . . . 1.0 110.654 -177.108 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.435 ' HG3' ' CH2' ' A' ' 152' ' ' TRP . 14.0 mmt180 -73.88 -44.54 55.05 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 116.084 -0.507 . . . . 1.0 111.122 -178.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 4.0 pp . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 120.993 0.425 . . . . 1.0 110.11 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.575 0 N-CA-C 111.653 -0.579 . . . . 1.0 111.653 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.7 mtm -88.89 81.21 6.95 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.607 -0.516 . . . . 1.0 109.607 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.747 ' HB3' ' HA3' ' A' ' 161' ' ' GLY . 26.9 p -80.96 117.25 21.42 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.941 -0.572 . . . . 1.0 110.316 -178.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.526 ' HB3' ' HD2' ' A' ' 4' ' ' PRO . 0.7 OUTLIER -65.27 159.81 63.06 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.124 -0.695 . . . . 1.0 109.124 177.306 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.526 ' HD2' ' HB3' ' A' ' 3' ' ' ASP . 56.9 Cg_endo -69.49 164.13 35.44 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.401 2.068 . . . . 1.0 113.642 -176.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.753 HD13 ' HB3' ' A' ' 84' ' ' ASP . 0.2 OUTLIER -68.44 -177.89 1.01 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.623 -1.171 . . . . 1.0 109.522 178.078 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.694 ' HA ' ' O ' ' A' ' 39' ' ' ARG . 2.4 t-160 -156.84 87.7 1.01 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.924 -0.398 . . . . 1.0 109.924 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.773 HG11 HD11 ' A' ' 85' ' ' LEU . 2.5 t -97.15 104.68 16.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.473 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.586 ' HA ' ' O ' ' A' ' 41' ' ' THR . 12.7 t -107.99 115.58 30.39 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.163 0.506 . . . . 1.0 110.453 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.529 ' HD1' ' HB ' ' A' ' 87' ' ' VAL . 0.7 OUTLIER -84.56 131.75 34.59 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.438 -178.009 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.619 HG23 HD12 ' A' ' 97' ' ' LEU . 43.6 t -116.19 112.58 40.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.223 0.535 . . . . 1.0 111.891 -176.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.654 ' HB2' HD22 ' A' ' 89' ' ' LEU . 17.7 t -141.65 165.8 26.49 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.934 -0.575 . . . . 1.0 109.689 177.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.65 HG23 ' HE2' ' A' ' 93' ' ' HIS . 1.2 p -73.47 101.6 3.56 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.959 0.409 . . . . 1.0 110.782 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.928 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 120.68 -43.34 1.55 Allowed Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.859 -0.686 . . . . 1.0 111.863 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.641 ' ND2' ' H ' ' A' ' 74' ' ' ALA . 59.0 t30 60.2 25.82 15.22 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 122.169 0.985 . . . . 1.0 110.883 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.6 pt -126.54 0.66 4.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 115.602 -0.726 . . . . 1.0 111.15 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 23.1 m -120.6 -88.79 0.62 Allowed 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.439 -0.504 . . . . 1.0 111.916 -176.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.877 HH22 ' HA ' ' A' ' 126' ' ' ASP . 38.1 ttm105 -71.94 -40.42 68.72 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.282 0.475 . . . . 1.0 112.282 -174.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.421 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 24.5 m -58.47 -58.34 19.79 Favored Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 111.846 0.313 . . . . 1.0 111.846 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.499 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 40.2 Cg_endo -64.49 -20.99 66.37 Favored 'Trans proline' 0 C--N 1.357 0.978 0 C-N-CA 122.035 1.823 . . . . 1.0 112.166 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.669 ' HB3' HD11 ' A' ' 142' ' ' ILE . 41.9 mmm -62.97 -54.45 38.14 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.625 -0.261 . . . . 1.0 110.499 177.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.445 ' HA ' ' HB2' ' A' ' 24' ' ' MET . . . -71.84 -27.83 63.16 Favored 'General case' 0 CA--C 1.509 -0.624 0 C-N-CA 120.461 -0.496 . . . . 1.0 110.076 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.684 ' O ' ' HB1' ' A' ' 26' ' ' ALA . 15.8 tt0 -50.47 -53.47 29.48 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-N 114.741 -1.118 . . . . 1.0 109.852 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.793 ' HB3' ' HG2' ' A' ' 68' ' ' PRO . 0.1 OUTLIER -82.78 -27.32 31.07 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.165 -0.925 . . . . 1.0 110.22 -175.958 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.743 ' HB3' HD12 ' A' ' 146' ' ' LEU . 7.9 mmm -62.87 -75.61 0.07 Allowed 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 112.993 0.738 . . . . 1.0 112.993 -176.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.828 ' HB3' HD21 ' A' ' 146' ' ' LEU . 19.8 p90 -78.04 -29.92 49.61 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 119.958 -0.697 . . . . 1.0 111.219 -175.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.684 ' HB1' ' O ' ' A' ' 22' ' ' GLU . . . -63.37 -38.15 90.02 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 119.413 -0.915 . . . . 1.0 110.57 179.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.65 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -63.36 -40.75 98.13 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.94 -0.763 . . . . 1.0 108.94 177.098 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.586 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 79.4 mt-30 -59.83 -41.88 92.32 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-N 115.85 -0.613 . . . . 1.0 110.679 176.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.655 ' HG ' ' O ' ' A' ' 25' ' ' PHE . 80.2 mt -55.89 -61.41 2.39 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.682 -0.69 . . . . 1.0 110.257 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.531 ' HB3' ' HA3' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -59.07 -33.56 70.95 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.793 -0.363 . . . . 1.0 111.374 178.553 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -63.37 -25.54 68.34 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.21 0.448 . . . . 1.0 112.21 176.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.583 ' HD3' HD13 ' A' ' 34' ' ' LEU . 8.3 ptm85 -98.6 -21.29 16.54 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 120.05 -0.66 . . . . 1.0 110.104 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.27 33.17 1.83 Allowed Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 114.991 -1.004 . . . . 1.0 112.437 177.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.583 HD13 ' HD3' ' A' ' 32' ' ' ARG . 36.1 mt -127.14 6.47 6.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.982 0.391 . . . . 1.0 110.709 -178.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.531 ' HA3' ' HB3' ' A' ' 30' ' ' ARG . . . -54.21 -35.84 55.87 Favored Glycine 0 CA--C 1.52 0.374 0 C-N-CA 121.27 -0.49 . . . . 1.0 113.573 -177.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.607 ' HA ' ' NH1' ' A' ' 39' ' ' ARG . 2.8 m-20 -92.29 -14.02 29.48 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.97 0.414 . . . . 1.0 110.925 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.83 -17.93 49.13 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.875 -0.602 . . . . 1.0 111.2 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.68 HG22 ' HB3' ' A' ' 5' ' ' LEU . 0.4 OUTLIER -144.64 124.3 7.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.39 0.614 . . . . 1.0 111.055 179.436 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.694 ' O ' ' HA ' ' A' ' 6' ' ' HIS . 25.8 mmt180 -95.66 101.45 13.15 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.634 -0.712 . . . . 1.0 110.948 -178.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.633 HG13 ' HB2' ' A' ' 26' ' ' ALA . 1.6 m -89.03 136.61 23.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 109.035 -0.728 . . . . 1.0 109.035 178.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.586 ' O ' ' HA ' ' A' ' 8' ' ' THR . 31.7 p -146.6 -176.11 5.05 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.045 -0.98 . . . . 1.0 109.742 -175.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.419 ' HB3' ' HD2' ' A' ' 9' ' ' PHE . 49.2 p -158.76 160.66 36.56 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.153 -0.619 . . . . 1.0 111.253 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.613 ' HB3' ' CD2' ' A' ' 80' ' ' HIS . . . -162.68 161.88 26.66 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.315 0.579 . . . . 1.0 111.582 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -124.33 138.53 11.31 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 111.096 -0.802 . . . . 1.0 111.096 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.511 HG23 HD11 ' A' ' 96' ' ' LEU . 33.7 p -74.36 -24.0 59.09 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 111.962 0.356 . . . . 1.0 111.962 -176.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.583 ' HA3' ' CZ3' ' A' ' 48' ' ' TRP . . . -110.76 9.39 29.97 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.533 -0.841 . . . . 1.0 113.083 -178.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 42.67 37.35 1.0 Allowed 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 113.885 1.068 . . . . 1.0 113.885 177.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.928 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 1.5 m-90 -44.81 -70.41 0.1 Allowed 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.559 0.695 . . . . 1.0 112.369 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.665 ' O ' ' HB2' ' A' ' 52' ' ' SER . 6.8 m-70 -109.65 43.73 1.28 Allowed 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.1 -0.954 . . . . 1.0 111.057 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.42 HG22 ' HA ' ' A' ' 74' ' ' ALA . 14.8 p -62.54 129.74 26.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 C-N-CA 120.425 -0.51 . . . . 1.0 110.169 178.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.14 -13.5 66.88 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 121.109 -0.567 . . . . 1.0 111.684 -176.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.665 ' HB2' ' O ' ' A' ' 49' ' ' HIS . 0.4 OUTLIER -80.0 -162.26 0.42 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.174 0.511 . . . . 1.0 110.669 179.58 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 33.7 t -126.45 175.94 7.52 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.291 -1.003 . . . . 1.0 108.291 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.06 141.06 47.21 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.955 0.407 . . . . 1.0 111.374 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.48 ' OD1' ' HG2' ' A' ' 57' ' ' ARG . 13.2 t70 -61.05 141.15 57.61 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.285 -0.87 . . . . 1.0 111.436 -177.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -46.24 -37.8 7.67 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.727 -1.124 . . . . 1.0 113.555 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.671 ' O ' HG23 ' A' ' 61' ' ' VAL . 14.9 ptp180 -69.95 -45.31 67.73 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 122.276 -0.265 . . . . 1.0 110.897 -176.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.0 -31.62 68.19 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.485 -178.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.64 -43.43 98.82 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.893 -0.594 . . . . 1.0 110.046 178.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.41 -42.4 97.65 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.786 -0.721 . . . . 1.0 111.486 177.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.671 HG23 ' O ' ' A' ' 57' ' ' ARG . 61.3 t -58.05 -58.53 6.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-O 120.975 0.417 . . . . 1.0 111.273 179.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.718 ' HB2' HG23 ' A' ' 69' ' ' THR . 90.1 mt -59.04 -51.21 71.02 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.061 -0.518 . . . . 1.0 111.662 -178.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -60.87 -29.27 69.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.482 -0.326 . . . . 1.0 110.894 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.19 -31.48 71.91 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.225 0.536 . . . . 1.0 110.546 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -99.42 1.89 44.63 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.492 -0.776 . . . . 1.0 111.505 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.97 16.26 56.41 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 121.045 -0.597 . . . . 1.0 113.213 177.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -92.08 149.58 38.96 Favored Pre-proline 0 C--N 1.322 -0.627 0 C-N-CA 122.083 0.153 . . . . 1.0 111.082 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.793 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 49.6 Cg_endo -68.89 158.23 58.72 Favored 'Trans proline' 0 CA--C 1.511 -0.634 0 C-N-CA 122.519 2.146 . . . . 1.0 110.36 176.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.718 HG23 ' HB2' ' A' ' 62' ' ' LEU . 58.1 p -134.53 3.53 3.31 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 119.562 -0.855 . . . . 1.0 112.65 -176.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -79.85 135.65 36.5 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.762 -0.375 . . . . 1.0 110.429 -179.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -175.58 153.99 1.54 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.698 -0.683 . . . . 1.0 109.251 -176.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -123.3 116.72 23.79 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.208 -1.034 . . . . 1.0 108.208 177.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.493 ' HB2' ' O ' ' A' ' 49' ' ' HIS . . . -61.3 139.02 58.24 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.259 0.552 . . . . 1.0 111.895 -176.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.641 ' H ' ' ND2' ' A' ' 14' ' ' ASN . . . -130.88 161.23 32.3 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.427 -0.806 . . . . 1.0 109.942 178.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -98.1 161.41 13.73 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.943 -0.762 . . . . 1.0 108.943 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.529 HG12 HD21 ' A' ' 97' ' ' LEU . 94.0 t -67.44 102.72 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.398 0.618 . . . . 1.0 110.388 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.548 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -120.79 -170.87 14.23 Favored Glycine 0 N--CA 1.443 -0.882 0 CA-C-N 115.046 -0.979 . . . . 1.0 111.824 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 88.4 m -55.92 -54.12 48.52 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.758 0.651 . . . . 1.0 112.758 -178.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.564 ' HG2' ' N ' ' A' ' 80' ' ' HIS . 0.6 OUTLIER -56.43 -31.36 63.84 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.893 -0.594 . . . . 1.0 111.089 -178.167 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.613 ' CD2' ' HB3' ' A' ' 43' ' ' ALA . 79.1 m80 -76.32 -42.36 45.4 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.6 -0.727 . . . . 1.0 110.064 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 23.2 mt -66.21 -19.77 65.93 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.476 178.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -84.77 -5.33 59.32 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.871 -0.604 . . . . 1.0 110.998 -178.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.561 ' HB3' ' O ' ' A' ' 6' ' ' HIS . . . -60.8 157.85 14.14 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.071 -0.513 . . . . 1.0 111.644 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.753 ' HB3' HD13 ' A' ' 5' ' ' LEU . 29.9 t70 -82.69 -16.57 47.67 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 115.915 -0.584 . . . . 1.0 109.807 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.773 HD11 HG11 ' A' ' 7' ' ' VAL . 0.4 OUTLIER -154.61 115.82 4.05 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.334 -0.848 . . . . 1.0 109.059 -176.581 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.579 HD23 HG21 ' A' ' 102' ' ' VAL . 5.4 mp -106.74 106.81 17.52 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-N 115.479 -0.782 . . . . 1.0 109.853 177.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.561 HG12 HD22 ' A' ' 110' ' ' LEU . 52.3 t -85.14 92.26 3.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 114.896 -1.047 . . . . 1.0 110.869 -176.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.27 147.54 32.49 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.514 -0.766 . . . . 1.0 110.98 179.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.654 HD22 ' HB2' ' A' ' 11' ' ' CYS . 2.9 mm? -103.73 -4.85 23.14 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.273 0.558 . . . . 1.0 110.49 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.456 ' CG ' ' H ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -155.37 153.37 30.35 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.71 -0.677 . . . . 1.0 111.223 178.538 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 25.4 ptt180 -50.19 -32.09 15.44 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 114.903 -1.044 . . . . 1.0 112.998 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.704 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 5.9 m-20 -76.3 -48.46 20.03 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.288 -0.264 . . . . 1.0 110.288 -176.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.65 ' HE2' HG23 ' A' ' 12' ' ' THR . 14.2 m170 -55.14 -48.46 73.65 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.73 -0.47 . . . . 1.0 109.73 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.451 ' HA ' HG22 ' A' ' 107' ' ' VAL . . . -59.3 -43.45 92.6 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.028 0.442 . . . . 1.0 110.849 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 9.8 ttt-85 -59.67 -45.51 91.84 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 115.408 -0.815 . . . . 1.0 111.66 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.761 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 56.0 mt -63.86 -49.49 72.55 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 115.902 -0.59 . . . . 1.0 110.028 -175.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.642 ' HG ' ' O ' ' A' ' 93' ' ' HIS . 22.6 mt -52.77 -57.83 8.86 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.668 -0.696 . . . . 1.0 111.368 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.573 ' HA ' ' HB ' ' A' ' 102' ' ' VAL . 9.4 ptt180 -60.42 -43.21 96.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.11 -0.496 . . . . 1.0 111.878 -176.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.639 ' HG3' ' O ' ' A' ' 96' ' ' LEU . 1.3 pp0? -68.33 -23.31 64.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.911 0.386 . . . . 1.0 110.287 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.761 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 11.4 mt -79.2 -13.43 59.71 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.87 -0.605 . . . . 1.0 112.194 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 148.4 -22.87 1.37 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.067 -1.063 . . . . 1.0 112.773 -178.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.914 HG12 ' H ' ' A' ' 103' ' ' GLU . 3.3 t -75.6 -156.09 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.123 0.487 . . . . 1.0 110.119 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.914 ' H ' HG12 ' A' ' 102' ' ' VAL . 9.3 pt-20 -170.44 163.84 8.57 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.755 -1.202 . . . . 1.0 107.755 -177.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.751 ' HA ' HG11 ' A' ' 107' ' ' VAL . . . -65.83 -22.14 66.53 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.754 0.311 . . . . 1.0 111.213 -176.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.462 ' HB1' ' HG3' ' A' ' 103' ' ' GLU . . . -58.52 -37.8 76.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.295 0.569 . . . . 1.0 109.947 174.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.676 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 10.5 mtt180 -96.21 -45.33 6.89 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 115.193 -0.912 . . . . 1.0 110.778 -177.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.751 HG11 ' HA ' ' A' ' 104' ' ' ALA . 8.2 p -79.07 124.8 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-O 121.289 0.566 . . . . 1.0 110.49 -176.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.529 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 10.6 mmm180 -140.85 147.92 39.71 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.285 -0.635 . . . . 1.0 109.285 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.445 ' HE2' ' HB3' ' A' ' 109' ' ' MET . 83.1 mmm -78.88 140.24 38.16 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.451 -0.34 . . . . 1.0 110.375 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.561 HD22 HG12 ' A' ' 87' ' ' VAL . 3.0 tm? -58.45 -51.69 68.77 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 122.973 0.171 . . . . 1.0 111.262 -179.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 46.1 ttm-85 -71.26 -14.51 62.25 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 120.278 -0.569 . . . . 1.0 110.442 -178.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.436 ' HB2' ' HB2' ' A' ' 109' ' ' MET . 42.2 t -73.62 -9.51 58.75 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.71 -0.396 . . . . 1.0 110.423 179.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.536 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 97.2 m-85 -91.02 -22.68 20.66 Favored 'General case' 0 C--N 1.341 0.213 0 N-CA-C 109.782 -0.451 . . . . 1.0 109.782 175.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -59.43 117.66 24.22 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.22 -0.9 . . . . 1.0 111.019 -178.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.478 ' HD2' ' O ' ' A' ' 144' ' ' SER . 47.9 Cg_endo -66.36 -23.54 51.25 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.917 2.412 . . . . 1.0 112.383 -179.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -91.93 1.0 57.46 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 116.6 -0.273 . . . . 1.0 111.492 -178.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 39.4 t -58.59 -51.31 70.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.245 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 87.91 -70.12 2.77 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.157 -1.021 . . . . 1.0 111.144 178.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.3 m -91.25 166.5 12.9 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.054 -0.721 . . . . 1.0 109.054 177.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 59.2 m170 -64.85 136.82 57.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.892 0.377 . . . . 1.0 110.208 178.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -106.75 89.91 3.16 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.686 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.435 ' HA ' ' HG3' ' A' ' 109' ' ' MET . 2.7 mm? -99.18 15.26 26.6 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.949 0.404 . . . . 1.0 110.155 178.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -168.49 130.09 1.33 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.722 -0.672 . . . . 1.0 109.421 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.456 ' HB ' ' O ' ' A' ' 89' ' ' LEU . 59.4 t -107.62 154.4 8.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.816 -0.629 . . . . 1.0 109.599 -179.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -64.67 -175.79 0.21 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.102 -0.499 . . . . 1.0 111.209 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.877 ' HA ' HH22 ' A' ' 17' ' ' ARG . 2.2 t70 -167.39 120.87 0.78 Allowed Pre-proline 0 C--N 1.324 -0.539 0 N-CA-C 108.55 -0.907 . . . . 1.0 108.55 178.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.925 ' HB2' ' HB3' ' A' ' 134' ' ' ASP . 68.8 Cg_endo -84.44 93.81 0.73 Allowed 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.988 2.459 . . . . 1.0 114.0 -173.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.78 -15.74 36.08 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 120.716 -0.394 . . . . 1.0 111.474 178.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -71.47 -36.18 71.1 Favored 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 117.841 -1.544 . . . . 1.0 110.283 -176.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.62 58.88 3.98 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 119.768 -1.206 . . . . 1.0 113.437 173.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -119.5 -175.72 3.0 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 107.967 -1.123 . . . . 1.0 107.967 176.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 6.0 t-160 -66.09 -36.08 82.24 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.568 -0.901 . . . . 1.0 108.568 178.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 15.2 m -60.97 -50.1 74.75 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.481 -0.781 . . . . 1.0 111.246 178.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.925 ' HB3' ' HB2' ' A' ' 127' ' ' PRO . 0.9 OUTLIER -50.92 -41.39 58.67 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 112.233 0.457 . . . . 1.0 112.233 -178.69 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.464 ' CE1' ' HD3' ' A' ' 57' ' ' ARG . 10.3 m-30 -72.16 -53.17 13.47 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.256 -0.429 . . . . 1.0 111.024 -174.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -66.76 -25.34 66.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.143 -0.481 . . . . 1.0 110.806 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -61.58 -51.56 68.04 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.659 -0.7 . . . . 1.0 110.126 178.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.951 ' HA ' HG21 ' A' ' 141' ' ' VAL . 71.9 t -59.85 -41.15 84.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.758 -0.655 . . . . 1.0 110.346 178.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.518 ' HB2' HG11 ' A' ' 61' ' ' VAL . 49.8 t80 -54.65 -43.6 72.51 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.185 -0.916 . . . . 1.0 109.418 176.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.513 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -63.94 -41.86 97.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.595 -0.729 . . . . 1.0 110.798 178.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.951 HG21 ' HA ' ' A' ' 138' ' ' VAL . 5.6 t -53.83 -53.1 29.22 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 CA-C-O 121.841 0.829 . . . . 1.0 110.031 177.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.669 HD11 ' HB3' ' A' ' 20' ' ' MET . 6.8 mt -64.97 -50.94 72.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 114.649 -1.16 . . . . 1.0 112.085 -177.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.534 ' HB3' ' HE2' ' A' ' 24' ' ' MET . 10.3 pt-20 -57.33 -30.87 65.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.677 0.275 . . . . 1.0 110.533 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.478 ' O ' ' HD2' ' A' ' 115' ' ' PRO . 1.9 t -73.49 -29.62 62.62 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-O 121.2 0.524 . . . . 1.0 110.164 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.505 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -86.7 -24.12 25.31 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-N 116.018 -0.537 . . . . 1.0 112.128 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.828 HD21 ' HB3' ' A' ' 25' ' ' PHE . 14.4 mt -55.15 -36.42 45.14 Favored Pre-proline 0 CA--C 1.545 0.769 0 N-CA-C 112.745 0.646 . . . . 1.0 112.745 -177.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 56.9 Cg_endo -70.22 -10.59 28.53 Favored 'Trans proline' 0 C--N 1.363 1.299 0 C-N-CA 122.63 2.22 . . . . 1.0 112.09 176.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -106.07 -33.74 3.39 Favored Glycine 0 N--CA 1.449 -0.492 0 N-CA-C 110.372 -1.091 . . . . 1.0 110.372 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.466 ' O ' HG13 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -73.02 -39.23 66.17 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.0 -1.111 . . . . 1.0 108.0 178.369 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.519 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 0.2 OUTLIER -52.97 -58.4 7.11 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 114.801 -1.091 . . . . 1.0 110.834 175.293 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -56.92 -39.83 75.22 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.766 -1.106 . . . . 1.0 111.304 -174.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . 0.746 ' HZ3' HD12 ' A' ' 5' ' ' LEU . 22.3 t90 -65.18 -55.75 16.8 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.602 -0.726 . . . . 1.0 110.875 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.466 HG13 ' O ' ' A' ' 149' ' ' LEU . 6.5 m -61.35 -41.97 91.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.888 -0.412 . . . . 1.0 109.888 -178.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.425 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 3.3 m-20 -60.19 -51.26 70.35 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-O 120.96 0.41 . . . . 1.0 110.855 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 7.1 pt-20 -63.4 -38.35 90.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.95 -177.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.52 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 5.5 mmt85 -73.81 -43.02 60.08 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.701 -0.681 . . . . 1.0 110.802 -176.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.427 HD12 ' C ' ' A' ' 157' ' ' LEU . 4.0 pp -68.06 -26.16 65.72 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.017 -0.538 . . . . 1.0 109.998 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -73.26 -49.37 28.07 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.745 -0.661 . . . . 1.0 110.764 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.439 ' HG2' ' O ' ' A' ' 155' ' ' GLU . 11.4 ptp180 -76.79 -16.55 59.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.776 -0.647 . . . . 1.0 112.228 -177.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -58.53 -46.91 85.81 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.721 -0.672 . . . . 1.0 111.599 -174.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.747 ' HA3' ' HB3' ' A' ' 2' ' ' SER . . . -121.64 145.39 16.87 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 119.72 -1.229 . . . . 1.0 112.357 176.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.461 ' HD3' ' HA2' ' A' ' 161' ' ' GLY . 6.3 Cg_endo -87.7 -149.89 0.04 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 123.647 2.898 . . . . 1.0 112.429 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.426 ' H ' ' HB2' ' A' ' 162' ' ' PRO . 21.5 t . . . . . 0 C--N 1.31 -1.119 0 CA-C-N 114.148 -1.387 . . . . 1.0 110.629 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . 0.408 ' C ' ' H ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.482 1.731 0 N-CA-C 111.96 -0.456 . . . . 1.0 111.96 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -82.93 23.66 0.82 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.138 0.494 . . . . 1.0 109.866 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.408 ' H ' ' C ' ' A' ' 0' ' ' GLY . 32.5 p -166.73 165.87 16.17 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.382 -0.827 . . . . 1.0 109.993 -177.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.832 ' HB2' ' HD2' ' A' ' 4' ' ' PRO . 4.0 p-10 -169.13 168.06 5.28 Favored Pre-proline 0 C--N 1.329 -0.319 0 N-CA-C 109.313 -0.625 . . . . 1.0 109.313 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.832 ' HD2' ' HB2' ' A' ' 3' ' ' ASP . 17.8 Cg_endo -61.35 164.61 14.72 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.744 2.296 . . . . 1.0 112.915 -178.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.794 ' HB3' HG23 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -65.38 175.92 1.57 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.599 -0.728 . . . . 1.0 109.684 179.67 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.772 ' H ' HD12 ' A' ' 5' ' ' LEU . 0.5 OUTLIER -153.75 100.28 2.37 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.883 -0.414 . . . . 1.0 109.883 179.175 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.662 HG11 HD13 ' A' ' 85' ' ' LEU . 1.8 t -103.6 116.84 48.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 107.983 -1.118 . . . . 1.0 107.983 178.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.604 ' CG2' ' HG ' ' A' ' 86' ' ' LEU . 15.1 t -119.77 114.31 21.95 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 120.589 -0.444 . . . . 1.0 110.81 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.763 ' HZ ' ' HE1' ' A' ' 25' ' ' PHE . 0.4 OUTLIER -84.35 131.41 34.7 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 120.398 -0.521 . . . . 1.0 110.177 -179.619 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.595 HG22 HD13 ' A' ' 97' ' ' LEU . 30.1 t -113.66 118.42 58.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 116.284 -0.416 . . . . 1.0 111.365 -176.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.408 ' HB2' HD22 ' A' ' 89' ' ' LEU . 46.2 t -148.65 146.8 28.34 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.996 -0.372 . . . . 1.0 109.996 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.54 93.27 1.19 Allowed 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 121.115 0.483 . . . . 1.0 110.394 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 148.08 -37.99 1.06 Allowed Glycine 0 N--CA 1.441 -1.01 0 CA-C-N 115.183 -0.917 . . . . 1.0 111.088 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.987 HD21 ' HB1' ' A' ' 73' ' ' ALA . 1.4 p-10 48.47 24.43 0.74 Allowed 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.063 0.945 . . . . 1.0 112.864 178.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.449 HG12 ' HB2' ' A' ' 49' ' ' HIS . 1.3 pt -148.23 47.2 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.451 0 CA-C-N 115.574 -0.739 . . . . 1.0 110.625 178.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.453 ' HA ' ' OD1' ' A' ' 55' ' ' ASP . 53.2 t -161.68 -84.56 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.535 -0.757 . . . . 1.0 109.599 173.082 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.604 ' NH2' ' HA ' ' A' ' 126' ' ' ASP . 27.4 mmt85 -59.79 -57.16 14.12 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.795 -0.639 . . . . 1.0 112.002 -178.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 1.093 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 6.2 m -52.11 -58.35 11.72 Favored Pre-proline 0 CA--C 1.546 0.825 0 CA-C-N 115.085 -0.961 . . . . 1.0 112.55 -177.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.646 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 37.3 Cg_endo -63.45 -27.82 70.71 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 121.985 1.79 . . . . 1.0 112.909 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.46 ' HB3' HD12 ' A' ' 142' ' ' ILE . 45.5 mmm -59.28 -57.31 13.58 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.295 -0.261 . . . . 1.0 110.295 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.538 ' O ' ' HD1' ' A' ' 25' ' ' PHE . . . -71.37 -32.16 68.16 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 115.885 -0.598 . . . . 1.0 110.507 -178.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.574 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 15.0 tt0 -49.79 -52.72 29.95 Favored 'General case' 0 C--O 1.216 -0.69 0 O-C-N 124.198 0.936 . . . . 1.0 109.917 -178.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.955 ' HE3' ' HB2' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -86.63 -22.33 26.24 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 119.592 -0.843 . . . . 1.0 110.9 -176.919 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.51 ' HE1' HD12 ' A' ' 146' ' ' LEU . 88.7 mtp -64.21 -75.16 0.09 Allowed 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.384 0.513 . . . . 1.0 112.384 -179.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.763 ' HE1' ' HZ ' ' A' ' 9' ' ' PHE . 0.8 OUTLIER -78.43 -28.29 46.72 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 119.754 -0.778 . . . . 1.0 111.613 -175.452 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.574 ' HB3' ' O ' ' A' ' 22' ' ' GLU . . . -64.54 -38.73 92.04 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 119.387 -0.925 . . . . 1.0 110.473 178.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.6 ' HG3' ' N ' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -64.75 -37.45 87.63 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.825 -0.806 . . . . 1.0 108.825 177.789 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.6 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 78.5 mt-30 -60.05 -43.01 95.68 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-N 115.967 -0.56 . . . . 1.0 109.897 175.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 25' ' ' PHE . 93.2 mt -56.02 -59.01 5.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.74 -0.664 . . . . 1.0 110.767 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.484 ' HG2' ' O ' ' A' ' 27' ' ' GLN . 0.2 OUTLIER -60.58 -34.27 73.94 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.372 -0.531 . . . . 1.0 111.349 178.463 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.8 m170 -59.42 -30.09 68.23 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 111.994 0.368 . . . . 1.0 111.994 176.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.463 ' HG2' ' O ' ' A' ' 28' ' ' GLN . 5.8 ptp180 -95.41 -19.25 20.05 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 119.501 -0.88 . . . . 1.0 110.261 179.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 107.42 38.44 2.09 Favored Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.238 -0.892 . . . . 1.0 112.339 177.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 25.2 mt -129.54 0.02 4.98 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 122.554 -0.38 . . . . 1.0 110.258 -178.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.441 ' H ' ' HA ' ' A' ' 30' ' ' ARG . . . -54.26 -28.41 42.72 Favored Glycine 0 CA--C 1.519 0.337 0 CA-C-N 116.028 -0.533 . . . . 1.0 113.837 -178.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.508 ' HA ' ' NH1' ' A' ' 39' ' ' ARG . 5.1 t70 -89.45 -24.88 21.75 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-O 121.54 0.686 . . . . 1.0 109.739 178.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -77.59 -19.38 55.7 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 114.716 -1.129 . . . . 1.0 111.438 -174.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.794 HG23 ' HB3' ' A' ' 5' ' ' LEU . 0.4 OUTLIER -145.05 124.24 6.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.964 -0.562 . . . . 1.0 109.889 179.81 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.508 ' NH1' ' HA ' ' A' ' 36' ' ' ASP . 29.1 mmt180 -90.16 137.44 32.34 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 109.291 -0.633 . . . . 1.0 109.291 -178.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 80.8 t -124.78 126.88 72.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 N-CA-C 109.425 -0.583 . . . . 1.0 109.425 -178.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.438 ' O ' ' HA ' ' A' ' 8' ' ' THR . 31.5 p -139.51 -178.11 5.24 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.175 -0.921 . . . . 1.0 110.557 -174.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 1.093 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 87.9 p -159.01 159.61 34.97 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.987 -0.551 . . . . 1.0 109.987 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.455 ' HA ' ' O ' ' A' ' 74' ' ' ALA . . . -164.44 166.17 20.8 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 121.32 0.581 . . . . 1.0 111.462 -178.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -124.58 138.96 11.47 Favored Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 110.789 -0.924 . . . . 1.0 110.789 177.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.566 HG21 HD12 ' A' ' 96' ' ' LEU . 28.3 p -71.79 -21.9 61.65 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.96 0.409 . . . . 1.0 110.977 -178.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -107.17 2.2 35.16 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 120.789 -0.72 . . . . 1.0 113.217 -177.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.481 ' HB3' ' HB2' ' A' ' 75' ' ' GLN . 3.1 p-10 44.23 35.99 1.41 Allowed 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 113.324 0.861 . . . . 1.0 113.324 178.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -43.87 -74.65 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.715 0.769 . . . . 1.0 112.453 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.449 ' HB2' HG12 ' A' ' 15' ' ' ILE . 79.0 m-70 -106.25 42.57 1.25 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.043 -0.98 . . . . 1.0 110.686 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.418 HG23 ' HA ' ' A' ' 74' ' ' ALA . 14.5 p -60.32 134.94 25.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.429 178.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.55 -13.63 60.03 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.885 -0.674 . . . . 1.0 112.303 -178.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.8 t -79.79 -162.67 0.45 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.163 0.506 . . . . 1.0 109.928 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 15.5 t -119.56 174.91 6.11 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.931 -0.766 . . . . 1.0 108.931 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.424 ' HB1' ' HB3' ' A' ' 71' ' ' HIS . . . -62.71 147.02 50.89 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.34 0.59 . . . . 1.0 111.485 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.608 ' OD2' ' HG3' ' A' ' 57' ' ' ARG . 9.8 p-10 -60.79 138.91 58.07 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.958 -1.019 . . . . 1.0 112.885 -178.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -48.6 -36.52 15.86 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 114.704 -1.134 . . . . 1.0 112.596 178.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.608 ' HG3' ' OD2' ' A' ' 55' ' ' ASP . 8.2 ptt180 -70.65 -44.23 67.54 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 122.298 0.239 . . . . 1.0 111.095 -178.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.34 -38.59 78.22 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 109.222 -0.658 . . . . 1.0 109.222 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.06 -44.9 94.38 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.604 -0.725 . . . . 1.0 109.984 178.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.411 ' O ' ' HG2' ' A' ' 63' ' ' ARG . . . -58.06 -44.1 94.83 Favored Glycine 0 N--CA 1.443 -0.882 0 CA-C-N 115.618 -0.719 . . . . 1.0 113.198 178.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.3 m -75.6 -39.24 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-N 117.326 0.563 . . . . 1.0 111.383 -178.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.591 ' HB2' HG21 ' A' ' 69' ' ' THR . 96.6 mt -61.59 -52.14 65.64 Favored 'General case' 0 C--O 1.23 0.044 0 C-N-CA 120.892 -0.323 . . . . 1.0 110.299 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.411 ' HG2' ' O ' ' A' ' 60' ' ' GLY . 6.8 ptm180 -59.63 -30.79 68.96 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.723 -0.671 . . . . 1.0 110.947 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.6 -33.23 74.58 Favored 'General case' 0 C--O 1.226 -0.141 0 CA-C-N 116.354 -0.385 . . . . 1.0 111.297 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.462 ' HB2' ' HD2' ' A' ' 67' ' ' TYR . 98.5 m-70 -96.33 2.51 52.84 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.341 -0.39 . . . . 1.0 111.237 -178.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 90.18 14.34 59.1 Favored Glycine 0 C--N 1.329 0.145 0 CA-C-N 116.005 -0.543 . . . . 1.0 112.536 177.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.462 ' HD2' ' HB2' ' A' ' 65' ' ' HIS . 69.0 m-85 -91.39 149.56 39.78 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-O 120.551 0.215 . . . . 1.0 110.855 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -69.05 153.71 71.76 Favored 'Trans proline' 0 CA--C 1.509 -0.742 0 C-N-CA 122.325 2.017 . . . . 1.0 110.666 177.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.591 HG21 ' HB2' ' A' ' 62' ' ' LEU . 42.3 p -124.74 15.68 8.71 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 121.552 0.691 . . . . 1.0 110.442 -177.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -84.2 120.11 25.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.056 -0.975 . . . . 1.0 110.154 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.955 ' HB2' ' HE3' ' A' ' 23' ' ' LYS . 32.3 t60 -159.11 147.72 18.17 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.761 -0.654 . . . . 1.0 110.587 -177.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.7 tpp180 -125.71 112.57 16.25 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 107.697 -1.223 . . . . 1.0 107.697 175.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.987 ' HB1' HD21 ' A' ' 14' ' ' ASN . . . -59.95 140.17 56.91 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.543 -0.753 . . . . 1.0 111.956 -176.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.455 ' O ' ' HA ' ' A' ' 43' ' ' ALA . . . -135.96 160.6 38.11 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.646 178.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.481 ' HB2' ' HB3' ' A' ' 47' ' ' ASN . 43.5 tt0 -98.68 155.82 17.14 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.767 -0.457 . . . . 1.0 109.767 178.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.466 HG11 HD23 ' A' ' 97' ' ' LEU . 36.5 t -66.48 111.32 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.365 0.603 . . . . 1.0 110.731 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.453 ' H ' ' HD1' ' A' ' 80' ' ' HIS . . . -123.86 -168.3 12.93 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.049 -0.978 . . . . 1.0 111.034 -179.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 80.6 m -55.73 -46.96 77.67 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.711 0.291 . . . . 1.0 111.377 -179.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -60.13 -29.57 68.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.407 -0.36 . . . . 1.0 111.553 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.453 ' HD1' ' H ' ' A' ' 77' ' ' GLY . 77.1 m80 -78.1 -39.26 42.0 Favored 'General case' 0 C--O 1.222 -0.357 0 N-CA-C 109.858 -0.423 . . . . 1.0 109.858 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.672 ' O ' HG23 ' A' ' 102' ' ' VAL . 15.6 mt -70.36 -18.18 63.06 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.308 -0.405 . . . . 1.0 110.451 176.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -88.43 -7.73 56.12 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 120.77 0.319 . . . . 1.0 110.232 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.579 ' HA ' ' HB3' ' A' ' 6' ' ' HIS . . . -59.65 148.01 35.36 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.81 -0.632 . . . . 1.0 109.888 178.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.529 ' HB3' HD12 ' A' ' 5' ' ' LEU . 28.5 t70 -74.44 -16.1 60.88 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.218 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.662 HD13 HG11 ' A' ' 7' ' ' VAL . 0.6 OUTLIER -153.17 116.47 4.64 Favored 'General case' 0 CA--C 1.51 -0.596 0 N-CA-C 109.336 -0.616 . . . . 1.0 109.336 -176.836 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.692 ' HB3' HD11 ' A' ' 97' ' ' LEU . 5.0 mp -106.89 105.52 15.59 Favored 'General case' 0 N--CA 1.426 -1.654 0 CA-C-N 115.489 -0.778 . . . . 1.0 109.782 178.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.612 HG12 HD22 ' A' ' 110' ' ' LEU . 86.6 t -84.63 93.39 3.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 114.554 -1.203 . . . . 1.0 111.263 -175.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.17 145.34 31.06 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.594 -0.73 . . . . 1.0 111.249 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.408 HD22 ' HB2' ' A' ' 11' ' ' CYS . 4.2 mm? -96.53 -11.53 25.32 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.821 -0.627 . . . . 1.0 109.774 178.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.464 ' CG ' ' H ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -148.78 153.62 38.41 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.631 -0.713 . . . . 1.0 110.747 179.859 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -57.96 -26.19 61.97 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.274 -0.876 . . . . 1.0 112.935 -178.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.62 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 82.8 m-20 -77.41 -47.34 20.03 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 110.125 -0.324 . . . . 1.0 110.125 -178.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.647 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 20.6 m170 -53.87 -47.64 70.84 Favored 'General case' 0 CA--C 1.522 -0.106 0 CA-C-N 115.981 -0.554 . . . . 1.0 109.666 177.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.95 -44.42 91.44 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.909 -0.587 . . . . 1.0 110.61 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.652 ' O ' ' HG2' ' A' ' 99' ' ' GLN . 9.8 ttp180 -56.54 -46.13 80.81 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.603 -0.726 . . . . 1.0 111.129 178.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.62 ' HG ' ' O ' ' A' ' 92' ' ' ASN . 42.7 mt -63.39 -47.87 80.22 Favored 'General case' 0 C--O 1.216 -0.696 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.547 -175.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.692 HD11 ' HB3' ' A' ' 86' ' ' LEU . 29.5 mt -53.03 -58.8 5.76 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.784 -0.644 . . . . 1.0 111.413 -177.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.673 ' CA ' HG12 ' A' ' 102' ' ' VAL . 2.2 ptm180 -59.33 -45.25 91.85 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.844 0.683 . . . . 1.0 112.844 -179.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.652 ' HG2' ' O ' ' A' ' 95' ' ' ARG . 7.5 pt20 -68.24 -23.6 64.81 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.165 -0.614 . . . . 1.0 110.49 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.618 HD12 ' O ' ' A' ' 96' ' ' LEU . 6.7 mp -78.98 -17.5 55.29 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 116.267 -0.424 . . . . 1.0 111.817 178.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 152.66 -23.44 0.83 Allowed Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 119.579 -1.296 . . . . 1.0 113.749 -178.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.673 HG12 ' CA ' ' A' ' 98' ' ' ARG . 0.4 OUTLIER -78.45 -163.89 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-N 117.77 0.785 . . . . 1.0 110.166 179.801 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.663 ' N ' HG11 ' A' ' 102' ' ' VAL . 13.1 pt-20 -156.38 165.22 36.99 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 107.736 -1.209 . . . . 1.0 107.736 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.763 ' HA ' HG11 ' A' ' 107' ' ' VAL . . . -61.37 -27.11 68.29 Favored 'General case' 0 C--N 1.316 -0.881 0 O-C-N 123.466 0.479 . . . . 1.0 111.278 -175.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.423 ' HA ' ' NH2' ' A' ' 108' ' ' ARG . . . -58.22 -34.07 70.0 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 120.713 0.292 . . . . 1.0 110.578 177.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.425 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 3.9 mtp180 -97.59 -42.84 7.48 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.955 -0.566 . . . . 1.0 111.343 -178.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.763 HG11 ' HA ' ' A' ' 104' ' ' ALA . 12.6 p -77.88 119.08 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-O 120.95 0.405 . . . . 1.0 110.032 -174.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.521 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 26.8 mmt180 -137.96 149.82 46.48 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 121.695 -0.628 . . . . 1.0 110.583 -178.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.629 ' HB2' ' HB2' ' A' ' 112' ' ' SER . 80.9 mmm -79.06 138.19 37.87 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.015 -0.539 . . . . 1.0 110.214 178.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.612 HD22 HG12 ' A' ' 87' ' ' VAL . 2.9 tm? -57.29 -48.8 78.0 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.037 0.446 . . . . 1.0 111.036 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.674 ' HB2' HG21 ' A' ' 124' ' ' VAL . 6.5 ttt-85 -69.68 -14.61 62.89 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.637 -0.71 . . . . 1.0 110.07 -178.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.629 ' HB2' ' HB2' ' A' ' 109' ' ' MET . 43.9 t -79.12 -8.97 59.41 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.921 -0.581 . . . . 1.0 111.289 -178.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.561 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 91.4 m-85 -91.36 -19.04 23.35 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 120.812 0.339 . . . . 1.0 110.266 176.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -63.27 122.59 76.52 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.854 -0.612 . . . . 1.0 111.143 -177.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.88 -32.48 55.17 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 123.16 2.573 . . . . 1.0 112.919 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 6.9 ptp85 -96.89 8.45 44.37 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.689 -0.687 . . . . 1.0 111.796 -175.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 48.0 p -54.84 -38.0 66.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.125 -0.489 . . . . 1.0 111.749 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 131.13 -52.65 0.82 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.84 -0.695 . . . . 1.0 111.901 178.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 90.7 m -157.54 -62.1 0.09 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.213 0.53 . . . . 1.0 110.471 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -161.0 150.83 17.28 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-N 115.669 -0.696 . . . . 1.0 109.958 -178.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.629 ' HB2' ' HB2' ' A' ' 112' ' ' SER . . . -97.64 170.78 8.77 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.231 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.62 HD13 ' O ' ' A' ' 121' ' ' ALA . 1.6 mm? -149.95 -26.56 0.26 Allowed 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 114.248 -1.342 . . . . 1.0 109.713 -177.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -171.16 138.33 1.24 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.038 -0.983 . . . . 1.0 109.006 -176.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.674 HG21 ' HB2' ' A' ' 111' ' ' ARG . 60.0 t -92.59 146.84 5.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.984 0.421 . . . . 1.0 110.403 -177.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -69.85 -163.83 0.06 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.657 -0.701 . . . . 1.0 111.821 -178.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.604 ' HA ' ' NH2' ' A' ' 17' ' ' ARG . 38.0 t70 -165.71 144.76 5.18 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.531 -0.759 . . . . 1.0 109.202 -176.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.656 ' HB3' ' HB3' ' A' ' 134' ' ' ASP . 25.5 Cg_exo -37.11 155.19 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 124.029 3.153 . . . . 1.0 113.777 177.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -93.92 -52.71 4.3 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.266 -0.879 . . . . 1.0 109.708 -177.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -109.85 -40.45 4.78 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.483 0.658 . . . . 1.0 109.505 179.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 102.78 66.33 0.75 Allowed Glycine 0 N--CA 1.442 -0.937 0 N-CA-C 110.418 -1.073 . . . . 1.0 110.418 -175.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.524 ' H ' ' HB2' ' A' ' 134' ' ' ASP . 1.6 p-10 -130.42 -171.42 2.54 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.851 -0.426 . . . . 1.0 109.851 -177.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 20.1 t-160 -58.14 -39.41 78.67 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.059 -0.518 . . . . 1.0 110.457 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 4.2 m -62.34 -54.79 35.44 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.609 -0.515 . . . . 1.0 109.609 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.656 ' HB3' ' HB3' ' A' ' 127' ' ' PRO . 28.1 m-20 -56.07 -36.12 67.72 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.728 0.64 . . . . 1.0 112.728 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 23.1 m-30 -68.75 -49.62 57.31 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.001 0.429 . . . . 1.0 110.813 -177.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -76.76 -17.37 59.1 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.864 -178.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.4 ' O ' ' HB2' ' A' ' 140' ' ' ALA . 4.3 tp10 -62.79 -47.5 83.2 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.961 -0.755 . . . . 1.0 108.961 175.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.984 ' HA ' HG22 ' A' ' 141' ' ' VAL . 55.3 t -61.93 -39.91 85.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 114.662 -1.153 . . . . 1.0 109.815 176.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -53.11 -43.45 66.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.965 -1.016 . . . . 1.0 108.912 175.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.648 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -65.14 -41.16 95.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.304 -0.862 . . . . 1.0 111.09 177.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.984 HG22 ' HA ' ' A' ' 138' ' ' VAL . 12.7 t -54.64 -52.55 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 121.841 0.829 . . . . 1.0 110.233 178.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.463 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 7.1 mt -65.81 -50.62 69.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 114.817 -1.083 . . . . 1.0 111.769 -179.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.648 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 11.3 pt-20 -58.91 -29.4 67.03 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 120.812 -0.355 . . . . 1.0 110.349 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 2.1 t -74.17 -27.58 60.89 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 121.114 0.483 . . . . 1.0 109.94 178.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.47 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -86.54 -24.72 25.38 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 115.882 -0.599 . . . . 1.0 111.597 178.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.72 HD21 ' HB3' ' A' ' 25' ' ' PHE . 17.9 mt -54.85 -36.84 49.25 Favored Pre-proline 0 CA--C 1.549 0.942 0 N-CA-C 112.636 0.606 . . . . 1.0 112.636 -178.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 56.2 Cg_endo -70.45 -12.28 31.33 Favored 'Trans proline' 0 C--N 1.368 1.578 0 C-N-CA 122.775 2.317 . . . . 1.0 112.022 177.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.561 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -104.13 -33.68 3.92 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 110.195 -1.162 . . . . 1.0 110.195 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.454 HD12 ' CE2' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -72.51 -39.15 67.82 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 108.267 -1.012 . . . . 1.0 108.267 178.446 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.508 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 0.2 OUTLIER -54.0 -58.86 5.75 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-N 114.52 -1.218 . . . . 1.0 110.845 175.994 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -55.15 -41.78 72.23 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 114.826 -1.079 . . . . 1.0 111.012 -174.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . 0.656 ' HZ3' HD11 ' A' ' 5' ' ' LEU . 18.6 t90 -63.35 -54.94 29.06 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.325 -0.852 . . . . 1.0 110.444 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.451 HG13 ' O ' ' A' ' 149' ' ' LEU . 6.2 m -64.82 -41.25 91.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 120.842 -0.343 . . . . 1.0 110.764 -178.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.44 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 15.3 m-20 -60.03 -49.46 77.59 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 121.269 0.557 . . . . 1.0 110.613 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.481 ' O ' ' HG3' ' A' ' 159' ' ' ARG . 5.7 pt-20 -65.31 -37.27 86.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.612 -0.722 . . . . 1.0 110.739 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.525 ' HD2' ' HD2' ' A' ' 159' ' ' ARG . 10.9 mmt180 -75.07 -39.3 60.95 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.186 -0.461 . . . . 1.0 111.565 -177.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 4.4 pp -68.09 -24.64 65.07 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.218 -0.66 . . . . 1.0 109.218 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -71.91 -49.66 35.93 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.072 -0.967 . . . . 1.0 110.432 178.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.525 ' HD2' ' HD2' ' A' ' 156' ' ' ARG . 0.0 OUTLIER -81.0 -10.06 59.76 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 112.57 0.581 . . . . 1.0 112.57 -178.984 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -62.31 -52.06 65.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.593 0.235 . . . . 1.0 110.748 -177.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -159.76 -167.79 20.85 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.034 -1.079 . . . . 1.0 112.02 178.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -80.61 29.38 0.52 Allowed 'Trans proline' 0 N--CA 1.475 0.403 0 C-N-CA 123.416 2.744 . . . . 1.0 113.028 -178.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 25.4 t . . . . . 0 C--N 1.297 -1.688 0 CA-C-N 114.756 -1.111 . . . . 1.0 110.435 -178.232 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.786 0 N-CA-C 112.049 -0.42 . . . . 1.0 112.049 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.7 mmt -75.95 -12.22 60.1 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 111.918 0.34 . . . . 1.0 111.918 -177.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.1 p -80.39 -64.65 1.14 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.148 0.499 . . . . 1.0 110.241 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -162.26 159.43 21.03 Favored Pre-proline 0 C--O 1.238 0.49 0 CA-C-N 115.505 -0.771 . . . . 1.0 111.671 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -73.34 168.21 25.35 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.566 2.844 . . . . 1.0 113.036 178.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.835 HD12 ' HZ3' ' A' ' 152' ' ' TRP . 0.2 OUTLIER -69.19 -179.36 1.55 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.659 -0.7 . . . . 1.0 109.831 177.973 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.664 ' H ' HD13 ' A' ' 5' ' ' LEU . 2.5 t-160 -158.45 89.73 0.99 Allowed 'General case' 0 C--N 1.326 -0.444 0 O-C-N 122.145 -0.347 . . . . 1.0 110.066 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.49 HG12 HD11 ' A' ' 85' ' ' LEU . 1.8 t -95.61 109.07 21.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.87 -0.419 . . . . 1.0 109.87 178.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.622 ' CG2' ' HG ' ' A' ' 86' ' ' LEU . 10.5 t -112.89 118.84 36.02 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 120.896 0.379 . . . . 1.0 110.043 177.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.575 ' HD1' ' HB ' ' A' ' 87' ' ' VAL . 1.3 m-85 -86.65 131.27 34.2 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 116.465 -0.334 . . . . 1.0 110.784 -178.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.622 HG22 HD11 ' A' ' 97' ' ' LEU . 21.3 t -115.49 109.61 28.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.852 -0.613 . . . . 1.0 110.964 -177.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.624 ' HB2' HD22 ' A' ' 89' ' ' LEU . 49.8 t -142.38 163.55 32.55 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.587 -0.523 . . . . 1.0 109.587 179.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.564 HG23 ' HE2' ' A' ' 93' ' ' HIS . 0.7 OUTLIER -75.13 100.6 4.3 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.017 0.437 . . . . 1.0 110.89 -179.054 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.836 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 125.0 -44.78 1.22 Allowed Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.935 -0.65 . . . . 1.0 111.831 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 65.7 11.82 7.83 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.278 0.631 . . . . 1.0 111.348 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.422 ' HA ' ' HG3' ' A' ' 19' ' ' PRO . 10.0 pt -120.57 8.74 6.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 O-C-N 121.736 -0.603 . . . . 1.0 111.738 -177.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.544 ' O ' ' HG3' ' A' ' 20' ' ' MET . 6.8 p -126.1 -86.56 0.61 Allowed 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.034 0.383 . . . . 1.0 112.034 -178.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.657 ' HD3' HG12 ' A' ' 138' ' ' VAL . 16.6 tpp180 -66.31 -48.53 70.04 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.981 0.42 . . . . 1.0 111.554 -176.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.614 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 14.2 m -56.55 -57.06 25.86 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 115.667 -0.697 . . . . 1.0 112.8 -178.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.687 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 39.0 Cg_endo -64.26 -27.54 64.0 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 121.806 1.67 . . . . 1.0 112.355 -177.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.619 ' HA ' HD23 ' A' ' 62' ' ' LEU . 66.1 mtp -62.43 -53.53 53.5 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.316 -0.554 . . . . 1.0 110.55 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.456 ' HA ' ' HB2' ' A' ' 24' ' ' MET . . . -70.59 -30.44 67.12 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.588 -0.445 . . . . 1.0 110.526 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.515 ' O ' ' HB1' ' A' ' 26' ' ' ALA . 14.7 tt0 -52.15 -51.79 55.79 Favored 'General case' 0 C--O 1.214 -0.777 0 CA-C-N 115.49 -0.777 . . . . 1.0 109.623 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.902 ' HE3' ' HB2' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -88.49 -21.28 24.25 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 119.674 -0.81 . . . . 1.0 111.228 -176.702 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.53 ' HE3' HD11 ' A' ' 146' ' ' LEU . 83.1 mtp -65.8 -74.47 0.11 Allowed 'General case' 0 C--O 1.237 0.418 0 N-CA-C 112.37 0.508 . . . . 1.0 112.37 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.702 ' HB3' HD23 ' A' ' 146' ' ' LEU . 17.0 p90 -76.17 -30.52 58.13 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 119.707 -0.797 . . . . 1.0 111.481 -175.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.515 ' HB1' ' O ' ' A' ' 22' ' ' GLU . . . -65.11 -35.8 82.26 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 119.17 -1.012 . . . . 1.0 110.893 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.716 ' HA ' ' HD3' ' A' ' 30' ' ' ARG . 0.1 OUTLIER -63.07 -39.34 94.42 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 108.454 -0.943 . . . . 1.0 108.454 177.21 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.616 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 78.9 mt-30 -58.68 -45.81 88.62 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.647 -0.706 . . . . 1.0 109.879 175.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 25' ' ' PHE . 96.7 mt -55.42 -58.85 6.02 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.502 -0.772 . . . . 1.0 110.978 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.716 ' HD3' ' HA ' ' A' ' 27' ' ' GLN . 0.4 OUTLIER -59.24 -36.24 75.11 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.49 -0.484 . . . . 1.0 111.258 179.125 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -63.35 -26.12 68.61 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.581 0.586 . . . . 1.0 112.581 177.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.63 ' HG3' ' HG ' ' A' ' 34' ' ' LEU . 8.3 ptp180 -95.54 -16.9 21.85 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 119.568 -0.853 . . . . 1.0 109.805 177.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 105.56 23.36 7.59 Favored Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 114.99 -1.004 . . . . 1.0 112.053 176.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.63 ' HG ' ' HG3' ' A' ' 32' ' ' ARG . 24.5 mt -111.69 1.5 16.75 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.172 -0.307 . . . . 1.0 110.172 -177.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -54.55 -26.03 37.07 Favored Glycine 0 CA--C 1.522 0.472 0 C-N-CA 121.115 -0.564 . . . . 1.0 113.2 -178.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.598 ' HA ' ' NH1' ' A' ' 39' ' ' ARG . 0.5 OUTLIER -95.98 -22.83 17.15 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 109.467 -0.568 . . . . 1.0 109.467 177.533 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -76.97 -23.28 52.33 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.903 -1.044 . . . . 1.0 111.002 -175.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.819 HG23 ' HB3' ' A' ' 5' ' ' LEU . 0.2 OUTLIER -143.38 122.59 8.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.733 -0.667 . . . . 1.0 109.334 177.911 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.598 ' NH1' ' HA ' ' A' ' 36' ' ' ASP . 30.2 mmt180 -87.18 143.33 27.34 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 109.201 -0.666 . . . . 1.0 109.201 -178.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.432 HG13 ' HB2' ' A' ' 26' ' ' ALA . 54.2 t -131.82 131.53 61.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 109.497 -0.557 . . . . 1.0 109.497 -178.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.501 ' O ' ' HA ' ' A' ' 8' ' ' THR . 43.2 p -145.95 -175.74 4.87 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.344 -0.844 . . . . 1.0 109.972 -174.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.614 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 90.6 p -161.7 166.04 27.24 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.799 -0.36 . . . . 1.0 110.52 178.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.613 ' HB2' ' CD2' ' A' ' 80' ' ' HIS . . . -165.52 169.0 15.97 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.398 0.618 . . . . 1.0 111.543 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -127.24 132.3 7.51 Favored Glycine 0 N--CA 1.44 -1.09 0 CA-C-N 114.924 -1.034 . . . . 1.0 110.937 177.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.566 HG21 HD11 ' A' ' 96' ' ' LEU . 17.8 p -67.75 -26.86 66.34 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.912 0.386 . . . . 1.0 111.707 -177.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -107.25 9.47 39.02 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.847 -0.692 . . . . 1.0 113.207 -177.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 43.5 38.17 1.73 Allowed 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 113.719 1.007 . . . . 1.0 113.719 176.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.836 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 1.1 m-90 -47.07 -74.21 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.514 0.674 . . . . 1.0 112.438 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.531 ' O ' ' HB1' ' A' ' 73' ' ' ALA . 3.8 m-70 -105.54 39.84 1.67 Allowed 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.184 -0.916 . . . . 1.0 111.16 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.8 p -60.17 127.19 19.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 120.377 -0.529 . . . . 1.0 110.068 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.602 ' HA2' ' NE ' ' A' ' 72' ' ' ARG . . . 93.47 -14.28 65.64 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.913 -0.661 . . . . 1.0 111.961 -177.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.514 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 3.1 t -81.4 -158.18 0.21 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.232 0.539 . . . . 1.0 110.034 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 18.7 t -133.28 175.29 9.53 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 115.676 -0.693 . . . . 1.0 109.153 -178.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.96 141.93 43.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.25 0.548 . . . . 1.0 111.85 -178.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.455 ' CG ' ' HG3' ' A' ' 57' ' ' ARG . 56.6 t0 -56.06 129.82 41.47 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.019 -0.991 . . . . 1.0 110.06 178.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -51.51 -29.69 17.58 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.103 0.779 . . . . 1.0 113.103 -179.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.59 ' O ' HG23 ' A' ' 61' ' ' VAL . 0.2 OUTLIER -74.03 -41.89 61.13 Favored 'General case' 0 N--CA 1.461 0.122 0 C-N-CA 120.261 -0.576 . . . . 1.0 110.412 178.602 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.43 -32.41 70.0 Favored 'General case' 0 N--CA 1.46 0.07 0 CA-C-O 120.918 0.39 . . . . 1.0 110.051 178.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.37 -42.42 98.68 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.762 -0.653 . . . . 1.0 110.025 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.43 ' O ' ' HG2' ' A' ' 63' ' ' ARG . . . -64.27 -40.4 97.89 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.563 -0.827 . . . . 1.0 111.217 178.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.59 HG23 ' O ' ' A' ' 57' ' ' ARG . 59.0 t -57.38 -57.47 9.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.091 0.472 . . . . 1.0 110.762 177.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.619 HD23 ' HA ' ' A' ' 20' ' ' MET . 5.7 mp -59.28 -52.28 66.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.972 -0.558 . . . . 1.0 111.109 -178.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 60' ' ' GLY . 5.9 ptm180 -60.08 -26.91 66.55 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.729 -0.669 . . . . 1.0 111.338 -178.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.54 -36.54 73.74 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.124 0.488 . . . . 1.0 110.379 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -93.15 3.82 55.04 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.577 -0.738 . . . . 1.0 111.019 -178.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.35 13.69 63.19 Favored Glycine 0 C--N 1.329 0.178 0 CA-C-N 115.735 -0.666 . . . . 1.0 112.593 176.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.466 ' CD1' ' HA ' ' A' ' 24' ' ' MET . 60.5 m-85 -90.03 147.48 37.3 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 110.258 -0.275 . . . . 1.0 110.258 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.469 ' HG2' ' CB ' ' A' ' 23' ' ' LYS . 56.8 Cg_endo -69.44 159.87 51.99 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.45 2.1 . . . . 1.0 110.572 177.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.0 p -130.38 12.69 5.5 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.541 0.686 . . . . 1.0 109.928 -178.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -70.94 114.35 8.91 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 114.725 -1.125 . . . . 1.0 109.994 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.902 ' HB2' ' HE3' ' A' ' 23' ' ' LYS . 62.5 t60 -160.48 149.83 17.35 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.928 0.394 . . . . 1.0 111.202 -176.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.602 ' NE ' ' HA2' ' A' ' 51' ' ' GLY . 1.4 tmt_? -135.61 112.36 10.13 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.684 -1.228 . . . . 1.0 107.684 175.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.531 ' HB1' ' O ' ' A' ' 49' ' ' HIS . . . -59.71 138.98 57.6 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.895 -1.048 . . . . 1.0 112.724 -174.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -130.06 160.62 33.17 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.249 -0.887 . . . . 1.0 110.354 178.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -97.31 155.16 17.0 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.43 -0.952 . . . . 1.0 108.43 178.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.48 HG11 HD21 ' A' ' 97' ' ' LEU . 19.1 t -68.42 112.59 3.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 120.938 0.399 . . . . 1.0 110.607 -178.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.437 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -122.97 -170.23 13.46 Favored Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 115.373 -0.831 . . . . 1.0 111.5 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 98.2 m -56.45 -44.15 80.22 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 122.388 0.275 . . . . 1.0 111.214 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -59.23 -29.71 67.73 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.972 0.415 . . . . 1.0 111.227 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.613 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 80.1 m80 -78.21 -41.66 33.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.161 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.723 ' HA ' HD21 ' A' ' 86' ' ' LEU . 15.6 mt -68.39 -17.41 64.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.255 0.55 . . . . 1.0 110.669 177.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.61 -4.5 59.18 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 116.167 -0.47 . . . . 1.0 110.539 -178.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.553 ' HB2' ' O ' ' A' ' 6' ' ' HIS . . . -63.41 160.0 17.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.99 -0.55 . . . . 1.0 111.049 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.744 ' HB3' HD13 ' A' ' 5' ' ' LEU . 15.5 t70 -85.29 -13.16 50.56 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.517 -0.549 . . . . 1.0 109.517 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.733 HD12 ' CE3' ' A' ' 152' ' ' TRP . 1.1 tt -157.73 112.2 2.63 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.746 -0.661 . . . . 1.0 109.6 -177.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.723 HD21 ' HA ' ' A' ' 81' ' ' LEU . 5.6 mp -103.84 89.18 3.23 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-N 115.396 -0.82 . . . . 1.0 110.832 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.629 HG21 HD23 ' A' ' 85' ' ' LEU . 54.0 t -66.22 91.34 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 113.816 -1.538 . . . . 1.0 112.05 -179.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.06 147.74 31.34 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.245 -1.343 . . . . 1.0 109.693 177.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.624 HD22 ' HB2' ' A' ' 11' ' ' CYS . 3.7 mm? -100.86 -10.86 20.3 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.308 0.575 . . . . 1.0 109.618 177.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -141.56 151.52 43.28 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.214 -0.903 . . . . 1.0 110.087 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.556 ' HB3' ' O ' ' A' ' 122' ' ' LEU . 11.6 ptm180 -65.07 -17.35 64.38 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 123.477 0.485 . . . . 1.0 110.089 176.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.633 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 5.3 m-20 -77.83 -50.04 13.09 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.668 -0.697 . . . . 1.0 109.817 178.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.671 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 16.3 m170 -59.26 -42.95 92.39 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.561 -0.533 . . . . 1.0 109.561 178.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.68 -44.48 93.6 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.559 178.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.601 ' O ' ' HG2' ' A' ' 99' ' ' GLN . 0.5 OUTLIER -56.66 -45.26 81.77 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 115.818 -0.628 . . . . 1.0 111.015 178.356 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.683 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 50.9 mt -64.39 -48.3 75.97 Favored 'General case' 0 C--O 1.216 -0.68 0 CA-C-N 115.944 -0.571 . . . . 1.0 110.425 -175.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.671 ' HG ' ' O ' ' A' ' 93' ' ' HIS . 33.2 mt -53.0 -60.16 3.63 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.898 -0.592 . . . . 1.0 111.474 -178.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.706 ' N ' HG12 ' A' ' 102' ' ' VAL . 1.2 ptm180 -59.26 -45.16 91.96 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.843 -0.617 . . . . 1.0 112.381 -179.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.601 ' HG2' ' O ' ' A' ' 95' ' ' ARG . 6.2 pt20 -66.74 -24.69 66.25 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 119.956 -0.698 . . . . 1.0 110.194 178.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.683 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 10.1 mt -80.7 -18.84 46.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.031 -0.531 . . . . 1.0 111.592 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 151.99 -21.27 0.88 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 119.748 -1.215 . . . . 1.0 114.44 -178.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.706 HG12 ' N ' ' A' ' 98' ' ' ARG . 0.3 OUTLIER -76.82 -162.36 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 118.113 0.956 . . . . 1.0 110.662 -179.492 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.764 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 12.3 pt-20 -157.3 160.32 38.43 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 107.703 -1.221 . . . . 1.0 107.703 -179.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.77 ' HA ' HG11 ' A' ' 107' ' ' VAL . . . -61.04 -26.13 67.41 Favored 'General case' 0 C--N 1.322 -0.601 0 O-C-N 123.366 0.416 . . . . 1.0 111.32 -175.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.43 ' HB2' ' HG3' ' A' ' 103' ' ' GLU . . . -57.06 -36.42 70.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.15 0.5 . . . . 1.0 110.533 175.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.764 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 7.9 mtt-85 -98.46 -42.37 7.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.237 -0.892 . . . . 1.0 111.194 -177.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.77 HG11 ' HA ' ' A' ' 104' ' ' ALA . 14.6 p -77.96 115.44 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 120.614 -0.435 . . . . 1.0 110.085 -175.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.612 ' HD2' ' O ' ' A' ' 107' ' ' VAL . 26.9 mmm180 -136.13 148.71 48.35 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 121.68 -0.637 . . . . 1.0 110.7 -178.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.423 ' HE1' ' C ' ' A' ' 89' ' ' LEU . 83.2 mmm -78.92 137.52 37.67 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.615 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.62 HD22 HG12 ' A' ' 87' ' ' VAL . 2.8 tm? -56.02 -52.68 63.36 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 122.455 0.302 . . . . 1.0 111.532 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 25.6 ttt85 -71.22 -16.83 62.52 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.586 -0.445 . . . . 1.0 111.222 -176.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 41.7 t -73.56 -7.63 52.68 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 120.585 -0.446 . . . . 1.0 110.703 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.636 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 83.3 m-85 -87.31 -21.74 25.55 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-O 120.664 0.269 . . . . 1.0 110.765 176.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -57.69 117.91 22.2 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.948 -0.569 . . . . 1.0 111.433 -177.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.71 -16.59 46.71 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.725 2.284 . . . . 1.0 111.24 178.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 37.8 mtp180 -86.06 -19.24 30.55 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.367 -0.833 . . . . 1.0 110.482 178.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 28.1 m -74.01 86.39 1.82 Allowed 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.419 -0.355 . . . . 1.0 111.467 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -57.26 -42.34 93.41 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.409 -0.9 . . . . 1.0 112.354 176.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.43 161.66 20.23 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.824 0.345 . . . . 1.0 110.415 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 38.7 m170 -77.38 131.85 38.26 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.47 -0.332 . . . . 1.0 110.409 178.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -101.64 90.57 4.08 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.034 -0.53 . . . . 1.0 111.038 -179.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.556 ' O ' ' HB3' ' A' ' 91' ' ' ARG . 2.7 mm? -96.69 13.02 29.79 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-N 116.523 -0.308 . . . . 1.0 110.933 178.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -169.1 143.09 2.94 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-O 121.215 0.531 . . . . 1.0 111.264 178.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 44.2 t -125.7 154.24 34.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 114.829 -1.078 . . . . 1.0 108.119 178.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.413 ' H ' ' HG3' ' A' ' 125' ' ' GLU . 0.4 OUTLIER -87.39 -163.18 0.89 Allowed 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.859 -0.61 . . . . 1.0 111.458 -177.455 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -162.55 98.97 1.1 Allowed Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 106.967 -1.494 . . . . 1.0 106.967 -178.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.527 ' HG2' ' CG2' ' A' ' 138' ' ' VAL . 23.2 Cg_exo -62.14 113.38 1.86 Allowed 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.881 2.387 . . . . 1.0 113.257 -174.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -99.99 -9.17 23.02 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.345 -0.843 . . . . 1.0 110.416 178.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.614 ' CD2' ' HB2' ' A' ' 134' ' ' ASP . 0.0 OUTLIER -69.68 -34.34 73.82 Favored 'General case' 0 CA--C 1.522 -0.121 0 N-CA-C 112.789 0.663 . . . . 1.0 112.789 -174.208 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 70.66 61.72 3.97 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.054 -1.069 . . . . 1.0 113.25 176.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.899 ' H ' ' HB3' ' A' ' 134' ' ' ASP . 21.9 t70 -121.95 169.47 10.78 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.204 -1.036 . . . . 1.0 108.204 176.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 18.9 t-160 -58.78 -43.28 90.37 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 108.678 -0.86 . . . . 1.0 108.678 174.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.448 ' O ' ' HB2' ' A' ' 137' ' ' GLU . 12.0 t -64.96 -36.74 85.36 Favored 'General case' 0 C--O 1.217 -0.63 0 CA-C-N 115.766 -0.652 . . . . 1.0 109.844 178.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.899 ' HB3' ' H ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -60.69 -43.6 97.54 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.063 -0.517 . . . . 1.0 111.382 -179.295 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.565 ' HD1' ' HE ' ' A' ' 57' ' ' ARG . 9.5 m-85 -69.7 -49.84 49.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.09 0.472 . . . . 1.0 110.634 -178.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -77.26 -15.04 59.63 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.013 -0.54 . . . . 1.0 111.277 -176.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.547 ' O ' HG22 ' A' ' 141' ' ' VAL . 11.1 tp10 -64.34 -48.3 76.08 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 108.073 -1.084 . . . . 1.0 108.073 174.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.657 HG12 ' HD3' ' A' ' 17' ' ' ARG . 57.4 t -56.52 -47.41 81.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 114.482 -1.235 . . . . 1.0 109.766 175.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.476 ' HB2' HG13 ' A' ' 61' ' ' VAL . 69.8 t80 -56.4 -44.12 79.98 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 113.858 -1.519 . . . . 1.0 110.147 178.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.687 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -63.42 -44.97 93.09 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.208 -0.451 . . . . 1.0 111.761 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.547 HG22 ' O ' ' A' ' 137' ' ' GLU . 36.3 t -55.43 -46.59 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.706 0.765 . . . . 1.0 110.005 178.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.448 HD13 ' O ' ' A' ' 138' ' ' VAL . 7.0 mt -69.51 -51.13 44.88 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 115.04 -0.982 . . . . 1.0 111.785 -178.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.687 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 6.2 pt-20 -56.14 -33.88 65.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.537 0.208 . . . . 1.0 110.665 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.8 t -73.33 -27.98 61.81 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.238 0.542 . . . . 1.0 110.124 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.474 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -86.69 -23.99 25.39 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-N 115.869 -0.605 . . . . 1.0 111.823 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.702 HD23 ' HB3' ' A' ' 25' ' ' PHE . 11.9 mt -55.16 -37.89 61.65 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 112.654 0.613 . . . . 1.0 112.654 -178.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 61.5 Cg_endo -70.65 -13.2 32.23 Favored 'Trans proline' 0 C--N 1.359 1.116 0 C-N-CA 122.649 2.232 . . . . 1.0 111.939 177.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.636 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -102.72 -32.35 4.81 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 110.099 -1.2 . . . . 1.0 110.099 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.508 ' O ' HG12 ' A' ' 153' ' ' VAL . 0.4 OUTLIER -73.73 -40.69 63.35 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.396 -0.964 . . . . 1.0 108.396 177.604 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.453 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -55.53 -54.7 40.76 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 114.81 -1.086 . . . . 1.0 110.135 175.667 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -58.94 -42.52 89.96 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.333 -0.849 . . . . 1.0 110.961 -175.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . 0.835 ' HZ3' HD12 ' A' ' 5' ' ' LEU . 23.6 t90 -63.02 -55.28 26.99 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.46 -0.791 . . . . 1.0 110.465 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.508 HG12 ' O ' ' A' ' 149' ' ' LEU . 10.7 m -62.7 -40.69 89.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.816 -0.354 . . . . 1.0 110.587 -177.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.484 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 4.1 m-20 -60.79 -50.93 71.46 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-O 120.838 0.351 . . . . 1.0 110.727 178.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.53 ' O ' ' HG3' ' A' ' 159' ' ' ARG . 6.8 pt-20 -64.11 -36.86 85.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.861 -178.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.498 ' HD2' ' HD2' ' A' ' 159' ' ' ARG . 10.4 mmt180 -73.56 -42.61 61.42 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 116.185 -0.461 . . . . 1.0 111.394 -178.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 4.3 pp -65.79 -24.8 67.01 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 109.27 -0.641 . . . . 1.0 109.27 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -73.34 -53.86 9.77 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.065 -0.97 . . . . 1.0 110.261 178.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.53 ' HG3' ' O ' ' A' ' 155' ' ' GLU . 0.0 OUTLIER -74.77 -9.68 58.79 Favored 'General case' 0 N--CA 1.462 0.143 0 N-CA-C 112.714 0.635 . . . . 1.0 112.714 -177.732 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -83.89 43.19 0.9 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.462 0.649 . . . . 1.0 110.51 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -123.06 155.06 17.21 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.723 -0.751 . . . . 1.0 112.036 175.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -87.3 -157.84 0.08 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 122.969 2.446 . . . . 1.0 112.272 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 25.1 m . . . . . 0 C--O 1.248 1.019 0 CA-C-N 114.776 -1.102 . . . . 1.0 111.606 -179.818 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.753 0 N-CA-C 111.793 -0.523 . . . . 1.0 111.793 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 mmt -87.2 64.56 8.41 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.907 0.353 . . . . 1.0 110.575 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.2 m -83.13 111.46 18.92 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.189 -0.46 . . . . 1.0 110.724 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.792 ' HB3' ' HD2' ' A' ' 4' ' ' PRO . 9.4 m-20 -69.24 166.65 27.26 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-O 121.035 0.445 . . . . 1.0 110.487 178.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.866 ' HG3' ' HE ' ' A' ' 39' ' ' ARG . 60.0 Cg_endo -72.22 170.05 20.07 Favored 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 123.26 2.64 . . . . 1.0 114.298 -178.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.852 ' HB3' HG22 ' A' ' 38' ' ' VAL . 0.8 OUTLIER -74.8 -173.31 1.82 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.05 -0.977 . . . . 1.0 110.836 178.146 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.472 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 0.2 OUTLIER -159.15 94.59 1.21 Allowed 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 121.087 -0.245 . . . . 1.0 111.448 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.743 HG13 HD11 ' A' ' 85' ' ' LEU . 2.2 t -95.94 113.48 30.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 108.893 -0.781 . . . . 1.0 108.893 175.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.612 ' CG2' ' HG ' ' A' ' 86' ' ' LEU . 14.5 t -114.15 115.26 27.22 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 120.992 0.425 . . . . 1.0 110.108 178.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.546 ' HD1' ' HB ' ' A' ' 87' ' ' VAL . 2.0 m-85 -81.81 146.77 29.72 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 109.56 -0.533 . . . . 1.0 109.56 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.632 HG21 HD12 ' A' ' 97' ' ' LEU . 42.5 t -130.42 114.0 27.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 121.059 0.457 . . . . 1.0 111.63 -177.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.609 ' SG ' ' HD2' ' A' ' 17' ' ' ARG . 47.9 t -143.93 161.25 39.19 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.821 -0.807 . . . . 1.0 108.821 177.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.88 97.07 3.23 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.269 0.556 . . . . 1.0 111.182 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.668 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 130.96 -44.74 1.18 Allowed Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.457 -0.792 . . . . 1.0 111.249 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.598 ' ND2' ' H ' ' A' ' 74' ' ' ALA . 58.6 t30 59.8 29.16 18.73 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.829 0.824 . . . . 1.0 111.179 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.3 pt -130.91 10.67 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.963 -0.562 . . . . 1.0 111.675 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.662 ' O ' ' HG3' ' A' ' 20' ' ' MET . 12.3 m -125.54 -89.64 0.57 Allowed 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.089 -0.644 . . . . 1.0 111.609 -178.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.813 HH22 ' HD3' ' A' ' 127' ' ' PRO . 1.9 ptp85 -74.27 -35.85 63.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.065 -0.516 . . . . 1.0 112.364 -176.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.513 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 16.5 m -58.99 -58.83 16.58 Favored Pre-proline 0 CA--C 1.541 0.602 0 C-N-CA 121.26 -0.176 . . . . 1.0 111.105 179.026 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.733 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 36.6 Cg_endo -61.93 -26.66 79.11 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.051 1.834 . . . . 1.0 111.937 178.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.662 ' HG3' ' O ' ' A' ' 16' ' ' CYS . 63.8 mtp -62.43 -54.57 38.22 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.847 -0.341 . . . . 1.0 111.106 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.405 ' HA ' ' HB2' ' A' ' 24' ' ' MET . . . -70.1 -28.5 65.45 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 120.452 -0.499 . . . . 1.0 109.666 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.605 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 7.4 tt0 -54.32 -51.9 63.24 Favored 'General case' 0 C--O 1.216 -0.672 0 CA-C-N 115.029 -0.987 . . . . 1.0 109.236 178.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.747 ' HB3' ' HG2' ' A' ' 68' ' ' PRO . 0.0 OUTLIER -80.36 -29.9 37.95 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.758 -0.655 . . . . 1.0 110.212 -176.846 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.554 ' HB3' HD12 ' A' ' 146' ' ' LEU . 3.1 mmm -63.33 -76.12 0.07 Allowed 'General case' 0 C--O 1.238 0.458 0 N-CA-C 113.058 0.762 . . . . 1.0 113.058 -176.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.66 ' HB3' HD23 ' A' ' 146' ' ' LEU . 22.6 p90 -76.76 -29.72 56.22 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 119.859 -0.736 . . . . 1.0 111.268 -174.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.605 ' HB3' ' O ' ' A' ' 22' ' ' GLU . . . -65.25 -37.82 88.43 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 119.036 -1.066 . . . . 1.0 111.134 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.646 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -63.2 -40.04 96.34 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.56 -0.904 . . . . 1.0 108.56 177.854 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.584 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 79.1 mt-30 -57.49 -47.71 81.19 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 115.608 -0.724 . . . . 1.0 110.082 176.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.517 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 93.3 mt -53.09 -59.55 4.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.69 -0.686 . . . . 1.0 111.06 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.591 ' HD3' ' HA ' ' A' ' 27' ' ' GLN . 0.1 OUTLIER -59.5 -37.25 77.81 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.484 -0.486 . . . . 1.0 111.275 178.955 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -63.9 -21.32 66.41 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.873 0.694 . . . . 1.0 112.873 178.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.517 ' HG2' ' O ' ' A' ' 29' ' ' LEU . 7.6 ptp180 -99.29 -21.54 16.01 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 119.677 -0.809 . . . . 1.0 110.037 176.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 107.34 42.35 1.51 Allowed Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 115.202 -0.908 . . . . 1.0 111.99 178.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.42 HD12 ' HG3' ' A' ' 32' ' ' ARG . 23.8 mt -135.83 -5.11 2.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.704 0.288 . . . . 1.0 110.372 -178.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.72 -25.19 58.4 Favored Glycine 0 C--N 1.329 0.168 0 C-N-CA 121.361 -0.447 . . . . 1.0 112.619 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.434 ' O ' ' HB3' ' A' ' 4' ' ' PRO . 49.3 m-20 -85.01 -28.92 25.4 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.28 0.562 . . . . 1.0 109.885 177.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.58 -18.56 51.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.09 -0.959 . . . . 1.0 112.015 -177.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.852 HG22 ' HB3' ' A' ' 5' ' ' LEU . 0.8 OUTLIER -144.85 122.85 5.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.255 0.55 . . . . 1.0 110.137 179.133 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.866 ' HE ' ' HG3' ' A' ' 4' ' ' PRO . 9.9 mmt180 -89.16 145.45 25.42 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.802 -0.636 . . . . 1.0 110.071 -178.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 77.5 t -132.55 118.88 36.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.439 0.638 . . . . 1.0 109.869 -178.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' A' ' 8' ' ' THR . 36.7 p -132.87 -174.42 3.47 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 114.279 -1.328 . . . . 1.0 111.365 -175.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.513 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 63.9 p -159.63 161.22 34.99 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.509 -178.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.647 ' HB1' ' CD2' ' A' ' 80' ' ' HIS . . . -162.38 163.09 27.99 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.294 0.569 . . . . 1.0 111.627 -178.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -123.73 131.77 8.17 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 110.863 -0.895 . . . . 1.0 110.863 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.582 HG23 ' CG1' ' A' ' 10' ' ' VAL . 18.0 p -67.72 -26.92 66.39 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.036 0.384 . . . . 1.0 112.036 -177.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -107.26 9.07 38.75 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.73 -0.748 . . . . 1.0 112.904 -177.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 41.02 41.93 1.41 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.834 0.854 . . . . 1.0 113.288 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.668 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 0.9 OUTLIER -50.34 -77.64 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.154 0.502 . . . . 1.0 112.013 179.009 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.416 ' O ' ' HB2' ' A' ' 73' ' ' ALA . 15.8 m-70 -101.97 41.12 1.24 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.907 -0.588 . . . . 1.0 110.919 -179.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.2 p -61.56 127.43 21.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.13 0.491 . . . . 1.0 110.105 178.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.766 ' HA2' ' HD3' ' A' ' 72' ' ' ARG . . . 97.02 -15.43 62.56 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.679 -0.691 . . . . 1.0 112.107 -177.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.0 t -80.27 -159.02 0.2 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.367 0.603 . . . . 1.0 109.926 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 31.7 t -132.91 173.08 11.77 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.359 -0.837 . . . . 1.0 109.01 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.91 139.95 32.23 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.982 0.42 . . . . 1.0 111.3 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.629 ' OD1' ' HG2' ' A' ' 57' ' ' ARG . 11.7 t70 -60.9 139.14 58.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.425 -0.807 . . . . 1.0 110.374 -178.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -48.21 -33.95 9.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.409 -0.814 . . . . 1.0 112.861 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.717 ' HB2' ' CD2' ' A' ' 135' ' ' PHE . 18.8 ptp180 -70.96 -46.07 63.03 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 122.26 -0.275 . . . . 1.0 110.589 -177.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.47 -32.84 68.75 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 116.086 -0.506 . . . . 1.0 109.743 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.99 -46.88 88.96 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.191 -0.67 . . . . 1.0 109.191 176.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.455 ' HA2' ' HD3' ' A' ' 63' ' ' ARG . . . -61.05 -39.69 97.44 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.818 -0.706 . . . . 1.0 111.574 177.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.565 HG22 ' O ' ' A' ' 57' ' ' ARG . 93.3 t -60.55 -60.31 2.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.803 0.335 . . . . 1.0 111.214 177.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.753 ' HB2' HG22 ' A' ' 69' ' ' THR . 81.8 mt -58.17 -51.79 68.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.211 -0.45 . . . . 1.0 111.526 -176.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.455 ' HD3' ' HA2' ' A' ' 60' ' ' GLY . 6.9 ptm180 -59.17 -29.15 67.25 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.315 -0.402 . . . . 1.0 111.191 -179.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.57 -30.63 61.79 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.343 0.592 . . . . 1.0 110.904 -179.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -95.06 3.97 54.25 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.854 -0.612 . . . . 1.0 110.668 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.09 10.61 60.94 Favored Glycine 0 C--N 1.331 0.264 0 CA-C-N 115.694 -0.685 . . . . 1.0 113.312 175.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.406 ' CD1' ' HA ' ' A' ' 24' ' ' MET . 66.5 m-85 -92.08 152.33 42.63 Favored Pre-proline 0 C--N 1.316 -0.871 0 CA-C-O 120.61 0.243 . . . . 1.0 111.543 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.747 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 33.0 Cg_endo -68.07 156.94 63.92 Favored 'Trans proline' 0 CA--C 1.514 -0.496 0 C-N-CA 122.515 2.144 . . . . 1.0 110.737 175.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.753 HG22 ' HB2' ' A' ' 62' ' ' LEU . 63.3 p -132.55 7.89 4.19 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 120.102 -0.639 . . . . 1.0 112.485 -176.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -90.5 133.09 35.29 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.008 0.432 . . . . 1.0 110.851 -178.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.434 ' HB2' ' HE3' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -173.03 150.71 2.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.41 -0.814 . . . . 1.0 109.207 -176.749 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.766 ' HD3' ' HA2' ' A' ' 51' ' ' GLY . 4.1 tmm_? -120.79 115.33 23.07 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.169 -1.049 . . . . 1.0 108.169 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.416 ' HB2' ' O ' ' A' ' 49' ' ' HIS . . . -58.03 137.08 57.16 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.462 0.648 . . . . 1.0 112.307 -175.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.598 ' H ' ' ND2' ' A' ' 14' ' ' ASN . . . -127.81 158.29 38.1 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.41 -0.813 . . . . 1.0 109.913 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -94.89 155.92 16.57 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.916 -0.772 . . . . 1.0 108.916 177.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.524 HG13 ' CD2' ' A' ' 97' ' ' LEU . 22.0 t -67.46 112.56 2.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.236 0.541 . . . . 1.0 110.09 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.545 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -126.24 -167.19 12.39 Favored Glycine 0 N--CA 1.438 -1.178 0 CA-C-N 115.445 -0.798 . . . . 1.0 111.38 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 54.4 m -55.42 -51.68 66.08 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 122.574 0.35 . . . . 1.0 111.931 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.485 ' HG2' ' N ' ' A' ' 80' ' ' HIS . 1.1 pm0 -57.2 -31.92 65.94 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.655 -0.702 . . . . 1.0 111.008 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.647 ' CD2' ' HB1' ' A' ' 43' ' ' ALA . 78.3 m80 -76.74 -41.86 43.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.034 179.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 24.4 mt -67.41 -19.26 65.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.939 -0.573 . . . . 1.0 110.992 177.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -87.38 -6.09 58.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.933 -0.576 . . . . 1.0 111.209 -178.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.472 ' HB2' ' O ' ' A' ' 6' ' ' HIS . . . -59.93 152.96 22.26 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.852 -0.613 . . . . 1.0 111.275 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -76.86 -17.48 58.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.102 0.477 . . . . 1.0 109.965 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.743 HD11 HG13 ' A' ' 7' ' ' VAL . 0.3 OUTLIER -153.26 116.42 4.6 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-N 115.604 -0.725 . . . . 1.0 109.443 -176.722 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.632 HD23 HG21 ' A' ' 102' ' ' VAL . 5.1 mp -106.72 107.3 18.25 Favored 'General case' 0 N--CA 1.422 -1.856 0 CA-C-N 115.774 -0.648 . . . . 1.0 110.01 177.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.546 ' HB ' ' HD1' ' A' ' 9' ' ' PHE . 51.5 t -85.49 93.3 3.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 114.994 -1.003 . . . . 1.0 110.934 -176.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.23 145.78 32.06 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.628 -0.714 . . . . 1.0 110.432 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.492 ' HG ' ' HD3' ' A' ' 17' ' ' ARG . 3.9 mm? -96.67 -12.44 23.84 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.208 0.528 . . . . 1.0 110.604 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.482 ' CG ' ' H ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -151.54 157.66 42.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.625 -0.716 . . . . 1.0 111.193 179.523 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -53.5 -29.68 37.44 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 113.467 0.914 . . . . 1.0 113.467 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.628 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 2.2 m120 -76.59 -48.37 19.43 Favored 'General case' 0 CA--C 1.512 -0.486 0 C-N-CA 120.364 -0.534 . . . . 1.0 110.864 -177.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.696 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 15.7 m170 -56.04 -46.36 78.91 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.838 -0.43 . . . . 1.0 109.838 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.45 -43.13 93.24 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.803 0.335 . . . . 1.0 110.794 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.431 ' O ' ' HG2' ' A' ' 98' ' ' ARG . 13.1 ttt180 -59.76 -44.64 93.76 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 115.845 -0.616 . . . . 1.0 111.629 179.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.742 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 58.5 mt -64.03 -48.98 74.2 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.169 -0.468 . . . . 1.0 110.083 -176.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.696 ' HG ' ' O ' ' A' ' 93' ' ' HIS . 32.7 mt -52.7 -57.12 11.15 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.845 -0.616 . . . . 1.0 111.22 -179.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.526 ' HA ' ' HB ' ' A' ' 102' ' ' VAL . 12.9 ptt180 -61.26 -41.31 96.71 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.216 -0.447 . . . . 1.0 111.832 -176.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.649 ' HG3' ' O ' ' A' ' 96' ' ' LEU . 1.1 pp0? -69.12 -25.32 64.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.993 0.425 . . . . 1.0 110.359 178.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.742 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 14.2 mt -78.53 -13.65 59.73 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.987 -0.551 . . . . 1.0 112.315 -179.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 148.59 -22.73 1.34 Allowed Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 119.995 -1.097 . . . . 1.0 112.935 -178.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.926 HG13 ' H ' ' A' ' 103' ' ' GLU . 3.3 t -76.24 -156.98 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 109.687 -0.486 . . . . 1.0 109.687 178.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.926 ' H ' HG13 ' A' ' 102' ' ' VAL . 16.8 pt-20 -171.18 168.08 6.87 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 107.66 -1.237 . . . . 1.0 107.66 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.725 ' HA ' HG11 ' A' ' 107' ' ' VAL . . . -66.45 -23.93 66.36 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.992 -0.283 . . . . 1.0 111.572 -174.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.04 -37.78 72.25 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.246 0.546 . . . . 1.0 110.509 176.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.741 ' HD2' HG12 ' A' ' 102' ' ' VAL . 15.1 mtt180 -96.11 -45.17 6.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.778 -1.101 . . . . 1.0 110.935 -176.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.725 HG11 ' HA ' ' A' ' 104' ' ' ALA . 8.0 p -79.46 124.78 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-O 121.572 0.701 . . . . 1.0 110.702 -177.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.543 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 21.2 mmm180 -140.52 146.69 38.46 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 -179.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.665 ' HE3' HG23 ' A' ' 124' ' ' VAL . 82.1 mmm -78.86 137.84 37.86 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.762 -0.654 . . . . 1.0 110.369 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.505 HD22 HG11 ' A' ' 87' ' ' VAL . 3.1 tm? -56.31 -48.7 76.16 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.077 0.465 . . . . 1.0 111.268 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.887 ' HB2' HG11 ' A' ' 124' ' ' VAL . 65.0 ttt180 -69.6 -20.59 63.62 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.98 -0.554 . . . . 1.0 110.303 -177.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.498 ' HB2' ' HB2' ' A' ' 109' ' ' MET . 36.1 t -76.15 -5.41 46.56 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.62 -0.718 . . . . 1.0 110.913 -177.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.55 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 86.9 m-85 -90.68 -22.77 20.98 Favored 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 122.172 -0.33 . . . . 1.0 110.237 175.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -61.0 119.39 44.73 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.733 -0.667 . . . . 1.0 110.263 -177.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -67.57 -17.26 48.3 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.669 2.246 . . . . 1.0 112.162 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 10.3 mmm180 -90.51 -22.61 21.25 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.718 -0.674 . . . . 1.0 110.814 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 36.2 t -75.25 64.49 1.47 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.001 -0.545 . . . . 1.0 112.377 -175.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 57.04 -102.14 0.19 Allowed Glycine 0 CA--C 1.52 0.373 0 C-N-CA 121.433 -0.413 . . . . 1.0 113.494 179.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 19.7 m -143.36 -40.04 0.31 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.027 0.442 . . . . 1.0 110.517 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -147.49 146.24 29.43 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 121.075 0.464 . . . . 1.0 110.38 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.438 ' HB2' ' HD3' ' A' ' 111' ' ' ARG . . . -131.42 106.05 8.0 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.672 -0.695 . . . . 1.0 110.663 -175.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -86.73 16.69 4.52 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.434 0.635 . . . . 1.0 110.61 177.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -169.06 136.69 1.89 Allowed 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 108.25 -1.019 . . . . 1.0 108.25 177.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.887 HG11 ' HB2' ' A' ' 111' ' ' ARG . 55.4 t -95.81 -86.92 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 113.392 0.886 . . . . 1.0 113.392 -173.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.553 ' OE1' HG21 ' A' ' 138' ' ' VAL . 9.8 pt-20 -137.59 172.78 12.45 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 115.051 -0.977 . . . . 1.0 111.363 -174.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 35.3 t70 178.03 121.98 0.19 Allowed Pre-proline 0 C--O 1.236 0.367 0 CA-C-N 115.216 -0.902 . . . . 1.0 109.086 177.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.813 ' HD3' HH22 ' A' ' 17' ' ' ARG . 19.7 Cg_endo -59.04 162.15 14.3 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 123.216 2.611 . . . . 1.0 113.216 -177.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.504 ' HD2' ' CD2' ' A' ' 129' ' ' TYR . 43.7 t80 -107.47 -28.3 9.9 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.948 -1.024 . . . . 1.0 110.174 -178.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.504 ' CD2' ' HD2' ' A' ' 128' ' ' TYR . 0.1 OUTLIER -142.19 -35.44 0.43 Allowed 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 111.98 0.363 . . . . 1.0 111.98 -179.705 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 94.18 68.3 1.06 Allowed Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.075 -1.06 . . . . 1.0 111.589 -178.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.649 ' H ' ' HB3' ' A' ' 134' ' ' ASP . 2.5 t70 -131.45 -170.68 2.43 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.471 -0.566 . . . . 1.0 109.471 -177.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.901 ' HA ' ' CZ ' ' A' ' 135' ' ' PHE . 4.4 t60 -58.63 -39.53 80.76 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 109.252 -0.647 . . . . 1.0 109.252 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 27.0 t -63.03 -33.51 75.59 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 114.994 -1.003 . . . . 1.0 111.066 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.649 ' HB3' ' H ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -65.16 -47.75 75.92 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 111.578 0.214 . . . . 1.0 111.578 -176.796 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.901 ' CZ ' ' HA ' ' A' ' 132' ' ' HIS . 6.7 p90 -75.98 -32.55 59.53 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 119.143 -1.023 . . . . 1.0 112.426 -175.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.433 ' HG3' ' CD2' ' A' ' 132' ' ' HIS . 1.6 mt-10 -77.06 -21.83 53.83 Favored 'General case' 0 C--N 1.312 -1.04 0 C-N-CA 120.144 -0.623 . . . . 1.0 109.853 175.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.418 ' O ' HG23 ' A' ' 141' ' ' VAL . 71.1 tt0 -67.8 -42.95 80.76 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 108.539 -0.911 . . . . 1.0 108.539 174.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.553 HG21 ' OE1' ' A' ' 125' ' ' GLU . 76.1 t -58.72 -44.34 89.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 114.514 -1.221 . . . . 1.0 109.583 176.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.49 ' HB2' ' HE2' ' A' ' 20' ' ' MET . 46.5 t80 -54.59 -43.41 72.11 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.444 -1.253 . . . . 1.0 110.257 177.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.429 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -63.9 -42.19 97.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.774 -0.648 . . . . 1.0 110.901 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 137' ' ' GLU . 31.2 t -57.7 -57.02 12.09 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 CA-C-O 121.384 0.611 . . . . 1.0 110.592 178.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.474 ' HA ' HD12 ' A' ' 110' ' ' LEU . 7.0 mt -57.7 -52.07 62.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.21 -0.904 . . . . 1.0 112.388 -177.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.491 ' HG3' ' N ' ' A' ' 144' ' ' SER . 2.2 pt-20 -56.34 -33.06 65.28 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.702 0.287 . . . . 1.0 110.536 -179.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.491 ' N ' ' HG3' ' A' ' 143' ' ' GLU . 4.0 t -73.52 -27.42 61.35 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.347 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.472 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -88.61 -22.34 23.54 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-N 115.914 -0.585 . . . . 1.0 111.86 179.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.66 HD23 ' HB3' ' A' ' 25' ' ' PHE . 12.5 mt -55.28 -37.31 55.37 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-O 119.212 -0.423 . . . . 1.0 112.117 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 43.3 Cg_endo -68.91 -12.17 33.74 Favored 'Trans proline' 0 C--N 1.365 1.409 0 C-N-CA 122.325 2.017 . . . . 1.0 111.943 176.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.55 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -104.51 -33.8 3.78 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 110.72 -0.952 . . . . 1.0 110.72 178.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.512 HD11 ' CE2' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -73.46 -39.62 64.79 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.348 -0.982 . . . . 1.0 108.348 178.93 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.51 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 0.2 OUTLIER -54.12 -55.01 31.76 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-N 115.136 -0.938 . . . . 1.0 110.628 175.347 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -56.29 -42.26 77.24 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.716 -1.129 . . . . 1.0 111.193 -175.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . 0.654 ' HZ3' HD21 ' A' ' 5' ' ' LEU . 22.1 t90 -64.97 -54.85 24.1 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.346 -0.843 . . . . 1.0 110.613 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.453 HG12 ' O ' ' A' ' 149' ' ' LEU . 6.4 m -62.21 -41.17 90.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 120.587 -0.445 . . . . 1.0 110.069 -178.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -60.19 -49.51 77.36 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-O 121.013 0.435 . . . . 1.0 110.792 178.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.529 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 11.8 pt-20 -63.61 -39.57 94.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.691 -0.686 . . . . 1.0 110.399 -178.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.508 ' HG3' ' CH2' ' A' ' 152' ' ' TRP . 15.6 mmt85 -74.59 -42.37 58.8 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.863 -0.608 . . . . 1.0 111.528 -175.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.409 HD12 ' C ' ' A' ' 157' ' ' LEU . 4.0 pp -67.45 -24.92 65.67 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.285 0.564 . . . . 1.0 109.576 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -73.42 -54.4 8.39 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.376 -0.829 . . . . 1.0 110.272 177.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.447 ' HG3' ' O ' ' A' ' 155' ' ' GLU . 0.1 OUTLIER -79.13 -1.15 34.71 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.902 -0.59 . . . . 1.0 111.907 -178.502 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -54.74 -45.17 74.1 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.828 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -164.34 -173.1 32.62 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 119.985 -1.103 . . . . 1.0 112.812 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -82.39 41.21 1.08 Allowed 'Trans proline' 0 N--CA 1.474 0.357 0 C-N-CA 124.002 3.134 . . . . 1.0 112.347 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 50.4 m . . . . . 0 C--N 1.314 -0.96 0 CA-C-N 114.292 -1.322 . . . . 1.0 110.016 -179.25 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.675 0 N-CA-C 111.615 -0.594 . . . . 1.0 111.615 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.2 mtt -82.16 131.39 35.24 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.934 0.367 . . . . 1.0 110.21 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.6 p -166.67 169.81 13.16 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.857 -0.611 . . . . 1.0 110.879 -178.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -163.32 149.7 10.12 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 115.343 -0.844 . . . . 1.0 109.415 176.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.624 ' HB2' ' HG2' ' A' ' 39' ' ' ARG . 18.9 Cg_endo -63.32 164.06 21.45 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 123.162 2.575 . . . . 1.0 113.886 -176.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.543 ' HB3' HG12 ' A' ' 38' ' ' VAL . 0.4 OUTLIER -71.1 -173.85 0.89 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.287 -1.324 . . . . 1.0 110.347 179.173 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.56 ' HB3' ' H ' ' A' ' 84' ' ' ASP . 1.5 t-160 -155.2 102.52 2.3 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 110.043 -0.355 . . . . 1.0 110.043 -178.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.624 HG11 HD11 ' A' ' 85' ' ' LEU . 2.1 t -106.53 112.48 39.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 108.125 -1.065 . . . . 1.0 108.125 177.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.522 HG21 ' HG ' ' A' ' 86' ' ' LEU . 9.0 t -114.58 114.11 25.29 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.033 0.444 . . . . 1.0 110.479 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.577 ' HD1' ' HB ' ' A' ' 87' ' ' VAL . 0.9 OUTLIER -83.87 134.83 34.68 Favored 'General case' 0 CA--C 1.511 -0.526 0 O-C-N 121.857 -0.527 . . . . 1.0 110.259 -179.541 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.535 ' CG1' HG23 ' A' ' 45' ' ' THR . 48.8 t -119.69 115.61 48.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-O 121.227 0.537 . . . . 1.0 111.453 -177.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 37.4 t -140.49 163.15 33.6 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.527 -0.76 . . . . 1.0 109.297 178.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.15 84.94 3.63 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.167 0.508 . . . . 1.0 111.23 -177.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.684 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 141.84 -39.14 1.42 Allowed Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.443 -0.799 . . . . 1.0 111.952 179.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 62.71 16.47 8.98 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.817 0.818 . . . . 1.0 111.347 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.432 ' O ' ' HB3' ' A' ' 55' ' ' ASP . 1.8 pt -131.44 32.87 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 O-C-N 121.827 -0.546 . . . . 1.0 110.553 -178.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.785 ' O ' ' HG3' ' A' ' 20' ' ' MET . 35.6 m -147.97 -88.21 0.09 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.915 -0.402 . . . . 1.0 109.915 175.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.41 -51.29 68.11 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.257 0.466 . . . . 1.0 112.257 -177.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.853 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 14.3 m -54.19 -58.99 11.21 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 115.99 -0.55 . . . . 1.0 112.369 -177.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.632 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 33.2 Cg_endo -61.62 -26.6 80.54 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 121.898 1.732 . . . . 1.0 112.705 -178.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.785 ' HG3' ' O ' ' A' ' 16' ' ' CYS . 72.9 mtp -60.43 -54.84 40.76 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.751 -0.38 . . . . 1.0 110.524 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.516 ' HA ' ' HB2' ' A' ' 24' ' ' MET . . . -74.75 -27.53 60.39 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.582 -0.447 . . . . 1.0 110.763 -178.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.46 ' HA ' ' CE2' ' A' ' 9' ' ' PHE . 18.1 tt0 -52.37 -53.36 45.82 Favored 'General case' 0 C--O 1.217 -0.634 0 O-C-N 124.064 0.852 . . . . 1.0 110.09 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.929 ' HE3' ' HB2' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -86.71 -22.35 26.08 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.43 -0.805 . . . . 1.0 110.69 -176.409 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.652 ' HB3' HD12 ' A' ' 146' ' ' LEU . 3.2 mmm -63.73 -76.66 0.06 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.216 0.45 . . . . 1.0 112.216 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.766 ' HB3' HD23 ' A' ' 146' ' ' LEU . 22.6 p90 -76.2 -29.76 57.74 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 119.697 -0.801 . . . . 1.0 111.68 -175.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.54 ' HA ' HD11 ' A' ' 29' ' ' LEU . . . -63.35 -36.62 84.31 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 119.321 -0.952 . . . . 1.0 110.714 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.633 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -65.48 -39.32 91.8 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 108.801 -0.815 . . . . 1.0 108.801 177.218 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.608 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 59.8 mt-30 -60.47 -37.73 81.96 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 121.098 0.475 . . . . 1.0 110.395 177.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.564 HD13 ' HB ' ' A' ' 38' ' ' VAL . 95.9 mt -57.01 -62.63 1.61 Allowed 'General case' 0 C--O 1.223 -0.308 0 CA-C-N 115.724 -0.671 . . . . 1.0 110.555 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.47 ' HB3' ' HA3' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -59.3 -31.01 68.74 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.154 -0.618 . . . . 1.0 111.548 179.099 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -59.88 -33.73 72.22 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.929 0.395 . . . . 1.0 111.213 176.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.557 ' HD3' HD12 ' A' ' 34' ' ' LEU . 11.6 ptm180 -95.71 -20.68 18.71 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 120.142 -0.623 . . . . 1.0 109.827 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 109.6 36.22 2.11 Favored Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 115.008 -0.996 . . . . 1.0 112.459 177.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.557 HD12 ' HD3' ' A' ' 32' ' ' ARG . 38.9 mt -129.03 4.36 5.31 Favored 'General case' 0 C--N 1.331 -0.239 0 O-C-N 122.275 -0.544 . . . . 1.0 110.174 -179.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.47 ' HA3' ' HB3' ' A' ' 30' ' ' ARG . . . -59.0 -29.53 65.3 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 121.276 -0.488 . . . . 1.0 113.27 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.583 ' HA ' ' NH1' ' A' ' 39' ' ' ARG . 11.8 m-20 -92.71 -17.63 24.0 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.117 0.484 . . . . 1.0 110.254 177.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.89 -24.13 38.51 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.659 -0.701 . . . . 1.0 110.428 178.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.564 ' HB ' HD13 ' A' ' 29' ' ' LEU . 12.0 t -130.94 123.92 55.12 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.446 -179.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.624 ' HG2' ' HB2' ' A' ' 4' ' ' PRO . 22.8 mmt180 -93.82 130.56 39.8 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 109.058 -0.719 . . . . 1.0 109.058 175.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 64.0 t -122.68 117.84 53.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-O 121.528 0.68 . . . . 1.0 109.599 -175.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.502 ' O ' ' HA ' ' A' ' 8' ' ' THR . 57.9 p -130.99 -177.11 4.23 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.379 -1.282 . . . . 1.0 110.322 -175.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.853 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 90.9 p -160.56 165.71 30.32 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.842 -0.343 . . . . 1.0 110.339 179.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.623 ' HB1' ' CD2' ' A' ' 80' ' ' HIS . . . -164.0 166.92 21.07 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 121.365 0.603 . . . . 1.0 111.677 -179.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -124.55 131.92 8.03 Favored Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 110.682 -0.967 . . . . 1.0 110.682 176.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.535 HG23 ' CG1' ' A' ' 10' ' ' VAL . 36.3 p -66.62 -28.87 68.83 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.108 0.41 . . . . 1.0 112.108 -176.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.434 ' HA3' ' CZ3' ' A' ' 48' ' ' TRP . . . -106.53 10.82 42.48 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.618 -0.801 . . . . 1.0 113.598 -175.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 44.87 34.51 1.23 Allowed 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.559 0.948 . . . . 1.0 113.559 177.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.684 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 1.2 m-90 -45.09 -74.87 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.596 0.712 . . . . 1.0 111.984 179.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -107.39 41.17 1.54 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.822 -1.081 . . . . 1.0 111.132 -178.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.9 p -60.64 127.84 20.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.405 178.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.03 -12.62 68.9 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.962 -0.637 . . . . 1.0 112.378 -178.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 t -80.81 -160.19 0.3 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.907 0.384 . . . . 1.0 110.615 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 31.7 t -129.91 170.42 13.95 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.688 -0.486 . . . . 1.0 109.688 -178.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.83 143.2 38.11 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.242 0.544 . . . . 1.0 112.094 -178.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.663 ' OD2' ' HG3' ' A' ' 57' ' ' ARG . 12.8 p-10 -63.54 144.58 56.88 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.71 -1.132 . . . . 1.0 112.655 -177.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -48.69 -43.3 36.93 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.546 -1.206 . . . . 1.0 113.311 178.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.663 ' HG3' ' OD2' ' A' ' 55' ' ' ASP . 4.0 ptp180 -71.49 -40.73 70.04 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 121.135 -0.226 . . . . 1.0 111.471 -175.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.621 ' HB1' ' HG2' ' A' ' 20' ' ' MET . . . -71.04 -35.66 72.05 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.045 0.45 . . . . 1.0 109.834 178.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.85 -42.3 97.6 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.905 -0.589 . . . . 1.0 111.04 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -67.53 -34.73 85.05 Favored Glycine 0 CA--C 1.489 -1.546 0 N-CA-C 110.379 -1.089 . . . . 1.0 110.379 -178.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.543 ' O ' ' HD2' ' A' ' 65' ' ' HIS . 1.1 t -63.07 -54.57 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 CA-C-N 113.557 -1.322 . . . . 1.0 110.882 176.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.684 HD11 ' HG3' ' A' ' 23' ' ' LYS . 89.5 mt -62.39 -51.86 65.88 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.772 0.32 . . . . 1.0 111.152 -177.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -64.83 -23.5 67.26 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.807 -0.633 . . . . 1.0 111.509 -177.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.68 -33.3 70.77 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.2 0.524 . . . . 1.0 110.589 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.543 ' HD2' ' O ' ' A' ' 61' ' ' VAL . 87.7 m-70 -96.12 1.46 52.45 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.713 -0.676 . . . . 1.0 111.063 -178.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 96.22 9.51 56.87 Favored Glycine 0 C--N 1.33 0.221 0 C-N-CA 120.886 -0.674 . . . . 1.0 113.112 176.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.494 ' CD1' ' HA ' ' A' ' 24' ' ' MET . 73.5 m-85 -88.99 149.37 43.21 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-O 120.413 0.149 . . . . 1.0 110.621 -179.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.471 ' HG2' ' CB ' ' A' ' 23' ' ' LYS . 40.9 Cg_endo -69.09 156.31 65.49 Favored 'Trans proline' 0 CA--C 1.51 -0.705 0 C-N-CA 122.252 1.968 . . . . 1.0 110.883 176.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.68 HG21 ' HB2' ' A' ' 62' ' ' LEU . 52.1 p -130.36 13.68 5.56 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.49 0.662 . . . . 1.0 110.443 -177.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -85.03 125.5 32.78 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.988 -1.006 . . . . 1.0 109.15 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.929 ' HB2' ' HE3' ' A' ' 23' ' ' LYS . 19.2 t60 -165.54 154.06 11.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.347 -0.388 . . . . 1.0 110.385 -175.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -133.95 113.85 12.63 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.628 -0.879 . . . . 1.0 108.628 176.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.63 140.27 56.53 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.171 -0.922 . . . . 1.0 112.558 -175.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.454 ' O ' ' HA ' ' A' ' 43' ' ' ALA . . . -134.18 150.74 51.1 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.257 -0.883 . . . . 1.0 109.81 178.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -86.62 155.33 20.48 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.615 -0.513 . . . . 1.0 109.615 176.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.574 HG11 ' CD2' ' A' ' 97' ' ' LEU . 8.8 t -67.41 112.62 2.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.123 0.487 . . . . 1.0 110.212 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.484 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -123.37 -166.92 12.72 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.58 -0.736 . . . . 1.0 111.437 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 44.3 m -57.11 -51.56 68.82 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.125 0.488 . . . . 1.0 111.687 -178.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.445 ' HG2' ' N ' ' A' ' 80' ' ' HIS . 1.4 pm0 -56.39 -31.57 63.97 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.3 -0.864 . . . . 1.0 111.114 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.623 ' CD2' ' HB1' ' A' ' 43' ' ' ALA . 80.1 m80 -75.28 -42.77 54.09 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 116.055 -0.52 . . . . 1.0 110.158 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.549 ' HA ' HD23 ' A' ' 86' ' ' LEU . 21.0 mt -67.69 -18.64 65.0 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.737 -0.665 . . . . 1.0 110.672 178.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.37 -2.9 58.82 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.852 -0.613 . . . . 1.0 110.853 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.549 ' HA ' ' HB3' ' A' ' 6' ' ' HIS . . . -60.23 155.14 18.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.827 -0.624 . . . . 1.0 111.498 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.707 ' HA ' ' NH1' ' A' ' 106' ' ' ARG . 25.0 t70 -79.5 -16.83 55.37 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.335 0.588 . . . . 1.0 109.883 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.624 HD11 HG11 ' A' ' 7' ' ' VAL . 0.5 OUTLIER -155.07 117.64 4.28 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.137 -0.938 . . . . 1.0 108.909 -177.405 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.6 HD22 HG21 ' A' ' 102' ' ' VAL . 5.0 mp -105.52 104.11 13.77 Favored 'General case' 0 N--CA 1.425 -1.704 0 CA-C-N 115.518 -0.765 . . . . 1.0 109.744 178.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.577 ' HB ' ' HD1' ' A' ' 9' ' ' PHE . 72.2 t -84.91 92.59 3.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.202 -0.908 . . . . 1.0 111.272 -176.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.02 146.03 30.86 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.18 -0.918 . . . . 1.0 110.785 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.476 ' O ' ' HB ' ' A' ' 124' ' ' VAL . 4.2 mm? -97.55 -7.63 30.9 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.37 0.605 . . . . 1.0 109.952 178.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.469 ' CG ' ' H ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -152.64 152.97 32.39 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.16 -0.927 . . . . 1.0 110.103 178.335 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.676 ' HB3' ' O ' ' A' ' 122' ' ' LEU . 18.7 ptt180 -64.3 -19.72 65.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.573 -0.74 . . . . 1.0 112.749 -176.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.627 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 7.1 m120 -75.62 -48.73 20.97 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.397 -0.594 . . . . 1.0 109.397 178.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.734 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 17.8 m170 -56.29 -47.32 78.89 Favored 'General case' 0 C--N 1.333 -0.124 0 N-CA-C 109.619 -0.512 . . . . 1.0 109.619 177.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.456 ' HA ' HG21 ' A' ' 107' ' ' VAL . . . -58.55 -44.33 89.63 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.308 -0.406 . . . . 1.0 110.961 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.439 ' O ' ' HG2' ' A' ' 98' ' ' ARG . 2.0 ttt85 -59.64 -41.76 91.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.128 -0.487 . . . . 1.0 111.517 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.75 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 50.4 mt -63.91 -49.27 73.32 Favored 'General case' 0 C--O 1.219 -0.52 0 N-CA-C 109.744 -0.465 . . . . 1.0 109.744 -177.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.734 ' HG ' ' O ' ' A' ' 93' ' ' HIS . 27.5 mt -55.78 -55.59 30.58 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.316 -0.856 . . . . 1.0 111.67 -178.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.439 ' HG2' ' O ' ' A' ' 95' ' ' ARG . 20.2 ptt180 -60.97 -43.6 98.56 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.214 -0.448 . . . . 1.0 111.554 -176.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.635 ' HG3' ' O ' ' A' ' 96' ' ' LEU . 1.1 pp0? -69.0 -21.38 64.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.125 0.488 . . . . 1.0 110.239 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.75 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 9.8 mt -78.61 -7.81 57.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.595 -0.729 . . . . 1.0 111.962 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 147.66 -31.13 1.38 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.047 -1.073 . . . . 1.0 113.223 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.711 HG12 ' H ' ' A' ' 103' ' ' GLU . 1.4 t -75.15 -153.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.359 0.6 . . . . 1.0 111.238 -178.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.711 ' H ' HG12 ' A' ' 102' ' ' VAL . 15.5 pt-20 -164.25 164.53 22.45 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.603 -0.888 . . . . 1.0 108.603 -178.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.806 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -67.69 -21.92 65.31 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.571 -0.286 . . . . 1.0 111.542 -175.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.61 -35.88 77.22 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.284 0.564 . . . . 1.0 110.371 175.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.711 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 0.6 OUTLIER -95.09 -44.84 7.48 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 115.201 -0.909 . . . . 1.0 110.364 -177.676 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.806 HG12 ' HA ' ' A' ' 104' ' ' ALA . 8.9 p -78.33 117.29 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-O 121.846 0.832 . . . . 1.0 109.595 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.573 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 29.1 mmm180 -134.43 148.62 50.66 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.662 -0.699 . . . . 1.0 109.915 -177.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.53 ' HG3' ' HA ' ' A' ' 122' ' ' LEU . 82.6 mmm -78.57 140.29 38.52 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.279 -0.873 . . . . 1.0 110.581 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.552 HD13 ' HA ' ' A' ' 142' ' ' ILE . 3.2 tm? -56.49 -50.47 71.66 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 123.085 0.241 . . . . 1.0 110.93 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 5.6 ttm-85 -70.96 -15.52 62.59 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.691 -0.404 . . . . 1.0 110.854 -178.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 33.5 t -75.26 -2.7 29.33 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 120.97 -0.292 . . . . 1.0 110.31 -179.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.665 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 85.9 m-85 -96.08 -17.77 20.67 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 121.972 -0.455 . . . . 1.0 110.617 175.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -59.27 121.14 53.92 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.882 -0.599 . . . . 1.0 110.47 -178.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -62.56 -21.92 73.4 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.425 2.083 . . . . 1.0 111.846 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 116' ' ' ARG . 33.3 mtm180 -89.53 0.65 56.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.964 -0.562 . . . . 1.0 112.092 -178.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 88.0 p -63.27 95.52 0.09 Allowed 'General case' 0 C--O 1.238 0.474 0 CA-C-O 121.261 0.553 . . . . 1.0 111.139 -178.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -58.41 -47.46 89.65 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.413 -0.812 . . . . 1.0 111.63 178.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.4 m -104.07 163.63 12.26 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.981 -0.748 . . . . 1.0 108.981 177.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 40.9 m170 -67.0 131.93 46.87 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.862 -0.792 . . . . 1.0 108.862 175.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -95.7 86.93 4.53 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.517 -0.765 . . . . 1.0 110.59 -177.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.676 ' O ' ' HB3' ' A' ' 91' ' ' ARG . 2.4 mm? -95.95 15.98 19.04 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.965 -0.754 . . . . 1.0 108.965 176.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.436 ' CA ' ' HE3' ' A' ' 109' ' ' MET . 9.0 t70 -168.69 137.83 2.24 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.013 -0.994 . . . . 1.0 109.415 -178.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.476 ' HB ' ' O ' ' A' ' 89' ' ' LEU . 92.3 t -105.96 147.27 11.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.672 -0.492 . . . . 1.0 109.672 -178.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -60.68 -178.1 0.09 Allowed 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.499 0.666 . . . . 1.0 112.11 -177.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -152.73 139.49 12.52 Favored Pre-proline 0 C--N 1.316 -0.891 0 CA-C-N 114.993 -1.003 . . . . 1.0 109.274 -174.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.659 ' HB3' ' HB3' ' A' ' 134' ' ' ASP . 97.6 Cg_exo -44.26 153.57 0.33 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 123.517 2.811 . . . . 1.0 113.315 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.1 -36.56 18.05 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.349 -0.841 . . . . 1.0 109.292 -178.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.26 -25.29 0.59 Allowed 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.288 -0.869 . . . . 1.0 111.463 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 91.37 60.93 1.27 Allowed Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.106 -1.045 . . . . 1.0 111.155 -179.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -133.91 -163.21 1.33 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.702 -0.851 . . . . 1.0 108.702 -177.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.799 ' HA ' ' CZ ' ' A' ' 135' ' ' PHE . 17.2 t-80 -51.43 -48.19 62.8 Favored 'General case' 0 C--N 1.329 -0.283 0 O-C-N 123.209 0.318 . . . . 1.0 111.839 -178.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.8 p -62.44 -39.51 93.57 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.039 -0.528 . . . . 1.0 112.395 -177.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.659 ' HB3' ' HB3' ' A' ' 127' ' ' PRO . 1.0 OUTLIER -68.03 -42.36 80.73 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.272 -0.876 . . . . 1.0 112.05 -174.434 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.799 ' CZ ' ' HA ' ' A' ' 132' ' ' HIS . 7.3 p90 -74.99 -33.36 61.84 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 119.121 -1.032 . . . . 1.0 111.613 -175.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -73.26 -25.02 60.54 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.634 -0.506 . . . . 1.0 109.634 175.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -65.56 -45.5 83.12 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 109.643 -0.503 . . . . 1.0 109.643 176.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.872 ' HA ' HG13 ' A' ' 141' ' ' VAL . 24.4 t -63.74 -40.39 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-O 121.756 0.788 . . . . 1.0 109.043 177.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -55.94 -42.18 75.77 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.328 -0.851 . . . . 1.0 109.309 175.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.543 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -66.99 -47.96 69.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.489 -0.778 . . . . 1.0 111.711 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.872 HG13 ' HA ' ' A' ' 138' ' ' VAL . 3.6 p -59.54 -43.86 91.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.709 0.766 . . . . 1.0 111.214 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.562 HD13 HG12 ' A' ' 138' ' ' VAL . 13.5 mt -67.13 -51.08 57.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 115.206 -0.906 . . . . 1.0 111.504 178.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.543 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 7.6 pt-20 -56.11 -30.25 61.8 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 109.934 -0.395 . . . . 1.0 109.934 179.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 4.2 t -72.57 -30.32 64.3 Favored 'General case' 0 C--O 1.226 -0.179 0 CA-C-N 115.749 -0.66 . . . . 1.0 110.315 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.46 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -87.84 -22.62 24.35 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-N 116.024 -0.535 . . . . 1.0 111.723 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.766 HD23 ' HB3' ' A' ' 25' ' ' PHE . 9.9 mt -54.77 -38.77 70.54 Favored Pre-proline 0 CA--C 1.545 0.774 0 CA-C-O 119.163 -0.446 . . . . 1.0 112.048 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.588 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 61.7 Cg_endo -71.28 -11.01 28.17 Favored 'Trans proline' 0 C--N 1.365 1.429 0 C-N-CA 122.695 2.264 . . . . 1.0 112.113 177.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.665 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -103.86 -33.32 4.11 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.372 -1.091 . . . . 1.0 110.372 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.479 HD11 ' CE2' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -74.28 -40.38 62.33 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.378 -0.971 . . . . 1.0 108.378 178.372 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.471 ' O ' ' HB2' ' A' ' 154' ' ' ASP . 1.0 OUTLIER -55.71 -52.1 65.05 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 114.716 -1.129 . . . . 1.0 110.966 176.111 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -61.73 -42.35 98.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.755 -0.657 . . . . 1.0 110.962 -176.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . 0.529 ' HZ3' HD22 ' A' ' 5' ' ' LEU . 28.0 t90 -60.98 -57.12 13.95 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.387 -0.824 . . . . 1.0 110.629 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.511 ' HB ' HD21 ' A' ' 5' ' ' LEU . 11.0 m -60.41 -38.49 78.0 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.279 0 N-CA-C 110.088 -0.338 . . . . 1.0 110.088 -178.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.508 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 0.5 OUTLIER -59.53 -56.19 25.07 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.403 0.62 . . . . 1.0 110.815 179.72 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.499 ' O ' ' HG3' ' A' ' 159' ' ' ARG . 5.4 pt-20 -61.44 -39.81 92.19 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.047 -0.978 . . . . 1.0 110.72 -177.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.429 ' HD3' ' HA ' ' A' ' 156' ' ' ARG . 11.4 mmt85 -72.07 -45.75 59.54 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 115.79 -0.641 . . . . 1.0 110.966 -176.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 3.6 pp -64.02 -28.82 70.06 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.789 -0.641 . . . . 1.0 109.372 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -73.6 -53.3 10.81 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.226 -0.897 . . . . 1.0 110.687 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.499 ' HG3' ' O ' ' A' ' 155' ' ' GLU . 0.0 OUTLIER -77.48 -8.84 58.4 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 112.664 0.616 . . . . 1.0 112.664 -176.497 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -59.35 -50.91 72.15 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 110.269 -0.271 . . . . 1.0 110.269 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 65.48 -151.28 51.76 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.812 -0.709 . . . . 1.0 111.972 179.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -80.2 -89.49 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.368 2.046 . . . . 1.0 111.631 177.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 25.8 m . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.24 -0.886 . . . . 1.0 109.257 177.07 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.722 0 N-CA-C 112.081 -0.407 . . . . 1.0 112.081 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ptt? -159.19 150.34 20.06 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.393 -0.595 . . . . 1.0 109.393 179.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.1 m -89.74 167.97 12.47 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.25 0.548 . . . . 1.0 112.091 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.86 ' HB2' ' HD2' ' A' ' 4' ' ' PRO . 1.3 p30 -170.98 167.82 3.98 Favored Pre-proline 0 N--CA 1.451 -0.424 0 N-CA-C 107.636 -1.246 . . . . 1.0 107.636 179.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.86 ' HD2' ' HB2' ' A' ' 3' ' ' ASP . 19.4 Cg_endo -58.59 165.35 7.95 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.37 2.047 . . . . 1.0 112.402 -177.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.773 ' HB3' HG21 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -65.04 177.17 1.05 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.667 -0.697 . . . . 1.0 109.304 -179.213 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.702 ' H ' HD13 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -157.24 90.93 1.14 Allowed 'General case' 0 C--N 1.318 -0.797 0 O-C-N 121.878 -0.514 . . . . 1.0 111.036 -179.134 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.561 HG11 HD13 ' A' ' 85' ' ' LEU . 1.7 t -95.74 109.09 22.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.731 -0.668 . . . . 1.0 109.557 178.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.598 ' CG2' ' HG ' ' A' ' 86' ' ' LEU . 10.1 t -112.56 117.28 31.9 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 109.623 -0.51 . . . . 1.0 109.623 178.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.722 ' HZ ' ' HE1' ' A' ' 25' ' ' PHE . 1.0 OUTLIER -86.3 134.49 33.74 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 120.843 0.354 . . . . 1.0 110.234 -178.919 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.698 HG21 HD12 ' A' ' 97' ' ' LEU . 33.7 t -116.5 113.67 43.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 116.083 -0.508 . . . . 1.0 111.649 -176.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.59 ' HB2' HD22 ' A' ' 89' ' ' LEU . 38.3 t -143.86 160.61 40.47 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.145 -0.48 . . . . 1.0 109.837 178.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.409 HG22 ' CZ3' ' A' ' 48' ' ' TRP . 0.6 OUTLIER -67.39 100.45 0.84 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.205 0.526 . . . . 1.0 111.18 -179.768 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.974 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 117.21 -40.01 2.48 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.513 -0.767 . . . . 1.0 112.18 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.626 ' ND2' ' H ' ' A' ' 74' ' ' ALA . 57.7 t30 60.61 25.72 15.43 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 122.449 1.119 . . . . 1.0 110.392 -177.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.584 ' O ' ' HB3' ' A' ' 55' ' ' ASP . 1.3 pt -134.76 39.02 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 114.908 -1.042 . . . . 1.0 109.658 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.754 ' O ' ' HG3' ' A' ' 20' ' ' MET . 6.9 p -151.38 -89.26 0.06 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.086 -0.507 . . . . 1.0 111.426 177.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.414 ' NH2' ' HA ' ' A' ' 126' ' ' ASP . 81.3 mtt180 -74.83 -45.1 45.56 Favored 'General case' 0 N--CA 1.464 0.249 0 O-C-N 122.004 -0.435 . . . . 1.0 111.543 -176.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.442 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 20.4 m -53.09 -56.32 24.96 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 116.117 -0.492 . . . . 1.0 111.364 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.442 ' HD3' ' HB2' ' A' ' 18' ' ' SER . 49.4 Cg_endo -67.28 -24.52 43.62 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 121.444 1.43 . . . . 1.0 112.909 -178.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.754 ' HG3' ' O ' ' A' ' 16' ' ' CYS . 63.4 mtp -59.15 -53.35 59.32 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 109.869 -0.419 . . . . 1.0 109.869 178.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.551 ' O ' ' HD1' ' A' ' 25' ' ' PHE . . . -72.77 -31.15 64.68 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 115.379 -0.828 . . . . 1.0 110.68 -177.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.563 ' O ' ' HB1' ' A' ' 26' ' ' ALA . 17.5 tt0 -50.66 -53.46 30.85 Favored 'General case' 0 C--O 1.218 -0.554 0 O-C-N 124.167 0.917 . . . . 1.0 110.162 -178.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.643 ' HZ3' ' HB2' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -84.9 -24.23 28.55 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.497 -0.774 . . . . 1.0 110.902 -176.618 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.511 ' HE2' HD11 ' A' ' 146' ' ' LEU . 85.4 mtp -63.61 -75.66 0.08 Allowed 'General case' 0 C--O 1.237 0.423 0 N-CA-C 112.621 0.6 . . . . 1.0 112.621 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.727 ' HB3' HD23 ' A' ' 146' ' ' LEU . 0.6 OUTLIER -78.62 -28.77 45.65 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.163 -0.615 . . . . 1.0 111.93 -174.885 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.563 ' HB1' ' O ' ' A' ' 22' ' ' GLU . . . -64.71 -38.07 89.75 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 119.346 -0.941 . . . . 1.0 110.389 178.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.641 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -62.92 -38.84 92.57 Favored 'General case' 0 CA--C 1.527 0.061 0 N-CA-C 108.406 -0.961 . . . . 1.0 108.406 177.046 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.638 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 79.4 mt-30 -59.89 -42.88 94.76 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 115.593 -0.73 . . . . 1.0 110.808 176.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 25' ' ' PHE . 96.5 mt -56.17 -60.05 4.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.104 -0.498 . . . . 1.0 111.322 -178.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.29 -34.91 74.42 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.144 -0.623 . . . . 1.0 111.178 178.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -60.76 -29.24 69.29 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 111.96 0.355 . . . . 1.0 111.96 177.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.605 ' HG2' ' O ' ' A' ' 28' ' ' GLN . 6.8 ptp180 -94.72 -21.1 18.98 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.098 -0.641 . . . . 1.0 110.275 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 107.43 40.38 1.78 Allowed Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.175 -0.921 . . . . 1.0 111.962 177.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 25.8 mt -132.32 0.32 3.71 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.965 -0.383 . . . . 1.0 109.965 -178.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.7 -28.91 60.7 Favored Glycine 0 C--N 1.332 0.351 0 CA-C-N 116.035 -0.53 . . . . 1.0 112.855 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -83.35 -25.76 31.14 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.17 0.509 . . . . 1.0 110.321 177.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.41 -23.11 40.6 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.559 -0.746 . . . . 1.0 111.571 -177.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.773 HG21 ' HB3' ' A' ' 5' ' ' LEU . 0.4 OUTLIER -141.33 125.09 16.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.296 0.569 . . . . 1.0 111.241 -179.396 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.454 ' HG2' ' HB2' ' A' ' 4' ' ' PRO . 17.3 mmt180 -88.93 142.43 27.65 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.475 -0.784 . . . . 1.0 108.998 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.4 HG13 ' HB2' ' A' ' 26' ' ' ALA . 77.0 t -129.8 130.13 66.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 109.173 -0.676 . . . . 1.0 109.173 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.496 ' O ' ' HA ' ' A' ' 8' ' ' THR . 37.0 p -143.8 -174.17 4.18 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.782 -1.099 . . . . 1.0 110.487 -174.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.456 ' OG ' ' HE1' ' A' ' 71' ' ' HIS . 65.2 p -160.43 163.03 33.37 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.598 -0.274 . . . . 1.0 110.427 -179.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.649 ' HB1' ' CD2' ' A' ' 80' ' ' HIS . . . -163.34 161.98 24.81 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.278 0.561 . . . . 1.0 111.345 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -123.37 133.42 8.95 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.453 -0.794 . . . . 1.0 111.481 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.492 HG22 ' CG1' ' A' ' 10' ' ' VAL . 17.9 p -71.44 -20.83 62.05 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.688 0.28 . . . . 1.0 111.727 -178.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.454 ' HA3' ' CZ3' ' A' ' 48' ' ' TRP . . . -109.66 5.33 31.09 Favored Glycine 0 C--O 1.226 -0.377 0 C-N-CA 120.603 -0.808 . . . . 1.0 113.026 -178.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.401 ' HB3' ' NE2' ' A' ' 75' ' ' GLN . 3.2 p-10 42.92 34.54 0.62 Allowed 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 113.518 0.933 . . . . 1.0 113.518 178.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.974 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 0.9 OUTLIER -46.83 -72.99 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.298 0.571 . . . . 1.0 112.419 -178.983 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.507 ' HB3' ' HB3' ' A' ' 52' ' ' SER . 3.2 m-70 -106.5 42.66 1.24 Allowed 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.734 -0.666 . . . . 1.0 111.186 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.437 HG21 ' HA ' ' A' ' 74' ' ' ALA . 11.9 p -61.34 126.92 20.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 120.573 -0.451 . . . . 1.0 109.985 178.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.0 -12.59 69.63 Favored Glycine 0 CA--C 1.519 0.303 0 N-CA-C 111.794 -0.523 . . . . 1.0 111.794 -176.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.511 ' O ' ' HD3' ' A' ' 72' ' ' ARG . 1.4 t -83.08 -159.58 0.35 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.149 0.5 . . . . 1.0 109.839 178.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.593 ' HA ' ' O ' ' A' ' 71' ' ' HIS . 25.0 t -131.17 170.38 14.64 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.955 -0.566 . . . . 1.0 109.573 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.643 ' HB2' ' HZ3' ' A' ' 23' ' ' LYS . . . -50.74 145.7 6.65 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 123.758 0.661 . . . . 1.0 111.553 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.677 ' OD1' ' HA ' ' A' ' 16' ' ' CYS . 9.6 p-10 -61.47 144.94 53.35 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.434 -0.803 . . . . 1.0 112.388 -178.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -45.75 -36.32 4.97 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.214 -1.357 . . . . 1.0 113.221 175.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.599 ' O ' HG21 ' A' ' 61' ' ' VAL . 17.1 mtt-85 -71.22 -49.66 41.09 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.843 0.354 . . . . 1.0 111.013 -175.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.65 -29.83 67.39 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.419 -0.81 . . . . 1.0 110.557 -178.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.65 -47.71 84.16 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.701 -0.481 . . . . 1.0 109.701 177.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.36 -38.09 95.7 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.962 -0.637 . . . . 1.0 112.101 178.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.599 HG21 ' O ' ' A' ' 57' ' ' ARG . 99.7 t -64.19 -58.87 5.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.25 0.548 . . . . 1.0 110.826 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.48 ' HB2' HG21 ' A' ' 69' ' ' THR . 8.6 mp -59.79 -48.65 80.84 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.686 -0.688 . . . . 1.0 111.54 -177.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.483 ' HB3' HG22 ' A' ' 69' ' ' THR . 9.9 ptm180 -60.59 -28.54 68.57 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.517 -0.31 . . . . 1.0 111.131 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.34 -33.88 75.1 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.417 0.627 . . . . 1.0 110.053 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -93.74 4.78 53.42 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.228 -0.896 . . . . 1.0 111.536 -178.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.89 16.18 65.98 Favored Glycine 0 N--CA 1.455 -0.093 0 C-N-CA 120.96 -0.638 . . . . 1.0 112.754 177.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -92.44 151.95 41.79 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 110.259 -0.274 . . . . 1.0 110.259 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.476 ' O ' ' HD2' ' A' ' 23' ' ' LYS . 27.8 Cg_endo -66.29 152.1 81.84 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 121.877 1.718 . . . . 1.0 110.155 176.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.483 HG22 ' HB3' ' A' ' 63' ' ' ARG . 66.7 p -131.28 25.61 4.85 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 120.266 -0.574 . . . . 1.0 112.041 -175.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.474 ' C ' ' HZ1' ' A' ' 23' ' ' LYS . 34.2 t70 -110.57 127.02 55.04 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.783 -0.451 . . . . 1.0 109.783 179.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.593 ' O ' ' HA ' ' A' ' 53' ' ' CYS . 0.2 OUTLIER -160.09 139.5 11.04 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.883 -179.61 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.511 ' HD3' ' O ' ' A' ' 52' ' ' SER . 5.1 tpp180 -102.72 114.98 29.67 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.969 -0.56 . . . . 1.0 110.132 178.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 49' ' ' HIS . . . -63.51 138.01 58.35 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.139 -0.482 . . . . 1.0 112.133 -178.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.626 ' H ' ' ND2' ' A' ' 14' ' ' ASN . . . -129.41 163.62 25.43 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.942 -0.572 . . . . 1.0 109.894 176.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.401 ' NE2' ' HB3' ' A' ' 47' ' ' ASN . 16.0 tt0 -98.07 159.41 14.95 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.977 -0.749 . . . . 1.0 108.977 178.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.543 HG13 HD21 ' A' ' 97' ' ' LEU . 47.8 t -70.83 115.26 10.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.936 0.398 . . . . 1.0 110.252 177.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.558 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -128.31 -167.0 12.13 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.723 -0.671 . . . . 1.0 111.697 178.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 30.3 m -57.35 -51.83 67.81 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.973 0.416 . . . . 1.0 111.747 -179.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.467 ' HG2' ' N ' ' A' ' 80' ' ' HIS . 1.6 pm0 -56.21 -31.93 63.95 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.623 -0.717 . . . . 1.0 110.981 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.649 ' CD2' ' HB1' ' A' ' 43' ' ' ALA . 80.0 m80 -74.87 -41.16 60.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.967 -0.561 . . . . 1.0 109.955 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.715 ' HA ' HD21 ' A' ' 86' ' ' LEU . 15.6 mt -68.78 -16.34 63.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.973 0.416 . . . . 1.0 110.238 176.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -87.35 -8.32 56.78 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 120.932 0.396 . . . . 1.0 110.112 -179.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 6' ' ' HIS . . . -59.18 156.16 12.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.86 -0.609 . . . . 1.0 110.774 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.763 ' HA ' ' NH1' ' A' ' 106' ' ' ARG . 3.0 t70 -82.35 -12.47 57.93 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.902 0.382 . . . . 1.0 110.153 -178.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.713 HD11 ' CE3' ' A' ' 152' ' ' TRP . 1.1 tt -158.0 115.26 2.94 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.81 -0.632 . . . . 1.0 109.539 -178.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.715 HD21 ' HA ' ' A' ' 81' ' ' LEU . 5.2 mp -107.08 87.64 2.55 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 115.669 -0.696 . . . . 1.0 110.802 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.617 HG12 HD21 ' A' ' 110' ' ' LEU . 76.7 t -66.01 92.91 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 113.886 -1.507 . . . . 1.0 112.521 -178.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.69 149.86 31.08 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.993 -1.003 . . . . 1.0 111.093 177.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.64 ' O ' ' HB ' ' A' ' 124' ' ' VAL . 3.9 mm? -98.7 -5.69 31.04 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.971 179.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.59 ' HA ' ' HE2' ' A' ' 109' ' ' MET . 17.9 p30 -159.09 166.43 31.62 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.506 0.67 . . . . 1.0 111.368 174.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 9.1 ptt180 -62.63 -18.98 63.32 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.11 -1.404 . . . . 1.0 112.305 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.61 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 5.9 m-20 -78.48 -53.24 7.45 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.749 0.309 . . . . 1.0 110.623 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.663 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 14.1 m170 -58.84 -44.73 91.02 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.958 -0.565 . . . . 1.0 109.674 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.17 -42.78 91.62 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.002 0.429 . . . . 1.0 110.817 179.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 4.3 ttm180 -57.99 -44.84 87.4 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.37 -0.832 . . . . 1.0 111.281 177.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.679 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 49.4 mt -64.85 -48.45 74.28 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.44 -175.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.698 HD12 HG21 ' A' ' 10' ' ' VAL . 29.0 mt -53.57 -59.77 4.16 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.642 -0.708 . . . . 1.0 111.771 -177.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.7 ' CA ' HG13 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -60.12 -44.33 94.98 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.47 0.545 . . . . 1.0 112.47 -179.308 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.522 ' HG3' ' O ' ' A' ' 96' ' ' LEU . 1.0 OUTLIER -66.56 -23.3 66.19 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.254 -0.578 . . . . 1.0 109.945 179.056 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.679 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 8.9 mt -80.98 -21.75 40.05 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.764 -0.653 . . . . 1.0 111.65 178.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 155.25 -22.72 0.58 Allowed Glycine 0 CA--C 1.521 0.453 0 C-N-CA 119.332 -1.413 . . . . 1.0 114.38 -177.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.7 HG13 ' CA ' ' A' ' 98' ' ' ARG . 0.3 OUTLIER -76.82 -162.09 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 117.836 0.818 . . . . 1.0 110.431 -179.78 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.736 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 16.7 pt-20 -156.37 159.85 39.13 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 107.624 -1.25 . . . . 1.0 107.624 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.733 ' HA ' HG13 ' A' ' 107' ' ' VAL . . . -62.91 -23.65 67.46 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.692 0.282 . . . . 1.0 111.625 -174.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.77 -36.57 74.6 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.376 174.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.763 ' NH1' ' HA ' ' A' ' 84' ' ' ASP . 0.7 OUTLIER -97.25 -42.17 7.93 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 115.323 -0.853 . . . . 1.0 111.063 -177.382 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.733 HG13 ' HA ' ' A' ' 104' ' ' ALA . 14.2 p -79.18 114.69 20.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.113 0.482 . . . . 1.0 109.798 -175.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.613 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 27.3 mmm180 -133.32 148.6 51.91 Favored 'General case' 0 C--N 1.318 -0.777 0 O-C-N 121.521 -0.737 . . . . 1.0 110.314 -177.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.59 ' HE2' ' HA ' ' A' ' 90' ' ' ASP . 74.8 mmm -78.91 138.16 37.97 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.454 -0.794 . . . . 1.0 110.526 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.617 HD21 HG12 ' A' ' 87' ' ' VAL . 3.2 tm? -57.66 -50.67 72.39 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 111.488 0.181 . . . . 1.0 111.488 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.435 ' O ' ' HG2' ' A' ' 111' ' ' ARG . 19.1 ttm180 -69.18 -17.99 63.87 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.661 -0.416 . . . . 1.0 110.227 -178.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.527 ' HB2' ' HB2' ' A' ' 109' ' ' MET . 39.3 t -73.48 -5.66 41.46 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.928 -0.309 . . . . 1.0 111.262 -178.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.643 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 88.6 m-85 -92.99 -18.07 23.15 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 121.073 0.463 . . . . 1.0 110.411 175.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.616 ' OD2' ' HG3' ' A' ' 116' ' ' ARG . 17.7 t0 -61.87 125.37 84.83 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.598 -0.728 . . . . 1.0 111.256 -177.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.412 ' HD2' ' OD1' ' A' ' 114' ' ' ASP . 35.9 Cg_endo -60.84 -31.72 91.99 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 123.5 2.8 . . . . 1.0 112.805 -178.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.616 ' HG3' ' OD2' ' A' ' 114' ' ' ASP . 1.0 OUTLIER -93.85 -1.57 54.66 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.828 -0.623 . . . . 1.0 111.809 -177.251 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.604 ' HB2' ' HB3' ' A' ' 114' ' ' ASP . 31.0 t -76.0 46.96 0.41 Allowed 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 111.47 0.174 . . . . 1.0 111.47 -178.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 50.57 -123.18 15.0 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 121.223 -0.513 . . . . 1.0 113.693 -177.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 15.8 m -100.27 -57.92 2.02 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.415 -0.392 . . . . 1.0 111.054 -179.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 5.6 m170 -134.18 154.62 51.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.964 0.412 . . . . 1.0 110.817 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -133.04 98.25 4.23 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.169 -0.923 . . . . 1.0 109.066 176.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -96.05 19.26 11.9 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.343 -0.389 . . . . 1.0 110.524 -177.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -171.27 133.66 0.86 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.062 -0.517 . . . . 1.0 109.731 -177.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.64 ' HB ' ' O ' ' A' ' 89' ' ' LEU . 88.2 t -105.54 148.76 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.596 -0.52 . . . . 1.0 109.596 179.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.33 -177.08 0.12 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.879 0.847 . . . . 1.0 113.081 -177.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.525 ' CG ' ' HD2' ' A' ' 127' ' ' PRO . 9.9 t70 -147.61 150.13 35.87 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 107.619 -1.252 . . . . 1.0 107.619 -176.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.575 ' HB3' ' OD1' ' A' ' 134' ' ' ASP . 28.9 Cg_endo -59.41 161.13 17.84 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 121.865 1.71 . . . . 1.0 111.972 -179.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.533 ' HD2' ' CD2' ' A' ' 129' ' ' TYR . 59.3 t80 -104.37 -30.04 10.36 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.237 -0.585 . . . . 1.0 110.522 -179.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.533 ' CD2' ' HD2' ' A' ' 128' ' ' TYR . 0.1 OUTLIER -143.73 -50.38 0.31 Allowed 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 122.097 -0.377 . . . . 1.0 110.651 -179.607 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.512 ' H ' ' HD1' ' A' ' 129' ' ' TYR . . . 110.79 75.97 0.83 Allowed Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.261 -0.971 . . . . 1.0 113.08 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -143.12 -176.69 5.02 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.327 -0.62 . . . . 1.0 109.327 177.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.525 ' CD2' ' HG3' ' A' ' 136' ' ' GLU . 3.8 t-160 -52.91 -42.9 65.81 Favored 'General case' 0 C--O 1.233 0.206 0 O-C-N 123.297 0.373 . . . . 1.0 110.911 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 4.6 m -64.27 -41.79 96.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.91 0.386 . . . . 1.0 110.605 -177.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.575 ' OD1' ' HB3' ' A' ' 127' ' ' PRO . 8.3 t0 -65.75 -40.21 91.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.407 -0.815 . . . . 1.0 110.546 -178.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.432 ' CE2' ' HB3' ' A' ' 57' ' ' ARG . 11.6 m-85 -68.72 -41.25 79.31 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.0 0.429 . . . . 1.0 110.742 -176.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.525 ' HG3' ' CD2' ' A' ' 132' ' ' HIS . 1.8 mt-10 -73.14 -21.56 60.69 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.44 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -65.08 -47.96 75.41 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.107 -0.701 . . . . 1.0 109.107 175.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.773 ' HA ' HG21 ' A' ' 141' ' ' VAL . 52.7 t -60.85 -42.41 92.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 115.833 -0.621 . . . . 1.0 109.545 176.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.449 ' HB2' HG12 ' A' ' 61' ' ' VAL . 70.0 t80 -54.56 -43.48 72.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.906 -1.043 . . . . 1.0 109.45 176.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.691 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -64.0 -38.53 91.41 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.516 -0.765 . . . . 1.0 110.737 177.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.773 HG21 ' HA ' ' A' ' 138' ' ' VAL . 13.6 t -58.33 -51.9 65.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-O 121.558 0.694 . . . . 1.0 110.067 177.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.437 ' HA ' HD13 ' A' ' 110' ' ' LEU . 5.8 mt -65.44 -50.96 69.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.177 -0.92 . . . . 1.0 111.89 -179.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.691 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 6.8 pt-20 -55.09 -33.47 62.82 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 110.033 -0.358 . . . . 1.0 110.033 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.493 ' HB2' ' O ' ' A' ' 140' ' ' ALA . 1.0 OUTLIER -73.5 -27.69 61.51 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.841 -0.618 . . . . 1.0 110.384 -179.694 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.448 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -86.94 -23.91 24.95 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 116.107 -0.497 . . . . 1.0 111.407 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.727 HD23 ' HB3' ' A' ' 25' ' ' PHE . 16.0 mt -55.22 -37.92 62.01 Favored Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 112.276 0.473 . . . . 1.0 112.276 -178.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 60.8 Cg_endo -71.61 -9.75 25.55 Favored 'Trans proline' 0 C--N 1.362 1.288 0 C-N-CA 122.634 2.222 . . . . 1.0 112.147 177.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.643 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -105.14 -30.86 4.6 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 110.317 -1.113 . . . . 1.0 110.317 178.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.553 HD12 ' CE2' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -75.54 -42.12 53.27 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.3 -1.0 . . . . 1.0 108.3 177.424 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.437 ' HE2' ' HB2' ' A' ' 25' ' ' PHE . 9.9 m170 -54.34 -49.76 69.0 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.087 -0.961 . . . . 1.0 110.777 176.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -61.54 -45.98 91.86 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.584 -0.735 . . . . 1.0 110.764 -177.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . 0.713 ' CE3' HD11 ' A' ' 85' ' ' LEU . 27.8 t90 -59.15 -57.02 14.89 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.914 -1.039 . . . . 1.0 110.722 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 15.8 m -58.88 -38.09 70.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.834 -0.346 . . . . 1.0 110.567 -178.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.51 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 9.9 t70 -58.84 -57.38 13.3 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 122.062 0.934 . . . . 1.0 110.897 178.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.435 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 4.5 pt-20 -62.23 -36.9 83.4 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 113.928 -1.487 . . . . 1.0 110.733 -176.118 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.509 ' HG3' ' CH2' ' A' ' 152' ' ' TRP . 3.8 mmt180 -74.72 -44.72 48.52 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.754 -0.657 . . . . 1.0 111.35 -177.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 3.7 pp -64.03 -26.16 68.44 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.566 -0.531 . . . . 1.0 109.566 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -72.76 -52.06 16.6 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.495 -0.775 . . . . 1.0 110.236 177.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.42 -8.44 55.91 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 112.33 0.493 . . . . 1.0 112.33 -178.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -90.16 8.04 34.93 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.678 0.751 . . . . 1.0 109.82 178.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.47 ' HA2' ' HD3' ' A' ' 162' ' ' PRO . . . -114.67 130.6 9.32 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.344 -0.844 . . . . 1.0 111.719 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.47 ' HD3' ' HA2' ' A' ' 161' ' ' GLY . 2.9 Cg_exo -78.3 -44.71 0.15 Allowed 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 123.658 2.905 . . . . 1.0 112.573 -178.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 51.1 m . . . . . 0 C--O 1.247 0.934 0 CA-C-N 115.363 -0.835 . . . . 1.0 109.75 -178.984 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.831 0 N-CA-C 111.578 -0.609 . . . . 1.0 111.578 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.7 mtm -151.88 153.69 34.67 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.807 0.304 . . . . 1.0 110.192 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.67 -73.93 0.32 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.091 -0.504 . . . . 1.0 111.139 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.553 ' HB2' ' HD2' ' A' ' 4' ' ' PRO . 3.9 p-10 -165.2 159.64 14.35 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-O 121.012 0.434 . . . . 1.0 111.112 -178.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.553 ' HD2' ' HB2' ' A' ' 3' ' ' ASP . 49.5 Cg_endo -72.04 168.04 25.09 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 123.099 2.532 . . . . 1.0 113.174 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.84 ' HB3' HG23 ' A' ' 38' ' ' VAL . 0.9 OUTLIER -73.57 -173.71 1.52 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.411 -0.813 . . . . 1.0 110.879 179.574 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.572 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 1.5 t-160 -158.09 93.93 1.27 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.462 -0.335 . . . . 1.0 111.027 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.781 HG13 HD12 ' A' ' 85' ' ' LEU . 2.3 t -94.28 109.31 21.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.037 -0.727 . . . . 1.0 109.037 176.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.689 ' CG2' ' HG ' ' A' ' 86' ' ' LEU . 12.8 t -112.32 112.98 24.95 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.116 0.484 . . . . 1.0 110.307 178.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.74 ' HZ ' ' HE1' ' A' ' 25' ' ' PHE . 0.9 OUTLIER -82.06 147.1 29.31 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 121.857 -0.527 . . . . 1.0 109.761 179.921 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.641 HG21 HD21 ' A' ' 97' ' ' LEU . 44.3 t -132.74 118.12 32.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.321 0.581 . . . . 1.0 111.634 -176.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.54 ' HB3' HD21 ' A' ' 89' ' ' LEU . 28.7 p -141.29 178.81 7.16 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.524 -0.762 . . . . 1.0 110.092 178.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.501 HG23 ' NE2' ' A' ' 93' ' ' HIS . 0.7 OUTLIER -86.36 86.64 7.34 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.988 0.423 . . . . 1.0 110.971 179.064 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.831 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 135.55 -37.6 1.89 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.656 -0.783 . . . . 1.0 112.077 178.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.464 HD22 ' CB ' ' A' ' 42' ' ' SER . 3.8 t-20 64.01 17.22 10.46 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.59 0.709 . . . . 1.0 111.103 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.0 pt -124.55 11.03 4.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 O-C-N 121.783 -0.573 . . . . 1.0 111.715 -177.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 7.5 p -127.45 -87.36 0.57 Allowed 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 112.112 0.412 . . . . 1.0 112.112 -177.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.68 -44.37 74.17 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 112.323 0.49 . . . . 1.0 112.323 -176.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.712 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 50.9 m -57.37 -58.03 20.92 Favored Pre-proline 0 CA--C 1.538 0.488 0 N-CA-C 112.378 0.51 . . . . 1.0 112.378 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.638 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 49.4 Cg_endo -64.96 -24.48 60.4 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 121.632 1.555 . . . . 1.0 112.071 -177.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.585 ' HB3' HD11 ' A' ' 142' ' ' ILE . 39.9 mmm -61.62 -54.39 43.54 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 121.13 -0.228 . . . . 1.0 110.767 178.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.537 ' O ' ' HD1' ' A' ' 25' ' ' PHE . . . -72.65 -32.02 65.53 Favored 'General case' 0 CA--C 1.507 -0.679 0 C-N-CA 120.615 -0.434 . . . . 1.0 110.124 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.565 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 11.3 tt0 -50.83 -51.79 47.56 Favored 'General case' 0 C--O 1.216 -0.708 0 O-C-N 124.399 1.062 . . . . 1.0 109.988 -178.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.87 ' HB3' ' HG2' ' A' ' 68' ' ' PRO . 0.0 OUTLIER -79.45 -30.33 42.15 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.829 -0.623 . . . . 1.0 110.014 -176.906 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.659 ' HE2' ' HB3' ' A' ' 143' ' ' GLU . 3.2 mmm -62.39 -75.78 0.07 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.436 0.902 . . . . 1.0 113.436 -176.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.74 ' HE1' ' HZ ' ' A' ' 9' ' ' PHE . 0.8 OUTLIER -78.86 -27.81 44.16 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.011 -0.676 . . . . 1.0 111.543 -174.628 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.565 ' HB3' ' O ' ' A' ' 22' ' ' GLU . . . -64.62 -37.16 86.63 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 118.934 -1.106 . . . . 1.0 110.262 177.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.706 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -63.48 -39.44 94.46 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.76 -0.83 . . . . 1.0 108.76 177.417 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.573 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 77.6 mt-30 -59.67 -45.02 93.3 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.982 -0.554 . . . . 1.0 110.39 176.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.602 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 90.8 mt -54.46 -61.38 2.34 Favored 'General case' 0 N--CA 1.461 0.094 0 CA-C-N 115.751 -0.659 . . . . 1.0 111.078 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.6 ' HD3' ' HA ' ' A' ' 27' ' ' GLN . 3.2 ptm180 -58.53 -39.72 80.96 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.211 -0.449 . . . . 1.0 111.47 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -62.27 -22.52 66.07 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 112.176 0.435 . . . . 1.0 112.176 178.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.602 ' HG2' ' O ' ' A' ' 29' ' ' LEU . 5.7 ptm85 -99.89 -17.79 17.44 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 119.346 -0.941 . . . . 1.0 110.158 178.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.17 35.75 2.86 Favored Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 115.016 -0.993 . . . . 1.0 112.077 177.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.501 ' HG ' ' HG3' ' A' ' 32' ' ' ARG . 43.5 mt -126.88 -1.28 6.61 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.739 0.304 . . . . 1.0 110.346 -178.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.32 -28.0 54.12 Favored Glycine 0 N--CA 1.46 0.288 0 CA-C-N 116.027 -0.533 . . . . 1.0 112.897 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.482 ' O ' ' HB3' ' A' ' 4' ' ' PRO . 4.9 m-20 -89.7 -22.36 22.26 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.666 0.27 . . . . 1.0 110.55 177.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.04 -26.33 39.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.033 -0.53 . . . . 1.0 111.497 -179.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.84 HG23 ' HB3' ' A' ' 5' ' ' LEU . 1.1 p -143.83 124.02 8.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.37 0.605 . . . . 1.0 110.198 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.417 ' HE ' ' HG3' ' A' ' 4' ' ' PRO . 17.7 mmt85 -90.17 147.42 23.59 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.287 -0.87 . . . . 1.0 109.704 -178.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 74.7 t -132.64 117.27 30.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.557 0.694 . . . . 1.0 110.584 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.498 ' O ' ' HA ' ' A' ' 8' ' ' THR . 69.8 p -132.23 -174.15 3.36 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.502 -1.226 . . . . 1.0 110.419 -177.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.712 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 93.2 p -160.98 168.91 23.62 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.806 -0.357 . . . . 1.0 110.58 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.576 ' HB1' ' CD2' ' A' ' 80' ' ' HIS . . . -163.96 167.44 20.55 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.186 0.517 . . . . 1.0 111.291 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -125.75 135.74 9.34 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 115.355 -0.839 . . . . 1.0 111.023 176.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.643 HG21 HD13 ' A' ' 96' ' ' LEU . 23.5 p -70.59 -26.47 63.53 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.315 0.487 . . . . 1.0 112.315 -177.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.458 ' HA3' ' CZ3' ' A' ' 48' ' ' TRP . . . -108.11 9.61 36.58 Favored Glycine 0 C--O 1.229 -0.179 0 C-N-CA 120.717 -0.754 . . . . 1.0 112.796 -177.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 42.97 38.87 1.55 Allowed 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.344 0.868 . . . . 1.0 113.344 178.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.831 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 1.1 m-90 -46.38 -75.34 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.326 0.584 . . . . 1.0 112.48 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.483 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 8.1 m-70 -106.42 41.31 1.45 Allowed 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.259 -0.882 . . . . 1.0 111.046 -179.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.528 HG21 ' HA ' ' A' ' 74' ' ' ALA . 15.0 p -61.27 125.01 16.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 120.471 -0.492 . . . . 1.0 110.281 178.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.42 -12.5 66.4 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.903 -0.665 . . . . 1.0 111.763 -177.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.409 ' CB ' ' HB3' ' A' ' 49' ' ' HIS . 2.8 t -81.15 -160.33 0.32 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.228 0.537 . . . . 1.0 110.08 178.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 34.9 t -129.87 171.45 12.72 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.465 -0.788 . . . . 1.0 109.325 -178.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.26 140.85 37.71 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.745 0.307 . . . . 1.0 111.464 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -59.47 141.35 54.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.605 -0.725 . . . . 1.0 111.52 -177.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -51.58 -28.89 15.36 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 113.378 0.881 . . . . 1.0 113.378 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.675 ' O ' HG23 ' A' ' 61' ' ' VAL . 18.9 mtp180 -68.46 -50.61 51.24 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 118.524 0.602 . . . . 1.0 109.506 178.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.21 -32.37 72.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.145 -0.934 . . . . 1.0 110.568 -176.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.85 -46.6 88.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.135 178.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.88 -37.81 95.51 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.667 -0.778 . . . . 1.0 111.843 177.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.675 HG23 ' O ' ' A' ' 57' ' ' ARG . 58.1 t -63.2 -58.95 5.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.21 0.529 . . . . 1.0 111.282 179.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.716 ' HB2' HG23 ' A' ' 69' ' ' THR . 92.3 mt -58.3 -53.16 61.38 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.745 -0.661 . . . . 1.0 111.356 -177.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -59.23 -29.71 67.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.44 -0.346 . . . . 1.0 111.083 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.79 -33.33 73.69 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.231 0.538 . . . . 1.0 111.03 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -98.8 6.37 46.92 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.065 -0.516 . . . . 1.0 111.216 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.23 13.81 63.23 Favored Glycine 0 C--N 1.332 0.323 0 CA-C-N 115.642 -0.708 . . . . 1.0 112.961 176.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -90.59 151.64 44.25 Favored Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 110.554 -0.165 . . . . 1.0 110.554 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.87 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 46.9 Cg_endo -70.2 160.07 50.87 Favored 'Trans proline' 0 CA--C 1.515 -0.428 0 C-N-CA 122.481 2.121 . . . . 1.0 111.111 176.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.716 HG23 ' HB2' ' A' ' 62' ' ' LEU . 65.8 p -134.1 4.11 3.47 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.419 -0.513 . . . . 1.0 111.697 -177.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -74.38 126.75 31.37 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.398 -0.364 . . . . 1.0 110.075 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.861 ' HB2' ' HE3' ' A' ' 23' ' ' LYS . 28.8 t60 -166.28 150.29 7.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.638 -0.256 . . . . 1.0 110.802 -176.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -131.03 110.22 11.07 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.905 -1.146 . . . . 1.0 107.905 177.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 49' ' ' HIS . . . -58.57 139.92 55.06 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.896 -1.047 . . . . 1.0 112.412 -174.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.528 ' HA ' HG21 ' A' ' 50' ' ' VAL . . . -130.81 165.55 22.75 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.789 -0.642 . . . . 1.0 110.478 178.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -101.52 159.31 15.4 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.017 -0.735 . . . . 1.0 109.017 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.538 HG12 HD22 ' A' ' 97' ' ' LEU . 96.5 t -66.87 110.56 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.903 0.383 . . . . 1.0 110.61 179.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.466 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -127.52 -169.43 12.67 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.696 -0.684 . . . . 1.0 112.324 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 99.1 m -54.51 -52.03 63.26 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 123.457 0.703 . . . . 1.0 112.595 -178.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.582 ' HG2' ' N ' ' A' ' 80' ' ' HIS . 0.8 OUTLIER -58.19 -29.84 65.96 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.281 0.562 . . . . 1.0 110.523 -178.204 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.582 ' N ' ' HG2' ' A' ' 79' ' ' GLU . 79.9 m80 -76.59 -42.77 41.34 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.535 -0.757 . . . . 1.0 110.014 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.637 ' O ' HG23 ' A' ' 102' ' ' VAL . 17.3 mt -67.71 -18.85 65.05 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.118 0.485 . . . . 1.0 110.681 177.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.69 -7.92 57.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.936 0.398 . . . . 1.0 110.494 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.572 ' HB2' ' O ' ' A' ' 6' ' ' HIS . . . -60.74 152.69 26.16 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.64 -0.709 . . . . 1.0 111.099 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.455 ' HB3' ' HG ' ' A' ' 5' ' ' LEU . 26.0 t70 -79.47 -15.13 58.3 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.991 -0.55 . . . . 1.0 109.775 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.781 HD12 HG13 ' A' ' 7' ' ' VAL . 0.4 OUTLIER -153.62 117.33 4.7 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 115.573 -0.74 . . . . 1.0 109.862 -177.16 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.689 ' HG ' ' CG2' ' A' ' 8' ' ' THR . 5.0 mp -109.45 105.98 15.55 Favored 'General case' 0 N--CA 1.427 -1.599 0 CA-C-N 115.42 -0.809 . . . . 1.0 109.865 177.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.664 ' HB ' ' HD1' ' A' ' 9' ' ' PHE . 64.7 t -85.43 91.8 3.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.014 -0.994 . . . . 1.0 111.389 -175.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.06 149.92 30.5 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.307 -0.861 . . . . 1.0 110.884 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.54 HD21 ' HB3' ' A' ' 11' ' ' CYS . 3.9 mm? -96.26 -10.55 27.67 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.844 -0.616 . . . . 1.0 110.674 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.536 ' HA ' ' HE2' ' A' ' 109' ' ' MET . 9.7 p30 -156.5 167.89 29.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.463 0.649 . . . . 1.0 111.85 175.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -57.3 -24.61 56.08 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.165 -1.38 . . . . 1.0 112.636 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.611 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 91.1 m-20 -76.43 -53.88 7.51 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.837 0.351 . . . . 1.0 110.656 -176.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.506 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 13.2 m170 -58.94 -42.61 90.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.223 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.55 -43.5 97.18 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.999 0.428 . . . . 1.0 110.586 178.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.443 HH11 ' HD3' ' A' ' 95' ' ' ARG . 5.0 ttm-85 -57.9 -43.62 86.27 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 115.508 -0.769 . . . . 1.0 110.999 177.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.643 HD13 HG21 ' A' ' 45' ' ' THR . 55.6 mt -65.88 -50.51 64.24 Favored 'General case' 0 C--O 1.217 -0.633 0 CA-C-N 115.906 -0.588 . . . . 1.0 110.365 -176.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.641 HD21 HG21 ' A' ' 10' ' ' VAL . 30.5 mt -51.87 -56.1 16.1 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.055 -0.521 . . . . 1.0 111.135 -178.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.706 ' CA ' HG11 ' A' ' 102' ' ' VAL . 14.2 ptt85 -62.37 -43.1 99.61 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.546 0.573 . . . . 1.0 112.546 -178.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.538 ' HG3' ' O ' ' A' ' 96' ' ' LEU . 0.9 OUTLIER -67.36 -26.77 66.64 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.592 -0.443 . . . . 1.0 110.045 179.262 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.508 HD13 ' O ' ' A' ' 96' ' ' LEU . 5.4 mp -76.51 -20.26 57.12 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 116.088 -0.505 . . . . 1.0 111.818 178.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 153.2 -22.38 0.76 Allowed Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 119.465 -1.35 . . . . 1.0 113.927 -177.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.98 HG21 ' HD2' ' A' ' 106' ' ' ARG . 0.4 OUTLIER -76.42 -163.52 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-N 117.633 0.717 . . . . 1.0 110.33 -178.756 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.65 ' N ' HG13 ' A' ' 102' ' ' VAL . 12.7 pt-20 -159.05 162.64 36.66 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 107.369 -1.345 . . . . 1.0 107.369 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.737 ' HA ' HG13 ' A' ' 107' ' ' VAL . . . -62.14 -24.72 67.34 Favored 'General case' 0 C--N 1.322 -0.617 0 O-C-N 123.135 0.272 . . . . 1.0 111.421 -175.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.438 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . . . -56.57 -38.05 71.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.42 0.628 . . . . 1.0 110.06 175.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.98 ' HD2' HG21 ' A' ' 102' ' ' VAL . 20.4 mtt180 -97.65 -43.64 7.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.755 -1.111 . . . . 1.0 111.12 -176.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.737 HG13 ' HA ' ' A' ' 104' ' ' ALA . 10.7 p -79.62 118.79 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-O 121.037 0.446 . . . . 1.0 110.187 -174.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.66 ' HD2' ' O ' ' A' ' 107' ' ' VAL . 19.6 mmm180 -137.37 149.53 47.05 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.386 0.612 . . . . 1.0 111.076 -178.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.536 ' HE2' ' HA ' ' A' ' 90' ' ' ASP . 80.3 mmm -80.25 137.58 36.66 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.185 -0.916 . . . . 1.0 110.692 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.518 HD21 HG11 ' A' ' 87' ' ' VAL . 3.1 tm? -58.71 -49.26 78.26 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.868 0.366 . . . . 1.0 111.09 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.735 ' HB2' HG23 ' A' ' 124' ' ' VAL . 1.2 ttt180 -69.42 -16.7 63.55 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.171 -177.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.448 ' HB2' ' HB2' ' A' ' 109' ' ' MET . 37.4 t -78.38 -7.76 57.69 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 116.147 -0.478 . . . . 1.0 111.355 -178.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.506 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 92.4 m-85 -91.15 -21.58 21.1 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 109.821 -0.436 . . . . 1.0 109.821 175.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -63.99 124.13 84.22 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 115.766 -0.652 . . . . 1.0 110.556 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -72.05 -17.38 28.36 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.441 2.094 . . . . 1.0 112.242 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.447 HH11 ' HD3' ' A' ' 116' ' ' ARG . 47.5 mtt180 -93.05 -5.05 51.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.703 -0.68 . . . . 1.0 111.353 -177.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 68.2 p -58.98 -59.87 4.78 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.13 -0.486 . . . . 1.0 111.336 -177.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 151.79 -103.74 0.25 Allowed Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 111.291 -0.724 . . . . 1.0 111.291 178.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 26.7 m -109.69 -51.04 2.92 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.118 0.485 . . . . 1.0 109.852 177.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -150.55 147.75 27.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.902 -0.59 . . . . 1.0 110.012 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -126.92 99.31 5.68 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.379 -0.373 . . . . 1.0 110.179 177.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.409 ' HA ' ' HG3' ' A' ' 109' ' ' MET . 2.9 mm? -97.98 19.26 14.22 Favored 'General case' 0 CA--C 1.505 -0.759 0 CA-C-O 121.071 0.462 . . . . 1.0 110.691 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.408 ' N ' ' HE1' ' A' ' 109' ' ' MET . 0.8 OUTLIER -170.63 144.79 2.41 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 115.24 -0.891 . . . . 1.0 109.852 178.18 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.735 HG23 ' HB2' ' A' ' 111' ' ' ARG . 70.0 t -104.65 145.79 12.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.934 -0.765 . . . . 1.0 108.934 178.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.67 -174.68 0.05 OUTLIER 'General case' 0 C--O 1.24 0.601 0 CA-C-O 122.073 0.94 . . . . 1.0 113.39 -176.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -143.35 143.77 25.55 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 114.379 -1.282 . . . . 1.0 108.574 -174.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.697 ' HB3' ' OD1' ' A' ' 134' ' ' ASP . 10.1 Cg_endo -50.45 152.86 8.19 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 123.096 2.531 . . . . 1.0 112.896 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -84.26 -33.83 23.95 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.29 -0.868 . . . . 1.0 109.593 -179.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -147.24 -38.98 0.2 Allowed 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.364 -0.835 . . . . 1.0 111.529 -179.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.466 ' HA2' ' OD2' ' A' ' 134' ' ' ASP . . . 103.98 65.87 0.7 Allowed Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.113 -0.795 . . . . 1.0 111.113 -177.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.563 ' H ' ' HB3' ' A' ' 134' ' ' ASP . 1.7 t70 -140.19 -172.54 3.44 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.104 -0.332 . . . . 1.0 110.104 -176.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -52.41 -47.32 66.38 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.915 0.339 . . . . 1.0 111.915 -176.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 33.1 t -62.57 -36.14 81.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.945 0.402 . . . . 1.0 110.638 -178.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.697 ' OD1' ' HB3' ' A' ' 127' ' ' PRO . 0.0 OUTLIER -68.77 -35.95 77.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.988 -0.551 . . . . 1.0 111.837 -178.303 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.438 ' HB3' ' CG2' ' A' ' 61' ' ' VAL . 5.7 m-85 -66.43 -45.93 78.18 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.917 -0.772 . . . . 1.0 108.917 -178.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -71.65 -25.89 62.32 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.834 -1.076 . . . . 1.0 110.959 -178.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -63.19 -50.94 68.32 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.77 -0.456 . . . . 1.0 109.77 177.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.986 ' HA ' HG22 ' A' ' 141' ' ' VAL . 96.1 t -61.27 -40.41 85.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.402 0.62 . . . . 1.0 109.979 178.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.456 ' HB2' HG11 ' A' ' 61' ' ' VAL . 22.9 t80 -53.49 -45.01 69.47 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.865 -1.061 . . . . 1.0 109.459 175.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.602 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -64.19 -40.16 95.5 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.393 -0.821 . . . . 1.0 110.543 177.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.986 HG22 ' HA ' ' A' ' 138' ' ' VAL . 13.9 t -55.44 -53.16 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-O 121.619 0.723 . . . . 1.0 109.908 177.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.585 HD11 ' HB3' ' A' ' 20' ' ' MET . 5.7 mt -63.99 -51.66 66.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 114.945 -1.025 . . . . 1.0 111.812 -178.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.659 ' HB3' ' HE2' ' A' ' 24' ' ' MET . 8.0 pt-20 -57.89 -30.2 65.66 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.74 -0.384 . . . . 1.0 110.397 -179.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 2.4 t -74.87 -26.7 59.85 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 121.253 0.549 . . . . 1.0 110.001 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.476 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -85.88 -25.81 25.97 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-N 115.794 -0.639 . . . . 1.0 111.277 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.681 HD22 ' HB3' ' A' ' 25' ' ' PHE . 16.7 mt -56.17 -36.4 45.72 Favored Pre-proline 0 CA--C 1.547 0.851 0 N-CA-C 112.719 0.637 . . . . 1.0 112.719 -178.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 43.9 Cg_endo -68.02 -14.4 40.92 Favored 'Trans proline' 0 C--N 1.364 1.357 0 C-N-CA 122.59 2.193 . . . . 1.0 111.495 177.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.506 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -103.29 -33.62 4.18 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 114.577 -1.192 . . . . 1.0 110.375 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.476 ' O ' HG13 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -73.19 -41.8 63.43 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 108.416 -0.957 . . . . 1.0 108.416 178.855 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.587 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 0.2 OUTLIER -53.93 -55.87 23.0 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-N 115.067 -0.969 . . . . 1.0 110.506 175.217 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -56.78 -42.92 80.28 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.764 -1.107 . . . . 1.0 110.781 -174.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . 0.701 ' HZ3' HD21 ' A' ' 5' ' ' LEU . 26.2 t90 -62.84 -56.17 19.73 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.181 -0.918 . . . . 1.0 110.286 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.476 HG13 ' O ' ' A' ' 149' ' ' LEU . 9.7 m -60.35 -40.3 83.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.904 -0.318 . . . . 1.0 110.463 -178.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.419 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 1.4 m-20 -60.46 -51.88 67.57 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 123.425 0.453 . . . . 1.0 111.042 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 7.9 pt-20 -63.32 -37.82 88.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.789 -0.641 . . . . 1.0 110.6 -178.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.517 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 10.4 mmt85 -72.84 -46.45 52.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.834 -0.621 . . . . 1.0 111.115 -176.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 4.0 pp -63.9 -26.05 68.43 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.658 -0.701 . . . . 1.0 109.686 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -71.73 -50.39 30.58 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.188 177.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.494 ' C ' ' H ' ' A' ' 161' ' ' GLY . 0.2 OUTLIER -78.55 4.9 12.13 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.752 0.649 . . . . 1.0 112.752 -179.259 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -69.58 13.85 0.12 Allowed 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.21 0.528 . . . . 1.0 111.809 177.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.494 ' H ' ' C ' ' A' ' 159' ' ' ARG . . . 92.5 149.02 23.93 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.94 -0.647 . . . . 1.0 112.437 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.485 ' O ' ' HB2' ' A' ' 163' ' ' SER . 43.5 Cg_endo -92.29 14.29 1.75 Allowed 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.555 2.17 . . . . 1.0 113.786 -177.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.485 ' HB2' ' O ' ' A' ' 162' ' ' PRO . 6.5 t . . . . . 0 C--N 1.314 -0.976 0 CA-C-N 115.029 -0.987 . . . . 1.0 110.329 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.074 0 N-CA-C 112.072 -0.411 . . . . 1.0 112.072 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -77.83 142.03 38.81 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.209 0.528 . . . . 1.0 111.184 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.8 m -87.76 125.04 34.2 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.522 -0.763 . . . . 1.0 110.351 -179.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.783 ' HB3' ' HD2' ' A' ' 4' ' ' PRO . 4.1 m-20 -66.65 166.58 17.43 Favored Pre-proline 0 C--N 1.329 -0.324 0 C-N-CA 120.622 -0.431 . . . . 1.0 110.824 177.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.783 ' HD2' ' HB3' ' A' ' 3' ' ' ASP . 39.9 Cg_endo -70.01 169.55 18.96 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 123.457 2.771 . . . . 1.0 113.481 -178.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.784 ' HB3' HG22 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -66.51 177.84 1.43 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.016 -0.993 . . . . 1.0 109.688 178.417 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.551 ' HB3' ' H ' ' A' ' 84' ' ' ASP . 3.3 t-160 -156.17 90.08 1.18 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 121.98 -0.45 . . . . 1.0 110.493 -179.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.716 HG13 HD13 ' A' ' 85' ' ' LEU . 2.0 t -94.33 113.17 28.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 N-CA-C 109.321 -0.622 . . . . 1.0 109.321 177.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.576 ' CG2' ' HG ' ' A' ' 86' ' ' LEU . 8.5 t -115.31 114.24 24.91 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.03 0.443 . . . . 1.0 110.589 178.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.629 ' HD2' ' HB3' ' A' ' 42' ' ' SER . 1.5 m-85 -84.71 132.83 34.41 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 122.138 -0.351 . . . . 1.0 110.744 -178.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.715 HG23 HD22 ' A' ' 97' ' ' LEU . 32.9 t -118.18 115.64 48.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.293 0.568 . . . . 1.0 111.975 -176.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.606 ' SG ' ' HD2' ' A' ' 17' ' ' ARG . 52.5 t -144.79 159.38 42.96 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.731 -0.668 . . . . 1.0 109.578 178.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -72.02 97.92 1.98 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.939 0.4 . . . . 1.0 110.336 178.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.888 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 127.88 -43.27 1.35 Allowed Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.481 -0.782 . . . . 1.0 111.549 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.417 HD22 ' CB ' ' A' ' 42' ' ' SER . 3.8 t-20 64.66 11.98 7.19 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 121.361 0.6 . . . . 1.0 111.752 179.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.447 ' HA ' ' HG3' ' A' ' 19' ' ' PRO . 7.5 pt -119.61 11.54 6.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 O-C-N 121.69 -0.631 . . . . 1.0 111.395 -178.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.1 p -127.36 -88.31 0.56 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.208 -0.451 . . . . 1.0 112.015 -178.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.606 ' HD2' ' SG ' ' A' ' 11' ' ' CYS . 57.7 mtt85 -63.54 -52.33 61.6 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 120.95 0.405 . . . . 1.0 111.845 -176.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.693 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 14.1 m -53.16 -58.37 12.73 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 115.666 -0.697 . . . . 1.0 112.679 -178.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.502 ' HD3' ' HB2' ' A' ' 18' ' ' SER . 57.7 Cg_endo -67.92 -20.72 44.79 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 121.556 1.504 . . . . 1.0 112.51 -176.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.585 ' HA ' HD12 ' A' ' 62' ' ' LEU . 47.2 mmm -61.89 -54.09 46.75 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 110.221 -0.288 . . . . 1.0 110.221 177.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.468 ' HA ' ' HB2' ' A' ' 24' ' ' MET . . . -74.9 -26.1 59.4 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 116.134 -0.485 . . . . 1.0 110.401 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.498 ' HA ' ' CE2' ' A' ' 9' ' ' PHE . 16.3 tt0 -51.29 -54.56 24.8 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.028 -0.987 . . . . 1.0 109.992 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.661 ' O ' ' HB3' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -85.69 -22.98 27.61 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.267 -0.879 . . . . 1.0 110.383 -176.023 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.67 ' HB3' HD12 ' A' ' 146' ' ' LEU . 6.3 mmm -63.03 -76.12 0.07 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.381 0.61 . . . . 1.0 112.592 -178.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.725 ' HB3' HD21 ' A' ' 146' ' ' LEU . 24.9 p90 -77.13 -29.63 54.77 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 119.864 -0.734 . . . . 1.0 111.546 -175.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.486 ' HB2' HG13 ' A' ' 40' ' ' VAL . . . -64.39 -38.2 90.19 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 119.493 -0.883 . . . . 1.0 110.817 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.936 ' HA ' ' HE ' ' A' ' 30' ' ' ARG . 0.1 OUTLIER -62.53 -39.68 94.34 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.906 -0.776 . . . . 1.0 108.906 177.03 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.606 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 79.2 mt-30 -59.06 -43.78 91.75 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.653 -0.703 . . . . 1.0 110.589 176.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 25' ' ' PHE . 92.5 mt -54.22 -62.68 1.5 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.942 -0.572 . . . . 1.0 111.207 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.936 ' HE ' ' HA ' ' A' ' 27' ' ' GLN . 0.1 OUTLIER -58.93 -34.04 71.27 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 120.559 -0.456 . . . . 1.0 111.466 178.683 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.0 m170 -62.12 -28.63 69.77 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.422 0.527 . . . . 1.0 112.422 177.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.533 ' HG2' ' O ' ' A' ' 28' ' ' GLN . 9.2 ptp180 -95.33 -20.29 19.26 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 119.535 -0.866 . . . . 1.0 110.101 178.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 108.17 39.32 1.84 Allowed Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.034 -0.985 . . . . 1.0 111.992 177.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 25.0 mt -131.03 2.21 4.31 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.567 -0.531 . . . . 1.0 109.567 -178.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -53.75 -35.73 53.27 Favored Glycine 0 C--O 1.226 -0.364 0 CA-C-N 115.545 -0.752 . . . . 1.0 113.35 -178.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.466 ' HA ' ' NH1' ' A' ' 39' ' ' ARG . 0.3 OUTLIER -86.94 -19.17 29.19 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 122.489 -0.418 . . . . 1.0 110.138 -179.86 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.89 -22.13 43.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.878 -0.601 . . . . 1.0 111.373 -177.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.784 HG22 ' HB3' ' A' ' 5' ' ' LEU . 0.4 OUTLIER -143.09 123.62 10.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.064 0.459 . . . . 1.0 110.66 -179.727 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.466 ' NH1' ' HA ' ' A' ' 36' ' ' ASP . 29.0 mmt180 -89.05 144.56 26.06 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.011 -0.541 . . . . 1.0 109.65 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.486 HG13 ' HB2' ' A' ' 26' ' ' ALA . 48.9 t -132.04 122.58 49.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 121.838 0.828 . . . . 1.0 110.234 -177.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.5 ' O ' ' HA ' ' A' ' 8' ' ' THR . 76.8 p -137.13 -176.87 4.53 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.203 -1.362 . . . . 1.0 110.511 -174.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.693 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 88.2 p -160.81 166.35 28.73 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.866 -0.334 . . . . 1.0 110.235 179.043 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.589 ' HB1' ' CD2' ' A' ' 80' ' ' HIS . . . -164.65 168.15 18.38 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.271 0.557 . . . . 1.0 111.353 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -125.83 132.81 8.04 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.26 -0.882 . . . . 1.0 110.997 177.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.572 HG21 ' CG1' ' A' ' 10' ' ' VAL . 26.0 p -68.77 -22.74 64.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.795 0.331 . . . . 1.0 111.831 -177.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.407 ' HA3' ' HZ3' ' A' ' 48' ' ' TRP . . . -112.41 9.11 26.47 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.875 -0.679 . . . . 1.0 113.133 -177.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 43.83 37.34 1.63 Allowed 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 114.156 1.169 . . . . 1.0 114.156 177.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.888 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 1.2 m-90 -45.77 -73.66 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.454 0.645 . . . . 1.0 112.404 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.48 ' O ' ' HB2' ' A' ' 73' ' ' ALA . 12.4 m-70 -106.06 40.84 1.51 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.248 -0.887 . . . . 1.0 111.063 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.0 p -60.18 129.37 22.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 120.65 -0.42 . . . . 1.0 110.375 179.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.25 -13.61 65.91 Favored Glycine 0 C--O 1.227 -0.33 0 C-N-CA 121.033 -0.603 . . . . 1.0 111.87 -177.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.5 t -80.58 -161.12 0.35 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.636 -0.505 . . . . 1.0 109.636 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 33.6 t -126.33 175.18 8.02 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.585 -0.894 . . . . 1.0 108.585 -178.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.14 141.08 47.44 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 123.098 0.248 . . . . 1.0 110.482 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.54 ' OD2' ' HG2' ' A' ' 57' ' ' ARG . 18.6 t70 -62.1 143.42 56.7 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.841 -177.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -46.69 -36.39 7.05 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.973 -1.012 . . . . 1.0 112.819 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.657 ' O ' HG22 ' A' ' 61' ' ' VAL . 19.3 ptp180 -69.69 -47.11 64.35 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 121.033 -0.267 . . . . 1.0 110.686 -176.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.408 ' HB2' ' SD ' ' A' ' 20' ' ' MET . . . -71.49 -31.96 67.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.097 0.475 . . . . 1.0 110.471 -177.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.14 -55.08 38.19 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.112 -0.699 . . . . 1.0 109.112 176.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -58.31 -39.69 93.0 Favored Glycine 0 N--CA 1.441 -1.009 0 CA-C-N 115.853 -0.612 . . . . 1.0 111.924 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.657 HG22 ' O ' ' A' ' 57' ' ' ARG . 98.7 t -58.98 -58.94 4.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.065 0.46 . . . . 1.0 110.992 177.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.605 HD13 ' HG3' ' A' ' 23' ' ' LYS . 87.7 mt -59.77 -52.46 65.36 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.881 -0.6 . . . . 1.0 111.61 -177.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.575 ' HB3' HG23 ' A' ' 69' ' ' THR . 0.0 OUTLIER -61.34 -33.31 73.41 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.727 -178.997 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.71 -32.93 74.13 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.212 0.53 . . . . 1.0 110.667 179.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -95.68 2.39 54.0 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.646 -0.706 . . . . 1.0 111.078 -178.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 94.12 9.51 59.35 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.978 -0.629 . . . . 1.0 113.531 176.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -90.68 152.15 44.62 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 110.061 -0.348 . . . . 1.0 110.061 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.546 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 36.0 Cg_endo -67.31 157.56 61.15 Favored 'Trans proline' 0 CA--C 1.512 -0.609 0 C-N-CA 122.189 1.926 . . . . 1.0 110.756 176.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.575 HG23 ' HB3' ' A' ' 63' ' ' ARG . 63.2 p -130.65 11.46 5.26 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 120.365 -0.534 . . . . 1.0 111.644 -176.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -80.87 133.51 35.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.77 -0.65 . . . . 1.0 110.087 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 51.7 t60 -169.22 152.24 4.93 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.892 0.377 . . . . 1.0 110.659 -176.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.431 ' HD3' ' HA ' ' A' ' 72' ' ' ARG . 9.4 tpp180 -133.93 110.86 10.0 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 108.084 -1.08 . . . . 1.0 108.084 175.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.48 ' HB2' ' O ' ' A' ' 49' ' ' HIS . . . -60.34 137.72 58.09 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.288 -0.869 . . . . 1.0 112.176 -175.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -130.96 160.25 35.08 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.437 -0.801 . . . . 1.0 110.013 178.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -97.43 154.82 17.23 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.026 -0.731 . . . . 1.0 109.026 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.511 HG13 HD23 ' A' ' 97' ' ' LEU . 14.5 t -67.35 113.19 3.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.053 0.454 . . . . 1.0 110.725 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.444 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -124.19 -169.59 13.12 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.128 -0.942 . . . . 1.0 111.538 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 97.9 m -58.51 -44.48 89.48 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 122.275 0.23 . . . . 1.0 111.548 -178.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -60.4 -28.48 68.26 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.937 0.399 . . . . 1.0 111.183 178.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.589 ' CD2' ' HB1' ' A' ' 43' ' ' ALA . 78.8 m80 -77.67 -41.43 38.2 Favored 'General case' 0 C--O 1.223 -0.297 0 N-CA-C 109.763 -0.458 . . . . 1.0 109.763 179.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.658 ' O ' HG23 ' A' ' 102' ' ' VAL . 15.6 mt -69.83 -14.42 62.75 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.6 177.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -88.49 -7.55 56.34 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 120.884 0.373 . . . . 1.0 110.618 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.547 ' HB2' ' O ' ' A' ' 6' ' ' HIS . . . -59.94 150.38 29.0 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.805 -0.634 . . . . 1.0 111.407 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.698 ' HB3' HD12 ' A' ' 5' ' ' LEU . 15.3 t70 -75.4 -15.19 60.48 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.941 -0.392 . . . . 1.0 109.941 178.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.716 HD13 HG13 ' A' ' 7' ' ' VAL . 0.5 OUTLIER -154.66 119.63 4.94 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 109.245 -0.65 . . . . 1.0 109.245 -177.787 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.659 ' HB3' HD11 ' A' ' 97' ' ' LEU . 5.1 mp -109.8 104.74 13.75 Favored 'General case' 0 N--CA 1.426 -1.652 0 CA-C-N 115.531 -0.759 . . . . 1.0 109.735 177.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.582 ' HA ' ' O ' ' A' ' 108' ' ' ARG . 53.6 t -83.79 91.54 2.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 114.924 -1.035 . . . . 1.0 111.115 -176.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.13 145.73 33.57 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.397 -0.82 . . . . 1.0 110.29 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.622 ' O ' ' HB ' ' A' ' 124' ' ' VAL . 3.9 mm? -99.35 -8.04 25.4 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.026 -0.534 . . . . 1.0 110.361 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.427 ' CG ' ' H ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -151.76 152.48 32.77 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.662 -0.699 . . . . 1.0 110.858 179.15 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.553 ' HB3' ' O ' ' A' ' 122' ' ' LEU . 11.4 ptm180 -58.16 -24.01 57.37 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.21 0.818 . . . . 1.0 113.21 -177.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.672 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 9.7 m120 -77.1 -48.07 18.76 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.933 -0.395 . . . . 1.0 109.933 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.547 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 11.7 m170 -56.6 -44.24 80.91 Favored 'General case' 0 N--CA 1.461 0.094 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.031 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.65 -45.17 92.81 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.952 178.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.6 ttt180 -59.26 -39.89 84.29 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.11 -0.496 . . . . 1.0 111.152 178.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.697 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 48.7 mt -66.16 -48.87 69.33 Favored 'General case' 0 C--O 1.218 -0.58 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.304 -176.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.715 HD22 HG23 ' A' ' 10' ' ' VAL . 36.2 mt -52.89 -58.39 7.07 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.086 -0.506 . . . . 1.0 111.374 -179.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.775 ' HA ' HG13 ' A' ' 102' ' ' VAL . 1.3 ptt180 -58.34 -44.69 88.83 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.801 -0.636 . . . . 1.0 111.811 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.636 ' HG3' ' O ' ' A' ' 96' ' ' LEU . 1.1 pp0? -67.8 -25.27 65.5 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.043 0.449 . . . . 1.0 109.948 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.697 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 13.2 mt -79.67 -12.6 59.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.668 -0.696 . . . . 1.0 111.612 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 145.99 -22.25 1.77 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 119.863 -1.16 . . . . 1.0 113.935 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.775 HG13 ' HA ' ' A' ' 98' ' ' ARG . 0.4 OUTLIER -75.93 -163.19 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 CA-C-N 117.419 0.609 . . . . 1.0 110.463 -178.813 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.726 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 12.4 pt-20 -155.87 163.11 40.21 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.702 -1.221 . . . . 1.0 107.702 -179.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.782 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -63.03 -24.98 68.17 Favored 'General case' 0 C--N 1.321 -0.664 0 O-C-N 123.186 0.304 . . . . 1.0 111.459 -175.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.2 -36.82 73.67 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.189 0.519 . . . . 1.0 110.042 175.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.726 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 5.5 mtt-85 -97.23 -42.42 7.82 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 115.368 -0.833 . . . . 1.0 111.6 -176.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.782 HG12 ' HA ' ' A' ' 104' ' ' ALA . 11.9 p -77.55 118.68 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 109.354 -0.61 . . . . 1.0 109.354 -175.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.582 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 16.1 mmm180 -138.64 147.31 42.73 Favored 'General case' 0 C--N 1.319 -0.755 0 O-C-N 121.623 -0.673 . . . . 1.0 110.764 -178.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.478 ' HB2' ' HB2' ' A' ' 112' ' ' SER . 77.1 mmm -79.76 137.54 37.03 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.523 -0.762 . . . . 1.0 110.639 179.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.496 HD22 HG13 ' A' ' 87' ' ' VAL . 3.1 tm? -57.5 -49.97 74.56 Favored 'General case' 0 N--CA 1.465 0.303 0 O-C-N 123.16 0.287 . . . . 1.0 111.221 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.43 ' CB ' HG22 ' A' ' 124' ' ' VAL . 46.1 ttt180 -70.29 -17.44 63.09 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.877 -0.329 . . . . 1.0 110.776 -177.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.478 ' HB2' ' HB2' ' A' ' 109' ' ' MET . 33.8 t -75.6 -4.58 40.81 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.984 -0.286 . . . . 1.0 110.969 -178.026 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.602 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 92.1 m-85 -92.26 -16.25 26.38 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 120.878 0.37 . . . . 1.0 110.196 175.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -65.57 122.5 80.75 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.0 -0.545 . . . . 1.0 110.712 -178.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -65.95 -20.82 57.57 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.778 2.318 . . . . 1.0 111.968 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 21.5 mtt-85 -90.72 -16.87 27.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.806 -0.634 . . . . 1.0 111.053 -177.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 25.7 m -75.54 65.28 1.75 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.46 0.541 . . . . 1.0 112.46 -177.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 52.86 -99.5 0.04 OUTLIER Glycine 0 C--N 1.333 0.41 0 C-N-CA 121.58 -0.343 . . . . 1.0 113.341 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 15.4 m -136.23 -45.92 0.63 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.192 0.52 . . . . 1.0 109.92 178.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 42.1 m80 -139.29 153.16 47.73 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.894 -0.593 . . . . 1.0 110.672 178.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -133.68 98.99 4.34 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.753 -0.658 . . . . 1.0 109.236 177.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.553 ' O ' ' HB3' ' A' ' 91' ' ' ARG . 2.9 mm? -87.76 11.45 15.35 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.374 -0.376 . . . . 1.0 111.323 -177.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.453 ' CA ' ' HE3' ' A' ' 109' ' ' MET . 32.4 t70 -169.48 136.63 1.71 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.021 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.622 ' HB ' ' O ' ' A' ' 89' ' ' LEU . 61.0 t -100.95 141.97 16.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 108.674 -0.862 . . . . 1.0 108.674 178.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -70.15 -170.83 0.39 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.447 0.641 . . . . 1.0 112.423 -175.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.468 ' HA ' HH21 ' A' ' 17' ' ' ARG . 12.6 t70 -141.5 143.84 31.35 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 108.141 -1.059 . . . . 1.0 108.141 -173.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.439 ' HB3' ' HB2' ' A' ' 134' ' ' ASP . 51.1 Cg_exo -48.62 162.39 0.36 Allowed 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.518 2.146 . . . . 1.0 112.523 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.444 ' HD2' ' CD2' ' A' ' 129' ' ' TYR . 64.0 t80 -102.4 -61.88 1.34 Allowed 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 120.252 -0.579 . . . . 1.0 111.923 -176.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.444 ' CD2' ' HD2' ' A' ' 128' ' ' TYR . 0.0 OUTLIER -92.73 -59.07 2.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.32 0.581 . . . . 1.0 110.965 -174.831 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 117.14 57.35 0.3 Allowed Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 109.464 -1.455 . . . . 1.0 109.464 -175.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.463 ' CG ' ' H ' ' A' ' 132' ' ' HIS . 9.2 t70 -140.87 -174.22 3.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.313 -0.443 . . . . 1.0 110.657 -174.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.5 ' HA ' ' CD2' ' A' ' 135' ' ' PHE . 12.5 t-80 -56.03 -37.27 68.99 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.957 -0.565 . . . . 1.0 111.35 -178.107 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 12.1 m -64.83 -39.36 93.46 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.08 -0.509 . . . . 1.0 111.058 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.439 ' HB2' ' HB3' ' A' ' 127' ' ' PRO . 0.0 OUTLIER -68.58 -32.79 72.94 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.376 -0.375 . . . . 1.0 110.958 -176.575 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.561 ' CD1' ' HD3' ' A' ' 57' ' ' ARG . 5.6 m-85 -68.96 -49.35 58.7 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.462 0.648 . . . . 1.0 109.929 -178.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -72.92 -18.9 61.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.413 -0.812 . . . . 1.0 110.908 -179.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -64.33 -50.73 66.62 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.62 0.724 . . . . 1.0 109.359 176.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 1.047 ' HA ' HG21 ' A' ' 141' ' ' VAL . 92.9 t -61.77 -38.7 81.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.01 -0.995 . . . . 1.0 109.992 177.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.511 ' HB2' ' HE2' ' A' ' 20' ' ' MET . 24.9 t80 -53.52 -42.06 67.02 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.098 -0.955 . . . . 1.0 109.325 175.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.51 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -65.33 -41.3 94.1 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.301 -0.863 . . . . 1.0 110.187 177.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 1.047 HG21 ' HA ' ' A' ' 138' ' ' VAL . 11.9 t -55.52 -52.43 47.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 121.604 0.716 . . . . 1.0 110.139 177.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.558 HD13 ' HB3' ' A' ' 20' ' ' MET . 6.5 mt -63.99 -51.74 65.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 114.954 -1.021 . . . . 1.0 112.055 -178.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.51 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 11.3 pt-20 -56.43 -31.5 63.99 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.862 0.363 . . . . 1.0 110.373 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.4 t -74.5 -28.35 60.95 Favored 'General case' 0 C--O 1.225 -0.206 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.253 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.481 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -86.54 -24.12 25.6 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-N 115.889 -0.596 . . . . 1.0 111.545 179.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.725 HD21 ' HB3' ' A' ' 25' ' ' PHE . 11.8 mt -55.65 -36.9 51.05 Favored Pre-proline 0 CA--C 1.544 0.727 0 N-CA-C 112.577 0.584 . . . . 1.0 112.577 -178.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 55.8 Cg_endo -69.88 -11.6 31.01 Favored 'Trans proline' 0 C--N 1.363 1.332 0 C-N-CA 122.339 2.026 . . . . 1.0 111.854 177.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.602 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -104.85 -33.94 3.64 Favored Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 110.703 -0.959 . . . . 1.0 110.703 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.517 HD11 ' CE2' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -74.21 -41.12 61.89 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.43 -0.952 . . . . 1.0 108.43 178.729 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.503 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 1.2 m-70 -54.29 -55.14 31.23 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 114.933 -1.031 . . . . 1.0 109.926 174.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -57.32 -40.83 78.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.315 -0.857 . . . . 1.0 110.71 -175.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . 0.707 ' HZ3' HD11 ' A' ' 5' ' ' LEU . 27.0 t90 -63.54 -57.54 9.83 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.596 -0.729 . . . . 1.0 110.748 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.409 HG12 ' O ' ' A' ' 149' ' ' LEU . 10.3 m -61.43 -41.17 88.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.803 -0.359 . . . . 1.0 110.195 -178.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.41 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 1.8 m-20 -60.5 -50.72 72.44 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 120.897 0.38 . . . . 1.0 110.42 178.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.545 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 6.3 pt-20 -63.23 -38.13 89.94 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.123 0.487 . . . . 1.0 110.936 -178.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.52 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 4.7 mmt180 -72.58 -45.15 60.54 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.664 -177.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 3.9 pp -67.12 -23.8 65.86 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.716 -0.675 . . . . 1.0 109.762 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -74.47 -51.22 15.45 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.58 -0.737 . . . . 1.0 110.529 178.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.472 ' HG2' ' O ' ' A' ' 155' ' ' GLU . 14.2 ptp180 -75.3 -7.83 54.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.063 -0.517 . . . . 1.0 111.72 -178.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . 0.439 ' HB2' ' O ' ' A' ' 156' ' ' ARG . 15.4 t-20 -78.24 21.49 0.35 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.285 0.564 . . . . 1.0 111.421 -176.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.412 ' H ' ' C ' ' A' ' 159' ' ' ARG . . . -65.67 141.87 42.91 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.819 -0.705 . . . . 1.0 112.079 178.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -81.56 25.53 0.65 Allowed 'Trans proline' 0 CA--C 1.515 -0.443 0 C-N-CA 123.707 2.938 . . . . 1.0 113.273 -176.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 58.9 m . . . . . 0 C--N 1.3 -1.586 0 CA-C-N 114.632 -1.167 . . . . 1.0 110.155 -179.622 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.738 0 N-CA-C 112.132 -0.387 . . . . 1.0 112.132 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.9 mtm -84.63 27.27 0.74 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.416 0.627 . . . . 1.0 110.989 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.7 m -158.61 146.41 18.07 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.884 -0.784 . . . . 1.0 108.884 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.549 ' HB2' ' HD2' ' A' ' 4' ' ' PRO . 0.5 OUTLIER -164.29 162.52 15.68 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 110.136 -0.32 . . . . 1.0 110.136 -178.742 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.549 ' HD2' ' HB2' ' A' ' 3' ' ' ASP . 27.6 Cg_endo -67.06 170.16 13.62 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.69 2.26 . . . . 1.0 112.834 -179.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.767 HD12 ' HB3' ' A' ' 84' ' ' ASP . 0.2 OUTLIER -67.13 177.82 1.65 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.532 -0.758 . . . . 1.0 109.384 178.749 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.62 ' O ' ' HB1' ' A' ' 83' ' ' ALA . 3.4 t-160 -157.55 89.32 1.03 Allowed 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.363 -0.606 . . . . 1.0 109.363 -179.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.792 HG12 HD11 ' A' ' 85' ' ' LEU . 2.4 t -95.95 107.38 19.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 109.759 -0.46 . . . . 1.0 109.759 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.598 ' CG2' ' HG ' ' A' ' 86' ' ' LEU . 11.8 t -108.25 114.97 29.26 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.084 0.469 . . . . 1.0 110.943 -179.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.543 ' HA ' ' O ' ' A' ' 87' ' ' VAL . 0.5 OUTLIER -85.76 134.55 33.94 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 122.203 -0.31 . . . . 1.0 110.262 -178.802 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.581 ' CG1' HG21 ' A' ' 45' ' ' THR . 42.4 t -120.66 119.87 60.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-O 121.385 0.612 . . . . 1.0 112.17 -175.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.467 ' HA ' ' CE1' ' A' ' 93' ' ' HIS . 15.4 p -143.68 167.63 21.81 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.214 -0.903 . . . . 1.0 109.453 177.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.98 93.54 3.82 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.417 0.627 . . . . 1.0 111.033 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.745 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 129.68 -37.03 2.24 Favored Glycine 0 N--CA 1.443 -0.855 0 CA-C-N 115.25 -0.886 . . . . 1.0 112.526 178.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.437 HD22 ' CB ' ' A' ' 42' ' ' SER . 3.6 t-20 64.49 19.1 11.69 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.924 0.868 . . . . 1.0 110.703 -179.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.475 ' O ' ' HB3' ' A' ' 55' ' ' ASP . 1.3 pt -135.95 47.38 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 CA-C-N 115.491 -0.777 . . . . 1.0 109.567 -178.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.681 ' O ' ' HG3' ' A' ' 20' ' ' MET . 4.4 p -157.23 -89.3 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.78 -1.1 . . . . 1.0 111.846 175.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.478 ' HD2' ' SG ' ' A' ' 16' ' ' CYS . 0.1 OUTLIER -74.96 -43.1 55.95 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 121.908 -0.495 . . . . 1.0 111.817 -175.569 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.821 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 46.8 m -54.33 -56.6 24.76 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 116.425 -0.352 . . . . 1.0 111.505 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.663 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 49.0 Cg_endo -66.47 -24.22 49.57 Favored 'Trans proline' 0 C--N 1.357 0.995 0 C-N-CA 121.548 1.499 . . . . 1.0 112.387 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.681 ' HG3' ' O ' ' A' ' 16' ' ' CYS . 51.0 mtp -62.94 -56.54 16.31 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.672 -0.411 . . . . 1.0 110.646 177.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.63 -28.02 64.5 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 120.724 -0.39 . . . . 1.0 110.217 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.77 ' O ' ' HB1' ' A' ' 26' ' ' ALA . 14.8 tt0 -51.85 -53.22 42.82 Favored 'General case' 0 C--O 1.214 -0.764 0 CA-C-N 114.74 -1.118 . . . . 1.0 109.614 178.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.911 ' HB3' ' HG2' ' A' ' 68' ' ' PRO . 0.1 OUTLIER -79.43 -32.39 42.81 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.36 -0.837 . . . . 1.0 110.235 -176.089 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.568 ' HB3' HD12 ' A' ' 146' ' ' LEU . 3.5 mmm -61.9 -75.61 0.07 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 113.173 0.805 . . . . 1.0 113.173 -175.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.738 ' HB3' HD22 ' A' ' 146' ' ' LEU . 14.0 p90 -78.44 -29.31 46.95 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 119.828 -0.749 . . . . 1.0 111.484 -174.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.77 ' HB1' ' O ' ' A' ' 22' ' ' GLU . . . -64.12 -36.62 84.62 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 119.146 -1.021 . . . . 1.0 110.461 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.638 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -64.03 -39.32 93.84 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.614 -0.884 . . . . 1.0 108.614 177.062 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.564 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 77.1 mt-30 -60.38 -39.45 87.33 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-N 115.719 -0.673 . . . . 1.0 110.916 176.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.572 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 88.7 mt -59.81 -59.89 4.71 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.756 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.472 ' HA ' ' H ' ' A' ' 35' ' ' GLY . 0.1 OUTLIER -58.96 -36.87 75.54 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.375 -0.53 . . . . 1.0 111.254 178.518 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -65.02 -25.46 67.86 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.382 0.512 . . . . 1.0 112.382 177.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.576 ' HD3' HD13 ' A' ' 34' ' ' LEU . 3.9 ptm180 -93.17 -19.46 21.44 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 119.461 -0.895 . . . . 1.0 109.465 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 110.4 35.02 2.17 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 114.955 -1.02 . . . . 1.0 111.926 177.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.576 HD13 ' HD3' ' A' ' 32' ' ' ARG . 46.9 mt -134.45 5.93 3.5 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 122.59 -0.359 . . . . 1.0 111.006 -177.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.472 ' H ' ' HA ' ' A' ' 30' ' ' ARG . . . -54.83 -29.62 50.75 Favored Glycine 0 C--N 1.33 0.24 0 C-N-CA 121.177 -0.535 . . . . 1.0 113.118 -178.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -94.92 -20.91 19.0 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.632 0.253 . . . . 1.0 110.985 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.48 -23.27 43.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.369 0.604 . . . . 1.0 111.342 -178.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.764 HG21 ' HB3' ' A' ' 5' ' ' LEU . 0.3 OUTLIER -142.44 119.5 6.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.53 -0.545 . . . . 1.0 109.53 178.001 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 16.9 mmt85 -91.13 148.42 22.39 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.618 -0.719 . . . . 1.0 109.295 -178.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.604 HG12 ' HB2' ' A' ' 26' ' ' ALA . 2.0 m -131.54 139.62 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.075 0 N-CA-C 108.391 -0.966 . . . . 1.0 108.391 178.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.493 ' O ' ' HA ' ' A' ' 8' ' ' THR . 21.7 p -146.36 -177.69 5.75 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.287 -0.87 . . . . 1.0 109.808 -175.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.821 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 93.4 p -159.32 163.96 35.23 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 120.613 -0.435 . . . . 1.0 109.982 178.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.557 ' HB3' ' CD2' ' A' ' 80' ' ' HIS . . . -164.38 164.96 22.0 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.452 0.644 . . . . 1.0 111.357 -179.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.462 ' HA2' ' O ' ' A' ' 11' ' ' CYS . . . -122.18 130.05 7.84 Favored Glycine 0 N--CA 1.439 -1.163 0 N-CA-C 110.41 -1.076 . . . . 1.0 110.41 177.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.581 HG21 ' CG1' ' A' ' 10' ' ' VAL . 18.8 p -65.25 -24.16 67.25 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 111.853 0.316 . . . . 1.0 111.853 -177.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -107.66 8.81 37.44 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.809 -0.71 . . . . 1.0 113.353 -177.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 42.96 37.77 1.22 Allowed 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.722 0.809 . . . . 1.0 113.078 179.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.745 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 0.7 OUTLIER -49.2 -76.66 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.524 0.565 . . . . 1.0 112.524 -179.59 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.468 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 36.1 m-70 -103.97 39.65 1.59 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.869 -0.605 . . . . 1.0 111.154 -178.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.499 HG22 ' HA ' ' A' ' 74' ' ' ALA . 11.0 p -59.4 126.31 16.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.019 0.438 . . . . 1.0 110.338 178.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.25 -14.76 62.12 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 121.037 -0.601 . . . . 1.0 111.942 -177.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.461 ' O ' ' HA ' ' A' ' 72' ' ' ARG . 3.8 t -81.61 -161.87 0.47 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.119 0.485 . . . . 1.0 110.138 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 30.2 t -120.84 178.59 4.65 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.737 -0.665 . . . . 1.0 109.289 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.403 ' HB1' ' HB3' ' A' ' 71' ' ' HIS . . . -67.21 146.91 53.71 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.224 0.535 . . . . 1.0 110.499 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.582 ' OD1' ' HA ' ' A' ' 16' ' ' CYS . 9.7 p-10 -64.46 150.69 46.04 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.889 -1.05 . . . . 1.0 113.588 -175.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -44.8 -49.62 10.63 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 113.533 -1.667 . . . . 1.0 114.121 176.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.48 ' HG2' ' OD2' ' A' ' 55' ' ' ASP . 9.6 ptp180 -71.04 -37.38 72.56 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.856 -0.338 . . . . 1.0 111.647 -174.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.452 ' HB1' ' HG2' ' A' ' 20' ' ' MET . . . -70.73 -40.95 72.45 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.906 -0.405 . . . . 1.0 109.906 177.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.5 -47.08 85.54 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.87 -0.604 . . . . 1.0 109.836 179.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -60.17 -46.87 93.44 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.912 -0.661 . . . . 1.0 113.318 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.43 HG11 ' O ' ' A' ' 57' ' ' ARG . 13.3 m -71.85 -38.06 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 CA-C-N 117.8 0.8 . . . . 1.0 111.663 -178.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.557 HD21 ' HG3' ' A' ' 23' ' ' LYS . 4.6 mp -63.9 -52.7 58.71 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 120.489 -0.484 . . . . 1.0 110.361 178.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 63' ' ' ARG . 0.3 OUTLIER -62.44 -27.67 69.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.013 -0.539 . . . . 1.0 111.416 -179.298 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.64 -33.9 69.33 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 120.817 0.341 . . . . 1.0 110.812 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -94.68 3.01 55.58 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.776 -178.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 90.56 13.49 59.66 Favored Glycine 0 CA--C 1.517 0.206 0 CA-C-N 115.697 -0.683 . . . . 1.0 113.257 176.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -90.26 155.4 46.72 Favored Pre-proline 0 C--N 1.318 -0.776 0 CA-C-O 120.45 0.167 . . . . 1.0 110.716 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.911 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 74.5 Cg_endo -72.91 162.24 41.56 Favored 'Trans proline' 0 CA--C 1.512 -0.604 0 C-N-CA 122.43 2.087 . . . . 1.0 110.871 177.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 35.0 p -137.83 10.93 2.89 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 120.043 -0.663 . . . . 1.0 111.228 -178.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -72.53 116.84 13.48 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.666 178.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.832 ' HB2' ' HE3' ' A' ' 23' ' ' LYS . 50.1 t60 -157.85 149.74 21.97 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.918 0.39 . . . . 1.0 111.175 -177.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' A' ' 52' ' ' SER . 4.8 tpt180 -133.66 114.19 13.2 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.785 -1.191 . . . . 1.0 107.785 175.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.468 ' HB3' ' O ' ' A' ' 49' ' ' HIS . . . -59.32 137.81 57.85 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.088 -0.96 . . . . 1.0 112.774 -175.074 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.499 ' HA ' HG22 ' A' ' 50' ' ' VAL . . . -129.65 161.65 30.11 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.213 -0.903 . . . . 1.0 110.078 178.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -97.53 156.73 16.37 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 108.244 -1.021 . . . . 1.0 108.244 178.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.498 HG12 ' CD2' ' A' ' 97' ' ' LEU . 8.1 t -66.91 104.26 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.303 0.573 . . . . 1.0 109.781 178.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.403 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -113.89 -175.09 18.93 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 115.184 -0.917 . . . . 1.0 111.269 -178.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 94.1 m -56.37 -43.36 79.1 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.814 0.34 . . . . 1.0 111.259 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -60.88 -29.76 69.74 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.091 -0.504 . . . . 1.0 111.312 178.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.557 ' CD2' ' HB3' ' A' ' 43' ' ' ALA . 80.0 m80 -78.19 -39.73 39.8 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-O 120.98 0.419 . . . . 1.0 109.875 178.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.518 ' HA ' HD21 ' A' ' 86' ' ' LEU . 33.9 mt -68.65 -18.75 64.34 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.784 -0.644 . . . . 1.0 110.758 178.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.8 -4.8 59.22 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.861 -0.608 . . . . 1.0 110.844 -178.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.62 ' HB1' ' O ' ' A' ' 6' ' ' HIS . . . -59.98 154.22 19.49 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.979 -0.555 . . . . 1.0 111.665 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.767 ' HB3' HD12 ' A' ' 5' ' ' LEU . 10.6 t70 -80.4 -12.08 59.62 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.52 -0.548 . . . . 1.0 109.52 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.792 HD11 HG12 ' A' ' 7' ' ' VAL . 0.4 OUTLIER -156.98 118.09 3.68 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 115.65 -0.705 . . . . 1.0 109.22 -177.615 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.694 ' HB3' HD13 ' A' ' 97' ' ' LEU . 5.1 mp -107.52 105.99 16.16 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-N 115.815 -0.629 . . . . 1.0 109.709 177.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.565 HG11 HD23 ' A' ' 110' ' ' LEU . 48.1 t -86.51 94.88 4.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 114.823 -1.081 . . . . 1.0 111.066 -176.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -82.73 144.67 30.04 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 114.975 -1.012 . . . . 1.0 110.949 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.412 HD13 ' HA ' ' A' ' 89' ' ' LEU . 4.3 mm? -95.04 -13.65 25.01 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.254 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.44 ' CG ' ' H ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -148.74 153.67 38.51 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.724 -0.671 . . . . 1.0 111.542 -178.89 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.405 ' H ' ' HG2' ' A' ' 91' ' ' ARG . 1.7 ptt180 -49.74 -32.2 13.1 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.666 1.186 . . . . 1.0 113.55 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.638 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 76.9 m-20 -77.36 -47.51 19.7 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.751 -0.38 . . . . 1.0 110.672 -177.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.715 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 13.5 m170 -54.52 -48.15 72.27 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.923 -0.399 . . . . 1.0 109.923 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.96 -43.03 91.24 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.073 0.463 . . . . 1.0 110.752 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.673 ' O ' ' HG2' ' A' ' 99' ' ' GLN . 11.5 ttp180 -58.32 -47.56 83.31 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.465 -0.789 . . . . 1.0 111.363 179.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.712 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 48.4 mt -62.16 -49.11 77.15 Favored 'General case' 0 C--O 1.219 -0.533 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.233 -175.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.715 ' HG ' ' O ' ' A' ' 93' ' ' HIS . 32.1 mt -53.42 -58.05 8.49 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.816 -0.629 . . . . 1.0 111.762 -177.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.511 ' HG2' ' O ' ' A' ' 95' ' ' ARG . 22.6 ptt180 -59.41 -44.83 92.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.451 . . . . 1.0 111.578 -176.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.673 ' HG2' ' O ' ' A' ' 95' ' ' ARG . 9.9 pt20 -70.89 -18.65 62.67 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.84 0.353 . . . . 1.0 111.227 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.712 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 5.5 mt -79.58 -8.1 58.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.068 -0.515 . . . . 1.0 111.706 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 146.87 -30.36 1.52 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.029 -1.082 . . . . 1.0 113.011 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.78 HG13 ' H ' ' A' ' 103' ' ' GLU . 2.0 t -73.32 -154.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 121.077 0.465 . . . . 1.0 110.868 -178.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.78 ' H ' HG13 ' A' ' 102' ' ' VAL . 15.6 pt-20 -164.61 165.14 21.31 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.977 -0.749 . . . . 1.0 108.977 -177.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.778 ' HA ' HG13 ' A' ' 107' ' ' VAL . . . -65.01 -24.87 67.63 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 123.409 0.443 . . . . 1.0 111.542 -176.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.5 -35.65 72.57 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.3 0.571 . . . . 1.0 110.254 175.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.689 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 4.7 mtt-85 -96.89 -42.71 7.81 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 115.2 -0.909 . . . . 1.0 111.029 -177.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.778 HG13 ' HA ' ' A' ' 104' ' ' ALA . 7.8 p -80.79 121.7 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-O 121.37 0.605 . . . . 1.0 109.981 -177.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.528 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 12.7 mmm180 -137.97 146.6 43.36 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.39 -0.596 . . . . 1.0 109.39 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.701 ' HE2' HG21 ' A' ' 124' ' ' VAL . 79.6 mmm -77.81 139.53 39.33 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.837 -0.619 . . . . 1.0 110.234 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.565 HD23 HG11 ' A' ' 87' ' ' VAL . 3.2 tm? -56.04 -48.29 76.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.517 0.198 . . . . 1.0 111.075 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.738 ' H ' HG22 ' A' ' 124' ' ' VAL . 20.7 ttt85 -71.35 -17.49 62.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.007 0.432 . . . . 1.0 110.498 -178.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.431 ' HB2' ' HB2' ' A' ' 109' ' ' MET . 30.5 t -70.67 -12.26 61.45 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.581 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.45 ' HZ ' HD21 ' A' ' 85' ' ' LEU . 97.6 m-85 -90.8 -25.38 19.96 Favored 'General case' 0 N--CA 1.456 -0.166 0 O-C-N 122.175 -0.328 . . . . 1.0 110.122 176.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -62.83 122.23 73.27 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.51 -0.768 . . . . 1.0 111.756 -177.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.73 -16.77 20.75 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.394 2.063 . . . . 1.0 111.867 177.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 2.2 mmt180 -88.08 -6.99 57.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.923 -0.58 . . . . 1.0 110.565 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 33.2 t -57.69 -54.29 48.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.571 -0.74 . . . . 1.0 110.332 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 116.15 -61.26 0.4 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.41 -0.9 . . . . 1.0 111.643 178.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.617 HG23 ' H ' ' A' ' 120' ' ' HIS . 0.6 OUTLIER -128.91 -170.91 2.35 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.004 -0.739 . . . . 1.0 109.004 178.581 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.617 ' H ' HG23 ' A' ' 119' ' ' THR . 0.9 OUTLIER -58.68 144.83 42.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.836 0.35 . . . . 1.0 110.67 177.746 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -120.46 99.86 6.81 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.512 -0.313 . . . . 1.0 111.282 -178.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -95.48 19.49 10.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 122.028 0.918 . . . . 1.0 108.839 175.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -165.93 131.2 2.4 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 113.804 -1.544 . . . . 1.0 107.374 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.738 HG22 ' H ' ' A' ' 111' ' ' ARG . 79.9 t -90.26 -81.71 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 112.457 0.54 . . . . 1.0 112.457 -174.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.405 ' OE2' HG23 ' A' ' 138' ' ' VAL . 7.3 pt-20 -137.09 175.23 9.81 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.185 -0.916 . . . . 1.0 112.285 -175.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.43 ' HA ' ' HD2' ' A' ' 127' ' ' PRO . 33.5 t70 -174.23 106.79 0.29 Allowed Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 114.108 -1.406 . . . . 1.0 108.526 175.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.439 ' HG3' ' NH2' ' A' ' 17' ' ' ARG . 17.7 Cg_endo -60.65 172.67 2.62 Favored 'Trans proline' 0 C--O 1.233 0.269 0 C-N-CA 123.103 2.536 . . . . 1.0 112.625 -178.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.548 ' HD2' ' CD2' ' A' ' 129' ' ' TYR . 66.6 t80 -110.22 -35.1 6.18 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 112.792 0.664 . . . . 1.0 112.792 -174.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.548 ' CD2' ' HD2' ' A' ' 128' ' ' TYR . 0.4 OUTLIER -141.25 -41.27 0.38 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.969 0.729 . . . . 1.0 112.969 -176.66 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.411 ' N ' ' HD1' ' A' ' 129' ' ' TYR . . . 101.46 66.48 0.79 Allowed Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.098 -1.048 . . . . 1.0 111.846 -176.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.627 ' H ' ' HB3' ' A' ' 134' ' ' ASP . 3.8 t70 -137.44 -175.38 4.04 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.675 -0.861 . . . . 1.0 108.675 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -52.81 -49.6 65.35 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.674 0.25 . . . . 1.0 111.674 -178.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 5.0 p -63.89 -36.49 84.11 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.311 0.577 . . . . 1.0 110.933 -179.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.627 ' HB3' ' H ' ' A' ' 131' ' ' ASP . 12.6 t70 -64.05 -39.96 95.24 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.911 -1.041 . . . . 1.0 110.722 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.419 ' CG ' ' HB2' ' A' ' 57' ' ' ARG . 9.8 m-30 -67.46 -46.59 72.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.897 -0.592 . . . . 1.0 110.605 -178.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -76.67 -15.43 59.8 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.951 -0.568 . . . . 1.0 111.237 -178.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.404 ' O ' HG23 ' A' ' 141' ' ' VAL . 20.0 tp10 -65.29 -46.76 79.12 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 108.187 -1.042 . . . . 1.0 108.187 174.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.405 HG23 ' OE2' ' A' ' 125' ' ' GLU . 72.3 t -60.08 -44.25 94.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 114.594 -1.185 . . . . 1.0 109.214 175.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -54.01 -42.79 69.47 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.453 -1.249 . . . . 1.0 109.828 176.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.519 ' HA ' ' OE2' ' A' ' 143' ' ' GLU . . . -64.26 -42.07 96.64 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.462 -0.79 . . . . 1.0 111.03 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 137' ' ' GLU . 16.9 t -56.96 -53.77 38.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.503 0.668 . . . . 1.0 110.235 178.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.461 ' HA ' HD11 ' A' ' 110' ' ' LEU . 4.7 mt -60.92 -52.27 63.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.376 -0.829 . . . . 1.0 112.289 -178.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.519 ' OE2' ' HA ' ' A' ' 140' ' ' ALA . 13.2 pt-20 -56.17 -32.18 64.09 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.932 0.396 . . . . 1.0 110.515 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 73.0 m -72.8 -28.9 62.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.574 -0.739 . . . . 1.0 110.939 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.467 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -87.18 -23.5 24.77 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-N 116.215 -0.448 . . . . 1.0 111.712 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.738 HD22 ' HB3' ' A' ' 25' ' ' PHE . 13.4 mt -56.01 -36.66 48.63 Favored Pre-proline 0 CA--C 1.548 0.874 0 N-CA-C 112.417 0.525 . . . . 1.0 112.417 -177.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.619 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 51.1 Cg_endo -69.7 -10.79 29.47 Favored 'Trans proline' 0 C--N 1.366 1.465 0 C-N-CA 122.733 2.288 . . . . 1.0 112.277 177.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -105.24 -32.6 3.95 Favored Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 110.465 -1.054 . . . . 1.0 110.465 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.467 ' O ' HG13 ' A' ' 153' ' ' VAL . 0.4 OUTLIER -74.48 -41.02 61.45 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.664 -0.865 . . . . 1.0 108.664 178.937 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -53.52 -55.38 25.96 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 114.814 -1.085 . . . . 1.0 110.921 175.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -60.75 -40.47 92.56 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.563 -0.744 . . . . 1.0 111.591 -176.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . 0.745 ' HZ3' HD11 ' A' ' 5' ' ' LEU . 29.0 t90 -63.36 -54.6 34.37 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.552 -0.749 . . . . 1.0 110.751 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.467 HG13 ' O ' ' A' ' 149' ' ' LEU . 11.1 m -60.11 -39.19 79.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 C-N-CA 120.84 -0.344 . . . . 1.0 110.075 -179.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.428 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 8.3 m-20 -59.68 -51.74 68.5 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.272 0.558 . . . . 1.0 110.966 178.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.509 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 5.1 pt-20 -63.46 -38.31 90.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.406 -0.815 . . . . 1.0 110.443 -178.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.508 ' HG3' ' CH2' ' A' ' 152' ' ' TRP . 10.9 mmt180 -74.89 -42.72 57.29 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.615 -0.72 . . . . 1.0 111.664 -177.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 4.2 pp -64.54 -24.77 67.72 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.157 0.503 . . . . 1.0 109.793 179.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -71.62 -47.63 53.34 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.549 -0.75 . . . . 1.0 110.033 177.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.94 -4.09 48.1 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.533 0.568 . . . . 1.0 112.533 179.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -106.3 4.61 28.88 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.747 0.308 . . . . 1.0 110.979 179.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -175.07 144.62 7.42 Favored Glycine 0 C--N 1.319 -0.362 0 C-N-CA 119.971 -1.109 . . . . 1.0 114.247 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -87.7 30.36 0.45 Allowed 'Trans proline' 0 CA--C 1.519 -0.26 0 C-N-CA 123.777 2.985 . . . . 1.0 112.152 178.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 36.0 t . . . . . 0 C--N 1.302 -1.49 0 CA-C-N 114.585 -1.189 . . . . 1.0 110.813 -178.031 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.885 0 N-CA-C 112.247 -0.341 . . . . 1.0 112.247 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -82.13 -3.43 54.83 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.019 0.377 . . . . 1.0 112.019 -178.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.7 t -80.27 -179.71 7.24 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 110.3 -0.259 . . . . 1.0 110.3 -178.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.58 ' HB2' ' HD2' ' A' ' 4' ' ' PRO . 1.3 p-10 -64.1 159.96 52.12 Favored Pre-proline 0 C--O 1.234 0.253 0 CA-C-O 121.033 0.444 . . . . 1.0 111.379 178.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.58 ' HD2' ' HB2' ' A' ' 3' ' ' ASP . 23.1 Cg_endo -62.4 167.39 11.34 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 123.477 2.785 . . . . 1.0 114.046 -175.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.838 ' HB3' HG21 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -66.11 177.66 1.34 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.635 -1.166 . . . . 1.0 109.578 178.084 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.573 ' H ' HD12 ' A' ' 5' ' ' LEU . 0.9 OUTLIER -155.51 99.0 2.0 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.763 -0.458 . . . . 1.0 109.763 179.617 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.617 HG12 HD13 ' A' ' 85' ' ' LEU . 2.3 t -104.09 118.27 50.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 108.147 -1.057 . . . . 1.0 108.147 177.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.617 HG22 ' HG ' ' A' ' 86' ' ' LEU . 11.7 t -119.75 113.59 20.86 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.302 0.572 . . . . 1.0 110.352 178.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.653 ' HD1' ' HB ' ' A' ' 87' ' ' VAL . 1.0 OUTLIER -84.51 133.21 34.47 Favored 'General case' 0 CA--C 1.512 -0.487 0 O-C-N 122.024 -0.423 . . . . 1.0 110.258 -178.18 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.557 ' CG1' HG21 ' A' ' 45' ' ' THR . 40.7 t -119.95 119.49 60.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.552 0.691 . . . . 1.0 112.042 -176.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.436 ' HA ' ' CE1' ' A' ' 93' ' ' HIS . 21.7 p -148.32 163.37 37.29 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.221 -0.9 . . . . 1.0 109.963 177.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.96 96.81 5.83 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 120.849 0.357 . . . . 1.0 110.39 177.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.487 ' O ' HG12 ' A' ' 15' ' ' ILE . . . 146.64 -36.62 1.24 Allowed Glycine 0 C--O 1.218 -0.89 0 CA-C-N 115.687 -0.688 . . . . 1.0 112.26 179.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.505 ' OD1' ' HB1' ' A' ' 73' ' ' ALA . 32.2 p30 49.27 18.54 0.26 Allowed 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 125.155 1.382 . . . . 1.0 114.115 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.487 HG12 ' O ' ' A' ' 13' ' ' GLY . 5.8 pt -136.44 2.6 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 112.13 0.419 . . . . 1.0 112.13 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.639 ' O ' ' HG3' ' A' ' 20' ' ' MET . 51.4 t -121.99 -86.79 0.65 Allowed 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.437 -0.505 . . . . 1.0 111.577 -178.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 54.1 mtt85 -59.2 -56.55 20.67 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.063 0.458 . . . . 1.0 112.103 -175.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.901 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 45.3 m -53.19 -59.0 10.21 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 115.552 -0.749 . . . . 1.0 112.497 -177.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -63.19 -25.34 72.52 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 121.954 1.769 . . . . 1.0 113.2 -178.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.639 ' HG3' ' O ' ' A' ' 16' ' ' CYS . 53.4 mtp -61.19 -53.34 58.14 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.778 -0.369 . . . . 1.0 110.3 178.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.423 ' HA ' ' HB2' ' A' ' 24' ' ' MET . . . -72.2 -26.74 62.17 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.265 -0.574 . . . . 1.0 110.178 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.511 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 17.7 tt0 -53.83 -52.1 61.43 Favored 'General case' 0 C--O 1.212 -0.874 0 CA-C-N 115.135 -0.939 . . . . 1.0 109.431 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.67 ' HZ3' ' HB3' ' A' ' 54' ' ' ALA . 0.1 OUTLIER -86.65 -23.03 25.8 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 120.06 -0.656 . . . . 1.0 110.879 -176.431 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.469 ' HB3' HD12 ' A' ' 146' ' ' LEU . 86.0 mtp -64.57 -75.78 0.08 Allowed 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.001 0.429 . . . . 1.0 112.132 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.599 ' HB3' HD13 ' A' ' 146' ' ' LEU . 17.5 p90 -77.04 -30.31 55.59 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 119.883 -0.727 . . . . 1.0 111.51 -175.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.511 ' HB2' ' O ' ' A' ' 22' ' ' GLU . . . -64.39 -36.96 85.84 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 118.951 -1.099 . . . . 1.0 110.991 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.611 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -63.56 -37.53 87.68 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 108.433 -0.951 . . . . 1.0 108.433 176.468 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.581 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 77.9 mt-30 -60.15 -41.07 91.96 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-N 116.022 -0.536 . . . . 1.0 110.187 175.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' A' ' 25' ' ' PHE . 70.7 mt -57.71 -59.69 4.83 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.004 -0.544 . . . . 1.0 110.907 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.52 ' HD3' ' HA ' ' A' ' 27' ' ' GLN . 0.3 OUTLIER -59.37 -34.36 72.31 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.556 -0.457 . . . . 1.0 110.779 178.225 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -63.01 -27.41 69.4 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.693 0.627 . . . . 1.0 112.693 176.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.473 ' HG2' ' O ' ' A' ' 28' ' ' GLN . 6.9 ptp180 -95.9 -15.01 22.68 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.566 0.698 . . . . 1.0 110.109 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.86 39.69 3.07 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 114.913 -1.039 . . . . 1.0 111.49 177.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.413 HD12 ' HG3' ' A' ' 32' ' ' ARG . 31.3 mt -132.32 3.8 3.98 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.987 -0.375 . . . . 1.0 109.987 -178.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.22 -26.93 51.41 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 121.037 -0.602 . . . . 1.0 112.507 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.637 ' HA ' ' NH1' ' A' ' 39' ' ' ARG . 11.9 m-20 -91.32 -21.69 20.91 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.623 0.249 . . . . 1.0 110.796 176.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -81.01 -23.55 38.57 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.338 -178.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.838 HG21 ' HB3' ' A' ' 5' ' ' LEU . 0.7 OUTLIER -142.68 123.91 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-O 121.269 0.557 . . . . 1.0 110.509 179.769 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.637 ' NH1' ' HA ' ' A' ' 36' ' ' ASP . 24.3 mmt180 -92.53 141.33 28.63 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 109.233 -0.655 . . . . 1.0 109.233 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.46 HG13 ' HB3' ' A' ' 26' ' ' ALA . 34.2 t -129.13 125.34 62.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-O 121.445 0.64 . . . . 1.0 109.931 -177.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 8' ' ' THR . 36.5 p -136.79 -177.69 4.85 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.165 -1.379 . . . . 1.0 110.298 -174.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.901 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 66.9 p -161.03 162.94 31.9 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.986 -0.376 . . . . 1.0 109.986 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.568 ' HB3' ' CD2' ' A' ' 80' ' ' HIS . . . -164.59 171.03 15.01 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.556 0.693 . . . . 1.0 111.922 -178.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -128.29 134.05 7.98 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 114.851 -1.068 . . . . 1.0 111.073 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.557 HG21 ' CG1' ' A' ' 10' ' ' VAL . 25.7 p -69.6 -18.13 63.59 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.045 0.45 . . . . 1.0 111.385 -178.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.51 ' HA3' ' CZ3' ' A' ' 48' ' ' TRP . . . -113.8 8.53 23.7 Favored Glycine 0 CA--C 1.521 0.436 0 C-N-CA 120.853 -0.689 . . . . 1.0 113.173 -179.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 44.01 39.19 2.6 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 113.821 1.045 . . . . 1.0 113.821 177.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.51 ' CZ3' ' HA3' ' A' ' 46' ' ' GLY . 1.2 m-90 -43.96 -77.32 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.534 0.683 . . . . 1.0 112.506 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.419 ' O ' ' HB2' ' A' ' 73' ' ' ALA . 24.4 m-70 -106.0 40.53 1.57 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.023 -0.99 . . . . 1.0 111.314 -179.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.426 HG23 ' HA ' ' A' ' 74' ' ' ALA . 12.0 p -58.2 127.63 17.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.853 179.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.6 -14.94 64.16 Favored Glycine 0 C--N 1.329 0.184 0 C-N-CA 121.196 -0.525 . . . . 1.0 112.195 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.6 t -81.56 -162.4 0.51 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.42 0.629 . . . . 1.0 110.356 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 14.0 t -118.89 175.74 5.61 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.703 -0.851 . . . . 1.0 108.703 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.67 ' HB3' ' HZ3' ' A' ' 23' ' ' LYS . . . -60.66 147.43 42.05 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 123.331 0.394 . . . . 1.0 111.525 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.484 ' OD1' ' HG2' ' A' ' 57' ' ' ARG . 11.5 t70 -63.0 142.84 58.23 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.698 -0.683 . . . . 1.0 111.163 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.439 ' HG3' ' N ' ' A' ' 57' ' ' ARG . 5.4 pt-20 -50.02 -37.06 31.2 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 113.522 0.934 . . . . 1.0 113.522 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.484 ' HG2' ' OD1' ' A' ' 55' ' ' ASP . 11.3 ptp180 -71.16 -37.56 72.2 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.039 0.447 . . . . 1.0 110.624 -176.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.52 -37.65 74.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.61 -0.723 . . . . 1.0 109.5 178.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.14 -42.97 99.77 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.743 -0.662 . . . . 1.0 109.281 176.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -58.77 -45.5 94.8 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.566 -0.743 . . . . 1.0 113.359 178.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.443 HG12 ' HG2' ' A' ' 136' ' ' GLU . 35.0 m -73.28 -41.73 57.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 117.569 0.685 . . . . 1.0 111.863 -179.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.7 ' HB2' HG23 ' A' ' 69' ' ' THR . 96.2 mt -60.63 -52.22 66.05 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 120.828 -0.349 . . . . 1.0 110.194 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -59.83 -32.48 70.7 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.101 -0.499 . . . . 1.0 111.079 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.5 -34.81 74.85 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 121.155 0.503 . . . . 1.0 110.877 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -93.33 4.49 53.89 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.897 -179.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.16 16.74 62.23 Favored Glycine 0 C--N 1.331 0.288 0 CA-C-N 115.832 -0.622 . . . . 1.0 112.964 176.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.444 ' HD1' ' HG2' ' A' ' 27' ' ' GLN . 55.3 m-85 -92.45 153.52 42.69 Favored Pre-proline 0 C--N 1.32 -0.686 0 N-CA-C 110.434 -0.21 . . . . 1.0 110.434 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -68.25 156.76 64.57 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.063 1.842 . . . . 1.0 110.509 175.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.7 HG23 ' HB2' ' A' ' 62' ' ' LEU . 72.2 p -130.83 27.73 4.9 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 120.222 -0.591 . . . . 1.0 111.342 -176.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.47 ' C ' ' HZ1' ' A' ' 23' ' ' LYS . 17.5 t0 -104.08 131.87 50.91 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.81 -0.632 . . . . 1.0 110.335 178.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -167.42 148.82 5.62 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.621 -0.718 . . . . 1.0 109.398 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -121.28 113.04 19.37 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 107.972 -1.121 . . . . 1.0 107.972 176.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.505 ' HB1' ' OD1' ' A' ' 14' ' ' ASN . . . -57.84 139.56 53.84 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.557 -0.747 . . . . 1.0 112.272 -175.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.426 ' HA ' HG23 ' A' ' 50' ' ' VAL . . . -132.98 161.95 32.97 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.742 178.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -97.66 156.59 16.47 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 108.134 -1.062 . . . . 1.0 108.134 177.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.588 HG12 ' CD2' ' A' ' 97' ' ' LEU . 14.5 t -66.24 104.69 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.529 0.681 . . . . 1.0 110.232 178.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.4 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -117.57 -171.77 15.67 Favored Glycine 0 N--CA 1.442 -0.962 0 CA-C-N 114.633 -1.167 . . . . 1.0 111.12 -178.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 98.9 m -56.99 -44.42 82.7 Favored 'General case' 0 C--N 1.319 -0.72 0 O-C-N 123.628 0.252 . . . . 1.0 111.3 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -60.71 -29.39 69.31 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.762 0.315 . . . . 1.0 111.216 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.568 ' CD2' ' HB3' ' A' ' 43' ' ' ALA . 79.1 m80 -79.22 -42.15 26.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.422 -0.354 . . . . 1.0 110.179 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.466 ' HA ' HD21 ' A' ' 86' ' ' LEU . 21.4 mt -66.77 -21.43 66.06 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.132 -0.485 . . . . 1.0 110.967 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.25 -5.01 59.28 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.166 -0.47 . . . . 1.0 111.438 -178.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.531 ' HA ' ' HB3' ' A' ' 6' ' ' HIS . . . -59.04 151.58 21.91 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.219 -0.446 . . . . 1.0 111.686 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.698 ' HB3' HD12 ' A' ' 5' ' ' LEU . 28.4 t70 -75.8 -16.26 60.12 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.924 -0.58 . . . . 1.0 109.635 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.617 HD13 HG12 ' A' ' 7' ' ' VAL . 0.4 OUTLIER -156.21 116.56 3.68 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.53 -0.759 . . . . 1.0 109.155 -176.931 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.617 ' HG ' HG22 ' A' ' 8' ' ' THR . 5.4 mp -106.59 106.48 17.02 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-N 115.778 -0.646 . . . . 1.0 109.562 177.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.653 ' HB ' ' HD1' ' A' ' 9' ' ' PHE . 54.9 t -85.18 93.15 3.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.124 -0.944 . . . . 1.0 110.994 -176.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.47 145.45 30.73 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.612 -0.722 . . . . 1.0 110.673 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.401 ' O ' ' HB ' ' A' ' 124' ' ' VAL . 4.4 mm? -96.38 -6.79 36.72 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.845 -0.616 . . . . 1.0 109.973 179.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.448 ' CG ' ' H ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -154.49 151.0 28.41 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.585 -0.734 . . . . 1.0 110.86 179.749 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.477 ' HB3' ' O ' ' A' ' 122' ' ' LEU . 13.7 ptp180 -58.04 -24.08 56.95 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.151 -0.931 . . . . 1.0 112.737 -177.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.681 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 82.3 m-20 -77.01 -47.64 20.12 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.983 -0.377 . . . . 1.0 109.983 -178.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.78 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 15.4 m170 -55.78 -48.26 75.64 Favored 'General case' 0 C--N 1.333 -0.119 0 N-CA-C 109.475 -0.565 . . . . 1.0 109.475 176.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.572 ' HA ' HG21 ' A' ' 107' ' ' VAL . . . -57.68 -42.46 83.65 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.477 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 10.2 ttp180 -58.76 -47.12 85.75 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 115.548 -0.751 . . . . 1.0 111.248 178.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.74 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 52.0 mt -62.89 -50.32 71.34 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.667 -0.697 . . . . 1.0 110.212 -175.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.78 ' HG ' ' O ' ' A' ' 93' ' ' HIS . 22.1 mt -54.71 -57.36 11.81 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.369 -0.832 . . . . 1.0 111.468 -178.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.663 ' HA ' ' HB ' ' A' ' 102' ' ' VAL . 15.9 ptt180 -60.63 -42.83 97.68 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.08 -0.509 . . . . 1.0 111.675 -175.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.592 ' HG3' ' O ' ' A' ' 96' ' ' LEU . 0.9 OUTLIER -67.82 -25.43 65.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.888 0.375 . . . . 1.0 110.191 179.222 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.74 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 11.6 mt -77.13 -12.46 59.95 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.609 0.596 . . . . 1.0 112.609 -178.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 151.52 -26.94 0.96 Allowed Glycine 0 N--CA 1.453 -0.18 0 C-N-CA 120.277 -0.963 . . . . 1.0 112.4 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.892 HG13 ' H ' ' A' ' 103' ' ' GLU . 2.7 t -73.97 -155.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 C-N-CA 123.122 0.569 . . . . 1.0 110.185 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.892 ' H ' HG13 ' A' ' 102' ' ' VAL . 15.4 pt-20 -170.48 164.32 8.54 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 107.883 -1.154 . . . . 1.0 107.883 -178.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.731 ' HA ' HG11 ' A' ' 107' ' ' VAL . . . -67.31 -21.69 65.66 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.771 0.319 . . . . 1.0 110.882 -176.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.5 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . . . -58.31 -38.21 76.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.924 -0.58 . . . . 1.0 109.869 174.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.705 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 31.7 mtt180 -95.36 -45.79 6.98 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 115.182 -0.917 . . . . 1.0 110.333 -177.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.731 HG11 ' HA ' ' A' ' 104' ' ' ALA . 8.9 p -79.6 119.83 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-O 121.634 0.731 . . . . 1.0 110.033 -177.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.558 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 22.4 mmm180 -134.77 145.71 48.66 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.414 -0.587 . . . . 1.0 109.414 -178.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.572 ' HE2' HG21 ' A' ' 124' ' ' VAL . 81.4 mmm -77.35 134.86 38.37 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.829 -0.623 . . . . 1.0 110.389 -178.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.516 HD22 HG11 ' A' ' 87' ' ' VAL . 3.0 tm? -55.33 -48.94 73.42 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.933 0.396 . . . . 1.0 111.066 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.642 ' HB2' HG12 ' A' ' 124' ' ' VAL . 37.8 ttt180 -69.98 -19.02 63.37 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.894 -0.594 . . . . 1.0 110.679 -177.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 41.7 t -77.31 -8.41 57.59 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.95 -178.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.57 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 90.4 m-85 -88.75 -17.62 29.47 Favored 'General case' 0 C--N 1.341 0.21 0 O-C-N 121.858 -0.526 . . . . 1.0 110.235 176.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -60.8 123.34 74.32 Favored Pre-proline 0 CA--C 1.521 -0.149 0 CA-C-N 115.993 -0.549 . . . . 1.0 110.908 -178.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -70.1 -18.67 35.25 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.312 2.008 . . . . 1.0 111.674 178.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -87.67 -3.17 58.98 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.673 -0.694 . . . . 1.0 111.55 -178.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 77.6 p -64.13 101.77 0.44 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.314 0.578 . . . . 1.0 111.996 -178.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -55.96 -33.04 59.95 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-N 115.122 -0.945 . . . . 1.0 113.574 178.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.6 m -131.17 168.04 18.14 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.307 -0.627 . . . . 1.0 109.307 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 52.7 m170 -61.37 137.68 58.24 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 109.373 -0.603 . . . . 1.0 109.373 176.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.412 ' C ' ' H ' ' A' ' 123' ' ' ASP . . . -100.82 84.95 2.79 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.101 0.476 . . . . 1.0 111.404 -177.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.477 ' O ' ' HB3' ' A' ' 91' ' ' ARG . 2.5 mm? -91.12 22.93 3.48 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 108.311 -0.996 . . . . 1.0 108.311 175.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.412 ' H ' ' C ' ' A' ' 121' ' ' ALA . 0.1 OUTLIER -171.97 140.98 1.29 Allowed 'General case' 0 N--CA 1.426 -1.663 0 CA-C-N 113.359 -1.746 . . . . 1.0 107.829 178.595 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.642 HG12 ' HB2' ' A' ' 111' ' ' ARG . 64.0 t -101.14 144.47 12.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 109.472 -0.566 . . . . 1.0 109.472 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -65.23 166.48 9.75 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.826 -0.805 . . . . 1.0 108.826 178.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.534 ' OD1' ' HD2' ' A' ' 127' ' ' PRO . 35.4 t70 -156.55 148.42 17.3 Favored Pre-proline 0 C--N 1.314 -0.977 0 C-N-CA 119.827 -0.749 . . . . 1.0 109.769 -172.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.534 ' HD2' ' OD1' ' A' ' 126' ' ' ASP . 10.7 Cg_endo -54.72 -176.33 0.04 OUTLIER 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 123.458 2.772 . . . . 1.0 112.426 176.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.516 ' HD2' ' CD2' ' A' ' 129' ' ' TYR . 68.7 t80 -131.45 -26.63 2.04 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 113.872 1.064 . . . . 1.0 113.872 -173.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.516 ' CD2' ' HD2' ' A' ' 128' ' ' TYR . 0.2 OUTLIER -140.7 -44.52 0.4 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 114.238 1.199 . . . . 1.0 114.238 -174.99 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 109.66 59.01 0.51 Allowed Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 119.972 -1.109 . . . . 1.0 111.7 -175.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.602 ' H ' ' CB ' ' A' ' 134' ' ' ASP . 11.2 m-20 -125.98 -168.78 1.9 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.067 -0.716 . . . . 1.0 109.067 178.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.622 ' HA ' ' CE2' ' A' ' 135' ' ' PHE . 4.4 t-160 -58.66 -54.36 47.96 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.959 0.409 . . . . 1.0 110.674 -178.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.4 p -62.41 -32.71 73.58 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.049 -0.523 . . . . 1.0 111.789 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.602 ' CB ' ' H ' ' A' ' 131' ' ' ASP . 15.1 t70 -61.53 -47.09 87.17 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 114.78 -1.1 . . . . 1.0 111.355 -176.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.622 ' CE2' ' HA ' ' A' ' 132' ' ' HIS . 7.0 p90 -76.24 -37.74 57.27 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 119.734 -0.786 . . . . 1.0 112.243 -177.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.443 ' HG2' HG12 ' A' ' 61' ' ' VAL . 32.3 mt-10 -69.79 -24.59 63.51 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.504 -0.478 . . . . 1.0 110.014 177.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.511 ' O ' HG23 ' A' ' 141' ' ' VAL . 8.3 tt0 -64.44 -45.05 89.17 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.583 -0.735 . . . . 1.0 109.885 178.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 40.6 t -58.22 -43.34 85.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.405 0.621 . . . . 1.0 110.07 177.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -54.35 -45.65 72.77 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.43 -1.259 . . . . 1.0 110.344 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.578 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -62.3 -41.36 98.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.954 -0.567 . . . . 1.0 111.334 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 137' ' ' GLU . 20.7 t -56.9 -52.58 53.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-O 121.637 0.732 . . . . 1.0 110.855 178.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 6.3 mt -64.11 -49.67 80.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 114.928 -1.033 . . . . 1.0 111.956 -177.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.578 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 7.2 pt-20 -56.99 -30.45 64.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.887 0.375 . . . . 1.0 110.272 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 2.8 t -72.21 -31.28 65.72 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-O 121.233 0.54 . . . . 1.0 110.265 179.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.472 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -86.24 -23.07 26.55 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-N 115.699 -0.682 . . . . 1.0 111.796 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.599 HD13 ' HB3' ' A' ' 25' ' ' PHE . 10.6 mt -54.54 -40.94 86.77 Favored Pre-proline 0 C--N 1.329 -0.305 0 N-CA-C 112.795 0.665 . . . . 1.0 112.795 -178.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.688 ' HA ' ' CD2' ' A' ' 150' ' ' HIS . 69.7 Cg_endo -69.07 -7.27 20.39 Favored 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 122.279 1.986 . . . . 1.0 112.182 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.57 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -108.09 -32.5 3.25 Favored Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 109.903 -1.279 . . . . 1.0 109.903 177.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.558 HD12 ' CE2' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -76.49 -53.33 8.25 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.689 -0.756 . . . . 1.0 109.91 -179.334 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.688 ' CD2' ' HA ' ' A' ' 147' ' ' PRO . 3.7 p80 -56.28 -45.38 80.18 Favored 'General case' 0 C--O 1.216 -0.67 0 CA-C-O 121.469 0.652 . . . . 1.0 110.682 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.407 ' N ' ' CG ' ' A' ' 150' ' ' HIS . 25.9 t70 -57.31 -42.79 82.48 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 114.458 -1.246 . . . . 1.0 110.279 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . 0.741 ' HZ3' HD11 ' A' ' 5' ' ' LEU . 18.1 t90 -62.45 -55.47 27.34 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 114.993 -1.003 . . . . 1.0 110.072 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.55 HG12 HG21 ' A' ' 7' ' ' VAL . 4.0 m -61.95 -40.28 86.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.453 -0.34 . . . . 1.0 110.143 -179.04 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.49 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 67.1 m-20 -59.47 -54.89 41.43 Favored 'General case' 0 C--N 1.338 0.105 0 CA-C-O 121.405 0.621 . . . . 1.0 110.287 178.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.494 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 5.5 pt-20 -60.4 -35.76 76.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.278 -0.874 . . . . 1.0 110.571 -178.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 10.3 mmt180 -74.79 -43.69 53.42 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 115.831 -0.622 . . . . 1.0 111.187 -178.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 4.4 pp -67.7 -21.44 65.32 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.498 0.666 . . . . 1.0 109.73 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -76.3 -56.96 4.16 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.334 -0.848 . . . . 1.0 110.186 176.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.47 ' C ' ' H ' ' A' ' 161' ' ' GLY . 0.0 OUTLIER -80.3 1.14 29.86 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.498 0.925 . . . . 1.0 113.498 -175.036 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -76.05 31.48 0.12 Allowed 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.524 0.678 . . . . 1.0 111.448 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.47 ' H ' ' C ' ' A' ' 159' ' ' ARG . . . -84.74 174.69 50.14 Favored Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.588 -0.733 . . . . 1.0 111.527 179.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -84.1 27.48 0.61 Allowed 'Trans proline' 0 N--CA 1.473 0.286 0 C-N-CA 123.055 2.503 . . . . 1.0 112.991 -178.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 29.5 p . . . . . 0 C--N 1.306 -1.321 0 CA-C-N 114.54 -1.209 . . . . 1.0 110.111 179.868 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . 0.415 ' O ' ' HB2' ' A' ' 1' ' ' MET . . . . . . . . 0 N--CA 1.485 1.9 0 N-CA-C 112.024 -0.43 . . . . 1.0 112.024 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.415 ' HB2' ' O ' ' A' ' 0' ' ' GLY . 64.5 mtt 74.72 32.79 0.84 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 122.082 0.944 . . . . 1.0 108.55 -179.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.3 p -155.0 170.12 22.51 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 113.901 -1.499 . . . . 1.0 108.525 -178.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.61 ' HB3' ' HD2' ' A' ' 4' ' ' PRO . 0.6 OUTLIER -66.32 159.8 69.8 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.404 0.621 . . . . 1.0 111.801 -178.412 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.61 ' HD2' ' HB3' ' A' ' 3' ' ' ASP . 37.3 Cg_endo -69.89 177.28 5.83 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 124.19 3.26 . . . . 1.0 113.601 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.775 ' HB3' HG22 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -66.56 177.61 1.51 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.472 -0.786 . . . . 1.0 109.432 177.868 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.738 ' H ' HD13 ' A' ' 5' ' ' LEU . 1.7 t-160 -156.0 90.57 1.22 Allowed 'General case' 0 C--N 1.321 -0.631 0 O-C-N 122.161 -0.337 . . . . 1.0 110.695 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.82 HG13 HD12 ' A' ' 85' ' ' LEU . 2.1 t -96.29 102.88 14.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.031 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.624 ' CG2' HD23 ' A' ' 86' ' ' LEU . 9.6 t -105.8 114.71 29.02 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 121.029 0.442 . . . . 1.0 111.143 -178.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.544 ' HD1' ' HB ' ' A' ' 87' ' ' VAL . 1.1 m-85 -83.42 131.15 35.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.834 0.35 . . . . 1.0 110.361 -179.122 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.686 HG22 HD11 ' A' ' 97' ' ' LEU . 37.3 t -117.59 113.68 43.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.07 -0.514 . . . . 1.0 111.848 -176.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.53 ' HA ' ' CE1' ' A' ' 93' ' ' HIS . 41.8 t -142.7 163.06 33.84 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.048 -0.723 . . . . 1.0 109.048 177.064 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.79 90.89 4.07 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.357 0.599 . . . . 1.0 110.94 -178.03 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.811 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 136.65 -44.0 1.19 Allowed Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.453 -0.794 . . . . 1.0 111.442 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.612 ' ND2' ' H ' ' A' ' 74' ' ' ALA . 59.3 t30 61.57 22.88 13.27 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.843 0.83 . . . . 1.0 111.998 177.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.9 pt -127.41 4.44 3.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 O-C-N 121.63 -0.669 . . . . 1.0 110.956 179.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.746 ' O ' ' HG3' ' A' ' 20' ' ' MET . 5.3 p -121.6 -87.77 0.63 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.91 -0.587 . . . . 1.0 112.429 -177.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.748 HH11 HG23 ' A' ' 138' ' ' VAL . 8.5 mmt180 -71.63 -44.89 63.55 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.297 -0.41 . . . . 1.0 111.52 -174.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.425 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 19.2 m -55.72 -56.18 32.75 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-N 116.163 -0.471 . . . . 1.0 112.192 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.523 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 55.6 Cg_endo -67.01 -19.07 52.14 Favored 'Trans proline' 0 C--N 1.357 1.026 0 C-N-CA 121.633 1.555 . . . . 1.0 112.245 -178.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.746 ' HG3' ' O ' ' A' ' 16' ' ' CYS . 61.3 mtp -62.7 -55.0 30.75 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 120.336 -0.545 . . . . 1.0 109.907 176.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.433 ' HA ' ' HB2' ' A' ' 24' ' ' MET . . . -71.73 -27.9 63.31 Favored 'General case' 0 CA--C 1.512 -0.505 0 C-N-CA 120.37 -0.532 . . . . 1.0 110.617 -179.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.72 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 13.2 tt0 -51.15 -54.08 28.55 Favored 'General case' 0 C--O 1.217 -0.626 0 O-C-N 124.334 1.021 . . . . 1.0 109.73 179.191 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.889 ' HB3' ' HG2' ' A' ' 68' ' ' PRO . 0.4 OUTLIER -81.7 -27.16 34.09 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.239 -0.891 . . . . 1.0 110.311 -176.093 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.638 ' HB3' HD11 ' A' ' 146' ' ' LEU . 6.0 mmm -62.4 -76.76 0.06 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.811 0.671 . . . . 1.0 112.811 -176.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.694 ' HB3' HD21 ' A' ' 146' ' ' LEU . 18.2 p90 -78.2 -28.58 48.08 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 119.945 -0.702 . . . . 1.0 111.051 -174.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.72 ' HB3' ' O ' ' A' ' 22' ' ' GLU . . . -65.18 -38.02 89.18 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 119.208 -0.997 . . . . 1.0 110.922 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.73 ' HA ' ' HD3' ' A' ' 30' ' ' ARG . 0.1 OUTLIER -63.2 -37.7 88.27 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 108.709 -0.849 . . . . 1.0 108.709 177.485 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.598 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 74.9 mt-30 -60.33 -45.37 93.66 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.688 -0.687 . . . . 1.0 110.259 175.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 25' ' ' PHE . 84.9 mt -54.95 -58.47 7.5 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.887 -0.597 . . . . 1.0 111.09 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.73 ' HD3' ' HA ' ' A' ' 27' ' ' GLN . 0.7 OUTLIER -58.93 -38.1 78.21 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.35 -0.386 . . . . 1.0 111.228 179.597 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -62.7 -26.32 68.61 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.543 0.571 . . . . 1.0 112.543 177.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.598 ' HG2' ' O ' ' A' ' 28' ' ' GLN . 7.0 ptp180 -95.26 -18.96 20.4 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 119.406 -0.917 . . . . 1.0 109.917 178.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 107.44 34.95 2.76 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.345 -0.843 . . . . 1.0 112.305 177.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 21.1 mt -126.41 2.36 6.98 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.924 -0.399 . . . . 1.0 109.924 -178.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -53.54 -31.04 43.56 Favored Glycine 0 CA--C 1.521 0.468 0 CA-C-N 116.014 -0.539 . . . . 1.0 113.262 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.654 ' HA ' ' NH1' ' A' ' 39' ' ' ARG . 15.0 m-20 -92.04 -17.85 24.46 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 122.648 -0.325 . . . . 1.0 110.65 177.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.55 -22.73 43.46 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.163 -0.471 . . . . 1.0 111.139 -177.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.775 HG22 ' HB3' ' A' ' 5' ' ' LEU . 0.3 OUTLIER -144.32 123.92 7.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.186 0.517 . . . . 1.0 110.922 -179.749 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.671 ' O ' ' HA ' ' A' ' 6' ' ' HIS . 15.0 mmt180 -95.33 104.82 16.72 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 115.698 -0.683 . . . . 1.0 111.153 -177.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.679 HG12 ' HB1' ' A' ' 26' ' ' ALA . 1.5 m -87.99 137.1 21.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 108.231 -1.026 . . . . 1.0 108.231 176.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.491 ' O ' ' HA ' ' A' ' 8' ' ' THR . 21.5 p -146.76 -177.75 5.82 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.354 -0.839 . . . . 1.0 109.819 -175.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.474 ' OG ' ' HE1' ' A' ' 71' ' ' HIS . 67.1 p -157.14 156.73 33.21 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 120.388 -0.525 . . . . 1.0 111.035 -177.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.522 ' O ' ' HA ' ' A' ' 10' ' ' VAL . . . -161.65 160.68 29.02 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 121.225 0.536 . . . . 1.0 111.061 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 11' ' ' CYS . . . -123.08 133.77 9.19 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 111.351 -0.7 . . . . 1.0 111.351 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.498 HG22 HD13 ' A' ' 96' ' ' LEU . 21.1 p -69.17 -22.57 63.91 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 111.931 0.345 . . . . 1.0 111.931 -177.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -110.46 7.1 30.2 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.866 -0.683 . . . . 1.0 113.111 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 42.87 35.98 0.81 Allowed 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 113.87 1.063 . . . . 1.0 113.87 178.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.811 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 1.0 OUTLIER -44.95 -70.29 0.11 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.422 0.629 . . . . 1.0 112.487 -178.315 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.486 ' O ' ' HB2' ' A' ' 73' ' ' ALA . 24.3 m-70 -110.58 44.08 1.31 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.317 -0.856 . . . . 1.0 111.244 179.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.457 HG21 ' HA ' ' A' ' 74' ' ' ALA . 12.0 p -61.56 129.17 24.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.772 -0.455 . . . . 1.0 109.772 177.055 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.585 ' HA2' ' HD3' ' A' ' 72' ' ' ARG . . . 92.58 -12.15 70.43 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.977 -0.63 . . . . 1.0 111.838 -177.271 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.487 ' O ' ' HA ' ' A' ' 72' ' ' ARG . 2.4 t -81.45 -158.56 0.22 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.357 0.598 . . . . 1.0 109.97 179.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 36.8 t -134.18 170.52 15.56 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 108.719 -0.845 . . . . 1.0 108.719 -178.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.54 140.77 27.39 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.193 0.52 . . . . 1.0 111.816 -178.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -59.35 137.37 58.01 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 114.432 -1.258 . . . . 1.0 110.43 -178.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -51.33 -29.15 14.27 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.315 -0.857 . . . . 1.0 113.109 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.6 ' HD3' ' CE1' ' A' ' 135' ' ' PHE . 30.9 mtt180 -69.63 -50.96 39.27 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.136 0.494 . . . . 1.0 110.267 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.43 -29.32 67.0 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.18 -0.918 . . . . 1.0 110.533 -177.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.27 -44.63 96.92 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.86 -0.609 . . . . 1.0 109.514 176.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.19 -39.67 96.27 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.715 -0.755 . . . . 1.0 111.667 178.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.491 ' O ' ' HD2' ' A' ' 65' ' ' HIS . 78.7 t -60.81 -56.28 18.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 CA-C-O 121.188 0.518 . . . . 1.0 110.957 178.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.775 HD11 ' HG3' ' A' ' 23' ' ' LYS . 70.5 mt -61.04 -50.95 71.24 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.936 -0.574 . . . . 1.0 111.366 -178.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -60.07 -28.24 67.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.419 -0.355 . . . . 1.0 110.675 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.65 -35.67 79.31 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 120.977 0.417 . . . . 1.0 110.818 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.491 ' HD2' ' O ' ' A' ' 61' ' ' VAL . 88.8 m-70 -96.64 4.05 52.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.871 -0.604 . . . . 1.0 111.329 -177.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 90.21 14.99 58.16 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 121.086 -0.578 . . . . 1.0 112.632 177.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.495 ' HD1' ' HG2' ' A' ' 27' ' ' GLN . 69.7 m-85 -89.9 151.05 44.87 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-O 120.44 0.162 . . . . 1.0 110.985 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.889 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 55.3 Cg_endo -68.9 160.58 49.22 Favored 'Trans proline' 0 CA--C 1.511 -0.67 0 C-N-CA 122.571 2.18 . . . . 1.0 110.125 175.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.702 HG22 ' HB2' ' A' ' 62' ' ' LEU . 47.5 p -135.62 -0.43 2.63 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 119.589 -0.844 . . . . 1.0 112.161 -177.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.484 ' O ' ' HE2' ' A' ' 23' ' ' LYS . 48.4 t0 -71.94 134.84 46.22 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.293 -0.632 . . . . 1.0 109.293 -179.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.614 ' HB2' ' HE2' ' A' ' 23' ' ' LYS . 32.7 t60 -169.05 154.81 6.28 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.971 0.415 . . . . 1.0 110.379 -174.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.585 ' HD3' ' HA2' ' A' ' 51' ' ' GLY . 5.0 tmm_? -136.4 108.37 7.15 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 107.468 -1.308 . . . . 1.0 107.468 176.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.486 ' HB2' ' O ' ' A' ' 49' ' ' HIS . . . -58.67 139.99 55.27 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.823 -1.081 . . . . 1.0 112.048 -175.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.612 ' H ' ' ND2' ' A' ' 14' ' ' ASN . . . -130.01 161.54 30.73 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.645 -0.707 . . . . 1.0 109.93 177.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -96.77 159.9 14.67 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.205 -0.665 . . . . 1.0 109.205 179.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.7 t -70.18 110.2 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.158 0.504 . . . . 1.0 110.316 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.564 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -123.95 -170.58 13.34 Favored Glycine 0 N--CA 1.441 -1.006 0 CA-C-N 115.397 -0.819 . . . . 1.0 111.564 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 43.3 m -58.63 -51.71 68.75 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.873 0.368 . . . . 1.0 111.647 -178.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.557 ' HG2' ' N ' ' A' ' 80' ' ' HIS . 0.7 OUTLIER -54.46 -32.74 58.27 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.563 -0.744 . . . . 1.0 111.007 179.789 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.557 ' N ' ' HG2' ' A' ' 79' ' ' GLU . 79.4 m80 -76.87 -40.61 47.0 Favored 'General case' 0 C--O 1.223 -0.321 0 N-CA-C 109.659 -0.497 . . . . 1.0 109.659 178.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.564 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 54.4 mt -65.75 -18.4 65.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.248 0.547 . . . . 1.0 110.539 178.143 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.39 -4.04 59.03 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.872 -0.604 . . . . 1.0 110.697 -178.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.56 ' HB2' ' O ' ' A' ' 6' ' ' HIS . . . -64.13 149.33 47.93 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.807 -0.633 . . . . 1.0 111.4 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.529 ' HB3' HD13 ' A' ' 5' ' ' LEU . 24.7 t70 -73.23 -14.4 61.33 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.07 0.462 . . . . 1.0 109.871 178.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.82 HD12 HG13 ' A' ' 7' ' ' VAL . 0.9 OUTLIER -154.08 120.94 5.59 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.597 -0.729 . . . . 1.0 110.504 -177.735 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 1.013 HD11 HG13 ' A' ' 102' ' ' VAL . 0.3 OUTLIER -105.99 104.33 14.02 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.747 -0.835 . . . . 1.0 108.747 175.158 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.573 HG23 HD23 ' A' ' 85' ' ' LEU . 54.5 t -83.73 92.18 2.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 121.493 0.663 . . . . 1.0 110.551 -178.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.21 146.78 30.3 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.195 -0.912 . . . . 1.0 111.231 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.679 ' O ' ' HB ' ' A' ' 124' ' ' VAL . 4.2 mm? -98.18 -13.68 20.76 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 115.689 -0.687 . . . . 1.0 109.741 178.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -139.44 153.55 47.59 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.496 -0.774 . . . . 1.0 109.961 -177.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.62 ' HB3' ' HB2' ' A' ' 123' ' ' ASP . 15.5 ptp180 -62.78 -20.38 64.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.36 0.6 . . . . 1.0 109.819 176.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.623 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 95.1 m-20 -76.49 -51.93 10.78 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.935 -1.029 . . . . 1.0 110.319 -178.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.53 ' CE1' ' HA ' ' A' ' 11' ' ' CYS . 19.0 m170 -58.3 -44.14 88.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.792 -0.64 . . . . 1.0 110.277 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.531 ' HA ' HD13 ' A' ' 97' ' ' LEU . . . -60.54 -42.77 97.19 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.026 0.441 . . . . 1.0 110.473 178.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 5.0 ttp-105 -58.59 -45.56 88.82 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 115.438 -0.801 . . . . 1.0 111.16 178.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.727 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 45.6 mt -63.69 -50.28 69.81 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.343 -176.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.686 HD11 HG22 ' A' ' 10' ' ' VAL . 14.0 mt -52.76 -58.52 6.61 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.936 -0.575 . . . . 1.0 111.835 -177.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 13.0 ptt180 -60.68 -44.8 96.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.281 -0.418 . . . . 1.0 111.922 -176.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.452 ' HG3' ' O ' ' A' ' 96' ' ' LEU . 1.2 pt20 -69.0 -20.18 64.15 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 121.01 0.433 . . . . 1.0 110.595 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.727 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 6.2 mt -79.22 -9.02 59.47 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.622 -0.717 . . . . 1.0 111.798 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 150.96 -32.89 0.96 Allowed Glycine 0 CA--C 1.505 -0.57 0 C-N-CA 119.842 -1.171 . . . . 1.0 113.352 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 1.013 HG13 HD11 ' A' ' 86' ' ' LEU . 0.8 OUTLIER -76.79 -151.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 121.716 0.769 . . . . 1.0 112.056 -176.697 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.626 ' H ' HG12 ' A' ' 102' ' ' VAL . 12.8 pt-20 -162.9 167.42 22.7 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.189 -0.914 . . . . 1.0 108.733 -178.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.756 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -67.23 -22.32 65.7 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.179 -0.464 . . . . 1.0 112.132 -174.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.24 -36.59 73.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.12 0.486 . . . . 1.0 110.687 176.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.579 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 1.0 OUTLIER -96.86 -40.36 8.96 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.207 -0.906 . . . . 1.0 110.805 -177.615 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.756 HG12 ' HA ' ' A' ' 104' ' ' ALA . 13.4 p -79.76 115.2 21.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.574 0.702 . . . . 1.0 110.352 -179.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.53 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 20.5 mmm180 -133.3 145.08 50.12 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.889 -0.596 . . . . 1.0 109.658 -177.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.607 ' HE3' ' HA ' ' A' ' 123' ' ' ASP . 84.6 mmm -77.52 137.52 38.67 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.947 -0.57 . . . . 1.0 110.543 -179.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.54 HD21 HG11 ' A' ' 87' ' ' VAL . 3.1 tm? -55.27 -49.81 71.11 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.802 0.334 . . . . 1.0 110.567 179.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.545 ' HB2' HG22 ' A' ' 124' ' ' VAL . 11.8 ttt-85 -72.94 -12.87 61.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.321 -0.4 . . . . 1.0 111.419 -176.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.513 ' HB2' ' O ' ' A' ' 121' ' ' ALA . 33.3 t -78.81 -8.97 59.28 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 121.15 -0.22 . . . . 1.0 110.855 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.609 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 82.6 m-85 -86.46 -18.27 32.11 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-O 120.975 0.417 . . . . 1.0 110.341 177.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -54.28 120.05 23.58 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.33 -0.85 . . . . 1.0 111.046 -179.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -67.1 -25.6 43.63 Favored 'Trans proline' 0 C--O 1.233 0.275 0 C-N-CA 122.736 2.291 . . . . 1.0 111.533 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 52.9 mtt180 -85.49 -1.22 56.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.393 -0.821 . . . . 1.0 111.181 -177.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 75.9 p -62.4 99.27 0.13 Allowed 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.174 0.511 . . . . 1.0 111.651 -178.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -66.19 -20.74 69.47 Favored Glycine 0 C--N 1.331 0.304 0 CA-C-N 115.658 -0.701 . . . . 1.0 112.09 177.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -131.94 164.03 27.04 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.975 -0.75 . . . . 1.0 108.975 178.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 36.6 m170 -70.83 138.39 50.26 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.961 0.41 . . . . 1.0 110.026 177.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.513 ' O ' ' HB2' ' A' ' 112' ' ' SER . . . -108.64 92.43 4.05 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.025 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.518 ' HA ' ' HG3' ' A' ' 109' ' ' MET . 2.2 mm? -96.49 9.02 42.67 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.21 -0.663 . . . . 1.0 109.21 179.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.62 ' HB2' ' HB3' ' A' ' 91' ' ' ARG . 34.8 t70 -168.35 144.86 3.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.662 -1.154 . . . . 1.0 108.05 -177.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.679 ' HB ' ' O ' ' A' ' 89' ' ' LEU . 92.9 t -102.56 148.43 7.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.051 0.453 . . . . 1.0 110.865 -176.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -66.44 -175.32 0.35 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.696 -0.684 . . . . 1.0 110.964 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -146.47 152.94 47.0 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 108.931 -0.766 . . . . 1.0 108.931 -175.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.95 172.31 3.08 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.98 2.453 . . . . 1.0 113.684 -175.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -97.11 -39.94 9.06 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.404 -0.816 . . . . 1.0 111.178 -178.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.47 ' HD1' ' N ' ' A' ' 130' ' ' GLY . 0.1 OUTLIER -143.53 -24.24 0.59 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 113.731 1.012 . . . . 1.0 113.731 -178.334 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.47 ' N ' ' HD1' ' A' ' 129' ' ' TYR . . . 89.54 67.2 1.24 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 119.96 -1.114 . . . . 1.0 111.552 -177.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.617 ' H ' ' HB3' ' A' ' 134' ' ' ASP . 8.5 t70 -135.29 -167.37 1.99 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.89 -0.782 . . . . 1.0 108.89 -177.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.403 ' H ' ' CG ' ' A' ' 131' ' ' ASP . 11.6 t-160 -56.71 -41.2 77.0 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.7 0.286 . . . . 1.0 110.75 -178.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 8.0 m -61.86 -37.1 83.26 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.854 179.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.617 ' HB3' ' H ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -65.74 -38.61 89.59 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.991 -177.61 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.6 ' CE1' ' HD3' ' A' ' 57' ' ' ARG . 2.9 m-85 -69.71 -44.08 71.07 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.644 -0.502 . . . . 1.0 109.644 -176.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.43 ' HA ' ' HB3' ' A' ' 139' ' ' PHE . 36.7 mt-10 -74.25 -26.21 60.09 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.723 -0.671 . . . . 1.0 110.382 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -63.22 -50.22 71.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.029 -0.532 . . . . 1.0 109.878 178.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 1.055 ' HA ' HG21 ' A' ' 141' ' ' VAL . 53.4 t -62.74 -40.16 87.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.663 -0.699 . . . . 1.0 109.857 175.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.524 ' HB2' ' HE1' ' A' ' 20' ' ' MET . 18.3 t80 -54.5 -41.77 69.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.113 -0.949 . . . . 1.0 109.172 175.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.564 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -65.63 -42.37 91.6 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.604 -0.725 . . . . 1.0 110.544 176.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 1.055 HG21 ' HA ' ' A' ' 138' ' ' VAL . 13.8 t -54.15 -52.11 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-O 121.863 0.84 . . . . 1.0 109.715 177.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.535 ' HA ' HD11 ' A' ' 110' ' ' LEU . 7.2 mt -65.29 -51.32 66.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 114.597 -1.183 . . . . 1.0 112.084 -178.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.564 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 8.4 pt-20 -55.29 -34.37 64.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.825 0.345 . . . . 1.0 110.479 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 67.1 m -72.24 -28.96 63.48 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.738 -0.664 . . . . 1.0 110.743 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.461 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -88.48 -22.77 23.48 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.776 -0.647 . . . . 1.0 112.08 179.253 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.694 HD21 ' HB3' ' A' ' 25' ' ' PHE . 12.0 mt -55.65 -37.74 60.3 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 112.266 0.469 . . . . 1.0 112.266 -178.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 60.3 Cg_endo -70.53 -10.31 27.67 Favored 'Trans proline' 0 C--N 1.361 1.204 0 C-N-CA 122.493 2.129 . . . . 1.0 111.832 177.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.609 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -104.67 -32.41 4.18 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 110.572 -1.011 . . . . 1.0 110.572 178.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.473 ' O ' HG12 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -75.63 -41.89 53.03 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.687 -0.857 . . . . 1.0 108.687 179.474 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.442 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 0.5 OUTLIER -54.08 -56.85 14.18 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 114.791 -1.095 . . . . 1.0 110.736 176.787 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -58.55 -40.64 83.58 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.226 -0.897 . . . . 1.0 111.504 -175.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . 0.735 ' HZ3' HD12 ' A' ' 5' ' ' LEU . 31.0 t90 -63.22 -55.23 26.75 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.624 -0.716 . . . . 1.0 110.615 -179.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.513 HG11 HG23 ' A' ' 7' ' ' VAL . 7.2 m -61.65 -40.38 86.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 120.723 -0.391 . . . . 1.0 110.598 -178.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.425 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 13.3 m-20 -59.69 -52.0 67.4 Favored 'General case' 0 CA--C 1.523 -0.084 0 CA-C-O 120.994 0.426 . . . . 1.0 110.721 178.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.578 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 6.2 pt-20 -61.86 -38.84 89.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.586 -0.734 . . . . 1.0 110.296 -178.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.499 ' HG3' ' CH2' ' A' ' 152' ' ' TRP . 20.4 mmt180 -72.11 -46.62 55.97 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.805 -0.634 . . . . 1.0 111.057 -177.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 4.1 pp -65.56 -23.81 66.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.337 0.589 . . . . 1.0 109.591 -179.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -74.63 -55.05 6.31 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.274 -0.876 . . . . 1.0 110.162 177.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.501 ' HG3' ' O ' ' A' ' 155' ' ' GLU . 0.1 OUTLIER -80.9 3.05 24.07 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 112.653 0.612 . . . . 1.0 112.653 -177.3 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -45.02 -36.41 3.44 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 123.276 0.36 . . . . 1.0 111.56 178.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 78.57 164.0 24.92 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.92 -0.657 . . . . 1.0 114.089 176.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -99.14 20.91 0.3 Allowed 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 123.545 2.83 . . . . 1.0 112.48 178.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 45.9 t . . . . . 0 C--N 1.306 -1.284 0 CA-C-N 114.124 -1.398 . . . . 1.0 109.311 -178.713 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.72 0 N-CA-C 111.715 -0.554 . . . . 1.0 111.715 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.6 mtt -82.24 70.44 9.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.942 0.371 . . . . 1.0 110.844 -178.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.3 m -158.68 176.48 12.32 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.574 -0.528 . . . . 1.0 109.574 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.76 155.84 75.1 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.942 175.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.466 ' HB2' ' HG2' ' A' ' 39' ' ' ARG . 35.1 Cg_endo -64.24 161.94 32.05 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.387 2.725 . . . . 1.0 113.836 -175.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.759 ' HB3' HG22 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -66.17 178.42 1.16 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.75 -1.114 . . . . 1.0 109.319 177.547 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.68 ' H ' HD11 ' A' ' 5' ' ' LEU . 4.0 t-160 -156.8 98.23 1.76 Allowed 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.503 -0.555 . . . . 1.0 109.503 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.703 HG11 HD12 ' A' ' 85' ' ' LEU . 2.1 t -103.18 117.97 49.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 N-CA-C 107.722 -1.214 . . . . 1.0 107.722 177.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.564 HG23 ' HG ' ' A' ' 86' ' ' LEU . 8.3 t -118.54 114.38 22.73 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 120.931 0.396 . . . . 1.0 110.204 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.565 ' HD2' ' HB3' ' A' ' 42' ' ' SER . 2.2 m-85 -82.89 126.07 32.06 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.076 0.465 . . . . 1.0 110.215 -178.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.66 HG23 HD11 ' A' ' 97' ' ' LEU . 35.4 t -110.23 112.01 38.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 CA-C-N 115.74 -0.664 . . . . 1.0 111.631 -176.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.615 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 37.7 t -139.91 161.28 37.96 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.149 -1.056 . . . . 1.0 108.149 177.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.435 HG23 ' HE2' ' A' ' 93' ' ' HIS . 0.5 OUTLIER -66.24 -39.89 89.86 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.217 0.532 . . . . 1.0 109.812 179.248 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.62 ' C ' ' H ' ' A' ' 15' ' ' ILE . . . -104.17 80.4 0.32 Allowed Glycine 0 N--CA 1.435 -1.432 0 CA-C-N 115.187 -0.915 . . . . 1.0 110.856 175.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.6 ' ND2' ' HB3' ' A' ' 73' ' ' ALA . 15.9 p-10 -59.5 17.72 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.74 1.616 . . . . 1.0 112.418 176.1 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.62 ' H ' ' C ' ' A' ' 13' ' ' GLY . 6.7 pt -121.59 -0.81 7.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.177 178.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 22.1 m -116.16 -87.09 0.61 Allowed 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.215 0.45 . . . . 1.0 112.215 -177.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.571 HH21 ' HB3' ' A' ' 89' ' ' LEU . 13.0 mtm-85 -72.38 -46.96 53.02 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 112.391 0.515 . . . . 1.0 112.391 -173.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.715 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 26.4 m -54.46 -58.72 12.71 Favored Pre-proline 0 CA--C 1.537 0.446 0 CA-C-N 116.306 -0.406 . . . . 1.0 111.333 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.437 ' CD ' ' HB2' ' A' ' 18' ' ' SER . 39.3 Cg_endo -63.56 -22.9 70.66 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 121.763 1.642 . . . . 1.0 113.345 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.66 ' HB3' HD11 ' A' ' 142' ' ' ILE . 35.6 mmm -60.97 -53.62 55.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.635 0.255 . . . . 1.0 110.846 178.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.92 -25.63 60.09 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.168 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.457 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 17.9 tt0 -51.92 -54.09 33.47 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 114.761 -1.109 . . . . 1.0 109.819 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.652 ' O ' ' HB3' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -83.51 -26.99 29.7 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.378 -0.828 . . . . 1.0 110.838 -175.753 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.555 ' HB3' HD11 ' A' ' 146' ' ' LEU . 5.6 mmm -60.85 -75.61 0.06 Allowed 'General case' 0 C--O 1.239 0.542 0 CA-C-O 121.453 0.644 . . . . 1.0 112.504 -178.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.665 ' HB3' HD12 ' A' ' 146' ' ' LEU . 22.3 p90 -79.37 -28.83 41.94 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.088 -0.645 . . . . 1.0 111.674 -174.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.457 ' HB2' ' O ' ' A' ' 22' ' ' GLU . . . -64.8 -36.2 83.56 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 119.082 -1.047 . . . . 1.0 110.739 178.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.652 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -63.73 -38.56 91.55 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.666 -0.864 . . . . 1.0 108.666 176.595 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.664 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 78.7 mt-30 -59.24 -44.56 92.35 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 115.608 -0.724 . . . . 1.0 110.499 175.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 25' ' ' PHE . 90.0 mt -54.26 -59.62 4.43 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.887 -0.597 . . . . 1.0 111.239 -179.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.515 ' HD3' ' HA ' ' A' ' 27' ' ' GLN . 1.5 ptm180 -59.31 -34.55 72.45 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.714 -0.394 . . . . 1.0 111.155 178.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -62.27 -28.96 70.08 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.315 0.487 . . . . 1.0 112.315 177.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.664 ' HG2' ' O ' ' A' ' 28' ' ' GLN . 4.8 ptp180 -94.16 -16.0 24.12 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 119.915 -0.714 . . . . 1.0 110.429 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 102.72 38.75 2.89 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.403 -0.817 . . . . 1.0 111.48 177.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 27.3 mt -132.72 1.51 3.66 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 110.088 -0.338 . . . . 1.0 110.088 -178.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.6 -27.29 58.48 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 121.05 -0.595 . . . . 1.0 112.343 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -82.55 -31.27 29.17 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.964 0.411 . . . . 1.0 109.928 177.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -78.94 -16.86 56.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.201 -0.909 . . . . 1.0 112.318 -174.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.759 HG22 ' HB3' ' A' ' 5' ' ' LEU . 0.3 OUTLIER -143.86 126.59 11.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 121.877 -0.515 . . . . 1.0 111.241 -179.998 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.466 ' HG2' ' HB2' ' A' ' 4' ' ' PRO . 7.7 mmt180 -90.46 132.62 35.55 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 108.636 -0.875 . . . . 1.0 108.636 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.402 HG13 ' HB3' ' A' ' 26' ' ' ALA . 68.3 t -124.9 119.41 55.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.264 -0.643 . . . . 1.0 109.264 -179.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' A' ' 8' ' ' THR . 78.0 p -132.49 -175.16 3.66 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.47 -1.241 . . . . 1.0 110.979 -174.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.715 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 87.8 p -158.58 163.39 37.04 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.682 -0.488 . . . . 1.0 109.682 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.558 ' HB1' ' CD2' ' A' ' 80' ' ' HIS . . . -164.93 168.78 17.23 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 121.219 0.533 . . . . 1.0 111.571 -178.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.615 ' HA2' ' O ' ' A' ' 11' ' ' CYS . . . -127.53 132.56 7.55 Favored Glycine 0 N--CA 1.438 -1.174 0 CA-C-N 115.078 -0.965 . . . . 1.0 111.462 178.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.492 HG21 ' CG1' ' A' ' 10' ' ' VAL . 26.9 p -69.47 -23.41 63.64 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.887 0.375 . . . . 1.0 111.325 -178.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.416 ' HA3' ' HZ3' ' A' ' 48' ' ' TRP . . . -112.92 9.1 25.41 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.858 -0.686 . . . . 1.0 112.304 -178.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.476 ' HB3' ' HB2' ' A' ' 75' ' ' GLN . 2.7 p-10 43.64 39.11 2.23 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.991 0.916 . . . . 1.0 113.41 177.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.416 ' HZ3' ' HA3' ' A' ' 46' ' ' GLY . 1.2 m-90 -42.8 -72.54 0.06 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.294 0.568 . . . . 1.0 112.386 -178.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.428 ' O ' ' HB1' ' A' ' 73' ' ' ALA . 75.9 m-70 -112.23 45.72 1.25 Allowed 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.283 -0.872 . . . . 1.0 111.243 178.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.422 HG21 ' HA ' ' A' ' 74' ' ' ALA . 11.6 p -61.78 129.93 25.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.622 -0.717 . . . . 1.0 110.135 177.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.603 ' HA2' ' HD3' ' A' ' 72' ' ' ARG . . . 93.66 -15.31 63.34 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.889 -0.672 . . . . 1.0 112.081 -177.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.4 t -80.06 -161.16 0.33 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.379 0.609 . . . . 1.0 109.914 179.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 35.5 t -127.98 170.62 12.66 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 115.288 -0.869 . . . . 1.0 108.932 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -52.06 136.13 29.99 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 123.338 0.398 . . . . 1.0 111.414 -178.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.697 ' OD1' ' HG2' ' A' ' 57' ' ' ARG . 12.5 t70 -57.17 140.27 50.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.389 -0.823 . . . . 1.0 111.309 -178.114 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -45.78 -37.93 6.57 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.99 -1.004 . . . . 1.0 113.519 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.697 ' HG2' ' OD1' ' A' ' 55' ' ' ASP . 15.3 ptp180 -70.12 -44.52 68.77 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 120.522 -0.471 . . . . 1.0 110.914 -177.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.406 ' HB2' ' SD ' ' A' ' 20' ' ' MET . . . -71.24 -30.91 66.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.035 0.445 . . . . 1.0 110.384 -178.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.02 -45.82 90.54 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.082 177.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.2 -36.87 94.01 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.937 -0.649 . . . . 1.0 111.773 177.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.64 HG22 ' O ' ' A' ' 57' ' ' ARG . 86.9 t -62.06 -59.04 4.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.23 0.538 . . . . 1.0 110.851 178.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.665 ' HB2' HG22 ' A' ' 69' ' ' THR . 96.8 mt -60.16 -50.12 74.95 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.836 -0.62 . . . . 1.0 111.363 -177.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 -59.25 -30.62 68.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.47 -0.332 . . . . 1.0 111.061 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.28 -33.24 73.99 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 121.124 0.488 . . . . 1.0 111.136 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -97.59 5.34 49.61 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.859 -0.61 . . . . 1.0 111.437 -178.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.48 13.44 63.32 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.899 -0.667 . . . . 1.0 112.837 177.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -91.13 148.95 39.01 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-O 120.561 0.22 . . . . 1.0 110.944 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.591 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 48.9 Cg_endo -69.95 158.13 57.73 Favored 'Trans proline' 0 CA--C 1.513 -0.563 0 C-N-CA 122.243 1.962 . . . . 1.0 110.841 176.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.665 HG22 ' HB2' ' A' ' 62' ' ' LEU . 53.1 p -131.3 9.09 4.73 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.341 -0.543 . . . . 1.0 110.803 -178.059 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -73.6 123.77 24.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.463 -0.79 . . . . 1.0 109.536 -178.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.434 ' HE1' ' OG ' ' A' ' 42' ' ' SER . 31.2 t60 -166.07 154.58 11.01 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.973 -175.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.603 ' HD3' ' HA2' ' A' ' 51' ' ' GLY . 2.3 tmm_? -135.8 110.1 8.42 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.048 -1.093 . . . . 1.0 108.048 175.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.6 ' HB3' ' ND2' ' A' ' 14' ' ' ASN . . . -55.7 136.68 50.59 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.621 -1.172 . . . . 1.0 112.527 -175.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.465 ' O ' ' HA ' ' A' ' 43' ' ' ALA . . . -129.45 160.4 33.26 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.822 -0.172 . . . . 1.0 110.743 178.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.476 ' HB2' ' HB3' ' A' ' 47' ' ' ASN . 9.3 tt0 -97.04 153.39 17.95 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.531 -0.914 . . . . 1.0 108.531 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.473 HG11 ' CD2' ' A' ' 97' ' ' LEU . 20.2 t -65.41 109.92 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.424 0.631 . . . . 1.0 110.748 179.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.413 ' H ' ' HD1' ' A' ' 80' ' ' HIS . . . -120.92 -169.67 13.87 Favored Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 115.396 -0.82 . . . . 1.0 111.103 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 53.9 m -58.8 -42.89 90.18 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.52 0.2 . . . . 1.0 110.692 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -57.78 -31.96 67.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.944 0.402 . . . . 1.0 111.303 177.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.558 ' CD2' ' HB1' ' A' ' 43' ' ' ALA . 79.3 m80 -79.22 -41.27 28.66 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-N 116.522 -0.308 . . . . 1.0 110.943 -179.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.652 ' HA ' HD23 ' A' ' 86' ' ' LEU . 16.8 mt -67.95 -19.04 64.93 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.914 0.387 . . . . 1.0 110.127 177.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.13 -5.16 59.26 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.849 0.357 . . . . 1.0 110.388 -178.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.488 ' HA ' ' HB3' ' A' ' 6' ' ' HIS . . . -58.2 153.72 14.53 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.822 -0.626 . . . . 1.0 110.782 178.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.744 ' HB3' HD11 ' A' ' 5' ' ' LEU . 12.1 t70 -79.96 -14.57 58.5 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.902 -0.59 . . . . 1.0 109.546 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.703 HD12 HG11 ' A' ' 7' ' ' VAL . 0.4 OUTLIER -155.69 118.31 4.2 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.342 -0.845 . . . . 1.0 108.842 -178.11 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.652 HD23 ' HA ' ' A' ' 81' ' ' LEU . 5.2 mp -107.93 105.55 15.4 Favored 'General case' 0 N--CA 1.425 -1.683 0 CA-C-O 121.305 0.574 . . . . 1.0 109.806 178.273 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.582 ' HA ' ' O ' ' A' ' 108' ' ' ARG . 55.8 t -84.9 92.59 3.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 114.652 -1.158 . . . . 1.0 111.453 -175.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.79 146.56 33.71 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.566 -0.743 . . . . 1.0 110.758 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.596 ' O ' ' HB ' ' A' ' 124' ' ' VAL . 3.9 mm? -100.83 -7.57 23.47 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.459 179.156 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.434 ' CG ' ' H ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -153.97 156.38 37.35 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.994 -0.548 . . . . 1.0 111.282 178.594 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 6.0 ptm85 -55.72 -24.65 35.98 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.479 0.918 . . . . 1.0 113.479 -178.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.646 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 87.8 m-20 -76.79 -51.49 11.27 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 110.186 -0.301 . . . . 1.0 110.186 -178.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.66 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 13.5 m170 -55.27 -46.33 76.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.011 -0.541 . . . . 1.0 110.527 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.85 -43.12 94.83 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.069 0.462 . . . . 1.0 110.713 179.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.69 ' O ' ' HG2' ' A' ' 99' ' ' GLN . 5.9 ttm180 -58.44 -46.49 86.43 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 115.482 -0.781 . . . . 1.0 111.005 177.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.732 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 46.6 mt -62.51 -51.14 68.59 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-N 115.921 -0.581 . . . . 1.0 110.412 -175.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.66 ' HG ' ' O ' ' A' ' 93' ' ' HIS . 40.8 mt -51.22 -58.34 6.42 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.954 -0.566 . . . . 1.0 111.684 -177.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.648 ' CA ' HG11 ' A' ' 102' ' ' VAL . 13.3 ptt180 -58.91 -46.99 86.59 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.015 -0.539 . . . . 1.0 112.258 -179.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.69 ' HG2' ' O ' ' A' ' 95' ' ' ARG . 12.8 pt20 -69.24 -19.39 63.94 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.649 -0.421 . . . . 1.0 110.665 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.732 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 10.8 mt -81.43 -18.96 43.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.969 -0.56 . . . . 1.0 110.963 177.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 153.35 -25.15 0.77 Allowed Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 119.706 -1.235 . . . . 1.0 113.655 -178.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.696 HG13 ' N ' ' A' ' 103' ' ' GLU . 0.4 OUTLIER -76.49 -161.6 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 CA-C-N 117.493 0.646 . . . . 1.0 110.555 -178.44 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.732 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 15.5 pt-20 -159.25 161.89 36.08 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.604 -1.258 . . . . 1.0 107.604 -178.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.78 ' HA ' HG13 ' A' ' 107' ' ' VAL . . . -62.84 -24.51 67.82 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.725 0.298 . . . . 1.0 111.406 -175.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.63 -36.05 73.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.01 -0.541 . . . . 1.0 110.171 174.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.742 ' NH1' ' HA ' ' A' ' 84' ' ' ASP . 1.6 mtt-85 -98.95 -41.37 7.62 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 115.604 -0.726 . . . . 1.0 111.366 -177.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.78 HG13 ' HA ' ' A' ' 104' ' ' ALA . 10.5 p -80.21 120.25 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-O 120.905 0.383 . . . . 1.0 110.015 -175.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.582 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 31.5 mmm180 -138.86 149.18 44.59 Favored 'General case' 0 C--N 1.318 -0.761 0 O-C-N 121.864 -0.522 . . . . 1.0 110.361 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.556 ' HB2' ' HB2' ' A' ' 112' ' ' SER . 83.3 mmm -78.73 136.21 37.35 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.848 -0.614 . . . . 1.0 110.41 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.519 HD23 HG12 ' A' ' 87' ' ' VAL . 2.8 tm? -53.57 -53.8 46.51 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.494 0.188 . . . . 1.0 110.853 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.506 ' O ' ' HB3' ' A' ' 114' ' ' ASP . 5.8 ttt85 -73.88 -9.92 59.14 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.082 -0.647 . . . . 1.0 111.323 -176.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.556 ' HB2' ' HB2' ' A' ' 109' ' ' MET . 41.5 t -75.5 -6.01 48.05 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.775 -0.454 . . . . 1.0 109.775 178.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.558 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 96.9 m-85 -94.74 -12.7 26.68 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.526 0.679 . . . . 1.0 109.402 175.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.506 ' HB3' ' O ' ' A' ' 111' ' ' ARG . 6.0 t0 -72.36 131.66 84.69 Favored Pre-proline 0 N--CA 1.466 0.368 0 CA-C-N 114.97 -1.014 . . . . 1.0 111.533 -177.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.42 ' HD2' ' O ' ' A' ' 144' ' ' SER . 58.8 Cg_endo -70.38 -15.24 34.74 Favored 'Trans proline' 0 CA--C 1.532 0.415 0 C-N-CA 122.862 2.375 . . . . 1.0 112.095 177.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -90.47 -8.66 49.88 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.195 -0.457 . . . . 1.0 111.109 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 96.5 p -73.46 31.75 0.07 Allowed 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.058 0.392 . . . . 1.0 112.058 -177.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.41 ' C ' ' HG1' ' A' ' 119' ' ' THR . . . 61.47 -75.03 0.02 OUTLIER Glycine 0 CA--C 1.522 0.501 0 C-N-CA 119.938 -1.125 . . . . 1.0 112.742 -173.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.41 ' HG1' ' C ' ' A' ' 118' ' ' GLY . 30.6 m -158.0 -28.26 0.08 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.367 0.603 . . . . 1.0 109.632 -179.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -154.37 141.67 19.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.538 -0.756 . . . . 1.0 110.879 -178.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -129.13 99.87 5.41 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.749 -0.66 . . . . 1.0 110.08 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -96.8 16.22 19.8 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.893 0.377 . . . . 1.0 110.831 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -169.33 124.09 0.83 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.042 -0.527 . . . . 1.0 109.738 -178.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.596 ' HB ' ' O ' ' A' ' 89' ' ' LEU . 94.1 t -101.55 146.11 10.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.777 -0.647 . . . . 1.0 109.953 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -68.44 -163.11 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.562 0.696 . . . . 1.0 112.34 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.735 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 8.6 p-10 -162.59 171.72 6.18 Favored Pre-proline 0 C--N 1.323 -0.572 0 N-CA-C 108.219 -1.03 . . . . 1.0 108.219 -178.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.735 ' HD2' ' HB2' ' A' ' 126' ' ' ASP . 18.6 Cg_endo -55.62 145.47 70.03 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 121.952 1.768 . . . . 1.0 112.087 -178.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.411 ' HD2' ' CD2' ' A' ' 129' ' ' TYR . 74.3 t80 -107.74 -49.46 3.23 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.138 -0.937 . . . . 1.0 111.601 -176.054 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.411 ' CD2' ' HD2' ' A' ' 128' ' ' TYR . 0.1 OUTLIER -104.05 -67.43 0.9 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.205 0.526 . . . . 1.0 111.137 -178.208 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 128.38 57.35 0.11 Allowed Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 109.302 -1.519 . . . . 1.0 109.302 -176.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -141.71 176.17 9.12 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.243 -0.479 . . . . 1.0 110.837 -174.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.49 ' HA ' ' CD2' ' A' ' 135' ' ' PHE . 22.4 t-160 -52.66 -33.46 47.24 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.415 -0.811 . . . . 1.0 110.554 176.39 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 42.8 t -65.21 -42.38 93.57 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.89 -0.595 . . . . 1.0 111.184 178.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.29 -34.57 78.65 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.845 -0.162 . . . . 1.0 111.143 -176.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.495 ' CD1' ' HB2' ' A' ' 57' ' ' ARG . 2.9 m-85 -68.44 -50.76 50.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.379 0.609 . . . . 1.0 110.027 -179.153 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.485 ' HA ' ' HB3' ' A' ' 139' ' ' PHE . 16.2 mt-10 -75.74 -17.95 59.73 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.368 -0.833 . . . . 1.0 111.496 -176.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 23.4 tp10 -64.42 -47.21 80.0 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 108.54 -0.911 . . . . 1.0 108.54 174.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.944 ' HA ' HG21 ' A' ' 141' ' ' VAL . 95.3 t -61.85 -40.5 87.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.9 -0.591 . . . . 1.0 109.746 176.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.509 ' HB2' HG13 ' A' ' 61' ' ' VAL . 13.5 t80 -52.75 -47.2 67.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.03 -0.986 . . . . 1.0 109.244 174.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.506 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -59.79 -43.06 94.62 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 115.351 -0.841 . . . . 1.0 110.228 177.279 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.944 HG21 ' HA ' ' A' ' 138' ' ' VAL . 8.2 t -54.54 -51.35 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 121.581 0.705 . . . . 1.0 110.505 177.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.66 HD11 ' HB3' ' A' ' 20' ' ' MET . 6.1 mt -66.16 -50.48 68.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 114.99 -1.005 . . . . 1.0 112.07 -178.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.506 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 8.8 pt-20 -56.06 -33.74 65.27 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.926 -0.398 . . . . 1.0 109.926 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.42 ' O ' ' HD2' ' A' ' 115' ' ' PRO . 70.7 m -72.48 -28.65 63.04 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.758 -0.655 . . . . 1.0 110.514 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.429 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -87.27 -22.37 25.22 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.172 -0.467 . . . . 1.0 111.85 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.665 HD12 ' HB3' ' A' ' 25' ' ' PHE . 12.8 mt -57.44 -37.47 57.24 Favored Pre-proline 0 CA--C 1.546 0.82 0 N-CA-C 112.656 0.613 . . . . 1.0 112.656 -178.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.622 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 48.0 Cg_endo -68.27 -12.07 33.88 Favored 'Trans proline' 0 C--N 1.365 1.44 0 C-N-CA 122.79 2.326 . . . . 1.0 111.665 177.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.558 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -103.88 -34.93 3.61 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 114.903 -1.044 . . . . 1.0 110.927 178.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.626 HD21 ' CE2' ' A' ' 25' ' ' PHE . 13.4 tp -75.77 -41.0 54.29 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.872 -0.788 . . . . 1.0 108.872 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.568 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 0.2 OUTLIER -53.92 -53.37 53.66 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 115.233 -0.894 . . . . 1.0 110.001 174.845 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -57.68 -43.76 85.32 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.871 -1.059 . . . . 1.0 110.679 -176.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . 0.736 ' HZ3' HD13 ' A' ' 5' ' ' LEU . 20.6 t90 -62.26 -55.78 25.0 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.395 -0.821 . . . . 1.0 110.486 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.447 HG12 HG21 ' A' ' 7' ' ' VAL . 12.6 m -62.02 -43.94 98.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 C-N-CA 120.72 -0.392 . . . . 1.0 111.091 -177.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.418 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 2.9 m-20 -59.81 -49.95 75.72 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 121.149 0.499 . . . . 1.0 110.76 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.602 ' O ' ' HG2' ' A' ' 159' ' ' ARG . 7.0 pt-20 -62.81 -39.23 93.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.626 -0.715 . . . . 1.0 110.554 -178.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.561 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 6.3 mmt85 -73.13 -47.35 44.87 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.871 -0.604 . . . . 1.0 111.13 -175.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 4.2 pp -62.2 -25.69 67.94 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.7 -0.682 . . . . 1.0 109.985 -178.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -73.81 -57.03 4.26 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.38 -0.827 . . . . 1.0 110.349 178.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.602 ' HG2' ' O ' ' A' ' 155' ' ' GLU . 3.6 ptp85 -76.08 -12.32 60.1 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.701 1.0 . . . . 1.0 113.701 -174.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -55.83 -41.6 74.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.955 0.407 . . . . 1.0 110.888 -176.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -103.81 -161.22 24.81 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.51 -0.853 . . . . 1.0 112.583 178.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -78.61 37.62 0.66 Allowed 'Trans proline' 0 N--CA 1.477 0.527 0 C-N-CA 123.691 2.927 . . . . 1.0 113.33 -178.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 15.1 t . . . . . 0 C--N 1.301 -1.53 0 CA-C-N 115.145 -0.934 . . . . 1.0 109.886 178.932 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.894 0 CA-C-O 119.81 -0.439 . . . . 1.0 112.427 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.2 ptp 45.52 41.58 6.98 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.773 0.829 . . . . 1.0 111.472 -178.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.8 m -164.64 111.01 1.01 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.304 -0.999 . . . . 1.0 108.304 -178.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.76 143.43 96.62 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-O 121.749 0.785 . . . . 1.0 111.997 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.558 ' HB2' ' HG2' ' A' ' 39' ' ' ARG . 26.0 Cg_endo -71.03 163.87 37.72 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 123.308 2.672 . . . . 1.0 113.58 -179.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.79 ' HB3' HG11 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -68.06 179.4 1.53 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.845 -1.07 . . . . 1.0 109.422 176.087 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.583 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 2.3 t-160 -156.07 87.73 1.07 Allowed 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.878 -0.416 . . . . 1.0 109.878 -179.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.783 HG13 HD12 ' A' ' 85' ' ' LEU . 2.2 t -93.12 108.99 21.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 109.4 -0.593 . . . . 1.0 109.4 178.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.681 ' CG2' HD22 ' A' ' 86' ' ' LEU . 10.0 t -110.76 111.44 22.62 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.949 0.404 . . . . 1.0 110.635 179.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.623 ' HD1' ' HB ' ' A' ' 87' ' ' VAL . 1.3 m-85 -82.22 136.71 35.05 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.705 -0.479 . . . . 1.0 109.705 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.655 HG21 HD21 ' A' ' 97' ' ' LEU . 47.8 t -124.57 115.29 44.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.018 0.437 . . . . 1.0 111.461 -177.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.522 ' HB2' HD21 ' A' ' 89' ' ' LEU . 44.7 t -146.52 153.14 40.05 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.957 -0.565 . . . . 1.0 110.091 178.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -71.31 98.45 1.76 Allowed 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.902 -0.407 . . . . 1.0 109.902 178.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 142.68 -40.59 1.25 Allowed Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 110.623 -0.991 . . . . 1.0 110.623 -178.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 1.004 HD21 ' HB3' ' A' ' 73' ' ' ALA . 1.1 p-10 49.37 23.45 0.86 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.601 1.16 . . . . 1.0 113.228 177.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.7 pt -140.83 9.44 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.288 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.478 177.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.46 ' O ' ' HG2' ' A' ' 20' ' ' MET . 5.1 p -122.41 -87.57 0.63 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.719 -0.673 . . . . 1.0 111.782 -176.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 17' ' ' ARG . 7.3 mmm-85 -67.2 -48.69 67.16 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 121.124 0.488 . . . . 1.0 111.25 -175.32 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.86 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 13.1 m -52.48 -58.28 12.36 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-N 115.063 -0.971 . . . . 1.0 112.396 -179.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.616 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 56.8 Cg_endo -67.06 -23.43 46.29 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 121.842 1.694 . . . . 1.0 112.914 -178.227 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.556 ' HB3' HD13 ' A' ' 142' ' ' ILE . 51.8 mmm -59.65 -57.11 14.36 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.906 -0.405 . . . . 1.0 109.906 178.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.43 ' HB2' ' CG2' ' A' ' 142' ' ' ILE . . . -73.5 -27.15 61.22 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.57 -0.741 . . . . 1.0 110.645 -179.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.514 ' O ' ' HB1' ' A' ' 26' ' ' ALA . 13.0 tt0 -52.82 -52.84 55.4 Favored 'General case' 0 C--O 1.215 -0.737 0 O-C-N 123.907 0.755 . . . . 1.0 109.946 -179.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.948 ' HE3' ' HB2' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -85.09 -25.81 27.33 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.837 -0.619 . . . . 1.0 110.777 -176.462 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.487 ' HB3' HD12 ' A' ' 146' ' ' LEU . 88.1 mtp -63.33 -74.59 0.09 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.564 0.579 . . . . 1.0 112.564 -177.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.706 ' HB3' HD21 ' A' ' 146' ' ' LEU . 17.2 p90 -76.81 -30.7 56.51 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 119.64 -0.824 . . . . 1.0 111.711 -176.003 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.514 ' HB1' ' O ' ' A' ' 22' ' ' GLU . . . -64.61 -37.51 87.82 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 119.284 -0.966 . . . . 1.0 111.172 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.617 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -63.32 -39.09 93.6 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 108.367 -0.975 . . . . 1.0 108.367 176.461 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.573 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 79.7 mt-30 -59.61 -42.49 92.74 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.562 -0.745 . . . . 1.0 110.172 175.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.629 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 88.8 mt -56.34 -61.13 2.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.947 -0.569 . . . . 1.0 110.719 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.479 ' HB3' ' HA3' ' A' ' 35' ' ' GLY . 0.2 OUTLIER -58.92 -35.78 73.66 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.778 -0.369 . . . . 1.0 111.382 178.642 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 3.1 m170 -63.23 -24.89 68.07 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.26 0.467 . . . . 1.0 112.26 177.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.629 ' HG2' ' O ' ' A' ' 29' ' ' LEU . 5.9 ptm85 -100.05 -20.18 16.16 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.442 0.639 . . . . 1.0 110.299 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 110.98 35.02 2.06 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.196 -0.911 . . . . 1.0 112.277 177.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.451 ' HG ' ' HG3' ' A' ' 32' ' ' ARG . 21.6 mt -128.33 3.89 5.72 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.877 -0.416 . . . . 1.0 109.877 -179.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.479 ' HA3' ' HB3' ' A' ' 30' ' ' ARG . . . -59.17 -31.44 69.2 Favored Glycine 0 C--O 1.229 -0.217 0 CA-C-N 115.777 -0.647 . . . . 1.0 113.383 -178.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.421 ' O ' ' HB3' ' A' ' 4' ' ' PRO . 3.3 t0 -86.98 -26.05 24.0 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 109.072 -0.714 . . . . 1.0 109.072 177.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.11 -20.82 47.72 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 114.558 -1.201 . . . . 1.0 110.795 -175.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.79 HG11 ' HB3' ' A' ' 5' ' ' LEU . 37.9 t -133.1 122.68 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 CA-C-N 116.393 -0.367 . . . . 1.0 110.207 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.558 ' HG2' ' HB2' ' A' ' 4' ' ' PRO . 11.9 mmt180 -89.78 133.32 34.76 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.04 -1.096 . . . . 1.0 108.04 175.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.494 HG13 ' HB2' ' A' ' 26' ' ' ALA . 45.5 t -127.53 115.58 40.5 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-O 121.375 0.607 . . . . 1.0 109.985 -178.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.427 ' O ' ' HA ' ' A' ' 8' ' ' THR . 67.3 p -130.53 -175.51 3.67 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.461 -1.245 . . . . 1.0 110.427 -175.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.86 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 85.4 p -159.86 165.08 32.98 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 110.004 -0.369 . . . . 1.0 110.004 178.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.534 ' O ' ' HA ' ' A' ' 10' ' ' VAL . . . -164.57 166.85 19.92 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 120.944 0.402 . . . . 1.0 110.775 -179.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.435 ' HA3' ' OD1' ' A' ' 14' ' ' ASN . . . -125.96 138.96 11.12 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 111.257 -0.737 . . . . 1.0 111.257 177.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.561 HG21 HD12 ' A' ' 96' ' ' LEU . 21.4 p -72.86 -25.21 61.02 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.722 0.296 . . . . 1.0 111.339 -178.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.451 ' HA3' ' HZ3' ' A' ' 48' ' ' TRP . . . -107.85 9.49 37.28 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.97 -0.633 . . . . 1.0 113.34 -177.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 45.43 36.25 2.32 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 113.719 1.007 . . . . 1.0 113.719 176.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.451 ' HZ3' ' HA3' ' A' ' 46' ' ' GLY . 1.2 m-90 -44.53 -78.82 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.592 0.711 . . . . 1.0 112.376 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.4 ' O ' ' HB1' ' A' ' 73' ' ' ALA . 8.2 m-70 -104.87 41.1 1.38 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.06 -0.973 . . . . 1.0 111.325 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.421 HG23 ' HA ' ' A' ' 74' ' ' ALA . 14.0 p -59.77 128.05 20.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.538 -0.301 . . . . 1.0 110.473 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.73 -13.5 67.35 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 121.071 -0.585 . . . . 1.0 112.202 -178.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.8 t -80.77 -161.79 0.42 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.321 0.582 . . . . 1.0 110.015 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 20.2 t -122.87 176.29 6.08 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.103 -1.073 . . . . 1.0 108.103 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.28 140.54 55.91 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.752 0.31 . . . . 1.0 110.56 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.43 ' OD1' ' HG2' ' A' ' 57' ' ' ARG . 9.8 t70 -59.12 140.2 56.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.86 -0.609 . . . . 1.0 111.079 -176.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -47.56 -37.1 11.61 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.485 -0.779 . . . . 1.0 112.873 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.43 ' HG2' ' OD1' ' A' ' 55' ' ' ASP . 11.5 ptp180 -73.83 -39.52 63.98 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 122.06 -0.4 . . . . 1.0 111.159 -177.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.92 -37.35 72.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.196 0.522 . . . . 1.0 110.06 178.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.41 -41.47 98.73 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.684 -0.689 . . . . 1.0 109.617 177.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.92 -48.09 81.64 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 115.687 -0.688 . . . . 1.0 112.679 178.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 23.6 m -72.17 -37.28 59.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 117.469 0.635 . . . . 1.0 111.614 -178.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.477 ' CD2' ' HG3' ' A' ' 23' ' ' LYS . 1.3 mp -62.05 -54.87 35.38 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.877 -0.329 . . . . 1.0 110.185 178.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -60.31 -32.79 71.55 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.862 -0.608 . . . . 1.0 110.911 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.47 -32.25 72.96 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-O 121.144 0.497 . . . . 1.0 111.192 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -98.11 5.85 48.18 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.961 -0.563 . . . . 1.0 111.515 -178.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 90.71 11.98 61.34 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 115.977 -0.556 . . . . 1.0 113.429 175.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.43 ' HD1' ' HG2' ' A' ' 27' ' ' GLN . 54.7 m-85 -92.67 151.01 40.66 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-O 120.624 0.25 . . . . 1.0 111.157 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.632 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 44.6 Cg_endo -70.22 158.93 54.82 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.19 1.926 . . . . 1.0 110.528 175.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 30.6 p -129.98 8.46 5.22 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.728 0.775 . . . . 1.0 109.823 -177.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -73.0 120.2 18.31 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.661 -1.154 . . . . 1.0 110.076 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.948 ' HB2' ' HE3' ' A' ' 23' ' ' LYS . 31.9 t60 -164.81 150.95 10.31 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.433 -0.349 . . . . 1.0 110.596 -175.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -132.29 111.26 11.22 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 108.489 -0.93 . . . . 1.0 108.489 175.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 1.004 ' HB3' HD21 ' A' ' 14' ' ' ASN . . . -59.47 141.53 54.5 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.211 -0.904 . . . . 1.0 112.606 -175.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.421 ' HA ' HG23 ' A' ' 50' ' ' VAL . . . -134.52 165.73 24.53 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.8 -0.637 . . . . 1.0 109.845 177.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -101.64 160.79 14.15 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.156 -0.683 . . . . 1.0 109.156 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 86.5 t -65.45 106.07 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.073 0.463 . . . . 1.0 110.88 179.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.454 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -120.77 -175.08 15.21 Favored Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 115.588 -0.733 . . . . 1.0 111.772 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 77.2 m -57.09 -49.45 75.82 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 122.742 0.417 . . . . 1.0 111.826 -178.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.455 ' HG2' ' N ' ' A' ' 80' ' ' HIS . 3.2 pm0 -57.33 -31.06 65.32 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.11 0.481 . . . . 1.0 111.062 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.455 ' N ' ' HG2' ' A' ' 79' ' ' GLU . 80.3 m80 -76.07 -41.55 50.21 Favored 'General case' 0 C--O 1.222 -0.356 0 CA-C-N 115.871 -0.604 . . . . 1.0 109.824 178.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 40.8 mt -66.1 -19.77 65.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.848 178.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.75 -6.26 59.14 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.92 -178.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.583 ' HB3' ' O ' ' A' ' 6' ' ' HIS . . . -60.33 148.56 36.53 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.399 -0.819 . . . . 1.0 111.756 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.686 ' HB3' HD13 ' A' ' 5' ' ' LEU . 15.5 t70 -74.46 -13.5 60.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.886 -0.597 . . . . 1.0 109.996 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.783 HD12 HG13 ' A' ' 7' ' ' VAL . 0.9 OUTLIER -154.37 122.76 6.1 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.685 -0.689 . . . . 1.0 110.198 -178.525 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.94 HD12 HG12 ' A' ' 102' ' ' VAL . 0.2 OUTLIER -108.15 105.0 14.53 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.904 -0.776 . . . . 1.0 108.904 174.653 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.623 ' HB ' ' HD1' ' A' ' 9' ' ' PHE . 53.7 t -84.31 91.27 2.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.663 0.744 . . . . 1.0 110.803 -178.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.93 147.0 30.49 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.434 -0.803 . . . . 1.0 111.207 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.522 HD21 ' HB2' ' A' ' 11' ' ' CYS . 4.2 mm? -100.79 -5.53 26.17 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.546 -0.752 . . . . 1.0 109.558 178.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -148.04 145.24 28.39 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.068 -0.969 . . . . 1.0 110.277 -178.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.443 ' HB3' ' O ' ' A' ' 122' ' ' LEU . 13.2 ptt180 -55.6 -26.28 43.03 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.418 0.687 . . . . 1.0 111.191 177.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.677 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 80.3 m-20 -75.21 -49.28 19.89 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.719 -0.673 . . . . 1.0 109.911 -178.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.461 ' HB3' HG11 ' A' ' 10' ' ' VAL . 11.8 m170 -58.19 -43.48 87.56 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 115.808 -0.633 . . . . 1.0 109.369 179.32 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.464 ' HA ' HG23 ' A' ' 107' ' ' VAL . . . -59.67 -47.12 86.88 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.915 -0.584 . . . . 1.0 110.718 178.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 13.2 ttm180 -59.59 -39.53 84.48 Favored 'General case' 0 CA--C 1.521 -0.143 0 CA-C-N 115.792 -0.64 . . . . 1.0 111.405 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.734 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 55.6 mt -66.14 -50.68 63.12 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 116.499 -0.319 . . . . 1.0 110.359 -177.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.655 HD21 HG21 ' A' ' 10' ' ' VAL . 14.2 mt -53.51 -56.35 17.75 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.858 -0.61 . . . . 1.0 111.452 -179.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 13.3 ptt85 -62.46 -43.9 97.7 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.161 -0.472 . . . . 1.0 111.844 -177.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.574 ' HG3' ' O ' ' A' ' 96' ' ' LEU . 0.9 OUTLIER -66.35 -22.22 66.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.378 0.608 . . . . 1.0 110.103 179.536 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.734 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 10.0 mt -77.87 -13.21 59.96 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.348 -0.842 . . . . 1.0 111.761 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 154.62 -33.52 0.69 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.003 -1.094 . . . . 1.0 113.279 -179.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.94 HG12 HD12 ' A' ' 86' ' ' LEU . 0.8 OUTLIER -76.36 -152.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.697 0.761 . . . . 1.0 112.221 -176.969 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.631 ' H ' HG11 ' A' ' 102' ' ' VAL . 11.4 pt-20 -164.72 167.32 19.14 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.449 -0.796 . . . . 1.0 109.125 -177.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.809 ' HA ' HG11 ' A' ' 107' ' ' VAL . . . -67.18 -23.26 65.74 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.231 -0.441 . . . . 1.0 111.81 -175.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.12 -34.76 70.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.361 0.601 . . . . 1.0 110.578 176.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.537 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 8.0 mtp180 -98.83 -40.93 7.87 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 115.475 -0.784 . . . . 1.0 110.825 -178.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.809 HG11 ' HA ' ' A' ' 104' ' ' ALA . 9.3 p -80.2 121.62 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-O 121.719 0.771 . . . . 1.0 110.721 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.515 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 21.1 mmm180 -138.05 150.07 46.59 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.808 -0.633 . . . . 1.0 110.177 -178.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.54 ' HB2' ' HB2' ' A' ' 112' ' ' SER . 81.7 mmm -78.45 138.86 38.68 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.619 -0.719 . . . . 1.0 109.715 178.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.554 HD21 HG12 ' A' ' 87' ' ' VAL . 3.0 tm? -55.68 -49.03 74.05 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.621 0.248 . . . . 1.0 110.765 179.01 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 18.4 ttt85 -71.46 -14.28 62.09 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.87 0.367 . . . . 1.0 110.662 -178.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.54 ' HB2' ' HB2' ' A' ' 109' ' ' MET . 26.4 t -70.88 -14.02 62.24 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.482 -0.326 . . . . 1.0 110.403 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.542 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 98.7 m-85 -90.39 -15.37 31.14 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 120.95 0.405 . . . . 1.0 110.44 177.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -72.4 124.12 90.39 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.785 -0.643 . . . . 1.0 111.206 -177.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.62 -15.77 33.91 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 122.573 2.182 . . . . 1.0 112.45 178.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 -92.66 -13.11 29.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.156 -0.474 . . . . 1.0 110.613 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 46.3 t -71.79 60.5 0.37 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.898 -0.592 . . . . 1.0 112.109 -178.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 48.74 -98.55 0.02 OUTLIER Glycine 0 C--N 1.334 0.471 0 C-N-CA 121.307 -0.473 . . . . 1.0 113.108 -178.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 25.9 m -132.07 -40.97 1.02 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.108 0.48 . . . . 1.0 110.326 178.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -151.05 154.6 37.32 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.117 0.484 . . . . 1.0 111.237 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.516 ' C ' HD23 ' A' ' 122' ' ' LEU . . . -107.53 172.3 6.91 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 115.141 -0.936 . . . . 1.0 109.714 177.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.516 HD23 ' C ' ' A' ' 121' ' ' ALA . 0.6 OUTLIER -160.2 -17.29 0.06 Allowed 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.041 -1.436 . . . . 1.0 109.759 -175.796 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -167.12 134.94 2.52 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.169 -1.048 . . . . 1.0 108.169 -176.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 67.1 t -96.91 147.45 6.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 110.031 -0.359 . . . . 1.0 110.031 -177.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -63.82 179.57 0.49 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.412 0.625 . . . . 1.0 112.543 -177.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.414 ' OD1' ' HD2' ' A' ' 127' ' ' PRO . 6.3 t70 -152.51 138.43 11.71 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 114.723 -1.126 . . . . 1.0 108.102 -174.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.414 ' HD2' ' OD1' ' A' ' 126' ' ' ASP . 84.7 Cg_exo -42.4 150.34 0.27 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 123.099 2.533 . . . . 1.0 112.937 -178.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.412 ' HD2' ' HD2' ' A' ' 129' ' ' TYR . 62.3 t80 -98.22 -32.56 11.51 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.306 -0.861 . . . . 1.0 110.821 -174.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.412 ' HD2' ' HD2' ' A' ' 128' ' ' TYR . 0.8 OUTLIER -137.04 -23.16 1.16 Allowed 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 120.909 -0.316 . . . . 1.0 111.175 178.384 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 86.06 71.22 1.31 Allowed Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.257 -0.973 . . . . 1.0 111.611 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -139.92 -174.43 3.91 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.503 -0.555 . . . . 1.0 109.503 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -55.98 -41.06 74.2 Favored 'General case' 0 C--N 1.323 -0.58 0 O-C-N 123.524 0.515 . . . . 1.0 110.994 -178.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 49.4 m -63.35 -50.26 70.68 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.894 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.4 ' HB3' ' HB3' ' A' ' 127' ' ' PRO . 22.1 m-20 -56.66 -33.53 66.46 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.149 0.426 . . . . 1.0 112.149 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 15.9 m-30 -70.29 -46.24 64.7 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.962 0.41 . . . . 1.0 110.49 -178.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -78.48 -20.11 51.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 1.0 111.34 -178.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -63.6 -48.37 77.64 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.588 -0.893 . . . . 1.0 108.588 175.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.99 ' HA ' HG22 ' A' ' 141' ' ' VAL . 54.6 t -60.85 -41.43 88.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.095 -0.957 . . . . 1.0 109.941 176.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -53.55 -42.17 67.23 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.912 -1.04 . . . . 1.0 109.203 176.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.744 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -66.95 -40.21 87.48 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.278 -0.874 . . . . 1.0 110.635 177.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.99 HG22 ' HA ' ' A' ' 138' ' ' VAL . 10.7 t -55.58 -49.96 70.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.65 0.738 . . . . 1.0 110.167 178.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.556 HD13 ' HB3' ' A' ' 20' ' ' MET . 6.2 mt -67.78 -49.79 66.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 114.996 -1.002 . . . . 1.0 111.825 -178.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.744 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 5.3 pt-20 -57.49 -28.3 63.3 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.905 0.383 . . . . 1.0 110.062 178.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.9 t -75.11 -28.19 60.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.06 177.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.472 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -86.52 -23.71 25.79 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-N 116.246 -0.434 . . . . 1.0 111.644 178.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.706 HD21 ' HB3' ' A' ' 25' ' ' PHE . 14.2 mt -56.83 -35.93 40.97 Favored Pre-proline 0 CA--C 1.546 0.798 0 CA-C-O 118.943 -0.551 . . . . 1.0 112.452 -178.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.616 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 37.6 Cg_endo -67.63 -12.75 36.66 Favored 'Trans proline' 0 C--N 1.365 1.402 0 C-N-CA 122.543 2.162 . . . . 1.0 111.494 177.028 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.542 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -104.52 -34.12 3.68 Favored Glycine 0 N--CA 1.44 -1.065 0 CA-C-N 114.995 -1.002 . . . . 1.0 110.611 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.54 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.4 OUTLIER -75.24 -40.9 58.53 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 108.9 -0.778 . . . . 1.0 108.9 179.318 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.44 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 1.1 m-70 -54.33 -52.87 60.17 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.187 -0.915 . . . . 1.0 110.244 175.137 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -60.01 -44.1 94.78 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.67 -0.695 . . . . 1.0 110.946 -176.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . 0.772 ' HZ3' HD12 ' A' ' 5' ' ' LEU . 26.4 t90 -60.56 -55.23 35.88 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.491 -0.777 . . . . 1.0 110.697 -178.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.417 HG11 ' O ' ' A' ' 149' ' ' LEU . 11.7 m -60.67 -39.71 82.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 121.071 -0.252 . . . . 1.0 110.772 -178.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.526 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 4.6 m-20 -59.49 -54.9 41.23 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.271 0.558 . . . . 1.0 110.975 178.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.488 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 6.6 pt-20 -62.28 -33.95 75.64 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.506 -0.77 . . . . 1.0 110.465 -178.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.738 ' O ' ' HG2' ' A' ' 159' ' ' ARG . 18.5 mmt-85 -74.38 -42.6 59.03 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.759 -0.655 . . . . 1.0 111.711 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 4.5 pp -67.89 -23.98 65.17 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.505 -0.554 . . . . 1.0 109.505 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -73.39 -42.28 62.33 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.29 -0.868 . . . . 1.0 110.273 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.738 ' HG2' ' O ' ' A' ' 156' ' ' ARG . 14.2 ptt-85 -71.64 -24.39 61.85 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 116.066 -0.516 . . . . 1.0 111.401 -178.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -62.85 -47.42 83.44 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 120.434 -0.506 . . . . 1.0 111.105 -172.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -87.52 160.56 31.7 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 118.557 -1.782 . . . . 1.0 112.609 174.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -92.58 27.86 0.36 Allowed 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 123.349 2.7 . . . . 1.0 113.383 -178.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 12.0 t . . . . . 0 C--N 1.301 -1.525 0 CA-C-N 115.132 -0.94 . . . . 1.0 109.979 -179.665 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.738 0 N-CA-C 111.369 -0.692 . . . . 1.0 111.369 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.7 ptp -80.89 34.35 0.34 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.009 0.433 . . . . 1.0 111.031 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.7 p -164.82 162.38 20.93 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.894 -0.593 . . . . 1.0 109.881 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -166.07 160.93 12.89 Favored Pre-proline 0 C--N 1.321 -0.671 0 N-CA-C 109.308 -0.627 . . . . 1.0 109.308 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.443 ' HB2' ' HG2' ' A' ' 39' ' ' ARG . 36.4 Cg_endo -66.02 165.49 23.78 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.754 2.303 . . . . 1.0 112.939 -178.058 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.784 ' HB3' HG23 ' A' ' 38' ' ' VAL . 0.6 OUTLIER -70.99 -174.18 0.91 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.322 -0.854 . . . . 1.0 110.989 -179.388 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.599 ' HB3' ' HA ' ' A' ' 83' ' ' ALA . 2.7 t-160 -156.51 104.83 2.21 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.468 -0.333 . . . . 1.0 110.659 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.667 HG13 HD13 ' A' ' 85' ' ' LEU . 2.8 t -105.16 119.47 54.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 107.32 -1.363 . . . . 1.0 107.32 175.018 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.555 HG22 ' HG ' ' A' ' 86' ' ' LEU . 8.2 t -121.74 114.01 20.51 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 120.44 -0.504 . . . . 1.0 110.484 179.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.66 ' HD2' ' HB3' ' A' ' 42' ' ' SER . 1.5 m-85 -83.15 127.35 33.53 Favored 'General case' 0 CA--C 1.512 -0.491 0 O-C-N 122.004 -0.435 . . . . 1.0 110.6 -179.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.601 HG21 HD22 ' A' ' 97' ' ' LEU . 23.8 t -111.39 111.76 37.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.008 0.432 . . . . 1.0 111.633 -176.194 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.542 ' HB2' HD22 ' A' ' 89' ' ' LEU . 42.2 t -141.24 155.98 45.95 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.331 179.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.42 92.59 0.61 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.103 0.478 . . . . 1.0 110.776 179.194 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.808 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 132.57 -41.92 1.44 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.791 -0.718 . . . . 1.0 111.869 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.406 HD22 ' CB ' ' A' ' 42' ' ' SER . 3.6 t-20 62.17 18.74 10.35 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.454 0.645 . . . . 1.0 111.766 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.2 pt -127.25 11.8 3.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 O-C-N 121.542 -0.724 . . . . 1.0 112.165 -176.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.715 ' O ' ' HG3' ' A' ' 20' ' ' MET . 80.5 m -126.6 -89.96 0.54 Allowed 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.122 -0.631 . . . . 1.0 111.852 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.405 ' HG3' ' HG ' ' A' ' 89' ' ' LEU . 0.9 OUTLIER -74.4 -30.13 61.82 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.674 0.62 . . . . 1.0 112.674 -175.819 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.641 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 17.2 m -62.46 -58.91 14.58 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 121.04 -0.264 . . . . 1.0 110.841 178.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.724 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 35.2 Cg_endo -62.78 -25.79 74.82 Favored 'Trans proline' 0 C--N 1.357 0.978 0 C-N-CA 122.213 1.942 . . . . 1.0 111.983 179.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.715 ' HG3' ' O ' ' A' ' 16' ' ' CYS . 71.3 mtp -61.85 -52.85 62.44 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.849 -0.34 . . . . 1.0 110.809 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.425 ' HA ' ' HB2' ' A' ' 24' ' ' MET . . . -74.16 -27.17 60.7 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.577 -0.449 . . . . 1.0 110.108 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.575 ' O ' ' HB1' ' A' ' 26' ' ' ALA . 7.9 tt0 -55.88 -49.78 72.44 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 115.159 -0.928 . . . . 1.0 109.302 179.254 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.901 ' HB3' ' HG2' ' A' ' 68' ' ' PRO . 0.0 OUTLIER -80.79 -32.15 35.46 Favored 'General case' 0 C--N 1.32 -0.691 0 O-C-N 121.825 -0.547 . . . . 1.0 110.002 -177.155 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.604 ' HB3' HD11 ' A' ' 146' ' ' LEU . 2.3 mmm -61.56 -76.15 0.06 Allowed 'General case' 0 C--O 1.236 0.362 0 N-CA-C 112.928 0.714 . . . . 1.0 112.928 -176.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.697 ' HB3' HD21 ' A' ' 146' ' ' LEU . 16.5 p90 -76.84 -30.36 56.28 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 119.645 -0.822 . . . . 1.0 111.749 -174.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.575 ' HB1' ' O ' ' A' ' 22' ' ' GLU . . . -63.87 -37.75 88.55 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 119.082 -1.047 . . . . 1.0 110.894 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.676 ' HA ' ' HD3' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -65.82 -37.71 86.99 Favored 'General case' 0 C--N 1.333 -0.13 0 N-CA-C 108.955 -0.758 . . . . 1.0 108.955 177.836 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.537 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 79.3 mt-30 -58.8 -42.09 88.28 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.114 175.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.643 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 85.9 mt -56.02 -60.54 3.34 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.706 -0.679 . . . . 1.0 110.578 179.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.676 ' HD3' ' HA ' ' A' ' 27' ' ' GLN . 0.7 OUTLIER -58.94 -37.69 77.3 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.59 -0.277 . . . . 1.0 111.168 179.254 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -60.93 -25.31 66.69 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.252 0.464 . . . . 1.0 112.252 177.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.643 ' HG2' ' O ' ' A' ' 29' ' ' LEU . 3.6 ptm180 -100.71 -18.94 16.27 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 119.602 -0.839 . . . . 1.0 110.418 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 108.04 36.04 2.43 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.236 -0.893 . . . . 1.0 112.502 176.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.416 HD12 ' HD3' ' A' ' 32' ' ' ARG . 23.2 mt -130.08 -3.62 4.5 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 122.625 -0.338 . . . . 1.0 110.535 -178.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.5 -25.93 61.41 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 121.126 -0.559 . . . . 1.0 112.488 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -80.06 -32.08 39.4 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.511 0.672 . . . . 1.0 109.847 177.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.74 -18.36 51.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.814 -1.085 . . . . 1.0 112.759 -175.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.784 HG23 ' HB3' ' A' ' 5' ' ' LEU . 0.8 OUTLIER -145.02 128.97 12.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.107 0.479 . . . . 1.0 110.869 -178.837 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.443 ' HG2' ' HB2' ' A' ' 4' ' ' PRO . 9.3 mmm180 -94.12 140.75 29.36 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.639 -0.709 . . . . 1.0 110.168 -178.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.441 HG11 ' HB2' ' A' ' 26' ' ' ALA . 77.9 t -127.77 120.0 53.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-O 121.659 0.743 . . . . 1.0 109.633 -178.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.534 ' O ' ' HA ' ' A' ' 8' ' ' THR . 69.3 p -136.05 -174.54 3.7 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.135 -1.393 . . . . 1.0 109.933 -175.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.66 ' HB3' ' HD2' ' A' ' 9' ' ' PHE . 84.4 p -162.69 167.32 23.28 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 116.485 -0.325 . . . . 1.0 110.49 179.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.588 ' HB2' ' CD2' ' A' ' 80' ' ' HIS . . . -162.83 166.7 23.79 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.578 0.704 . . . . 1.0 111.727 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.439 ' HA2' ' O ' ' A' ' 11' ' ' CYS . . . -124.87 131.34 7.74 Favored Glycine 0 N--CA 1.443 -0.86 0 CA-C-N 114.785 -1.098 . . . . 1.0 111.252 178.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.494 HG23 HD11 ' A' ' 96' ' ' LEU . 40.9 p -70.11 -27.49 64.63 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.985 0.421 . . . . 1.0 111.108 -178.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -102.28 5.93 52.85 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 121.069 -0.586 . . . . 1.0 113.161 -176.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 44.19 34.6 1.03 Allowed 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 114.269 1.211 . . . . 1.0 114.269 176.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.808 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 0.9 OUTLIER -46.75 -72.62 0.05 Allowed 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.638 0.732 . . . . 1.0 112.494 -179.846 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.402 ' O ' ' HB1' ' A' ' 73' ' ' ALA . 17.7 m-70 -107.75 42.58 1.32 Allowed 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.045 -0.979 . . . . 1.0 111.016 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.2 p -62.84 128.48 24.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.098 0.475 . . . . 1.0 110.284 178.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.48 -13.56 67.28 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.761 -0.733 . . . . 1.0 111.828 -177.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.4 t -80.66 -158.74 0.2 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.063 0.459 . . . . 1.0 110.036 178.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 21.6 t -131.15 174.69 9.78 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.117 -1.068 . . . . 1.0 108.117 -179.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.2 137.31 47.4 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.713 0.292 . . . . 1.0 111.032 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.719 ' OD1' ' HG2' ' A' ' 57' ' ' ARG . 11.3 t70 -62.66 140.64 58.71 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 115.881 -0.599 . . . . 1.0 110.145 -177.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -51.53 -30.4 20.26 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 113.341 0.867 . . . . 1.0 113.341 -178.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.719 ' HG2' ' OD1' ' A' ' 55' ' ' ASP . 3.9 ptp180 -70.99 -44.4 66.02 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 118.351 0.523 . . . . 1.0 110.769 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.69 -35.82 70.38 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.739 -0.664 . . . . 1.0 109.583 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.84 -44.22 96.73 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.402 -0.817 . . . . 1.0 109.472 177.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.424 ' O ' ' HG2' ' A' ' 63' ' ' ARG . . . -56.75 -45.92 90.33 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.95 -0.643 . . . . 1.0 113.301 178.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.1 m -73.29 -38.62 54.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 117.793 0.797 . . . . 1.0 111.478 -178.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.656 HD21 ' HA ' ' A' ' 20' ' ' MET . 5.6 mp -62.17 -53.29 57.35 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.85 -0.34 . . . . 1.0 110.556 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.424 ' HG2' ' O ' ' A' ' 60' ' ' GLY . 11.6 ptm180 -59.98 -28.37 67.63 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.952 -0.567 . . . . 1.0 111.377 179.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.39 -30.27 65.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.22 0.533 . . . . 1.0 110.738 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -96.83 4.76 51.53 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.872 -0.604 . . . . 1.0 110.526 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.62 13.41 65.18 Favored Glycine 0 C--N 1.331 0.257 0 CA-C-N 115.681 -0.691 . . . . 1.0 113.087 176.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -92.06 150.84 41.18 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-O 120.498 0.19 . . . . 1.0 110.882 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.901 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 39.3 Cg_endo -67.8 155.79 68.51 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.395 2.063 . . . . 1.0 110.612 176.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 57.0 p -130.86 10.74 5.08 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 120.262 -0.575 . . . . 1.0 111.834 -176.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -97.32 136.5 37.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.915 0.388 . . . . 1.0 110.853 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.69 ' HB3' ' HE3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -178.98 162.55 1.26 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.523 -1.288 . . . . 1.0 107.523 177.729 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -121.56 120.82 35.93 Favored 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 119.548 -0.861 . . . . 1.0 108.871 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.402 ' HB1' ' O ' ' A' ' 49' ' ' HIS . . . -60.03 140.67 56.66 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.763 -0.653 . . . . 1.0 111.288 -177.154 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.441 ' O ' ' HA ' ' A' ' 43' ' ' ALA . . . -134.65 151.07 50.77 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.907 -0.588 . . . . 1.0 110.132 179.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -87.57 153.31 21.5 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.644 -0.872 . . . . 1.0 108.644 177.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.544 HG12 HD23 ' A' ' 97' ' ' LEU . 21.7 t -63.91 114.2 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.217 0.532 . . . . 1.0 110.506 -179.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.436 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -125.27 -169.31 12.9 Favored Glycine 0 N--CA 1.442 -0.948 0 CA-C-N 115.129 -0.941 . . . . 1.0 111.279 179.299 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 51.9 m -59.86 -43.72 94.53 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.453 0.168 . . . . 1.0 111.196 -178.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -59.09 -31.34 68.81 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 120.952 0.406 . . . . 1.0 111.249 177.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.588 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 78.6 m80 -76.52 -40.69 49.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.497 -0.32 . . . . 1.0 110.276 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.699 ' HA ' HD23 ' A' ' 86' ' ' LEU . 14.6 mt -70.18 -17.09 63.15 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 120.774 0.321 . . . . 1.0 110.444 177.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.73 -7.09 58.99 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 120.777 0.322 . . . . 1.0 110.223 -179.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.599 ' HA ' ' HB3' ' A' ' 6' ' ' HIS . . . -58.45 149.23 25.62 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.961 -0.563 . . . . 1.0 110.922 178.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.515 ' HA ' ' HE ' ' A' ' 106' ' ' ARG . 32.1 t70 -75.49 -16.19 60.33 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.179 0.514 . . . . 1.0 109.739 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.667 HD13 HG13 ' A' ' 7' ' ' VAL . 0.6 OUTLIER -152.73 117.68 5.13 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.205 -0.907 . . . . 1.0 109.043 -177.688 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.699 HD23 ' HA ' ' A' ' 81' ' ' LEU . 4.9 mp -108.06 104.23 13.62 Favored 'General case' 0 N--CA 1.424 -1.758 0 CA-C-N 115.824 -0.625 . . . . 1.0 109.535 178.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.583 ' HB ' ' HD1' ' A' ' 9' ' ' PHE . 52.9 t -83.32 90.58 2.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.01 -0.996 . . . . 1.0 110.757 -175.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.63 146.06 34.31 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.484 -0.78 . . . . 1.0 110.441 179.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.542 HD22 ' HB2' ' A' ' 11' ' ' CYS . 4.1 mm? -95.33 -8.63 35.24 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.335 0.588 . . . . 1.0 109.592 178.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -151.18 154.61 37.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.451 -0.795 . . . . 1.0 111.18 178.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.441 ' H ' ' HG2' ' A' ' 91' ' ' ARG . 13.5 ptt180 -61.63 -20.02 62.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.42 -0.809 . . . . 1.0 111.523 177.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.652 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 4.2 m-20 -75.2 -51.9 12.22 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.044 -0.725 . . . . 1.0 109.044 179.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.545 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 10.4 m170 -58.32 -44.68 88.76 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.073 -0.967 . . . . 1.0 109.792 178.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.466 ' HA ' HD13 ' A' ' 97' ' ' LEU . . . -60.23 -44.51 95.14 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 116.297 -0.41 . . . . 1.0 111.072 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.645 ' O ' ' HG2' ' A' ' 99' ' ' GLN . 2.4 ttt180 -57.23 -44.8 84.12 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 115.934 -0.575 . . . . 1.0 110.954 178.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.652 ' HG ' ' O ' ' A' ' 92' ' ' ASN . 49.3 mt -63.34 -45.41 91.38 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 116.121 -0.49 . . . . 1.0 110.515 -175.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.612 HD12 ' HB3' ' A' ' 86' ' ' LEU . 31.2 mt -54.52 -61.08 2.54 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.814 -0.63 . . . . 1.0 111.433 -178.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.719 ' N ' HG12 ' A' ' 102' ' ' VAL . 7.3 ptm180 -58.8 -45.19 90.47 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.73 0.641 . . . . 1.0 112.73 -179.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.645 ' HG2' ' O ' ' A' ' 95' ' ' ARG . 6.6 pt20 -66.57 -23.91 66.27 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 119.978 -0.689 . . . . 1.0 109.915 179.061 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.593 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 3.4 mt -81.68 -13.73 57.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.605 -0.725 . . . . 1.0 111.789 178.274 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 150.83 -26.16 1.04 Allowed Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 119.769 -1.205 . . . . 1.0 114.138 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.719 HG12 ' N ' ' A' ' 98' ' ' ARG . 0.3 OUTLIER -77.26 -161.64 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-N 118.026 0.913 . . . . 1.0 111.252 -177.967 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.678 ' N ' HG11 ' A' ' 102' ' ' VAL . 12.9 pt-20 -159.05 164.49 35.39 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.844 -1.169 . . . . 1.0 107.844 -178.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.818 ' HA ' HG11 ' A' ' 107' ' ' VAL . . . -63.48 -24.22 67.73 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 123.354 0.409 . . . . 1.0 111.379 -175.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.94 -34.42 71.73 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.206 176.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.611 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 1.2 mtp85 -102.16 -40.42 6.81 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.653 -0.703 . . . . 1.0 111.541 -177.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.818 HG11 ' HA ' ' A' ' 104' ' ' ALA . 8.6 p -77.13 120.7 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 N-CA-C 109.415 -0.587 . . . . 1.0 109.415 -175.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.573 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 12.0 mmm180 -139.75 145.57 38.43 Favored 'General case' 0 C--N 1.322 -0.604 0 O-C-N 121.762 -0.586 . . . . 1.0 110.358 -178.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.504 ' HB2' ' HB2' ' A' ' 112' ' ' SER . 73.5 mmm -78.67 138.78 38.46 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.917 -0.583 . . . . 1.0 110.56 178.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.519 HD23 HG12 ' A' ' 87' ' ' VAL . 3.0 tm? -57.37 -50.53 72.67 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.668 0.27 . . . . 1.0 111.472 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.518 ' HB2' HG22 ' A' ' 124' ' ' VAL . 14.2 ttt180 -70.06 -17.23 63.23 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.041 0.448 . . . . 1.0 110.624 -177.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.504 ' HB2' ' HB2' ' A' ' 109' ' ' MET . 32.5 t -75.2 -7.65 54.43 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.888 -178.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.558 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 92.4 m-85 -90.56 -17.89 26.19 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 110.287 -0.264 . . . . 1.0 110.287 176.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -68.0 118.11 55.21 Favored Pre-proline 0 N--CA 1.464 0.241 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.799 -178.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.82 -17.18 29.32 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 121.942 1.761 . . . . 1.0 111.822 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.839 ' HA ' ' HE ' ' A' ' 116' ' ' ARG . 0.0 OUTLIER -90.44 -14.04 33.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.918 -0.583 . . . . 1.0 111.473 -179.301 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 3.8 m -62.81 -67.69 0.4 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.515 -0.311 . . . . 1.0 111.757 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 172.74 -123.29 0.99 Allowed Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.419 -0.896 . . . . 1.0 111.484 177.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 24.0 m -96.18 -42.44 8.2 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.059 0.457 . . . . 1.0 109.982 178.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -160.4 148.12 16.27 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.91 -0.586 . . . . 1.0 110.458 179.082 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -127.54 103.3 7.26 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.679 -0.691 . . . . 1.0 109.834 -178.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.411 ' N ' HD23 ' A' ' 122' ' ' LEU . 2.8 mm? -91.04 14.84 12.89 Favored 'General case' 0 CA--C 1.501 -0.904 0 CA-C-N 116.683 -0.235 . . . . 1.0 111.302 -179.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.435 ' CA ' ' HE2' ' A' ' 109' ' ' MET . 4.5 p-10 -170.54 146.61 2.78 Favored 'General case' 0 N--CA 1.433 -1.319 0 C-N-CA 120.222 -0.591 . . . . 1.0 111.313 -178.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.518 HG22 ' HB2' ' A' ' 111' ' ' ARG . 62.2 t -111.69 147.52 15.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.343 -0.614 . . . . 1.0 109.343 178.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -74.86 -175.34 2.49 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.622 -0.431 . . . . 1.0 111.965 -177.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.496 ' OD1' ' HD2' ' A' ' 127' ' ' PRO . 37.8 t70 -148.91 146.82 22.43 Favored Pre-proline 0 C--N 1.321 -0.646 0 N-CA-C 108.513 -0.921 . . . . 1.0 108.513 -173.034 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.496 ' HD2' ' OD1' ' A' ' 126' ' ' ASP . 69.5 Cg_exo -41.94 147.58 0.44 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.865 2.376 . . . . 1.0 112.787 179.008 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.483 ' HD2' ' CD2' ' A' ' 129' ' ' TYR . 55.7 t80 -99.76 -54.41 2.92 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.271 -0.877 . . . . 1.0 110.593 -175.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.483 ' CD2' ' HD2' ' A' ' 128' ' ' TYR . 0.0 OUTLIER -103.56 -32.26 9.53 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.472 0.653 . . . . 1.0 109.401 179.928 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 90.69 61.33 1.3 Allowed Glycine 0 N--CA 1.443 -0.892 0 N-CA-C 110.658 -0.977 . . . . 1.0 110.658 -175.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.433 ' CG ' ' H ' ' A' ' 132' ' ' HIS . 31.7 t70 -128.27 -178.88 4.73 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.374 -0.602 . . . . 1.0 109.374 -176.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.433 ' H ' ' CG ' ' A' ' 131' ' ' ASP . 17.8 t-80 -55.5 -34.94 65.05 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.046 -0.525 . . . . 1.0 110.511 176.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 5.8 m -62.02 -53.11 60.16 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.826 -0.625 . . . . 1.0 110.408 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -54.78 -33.6 61.58 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 115.547 -0.751 . . . . 1.0 112.111 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 10.9 m-30 -70.28 -47.87 59.3 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.339 0.59 . . . . 1.0 109.847 -177.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -69.49 -24.0 63.7 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.402 -0.817 . . . . 1.0 111.337 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -63.42 -47.12 83.25 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 109.251 -0.648 . . . . 1.0 109.251 175.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.919 ' HA ' HG11 ' A' ' 141' ' ' VAL . 85.5 t -62.74 -39.83 86.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.576 0.703 . . . . 1.0 109.259 177.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -56.33 -42.22 77.31 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.584 -0.735 . . . . 1.0 109.481 175.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.484 ' O ' ' HG2' ' A' ' 143' ' ' GLU . . . -67.14 -49.14 65.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.047 -0.979 . . . . 1.0 111.32 179.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.919 HG11 ' HA ' ' A' ' 138' ' ' VAL . 2.9 p -58.37 -40.34 77.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.456 0.646 . . . . 1.0 110.779 -178.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.554 HD12 HG11 ' A' ' 138' ' ' VAL . 14.2 mt -70.26 -51.54 37.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 115.187 -0.915 . . . . 1.0 112.228 178.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.515 ' HB3' ' HE1' ' A' ' 24' ' ' MET . 11.6 pt-20 -55.46 -31.18 61.75 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.309 0.576 . . . . 1.0 110.287 179.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 65.9 m -74.97 -27.66 60.26 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.102 -0.954 . . . . 1.0 110.468 179.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.477 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -86.24 -24.68 25.92 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 115.99 -0.55 . . . . 1.0 111.725 178.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.697 HD21 ' HB3' ' A' ' 25' ' ' PHE . 12.7 mt -55.89 -37.28 55.38 Favored Pre-proline 0 CA--C 1.547 0.846 0 N-CA-C 112.468 0.544 . . . . 1.0 112.468 -178.11 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.627 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 38.3 Cg_endo -67.04 -14.04 42.09 Favored 'Trans proline' 0 C--N 1.363 1.311 0 C-N-CA 122.495 2.13 . . . . 1.0 111.908 177.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.558 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -104.19 -34.05 3.79 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.084 -0.962 . . . . 1.0 110.714 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.571 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -73.68 -40.93 63.31 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.889 -0.782 . . . . 1.0 108.889 179.543 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.542 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 0.2 OUTLIER -53.08 -57.04 11.76 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 115.103 -0.953 . . . . 1.0 110.837 175.672 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -57.01 -40.19 76.15 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.727 -1.124 . . . . 1.0 111.069 -174.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . 0.611 ' HZ3' HD21 ' A' ' 5' ' ' LEU . 24.3 t90 -63.22 -58.01 8.59 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.173 -0.922 . . . . 1.0 110.614 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.428 HG12 ' O ' ' A' ' 149' ' ' LEU . 5.7 m -60.73 -40.55 85.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.81 -0.356 . . . . 1.0 110.303 -177.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.409 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 5.8 m-20 -61.17 -49.5 76.93 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.832 0.349 . . . . 1.0 110.904 178.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.517 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 9.3 pt-20 -63.51 -39.39 94.3 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.095 0.474 . . . . 1.0 110.548 -178.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.516 ' HG3' ' CH2' ' A' ' 152' ' ' TRP . 18.4 mmt85 -71.32 -46.73 59.95 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.516 -0.766 . . . . 1.0 110.837 -176.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 4.2 pp -63.85 -24.78 67.88 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.228 0.537 . . . . 1.0 109.941 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -74.48 -52.84 10.81 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.596 -0.729 . . . . 1.0 110.902 177.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' A' ' 155' ' ' GLU . 0.0 OUTLIER -79.14 -18.65 52.78 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 113.278 0.844 . . . . 1.0 113.278 -176.083 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -90.71 47.06 1.38 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.579 0.704 . . . . 1.0 109.842 -177.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -76.92 -175.84 42.54 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.338 -0.847 . . . . 1.0 112.625 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -79.85 24.81 0.61 Allowed 'Trans proline' 0 N--CA 1.477 0.504 0 C-N-CA 123.642 2.895 . . . . 1.0 113.042 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 19.1 m . . . . . 0 C--N 1.294 -1.839 0 CA-C-N 114.481 -1.236 . . . . 1.0 110.797 -176.969 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.651 0 N-CA-C 112.234 -0.347 . . . . 1.0 112.234 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.8 mtt -148.56 134.89 19.46 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.114 0.483 . . . . 1.0 110.433 -178.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.8 p -90.71 118.56 30.24 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.552 -0.749 . . . . 1.0 110.15 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.676 ' HB2' ' HD2' ' A' ' 4' ' ' PRO . 5.1 p-10 -67.58 159.19 79.67 Favored Pre-proline 0 C--N 1.325 -0.481 0 C-N-CA 120.244 -0.582 . . . . 1.0 110.796 177.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.676 ' HD2' ' HB2' ' A' ' 3' ' ' ASP . 13.0 Cg_endo -57.98 166.89 4.9 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 123.568 2.845 . . . . 1.0 114.101 -175.052 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.824 ' HB3' HG21 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -65.19 178.51 0.87 Allowed 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.637 -1.165 . . . . 1.0 108.453 178.608 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.725 ' H ' HD11 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -155.55 100.97 2.14 Favored 'General case' 0 C--N 1.318 -0.803 0 O-C-N 121.549 -0.72 . . . . 1.0 109.585 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.457 HG23 HG12 ' A' ' 153' ' ' VAL . 2.2 t -104.68 116.01 47.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 107.964 -1.125 . . . . 1.0 107.964 178.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.619 HG22 ' HG ' ' A' ' 86' ' ' LEU . 6.3 t -119.06 117.89 29.96 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 120.52 -0.472 . . . . 1.0 109.918 178.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.587 ' HD2' ' HB3' ' A' ' 42' ' ' SER . 1.6 m-85 -85.22 133.19 34.19 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.016 -178.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.621 HG22 HD13 ' A' ' 97' ' ' LEU . 22.5 t -118.04 113.42 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.775 0 CA-C-O 121.123 0.487 . . . . 1.0 111.383 -176.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.669 ' SG ' ' HD3' ' A' ' 17' ' ' ARG . 42.2 t -144.94 160.23 41.66 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.657 -0.701 . . . . 1.0 109.491 178.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.446 HG22 ' NE2' ' A' ' 93' ' ' HIS . 2.7 p -68.56 112.28 5.26 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 120.941 0.401 . . . . 1.0 110.226 178.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.956 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 110.57 -45.16 1.36 Allowed Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.651 -0.785 . . . . 1.0 112.286 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.566 ' ND2' ' H ' ' A' ' 74' ' ' ALA . 57.5 t30 59.66 35.25 22.36 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 122.016 0.912 . . . . 1.0 110.953 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.406 HD13 ' ND1' ' A' ' 49' ' ' HIS . 4.5 pt -130.32 -4.39 2.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 O-C-N 121.682 -0.636 . . . . 1.0 112.483 -179.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.718 ' O ' ' HG3' ' A' ' 20' ' ' MET . 32.7 m -115.43 -89.05 0.57 Allowed 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 119.671 -0.812 . . . . 1.0 111.881 -177.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.94 ' HG3' ' HG ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -70.76 -39.99 72.91 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.821 0.674 . . . . 1.0 112.821 -175.071 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.478 ' HB3' ' HB2' ' A' ' 9' ' ' PHE . 19.4 m -57.58 -57.4 25.59 Favored Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 111.518 0.192 . . . . 1.0 111.518 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.453 ' HD3' ' HB2' ' A' ' 18' ' ' SER . 40.0 Cg_endo -65.15 -23.93 59.68 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 121.886 1.724 . . . . 1.0 112.395 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.718 ' HG3' ' O ' ' A' ' 16' ' ' CYS . 78.0 mtp -61.78 -52.33 64.66 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.111 -0.329 . . . . 1.0 110.111 179.046 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.453 ' HA ' ' HB2' ' A' ' 24' ' ' MET . . . -72.37 -27.56 62.46 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-N 115.632 -0.713 . . . . 1.0 110.138 -178.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.488 ' O ' ' HB1' ' A' ' 26' ' ' ALA . 17.2 tt0 -52.63 -51.99 57.59 Favored 'General case' 0 C--O 1.216 -0.664 0 CA-C-N 114.981 -1.009 . . . . 1.0 109.361 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.687 ' O ' ' HB3' ' A' ' 27' ' ' GLN . 0.1 OUTLIER -88.14 -22.79 23.88 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.815 -1.084 . . . . 1.0 110.99 -175.974 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.516 ' HB3' HD12 ' A' ' 146' ' ' LEU . 89.2 mtp -65.39 -74.97 0.09 Allowed 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.101 0.476 . . . . 1.0 112.246 -179.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.71 ' HB3' HD22 ' A' ' 146' ' ' LEU . 17.9 p90 -75.48 -30.64 59.95 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.003 -0.679 . . . . 1.0 111.601 -175.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.505 ' HA ' HD13 ' A' ' 29' ' ' LEU . . . -64.79 -35.79 82.24 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 119.305 -0.958 . . . . 1.0 110.905 179.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.687 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -63.79 -37.88 89.01 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.402 -0.962 . . . . 1.0 108.402 177.147 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.582 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 77.9 mt-30 -59.5 -45.54 91.39 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 115.519 -0.764 . . . . 1.0 110.351 175.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.505 HD13 ' HA ' ' A' ' 26' ' ' ALA . 81.8 mt -53.3 -62.48 1.63 Allowed 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 115.859 -0.61 . . . . 1.0 111.317 -179.179 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.429 ' HA ' ' H ' ' A' ' 35' ' ' GLY . 0.3 OUTLIER -58.77 -35.48 72.85 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 120.831 -0.348 . . . . 1.0 111.502 179.863 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -62.14 -28.62 69.77 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.139 0.422 . . . . 1.0 112.139 177.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.582 ' HG2' ' O ' ' A' ' 28' ' ' GLN . 7.3 ptp180 -94.71 -20.25 19.69 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 119.452 -0.899 . . . . 1.0 109.949 178.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 110.52 35.52 2.06 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.202 -0.908 . . . . 1.0 112.277 176.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.461 ' HG ' ' HG3' ' A' ' 32' ' ' ARG . 17.9 mt -126.16 1.43 7.16 Favored 'General case' 0 N--CA 1.452 -0.358 0 O-C-N 122.432 -0.452 . . . . 1.0 110.0 -178.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.429 ' H ' ' HA ' ' A' ' 30' ' ' ARG . . . -55.75 -30.2 56.03 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 121.094 -0.574 . . . . 1.0 112.709 -178.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -88.79 -20.77 24.29 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.924 0.392 . . . . 1.0 110.55 178.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.92 -21.54 40.44 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.73 -0.668 . . . . 1.0 111.802 -179.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.824 HG21 ' HB3' ' A' ' 5' ' ' LEU . 0.6 OUTLIER -144.21 125.8 9.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.283 0.563 . . . . 1.0 111.386 -179.727 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.45 ' HG2' ' HB2' ' A' ' 4' ' ' PRO . 11.8 mmt180 -88.33 135.01 33.66 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.693 -0.855 . . . . 1.0 108.693 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.479 HG11 ' HB2' ' A' ' 26' ' ' ALA . 53.9 t -124.76 123.25 65.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.546 0.689 . . . . 1.0 109.385 -178.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.549 ' O ' ' HA ' ' A' ' 8' ' ' THR . 42.8 p -138.54 -175.75 4.23 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.491 -1.231 . . . . 1.0 110.989 -174.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.587 ' HB3' ' HD2' ' A' ' 9' ' ' PHE . 59.6 p -160.13 162.6 34.01 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.397 -0.365 . . . . 1.0 110.135 -178.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.609 ' HB2' ' CD2' ' A' ' 80' ' ' HIS . . . -162.88 163.19 26.5 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.36 0.6 . . . . 1.0 111.636 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.46 ' HA2' ' O ' ' A' ' 11' ' ' CYS . . . -123.23 131.64 8.25 Favored Glycine 0 N--CA 1.442 -0.909 0 N-CA-C 110.778 -0.929 . . . . 1.0 110.778 178.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.499 HG23 ' CG1' ' A' ' 10' ' ' VAL . 23.2 p -69.98 -25.36 63.58 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.805 0.336 . . . . 1.0 111.752 -177.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.512 ' HA3' ' HZ3' ' A' ' 48' ' ' TRP . . . -110.91 9.16 29.64 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 120.851 -0.69 . . . . 1.0 113.409 -176.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 41.98 41.81 2.08 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 114.25 1.204 . . . . 1.0 114.25 176.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.956 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 1.2 m-90 -49.1 -76.02 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.694 0.759 . . . . 1.0 111.903 177.19 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.406 ' ND1' HD13 ' A' ' 15' ' ' ILE . 9.1 m170 -102.39 39.19 1.54 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.178 -0.919 . . . . 1.0 111.04 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.9 p -60.05 128.41 21.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.147 0.499 . . . . 1.0 110.529 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.43 ' HA2' ' HD3' ' A' ' 72' ' ' ARG . . . 93.3 -14.22 65.78 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.944 -0.646 . . . . 1.0 111.99 -177.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.1 t -80.63 -161.12 0.35 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.183 0.516 . . . . 1.0 110.004 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 71' ' ' HIS . 24.8 t -121.39 176.23 5.76 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 108.448 -0.945 . . . . 1.0 108.448 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.499 ' HB2' ' HZ2' ' A' ' 23' ' ' LYS . . . -59.63 143.68 49.86 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.313 -0.403 . . . . 1.0 111.273 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.464 ' OD1' ' HG3' ' A' ' 57' ' ' ARG . 51.6 t0 -49.58 123.93 8.62 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.898 -1.046 . . . . 1.0 110.115 178.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -44.57 -37.02 3.3 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.444 -0.798 . . . . 1.0 112.64 178.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.627 HH11 ' HD1' ' A' ' 135' ' ' PHE . 0.2 OUTLIER -73.27 -38.06 66.07 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.095 -0.642 . . . . 1.0 111.178 -179.102 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.11 -36.37 72.12 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.55 0.214 . . . . 1.0 110.472 177.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.47 -41.88 97.92 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.046 177.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.09 -42.3 99.74 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 111.084 -0.807 . . . . 1.0 111.084 176.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.589 HG21 ' O ' ' A' ' 57' ' ' ARG . 85.0 t -59.14 -57.36 11.74 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 CA-C-N 115.273 -0.464 . . . . 1.0 111.127 178.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.643 ' HB2' HG22 ' A' ' 69' ' ' THR . 85.7 mt -59.5 -50.36 74.22 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.227 -0.442 . . . . 1.0 111.504 -177.152 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.665 ' HB3' HG23 ' A' ' 69' ' ' THR . 2.2 ptt180 -63.25 -27.74 69.55 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.727 -0.67 . . . . 1.0 110.823 -178.162 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.86 -29.68 68.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.128 0.49 . . . . 1.0 110.702 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -98.81 4.31 47.58 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.837 -0.619 . . . . 1.0 111.452 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.39 12.39 63.1 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.712 -0.756 . . . . 1.0 112.691 177.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.517 ' HD1' ' HG2' ' A' ' 27' ' ' GLN . 62.3 m-85 -86.96 152.31 53.3 Favored Pre-proline 0 C--N 1.323 -0.574 0 O-C-N 122.756 -0.261 . . . . 1.0 110.409 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.626 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 17.8 Cg_endo -64.81 153.25 78.81 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.295 1.997 . . . . 1.0 110.417 175.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.665 HG23 ' HB3' ' A' ' 63' ' ' ARG . 61.5 p -135.35 28.84 3.36 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 120.232 -0.587 . . . . 1.0 112.336 -176.074 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -104.38 130.47 52.25 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.343 -0.614 . . . . 1.0 109.343 178.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.684 ' HB2' ' HE2' ' A' ' 23' ' ' LYS . 18.7 t60 -164.95 148.34 8.56 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.287 -177.466 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.443 ' HD2' ' C ' ' A' ' 72' ' ' ARG . 6.3 tmm_? -127.41 111.31 13.71 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 107.493 -1.299 . . . . 1.0 107.493 177.342 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.58 134.25 55.97 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.1 -0.955 . . . . 1.0 111.918 -175.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.566 ' H ' ' ND2' ' A' ' 14' ' ' ASN . . . -128.8 147.98 50.84 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.725 -0.67 . . . . 1.0 109.791 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -87.09 155.83 19.97 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.747 -0.464 . . . . 1.0 109.747 176.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.481 HG12 HD21 ' A' ' 97' ' ' LEU . 12.9 t -64.11 112.58 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.488 0.661 . . . . 1.0 111.229 -179.374 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -122.64 -171.75 13.86 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 114.937 -1.029 . . . . 1.0 111.748 179.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 96.6 m -56.41 -44.45 80.35 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 123.704 0.297 . . . . 1.0 111.212 -179.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -60.07 -27.83 67.3 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.873 0.368 . . . . 1.0 110.939 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.609 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 79.6 m80 -79.73 -41.56 26.44 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 116.421 -0.354 . . . . 1.0 110.389 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.639 ' O ' HG21 ' A' ' 102' ' ' VAL . 17.9 mt -67.61 -17.0 64.46 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.241 176.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.76 -8.28 57.5 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.395 -0.366 . . . . 1.0 110.848 -179.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.527 ' HA ' ' HB3' ' A' ' 6' ' ' HIS . . . -60.15 151.17 27.67 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.074 -0.512 . . . . 1.0 111.569 -179.488 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.75 ' HB3' HD11 ' A' ' 5' ' ' LEU . 9.9 t70 -76.13 -14.98 60.16 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.759 -0.655 . . . . 1.0 109.712 179.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.742 HD13 ' CE3' ' A' ' 152' ' ' TRP . 1.2 tt -157.48 116.53 3.28 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.89 -0.595 . . . . 1.0 109.572 -177.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.619 ' HG ' HG22 ' A' ' 8' ' ' THR . 5.3 mp -107.27 88.44 2.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 116.018 -0.537 . . . . 1.0 110.671 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.617 HG22 HD23 ' A' ' 85' ' ' LEU . 70.3 t -66.18 91.02 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 113.801 -1.545 . . . . 1.0 112.363 -179.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.49 146.32 32.77 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.509 -1.223 . . . . 1.0 110.655 177.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.94 ' HG ' ' HG3' ' A' ' 17' ' ' ARG . 4.3 mm? -99.04 -8.47 25.27 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.253 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.441 ' CG ' ' H ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -153.32 155.22 36.07 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.08 -0.509 . . . . 1.0 111.142 -179.843 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.438 ' HB3' ' O ' ' A' ' 122' ' ' LEU . 0.5 OUTLIER -56.91 -27.02 60.25 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.24 -0.891 . . . . 1.0 113.31 -178.598 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.647 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 7.0 m-20 -75.58 -49.93 17.08 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.977 -0.379 . . . . 1.0 109.977 -178.061 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.661 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 9.9 m170 -55.28 -47.33 75.69 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.73 -0.668 . . . . 1.0 110.295 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.96 -43.96 91.41 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.09 0.471 . . . . 1.0 110.704 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.456 ' O ' ' HG2' ' A' ' 99' ' ' GLN . 17.1 ttt180 -59.4 -44.42 92.82 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.759 -0.655 . . . . 1.0 111.332 178.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.647 ' HG ' ' O ' ' A' ' 92' ' ' ASN . 60.2 mt -62.69 -47.32 84.16 Favored 'General case' 0 C--O 1.215 -0.737 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.425 -176.358 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.661 ' HG ' ' O ' ' A' ' 93' ' ' HIS . 29.5 mt -54.32 -59.46 4.64 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.636 -0.711 . . . . 1.0 111.417 -178.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.683 ' CA ' HG12 ' A' ' 102' ' ' VAL . 16.5 ptt85 -59.7 -44.71 93.56 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.305 0.483 . . . . 1.0 112.305 -178.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' A' ' 95' ' ' ARG . 2.3 pt20 -68.06 -24.63 65.09 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.497 -0.481 . . . . 1.0 109.918 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.641 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 6.1 mt -81.48 -16.14 52.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.718 -0.674 . . . . 1.0 112.037 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 151.06 -23.44 0.99 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 119.873 -1.156 . . . . 1.0 114.184 -178.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.867 HG22 ' HD2' ' A' ' 106' ' ' ARG . 0.4 OUTLIER -76.62 -163.11 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 CA-C-N 117.958 0.879 . . . . 1.0 110.295 -179.091 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.685 ' N ' HG11 ' A' ' 102' ' ' VAL . 14.2 pt-20 -158.11 161.4 37.94 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 107.702 -1.221 . . . . 1.0 107.702 -179.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.772 ' HA ' HG13 ' A' ' 107' ' ' VAL . . . -61.86 -25.02 67.28 Favored 'General case' 0 C--N 1.32 -0.717 0 O-C-N 123.285 0.366 . . . . 1.0 111.273 -175.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.418 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . . . -56.37 -39.31 72.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.318 0.58 . . . . 1.0 110.286 175.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.867 ' HD2' HG22 ' A' ' 102' ' ' VAL . 22.5 mtt180 -96.82 -42.51 7.93 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 115.036 -0.983 . . . . 1.0 111.13 -176.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.772 HG13 ' HA ' ' A' ' 104' ' ' ALA . 11.5 p -78.86 117.75 24.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 120.694 -0.402 . . . . 1.0 110.03 -174.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.612 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 0.1 OUTLIER -138.35 148.44 44.57 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 121.716 -0.615 . . . . 1.0 110.455 -178.97 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.439 ' HE3' HG21 ' A' ' 124' ' ' VAL . 83.9 mmm -80.86 140.53 35.33 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.977 -0.556 . . . . 1.0 111.006 -178.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.555 HD23 HG12 ' A' ' 87' ' ' VAL . 3.1 tm? -59.11 -48.71 80.62 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 111.552 0.204 . . . . 1.0 111.552 -179.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 7.7 ttm180 -69.26 -19.92 63.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.707 0.289 . . . . 1.0 110.528 -178.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 30.4 t -74.26 -7.0 51.2 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.464 -0.335 . . . . 1.0 111.177 -178.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.624 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 87.6 m-85 -92.93 -19.11 21.96 Favored 'General case' 0 C--N 1.34 0.181 0 O-C-N 121.834 -0.541 . . . . 1.0 110.65 177.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -60.27 121.82 62.46 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.885 -0.598 . . . . 1.0 111.041 -178.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -64.33 -16.8 57.05 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.844 2.363 . . . . 1.0 111.802 179.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 18.3 mtp180 -91.22 -5.68 54.5 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.647 -0.706 . . . . 1.0 111.122 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 14.8 t -71.57 81.97 0.82 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.823 0.344 . . . . 1.0 110.702 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -52.82 -39.19 55.29 Favored Glycine 0 C--N 1.335 0.475 0 CA-C-N 115.895 -0.593 . . . . 1.0 113.042 179.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.76 162.67 12.74 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.813 -0.44 . . . . 1.0 109.813 178.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 28.3 m170 -63.89 133.7 53.78 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.019 -0.734 . . . . 1.0 109.019 175.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -100.63 87.98 3.49 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 116.086 -0.506 . . . . 1.0 111.241 -178.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.438 ' O ' ' HB3' ' A' ' 91' ' ' ARG . 2.5 mm? -95.26 17.34 14.51 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.664 -0.865 . . . . 1.0 108.664 175.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -168.38 132.95 1.65 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.615 -1.175 . . . . 1.0 109.487 -176.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.439 HG21 ' HE3' ' A' ' 109' ' ' MET . 62.3 t -104.04 148.38 8.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.12 -0.696 . . . . 1.0 109.12 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -64.22 -173.81 0.1 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.612 0.72 . . . . 1.0 112.767 -178.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.452 ' OD1' ' HD2' ' A' ' 127' ' ' PRO . 32.1 t70 -165.82 144.71 5.07 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 114.552 -1.204 . . . . 1.0 108.498 -175.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.452 ' HD2' ' OD1' ' A' ' 126' ' ' ASP . 7.9 Cg_endo -49.15 168.81 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.673 2.915 . . . . 1.0 113.636 -178.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.479 ' HD2' ' CE2' ' A' ' 129' ' ' TYR . 30.3 t80 -113.48 -22.4 10.36 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.072 -0.967 . . . . 1.0 111.449 -177.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.479 ' CE2' ' HD2' ' A' ' 128' ' ' TYR . 0.0 OUTLIER -140.1 -60.3 0.53 Allowed 'General case' 0 C--N 1.332 -0.181 0 O-C-N 122.061 -0.399 . . . . 1.0 110.903 179.652 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 121.62 73.4 0.31 Allowed Glycine 0 N--CA 1.451 -0.354 0 N-CA-C 111.042 -0.823 . . . . 1.0 111.042 -177.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.655 ' H ' ' HB3' ' A' ' 134' ' ' ASP . 5.2 p-10 -143.98 -167.03 2.5 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.774 0.321 . . . . 1.0 110.488 -177.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -54.34 -42.52 70.31 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.863 -0.608 . . . . 1.0 111.005 178.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.7 m -61.89 -40.5 95.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.501 -0.318 . . . . 1.0 110.669 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.655 ' HB3' ' H ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -63.35 -39.92 95.85 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.472 -0.786 . . . . 1.0 111.579 -177.601 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.627 ' HD1' HH11 ' A' ' 57' ' ' ARG . 5.4 m-85 -68.98 -45.55 70.36 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.161 0.505 . . . . 1.0 110.466 -176.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -75.1 -24.66 58.14 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.926 -0.579 . . . . 1.0 111.182 -178.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.601 ' O ' HG21 ' A' ' 141' ' ' VAL . 2.8 tt0 -63.85 -49.4 72.93 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.794 -0.447 . . . . 1.0 109.794 177.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.436 HG13 HD11 ' A' ' 142' ' ' ILE . 84.3 t -59.05 -44.54 91.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.479 0.657 . . . . 1.0 109.692 177.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -56.7 -40.11 75.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.804 -1.089 . . . . 1.0 110.058 177.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.561 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -67.18 -41.94 85.07 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.246 -0.433 . . . . 1.0 110.746 178.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.601 HG21 ' O ' ' A' ' 137' ' ' GLU . 33.4 t -56.33 -51.06 68.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.645 0.736 . . . . 1.0 110.425 178.212 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.436 HD11 HG13 ' A' ' 138' ' ' VAL . 7.7 mt -65.96 -50.36 70.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 114.782 -1.099 . . . . 1.0 111.588 -178.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.561 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 12.7 pt-20 -57.49 -30.41 65.08 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 121.003 -0.279 . . . . 1.0 110.354 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 2.9 t -74.76 -28.85 60.92 Favored 'General case' 0 C--O 1.226 -0.167 0 CA-C-O 121.155 0.502 . . . . 1.0 110.384 178.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.462 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -86.98 -22.31 25.64 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 116.014 -0.539 . . . . 1.0 111.523 179.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.71 HD22 ' HB3' ' A' ' 25' ' ' PHE . 11.2 mt -55.57 -37.49 57.52 Favored Pre-proline 0 CA--C 1.54 0.569 0 N-CA-C 112.523 0.564 . . . . 1.0 112.523 -179.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 57.1 Cg_endo -70.59 -8.53 23.83 Favored 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 122.495 2.13 . . . . 1.0 112.255 177.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.624 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -108.73 -33.93 2.74 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.214 -1.154 . . . . 1.0 110.214 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.564 HD12 HG21 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -73.44 -43.63 59.93 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.163 -1.051 . . . . 1.0 108.163 178.509 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.658 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 0.2 OUTLIER -54.21 -52.52 61.01 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-N 114.768 -1.106 . . . . 1.0 110.227 174.865 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -57.59 -43.89 84.97 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.324 -1.307 . . . . 1.0 110.89 -175.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . 0.742 ' CE3' HD13 ' A' ' 85' ' ' LEU . 22.9 t90 -63.01 -57.05 12.01 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.095 -0.957 . . . . 1.0 110.414 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.457 HG12 HG23 ' A' ' 7' ' ' VAL . 8.4 m -61.95 -42.09 93.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.776 -0.37 . . . . 1.0 110.566 -177.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -60.33 -51.22 70.45 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.907 0.384 . . . . 1.0 110.777 179.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.708 ' O ' ' HG2' ' A' ' 159' ' ' ARG . 13.8 pt-20 -62.66 -38.76 91.57 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.771 -0.65 . . . . 1.0 110.403 -178.466 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.497 ' HD3' ' HA ' ' A' ' 156' ' ' ARG . 1.8 mmt180 -72.65 -50.66 23.6 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.893 -0.594 . . . . 1.0 111.029 -177.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.1 pp -59.65 -27.45 66.38 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.069 -0.514 . . . . 1.0 109.885 -178.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -76.0 -50.96 13.41 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.586 -0.734 . . . . 1.0 111.355 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.708 ' HG2' ' O ' ' A' ' 155' ' ' GLU . 5.1 ptp180 -78.04 -25.29 47.76 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.896 0.702 . . . . 1.0 112.896 -174.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . 0.456 ' N ' ' HG3' ' A' ' 159' ' ' ARG . 5.9 m-20 -56.12 -59.91 4.24 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 123.34 0.4 . . . . 1.0 111.385 -173.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 63.75 -177.62 7.86 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.255 -0.974 . . . . 1.0 113.867 178.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -84.34 28.06 0.59 Allowed 'Trans proline' 0 CA--C 1.515 -0.432 0 C-N-CA 123.292 2.661 . . . . 1.0 112.573 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 22.6 t . . . . . 0 C--N 1.297 -1.694 0 CA-C-N 114.329 -1.305 . . . . 1.0 110.156 -177.981 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.794 0 N-CA-C 111.811 -0.515 . . . . 1.0 111.811 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.9 mtt -87.92 173.48 8.89 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.688 0.28 . . . . 1.0 110.611 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.7 p -157.5 163.73 38.13 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.878 -0.416 . . . . 1.0 109.878 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.563 ' HB2' ' HD2' ' A' ' 4' ' ' PRO . 1.9 p-10 -67.72 157.31 86.74 Favored Pre-proline 0 C--O 1.236 0.375 0 CA-C-O 121.258 0.551 . . . . 1.0 111.646 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.572 ' HB3' ' O ' ' A' ' 36' ' ' ASP . 35.0 Cg_endo -64.55 169.22 11.61 Favored 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 123.478 2.785 . . . . 1.0 113.826 -176.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.827 ' HB3' HG22 ' A' ' 38' ' ' VAL . 0.5 OUTLIER -73.21 -172.49 1.12 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.694 -1.139 . . . . 1.0 110.711 -179.303 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.612 ' HB3' ' HA ' ' A' ' 83' ' ' ALA . 0.3 OUTLIER -157.38 94.41 1.38 Allowed 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.897 -0.321 . . . . 1.0 110.881 179.295 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.673 HG13 HD11 ' A' ' 85' ' ' LEU . 2.1 t -96.06 115.62 35.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.876 -0.786 . . . . 1.0 108.876 176.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.586 ' CG2' ' HG ' ' A' ' 86' ' ' LEU . 14.2 t -118.52 115.35 24.42 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 120.92 0.391 . . . . 1.0 110.585 178.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.58 ' HD1' ' HB ' ' A' ' 87' ' ' VAL . 1.0 OUTLIER -83.54 132.42 34.93 Favored 'General case' 0 CA--C 1.511 -0.55 0 O-C-N 122.162 -0.336 . . . . 1.0 110.472 -179.025 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.703 HG23 HD11 ' A' ' 97' ' ' LEU . 44.5 t -115.37 119.98 63.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.221 0.534 . . . . 1.0 111.803 -176.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.52 ' HA ' ' CE1' ' A' ' 93' ' ' HIS . 47.0 t -147.59 164.92 31.95 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.654 -0.703 . . . . 1.0 109.712 178.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.517 HG22 ' HE2' ' A' ' 93' ' ' HIS . 0.6 OUTLIER -74.6 96.22 2.94 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.186 0.517 . . . . 1.0 110.66 179.097 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.954 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 125.04 -39.81 2.01 Favored Glycine 0 N--CA 1.441 -1.01 0 CA-C-N 115.486 -0.779 . . . . 1.0 111.972 179.117 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.478 HD22 ' CB ' ' A' ' 42' ' ' SER . 3.6 t-20 65.05 18.88 11.67 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 122.115 0.96 . . . . 1.0 110.078 -178.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.505 HG12 ' HB2' ' A' ' 49' ' ' HIS . 1.2 pt -134.58 48.43 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-N 115.078 -0.964 . . . . 1.0 110.103 -177.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.739 ' O ' ' HG3' ' A' ' 20' ' ' MET . 4.7 p -157.9 -90.12 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.285 -0.87 . . . . 1.0 111.495 174.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.634 HH11 ' HB3' ' A' ' 89' ' ' LEU . 1.2 mtt180 -70.73 -44.46 66.8 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.986 0.422 . . . . 1.0 111.187 -177.071 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.683 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 15.1 m -54.41 -58.13 15.39 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-N 115.756 -0.657 . . . . 1.0 111.838 -179.364 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.511 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 33.6 Cg_endo -64.1 -24.58 66.24 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 121.68 1.586 . . . . 1.0 112.627 -179.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.739 ' HG3' ' O ' ' A' ' 16' ' ' CYS . 57.6 mtp -62.01 -53.81 50.38 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.902 -0.319 . . . . 1.0 110.607 178.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.429 ' HA ' ' HB2' ' A' ' 24' ' ' MET . . . -74.91 -26.14 59.43 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.488 -178.022 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.472 ' O ' ' HB1' ' A' ' 26' ' ' ALA . 12.5 tt0 -53.84 -51.28 64.06 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.274 -0.876 . . . . 1.0 109.528 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.803 ' HB3' ' HG2' ' A' ' 68' ' ' PRO . 0.2 OUTLIER -80.7 -31.14 36.27 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.549 -0.75 . . . . 1.0 110.451 -177.244 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.63 ' HB3' HD11 ' A' ' 146' ' ' LEU . 6.0 mmm -60.85 -75.49 0.06 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.902 0.704 . . . . 1.0 112.902 -175.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.669 ' O ' ' HG ' ' A' ' 29' ' ' LEU . 19.0 p90 -77.94 -30.77 50.61 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 119.815 -0.754 . . . . 1.0 111.527 -175.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.472 ' HB1' ' O ' ' A' ' 22' ' ' GLU . . . -63.03 -38.23 90.37 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 119.06 -1.056 . . . . 1.0 110.648 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.649 ' HA ' ' HD3' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -65.39 -40.13 93.1 Favored 'General case' 0 C--N 1.339 0.118 0 N-CA-C 108.936 -0.765 . . . . 1.0 108.936 177.504 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.653 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 50.7 mt-30 -61.59 -40.46 94.84 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.751 176.241 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.669 ' HG ' ' O ' ' A' ' 25' ' ' PHE . 83.9 mt -56.73 -57.65 11.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.638 178.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.649 ' HD3' ' HA ' ' A' ' 27' ' ' GLN . 1.6 ptm180 -59.9 -32.28 70.6 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.485 -0.486 . . . . 1.0 111.129 178.051 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -62.27 -32.93 73.7 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 111.967 0.358 . . . . 1.0 111.967 175.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.653 ' HG2' ' O ' ' A' ' 28' ' ' GLN . 4.8 ptp180 -91.94 -17.5 25.08 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.632 0.729 . . . . 1.0 109.706 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.22 33.64 5.1 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 114.911 -1.041 . . . . 1.0 111.435 177.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 33.2 mt -123.42 -0.75 8.69 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.566 -0.531 . . . . 1.0 109.566 -177.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.25 -27.52 60.45 Favored Glycine 0 C--O 1.227 -0.338 0 CA-C-N 115.889 -0.596 . . . . 1.0 112.486 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.572 ' O ' ' HB3' ' A' ' 4' ' ' PRO . 0.9 OUTLIER -86.34 -25.86 25.18 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 109.716 -0.475 . . . . 1.0 109.716 177.549 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -78.42 -21.69 48.85 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.137 -0.938 . . . . 1.0 111.341 -176.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.827 HG22 ' HB3' ' A' ' 5' ' ' LEU . 1.2 p -144.45 126.85 10.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.229 0.538 . . . . 1.0 110.378 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.477 ' HG2' ' HB2' ' A' ' 4' ' ' PRO . 11.0 mmt180 -90.0 144.59 25.78 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.462 -0.79 . . . . 1.0 109.585 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.428 HG11 ' HB2' ' A' ' 26' ' ' ALA . 77.8 t -129.68 127.73 64.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 121.382 0.611 . . . . 1.0 109.93 -178.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.527 ' O ' ' HA ' ' A' ' 8' ' ' THR . 40.0 p -143.89 -175.54 4.63 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.476 -1.238 . . . . 1.0 110.024 -175.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.683 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 86.4 p -161.27 167.03 26.72 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 110.006 -0.368 . . . . 1.0 110.006 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.594 ' HB1' ' CD2' ' A' ' 80' ' ' HIS . . . -163.5 166.41 22.66 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.156 0.503 . . . . 1.0 111.695 -178.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.505 ' HA2' ' O ' ' A' ' 11' ' ' CYS . . . -125.15 137.71 10.56 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.302 -0.863 . . . . 1.0 111.398 178.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.64 HG23 HD12 ' A' ' 96' ' ' LEU . 22.1 p -74.17 -22.93 59.21 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.805 0.303 . . . . 1.0 111.747 -177.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.455 ' HA3' ' CZ3' ' A' ' 48' ' ' TRP . . . -111.31 8.31 28.73 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.668 -0.777 . . . . 1.0 113.03 -178.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.451 ' HB3' ' HB2' ' A' ' 75' ' ' GLN . 2.7 p-10 43.01 37.02 1.0 Allowed 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 113.875 1.065 . . . . 1.0 113.875 177.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.954 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 1.1 m-90 -46.8 -64.4 0.78 Allowed 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.325 0.583 . . . . 1.0 112.532 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.567 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 2.3 m-70 -111.99 39.25 2.44 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.753 -0.658 . . . . 1.0 111.281 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.507 HG22 ' HA ' ' A' ' 74' ' ' ALA . 14.9 p -59.87 126.87 18.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 C-N-CA 120.207 -0.597 . . . . 1.0 110.473 179.056 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.64 -14.17 65.62 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-N 116.032 -0.531 . . . . 1.0 111.948 -177.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.464 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 3.3 t -79.93 -160.72 0.29 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.45 0.643 . . . . 1.0 109.961 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 47.7 t -124.48 175.02 7.41 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 115.445 -0.798 . . . . 1.0 108.971 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.38 147.56 48.06 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.54 0.686 . . . . 1.0 111.49 -178.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.428 ' N ' ' OD1' ' A' ' 55' ' ' ASP . 9.0 p-10 -59.75 137.76 57.96 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.437 -1.256 . . . . 1.0 112.034 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -48.36 -35.25 12.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.672 -1.149 . . . . 1.0 112.785 179.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.426 ' H ' ' HG2' ' A' ' 57' ' ' ARG . 17.3 ptt180 -71.93 -43.69 64.86 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.377 0.132 . . . . 1.0 111.071 -177.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.444 ' O ' ' HG ' ' A' ' 62' ' ' LEU . . . -69.56 -39.13 77.59 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 109.378 -0.601 . . . . 1.0 109.378 178.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.4 -45.53 93.93 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.672 -0.695 . . . . 1.0 109.398 177.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.4 ' O ' ' HG2' ' A' ' 63' ' ' ARG . . . -57.83 -47.21 90.29 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 115.768 -0.651 . . . . 1.0 113.36 178.058 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.6 m -70.34 -39.99 77.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 117.699 0.749 . . . . 1.0 111.045 -178.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.699 HD11 ' HG3' ' A' ' 23' ' ' LYS . 96.0 mt -63.64 -52.56 60.26 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 120.605 -0.438 . . . . 1.0 110.653 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.4 ' HG2' ' O ' ' A' ' 60' ' ' GLY . 4.5 ptm180 -61.13 -30.26 70.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.554 -0.294 . . . . 1.0 110.997 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.99 -33.45 75.6 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 120.946 0.403 . . . . 1.0 110.735 179.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -96.68 3.35 52.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.839 -0.619 . . . . 1.0 110.873 -178.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.41 13.8 62.89 Favored Glycine 0 N--CA 1.452 -0.257 0 CA-C-N 115.962 -0.563 . . . . 1.0 112.906 177.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -89.48 152.8 47.81 Favored Pre-proline 0 C--N 1.322 -0.616 0 N-CA-C 110.571 -0.159 . . . . 1.0 110.571 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.803 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 45.7 Cg_endo -69.8 158.46 56.84 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.182 1.921 . . . . 1.0 110.713 176.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.583 HG23 ' HB2' ' A' ' 62' ' ' LEU . 36.4 p -133.32 4.04 3.68 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 119.856 -0.738 . . . . 1.0 111.807 -177.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.4 ' O ' ' HE2' ' A' ' 23' ' ' LYS . 24.4 t70 -67.74 127.09 31.5 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.976 -0.556 . . . . 1.0 110.099 178.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.514 ' HB2' ' HE2' ' A' ' 23' ' ' LYS . 59.0 t60 -165.39 149.67 8.61 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.951 0.405 . . . . 1.0 111.116 -176.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.458 ' HA ' ' O ' ' A' ' 52' ' ' SER . 0.9 OUTLIER -134.16 112.65 11.29 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.113 -1.069 . . . . 1.0 108.113 175.136 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.567 ' HB3' ' O ' ' A' ' 49' ' ' HIS . . . -61.42 142.53 56.91 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.656 -1.157 . . . . 1.0 112.294 -176.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.507 ' HA ' HG22 ' A' ' 50' ' ' VAL . . . -133.55 161.25 35.11 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.469 -0.787 . . . . 1.0 109.885 178.072 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.451 ' HB2' ' HB3' ' A' ' 47' ' ' ASN . 46.8 tt0 -97.57 160.04 14.56 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.611 -0.885 . . . . 1.0 108.611 178.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.486 HG13 HD22 ' A' ' 97' ' ' LEU . 93.8 t -64.97 102.82 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.353 0.597 . . . . 1.0 110.093 178.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -119.57 -174.94 15.78 Favored Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 114.834 -1.075 . . . . 1.0 111.769 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 93.0 m -57.75 -45.75 85.44 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 111.616 0.228 . . . . 1.0 111.616 -177.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -59.12 -29.65 67.55 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.871 0.367 . . . . 1.0 111.305 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.594 ' CD2' ' HB1' ' A' ' 43' ' ' ALA . 78.2 m80 -78.39 -41.24 33.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.394 -0.366 . . . . 1.0 110.491 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.636 ' O ' HG21 ' A' ' 102' ' ' VAL . 18.2 mt -68.31 -17.28 64.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.404 177.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.87 -8.27 58.17 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.846 0.355 . . . . 1.0 110.487 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.612 ' HA ' ' HB3' ' A' ' 6' ' ' HIS . . . -58.91 151.85 20.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.664 -0.698 . . . . 1.0 111.427 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.6 ' HA ' ' NH1' ' A' ' 106' ' ' ARG . 27.0 t70 -78.73 -14.45 59.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.333 -0.394 . . . . 1.0 109.956 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.673 HD11 HG13 ' A' ' 7' ' ' VAL . 0.5 OUTLIER -155.36 117.33 4.11 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.65 -0.705 . . . . 1.0 109.311 -177.909 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.595 ' HB3' HD12 ' A' ' 97' ' ' LEU . 5.0 mp -107.67 105.94 16.04 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-N 115.622 -0.717 . . . . 1.0 109.897 177.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.58 ' HB ' ' HD1' ' A' ' 9' ' ' PHE . 56.0 t -84.5 92.94 3.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 114.803 -1.09 . . . . 1.0 111.002 -176.094 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.7 141.81 37.6 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.474 -0.785 . . . . 1.0 110.62 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.634 ' HB3' HH11 ' A' ' 17' ' ' ARG . 3.8 mm? -95.82 -8.77 33.32 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.261 0.553 . . . . 1.0 109.82 178.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.502 ' HA ' ' OD1' ' A' ' 123' ' ' ASP . 0.0 OUTLIER -149.73 151.55 33.83 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.249 -0.887 . . . . 1.0 110.786 -179.939 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.47 ' HG2' ' HB2' ' A' ' 123' ' ' ASP . 9.3 ptm180 -55.16 -29.86 58.67 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.262 -0.881 . . . . 1.0 112.92 -179.082 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.681 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 43.2 m-80 -75.06 -49.51 19.48 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.614 -0.513 . . . . 1.0 109.614 -176.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.555 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 16.7 m170 -52.44 -46.07 66.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.535 -0.757 . . . . 1.0 110.121 178.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.404 ' HA ' HG23 ' A' ' 107' ' ' VAL . . . -58.85 -46.44 87.74 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.42 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.1 ttm180 -61.47 -39.27 90.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.722 -0.672 . . . . 1.0 111.626 178.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.681 ' HG ' ' O ' ' A' ' 92' ' ' ASN . 36.1 mt -65.85 -47.19 75.77 Favored 'General case' 0 C--O 1.218 -0.594 0 N-CA-C 110.229 -0.285 . . . . 1.0 110.229 -177.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.703 HD11 HG23 ' A' ' 10' ' ' VAL . 31.6 mt -55.14 -58.78 6.27 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.145 -0.48 . . . . 1.0 111.655 -178.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.664 ' HD2' HG11 ' A' ' 107' ' ' VAL . 2.9 ptm180 -60.3 -41.52 93.59 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.826 -0.624 . . . . 1.0 112.473 -178.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.639 ' HG3' ' O ' ' A' ' 96' ' ' LEU . 1.0 OUTLIER -66.8 -27.76 67.83 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.361 -0.607 . . . . 1.0 109.361 178.536 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.656 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 11.1 mt -79.46 -13.44 59.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.537 -0.756 . . . . 1.0 111.769 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 149.36 -25.31 1.23 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 119.907 -1.14 . . . . 1.0 113.678 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.66 HG11 ' H ' ' A' ' 103' ' ' GLU . 0.4 OUTLIER -76.73 -163.02 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-N 117.437 0.619 . . . . 1.0 110.321 -178.615 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.66 ' H ' HG11 ' A' ' 102' ' ' VAL . 12.5 pt-20 -159.97 166.64 29.67 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 108.389 -0.967 . . . . 1.0 108.389 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.777 ' HA ' HG13 ' A' ' 107' ' ' VAL . . . -63.75 -25.23 68.1 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 123.304 0.378 . . . . 1.0 111.686 -174.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.41 -36.19 75.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.112 0.482 . . . . 1.0 110.142 175.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.6 ' NH1' ' HA ' ' A' ' 84' ' ' ASP . 0.8 OUTLIER -98.15 -42.82 7.27 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 115.525 -0.761 . . . . 1.0 111.293 -177.163 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.777 HG13 ' HA ' ' A' ' 104' ' ' ALA . 7.7 p -78.34 118.09 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 N-CA-C 109.266 -0.642 . . . . 1.0 109.266 -176.311 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.541 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 17.7 mmm180 -136.3 147.53 47.51 Favored 'General case' 0 C--N 1.32 -0.703 0 O-C-N 121.633 -0.667 . . . . 1.0 110.352 -178.042 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.413 ' HE2' ' HB3' ' A' ' 109' ' ' MET . 83.0 mmm -78.09 137.45 38.23 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.889 -0.596 . . . . 1.0 110.382 179.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.526 HD22 HG11 ' A' ' 87' ' ' VAL . 3.1 tm? -56.06 -49.09 74.75 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 123.031 0.207 . . . . 1.0 111.239 179.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 21.0 ttt180 -71.87 -11.9 61.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.011 0.434 . . . . 1.0 111.007 -178.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.799 ' HB2' ' HB3' ' A' ' 121' ' ' ALA . 26.7 t -75.81 -9.67 58.79 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.944 -0.303 . . . . 1.0 110.705 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.558 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 97.3 m-85 -92.41 -19.81 21.68 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.237 0.542 . . . . 1.0 110.366 176.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -60.72 124.22 78.19 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 114.945 -1.025 . . . . 1.0 111.685 -177.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.475 ' HD2' ' O ' ' A' ' 144' ' ' SER . 59.5 Cg_endo -73.93 -16.72 22.98 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.441 2.094 . . . . 1.0 111.939 176.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 28.5 mmm180 -86.61 -4.17 59.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.957 -0.565 . . . . 1.0 110.991 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 79.5 p -62.86 100.11 0.19 Allowed 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.337 0.589 . . . . 1.0 111.982 -178.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -56.06 -46.09 85.68 Favored Glycine 0 C--N 1.333 0.391 0 CA-C-N 115.367 -0.833 . . . . 1.0 111.96 176.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.579 HG22 ' H ' ' A' ' 120' ' ' HIS . 1.3 m -112.35 173.61 6.29 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.125 -0.694 . . . . 1.0 109.125 176.077 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.579 ' H ' HG22 ' A' ' 119' ' ' THR . 24.6 m-70 -75.46 147.84 39.55 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 109.569 -0.53 . . . . 1.0 109.569 178.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.799 ' HB3' ' HB2' ' A' ' 112' ' ' SER . . . -79.53 151.88 30.48 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 115.358 -0.837 . . . . 1.0 110.04 178.294 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.527 HD12 ' O ' ' A' ' 121' ' ' ALA . 1.0 OUTLIER -152.01 -27.01 0.18 Allowed 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 113.275 -1.784 . . . . 1.0 108.434 -178.256 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.502 ' OD1' ' HA ' ' A' ' 90' ' ' ASP . 17.6 t0 -167.41 143.48 4.18 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.504 -1.225 . . . . 1.0 107.83 -178.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.454 ' HB ' ' O ' ' A' ' 89' ' ' LEU . 94.9 t -94.54 144.57 9.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 110.121 -0.326 . . . . 1.0 110.121 -178.11 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -73.23 -165.76 0.27 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.885 0.374 . . . . 1.0 110.733 -178.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -161.06 162.98 21.42 Favored Pre-proline 0 C--N 1.318 -0.773 0 C-N-CA 120.35 -0.54 . . . . 1.0 109.595 -174.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.609 ' HB3' ' HB3' ' A' ' 134' ' ' ASP . 99.1 Cg_exo -47.73 155.73 1.45 Allowed 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 123.175 2.584 . . . . 1.0 113.246 178.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.436 ' HD2' ' CD2' ' A' ' 129' ' ' TYR . 79.2 t80 -93.81 -46.97 6.97 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.579 -0.737 . . . . 1.0 109.457 -179.092 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.436 ' CD2' ' HD2' ' A' ' 128' ' ' TYR . 0.4 OUTLIER -123.15 -21.85 5.32 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.813 176.175 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 87.19 59.01 1.8 Allowed Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.213 -0.994 . . . . 1.0 111.975 178.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.402 ' CG ' ' H ' ' A' ' 132' ' ' HIS . 8.7 t70 -113.13 -168.42 1.32 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.054 -1.091 . . . . 1.0 108.054 178.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.402 ' H ' ' CG ' ' A' ' 131' ' ' ASP . 7.0 t60 -62.12 -38.48 89.06 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.633 -0.506 . . . . 1.0 109.633 178.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 7.6 m -60.7 -49.6 76.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.865 -0.607 . . . . 1.0 110.579 -179.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.609 ' HB3' ' HB3' ' A' ' 127' ' ' PRO . 1.2 m-20 -56.89 -34.24 67.68 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.168 -0.469 . . . . 1.0 112.188 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -70.22 -44.41 68.67 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.869 0.366 . . . . 1.0 110.423 -177.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -79.27 -17.42 54.75 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.607 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -64.31 -48.28 76.23 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.543 -0.91 . . . . 1.0 108.543 174.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 1.013 ' HA ' HG23 ' A' ' 141' ' ' VAL . 54.8 t -61.9 -39.74 84.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.225 -0.898 . . . . 1.0 109.648 176.006 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.432 ' HB2' ' HE2' ' A' ' 20' ' ' MET . 46.1 t80 -53.44 -41.4 66.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.203 -0.908 . . . . 1.0 109.107 175.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.674 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -68.28 -39.83 82.01 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.323 -0.853 . . . . 1.0 110.629 177.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 1.013 HG23 ' HA ' ' A' ' 138' ' ' VAL . 15.9 t -55.6 -51.43 58.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-O 121.932 0.872 . . . . 1.0 109.83 177.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.454 HD11 HG13 ' A' ' 138' ' ' VAL . 7.0 mt -65.51 -51.59 61.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 114.755 -1.111 . . . . 1.0 111.775 -178.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.674 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 8.1 pt-20 -55.12 -32.79 62.32 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.839 -0.344 . . . . 1.0 110.29 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.475 ' O ' ' HD2' ' A' ' 115' ' ' PRO . 2.3 t -73.64 -30.18 62.79 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.488 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.455 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -86.17 -22.63 26.9 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-N 116.006 -0.543 . . . . 1.0 111.636 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.645 HD23 ' HB3' ' A' ' 25' ' ' PHE . 11.0 mt -54.18 -41.72 90.05 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 112.744 0.646 . . . . 1.0 112.744 -178.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.682 ' HA ' ' CD2' ' A' ' 150' ' ' HIS . 60.3 Cg_endo -68.36 -7.68 20.84 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 122.371 2.048 . . . . 1.0 111.866 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.558 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -108.48 -33.55 2.88 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 110.234 -1.146 . . . . 1.0 110.234 178.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.526 HD12 ' CE2' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -75.14 -54.34 7.31 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.327 -0.62 . . . . 1.0 109.327 -179.797 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.682 ' CD2' ' HA ' ' A' ' 147' ' ' PRO . 2.0 p80 -56.16 -46.81 79.15 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 115.268 -0.878 . . . . 1.0 110.471 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.448 ' N ' ' CG ' ' A' ' 150' ' ' HIS . 2.0 t70 -59.62 -37.94 79.98 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.764 -1.107 . . . . 1.0 110.411 -178.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . 0.772 ' HZ3' HD21 ' A' ' 5' ' ' LEU . 28.2 t90 -64.52 -54.66 28.87 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 115.637 -0.71 . . . . 1.0 109.858 178.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.603 HG21 ' O ' ' A' ' 150' ' ' HIS . 3.5 m -58.77 -37.8 68.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.571 -0.529 . . . . 1.0 109.571 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.448 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 2.7 m-20 -59.44 -56.39 22.61 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 121.487 0.661 . . . . 1.0 110.765 177.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.596 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 6.3 pt-20 -60.63 -37.92 83.06 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 114.901 -1.045 . . . . 1.0 110.369 -177.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.475 ' HA ' ' HD3' ' A' ' 156' ' ' ARG . 1.0 OUTLIER -74.11 -48.67 27.97 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.571 -0.741 . . . . 1.0 111.361 -177.222 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 3.9 pp -60.82 -27.77 68.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.233 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -72.64 -52.11 16.72 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.842 -0.617 . . . . 1.0 110.802 178.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.413 ' C ' ' H ' ' A' ' 161' ' ' GLY . 0.0 OUTLIER -80.56 -3.49 50.46 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.546 0.572 . . . . 1.0 112.546 -178.181 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -78.3 40.95 0.37 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.592 0.71 . . . . 1.0 111.39 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.413 ' H ' ' C ' ' A' ' 159' ' ' ARG . . . -76.18 178.98 48.61 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.662 -0.699 . . . . 1.0 111.887 177.064 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -82.87 23.92 0.78 Allowed 'Trans proline' 0 CA--C 1.517 -0.336 0 C-N-CA 123.144 2.563 . . . . 1.0 112.825 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 53.6 m . . . . . 0 C--N 1.304 -1.412 0 CA-C-N 114.738 -1.119 . . . . 1.0 110.631 -179.525 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.683 0 N-CA-C 112.117 -0.393 . . . . 1.0 112.117 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt 69.83 32.68 3.1 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.642 0.735 . . . . 1.0 110.467 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.3 m -89.31 129.24 35.89 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.887 -1.051 . . . . 1.0 109.69 178.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.26 148.06 93.53 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.215 0.531 . . . . 1.0 110.723 178.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.563 ' HB2' ' HG2' ' A' ' 39' ' ' ARG . 25.3 Cg_endo -63.56 167.25 13.66 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 123.708 2.939 . . . . 1.0 115.253 -174.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.641 HD23 ' HZ3' ' A' ' 152' ' ' TRP . 0.4 OUTLIER -74.3 -173.35 1.67 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 113.487 -1.688 . . . . 1.0 110.024 178.273 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.63 ' HB3' ' H ' ' A' ' 84' ' ' ASP . 3.0 t-160 -156.48 92.14 1.29 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.578 -0.449 . . . . 1.0 110.878 -178.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.743 HG13 HD12 ' A' ' 85' ' ' LEU . 2.9 t -96.1 111.11 25.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.351 -0.611 . . . . 1.0 109.351 177.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.524 ' CG2' ' HG ' ' A' ' 86' ' ' LEU . 9.2 t -112.17 113.88 26.38 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.221 0.534 . . . . 1.0 110.291 179.152 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.566 ' CE2' ' HA ' ' A' ' 22' ' ' GLU . 1.0 OUTLIER -83.43 125.3 31.56 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 122.004 -0.435 . . . . 1.0 110.289 -178.564 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.529 HG23 HD11 ' A' ' 97' ' ' LEU . 37.6 t -112.18 111.12 34.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.802 -0.635 . . . . 1.0 112.161 -176.357 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.576 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 48.3 t -135.73 160.0 39.89 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.043 -1.095 . . . . 1.0 108.043 176.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -64.21 -32.23 73.73 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.334 0.588 . . . . 1.0 109.79 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.562 ' C ' ' H ' ' A' ' 15' ' ' ILE . . . -111.27 84.66 0.37 Allowed Glycine 0 N--CA 1.436 -1.328 0 CA-C-N 115.149 -0.932 . . . . 1.0 110.868 174.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.568 ' ND2' ' HB3' ' A' ' 73' ' ' ALA . 10.5 p-10 -65.0 16.07 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.262 1.425 . . . . 1.0 112.105 178.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.562 ' H ' ' C ' ' A' ' 13' ' ' GLY . 6.9 pt -119.89 -3.34 9.42 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.045 177.447 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 9.2 m -115.13 -87.08 0.59 Allowed 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.679 -0.408 . . . . 1.0 112.041 -176.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.674 ' HG2' ' HG ' ' A' ' 89' ' ' LEU . 15.7 tpp180 -67.45 -50.43 59.24 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.352 -0.385 . . . . 1.0 112.014 -174.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.559 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 33.8 m -54.39 -59.05 11.24 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-N 116.321 -0.4 . . . . 1.0 111.882 -178.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.446 ' HG3' ' HA ' ' A' ' 15' ' ' ILE . 40.6 Cg_endo -63.89 -20.87 68.84 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 121.933 1.755 . . . . 1.0 113.029 -179.087 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.531 ' HB3' HD12 ' A' ' 142' ' ' ILE . 39.5 mmm -61.54 -55.51 30.2 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 110.056 -0.35 . . . . 1.0 110.056 177.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.415 ' HB2' HG23 ' A' ' 142' ' ' ILE . . . -72.24 -26.67 62.1 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 115.81 -0.632 . . . . 1.0 110.416 -179.008 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.76 ' O ' ' HB1' ' A' ' 26' ' ' ALA . 18.1 tt0 -50.7 -54.56 22.14 Favored 'General case' 0 C--O 1.216 -0.686 0 CA-C-N 114.776 -1.102 . . . . 1.0 109.811 179.096 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.726 ' HB3' ' HG2' ' A' ' 68' ' ' PRO . 0.0 OUTLIER -84.15 -26.3 28.97 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.443 -0.799 . . . . 1.0 110.729 -175.803 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.524 ' HB3' HD13 ' A' ' 146' ' ' LEU . 90.9 mtp -63.91 -75.52 0.08 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.644 0.609 . . . . 1.0 112.644 -176.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.722 ' HB3' HD23 ' A' ' 146' ' ' LEU . 18.2 p90 -76.99 -29.57 55.54 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 119.696 -0.801 . . . . 1.0 111.311 -175.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.76 ' HB1' ' O ' ' A' ' 22' ' ' GLU . . . -63.86 -37.0 85.75 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 119.2 -1.0 . . . . 1.0 110.562 179.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.685 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -63.84 -38.42 91.03 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 108.801 -0.814 . . . . 1.0 108.801 177.363 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.52 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 60.7 mt-30 -58.83 -43.84 90.79 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-O 121.149 0.499 . . . . 1.0 110.107 175.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.666 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 95.6 mt -54.84 -61.5 2.27 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.425 -0.807 . . . . 1.0 110.984 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.62 ' HD3' ' HA ' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -59.54 -35.73 74.77 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.763 -0.375 . . . . 1.0 111.565 179.633 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 3.4 m170 -62.83 -27.96 69.68 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 111.934 0.346 . . . . 1.0 111.934 177.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.666 ' HG2' ' O ' ' A' ' 29' ' ' LEU . 4.7 ptm85 -97.13 -22.0 17.01 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 119.796 -0.762 . . . . 1.0 110.291 -179.105 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 112.34 36.16 1.66 Allowed Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.226 -0.897 . . . . 1.0 112.528 177.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.414 HD13 ' HD3' ' A' ' 32' ' ' ARG . 18.9 mt -131.74 7.48 4.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.158 0.504 . . . . 1.0 109.814 -179.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.56 -32.25 77.47 Favored Glycine 0 C--N 1.332 0.321 0 CA-C-N 115.831 -0.622 . . . . 1.0 113.03 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.638 ' HA ' ' NH1' ' A' ' 39' ' ' ARG . 3.2 m-20 -90.29 -15.41 31.28 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.935 0.398 . . . . 1.0 110.179 177.115 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -81.16 -22.7 38.77 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.61 -0.723 . . . . 1.0 110.916 178.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.527 HG11 ' HB3' ' A' ' 5' ' ' LEU . 8.7 t -133.7 123.35 45.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.675 0.274 . . . . 1.0 110.932 -178.456 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.638 ' NH1' ' HA ' ' A' ' 36' ' ' ASP . 24.2 mmt180 -96.92 98.0 9.74 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.157 0.503 . . . . 1.0 110.757 178.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.606 HG23 ' HB2' ' A' ' 26' ' ' ALA . 0.8 OUTLIER -92.25 120.89 42.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-O 122.209 1.005 . . . . 1.0 110.699 179.652 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.486 ' O ' ' HA ' ' A' ' 8' ' ' THR . 82.3 p -131.41 -175.24 3.64 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 113.466 -1.697 . . . . 1.0 110.082 -177.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.559 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 78.3 p -157.82 161.46 38.37 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.797 -0.361 . . . . 1.0 110.57 -178.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.635 ' HA ' ' O ' ' A' ' 74' ' ' ALA . . . -163.48 165.71 23.46 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.283 0.564 . . . . 1.0 111.522 -178.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.576 ' HA2' ' O ' ' A' ' 11' ' ' CYS . . . -126.01 134.07 8.51 Favored Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 115.284 -0.871 . . . . 1.0 111.415 178.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.479 HG21 HD12 ' A' ' 96' ' ' LEU . 26.9 p -71.57 -26.39 62.6 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.827 0.313 . . . . 1.0 111.433 -178.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -107.88 7.8 36.09 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.892 -0.671 . . . . 1.0 112.545 -177.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 43.34 39.8 2.3 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 113.569 0.951 . . . . 1.0 113.569 178.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -44.67 -76.2 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.443 0.639 . . . . 1.0 112.063 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 52.6 m-70 -107.01 44.46 1.06 Allowed 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.278 -0.873 . . . . 1.0 111.162 178.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.0 p -60.06 129.04 22.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.915 -0.584 . . . . 1.0 110.809 178.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.84 -13.42 66.0 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.899 -0.667 . . . . 1.0 112.26 -178.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -82.29 -162.48 0.56 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.009 0.433 . . . . 1.0 109.864 179.058 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 38.4 t -119.36 173.48 6.93 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.239 -0.652 . . . . 1.0 109.239 -179.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.73 135.55 47.06 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.821 0.343 . . . . 1.0 111.61 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.782 ' OD1' ' HG3' ' A' ' 57' ' ' ARG . 15.6 t0 -51.54 134.62 29.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.139 -0.937 . . . . 1.0 111.191 -179.046 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -48.31 -32.1 6.91 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.159 -0.928 . . . . 1.0 113.04 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.782 ' HG3' ' OD1' ' A' ' 55' ' ' ASP . 6.5 mtt180 -68.56 -50.71 49.76 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.254 0.55 . . . . 1.0 109.625 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.5 -32.19 71.98 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.006 -0.997 . . . . 1.0 110.405 -176.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.09 -45.45 94.68 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 109.433 -0.581 . . . . 1.0 109.433 176.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.25 -44.59 95.33 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.927 -0.654 . . . . 1.0 111.76 176.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.616 HG21 ' O ' ' A' ' 57' ' ' ARG . 64.5 t -57.05 -56.51 14.37 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 CA-C-O 121.279 0.561 . . . . 1.0 111.152 178.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.743 ' HB2' HG23 ' A' ' 69' ' ' THR . 88.4 mt -60.13 -52.46 65.25 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.087 -0.506 . . . . 1.0 111.398 -179.271 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -60.59 -28.61 68.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.687 -0.233 . . . . 1.0 110.897 -178.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.49 -34.12 77.22 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-O 121.106 0.479 . . . . 1.0 110.333 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -95.55 4.95 52.68 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.859 -0.61 . . . . 1.0 111.178 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.58 21.52 61.83 Favored Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 116.002 -0.544 . . . . 1.0 112.308 178.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -91.84 150.91 41.58 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.771 -0.214 . . . . 1.0 110.444 178.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.726 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 37.8 Cg_endo -68.41 155.68 68.32 Favored 'Trans proline' 0 CA--C 1.51 -0.687 0 C-N-CA 122.334 2.023 . . . . 1.0 110.162 176.289 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.743 HG23 ' HB2' ' A' ' 62' ' ' LEU . 56.6 p -134.79 7.3 3.49 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 119.778 -0.769 . . . . 1.0 111.709 -177.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.424 ' O ' ' HE2' ' A' ' 23' ' ' LYS . 12.8 t70 -74.49 132.52 41.96 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 108.791 -0.818 . . . . 1.0 108.791 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.44 ' HE1' ' OG ' ' A' ' 42' ' ' SER . 37.2 t60 -170.05 151.12 3.91 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.132 0.491 . . . . 1.0 110.585 -175.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.41 ' HD3' ' HA ' ' A' ' 72' ' ' ARG . 3.2 tpp85 -130.71 109.37 10.57 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 107.818 -1.178 . . . . 1.0 107.818 176.057 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.568 ' HB3' ' ND2' ' A' ' 14' ' ' ASN . . . -56.32 137.45 52.42 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.097 -0.956 . . . . 1.0 112.084 -176.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.635 ' O ' ' HA ' ' A' ' 43' ' ' ALA . . . -133.6 145.41 50.01 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.834 -0.621 . . . . 1.0 109.976 179.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -84.45 154.77 22.57 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.737 -0.468 . . . . 1.0 109.737 177.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.552 HG12 ' CD2' ' A' ' 97' ' ' LEU . 16.6 t -62.39 107.17 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.359 0.599 . . . . 1.0 110.528 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.446 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -115.67 -174.21 17.74 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 115.089 -0.96 . . . . 1.0 110.869 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 68.2 m -57.04 -43.23 81.76 Favored 'General case' 0 C--N 1.319 -0.75 0 O-C-N 123.681 0.283 . . . . 1.0 110.304 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -58.33 -31.26 67.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 1.0 111.536 178.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.558 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 80.2 m80 -79.5 -37.71 36.08 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.834 0.35 . . . . 1.0 110.251 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 41.4 mt -67.97 -19.11 64.92 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.783 -0.644 . . . . 1.0 110.782 177.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.44 -3.39 59.0 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.909 -0.587 . . . . 1.0 110.732 -178.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 6' ' ' HIS . . . -61.81 152.08 32.52 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.948 -0.569 . . . . 1.0 111.646 179.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.63 ' H ' ' HB3' ' A' ' 6' ' ' HIS . 11.4 t70 -79.79 -14.32 58.79 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.071 0.463 . . . . 1.0 109.872 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.743 HD12 HG13 ' A' ' 7' ' ' VAL . 0.3 OUTLIER -154.2 117.06 4.44 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 108.641 -0.874 . . . . 1.0 108.641 -176.818 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.593 ' HB3' HD12 ' A' ' 97' ' ' LEU . 5.3 mp -107.98 106.31 16.5 Favored 'General case' 0 N--CA 1.423 -1.805 0 CA-C-N 115.683 -0.689 . . . . 1.0 109.639 178.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.543 HG12 HD23 ' A' ' 110' ' ' LEU . 55.6 t -85.72 91.71 3.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.204 -0.907 . . . . 1.0 110.542 -176.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.7 149.69 29.63 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.332 -0.849 . . . . 1.0 110.85 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.674 ' HG ' ' HG2' ' A' ' 17' ' ' ARG . 3.7 mm? -106.3 1.18 25.68 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.851 -0.613 . . . . 1.0 109.754 178.157 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -154.0 146.98 24.48 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.464 -0.789 . . . . 1.0 110.519 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 11.4 ptt180 -60.58 -20.65 61.12 Favored 'General case' 0 C--N 1.33 -0.247 0 O-C-N 123.983 0.802 . . . . 1.0 110.946 177.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.717 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 78.9 m-20 -77.63 -47.82 18.36 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.19 -0.67 . . . . 1.0 109.19 178.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.728 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 8.8 m170 -61.26 -47.05 87.8 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 109.508 -0.552 . . . . 1.0 109.508 179.002 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.481 ' HA ' HG21 ' A' ' 107' ' ' VAL . . . -58.12 -42.37 85.62 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.1 -0.5 . . . . 1.0 110.732 179.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.687 ' O ' ' HG2' ' A' ' 99' ' ' GLN . 16.9 ttm180 -60.27 -45.29 93.8 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 115.636 -0.711 . . . . 1.0 111.47 178.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.754 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 50.1 mt -63.23 -49.99 72.01 Favored 'General case' 0 C--O 1.22 -0.475 0 O-C-N 123.52 0.513 . . . . 1.0 109.979 -175.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.728 ' HG ' ' O ' ' A' ' 93' ' ' HIS . 27.3 mt -53.49 -57.74 9.61 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.771 -0.649 . . . . 1.0 111.467 -178.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.553 ' HA ' ' HB ' ' A' ' 102' ' ' VAL . 6.6 ptt180 -60.42 -44.82 95.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.042 -0.526 . . . . 1.0 111.778 -176.385 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.687 ' HG2' ' O ' ' A' ' 95' ' ' ARG . 8.4 pt20 -67.71 -20.82 65.31 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.068 0.461 . . . . 1.0 110.608 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.754 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 8.2 mt -80.08 -8.32 59.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.967 -0.56 . . . . 1.0 111.814 179.403 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 147.5 -28.75 1.48 Allowed Glycine 0 C--N 1.331 0.303 0 C-N-CA 119.786 -1.197 . . . . 1.0 112.955 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.814 HG11 ' H ' ' A' ' 103' ' ' GLU . 2.1 t -73.84 -154.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 C-N-CA 123.036 0.535 . . . . 1.0 110.949 -178.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.814 ' H ' HG11 ' A' ' 102' ' ' VAL . 12.5 pt-20 -168.02 165.7 13.45 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.646 -0.872 . . . . 1.0 108.646 -179.092 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.786 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -65.59 -24.02 66.97 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.676 0.274 . . . . 1.0 111.664 -176.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.7 -36.62 74.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.418 0.628 . . . . 1.0 109.983 175.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.623 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 7.7 mtt-85 -94.92 -45.16 7.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.039 -0.982 . . . . 1.0 110.704 -177.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.786 HG12 ' HA ' ' A' ' 104' ' ' ALA . 7.3 p -79.94 122.6 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-O 121.415 0.626 . . . . 1.0 110.092 -177.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.539 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 7.8 mmm180 -138.12 146.31 42.68 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.079 -0.712 . . . . 1.0 109.079 -178.216 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.427 ' HE3' ' HB3' ' A' ' 109' ' ' MET . 86.5 mmm -79.22 134.95 36.66 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.024 -0.534 . . . . 1.0 110.378 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.543 HD23 HG12 ' A' ' 87' ' ' VAL . 3.2 tm? -56.97 -49.18 76.49 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.671 0.272 . . . . 1.0 111.108 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 16.6 ttm180 -69.52 -21.35 63.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.886 0.374 . . . . 1.0 110.53 -177.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 32.6 t -77.04 -6.04 51.16 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.424 -0.353 . . . . 1.0 111.138 -178.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.556 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 85.6 m-85 -87.44 -19.97 27.28 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.952 -0.388 . . . . 1.0 109.952 175.235 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.502 ' HB3' ' HB2' ' A' ' 117' ' ' SER . 61.7 t0 -65.33 118.56 51.45 Favored Pre-proline 0 C--O 1.233 0.19 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.198 -178.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -66.75 -16.73 51.11 Favored 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 122.357 2.038 . . . . 1.0 111.849 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 30.8 mmm-85 -92.91 -21.5 19.79 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.726 -0.67 . . . . 1.0 110.655 -178.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.502 ' HB2' ' HB3' ' A' ' 114' ' ' ASP . 7.2 t -75.59 58.73 1.08 Allowed 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.135 -0.484 . . . . 1.0 111.579 -177.076 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 62.15 -99.17 0.22 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.895 -0.669 . . . . 1.0 112.946 -178.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 91.1 m -158.32 -36.16 0.07 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.503 0.668 . . . . 1.0 110.1 -178.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 26.4 m80 -133.32 134.57 44.0 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.486 178.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -132.24 95.42 3.65 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.087 -0.708 . . . . 1.0 109.087 177.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -94.41 24.05 4.78 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.222 -177.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -171.14 135.35 0.98 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.029 -0.532 . . . . 1.0 109.718 -178.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.557 ' HB ' ' O ' ' A' ' 89' ' ' LEU . 42.2 t -121.75 152.32 25.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.104 0.478 . . . . 1.0 109.964 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.527 ' HG3' ' NH2' ' A' ' 17' ' ' ARG . 4.2 pt-20 -63.94 179.63 0.5 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.265 -0.88 . . . . 1.0 112.854 -178.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -152.75 115.11 2.81 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 114.586 -1.188 . . . . 1.0 109.274 -179.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.624 ' HG3' HG23 ' A' ' 138' ' ' VAL . 73.6 Cg_endo -79.02 92.14 1.16 Allowed 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.389 2.059 . . . . 1.0 112.89 -177.264 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -92.52 -28.37 16.83 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 113.862 1.06 . . . . 1.0 113.862 179.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -69.24 -35.31 75.99 Favored 'General case' 0 CA--C 1.512 -0.514 0 C-N-CA 119.189 -1.004 . . . . 1.0 112.803 -173.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 77.2 52.82 5.47 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 118.887 -1.625 . . . . 1.0 112.589 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.576 ' H ' ' HB3' ' A' ' 134' ' ' ASP . 3.2 t0 -108.65 172.44 6.84 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 107.781 -1.192 . . . . 1.0 107.781 177.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -66.12 -39.19 89.73 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 108.693 -0.854 . . . . 1.0 108.693 176.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 10.7 m -63.44 -49.73 72.57 Favored 'General case' 0 C--O 1.222 -0.365 0 CA-C-N 115.1 -0.955 . . . . 1.0 109.382 177.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.576 ' HB3' ' H ' ' A' ' 131' ' ' ASP . 38.8 t70 -51.67 -37.14 49.25 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.192 -0.913 . . . . 1.0 111.833 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.482 ' CE1' ' HD3' ' A' ' 57' ' ' ARG . 15.3 m-30 -72.69 -52.6 14.59 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.497 0.665 . . . . 1.0 110.694 -178.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -71.38 -22.85 61.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.5 -0.773 . . . . 1.0 111.307 -176.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.597 ' O ' HG21 ' A' ' 141' ' ' VAL . 7.9 tp10 -61.22 -47.66 85.06 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 108.7 -0.852 . . . . 1.0 108.7 176.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.628 HG13 ' HD3' ' A' ' 17' ' ' ARG . 75.6 t -56.7 -47.54 82.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 114.419 -1.264 . . . . 1.0 110.084 176.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.49 ' HB2' HG12 ' A' ' 61' ' ' VAL . 52.7 t80 -55.58 -44.56 77.03 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.616 -1.174 . . . . 1.0 110.5 178.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.418 ' O ' ' HG2' ' A' ' 143' ' ' GLU . . . -62.83 -44.69 95.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.991 -0.55 . . . . 1.0 111.518 -179.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.597 HG21 ' O ' ' A' ' 137' ' ' GLU . 21.2 t -56.28 -48.03 80.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.338 0.59 . . . . 1.0 110.584 178.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.531 HD12 ' HB3' ' A' ' 20' ' ' MET . 5.8 mt -67.11 -49.56 71.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 115.413 -0.812 . . . . 1.0 112.127 -178.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.466 ' HA ' ' HG ' ' A' ' 146' ' ' LEU . 11.2 pt-20 -56.19 -32.7 64.61 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.98 0.419 . . . . 1.0 110.451 179.359 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 63.3 m -73.06 -27.4 61.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.902 -0.59 . . . . 1.0 110.612 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.479 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -86.44 -25.09 25.41 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 115.67 -0.696 . . . . 1.0 111.92 178.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.722 HD23 ' HB3' ' A' ' 25' ' ' PHE . 14.9 mt -55.49 -36.69 48.58 Favored Pre-proline 0 CA--C 1.546 0.814 0 N-CA-C 112.745 0.646 . . . . 1.0 112.745 -178.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.621 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 42.1 Cg_endo -68.58 -14.91 40.65 Favored 'Trans proline' 0 C--N 1.359 1.106 0 C-N-CA 122.317 2.011 . . . . 1.0 111.661 176.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.556 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -101.97 -34.12 4.42 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.133 -0.94 . . . . 1.0 110.941 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.488 HD13 HG23 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -72.49 -40.0 67.22 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.18 -1.044 . . . . 1.0 108.18 179.334 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.482 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 0.2 OUTLIER -54.54 -54.28 43.33 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 114.648 -1.16 . . . . 1.0 110.541 175.427 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -57.27 -42.32 81.38 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.125 -0.943 . . . . 1.0 111.445 -175.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . 0.641 ' HZ3' HD23 ' A' ' 5' ' ' LEU . 18.0 t90 -62.27 -57.91 9.67 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.415 -0.811 . . . . 1.0 110.084 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.514 ' HB ' HD22 ' A' ' 5' ' ' LEU . 7.8 m -60.65 -43.82 95.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.675 -177.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.407 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 8.7 m-20 -60.87 -49.55 77.01 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 121.208 0.527 . . . . 1.0 111.015 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.422 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 5.4 pt-20 -64.85 -36.26 83.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.977 -0.556 . . . . 1.0 110.656 -178.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.522 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 0.6 OUTLIER -74.13 -43.41 57.61 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 115.769 -0.65 . . . . 1.0 110.869 -176.985 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 4.2 pp -66.31 -22.18 66.28 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.124 0.487 . . . . 1.0 109.748 178.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -72.08 -51.37 21.9 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.847 -0.615 . . . . 1.0 109.559 175.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.7 3.34 11.9 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.974 0.416 . . . . 1.0 111.569 178.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -78.51 -1.94 36.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.373 0.606 . . . . 1.0 109.935 176.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -97.57 143.05 16.49 Favored Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.388 -0.824 . . . . 1.0 111.57 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -85.57 29.5 0.53 Allowed 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 123.516 2.811 . . . . 1.0 112.65 -178.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 9.4 t . . . . . 0 C--N 1.3 -1.548 0 CA-C-N 114.613 -1.176 . . . . 1.0 109.709 -179.506 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.801 0 N-CA-C 112.391 -0.284 . . . . 1.0 112.391 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ptt? -160.42 173.71 15.2 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.705 -0.48 . . . . 1.0 109.705 -179.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.1 m -84.48 -62.48 1.54 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.273 0.558 . . . . 1.0 110.016 178.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -157.0 160.47 30.66 Favored Pre-proline 0 C--O 1.236 0.381 0 CA-C-N 115.071 -0.968 . . . . 1.0 108.404 -179.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -69.96 170.04 17.76 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.649 2.232 . . . . 1.0 111.842 176.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.787 HD13 ' HB3' ' A' ' 84' ' ' ASP . 0.2 OUTLIER -67.02 178.46 1.4 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.456 -0.572 . . . . 1.0 109.456 178.101 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.662 ' HA ' ' O ' ' A' ' 39' ' ' ARG . 2.7 t-160 -156.06 89.48 1.15 Allowed 'General case' 0 C--N 1.321 -0.651 0 O-C-N 122.053 -0.404 . . . . 1.0 109.989 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.714 HG12 HD11 ' A' ' 85' ' ' LEU . 2.1 t -96.51 105.57 17.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.366 -0.379 . . . . 1.0 110.134 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.632 ' CG2' ' HG ' ' A' ' 86' ' ' LEU . 13.0 t -108.65 115.44 30.09 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.079 0.466 . . . . 1.0 110.199 -179.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.568 ' HD1' ' HB ' ' A' ' 87' ' ' VAL . 0.7 OUTLIER -83.74 129.89 34.95 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.793 -0.447 . . . . 1.0 109.793 -178.952 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.71 HG21 HD12 ' A' ' 97' ' ' LEU . 22.0 t -114.38 113.01 42.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.737 -0.665 . . . . 1.0 111.945 -174.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.504 ' HA ' ' CE1' ' A' ' 93' ' ' HIS . 49.2 t -142.78 155.26 44.81 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.359 -0.608 . . . . 1.0 109.359 178.048 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.1 88.66 2.44 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.393 0.616 . . . . 1.0 111.157 -178.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.754 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 140.59 -45.74 0.96 Allowed Glycine 0 N--CA 1.445 -0.754 0 CA-C-N 115.313 -0.858 . . . . 1.0 111.062 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.621 ' ND2' ' H ' ' A' ' 74' ' ' ALA . 61.0 t30 58.63 23.86 11.43 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.674 0.75 . . . . 1.0 112.202 178.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.4 pt -124.51 3.88 4.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 O-C-N 121.616 -0.678 . . . . 1.0 111.494 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.681 ' O ' ' HG3' ' A' ' 20' ' ' MET . 27.9 m -129.4 -84.19 0.56 Allowed 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.597 -0.441 . . . . 1.0 111.064 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.426 HH21 ' CG ' ' A' ' 126' ' ' ASP . 1.5 mpt_? -61.56 -58.83 6.58 Favored 'General case' 0 C--O 1.243 0.728 0 CA-C-N 116.211 -0.449 . . . . 1.0 111.939 -175.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.0 m -51.49 -58.58 10.32 Favored Pre-proline 0 CA--C 1.54 0.587 0 N-CA-C 112.982 0.734 . . . . 1.0 112.982 -178.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -63.67 -23.57 69.77 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 121.636 1.557 . . . . 1.0 112.495 -177.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.681 ' HG3' ' O ' ' A' ' 16' ' ' CYS . 61.2 mtp -61.98 -51.65 67.21 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.674 -0.41 . . . . 1.0 110.349 179.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.443 ' HA ' ' HB2' ' A' ' 24' ' ' MET . . . -71.58 -29.42 64.69 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.15 -0.62 . . . . 1.0 110.672 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.751 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 22.1 tt0 -53.17 -53.25 53.26 Favored 'General case' 0 C--O 1.219 -0.514 0 O-C-N 124.166 0.916 . . . . 1.0 110.171 -179.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.726 ' O ' ' HB3' ' A' ' 27' ' ' GLN . 0.3 OUTLIER -84.8 -23.11 29.28 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.031 -0.986 . . . . 1.0 110.364 -175.493 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.63 ' HE1' ' HB3' ' A' ' 143' ' ' GLU . 2.2 mmm -65.22 -76.35 0.07 Allowed 'General case' 0 C--O 1.238 0.477 0 N-CA-C 113.076 0.769 . . . . 1.0 113.076 -179.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.757 ' HB3' HD21 ' A' ' 146' ' ' LEU . 18.0 p90 -76.37 -29.38 57.13 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 119.852 -0.739 . . . . 1.0 111.243 -174.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.751 ' HB3' ' O ' ' A' ' 22' ' ' GLU . . . -64.38 -35.73 81.85 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 119.577 -0.849 . . . . 1.0 110.818 178.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.726 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -63.99 -38.82 92.46 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.63 -0.878 . . . . 1.0 108.63 177.175 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.573 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 71.1 mt-30 -61.04 -41.71 97.09 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 115.285 -0.87 . . . . 1.0 110.638 175.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 25' ' ' PHE . 90.1 mt -57.07 -62.01 2.05 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 115.956 -0.566 . . . . 1.0 111.172 -179.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.652 ' HE ' ' HA ' ' A' ' 27' ' ' GLN . 0.1 OUTLIER -58.06 -32.55 68.12 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 120.468 -0.493 . . . . 1.0 111.325 179.582 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -64.11 -28.07 69.52 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.15 0.426 . . . . 1.0 112.15 176.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.58 ' HG3' ' HG ' ' A' ' 34' ' ' LEU . 7.3 ptp180 -95.4 -20.54 19.01 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 121.843 0.83 . . . . 1.0 109.625 178.042 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 108.77 31.93 3.26 Favored Glycine 0 N--CA 1.441 -0.972 0 CA-C-N 114.833 -1.076 . . . . 1.0 112.101 176.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.58 ' HG ' ' HG3' ' A' ' 32' ' ' ARG . 22.7 mt -119.54 0.5 11.03 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 122.434 -0.451 . . . . 1.0 109.959 -178.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -53.9 -32.13 48.11 Favored Glycine 0 C--N 1.331 0.295 0 CA-C-N 115.943 -0.572 . . . . 1.0 113.137 -179.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.763 ' HA ' ' NH1' ' A' ' 39' ' ' ARG . 0.1 OUTLIER -89.52 -20.63 23.59 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-O 121.273 0.559 . . . . 1.0 110.312 178.66 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.89 -25.09 40.73 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.568 -0.742 . . . . 1.0 111.127 -177.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.713 HG22 ' HB3' ' A' ' 5' ' ' LEU . 0.5 OUTLIER -141.16 124.77 16.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.219 0.533 . . . . 1.0 110.826 179.707 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.763 ' NH1' ' HA ' ' A' ' 36' ' ' ASP . 24.6 mmt180 -95.5 106.5 18.58 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.57 -0.741 . . . . 1.0 111.262 -178.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.68 HG12 ' HB1' ' A' ' 26' ' ' ALA . 1.5 m -90.49 137.64 21.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-N 115.884 -0.598 . . . . 1.0 109.396 178.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.513 ' O ' ' HA ' ' A' ' 8' ' ' THR . 24.6 p -146.25 -178.07 5.95 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.063 -0.971 . . . . 1.0 110.009 -175.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.3 p -158.01 157.18 32.49 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.296 -0.562 . . . . 1.0 110.866 -177.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.604 ' HB3' ' CD2' ' A' ' 80' ' ' HIS . . . -163.23 164.51 25.03 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 121.475 0.655 . . . . 1.0 111.64 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' A' ' 11' ' ' CYS . . . -122.63 133.92 9.4 Favored Glycine 0 N--CA 1.441 -0.984 0 CA-C-N 115.06 -0.973 . . . . 1.0 111.046 177.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.52 HG23 ' CG1' ' A' ' 10' ' ' VAL . 12.3 p -69.68 -23.47 63.45 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.834 0.349 . . . . 1.0 111.762 -177.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.432 ' HA3' ' CZ3' ' A' ' 48' ' ' TRP . . . -109.84 8.48 31.79 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.723 -0.751 . . . . 1.0 113.239 -178.315 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 42.11 38.68 1.16 Allowed 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 113.551 0.945 . . . . 1.0 113.551 178.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.754 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 1.2 m-90 -46.9 -74.29 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.347 0.594 . . . . 1.0 112.278 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.445 ' O ' ' HB1' ' A' ' 73' ' ' ALA . 46.5 m-70 -107.07 42.45 1.3 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.314 -0.857 . . . . 1.0 111.349 -179.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.452 HG22 ' HA ' ' A' ' 74' ' ' ALA . 14.6 p -61.58 132.02 26.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.215 178.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.35 -14.53 63.52 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.921 -0.657 . . . . 1.0 112.186 -177.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.49 -158.84 0.28 Allowed 'General case' 0 C--O 1.236 0.391 0 CA-C-O 120.986 0.422 . . . . 1.0 109.959 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.3 t -133.55 173.36 11.59 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.494 -0.558 . . . . 1.0 109.494 -178.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.454 ' HB2' ' HZ3' ' A' ' 23' ' ' LYS . . . -56.67 148.15 20.82 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.015 -0.539 . . . . 1.0 111.507 -178.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.428 ' OD1' ' HG2' ' A' ' 57' ' ' ARG . 15.6 t70 -68.41 145.8 53.79 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.371 -0.831 . . . . 1.0 111.417 -178.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.414 ' HG3' ' N ' ' A' ' 57' ' ' ARG . 6.4 pt-20 -47.58 -37.74 12.97 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.953 -1.021 . . . . 1.0 113.224 178.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.592 ' O ' HG22 ' A' ' 61' ' ' VAL . 19.9 ptp180 -70.68 -44.43 67.02 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 121.136 -0.226 . . . . 1.0 110.777 -176.071 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.15 -30.86 68.13 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.689 -0.486 . . . . 1.0 109.689 -179.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.46 -46.75 84.8 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.635 -0.711 . . . . 1.0 109.504 176.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.439 ' O ' ' HG2' ' A' ' 63' ' ' ARG . . . -62.72 -41.98 99.76 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.843 -0.694 . . . . 1.0 111.927 178.249 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.592 HG22 ' O ' ' A' ' 57' ' ' ARG . 97.5 t -58.23 -59.35 3.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.429 0.633 . . . . 1.0 111.622 178.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.463 ' HB2' HG23 ' A' ' 69' ' ' THR . 10.0 mp -61.72 -48.05 82.51 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.754 -0.657 . . . . 1.0 111.048 -177.155 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.439 ' HG2' ' O ' ' A' ' 60' ' ' GLY . 22.1 ptt180 -58.74 -31.44 68.32 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.611 -0.268 . . . . 1.0 110.888 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.65 -34.24 76.55 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.223 0.535 . . . . 1.0 110.826 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.457 ' HD2' ' O ' ' A' ' 61' ' ' VAL . 90.1 m-70 -96.91 5.55 50.3 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.587 -0.733 . . . . 1.0 110.866 -178.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.85 17.38 63.53 Favored Glycine 0 C--N 1.33 0.236 0 CA-C-N 115.7 -0.682 . . . . 1.0 113.165 176.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.535 ' HD1' ' HG2' ' A' ' 27' ' ' GLN . 71.1 m-85 -88.68 154.89 50.78 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-O 120.501 0.191 . . . . 1.0 110.827 179.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.563 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 21.9 Cg_endo -67.46 151.81 79.54 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.354 2.036 . . . . 1.0 110.123 174.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.463 HG23 ' HB2' ' A' ' 62' ' ' LEU . 67.1 p -132.68 20.15 4.24 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 120.271 -0.572 . . . . 1.0 112.181 -175.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.559 ' C ' ' HZ1' ' A' ' 23' ' ' LYS . 31.3 t70 -113.8 128.2 56.31 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.965 -177.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.573 ' HB3' ' NZ ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -165.76 159.44 16.19 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.429 -0.805 . . . . 1.0 108.923 178.838 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -116.35 120.15 37.94 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.627 -0.879 . . . . 1.0 108.627 178.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.445 ' HB1' ' O ' ' A' ' 49' ' ' HIS . . . -61.03 136.89 58.22 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.833 0.349 . . . . 1.0 111.77 -178.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.621 ' H ' ' ND2' ' A' ' 14' ' ' ASN . . . -127.63 163.54 24.0 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.07 178.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -98.91 157.26 16.43 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.476 -0.935 . . . . 1.0 108.476 178.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.512 HG13 HD21 ' A' ' 97' ' ' LEU . 41.9 t -71.71 111.98 6.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.159 0.504 . . . . 1.0 110.271 179.229 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.45 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -124.43 -165.21 12.13 Favored Glycine 0 N--CA 1.437 -1.275 0 CA-C-N 115.497 -0.774 . . . . 1.0 111.324 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 83.5 m -56.17 -51.2 68.88 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 122.651 0.381 . . . . 1.0 111.877 -179.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.546 ' HG2' ' N ' ' A' ' 80' ' ' HIS . 0.7 OUTLIER -58.15 -29.76 65.83 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.844 -0.616 . . . . 1.0 110.704 -178.589 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.604 ' CD2' ' HB3' ' A' ' 43' ' ' ALA . 79.3 m80 -76.82 -41.61 43.63 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 115.793 -0.64 . . . . 1.0 110.349 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.645 ' O ' HG23 ' A' ' 102' ' ' VAL . 16.6 mt -68.83 -18.67 64.2 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.442 176.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.06 -5.51 59.2 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.185 -178.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.589 ' HB2' ' O ' ' A' ' 6' ' ' HIS . . . -61.34 153.23 27.27 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.534 -0.757 . . . . 1.0 110.764 179.084 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.787 ' HB3' HD13 ' A' ' 5' ' ' LEU . 12.2 t70 -82.46 -11.93 58.18 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.242 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.714 HD11 HG12 ' A' ' 7' ' ' VAL . 0.3 OUTLIER -156.61 114.19 3.2 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 109.283 -0.636 . . . . 1.0 109.283 -178.224 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.632 ' HG ' ' CG2' ' A' ' 8' ' ' THR . 5.1 mp -105.74 106.33 16.78 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 115.407 -0.815 . . . . 1.0 110.069 178.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.589 HG11 HD21 ' A' ' 110' ' ' LEU . 52.6 t -84.79 93.43 3.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 114.772 -1.104 . . . . 1.0 110.856 -176.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.54 143.98 34.34 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.193 -0.912 . . . . 1.0 110.562 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.553 ' O ' ' HB ' ' A' ' 124' ' ' VAL . 4.3 mm? -93.39 -19.24 21.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.494 0.664 . . . . 1.0 109.848 178.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -139.86 154.91 47.42 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.443 -0.799 . . . . 1.0 110.311 -178.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.589 ' HB3' ' O ' ' A' ' 122' ' ' LEU . 5.2 ptm180 -58.67 -22.32 56.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.889 -0.596 . . . . 1.0 111.619 178.08 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.635 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 94.5 m-20 -75.41 -52.08 11.59 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.861 -0.609 . . . . 1.0 110.278 -178.194 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.66 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 17.5 m170 -55.92 -45.24 78.77 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.38 -0.827 . . . . 1.0 110.814 -179.23 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.425 ' HA ' HD11 ' A' ' 97' ' ' LEU . . . -59.86 -44.07 94.33 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.107 0.48 . . . . 1.0 110.463 178.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 13.6 ttm180 -58.99 -42.65 90.54 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.317 -0.856 . . . . 1.0 111.522 178.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.666 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 34.9 mt -66.32 -47.16 74.43 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.599 -177.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.71 HD12 HG21 ' A' ' 10' ' ' VAL . 33.1 mt -53.14 -59.84 4.05 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.189 -0.459 . . . . 1.0 111.725 -177.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.673 ' CA ' HG13 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -58.46 -44.25 89.2 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.406 0.521 . . . . 1.0 112.406 -179.66 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.588 ' HG3' ' O ' ' A' ' 96' ' ' LEU . 1.0 OUTLIER -67.25 -24.74 65.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.115 0.483 . . . . 1.0 109.814 179.599 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.666 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 12.5 mt -80.82 -19.46 44.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.456 -0.793 . . . . 1.0 111.896 178.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 152.71 -22.84 0.82 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 119.37 -1.395 . . . . 1.0 114.314 -177.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.673 HG13 ' CA ' ' A' ' 98' ' ' ARG . 0.3 OUTLIER -76.05 -161.92 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-N 117.988 0.894 . . . . 1.0 110.502 -179.096 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.802 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 8.6 pt-20 -158.06 160.27 37.21 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 107.671 -1.233 . . . . 1.0 107.671 -177.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.783 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -60.86 -27.08 67.86 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 123.194 0.309 . . . . 1.0 111.183 -175.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.424 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . . . -57.4 -35.38 69.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.101 0.477 . . . . 1.0 110.706 176.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.802 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 9.4 mtt-85 -99.51 -39.68 8.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.508 -0.769 . . . . 1.0 111.551 -177.15 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.783 HG12 ' HA ' ' A' ' 104' ' ' ALA . 9.3 p -80.06 122.25 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 120.661 -0.416 . . . . 1.0 110.85 -174.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.49 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 14.3 mmm180 -141.56 150.54 42.22 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 121.846 -0.534 . . . . 1.0 111.057 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.628 ' HE3' HG21 ' A' ' 124' ' ' VAL . 85.7 mmm -80.92 140.0 35.55 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.726 -0.67 . . . . 1.0 110.525 178.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.589 HD21 HG11 ' A' ' 87' ' ' VAL . 3.0 tm? -58.31 -49.73 76.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.588 0.232 . . . . 1.0 111.245 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 47.7 ttt180 -72.03 -15.7 62.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.714 0.292 . . . . 1.0 111.031 -177.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.4 t -72.46 -10.62 60.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.659 -0.246 . . . . 1.0 110.636 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.518 ' HZ ' HD23 ' A' ' 85' ' ' LEU . 95.8 m-85 -89.39 -20.1 24.38 Favored 'General case' 0 C--O 1.233 0.203 0 O-C-N 122.224 -0.297 . . . . 1.0 110.826 177.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -59.29 119.81 42.4 Favored Pre-proline 0 N--CA 1.466 0.325 0 CA-C-N 115.969 -0.559 . . . . 1.0 111.554 -177.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.74 -22.12 43.87 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.466 2.111 . . . . 1.0 111.869 179.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 27.3 mtm180 -86.65 -15.5 39.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.253 -0.43 . . . . 1.0 111.49 -179.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.0 m -68.97 93.34 0.56 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.88 0.371 . . . . 1.0 111.184 -178.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -52.23 -54.64 25.58 Favored Glycine 0 CA--C 1.52 0.383 0 CA-C-N 115.17 -0.923 . . . . 1.0 113.338 178.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.522 HG21 ' H ' ' A' ' 120' ' ' HIS . 0.7 OUTLIER -86.07 171.31 11.48 Favored 'General case' 0 C--N 1.32 -0.682 0 O-C-N 122.596 -0.356 . . . . 1.0 110.634 -179.548 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.522 ' H ' HG21 ' A' ' 119' ' ' THR . 36.6 m170 -75.86 133.62 40.54 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.817 -0.438 . . . . 1.0 109.817 177.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -103.19 87.11 2.81 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.066 -0.515 . . . . 1.0 110.933 179.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.589 ' O ' ' HB3' ' A' ' 91' ' ' ARG . 2.4 mm? -95.26 15.61 18.82 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.239 -1.022 . . . . 1.0 108.239 175.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.47 ' CA ' ' HE1' ' A' ' 109' ' ' MET . 19.0 t70 -167.76 133.43 1.98 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.358 -1.292 . . . . 1.0 108.182 -177.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.628 HG21 ' HE3' ' A' ' 109' ' ' MET . 40.1 t -109.7 156.15 10.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.843 -0.428 . . . . 1.0 109.843 -177.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -74.05 168.52 19.37 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.859 -0.422 . . . . 1.0 109.859 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.426 ' CG ' HH21 ' A' ' 17' ' ' ARG . 15.9 t70 -156.94 96.41 2.14 Favored Pre-proline 0 C--N 1.319 -0.751 0 N-CA-C 108.387 -0.968 . . . . 1.0 108.387 -175.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.697 ' HB2' ' OD1' ' A' ' 134' ' ' ASP . 31.2 Cg_exo -61.88 90.39 0.11 Allowed 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.381 2.054 . . . . 1.0 113.035 -178.234 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -94.25 41.47 1.09 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.18 0.514 . . . . 1.0 111.672 177.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.606 ' CE2' ' HB3' ' A' ' 127' ' ' PRO . 0.0 OUTLIER -111.95 -32.6 6.54 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.8 -0.815 . . . . 1.0 108.8 -179.446 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 68.86 55.92 10.23 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.06 -0.973 . . . . 1.0 113.244 177.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.614 ' H ' ' HB3' ' A' ' 134' ' ' ASP . 44.9 m-20 -124.2 178.5 5.31 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.107 -1.071 . . . . 1.0 108.107 178.247 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 12.0 t-160 -58.77 -36.3 74.16 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.29 -0.633 . . . . 1.0 109.29 179.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.5 p -61.55 -37.58 84.32 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.005 -0.998 . . . . 1.0 111.226 177.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.697 ' OD1' ' HB2' ' A' ' 127' ' ' PRO . 0.4 OUTLIER -60.31 -44.41 95.46 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 116.058 -0.519 . . . . 1.0 111.352 -177.577 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.524 ' CD1' ' HB2' ' A' ' 57' ' ' ARG . 0.5 OUTLIER -70.87 -48.96 50.98 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.135 0.493 . . . . 1.0 110.391 -175.516 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -70.45 -25.36 63.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.739 -0.664 . . . . 1.0 111.176 -177.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -63.76 -51.07 66.52 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.108 0.48 . . . . 1.0 109.823 177.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.838 ' HA ' HG11 ' A' ' 141' ' ' VAL . 21.3 t -63.11 -41.13 91.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.749 0.785 . . . . 1.0 109.335 177.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.456 ' HB2' HG12 ' A' ' 61' ' ' VAL . 66.8 t80 -56.31 -43.22 78.75 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.566 -0.743 . . . . 1.0 109.727 177.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.502 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -66.92 -49.88 64.16 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.389 -0.823 . . . . 1.0 111.871 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.838 HG11 ' HA ' ' A' ' 138' ' ' VAL . 5.6 p -57.2 -43.19 81.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 CA-C-O 121.565 0.698 . . . . 1.0 110.671 -178.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.577 HD11 HG12 ' A' ' 138' ' ' VAL . 16.4 mt -68.46 -53.83 25.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 115.031 -0.986 . . . . 1.0 111.934 178.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.63 ' HB3' ' HE1' ' A' ' 24' ' ' MET . 8.3 pt-20 -57.56 -28.43 63.54 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.513 -0.312 . . . . 1.0 110.372 -179.016 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 3.1 t -73.78 -30.04 62.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.085 0.469 . . . . 1.0 110.265 177.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.474 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -86.57 -23.37 25.83 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 116.187 -0.461 . . . . 1.0 111.904 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.757 HD21 ' HB3' ' A' ' 25' ' ' PHE . 17.5 mt -54.9 -37.56 57.51 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 112.146 0.424 . . . . 1.0 112.146 -178.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.604 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 56.1 Cg_endo -69.58 -9.19 25.53 Favored 'Trans proline' 0 C--N 1.364 1.366 0 C-N-CA 122.413 2.076 . . . . 1.0 112.35 177.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.515 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -106.09 -33.27 3.51 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 110.257 -1.137 . . . . 1.0 110.257 178.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.461 ' O ' HG13 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -73.4 -41.66 63.05 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.814 -0.81 . . . . 1.0 108.814 178.934 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.433 ' O ' ' HB2' ' A' ' 154' ' ' ASP . 2.1 m-70 -54.56 -50.88 66.9 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.134 -0.939 . . . . 1.0 110.628 177.067 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -60.98 -46.28 91.39 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.493 -0.776 . . . . 1.0 111.389 -176.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . 0.758 ' HZ3' HD12 ' A' ' 5' ' ' LEU . 21.1 t90 -59.45 -55.5 33.88 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.164 -0.925 . . . . 1.0 111.033 -177.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.509 HG12 HG22 ' A' ' 7' ' ' VAL . 6.1 m -61.88 -40.15 86.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.44 -177.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.556 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 1.1 t70 -60.03 -56.23 24.19 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 121.562 0.696 . . . . 1.0 110.574 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.615 ' O ' ' HG3' ' A' ' 159' ' ' ARG . 6.2 pt-20 -63.25 -35.66 81.09 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.894 -1.048 . . . . 1.0 110.922 -176.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 19.5 mmt-85 -72.17 -45.74 59.22 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.743 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.556 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 4.0 pp -65.77 -24.21 66.89 Favored 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 109.417 -0.586 . . . . 1.0 109.417 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -74.99 -52.89 9.98 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.233 -0.894 . . . . 1.0 111.002 178.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.615 ' HG3' ' O ' ' A' ' 155' ' ' GLU . 0.0 OUTLIER -79.38 -9.39 59.58 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 113.273 0.842 . . . . 1.0 113.273 -175.951 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . 0.42 ' HA ' HH11 ' A' ' 159' ' ' ARG . 64.9 t30 -63.02 -48.16 79.93 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.65 -0.42 . . . . 1.0 110.883 -177.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 71.49 -159.88 53.93 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.49 -0.862 . . . . 1.0 112.79 177.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -94.06 29.25 0.27 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 123.718 2.945 . . . . 1.0 112.949 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 1.7 t . . . . . 0 C--N 1.306 -1.325 0 CA-C-N 114.936 -1.029 . . . . 1.0 110.268 179.279 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.615 0 N-CA-C 111.945 -0.462 . . . . 1.0 111.945 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.9 mtt -100.42 -166.22 1.3 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 110.179 -0.304 . . . . 1.0 110.179 179.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 75.5 m -154.99 169.49 23.95 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 110.425 -0.213 . . . . 1.0 110.425 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.604 ' HB3' ' HD2' ' A' ' 4' ' ' PRO . 0.6 OUTLIER -67.97 162.41 59.4 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.404 179.397 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.695 ' HG3' ' HE ' ' A' ' 39' ' ' ARG . 49.0 Cg_endo -72.07 171.11 17.41 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 123.05 2.5 . . . . 1.0 113.541 -179.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.794 HD21 ' HZ3' ' A' ' 152' ' ' TRP . 0.6 OUTLIER -75.65 -172.58 1.91 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.155 -0.93 . . . . 1.0 110.662 178.219 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.509 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 0.1 OUTLIER -157.11 92.8 1.28 Allowed 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 121.107 -0.237 . . . . 1.0 111.136 179.641 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.643 HG13 HD13 ' A' ' 85' ' ' LEU . 1.9 t -97.12 115.3 36.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 108.802 -0.814 . . . . 1.0 108.802 176.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.602 ' CG2' ' HG ' ' A' ' 86' ' ' LEU . 7.2 t -116.28 117.58 30.39 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 120.821 0.343 . . . . 1.0 110.239 178.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.603 ' HD2' ' HB3' ' A' ' 42' ' ' SER . 2.0 m-85 -85.52 133.89 34.06 Favored 'General case' 0 CA--C 1.518 -0.276 0 O-C-N 121.974 -0.454 . . . . 1.0 110.883 -179.08 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.659 HG21 HD13 ' A' ' 97' ' ' LEU . 28.8 t -118.07 118.69 59.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.204 0.526 . . . . 1.0 111.497 -177.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.496 ' HA ' ' CE1' ' A' ' 93' ' ' HIS . 33.9 t -146.54 170.82 16.11 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 178.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.798 HG23 ' HE2' ' A' ' 93' ' ' HIS . 0.9 OUTLIER -80.64 92.65 6.01 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.25 0.548 . . . . 1.0 110.856 179.959 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.939 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 129.35 -40.39 1.7 Allowed Glycine 0 N--CA 1.441 -0.97 0 C-N-CA 120.597 -0.811 . . . . 1.0 111.74 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.422 HD22 ' CB ' ' A' ' 42' ' ' SER . 4.2 t-20 64.33 14.62 8.89 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.843 0.83 . . . . 1.0 111.338 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.451 ' HA ' ' HG3' ' A' ' 19' ' ' PRO . 14.5 pt -121.54 4.21 6.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 O-C-N 121.705 -0.622 . . . . 1.0 112.074 -177.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 6.1 p -120.3 -87.55 0.64 Allowed 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.926 -0.309 . . . . 1.0 111.81 -177.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.438 HH21 ' HB ' ' A' ' 124' ' ' VAL . 12.6 mtp180 -72.21 -45.06 61.86 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.29 0.478 . . . . 1.0 112.29 -175.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.529 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 18.5 m -55.01 -56.72 24.82 Favored Pre-proline 0 CA--C 1.541 0.603 0 N-CA-C 112.099 0.407 . . . . 1.0 112.099 179.276 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.47 ' HD3' ' HB2' ' A' ' 18' ' ' SER . 57.6 Cg_endo -68.53 -21.59 39.78 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 121.765 1.644 . . . . 1.0 112.539 -177.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.56 ' HB3' HD13 ' A' ' 142' ' ' ILE . 34.0 mmm -60.82 -53.13 61.06 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.601 -0.272 . . . . 1.0 110.32 177.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.474 ' HA ' ' HB2' ' A' ' 24' ' ' MET . . . -75.26 -25.43 58.03 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.234 -0.586 . . . . 1.0 110.61 -179.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.533 ' HA ' ' HE2' ' A' ' 9' ' ' PHE . 17.8 tt0 -52.31 -53.58 42.5 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 115.489 -0.778 . . . . 1.0 109.94 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.591 ' O ' ' HB3' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -85.88 -23.58 27.0 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.209 -0.905 . . . . 1.0 110.758 -175.787 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.625 ' HB3' HD13 ' A' ' 146' ' ' LEU . 7.0 mmm -61.78 -75.55 0.07 Allowed 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.563 0.579 . . . . 1.0 112.563 -178.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.677 ' HB3' HD11 ' A' ' 146' ' ' LEU . 26.5 p90 -80.65 -28.72 36.79 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.179 -0.608 . . . . 1.0 111.573 -174.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' 22' ' ' GLU . . . -63.65 -38.97 93.11 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 119.237 -0.985 . . . . 1.0 110.261 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.6 ' HA ' ' HD3' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -64.88 -37.65 88.35 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 108.845 -0.798 . . . . 1.0 108.845 177.272 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.602 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 79.1 mt-30 -59.02 -47.59 84.66 Favored 'General case' 0 CA--C 1.522 -0.097 0 CA-C-N 116.433 -0.349 . . . . 1.0 110.413 175.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 25' ' ' PHE . 95.6 mt -52.07 -56.26 15.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.835 -0.62 . . . . 1.0 111.071 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.6 ' HD3' ' HA ' ' A' ' 27' ' ' GLN . 0.1 OUTLIER -61.67 -37.4 83.93 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.647 -0.421 . . . . 1.0 111.797 178.866 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 8.1 m170 -62.82 -23.39 67.24 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.391 0.515 . . . . 1.0 112.391 178.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.602 ' HG2' ' O ' ' A' ' 28' ' ' GLN . 7.9 ptp180 -98.49 -21.52 16.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.48 0.657 . . . . 1.0 110.185 178.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 108.03 39.85 1.78 Allowed Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 115.24 -0.891 . . . . 1.0 112.297 177.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 15.9 mt -137.46 -3.11 1.93 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.034 0.445 . . . . 1.0 109.9 -177.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.414 ' HA3' ' HB3' ' A' ' 30' ' ' ARG . . . -62.82 -23.58 65.65 Favored Glycine 0 C--N 1.332 0.325 0 CA-C-N 115.856 -0.611 . . . . 1.0 112.585 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -83.75 -32.86 25.22 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.272 0.558 . . . . 1.0 109.537 176.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.49 -15.84 55.75 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.45 -0.796 . . . . 1.0 111.334 -178.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.5 t -130.58 121.61 51.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 110.237 -0.282 . . . . 1.0 110.237 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.695 ' HE ' ' HG3' ' A' ' 4' ' ' PRO . 7.2 mmt180 -93.24 134.83 35.04 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 109.873 -0.417 . . . . 1.0 109.873 177.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.447 HG12 ' HB1' ' A' ' 26' ' ' ALA . 55.1 t -129.85 119.72 48.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 121.699 0.761 . . . . 1.0 109.877 -177.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.487 ' O ' ' HA ' ' A' ' 8' ' ' THR . 48.0 p -133.65 -174.12 3.43 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 113.693 -1.594 . . . . 1.0 110.809 -175.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.603 ' HB3' ' HD2' ' A' ' 9' ' ' PHE . 81.8 p -161.82 166.9 25.73 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 120.931 -0.308 . . . . 1.0 110.47 179.136 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.591 ' HB2' ' CD2' ' A' ' 80' ' ' HIS . . . -164.54 169.61 16.88 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.447 0.642 . . . . 1.0 111.728 -179.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -127.85 140.9 12.15 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.266 -0.879 . . . . 1.0 111.028 178.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.479 HG23 HD13 ' A' ' 96' ' ' LEU . 39.9 p -76.7 -23.2 53.15 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.935 0.368 . . . . 1.0 111.829 -177.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.5 ' HA3' ' CZ3' ' A' ' 48' ' ' TRP . . . -112.03 11.91 26.91 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.511 -0.852 . . . . 1.0 113.156 -177.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.416 ' HB3' ' HB2' ' A' ' 75' ' ' GLN . 2.7 p-10 43.11 39.9 2.1 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 113.572 0.953 . . . . 1.0 113.572 178.165 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.939 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 1.3 m-90 -46.84 -77.0 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.531 0.682 . . . . 1.0 112.306 179.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.558 ' O ' ' HB2' ' A' ' 73' ' ' ALA . 11.3 m-70 -105.45 41.77 1.32 Allowed 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.525 -0.761 . . . . 1.0 111.06 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.549 HG22 ' HA ' ' A' ' 74' ' ' ALA . 12.9 p -61.04 125.85 17.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.119 0.485 . . . . 1.0 110.181 178.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.794 ' HA2' ' HD3' ' A' ' 72' ' ' ARG . . . 95.27 -15.23 63.74 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 121.06 -0.591 . . . . 1.0 111.637 -176.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.484 ' CB ' ' HB3' ' A' ' 49' ' ' HIS . 3.3 t -79.58 -159.99 0.23 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.251 0.548 . . . . 1.0 109.746 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 36.1 t -128.14 175.06 8.71 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 109.189 -0.671 . . . . 1.0 109.189 -179.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.57 142.48 39.25 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.87 0.367 . . . . 1.0 111.29 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -62.79 143.62 57.33 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.663 -0.699 . . . . 1.0 112.557 -176.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.566 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 12.2 pt-20 -43.61 -42.32 5.1 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 114.383 -1.28 . . . . 1.0 113.748 178.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.669 ' O ' HG23 ' A' ' 61' ' ' VAL . 10.0 mtt-85 -70.16 -48.4 57.51 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 120.784 0.326 . . . . 1.0 110.462 -176.497 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.38 -31.49 70.89 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.224 -0.898 . . . . 1.0 110.298 -177.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.73 -45.84 84.77 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.66 -0.496 . . . . 1.0 109.66 176.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.07 -39.93 98.62 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.708 -0.758 . . . . 1.0 111.489 178.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 57' ' ' ARG . 88.8 t -58.67 -59.16 4.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-O 121.233 0.54 . . . . 1.0 111.242 178.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.649 ' HB2' HG23 ' A' ' 69' ' ' THR . 96.6 mt -60.4 -50.09 74.99 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.939 -0.573 . . . . 1.0 111.54 -177.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 6.9 ptm85 -61.72 -27.56 68.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.723 -0.217 . . . . 1.0 111.008 -178.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.7 -34.14 76.3 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.453 0.644 . . . . 1.0 110.387 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.42 ' HD2' ' O ' ' A' ' 61' ' ' VAL . 94.1 m-70 -96.41 4.98 51.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.562 -0.744 . . . . 1.0 111.43 -178.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.15 11.48 64.78 Favored Glycine 0 C--N 1.329 0.188 0 C-N-CA 121.026 -0.607 . . . . 1.0 112.743 177.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -89.84 149.75 42.54 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-O 120.691 0.282 . . . . 1.0 110.773 -179.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.428 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 37.6 Cg_endo -67.91 156.14 67.05 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.285 1.99 . . . . 1.0 110.878 177.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.649 HG23 ' HB2' ' A' ' 62' ' ' LEU . 80.4 p -130.85 14.24 5.3 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 120.191 -0.604 . . . . 1.0 111.032 -176.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -77.2 132.66 38.86 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.513 -0.767 . . . . 1.0 109.856 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.41 ' HB2' ' HE2' ' A' ' 23' ' ' LYS . 54.4 t60 -172.17 148.0 2.11 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.038 0.447 . . . . 1.0 110.797 -177.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.794 ' HD3' ' HA2' ' A' ' 51' ' ' GLY . 5.3 tmm_? -131.41 108.45 9.62 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 107.153 -1.425 . . . . 1.0 107.153 176.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.558 ' HB2' ' O ' ' A' ' 49' ' ' HIS . . . -58.73 139.99 55.44 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.071 -0.968 . . . . 1.0 112.474 -174.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.549 ' HA ' HG22 ' A' ' 50' ' ' VAL . . . -134.58 147.16 50.18 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.707 -0.678 . . . . 1.0 110.113 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.416 ' HB2' ' HB3' ' A' ' 47' ' ' ASN . 49.0 tt0 -83.79 153.56 24.03 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 110.116 -0.327 . . . . 1.0 110.116 176.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.573 HG13 HD23 ' A' ' 97' ' ' LEU . 82.0 t -63.56 112.56 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.033 -0.531 . . . . 1.0 110.909 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.425 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -122.4 -171.79 13.94 Favored Glycine 0 N--CA 1.442 -0.915 0 N-CA-C 111.055 -0.818 . . . . 1.0 111.055 178.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 90.8 m -57.88 -44.19 86.52 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.707 0.289 . . . . 1.0 110.935 -179.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -58.97 -29.99 67.6 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.186 -0.461 . . . . 1.0 111.641 178.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.591 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 79.7 m80 -78.66 -39.62 36.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.821 0.343 . . . . 1.0 110.169 179.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.697 ' HA ' HD23 ' A' ' 86' ' ' LEU . 16.2 mt -69.49 -15.19 63.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.112 0.482 . . . . 1.0 110.101 177.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.37 -5.83 59.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.323 -0.399 . . . . 1.0 110.543 -179.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.509 ' HB3' ' O ' ' A' ' 6' ' ' HIS . . . -63.35 154.36 32.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.906 -0.588 . . . . 1.0 110.976 179.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -80.9 -14.78 57.69 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 109.871 -0.418 . . . . 1.0 109.871 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.748 HD11 ' CE3' ' A' ' 152' ' ' TRP . 0.9 OUTLIER -152.72 113.51 4.13 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.484 -0.78 . . . . 1.0 109.73 -177.43 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.697 HD23 ' HA ' ' A' ' 81' ' ' LEU . 5.5 mp -105.72 87.65 2.64 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.534 -0.757 . . . . 1.0 110.951 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.609 HG23 HD23 ' A' ' 85' ' ' LEU . 54.6 t -66.36 92.88 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 113.806 -1.543 . . . . 1.0 112.237 -178.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.06 145.54 32.4 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.393 -1.276 . . . . 1.0 109.917 177.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.509 ' O ' ' HB ' ' A' ' 124' ' ' VAL . 4.0 mm? -98.57 -8.53 26.32 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.955 0.407 . . . . 1.0 110.094 179.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.443 ' CG ' ' H ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -152.03 153.81 34.74 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.694 -0.685 . . . . 1.0 111.066 179.945 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -55.3 -27.67 48.35 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.251 -0.886 . . . . 1.0 113.104 -178.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.569 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 91.6 m-20 -75.51 -49.97 17.09 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.734 0.302 . . . . 1.0 110.504 -177.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.798 ' HE2' HG23 ' A' ' 12' ' ' THR . 18.2 m170 -53.94 -46.02 71.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.428 179.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.91 -43.94 91.17 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.941 0.4 . . . . 1.0 110.735 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 16.6 ttm180 -61.3 -39.84 91.96 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.722 -0.672 . . . . 1.0 111.602 178.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.569 ' HG ' ' O ' ' A' ' 92' ' ' ASN . 43.9 mt -67.06 -50.74 60.87 Favored 'General case' 0 C--O 1.217 -0.645 0 CA-C-N 116.43 -0.35 . . . . 1.0 110.416 -178.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.659 HD13 HG21 ' A' ' 10' ' ' VAL . 29.2 mt -52.0 -57.45 9.44 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.971 -0.559 . . . . 1.0 111.387 -177.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.739 ' CA ' HG12 ' A' ' 102' ' ' VAL . 9.5 ptt180 -59.75 -44.12 93.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.659 -0.7 . . . . 1.0 112.439 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.531 ' HG3' ' O ' ' A' ' 96' ' ' LEU . 0.9 OUTLIER -67.66 -25.24 65.61 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.394 -0.522 . . . . 1.0 109.895 -179.972 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.445 HD13 ' O ' ' A' ' 96' ' ' LEU . 5.9 mp -77.68 -20.7 53.25 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 116.096 -0.502 . . . . 1.0 111.592 177.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 152.87 -21.15 0.78 Allowed Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 119.477 -1.344 . . . . 1.0 114.216 -178.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.739 HG12 ' CA ' ' A' ' 98' ' ' ARG . 0.3 OUTLIER -76.05 -162.35 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 118.048 0.924 . . . . 1.0 110.313 -179.51 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.734 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 10.7 pt-20 -159.34 160.6 35.23 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 107.753 -1.203 . . . . 1.0 107.753 -177.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.737 ' HA ' HG13 ' A' ' 107' ' ' VAL . . . -62.2 -25.1 67.6 Favored 'General case' 0 C--N 1.316 -0.876 0 O-C-N 123.465 0.478 . . . . 1.0 111.274 -175.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.04 -30.2 67.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.011 0.434 . . . . 1.0 110.546 175.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.734 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 11.5 mtt-85 -105.41 -43.16 5.04 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 115.531 -0.759 . . . . 1.0 111.464 -177.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.737 HG13 ' HA ' ' A' ' 104' ' ' ALA . 11.3 p -78.38 117.93 24.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.497 -0.557 . . . . 1.0 109.497 -174.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.582 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 8.5 mmm180 -139.24 149.79 44.74 Favored 'General case' 0 C--N 1.322 -0.597 0 O-C-N 121.604 -0.685 . . . . 1.0 110.59 -176.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.498 ' HE1' HG22 ' A' ' 124' ' ' VAL . 87.7 mmm -80.39 131.49 35.62 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.079 -0.51 . . . . 1.0 111.26 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.53 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 2.8 tm? -53.54 -50.54 65.27 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 123.402 0.439 . . . . 1.0 111.028 179.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.584 ' HB2' HG23 ' A' ' 124' ' ' VAL . 43.7 ttt-85 -71.07 -16.67 62.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.308 -0.406 . . . . 1.0 110.956 -176.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 46.8 t -79.81 -2.31 42.75 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 120.706 -0.398 . . . . 1.0 111.034 -179.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.721 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 87.8 m-85 -92.74 -16.61 25.24 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-O 120.914 0.388 . . . . 1.0 109.972 175.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.487 ' HB3' ' HB2' ' A' ' 117' ' ' SER . 22.1 t0 -61.29 116.95 22.22 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.727 -0.669 . . . . 1.0 111.291 -178.261 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.44 ' HD2' ' O ' ' A' ' 144' ' ' SER . 38.2 Cg_endo -66.65 -19.31 54.01 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.607 2.205 . . . . 1.0 111.487 178.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 17.6 mmm180 -85.2 -14.3 47.29 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.836 -0.62 . . . . 1.0 110.094 179.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.487 ' HB2' ' HB3' ' A' ' 114' ' ' ASP . 10.9 t -71.88 86.97 0.99 Allowed 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.017 -0.538 . . . . 1.0 110.713 -179.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -57.28 -41.69 93.1 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.87 -0.681 . . . . 1.0 111.799 177.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.27 153.72 21.25 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 110.228 -0.286 . . . . 1.0 110.228 177.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -73.57 137.54 44.37 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.789 -0.819 . . . . 1.0 108.789 177.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -105.91 89.24 3.02 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.25 -0.432 . . . . 1.0 111.236 -177.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -89.25 7.36 35.89 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.616 -0.883 . . . . 1.0 108.616 176.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.494 ' HA ' ' HE2' ' A' ' 109' ' ' MET . 29.3 t70 -166.16 139.56 4.16 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 114.339 -1.3 . . . . 1.0 108.519 -179.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.584 HG23 ' HB2' ' A' ' 111' ' ' ARG . 85.3 t -98.33 144.47 11.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 110.292 -0.262 . . . . 1.0 110.292 -177.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -64.59 -176.52 0.25 Allowed 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.116 -0.493 . . . . 1.0 111.547 -177.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -153.46 159.57 31.98 Favored Pre-proline 0 C--N 1.326 -0.429 0 N-CA-C 109.93 -0.396 . . . . 1.0 109.93 -174.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.602 ' HB3' ' HB3' ' A' ' 134' ' ' ASP . 77.2 Cg_exo -53.57 154.16 16.5 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.757 2.305 . . . . 1.0 112.389 177.3 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -94.55 -36.16 11.94 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.668 -0.696 . . . . 1.0 109.73 -178.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -134.25 -24.18 1.64 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.685 -0.689 . . . . 1.0 111.214 176.272 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 85.72 53.64 2.99 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.483 -0.865 . . . . 1.0 112.111 178.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -115.57 -167.92 1.33 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.344 -0.984 . . . . 1.0 108.344 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 15.2 t-80 -58.03 -39.28 77.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.632 0.253 . . . . 1.0 110.653 -179.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.3 p -62.17 -38.69 90.02 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.026 -0.533 . . . . 1.0 111.663 179.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.602 ' HB3' ' HB3' ' A' ' 127' ' ' PRO . 1.4 m-20 -69.62 -33.97 73.4 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.35 -0.841 . . . . 1.0 111.382 -177.16 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.435 ' CE1' ' HD3' ' A' ' 57' ' ' ARG . 8.5 m-85 -70.68 -45.39 65.14 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.312 0.577 . . . . 1.0 110.069 -177.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -70.82 -26.54 63.34 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.333 -0.848 . . . . 1.0 110.248 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -62.76 -48.77 77.75 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.289 0.566 . . . . 1.0 110.048 178.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.998 ' HA ' HG22 ' A' ' 141' ' ' VAL . 73.5 t -61.51 -40.37 86.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.36 -0.836 . . . . 1.0 110.044 177.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.512 ' HB2' HG11 ' A' ' 61' ' ' VAL . 35.7 t80 -53.65 -42.12 67.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.129 -0.942 . . . . 1.0 109.204 175.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.63 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -67.18 -38.17 84.94 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.343 -0.844 . . . . 1.0 110.599 177.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.998 HG22 ' HA ' ' A' ' 138' ' ' VAL . 13.2 t -56.6 -53.58 39.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.58 0.705 . . . . 1.0 109.986 176.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.56 HD13 ' HB3' ' A' ' 20' ' ' MET . 6.0 mt -62.9 -50.43 79.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 114.883 -1.053 . . . . 1.0 111.842 -178.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.63 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 8.3 pt-20 -55.54 -33.33 63.72 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.628 0.252 . . . . 1.0 110.396 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.44 ' O ' ' HD2' ' A' ' 115' ' ' PRO . 2.0 t -74.18 -28.53 61.33 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-O 121.064 0.459 . . . . 1.0 110.327 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.451 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -86.41 -23.3 26.14 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 116.329 -0.396 . . . . 1.0 111.851 179.228 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.677 HD11 ' HB3' ' A' ' 25' ' ' PHE . 11.9 mt -55.45 -38.31 66.5 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 112.37 0.507 . . . . 1.0 112.37 -179.063 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 58.0 Cg_endo -70.81 -10.13 27.12 Favored 'Trans proline' 0 C--N 1.359 1.107 0 C-N-CA 122.56 2.173 . . . . 1.0 112.211 178.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.721 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -105.12 -33.44 3.71 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 110.442 -1.063 . . . . 1.0 110.442 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.578 HD21 ' CE2' ' A' ' 25' ' ' PHE . 13.0 tp -73.86 -37.41 64.79 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.451 -1.314 . . . . 1.0 107.451 177.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.457 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 0.2 OUTLIER -54.24 -51.5 64.29 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 114.549 -1.205 . . . . 1.0 109.57 174.195 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -59.16 -46.65 87.84 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.963 -1.017 . . . . 1.0 111.342 -176.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . 0.794 ' HZ3' HD21 ' A' ' 5' ' ' LEU . 28.7 t90 -63.0 -52.17 64.0 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.49 -0.777 . . . . 1.0 111.056 -178.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.482 HG12 ' O ' ' A' ' 149' ' ' LEU . 12.3 m -61.01 -39.39 82.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 120.545 -0.462 . . . . 1.0 109.919 -179.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.11 -51.54 68.7 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 116.417 -0.356 . . . . 1.0 111.076 177.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.531 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 4.8 pt-20 -60.18 -39.34 86.12 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.256 0.55 . . . . 1.0 110.235 -178.017 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.544 ' HG3' ' CH2' ' A' ' 152' ' ' TRP . 17.3 mmt85 -72.11 -46.24 57.44 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.369 -0.832 . . . . 1.0 111.437 -176.133 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.3 pp -67.14 -22.8 65.76 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.317 -0.623 . . . . 1.0 109.317 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -73.82 -51.21 17.08 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.544 -0.753 . . . . 1.0 110.195 178.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.424 ' C ' ' H ' ' A' ' 161' ' ' GLY . 1.4 ptp85 -77.67 0.8 21.97 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 112.429 0.529 . . . . 1.0 112.429 -179.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -71.81 -4.18 26.44 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.947 -0.39 . . . . 1.0 109.947 177.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.424 ' H ' ' C ' ' A' ' 159' ' ' ARG . . . 35.5 -144.47 0.08 OUTLIER Glycine 0 C--N 1.335 0.502 0 CA-C-N 114.787 -1.097 . . . . 1.0 114.639 -179.188 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -92.24 -9.72 2.44 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 123.029 2.486 . . . . 1.0 113.12 177.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 68.9 m . . . . . 0 C--O 1.25 1.097 0 CA-C-N 114.972 -1.013 . . . . 1.0 111.742 -178.194 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . 0.489 ' CA ' ' HA ' ' A' ' 163' ' ' SER . . . . . . . . 0 N--CA 1.484 1.835 0 N-CA-C 112.288 -0.325 . . . . 1.0 112.288 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.624 ' H ' ' HA ' ' A' ' 163' ' ' SER . 64.1 mtt 65.65 101.18 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.308 0.643 . . . . 1.0 110.947 -178.572 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 73.6 m -76.31 177.8 7.0 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-O 120.739 0.305 . . . . 1.0 110.913 178.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.87 150.81 97.52 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-O 121.348 0.594 . . . . 1.0 112.015 -179.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.578 ' HB2' ' HG2' ' A' ' 39' ' ' ARG . 11.1 Cg_endo -58.63 168.61 3.94 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 124.213 3.275 . . . . 1.0 114.803 -175.577 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.685 HD23 ' HZ3' ' A' ' 152' ' ' TRP . 0.7 OUTLIER -70.79 -174.14 0.88 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 114.006 -1.452 . . . . 1.0 110.118 179.949 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.657 ' HA ' ' O ' ' A' ' 39' ' ' ARG . 1.4 t-160 -157.54 93.3 1.28 Allowed 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.493 -0.483 . . . . 1.0 111.159 -178.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.717 HG11 HD11 ' A' ' 85' ' ' LEU . 2.5 t -98.27 108.63 22.33 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.454 0 N-CA-C 109.916 -0.402 . . . . 1.0 109.916 177.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' A' ' 41' ' ' THR . 14.7 t -109.88 116.88 32.44 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.143 0.497 . . . . 1.0 110.937 -179.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.564 ' CE2' ' HA ' ' A' ' 22' ' ' GLU . 0.4 OUTLIER -86.95 129.43 34.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.902 0.382 . . . . 1.0 110.653 -179.166 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.627 HG22 HD21 ' A' ' 97' ' ' LEU . 41.2 t -114.14 116.59 53.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.914 -0.585 . . . . 1.0 111.782 -176.206 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.507 ' HA ' ' CE1' ' A' ' 93' ' ' HIS . 45.1 t -145.32 151.9 39.05 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.409 178.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.34 99.71 2.99 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.285 0.564 . . . . 1.0 110.423 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.528 ' O ' HG12 ' A' ' 15' ' ' ILE . . . 140.02 -32.85 2.16 Favored Glycine 0 C--O 1.217 -0.951 0 CA-C-N 115.555 -0.748 . . . . 1.0 111.488 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.581 ' OD1' ' HB3' ' A' ' 73' ' ' ALA . 34.3 p30 48.7 20.98 0.38 Allowed 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 125.268 1.427 . . . . 1.0 113.901 179.198 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.528 HG12 ' O ' ' A' ' 13' ' ' GLY . 5.3 pt -139.46 10.26 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 122.233 -0.292 . . . . 1.0 111.362 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 47.9 t -125.1 -87.34 0.61 Allowed 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.263 -0.575 . . . . 1.0 112.131 -178.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.93 HH22 ' HA ' ' A' ' 126' ' ' ASP . 35.8 mtt180 -71.21 -39.47 71.72 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.23 0.456 . . . . 1.0 112.23 -174.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.891 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 16.5 m -58.29 -58.59 17.8 Favored Pre-proline 0 CA--C 1.543 0.677 0 N-CA-C 111.753 0.279 . . . . 1.0 111.753 179.155 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.619 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 38.1 Cg_endo -63.71 -23.94 69.31 Favored 'Trans proline' 0 C--N 1.358 1.042 0 C-N-CA 122.341 2.027 . . . . 1.0 112.431 178.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.63 ' HB3' HD11 ' A' ' 142' ' ' ILE . 49.0 mmm -59.74 -55.47 33.97 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.228 -0.286 . . . . 1.0 110.228 179.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.454 ' HA ' ' HB2' ' A' ' 24' ' ' MET . . . -75.36 -26.19 58.32 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.238 -0.585 . . . . 1.0 110.522 -179.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.696 ' O ' ' HB1' ' A' ' 26' ' ' ALA . 11.8 tt0 -52.44 -54.3 34.01 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 115.377 -0.828 . . . . 1.0 110.008 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.668 ' HE3' ' HB2' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -84.78 -23.44 29.19 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.362 -0.836 . . . . 1.0 110.576 -175.844 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.595 ' HB3' HD12 ' A' ' 146' ' ' LEU . 5.2 mmm -62.82 -75.74 0.07 Allowed 'General case' 0 C--O 1.237 0.442 0 N-CA-C 112.679 0.622 . . . . 1.0 112.679 -178.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.758 ' HB3' HD21 ' A' ' 146' ' ' LEU . 18.6 p90 -79.06 -28.92 43.22 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 119.848 -0.741 . . . . 1.0 111.251 -174.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.696 ' HB1' ' O ' ' A' ' 22' ' ' GLU . . . -64.06 -37.15 86.38 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 119.486 -0.886 . . . . 1.0 110.661 179.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.615 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -64.54 -38.69 91.87 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.676 -0.861 . . . . 1.0 108.676 176.507 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.565 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 77.8 mt-30 -60.63 -41.56 95.12 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.619 -0.718 . . . . 1.0 110.426 176.07 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.635 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 88.2 mt -57.01 -58.97 5.84 Favored 'General case' 0 C--O 1.225 -0.201 0 CA-C-N 115.774 -0.648 . . . . 1.0 110.89 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.508 ' HD3' ' HA ' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -59.31 -35.37 73.67 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.204 -0.598 . . . . 1.0 111.163 178.654 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -63.33 -26.29 68.7 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.244 0.461 . . . . 1.0 112.244 177.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.635 ' HG2' ' O ' ' A' ' 29' ' ' LEU . 4.0 ptm85 -96.21 -23.37 16.75 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 119.775 -0.77 . . . . 1.0 109.954 178.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 113.47 34.65 1.71 Allowed Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.174 -0.921 . . . . 1.0 112.433 177.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 25.8 mt -129.37 5.08 5.19 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.853 -0.425 . . . . 1.0 109.853 -178.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.429 ' HA3' ' HB3' ' A' ' 30' ' ' ARG . . . -59.39 -31.6 70.54 Favored Glycine 0 C--N 1.332 0.308 0 CA-C-N 115.819 -0.628 . . . . 1.0 112.967 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -88.17 -20.85 25.03 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.864 0.364 . . . . 1.0 110.186 176.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.02 -25.05 40.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.814 -0.63 . . . . 1.0 111.299 -178.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.614 HG12 ' HB3' ' A' ' 5' ' ' LEU . 5.9 t -130.13 126.29 61.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 121.106 -0.238 . . . . 1.0 110.604 -178.337 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.657 ' O ' ' HA ' ' A' ' 6' ' ' HIS . 24.2 mmt180 -99.61 98.89 9.7 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.185 0.517 . . . . 1.0 110.876 177.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.681 HG11 ' HB2' ' A' ' 26' ' ' ALA . 1.5 m -88.45 136.75 22.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 CA-C-N 115.703 -0.68 . . . . 1.0 109.299 178.228 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.525 ' O ' ' HA ' ' A' ' 8' ' ' THR . 28.9 p -146.59 -179.8 7.02 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.117 -0.947 . . . . 1.0 109.756 -175.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.891 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 95.1 p -158.19 161.4 37.83 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.382 -0.527 . . . . 1.0 110.936 -178.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.501 ' HB1' ' CD2' ' A' ' 80' ' ' HIS . . . -165.09 168.37 17.36 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.309 0.576 . . . . 1.0 111.415 -179.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -124.68 132.15 8.08 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 110.805 -0.918 . . . . 1.0 110.805 177.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.577 HG21 ' CG1' ' A' ' 10' ' ' VAL . 20.2 p -66.72 -28.82 68.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.948 0.404 . . . . 1.0 111.446 -176.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -101.64 7.13 55.49 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.653 -0.784 . . . . 1.0 113.059 -176.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 42.85 39.39 1.7 Allowed 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 113.46 0.911 . . . . 1.0 113.46 178.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -47.18 -79.64 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.635 0.731 . . . . 1.0 112.533 178.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -103.79 42.11 1.21 Allowed 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.992 -1.004 . . . . 1.0 111.095 -178.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.4 p -60.53 125.63 17.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.797 -0.638 . . . . 1.0 110.408 178.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.33 -12.76 64.99 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.703 -0.76 . . . . 1.0 111.834 -177.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.33 -161.06 0.38 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.728 -0.471 . . . . 1.0 109.728 178.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 71' ' ' HIS . 30.0 t -127.34 169.45 13.56 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.512 -0.921 . . . . 1.0 108.512 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -51.14 138.96 19.2 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.921 0.391 . . . . 1.0 111.707 -179.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.744 ' OD1' ' HG2' ' A' ' 57' ' ' ARG . 12.1 t70 -62.62 140.97 58.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.585 -0.734 . . . . 1.0 111.05 -176.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -51.06 -33.62 26.45 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.793 1.035 . . . . 1.0 113.793 -178.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.744 ' HG2' ' OD1' ' A' ' 55' ' ' ASP . 9.9 ptm180 -72.63 -41.16 65.81 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 118.958 0.799 . . . . 1.0 110.619 -178.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.15 -38.89 75.57 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.134 0.493 . . . . 1.0 109.955 179.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.13 -42.8 99.2 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.517 -0.765 . . . . 1.0 109.909 178.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -57.82 -45.92 92.97 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.903 -0.665 . . . . 1.0 113.224 178.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 5.8 m -72.88 -39.75 59.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 117.585 0.692 . . . . 1.0 111.414 -178.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.611 ' HB2' HG22 ' A' ' 69' ' ' THR . 94.8 mt -60.92 -55.2 35.81 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 120.774 0.321 . . . . 1.0 110.5 179.063 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -58.59 -33.16 69.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.75 -0.659 . . . . 1.0 110.729 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.95 -34.48 78.08 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.081 0.467 . . . . 1.0 110.932 179.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -95.62 5.68 50.86 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.891 -0.595 . . . . 1.0 111.409 -178.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.91 12.4 66.23 Favored Glycine 0 N--CA 1.452 -0.267 0 CA-C-N 115.589 -0.732 . . . . 1.0 112.575 176.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -91.5 147.88 36.24 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-O 120.625 0.25 . . . . 1.0 110.827 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.518 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 38.1 Cg_endo -69.0 154.85 70.05 Favored 'Trans proline' 0 CA--C 1.508 -0.799 0 C-N-CA 122.529 2.152 . . . . 1.0 110.544 177.106 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.611 HG22 ' HB2' ' A' ' 62' ' ' LEU . 27.9 p -127.85 14.85 6.92 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.226 0.536 . . . . 1.0 110.428 -178.054 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -84.03 119.03 24.45 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.32 -0.855 . . . . 1.0 109.839 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.668 ' HB2' ' HE3' ' A' ' 23' ' ' LYS . 3.5 t60 -162.18 142.58 10.14 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.334 -176.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 -113.69 115.52 27.99 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 107.887 -1.153 . . . . 1.0 107.887 177.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.581 ' HB3' ' OD1' ' A' ' 14' ' ' ASN . . . -60.02 138.44 57.86 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 112.28 0.474 . . . . 1.0 112.28 -177.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -134.74 158.02 45.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.228 178.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -94.09 155.43 17.09 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.385 -0.598 . . . . 1.0 109.385 177.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.487 HG11 ' CD2' ' A' ' 97' ' ' LEU . 5.0 t -69.63 113.31 5.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.559 -0.534 . . . . 1.0 109.559 178.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.5 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -125.31 -166.65 12.38 Favored Glycine 0 N--CA 1.44 -1.061 0 CA-C-N 115.44 -0.8 . . . . 1.0 111.353 -179.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 83.8 m -55.83 -53.31 58.26 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.967 0.413 . . . . 1.0 111.623 -178.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.442 ' HG2' ' N ' ' A' ' 80' ' ' HIS . 1.6 pm0 -56.14 -32.72 64.51 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.415 -0.811 . . . . 1.0 111.287 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.501 ' CD2' ' HB1' ' A' ' 43' ' ' ALA . 78.3 m80 -74.81 -39.73 61.52 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.048 -0.524 . . . . 1.0 109.727 179.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.618 ' HA ' HD21 ' A' ' 86' ' ' LEU . 29.5 mt -69.03 -20.76 64.13 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.89 -0.595 . . . . 1.0 110.997 177.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.41 -4.6 59.21 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.773 -177.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.539 ' HB3' ' O ' ' A' ' 6' ' ' HIS . . . -59.58 153.61 19.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.706 -0.679 . . . . 1.0 111.064 179.234 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.404 ' H ' ' HB3' ' A' ' 6' ' ' HIS . 13.8 t70 -79.4 -16.82 55.58 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.162 0.506 . . . . 1.0 110.036 -179.623 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.717 HD11 HG11 ' A' ' 7' ' ' VAL . 0.3 OUTLIER -152.91 114.12 4.2 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.403 -0.817 . . . . 1.0 109.088 -178.057 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.618 HD21 ' HA ' ' A' ' 81' ' ' LEU . 4.9 mp -104.32 106.48 17.0 Favored 'General case' 0 N--CA 1.424 -1.726 0 CA-C-N 115.322 -0.854 . . . . 1.0 109.724 178.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.643 HG11 HD23 ' A' ' 110' ' ' LEU . 53.9 t -86.67 94.98 4.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 114.926 -1.034 . . . . 1.0 111.242 -177.173 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.92 143.68 31.49 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.501 -0.772 . . . . 1.0 110.805 178.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.502 HD23 ' HB2' ' A' ' 11' ' ' CYS . 4.4 mm? -93.93 -16.29 24.12 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.758 -0.655 . . . . 1.0 109.535 178.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -141.49 152.48 44.22 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.504 -0.771 . . . . 1.0 110.514 -177.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.403 ' H ' ' HG2' ' A' ' 91' ' ' ARG . 9.2 ptt180 -61.15 -21.45 63.77 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.649 0.593 . . . . 1.0 111.238 177.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.681 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 95.4 m-20 -73.84 -50.6 19.61 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 109.644 -0.502 . . . . 1.0 109.644 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.647 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 8.5 m170 -60.16 -43.63 95.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.452 -0.795 . . . . 1.0 109.786 178.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.95 -44.68 94.26 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.164 0.507 . . . . 1.0 110.544 179.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.458 ' O ' ' HG2' ' A' ' 98' ' ' ARG . 0.3 OUTLIER -57.83 -44.07 86.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.38 -0.827 . . . . 1.0 111.225 178.173 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.732 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 50.8 mt -64.69 -49.87 69.21 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 116.279 -0.418 . . . . 1.0 110.49 -177.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.647 ' HG ' ' O ' ' A' ' 93' ' ' HIS . 49.3 mt -51.97 -56.76 12.2 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.947 -0.57 . . . . 1.0 111.641 -178.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.458 ' HG2' ' O ' ' A' ' 95' ' ' ARG . 26.1 ptt85 -59.62 -45.57 91.56 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.138 -0.483 . . . . 1.0 111.729 -176.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.624 ' HG3' ' O ' ' A' ' 96' ' ' LEU . 1.2 pp0? -69.42 -21.55 63.74 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 120.967 0.413 . . . . 1.0 110.857 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.732 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 10.8 mt -78.72 -6.82 56.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.043 -0.526 . . . . 1.0 111.966 -178.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 144.1 -29.31 1.94 Allowed Glycine 0 CA--C 1.506 -0.479 0 C-N-CA 119.828 -1.177 . . . . 1.0 113.021 178.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.762 HG11 ' H ' ' A' ' 103' ' ' GLU . 1.6 t -74.85 -153.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-O 121.541 0.686 . . . . 1.0 110.814 -178.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.762 ' H ' HG11 ' A' ' 102' ' ' VAL . 12.6 pt-20 -163.59 159.45 21.83 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.895 -1.15 . . . . 1.0 107.895 -178.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.45 ' HA ' ' HB ' ' A' ' 107' ' ' VAL . . . -67.71 -17.28 64.51 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.665 -0.414 . . . . 1.0 112.031 -173.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.92 -37.17 76.06 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 173.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.599 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 2.5 mtp85 -94.73 -34.98 12.33 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 114.744 -1.116 . . . . 1.0 110.422 -178.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.563 HG22 ' O ' ' A' ' 103' ' ' GLU . 39.5 t -79.57 114.56 20.57 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.423 -179.106 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.472 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 15.1 mmt180 -135.42 147.37 48.95 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 120.212 -0.595 . . . . 1.0 110.403 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.611 ' HB2' ' HB2' ' A' ' 112' ' ' SER . 77.0 mmm -78.07 139.05 39.06 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.691 -0.686 . . . . 1.0 110.037 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.643 HD23 HG11 ' A' ' 87' ' ' VAL . 2.9 tm? -56.89 -50.18 73.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.602 0.239 . . . . 1.0 110.963 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.09 -12.08 61.04 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.082 0.468 . . . . 1.0 110.747 -177.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.794 ' HB2' ' HB2' ' A' ' 121' ' ' ALA . 32.5 t -78.69 -4.86 51.22 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.978 -0.555 . . . . 1.0 111.011 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.566 ' HZ ' HD21 ' A' ' 85' ' ' LEU . 86.4 m-85 -91.8 -21.06 20.87 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.049 0.452 . . . . 1.0 109.873 175.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -61.25 121.02 60.13 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.303 -0.862 . . . . 1.0 110.533 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -67.13 -17.86 50.83 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 122.723 2.282 . . . . 1.0 112.267 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.421 ' HA ' ' HD3' ' A' ' 116' ' ' ARG . 1.2 mmt180 -93.99 0.46 56.03 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.995 -0.548 . . . . 1.0 111.186 -179.034 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 31.7 t -60.4 -68.35 0.31 Allowed 'General case' 0 C--N 1.332 -0.154 0 O-C-N 123.322 0.389 . . . . 1.0 111.018 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 149.95 -102.52 0.23 Allowed Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.736 -0.745 . . . . 1.0 111.412 179.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 20.5 m -103.71 -56.22 2.25 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.126 0.489 . . . . 1.0 110.264 178.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 24.7 m-70 -150.87 150.97 31.56 Favored 'General case' 0 CA--C 1.5 -0.951 0 CA-C-N 115.853 -0.612 . . . . 1.0 110.712 178.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.794 ' HB2' ' HB2' ' A' ' 112' ' ' SER . . . -97.79 161.9 13.52 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 107.456 -1.313 . . . . 1.0 107.456 173.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.649 HD12 ' O ' ' A' ' 121' ' ' ALA . 2.4 mm? -137.25 -29.4 0.89 Allowed 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.377 -0.829 . . . . 1.0 110.352 -174.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.433 ' HA ' ' HE3' ' A' ' 109' ' ' MET . 0.7 OUTLIER -173.79 154.93 2.52 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.988 -177.362 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 74.5 t -98.61 141.7 15.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.883 -0.598 . . . . 1.0 109.765 178.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.41 ' HB2' ' H ' ' A' ' 126' ' ' ASP . 0.0 OUTLIER -62.18 -162.02 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.276 -1.329 . . . . 1.0 112.802 -179.533 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.93 ' HA ' HH22 ' A' ' 17' ' ' ARG . 5.3 p-10 -158.53 142.43 11.21 Favored Pre-proline 0 C--N 1.318 -0.775 0 CA-C-N 114.714 -1.13 . . . . 1.0 108.056 179.135 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.616 ' HB3' ' HB3' ' A' ' 134' ' ' ASP . 72.8 Cg_exo -44.47 154.86 0.29 Allowed 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.35 2.7 . . . . 1.0 113.028 -176.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.576 ' HD2' ' CD2' ' A' ' 129' ' ' TYR . 49.7 t80 -102.14 -35.87 8.75 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.478 -0.783 . . . . 1.0 111.641 -174.431 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.576 ' CD2' ' HD2' ' A' ' 128' ' ' TYR . 0.2 OUTLIER -139.0 -25.88 0.86 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 120.541 -0.463 . . . . 1.0 111.698 -179.736 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 93.82 77.45 1.37 Allowed Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.24 -0.981 . . . . 1.0 111.975 179.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -140.1 -172.6 3.44 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.77 -0.826 . . . . 1.0 108.77 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -61.08 -33.59 73.58 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.956 -0.387 . . . . 1.0 109.956 179.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 9.9 p -62.41 -53.65 51.79 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.707 -0.679 . . . . 1.0 110.342 178.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.616 ' HB3' ' HB3' ' A' ' 127' ' ' PRO . 1.8 m-20 -53.9 -35.77 61.99 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.966 0.413 . . . . 1.0 111.651 -178.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 14.4 m-30 -71.07 -53.1 15.85 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.391 -0.368 . . . . 1.0 110.561 -178.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.413 ' HA ' ' HB3' ' A' ' 139' ' ' PHE . 20.4 mt-10 -76.42 -16.25 59.74 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.883 -178.01 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.523 ' O ' HG21 ' A' ' 141' ' ' VAL . 23.5 tp10 -63.99 -49.98 70.36 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.994 -0.743 . . . . 1.0 108.994 175.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.412 ' O ' HD12 ' A' ' 142' ' ' ILE . 87.2 t -59.41 -42.91 89.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.323 -0.853 . . . . 1.0 108.889 175.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.462 ' HD2' ' HE2' ' A' ' 20' ' ' MET . 45.6 t80 -53.9 -43.41 69.67 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.159 -1.382 . . . . 1.0 109.553 175.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.546 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -65.03 -40.86 95.43 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.583 -0.735 . . . . 1.0 110.913 179.012 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.523 HG21 ' O ' ' A' ' 137' ' ' GLU . 21.5 t -56.17 -48.63 78.95 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 CA-C-O 121.868 0.842 . . . . 1.0 109.537 177.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.63 HD11 ' HB3' ' A' ' 20' ' ' MET . 5.3 mt -65.62 -51.88 57.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 114.763 -1.108 . . . . 1.0 111.593 -179.346 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.546 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 8.8 pt-20 -56.09 -33.21 64.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.745 0.307 . . . . 1.0 110.506 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 72.7 m -72.37 -28.44 63.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.889 -0.596 . . . . 1.0 110.927 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.467 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -87.61 -23.86 24.15 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-N 115.838 -0.619 . . . . 1.0 111.801 179.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.758 HD21 ' HB3' ' A' ' 25' ' ' PHE . 13.6 mt -55.86 -37.97 63.02 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 120.562 -0.455 . . . . 1.0 112.033 -177.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . 0.611 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 57.8 Cg_endo -69.73 -9.65 26.65 Favored 'Trans proline' 0 C--N 1.363 1.314 0 C-N-CA 122.666 2.244 . . . . 1.0 112.084 178.223 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.541 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -106.09 -32.28 3.83 Favored Glycine 0 N--CA 1.442 -0.934 0 N-CA-C 109.896 -1.282 . . . . 1.0 109.896 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.468 ' O ' HG12 ' A' ' 153' ' ' VAL . 0.4 OUTLIER -74.96 -39.83 61.11 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.448 -0.945 . . . . 1.0 108.448 178.507 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -54.52 -50.99 66.53 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.364 -0.835 . . . . 1.0 110.578 175.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -60.79 -45.76 93.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.367 -0.833 . . . . 1.0 111.611 -176.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . 0.685 ' HZ3' HD23 ' A' ' 5' ' ' LEU . 22.2 t90 -60.2 -55.24 36.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.136 -0.938 . . . . 1.0 110.695 -177.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.468 HG12 ' O ' ' A' ' 149' ' ' LEU . 5.3 m -61.19 -40.39 85.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.524 -0.307 . . . . 1.0 110.527 -178.047 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.441 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 0.5 OUTLIER -60.95 -53.92 51.32 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.085 0.469 . . . . 1.0 111.104 179.216 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.584 ' O ' ' HG2' ' A' ' 159' ' ' ARG . 10.5 pt-20 -61.97 -36.47 81.57 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.698 -0.683 . . . . 1.0 110.654 -177.108 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.439 ' O ' ' HG3' ' A' ' 159' ' ' ARG . 14.0 mmt180 -73.88 -44.54 55.05 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 116.084 -0.507 . . . . 1.0 111.122 -178.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 4.0 pp -67.12 -24.12 65.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.993 0.425 . . . . 1.0 110.11 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -70.99 -49.76 41.74 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.691 -0.686 . . . . 1.0 109.86 179.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.584 ' HG2' ' O ' ' A' ' 155' ' ' GLU . 1.4 ptp180 -79.35 -2.89 43.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.476 -0.784 . . . . 1.0 112.268 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -72.05 19.45 0.07 Allowed 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.236 0.541 . . . . 1.0 111.732 -178.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.53 ' H ' ' C ' ' A' ' 159' ' ' ARG . . . 76.75 139.16 0.96 Allowed Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.513 -0.767 . . . . 1.0 113.785 178.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -89.45 20.0 1.16 Allowed 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 123.114 2.542 . . . . 1.0 111.686 177.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.624 ' HA ' ' H ' ' A' ' 1' ' ' MET . 5.0 t . . . . . 0 C--N 1.306 -1.309 0 CA-C-N 114.265 -1.334 . . . . 1.0 109.825 -177.109 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.457 ' HB3' ' O ' ' A' ' 36' ' ' ASP . 56.9 Cg_endo . . . . . 0 N--CA 1.457 -0.64 0 CA-C-O 121.732 0.638 . . . . 1.0 113.642 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.765 HD13 ' HB3' ' A' ' 84' ' ' ASP . 0.2 OUTLIER -68.44 -177.89 1.01 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.623 -1.171 . . . . 1.0 109.522 178.078 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.696 ' HA ' ' O ' ' A' ' 39' ' ' ARG . 2.4 t-160 -156.84 87.7 1.01 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.924 -0.398 . . . . 1.0 109.924 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.794 HG13 HD13 ' A' ' 85' ' ' LEU . 2.5 t -97.15 104.68 16.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.473 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.591 ' HA ' ' O ' ' A' ' 41' ' ' THR . 12.7 t -107.99 115.58 30.39 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.163 0.506 . . . . 1.0 110.453 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.533 ' HD1' ' HB ' ' A' ' 87' ' ' VAL . 0.7 OUTLIER -84.56 131.75 34.59 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.438 -178.009 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.588 HG21 HD11 ' A' ' 97' ' ' LEU . 43.6 t -116.19 112.58 40.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.223 0.535 . . . . 1.0 111.891 -176.11 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.661 ' HB2' HD23 ' A' ' 89' ' ' LEU . 17.7 t -141.65 165.8 26.49 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.934 -0.575 . . . . 1.0 109.689 177.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.59 HG23 ' NE2' ' A' ' 93' ' ' HIS . 1.2 p -73.47 101.6 3.56 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.959 0.409 . . . . 1.0 110.782 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.944 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 120.68 -43.34 1.55 Allowed Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.859 -0.686 . . . . 1.0 111.863 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.711 ' ND2' ' H ' ' A' ' 74' ' ' ALA . 59.0 t30 60.2 25.82 15.22 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 122.169 0.985 . . . . 1.0 110.883 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.6 pt -126.54 0.66 4.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 115.602 -0.726 . . . . 1.0 111.15 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 23.1 m -120.6 -88.79 0.62 Allowed 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.439 -0.504 . . . . 1.0 111.916 -176.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.41 ' HG3' HD11 ' A' ' 142' ' ' ILE . 38.1 ttm105 -71.94 -40.42 68.72 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.282 0.475 . . . . 1.0 112.282 -174.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.453 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 24.5 m -58.47 -58.34 19.79 Favored Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 111.846 0.313 . . . . 1.0 111.846 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.526 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 40.2 Cg_endo -64.49 -20.99 66.37 Favored 'Trans proline' 0 C--N 1.357 0.978 0 C-N-CA 122.035 1.823 . . . . 1.0 112.166 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.697 ' HB3' HD13 ' A' ' 142' ' ' ILE . 41.9 mmm -62.97 -54.45 38.14 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.625 -0.261 . . . . 1.0 110.499 177.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.475 ' HA ' HG21 ' A' ' 142' ' ' ILE . . . -71.84 -27.83 63.16 Favored 'General case' 0 CA--C 1.509 -0.624 0 C-N-CA 120.461 -0.496 . . . . 1.0 110.076 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.619 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 15.8 tt0 -50.47 -53.47 29.48 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-N 114.741 -1.118 . . . . 1.0 109.852 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.821 ' HB3' ' HG2' ' A' ' 68' ' ' PRO . 0.1 OUTLIER -82.78 -27.32 31.07 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.165 -0.925 . . . . 1.0 110.22 -175.958 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.785 ' HB3' HD11 ' A' ' 146' ' ' LEU . 7.9 mmm -62.87 -75.61 0.07 Allowed 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 112.993 0.738 . . . . 1.0 112.993 -176.013 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.833 ' HB3' HD22 ' A' ' 146' ' ' LEU . 19.8 p90 -78.04 -29.92 49.61 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 119.958 -0.697 . . . . 1.0 111.219 -175.187 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.649 ' HB2' HG11 ' A' ' 40' ' ' VAL . . . -63.37 -38.15 90.02 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 119.413 -0.915 . . . . 1.0 110.57 179.106 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.643 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -63.36 -40.75 98.13 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.94 -0.763 . . . . 1.0 108.94 177.098 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.582 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 79.4 mt-30 -59.83 -41.88 92.32 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-N 115.85 -0.613 . . . . 1.0 110.679 176.224 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.67 ' HG ' ' O ' ' A' ' 25' ' ' PHE . 80.2 mt -55.89 -61.41 2.39 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.682 -0.69 . . . . 1.0 110.257 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.555 ' HB3' ' HA3' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -59.07 -33.56 70.95 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.793 -0.363 . . . . 1.0 111.374 178.553 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -63.37 -25.54 68.34 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.21 0.448 . . . . 1.0 112.21 176.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.598 ' HG2' ' O ' ' A' ' 29' ' ' LEU . 8.3 ptm85 -98.6 -21.29 16.54 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 120.05 -0.66 . . . . 1.0 110.104 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.27 33.17 1.83 Allowed Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 114.991 -1.004 . . . . 1.0 112.437 177.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.574 ' HG ' ' HG3' ' A' ' 32' ' ' ARG . 36.1 mt -127.14 6.47 6.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.982 0.391 . . . . 1.0 110.709 -178.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.555 ' HA3' ' HB3' ' A' ' 30' ' ' ARG . . . -54.21 -35.84 55.87 Favored Glycine 0 CA--C 1.52 0.374 0 C-N-CA 121.27 -0.49 . . . . 1.0 113.573 -177.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.614 ' HA ' ' NH1' ' A' ' 39' ' ' ARG . 2.8 m-20 -92.29 -14.02 29.48 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.97 0.414 . . . . 1.0 110.925 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.83 -17.93 49.13 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.875 -0.602 . . . . 1.0 111.2 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.705 HG23 ' HB3' ' A' ' 5' ' ' LEU . 0.4 OUTLIER -144.64 124.3 7.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.39 0.614 . . . . 1.0 111.055 179.436 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.696 ' O ' ' HA ' ' A' ' 6' ' ' HIS . 25.8 mmt180 -95.66 101.45 13.15 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.634 -0.712 . . . . 1.0 110.948 -178.176 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.649 HG11 ' HB2' ' A' ' 26' ' ' ALA . 1.6 m -89.03 136.61 23.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 109.035 -0.728 . . . . 1.0 109.035 178.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.591 ' O ' ' HA ' ' A' ' 8' ' ' THR . 31.7 p -146.6 -176.11 5.05 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.045 -0.98 . . . . 1.0 109.742 -175.054 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.439 ' HB3' ' HD2' ' A' ' 9' ' ' PHE . 49.2 p -158.76 160.66 36.56 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.153 -0.619 . . . . 1.0 111.253 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.619 ' HB2' ' CD2' ' A' ' 80' ' ' HIS . . . -162.68 161.88 26.66 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.315 0.579 . . . . 1.0 111.582 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -124.33 138.53 11.31 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 111.096 -0.802 . . . . 1.0 111.096 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.445 HG21 HD12 ' A' ' 96' ' ' LEU . 33.7 p -74.36 -24.0 59.09 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 111.962 0.356 . . . . 1.0 111.962 -176.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.584 ' HA3' ' CZ3' ' A' ' 48' ' ' TRP . . . -110.76 9.39 29.97 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.533 -0.841 . . . . 1.0 113.083 -178.162 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 42.67 37.35 1.0 Allowed 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 113.885 1.068 . . . . 1.0 113.885 177.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.944 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 1.5 m-90 -44.81 -70.41 0.1 Allowed 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.559 0.695 . . . . 1.0 112.369 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.686 ' O ' ' HB2' ' A' ' 52' ' ' SER . 6.8 m-70 -109.65 43.73 1.28 Allowed 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.1 -0.954 . . . . 1.0 111.057 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.43 HG23 ' HA ' ' A' ' 74' ' ' ALA . 14.8 p -62.54 129.74 26.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 C-N-CA 120.425 -0.51 . . . . 1.0 110.169 178.34 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.14 -13.5 66.88 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 121.109 -0.567 . . . . 1.0 111.684 -176.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.686 ' HB2' ' O ' ' A' ' 49' ' ' HIS . 0.4 OUTLIER -80.0 -162.26 0.42 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.174 0.511 . . . . 1.0 110.669 179.58 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 33.7 t -126.45 175.94 7.52 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.291 -1.003 . . . . 1.0 108.291 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.06 141.06 47.21 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.955 0.407 . . . . 1.0 111.374 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.456 ' OD1' ' HG2' ' A' ' 57' ' ' ARG . 13.2 t70 -61.05 141.15 57.61 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.285 -0.87 . . . . 1.0 111.436 -177.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -46.24 -37.8 7.67 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.727 -1.124 . . . . 1.0 113.555 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.674 ' O ' HG23 ' A' ' 61' ' ' VAL . 14.9 ptp180 -69.95 -45.31 67.73 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 122.276 -0.265 . . . . 1.0 110.897 -176.61 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.0 -31.62 68.19 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.485 -178.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.64 -43.43 98.82 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.893 -0.594 . . . . 1.0 110.046 178.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.41 -42.4 97.65 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.786 -0.721 . . . . 1.0 111.486 177.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.674 HG23 ' O ' ' A' ' 57' ' ' ARG . 61.3 t -58.05 -58.53 6.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-O 120.975 0.417 . . . . 1.0 111.273 179.172 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.735 ' HB2' HG22 ' A' ' 69' ' ' THR . 90.1 mt -59.04 -51.21 71.02 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.061 -0.518 . . . . 1.0 111.662 -178.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -60.87 -29.27 69.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.482 -0.326 . . . . 1.0 110.894 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.19 -31.48 71.91 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.225 0.536 . . . . 1.0 110.546 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -99.42 1.89 44.63 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.492 -0.776 . . . . 1.0 111.505 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.97 16.26 56.41 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 121.045 -0.597 . . . . 1.0 113.213 177.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -92.08 149.58 38.96 Favored Pre-proline 0 C--N 1.322 -0.627 0 C-N-CA 122.083 0.153 . . . . 1.0 111.082 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.821 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 49.6 Cg_endo -68.89 158.23 58.72 Favored 'Trans proline' 0 CA--C 1.511 -0.634 0 C-N-CA 122.519 2.146 . . . . 1.0 110.36 176.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.735 HG22 ' HB2' ' A' ' 62' ' ' LEU . 58.1 p -134.53 3.53 3.31 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 119.562 -0.855 . . . . 1.0 112.65 -176.526 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -79.85 135.65 36.5 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.762 -0.375 . . . . 1.0 110.429 -179.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -175.58 153.99 1.54 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.698 -0.683 . . . . 1.0 109.251 -176.414 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -123.3 116.72 23.79 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.208 -1.034 . . . . 1.0 108.208 177.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' A' ' 49' ' ' HIS . . . -61.3 139.02 58.24 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.259 0.552 . . . . 1.0 111.895 -176.35 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.711 ' H ' ' ND2' ' A' ' 14' ' ' ASN . . . -130.88 161.23 32.3 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.427 -0.806 . . . . 1.0 109.942 178.325 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -98.1 161.41 13.73 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.943 -0.762 . . . . 1.0 108.943 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.548 HG11 HD23 ' A' ' 97' ' ' LEU . 94.0 t -67.44 102.72 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.398 0.618 . . . . 1.0 110.388 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.556 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -120.79 -170.87 14.23 Favored Glycine 0 N--CA 1.443 -0.882 0 CA-C-N 115.046 -0.979 . . . . 1.0 111.824 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 88.4 m -55.92 -54.12 48.52 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.758 0.651 . . . . 1.0 112.758 -178.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.533 ' HG2' ' N ' ' A' ' 80' ' ' HIS . 0.6 OUTLIER -56.43 -31.36 63.84 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.893 -0.594 . . . . 1.0 111.089 -178.167 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.619 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 79.1 m80 -76.32 -42.36 45.4 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.6 -0.727 . . . . 1.0 110.064 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.556 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 23.2 mt -66.21 -19.77 65.93 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.476 178.426 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -84.77 -5.33 59.32 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.871 -0.604 . . . . 1.0 110.998 -178.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.573 ' HB1' ' O ' ' A' ' 6' ' ' HIS . . . -60.8 157.85 14.14 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.071 -0.513 . . . . 1.0 111.644 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.765 ' HB3' HD13 ' A' ' 5' ' ' LEU . 29.9 t70 -82.69 -16.57 47.67 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 115.915 -0.584 . . . . 1.0 109.807 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.794 HD13 HG13 ' A' ' 7' ' ' VAL . 0.4 OUTLIER -154.61 115.82 4.05 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.334 -0.848 . . . . 1.0 109.059 -176.581 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.577 ' HG ' HG22 ' A' ' 8' ' ' THR . 5.4 mp -106.74 106.81 17.52 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-N 115.479 -0.782 . . . . 1.0 109.853 177.453 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.559 HG11 HD23 ' A' ' 110' ' ' LEU . 52.3 t -85.14 92.26 3.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 114.896 -1.047 . . . . 1.0 110.869 -176.038 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.27 147.54 32.49 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.514 -0.766 . . . . 1.0 110.98 179.194 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.661 HD23 ' HB2' ' A' ' 11' ' ' CYS . 2.9 mm? -103.73 -4.85 23.14 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.273 0.558 . . . . 1.0 110.49 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.419 ' CG ' ' H ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -155.37 153.37 30.35 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.71 -0.677 . . . . 1.0 111.223 178.538 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 25.4 ptt180 -50.19 -32.09 15.44 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 114.903 -1.044 . . . . 1.0 112.998 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.714 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 5.9 m-20 -76.3 -48.46 20.03 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.288 -0.264 . . . . 1.0 110.288 -176.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.651 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 14.2 m170 -55.14 -48.46 73.65 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.73 -0.47 . . . . 1.0 109.73 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.458 ' HA ' HG21 ' A' ' 107' ' ' VAL . . . -59.3 -43.45 92.6 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.028 0.442 . . . . 1.0 110.849 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 9.8 ttt-85 -59.67 -45.51 91.84 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 115.408 -0.815 . . . . 1.0 111.66 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.772 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 56.0 mt -63.86 -49.49 72.55 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 115.902 -0.59 . . . . 1.0 110.028 -175.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.651 ' HG ' ' O ' ' A' ' 93' ' ' HIS . 22.6 mt -52.77 -57.83 8.86 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.668 -0.696 . . . . 1.0 111.368 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.604 ' HA ' ' HB ' ' A' ' 102' ' ' VAL . 9.4 ptt180 -60.42 -43.21 96.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.11 -0.496 . . . . 1.0 111.878 -176.214 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.648 ' HG3' ' O ' ' A' ' 96' ' ' LEU . 1.3 pp0? -68.33 -23.31 64.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.911 0.386 . . . . 1.0 110.287 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.772 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 11.4 mt -79.2 -13.43 59.71 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.87 -0.605 . . . . 1.0 112.194 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 148.4 -22.87 1.37 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.067 -1.063 . . . . 1.0 112.773 -178.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.975 HG12 ' H ' ' A' ' 103' ' ' GLU . 3.3 t -75.6 -156.09 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.123 0.487 . . . . 1.0 110.119 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.975 ' H ' HG12 ' A' ' 102' ' ' VAL . 9.3 pt-20 -170.44 163.84 8.57 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.755 -1.202 . . . . 1.0 107.755 -177.641 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.738 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -65.83 -22.14 66.53 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.754 0.311 . . . . 1.0 111.213 -176.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.487 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . . . -58.52 -37.8 76.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.295 0.569 . . . . 1.0 109.947 174.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.698 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 10.5 mtt180 -96.21 -45.33 6.89 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 115.193 -0.912 . . . . 1.0 110.778 -177.036 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.738 HG12 ' HA ' ' A' ' 104' ' ' ALA . 8.2 p -79.07 124.8 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-O 121.289 0.566 . . . . 1.0 110.49 -176.574 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.532 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 10.6 mmm180 -140.85 147.92 39.71 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.285 -0.635 . . . . 1.0 109.285 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.479 ' HB2' ' HB2' ' A' ' 112' ' ' SER . 83.1 mmm -78.88 140.24 38.16 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.451 -0.34 . . . . 1.0 110.375 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.559 HD23 HG11 ' A' ' 87' ' ' VAL . 3.0 tm? -58.45 -51.69 68.77 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 122.973 0.171 . . . . 1.0 111.262 -179.161 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 46.1 ttm-85 -71.26 -14.51 62.25 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 120.278 -0.569 . . . . 1.0 110.442 -178.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.479 ' HB2' ' HB2' ' A' ' 109' ' ' MET . 42.2 t -73.62 -9.51 58.75 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.71 -0.396 . . . . 1.0 110.423 179.222 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.553 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 97.2 m-85 -91.02 -22.68 20.66 Favored 'General case' 0 C--N 1.341 0.213 0 N-CA-C 109.782 -0.451 . . . . 1.0 109.782 175.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.5 t0 . . . . . 0 C--N 1.331 -0.237 0 CA-C-N 115.22 -0.9 . . . . 1.0 111.019 -178.435 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 . . . . . 0 C--O 1.233 0.204 0 CA-C-O 120.96 0.409 . . . . 1.0 110.806 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.543 ' O ' HG23 ' A' ' 141' ' ' VAL . 16.9 tp10 -61.58 -51.56 68.04 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.659 -0.7 . . . . 1.0 110.126 178.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.641 ' HA ' HG23 ' A' ' 141' ' ' VAL . 71.9 t -59.85 -41.15 84.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.758 -0.655 . . . . 1.0 110.346 178.471 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.543 ' HB2' HG11 ' A' ' 61' ' ' VAL . 49.8 t80 -54.65 -43.6 72.51 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.185 -0.916 . . . . 1.0 109.418 176.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.53 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -63.94 -41.86 97.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.595 -0.729 . . . . 1.0 110.798 178.058 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.641 HG23 ' HA ' ' A' ' 138' ' ' VAL . 5.6 t -53.83 -53.1 29.22 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 CA-C-O 121.841 0.829 . . . . 1.0 110.031 177.58 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.697 HD13 ' HB3' ' A' ' 20' ' ' MET . 6.8 mt -64.97 -50.94 72.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 114.649 -1.16 . . . . 1.0 112.085 -177.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.53 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 10.3 pt-20 -57.33 -30.87 65.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.677 0.275 . . . . 1.0 110.533 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.9 t -73.49 -29.62 62.62 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-O 121.2 0.524 . . . . 1.0 110.164 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.502 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -86.7 -24.12 25.31 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-N 116.018 -0.537 . . . . 1.0 112.128 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.833 HD22 ' HB3' ' A' ' 25' ' ' PHE . 14.4 mt -55.15 -36.42 45.14 Favored Pre-proline 0 CA--C 1.545 0.769 0 N-CA-C 112.745 0.646 . . . . 1.0 112.745 -177.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.632 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 56.9 Cg_endo -70.22 -10.59 28.53 Favored 'Trans proline' 0 C--N 1.363 1.299 0 C-N-CA 122.63 2.22 . . . . 1.0 112.09 176.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.553 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -106.07 -33.74 3.39 Favored Glycine 0 N--CA 1.449 -0.492 0 N-CA-C 110.372 -1.091 . . . . 1.0 110.372 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.468 ' O ' HG13 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -73.02 -39.23 66.17 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.0 -1.111 . . . . 1.0 108.0 178.369 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 150' ' ' HIS . . . . . 0.517 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 0.2 OUTLIER -52.97 -58.4 7.11 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 114.801 -1.091 . . . . 1.0 110.834 175.293 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -56.92 -39.83 75.22 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.766 -1.106 . . . . 1.0 111.304 -174.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' TRP . . . . . 0.758 ' HZ3' HD11 ' A' ' 5' ' ' LEU . 22.3 t90 -65.18 -55.75 16.8 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.602 -0.726 . . . . 1.0 110.875 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.468 HG13 ' O ' ' A' ' 149' ' ' LEU . 6.5 m -61.35 -41.97 91.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.888 -0.412 . . . . 1.0 109.888 -178.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.438 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 3.3 m-20 -60.19 -51.26 70.35 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-O 120.96 0.41 . . . . 1.0 110.855 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 7.1 pt-20 -63.4 -38.35 90.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.95 -177.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.529 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 5.5 mmt85 -73.81 -43.02 60.08 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.701 -0.681 . . . . 1.0 110.802 -176.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 4.0 pp . . . . . 0 C--N 1.322 -0.596 0 CA-C-N 116.017 -0.538 . . . . 1.0 109.998 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.447 ' HB2' ' HG2' ' A' ' 39' ' ' ARG . 17.8 Cg_endo . . . . . 0 N--CA 1.461 -0.385 0 CA-C-O 121.091 0.371 . . . . 1.0 112.915 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.818 ' HB3' HG23 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -65.38 175.92 1.57 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.599 -0.728 . . . . 1.0 109.684 179.67 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.803 ' H ' HD13 ' A' ' 5' ' ' LEU . 0.5 OUTLIER -153.75 100.28 2.37 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.883 -0.414 . . . . 1.0 109.883 179.175 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.705 HG13 HD13 ' A' ' 85' ' ' LEU . 1.8 t -103.6 116.84 48.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 107.983 -1.118 . . . . 1.0 107.983 178.225 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.621 ' CG2' ' HG ' ' A' ' 86' ' ' LEU . 15.1 t -119.77 114.31 21.95 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 120.589 -0.444 . . . . 1.0 110.81 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.759 ' HZ ' ' HE1' ' A' ' 25' ' ' PHE . 0.4 OUTLIER -84.35 131.41 34.7 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 120.398 -0.521 . . . . 1.0 110.177 -179.619 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.596 HG21 HD11 ' A' ' 97' ' ' LEU . 30.1 t -113.66 118.42 58.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 116.284 -0.416 . . . . 1.0 111.365 -176.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.44 ' HB2' HD23 ' A' ' 89' ' ' LEU . 46.2 t -148.65 146.8 28.34 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.996 -0.372 . . . . 1.0 109.996 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.54 93.27 1.19 Allowed 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 121.115 0.483 . . . . 1.0 110.394 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 148.08 -37.99 1.06 Allowed Glycine 0 N--CA 1.441 -1.01 0 CA-C-N 115.183 -0.917 . . . . 1.0 111.088 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.894 HD21 ' HA3' ' A' ' 44' ' ' GLY . 1.4 p30 48.47 24.43 0.74 Allowed 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.063 0.945 . . . . 1.0 112.864 178.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.446 HG12 ' HB2' ' A' ' 49' ' ' HIS . 1.3 pt -148.23 47.2 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.451 0 CA-C-N 115.574 -0.739 . . . . 1.0 110.625 178.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.45 ' HA ' ' OD1' ' A' ' 55' ' ' ASP . 53.2 t -161.68 -84.56 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.535 -0.757 . . . . 1.0 109.599 173.082 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 27.4 mmt85 -59.79 -57.16 14.12 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.795 -0.639 . . . . 1.0 112.002 -178.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' SER . . . . . 1.067 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 6.2 m -52.11 -58.35 11.72 Favored Pre-proline 0 CA--C 1.546 0.825 0 CA-C-N 115.085 -0.961 . . . . 1.0 112.55 -177.005 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.673 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 37.3 Cg_endo -63.45 -27.82 70.71 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 121.985 1.79 . . . . 1.0 112.909 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.477 ' HB3' HD13 ' A' ' 142' ' ' ILE . 45.5 mmm -59.28 -57.31 13.58 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.295 -0.261 . . . . 1.0 110.295 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.541 ' O ' ' HD1' ' A' ' 25' ' ' PHE . . . -71.37 -32.16 68.16 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 115.885 -0.598 . . . . 1.0 110.507 -178.526 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.633 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 15.0 tt0 -49.79 -52.72 29.95 Favored 'General case' 0 C--O 1.216 -0.69 0 O-C-N 124.198 0.936 . . . . 1.0 109.917 -178.019 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.972 ' HE3' ' HB2' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -86.63 -22.33 26.24 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 119.592 -0.843 . . . . 1.0 110.9 -176.919 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.472 ' HB3' HD11 ' A' ' 146' ' ' LEU . 88.7 mtp -64.21 -75.16 0.09 Allowed 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.384 0.513 . . . . 1.0 112.384 -179.052 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.759 ' HE1' ' HZ ' ' A' ' 9' ' ' PHE . 0.8 OUTLIER -78.43 -28.29 46.72 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 119.754 -0.778 . . . . 1.0 111.613 -175.452 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.633 ' HB3' ' O ' ' A' ' 22' ' ' GLU . . . -64.54 -38.73 92.04 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 119.387 -0.925 . . . . 1.0 110.473 178.419 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.602 ' HG3' ' N ' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -64.75 -37.45 87.63 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.825 -0.806 . . . . 1.0 108.825 177.789 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.602 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 78.5 mt-30 -60.05 -43.01 95.68 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-N 115.967 -0.56 . . . . 1.0 109.897 175.431 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 25' ' ' PHE . 93.2 mt -56.02 -59.01 5.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.74 -0.664 . . . . 1.0 110.767 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.502 ' HG2' ' O ' ' A' ' 27' ' ' GLN . 0.2 OUTLIER -60.58 -34.27 73.94 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.372 -0.531 . . . . 1.0 111.349 178.463 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.8 m170 -59.42 -30.09 68.23 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 111.994 0.368 . . . . 1.0 111.994 176.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.459 ' HG2' ' O ' ' A' ' 28' ' ' GLN . 5.8 ptp180 -95.41 -19.25 20.05 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 119.501 -0.88 . . . . 1.0 110.261 179.165 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 107.42 38.44 2.09 Favored Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.238 -0.892 . . . . 1.0 112.339 177.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 25.2 mt -129.54 0.02 4.98 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 122.554 -0.38 . . . . 1.0 110.258 -178.065 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.474 ' H ' ' HA ' ' A' ' 30' ' ' ARG . . . -54.26 -28.41 42.72 Favored Glycine 0 CA--C 1.519 0.337 0 CA-C-N 116.028 -0.533 . . . . 1.0 113.837 -178.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.499 ' HA ' ' NH1' ' A' ' 39' ' ' ARG . 5.1 t70 -89.45 -24.88 21.75 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-O 121.54 0.686 . . . . 1.0 109.739 178.09 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -77.59 -19.38 55.7 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 114.716 -1.129 . . . . 1.0 111.438 -174.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.818 HG23 ' HB3' ' A' ' 5' ' ' LEU . 0.4 OUTLIER -145.05 124.24 6.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.964 -0.562 . . . . 1.0 109.889 179.81 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.499 ' NH1' ' HA ' ' A' ' 36' ' ' ASP . 29.1 mmt180 -90.16 137.44 32.34 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 109.291 -0.633 . . . . 1.0 109.291 -178.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 80.8 t -124.78 126.88 72.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 N-CA-C 109.425 -0.583 . . . . 1.0 109.425 -178.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' ' 8' ' ' THR . 31.5 p -139.51 -178.11 5.24 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.175 -0.921 . . . . 1.0 110.557 -174.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' SER . . . . . 1.067 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 87.9 p -159.01 159.61 34.97 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.987 -0.551 . . . . 1.0 109.987 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.457 ' HA ' ' O ' ' A' ' 74' ' ' ALA . . . -164.44 166.17 20.8 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 121.32 0.581 . . . . 1.0 111.462 -178.356 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.894 ' HA3' HD21 ' A' ' 14' ' ' ASN . . . -124.58 138.96 11.47 Favored Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 110.789 -0.924 . . . . 1.0 110.789 177.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.54 HG21 HD12 ' A' ' 96' ' ' LEU . 28.3 p -71.79 -21.9 61.65 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.96 0.409 . . . . 1.0 110.977 -178.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -107.17 2.2 35.16 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 120.789 -0.72 . . . . 1.0 113.217 -177.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.493 ' HB3' ' HB2' ' A' ' 75' ' ' GLN . 3.1 p-10 44.23 35.99 1.41 Allowed 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 113.324 0.861 . . . . 1.0 113.324 178.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -43.87 -74.65 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.715 0.769 . . . . 1.0 112.453 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.446 ' HB2' HG12 ' A' ' 15' ' ' ILE . 79.0 m-70 -106.25 42.57 1.25 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.043 -0.98 . . . . 1.0 110.686 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.435 HG23 ' HA ' ' A' ' 74' ' ' ALA . 14.5 p -60.32 134.94 25.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.429 178.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.55 -13.63 60.03 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.885 -0.674 . . . . 1.0 112.303 -178.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.8 t -79.79 -162.67 0.45 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.163 0.506 . . . . 1.0 109.928 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 15.5 t -119.56 174.91 6.11 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.931 -0.766 . . . . 1.0 108.931 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.409 ' HB2' ' HB3' ' A' ' 71' ' ' HIS . . . -62.71 147.02 50.89 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.34 0.59 . . . . 1.0 111.485 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.621 ' OD2' ' HG3' ' A' ' 57' ' ' ARG . 9.8 p-10 -60.79 138.91 58.07 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.958 -1.019 . . . . 1.0 112.885 -178.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -48.6 -36.52 15.86 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 114.704 -1.134 . . . . 1.0 112.596 178.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.621 ' HG3' ' OD2' ' A' ' 55' ' ' ASP . 8.2 ptt180 -70.65 -44.23 67.54 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 122.298 0.239 . . . . 1.0 111.095 -178.048 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.34 -38.59 78.22 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 109.222 -0.658 . . . . 1.0 109.222 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.06 -44.9 94.38 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.604 -0.725 . . . . 1.0 109.984 178.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.427 ' O ' ' HG2' ' A' ' 63' ' ' ARG . . . -58.06 -44.1 94.83 Favored Glycine 0 N--CA 1.443 -0.882 0 CA-C-N 115.618 -0.719 . . . . 1.0 113.198 178.48 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.3 m -75.6 -39.24 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-N 117.326 0.563 . . . . 1.0 111.383 -178.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.618 ' HB2' HG22 ' A' ' 69' ' ' THR . 96.6 mt -61.59 -52.14 65.64 Favored 'General case' 0 C--O 1.23 0.044 0 C-N-CA 120.892 -0.323 . . . . 1.0 110.299 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.427 ' HG2' ' O ' ' A' ' 60' ' ' GLY . 6.8 ptm180 -59.63 -30.79 68.96 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.723 -0.671 . . . . 1.0 110.947 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.6 -33.23 74.58 Favored 'General case' 0 C--O 1.226 -0.141 0 CA-C-N 116.354 -0.385 . . . . 1.0 111.297 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.491 ' HB2' ' HD2' ' A' ' 67' ' ' TYR . 98.5 m-70 -96.33 2.51 52.84 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.341 -0.39 . . . . 1.0 111.237 -178.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 90.18 14.34 59.1 Favored Glycine 0 C--N 1.329 0.145 0 CA-C-N 116.005 -0.543 . . . . 1.0 112.536 177.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.491 ' HD2' ' HB2' ' A' ' 65' ' ' HIS . 69.0 m-85 -91.39 149.56 39.78 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-O 120.551 0.215 . . . . 1.0 110.855 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.407 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 52.1 Cg_endo -69.05 153.71 71.76 Favored 'Trans proline' 0 CA--C 1.509 -0.742 0 C-N-CA 122.325 2.017 . . . . 1.0 110.666 177.015 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.618 HG22 ' HB2' ' A' ' 62' ' ' LEU . 42.3 p -124.74 15.68 8.71 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 121.552 0.691 . . . . 1.0 110.442 -177.586 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -84.2 120.11 25.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.056 -0.975 . . . . 1.0 110.154 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.972 ' HB2' ' HE3' ' A' ' 23' ' ' LYS . 32.3 t60 -159.11 147.72 18.17 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.761 -0.654 . . . . 1.0 110.587 -177.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.7 tpp180 -125.71 112.57 16.25 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 107.697 -1.223 . . . . 1.0 107.697 175.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.546 ' HB1' ' OD1' ' A' ' 14' ' ' ASN . . . -59.95 140.17 56.91 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.543 -0.753 . . . . 1.0 111.956 -176.337 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 43' ' ' ALA . . . -135.96 160.6 38.11 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.646 178.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.493 ' HB2' ' HB3' ' A' ' 47' ' ' ASN . 43.5 tt0 -98.68 155.82 17.14 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.767 -0.457 . . . . 1.0 109.767 178.559 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.487 HG11 HD23 ' A' ' 97' ' ' LEU . 36.5 t -66.48 111.32 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.365 0.603 . . . . 1.0 110.731 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -123.86 -168.3 12.93 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.049 -0.978 . . . . 1.0 111.034 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 80.6 m -55.73 -46.96 77.67 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.711 0.291 . . . . 1.0 111.377 -179.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -60.13 -29.57 68.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.407 -0.36 . . . . 1.0 111.553 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.424 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 77.1 m80 -78.1 -39.26 42.0 Favored 'General case' 0 C--O 1.222 -0.357 0 N-CA-C 109.858 -0.423 . . . . 1.0 109.858 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.664 ' O ' HG23 ' A' ' 102' ' ' VAL . 15.6 mt -70.36 -18.18 63.06 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.308 -0.405 . . . . 1.0 110.451 176.369 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -88.43 -7.73 56.12 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 120.77 0.319 . . . . 1.0 110.232 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.603 ' HA ' ' HB3' ' A' ' 6' ' ' HIS . . . -59.65 148.01 35.36 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.81 -0.632 . . . . 1.0 109.888 178.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.544 ' HB3' HD13 ' A' ' 5' ' ' LEU . 28.5 t70 -74.44 -16.1 60.88 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.218 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.705 HD13 HG13 ' A' ' 7' ' ' VAL . 0.6 OUTLIER -153.17 116.47 4.64 Favored 'General case' 0 CA--C 1.51 -0.596 0 N-CA-C 109.336 -0.616 . . . . 1.0 109.336 -176.836 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.716 ' HB3' HD13 ' A' ' 97' ' ' LEU . 5.0 mp -106.89 105.52 15.59 Favored 'General case' 0 N--CA 1.426 -1.654 0 CA-C-N 115.489 -0.778 . . . . 1.0 109.782 178.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.628 HG11 HD23 ' A' ' 110' ' ' LEU . 86.6 t -84.63 93.39 3.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 114.554 -1.203 . . . . 1.0 111.263 -175.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.17 145.34 31.06 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.594 -0.73 . . . . 1.0 111.249 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.44 HD23 ' HB2' ' A' ' 11' ' ' CYS . 4.2 mm? -96.53 -11.53 25.32 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.821 -0.627 . . . . 1.0 109.774 178.227 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.426 ' CG ' ' H ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -148.78 153.62 38.41 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.631 -0.713 . . . . 1.0 110.747 179.859 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -57.96 -26.19 61.97 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.274 -0.876 . . . . 1.0 112.935 -178.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.629 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 82.8 m-20 -77.41 -47.34 20.03 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 110.125 -0.324 . . . . 1.0 110.125 -178.125 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.656 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 20.6 m170 -53.87 -47.64 70.84 Favored 'General case' 0 CA--C 1.522 -0.106 0 CA-C-N 115.981 -0.554 . . . . 1.0 109.666 177.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.95 -44.42 91.44 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.909 -0.587 . . . . 1.0 110.61 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.655 ' O ' ' HG2' ' A' ' 99' ' ' GLN . 9.8 ttp180 -56.54 -46.13 80.81 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.603 -0.726 . . . . 1.0 111.129 178.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.629 ' HG ' ' O ' ' A' ' 92' ' ' ASN . 42.7 mt -63.39 -47.87 80.22 Favored 'General case' 0 C--O 1.216 -0.696 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.547 -175.12 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.716 HD13 ' HB3' ' A' ' 86' ' ' LEU . 29.5 mt -53.03 -58.8 5.76 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.784 -0.644 . . . . 1.0 111.413 -177.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.678 ' CA ' HG12 ' A' ' 102' ' ' VAL . 2.2 ptm180 -59.33 -45.25 91.85 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.844 0.683 . . . . 1.0 112.844 -179.164 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.655 ' HG2' ' O ' ' A' ' 95' ' ' ARG . 7.5 pt20 -68.24 -23.6 64.81 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.165 -0.614 . . . . 1.0 110.49 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.612 HD13 ' O ' ' A' ' 96' ' ' LEU . 6.7 mp -78.98 -17.5 55.29 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 116.267 -0.424 . . . . 1.0 111.817 178.12 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 152.66 -23.44 0.83 Allowed Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 119.579 -1.296 . . . . 1.0 113.749 -178.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.678 HG12 ' CA ' ' A' ' 98' ' ' ARG . 0.4 OUTLIER -78.45 -163.89 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-N 117.77 0.785 . . . . 1.0 110.166 179.801 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.677 ' N ' HG13 ' A' ' 102' ' ' VAL . 13.1 pt-20 -156.38 165.22 36.99 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 107.736 -1.209 . . . . 1.0 107.736 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.781 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -61.37 -27.11 68.29 Favored 'General case' 0 C--N 1.316 -0.881 0 O-C-N 123.466 0.479 . . . . 1.0 111.278 -175.383 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.431 ' HA ' ' NH2' ' A' ' 108' ' ' ARG . . . -58.22 -34.07 70.0 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 120.713 0.292 . . . . 1.0 110.578 177.084 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.43 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 3.9 mtp180 -97.59 -42.84 7.48 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.955 -0.566 . . . . 1.0 111.343 -178.38 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.781 HG12 ' HA ' ' A' ' 104' ' ' ALA . 12.6 p -77.88 119.08 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-O 120.95 0.405 . . . . 1.0 110.032 -174.362 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.529 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 26.8 mmt180 -137.96 149.82 46.48 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 121.695 -0.628 . . . . 1.0 110.583 -178.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.676 ' HB2' ' HB2' ' A' ' 112' ' ' SER . 80.9 mmm -79.06 138.19 37.87 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.015 -0.539 . . . . 1.0 110.214 178.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.628 HD23 HG11 ' A' ' 87' ' ' VAL . 2.9 tm? -57.29 -48.8 78.0 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.037 0.446 . . . . 1.0 111.036 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 6.5 ttt-85 -69.68 -14.61 62.89 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.637 -0.71 . . . . 1.0 110.07 -178.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.676 ' HB2' ' HB2' ' A' ' 109' ' ' MET . 43.9 t -79.12 -8.97 59.41 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.921 -0.581 . . . . 1.0 111.289 -178.413 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.577 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 91.4 m-85 -91.36 -19.04 23.35 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 120.812 0.339 . . . . 1.0 110.266 176.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 15.8 t0 . . . . . 0 C--N 1.325 -0.491 0 CA-C-N 115.854 -0.612 . . . . 1.0 111.143 -177.456 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.408 ' O ' ' HB3' ' A' ' 139' ' ' PHE . 6.8 mt-10 . . . . . 0 N--CA 1.454 -0.261 0 CA-C-O 120.791 0.329 . . . . 1.0 110.864 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.512 ' O ' HG23 ' A' ' 141' ' ' VAL . 4.3 tp10 -62.79 -47.5 83.2 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.961 -0.755 . . . . 1.0 108.961 175.292 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.679 ' HA ' HG23 ' A' ' 141' ' ' VAL . 55.3 t -61.93 -39.91 85.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 114.662 -1.153 . . . . 1.0 109.815 176.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.408 ' HB3' ' O ' ' A' ' 136' ' ' GLU . 74.4 t80 -53.11 -43.45 66.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.965 -1.016 . . . . 1.0 108.912 175.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.676 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -65.14 -41.16 95.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.304 -0.862 . . . . 1.0 111.09 177.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.679 HG23 ' HA ' ' A' ' 138' ' ' VAL . 12.7 t -54.64 -52.55 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 121.841 0.829 . . . . 1.0 110.233 178.344 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.477 HD13 ' HB3' ' A' ' 20' ' ' MET . 7.1 mt -65.81 -50.62 69.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 114.817 -1.083 . . . . 1.0 111.769 -179.015 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.676 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 11.3 pt-20 -58.91 -29.4 67.03 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 120.812 -0.355 . . . . 1.0 110.349 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' SER . . . . . 0.412 ' HB2' ' O ' ' A' ' 140' ' ' ALA . 2.1 t -74.17 -27.58 60.89 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 121.114 0.483 . . . . 1.0 109.94 178.389 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.468 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -86.54 -24.72 25.38 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 115.882 -0.599 . . . . 1.0 111.597 178.371 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.759 HD22 ' HB3' ' A' ' 25' ' ' PHE . 17.9 mt -54.85 -36.84 49.25 Favored Pre-proline 0 CA--C 1.549 0.942 0 N-CA-C 112.636 0.606 . . . . 1.0 112.636 -178.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.615 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 56.2 Cg_endo -70.45 -12.28 31.33 Favored 'Trans proline' 0 C--N 1.368 1.578 0 C-N-CA 122.775 2.317 . . . . 1.0 112.022 177.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.577 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -104.13 -33.68 3.92 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 110.195 -1.162 . . . . 1.0 110.195 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.457 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -72.51 -39.15 67.82 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 108.267 -1.012 . . . . 1.0 108.267 178.446 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 150' ' ' HIS . . . . . 0.507 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 0.2 OUTLIER -54.0 -58.86 5.75 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-N 114.52 -1.218 . . . . 1.0 110.845 175.994 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -55.15 -41.78 72.23 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 114.826 -1.079 . . . . 1.0 111.012 -174.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' TRP . . . . . 0.667 ' HZ3' HD11 ' A' ' 5' ' ' LEU . 18.6 t90 -63.35 -54.94 29.06 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.325 -0.852 . . . . 1.0 110.444 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.453 HG13 ' O ' ' A' ' 149' ' ' LEU . 6.2 m -64.82 -41.25 91.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 120.842 -0.343 . . . . 1.0 110.764 -178.018 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.447 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 15.3 m-20 -60.03 -49.46 77.59 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 121.269 0.557 . . . . 1.0 110.613 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 5.7 pt-20 -65.31 -37.27 86.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.612 -0.722 . . . . 1.0 110.739 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.458 ' HG3' ' CH2' ' A' ' 152' ' ' TRP . 10.9 mmt180 -75.07 -39.3 60.95 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.186 -0.461 . . . . 1.0 111.565 -177.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 4.4 pp . . . . . 0 C--N 1.326 -0.43 0 N-CA-C 109.218 -0.66 . . . . 1.0 109.218 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo . . . . . 0 C--O 1.232 0.202 0 CA-C-O 121.145 0.394 . . . . 1.0 113.036 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.85 ' HB3' HG23 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -69.19 -179.36 1.55 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.659 -0.7 . . . . 1.0 109.831 177.973 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.674 ' H ' HD13 ' A' ' 5' ' ' LEU . 2.5 t-160 -158.45 89.73 0.99 Allowed 'General case' 0 C--N 1.326 -0.444 0 O-C-N 122.145 -0.347 . . . . 1.0 110.066 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.479 HG13 HD13 ' A' ' 85' ' ' LEU . 1.8 t -95.61 109.07 21.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.87 -0.419 . . . . 1.0 109.87 178.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.637 ' CG2' ' HG ' ' A' ' 86' ' ' LEU . 10.5 t -112.89 118.84 36.02 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 120.896 0.379 . . . . 1.0 110.043 177.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.576 ' HD1' ' HB ' ' A' ' 87' ' ' VAL . 1.3 m-85 -86.65 131.27 34.2 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 116.465 -0.334 . . . . 1.0 110.784 -178.48 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.567 HG21 HD11 ' A' ' 97' ' ' LEU . 21.3 t -115.49 109.61 28.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.852 -0.613 . . . . 1.0 110.964 -177.342 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.644 ' HB2' HD23 ' A' ' 89' ' ' LEU . 49.8 t -142.38 163.55 32.55 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.587 -0.523 . . . . 1.0 109.587 179.28 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.57 HG23 ' NE2' ' A' ' 93' ' ' HIS . 0.7 OUTLIER -75.13 100.6 4.3 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.017 0.437 . . . . 1.0 110.89 -179.054 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.857 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 125.0 -44.78 1.22 Allowed Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.935 -0.65 . . . . 1.0 111.831 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.449 HD21 ' CB ' ' A' ' 42' ' ' SER . 4.5 t-20 65.7 11.82 7.83 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.278 0.631 . . . . 1.0 111.348 179.188 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.447 ' HA ' ' HG3' ' A' ' 19' ' ' PRO . 10.0 pt -120.57 8.74 6.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 O-C-N 121.736 -0.603 . . . . 1.0 111.738 -177.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.54 ' O ' ' HG3' ' A' ' 20' ' ' MET . 6.8 p -126.1 -86.56 0.61 Allowed 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.034 0.383 . . . . 1.0 112.034 -178.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.684 ' HD3' HG13 ' A' ' 138' ' ' VAL . 16.6 tpp180 -66.31 -48.53 70.04 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.981 0.42 . . . . 1.0 111.554 -176.026 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.654 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 14.2 m -56.55 -57.06 25.86 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 115.667 -0.697 . . . . 1.0 112.8 -178.344 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.714 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 39.0 Cg_endo -64.26 -27.54 64.0 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 121.806 1.67 . . . . 1.0 112.355 -177.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.622 ' HA ' HD21 ' A' ' 62' ' ' LEU . 66.1 mtp -62.43 -53.53 53.5 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.316 -0.554 . . . . 1.0 110.55 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.462 ' HA ' ' HB2' ' A' ' 24' ' ' MET . . . -70.59 -30.44 67.12 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.588 -0.445 . . . . 1.0 110.526 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.672 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 14.7 tt0 -52.15 -51.79 55.79 Favored 'General case' 0 C--O 1.214 -0.777 0 CA-C-N 115.49 -0.777 . . . . 1.0 109.623 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.944 ' HE3' ' HB2' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -88.49 -21.28 24.25 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 119.674 -0.81 . . . . 1.0 111.228 -176.702 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.511 ' HB3' HD11 ' A' ' 146' ' ' LEU . 83.1 mtp -65.8 -74.47 0.11 Allowed 'General case' 0 C--O 1.237 0.418 0 N-CA-C 112.37 0.508 . . . . 1.0 112.37 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.687 ' HB3' HD22 ' A' ' 146' ' ' LEU . 17.0 p90 -76.17 -30.52 58.13 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 119.707 -0.797 . . . . 1.0 111.481 -175.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.672 ' HB3' ' O ' ' A' ' 22' ' ' GLU . . . -65.11 -35.8 82.26 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 119.17 -1.012 . . . . 1.0 110.893 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.725 ' HA ' ' HD3' ' A' ' 30' ' ' ARG . 0.1 OUTLIER -63.07 -39.34 94.42 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 108.454 -0.943 . . . . 1.0 108.454 177.21 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.616 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 78.9 mt-30 -58.68 -45.81 88.62 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.647 -0.706 . . . . 1.0 109.879 175.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' A' ' 25' ' ' PHE . 96.7 mt -55.42 -58.85 6.02 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.502 -0.772 . . . . 1.0 110.978 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.725 ' HD3' ' HA ' ' A' ' 27' ' ' GLN . 0.4 OUTLIER -59.24 -36.24 75.11 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.49 -0.484 . . . . 1.0 111.258 179.125 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -63.35 -26.12 68.61 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.581 0.586 . . . . 1.0 112.581 177.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.634 ' HG3' ' HG ' ' A' ' 34' ' ' LEU . 8.3 ptp180 -95.54 -16.9 21.85 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 119.568 -0.853 . . . . 1.0 109.805 177.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 105.56 23.36 7.59 Favored Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 114.99 -1.004 . . . . 1.0 112.053 176.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.634 ' HG ' ' HG3' ' A' ' 32' ' ' ARG . 24.5 mt -111.69 1.5 16.75 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.172 -0.307 . . . . 1.0 110.172 -177.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -54.55 -26.03 37.07 Favored Glycine 0 CA--C 1.522 0.472 0 C-N-CA 121.115 -0.564 . . . . 1.0 113.2 -178.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.598 ' HA ' ' NH1' ' A' ' 39' ' ' ARG . 0.5 OUTLIER -95.98 -22.83 17.15 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 109.467 -0.568 . . . . 1.0 109.467 177.533 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -76.97 -23.28 52.33 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.903 -1.044 . . . . 1.0 111.002 -175.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.85 HG23 ' HB3' ' A' ' 5' ' ' LEU . 0.2 OUTLIER -143.38 122.59 8.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.733 -0.667 . . . . 1.0 109.334 177.911 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.598 ' NH1' ' HA ' ' A' ' 36' ' ' ASP . 30.2 mmt180 -87.18 143.33 27.34 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 109.201 -0.666 . . . . 1.0 109.201 -178.438 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.427 HG11 ' HB2' ' A' ' 26' ' ' ALA . 54.2 t -131.82 131.53 61.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 109.497 -0.557 . . . . 1.0 109.497 -178.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.508 ' O ' ' HA ' ' A' ' 8' ' ' THR . 43.2 p -145.95 -175.74 4.87 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.344 -0.844 . . . . 1.0 109.972 -174.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.654 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 90.6 p -161.7 166.04 27.24 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.799 -0.36 . . . . 1.0 110.52 178.402 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.588 ' HB2' ' CD2' ' A' ' 80' ' ' HIS . . . -165.52 169.0 15.97 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.398 0.618 . . . . 1.0 111.543 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -127.24 132.3 7.51 Favored Glycine 0 N--CA 1.44 -1.09 0 CA-C-N 114.924 -1.034 . . . . 1.0 110.937 177.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.524 HG23 ' CG1' ' A' ' 10' ' ' VAL . 17.8 p -67.75 -26.86 66.34 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.912 0.386 . . . . 1.0 111.707 -177.462 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -107.25 9.47 39.02 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.847 -0.692 . . . . 1.0 113.207 -177.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 43.5 38.17 1.73 Allowed 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 113.719 1.007 . . . . 1.0 113.719 176.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.857 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 1.1 m-90 -47.07 -74.21 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.514 0.674 . . . . 1.0 112.438 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.557 ' HB3' ' HB3' ' A' ' 52' ' ' SER . 3.8 m-70 -105.54 39.84 1.67 Allowed 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.184 -0.916 . . . . 1.0 111.16 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.418 HG23 ' HA ' ' A' ' 74' ' ' ALA . 14.8 p -60.17 127.19 19.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 120.377 -0.529 . . . . 1.0 110.068 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.606 ' HA2' ' NE ' ' A' ' 72' ' ' ARG . . . 93.47 -14.28 65.64 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.913 -0.661 . . . . 1.0 111.961 -177.116 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.557 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 3.1 t -81.4 -158.18 0.21 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.232 0.539 . . . . 1.0 110.034 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 18.7 t -133.28 175.29 9.53 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 115.676 -0.693 . . . . 1.0 109.153 -178.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.96 141.93 43.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.25 0.548 . . . . 1.0 111.85 -178.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.468 ' OD1' ' HG3' ' A' ' 57' ' ' ARG . 56.6 t0 -56.06 129.82 41.47 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.019 -0.991 . . . . 1.0 110.06 178.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -51.51 -29.69 17.58 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.103 0.779 . . . . 1.0 113.103 -179.032 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.609 ' O ' HG23 ' A' ' 61' ' ' VAL . 0.2 OUTLIER -74.03 -41.89 61.13 Favored 'General case' 0 N--CA 1.461 0.122 0 C-N-CA 120.261 -0.576 . . . . 1.0 110.412 178.602 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.43 -32.41 70.0 Favored 'General case' 0 N--CA 1.46 0.07 0 CA-C-O 120.918 0.39 . . . . 1.0 110.051 178.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.37 -42.42 98.68 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.762 -0.653 . . . . 1.0 110.025 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.448 ' O ' ' HG2' ' A' ' 63' ' ' ARG . . . -64.27 -40.4 97.89 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.563 -0.827 . . . . 1.0 111.217 178.306 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 57' ' ' ARG . 59.0 t -57.38 -57.47 9.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.091 0.472 . . . . 1.0 110.762 177.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.622 HD21 ' HA ' ' A' ' 20' ' ' MET . 5.7 mp -59.28 -52.28 66.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.972 -0.558 . . . . 1.0 111.109 -178.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.448 ' HG2' ' O ' ' A' ' 60' ' ' GLY . 5.9 ptm180 -60.08 -26.91 66.55 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.729 -0.669 . . . . 1.0 111.338 -178.291 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.54 -36.54 73.74 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.124 0.488 . . . . 1.0 110.379 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -93.15 3.82 55.04 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.577 -0.738 . . . . 1.0 111.019 -178.012 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.35 13.69 63.19 Favored Glycine 0 C--N 1.329 0.178 0 CA-C-N 115.735 -0.666 . . . . 1.0 112.593 176.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.48 ' CD1' ' HA ' ' A' ' 24' ' ' MET . 60.5 m-85 -90.03 147.48 37.3 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 110.258 -0.275 . . . . 1.0 110.258 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.474 ' HG2' ' CB ' ' A' ' 23' ' ' LYS . 56.8 Cg_endo -69.44 159.87 51.99 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.45 2.1 . . . . 1.0 110.572 177.293 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.0 p -130.38 12.69 5.5 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.541 0.686 . . . . 1.0 109.928 -178.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -70.94 114.35 8.91 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 114.725 -1.125 . . . . 1.0 109.994 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.944 ' HB2' ' HE3' ' A' ' 23' ' ' LYS . 62.5 t60 -160.48 149.83 17.35 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.928 0.394 . . . . 1.0 111.202 -176.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.606 ' NE ' ' HA2' ' A' ' 51' ' ' GLY . 1.4 tmt_? -135.61 112.36 10.13 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.684 -1.228 . . . . 1.0 107.684 175.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.524 ' HB3' ' O ' ' A' ' 49' ' ' HIS . . . -59.71 138.98 57.6 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.895 -1.048 . . . . 1.0 112.724 -174.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.418 ' HA ' HG23 ' A' ' 50' ' ' VAL . . . -130.06 160.62 33.17 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.249 -0.887 . . . . 1.0 110.354 178.242 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -97.31 155.16 17.0 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.43 -0.952 . . . . 1.0 108.43 178.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.504 HG11 HD23 ' A' ' 97' ' ' LEU . 19.1 t -68.42 112.59 3.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 120.938 0.399 . . . . 1.0 110.607 -178.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.444 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -122.97 -170.23 13.46 Favored Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 115.373 -0.831 . . . . 1.0 111.5 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 98.2 m -56.45 -44.15 80.22 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 122.388 0.275 . . . . 1.0 111.214 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -59.23 -29.71 67.73 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.972 0.415 . . . . 1.0 111.227 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.588 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 80.1 m80 -78.21 -41.66 33.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.161 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.746 ' HA ' HD21 ' A' ' 86' ' ' LEU . 15.6 mt -68.39 -17.41 64.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.255 0.55 . . . . 1.0 110.669 177.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.61 -4.5 59.18 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 116.167 -0.47 . . . . 1.0 110.539 -178.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.563 ' HB1' ' O ' ' A' ' 6' ' ' HIS . . . -63.41 160.0 17.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.99 -0.55 . . . . 1.0 111.049 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.753 ' HB3' HD13 ' A' ' 5' ' ' LEU . 15.5 t70 -85.29 -13.16 50.56 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.517 -0.549 . . . . 1.0 109.517 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.741 HD12 ' CE3' ' A' ' 152' ' ' TRP . 1.1 tt -157.73 112.2 2.63 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.746 -0.661 . . . . 1.0 109.6 -177.345 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.746 HD21 ' HA ' ' A' ' 81' ' ' LEU . 5.6 mp -103.84 89.18 3.23 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-N 115.396 -0.82 . . . . 1.0 110.832 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.637 HG23 HD22 ' A' ' 85' ' ' LEU . 54.0 t -66.22 91.34 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 113.816 -1.538 . . . . 1.0 112.05 -179.096 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.06 147.74 31.34 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.245 -1.343 . . . . 1.0 109.693 177.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.644 HD23 ' HB2' ' A' ' 11' ' ' CYS . 3.7 mm? -100.86 -10.86 20.3 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.308 0.575 . . . . 1.0 109.618 177.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -141.56 151.52 43.28 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.214 -0.903 . . . . 1.0 110.087 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -65.07 -17.35 64.38 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 123.477 0.485 . . . . 1.0 110.089 176.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.643 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 5.3 m-20 -77.83 -50.04 13.09 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.668 -0.697 . . . . 1.0 109.817 178.547 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.682 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 16.3 m170 -59.26 -42.95 92.39 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.561 -0.533 . . . . 1.0 109.561 178.449 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.68 -44.48 93.6 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.559 178.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.604 ' O ' ' HG2' ' A' ' 99' ' ' GLN . 0.5 OUTLIER -56.66 -45.26 81.77 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 115.818 -0.628 . . . . 1.0 111.015 178.356 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.694 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 50.9 mt -64.39 -48.3 75.97 Favored 'General case' 0 C--O 1.216 -0.68 0 CA-C-N 115.944 -0.571 . . . . 1.0 110.425 -175.047 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.682 ' HG ' ' O ' ' A' ' 93' ' ' HIS . 33.2 mt -53.0 -60.16 3.63 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.898 -0.592 . . . . 1.0 111.474 -178.415 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.72 ' N ' HG12 ' A' ' 102' ' ' VAL . 1.2 ptm180 -59.26 -45.16 91.96 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.843 -0.617 . . . . 1.0 112.381 -179.117 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.604 ' HG2' ' O ' ' A' ' 95' ' ' ARG . 6.2 pt20 -66.74 -24.69 66.25 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 119.956 -0.698 . . . . 1.0 110.194 178.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.694 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 10.1 mt -80.7 -18.84 46.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.031 -0.531 . . . . 1.0 111.592 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 151.99 -21.27 0.88 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 119.748 -1.215 . . . . 1.0 114.44 -178.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.72 HG12 ' N ' ' A' ' 98' ' ' ARG . 0.3 OUTLIER -76.82 -162.36 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 118.113 0.956 . . . . 1.0 110.662 -179.492 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.773 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 12.3 pt-20 -157.3 160.32 38.43 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 107.703 -1.221 . . . . 1.0 107.703 -179.02 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.775 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -61.04 -26.13 67.41 Favored 'General case' 0 C--N 1.322 -0.601 0 O-C-N 123.366 0.416 . . . . 1.0 111.32 -175.427 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.48 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . . . -57.06 -36.42 70.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.15 0.5 . . . . 1.0 110.533 175.523 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.773 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 7.9 mtt-85 -98.46 -42.37 7.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.237 -0.892 . . . . 1.0 111.194 -177.209 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.775 HG12 ' HA ' ' A' ' 104' ' ' ALA . 14.6 p -77.96 115.44 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 120.614 -0.435 . . . . 1.0 110.085 -175.068 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.624 ' HD2' ' O ' ' A' ' 107' ' ' VAL . 26.9 mmm180 -136.13 148.71 48.35 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 121.68 -0.637 . . . . 1.0 110.7 -178.283 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 83.2 mmm -78.92 137.52 37.67 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.615 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.597 HD23 HG11 ' A' ' 87' ' ' VAL . 2.8 tm? -56.02 -52.68 63.36 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 122.455 0.302 . . . . 1.0 111.532 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 111' ' ' ARG . 25.6 ttt85 -71.22 -16.83 62.52 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.586 -0.445 . . . . 1.0 111.222 -176.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 41.7 t -73.56 -7.63 52.68 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 120.585 -0.446 . . . . 1.0 110.703 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.652 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 83.3 m-85 -87.31 -21.74 25.55 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-O 120.664 0.269 . . . . 1.0 110.765 176.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 16.8 t0 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 115.948 -0.569 . . . . 1.0 111.433 -177.647 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 . . . . . 0 N--CA 1.452 -0.348 0 CA-C-O 120.699 0.285 . . . . 1.0 111.277 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.615 ' O ' HG23 ' A' ' 141' ' ' VAL . 11.1 tp10 -64.34 -48.3 76.08 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 108.073 -1.084 . . . . 1.0 108.073 174.154 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.684 HG13 ' HD3' ' A' ' 17' ' ' ARG . 57.4 t -56.52 -47.41 81.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 114.482 -1.235 . . . . 1.0 109.766 175.718 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.507 ' HB2' HG11 ' A' ' 61' ' ' VAL . 69.8 t80 -56.4 -44.12 79.98 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 113.858 -1.519 . . . . 1.0 110.147 178.411 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.71 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -63.42 -44.97 93.09 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.208 -0.451 . . . . 1.0 111.761 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 137' ' ' GLU . 36.3 t -55.43 -46.59 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.706 0.765 . . . . 1.0 110.005 178.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.455 ' CG2' ' HB2' ' A' ' 21' ' ' ALA . 7.0 mt -69.51 -51.13 44.88 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 115.04 -0.982 . . . . 1.0 111.785 -178.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.71 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 6.2 pt-20 -56.14 -33.88 65.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.537 0.208 . . . . 1.0 110.665 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.8 t -73.33 -27.98 61.81 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.238 0.542 . . . . 1.0 110.124 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.472 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -86.69 -23.99 25.39 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-N 115.869 -0.605 . . . . 1.0 111.823 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.687 HD22 ' HB3' ' A' ' 25' ' ' PHE . 11.9 mt -55.16 -37.89 61.65 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 112.654 0.613 . . . . 1.0 112.654 -178.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 61.5 Cg_endo -70.65 -13.2 32.23 Favored 'Trans proline' 0 C--N 1.359 1.116 0 C-N-CA 122.649 2.232 . . . . 1.0 111.939 177.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.652 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -102.72 -32.35 4.81 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 110.099 -1.2 . . . . 1.0 110.099 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.495 ' O ' HG13 ' A' ' 153' ' ' VAL . 0.4 OUTLIER -73.73 -40.69 63.35 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.396 -0.964 . . . . 1.0 108.396 177.604 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 150' ' ' HIS . . . . . 0.448 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -55.53 -54.7 40.76 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 114.81 -1.086 . . . . 1.0 110.135 175.667 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -58.94 -42.52 89.96 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.333 -0.849 . . . . 1.0 110.961 -175.186 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' TRP . . . . . 0.845 ' HZ3' HD11 ' A' ' 5' ' ' LEU . 23.6 t90 -63.02 -55.28 26.99 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.46 -0.791 . . . . 1.0 110.465 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.495 HG13 ' O ' ' A' ' 149' ' ' LEU . 10.7 m -62.7 -40.69 89.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.816 -0.354 . . . . 1.0 110.587 -177.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.495 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 4.1 m-20 -60.79 -50.93 71.46 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-O 120.838 0.351 . . . . 1.0 110.727 178.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.486 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 6.8 pt-20 -64.11 -36.86 85.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.861 -178.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.485 ' HG3' ' CH2' ' A' ' 152' ' ' TRP . 10.4 mmt180 -73.56 -42.61 61.42 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 116.185 -0.461 . . . . 1.0 111.394 -178.294 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 4.3 pp . . . . . 0 C--O 1.236 0.356 0 N-CA-C 109.27 -0.641 . . . . 1.0 109.27 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.918 ' HG3' ' HE ' ' A' ' 39' ' ' ARG . 60.0 Cg_endo . . . . . 0 C--O 1.236 0.402 0 N-CA-C 114.298 0.846 . . . . 1.0 114.298 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.869 ' HB3' HG23 ' A' ' 38' ' ' VAL . 0.8 OUTLIER -74.8 -173.31 1.82 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.05 -0.977 . . . . 1.0 110.836 178.146 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.492 ' O ' ' HB1' ' A' ' 83' ' ' ALA . 0.2 OUTLIER -159.15 94.59 1.21 Allowed 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 121.087 -0.245 . . . . 1.0 111.448 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.79 HG13 HD13 ' A' ' 85' ' ' LEU . 2.2 t -95.94 113.48 30.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 108.893 -0.781 . . . . 1.0 108.893 175.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.624 ' CG2' ' HG ' ' A' ' 86' ' ' LEU . 14.5 t -114.15 115.26 27.22 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 120.992 0.425 . . . . 1.0 110.108 178.11 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.549 ' HD1' ' HB ' ' A' ' 87' ' ' VAL . 2.0 m-85 -81.81 146.77 29.72 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 109.56 -0.533 . . . . 1.0 109.56 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.603 HG21 HD11 ' A' ' 97' ' ' LEU . 42.5 t -130.42 114.0 27.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 121.059 0.457 . . . . 1.0 111.63 -177.528 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.615 ' SG ' ' HD2' ' A' ' 17' ' ' ARG . 47.9 t -143.93 161.25 39.19 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.821 -0.807 . . . . 1.0 108.821 177.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.88 97.07 3.23 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.269 0.556 . . . . 1.0 111.182 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.691 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 130.96 -44.74 1.18 Allowed Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.457 -0.792 . . . . 1.0 111.249 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.662 ' ND2' ' H ' ' A' ' 74' ' ' ALA . 58.6 t30 59.8 29.16 18.73 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.829 0.824 . . . . 1.0 111.179 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.3 pt -130.91 10.67 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.963 -0.562 . . . . 1.0 111.675 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.66 ' O ' ' HG3' ' A' ' 20' ' ' MET . 12.3 m -125.54 -89.64 0.57 Allowed 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.089 -0.644 . . . . 1.0 111.609 -178.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.615 ' HD2' ' SG ' ' A' ' 11' ' ' CYS . 1.9 ptp85 -74.27 -35.85 63.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.065 -0.516 . . . . 1.0 112.364 -176.226 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.554 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 16.5 m -58.99 -58.83 16.58 Favored Pre-proline 0 CA--C 1.541 0.602 0 C-N-CA 121.26 -0.176 . . . . 1.0 111.105 179.026 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.76 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 36.6 Cg_endo -61.93 -26.66 79.11 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.051 1.834 . . . . 1.0 111.937 178.581 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.66 ' HG3' ' O ' ' A' ' 16' ' ' CYS . 63.8 mtp -62.43 -54.57 38.22 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.847 -0.341 . . . . 1.0 111.106 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.1 -28.5 65.45 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 120.452 -0.499 . . . . 1.0 109.666 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.703 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 7.4 tt0 -54.32 -51.9 63.24 Favored 'General case' 0 C--O 1.216 -0.672 0 CA-C-N 115.029 -0.987 . . . . 1.0 109.236 178.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.775 ' HB3' ' HG2' ' A' ' 68' ' ' PRO . 0.0 OUTLIER -80.36 -29.9 37.95 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.758 -0.655 . . . . 1.0 110.212 -176.846 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.585 ' HB3' HD11 ' A' ' 146' ' ' LEU . 3.1 mmm -63.33 -76.12 0.07 Allowed 'General case' 0 C--O 1.238 0.458 0 N-CA-C 113.058 0.762 . . . . 1.0 113.058 -176.346 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.658 ' HB3' HD22 ' A' ' 146' ' ' LEU . 22.6 p90 -76.76 -29.72 56.22 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 119.859 -0.736 . . . . 1.0 111.268 -174.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.703 ' HB3' ' O ' ' A' ' 22' ' ' GLU . . . -65.25 -37.82 88.43 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 119.036 -1.066 . . . . 1.0 111.134 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.642 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -63.2 -40.04 96.34 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.56 -0.904 . . . . 1.0 108.56 177.854 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.571 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 79.1 mt-30 -57.49 -47.71 81.19 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 115.608 -0.724 . . . . 1.0 110.082 176.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.539 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 93.3 mt -53.09 -59.55 4.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.69 -0.686 . . . . 1.0 111.06 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.597 ' HD3' ' HA ' ' A' ' 27' ' ' GLN . 0.1 OUTLIER -59.5 -37.25 77.81 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.484 -0.486 . . . . 1.0 111.275 178.955 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -63.9 -21.32 66.41 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.873 0.694 . . . . 1.0 112.873 178.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.539 ' HG2' ' O ' ' A' ' 29' ' ' LEU . 7.6 ptp180 -99.29 -21.54 16.01 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 119.677 -0.809 . . . . 1.0 110.037 176.187 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 107.34 42.35 1.51 Allowed Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 115.202 -0.908 . . . . 1.0 111.99 178.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 23.8 mt -135.83 -5.11 2.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.704 0.288 . . . . 1.0 110.372 -178.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.455 ' H ' ' HA ' ' A' ' 30' ' ' ARG . . . -58.72 -25.19 58.4 Favored Glycine 0 C--N 1.329 0.168 0 C-N-CA 121.361 -0.447 . . . . 1.0 112.619 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.46 ' O ' ' HB3' ' A' ' 4' ' ' PRO . 49.3 m-20 -85.01 -28.92 25.4 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.28 0.562 . . . . 1.0 109.885 177.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.58 -18.56 51.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.09 -0.959 . . . . 1.0 112.015 -177.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.869 HG23 ' HB3' ' A' ' 5' ' ' LEU . 0.8 OUTLIER -144.85 122.85 5.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.255 0.55 . . . . 1.0 110.137 179.133 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.918 ' HE ' ' HG3' ' A' ' 4' ' ' PRO . 9.9 mmt180 -89.16 145.45 25.42 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.802 -0.636 . . . . 1.0 110.071 -178.324 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 77.5 t -132.55 118.88 36.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.439 0.638 . . . . 1.0 109.869 -178.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 8' ' ' THR . 36.7 p -132.87 -174.42 3.47 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 114.279 -1.328 . . . . 1.0 111.365 -175.42 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.554 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 63.9 p -159.63 161.22 34.99 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.509 -178.071 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.663 ' HB2' ' CD2' ' A' ' 80' ' ' HIS . . . -162.38 163.09 27.99 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.294 0.569 . . . . 1.0 111.627 -178.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.404 ' HA2' ' O ' ' A' ' 11' ' ' CYS . . . -123.73 131.77 8.17 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 110.863 -0.895 . . . . 1.0 110.863 178.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.587 HG23 ' CG1' ' A' ' 10' ' ' VAL . 18.0 p -67.72 -26.92 66.39 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.036 0.384 . . . . 1.0 112.036 -177.219 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -107.26 9.07 38.75 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.73 -0.748 . . . . 1.0 112.904 -177.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.401 ' HB3' ' HB2' ' A' ' 75' ' ' GLN . 3.8 p-10 41.02 41.93 1.41 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.834 0.854 . . . . 1.0 113.288 179.41 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.691 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 0.9 OUTLIER -50.34 -77.64 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.154 0.502 . . . . 1.0 112.013 179.009 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.422 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 15.8 m-70 -101.97 41.12 1.24 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.907 -0.588 . . . . 1.0 110.919 -179.148 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.2 p -61.56 127.43 21.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.13 0.491 . . . . 1.0 110.105 178.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.767 ' HA2' ' HD3' ' A' ' 72' ' ' ARG . . . 97.02 -15.43 62.56 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.679 -0.691 . . . . 1.0 112.107 -177.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.0 t -80.27 -159.02 0.2 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.367 0.603 . . . . 1.0 109.926 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 31.7 t -132.91 173.08 11.77 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.359 -0.837 . . . . 1.0 109.01 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.91 139.95 32.23 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.982 0.42 . . . . 1.0 111.3 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.614 ' OD1' ' HG2' ' A' ' 57' ' ' ARG . 11.7 t70 -60.9 139.14 58.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.425 -0.807 . . . . 1.0 110.374 -178.036 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -48.21 -33.95 9.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.409 -0.814 . . . . 1.0 112.861 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.614 ' HG2' ' OD1' ' A' ' 55' ' ' ASP . 18.8 ptp180 -70.96 -46.07 63.03 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 122.26 -0.275 . . . . 1.0 110.589 -177.032 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.47 -32.84 68.75 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 116.086 -0.506 . . . . 1.0 109.743 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.99 -46.88 88.96 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.191 -0.67 . . . . 1.0 109.191 176.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.477 ' HA2' ' HD3' ' A' ' 63' ' ' ARG . . . -61.05 -39.69 97.44 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.818 -0.706 . . . . 1.0 111.574 177.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 57' ' ' ARG . 93.3 t -60.55 -60.31 2.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.803 0.335 . . . . 1.0 111.214 177.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.779 ' HB2' HG22 ' A' ' 69' ' ' THR . 81.8 mt -58.17 -51.79 68.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.211 -0.45 . . . . 1.0 111.526 -176.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.477 ' HD3' ' HA2' ' A' ' 60' ' ' GLY . 6.9 ptm180 -59.17 -29.15 67.25 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.315 -0.402 . . . . 1.0 111.191 -179.207 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.57 -30.63 61.79 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.343 0.592 . . . . 1.0 110.904 -179.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -95.06 3.97 54.25 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.854 -0.612 . . . . 1.0 110.668 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.09 10.61 60.94 Favored Glycine 0 C--N 1.331 0.264 0 CA-C-N 115.694 -0.685 . . . . 1.0 113.312 175.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.425 ' CD1' ' HA ' ' A' ' 24' ' ' MET . 66.5 m-85 -92.08 152.33 42.63 Favored Pre-proline 0 C--N 1.316 -0.871 0 CA-C-O 120.61 0.243 . . . . 1.0 111.543 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.775 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 33.0 Cg_endo -68.07 156.94 63.92 Favored 'Trans proline' 0 CA--C 1.514 -0.496 0 C-N-CA 122.515 2.144 . . . . 1.0 110.737 175.01 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.779 HG22 ' HB2' ' A' ' 62' ' ' LEU . 63.3 p -132.55 7.89 4.19 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 120.102 -0.639 . . . . 1.0 112.485 -176.175 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -90.5 133.09 35.29 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.008 0.432 . . . . 1.0 110.851 -178.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.483 ' HB2' ' HE3' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -173.03 150.71 2.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.41 -0.814 . . . . 1.0 109.207 -176.749 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.767 ' HD3' ' HA2' ' A' ' 51' ' ' GLY . 4.1 tmm_? -120.79 115.33 23.07 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.169 -1.049 . . . . 1.0 108.169 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' A' ' 49' ' ' HIS . . . -58.03 137.08 57.16 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.462 0.648 . . . . 1.0 112.307 -175.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.662 ' H ' ' ND2' ' A' ' 14' ' ' ASN . . . -127.81 158.29 38.1 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.41 -0.813 . . . . 1.0 109.913 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.401 ' HB2' ' HB3' ' A' ' 47' ' ' ASN . 34.2 tt0 -94.89 155.92 16.57 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.916 -0.772 . . . . 1.0 108.916 177.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.506 HG11 ' CD2' ' A' ' 97' ' ' LEU . 22.0 t -67.46 112.56 2.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.236 0.541 . . . . 1.0 110.09 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.549 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -126.24 -167.19 12.39 Favored Glycine 0 N--CA 1.438 -1.178 0 CA-C-N 115.445 -0.798 . . . . 1.0 111.38 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 54.4 m -55.42 -51.68 66.08 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 122.574 0.35 . . . . 1.0 111.931 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.45 ' HG2' ' N ' ' A' ' 80' ' ' HIS . 1.1 pm0 -57.2 -31.92 65.94 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.655 -0.702 . . . . 1.0 111.008 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.663 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 78.3 m80 -76.74 -41.86 43.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.034 179.168 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 24.4 mt -67.41 -19.26 65.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.939 -0.573 . . . . 1.0 110.992 177.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -87.38 -6.09 58.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.933 -0.576 . . . . 1.0 111.209 -178.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.492 ' HB1' ' O ' ' A' ' 6' ' ' HIS . . . -59.93 152.96 22.26 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.852 -0.613 . . . . 1.0 111.275 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -76.86 -17.48 58.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.102 0.477 . . . . 1.0 109.965 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.79 HD13 HG13 ' A' ' 7' ' ' VAL . 0.3 OUTLIER -153.26 116.42 4.6 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-N 115.604 -0.725 . . . . 1.0 109.443 -176.722 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.624 ' HG ' ' CG2' ' A' ' 8' ' ' THR . 5.1 mp -106.72 107.3 18.25 Favored 'General case' 0 N--CA 1.422 -1.856 0 CA-C-N 115.774 -0.648 . . . . 1.0 110.01 177.126 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.549 ' HB ' ' HD1' ' A' ' 9' ' ' PHE . 51.5 t -85.49 93.3 3.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 114.994 -1.003 . . . . 1.0 110.934 -176.296 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.23 145.78 32.06 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.628 -0.714 . . . . 1.0 110.432 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.501 ' HG ' ' HD3' ' A' ' 17' ' ' ARG . 3.9 mm? -96.67 -12.44 23.84 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.208 0.528 . . . . 1.0 110.604 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.446 ' CG ' ' H ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -151.54 157.66 42.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.625 -0.716 . . . . 1.0 111.193 179.523 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -53.5 -29.68 37.44 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 113.467 0.914 . . . . 1.0 113.467 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.637 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 43.3 m-20 -76.59 -48.37 19.43 Favored 'General case' 0 CA--C 1.512 -0.486 0 C-N-CA 120.364 -0.534 . . . . 1.0 110.864 -177.356 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.705 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 15.7 m170 -56.04 -46.36 78.91 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.838 -0.43 . . . . 1.0 109.838 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.45 -43.13 93.24 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.803 0.335 . . . . 1.0 110.794 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.453 ' O ' ' HG2' ' A' ' 98' ' ' ARG . 13.1 ttt180 -59.76 -44.64 93.76 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 115.845 -0.616 . . . . 1.0 111.629 179.108 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.754 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 58.5 mt -64.03 -48.98 74.2 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.169 -0.468 . . . . 1.0 110.083 -176.17 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.705 ' HG ' ' O ' ' A' ' 93' ' ' HIS . 32.7 mt -52.7 -57.12 11.15 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.845 -0.616 . . . . 1.0 111.22 -179.094 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.556 ' HA ' ' HB ' ' A' ' 102' ' ' VAL . 12.9 ptt180 -61.26 -41.31 96.71 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.216 -0.447 . . . . 1.0 111.832 -176.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.665 ' HG3' ' O ' ' A' ' 96' ' ' LEU . 1.1 pp0? -69.12 -25.32 64.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.993 0.425 . . . . 1.0 110.359 178.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.754 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 14.2 mt -78.53 -13.65 59.73 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.987 -0.551 . . . . 1.0 112.315 -179.076 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 148.59 -22.73 1.34 Allowed Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 119.995 -1.097 . . . . 1.0 112.935 -178.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.951 HG12 ' H ' ' A' ' 103' ' ' GLU . 3.3 t -76.24 -156.98 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 109.687 -0.486 . . . . 1.0 109.687 178.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.951 ' H ' HG12 ' A' ' 102' ' ' VAL . 16.8 pt-20 -171.18 168.08 6.87 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 107.66 -1.237 . . . . 1.0 107.66 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.735 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -66.45 -23.93 66.36 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.992 -0.283 . . . . 1.0 111.572 -174.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.04 -37.78 72.25 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.246 0.546 . . . . 1.0 110.509 176.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.752 ' HD2' HG13 ' A' ' 102' ' ' VAL . 15.1 mtt180 -96.11 -45.17 6.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.778 -1.101 . . . . 1.0 110.935 -176.211 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.735 HG12 ' HA ' ' A' ' 104' ' ' ALA . 8.0 p -79.46 124.78 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-O 121.572 0.701 . . . . 1.0 110.702 -177.13 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.546 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 21.2 mmm180 -140.52 146.69 38.46 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 -179.271 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.542 ' HB2' ' HB2' ' A' ' 112' ' ' SER . 82.1 mmm -78.86 137.84 37.86 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.762 -0.654 . . . . 1.0 110.369 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.503 HD23 HG11 ' A' ' 87' ' ' VAL . 3.1 tm? -56.31 -48.7 76.16 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.077 0.465 . . . . 1.0 111.268 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 65.0 ttt180 -69.6 -20.59 63.62 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.98 -0.554 . . . . 1.0 110.303 -177.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.542 ' HB2' ' HB2' ' A' ' 109' ' ' MET . 36.1 t -76.15 -5.41 46.56 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.62 -0.718 . . . . 1.0 110.913 -177.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.568 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 86.9 m-85 -90.68 -22.77 20.98 Favored 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 122.172 -0.33 . . . . 1.0 110.237 175.314 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 58.6 t0 . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 115.733 -0.667 . . . . 1.0 110.263 -177.767 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 . . . . . 0 N--CA 1.454 -0.229 0 CA-C-O 121.045 0.45 . . . . 1.0 109.853 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.489 ' O ' HG23 ' A' ' 141' ' ' VAL . 71.1 tt0 -67.8 -42.95 80.76 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 108.539 -0.911 . . . . 1.0 108.539 174.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.449 HG12 HD12 ' A' ' 142' ' ' ILE . 76.1 t -58.72 -44.34 89.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 114.514 -1.221 . . . . 1.0 109.583 176.19 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.554 ' HB2' ' HE1' ' A' ' 20' ' ' MET . 46.5 t80 -54.59 -43.41 72.11 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.444 -1.253 . . . . 1.0 110.257 177.178 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.451 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -63.9 -42.19 97.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.774 -0.648 . . . . 1.0 110.901 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 137' ' ' GLU . 31.2 t -57.7 -57.02 12.09 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 CA-C-O 121.384 0.611 . . . . 1.0 110.592 178.065 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.482 ' HA ' HD11 ' A' ' 110' ' ' LEU . 7.0 mt -57.7 -52.07 62.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.21 -0.904 . . . . 1.0 112.388 -177.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.498 ' HG3' ' N ' ' A' ' 144' ' ' SER . 2.2 pt-20 -56.34 -33.06 65.28 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.702 0.287 . . . . 1.0 110.536 -179.081 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' SER . . . . . 0.498 ' N ' ' HG3' ' A' ' 143' ' ' GLU . 4.0 t -73.52 -27.42 61.35 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.347 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.466 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -88.61 -22.34 23.54 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-N 115.914 -0.585 . . . . 1.0 111.86 179.152 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.658 HD22 ' HB3' ' A' ' 25' ' ' PHE . 12.5 mt -55.28 -37.31 55.37 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-O 119.212 -0.423 . . . . 1.0 112.117 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.626 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 43.3 Cg_endo -68.91 -12.17 33.74 Favored 'Trans proline' 0 C--N 1.365 1.409 0 C-N-CA 122.325 2.017 . . . . 1.0 111.943 176.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.568 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -104.51 -33.8 3.78 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 110.72 -0.952 . . . . 1.0 110.72 178.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.517 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -73.46 -39.62 64.79 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.348 -0.982 . . . . 1.0 108.348 178.93 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 150' ' ' HIS . . . . . 0.511 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 0.2 OUTLIER -54.12 -55.01 31.76 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-N 115.136 -0.938 . . . . 1.0 110.628 175.347 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -56.29 -42.26 77.24 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.716 -1.129 . . . . 1.0 111.193 -175.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' TRP . . . . . 0.666 ' HZ3' HD21 ' A' ' 5' ' ' LEU . 22.1 t90 -64.97 -54.85 24.1 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.346 -0.843 . . . . 1.0 110.613 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.446 HG13 ' O ' ' A' ' 149' ' ' LEU . 6.4 m -62.21 -41.17 90.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 120.587 -0.445 . . . . 1.0 110.069 -178.466 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -60.19 -49.51 77.36 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-O 121.013 0.435 . . . . 1.0 110.792 178.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.543 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 11.8 pt-20 -63.61 -39.57 94.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.691 -0.686 . . . . 1.0 110.399 -178.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.527 ' HG3' ' CH2' ' A' ' 152' ' ' TRP . 15.6 mmt85 -74.59 -42.37 58.8 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.863 -0.608 . . . . 1.0 111.528 -175.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.409 ' C ' HD12 ' A' ' 157' ' ' LEU . 4.0 pp . . . . . 0 C--N 1.325 -0.487 0 CA-C-O 121.285 0.564 . . . . 1.0 109.576 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.643 ' HB2' ' HG2' ' A' ' 39' ' ' ARG . 18.9 Cg_endo . . . . . 0 N--CA 1.46 -0.443 0 N-CA-C 113.886 0.687 . . . . 1.0 113.886 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.577 ' HB3' HG13 ' A' ' 38' ' ' VAL . 0.4 OUTLIER -71.1 -173.85 0.89 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.287 -1.324 . . . . 1.0 110.347 179.173 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.573 ' HB3' ' H ' ' A' ' 84' ' ' ASP . 1.5 t-160 -155.2 102.52 2.3 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 110.043 -0.355 . . . . 1.0 110.043 -178.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.699 HG13 HD13 ' A' ' 85' ' ' LEU . 2.1 t -106.53 112.48 39.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 108.125 -1.065 . . . . 1.0 108.125 177.479 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.55 HG22 ' HG ' ' A' ' 86' ' ' LEU . 9.0 t -114.58 114.11 25.29 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.033 0.444 . . . . 1.0 110.479 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.566 ' HD1' ' HB ' ' A' ' 87' ' ' VAL . 0.9 OUTLIER -83.87 134.83 34.68 Favored 'General case' 0 CA--C 1.511 -0.526 0 O-C-N 121.857 -0.527 . . . . 1.0 110.259 -179.541 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.577 HG21 HD11 ' A' ' 97' ' ' LEU . 48.8 t -119.69 115.61 48.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-O 121.227 0.537 . . . . 1.0 111.453 -177.545 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 37.4 t -140.49 163.15 33.6 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.527 -0.76 . . . . 1.0 109.297 178.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.15 84.94 3.63 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.167 0.508 . . . . 1.0 111.23 -177.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.708 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 141.84 -39.14 1.42 Allowed Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.443 -0.799 . . . . 1.0 111.952 179.064 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.407 HD21 ' CB ' ' A' ' 42' ' ' SER . 3.8 t-20 62.71 16.47 8.98 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.817 0.818 . . . . 1.0 111.347 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.418 ' O ' ' HB3' ' A' ' 55' ' ' ASP . 1.8 pt -131.44 32.87 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 O-C-N 121.827 -0.546 . . . . 1.0 110.553 -178.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.787 ' O ' ' HG3' ' A' ' 20' ' ' MET . 35.6 m -147.97 -88.21 0.09 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.915 -0.402 . . . . 1.0 109.915 175.378 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.41 -51.29 68.11 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.257 0.466 . . . . 1.0 112.257 -177.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.872 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 14.3 m -54.19 -58.99 11.21 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 115.99 -0.55 . . . . 1.0 112.369 -177.109 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.657 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 33.2 Cg_endo -61.62 -26.6 80.54 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 121.898 1.732 . . . . 1.0 112.705 -178.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.787 ' HG3' ' O ' ' A' ' 16' ' ' CYS . 72.9 mtp -60.43 -54.84 40.76 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.751 -0.38 . . . . 1.0 110.524 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.524 ' HA ' ' HB2' ' A' ' 24' ' ' MET . . . -74.75 -27.53 60.39 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.582 -0.447 . . . . 1.0 110.763 -178.201 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.601 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 18.1 tt0 -52.37 -53.36 45.82 Favored 'General case' 0 C--O 1.217 -0.634 0 O-C-N 124.064 0.852 . . . . 1.0 110.09 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.981 ' HE3' ' HB2' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -86.71 -22.35 26.08 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.43 -0.805 . . . . 1.0 110.69 -176.409 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.704 ' HB3' HD11 ' A' ' 146' ' ' LEU . 3.2 mmm -63.73 -76.66 0.06 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.216 0.45 . . . . 1.0 112.216 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.762 ' HB3' HD22 ' A' ' 146' ' ' LEU . 22.6 p90 -76.2 -29.76 57.74 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 119.697 -0.801 . . . . 1.0 111.68 -175.349 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.601 ' HB3' ' O ' ' A' ' 22' ' ' GLU . . . -63.35 -36.62 84.31 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 119.321 -0.952 . . . . 1.0 110.714 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.625 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -65.48 -39.32 91.8 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 108.801 -0.815 . . . . 1.0 108.801 177.218 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.616 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 59.8 mt-30 -60.47 -37.73 81.96 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 121.098 0.475 . . . . 1.0 110.395 177.181 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.582 HD13 ' HB ' ' A' ' 38' ' ' VAL . 95.9 mt -57.01 -62.63 1.61 Allowed 'General case' 0 C--O 1.223 -0.308 0 CA-C-N 115.724 -0.671 . . . . 1.0 110.555 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.485 ' HB3' ' HA3' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -59.3 -31.01 68.74 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.154 -0.618 . . . . 1.0 111.548 179.099 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -59.88 -33.73 72.22 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.929 0.395 . . . . 1.0 111.213 176.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.566 ' HG3' ' HG ' ' A' ' 34' ' ' LEU . 11.6 ptm180 -95.71 -20.68 18.71 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 120.142 -0.623 . . . . 1.0 109.827 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 109.6 36.22 2.11 Favored Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 115.008 -0.996 . . . . 1.0 112.459 177.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.566 ' HG ' ' HG3' ' A' ' 32' ' ' ARG . 38.9 mt -129.03 4.36 5.31 Favored 'General case' 0 C--N 1.331 -0.239 0 O-C-N 122.275 -0.544 . . . . 1.0 110.174 -179.042 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.485 ' HA3' ' HB3' ' A' ' 30' ' ' ARG . . . -59.0 -29.53 65.3 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 121.276 -0.488 . . . . 1.0 113.27 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.594 ' HA ' ' NH1' ' A' ' 39' ' ' ARG . 11.8 m-20 -92.71 -17.63 24.0 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.117 0.484 . . . . 1.0 110.254 177.438 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.89 -24.13 38.51 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.659 -0.701 . . . . 1.0 110.428 178.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.582 ' HB ' HD13 ' A' ' 29' ' ' LEU . 12.0 t -130.94 123.92 55.12 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.446 -179.534 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.643 ' HG2' ' HB2' ' A' ' 4' ' ' PRO . 22.8 mmt180 -93.82 130.56 39.8 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 109.058 -0.719 . . . . 1.0 109.058 175.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 64.0 t -122.68 117.84 53.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-O 121.528 0.68 . . . . 1.0 109.599 -175.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.507 ' O ' ' HA ' ' A' ' 8' ' ' THR . 57.9 p -130.99 -177.11 4.23 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.379 -1.282 . . . . 1.0 110.322 -175.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.872 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 90.9 p -160.56 165.71 30.32 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.842 -0.343 . . . . 1.0 110.339 179.027 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.624 ' HB2' ' CD2' ' A' ' 80' ' ' HIS . . . -164.0 166.92 21.07 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 121.365 0.603 . . . . 1.0 111.677 -179.247 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -124.55 131.92 8.03 Favored Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 110.682 -0.967 . . . . 1.0 110.682 176.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.568 HG23 ' CG1' ' A' ' 10' ' ' VAL . 36.3 p -66.62 -28.87 68.83 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.108 0.41 . . . . 1.0 112.108 -176.113 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.443 ' HA3' ' HZ3' ' A' ' 48' ' ' TRP . . . -106.53 10.82 42.48 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.618 -0.801 . . . . 1.0 113.598 -175.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 44.87 34.51 1.23 Allowed 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.559 0.948 . . . . 1.0 113.559 177.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.708 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 1.2 m-90 -45.09 -74.87 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.596 0.712 . . . . 1.0 111.984 179.375 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -107.39 41.17 1.54 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.822 -1.081 . . . . 1.0 111.132 -178.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.9 p -60.64 127.84 20.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.405 178.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.03 -12.62 68.9 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.962 -0.637 . . . . 1.0 112.378 -178.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 t -80.81 -160.19 0.3 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.907 0.384 . . . . 1.0 110.615 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 31.7 t -129.91 170.42 13.95 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.688 -0.486 . . . . 1.0 109.688 -178.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.83 143.2 38.11 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.242 0.544 . . . . 1.0 112.094 -178.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.682 ' OD2' ' HG3' ' A' ' 57' ' ' ARG . 12.8 p-10 -63.54 144.58 56.88 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.71 -1.132 . . . . 1.0 112.655 -177.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -48.69 -43.3 36.93 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.546 -1.206 . . . . 1.0 113.311 178.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.682 ' HG3' ' OD2' ' A' ' 55' ' ' ASP . 4.0 ptp180 -71.49 -40.73 70.04 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 121.135 -0.226 . . . . 1.0 111.471 -175.009 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.635 ' HB1' ' HG2' ' A' ' 20' ' ' MET . . . -71.04 -35.66 72.05 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.045 0.45 . . . . 1.0 109.834 178.015 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.85 -42.3 97.6 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.905 -0.589 . . . . 1.0 111.04 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -67.53 -34.73 85.05 Favored Glycine 0 CA--C 1.489 -1.546 0 N-CA-C 110.379 -1.089 . . . . 1.0 110.379 -178.275 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.466 HG12 ' N ' ' A' ' 62' ' ' LEU . 1.1 t -63.07 -54.57 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 CA-C-N 113.557 -1.322 . . . . 1.0 110.882 176.302 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.711 HD13 ' HG3' ' A' ' 23' ' ' LYS . 89.5 mt -62.39 -51.86 65.88 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.772 0.32 . . . . 1.0 111.152 -177.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -64.83 -23.5 67.26 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.807 -0.633 . . . . 1.0 111.509 -177.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.68 -33.3 70.77 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.2 0.524 . . . . 1.0 110.589 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -96.12 1.46 52.45 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.713 -0.676 . . . . 1.0 111.063 -178.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 96.22 9.51 56.87 Favored Glycine 0 C--N 1.33 0.221 0 C-N-CA 120.886 -0.674 . . . . 1.0 113.112 176.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.511 ' CD1' ' HA ' ' A' ' 24' ' ' MET . 73.5 m-85 -88.99 149.37 43.21 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-O 120.413 0.149 . . . . 1.0 110.621 -179.305 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.475 ' HG2' ' CB ' ' A' ' 23' ' ' LYS . 40.9 Cg_endo -69.09 156.31 65.49 Favored 'Trans proline' 0 CA--C 1.51 -0.705 0 C-N-CA 122.252 1.968 . . . . 1.0 110.883 176.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.706 HG22 ' HB2' ' A' ' 62' ' ' LEU . 52.1 p -130.36 13.68 5.56 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.49 0.662 . . . . 1.0 110.443 -177.561 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -85.03 125.5 32.78 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.988 -1.006 . . . . 1.0 109.15 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.981 ' HB2' ' HE3' ' A' ' 23' ' ' LYS . 19.2 t60 -165.54 154.06 11.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.347 -0.388 . . . . 1.0 110.385 -175.001 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -133.95 113.85 12.63 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.628 -0.879 . . . . 1.0 108.628 176.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.63 140.27 56.53 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.171 -0.922 . . . . 1.0 112.558 -175.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.449 ' O ' ' HA ' ' A' ' 43' ' ' ALA . . . -134.18 150.74 51.1 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.257 -0.883 . . . . 1.0 109.81 178.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -86.62 155.33 20.48 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.615 -0.513 . . . . 1.0 109.615 176.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.591 HG11 ' CD2' ' A' ' 97' ' ' LEU . 8.8 t -67.41 112.62 2.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.123 0.487 . . . . 1.0 110.212 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.493 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -123.37 -166.92 12.72 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.58 -0.736 . . . . 1.0 111.437 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 44.3 m -57.11 -51.56 68.82 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.125 0.488 . . . . 1.0 111.687 -178.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.448 ' CD ' ' H ' ' A' ' 79' ' ' GLU . 1.4 pm0 -56.39 -31.57 63.97 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.3 -0.864 . . . . 1.0 111.114 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.624 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 80.1 m80 -75.28 -42.77 54.09 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 116.055 -0.52 . . . . 1.0 110.158 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.522 ' HA ' HD21 ' A' ' 86' ' ' LEU . 21.0 mt -67.69 -18.64 65.0 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.737 -0.665 . . . . 1.0 110.672 178.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.37 -2.9 58.82 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.852 -0.613 . . . . 1.0 110.853 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.555 ' HA ' ' HB3' ' A' ' 6' ' ' HIS . . . -60.23 155.14 18.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.827 -0.624 . . . . 1.0 111.498 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.709 ' HA ' ' NH1' ' A' ' 106' ' ' ARG . 25.0 t70 -79.5 -16.83 55.37 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.335 0.588 . . . . 1.0 109.883 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.699 HD13 HG13 ' A' ' 7' ' ' VAL . 0.5 OUTLIER -155.07 117.64 4.28 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.137 -0.938 . . . . 1.0 108.909 -177.405 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.586 HD12 ' N ' ' A' ' 86' ' ' LEU . 5.0 mp -105.52 104.11 13.77 Favored 'General case' 0 N--CA 1.425 -1.704 0 CA-C-N 115.518 -0.765 . . . . 1.0 109.744 178.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.575 ' HA ' ' O ' ' A' ' 108' ' ' ARG . 72.2 t -84.91 92.59 3.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.202 -0.908 . . . . 1.0 111.272 -176.158 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.02 146.03 30.86 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.18 -0.918 . . . . 1.0 110.785 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.403 HD13 ' HA ' ' A' ' 89' ' ' LEU . 4.2 mm? -97.55 -7.63 30.9 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.37 0.605 . . . . 1.0 109.952 178.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.441 ' CG ' ' H ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -152.64 152.97 32.39 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.16 -0.927 . . . . 1.0 110.103 178.335 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 18.7 ptt180 -64.3 -19.72 65.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.573 -0.74 . . . . 1.0 112.749 -176.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.637 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 78.3 m-20 -75.62 -48.73 20.97 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.397 -0.594 . . . . 1.0 109.397 178.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.744 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 17.8 m170 -56.29 -47.32 78.89 Favored 'General case' 0 C--N 1.333 -0.124 0 N-CA-C 109.619 -0.512 . . . . 1.0 109.619 177.134 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.466 ' HA ' HG21 ' A' ' 107' ' ' VAL . . . -58.55 -44.33 89.63 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.308 -0.406 . . . . 1.0 110.961 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.458 ' O ' ' HG2' ' A' ' 98' ' ' ARG . 2.0 ttt85 -59.64 -41.76 91.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.128 -0.487 . . . . 1.0 111.517 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.761 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 50.4 mt -63.91 -49.27 73.32 Favored 'General case' 0 C--O 1.219 -0.52 0 N-CA-C 109.744 -0.465 . . . . 1.0 109.744 -177.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.744 ' HG ' ' O ' ' A' ' 93' ' ' HIS . 27.5 mt -55.78 -55.59 30.58 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.316 -0.856 . . . . 1.0 111.67 -178.345 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.458 ' HG2' ' O ' ' A' ' 95' ' ' ARG . 20.2 ptt180 -60.97 -43.6 98.56 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.214 -0.448 . . . . 1.0 111.554 -176.553 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.647 ' HG3' ' O ' ' A' ' 96' ' ' LEU . 1.1 pp0? -69.0 -21.38 64.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.125 0.488 . . . . 1.0 110.239 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.761 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 9.8 mt -78.61 -7.81 57.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.595 -0.729 . . . . 1.0 111.962 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 147.66 -31.13 1.38 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.047 -1.073 . . . . 1.0 113.223 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.698 HG12 ' H ' ' A' ' 103' ' ' GLU . 1.4 t -75.15 -153.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.359 0.6 . . . . 1.0 111.238 -178.455 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.731 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 15.5 pt-20 -164.25 164.53 22.45 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.603 -0.888 . . . . 1.0 108.603 -178.125 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.811 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -67.69 -21.92 65.31 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.571 -0.286 . . . . 1.0 111.542 -175.405 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.61 -35.88 77.22 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.284 0.564 . . . . 1.0 110.371 175.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.731 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 0.6 OUTLIER -95.09 -44.84 7.48 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 115.201 -0.909 . . . . 1.0 110.364 -177.676 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.811 HG12 ' HA ' ' A' ' 104' ' ' ALA . 8.9 p -78.33 117.29 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-O 121.846 0.832 . . . . 1.0 109.595 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.575 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 29.1 mmm180 -134.43 148.62 50.66 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.662 -0.699 . . . . 1.0 109.915 -177.224 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.433 ' HB2' ' HB2' ' A' ' 112' ' ' SER . 82.6 mmm -78.57 140.29 38.52 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.279 -0.873 . . . . 1.0 110.581 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.571 HD11 ' HA ' ' A' ' 142' ' ' ILE . 3.2 tm? -56.49 -50.47 71.66 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 123.085 0.241 . . . . 1.0 110.93 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 5.6 ttm-85 -70.96 -15.52 62.59 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.691 -0.404 . . . . 1.0 110.854 -178.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.433 ' HB2' ' HB2' ' A' ' 109' ' ' MET . 33.5 t -75.26 -2.7 29.33 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 120.97 -0.292 . . . . 1.0 110.31 -179.131 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.68 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 85.9 m-85 -96.08 -17.77 20.67 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 121.972 -0.455 . . . . 1.0 110.617 175.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.7 t0 . . . . . 0 C--N 1.326 -0.438 0 CA-C-N 115.882 -0.599 . . . . 1.0 110.47 -178.307 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 . . . . . 0 N--CA 1.452 -0.348 0 N-CA-C 109.634 -0.506 . . . . 1.0 109.634 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -65.56 -45.5 83.12 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 109.643 -0.503 . . . . 1.0 109.643 176.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.842 ' HA ' HG12 ' A' ' 141' ' ' VAL . 24.4 t -63.74 -40.39 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-O 121.756 0.788 . . . . 1.0 109.043 177.534 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -55.94 -42.18 75.77 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.328 -0.851 . . . . 1.0 109.309 175.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.58 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -66.99 -47.96 69.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.489 -0.778 . . . . 1.0 111.711 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.842 HG12 ' HA ' ' A' ' 138' ' ' VAL . 3.6 p -59.54 -43.86 91.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.709 0.766 . . . . 1.0 111.214 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.611 HD12 HG12 ' A' ' 138' ' ' VAL . 13.5 mt -67.13 -51.08 57.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 115.206 -0.906 . . . . 1.0 111.504 178.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.58 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 7.6 pt-20 -56.11 -30.25 61.8 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 109.934 -0.395 . . . . 1.0 109.934 179.084 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 4.2 t -72.57 -30.32 64.3 Favored 'General case' 0 C--O 1.226 -0.179 0 CA-C-N 115.749 -0.66 . . . . 1.0 110.315 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.457 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -87.84 -22.62 24.35 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-N 116.024 -0.535 . . . . 1.0 111.723 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.762 HD22 ' HB3' ' A' ' 25' ' ' PHE . 9.9 mt -54.77 -38.77 70.54 Favored Pre-proline 0 CA--C 1.545 0.774 0 CA-C-O 119.163 -0.446 . . . . 1.0 112.048 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 61.7 Cg_endo -71.28 -11.01 28.17 Favored 'Trans proline' 0 C--N 1.365 1.429 0 C-N-CA 122.695 2.264 . . . . 1.0 112.113 177.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.68 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -103.86 -33.32 4.11 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.372 -1.091 . . . . 1.0 110.372 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.498 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -74.28 -40.38 62.33 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.378 -0.971 . . . . 1.0 108.378 178.372 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 150' ' ' HIS . . . . . 0.484 ' O ' ' HB2' ' A' ' 154' ' ' ASP . 1.0 OUTLIER -55.71 -52.1 65.05 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 114.716 -1.129 . . . . 1.0 110.966 176.111 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -61.73 -42.35 98.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.755 -0.657 . . . . 1.0 110.962 -176.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' TRP . . . . . 0.577 ' CE3' HD12 ' A' ' 85' ' ' LEU . 28.0 t90 -60.98 -57.12 13.95 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.387 -0.824 . . . . 1.0 110.629 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.508 ' HB ' HD22 ' A' ' 5' ' ' LEU . 11.0 m -60.41 -38.49 78.0 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.279 0 N-CA-C 110.088 -0.338 . . . . 1.0 110.088 -178.164 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.525 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 0.5 OUTLIER -59.53 -56.19 25.07 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.403 0.62 . . . . 1.0 110.815 179.72 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -61.44 -39.81 92.19 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.047 -0.978 . . . . 1.0 110.72 -177.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.43 ' HD3' ' HA ' ' A' ' 156' ' ' ARG . 11.4 mmt85 -72.07 -45.75 59.54 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 115.79 -0.641 . . . . 1.0 110.966 -176.263 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.525 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 3.6 pp . . . . . 0 C--N 1.326 -0.439 0 CA-C-N 115.789 -0.641 . . . . 1.0 109.372 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.466 ' HB2' ' HG2' ' A' ' 39' ' ' ARG . 19.4 Cg_endo . . . . . 0 N--CA 1.458 -0.584 0 CA-C-O 121.112 0.38 . . . . 1.0 112.402 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.794 ' HB3' HG23 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -65.04 177.17 1.05 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.667 -0.697 . . . . 1.0 109.304 -179.213 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.738 ' H ' HD13 ' A' ' 5' ' ' LEU . 0.1 OUTLIER -157.24 90.93 1.14 Allowed 'General case' 0 C--N 1.318 -0.797 0 O-C-N 121.878 -0.514 . . . . 1.0 111.036 -179.134 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.582 HG13 HD13 ' A' ' 85' ' ' LEU . 1.7 t -95.74 109.09 22.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.731 -0.668 . . . . 1.0 109.557 178.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.614 ' CG2' ' HG ' ' A' ' 86' ' ' LEU . 10.1 t -112.56 117.28 31.9 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 109.623 -0.51 . . . . 1.0 109.623 178.044 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.727 ' HZ ' ' HE1' ' A' ' 25' ' ' PHE . 1.0 OUTLIER -86.3 134.49 33.74 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 120.843 0.354 . . . . 1.0 110.234 -178.919 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.598 HG21 HD11 ' A' ' 97' ' ' LEU . 33.7 t -116.5 113.67 43.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 116.083 -0.508 . . . . 1.0 111.649 -176.337 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.638 ' HB2' HD23 ' A' ' 89' ' ' LEU . 38.3 t -143.86 160.61 40.47 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.145 -0.48 . . . . 1.0 109.837 178.46 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.423 HG23 ' NE2' ' A' ' 93' ' ' HIS . 0.6 OUTLIER -67.39 100.45 0.84 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.205 0.526 . . . . 1.0 111.18 -179.768 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 1.008 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 117.21 -40.01 2.48 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.513 -0.767 . . . . 1.0 112.18 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.706 ' ND2' ' H ' ' A' ' 74' ' ' ALA . 57.7 t30 60.61 25.72 15.43 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 122.449 1.119 . . . . 1.0 110.392 -177.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.578 ' O ' ' HB3' ' A' ' 55' ' ' ASP . 1.3 pt -134.76 39.02 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 114.908 -1.042 . . . . 1.0 109.658 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.763 ' O ' ' HG3' ' A' ' 20' ' ' MET . 6.9 p -151.38 -89.26 0.06 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.086 -0.507 . . . . 1.0 111.426 177.583 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 81.3 mtt180 -74.83 -45.1 45.56 Favored 'General case' 0 N--CA 1.464 0.249 0 O-C-N 122.004 -0.435 . . . . 1.0 111.543 -176.155 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.472 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 20.4 m -53.09 -56.32 24.96 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 116.117 -0.492 . . . . 1.0 111.364 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.472 ' HD3' ' HB2' ' A' ' 18' ' ' SER . 49.4 Cg_endo -67.28 -24.52 43.62 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 121.444 1.43 . . . . 1.0 112.909 -178.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.763 ' HG3' ' O ' ' A' ' 16' ' ' CYS . 63.4 mtp -59.15 -53.35 59.32 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 109.869 -0.419 . . . . 1.0 109.869 178.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.554 ' O ' ' HD1' ' A' ' 25' ' ' PHE . . . -72.77 -31.15 64.68 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 115.379 -0.828 . . . . 1.0 110.68 -177.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.636 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 17.5 tt0 -50.66 -53.46 30.85 Favored 'General case' 0 C--O 1.218 -0.554 0 O-C-N 124.167 0.917 . . . . 1.0 110.162 -178.006 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.675 ' HZ1' ' HB3' ' A' ' 71' ' ' HIS . 0.2 OUTLIER -84.9 -24.23 28.55 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.497 -0.774 . . . . 1.0 110.902 -176.618 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.431 ' HB3' HD11 ' A' ' 146' ' ' LEU . 85.4 mtp -63.61 -75.66 0.08 Allowed 'General case' 0 C--O 1.237 0.423 0 N-CA-C 112.621 0.6 . . . . 1.0 112.621 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.754 ' HB3' HD22 ' A' ' 146' ' ' LEU . 0.6 OUTLIER -78.62 -28.77 45.65 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.163 -0.615 . . . . 1.0 111.93 -174.885 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.636 ' HB3' ' O ' ' A' ' 22' ' ' GLU . . . -64.71 -38.07 89.75 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 119.346 -0.941 . . . . 1.0 110.389 178.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.635 ' HG3' ' N ' ' A' ' 28' ' ' GLN . 0.1 OUTLIER -62.92 -38.84 92.57 Favored 'General case' 0 CA--C 1.527 0.061 0 N-CA-C 108.406 -0.961 . . . . 1.0 108.406 177.046 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.635 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 79.4 mt-30 -59.89 -42.88 94.76 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 115.593 -0.73 . . . . 1.0 110.808 176.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 25' ' ' PHE . 96.5 mt -56.17 -60.05 4.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.104 -0.498 . . . . 1.0 111.322 -178.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.425 ' HA ' ' H ' ' A' ' 35' ' ' GLY . 0.1 OUTLIER -60.29 -34.91 74.42 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.144 -0.623 . . . . 1.0 111.178 178.904 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -60.76 -29.24 69.29 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 111.96 0.355 . . . . 1.0 111.96 177.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.603 ' HG2' ' O ' ' A' ' 28' ' ' GLN . 6.8 ptp180 -94.72 -21.1 18.98 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.098 -0.641 . . . . 1.0 110.275 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 107.43 40.38 1.78 Allowed Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.175 -0.921 . . . . 1.0 111.962 177.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 25.8 mt -132.32 0.32 3.71 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.965 -0.383 . . . . 1.0 109.965 -178.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.425 ' H ' ' HA ' ' A' ' 30' ' ' ARG . . . -57.7 -28.91 60.7 Favored Glycine 0 C--N 1.332 0.351 0 CA-C-N 116.035 -0.53 . . . . 1.0 112.855 -179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -83.35 -25.76 31.14 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.17 0.509 . . . . 1.0 110.321 177.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.41 -23.11 40.6 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.559 -0.746 . . . . 1.0 111.571 -177.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.794 HG23 ' HB3' ' A' ' 5' ' ' LEU . 0.4 OUTLIER -141.33 125.09 16.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.296 0.569 . . . . 1.0 111.241 -179.396 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.466 ' HG2' ' HB2' ' A' ' 4' ' ' PRO . 17.3 mmt180 -88.93 142.43 27.65 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.475 -0.784 . . . . 1.0 108.998 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 77.0 t -129.8 130.13 66.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 109.173 -0.676 . . . . 1.0 109.173 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.494 ' O ' ' HA ' ' A' ' 8' ' ' THR . 37.0 p -143.8 -174.17 4.18 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.782 -1.099 . . . . 1.0 110.487 -174.355 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.472 ' OG ' ' HE1' ' A' ' 71' ' ' HIS . 65.2 p -160.43 163.03 33.37 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.598 -0.274 . . . . 1.0 110.427 -179.072 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.657 ' HB2' ' CD2' ' A' ' 80' ' ' HIS . . . -163.34 161.98 24.81 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.278 0.561 . . . . 1.0 111.345 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -123.37 133.42 8.95 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.453 -0.794 . . . . 1.0 111.481 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.504 HG23 ' CG1' ' A' ' 10' ' ' VAL . 17.9 p -71.44 -20.83 62.05 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.688 0.28 . . . . 1.0 111.727 -178.128 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.46 ' HA3' ' CZ3' ' A' ' 48' ' ' TRP . . . -109.66 5.33 31.09 Favored Glycine 0 C--O 1.226 -0.377 0 C-N-CA 120.603 -0.808 . . . . 1.0 113.026 -178.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 42.92 34.54 0.62 Allowed 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 113.518 0.933 . . . . 1.0 113.518 178.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 1.008 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 0.9 OUTLIER -46.83 -72.99 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.298 0.571 . . . . 1.0 112.419 -178.983 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.545 ' HB3' ' HB3' ' A' ' 52' ' ' SER . 3.2 m-70 -106.5 42.66 1.24 Allowed 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.734 -0.666 . . . . 1.0 111.186 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.434 HG23 ' HA ' ' A' ' 74' ' ' ALA . 11.9 p -61.34 126.92 20.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 120.573 -0.451 . . . . 1.0 109.985 178.399 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.0 -12.59 69.63 Favored Glycine 0 CA--C 1.519 0.303 0 N-CA-C 111.794 -0.523 . . . . 1.0 111.794 -176.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.545 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 1.4 t -83.08 -159.58 0.35 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.149 0.5 . . . . 1.0 109.839 178.762 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.614 ' HA ' ' O ' ' A' ' 71' ' ' HIS . 25.0 t -131.17 170.38 14.64 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.955 -0.566 . . . . 1.0 109.573 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -50.74 145.7 6.65 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 123.758 0.661 . . . . 1.0 111.553 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.672 ' OD1' ' HA ' ' A' ' 16' ' ' CYS . 9.6 p-10 -61.47 144.94 53.35 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.434 -0.803 . . . . 1.0 112.388 -178.289 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -45.75 -36.32 4.97 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.214 -1.357 . . . . 1.0 113.221 175.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.611 ' O ' HG23 ' A' ' 61' ' ' VAL . 17.1 mtt-85 -71.22 -49.66 41.09 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.843 0.354 . . . . 1.0 111.013 -175.238 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.479 ' HB1' ' HG2' ' A' ' 20' ' ' MET . . . -69.65 -29.83 67.39 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.419 -0.81 . . . . 1.0 110.557 -178.391 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.401 ' O ' HG21 ' A' ' 69' ' ' THR . . . -61.65 -47.71 84.16 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.701 -0.481 . . . . 1.0 109.701 177.266 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.36 -38.09 95.7 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.962 -0.637 . . . . 1.0 112.101 178.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 57' ' ' ARG . 99.7 t -64.19 -58.87 5.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.25 0.548 . . . . 1.0 110.826 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.479 ' HB2' HG22 ' A' ' 69' ' ' THR . 8.6 mp -59.79 -48.65 80.84 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.686 -0.688 . . . . 1.0 111.54 -177.2 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.448 ' HB3' HG21 ' A' ' 69' ' ' THR . 9.9 ptm180 -60.59 -28.54 68.57 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.517 -0.31 . . . . 1.0 111.131 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.34 -33.88 75.1 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.417 0.627 . . . . 1.0 110.053 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -93.74 4.78 53.42 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.228 -0.896 . . . . 1.0 111.536 -178.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.89 16.18 65.98 Favored Glycine 0 N--CA 1.455 -0.093 0 C-N-CA 120.96 -0.638 . . . . 1.0 112.754 177.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -92.44 151.95 41.79 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 110.259 -0.274 . . . . 1.0 110.259 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.482 ' O ' ' HD2' ' A' ' 23' ' ' LYS . 27.8 Cg_endo -66.29 152.1 81.84 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 121.877 1.718 . . . . 1.0 110.155 176.566 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.479 HG22 ' HB2' ' A' ' 62' ' ' LEU . 66.7 p -131.28 25.61 4.85 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 120.266 -0.574 . . . . 1.0 112.041 -175.334 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -110.57 127.02 55.04 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.783 -0.451 . . . . 1.0 109.783 179.168 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.675 ' HB3' ' HZ1' ' A' ' 23' ' ' LYS . 0.2 OUTLIER -160.09 139.5 11.04 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.883 -179.61 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.526 ' HD3' ' O ' ' A' ' 52' ' ' SER . 5.1 tpp180 -102.72 114.98 29.67 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.969 -0.56 . . . . 1.0 110.132 178.565 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 49' ' ' HIS . . . -63.51 138.01 58.35 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.139 -0.482 . . . . 1.0 112.133 -178.378 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.706 ' H ' ' ND2' ' A' ' 14' ' ' ASN . . . -129.41 163.62 25.43 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.942 -0.572 . . . . 1.0 109.894 176.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -98.07 159.41 14.95 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.977 -0.749 . . . . 1.0 108.977 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.578 HG11 HD23 ' A' ' 97' ' ' LEU . 47.8 t -70.83 115.26 10.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.936 0.398 . . . . 1.0 110.252 177.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.567 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -128.31 -167.0 12.13 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.723 -0.671 . . . . 1.0 111.697 178.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 30.3 m -57.35 -51.83 67.81 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.973 0.416 . . . . 1.0 111.747 -179.136 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.472 ' CD ' ' H ' ' A' ' 79' ' ' GLU . 1.6 pm0 -56.21 -31.93 63.95 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.623 -0.717 . . . . 1.0 110.981 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.657 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 80.0 m80 -74.87 -41.16 60.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.967 -0.561 . . . . 1.0 109.955 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.735 ' HA ' HD21 ' A' ' 86' ' ' LEU . 15.6 mt -68.78 -16.34 63.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.973 0.416 . . . . 1.0 110.238 176.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -87.35 -8.32 56.78 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 120.932 0.396 . . . . 1.0 110.112 -179.209 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.475 ' HB1' ' O ' ' A' ' 6' ' ' HIS . . . -59.18 156.16 12.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.86 -0.609 . . . . 1.0 110.774 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.77 ' HA ' ' NH1' ' A' ' 106' ' ' ARG . 3.0 t70 -82.35 -12.47 57.93 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.902 0.382 . . . . 1.0 110.153 -178.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.735 HD12 ' CE3' ' A' ' 152' ' ' TRP . 1.1 tt -158.0 115.26 2.94 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.81 -0.632 . . . . 1.0 109.539 -178.257 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.735 HD21 ' HA ' ' A' ' 81' ' ' LEU . 5.2 mp -107.08 87.64 2.55 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 115.669 -0.696 . . . . 1.0 110.802 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.632 HG11 HD23 ' A' ' 110' ' ' LEU . 76.7 t -66.01 92.91 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 113.886 -1.507 . . . . 1.0 112.521 -178.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.69 149.86 31.08 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.993 -1.003 . . . . 1.0 111.093 177.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.638 HD23 ' HB2' ' A' ' 11' ' ' CYS . 3.9 mm? -98.7 -5.69 31.04 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.971 179.119 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.9 p30 -159.09 166.43 31.62 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.506 0.67 . . . . 1.0 111.368 174.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.452 ' HG2' ' H ' ' A' ' 91' ' ' ARG . 9.1 ptt180 -62.63 -18.98 63.32 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.11 -1.404 . . . . 1.0 112.305 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.622 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 5.9 m-20 -78.48 -53.24 7.45 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.749 0.309 . . . . 1.0 110.623 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.669 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 14.1 m170 -58.84 -44.73 91.02 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.958 -0.565 . . . . 1.0 109.674 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.17 -42.78 91.62 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.002 0.429 . . . . 1.0 110.817 179.023 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 95' ' ' ARG . 4.3 ttm180 -57.99 -44.84 87.4 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.37 -0.832 . . . . 1.0 111.281 177.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.691 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 49.4 mt -64.85 -48.45 74.28 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.44 -175.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.669 ' HG ' ' O ' ' A' ' 93' ' ' HIS . 29.0 mt -53.57 -59.77 4.16 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.642 -0.708 . . . . 1.0 111.771 -177.489 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.714 ' N ' HG12 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -60.12 -44.33 94.98 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.47 0.545 . . . . 1.0 112.47 -179.308 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.539 ' HG3' ' O ' ' A' ' 96' ' ' LEU . 1.0 OUTLIER -66.56 -23.3 66.19 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.254 -0.578 . . . . 1.0 109.945 179.056 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.691 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 8.9 mt -80.98 -21.75 40.05 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.764 -0.653 . . . . 1.0 111.65 178.155 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 155.25 -22.72 0.58 Allowed Glycine 0 CA--C 1.521 0.453 0 C-N-CA 119.332 -1.413 . . . . 1.0 114.38 -177.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.714 HG12 ' N ' ' A' ' 98' ' ' ARG . 0.3 OUTLIER -76.82 -162.09 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 117.836 0.818 . . . . 1.0 110.431 -179.78 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.756 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 16.7 pt-20 -156.37 159.85 39.13 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 107.624 -1.25 . . . . 1.0 107.624 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.767 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -62.91 -23.65 67.46 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.692 0.282 . . . . 1.0 111.625 -174.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.77 -36.57 74.6 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.376 174.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.77 ' NH1' ' HA ' ' A' ' 84' ' ' ASP . 0.7 OUTLIER -97.25 -42.17 7.93 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 115.323 -0.853 . . . . 1.0 111.063 -177.382 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.767 HG12 ' HA ' ' A' ' 104' ' ' ALA . 14.2 p -79.18 114.69 20.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.113 0.482 . . . . 1.0 109.798 -175.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.631 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 27.3 mmm180 -133.32 148.6 51.91 Favored 'General case' 0 C--N 1.318 -0.777 0 O-C-N 121.521 -0.737 . . . . 1.0 110.314 -177.262 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.573 ' HB2' ' HB2' ' A' ' 112' ' ' SER . 74.8 mmm -78.91 138.16 37.97 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.454 -0.794 . . . . 1.0 110.526 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.632 HD23 HG11 ' A' ' 87' ' ' VAL . 3.2 tm? -57.66 -50.67 72.39 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 111.488 0.181 . . . . 1.0 111.488 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.437 ' O ' ' HG2' ' A' ' 111' ' ' ARG . 19.1 ttm180 -69.18 -17.99 63.87 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.661 -0.416 . . . . 1.0 110.227 -178.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.573 ' HB2' ' HB2' ' A' ' 109' ' ' MET . 39.3 t -73.48 -5.66 41.46 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.928 -0.309 . . . . 1.0 111.262 -178.293 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.66 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 88.6 m-85 -92.99 -18.07 23.15 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 121.073 0.463 . . . . 1.0 110.411 175.421 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 17.7 t0 . . . . . 0 C--N 1.327 -0.401 0 CA-C-N 115.598 -0.728 . . . . 1.0 111.256 -177.211 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 . . . . . 0 N--CA 1.452 -0.349 0 CA-C-O 120.882 0.372 . . . . 1.0 110.44 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.57 ' O ' HG23 ' A' ' 141' ' ' VAL . 20.4 tp10 -65.08 -47.96 75.41 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.107 -0.701 . . . . 1.0 109.107 175.156 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.534 ' HA ' HG23 ' A' ' 141' ' ' VAL . 52.7 t -60.85 -42.41 92.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 115.833 -0.621 . . . . 1.0 109.545 176.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.473 ' HB2' HG11 ' A' ' 61' ' ' VAL . 70.0 t80 -54.56 -43.48 72.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.906 -1.043 . . . . 1.0 109.45 176.215 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.711 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -64.0 -38.53 91.41 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.516 -0.765 . . . . 1.0 110.737 177.325 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 137' ' ' GLU . 13.6 t -58.33 -51.9 65.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-O 121.558 0.694 . . . . 1.0 110.067 177.271 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.461 ' CG2' ' HB2' ' A' ' 21' ' ' ALA . 5.8 mt -65.44 -50.96 69.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.177 -0.92 . . . . 1.0 111.89 -179.06 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.711 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 6.8 pt-20 -55.09 -33.47 62.82 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 110.033 -0.358 . . . . 1.0 110.033 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' SER . . . . . 0.511 ' HB2' ' O ' ' A' ' 140' ' ' ALA . 1.0 OUTLIER -73.5 -27.69 61.51 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.841 -0.618 . . . . 1.0 110.384 -179.694 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.444 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -86.94 -23.91 24.95 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 116.107 -0.497 . . . . 1.0 111.407 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.754 HD22 ' HB3' ' A' ' 25' ' ' PHE . 16.0 mt -55.22 -37.92 62.01 Favored Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 112.276 0.473 . . . . 1.0 112.276 -178.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 60.8 Cg_endo -71.61 -9.75 25.55 Favored 'Trans proline' 0 C--N 1.362 1.288 0 C-N-CA 122.634 2.222 . . . . 1.0 112.147 177.321 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.66 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -105.14 -30.86 4.6 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 110.317 -1.113 . . . . 1.0 110.317 178.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.565 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -75.54 -42.12 53.27 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.3 -1.0 . . . . 1.0 108.3 177.424 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 9.9 m170 -54.34 -49.76 69.0 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.087 -0.961 . . . . 1.0 110.777 176.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -61.54 -45.98 91.86 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.584 -0.735 . . . . 1.0 110.764 -177.185 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' TRP . . . . . 0.735 ' CE3' HD12 ' A' ' 85' ' ' LEU . 27.8 t90 -59.15 -57.02 14.89 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.914 -1.039 . . . . 1.0 110.722 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 15.8 m -58.88 -38.09 70.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.834 -0.346 . . . . 1.0 110.567 -178.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.521 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 9.9 t70 -58.84 -57.38 13.3 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 122.062 0.934 . . . . 1.0 110.897 178.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 4.5 pt-20 -62.23 -36.9 83.4 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 113.928 -1.487 . . . . 1.0 110.733 -176.118 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.524 ' HG3' ' CH2' ' A' ' 152' ' ' TRP . 3.8 mmt180 -74.72 -44.72 48.52 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.754 -0.657 . . . . 1.0 111.35 -177.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 3.7 pp . . . . . 0 C--N 1.327 -0.396 0 N-CA-C 109.566 -0.531 . . . . 1.0 109.566 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.503 ' HB3' ' O ' ' A' ' 36' ' ' ASP . 49.5 Cg_endo . . . . . 0 N--CA 1.46 -0.449 0 CA-C-O 121.25 0.437 . . . . 1.0 113.174 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.851 ' HB3' HG23 ' A' ' 38' ' ' VAL . 0.9 OUTLIER -73.57 -173.71 1.52 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.411 -0.813 . . . . 1.0 110.879 179.574 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.58 ' O ' ' HB1' ' A' ' 83' ' ' ALA . 1.5 t-160 -158.09 93.93 1.27 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.462 -0.335 . . . . 1.0 111.027 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.79 HG13 HD13 ' A' ' 85' ' ' LEU . 2.3 t -94.28 109.31 21.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.037 -0.727 . . . . 1.0 109.037 176.308 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.698 ' CG2' ' HG ' ' A' ' 86' ' ' LEU . 12.8 t -112.32 112.98 24.95 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.116 0.484 . . . . 1.0 110.307 178.279 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.741 ' HZ ' ' HE1' ' A' ' 25' ' ' PHE . 0.9 OUTLIER -82.06 147.1 29.31 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 121.857 -0.527 . . . . 1.0 109.761 179.921 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.68 HG21 HD21 ' A' ' 97' ' ' LEU . 44.3 t -132.74 118.12 32.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.321 0.581 . . . . 1.0 111.634 -176.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.584 ' HB3' HD23 ' A' ' 89' ' ' LEU . 28.7 p -141.29 178.81 7.16 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.524 -0.762 . . . . 1.0 110.092 178.662 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.521 HG23 ' NE2' ' A' ' 93' ' ' HIS . 0.7 OUTLIER -86.36 86.64 7.34 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.988 0.423 . . . . 1.0 110.971 179.064 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.857 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 135.55 -37.6 1.89 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.656 -0.783 . . . . 1.0 112.077 178.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.516 HD21 ' CB ' ' A' ' 42' ' ' SER . 3.8 t-20 64.01 17.22 10.46 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.59 0.709 . . . . 1.0 111.103 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.0 pt -124.55 11.03 4.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 O-C-N 121.783 -0.573 . . . . 1.0 111.715 -177.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 7.5 p -127.45 -87.36 0.57 Allowed 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 112.112 0.412 . . . . 1.0 112.112 -177.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.68 -44.37 74.17 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 112.323 0.49 . . . . 1.0 112.323 -176.549 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.738 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 50.9 m -57.37 -58.03 20.92 Favored Pre-proline 0 CA--C 1.538 0.488 0 N-CA-C 112.378 0.51 . . . . 1.0 112.378 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.665 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 49.4 Cg_endo -64.96 -24.48 60.4 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 121.632 1.555 . . . . 1.0 112.071 -177.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.617 ' HB3' HD13 ' A' ' 142' ' ' ILE . 39.9 mmm -61.62 -54.39 43.54 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 121.13 -0.228 . . . . 1.0 110.767 178.153 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.539 ' O ' ' HD1' ' A' ' 25' ' ' PHE . . . -72.65 -32.02 65.53 Favored 'General case' 0 CA--C 1.507 -0.679 0 C-N-CA 120.615 -0.434 . . . . 1.0 110.124 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.651 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 11.3 tt0 -50.83 -51.79 47.56 Favored 'General case' 0 C--O 1.216 -0.708 0 O-C-N 124.399 1.062 . . . . 1.0 109.988 -178.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.904 ' HE3' ' HB2' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -79.45 -30.33 42.15 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.829 -0.623 . . . . 1.0 110.014 -176.906 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.587 ' HB3' HD11 ' A' ' 146' ' ' LEU . 3.2 mmm -62.39 -75.78 0.07 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.436 0.902 . . . . 1.0 113.436 -176.373 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.741 ' HE1' ' HZ ' ' A' ' 9' ' ' PHE . 0.8 OUTLIER -78.86 -27.81 44.16 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.011 -0.676 . . . . 1.0 111.543 -174.628 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.651 ' HB3' ' O ' ' A' ' 22' ' ' GLU . . . -64.62 -37.16 86.63 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 118.934 -1.106 . . . . 1.0 110.262 177.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.694 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -63.48 -39.44 94.46 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.76 -0.83 . . . . 1.0 108.76 177.417 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.562 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 77.6 mt-30 -59.67 -45.02 93.3 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.982 -0.554 . . . . 1.0 110.39 176.299 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.623 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 90.8 mt -54.46 -61.38 2.34 Favored 'General case' 0 N--CA 1.461 0.094 0 CA-C-N 115.751 -0.659 . . . . 1.0 111.078 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.6 ' HD3' ' HA ' ' A' ' 27' ' ' GLN . 3.2 ptm180 -58.53 -39.72 80.96 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.211 -0.449 . . . . 1.0 111.47 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -62.27 -22.52 66.07 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 112.176 0.435 . . . . 1.0 112.176 178.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.623 ' HG2' ' O ' ' A' ' 29' ' ' LEU . 5.7 ptm85 -99.89 -17.79 17.44 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 119.346 -0.941 . . . . 1.0 110.158 178.331 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.17 35.75 2.86 Favored Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 115.016 -0.993 . . . . 1.0 112.077 177.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.521 ' HG ' ' HG3' ' A' ' 32' ' ' ARG . 43.5 mt -126.88 -1.28 6.61 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.739 0.304 . . . . 1.0 110.346 -178.544 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.429 ' H ' ' HA ' ' A' ' 30' ' ' ARG . . . -56.32 -28.0 54.12 Favored Glycine 0 N--CA 1.46 0.288 0 CA-C-N 116.027 -0.533 . . . . 1.0 112.897 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.503 ' O ' ' HB3' ' A' ' 4' ' ' PRO . 4.9 m-20 -89.7 -22.36 22.26 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.666 0.27 . . . . 1.0 110.55 177.502 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.04 -26.33 39.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.033 -0.53 . . . . 1.0 111.497 -179.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.851 HG23 ' HB3' ' A' ' 5' ' ' LEU . 1.1 p -143.83 124.02 8.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.37 0.605 . . . . 1.0 110.198 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.453 ' HE ' ' HG3' ' A' ' 4' ' ' PRO . 17.7 mmt85 -90.17 147.42 23.59 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.287 -0.87 . . . . 1.0 109.704 -178.135 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 74.7 t -132.64 117.27 30.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.557 0.694 . . . . 1.0 110.584 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.498 ' O ' ' HA ' ' A' ' 8' ' ' THR . 69.8 p -132.23 -174.15 3.36 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.502 -1.226 . . . . 1.0 110.419 -177.025 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.738 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 93.2 p -160.98 168.91 23.62 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.806 -0.357 . . . . 1.0 110.58 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.464 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -163.96 167.44 20.55 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.186 0.517 . . . . 1.0 111.291 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -125.75 135.74 9.34 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 115.355 -0.839 . . . . 1.0 111.023 176.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.59 HG21 HD12 ' A' ' 96' ' ' LEU . 23.5 p -70.59 -26.47 63.53 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.315 0.487 . . . . 1.0 112.315 -177.044 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.461 ' HA3' ' CZ3' ' A' ' 48' ' ' TRP . . . -108.11 9.61 36.58 Favored Glycine 0 C--O 1.229 -0.179 0 C-N-CA 120.717 -0.754 . . . . 1.0 112.796 -177.425 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 42.97 38.87 1.55 Allowed 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.344 0.868 . . . . 1.0 113.344 178.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.857 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 1.1 m-90 -46.38 -75.34 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.326 0.584 . . . . 1.0 112.48 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.483 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 8.1 m-70 -106.42 41.31 1.45 Allowed 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.259 -0.882 . . . . 1.0 111.046 -179.059 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.531 HG23 ' HA ' ' A' ' 74' ' ' ALA . 15.0 p -61.27 125.01 16.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 120.471 -0.492 . . . . 1.0 110.281 178.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.42 -12.5 66.4 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.903 -0.665 . . . . 1.0 111.763 -177.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.45 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 2.8 t -81.15 -160.33 0.32 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.228 0.537 . . . . 1.0 110.08 178.263 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 34.9 t -129.87 171.45 12.72 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.465 -0.788 . . . . 1.0 109.325 -178.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.26 140.85 37.71 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.745 0.307 . . . . 1.0 111.464 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -59.47 141.35 54.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.605 -0.725 . . . . 1.0 111.52 -177.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -51.58 -28.89 15.36 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 113.378 0.881 . . . . 1.0 113.378 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.68 ' O ' HG23 ' A' ' 61' ' ' VAL . 18.9 mtp180 -68.46 -50.61 51.24 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 118.524 0.602 . . . . 1.0 109.506 178.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.21 -32.37 72.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.145 -0.934 . . . . 1.0 110.568 -176.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.85 -46.6 88.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.135 178.283 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.88 -37.81 95.51 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.667 -0.778 . . . . 1.0 111.843 177.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 57' ' ' ARG . 58.1 t -63.2 -58.95 5.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.21 0.529 . . . . 1.0 111.282 179.14 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.738 ' HB2' HG22 ' A' ' 69' ' ' THR . 92.3 mt -58.3 -53.16 61.38 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.745 -0.661 . . . . 1.0 111.356 -177.205 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -59.23 -29.71 67.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.44 -0.346 . . . . 1.0 111.083 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.79 -33.33 73.69 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.231 0.538 . . . . 1.0 111.03 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 73.1 m80 -98.8 6.37 46.92 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.065 -0.516 . . . . 1.0 111.216 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.23 13.81 63.23 Favored Glycine 0 C--N 1.332 0.323 0 CA-C-N 115.642 -0.708 . . . . 1.0 112.961 176.397 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.403 ' CD1' ' HA ' ' A' ' 24' ' ' MET . 64.8 m-85 -90.59 151.64 44.25 Favored Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 110.554 -0.165 . . . . 1.0 110.554 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.891 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 46.9 Cg_endo -70.2 160.07 50.87 Favored 'Trans proline' 0 CA--C 1.515 -0.428 0 C-N-CA 122.481 2.121 . . . . 1.0 111.111 176.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.738 HG22 ' HB2' ' A' ' 62' ' ' LEU . 65.8 p -134.1 4.11 3.47 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.419 -0.513 . . . . 1.0 111.697 -177.339 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -74.38 126.75 31.37 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.398 -0.364 . . . . 1.0 110.075 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.904 ' HB2' ' HE3' ' A' ' 23' ' ' LYS . 28.8 t60 -166.28 150.29 7.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.638 -0.256 . . . . 1.0 110.802 -176.359 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.408 ' HA ' ' O ' ' A' ' 52' ' ' SER . 2.0 tmt_? -131.03 110.22 11.07 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.905 -1.146 . . . . 1.0 107.905 177.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 49' ' ' HIS . . . -58.57 139.92 55.06 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.896 -1.047 . . . . 1.0 112.412 -174.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.531 ' HA ' HG23 ' A' ' 50' ' ' VAL . . . -130.81 165.55 22.75 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.789 -0.642 . . . . 1.0 110.478 178.12 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -101.52 159.31 15.4 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.017 -0.735 . . . . 1.0 109.017 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.537 HG11 HD23 ' A' ' 97' ' ' LEU . 96.5 t -66.87 110.56 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.903 0.383 . . . . 1.0 110.61 179.092 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.506 ' H ' ' CD2' ' A' ' 80' ' ' HIS . . . -127.52 -169.43 12.67 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.696 -0.684 . . . . 1.0 112.324 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 99.1 m -54.51 -52.03 63.26 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 123.457 0.703 . . . . 1.0 112.595 -178.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.565 ' HG2' ' N ' ' A' ' 80' ' ' HIS . 0.8 OUTLIER -58.19 -29.84 65.96 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.281 0.562 . . . . 1.0 110.523 -178.204 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.565 ' N ' ' HG2' ' A' ' 79' ' ' GLU . 84.6 m-70 -76.59 -42.77 41.34 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.535 -0.757 . . . . 1.0 110.014 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.648 ' O ' HG23 ' A' ' 102' ' ' VAL . 17.3 mt -67.71 -18.85 65.05 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.118 0.485 . . . . 1.0 110.681 177.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.69 -7.92 57.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.936 0.398 . . . . 1.0 110.494 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.58 ' HB1' ' O ' ' A' ' 6' ' ' HIS . . . -60.74 152.69 26.16 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.64 -0.709 . . . . 1.0 111.099 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.476 ' HB3' ' HG ' ' A' ' 5' ' ' LEU . 26.0 t70 -79.47 -15.13 58.3 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.991 -0.55 . . . . 1.0 109.775 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.79 HD13 HG13 ' A' ' 7' ' ' VAL . 0.4 OUTLIER -153.62 117.33 4.7 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 115.573 -0.74 . . . . 1.0 109.862 -177.16 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.698 ' HG ' ' CG2' ' A' ' 8' ' ' THR . 5.0 mp -109.45 105.98 15.55 Favored 'General case' 0 N--CA 1.427 -1.599 0 CA-C-N 115.42 -0.809 . . . . 1.0 109.865 177.437 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.661 ' HB ' ' HD1' ' A' ' 9' ' ' PHE . 64.7 t -85.43 91.8 3.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.014 -0.994 . . . . 1.0 111.389 -175.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.06 149.92 30.5 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.307 -0.861 . . . . 1.0 110.884 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.584 HD23 ' HB3' ' A' ' 11' ' ' CYS . 3.9 mm? -96.26 -10.55 27.67 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.844 -0.616 . . . . 1.0 110.674 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.608 ' HA ' ' HE1' ' A' ' 109' ' ' MET . 9.7 p30 -156.5 167.89 29.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.463 0.649 . . . . 1.0 111.85 175.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -57.3 -24.61 56.08 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.165 -1.38 . . . . 1.0 112.636 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.619 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 91.1 m-20 -76.43 -53.88 7.51 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.837 0.351 . . . . 1.0 110.656 -176.382 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.521 ' NE2' HG23 ' A' ' 12' ' ' THR . 13.2 m170 -58.94 -42.61 90.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.223 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.55 -43.5 97.18 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.999 0.428 . . . . 1.0 110.586 178.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.446 HH11 ' HD3' ' A' ' 95' ' ' ARG . 5.0 ttm-85 -57.9 -43.62 86.27 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 115.508 -0.769 . . . . 1.0 110.999 177.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.619 ' HG ' ' O ' ' A' ' 92' ' ' ASN . 55.6 mt -65.88 -50.51 64.24 Favored 'General case' 0 C--O 1.217 -0.633 0 CA-C-N 115.906 -0.588 . . . . 1.0 110.365 -176.025 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.68 HD21 HG21 ' A' ' 10' ' ' VAL . 30.5 mt -51.87 -56.1 16.1 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.055 -0.521 . . . . 1.0 111.135 -178.201 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.706 ' CA ' HG12 ' A' ' 102' ' ' VAL . 14.2 ptt85 -62.37 -43.1 99.61 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.546 0.573 . . . . 1.0 112.546 -178.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.556 ' HG3' ' O ' ' A' ' 96' ' ' LEU . 0.9 OUTLIER -67.36 -26.77 66.64 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.592 -0.443 . . . . 1.0 110.045 179.262 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.485 HD13 ' O ' ' A' ' 96' ' ' LEU . 5.4 mp -76.51 -20.26 57.12 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 116.088 -0.505 . . . . 1.0 111.818 178.266 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 153.2 -22.38 0.76 Allowed Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 119.465 -1.35 . . . . 1.0 113.927 -177.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.986 HG22 ' HD2' ' A' ' 106' ' ' ARG . 0.4 OUTLIER -76.42 -163.52 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-N 117.633 0.717 . . . . 1.0 110.33 -178.756 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.7 ' N ' HG13 ' A' ' 102' ' ' VAL . 12.7 pt-20 -159.05 162.64 36.66 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 107.369 -1.345 . . . . 1.0 107.369 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.745 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -62.14 -24.72 67.34 Favored 'General case' 0 C--N 1.322 -0.617 0 O-C-N 123.135 0.272 . . . . 1.0 111.421 -175.25 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.454 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . . . -56.57 -38.05 71.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.42 0.628 . . . . 1.0 110.06 175.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.986 ' HD2' HG22 ' A' ' 102' ' ' VAL . 20.4 mtt180 -97.65 -43.64 7.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.755 -1.111 . . . . 1.0 111.12 -176.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.745 HG12 ' HA ' ' A' ' 104' ' ' ALA . 10.7 p -79.62 118.79 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-O 121.037 0.446 . . . . 1.0 110.187 -174.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.666 ' HD2' ' O ' ' A' ' 107' ' ' VAL . 19.6 mmm180 -137.37 149.53 47.05 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.386 0.612 . . . . 1.0 111.076 -178.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.608 ' HE1' ' HA ' ' A' ' 90' ' ' ASP . 80.3 mmm -80.25 137.58 36.66 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.185 -0.916 . . . . 1.0 110.692 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.552 HD23 HG11 ' A' ' 87' ' ' VAL . 3.1 tm? -58.71 -49.26 78.26 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.868 0.366 . . . . 1.0 111.09 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -69.42 -16.7 63.55 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.171 -177.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.493 ' HB2' ' HB2' ' A' ' 109' ' ' MET . 37.4 t -78.38 -7.76 57.69 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 116.147 -0.478 . . . . 1.0 111.355 -178.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.522 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 92.4 m-85 -91.15 -21.58 21.1 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 109.821 -0.436 . . . . 1.0 109.821 175.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.7 t0 . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 115.766 -0.652 . . . . 1.0 110.556 -179.576 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 . . . . . 0 N--CA 1.453 -0.312 0 CA-C-O 120.518 0.199 . . . . 1.0 110.959 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.609 ' O ' HG23 ' A' ' 141' ' ' VAL . 8.5 tp10 -63.19 -50.94 68.32 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.77 -0.456 . . . . 1.0 109.77 177.662 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.64 ' HA ' HG23 ' A' ' 141' ' ' VAL . 96.1 t -61.27 -40.41 85.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.402 0.62 . . . . 1.0 109.979 178.501 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.487 ' HB2' HG11 ' A' ' 61' ' ' VAL . 22.9 t80 -53.49 -45.01 69.47 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.865 -1.061 . . . . 1.0 109.459 175.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.625 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -64.19 -40.16 95.5 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.393 -0.821 . . . . 1.0 110.543 177.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.64 HG23 ' HA ' ' A' ' 138' ' ' VAL . 13.9 t -55.44 -53.16 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-O 121.619 0.723 . . . . 1.0 109.908 177.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.617 HD13 ' HB3' ' A' ' 20' ' ' MET . 5.7 mt -63.99 -51.66 66.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 114.945 -1.025 . . . . 1.0 111.812 -178.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.625 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 8.0 pt-20 -57.89 -30.2 65.66 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.74 -0.384 . . . . 1.0 110.397 -179.293 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 2.4 t -74.87 -26.7 59.85 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 121.253 0.549 . . . . 1.0 110.001 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.473 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -85.88 -25.81 25.97 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-N 115.794 -0.639 . . . . 1.0 111.277 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.705 HD22 ' HB3' ' A' ' 25' ' ' PHE . 16.7 mt -56.17 -36.4 45.72 Favored Pre-proline 0 CA--C 1.547 0.851 0 N-CA-C 112.719 0.637 . . . . 1.0 112.719 -178.03 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.626 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 43.9 Cg_endo -68.02 -14.4 40.92 Favored 'Trans proline' 0 C--N 1.364 1.357 0 C-N-CA 122.59 2.193 . . . . 1.0 111.495 177.244 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.522 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -103.29 -33.62 4.18 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 114.577 -1.192 . . . . 1.0 110.375 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.492 ' O ' HG13 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -73.19 -41.8 63.43 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 108.416 -0.957 . . . . 1.0 108.416 178.855 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 150' ' ' HIS . . . . . 0.591 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 0.2 OUTLIER -53.93 -55.87 23.0 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-N 115.067 -0.969 . . . . 1.0 110.506 175.217 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -56.78 -42.92 80.28 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.764 -1.107 . . . . 1.0 110.781 -174.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' TRP . . . . . 0.715 ' HZ3' HD21 ' A' ' 5' ' ' LEU . 26.2 t90 -62.84 -56.17 19.73 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.181 -0.918 . . . . 1.0 110.286 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.492 HG13 ' O ' ' A' ' 149' ' ' LEU . 9.7 m -60.35 -40.3 83.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.904 -0.318 . . . . 1.0 110.463 -178.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.435 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 1.4 m-20 -60.46 -51.88 67.57 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 123.425 0.453 . . . . 1.0 111.042 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 7.9 pt-20 -63.32 -37.82 88.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.789 -0.641 . . . . 1.0 110.6 -178.22 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.526 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 10.4 mmt85 -72.84 -46.45 52.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.834 -0.621 . . . . 1.0 111.115 -176.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 4.0 pp . . . . . 0 C--N 1.325 -0.494 0 CA-C-N 115.658 -0.701 . . . . 1.0 109.686 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo . . . . . 0 C--O 1.234 0.306 0 N-CA-C 113.481 0.531 . . . . 1.0 113.481 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.822 ' HB3' HG23 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -66.51 177.84 1.43 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.016 -0.993 . . . . 1.0 109.688 178.417 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.573 ' O ' ' HB1' ' A' ' 83' ' ' ALA . 3.3 t-160 -156.17 90.08 1.18 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 121.98 -0.45 . . . . 1.0 110.493 -179.094 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.753 HG13 HD13 ' A' ' 85' ' ' LEU . 2.0 t -94.33 113.17 28.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 N-CA-C 109.321 -0.622 . . . . 1.0 109.321 177.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.597 HG22 ' HG ' ' A' ' 86' ' ' LEU . 8.5 t -115.31 114.24 24.91 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.03 0.443 . . . . 1.0 110.589 178.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.648 ' HD2' ' HB3' ' A' ' 42' ' ' SER . 1.5 m-85 -84.71 132.83 34.41 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 122.138 -0.351 . . . . 1.0 110.744 -178.112 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.728 HG21 HD21 ' A' ' 97' ' ' LEU . 32.9 t -118.18 115.64 48.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.293 0.568 . . . . 1.0 111.975 -176.581 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.617 ' SG ' ' HD2' ' A' ' 17' ' ' ARG . 52.5 t -144.79 159.38 42.96 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.731 -0.668 . . . . 1.0 109.578 178.188 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -72.02 97.92 1.98 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.939 0.4 . . . . 1.0 110.336 178.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.911 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 127.88 -43.27 1.35 Allowed Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.481 -0.782 . . . . 1.0 111.549 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.469 HD21 ' CB ' ' A' ' 42' ' ' SER . 3.8 t-20 64.66 11.98 7.19 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 121.361 0.6 . . . . 1.0 111.752 179.005 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.458 ' HA ' ' HG3' ' A' ' 19' ' ' PRO . 7.5 pt -119.61 11.54 6.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 O-C-N 121.69 -0.631 . . . . 1.0 111.395 -178.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.1 p -127.36 -88.31 0.56 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.208 -0.451 . . . . 1.0 112.015 -178.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.617 ' HD2' ' SG ' ' A' ' 11' ' ' CYS . 57.7 mtt85 -63.54 -52.33 61.6 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 120.95 0.405 . . . . 1.0 111.845 -176.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.726 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 14.1 m -53.16 -58.37 12.73 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 115.666 -0.697 . . . . 1.0 112.679 -178.204 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.524 ' HD3' ' HB2' ' A' ' 18' ' ' SER . 57.7 Cg_endo -67.92 -20.72 44.79 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 121.556 1.504 . . . . 1.0 112.51 -176.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.606 ' HA ' HD11 ' A' ' 62' ' ' LEU . 47.2 mmm -61.89 -54.09 46.75 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 110.221 -0.288 . . . . 1.0 110.221 177.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.468 ' HA ' ' HB2' ' A' ' 24' ' ' MET . . . -74.9 -26.1 59.4 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 116.134 -0.485 . . . . 1.0 110.401 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.61 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 16.3 tt0 -51.29 -54.56 24.8 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.028 -0.987 . . . . 1.0 109.992 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.656 ' O ' ' HB3' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -85.69 -22.98 27.61 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.267 -0.879 . . . . 1.0 110.383 -176.023 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.708 ' HB3' HD11 ' A' ' 146' ' ' LEU . 6.3 mmm -63.03 -76.12 0.07 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.381 0.61 . . . . 1.0 112.592 -178.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.717 ' HB3' HD22 ' A' ' 146' ' ' LEU . 24.9 p90 -77.13 -29.63 54.77 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 119.864 -0.734 . . . . 1.0 111.546 -175.302 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.61 ' HB3' ' O ' ' A' ' 22' ' ' GLU . . . -64.39 -38.2 90.19 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 119.493 -0.883 . . . . 1.0 110.817 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.962 ' HA ' ' HE ' ' A' ' 30' ' ' ARG . 0.1 OUTLIER -62.53 -39.68 94.34 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.906 -0.776 . . . . 1.0 108.906 177.03 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.6 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 79.2 mt-30 -59.06 -43.78 91.75 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.653 -0.703 . . . . 1.0 110.589 176.003 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 25' ' ' PHE . 92.5 mt -54.22 -62.68 1.5 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.942 -0.572 . . . . 1.0 111.207 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.962 ' HE ' ' HA ' ' A' ' 27' ' ' GLN . 0.1 OUTLIER -58.93 -34.04 71.27 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 120.559 -0.456 . . . . 1.0 111.466 178.683 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.0 m170 -62.12 -28.63 69.77 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.422 0.527 . . . . 1.0 112.422 177.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.525 ' HG2' ' O ' ' A' ' 28' ' ' GLN . 9.2 ptp180 -95.33 -20.29 19.26 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 119.535 -0.866 . . . . 1.0 110.101 178.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 108.17 39.32 1.84 Allowed Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.034 -0.985 . . . . 1.0 111.992 177.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 25.0 mt -131.03 2.21 4.31 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.567 -0.531 . . . . 1.0 109.567 -178.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.415 ' H ' ' HA ' ' A' ' 30' ' ' ARG . . . -53.75 -35.73 53.27 Favored Glycine 0 C--O 1.226 -0.364 0 CA-C-N 115.545 -0.752 . . . . 1.0 113.35 -178.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.473 ' HA ' ' NH1' ' A' ' 39' ' ' ARG . 0.3 OUTLIER -86.94 -19.17 29.19 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 122.489 -0.418 . . . . 1.0 110.138 -179.86 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.89 -22.13 43.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.878 -0.601 . . . . 1.0 111.373 -177.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.822 HG23 ' HB3' ' A' ' 5' ' ' LEU . 0.4 OUTLIER -143.09 123.62 10.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.064 0.459 . . . . 1.0 110.66 -179.727 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.473 ' NH1' ' HA ' ' A' ' 36' ' ' ASP . 29.0 mmt180 -89.05 144.56 26.06 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.011 -0.541 . . . . 1.0 109.65 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.483 HG11 ' HB2' ' A' ' 26' ' ' ALA . 48.9 t -132.04 122.58 49.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 121.838 0.828 . . . . 1.0 110.234 -177.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.506 ' O ' ' HA ' ' A' ' 8' ' ' THR . 76.8 p -137.13 -176.87 4.53 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.203 -1.362 . . . . 1.0 110.511 -174.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.726 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 88.2 p -160.81 166.35 28.73 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.866 -0.334 . . . . 1.0 110.235 179.043 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.585 ' HB2' ' CD2' ' A' ' 80' ' ' HIS . . . -164.65 168.15 18.38 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.271 0.557 . . . . 1.0 111.353 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -125.83 132.81 8.04 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.26 -0.882 . . . . 1.0 110.997 177.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.583 HG23 ' CG1' ' A' ' 10' ' ' VAL . 26.0 p -68.77 -22.74 64.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.795 0.331 . . . . 1.0 111.831 -177.336 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.422 ' HA3' ' HZ3' ' A' ' 48' ' ' TRP . . . -112.41 9.11 26.47 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.875 -0.679 . . . . 1.0 113.133 -177.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 43.83 37.34 1.63 Allowed 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 114.156 1.169 . . . . 1.0 114.156 177.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.911 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 1.2 m-90 -45.77 -73.66 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.454 0.645 . . . . 1.0 112.404 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.468 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 12.4 m-70 -106.06 40.84 1.51 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.248 -0.887 . . . . 1.0 111.063 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.403 HG23 ' HA ' ' A' ' 74' ' ' ALA . 14.0 p -60.18 129.37 22.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 120.65 -0.42 . . . . 1.0 110.375 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.25 -13.61 65.91 Favored Glycine 0 C--O 1.227 -0.33 0 C-N-CA 121.033 -0.603 . . . . 1.0 111.87 -177.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.5 t -80.58 -161.12 0.35 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.636 -0.505 . . . . 1.0 109.636 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 33.6 t -126.33 175.18 8.02 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.585 -0.894 . . . . 1.0 108.585 -178.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.14 141.08 47.44 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 123.098 0.248 . . . . 1.0 110.482 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.524 ' OD2' ' HG2' ' A' ' 57' ' ' ARG . 18.6 t70 -62.1 143.42 56.7 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.841 -177.224 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -46.69 -36.39 7.05 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.973 -1.012 . . . . 1.0 112.819 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.685 ' O ' HG23 ' A' ' 61' ' ' VAL . 19.3 ptp180 -69.69 -47.11 64.35 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 121.033 -0.267 . . . . 1.0 110.686 -176.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.408 ' HB1' ' SD ' ' A' ' 20' ' ' MET . . . -71.49 -31.96 67.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.097 0.475 . . . . 1.0 110.471 -177.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.14 -55.08 38.19 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.112 -0.699 . . . . 1.0 109.112 176.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -58.31 -39.69 93.0 Favored Glycine 0 N--CA 1.441 -1.009 0 CA-C-N 115.853 -0.612 . . . . 1.0 111.924 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.685 HG23 ' O ' ' A' ' 57' ' ' ARG . 98.7 t -58.98 -58.94 4.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.065 0.46 . . . . 1.0 110.992 177.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.611 HD13 ' HG3' ' A' ' 23' ' ' LYS . 87.7 mt -59.77 -52.46 65.36 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.881 -0.6 . . . . 1.0 111.61 -177.471 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.487 ' HB3' HG21 ' A' ' 69' ' ' THR . 0.0 OUTLIER -61.34 -33.31 73.41 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.727 -178.997 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.71 -32.93 74.13 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.212 0.53 . . . . 1.0 110.667 179.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -95.68 2.39 54.0 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.646 -0.706 . . . . 1.0 111.078 -178.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 94.12 9.51 59.35 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.978 -0.629 . . . . 1.0 113.531 176.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.41 ' CD1' ' HA ' ' A' ' 24' ' ' MET . 65.9 m-85 -90.68 152.15 44.62 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 110.061 -0.348 . . . . 1.0 110.061 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.583 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 36.0 Cg_endo -67.31 157.56 61.15 Favored 'Trans proline' 0 CA--C 1.512 -0.609 0 C-N-CA 122.189 1.926 . . . . 1.0 110.756 176.532 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.558 HG22 ' HB2' ' A' ' 62' ' ' LEU . 63.2 p -130.65 11.46 5.26 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 120.365 -0.534 . . . . 1.0 111.644 -176.562 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -80.87 133.51 35.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.77 -0.65 . . . . 1.0 110.087 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 51.7 t60 -169.22 152.24 4.93 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.892 0.377 . . . . 1.0 110.659 -176.263 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.436 ' HD3' ' HA ' ' A' ' 72' ' ' ARG . 9.4 tpp180 -133.93 110.86 10.0 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 108.084 -1.08 . . . . 1.0 108.084 175.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.468 ' HB3' ' O ' ' A' ' 49' ' ' HIS . . . -60.34 137.72 58.09 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.288 -0.869 . . . . 1.0 112.176 -175.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.403 ' HA ' HG23 ' A' ' 50' ' ' VAL . . . -130.96 160.25 35.08 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.437 -0.801 . . . . 1.0 110.013 178.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -97.43 154.82 17.23 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.026 -0.731 . . . . 1.0 109.026 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.527 HG11 HD23 ' A' ' 97' ' ' LEU . 14.5 t -67.35 113.19 3.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.053 0.454 . . . . 1.0 110.725 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.454 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -124.19 -169.59 13.12 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.128 -0.942 . . . . 1.0 111.538 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 97.9 m -58.51 -44.48 89.48 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 122.275 0.23 . . . . 1.0 111.548 -178.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -60.4 -28.48 68.26 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.937 0.399 . . . . 1.0 111.183 178.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.585 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 78.8 m80 -77.67 -41.43 38.2 Favored 'General case' 0 C--O 1.223 -0.297 0 N-CA-C 109.763 -0.458 . . . . 1.0 109.763 179.181 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.645 ' O ' HG23 ' A' ' 102' ' ' VAL . 15.6 mt -69.83 -14.42 62.75 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.6 177.287 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -88.49 -7.55 56.34 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 120.884 0.373 . . . . 1.0 110.618 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.573 ' HB1' ' O ' ' A' ' 6' ' ' HIS . . . -59.94 150.38 29.0 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.805 -0.634 . . . . 1.0 111.407 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.711 ' HB3' HD13 ' A' ' 5' ' ' LEU . 15.3 t70 -75.4 -15.19 60.48 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.941 -0.392 . . . . 1.0 109.941 178.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.753 HD13 HG13 ' A' ' 7' ' ' VAL . 0.5 OUTLIER -154.66 119.63 4.94 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 109.245 -0.65 . . . . 1.0 109.245 -177.787 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.689 ' HB3' HD13 ' A' ' 97' ' ' LEU . 5.1 mp -109.8 104.74 13.75 Favored 'General case' 0 N--CA 1.426 -1.652 0 CA-C-N 115.531 -0.759 . . . . 1.0 109.735 177.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.589 ' HA ' ' O ' ' A' ' 108' ' ' ARG . 53.6 t -83.79 91.54 2.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 114.924 -1.035 . . . . 1.0 111.115 -176.006 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.13 145.73 33.57 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.397 -0.82 . . . . 1.0 110.29 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.474 ' HG ' ' CB ' ' A' ' 17' ' ' ARG . 3.9 mm? -99.35 -8.04 25.4 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.026 -0.534 . . . . 1.0 110.361 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.405 ' CG ' ' H ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -151.76 152.48 32.77 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.662 -0.699 . . . . 1.0 110.858 179.15 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -58.16 -24.01 57.37 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.21 0.818 . . . . 1.0 113.21 -177.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.682 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 9.7 m120 -77.1 -48.07 18.76 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.933 -0.395 . . . . 1.0 109.933 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.56 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 11.7 m170 -56.6 -44.24 80.91 Favored 'General case' 0 N--CA 1.461 0.094 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.031 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.65 -45.17 92.81 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.952 178.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.6 ttt180 -59.26 -39.89 84.29 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.11 -0.496 . . . . 1.0 111.152 178.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.707 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 48.7 mt -66.16 -48.87 69.33 Favored 'General case' 0 C--O 1.218 -0.58 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.304 -176.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.728 HD21 HG21 ' A' ' 10' ' ' VAL . 36.2 mt -52.89 -58.39 7.07 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.086 -0.506 . . . . 1.0 111.374 -179.023 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.74 ' HA ' HG12 ' A' ' 102' ' ' VAL . 1.3 ptt180 -58.34 -44.69 88.83 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.801 -0.636 . . . . 1.0 111.811 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.653 ' HG3' ' O ' ' A' ' 96' ' ' LEU . 1.1 pp0? -67.8 -25.27 65.5 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.043 0.449 . . . . 1.0 109.948 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.707 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 13.2 mt -79.67 -12.6 59.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.668 -0.696 . . . . 1.0 111.612 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 145.99 -22.25 1.77 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 119.863 -1.16 . . . . 1.0 113.935 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.74 HG12 ' HA ' ' A' ' 98' ' ' ARG . 0.4 OUTLIER -75.93 -163.19 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 CA-C-N 117.419 0.609 . . . . 1.0 110.463 -178.813 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.752 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 12.4 pt-20 -155.87 163.11 40.21 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.702 -1.221 . . . . 1.0 107.702 -179.369 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.801 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -63.03 -24.98 68.17 Favored 'General case' 0 C--N 1.321 -0.664 0 O-C-N 123.186 0.304 . . . . 1.0 111.459 -175.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.2 -36.82 73.67 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.189 0.519 . . . . 1.0 110.042 175.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.752 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 5.5 mtt-85 -97.23 -42.42 7.82 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 115.368 -0.833 . . . . 1.0 111.6 -176.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.801 HG12 ' HA ' ' A' ' 104' ' ' ALA . 11.9 p -77.55 118.68 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 109.354 -0.61 . . . . 1.0 109.354 -175.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.589 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 16.1 mmm180 -138.64 147.31 42.73 Favored 'General case' 0 C--N 1.319 -0.755 0 O-C-N 121.623 -0.673 . . . . 1.0 110.764 -178.221 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.523 ' HB2' ' HB2' ' A' ' 112' ' ' SER . 77.1 mmm -79.76 137.54 37.03 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.523 -0.762 . . . . 1.0 110.639 179.506 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.526 HD23 HG11 ' A' ' 87' ' ' VAL . 3.1 tm? -57.5 -49.97 74.56 Favored 'General case' 0 N--CA 1.465 0.303 0 O-C-N 123.16 0.287 . . . . 1.0 111.221 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.403 ' O ' ' HG2' ' A' ' 111' ' ' ARG . 46.1 ttt180 -70.29 -17.44 63.09 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.877 -0.329 . . . . 1.0 110.776 -177.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.523 ' HB2' ' HB2' ' A' ' 109' ' ' MET . 33.8 t -75.6 -4.58 40.81 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.984 -0.286 . . . . 1.0 110.969 -178.026 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.618 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 92.1 m-85 -92.26 -16.25 26.38 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 120.878 0.37 . . . . 1.0 110.196 175.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 17.9 t0 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.0 -0.545 . . . . 1.0 110.712 -178.552 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 . . . . . 0 N--CA 1.454 -0.258 0 CA-C-O 120.758 0.313 . . . . 1.0 110.908 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.414 ' O ' HG23 ' A' ' 141' ' ' VAL . 5.6 tp10 -64.33 -50.73 66.62 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.62 0.724 . . . . 1.0 109.359 176.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.697 ' HA ' HG23 ' A' ' 141' ' ' VAL . 92.9 t -61.77 -38.7 81.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.01 -0.995 . . . . 1.0 109.992 177.291 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -53.52 -42.06 67.02 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.098 -0.955 . . . . 1.0 109.325 175.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.519 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -65.33 -41.3 94.1 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.301 -0.863 . . . . 1.0 110.187 177.563 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.697 HG23 ' HA ' ' A' ' 138' ' ' VAL . 11.9 t -55.52 -52.43 47.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 121.604 0.716 . . . . 1.0 110.139 177.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.597 HD13 ' HB3' ' A' ' 20' ' ' MET . 6.5 mt -63.99 -51.74 65.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 114.954 -1.021 . . . . 1.0 112.055 -178.221 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.519 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 11.3 pt-20 -56.43 -31.5 63.99 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.862 0.363 . . . . 1.0 110.373 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.4 t -74.5 -28.35 60.95 Favored 'General case' 0 C--O 1.225 -0.206 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.253 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.478 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -86.54 -24.12 25.6 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-N 115.889 -0.596 . . . . 1.0 111.545 179.149 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.717 HD22 ' HB3' ' A' ' 25' ' ' PHE . 11.8 mt -55.65 -36.9 51.05 Favored Pre-proline 0 CA--C 1.544 0.727 0 N-CA-C 112.577 0.584 . . . . 1.0 112.577 -178.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.622 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 55.8 Cg_endo -69.88 -11.6 31.01 Favored 'Trans proline' 0 C--N 1.363 1.332 0 C-N-CA 122.339 2.026 . . . . 1.0 111.854 177.041 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.618 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -104.85 -33.94 3.64 Favored Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 110.703 -0.959 . . . . 1.0 110.703 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.529 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -74.21 -41.12 61.89 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.43 -0.952 . . . . 1.0 108.43 178.729 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 150' ' ' HIS . . . . . 0.5 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 1.2 m-70 -54.29 -55.14 31.23 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 114.933 -1.031 . . . . 1.0 109.926 174.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -57.32 -40.83 78.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.315 -0.857 . . . . 1.0 110.71 -175.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' TRP . . . . . 0.708 ' HZ3' HD11 ' A' ' 5' ' ' LEU . 27.0 t90 -63.54 -57.54 9.83 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.596 -0.729 . . . . 1.0 110.748 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 10.3 m -61.43 -41.17 88.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.803 -0.359 . . . . 1.0 110.195 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.424 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 1.8 m-20 -60.5 -50.72 72.44 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 120.897 0.38 . . . . 1.0 110.42 178.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.559 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 6.3 pt-20 -63.23 -38.13 89.94 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.123 0.487 . . . . 1.0 110.936 -178.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.527 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 4.7 mmt180 -72.58 -45.15 60.54 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.664 -177.031 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.426 ' HB3' HD23 ' A' ' 5' ' ' LEU . 3.9 pp . . . . . 0 C--N 1.32 -0.704 0 CA-C-N 115.716 -0.675 . . . . 1.0 109.762 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.41 ' HG3' ' HE ' ' A' ' 39' ' ' ARG . 27.6 Cg_endo . . . . . 0 N--CA 1.46 -0.443 0 CA-C-O 121.002 0.334 . . . . 1.0 112.834 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.809 HD13 ' HB3' ' A' ' 84' ' ' ASP . 0.2 OUTLIER -67.13 177.82 1.65 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.532 -0.758 . . . . 1.0 109.384 178.749 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.64 ' O ' ' HB1' ' A' ' 83' ' ' ALA . 3.4 t-160 -157.55 89.32 1.03 Allowed 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.363 -0.606 . . . . 1.0 109.363 -179.186 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.808 HG13 HD13 ' A' ' 85' ' ' LEU . 2.4 t -95.95 107.38 19.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 109.759 -0.46 . . . . 1.0 109.759 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.619 ' CG2' ' HG ' ' A' ' 86' ' ' LEU . 11.8 t -108.25 114.97 29.26 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.084 0.469 . . . . 1.0 110.943 -179.179 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.542 ' HA ' ' O ' ' A' ' 87' ' ' VAL . 0.5 OUTLIER -85.76 134.55 33.94 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 122.203 -0.31 . . . . 1.0 110.262 -178.802 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.588 ' CG1' HG23 ' A' ' 45' ' ' THR . 42.4 t -120.66 119.87 60.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-O 121.385 0.612 . . . . 1.0 112.17 -175.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.483 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 15.4 p -143.68 167.63 21.81 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.214 -0.903 . . . . 1.0 109.453 177.09 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.98 93.54 3.82 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.417 0.627 . . . . 1.0 111.033 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.776 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 129.68 -37.03 2.24 Favored Glycine 0 N--CA 1.443 -0.855 0 CA-C-N 115.25 -0.886 . . . . 1.0 112.526 178.575 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.488 HD21 ' CB ' ' A' ' 42' ' ' SER . 3.6 t-20 64.49 19.1 11.69 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.924 0.868 . . . . 1.0 110.703 -179.133 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.469 ' O ' ' HB3' ' A' ' 55' ' ' ASP . 1.3 pt -135.95 47.38 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 CA-C-N 115.491 -0.777 . . . . 1.0 109.567 -178.145 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.691 ' O ' ' HG3' ' A' ' 20' ' ' MET . 4.4 p -157.23 -89.3 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.78 -1.1 . . . . 1.0 111.846 175.398 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.514 ' HD2' ' H ' ' A' ' 17' ' ' ARG . 0.1 OUTLIER -74.96 -43.1 55.95 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 121.908 -0.495 . . . . 1.0 111.817 -175.569 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.869 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 46.8 m -54.33 -56.6 24.76 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 116.425 -0.352 . . . . 1.0 111.505 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.683 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 49.0 Cg_endo -66.47 -24.22 49.57 Favored 'Trans proline' 0 C--N 1.357 0.995 0 C-N-CA 121.548 1.499 . . . . 1.0 112.387 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.691 ' HG3' ' O ' ' A' ' 16' ' ' CYS . 51.0 mtp -62.94 -56.54 16.31 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.672 -0.411 . . . . 1.0 110.646 177.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.63 -28.02 64.5 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 120.724 -0.39 . . . . 1.0 110.217 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.67 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 14.8 tt0 -51.85 -53.22 42.82 Favored 'General case' 0 C--O 1.214 -0.764 0 CA-C-N 114.74 -1.118 . . . . 1.0 109.614 178.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.946 ' HB3' ' HG2' ' A' ' 68' ' ' PRO . 0.1 OUTLIER -79.43 -32.39 42.81 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.36 -0.837 . . . . 1.0 110.235 -176.089 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.605 ' HB3' HD11 ' A' ' 146' ' ' LEU . 3.5 mmm -61.9 -75.61 0.07 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 113.173 0.805 . . . . 1.0 113.173 -175.313 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.749 ' HB3' HD22 ' A' ' 146' ' ' LEU . 14.0 p90 -78.44 -29.31 46.95 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 119.828 -0.749 . . . . 1.0 111.484 -174.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.707 ' HB2' HG21 ' A' ' 40' ' ' VAL . . . -64.12 -36.62 84.62 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 119.146 -1.021 . . . . 1.0 110.461 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.629 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -64.03 -39.32 93.84 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.614 -0.884 . . . . 1.0 108.614 177.062 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.555 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 77.1 mt-30 -60.38 -39.45 87.33 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-N 115.719 -0.673 . . . . 1.0 110.916 176.405 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.593 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 88.7 mt -59.81 -59.89 4.71 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.756 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.533 ' HA ' ' H ' ' A' ' 35' ' ' GLY . 0.1 OUTLIER -58.96 -36.87 75.54 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.375 -0.53 . . . . 1.0 111.254 178.518 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -65.02 -25.46 67.86 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.382 0.512 . . . . 1.0 112.382 177.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.593 ' HG2' ' O ' ' A' ' 29' ' ' LEU . 3.9 ptm180 -93.17 -19.46 21.44 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 119.461 -0.895 . . . . 1.0 109.465 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 110.4 35.02 2.17 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 114.955 -1.02 . . . . 1.0 111.926 177.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.563 HD12 ' HD3' ' A' ' 32' ' ' ARG . 46.9 mt -134.45 5.93 3.5 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 122.59 -0.359 . . . . 1.0 111.006 -177.385 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.533 ' H ' ' HA ' ' A' ' 30' ' ' ARG . . . -54.83 -29.62 50.75 Favored Glycine 0 C--N 1.33 0.24 0 C-N-CA 121.177 -0.535 . . . . 1.0 113.118 -178.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -94.92 -20.91 19.0 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.632 0.253 . . . . 1.0 110.985 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.48 -23.27 43.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.369 0.604 . . . . 1.0 111.342 -178.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.8 HG23 ' HB3' ' A' ' 5' ' ' LEU . 0.3 OUTLIER -142.44 119.5 6.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.53 -0.545 . . . . 1.0 109.53 178.001 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.41 ' HE ' ' HG3' ' A' ' 4' ' ' PRO . 16.9 mmt85 -91.13 148.42 22.39 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.618 -0.719 . . . . 1.0 109.295 -178.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.707 HG21 ' HB2' ' A' ' 26' ' ' ALA . 2.0 m -131.54 139.62 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.075 0 N-CA-C 108.391 -0.966 . . . . 1.0 108.391 178.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.503 ' O ' ' HA ' ' A' ' 8' ' ' THR . 21.7 p -146.36 -177.69 5.75 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.287 -0.87 . . . . 1.0 109.808 -175.395 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.869 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 93.4 p -159.32 163.96 35.23 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 120.613 -0.435 . . . . 1.0 109.982 178.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.557 ' HB2' ' CD2' ' A' ' 80' ' ' HIS . . . -164.38 164.96 22.0 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.452 0.644 . . . . 1.0 111.357 -179.211 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.483 ' HA2' ' O ' ' A' ' 11' ' ' CYS . . . -122.18 130.05 7.84 Favored Glycine 0 N--CA 1.439 -1.163 0 N-CA-C 110.41 -1.076 . . . . 1.0 110.41 177.233 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.588 HG23 ' CG1' ' A' ' 10' ' ' VAL . 18.8 p -65.25 -24.16 67.25 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 111.853 0.316 . . . . 1.0 111.853 -177.212 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -107.66 8.81 37.44 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.809 -0.71 . . . . 1.0 113.353 -177.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 42.96 37.77 1.22 Allowed 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.722 0.809 . . . . 1.0 113.078 179.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.776 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 0.7 OUTLIER -49.2 -76.66 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.524 0.565 . . . . 1.0 112.524 -179.59 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.458 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 36.1 m-70 -103.97 39.65 1.59 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.869 -0.605 . . . . 1.0 111.154 -178.388 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.506 HG23 ' HA ' ' A' ' 74' ' ' ALA . 11.0 p -59.4 126.31 16.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.019 0.438 . . . . 1.0 110.338 178.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.25 -14.76 62.12 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 121.037 -0.601 . . . . 1.0 111.942 -177.39 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.461 ' O ' ' HA ' ' A' ' 72' ' ' ARG . 3.8 t -81.61 -161.87 0.47 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.119 0.485 . . . . 1.0 110.138 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 30.2 t -120.84 178.59 4.65 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.737 -0.665 . . . . 1.0 109.289 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.21 146.91 53.71 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.224 0.535 . . . . 1.0 110.499 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.579 ' OD1' ' HA ' ' A' ' 16' ' ' CYS . 9.7 p-10 -64.46 150.69 46.04 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.889 -1.05 . . . . 1.0 113.588 -175.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.409 ' HG3' ' H ' ' A' ' 57' ' ' ARG . 1.7 pt-20 -44.8 -49.62 10.63 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 113.533 -1.667 . . . . 1.0 114.121 176.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.509 ' HG2' ' OD2' ' A' ' 55' ' ' ASP . 9.6 ptp180 -71.04 -37.38 72.56 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.856 -0.338 . . . . 1.0 111.647 -174.374 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.454 ' HB1' ' HG2' ' A' ' 20' ' ' MET . . . -70.73 -40.95 72.45 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.906 -0.405 . . . . 1.0 109.906 177.239 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.5 -47.08 85.54 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.87 -0.604 . . . . 1.0 109.836 179.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -60.17 -46.87 93.44 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.912 -0.661 . . . . 1.0 113.318 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.425 HG13 ' O ' ' A' ' 57' ' ' ARG . 13.3 m -71.85 -38.06 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 CA-C-N 117.8 0.8 . . . . 1.0 111.663 -178.201 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.586 HD23 ' HG3' ' A' ' 23' ' ' LYS . 4.6 mp -63.9 -52.7 58.71 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 120.489 -0.484 . . . . 1.0 110.361 178.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 63' ' ' ARG . 0.3 OUTLIER -62.44 -27.67 69.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.013 -0.539 . . . . 1.0 111.416 -179.298 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.64 -33.9 69.33 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 120.817 0.341 . . . . 1.0 110.812 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -94.68 3.01 55.58 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.776 -178.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 90.56 13.49 59.66 Favored Glycine 0 CA--C 1.517 0.206 0 CA-C-N 115.697 -0.683 . . . . 1.0 113.257 176.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -90.26 155.4 46.72 Favored Pre-proline 0 C--N 1.318 -0.776 0 CA-C-O 120.45 0.167 . . . . 1.0 110.716 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.946 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 74.5 Cg_endo -72.91 162.24 41.56 Favored 'Trans proline' 0 CA--C 1.512 -0.604 0 C-N-CA 122.43 2.087 . . . . 1.0 110.871 177.267 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 35.0 p -137.83 10.93 2.89 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 120.043 -0.663 . . . . 1.0 111.228 -178.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -72.53 116.84 13.48 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.666 178.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.853 ' HB2' ' HE3' ' A' ' 23' ' ' LYS . 50.1 t60 -157.85 149.74 21.97 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.918 0.39 . . . . 1.0 111.175 -177.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' A' ' 52' ' ' SER . 4.8 tpt180 -133.66 114.19 13.2 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.785 -1.191 . . . . 1.0 107.785 175.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.458 ' HB3' ' O ' ' A' ' 49' ' ' HIS . . . -59.32 137.81 57.85 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.088 -0.96 . . . . 1.0 112.774 -175.074 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.506 ' HA ' HG23 ' A' ' 50' ' ' VAL . . . -129.65 161.65 30.11 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.213 -0.903 . . . . 1.0 110.078 178.143 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -97.53 156.73 16.37 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 108.244 -1.021 . . . . 1.0 108.244 178.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.5 HG11 ' CD2' ' A' ' 97' ' ' LEU . 8.1 t -66.91 104.26 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.303 0.573 . . . . 1.0 109.781 178.179 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.412 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -113.89 -175.09 18.93 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 115.184 -0.917 . . . . 1.0 111.269 -178.173 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 94.1 m -56.37 -43.36 79.1 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.814 0.34 . . . . 1.0 111.259 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -60.88 -29.76 69.74 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.091 -0.504 . . . . 1.0 111.312 178.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.557 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 80.0 m80 -78.19 -39.73 39.8 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-O 120.98 0.419 . . . . 1.0 109.875 178.548 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.519 ' HA ' HD21 ' A' ' 86' ' ' LEU . 33.9 mt -68.65 -18.75 64.34 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.784 -0.644 . . . . 1.0 110.758 178.123 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.8 -4.8 59.22 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.861 -0.608 . . . . 1.0 110.844 -178.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.64 ' HB1' ' O ' ' A' ' 6' ' ' HIS . . . -59.98 154.22 19.49 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.979 -0.555 . . . . 1.0 111.665 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.809 ' HB3' HD13 ' A' ' 5' ' ' LEU . 10.6 t70 -80.4 -12.08 59.62 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.52 -0.548 . . . . 1.0 109.52 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.808 HD13 HG13 ' A' ' 7' ' ' VAL . 0.4 OUTLIER -156.98 118.09 3.68 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 115.65 -0.705 . . . . 1.0 109.22 -177.615 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.716 ' HB3' HD13 ' A' ' 97' ' ' LEU . 5.1 mp -107.52 105.99 16.16 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-N 115.815 -0.629 . . . . 1.0 109.709 177.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.597 HG11 HD23 ' A' ' 110' ' ' LEU . 48.1 t -86.51 94.88 4.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 114.823 -1.081 . . . . 1.0 111.066 -176.658 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -82.73 144.67 30.04 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 114.975 -1.012 . . . . 1.0 110.949 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.413 ' HA ' HD13 ' A' ' 89' ' ' LEU . 4.3 mm? -95.04 -13.65 25.01 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.254 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.409 ' CG ' ' H ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -148.74 153.67 38.51 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.724 -0.671 . . . . 1.0 111.542 -178.89 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.7 ptt180 -49.74 -32.2 13.1 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.666 1.186 . . . . 1.0 113.55 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.646 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 76.9 m-20 -77.36 -47.51 19.7 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.751 -0.38 . . . . 1.0 110.672 -177.229 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.724 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 13.5 m170 -54.52 -48.15 72.27 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.923 -0.399 . . . . 1.0 109.923 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.96 -43.03 91.24 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.073 0.463 . . . . 1.0 110.752 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.674 ' O ' ' HG2' ' A' ' 99' ' ' GLN . 11.5 ttp180 -58.32 -47.56 83.31 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.465 -0.789 . . . . 1.0 111.363 179.08 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.722 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 48.4 mt -62.16 -49.11 77.15 Favored 'General case' 0 C--O 1.219 -0.533 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.233 -175.297 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.724 ' HG ' ' O ' ' A' ' 93' ' ' HIS . 32.1 mt -53.42 -58.05 8.49 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.816 -0.629 . . . . 1.0 111.762 -177.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.526 ' HG2' ' O ' ' A' ' 95' ' ' ARG . 22.6 ptt180 -59.41 -44.83 92.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.451 . . . . 1.0 111.578 -176.587 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.674 ' HG2' ' O ' ' A' ' 95' ' ' ARG . 9.9 pt20 -70.89 -18.65 62.67 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.84 0.353 . . . . 1.0 111.227 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.722 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 5.5 mt -79.58 -8.1 58.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.068 -0.515 . . . . 1.0 111.706 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 146.87 -30.36 1.52 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.029 -1.082 . . . . 1.0 113.011 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.8 HG12 ' H ' ' A' ' 103' ' ' GLU . 2.0 t -73.32 -154.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 121.077 0.465 . . . . 1.0 110.868 -178.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.8 ' H ' HG12 ' A' ' 102' ' ' VAL . 15.6 pt-20 -164.61 165.14 21.31 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.977 -0.749 . . . . 1.0 108.977 -177.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.788 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -65.01 -24.87 67.63 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 123.409 0.443 . . . . 1.0 111.542 -176.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.5 -35.65 72.57 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.3 0.571 . . . . 1.0 110.254 175.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.716 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 4.7 mtt-85 -96.89 -42.71 7.81 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 115.2 -0.909 . . . . 1.0 111.029 -177.261 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.788 HG12 ' HA ' ' A' ' 104' ' ' ALA . 7.8 p -80.79 121.7 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-O 121.37 0.605 . . . . 1.0 109.981 -177.58 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.533 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 12.7 mmm180 -137.97 146.6 43.36 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.39 -0.596 . . . . 1.0 109.39 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.483 ' HB2' ' HB2' ' A' ' 112' ' ' SER . 79.6 mmm -77.81 139.53 39.33 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.837 -0.619 . . . . 1.0 110.234 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.597 HD23 HG11 ' A' ' 87' ' ' VAL . 3.2 tm? -56.04 -48.29 76.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.517 0.198 . . . . 1.0 111.075 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.407 ' O ' ' HG2' ' A' ' 111' ' ' ARG . 20.7 ttt85 -71.35 -17.49 62.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.007 0.432 . . . . 1.0 110.498 -178.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.483 ' HB2' ' HB2' ' A' ' 109' ' ' MET . 30.5 t -70.67 -12.26 61.45 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.581 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.458 ' HZ ' HD21 ' A' ' 85' ' ' LEU . 97.6 m-85 -90.8 -25.38 19.96 Favored 'General case' 0 N--CA 1.456 -0.166 0 O-C-N 122.175 -0.328 . . . . 1.0 110.122 176.161 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 13.1 t0 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 115.51 -0.768 . . . . 1.0 111.756 -177.432 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.43 ' HA ' ' HB3' ' A' ' 139' ' ' PHE . 10.1 mt-10 . . . . . 0 N--CA 1.45 -0.453 0 CA-C-O 120.528 0.204 . . . . 1.0 111.237 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.5 ' O ' HG23 ' A' ' 141' ' ' VAL . 20.0 tp10 -65.29 -46.76 79.12 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 108.187 -1.042 . . . . 1.0 108.187 174.215 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 72.3 t -60.08 -44.25 94.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 114.594 -1.185 . . . . 1.0 109.214 175.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.43 ' HB3' ' HA ' ' A' ' 136' ' ' GLU . 49.9 t80 -54.01 -42.79 69.47 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.453 -1.249 . . . . 1.0 109.828 176.436 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.52 ' HA ' ' OE2' ' A' ' 143' ' ' GLU . . . -64.26 -42.07 96.64 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.462 -0.79 . . . . 1.0 111.03 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 137' ' ' GLU . 16.9 t -56.96 -53.77 38.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.503 0.668 . . . . 1.0 110.235 178.258 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.475 ' HA ' HD11 ' A' ' 110' ' ' LEU . 4.7 mt -60.92 -52.27 63.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.376 -0.829 . . . . 1.0 112.289 -178.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.52 ' OE2' ' HA ' ' A' ' 140' ' ' ALA . 13.2 pt-20 -56.17 -32.18 64.09 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.932 0.396 . . . . 1.0 110.515 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 73.0 m -72.8 -28.9 62.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.574 -0.739 . . . . 1.0 110.939 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.459 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -87.18 -23.5 24.77 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-N 116.215 -0.448 . . . . 1.0 111.712 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.749 HD22 ' HB3' ' A' ' 25' ' ' PHE . 13.4 mt -56.01 -36.66 48.63 Favored Pre-proline 0 CA--C 1.548 0.874 0 N-CA-C 112.417 0.525 . . . . 1.0 112.417 -177.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.636 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 51.1 Cg_endo -69.7 -10.79 29.47 Favored 'Trans proline' 0 C--N 1.366 1.465 0 C-N-CA 122.733 2.288 . . . . 1.0 112.277 177.081 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.429 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -105.24 -32.6 3.95 Favored Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 110.465 -1.054 . . . . 1.0 110.465 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.464 HD11 HG21 ' A' ' 87' ' ' VAL . 0.4 OUTLIER -74.48 -41.02 61.45 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.664 -0.865 . . . . 1.0 108.664 178.937 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 150' ' ' HIS . . . . . 0.403 ' O ' HG22 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -53.52 -55.38 25.96 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 114.814 -1.085 . . . . 1.0 110.921 175.657 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -60.75 -40.47 92.56 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.563 -0.744 . . . . 1.0 111.591 -176.056 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' TRP . . . . . 0.756 ' HZ3' HD11 ' A' ' 5' ' ' LEU . 29.0 t90 -63.36 -54.6 34.37 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.552 -0.749 . . . . 1.0 110.751 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.458 HG13 ' O ' ' A' ' 149' ' ' LEU . 11.1 m -60.11 -39.19 79.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 C-N-CA 120.84 -0.344 . . . . 1.0 110.075 -179.185 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.442 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 8.3 m-20 -59.68 -51.74 68.5 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.272 0.558 . . . . 1.0 110.966 178.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.524 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 5.1 pt-20 -63.46 -38.31 90.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.406 -0.815 . . . . 1.0 110.443 -178.015 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.525 ' HG3' ' CH2' ' A' ' 152' ' ' TRP . 10.9 mmt180 -74.89 -42.72 57.29 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.615 -0.72 . . . . 1.0 111.664 -177.031 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 4.2 pp . . . . . 0 C--N 1.322 -0.599 0 CA-C-O 121.157 0.503 . . . . 1.0 109.793 179.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.589 ' HB3' ' O ' ' A' ' 36' ' ' ASP . 23.1 Cg_endo . . . . . 0 N--CA 1.464 -0.26 0 N-CA-C 114.046 0.748 . . . . 1.0 114.046 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.844 ' HB3' HG23 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -66.11 177.66 1.34 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.635 -1.166 . . . . 1.0 109.578 178.084 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.575 ' H ' HD13 ' A' ' 5' ' ' LEU . 0.9 OUTLIER -155.51 99.0 2.0 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.763 -0.458 . . . . 1.0 109.763 179.617 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.637 HG13 HD13 ' A' ' 85' ' ' LEU . 2.3 t -104.09 118.27 50.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 108.147 -1.057 . . . . 1.0 108.147 177.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.643 HG22 ' HG ' ' A' ' 86' ' ' LEU . 11.7 t -119.75 113.59 20.86 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.302 0.572 . . . . 1.0 110.352 178.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.647 ' HD1' ' HB ' ' A' ' 87' ' ' VAL . 1.0 OUTLIER -84.51 133.21 34.47 Favored 'General case' 0 CA--C 1.512 -0.487 0 O-C-N 122.024 -0.423 . . . . 1.0 110.258 -178.18 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.57 ' CG1' HG23 ' A' ' 45' ' ' THR . 40.7 t -119.95 119.49 60.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.552 0.691 . . . . 1.0 112.042 -176.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.445 ' HA ' ' CE1' ' A' ' 93' ' ' HIS . 21.7 p -148.32 163.37 37.29 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.221 -0.9 . . . . 1.0 109.963 177.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.96 96.81 5.83 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 120.849 0.357 . . . . 1.0 110.39 177.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.513 ' O ' HG12 ' A' ' 15' ' ' ILE . . . 146.64 -36.62 1.24 Allowed Glycine 0 C--O 1.218 -0.89 0 CA-C-N 115.687 -0.688 . . . . 1.0 112.26 179.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.503 ' OD1' ' HB1' ' A' ' 73' ' ' ALA . 32.2 p30 49.27 18.54 0.26 Allowed 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 125.155 1.382 . . . . 1.0 114.115 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.513 HG12 ' O ' ' A' ' 13' ' ' GLY . 5.8 pt -136.44 2.6 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 112.13 0.419 . . . . 1.0 112.13 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.646 ' O ' ' HG3' ' A' ' 20' ' ' MET . 51.4 t -121.99 -86.79 0.65 Allowed 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.437 -0.505 . . . . 1.0 111.577 -178.536 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 54.1 mtt85 -59.2 -56.55 20.67 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.063 0.458 . . . . 1.0 112.103 -175.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.948 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 45.3 m -53.19 -59.0 10.21 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 115.552 -0.749 . . . . 1.0 112.497 -177.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.409 ' HD3' ' HB2' ' A' ' 18' ' ' SER . 41.2 Cg_endo -63.19 -25.34 72.52 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 121.954 1.769 . . . . 1.0 113.2 -178.108 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.646 ' HG3' ' O ' ' A' ' 16' ' ' CYS . 53.4 mtp -61.19 -53.34 58.14 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.778 -0.369 . . . . 1.0 110.3 178.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.468 ' HB2' ' CG2' ' A' ' 142' ' ' ILE . . . -72.2 -26.74 62.17 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.265 -0.574 . . . . 1.0 110.178 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.685 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 17.7 tt0 -53.83 -52.1 61.43 Favored 'General case' 0 C--O 1.212 -0.874 0 CA-C-N 115.135 -0.939 . . . . 1.0 109.431 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.618 ' HZ1' ' HB3' ' A' ' 71' ' ' HIS . 0.1 OUTLIER -86.65 -23.03 25.8 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 120.06 -0.656 . . . . 1.0 110.879 -176.431 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.503 ' HB3' HD11 ' A' ' 146' ' ' LEU . 86.0 mtp -64.57 -75.78 0.08 Allowed 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.001 0.429 . . . . 1.0 112.132 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.617 ' HB3' HD22 ' A' ' 146' ' ' LEU . 17.5 p90 -77.04 -30.31 55.59 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 119.883 -0.727 . . . . 1.0 111.51 -175.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.685 ' HB3' ' O ' ' A' ' 22' ' ' GLU . . . -64.39 -36.96 85.84 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 118.951 -1.099 . . . . 1.0 110.991 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.605 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.2 OUTLIER -63.56 -37.53 87.68 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 108.433 -0.951 . . . . 1.0 108.433 176.468 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.581 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 77.9 mt-30 -60.15 -41.07 91.96 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-N 116.022 -0.536 . . . . 1.0 110.187 175.146 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.559 ' HG ' ' O ' ' A' ' 25' ' ' PHE . 70.7 mt -57.71 -59.69 4.83 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.004 -0.544 . . . . 1.0 110.907 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.525 ' HD3' ' HA ' ' A' ' 27' ' ' GLN . 0.3 OUTLIER -59.37 -34.36 72.31 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.556 -0.457 . . . . 1.0 110.779 178.225 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -63.01 -27.41 69.4 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.693 0.627 . . . . 1.0 112.693 176.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.46 ' HG2' ' O ' ' A' ' 28' ' ' GLN . 6.9 ptp180 -95.9 -15.01 22.68 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.566 0.698 . . . . 1.0 110.109 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.86 39.69 3.07 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 114.913 -1.039 . . . . 1.0 111.49 177.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 31.3 mt -132.32 3.8 3.98 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.987 -0.375 . . . . 1.0 109.987 -178.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.423 ' H ' ' HA ' ' A' ' 30' ' ' ARG . . . -56.22 -26.93 51.41 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 121.037 -0.602 . . . . 1.0 112.507 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.645 ' HA ' ' NH1' ' A' ' 39' ' ' ARG . 11.9 m-20 -91.32 -21.69 20.91 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.623 0.249 . . . . 1.0 110.796 176.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -81.01 -23.55 38.57 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.338 -178.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.844 HG23 ' HB3' ' A' ' 5' ' ' LEU . 0.7 OUTLIER -142.68 123.91 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-O 121.269 0.557 . . . . 1.0 110.509 179.769 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.645 ' NH1' ' HA ' ' A' ' 36' ' ' ASP . 24.3 mmt180 -92.53 141.33 28.63 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 109.233 -0.655 . . . . 1.0 109.233 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.441 HG13 ' CZ ' ' A' ' 9' ' ' PHE . 34.2 t -129.13 125.34 62.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-O 121.445 0.64 . . . . 1.0 109.931 -177.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' A' ' 8' ' ' THR . 36.5 p -136.79 -177.69 4.85 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.165 -1.379 . . . . 1.0 110.298 -174.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.948 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 66.9 p -161.03 162.94 31.9 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.986 -0.376 . . . . 1.0 109.986 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.561 ' HB2' ' CD2' ' A' ' 80' ' ' HIS . . . -164.59 171.03 15.01 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.556 0.693 . . . . 1.0 111.922 -178.082 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -128.29 134.05 7.98 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 114.851 -1.068 . . . . 1.0 111.073 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.57 HG23 ' CG1' ' A' ' 10' ' ' VAL . 25.7 p -69.6 -18.13 63.59 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.045 0.45 . . . . 1.0 111.385 -178.216 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.509 ' HA3' ' CZ3' ' A' ' 48' ' ' TRP . . . -113.8 8.53 23.7 Favored Glycine 0 CA--C 1.521 0.436 0 C-N-CA 120.853 -0.689 . . . . 1.0 113.173 -179.205 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 44.01 39.19 2.6 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 113.821 1.045 . . . . 1.0 113.821 177.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.509 ' CZ3' ' HA3' ' A' ' 46' ' ' GLY . 1.2 m-90 -43.96 -77.32 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.534 0.683 . . . . 1.0 112.506 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.428 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 24.4 m-70 -106.0 40.53 1.57 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.023 -0.99 . . . . 1.0 111.314 -179.282 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.446 HG23 ' HA ' ' A' ' 74' ' ' ALA . 12.0 p -58.2 127.63 17.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.853 179.276 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.6 -14.94 64.16 Favored Glycine 0 C--N 1.329 0.184 0 C-N-CA 121.196 -0.525 . . . . 1.0 112.195 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.6 t -81.56 -162.4 0.51 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.42 0.629 . . . . 1.0 110.356 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 14.0 t -118.89 175.74 5.61 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.703 -0.851 . . . . 1.0 108.703 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.458 ' HB2' ' HZ1' ' A' ' 23' ' ' LYS . . . -60.66 147.43 42.05 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 123.331 0.394 . . . . 1.0 111.525 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.454 ' OD1' ' HG2' ' A' ' 57' ' ' ARG . 11.5 t70 -63.0 142.84 58.23 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.698 -0.683 . . . . 1.0 111.163 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.437 ' HG3' ' N ' ' A' ' 57' ' ' ARG . 5.4 pt-20 -50.02 -37.06 31.2 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 113.522 0.934 . . . . 1.0 113.522 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.454 ' HG2' ' OD1' ' A' ' 55' ' ' ASP . 11.3 ptp180 -71.16 -37.56 72.2 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.039 0.447 . . . . 1.0 110.624 -176.039 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.417 ' HB1' ' HG2' ' A' ' 20' ' ' MET . . . -70.52 -37.65 74.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.61 -0.723 . . . . 1.0 109.5 178.165 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.14 -42.97 99.77 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.743 -0.662 . . . . 1.0 109.281 176.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.416 ' O ' ' HG2' ' A' ' 63' ' ' ARG . . . -58.77 -45.5 94.8 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.566 -0.743 . . . . 1.0 113.359 178.542 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.481 HG12 ' HG2' ' A' ' 136' ' ' GLU . 35.0 m -73.28 -41.73 57.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 117.569 0.685 . . . . 1.0 111.863 -179.195 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.735 ' HB2' HG22 ' A' ' 69' ' ' THR . 96.2 mt -60.63 -52.22 66.05 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 120.828 -0.349 . . . . 1.0 110.194 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.416 ' HG2' ' O ' ' A' ' 60' ' ' GLY . 2.4 ptm180 -59.83 -32.48 70.7 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.101 -0.499 . . . . 1.0 111.079 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.5 -34.81 74.85 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 121.155 0.503 . . . . 1.0 110.877 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.405 ' HB2' ' HD2' ' A' ' 67' ' ' TYR . 60.6 m80 -93.33 4.49 53.89 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.897 -179.021 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.16 16.74 62.23 Favored Glycine 0 C--N 1.331 0.288 0 CA-C-N 115.832 -0.622 . . . . 1.0 112.964 176.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.448 ' HD1' ' HG2' ' A' ' 27' ' ' GLN . 55.3 m-85 -92.45 153.52 42.69 Favored Pre-proline 0 C--N 1.32 -0.686 0 N-CA-C 110.434 -0.21 . . . . 1.0 110.434 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.402 ' O ' ' HD2' ' A' ' 23' ' ' LYS . 35.5 Cg_endo -68.25 156.76 64.57 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.063 1.842 . . . . 1.0 110.509 175.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.735 HG22 ' HB2' ' A' ' 62' ' ' LEU . 72.2 p -130.83 27.73 4.9 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 120.222 -0.591 . . . . 1.0 111.342 -176.467 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -104.08 131.87 50.91 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.81 -0.632 . . . . 1.0 110.335 178.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.618 ' HB3' ' HZ1' ' A' ' 23' ' ' LYS . 3.2 t60 -167.42 148.82 5.62 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.621 -0.718 . . . . 1.0 109.398 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -121.28 113.04 19.37 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 107.972 -1.121 . . . . 1.0 107.972 176.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.503 ' HB1' ' OD1' ' A' ' 14' ' ' ASN . . . -57.84 139.56 53.84 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.557 -0.747 . . . . 1.0 112.272 -175.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.446 ' HA ' HG23 ' A' ' 50' ' ' VAL . . . -132.98 161.95 32.97 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.742 178.314 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -97.66 156.59 16.47 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 108.134 -1.062 . . . . 1.0 108.134 177.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.59 HG11 ' CD2' ' A' ' 97' ' ' LEU . 14.5 t -66.24 104.69 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.529 0.681 . . . . 1.0 110.232 178.526 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.409 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -117.57 -171.77 15.67 Favored Glycine 0 N--CA 1.442 -0.962 0 CA-C-N 114.633 -1.167 . . . . 1.0 111.12 -178.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 98.9 m -56.99 -44.42 82.7 Favored 'General case' 0 C--N 1.319 -0.72 0 O-C-N 123.628 0.252 . . . . 1.0 111.3 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -60.71 -29.39 69.31 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.762 0.315 . . . . 1.0 111.216 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.561 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 79.1 m80 -79.22 -42.15 26.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.422 -0.354 . . . . 1.0 110.179 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.499 ' HA ' HD21 ' A' ' 86' ' ' LEU . 21.4 mt -66.77 -21.43 66.06 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.132 -0.485 . . . . 1.0 110.967 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.25 -5.01 59.28 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.166 -0.47 . . . . 1.0 111.438 -178.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.541 ' HA ' ' HB3' ' A' ' 6' ' ' HIS . . . -59.04 151.58 21.91 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.219 -0.446 . . . . 1.0 111.686 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.719 ' HB3' HD13 ' A' ' 5' ' ' LEU . 28.4 t70 -75.8 -16.26 60.12 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.924 -0.58 . . . . 1.0 109.635 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.637 HD13 HG13 ' A' ' 7' ' ' VAL . 0.4 OUTLIER -156.21 116.56 3.68 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.53 -0.759 . . . . 1.0 109.155 -176.931 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.643 ' HG ' HG22 ' A' ' 8' ' ' THR . 5.4 mp -106.59 106.48 17.02 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-N 115.778 -0.646 . . . . 1.0 109.562 177.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.647 ' HB ' ' HD1' ' A' ' 9' ' ' PHE . 54.9 t -85.18 93.15 3.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.124 -0.944 . . . . 1.0 110.994 -176.307 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.47 145.45 30.73 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.612 -0.722 . . . . 1.0 110.673 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -96.38 -6.79 36.72 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.845 -0.616 . . . . 1.0 109.973 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.427 ' CG ' ' H ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -154.49 151.0 28.41 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.585 -0.734 . . . . 1.0 110.86 179.749 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 13.7 ptp180 -58.04 -24.08 56.95 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.151 -0.931 . . . . 1.0 112.737 -177.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.689 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 82.3 m-20 -77.01 -47.64 20.12 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.983 -0.377 . . . . 1.0 109.983 -178.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.789 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 15.4 m170 -55.78 -48.26 75.64 Favored 'General case' 0 C--N 1.333 -0.119 0 N-CA-C 109.475 -0.565 . . . . 1.0 109.475 176.667 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.584 ' HA ' HG21 ' A' ' 107' ' ' VAL . . . -57.68 -42.46 83.65 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.477 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.401 ' O ' ' HG2' ' A' ' 98' ' ' ARG . 10.2 ttp180 -58.76 -47.12 85.75 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 115.548 -0.751 . . . . 1.0 111.248 178.29 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.752 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 52.0 mt -62.89 -50.32 71.34 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.667 -0.697 . . . . 1.0 110.212 -175.251 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.789 ' HG ' ' O ' ' A' ' 93' ' ' HIS . 22.1 mt -54.71 -57.36 11.81 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.369 -0.832 . . . . 1.0 111.468 -178.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.697 ' HA ' ' HB ' ' A' ' 102' ' ' VAL . 15.9 ptt180 -60.63 -42.83 97.68 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.08 -0.509 . . . . 1.0 111.675 -175.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.607 ' HG3' ' O ' ' A' ' 96' ' ' LEU . 0.9 OUTLIER -67.82 -25.43 65.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.888 0.375 . . . . 1.0 110.191 179.222 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.752 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 11.6 mt -77.13 -12.46 59.95 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.609 0.596 . . . . 1.0 112.609 -178.502 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 151.52 -26.94 0.96 Allowed Glycine 0 N--CA 1.453 -0.18 0 C-N-CA 120.277 -0.963 . . . . 1.0 112.4 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.931 HG12 ' H ' ' A' ' 103' ' ' GLU . 2.7 t -73.97 -155.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 C-N-CA 123.122 0.569 . . . . 1.0 110.185 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.931 ' H ' HG12 ' A' ' 102' ' ' VAL . 15.4 pt-20 -170.48 164.32 8.54 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 107.883 -1.154 . . . . 1.0 107.883 -178.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.707 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -67.31 -21.69 65.66 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.771 0.319 . . . . 1.0 110.882 -176.481 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.499 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . . . -58.31 -38.21 76.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.924 -0.58 . . . . 1.0 109.869 174.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.716 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 31.7 mtt180 -95.36 -45.79 6.98 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 115.182 -0.917 . . . . 1.0 110.333 -177.515 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.707 HG12 ' HA ' ' A' ' 104' ' ' ALA . 8.9 p -79.6 119.83 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-O 121.634 0.731 . . . . 1.0 110.033 -177.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.562 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 22.4 mmm180 -134.77 145.71 48.66 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.414 -0.587 . . . . 1.0 109.414 -178.047 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 81.4 mmm -77.35 134.86 38.37 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.829 -0.623 . . . . 1.0 110.389 -178.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.538 HD23 HG11 ' A' ' 87' ' ' VAL . 3.0 tm? -55.33 -48.94 73.42 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.933 0.396 . . . . 1.0 111.066 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 37.8 ttt180 -69.98 -19.02 63.37 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.894 -0.594 . . . . 1.0 110.679 -177.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 41.7 t -77.31 -8.41 57.59 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.95 -178.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.587 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 90.4 m-85 -88.75 -17.62 29.47 Favored 'General case' 0 C--N 1.341 0.21 0 O-C-N 121.858 -0.526 . . . . 1.0 110.235 176.234 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.5 t0 . . . . . 0 CA--C 1.521 -0.149 0 CA-C-N 115.993 -0.549 . . . . 1.0 110.908 -178.651 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.481 ' HG2' HG12 ' A' ' 61' ' ' VAL . 32.3 mt-10 . . . . . 0 C--O 1.234 0.259 0 CA-C-O 120.871 0.367 . . . . 1.0 110.014 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.561 ' O ' HG23 ' A' ' 141' ' ' VAL . 8.3 tt0 -64.44 -45.05 89.17 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.583 -0.735 . . . . 1.0 109.885 178.16 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 40.6 t -58.22 -43.34 85.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.405 0.621 . . . . 1.0 110.07 177.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -54.35 -45.65 72.77 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.43 -1.259 . . . . 1.0 110.344 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.613 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -62.3 -41.36 98.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.954 -0.567 . . . . 1.0 111.334 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 137' ' ' GLU . 20.7 t -56.9 -52.58 53.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-O 121.637 0.732 . . . . 1.0 110.855 178.274 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.468 ' CG2' ' HB2' ' A' ' 21' ' ' ALA . 6.3 mt -64.11 -49.67 80.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 114.928 -1.033 . . . . 1.0 111.956 -177.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.613 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 7.2 pt-20 -56.99 -30.45 64.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.887 0.375 . . . . 1.0 110.272 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 2.8 t -72.21 -31.28 65.72 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-O 121.233 0.54 . . . . 1.0 110.265 179.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.473 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -86.24 -23.07 26.55 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-N 115.699 -0.682 . . . . 1.0 111.796 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.617 HD22 ' HB3' ' A' ' 25' ' ' PHE . 10.6 mt -54.54 -40.94 86.77 Favored Pre-proline 0 C--N 1.329 -0.305 0 N-CA-C 112.795 0.665 . . . . 1.0 112.795 -178.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.725 ' HA ' ' CD2' ' A' ' 150' ' ' HIS . 69.7 Cg_endo -69.07 -7.27 20.39 Favored 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 122.279 1.986 . . . . 1.0 112.182 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.587 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -108.09 -32.5 3.25 Favored Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 109.903 -1.279 . . . . 1.0 109.903 177.336 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.556 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -76.49 -53.33 8.25 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.689 -0.756 . . . . 1.0 109.91 -179.334 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 150' ' ' HIS . . . . . 0.725 ' CD2' ' HA ' ' A' ' 147' ' ' PRO . 3.7 p80 -56.28 -45.38 80.18 Favored 'General case' 0 C--O 1.216 -0.67 0 CA-C-O 121.469 0.652 . . . . 1.0 110.682 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.407 ' N ' ' CG ' ' A' ' 150' ' ' HIS . 25.9 t70 -57.31 -42.79 82.48 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 114.458 -1.246 . . . . 1.0 110.279 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' TRP . . . . . 0.756 ' HZ3' HD11 ' A' ' 5' ' ' LEU . 18.1 t90 -62.45 -55.47 27.34 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 114.993 -1.003 . . . . 1.0 110.072 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.535 HG11 HG21 ' A' ' 7' ' ' VAL . 4.0 m -61.95 -40.28 86.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.453 -0.34 . . . . 1.0 110.143 -179.04 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.503 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 67.1 m-20 -59.47 -54.89 41.43 Favored 'General case' 0 C--N 1.338 0.105 0 CA-C-O 121.405 0.621 . . . . 1.0 110.287 178.128 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.506 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 5.5 pt-20 -60.4 -35.76 76.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.278 -0.874 . . . . 1.0 110.571 -178.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.403 ' HG3' ' CH2' ' A' ' 152' ' ' TRP . 10.3 mmt180 -74.79 -43.69 53.42 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 115.831 -0.622 . . . . 1.0 111.187 -178.416 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 4.4 pp . . . . . 0 N--CA 1.464 0.264 0 CA-C-O 121.498 0.666 . . . . 1.0 109.73 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.493 ' HG2' ' HG2' ' A' ' 39' ' ' ARG . 37.3 Cg_endo . . . . . 0 C--O 1.233 0.245 0 N-CA-C 113.601 0.577 . . . . 1.0 113.601 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.813 ' HB3' HG23 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -66.56 177.61 1.51 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.472 -0.786 . . . . 1.0 109.432 177.868 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.743 ' H ' HD13 ' A' ' 5' ' ' LEU . 1.7 t-160 -156.0 90.57 1.22 Allowed 'General case' 0 C--N 1.321 -0.631 0 O-C-N 122.161 -0.337 . . . . 1.0 110.695 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.859 HG13 HD13 ' A' ' 85' ' ' LEU . 2.1 t -96.29 102.88 14.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.031 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.633 ' CG2' HD23 ' A' ' 86' ' ' LEU . 9.6 t -105.8 114.71 29.02 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 121.029 0.442 . . . . 1.0 111.143 -178.7 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.545 ' HD1' ' HB ' ' A' ' 87' ' ' VAL . 1.1 m-85 -83.42 131.15 35.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.834 0.35 . . . . 1.0 110.361 -179.122 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.689 HG21 HD11 ' A' ' 97' ' ' LEU . 37.3 t -117.59 113.68 43.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.07 -0.514 . . . . 1.0 111.848 -176.166 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.49 ' HA ' ' CD2' ' A' ' 93' ' ' HIS . 41.8 t -142.7 163.06 33.84 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.048 -0.723 . . . . 1.0 109.048 177.064 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.79 90.89 4.07 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.357 0.599 . . . . 1.0 110.94 -178.03 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.833 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 136.65 -44.0 1.19 Allowed Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.453 -0.794 . . . . 1.0 111.442 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.678 ' ND2' ' H ' ' A' ' 74' ' ' ALA . 59.3 t30 61.57 22.88 13.27 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.843 0.83 . . . . 1.0 111.998 177.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.9 pt -127.41 4.44 3.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 O-C-N 121.63 -0.669 . . . . 1.0 110.956 179.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.756 ' O ' ' HG3' ' A' ' 20' ' ' MET . 5.3 p -121.6 -87.77 0.63 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.91 -0.587 . . . . 1.0 112.429 -177.131 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.782 HH11 HG21 ' A' ' 138' ' ' VAL . 8.5 mmt180 -71.63 -44.89 63.55 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.297 -0.41 . . . . 1.0 111.52 -174.444 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.451 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 19.2 m -55.72 -56.18 32.75 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-N 116.163 -0.471 . . . . 1.0 112.192 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.547 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 55.6 Cg_endo -67.01 -19.07 52.14 Favored 'Trans proline' 0 C--N 1.357 1.026 0 C-N-CA 121.633 1.555 . . . . 1.0 112.245 -178.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.756 ' HG3' ' O ' ' A' ' 16' ' ' CYS . 61.3 mtp -62.7 -55.0 30.75 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 120.336 -0.545 . . . . 1.0 109.907 176.535 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.424 ' HA ' ' HB2' ' A' ' 24' ' ' MET . . . -71.73 -27.9 63.31 Favored 'General case' 0 CA--C 1.512 -0.505 0 C-N-CA 120.37 -0.532 . . . . 1.0 110.617 -179.265 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.672 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 13.2 tt0 -51.15 -54.08 28.55 Favored 'General case' 0 C--O 1.217 -0.626 0 O-C-N 124.334 1.021 . . . . 1.0 109.73 179.191 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.925 ' HB3' ' HG2' ' A' ' 68' ' ' PRO . 0.4 OUTLIER -81.7 -27.16 34.09 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.239 -0.891 . . . . 1.0 110.311 -176.093 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.7 ' HB3' HD11 ' A' ' 146' ' ' LEU . 6.0 mmm -62.4 -76.76 0.06 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.811 0.671 . . . . 1.0 112.811 -176.34 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.701 ' HB3' HD22 ' A' ' 146' ' ' LEU . 18.2 p90 -78.2 -28.58 48.08 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 119.945 -0.702 . . . . 1.0 111.051 -174.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.672 ' HB3' ' O ' ' A' ' 22' ' ' GLU . . . -65.18 -38.02 89.18 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 119.208 -0.997 . . . . 1.0 110.922 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.699 ' HA ' ' HD3' ' A' ' 30' ' ' ARG . 0.1 OUTLIER -63.2 -37.7 88.27 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 108.709 -0.849 . . . . 1.0 108.709 177.485 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.593 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 74.9 mt-30 -60.33 -45.37 93.66 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.688 -0.687 . . . . 1.0 110.259 175.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.582 ' HG ' ' O ' ' A' ' 25' ' ' PHE . 84.9 mt -54.95 -58.47 7.5 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.887 -0.597 . . . . 1.0 111.09 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.699 ' HD3' ' HA ' ' A' ' 27' ' ' GLN . 0.7 OUTLIER -58.93 -38.1 78.21 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.35 -0.386 . . . . 1.0 111.228 179.597 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -62.7 -26.32 68.61 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.543 0.571 . . . . 1.0 112.543 177.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.593 ' HG2' ' O ' ' A' ' 28' ' ' GLN . 7.0 ptp180 -95.26 -18.96 20.4 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 119.406 -0.917 . . . . 1.0 109.917 178.706 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 107.44 34.95 2.76 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.345 -0.843 . . . . 1.0 112.305 177.261 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 21.1 mt -126.41 2.36 6.98 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.924 -0.399 . . . . 1.0 109.924 -178.234 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -53.54 -31.04 43.56 Favored Glycine 0 CA--C 1.521 0.468 0 CA-C-N 116.014 -0.539 . . . . 1.0 113.262 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.662 ' HA ' ' NH1' ' A' ' 39' ' ' ARG . 15.0 m-20 -92.04 -17.85 24.46 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 122.648 -0.325 . . . . 1.0 110.65 177.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.55 -22.73 43.46 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.163 -0.471 . . . . 1.0 111.139 -177.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.813 HG23 ' HB3' ' A' ' 5' ' ' LEU . 0.3 OUTLIER -144.32 123.92 7.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.186 0.517 . . . . 1.0 110.922 -179.749 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.682 ' O ' ' HA ' ' A' ' 6' ' ' HIS . 15.0 mmt180 -95.33 104.82 16.72 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 115.698 -0.683 . . . . 1.0 111.153 -177.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.652 HG11 ' HB2' ' A' ' 26' ' ' ALA . 1.5 m -87.99 137.1 21.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 108.231 -1.026 . . . . 1.0 108.231 176.571 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.502 ' O ' ' HA ' ' A' ' 8' ' ' THR . 21.5 p -146.76 -177.75 5.82 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.354 -0.839 . . . . 1.0 109.819 -175.283 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.475 ' OG ' ' HE1' ' A' ' 71' ' ' HIS . 67.1 p -157.14 156.73 33.21 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 120.388 -0.525 . . . . 1.0 111.035 -177.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.534 ' O ' ' HA ' ' A' ' 10' ' ' VAL . . . -161.65 160.68 29.02 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 121.225 0.536 . . . . 1.0 111.061 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.427 ' HA2' ' O ' ' A' ' 11' ' ' CYS . . . -123.08 133.77 9.19 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 111.351 -0.7 . . . . 1.0 111.351 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.479 HG21 HD12 ' A' ' 96' ' ' LEU . 21.1 p -69.17 -22.57 63.91 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 111.931 0.345 . . . . 1.0 111.931 -177.387 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -110.46 7.1 30.2 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.866 -0.683 . . . . 1.0 113.111 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 42.87 35.98 0.81 Allowed 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 113.87 1.063 . . . . 1.0 113.87 178.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.833 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 1.0 OUTLIER -44.95 -70.29 0.11 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.422 0.629 . . . . 1.0 112.487 -178.315 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.475 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 24.3 m-70 -110.58 44.08 1.31 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.317 -0.856 . . . . 1.0 111.244 179.434 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.469 HG23 ' HA ' ' A' ' 74' ' ' ALA . 12.0 p -61.56 129.17 24.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.772 -0.455 . . . . 1.0 109.772 177.055 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.597 ' HA2' ' HD3' ' A' ' 72' ' ' ARG . . . 92.58 -12.15 70.43 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.977 -0.63 . . . . 1.0 111.838 -177.271 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.495 ' O ' ' HA ' ' A' ' 72' ' ' ARG . 2.4 t -81.45 -158.56 0.22 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.357 0.598 . . . . 1.0 109.97 179.397 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 36.8 t -134.18 170.52 15.56 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 108.719 -0.845 . . . . 1.0 108.719 -178.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.54 140.77 27.39 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.193 0.52 . . . . 1.0 111.816 -178.452 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -59.35 137.37 58.01 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 114.432 -1.258 . . . . 1.0 110.43 -178.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -51.33 -29.15 14.27 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.315 -0.857 . . . . 1.0 113.109 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.457 ' O ' HG23 ' A' ' 61' ' ' VAL . 30.9 mtt180 -69.63 -50.96 39.27 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.136 0.494 . . . . 1.0 110.267 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.407 ' O ' ' HG ' ' A' ' 62' ' ' LEU . . . -69.43 -29.32 67.0 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.18 -0.918 . . . . 1.0 110.533 -177.197 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.27 -44.63 96.92 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.86 -0.609 . . . . 1.0 109.514 176.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.19 -39.67 96.27 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.715 -0.755 . . . . 1.0 111.667 178.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 57' ' ' ARG . 78.7 t -60.81 -56.28 18.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 CA-C-O 121.188 0.518 . . . . 1.0 110.957 178.807 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.788 HD13 ' HG3' ' A' ' 23' ' ' LYS . 70.5 mt -61.04 -50.95 71.24 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.936 -0.574 . . . . 1.0 111.366 -178.52 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -60.07 -28.24 67.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.419 -0.355 . . . . 1.0 110.675 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.65 -35.67 79.31 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 120.977 0.417 . . . . 1.0 110.818 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.435 ' HB2' ' HD2' ' A' ' 67' ' ' TYR . 76.0 m80 -96.64 4.05 52.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.871 -0.604 . . . . 1.0 111.329 -177.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 90.21 14.99 58.16 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 121.086 -0.578 . . . . 1.0 112.632 177.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.508 ' HD1' ' HG2' ' A' ' 27' ' ' GLN . 69.7 m-85 -89.9 151.05 44.87 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-O 120.44 0.162 . . . . 1.0 110.985 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.925 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 55.3 Cg_endo -68.9 160.58 49.22 Favored 'Trans proline' 0 CA--C 1.511 -0.67 0 C-N-CA 122.571 2.18 . . . . 1.0 110.125 175.75 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.709 HG22 ' HB2' ' A' ' 62' ' ' LEU . 47.5 p -135.62 -0.43 2.63 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 119.589 -0.844 . . . . 1.0 112.161 -177.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.49 ' O ' ' HE2' ' A' ' 23' ' ' LYS . 48.4 t0 -71.94 134.84 46.22 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.293 -0.632 . . . . 1.0 109.293 -179.222 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.659 ' HB2' ' HE2' ' A' ' 23' ' ' LYS . 32.7 t60 -169.05 154.81 6.28 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.971 0.415 . . . . 1.0 110.379 -174.334 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.597 ' HD3' ' HA2' ' A' ' 51' ' ' GLY . 5.0 tmm_? -136.4 108.37 7.15 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 107.468 -1.308 . . . . 1.0 107.468 176.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 49' ' ' HIS . . . -58.67 139.99 55.27 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.823 -1.081 . . . . 1.0 112.048 -175.173 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.678 ' H ' ' ND2' ' A' ' 14' ' ' ASN . . . -130.01 161.54 30.73 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.645 -0.707 . . . . 1.0 109.93 177.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -96.77 159.9 14.67 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.205 -0.665 . . . . 1.0 109.205 179.079 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.424 HG11 HD23 ' A' ' 97' ' ' LEU . 61.7 t -70.18 110.2 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.158 0.504 . . . . 1.0 110.316 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.575 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -123.95 -170.58 13.34 Favored Glycine 0 N--CA 1.441 -1.006 0 CA-C-N 115.397 -0.819 . . . . 1.0 111.564 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 43.3 m -58.63 -51.71 68.75 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.873 0.368 . . . . 1.0 111.647 -178.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.522 ' HG2' ' N ' ' A' ' 80' ' ' HIS . 0.7 OUTLIER -54.46 -32.74 58.27 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.563 -0.744 . . . . 1.0 111.007 179.789 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.53 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 79.4 m80 -76.87 -40.61 47.0 Favored 'General case' 0 C--O 1.223 -0.321 0 N-CA-C 109.659 -0.497 . . . . 1.0 109.659 178.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.575 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 54.4 mt -65.75 -18.4 65.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.248 0.547 . . . . 1.0 110.539 178.143 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.39 -4.04 59.03 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.872 -0.604 . . . . 1.0 110.697 -178.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.569 ' HB1' ' O ' ' A' ' 6' ' ' HIS . . . -64.13 149.33 47.93 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.807 -0.633 . . . . 1.0 111.4 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.563 ' HB3' HD13 ' A' ' 5' ' ' LEU . 24.7 t70 -73.23 -14.4 61.33 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.07 0.462 . . . . 1.0 109.871 178.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.859 HD13 HG13 ' A' ' 7' ' ' VAL . 0.9 OUTLIER -154.08 120.94 5.59 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.597 -0.729 . . . . 1.0 110.504 -177.735 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 1.037 HD11 HG11 ' A' ' 102' ' ' VAL . 0.3 OUTLIER -105.99 104.33 14.02 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.747 -0.835 . . . . 1.0 108.747 175.158 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.571 HG23 HD22 ' A' ' 85' ' ' LEU . 54.5 t -83.73 92.18 2.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 121.493 0.663 . . . . 1.0 110.551 -178.092 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.21 146.78 30.3 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.195 -0.912 . . . . 1.0 111.231 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.467 HD23 ' HB2' ' A' ' 11' ' ' CYS . 4.2 mm? -98.18 -13.68 20.76 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 115.689 -0.687 . . . . 1.0 109.741 178.054 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -139.44 153.55 47.59 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.496 -0.774 . . . . 1.0 109.961 -177.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -62.78 -20.38 64.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.36 0.6 . . . . 1.0 109.819 176.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.632 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 95.1 m-20 -76.49 -51.93 10.78 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.935 -1.029 . . . . 1.0 110.319 -178.46 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.49 ' CD2' ' HA ' ' A' ' 11' ' ' CYS . 17.4 m-70 -58.3 -44.14 88.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.792 -0.64 . . . . 1.0 110.277 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.549 ' HA ' HD12 ' A' ' 97' ' ' LEU . . . -60.54 -42.77 97.19 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.026 0.441 . . . . 1.0 110.473 178.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 5.0 ttp-105 -58.59 -45.56 88.82 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 115.438 -0.801 . . . . 1.0 111.16 178.227 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.736 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 45.6 mt -63.69 -50.28 69.81 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.343 -176.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.689 HD11 HG21 ' A' ' 10' ' ' VAL . 14.0 mt -52.76 -58.52 6.61 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.936 -0.575 . . . . 1.0 111.835 -177.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 13.0 ptt180 -60.68 -44.8 96.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.281 -0.418 . . . . 1.0 111.922 -176.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.47 ' HG3' ' O ' ' A' ' 96' ' ' LEU . 1.2 pt20 -69.0 -20.18 64.15 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 121.01 0.433 . . . . 1.0 110.595 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.736 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 6.2 mt -79.22 -9.02 59.47 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.622 -0.717 . . . . 1.0 111.798 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 150.96 -32.89 0.96 Allowed Glycine 0 CA--C 1.505 -0.57 0 C-N-CA 119.842 -1.171 . . . . 1.0 113.352 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 1.037 HG11 HD11 ' A' ' 86' ' ' LEU . 0.8 OUTLIER -76.79 -151.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 121.716 0.769 . . . . 1.0 112.056 -176.697 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.639 ' H ' HG12 ' A' ' 102' ' ' VAL . 12.8 pt-20 -162.9 167.42 22.7 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.189 -0.914 . . . . 1.0 108.733 -178.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.763 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -67.23 -22.32 65.7 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.179 -0.464 . . . . 1.0 112.132 -174.4 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.24 -36.59 73.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.12 0.486 . . . . 1.0 110.687 176.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.591 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 1.0 OUTLIER -96.86 -40.36 8.96 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.207 -0.906 . . . . 1.0 110.805 -177.615 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.763 HG12 ' HA ' ' A' ' 104' ' ' ALA . 13.4 p -79.76 115.2 21.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.574 0.702 . . . . 1.0 110.352 -179.294 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.527 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 20.5 mmm180 -133.3 145.08 50.12 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.889 -0.596 . . . . 1.0 109.658 -177.483 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 84.6 mmm -77.52 137.52 38.67 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.947 -0.57 . . . . 1.0 110.543 -179.176 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.55 HD11 ' HA ' ' A' ' 142' ' ' ILE . 3.1 tm? -55.27 -49.81 71.11 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.802 0.334 . . . . 1.0 110.567 179.323 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.482 ' HG2' HH11 ' A' ' 111' ' ' ARG . 11.8 ttt-85 -72.94 -12.87 61.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.321 -0.4 . . . . 1.0 111.419 -176.363 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 33.3 t -78.81 -8.97 59.28 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 121.15 -0.22 . . . . 1.0 110.855 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.627 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 82.6 m-85 -86.46 -18.27 32.11 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-O 120.975 0.417 . . . . 1.0 110.341 177.532 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.8 t0 . . . . . 0 C--N 1.327 -0.41 0 CA-C-N 115.33 -0.85 . . . . 1.0 111.046 -179.44 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.437 ' HA ' ' HB3' ' A' ' 139' ' ' PHE . 36.7 mt-10 . . . . . 0 N--CA 1.452 -0.345 0 CA-C-O 120.857 0.361 . . . . 1.0 110.382 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.528 ' O ' HG23 ' A' ' 141' ' ' VAL . 32.7 tt0 -63.22 -50.22 71.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.029 -0.532 . . . . 1.0 109.878 178.169 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.782 HG21 HH11 ' A' ' 17' ' ' ARG . 53.4 t -62.74 -40.16 87.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.663 -0.699 . . . . 1.0 109.857 175.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.548 ' HB2' ' HE1' ' A' ' 20' ' ' MET . 18.3 t80 -54.5 -41.77 69.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.113 -0.949 . . . . 1.0 109.172 175.722 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.575 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -65.63 -42.37 91.6 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.604 -0.725 . . . . 1.0 110.544 176.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.661 HG23 ' HA ' ' A' ' 138' ' ' VAL . 13.8 t -54.15 -52.11 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-O 121.863 0.84 . . . . 1.0 109.715 177.537 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.55 ' HA ' HD11 ' A' ' 110' ' ' LEU . 7.2 mt -65.29 -51.32 66.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 114.597 -1.183 . . . . 1.0 112.084 -178.167 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.575 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 8.4 pt-20 -55.29 -34.37 64.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.825 0.345 . . . . 1.0 110.479 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 67.1 m -72.24 -28.96 63.48 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.738 -0.664 . . . . 1.0 110.743 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.458 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -88.48 -22.77 23.48 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.776 -0.647 . . . . 1.0 112.08 179.253 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.701 HD22 ' HB3' ' A' ' 25' ' ' PHE . 12.0 mt -55.65 -37.74 60.3 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 112.266 0.469 . . . . 1.0 112.266 -178.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.623 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 60.3 Cg_endo -70.53 -10.31 27.67 Favored 'Trans proline' 0 C--N 1.361 1.204 0 C-N-CA 122.493 2.129 . . . . 1.0 111.832 177.728 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.627 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -104.67 -32.41 4.18 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 110.572 -1.011 . . . . 1.0 110.572 178.289 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.459 ' O ' HG13 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -75.63 -41.89 53.03 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.687 -0.857 . . . . 1.0 108.687 179.474 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 150' ' ' HIS . . . . . 0.432 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 0.5 OUTLIER -54.08 -56.85 14.18 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 114.791 -1.095 . . . . 1.0 110.736 176.787 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -58.55 -40.64 83.58 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.226 -0.897 . . . . 1.0 111.504 -175.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' TRP . . . . . 0.747 ' HZ3' HD11 ' A' ' 5' ' ' LEU . 31.0 t90 -63.22 -55.23 26.75 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.624 -0.716 . . . . 1.0 110.615 -179.346 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.474 HG11 HG21 ' A' ' 7' ' ' VAL . 7.2 m -61.65 -40.38 86.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 120.723 -0.391 . . . . 1.0 110.598 -178.51 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.435 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 13.3 m-20 -59.69 -52.0 67.4 Favored 'General case' 0 CA--C 1.523 -0.084 0 CA-C-O 120.994 0.426 . . . . 1.0 110.721 178.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.59 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 6.2 pt-20 -61.86 -38.84 89.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.586 -0.734 . . . . 1.0 110.296 -178.517 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.515 ' HG3' ' CH2' ' A' ' 152' ' ' TRP . 20.4 mmt180 -72.11 -46.62 55.97 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.805 -0.634 . . . . 1.0 111.057 -177.291 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 4.1 pp . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 121.337 0.589 . . . . 1.0 109.591 -179.176 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.489 ' HB2' ' HG2' ' A' ' 39' ' ' ARG . 35.1 Cg_endo . . . . . 0 C--O 1.235 0.327 0 N-CA-C 113.836 0.668 . . . . 1.0 113.836 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.77 ' HB3' HG23 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -66.17 178.42 1.16 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.75 -1.114 . . . . 1.0 109.319 177.547 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.704 ' H ' HD13 ' A' ' 5' ' ' LEU . 4.0 t-160 -156.8 98.23 1.76 Allowed 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.503 -0.555 . . . . 1.0 109.503 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.775 HG13 HD13 ' A' ' 85' ' ' LEU . 2.1 t -103.18 117.97 49.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 N-CA-C 107.722 -1.214 . . . . 1.0 107.722 177.794 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.592 HG22 ' HG ' ' A' ' 86' ' ' LEU . 8.3 t -118.54 114.38 22.73 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 120.931 0.396 . . . . 1.0 110.204 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.591 ' HD2' ' HB3' ' A' ' 42' ' ' SER . 2.2 m-85 -82.89 126.07 32.06 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.076 0.465 . . . . 1.0 110.215 -178.681 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.665 HG21 HD11 ' A' ' 97' ' ' LEU . 35.4 t -110.23 112.01 38.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 CA-C-N 115.74 -0.664 . . . . 1.0 111.631 -176.251 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.639 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 37.7 t -139.91 161.28 37.96 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.149 -1.056 . . . . 1.0 108.149 177.174 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -66.24 -39.89 89.86 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.217 0.532 . . . . 1.0 109.812 179.248 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.588 ' C ' ' H ' ' A' ' 15' ' ' ILE . . . -104.17 80.4 0.32 Allowed Glycine 0 N--CA 1.435 -1.432 0 CA-C-N 115.187 -0.915 . . . . 1.0 110.856 175.371 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.628 ' ND2' ' HB1' ' A' ' 73' ' ' ALA . 15.9 p-10 -59.5 17.72 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.74 1.616 . . . . 1.0 112.418 176.1 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.588 ' H ' ' C ' ' A' ' 13' ' ' GLY . 6.7 pt -121.59 -0.81 7.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.177 178.398 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 22.1 m -116.16 -87.09 0.61 Allowed 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.215 0.45 . . . . 1.0 112.215 -177.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.587 HH21 ' HB3' ' A' ' 89' ' ' LEU . 13.0 mtm-85 -72.38 -46.96 53.02 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 112.391 0.515 . . . . 1.0 112.391 -173.462 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.76 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 26.4 m -54.46 -58.72 12.71 Favored Pre-proline 0 CA--C 1.537 0.446 0 CA-C-N 116.306 -0.406 . . . . 1.0 111.333 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.451 ' HA ' ' HB2' ' A' ' 22' ' ' GLU . 39.3 Cg_endo -63.56 -22.9 70.66 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 121.763 1.642 . . . . 1.0 113.345 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.698 ' HB3' HD13 ' A' ' 142' ' ' ILE . 35.6 mmm -60.97 -53.62 55.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.635 0.255 . . . . 1.0 110.846 178.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.92 -25.63 60.09 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.168 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.632 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 17.9 tt0 -51.92 -54.09 33.47 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 114.761 -1.109 . . . . 1.0 109.819 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.647 ' O ' ' HB3' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -83.51 -26.99 29.7 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.378 -0.828 . . . . 1.0 110.838 -175.753 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.599 ' HB3' HD11 ' A' ' 146' ' ' LEU . 5.6 mmm -60.85 -75.61 0.06 Allowed 'General case' 0 C--O 1.239 0.542 0 CA-C-O 121.453 0.644 . . . . 1.0 112.504 -178.062 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.677 ' CE2' HD23 ' A' ' 149' ' ' LEU . 22.3 p90 -79.37 -28.83 41.94 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.088 -0.645 . . . . 1.0 111.674 -174.764 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.632 ' HB3' ' O ' ' A' ' 22' ' ' GLU . . . -64.8 -36.2 83.56 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 119.082 -1.047 . . . . 1.0 110.739 178.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.647 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -63.73 -38.56 91.55 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.666 -0.864 . . . . 1.0 108.666 176.595 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.673 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 78.7 mt-30 -59.24 -44.56 92.35 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 115.608 -0.724 . . . . 1.0 110.499 175.696 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 25' ' ' PHE . 90.0 mt -54.26 -59.62 4.43 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.887 -0.597 . . . . 1.0 111.239 -179.319 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.531 ' HD3' ' HA ' ' A' ' 27' ' ' GLN . 1.5 ptm180 -59.31 -34.55 72.45 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.714 -0.394 . . . . 1.0 111.155 178.586 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -62.27 -28.96 70.08 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.315 0.487 . . . . 1.0 112.315 177.087 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.673 ' HG2' ' O ' ' A' ' 28' ' ' GLN . 4.8 ptp180 -94.16 -16.0 24.12 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 119.915 -0.714 . . . . 1.0 110.429 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 102.72 38.75 2.89 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.403 -0.817 . . . . 1.0 111.48 177.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 27.3 mt -132.72 1.51 3.66 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 110.088 -0.338 . . . . 1.0 110.088 -178.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.462 ' H ' ' HA ' ' A' ' 30' ' ' ARG . . . -57.6 -27.29 58.48 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 121.05 -0.595 . . . . 1.0 112.343 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -82.55 -31.27 29.17 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.964 0.411 . . . . 1.0 109.928 177.512 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -78.94 -16.86 56.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.201 -0.909 . . . . 1.0 112.318 -174.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.77 HG23 ' HB3' ' A' ' 5' ' ' LEU . 0.3 OUTLIER -143.86 126.59 11.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 121.877 -0.515 . . . . 1.0 111.241 -179.998 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.489 ' HG2' ' HB2' ' A' ' 4' ' ' PRO . 7.7 mmt180 -90.46 132.62 35.55 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 108.636 -0.875 . . . . 1.0 108.636 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 68.3 t -124.9 119.41 55.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.264 -0.643 . . . . 1.0 109.264 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.436 ' O ' ' HA ' ' A' ' 8' ' ' THR . 78.0 p -132.49 -175.16 3.66 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.47 -1.241 . . . . 1.0 110.979 -174.638 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.76 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 87.8 p -158.58 163.39 37.04 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.682 -0.488 . . . . 1.0 109.682 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.54 ' HB2' ' CD2' ' A' ' 80' ' ' HIS . . . -164.93 168.78 17.23 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 121.219 0.533 . . . . 1.0 111.571 -178.447 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.639 ' HA2' ' O ' ' A' ' 11' ' ' CYS . . . -127.53 132.56 7.55 Favored Glycine 0 N--CA 1.438 -1.174 0 CA-C-N 115.078 -0.965 . . . . 1.0 111.462 178.634 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.499 HG23 ' CG1' ' A' ' 10' ' ' VAL . 26.9 p -69.47 -23.41 63.64 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.887 0.375 . . . . 1.0 111.325 -178.145 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.429 ' HA3' ' HZ3' ' A' ' 48' ' ' TRP . . . -112.92 9.1 25.41 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.858 -0.686 . . . . 1.0 112.304 -178.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.494 ' HB3' ' HB2' ' A' ' 75' ' ' GLN . 10.1 p30 43.64 39.11 2.23 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.991 0.916 . . . . 1.0 113.41 177.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.429 ' HZ3' ' HA3' ' A' ' 46' ' ' GLY . 1.2 m-90 -42.8 -72.54 0.06 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.294 0.568 . . . . 1.0 112.386 -178.623 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.418 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 75.9 m-70 -112.23 45.72 1.25 Allowed 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.283 -0.872 . . . . 1.0 111.243 178.645 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.446 HG23 ' HA ' ' A' ' 74' ' ' ALA . 11.6 p -61.78 129.93 25.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.622 -0.717 . . . . 1.0 110.135 177.563 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.607 ' HA2' ' HD3' ' A' ' 72' ' ' ARG . . . 93.66 -15.31 63.34 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.889 -0.672 . . . . 1.0 112.081 -177.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.4 t -80.06 -161.16 0.33 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.379 0.609 . . . . 1.0 109.914 179.277 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 35.5 t -127.98 170.62 12.66 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 115.288 -0.869 . . . . 1.0 108.932 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -52.06 136.13 29.99 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 123.338 0.398 . . . . 1.0 111.414 -178.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.698 ' OD1' ' HG2' ' A' ' 57' ' ' ARG . 12.5 t70 -57.17 140.27 50.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.389 -0.823 . . . . 1.0 111.309 -178.114 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -45.78 -37.93 6.57 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.99 -1.004 . . . . 1.0 113.519 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.698 ' HG2' ' OD1' ' A' ' 55' ' ' ASP . 15.3 ptp180 -70.12 -44.52 68.77 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 120.522 -0.471 . . . . 1.0 110.914 -177.466 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.24 -30.91 66.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.035 0.445 . . . . 1.0 110.384 -178.324 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.02 -45.82 90.54 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.082 177.356 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.2 -36.87 94.01 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.937 -0.649 . . . . 1.0 111.773 177.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 57' ' ' ARG . 86.9 t -62.06 -59.04 4.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.23 0.538 . . . . 1.0 110.851 178.163 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.682 ' HB2' HG22 ' A' ' 69' ' ' THR . 96.8 mt -60.16 -50.12 74.95 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.836 -0.62 . . . . 1.0 111.363 -177.062 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 -59.25 -30.62 68.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.47 -0.332 . . . . 1.0 111.061 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.28 -33.24 73.99 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 121.124 0.488 . . . . 1.0 111.136 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -97.59 5.34 49.61 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.859 -0.61 . . . . 1.0 111.437 -178.503 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.48 13.44 63.32 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.899 -0.667 . . . . 1.0 112.837 177.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -91.13 148.95 39.01 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-O 120.561 0.22 . . . . 1.0 110.944 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.614 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 48.9 Cg_endo -69.95 158.13 57.73 Favored 'Trans proline' 0 CA--C 1.513 -0.563 0 C-N-CA 122.243 1.962 . . . . 1.0 110.841 176.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.682 HG22 ' HB2' ' A' ' 62' ' ' LEU . 53.1 p -131.3 9.09 4.73 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.341 -0.543 . . . . 1.0 110.803 -178.059 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -73.6 123.77 24.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.463 -0.79 . . . . 1.0 109.536 -178.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.48 ' HB2' ' HE2' ' A' ' 23' ' ' LYS . 31.2 t60 -166.07 154.58 11.01 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.973 -175.381 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.607 ' HD3' ' HA2' ' A' ' 51' ' ' GLY . 2.3 tmm_? -135.8 110.1 8.42 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.048 -1.093 . . . . 1.0 108.048 175.638 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.628 ' HB1' ' ND2' ' A' ' 14' ' ' ASN . . . -55.7 136.68 50.59 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.621 -1.172 . . . . 1.0 112.527 -175.452 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.464 ' O ' ' HA ' ' A' ' 43' ' ' ALA . . . -129.45 160.4 33.26 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.822 -0.172 . . . . 1.0 110.743 178.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.494 ' HB2' ' HB3' ' A' ' 47' ' ' ASN . 8.9 tt0 -97.04 153.39 17.95 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.531 -0.914 . . . . 1.0 108.531 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.504 HG11 ' CD2' ' A' ' 97' ' ' LEU . 20.2 t -65.41 109.92 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.424 0.631 . . . . 1.0 110.748 179.306 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -120.92 -169.67 13.87 Favored Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 115.396 -0.82 . . . . 1.0 111.103 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 53.9 m -58.8 -42.89 90.18 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.52 0.2 . . . . 1.0 110.692 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -57.78 -31.96 67.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.944 0.402 . . . . 1.0 111.303 177.185 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.54 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 79.3 m80 -79.22 -41.27 28.66 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-N 116.522 -0.308 . . . . 1.0 110.943 -179.201 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.688 ' HA ' HD21 ' A' ' 86' ' ' LEU . 16.8 mt -67.95 -19.04 64.93 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.914 0.387 . . . . 1.0 110.127 177.51 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.13 -5.16 59.26 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.849 0.357 . . . . 1.0 110.388 -178.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.497 ' HA ' ' HB3' ' A' ' 6' ' ' HIS . . . -58.2 153.72 14.53 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.822 -0.626 . . . . 1.0 110.782 178.517 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.757 ' HB3' HD13 ' A' ' 5' ' ' LEU . 12.1 t70 -79.96 -14.57 58.5 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.902 -0.59 . . . . 1.0 109.546 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.775 HD13 HG13 ' A' ' 7' ' ' VAL . 0.4 OUTLIER -155.69 118.31 4.2 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.342 -0.845 . . . . 1.0 108.842 -178.11 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.688 HD21 ' HA ' ' A' ' 81' ' ' LEU . 5.2 mp -107.93 105.55 15.4 Favored 'General case' 0 N--CA 1.425 -1.683 0 CA-C-O 121.305 0.574 . . . . 1.0 109.806 178.273 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.593 ' HA ' ' O ' ' A' ' 108' ' ' ARG . 55.8 t -84.9 92.59 3.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 114.652 -1.158 . . . . 1.0 111.453 -175.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.79 146.56 33.71 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.566 -0.743 . . . . 1.0 110.758 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.587 ' HB3' HH21 ' A' ' 17' ' ' ARG . 3.9 mm? -100.83 -7.57 23.47 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.459 179.156 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.426 ' CG ' ' H ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -153.97 156.38 37.35 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.994 -0.548 . . . . 1.0 111.282 178.594 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 6.0 ptm85 -55.72 -24.65 35.98 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.479 0.918 . . . . 1.0 113.479 -178.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.655 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 87.8 m-20 -76.79 -51.49 11.27 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 110.186 -0.301 . . . . 1.0 110.186 -178.515 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.668 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 13.5 m170 -55.27 -46.33 76.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.011 -0.541 . . . . 1.0 110.527 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.85 -43.12 94.83 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.069 0.462 . . . . 1.0 110.713 179.356 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.682 ' O ' ' HG2' ' A' ' 99' ' ' GLN . 5.9 ttm180 -58.44 -46.49 86.43 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 115.482 -0.781 . . . . 1.0 111.005 177.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.744 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 46.6 mt -62.51 -51.14 68.59 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-N 115.921 -0.581 . . . . 1.0 110.412 -175.7 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.668 ' HG ' ' O ' ' A' ' 93' ' ' HIS . 40.8 mt -51.22 -58.34 6.42 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.954 -0.566 . . . . 1.0 111.684 -177.276 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.663 ' CA ' HG12 ' A' ' 102' ' ' VAL . 13.3 ptt180 -58.91 -46.99 86.59 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.015 -0.539 . . . . 1.0 112.258 -179.16 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.682 ' HG2' ' O ' ' A' ' 95' ' ' ARG . 12.8 pt20 -69.24 -19.39 63.94 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.649 -0.421 . . . . 1.0 110.665 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.744 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 10.8 mt -81.43 -18.96 43.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.969 -0.56 . . . . 1.0 110.963 177.162 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 153.35 -25.15 0.77 Allowed Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 119.706 -1.235 . . . . 1.0 113.655 -178.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.7 HG13 ' N ' ' A' ' 103' ' ' GLU . 0.4 OUTLIER -76.49 -161.6 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 CA-C-N 117.493 0.646 . . . . 1.0 110.555 -178.44 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.761 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 15.5 pt-20 -159.25 161.89 36.08 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.604 -1.258 . . . . 1.0 107.604 -178.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.772 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -62.84 -24.51 67.82 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.725 0.298 . . . . 1.0 111.406 -175.387 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.434 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . . . -58.63 -36.05 73.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.01 -0.541 . . . . 1.0 110.171 174.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.761 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 1.6 mtt-85 -98.95 -41.37 7.62 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 115.604 -0.726 . . . . 1.0 111.366 -177.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.772 HG12 ' HA ' ' A' ' 104' ' ' ALA . 10.5 p -80.21 120.25 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-O 120.905 0.383 . . . . 1.0 110.015 -175.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.593 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 31.5 mmm180 -138.86 149.18 44.59 Favored 'General case' 0 C--N 1.318 -0.761 0 O-C-N 121.864 -0.522 . . . . 1.0 110.361 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.596 ' HB2' ' HB2' ' A' ' 112' ' ' SER . 83.3 mmm -78.73 136.21 37.35 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.848 -0.614 . . . . 1.0 110.41 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.524 HD23 HG11 ' A' ' 87' ' ' VAL . 2.8 tm? -53.57 -53.8 46.51 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.494 0.188 . . . . 1.0 110.853 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.524 ' O ' ' HB3' ' A' ' 114' ' ' ASP . 5.8 ttt85 -73.88 -9.92 59.14 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.082 -0.647 . . . . 1.0 111.323 -176.408 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.596 ' HB2' ' HB2' ' A' ' 109' ' ' MET . 41.5 t -75.5 -6.01 48.05 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.775 -0.454 . . . . 1.0 109.775 178.444 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.575 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 96.9 m-85 -94.74 -12.7 26.68 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.526 0.679 . . . . 1.0 109.402 175.171 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.524 ' HB3' ' O ' ' A' ' 111' ' ' ARG . 6.0 t0 . . . . . 0 N--CA 1.466 0.368 0 CA-C-N 114.97 -1.014 . . . . 1.0 111.533 -177.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.517 ' HA ' ' HB3' ' A' ' 139' ' ' PHE . 16.2 mt-10 . . . . . 0 N--CA 1.451 -0.398 0 N-CA-C 111.496 0.184 . . . . 1.0 111.496 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.574 ' O ' HG23 ' A' ' 141' ' ' VAL . 23.4 tp10 -64.42 -47.21 80.0 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 108.54 -0.911 . . . . 1.0 108.54 174.214 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.642 ' HA ' HG23 ' A' ' 141' ' ' VAL . 95.3 t -61.85 -40.5 87.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.9 -0.591 . . . . 1.0 109.746 176.357 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.546 ' HB2' HG11 ' A' ' 61' ' ' VAL . 13.5 t80 -52.75 -47.2 67.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.03 -0.986 . . . . 1.0 109.244 174.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.518 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -59.79 -43.06 94.62 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 115.351 -0.841 . . . . 1.0 110.228 177.279 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.642 HG23 ' HA ' ' A' ' 138' ' ' VAL . 8.2 t -54.54 -51.35 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 121.581 0.705 . . . . 1.0 110.505 177.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.698 HD13 ' HB3' ' A' ' 20' ' ' MET . 6.1 mt -66.16 -50.48 68.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 114.99 -1.005 . . . . 1.0 112.07 -178.378 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.518 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 8.8 pt-20 -56.06 -33.74 65.27 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.926 -0.398 . . . . 1.0 109.926 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' SER . . . . . 0.426 ' HB3' ' OD1' ' A' ' 114' ' ' ASP . 70.7 m -72.48 -28.65 63.04 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.758 -0.655 . . . . 1.0 110.514 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.419 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -87.27 -22.37 25.22 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.172 -0.467 . . . . 1.0 111.85 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.646 HD13 ' HB3' ' A' ' 25' ' ' PHE . 12.8 mt -57.44 -37.47 57.24 Favored Pre-proline 0 CA--C 1.546 0.82 0 N-CA-C 112.656 0.613 . . . . 1.0 112.656 -178.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.64 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 48.0 Cg_endo -68.27 -12.07 33.88 Favored 'Trans proline' 0 C--N 1.365 1.44 0 C-N-CA 122.79 2.326 . . . . 1.0 111.665 177.537 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.575 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -103.88 -34.93 3.61 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 114.903 -1.044 . . . . 1.0 110.927 178.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.677 HD23 ' CE2' ' A' ' 25' ' ' PHE . 13.4 tp -75.77 -41.0 54.29 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.872 -0.788 . . . . 1.0 108.872 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' HIS . . . . . 0.571 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 0.2 OUTLIER -53.92 -53.37 53.66 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 115.233 -0.894 . . . . 1.0 110.001 174.845 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -57.68 -43.76 85.32 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.871 -1.059 . . . . 1.0 110.679 -176.256 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' TRP . . . . . 0.745 ' HZ3' HD11 ' A' ' 5' ' ' LEU . 20.6 t90 -62.26 -55.78 25.0 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.395 -0.821 . . . . 1.0 110.486 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.452 HG11 HG21 ' A' ' 7' ' ' VAL . 12.6 m -62.02 -43.94 98.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 C-N-CA 120.72 -0.392 . . . . 1.0 111.091 -177.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.421 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 2.9 m-20 -59.81 -49.95 75.72 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 121.149 0.499 . . . . 1.0 110.76 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.535 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 7.0 pt-20 -62.81 -39.23 93.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.626 -0.715 . . . . 1.0 110.554 -178.175 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.571 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 6.3 mmt85 -73.13 -47.35 44.87 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.871 -0.604 . . . . 1.0 111.13 -175.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 4.2 pp . . . . . 0 C--N 1.326 -0.449 0 CA-C-N 115.7 -0.682 . . . . 1.0 109.985 -178.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.569 ' HB2' ' HG2' ' A' ' 39' ' ' ARG . 26.0 Cg_endo . . . . . 0 N--CA 1.458 -0.592 0 N-CA-C 113.58 0.569 . . . . 1.0 113.58 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.813 ' HB3' HG13 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -68.06 179.4 1.53 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.845 -1.07 . . . . 1.0 109.422 176.087 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.597 ' O ' ' HB1' ' A' ' 83' ' ' ALA . 2.3 t-160 -156.07 87.73 1.07 Allowed 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.878 -0.416 . . . . 1.0 109.878 -179.26 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.818 HG13 HD13 ' A' ' 85' ' ' LEU . 2.2 t -93.12 108.99 21.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 109.4 -0.593 . . . . 1.0 109.4 178.236 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.679 ' CG2' HD23 ' A' ' 86' ' ' LEU . 10.0 t -110.76 111.44 22.62 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.949 0.404 . . . . 1.0 110.635 179.041 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.615 ' HD1' ' HB ' ' A' ' 87' ' ' VAL . 1.3 m-85 -82.22 136.71 35.05 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.705 -0.479 . . . . 1.0 109.705 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.674 HG21 HD21 ' A' ' 97' ' ' LEU . 47.8 t -124.57 115.29 44.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.018 0.437 . . . . 1.0 111.461 -177.215 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.554 ' HB2' HD23 ' A' ' 89' ' ' LEU . 44.7 t -146.52 153.14 40.05 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.957 -0.565 . . . . 1.0 110.091 178.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -71.31 98.45 1.76 Allowed 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.902 -0.407 . . . . 1.0 109.902 178.196 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 142.68 -40.59 1.25 Allowed Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 110.623 -0.991 . . . . 1.0 110.623 -178.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.853 HD21 ' HA3' ' A' ' 44' ' ' GLY . 0.7 OUTLIER 49.37 23.45 0.86 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.601 1.16 . . . . 1.0 113.228 177.983 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.7 pt -140.83 9.44 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.288 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.478 177.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.482 ' O ' ' HG2' ' A' ' 20' ' ' MET . 5.1 p -122.41 -87.57 0.63 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.719 -0.673 . . . . 1.0 111.782 -176.595 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.434 HH11 ' HD3' ' A' ' 17' ' ' ARG . 7.3 mmm-85 -67.2 -48.69 67.16 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 121.124 0.488 . . . . 1.0 111.25 -175.32 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.905 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 13.1 m -52.48 -58.28 12.36 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-N 115.063 -0.971 . . . . 1.0 112.396 -179.318 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.638 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 56.8 Cg_endo -67.06 -23.43 46.29 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 121.842 1.694 . . . . 1.0 112.914 -178.227 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.581 ' HB3' HD13 ' A' ' 142' ' ' ILE . 51.8 mmm -59.65 -57.11 14.36 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.906 -0.405 . . . . 1.0 109.906 178.605 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.438 ' HB2' ' CG2' ' A' ' 142' ' ' ILE . . . -73.5 -27.15 61.22 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.57 -0.741 . . . . 1.0 110.645 -179.176 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.65 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 13.0 tt0 -52.82 -52.84 55.4 Favored 'General case' 0 C--O 1.215 -0.737 0 O-C-N 123.907 0.755 . . . . 1.0 109.946 -179.221 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.997 ' HE3' ' HB2' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -85.09 -25.81 27.33 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.837 -0.619 . . . . 1.0 110.777 -176.462 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.532 ' HB3' HD11 ' A' ' 146' ' ' LEU . 88.1 mtp -63.33 -74.59 0.09 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.564 0.579 . . . . 1.0 112.564 -177.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.732 ' HB3' HD22 ' A' ' 146' ' ' LEU . 17.2 p90 -76.81 -30.7 56.51 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 119.64 -0.824 . . . . 1.0 111.711 -176.003 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.65 ' HB3' ' O ' ' A' ' 22' ' ' GLU . . . -64.61 -37.51 87.82 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 119.284 -0.966 . . . . 1.0 111.172 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.611 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -63.32 -39.09 93.6 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 108.367 -0.975 . . . . 1.0 108.367 176.461 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.567 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 79.7 mt-30 -59.61 -42.49 92.74 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.562 -0.745 . . . . 1.0 110.172 175.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.646 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 88.8 mt -56.34 -61.13 2.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.947 -0.569 . . . . 1.0 110.719 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.501 ' HB3' ' HA3' ' A' ' 35' ' ' GLY . 0.2 OUTLIER -58.92 -35.78 73.66 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.778 -0.369 . . . . 1.0 111.382 178.642 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 3.1 m170 -63.23 -24.89 68.07 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.26 0.467 . . . . 1.0 112.26 177.103 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.646 ' HG2' ' O ' ' A' ' 29' ' ' LEU . 5.9 ptm85 -100.05 -20.18 16.16 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.442 0.639 . . . . 1.0 110.299 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 110.98 35.02 2.06 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.196 -0.911 . . . . 1.0 112.277 177.034 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.472 ' HG ' ' HG3' ' A' ' 32' ' ' ARG . 21.6 mt -128.33 3.89 5.72 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.877 -0.416 . . . . 1.0 109.877 -179.322 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.501 ' HA3' ' HB3' ' A' ' 30' ' ' ARG . . . -59.17 -31.44 69.2 Favored Glycine 0 C--O 1.229 -0.217 0 CA-C-N 115.777 -0.647 . . . . 1.0 113.383 -178.248 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.441 ' O ' ' HB3' ' A' ' 4' ' ' PRO . 3.3 t0 -86.98 -26.05 24.0 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 109.072 -0.714 . . . . 1.0 109.072 177.331 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.11 -20.82 47.72 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 114.558 -1.201 . . . . 1.0 110.795 -175.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.813 HG13 ' HB3' ' A' ' 5' ' ' LEU . 37.9 t -133.1 122.68 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 CA-C-N 116.393 -0.367 . . . . 1.0 110.207 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.569 ' HG2' ' HB2' ' A' ' 4' ' ' PRO . 11.9 mmt180 -89.78 133.32 34.76 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.04 -1.096 . . . . 1.0 108.04 175.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.458 HG11 ' HB2' ' A' ' 26' ' ' ALA . 45.5 t -127.53 115.58 40.5 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-O 121.375 0.607 . . . . 1.0 109.985 -178.011 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' A' ' 8' ' ' THR . 67.3 p -130.53 -175.51 3.67 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.461 -1.245 . . . . 1.0 110.427 -175.216 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.905 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 85.4 p -159.86 165.08 32.98 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 110.004 -0.369 . . . . 1.0 110.004 178.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.545 ' O ' ' HA ' ' A' ' 10' ' ' VAL . . . -164.57 166.85 19.92 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 120.944 0.402 . . . . 1.0 110.775 -179.476 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.853 ' HA3' HD21 ' A' ' 14' ' ' ASN . . . -125.96 138.96 11.12 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 111.257 -0.737 . . . . 1.0 111.257 177.704 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.526 HG21 HD12 ' A' ' 96' ' ' LEU . 21.4 p -72.86 -25.21 61.02 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.722 0.296 . . . . 1.0 111.339 -178.249 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.465 ' HA3' ' HZ3' ' A' ' 48' ' ' TRP . . . -107.85 9.49 37.28 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.97 -0.633 . . . . 1.0 113.34 -177.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 45.43 36.25 2.32 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 113.719 1.007 . . . . 1.0 113.719 176.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.465 ' HZ3' ' HA3' ' A' ' 46' ' ' GLY . 1.2 m-90 -44.53 -78.82 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.592 0.711 . . . . 1.0 112.376 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.407 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 8.2 m-70 -104.87 41.1 1.38 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.06 -0.973 . . . . 1.0 111.325 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.421 HG23 ' HA ' ' A' ' 74' ' ' ALA . 14.0 p -59.77 128.05 20.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.538 -0.301 . . . . 1.0 110.473 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.73 -13.5 67.35 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 121.071 -0.585 . . . . 1.0 112.202 -178.004 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.8 t -80.77 -161.79 0.42 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.321 0.582 . . . . 1.0 110.015 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 20.2 t -122.87 176.29 6.08 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.103 -1.073 . . . . 1.0 108.103 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.28 140.54 55.91 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.752 0.31 . . . . 1.0 110.56 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.41 ' OD1' ' HG2' ' A' ' 57' ' ' ARG . 9.8 t70 -59.12 140.2 56.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.86 -0.609 . . . . 1.0 111.079 -176.602 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -47.56 -37.1 11.61 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.485 -0.779 . . . . 1.0 112.873 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.41 ' HG2' ' OD1' ' A' ' 55' ' ' ASP . 11.5 ptp180 -73.83 -39.52 63.98 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 122.06 -0.4 . . . . 1.0 111.159 -177.065 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.92 -37.35 72.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.196 0.522 . . . . 1.0 110.06 178.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.41 -41.47 98.73 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.684 -0.689 . . . . 1.0 109.617 177.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.92 -48.09 81.64 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 115.687 -0.688 . . . . 1.0 112.679 178.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 23.6 m -72.17 -37.28 59.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 117.469 0.635 . . . . 1.0 111.614 -178.313 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.495 ' CD2' ' HG3' ' A' ' 23' ' ' LYS . 1.3 mp -62.05 -54.87 35.38 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.877 -0.329 . . . . 1.0 110.185 178.094 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -60.31 -32.79 71.55 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.862 -0.608 . . . . 1.0 110.911 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.47 -32.25 72.96 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-O 121.144 0.497 . . . . 1.0 111.192 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -98.11 5.85 48.18 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.961 -0.563 . . . . 1.0 111.515 -178.517 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 90.71 11.98 61.34 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 115.977 -0.556 . . . . 1.0 113.429 175.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.444 ' HD1' ' HG2' ' A' ' 27' ' ' GLN . 54.7 m-85 -92.67 151.01 40.66 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-O 120.624 0.25 . . . . 1.0 111.157 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.661 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 44.6 Cg_endo -70.22 158.93 54.82 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.19 1.926 . . . . 1.0 110.528 175.556 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 30.6 p -129.98 8.46 5.22 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.728 0.775 . . . . 1.0 109.823 -177.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -73.0 120.2 18.31 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.661 -1.154 . . . . 1.0 110.076 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.997 ' HB2' ' HE3' ' A' ' 23' ' ' LYS . 31.9 t60 -164.81 150.95 10.31 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.433 -0.349 . . . . 1.0 110.596 -175.331 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -132.29 111.26 11.22 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 108.489 -0.93 . . . . 1.0 108.489 175.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.512 ' HB1' ' OD1' ' A' ' 14' ' ' ASN . . . -59.47 141.53 54.5 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.211 -0.904 . . . . 1.0 112.606 -175.7 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.421 ' HA ' HG23 ' A' ' 50' ' ' VAL . . . -134.52 165.73 24.53 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.8 -0.637 . . . . 1.0 109.845 177.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -101.64 160.79 14.15 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.156 -0.683 . . . . 1.0 109.156 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 86.5 t -65.45 106.07 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.073 0.463 . . . . 1.0 110.88 179.379 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.464 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -120.77 -175.08 15.21 Favored Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 115.588 -0.733 . . . . 1.0 111.772 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 77.2 m -57.09 -49.45 75.82 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 122.742 0.417 . . . . 1.0 111.826 -178.268 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.444 ' HG2' ' N ' ' A' ' 80' ' ' HIS . 3.2 pm0 -57.33 -31.06 65.32 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.11 0.481 . . . . 1.0 111.062 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.444 ' N ' ' HG2' ' A' ' 79' ' ' GLU . 80.3 m80 -76.07 -41.55 50.21 Favored 'General case' 0 C--O 1.222 -0.356 0 CA-C-N 115.871 -0.604 . . . . 1.0 109.824 178.656 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 40.8 mt -66.1 -19.77 65.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.848 178.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.75 -6.26 59.14 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.92 -178.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.597 ' HB1' ' O ' ' A' ' 6' ' ' HIS . . . -60.33 148.56 36.53 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.399 -0.819 . . . . 1.0 111.756 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.691 ' HB3' HD13 ' A' ' 5' ' ' LEU . 15.5 t70 -74.46 -13.5 60.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.886 -0.597 . . . . 1.0 109.996 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.818 HD13 HG13 ' A' ' 7' ' ' VAL . 0.9 OUTLIER -154.37 122.76 6.1 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.685 -0.689 . . . . 1.0 110.198 -178.525 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 1.066 HD11 HG11 ' A' ' 102' ' ' VAL . 0.2 OUTLIER -108.15 105.0 14.53 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.904 -0.776 . . . . 1.0 108.904 174.653 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.615 ' HB ' ' HD1' ' A' ' 9' ' ' PHE . 53.7 t -84.31 91.27 2.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.663 0.744 . . . . 1.0 110.803 -178.398 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.93 147.0 30.49 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.434 -0.803 . . . . 1.0 111.207 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.554 HD23 ' HB2' ' A' ' 11' ' ' CYS . 4.2 mm? -100.79 -5.53 26.17 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.546 -0.752 . . . . 1.0 109.558 178.55 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -148.04 145.24 28.39 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.068 -0.969 . . . . 1.0 110.277 -178.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -55.6 -26.28 43.03 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.418 0.687 . . . . 1.0 111.191 177.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.685 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 80.3 m-20 -75.21 -49.28 19.89 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.719 -0.673 . . . . 1.0 109.911 -178.153 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.466 ' HB3' HG12 ' A' ' 10' ' ' VAL . 11.8 m170 -58.19 -43.48 87.56 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 115.808 -0.633 . . . . 1.0 109.369 179.32 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.473 ' HA ' HG21 ' A' ' 107' ' ' VAL . . . -59.67 -47.12 86.88 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.915 -0.584 . . . . 1.0 110.718 178.627 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 13.2 ttm180 -59.59 -39.53 84.48 Favored 'General case' 0 CA--C 1.521 -0.143 0 CA-C-N 115.792 -0.64 . . . . 1.0 111.405 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.746 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 55.6 mt -66.14 -50.68 63.12 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 116.499 -0.319 . . . . 1.0 110.359 -177.377 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.674 HD21 HG21 ' A' ' 10' ' ' VAL . 14.2 mt -53.51 -56.35 17.75 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.858 -0.61 . . . . 1.0 111.452 -179.013 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 13.3 ptt85 -62.46 -43.9 97.7 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.161 -0.472 . . . . 1.0 111.844 -177.264 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.589 ' HG3' ' O ' ' A' ' 96' ' ' LEU . 0.9 OUTLIER -66.35 -22.22 66.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.378 0.608 . . . . 1.0 110.103 179.536 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.746 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 10.0 mt -77.87 -13.21 59.96 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.348 -0.842 . . . . 1.0 111.761 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 154.62 -33.52 0.69 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.003 -1.094 . . . . 1.0 113.279 -179.122 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 1.066 HG11 HD11 ' A' ' 86' ' ' LEU . 0.8 OUTLIER -76.36 -152.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.697 0.761 . . . . 1.0 112.221 -176.969 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.636 ' H ' HG12 ' A' ' 102' ' ' VAL . 11.4 pt-20 -164.72 167.32 19.14 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.449 -0.796 . . . . 1.0 109.125 -177.091 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.808 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -67.18 -23.26 65.74 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.231 -0.441 . . . . 1.0 111.81 -175.176 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.12 -34.76 70.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.361 0.601 . . . . 1.0 110.578 176.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.544 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 8.0 mtp180 -98.83 -40.93 7.87 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 115.475 -0.784 . . . . 1.0 110.825 -178.551 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.808 HG12 ' HA ' ' A' ' 104' ' ' ALA . 9.3 p -80.2 121.62 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-O 121.719 0.771 . . . . 1.0 110.721 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.508 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 21.1 mmm180 -138.05 150.07 46.59 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.808 -0.633 . . . . 1.0 110.177 -178.554 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.586 ' HB2' ' HB2' ' A' ' 112' ' ' SER . 81.7 mmm -78.45 138.86 38.68 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.619 -0.719 . . . . 1.0 109.715 178.682 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.549 HD23 HG11 ' A' ' 87' ' ' VAL . 3.0 tm? -55.68 -49.03 74.05 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.621 0.248 . . . . 1.0 110.765 179.01 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 111' ' ' ARG . 18.4 ttt85 -71.46 -14.28 62.09 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.87 0.367 . . . . 1.0 110.662 -178.522 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.586 ' HB2' ' HB2' ' A' ' 109' ' ' MET . 26.4 t -70.88 -14.02 62.24 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.482 -0.326 . . . . 1.0 110.403 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.56 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 98.7 m-85 -90.39 -15.37 31.14 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 120.95 0.405 . . . . 1.0 110.44 177.56 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 13.5 t0 . . . . . 0 C--N 1.327 -0.382 0 CA-C-N 115.785 -0.643 . . . . 1.0 111.206 -177.045 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 . . . . . 0 N--CA 1.456 -0.168 0 CA-C-O 120.56 0.219 . . . . 1.0 111.34 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.575 ' O ' HG23 ' A' ' 141' ' ' VAL . 11.1 tp10 -63.6 -48.37 77.64 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.588 -0.893 . . . . 1.0 108.588 175.499 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.663 ' HA ' HG23 ' A' ' 141' ' ' VAL . 54.6 t -60.85 -41.43 88.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.095 -0.957 . . . . 1.0 109.941 176.688 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -53.55 -42.17 67.23 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.912 -1.04 . . . . 1.0 109.203 176.221 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.76 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -66.95 -40.21 87.48 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.278 -0.874 . . . . 1.0 110.635 177.549 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.663 HG23 ' HA ' ' A' ' 138' ' ' VAL . 10.7 t -55.58 -49.96 70.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.65 0.738 . . . . 1.0 110.167 178.136 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.581 HD13 ' HB3' ' A' ' 20' ' ' MET . 6.2 mt -67.78 -49.79 66.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 114.996 -1.002 . . . . 1.0 111.825 -178.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.76 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 5.3 pt-20 -57.49 -28.3 63.3 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.905 0.383 . . . . 1.0 110.062 178.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.9 t -75.11 -28.19 60.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.06 177.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.469 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -86.52 -23.71 25.79 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-N 116.246 -0.434 . . . . 1.0 111.644 178.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.732 HD22 ' HB3' ' A' ' 25' ' ' PHE . 14.2 mt -56.83 -35.93 40.97 Favored Pre-proline 0 CA--C 1.546 0.798 0 CA-C-O 118.943 -0.551 . . . . 1.0 112.452 -178.157 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.635 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 37.6 Cg_endo -67.63 -12.75 36.66 Favored 'Trans proline' 0 C--N 1.365 1.402 0 C-N-CA 122.543 2.162 . . . . 1.0 111.494 177.028 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.56 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -104.52 -34.12 3.68 Favored Glycine 0 N--CA 1.44 -1.065 0 CA-C-N 114.995 -1.002 . . . . 1.0 110.611 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.558 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.4 OUTLIER -75.24 -40.9 58.53 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 108.9 -0.778 . . . . 1.0 108.9 179.318 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 150' ' ' HIS . . . . . 0.434 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 1.1 m-70 -54.33 -52.87 60.17 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.187 -0.915 . . . . 1.0 110.244 175.137 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -60.01 -44.1 94.78 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.67 -0.695 . . . . 1.0 110.946 -176.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' TRP . . . . . 0.775 ' HZ3' HD11 ' A' ' 5' ' ' LEU . 26.4 t90 -60.56 -55.23 35.88 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.491 -0.777 . . . . 1.0 110.697 -178.665 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.411 HG13 ' O ' ' A' ' 149' ' ' LEU . 11.7 m -60.67 -39.71 82.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 121.071 -0.252 . . . . 1.0 110.772 -178.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.537 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 4.6 m-20 -59.49 -54.9 41.23 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.271 0.558 . . . . 1.0 110.975 178.692 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 6.6 pt-20 -62.28 -33.95 75.64 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.506 -0.77 . . . . 1.0 110.465 -178.237 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.574 ' HG3' ' CH2' ' A' ' 152' ' ' TRP . 18.5 mmt-85 -74.38 -42.6 59.03 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.759 -0.655 . . . . 1.0 111.711 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 4.5 pp . . . . . 0 C--N 1.323 -0.552 0 N-CA-C 109.505 -0.554 . . . . 1.0 109.505 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.459 ' HB2' ' HG2' ' A' ' 39' ' ' ARG . 36.4 Cg_endo . . . . . 0 C--O 1.233 0.272 0 CA-C-O 121.396 0.498 . . . . 1.0 112.939 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.785 ' HB3' HG23 ' A' ' 38' ' ' VAL . 0.6 OUTLIER -70.99 -174.18 0.91 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.322 -0.854 . . . . 1.0 110.989 -179.388 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.612 ' HB3' ' HA ' ' A' ' 83' ' ' ALA . 2.7 t-160 -156.51 104.83 2.21 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.468 -0.333 . . . . 1.0 110.659 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.671 HG13 HD13 ' A' ' 85' ' ' LEU . 2.8 t -105.16 119.47 54.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 107.32 -1.363 . . . . 1.0 107.32 175.018 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.591 HG22 ' HG ' ' A' ' 86' ' ' LEU . 8.2 t -121.74 114.01 20.51 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 120.44 -0.504 . . . . 1.0 110.484 179.276 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.677 ' HD2' ' HB3' ' A' ' 42' ' ' SER . 1.5 m-85 -83.15 127.35 33.53 Favored 'General case' 0 CA--C 1.512 -0.491 0 O-C-N 122.004 -0.435 . . . . 1.0 110.6 -179.144 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.643 HG21 HD21 ' A' ' 97' ' ' LEU . 23.8 t -111.39 111.76 37.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.008 0.432 . . . . 1.0 111.633 -176.194 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.569 ' HB2' HD23 ' A' ' 89' ' ' LEU . 42.2 t -141.24 155.98 45.95 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.331 179.227 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.42 92.59 0.61 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.103 0.478 . . . . 1.0 110.776 179.194 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.835 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 132.57 -41.92 1.44 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.791 -0.718 . . . . 1.0 111.869 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.464 HD21 ' CB ' ' A' ' 42' ' ' SER . 3.6 t-20 62.17 18.74 10.35 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.454 0.645 . . . . 1.0 111.766 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.2 pt -127.25 11.8 3.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 O-C-N 121.542 -0.724 . . . . 1.0 112.165 -176.263 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.719 ' O ' ' HG3' ' A' ' 20' ' ' MET . 80.5 m -126.6 -89.96 0.54 Allowed 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.122 -0.631 . . . . 1.0 111.852 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.446 ' H ' ' HG2' ' A' ' 17' ' ' ARG . 0.9 OUTLIER -74.4 -30.13 61.82 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.674 0.62 . . . . 1.0 112.674 -175.819 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.658 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 17.2 m -62.46 -58.91 14.58 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 121.04 -0.264 . . . . 1.0 110.841 178.356 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.745 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 35.2 Cg_endo -62.78 -25.79 74.82 Favored 'Trans proline' 0 C--N 1.357 0.978 0 C-N-CA 122.213 1.942 . . . . 1.0 111.983 179.429 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.719 ' HG3' ' O ' ' A' ' 16' ' ' CYS . 71.3 mtp -61.85 -52.85 62.44 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.849 -0.34 . . . . 1.0 110.809 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.424 ' HA ' ' HB2' ' A' ' 24' ' ' MET . . . -74.16 -27.17 60.7 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.577 -0.449 . . . . 1.0 110.108 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.687 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 7.9 tt0 -55.88 -49.78 72.44 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 115.159 -0.928 . . . . 1.0 109.302 179.254 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.916 ' HB3' ' HG2' ' A' ' 68' ' ' PRO . 0.0 OUTLIER -80.79 -32.15 35.46 Favored 'General case' 0 C--N 1.32 -0.691 0 O-C-N 121.825 -0.547 . . . . 1.0 110.002 -177.155 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.651 ' HB3' HD11 ' A' ' 146' ' ' LEU . 2.3 mmm -61.56 -76.15 0.06 Allowed 'General case' 0 C--O 1.236 0.362 0 N-CA-C 112.928 0.714 . . . . 1.0 112.928 -176.006 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.678 ' HB3' HD22 ' A' ' 146' ' ' LEU . 16.5 p90 -76.84 -30.36 56.28 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 119.645 -0.822 . . . . 1.0 111.749 -174.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.687 ' HB3' ' O ' ' A' ' 22' ' ' GLU . . . -63.87 -37.75 88.55 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 119.082 -1.047 . . . . 1.0 110.894 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.687 ' HA ' ' HD3' ' A' ' 30' ' ' ARG . 0.8 OUTLIER -65.82 -37.71 86.99 Favored 'General case' 0 C--N 1.333 -0.13 0 N-CA-C 108.955 -0.758 . . . . 1.0 108.955 177.836 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.546 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 79.3 mt-30 -58.8 -42.09 88.28 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.114 175.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.659 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 85.9 mt -56.02 -60.54 3.34 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.706 -0.679 . . . . 1.0 110.578 179.575 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.687 ' HD3' ' HA ' ' A' ' 27' ' ' GLN . 0.7 OUTLIER -58.94 -37.69 77.3 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.59 -0.277 . . . . 1.0 111.168 179.254 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -60.93 -25.31 66.69 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.252 0.464 . . . . 1.0 112.252 177.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.659 ' HG2' ' O ' ' A' ' 29' ' ' LEU . 3.6 ptm180 -100.71 -18.94 16.27 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 119.602 -0.839 . . . . 1.0 110.418 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 108.04 36.04 2.43 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.236 -0.893 . . . . 1.0 112.502 176.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 23.2 mt -130.08 -3.62 4.5 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 122.625 -0.338 . . . . 1.0 110.535 -178.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.415 ' H ' ' HA ' ' A' ' 30' ' ' ARG . . . -59.5 -25.93 61.41 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 121.126 -0.559 . . . . 1.0 112.488 -179.282 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -80.06 -32.08 39.4 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.511 0.672 . . . . 1.0 109.847 177.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.74 -18.36 51.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.814 -1.085 . . . . 1.0 112.759 -175.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.785 HG23 ' HB3' ' A' ' 5' ' ' LEU . 0.8 OUTLIER -145.02 128.97 12.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.107 0.479 . . . . 1.0 110.869 -178.837 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.459 ' HG2' ' HB2' ' A' ' 4' ' ' PRO . 9.3 mmm180 -94.12 140.75 29.36 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.639 -0.709 . . . . 1.0 110.168 -178.105 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.436 HG11 ' HB2' ' A' ' 26' ' ' ALA . 77.9 t -127.77 120.0 53.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-O 121.659 0.743 . . . . 1.0 109.633 -178.435 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.541 ' O ' ' HA ' ' A' ' 8' ' ' THR . 69.3 p -136.05 -174.54 3.7 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.135 -1.393 . . . . 1.0 109.933 -175.201 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.677 ' HB3' ' HD2' ' A' ' 9' ' ' PHE . 84.4 p -162.69 167.32 23.28 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 116.485 -0.325 . . . . 1.0 110.49 179.022 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.583 ' HB2' ' CD2' ' A' ' 80' ' ' HIS . . . -162.83 166.7 23.79 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.578 0.704 . . . . 1.0 111.727 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.456 ' HA2' ' O ' ' A' ' 11' ' ' CYS . . . -124.87 131.34 7.74 Favored Glycine 0 N--CA 1.443 -0.86 0 CA-C-N 114.785 -1.098 . . . . 1.0 111.252 178.491 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.521 HG21 HD12 ' A' ' 96' ' ' LEU . 40.9 p -70.11 -27.49 64.63 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.985 0.421 . . . . 1.0 111.108 -178.222 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -102.28 5.93 52.85 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 121.069 -0.586 . . . . 1.0 113.161 -176.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 44.19 34.6 1.03 Allowed 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 114.269 1.211 . . . . 1.0 114.269 176.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.835 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 0.9 OUTLIER -46.75 -72.62 0.05 Allowed 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.638 0.732 . . . . 1.0 112.494 -179.846 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -107.75 42.58 1.32 Allowed 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.045 -0.979 . . . . 1.0 111.016 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.2 p -62.84 128.48 24.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.098 0.475 . . . . 1.0 110.284 178.413 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.48 -13.56 67.28 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.761 -0.733 . . . . 1.0 111.828 -177.574 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.4 t -80.66 -158.74 0.2 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.063 0.459 . . . . 1.0 110.036 178.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 21.6 t -131.15 174.69 9.78 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.117 -1.068 . . . . 1.0 108.117 -179.014 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.2 137.31 47.4 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.713 0.292 . . . . 1.0 111.032 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.718 ' OD1' ' HG2' ' A' ' 57' ' ' ARG . 11.3 t70 -62.66 140.64 58.71 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 115.881 -0.599 . . . . 1.0 110.145 -177.565 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -51.53 -30.4 20.26 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 113.341 0.867 . . . . 1.0 113.341 -178.07 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.718 ' HG2' ' OD1' ' A' ' 55' ' ' ASP . 3.9 ptp180 -70.99 -44.4 66.02 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 118.351 0.523 . . . . 1.0 110.769 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.69 -35.82 70.38 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.739 -0.664 . . . . 1.0 109.583 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.84 -44.22 96.73 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.402 -0.817 . . . . 1.0 109.472 177.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.44 ' O ' ' HG2' ' A' ' 63' ' ' ARG . . . -56.75 -45.92 90.33 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.95 -0.643 . . . . 1.0 113.301 178.624 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.1 m -73.29 -38.62 54.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 117.793 0.797 . . . . 1.0 111.478 -178.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.667 HD21 ' HA ' ' A' ' 20' ' ' MET . 5.6 mp -62.17 -53.29 57.35 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.85 -0.34 . . . . 1.0 110.556 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.44 ' HG2' ' O ' ' A' ' 60' ' ' GLY . 11.6 ptm180 -59.98 -28.37 67.63 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.952 -0.567 . . . . 1.0 111.377 179.162 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.39 -30.27 65.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.22 0.533 . . . . 1.0 110.738 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -96.83 4.76 51.53 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.872 -0.604 . . . . 1.0 110.526 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.62 13.41 65.18 Favored Glycine 0 C--N 1.331 0.257 0 CA-C-N 115.681 -0.691 . . . . 1.0 113.087 176.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -92.06 150.84 41.18 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-O 120.498 0.19 . . . . 1.0 110.882 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.916 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 39.3 Cg_endo -67.8 155.79 68.51 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.395 2.063 . . . . 1.0 110.612 176.166 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 57.0 p -130.86 10.74 5.08 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 120.262 -0.575 . . . . 1.0 111.834 -176.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -97.32 136.5 37.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.915 0.388 . . . . 1.0 110.853 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.712 ' HB3' ' HE3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -178.98 162.55 1.26 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.523 -1.288 . . . . 1.0 107.523 177.729 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -121.56 120.82 35.93 Favored 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 119.548 -0.861 . . . . 1.0 108.871 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.03 140.67 56.66 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.763 -0.653 . . . . 1.0 111.288 -177.154 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.43 ' O ' ' HA ' ' A' ' 43' ' ' ALA . . . -134.65 151.07 50.77 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.907 -0.588 . . . . 1.0 110.132 179.401 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -87.57 153.31 21.5 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.644 -0.872 . . . . 1.0 108.644 177.215 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.567 HG11 HD23 ' A' ' 97' ' ' LEU . 21.7 t -63.91 114.2 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.217 0.532 . . . . 1.0 110.506 -179.166 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.447 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -125.27 -169.31 12.9 Favored Glycine 0 N--CA 1.442 -0.948 0 CA-C-N 115.129 -0.941 . . . . 1.0 111.279 179.299 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 51.9 m -59.86 -43.72 94.53 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.453 0.168 . . . . 1.0 111.196 -178.367 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -59.09 -31.34 68.81 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 120.952 0.406 . . . . 1.0 111.249 177.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.583 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 78.6 m80 -76.52 -40.69 49.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.497 -0.32 . . . . 1.0 110.276 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.724 ' HA ' HD21 ' A' ' 86' ' ' LEU . 14.6 mt -70.18 -17.09 63.15 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 120.774 0.321 . . . . 1.0 110.444 177.387 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.73 -7.09 58.99 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 120.777 0.322 . . . . 1.0 110.223 -179.11 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.612 ' HA ' ' HB3' ' A' ' 6' ' ' HIS . . . -58.45 149.23 25.62 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.961 -0.563 . . . . 1.0 110.922 178.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.555 ' HA ' ' HE ' ' A' ' 106' ' ' ARG . 32.1 t70 -75.49 -16.19 60.33 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.179 0.514 . . . . 1.0 109.739 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.671 HD13 HG13 ' A' ' 7' ' ' VAL . 0.6 OUTLIER -152.73 117.68 5.13 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.205 -0.907 . . . . 1.0 109.043 -177.688 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.724 HD21 ' HA ' ' A' ' 81' ' ' LEU . 4.9 mp -108.06 104.23 13.62 Favored 'General case' 0 N--CA 1.424 -1.758 0 CA-C-N 115.824 -0.625 . . . . 1.0 109.535 178.337 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.582 ' HB ' ' HD1' ' A' ' 9' ' ' PHE . 52.9 t -83.32 90.58 2.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.01 -0.996 . . . . 1.0 110.757 -175.817 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.63 146.06 34.31 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.484 -0.78 . . . . 1.0 110.441 179.597 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.569 HD23 ' HB2' ' A' ' 11' ' ' CYS . 4.1 mm? -95.33 -8.63 35.24 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.335 0.588 . . . . 1.0 109.592 178.08 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -151.18 154.61 37.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.451 -0.795 . . . . 1.0 111.18 178.461 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 13.5 ptt180 -61.63 -20.02 62.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.42 -0.809 . . . . 1.0 111.523 177.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.664 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 4.2 m-20 -75.2 -51.9 12.22 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.044 -0.725 . . . . 1.0 109.044 179.544 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.554 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 10.4 m170 -58.32 -44.68 88.76 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.073 -0.967 . . . . 1.0 109.792 178.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.506 ' HA ' HD12 ' A' ' 97' ' ' LEU . . . -60.23 -44.51 95.14 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 116.297 -0.41 . . . . 1.0 111.072 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.648 ' O ' ' HG2' ' A' ' 99' ' ' GLN . 2.4 ttt180 -57.23 -44.8 84.12 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 115.934 -0.575 . . . . 1.0 110.954 178.701 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.664 ' HG ' ' O ' ' A' ' 92' ' ' ASN . 49.3 mt -63.34 -45.41 91.38 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 116.121 -0.49 . . . . 1.0 110.515 -175.26 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.643 HD21 HG21 ' A' ' 10' ' ' VAL . 31.2 mt -54.52 -61.08 2.54 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.814 -0.63 . . . . 1.0 111.433 -178.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.729 ' N ' HG12 ' A' ' 102' ' ' VAL . 7.3 ptm180 -58.8 -45.19 90.47 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.73 0.641 . . . . 1.0 112.73 -179.108 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.648 ' HG2' ' O ' ' A' ' 95' ' ' ARG . 6.6 pt20 -66.57 -23.91 66.27 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 119.978 -0.689 . . . . 1.0 109.915 179.061 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.606 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 3.4 mt -81.68 -13.73 57.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.605 -0.725 . . . . 1.0 111.789 178.274 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 150.83 -26.16 1.04 Allowed Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 119.769 -1.205 . . . . 1.0 114.138 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.729 HG12 ' N ' ' A' ' 98' ' ' ARG . 0.3 OUTLIER -77.26 -161.64 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-N 118.026 0.913 . . . . 1.0 111.252 -177.967 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.688 ' N ' HG13 ' A' ' 102' ' ' VAL . 12.9 pt-20 -159.05 164.49 35.39 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.844 -1.169 . . . . 1.0 107.844 -178.489 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.835 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -63.48 -24.22 67.73 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 123.354 0.409 . . . . 1.0 111.379 -175.41 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.94 -34.42 71.73 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.206 176.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.645 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 1.2 mtp85 -102.16 -40.42 6.81 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.653 -0.703 . . . . 1.0 111.541 -177.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.835 HG12 ' HA ' ' A' ' 104' ' ' ALA . 8.6 p -77.13 120.7 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 N-CA-C 109.415 -0.587 . . . . 1.0 109.415 -175.497 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.575 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 12.0 mmm180 -139.75 145.57 38.43 Favored 'General case' 0 C--N 1.322 -0.604 0 O-C-N 121.762 -0.586 . . . . 1.0 110.358 -178.427 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.547 ' HB2' ' HB2' ' A' ' 112' ' ' SER . 73.5 mmm -78.67 138.78 38.46 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.917 -0.583 . . . . 1.0 110.56 178.682 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.523 HD23 HG11 ' A' ' 87' ' ' VAL . 3.0 tm? -57.37 -50.53 72.67 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.668 0.27 . . . . 1.0 111.472 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 14.2 ttt180 -70.06 -17.23 63.23 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.041 0.448 . . . . 1.0 110.624 -177.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.547 ' HB2' ' HB2' ' A' ' 109' ' ' MET . 32.5 t -75.2 -7.65 54.43 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.888 -178.455 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.57 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 92.4 m-85 -90.56 -17.89 26.19 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 110.287 -0.264 . . . . 1.0 110.287 176.211 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 27.4 t0 . . . . . 0 N--CA 1.464 0.241 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.799 -178.53 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 . . . . . 0 N--CA 1.456 -0.141 0 CA-C-O 120.594 0.235 . . . . 1.0 111.337 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -63.42 -47.12 83.25 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 109.251 -0.648 . . . . 1.0 109.251 175.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.836 ' HA ' HG12 ' A' ' 141' ' ' VAL . 85.5 t -62.74 -39.83 86.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.576 0.703 . . . . 1.0 109.259 177.185 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -56.33 -42.22 77.31 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.584 -0.735 . . . . 1.0 109.481 175.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.5 ' O ' ' HG2' ' A' ' 143' ' ' GLU . . . -67.14 -49.14 65.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.047 -0.979 . . . . 1.0 111.32 179.376 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.836 HG12 ' HA ' ' A' ' 138' ' ' VAL . 2.9 p -58.37 -40.34 77.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.456 0.646 . . . . 1.0 110.779 -178.508 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.536 HD12 HG12 ' A' ' 138' ' ' VAL . 14.2 mt -70.26 -51.54 37.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 115.187 -0.915 . . . . 1.0 112.228 178.416 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.5 ' HG2' ' O ' ' A' ' 140' ' ' ALA . 11.6 pt-20 -55.46 -31.18 61.75 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.309 0.576 . . . . 1.0 110.287 179.414 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 65.9 m -74.97 -27.66 60.26 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.102 -0.954 . . . . 1.0 110.468 179.053 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.472 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -86.24 -24.68 25.92 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 115.99 -0.55 . . . . 1.0 111.725 178.193 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.678 HD22 ' HB3' ' A' ' 25' ' ' PHE . 12.7 mt -55.89 -37.28 55.38 Favored Pre-proline 0 CA--C 1.547 0.846 0 N-CA-C 112.468 0.544 . . . . 1.0 112.468 -178.11 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.646 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 38.3 Cg_endo -67.04 -14.04 42.09 Favored 'Trans proline' 0 C--N 1.363 1.311 0 C-N-CA 122.495 2.13 . . . . 1.0 111.908 177.307 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.57 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -104.19 -34.05 3.79 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.084 -0.962 . . . . 1.0 110.714 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.576 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -73.68 -40.93 63.31 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.889 -0.782 . . . . 1.0 108.889 179.543 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 150' ' ' HIS . . . . . 0.548 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 0.2 OUTLIER -53.08 -57.04 11.76 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 115.103 -0.953 . . . . 1.0 110.837 175.672 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -57.01 -40.19 76.15 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.727 -1.124 . . . . 1.0 111.069 -174.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' TRP . . . . . 0.654 ' CE3' HD12 ' A' ' 85' ' ' LEU . 24.3 t90 -63.22 -58.01 8.59 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.173 -0.922 . . . . 1.0 110.614 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.425 HG13 ' O ' ' A' ' 149' ' ' LEU . 5.7 m -60.73 -40.55 85.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.81 -0.356 . . . . 1.0 110.303 -177.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.42 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 5.8 m-20 -61.17 -49.5 76.93 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.832 0.349 . . . . 1.0 110.904 178.648 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.528 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 9.3 pt-20 -63.51 -39.39 94.3 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.095 0.474 . . . . 1.0 110.548 -178.54 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.534 ' HG3' ' CH2' ' A' ' 152' ' ' TRP . 18.4 mmt85 -71.32 -46.73 59.95 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.516 -0.766 . . . . 1.0 110.837 -176.459 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 4.2 pp . . . . . 0 C--N 1.326 -0.453 0 CA-C-O 121.228 0.537 . . . . 1.0 109.941 -179.342 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.457 ' HB2' ' HG2' ' A' ' 39' ' ' ARG . 13.0 Cg_endo . . . . . 0 N--CA 1.461 -0.386 0 N-CA-C 114.101 0.769 . . . . 1.0 114.101 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.844 ' HB3' HG23 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -65.19 178.51 0.87 Allowed 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.637 -1.165 . . . . 1.0 108.453 178.608 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.763 ' H ' HD13 ' A' ' 5' ' ' LEU . 0.4 OUTLIER -155.55 100.97 2.14 Favored 'General case' 0 C--N 1.318 -0.803 0 O-C-N 121.549 -0.72 . . . . 1.0 109.585 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.425 HG21 HG11 ' A' ' 153' ' ' VAL . 2.2 t -104.68 116.01 47.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 107.964 -1.125 . . . . 1.0 107.964 178.74 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.648 HG22 ' HG ' ' A' ' 86' ' ' LEU . 6.3 t -119.06 117.89 29.96 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 120.52 -0.472 . . . . 1.0 109.918 178.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.612 ' HD2' ' HB3' ' A' ' 42' ' ' SER . 1.6 m-85 -85.22 133.19 34.19 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.016 -178.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.612 HG21 HD11 ' A' ' 97' ' ' LEU . 22.5 t -118.04 113.42 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.775 0 CA-C-O 121.123 0.487 . . . . 1.0 111.383 -176.617 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.666 ' SG ' ' HD3' ' A' ' 17' ' ' ARG . 42.2 t -144.94 160.23 41.66 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.657 -0.701 . . . . 1.0 109.491 178.214 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.453 HG23 ' NE2' ' A' ' 93' ' ' HIS . 2.7 p -68.56 112.28 5.26 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 120.941 0.401 . . . . 1.0 110.226 178.511 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.978 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 110.57 -45.16 1.36 Allowed Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.651 -0.785 . . . . 1.0 112.286 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.64 HD22 ' H ' ' A' ' 74' ' ' ALA . 57.5 t30 59.66 35.25 22.36 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 122.016 0.912 . . . . 1.0 110.953 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.414 HD13 ' ND1' ' A' ' 49' ' ' HIS . 4.5 pt -130.32 -4.39 2.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 O-C-N 121.682 -0.636 . . . . 1.0 112.483 -179.425 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.715 ' O ' ' HG3' ' A' ' 20' ' ' MET . 32.7 m -115.43 -89.05 0.57 Allowed 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 119.671 -0.812 . . . . 1.0 111.881 -177.347 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.96 ' HG3' ' HG ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -70.76 -39.99 72.91 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.821 0.674 . . . . 1.0 112.821 -175.071 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.481 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 19.4 m -57.58 -57.4 25.59 Favored Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 111.518 0.192 . . . . 1.0 111.518 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.481 ' HD3' ' HB2' ' A' ' 18' ' ' SER . 40.0 Cg_endo -65.15 -23.93 59.68 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 121.886 1.724 . . . . 1.0 112.395 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.715 ' HG3' ' O ' ' A' ' 16' ' ' CYS . 78.0 mtp -61.78 -52.33 64.66 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.111 -0.329 . . . . 1.0 110.111 179.046 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.459 ' HA ' ' HB2' ' A' ' 24' ' ' MET . . . -72.37 -27.56 62.46 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-N 115.632 -0.713 . . . . 1.0 110.138 -178.81 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.646 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 17.2 tt0 -52.63 -51.99 57.59 Favored 'General case' 0 C--O 1.216 -0.664 0 CA-C-N 114.981 -1.009 . . . . 1.0 109.361 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.709 ' HE2' ' HB2' ' A' ' 71' ' ' HIS . 0.1 OUTLIER -88.14 -22.79 23.88 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.815 -1.084 . . . . 1.0 110.99 -175.974 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.547 ' HB3' HD11 ' A' ' 146' ' ' LEU . 89.2 mtp -65.39 -74.97 0.09 Allowed 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.101 0.476 . . . . 1.0 112.246 -179.559 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.697 ' HB3' HD22 ' A' ' 146' ' ' LEU . 17.9 p90 -75.48 -30.64 59.95 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.003 -0.679 . . . . 1.0 111.601 -175.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.646 ' HB3' ' O ' ' A' ' 22' ' ' GLU . . . -64.79 -35.79 82.24 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 119.305 -0.958 . . . . 1.0 110.905 179.332 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.682 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -63.79 -37.88 89.01 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.402 -0.962 . . . . 1.0 108.402 177.147 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.578 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 77.9 mt-30 -59.5 -45.54 91.39 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 115.519 -0.764 . . . . 1.0 110.351 175.634 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.523 HD13 HG13 ' A' ' 38' ' ' VAL . 81.8 mt -53.3 -62.48 1.63 Allowed 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 115.859 -0.61 . . . . 1.0 111.317 -179.179 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.482 ' HA ' ' H ' ' A' ' 35' ' ' GLY . 0.3 OUTLIER -58.77 -35.48 72.85 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 120.831 -0.348 . . . . 1.0 111.502 179.863 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -62.14 -28.62 69.77 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.139 0.422 . . . . 1.0 112.139 177.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.578 ' HG2' ' O ' ' A' ' 28' ' ' GLN . 7.3 ptp180 -94.71 -20.25 19.69 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 119.452 -0.899 . . . . 1.0 109.949 178.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 110.52 35.52 2.06 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.202 -0.908 . . . . 1.0 112.277 176.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.464 ' HG ' ' HG3' ' A' ' 32' ' ' ARG . 17.9 mt -126.16 1.43 7.16 Favored 'General case' 0 N--CA 1.452 -0.358 0 O-C-N 122.432 -0.452 . . . . 1.0 110.0 -178.655 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.482 ' H ' ' HA ' ' A' ' 30' ' ' ARG . . . -55.75 -30.2 56.03 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 121.094 -0.574 . . . . 1.0 112.709 -178.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -88.79 -20.77 24.29 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.924 0.392 . . . . 1.0 110.55 178.067 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.92 -21.54 40.44 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.73 -0.668 . . . . 1.0 111.802 -179.126 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.844 HG23 ' HB3' ' A' ' 5' ' ' LEU . 0.6 OUTLIER -144.21 125.8 9.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.283 0.563 . . . . 1.0 111.386 -179.727 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.457 ' HG2' ' HB2' ' A' ' 4' ' ' PRO . 11.8 mmt180 -88.33 135.01 33.66 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.693 -0.855 . . . . 1.0 108.693 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.448 HG11 ' HB2' ' A' ' 26' ' ' ALA . 53.9 t -124.76 123.25 65.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.546 0.689 . . . . 1.0 109.385 -178.307 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.553 ' O ' ' HA ' ' A' ' 8' ' ' THR . 42.8 p -138.54 -175.75 4.23 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.491 -1.231 . . . . 1.0 110.989 -174.322 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.612 ' HB3' ' HD2' ' A' ' 9' ' ' PHE . 59.6 p -160.13 162.6 34.01 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.397 -0.365 . . . . 1.0 110.135 -178.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.527 ' HA ' ' O ' ' A' ' 74' ' ' ALA . . . -162.88 163.19 26.5 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.36 0.6 . . . . 1.0 111.636 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.481 ' HA2' ' O ' ' A' ' 11' ' ' CYS . . . -123.23 131.64 8.25 Favored Glycine 0 N--CA 1.442 -0.909 0 N-CA-C 110.778 -0.929 . . . . 1.0 110.778 178.724 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.519 HG23 ' CG1' ' A' ' 10' ' ' VAL . 23.2 p -69.98 -25.36 63.58 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.805 0.336 . . . . 1.0 111.752 -177.572 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.526 ' HA3' ' HZ3' ' A' ' 48' ' ' TRP . . . -110.91 9.16 29.64 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 120.851 -0.69 . . . . 1.0 113.409 -176.652 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 41.98 41.81 2.08 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 114.25 1.204 . . . . 1.0 114.25 176.307 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.978 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 1.2 m-90 -49.1 -76.02 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.694 0.759 . . . . 1.0 111.903 177.19 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.414 ' ND1' HD13 ' A' ' 15' ' ' ILE . 9.1 m170 -102.39 39.19 1.54 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.178 -0.919 . . . . 1.0 111.04 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.9 p -60.05 128.41 21.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.147 0.499 . . . . 1.0 110.529 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.439 ' HA2' ' HD3' ' A' ' 72' ' ' ARG . . . 93.3 -14.22 65.78 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.944 -0.646 . . . . 1.0 111.99 -177.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.409 ' O ' ' HA ' ' A' ' 72' ' ' ARG . 4.1 t -80.63 -161.12 0.35 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.183 0.516 . . . . 1.0 110.004 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 71' ' ' HIS . 24.8 t -121.39 176.23 5.76 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 108.448 -0.945 . . . . 1.0 108.448 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.501 ' HB2' ' HZ1' ' A' ' 23' ' ' LYS . . . -59.63 143.68 49.86 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.313 -0.403 . . . . 1.0 111.273 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.482 ' OD1' ' HG3' ' A' ' 57' ' ' ARG . 51.6 t0 -49.58 123.93 8.62 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.898 -1.046 . . . . 1.0 110.115 178.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -44.57 -37.02 3.3 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.444 -0.798 . . . . 1.0 112.64 178.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.607 ' O ' HG23 ' A' ' 61' ' ' VAL . 0.2 OUTLIER -73.27 -38.06 66.07 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.095 -0.642 . . . . 1.0 111.178 -179.102 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.11 -36.37 72.12 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.55 0.214 . . . . 1.0 110.472 177.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.417 ' O ' HG21 ' A' ' 69' ' ' THR . . . -61.47 -41.88 97.92 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.046 177.204 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.09 -42.3 99.74 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 111.084 -0.807 . . . . 1.0 111.084 176.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.607 HG23 ' O ' ' A' ' 57' ' ' ARG . 85.0 t -59.14 -57.36 11.74 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 CA-C-N 115.273 -0.464 . . . . 1.0 111.127 178.551 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.712 ' HB2' HG22 ' A' ' 69' ' ' THR . 85.7 mt -59.5 -50.36 74.22 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.227 -0.442 . . . . 1.0 111.504 -177.152 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.599 ' HB3' HG21 ' A' ' 69' ' ' THR . 2.2 ptt180 -63.25 -27.74 69.55 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.727 -0.67 . . . . 1.0 110.823 -178.162 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.86 -29.68 68.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.128 0.49 . . . . 1.0 110.702 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -98.81 4.31 47.58 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.837 -0.619 . . . . 1.0 111.452 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.39 12.39 63.1 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.712 -0.756 . . . . 1.0 112.691 177.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.527 ' HD1' ' HG2' ' A' ' 27' ' ' GLN . 62.3 m-85 -86.96 152.31 53.3 Favored Pre-proline 0 C--N 1.323 -0.574 0 O-C-N 122.756 -0.261 . . . . 1.0 110.409 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.652 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 17.8 Cg_endo -64.81 153.25 78.81 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.295 1.997 . . . . 1.0 110.417 175.631 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.712 HG22 ' HB2' ' A' ' 62' ' ' LEU . 61.5 p -135.35 28.84 3.36 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 120.232 -0.587 . . . . 1.0 112.336 -176.074 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -104.38 130.47 52.25 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.343 -0.614 . . . . 1.0 109.343 178.271 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.709 ' HB2' ' HE2' ' A' ' 23' ' ' LYS . 18.7 t60 -164.95 148.34 8.56 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.287 -177.466 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.439 ' HD3' ' HA2' ' A' ' 51' ' ' GLY . 6.3 tmm_? -127.41 111.31 13.71 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 107.493 -1.299 . . . . 1.0 107.493 177.342 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.58 134.25 55.97 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.1 -0.955 . . . . 1.0 111.918 -175.135 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.64 ' H ' HD22 ' A' ' 14' ' ' ASN . . . -128.8 147.98 50.84 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.725 -0.67 . . . . 1.0 109.791 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -87.09 155.83 19.97 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.747 -0.464 . . . . 1.0 109.747 176.112 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.505 HG11 HD23 ' A' ' 97' ' ' LEU . 12.9 t -64.11 112.58 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.488 0.661 . . . . 1.0 111.229 -179.374 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.64 ' H ' ' CD2' ' A' ' 80' ' ' HIS . . . -122.64 -171.75 13.86 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 114.937 -1.029 . . . . 1.0 111.748 179.033 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 96.6 m -56.41 -44.45 80.35 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 123.704 0.297 . . . . 1.0 111.212 -179.234 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -60.07 -27.83 67.3 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.873 0.368 . . . . 1.0 110.939 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.64 ' CD2' ' H ' ' A' ' 77' ' ' GLY . 90.8 m-70 -79.73 -41.56 26.44 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 116.421 -0.354 . . . . 1.0 110.389 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.649 ' O ' HG23 ' A' ' 102' ' ' VAL . 17.9 mt -67.61 -17.0 64.46 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.241 176.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.76 -8.28 57.5 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.395 -0.366 . . . . 1.0 110.848 -179.101 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.538 ' HA ' ' HB3' ' A' ' 6' ' ' HIS . . . -60.15 151.17 27.67 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.074 -0.512 . . . . 1.0 111.569 -179.488 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.753 ' HB3' HD13 ' A' ' 5' ' ' LEU . 9.9 t70 -76.13 -14.98 60.16 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.759 -0.655 . . . . 1.0 109.712 179.27 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.745 HD12 ' CE3' ' A' ' 152' ' ' TRP . 1.2 tt -157.48 116.53 3.28 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.89 -0.595 . . . . 1.0 109.572 -177.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.648 ' HG ' HG22 ' A' ' 8' ' ' THR . 5.3 mp -107.27 88.44 2.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 116.018 -0.537 . . . . 1.0 110.671 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.633 ' HA ' ' O ' ' A' ' 108' ' ' ARG . 70.3 t -66.18 91.02 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 113.801 -1.545 . . . . 1.0 112.363 -179.219 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.49 146.32 32.77 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.509 -1.223 . . . . 1.0 110.655 177.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.96 ' HG ' ' HG3' ' A' ' 17' ' ' ARG . 4.3 mm? -99.04 -8.47 25.27 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.253 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.429 ' OD1' ' HB2' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -153.32 155.22 36.07 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.08 -0.509 . . . . 1.0 111.142 -179.843 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -56.91 -27.02 60.25 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.24 -0.891 . . . . 1.0 113.31 -178.598 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.655 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 7.0 m-20 -75.58 -49.93 17.08 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.977 -0.379 . . . . 1.0 109.977 -178.061 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.672 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 9.9 m170 -55.28 -47.33 75.69 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.73 -0.668 . . . . 1.0 110.295 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.96 -43.96 91.41 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.09 0.471 . . . . 1.0 110.704 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.469 ' O ' ' HG2' ' A' ' 99' ' ' GLN . 17.1 ttt180 -59.4 -44.42 92.82 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.759 -0.655 . . . . 1.0 111.332 178.105 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.655 ' HG ' ' O ' ' A' ' 92' ' ' ASN . 60.2 mt -62.69 -47.32 84.16 Favored 'General case' 0 C--O 1.215 -0.737 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.425 -176.358 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.672 ' HG ' ' O ' ' A' ' 93' ' ' HIS . 29.5 mt -54.32 -59.46 4.64 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.636 -0.711 . . . . 1.0 111.417 -178.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.688 ' CA ' HG12 ' A' ' 102' ' ' VAL . 16.5 ptt85 -59.7 -44.71 93.56 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.305 0.483 . . . . 1.0 112.305 -178.45 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.469 ' HG2' ' O ' ' A' ' 95' ' ' ARG . 2.3 pt20 -68.06 -24.63 65.09 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.497 -0.481 . . . . 1.0 109.918 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.653 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 6.1 mt -81.48 -16.14 52.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.718 -0.674 . . . . 1.0 112.037 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 151.06 -23.44 0.99 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 119.873 -1.156 . . . . 1.0 114.184 -178.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.841 HG22 ' HD2' ' A' ' 106' ' ' ARG . 0.4 OUTLIER -76.62 -163.11 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 CA-C-N 117.958 0.879 . . . . 1.0 110.295 -179.091 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.705 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 14.2 pt-20 -158.11 161.4 37.94 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 107.702 -1.221 . . . . 1.0 107.702 -179.193 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.763 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -61.86 -25.02 67.28 Favored 'General case' 0 C--N 1.32 -0.717 0 O-C-N 123.285 0.366 . . . . 1.0 111.273 -175.354 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.476 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . . . -56.37 -39.31 72.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.318 0.58 . . . . 1.0 110.286 175.158 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.841 ' HD2' HG22 ' A' ' 102' ' ' VAL . 22.5 mtt180 -96.82 -42.51 7.93 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 115.036 -0.983 . . . . 1.0 111.13 -176.538 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.763 HG12 ' HA ' ' A' ' 104' ' ' ALA . 11.5 p -78.86 117.75 24.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 120.694 -0.402 . . . . 1.0 110.03 -174.595 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.633 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 0.1 OUTLIER -138.35 148.44 44.57 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 121.716 -0.615 . . . . 1.0 110.455 -178.97 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 83.9 mmm -80.86 140.53 35.33 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.977 -0.556 . . . . 1.0 111.006 -178.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.55 HD23 HG11 ' A' ' 87' ' ' VAL . 3.1 tm? -59.11 -48.71 80.62 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 111.552 0.204 . . . . 1.0 111.552 -179.398 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 7.7 ttm180 -69.26 -19.92 63.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.707 0.289 . . . . 1.0 110.528 -178.155 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 30.4 t -74.26 -7.0 51.2 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.464 -0.335 . . . . 1.0 111.177 -178.445 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.641 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 87.6 m-85 -92.93 -19.11 21.96 Favored 'General case' 0 C--N 1.34 0.181 0 O-C-N 121.834 -0.541 . . . . 1.0 110.65 177.022 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 13.6 t0 . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 115.885 -0.598 . . . . 1.0 111.041 -178.58 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 . . . . . 0 N--CA 1.451 -0.384 0 CA-C-O 120.427 0.156 . . . . 1.0 111.182 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.664 ' O ' HG23 ' A' ' 141' ' ' VAL . 2.8 tt0 -63.85 -49.4 72.93 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.794 -0.447 . . . . 1.0 109.794 177.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.45 HG12 HD12 ' A' ' 142' ' ' ILE . 84.3 t -59.05 -44.54 91.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.479 0.657 . . . . 1.0 109.692 177.244 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.428 ' HB2' HG11 ' A' ' 61' ' ' VAL . 67.6 t80 -56.7 -40.11 75.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.804 -1.089 . . . . 1.0 110.058 177.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.58 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -67.18 -41.94 85.07 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.246 -0.433 . . . . 1.0 110.746 178.457 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.664 HG23 ' O ' ' A' ' 137' ' ' GLU . 33.4 t -56.33 -51.06 68.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.645 0.736 . . . . 1.0 110.425 178.212 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.45 HD12 HG12 ' A' ' 138' ' ' VAL . 7.7 mt -65.96 -50.36 70.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 114.782 -1.099 . . . . 1.0 111.588 -178.253 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.58 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 12.7 pt-20 -57.49 -30.41 65.08 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 121.003 -0.279 . . . . 1.0 110.354 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 2.9 t -74.76 -28.85 60.92 Favored 'General case' 0 C--O 1.226 -0.167 0 CA-C-O 121.155 0.502 . . . . 1.0 110.384 178.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.459 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -86.98 -22.31 25.64 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 116.014 -0.539 . . . . 1.0 111.523 179.304 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.697 HD22 ' HB3' ' A' ' 25' ' ' PHE . 11.2 mt -55.57 -37.49 57.52 Favored Pre-proline 0 CA--C 1.54 0.569 0 N-CA-C 112.523 0.564 . . . . 1.0 112.523 -179.439 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.62 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 57.1 Cg_endo -70.59 -8.53 23.83 Favored 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 122.495 2.13 . . . . 1.0 112.255 177.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.641 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -108.73 -33.93 2.74 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.214 -1.154 . . . . 1.0 110.214 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.579 HD11 HG21 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -73.44 -43.63 59.93 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.163 -1.051 . . . . 1.0 108.163 178.509 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 150' ' ' HIS . . . . . 0.658 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 0.2 OUTLIER -54.21 -52.52 61.01 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-N 114.768 -1.106 . . . . 1.0 110.227 174.865 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -57.59 -43.89 84.97 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.324 -1.307 . . . . 1.0 110.89 -175.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' TRP . . . . . 0.745 ' CE3' HD12 ' A' ' 85' ' ' LEU . 22.9 t90 -63.01 -57.05 12.01 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.095 -0.957 . . . . 1.0 110.414 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.437 HG13 ' O ' ' A' ' 149' ' ' LEU . 8.4 m -61.95 -42.09 93.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.776 -0.37 . . . . 1.0 110.566 -177.513 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -60.33 -51.22 70.45 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.907 0.384 . . . . 1.0 110.777 179.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.534 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 13.8 pt-20 -62.66 -38.76 91.57 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.771 -0.65 . . . . 1.0 110.403 -178.466 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.499 ' HD3' ' HA ' ' A' ' 156' ' ' ARG . 1.8 mmt180 -72.65 -50.66 23.6 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.893 -0.594 . . . . 1.0 111.029 -177.083 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.1 pp . . . . . 0 C--N 1.322 -0.601 0 CA-C-N 116.069 -0.514 . . . . 1.0 109.885 -178.941 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.59 ' HB3' ' O ' ' A' ' 36' ' ' ASP . 35.0 Cg_endo . . . . . 0 N--CA 1.463 -0.292 0 N-CA-C 113.826 0.664 . . . . 1.0 113.826 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.846 ' HB3' HG23 ' A' ' 38' ' ' VAL . 0.5 OUTLIER -73.21 -172.49 1.12 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.694 -1.139 . . . . 1.0 110.711 -179.303 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.624 ' HB3' ' HA ' ' A' ' 83' ' ' ALA . 0.3 OUTLIER -157.38 94.41 1.38 Allowed 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.897 -0.321 . . . . 1.0 110.881 179.295 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.69 HG13 HD13 ' A' ' 85' ' ' LEU . 2.1 t -96.06 115.62 35.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.876 -0.786 . . . . 1.0 108.876 176.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.603 ' CG2' ' HG ' ' A' ' 86' ' ' LEU . 14.2 t -118.52 115.35 24.42 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 120.92 0.391 . . . . 1.0 110.585 178.524 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.578 ' HD1' ' HB ' ' A' ' 87' ' ' VAL . 1.0 OUTLIER -83.54 132.42 34.93 Favored 'General case' 0 CA--C 1.511 -0.55 0 O-C-N 122.162 -0.336 . . . . 1.0 110.472 -179.025 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.713 HG21 HD11 ' A' ' 97' ' ' LEU . 44.5 t -115.37 119.98 63.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.221 0.534 . . . . 1.0 111.803 -176.416 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.528 ' HA ' ' CE1' ' A' ' 93' ' ' HIS . 47.0 t -147.59 164.92 31.95 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.654 -0.703 . . . . 1.0 109.712 178.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.6 96.22 2.94 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.186 0.517 . . . . 1.0 110.66 179.097 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.983 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 125.04 -39.81 2.01 Favored Glycine 0 N--CA 1.441 -1.01 0 CA-C-N 115.486 -0.779 . . . . 1.0 111.972 179.117 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.528 HD21 ' CB ' ' A' ' 42' ' ' SER . 3.6 t-20 65.05 18.88 11.67 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 122.115 0.96 . . . . 1.0 110.078 -178.529 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.501 HG12 ' HB2' ' A' ' 49' ' ' HIS . 1.2 pt -134.58 48.43 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-N 115.078 -0.964 . . . . 1.0 110.103 -177.23 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.742 ' O ' ' HG3' ' A' ' 20' ' ' MET . 4.7 p -157.9 -90.12 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.285 -0.87 . . . . 1.0 111.495 174.309 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.647 HH11 ' HB3' ' A' ' 89' ' ' LEU . 1.2 mtt180 -70.73 -44.46 66.8 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.986 0.422 . . . . 1.0 111.187 -177.071 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.712 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 15.1 m -54.41 -58.13 15.39 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-N 115.756 -0.657 . . . . 1.0 111.838 -179.364 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.537 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 33.6 Cg_endo -64.1 -24.58 66.24 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 121.68 1.586 . . . . 1.0 112.627 -179.334 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.742 ' HG3' ' O ' ' A' ' 16' ' ' CYS . 57.6 mtp -62.01 -53.81 50.38 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.902 -0.319 . . . . 1.0 110.607 178.638 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.428 ' HA ' ' HB2' ' A' ' 24' ' ' MET . . . -74.91 -26.14 59.43 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.488 -178.022 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.631 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 12.5 tt0 -53.84 -51.28 64.06 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.274 -0.876 . . . . 1.0 109.528 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.821 ' HB3' ' HG2' ' A' ' 68' ' ' PRO . 0.2 OUTLIER -80.7 -31.14 36.27 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.549 -0.75 . . . . 1.0 110.451 -177.244 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.65 ' HB3' HD11 ' A' ' 146' ' ' LEU . 6.0 mmm -60.85 -75.49 0.06 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.902 0.704 . . . . 1.0 112.902 -175.758 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.686 ' HB3' HD22 ' A' ' 146' ' ' LEU . 19.0 p90 -77.94 -30.77 50.61 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 119.815 -0.754 . . . . 1.0 111.527 -175.054 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.631 ' HB3' ' O ' ' A' ' 22' ' ' GLU . . . -63.03 -38.23 90.37 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 119.06 -1.056 . . . . 1.0 110.648 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.672 ' HA ' ' HD3' ' A' ' 30' ' ' ARG . 0.1 OUTLIER -65.39 -40.13 93.1 Favored 'General case' 0 C--N 1.339 0.118 0 N-CA-C 108.936 -0.765 . . . . 1.0 108.936 177.504 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.652 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 49.2 mt-30 -61.59 -40.46 94.84 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.751 176.241 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.677 ' HG ' ' O ' ' A' ' 25' ' ' PHE . 83.9 mt -56.73 -57.65 11.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.638 178.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.672 ' HD3' ' HA ' ' A' ' 27' ' ' GLN . 1.6 ptm180 -59.9 -32.28 70.6 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.485 -0.486 . . . . 1.0 111.129 178.051 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -62.27 -32.93 73.7 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 111.967 0.358 . . . . 1.0 111.967 175.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.652 ' HG2' ' O ' ' A' ' 28' ' ' GLN . 4.8 ptp180 -91.94 -17.5 25.08 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.632 0.729 . . . . 1.0 109.706 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.22 33.64 5.1 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 114.911 -1.041 . . . . 1.0 111.435 177.089 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 33.2 mt -123.42 -0.75 8.69 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.566 -0.531 . . . . 1.0 109.566 -177.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.25 -27.52 60.45 Favored Glycine 0 C--O 1.227 -0.338 0 CA-C-N 115.889 -0.596 . . . . 1.0 112.486 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.59 ' O ' ' HB3' ' A' ' 4' ' ' PRO . 0.9 OUTLIER -86.34 -25.86 25.18 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 109.716 -0.475 . . . . 1.0 109.716 177.549 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -78.42 -21.69 48.85 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.137 -0.938 . . . . 1.0 111.341 -176.156 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.846 HG23 ' HB3' ' A' ' 5' ' ' LEU . 1.2 p -144.45 126.85 10.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.229 0.538 . . . . 1.0 110.378 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.487 ' HG2' ' HB2' ' A' ' 4' ' ' PRO . 11.0 mmt180 -90.0 144.59 25.78 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.462 -0.79 . . . . 1.0 109.585 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.415 HG11 ' HB2' ' A' ' 26' ' ' ALA . 77.8 t -129.68 127.73 64.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 121.382 0.611 . . . . 1.0 109.93 -178.339 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.534 ' O ' ' HA ' ' A' ' 8' ' ' THR . 40.0 p -143.89 -175.54 4.63 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.476 -1.238 . . . . 1.0 110.024 -175.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.712 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 86.4 p -161.27 167.03 26.72 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 110.006 -0.368 . . . . 1.0 110.006 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 10' ' ' VAL . . . -163.5 166.41 22.66 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.156 0.503 . . . . 1.0 111.695 -178.716 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.523 ' HA2' ' O ' ' A' ' 11' ' ' CYS . . . -125.15 137.71 10.56 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.302 -0.863 . . . . 1.0 111.398 178.699 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.618 HG21 HD12 ' A' ' 96' ' ' LEU . 22.1 p -74.17 -22.93 59.21 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.805 0.303 . . . . 1.0 111.747 -177.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.459 ' HA3' ' CZ3' ' A' ' 48' ' ' TRP . . . -111.31 8.31 28.73 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.668 -0.777 . . . . 1.0 113.03 -178.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.459 ' HB3' ' HB2' ' A' ' 75' ' ' GLN . 2.7 p-10 43.01 37.02 1.0 Allowed 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 113.875 1.065 . . . . 1.0 113.875 177.66 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.983 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 1.1 m-90 -46.8 -64.4 0.78 Allowed 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.325 0.583 . . . . 1.0 112.532 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.573 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 2.3 m-70 -111.99 39.25 2.44 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.753 -0.658 . . . . 1.0 111.281 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.51 HG23 ' HA ' ' A' ' 74' ' ' ALA . 14.9 p -59.87 126.87 18.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 C-N-CA 120.207 -0.597 . . . . 1.0 110.473 179.056 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.64 -14.17 65.62 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-N 116.032 -0.531 . . . . 1.0 111.948 -177.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.503 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 3.3 t -79.93 -160.72 0.29 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.45 0.643 . . . . 1.0 109.961 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 47.7 t -124.48 175.02 7.41 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 115.445 -0.798 . . . . 1.0 108.971 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.38 147.56 48.06 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.54 0.686 . . . . 1.0 111.49 -178.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.428 ' N ' ' OD1' ' A' ' 55' ' ' ASP . 9.0 p-10 -59.75 137.76 57.96 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.437 -1.256 . . . . 1.0 112.034 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -48.36 -35.25 12.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.672 -1.149 . . . . 1.0 112.785 179.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.484 ' H ' ' HG2' ' A' ' 57' ' ' ARG . 17.3 ptt180 -71.93 -43.69 64.86 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.377 0.132 . . . . 1.0 111.071 -177.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.461 ' HB1' ' HG2' ' A' ' 20' ' ' MET . . . -69.56 -39.13 77.59 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 109.378 -0.601 . . . . 1.0 109.378 178.644 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.4 -45.53 93.93 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.672 -0.695 . . . . 1.0 109.398 177.141 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.42 ' O ' ' HG2' ' A' ' 63' ' ' ARG . . . -57.83 -47.21 90.29 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 115.768 -0.651 . . . . 1.0 113.36 178.058 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.6 m -70.34 -39.99 77.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 117.699 0.749 . . . . 1.0 111.045 -178.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.718 HD13 ' HG3' ' A' ' 23' ' ' LYS . 96.0 mt -63.64 -52.56 60.26 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 120.605 -0.438 . . . . 1.0 110.653 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.42 ' HG2' ' O ' ' A' ' 60' ' ' GLY . 4.5 ptm180 -61.13 -30.26 70.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.554 -0.294 . . . . 1.0 110.997 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.99 -33.45 75.6 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 120.946 0.403 . . . . 1.0 110.735 179.485 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -96.68 3.35 52.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.839 -0.619 . . . . 1.0 110.873 -178.306 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.41 13.8 62.89 Favored Glycine 0 N--CA 1.452 -0.257 0 CA-C-N 115.962 -0.563 . . . . 1.0 112.906 177.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -89.48 152.8 47.81 Favored Pre-proline 0 C--N 1.322 -0.616 0 N-CA-C 110.571 -0.159 . . . . 1.0 110.571 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.821 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 45.7 Cg_endo -69.8 158.46 56.84 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.182 1.921 . . . . 1.0 110.713 176.696 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.62 HG22 ' HB2' ' A' ' 62' ' ' LEU . 36.4 p -133.32 4.04 3.68 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 119.856 -0.738 . . . . 1.0 111.807 -177.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.412 ' O ' ' HE2' ' A' ' 23' ' ' LYS . 24.4 t70 -67.74 127.09 31.5 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.976 -0.556 . . . . 1.0 110.099 178.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.567 ' HB2' ' HE2' ' A' ' 23' ' ' LYS . 59.0 t60 -165.39 149.67 8.61 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.951 0.405 . . . . 1.0 111.116 -176.286 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.459 ' HA ' ' O ' ' A' ' 52' ' ' SER . 0.9 OUTLIER -134.16 112.65 11.29 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.113 -1.069 . . . . 1.0 108.113 175.136 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.573 ' HB3' ' O ' ' A' ' 49' ' ' HIS . . . -61.42 142.53 56.91 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.656 -1.157 . . . . 1.0 112.294 -176.259 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.51 ' HA ' HG23 ' A' ' 50' ' ' VAL . . . -133.55 161.25 35.11 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.469 -0.787 . . . . 1.0 109.885 178.072 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.459 ' HB2' ' HB3' ' A' ' 47' ' ' ASN . 46.8 tt0 -97.57 160.04 14.56 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.611 -0.885 . . . . 1.0 108.611 178.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.474 HG11 HD23 ' A' ' 97' ' ' LEU . 93.8 t -64.97 102.82 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.353 0.597 . . . . 1.0 110.093 178.393 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.448 ' H ' ' CD2' ' A' ' 80' ' ' HIS . . . -119.57 -174.94 15.78 Favored Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 114.834 -1.075 . . . . 1.0 111.769 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 93.0 m -57.75 -45.75 85.44 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 111.616 0.228 . . . . 1.0 111.616 -177.311 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -59.12 -29.65 67.55 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.871 0.367 . . . . 1.0 111.305 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.448 ' CD2' ' H ' ' A' ' 77' ' ' GLY . 92.4 m-70 -78.39 -41.24 33.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.394 -0.366 . . . . 1.0 110.491 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.623 ' O ' HG23 ' A' ' 102' ' ' VAL . 18.2 mt -68.31 -17.28 64.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.404 177.727 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.87 -8.27 58.17 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.846 0.355 . . . . 1.0 110.487 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.624 ' HA ' ' HB3' ' A' ' 6' ' ' HIS . . . -58.91 151.85 20.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.664 -0.698 . . . . 1.0 111.427 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.602 ' HA ' ' NH1' ' A' ' 106' ' ' ARG . 27.0 t70 -78.73 -14.45 59.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.333 -0.394 . . . . 1.0 109.956 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.69 HD13 HG13 ' A' ' 7' ' ' VAL . 0.5 OUTLIER -155.36 117.33 4.11 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.65 -0.705 . . . . 1.0 109.311 -177.909 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.618 ' HB3' HD13 ' A' ' 97' ' ' LEU . 5.0 mp -107.67 105.94 16.04 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-N 115.622 -0.717 . . . . 1.0 109.897 177.798 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.578 ' HB ' ' HD1' ' A' ' 9' ' ' PHE . 56.0 t -84.5 92.94 3.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 114.803 -1.09 . . . . 1.0 111.002 -176.094 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.7 141.81 37.6 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.474 -0.785 . . . . 1.0 110.62 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.647 ' HB3' HH11 ' A' ' 17' ' ' ARG . 3.8 mm? -95.82 -8.77 33.32 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.261 0.553 . . . . 1.0 109.82 178.829 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.454 ' OD2' ' HB2' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -149.73 151.55 33.83 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.249 -0.887 . . . . 1.0 110.786 -179.939 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -55.16 -29.86 58.67 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.262 -0.881 . . . . 1.0 112.92 -179.082 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.694 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 43.2 m-80 -75.06 -49.51 19.48 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.614 -0.513 . . . . 1.0 109.614 -176.537 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.565 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 16.7 m170 -52.44 -46.07 66.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.535 -0.757 . . . . 1.0 110.121 178.705 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.416 ' HA ' HG21 ' A' ' 107' ' ' VAL . . . -58.85 -46.44 87.74 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.42 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.1 ttm180 -61.47 -39.27 90.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.722 -0.672 . . . . 1.0 111.626 178.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.694 ' HG ' ' O ' ' A' ' 92' ' ' ASN . 36.1 mt -65.85 -47.19 75.77 Favored 'General case' 0 C--O 1.218 -0.594 0 N-CA-C 110.229 -0.285 . . . . 1.0 110.229 -177.757 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.713 HD11 HG21 ' A' ' 10' ' ' VAL . 31.6 mt -55.14 -58.78 6.27 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.145 -0.48 . . . . 1.0 111.655 -178.661 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.685 ' HD2' HG11 ' A' ' 107' ' ' VAL . 2.9 ptm180 -60.3 -41.52 93.59 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.826 -0.624 . . . . 1.0 112.473 -178.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.652 ' HG3' ' O ' ' A' ' 96' ' ' LEU . 1.0 OUTLIER -66.8 -27.76 67.83 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.361 -0.607 . . . . 1.0 109.361 178.536 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.667 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 11.1 mt -79.46 -13.44 59.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.537 -0.756 . . . . 1.0 111.769 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 149.36 -25.31 1.23 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 119.907 -1.14 . . . . 1.0 113.678 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.68 HG13 ' H ' ' A' ' 103' ' ' GLU . 0.4 OUTLIER -76.73 -163.02 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-N 117.437 0.619 . . . . 1.0 110.321 -178.615 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.68 ' H ' HG13 ' A' ' 102' ' ' VAL . 12.5 pt-20 -159.97 166.64 29.67 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 108.389 -0.967 . . . . 1.0 108.389 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.778 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -63.75 -25.23 68.1 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 123.304 0.378 . . . . 1.0 111.686 -174.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.41 -36.19 75.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.112 0.482 . . . . 1.0 110.142 175.196 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.623 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 0.8 OUTLIER -98.15 -42.82 7.27 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 115.525 -0.761 . . . . 1.0 111.293 -177.163 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.778 HG12 ' HA ' ' A' ' 104' ' ' ALA . 7.7 p -78.34 118.09 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 N-CA-C 109.266 -0.642 . . . . 1.0 109.266 -176.311 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.549 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 17.7 mmm180 -136.3 147.53 47.51 Favored 'General case' 0 C--N 1.32 -0.703 0 O-C-N 121.633 -0.667 . . . . 1.0 110.352 -178.042 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 83.0 mmm -78.09 137.45 38.23 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.889 -0.596 . . . . 1.0 110.382 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.529 HD23 HG11 ' A' ' 87' ' ' VAL . 3.1 tm? -56.06 -49.09 74.75 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 123.031 0.207 . . . . 1.0 111.239 179.607 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 21.0 ttt180 -71.87 -11.9 61.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.011 0.434 . . . . 1.0 111.007 -178.34 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 26.7 t -75.81 -9.67 58.79 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.944 -0.303 . . . . 1.0 110.705 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.574 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 97.3 m-85 -92.41 -19.81 21.68 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.237 0.542 . . . . 1.0 110.366 176.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 20.7 t0 . . . . . 0 C--N 1.325 -0.481 0 CA-C-N 114.945 -1.025 . . . . 1.0 111.685 -177.116 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 . . . . . 0 N--CA 1.454 -0.233 0 CA-C-O 120.862 0.363 . . . . 1.0 110.607 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.552 ' O ' HG23 ' A' ' 141' ' ' VAL . 10.9 tp10 -64.31 -48.28 76.23 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.543 -0.91 . . . . 1.0 108.543 174.659 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.683 ' HA ' HG23 ' A' ' 141' ' ' VAL . 54.8 t -61.9 -39.74 84.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.225 -0.898 . . . . 1.0 109.648 176.006 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.446 ' HB2' ' HE1' ' A' ' 20' ' ' MET . 46.1 t80 -53.44 -41.4 66.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.203 -0.908 . . . . 1.0 109.107 175.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.694 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -68.28 -39.83 82.01 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.323 -0.853 . . . . 1.0 110.629 177.503 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.683 HG23 ' HA ' ' A' ' 138' ' ' VAL . 15.9 t -55.6 -51.43 58.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-O 121.932 0.872 . . . . 1.0 109.83 177.599 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.446 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 7.0 mt -65.51 -51.59 61.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 114.755 -1.111 . . . . 1.0 111.775 -178.641 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.694 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 8.1 pt-20 -55.12 -32.79 62.32 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.839 -0.344 . . . . 1.0 110.29 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 2.3 t -73.64 -30.18 62.79 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.488 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.453 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -86.17 -22.63 26.9 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-N 116.006 -0.543 . . . . 1.0 111.636 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.686 HD22 ' HB3' ' A' ' 25' ' ' PHE . 11.0 mt -54.18 -41.72 90.05 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 112.744 0.646 . . . . 1.0 112.744 -178.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.715 ' HA ' ' CD2' ' A' ' 150' ' ' HIS . 60.3 Cg_endo -68.36 -7.68 20.84 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 122.371 2.048 . . . . 1.0 111.866 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.574 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -108.48 -33.55 2.88 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 110.234 -1.146 . . . . 1.0 110.234 178.388 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.538 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -75.14 -54.34 7.31 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.327 -0.62 . . . . 1.0 109.327 -179.797 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 150' ' ' HIS . . . . . 0.715 ' CD2' ' HA ' ' A' ' 147' ' ' PRO . 2.0 p80 -56.16 -46.81 79.15 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 115.268 -0.878 . . . . 1.0 110.471 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.448 ' N ' ' CG ' ' A' ' 150' ' ' HIS . 2.0 t70 -59.62 -37.94 79.98 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.764 -1.107 . . . . 1.0 110.411 -178.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' TRP . . . . . 0.784 ' HZ3' HD21 ' A' ' 5' ' ' LEU . 28.2 t90 -64.52 -54.66 28.87 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 115.637 -0.71 . . . . 1.0 109.858 178.149 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.636 HG22 ' O ' ' A' ' 150' ' ' HIS . 3.5 m -58.77 -37.8 68.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.571 -0.529 . . . . 1.0 109.571 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.462 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 2.7 m-20 -59.44 -56.39 22.61 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 121.487 0.661 . . . . 1.0 110.765 177.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.609 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 6.3 pt-20 -60.63 -37.92 83.06 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 114.901 -1.045 . . . . 1.0 110.369 -177.35 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.477 ' HD3' ' HA ' ' A' ' 156' ' ' ARG . 1.0 OUTLIER -74.11 -48.67 27.97 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.571 -0.741 . . . . 1.0 111.361 -177.222 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 3.9 pp . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.233 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.579 ' HB2' ' HG2' ' A' ' 39' ' ' ARG . 25.3 Cg_endo . . . . . 0 C--O 1.235 0.338 0 N-CA-C 115.253 1.213 . . . . 1.0 115.253 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.655 HD21 ' HZ3' ' A' ' 152' ' ' TRP . 0.4 OUTLIER -74.3 -173.35 1.67 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 113.487 -1.688 . . . . 1.0 110.024 178.273 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.63 ' HB3' ' H ' ' A' ' 84' ' ' ASP . 3.0 t-160 -156.48 92.14 1.29 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.578 -0.449 . . . . 1.0 110.878 -178.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.784 HG13 HD13 ' A' ' 85' ' ' LEU . 2.9 t -96.1 111.11 25.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.351 -0.611 . . . . 1.0 109.351 177.7 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.57 HG22 ' HG ' ' A' ' 86' ' ' LEU . 9.2 t -112.17 113.88 26.38 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.221 0.534 . . . . 1.0 110.291 179.152 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.548 ' CE2' ' HA ' ' A' ' 22' ' ' GLU . 1.0 OUTLIER -83.43 125.3 31.56 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 122.004 -0.435 . . . . 1.0 110.289 -178.564 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.492 ' CG1' HG23 ' A' ' 45' ' ' THR . 37.6 t -112.18 111.12 34.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.802 -0.635 . . . . 1.0 112.161 -176.357 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.596 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 48.3 t -135.73 160.0 39.89 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.043 -1.095 . . . . 1.0 108.043 176.131 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -64.21 -32.23 73.73 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.334 0.588 . . . . 1.0 109.79 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.538 ' C ' ' H ' ' A' ' 15' ' ' ILE . . . -111.27 84.66 0.37 Allowed Glycine 0 N--CA 1.436 -1.328 0 CA-C-N 115.149 -0.932 . . . . 1.0 110.868 174.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.604 ' ND2' ' HB1' ' A' ' 73' ' ' ALA . 10.5 p-10 -65.0 16.07 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.262 1.425 . . . . 1.0 112.105 178.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.538 ' H ' ' C ' ' A' ' 13' ' ' GLY . 6.9 pt -119.89 -3.34 9.42 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.045 177.447 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.433 ' HB2' ' H ' ' A' ' 17' ' ' ARG . 9.2 m -115.13 -87.08 0.59 Allowed 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.679 -0.408 . . . . 1.0 112.041 -176.713 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.677 ' HG2' ' HG ' ' A' ' 89' ' ' LEU . 15.7 tpp180 -67.45 -50.43 59.24 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.352 -0.385 . . . . 1.0 112.014 -174.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.605 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 33.8 m -54.39 -59.05 11.24 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-N 116.321 -0.4 . . . . 1.0 111.882 -178.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.472 ' HA ' ' HB2' ' A' ' 22' ' ' GLU . 40.6 Cg_endo -63.89 -20.87 68.84 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 121.933 1.755 . . . . 1.0 113.029 -179.087 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.559 ' HB3' HD13 ' A' ' 142' ' ' ILE . 39.5 mmm -61.54 -55.51 30.2 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 110.056 -0.35 . . . . 1.0 110.056 177.514 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.418 ' HB2' ' CG2' ' A' ' 142' ' ' ILE . . . -72.24 -26.67 62.1 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 115.81 -0.632 . . . . 1.0 110.416 -179.008 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.64 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 18.1 tt0 -50.7 -54.56 22.14 Favored 'General case' 0 C--O 1.216 -0.686 0 CA-C-N 114.776 -1.102 . . . . 1.0 109.811 179.096 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.753 ' HB3' ' HG2' ' A' ' 68' ' ' PRO . 0.0 OUTLIER -84.15 -26.3 28.97 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.443 -0.799 . . . . 1.0 110.729 -175.803 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.565 ' HB3' HD11 ' A' ' 146' ' ' LEU . 90.9 mtp -63.91 -75.52 0.08 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.644 0.609 . . . . 1.0 112.644 -176.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.749 ' HB3' HD22 ' A' ' 146' ' ' LEU . 18.2 p90 -76.99 -29.57 55.54 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 119.696 -0.801 . . . . 1.0 111.311 -175.503 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.708 ' HB2' HG21 ' A' ' 40' ' ' VAL . . . -63.86 -37.0 85.75 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 119.2 -1.0 . . . . 1.0 110.562 179.344 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.676 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -63.84 -38.42 91.03 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 108.801 -0.814 . . . . 1.0 108.801 177.363 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.513 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 60.7 mt-30 -58.83 -43.84 90.79 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-O 121.149 0.499 . . . . 1.0 110.107 175.759 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.681 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 95.6 mt -54.84 -61.5 2.27 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.425 -0.807 . . . . 1.0 110.984 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.653 ' HD3' ' HA ' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -59.54 -35.73 74.77 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.763 -0.375 . . . . 1.0 111.565 179.633 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 3.4 m170 -62.83 -27.96 69.68 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 111.934 0.346 . . . . 1.0 111.934 177.256 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.681 ' HG2' ' O ' ' A' ' 29' ' ' LEU . 4.7 ptm85 -97.13 -22.0 17.01 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 119.796 -0.762 . . . . 1.0 110.291 -179.105 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 112.34 36.16 1.66 Allowed Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.226 -0.897 . . . . 1.0 112.528 177.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 18.9 mt -131.74 7.48 4.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.158 0.504 . . . . 1.0 109.814 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.409 ' HA3' ' HB3' ' A' ' 30' ' ' ARG . . . -60.56 -32.25 77.47 Favored Glycine 0 C--N 1.332 0.321 0 CA-C-N 115.831 -0.622 . . . . 1.0 113.03 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.648 ' HA ' ' NH1' ' A' ' 39' ' ' ARG . 3.2 m-20 -90.29 -15.41 31.28 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.935 0.398 . . . . 1.0 110.179 177.115 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -81.16 -22.7 38.77 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.61 -0.723 . . . . 1.0 110.916 178.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.594 HG13 ' HB3' ' A' ' 5' ' ' LEU . 8.7 t -133.7 123.35 45.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.675 0.274 . . . . 1.0 110.932 -178.456 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.648 ' NH1' ' HA ' ' A' ' 36' ' ' ASP . 24.2 mmt180 -96.92 98.0 9.74 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.157 0.503 . . . . 1.0 110.757 178.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.708 HG21 ' HB2' ' A' ' 26' ' ' ALA . 0.8 OUTLIER -92.25 120.89 42.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-O 122.209 1.005 . . . . 1.0 110.699 179.652 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.486 ' O ' ' HA ' ' A' ' 8' ' ' THR . 82.3 p -131.41 -175.24 3.64 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 113.466 -1.697 . . . . 1.0 110.082 -177.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.605 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 78.3 p -157.82 161.46 38.37 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.797 -0.361 . . . . 1.0 110.57 -178.585 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.635 ' HA ' ' O ' ' A' ' 74' ' ' ALA . . . -163.48 165.71 23.46 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.283 0.564 . . . . 1.0 111.522 -178.632 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.596 ' HA2' ' O ' ' A' ' 11' ' ' CYS . . . -126.01 134.07 8.51 Favored Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 115.284 -0.871 . . . . 1.0 111.415 178.67 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.492 HG23 ' CG1' ' A' ' 10' ' ' VAL . 26.9 p -71.57 -26.39 62.6 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.827 0.313 . . . . 1.0 111.433 -178.151 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -107.88 7.8 36.09 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.892 -0.671 . . . . 1.0 112.545 -177.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 43.34 39.8 2.3 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 113.569 0.951 . . . . 1.0 113.569 178.437 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -44.67 -76.2 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.443 0.639 . . . . 1.0 112.063 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 52.6 m-70 -107.01 44.46 1.06 Allowed 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.278 -0.873 . . . . 1.0 111.162 178.656 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.0 p -60.06 129.04 22.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.915 -0.584 . . . . 1.0 110.809 178.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.84 -13.42 66.0 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.899 -0.667 . . . . 1.0 112.26 -178.627 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -82.29 -162.48 0.56 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.009 0.433 . . . . 1.0 109.864 179.058 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 38.4 t -119.36 173.48 6.93 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.239 -0.652 . . . . 1.0 109.239 -179.218 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.73 135.55 47.06 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.821 0.343 . . . . 1.0 111.61 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.79 ' OD1' ' HG3' ' A' ' 57' ' ' ARG . 15.6 t0 -51.54 134.62 29.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.139 -0.937 . . . . 1.0 111.191 -179.046 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -48.31 -32.1 6.91 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.159 -0.928 . . . . 1.0 113.04 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.79 ' HG3' ' OD1' ' A' ' 55' ' ' ASP . 6.5 mtt180 -68.56 -50.71 49.76 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.254 0.55 . . . . 1.0 109.625 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.5 -32.19 71.98 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.006 -0.997 . . . . 1.0 110.405 -176.401 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.09 -45.45 94.68 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 109.433 -0.581 . . . . 1.0 109.433 176.526 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.25 -44.59 95.33 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.927 -0.654 . . . . 1.0 111.76 176.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.627 HG23 ' O ' ' A' ' 57' ' ' ARG . 64.5 t -57.05 -56.51 14.37 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 CA-C-O 121.279 0.561 . . . . 1.0 111.152 178.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.763 ' HB2' HG22 ' A' ' 69' ' ' THR . 88.4 mt -60.13 -52.46 65.25 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.087 -0.506 . . . . 1.0 111.398 -179.271 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -60.59 -28.61 68.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.687 -0.233 . . . . 1.0 110.897 -178.562 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.49 -34.12 77.22 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-O 121.106 0.479 . . . . 1.0 110.333 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -95.55 4.95 52.68 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.859 -0.61 . . . . 1.0 111.178 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.58 21.52 61.83 Favored Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 116.002 -0.544 . . . . 1.0 112.308 178.395 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -91.84 150.91 41.58 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.771 -0.214 . . . . 1.0 110.444 178.105 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.753 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 37.8 Cg_endo -68.41 155.68 68.32 Favored 'Trans proline' 0 CA--C 1.51 -0.687 0 C-N-CA 122.334 2.023 . . . . 1.0 110.162 176.289 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.763 HG22 ' HB2' ' A' ' 62' ' ' LEU . 56.6 p -134.79 7.3 3.49 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 119.778 -0.769 . . . . 1.0 111.709 -177.446 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.434 ' O ' ' HE2' ' A' ' 23' ' ' LYS . 12.8 t70 -74.49 132.52 41.96 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 108.791 -0.818 . . . . 1.0 108.791 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.485 ' HB2' ' HE2' ' A' ' 23' ' ' LYS . 37.2 t60 -170.05 151.12 3.91 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.132 0.491 . . . . 1.0 110.585 -175.528 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.405 ' HD3' ' HA ' ' A' ' 72' ' ' ARG . 3.2 tpp85 -130.71 109.37 10.57 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 107.818 -1.178 . . . . 1.0 107.818 176.057 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.604 ' HB1' ' ND2' ' A' ' 14' ' ' ASN . . . -56.32 137.45 52.42 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.097 -0.956 . . . . 1.0 112.084 -176.151 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.635 ' O ' ' HA ' ' A' ' 43' ' ' ALA . . . -133.6 145.41 50.01 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.834 -0.621 . . . . 1.0 109.976 179.333 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -84.45 154.77 22.57 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.737 -0.468 . . . . 1.0 109.737 177.31 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.538 HG11 ' CD2' ' A' ' 97' ' ' LEU . 16.6 t -62.39 107.17 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.359 0.599 . . . . 1.0 110.528 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.456 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -115.67 -174.21 17.74 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 115.089 -0.96 . . . . 1.0 110.869 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 68.2 m -57.04 -43.23 81.76 Favored 'General case' 0 C--N 1.319 -0.75 0 O-C-N 123.681 0.283 . . . . 1.0 110.304 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -58.33 -31.26 67.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 1.0 111.536 178.48 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.554 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 80.2 m80 -79.5 -37.71 36.08 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.834 0.35 . . . . 1.0 110.251 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 41.4 mt -67.97 -19.11 64.92 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.783 -0.644 . . . . 1.0 110.782 177.408 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.44 -3.39 59.0 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.909 -0.587 . . . . 1.0 110.732 -178.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.542 ' HB1' ' O ' ' A' ' 6' ' ' HIS . . . -61.81 152.08 32.52 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.948 -0.569 . . . . 1.0 111.646 179.206 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.63 ' H ' ' HB3' ' A' ' 6' ' ' HIS . 11.4 t70 -79.79 -14.32 58.79 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.071 0.463 . . . . 1.0 109.872 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.784 HD13 HG13 ' A' ' 7' ' ' VAL . 0.3 OUTLIER -154.2 117.06 4.44 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 108.641 -0.874 . . . . 1.0 108.641 -176.818 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.615 ' HB3' HD13 ' A' ' 97' ' ' LEU . 5.3 mp -107.98 106.31 16.5 Favored 'General case' 0 N--CA 1.423 -1.805 0 CA-C-N 115.683 -0.689 . . . . 1.0 109.639 178.209 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.547 HG11 HD23 ' A' ' 110' ' ' LEU . 55.6 t -85.72 91.71 3.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.204 -0.907 . . . . 1.0 110.542 -176.801 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.7 149.69 29.63 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.332 -0.849 . . . . 1.0 110.85 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.677 ' HG ' ' HG2' ' A' ' 17' ' ' ARG . 3.7 mm? -106.3 1.18 25.68 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.851 -0.613 . . . . 1.0 109.754 178.157 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -154.0 146.98 24.48 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.464 -0.789 . . . . 1.0 110.519 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.406 ' HG2' ' H ' ' A' ' 91' ' ' ARG . 11.4 ptt180 -60.58 -20.65 61.12 Favored 'General case' 0 C--N 1.33 -0.247 0 O-C-N 123.983 0.802 . . . . 1.0 110.946 177.805 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.726 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 78.9 m-20 -77.63 -47.82 18.36 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.19 -0.67 . . . . 1.0 109.19 178.557 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.737 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 8.8 m170 -61.26 -47.05 87.8 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 109.508 -0.552 . . . . 1.0 109.508 179.002 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.489 ' HA ' HG21 ' A' ' 107' ' ' VAL . . . -58.12 -42.37 85.62 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.1 -0.5 . . . . 1.0 110.732 179.434 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.69 ' O ' ' HG2' ' A' ' 99' ' ' GLN . 16.9 ttm180 -60.27 -45.29 93.8 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 115.636 -0.711 . . . . 1.0 111.47 178.588 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.765 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 50.1 mt -63.23 -49.99 72.01 Favored 'General case' 0 C--O 1.22 -0.475 0 O-C-N 123.52 0.513 . . . . 1.0 109.979 -175.768 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.737 ' HG ' ' O ' ' A' ' 93' ' ' HIS . 27.3 mt -53.49 -57.74 9.61 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.771 -0.649 . . . . 1.0 111.467 -178.714 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.575 ' HA ' ' HB ' ' A' ' 102' ' ' VAL . 6.6 ptt180 -60.42 -44.82 95.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.042 -0.526 . . . . 1.0 111.778 -176.385 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.69 ' HG2' ' O ' ' A' ' 95' ' ' ARG . 8.4 pt20 -67.71 -20.82 65.31 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.068 0.461 . . . . 1.0 110.608 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.765 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 8.2 mt -80.08 -8.32 59.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.967 -0.56 . . . . 1.0 111.814 179.403 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 147.5 -28.75 1.48 Allowed Glycine 0 C--N 1.331 0.303 0 C-N-CA 119.786 -1.197 . . . . 1.0 112.955 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.816 HG12 ' H ' ' A' ' 103' ' ' GLU . 2.1 t -73.84 -154.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 C-N-CA 123.036 0.535 . . . . 1.0 110.949 -178.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.816 ' H ' HG12 ' A' ' 102' ' ' VAL . 12.5 pt-20 -168.02 165.7 13.45 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.646 -0.872 . . . . 1.0 108.646 -179.092 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.78 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -65.59 -24.02 66.97 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.676 0.274 . . . . 1.0 111.664 -176.277 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.7 -36.62 74.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.418 0.628 . . . . 1.0 109.983 175.246 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.653 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 7.7 mtt-85 -94.92 -45.16 7.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.039 -0.982 . . . . 1.0 110.704 -177.349 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.78 HG12 ' HA ' ' A' ' 104' ' ' ALA . 7.3 p -79.94 122.6 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-O 121.415 0.626 . . . . 1.0 110.092 -177.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.538 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 7.8 mmm180 -138.12 146.31 42.68 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.079 -0.712 . . . . 1.0 109.079 -178.216 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.405 ' HB2' ' CB ' ' A' ' 112' ' ' SER . 86.5 mmm -79.22 134.95 36.66 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.024 -0.534 . . . . 1.0 110.378 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.547 HD23 HG11 ' A' ' 87' ' ' VAL . 3.2 tm? -56.97 -49.18 76.49 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.671 0.272 . . . . 1.0 111.108 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 16.6 ttm180 -69.52 -21.35 63.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.886 0.374 . . . . 1.0 110.53 -177.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.405 ' CB ' ' HB2' ' A' ' 109' ' ' MET . 32.6 t -77.04 -6.04 51.16 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.424 -0.353 . . . . 1.0 111.138 -178.454 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.571 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 85.6 m-85 -87.44 -19.97 27.28 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.952 -0.388 . . . . 1.0 109.952 175.235 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 61.7 t0 . . . . . 0 C--O 1.233 0.19 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.198 -178.836 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 . . . . . 0 CA--C 1.522 -0.128 0 CA-C-O 120.657 0.265 . . . . 1.0 111.307 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.62 ' O ' HG23 ' A' ' 141' ' ' VAL . 7.9 tp10 -61.22 -47.66 85.06 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 108.7 -0.852 . . . . 1.0 108.7 176.518 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.645 HG13 ' HD3' ' A' ' 17' ' ' ARG . 75.6 t -56.7 -47.54 82.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 114.419 -1.264 . . . . 1.0 110.084 176.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.518 ' HB2' HG11 ' A' ' 61' ' ' VAL . 52.7 t80 -55.58 -44.56 77.03 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.616 -1.174 . . . . 1.0 110.5 178.66 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.433 ' O ' ' HG2' ' A' ' 143' ' ' GLU . . . -62.83 -44.69 95.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.991 -0.55 . . . . 1.0 111.518 -179.241 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 137' ' ' GLU . 21.2 t -56.28 -48.03 80.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.338 0.59 . . . . 1.0 110.584 178.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.559 HD13 ' HB3' ' A' ' 20' ' ' MET . 5.8 mt -67.11 -49.56 71.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 115.413 -0.812 . . . . 1.0 112.127 -178.541 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.464 ' HA ' ' HG ' ' A' ' 146' ' ' LEU . 11.2 pt-20 -56.19 -32.7 64.61 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.98 0.419 . . . . 1.0 110.451 179.359 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 63.3 m -73.06 -27.4 61.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.902 -0.59 . . . . 1.0 110.612 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.477 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -86.44 -25.09 25.41 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 115.67 -0.696 . . . . 1.0 111.92 178.711 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.749 HD22 ' HB3' ' A' ' 25' ' ' PHE . 14.9 mt -55.49 -36.69 48.58 Favored Pre-proline 0 CA--C 1.546 0.814 0 N-CA-C 112.745 0.646 . . . . 1.0 112.745 -178.037 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.643 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 42.1 Cg_endo -68.58 -14.91 40.65 Favored 'Trans proline' 0 C--N 1.359 1.106 0 C-N-CA 122.317 2.011 . . . . 1.0 111.661 176.712 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.571 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -101.97 -34.12 4.42 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.133 -0.94 . . . . 1.0 110.941 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.501 HD11 HG21 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -72.49 -40.0 67.22 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.18 -1.044 . . . . 1.0 108.18 179.334 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 150' ' ' HIS . . . . . 0.482 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 0.2 OUTLIER -54.54 -54.28 43.33 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 114.648 -1.16 . . . . 1.0 110.541 175.427 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -57.27 -42.32 81.38 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.125 -0.943 . . . . 1.0 111.445 -175.007 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' TRP . . . . . 0.655 ' HZ3' HD21 ' A' ' 5' ' ' LEU . 18.0 t90 -62.27 -57.91 9.67 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.415 -0.811 . . . . 1.0 110.084 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.506 ' HB ' HD22 ' A' ' 5' ' ' LEU . 7.8 m -60.65 -43.82 95.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.675 -177.437 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.42 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 8.7 m-20 -60.87 -49.55 77.01 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 121.208 0.527 . . . . 1.0 111.015 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 5.4 pt-20 -64.85 -36.26 83.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.977 -0.556 . . . . 1.0 110.656 -178.497 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.53 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 0.6 OUTLIER -74.13 -43.41 57.61 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 115.769 -0.65 . . . . 1.0 110.869 -176.985 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 4.2 pp . . . . . 0 C--N 1.324 -0.5 0 CA-C-O 121.124 0.487 . . . . 1.0 109.748 178.362 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo . . . . . 0 N--CA 1.462 -0.325 0 CA-C-O 120.843 0.268 . . . . 1.0 111.842 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.798 HD13 ' HB3' ' A' ' 84' ' ' ASP . 0.2 OUTLIER -67.02 178.46 1.4 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.456 -0.572 . . . . 1.0 109.456 178.101 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.664 ' HA ' ' O ' ' A' ' 39' ' ' ARG . 2.7 t-160 -156.06 89.48 1.15 Allowed 'General case' 0 C--N 1.321 -0.651 0 O-C-N 122.053 -0.404 . . . . 1.0 109.989 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.769 HG13 HD13 ' A' ' 85' ' ' LEU . 2.1 t -96.51 105.57 17.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.366 -0.379 . . . . 1.0 110.134 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.645 ' CG2' ' HG ' ' A' ' 86' ' ' LEU . 13.0 t -108.65 115.44 30.09 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.079 0.466 . . . . 1.0 110.199 -179.634 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.568 ' HD1' ' HB ' ' A' ' 87' ' ' VAL . 0.7 OUTLIER -83.74 129.89 34.95 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.793 -0.447 . . . . 1.0 109.793 -178.952 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.657 HG21 HD11 ' A' ' 97' ' ' LEU . 22.0 t -114.38 113.01 42.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.737 -0.665 . . . . 1.0 111.945 -174.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.516 ' HA ' ' CE1' ' A' ' 93' ' ' HIS . 49.2 t -142.78 155.26 44.81 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.359 -0.608 . . . . 1.0 109.359 178.048 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.1 88.66 2.44 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.393 0.616 . . . . 1.0 111.157 -178.392 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.775 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 140.59 -45.74 0.96 Allowed Glycine 0 N--CA 1.445 -0.754 0 CA-C-N 115.313 -0.858 . . . . 1.0 111.062 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.676 ' ND2' ' H ' ' A' ' 74' ' ' ALA . 61.0 t30 58.63 23.86 11.43 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.674 0.75 . . . . 1.0 112.202 178.262 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.4 pt -124.51 3.88 4.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 O-C-N 121.616 -0.678 . . . . 1.0 111.494 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.673 ' O ' ' HG3' ' A' ' 20' ' ' MET . 27.9 m -129.4 -84.19 0.56 Allowed 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.597 -0.441 . . . . 1.0 111.064 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.49 ' HD3' ' H ' ' A' ' 17' ' ' ARG . 1.5 mpt_? -61.56 -58.83 6.58 Favored 'General case' 0 C--O 1.243 0.728 0 CA-C-N 116.211 -0.449 . . . . 1.0 111.939 -175.524 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.408 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 38.0 m -51.49 -58.58 10.32 Favored Pre-proline 0 CA--C 1.54 0.587 0 N-CA-C 112.982 0.734 . . . . 1.0 112.982 -178.665 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.408 ' HD3' ' HB2' ' A' ' 18' ' ' SER . 51.7 Cg_endo -63.67 -23.57 69.77 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 121.636 1.557 . . . . 1.0 112.495 -177.196 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.673 ' HG3' ' O ' ' A' ' 16' ' ' CYS . 61.2 mtp -61.98 -51.65 67.21 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.674 -0.41 . . . . 1.0 110.349 179.32 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.441 ' HA ' ' HB2' ' A' ' 24' ' ' MET . . . -71.58 -29.42 64.69 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.15 -0.62 . . . . 1.0 110.672 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.632 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 22.1 tt0 -53.17 -53.25 53.26 Favored 'General case' 0 C--O 1.219 -0.514 0 O-C-N 124.166 0.916 . . . . 1.0 110.171 -179.367 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.723 ' O ' ' HB3' ' A' ' 27' ' ' GLN . 0.3 OUTLIER -84.8 -23.11 29.28 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.031 -0.986 . . . . 1.0 110.364 -175.493 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.513 ' HB3' HD11 ' A' ' 146' ' ' LEU . 2.2 mmm -65.22 -76.35 0.07 Allowed 'General case' 0 C--O 1.238 0.477 0 N-CA-C 113.076 0.769 . . . . 1.0 113.076 -179.215 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.759 ' HB3' HD22 ' A' ' 146' ' ' LEU . 18.0 p90 -76.37 -29.38 57.13 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 119.852 -0.739 . . . . 1.0 111.243 -174.774 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.673 ' HB2' HG21 ' A' ' 40' ' ' VAL . . . -64.38 -35.73 81.85 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 119.577 -0.849 . . . . 1.0 110.818 178.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.723 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -63.99 -38.82 92.46 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.63 -0.878 . . . . 1.0 108.63 177.175 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.569 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 71.1 mt-30 -61.04 -41.71 97.09 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 115.285 -0.87 . . . . 1.0 110.638 175.713 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.562 ' HG ' ' O ' ' A' ' 25' ' ' PHE . 90.1 mt -57.07 -62.01 2.05 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 115.956 -0.566 . . . . 1.0 111.172 -179.411 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.699 ' HE ' ' HA ' ' A' ' 27' ' ' GLN . 0.1 OUTLIER -58.06 -32.55 68.12 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 120.468 -0.493 . . . . 1.0 111.325 179.582 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -64.11 -28.07 69.52 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.15 0.426 . . . . 1.0 112.15 176.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.583 ' HG3' ' HG ' ' A' ' 34' ' ' LEU . 7.3 ptp180 -95.4 -20.54 19.01 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 121.843 0.83 . . . . 1.0 109.625 178.042 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 108.77 31.93 3.26 Favored Glycine 0 N--CA 1.441 -0.972 0 CA-C-N 114.833 -1.076 . . . . 1.0 112.101 176.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.583 ' HG ' ' HG3' ' A' ' 32' ' ' ARG . 22.7 mt -119.54 0.5 11.03 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 122.434 -0.451 . . . . 1.0 109.959 -178.63 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.419 ' H ' ' HA ' ' A' ' 30' ' ' ARG . . . -53.9 -32.13 48.11 Favored Glycine 0 C--N 1.331 0.295 0 CA-C-N 115.943 -0.572 . . . . 1.0 113.137 -179.099 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.774 ' HA ' ' NH1' ' A' ' 39' ' ' ARG . 0.1 OUTLIER -89.52 -20.63 23.59 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-O 121.273 0.559 . . . . 1.0 110.312 178.66 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.89 -25.09 40.73 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.568 -0.742 . . . . 1.0 111.127 -177.045 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.74 HG23 ' HB3' ' A' ' 5' ' ' LEU . 0.5 OUTLIER -141.16 124.77 16.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.219 0.533 . . . . 1.0 110.826 179.707 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.774 ' NH1' ' HA ' ' A' ' 36' ' ' ASP . 24.6 mmt180 -95.5 106.5 18.58 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.57 -0.741 . . . . 1.0 111.262 -178.58 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.673 HG21 ' HB2' ' A' ' 26' ' ' ALA . 1.5 m -90.49 137.64 21.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-N 115.884 -0.598 . . . . 1.0 109.396 178.327 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.517 ' O ' ' HA ' ' A' ' 8' ' ' THR . 24.6 p -146.25 -178.07 5.95 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.063 -0.971 . . . . 1.0 110.009 -175.434 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.3 p -158.01 157.18 32.49 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.296 -0.562 . . . . 1.0 110.866 -177.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.606 ' HB2' ' CD2' ' A' ' 80' ' ' HIS . . . -163.23 164.51 25.03 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 121.475 0.655 . . . . 1.0 111.64 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' A' ' 11' ' ' CYS . . . -122.63 133.92 9.4 Favored Glycine 0 N--CA 1.441 -0.984 0 CA-C-N 115.06 -0.973 . . . . 1.0 111.046 177.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.529 HG23 ' CG1' ' A' ' 10' ' ' VAL . 12.3 p -69.68 -23.47 63.45 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.834 0.349 . . . . 1.0 111.762 -177.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.439 ' HA3' ' CZ3' ' A' ' 48' ' ' TRP . . . -109.84 8.48 31.79 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.723 -0.751 . . . . 1.0 113.239 -178.315 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 42.11 38.68 1.16 Allowed 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 113.551 0.945 . . . . 1.0 113.551 178.315 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.775 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 1.2 m-90 -46.9 -74.29 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.347 0.594 . . . . 1.0 112.278 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.452 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 46.5 m-70 -107.07 42.45 1.3 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.314 -0.857 . . . . 1.0 111.349 -179.085 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.451 HG23 ' HA ' ' A' ' 74' ' ' ALA . 14.6 p -61.58 132.02 26.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.215 178.708 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.35 -14.53 63.52 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.921 -0.657 . . . . 1.0 112.186 -177.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.49 -158.84 0.28 Allowed 'General case' 0 C--O 1.236 0.391 0 CA-C-O 120.986 0.422 . . . . 1.0 109.959 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.3 t -133.55 173.36 11.59 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.494 -0.558 . . . . 1.0 109.494 -178.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.67 148.15 20.82 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.015 -0.539 . . . . 1.0 111.507 -178.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.406 ' OD1' ' HG2' ' A' ' 57' ' ' ARG . 15.6 t70 -68.41 145.8 53.79 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.371 -0.831 . . . . 1.0 111.417 -178.348 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.416 ' HG3' ' N ' ' A' ' 57' ' ' ARG . 6.4 pt-20 -47.58 -37.74 12.97 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.953 -1.021 . . . . 1.0 113.224 178.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.613 ' O ' HG23 ' A' ' 61' ' ' VAL . 19.9 ptp180 -70.68 -44.43 67.02 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 121.136 -0.226 . . . . 1.0 110.777 -176.071 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.404 ' O ' HD13 ' A' ' 62' ' ' LEU . . . -70.15 -30.86 68.13 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.689 -0.486 . . . . 1.0 109.689 -179.19 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.46 -46.75 84.8 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.635 -0.711 . . . . 1.0 109.504 176.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.458 ' O ' ' HG2' ' A' ' 63' ' ' ARG . . . -62.72 -41.98 99.76 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.843 -0.694 . . . . 1.0 111.927 178.249 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 57' ' ' ARG . 97.5 t -58.23 -59.35 3.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.429 0.633 . . . . 1.0 111.622 178.458 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.488 ' HB2' HG22 ' A' ' 69' ' ' THR . 10.0 mp -61.72 -48.05 82.51 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.754 -0.657 . . . . 1.0 111.048 -177.155 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.458 ' HG2' ' O ' ' A' ' 60' ' ' GLY . 22.1 ptt180 -58.74 -31.44 68.32 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.611 -0.268 . . . . 1.0 110.888 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.65 -34.24 76.55 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.223 0.535 . . . . 1.0 110.826 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.452 ' HB2' ' HD2' ' A' ' 67' ' ' TYR . 78.8 m80 -96.91 5.55 50.3 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.587 -0.733 . . . . 1.0 110.866 -178.408 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.85 17.38 63.53 Favored Glycine 0 C--N 1.33 0.236 0 CA-C-N 115.7 -0.682 . . . . 1.0 113.165 176.373 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.544 ' HD1' ' HG2' ' A' ' 27' ' ' GLN . 71.1 m-85 -88.68 154.89 50.78 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-O 120.501 0.191 . . . . 1.0 110.827 179.32 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.596 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 21.9 Cg_endo -67.46 151.81 79.54 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.354 2.036 . . . . 1.0 110.123 174.387 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.488 HG22 ' HB2' ' A' ' 62' ' ' LEU . 67.1 p -132.68 20.15 4.24 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 120.271 -0.572 . . . . 1.0 112.181 -175.457 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.41 ' C ' ' HZ3' ' A' ' 23' ' ' LYS . 31.3 t70 -113.8 128.2 56.31 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.965 -177.75 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.581 ' HB3' ' NZ ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -165.76 159.44 16.19 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.429 -0.805 . . . . 1.0 108.923 178.838 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -116.35 120.15 37.94 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.627 -0.879 . . . . 1.0 108.627 178.455 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 49' ' ' HIS . . . -61.03 136.89 58.22 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.833 0.349 . . . . 1.0 111.77 -178.187 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.676 ' H ' ' ND2' ' A' ' 14' ' ' ASN . . . -127.63 163.54 24.0 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.07 178.645 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -98.91 157.26 16.43 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.476 -0.935 . . . . 1.0 108.476 178.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.546 HG11 HD23 ' A' ' 97' ' ' LEU . 41.9 t -71.71 111.98 6.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.159 0.504 . . . . 1.0 110.271 179.229 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.46 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -124.43 -165.21 12.13 Favored Glycine 0 N--CA 1.437 -1.275 0 CA-C-N 115.497 -0.774 . . . . 1.0 111.324 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 83.5 m -56.17 -51.2 68.88 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 122.651 0.381 . . . . 1.0 111.877 -179.297 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.516 ' HG2' ' N ' ' A' ' 80' ' ' HIS . 0.7 OUTLIER -58.15 -29.76 65.83 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.844 -0.616 . . . . 1.0 110.704 -178.589 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.606 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 79.3 m80 -76.82 -41.61 43.63 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 115.793 -0.64 . . . . 1.0 110.349 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.64 ' O ' HG23 ' A' ' 102' ' ' VAL . 16.6 mt -68.83 -18.67 64.2 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.442 176.581 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.06 -5.51 59.2 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.185 -178.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.601 ' HB1' ' O ' ' A' ' 6' ' ' HIS . . . -61.34 153.23 27.27 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.534 -0.757 . . . . 1.0 110.764 179.084 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.798 ' HB3' HD13 ' A' ' 5' ' ' LEU . 12.2 t70 -82.46 -11.93 58.18 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.242 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.769 HD13 HG13 ' A' ' 7' ' ' VAL . 0.3 OUTLIER -156.61 114.19 3.2 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 109.283 -0.636 . . . . 1.0 109.283 -178.224 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.645 ' HG ' ' CG2' ' A' ' 8' ' ' THR . 5.1 mp -105.74 106.33 16.78 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 115.407 -0.815 . . . . 1.0 110.069 178.356 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.6 HG11 HD23 ' A' ' 110' ' ' LEU . 52.6 t -84.79 93.43 3.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 114.772 -1.104 . . . . 1.0 110.856 -176.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.54 143.98 34.34 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.193 -0.912 . . . . 1.0 110.562 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.424 HD23 ' HB2' ' A' ' 11' ' ' CYS . 4.3 mm? -93.39 -19.24 21.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.494 0.664 . . . . 1.0 109.848 178.337 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -139.86 154.91 47.42 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.443 -0.799 . . . . 1.0 110.311 -178.191 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.402 ' HG2' ' H ' ' A' ' 91' ' ' ARG . 5.2 ptm180 -58.67 -22.32 56.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.889 -0.596 . . . . 1.0 111.619 178.08 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.642 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 94.5 m-20 -75.41 -52.08 11.59 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.861 -0.609 . . . . 1.0 110.278 -178.194 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.669 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 17.5 m170 -55.92 -45.24 78.77 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.38 -0.827 . . . . 1.0 110.814 -179.23 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.428 ' HA ' HD12 ' A' ' 97' ' ' LEU . . . -59.86 -44.07 94.33 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.107 0.48 . . . . 1.0 110.463 178.789 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 13.6 ttm180 -58.99 -42.65 90.54 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.317 -0.856 . . . . 1.0 111.522 178.614 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.675 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 34.9 mt -66.32 -47.16 74.43 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.599 -177.678 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.669 ' HG ' ' O ' ' A' ' 93' ' ' HIS . 33.1 mt -53.14 -59.84 4.05 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.189 -0.459 . . . . 1.0 111.725 -177.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.67 ' CA ' HG12 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -58.46 -44.25 89.2 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.406 0.521 . . . . 1.0 112.406 -179.66 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.605 ' HG3' ' O ' ' A' ' 96' ' ' LEU . 1.0 OUTLIER -67.25 -24.74 65.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.115 0.483 . . . . 1.0 109.814 179.599 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.675 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 12.5 mt -80.82 -19.46 44.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.456 -0.793 . . . . 1.0 111.896 178.772 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 152.71 -22.84 0.82 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 119.37 -1.395 . . . . 1.0 114.314 -177.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.687 HG13 ' N ' ' A' ' 103' ' ' GLU . 0.3 OUTLIER -76.05 -161.92 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-N 117.988 0.894 . . . . 1.0 110.502 -179.096 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.824 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 8.6 pt-20 -158.06 160.27 37.21 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 107.671 -1.233 . . . . 1.0 107.671 -177.665 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.775 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -60.86 -27.08 67.86 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 123.194 0.309 . . . . 1.0 111.183 -175.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.48 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . . . -57.4 -35.38 69.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.101 0.477 . . . . 1.0 110.706 176.327 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.824 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 9.4 mtt-85 -99.51 -39.68 8.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.508 -0.769 . . . . 1.0 111.551 -177.15 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.775 HG12 ' HA ' ' A' ' 104' ' ' ALA . 9.3 p -80.06 122.25 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 120.661 -0.416 . . . . 1.0 110.85 -174.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.497 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 14.3 mmm180 -141.56 150.54 42.22 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 121.846 -0.534 . . . . 1.0 111.057 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 85.7 mmm -80.92 140.0 35.55 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.726 -0.67 . . . . 1.0 110.525 178.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.6 HD23 HG11 ' A' ' 87' ' ' VAL . 3.0 tm? -58.31 -49.73 76.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.588 0.232 . . . . 1.0 111.245 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 47.7 ttt180 -72.03 -15.7 62.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.714 0.292 . . . . 1.0 111.031 -177.136 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.4 t -72.46 -10.62 60.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.659 -0.246 . . . . 1.0 110.636 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.533 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 95.8 m-85 -89.39 -20.1 24.38 Favored 'General case' 0 C--O 1.233 0.203 0 O-C-N 122.224 -0.297 . . . . 1.0 110.826 177.733 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 19.8 t0 . . . . . 0 N--CA 1.466 0.325 0 CA-C-N 115.969 -0.559 . . . . 1.0 111.554 -177.133 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 . . . . . 0 N--CA 1.455 -0.183 0 CA-C-O 120.467 0.175 . . . . 1.0 111.176 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -63.76 -51.07 66.52 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.108 0.48 . . . . 1.0 109.823 177.053 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.788 ' HA ' HG12 ' A' ' 141' ' ' VAL . 21.3 t -63.11 -41.13 91.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.749 0.785 . . . . 1.0 109.335 177.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.494 ' HB2' HG11 ' A' ' 61' ' ' VAL . 66.8 t80 -56.31 -43.22 78.75 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.566 -0.743 . . . . 1.0 109.727 177.374 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.531 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -66.92 -49.88 64.16 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.389 -0.823 . . . . 1.0 111.871 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.788 HG12 ' HA ' ' A' ' 138' ' ' VAL . 5.6 p -57.2 -43.19 81.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 CA-C-O 121.565 0.698 . . . . 1.0 110.671 -178.565 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.633 HD12 HG12 ' A' ' 138' ' ' VAL . 16.4 mt -68.46 -53.83 25.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 115.031 -0.986 . . . . 1.0 111.934 178.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.536 ' HA ' ' HG ' ' A' ' 146' ' ' LEU . 8.3 pt-20 -57.56 -28.43 63.54 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.513 -0.312 . . . . 1.0 110.372 -179.016 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 3.1 t -73.78 -30.04 62.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.085 0.469 . . . . 1.0 110.265 177.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.468 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -86.57 -23.37 25.83 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 116.187 -0.461 . . . . 1.0 111.904 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.759 HD22 ' HB3' ' A' ' 25' ' ' PHE . 17.5 mt -54.9 -37.56 57.51 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 112.146 0.424 . . . . 1.0 112.146 -178.597 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.622 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 56.1 Cg_endo -69.58 -9.19 25.53 Favored 'Trans proline' 0 C--N 1.364 1.366 0 C-N-CA 122.413 2.076 . . . . 1.0 112.35 177.606 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.533 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -106.09 -33.27 3.51 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 110.257 -1.137 . . . . 1.0 110.257 178.596 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.466 HD11 HG21 ' A' ' 87' ' ' VAL . 0.3 OUTLIER -73.4 -41.66 63.05 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.814 -0.81 . . . . 1.0 108.814 178.934 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 150' ' ' HIS . . . . . 0.447 ' O ' ' HB2' ' A' ' 154' ' ' ASP . 2.1 m-70 -54.56 -50.88 66.9 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.134 -0.939 . . . . 1.0 110.628 177.067 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -60.98 -46.28 91.39 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.493 -0.776 . . . . 1.0 111.389 -176.161 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' TRP . . . . . 0.767 ' HZ3' HD11 ' A' ' 5' ' ' LEU . 21.1 t90 -59.45 -55.5 33.88 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.164 -0.925 . . . . 1.0 111.033 -177.414 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.485 HG11 HG21 ' A' ' 7' ' ' VAL . 6.1 m -61.88 -40.15 86.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.44 -177.811 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.571 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 1.1 t70 -60.03 -56.23 24.19 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 121.562 0.696 . . . . 1.0 110.574 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -63.25 -35.66 81.09 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.894 -1.048 . . . . 1.0 110.922 -176.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 19.5 mmt-85 -72.17 -45.74 59.22 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.743 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.571 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 4.0 pp . . . . . 0 CA--C 1.52 -0.184 0 N-CA-C 109.417 -0.586 . . . . 1.0 109.417 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.774 ' HG3' ' HE ' ' A' ' 39' ' ' ARG . 49.0 Cg_endo . . . . . 0 N--CA 1.462 -0.348 0 N-CA-C 113.541 0.554 . . . . 1.0 113.541 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.813 HD21 ' HZ3' ' A' ' 152' ' ' TRP . 0.6 OUTLIER -75.65 -172.58 1.91 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.155 -0.93 . . . . 1.0 110.662 178.219 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.509 ' O ' ' HB1' ' A' ' 83' ' ' ALA . 0.1 OUTLIER -157.11 92.8 1.28 Allowed 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 121.107 -0.237 . . . . 1.0 111.136 179.641 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.639 HG13 HD13 ' A' ' 85' ' ' LEU . 1.9 t -97.12 115.3 36.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 108.802 -0.814 . . . . 1.0 108.802 176.343 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.616 ' CG2' ' HG ' ' A' ' 86' ' ' LEU . 7.2 t -116.28 117.58 30.39 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 120.821 0.343 . . . . 1.0 110.239 178.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.627 ' HD2' ' HB3' ' A' ' 42' ' ' SER . 2.0 m-85 -85.52 133.89 34.06 Favored 'General case' 0 CA--C 1.518 -0.276 0 O-C-N 121.974 -0.454 . . . . 1.0 110.883 -179.08 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.633 HG21 HD11 ' A' ' 97' ' ' LEU . 28.8 t -118.07 118.69 59.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.204 0.526 . . . . 1.0 111.497 -177.594 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.502 ' HA ' ' CE1' ' A' ' 93' ' ' HIS . 33.9 t -146.54 170.82 16.11 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 178.599 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.623 HG23 ' NE2' ' A' ' 93' ' ' HIS . 0.9 OUTLIER -80.64 92.65 6.01 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.25 0.548 . . . . 1.0 110.856 179.959 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.967 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 129.35 -40.39 1.7 Allowed Glycine 0 N--CA 1.441 -0.97 0 C-N-CA 120.597 -0.811 . . . . 1.0 111.74 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.472 HD21 ' CB ' ' A' ' 42' ' ' SER . 4.2 t-20 64.33 14.62 8.89 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.843 0.83 . . . . 1.0 111.338 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.486 ' HA ' ' HG3' ' A' ' 19' ' ' PRO . 14.5 pt -121.54 4.21 6.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 O-C-N 121.705 -0.622 . . . . 1.0 112.074 -177.447 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 6.1 p -120.3 -87.55 0.64 Allowed 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.926 -0.309 . . . . 1.0 111.81 -177.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 12.6 mtp180 -72.21 -45.06 61.86 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.29 0.478 . . . . 1.0 112.29 -175.506 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.567 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 18.5 m -55.01 -56.72 24.82 Favored Pre-proline 0 CA--C 1.541 0.603 0 N-CA-C 112.099 0.407 . . . . 1.0 112.099 179.276 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.494 ' HD3' ' HB2' ' A' ' 18' ' ' SER . 57.6 Cg_endo -68.53 -21.59 39.78 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 121.765 1.644 . . . . 1.0 112.539 -177.798 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.594 ' HB3' HD13 ' A' ' 142' ' ' ILE . 34.0 mmm -60.82 -53.13 61.06 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.601 -0.272 . . . . 1.0 110.32 177.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.473 ' HA ' ' HB2' ' A' ' 24' ' ' MET . . . -75.26 -25.43 58.03 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.234 -0.586 . . . . 1.0 110.61 -179.155 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.615 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 17.8 tt0 -52.31 -53.58 42.5 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 115.489 -0.778 . . . . 1.0 109.94 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.586 ' O ' ' HB3' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -85.88 -23.58 27.0 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.209 -0.905 . . . . 1.0 110.758 -175.787 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.646 ' HB3' HD11 ' A' ' 146' ' ' LEU . 7.0 mmm -61.78 -75.55 0.07 Allowed 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.563 0.579 . . . . 1.0 112.563 -178.558 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.702 ' HB3' HD13 ' A' ' 146' ' ' LEU . 26.5 p90 -80.65 -28.72 36.79 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.179 -0.608 . . . . 1.0 111.573 -174.717 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' A' ' 22' ' ' GLU . . . -63.65 -38.97 93.11 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 119.237 -0.985 . . . . 1.0 110.261 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.612 ' HA ' ' HD3' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -64.88 -37.65 88.35 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 108.845 -0.798 . . . . 1.0 108.845 177.272 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.6 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 79.1 mt-30 -59.02 -47.59 84.66 Favored 'General case' 0 CA--C 1.522 -0.097 0 CA-C-N 116.433 -0.349 . . . . 1.0 110.413 175.628 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 25' ' ' PHE . 95.6 mt -52.07 -56.26 15.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.835 -0.62 . . . . 1.0 111.071 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.612 ' HD3' ' HA ' ' A' ' 27' ' ' GLN . 0.1 OUTLIER -61.67 -37.4 83.93 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.647 -0.421 . . . . 1.0 111.797 178.866 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 8.1 m170 -62.82 -23.39 67.24 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.391 0.515 . . . . 1.0 112.391 178.1 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.6 ' HG2' ' O ' ' A' ' 28' ' ' GLN . 7.9 ptp180 -98.49 -21.52 16.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.48 0.657 . . . . 1.0 110.185 178.024 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 108.03 39.85 1.78 Allowed Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 115.24 -0.891 . . . . 1.0 112.297 177.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 15.9 mt -137.46 -3.11 1.93 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.034 0.445 . . . . 1.0 109.9 -177.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.463 ' H ' ' HA ' ' A' ' 30' ' ' ARG . . . -62.82 -23.58 65.65 Favored Glycine 0 C--N 1.332 0.325 0 CA-C-N 115.856 -0.611 . . . . 1.0 112.585 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -83.75 -32.86 25.22 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.272 0.558 . . . . 1.0 109.537 176.284 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.49 -15.84 55.75 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.45 -0.796 . . . . 1.0 111.334 -178.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.427 HG13 ' HB3' ' A' ' 5' ' ' LEU . 35.5 t -130.58 121.61 51.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 110.237 -0.282 . . . . 1.0 110.237 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.774 ' HE ' ' HG3' ' A' ' 4' ' ' PRO . 7.2 mmt180 -93.24 134.83 35.04 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 109.873 -0.417 . . . . 1.0 109.873 177.664 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.43 HG11 ' HB2' ' A' ' 26' ' ' ALA . 55.1 t -129.85 119.72 48.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 121.699 0.761 . . . . 1.0 109.877 -177.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.494 ' O ' ' HA ' ' A' ' 8' ' ' THR . 48.0 p -133.65 -174.12 3.43 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 113.693 -1.594 . . . . 1.0 110.809 -175.277 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.627 ' HB3' ' HD2' ' A' ' 9' ' ' PHE . 81.8 p -161.82 166.9 25.73 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 120.931 -0.308 . . . . 1.0 110.47 179.136 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.578 ' HB2' ' CD2' ' A' ' 80' ' ' HIS . . . -164.54 169.61 16.88 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.447 0.642 . . . . 1.0 111.728 -179.32 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -127.85 140.9 12.15 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.266 -0.879 . . . . 1.0 111.028 178.501 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.475 HG21 HD12 ' A' ' 96' ' ' LEU . 39.9 p -76.7 -23.2 53.15 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.935 0.368 . . . . 1.0 111.829 -177.031 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.498 ' HA3' ' CZ3' ' A' ' 48' ' ' TRP . . . -112.03 11.91 26.91 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.511 -0.852 . . . . 1.0 113.156 -177.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.43 ' HB3' ' HB2' ' A' ' 75' ' ' GLN . 2.7 p-10 43.11 39.9 2.1 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 113.572 0.953 . . . . 1.0 113.572 178.165 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.967 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 1.3 m-90 -46.84 -77.0 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.531 0.682 . . . . 1.0 112.306 179.758 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.556 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 11.3 m-70 -105.45 41.77 1.32 Allowed 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.525 -0.761 . . . . 1.0 111.06 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.558 HG23 ' HA ' ' A' ' 74' ' ' ALA . 12.9 p -61.04 125.85 17.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.119 0.485 . . . . 1.0 110.181 178.655 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.805 ' HA2' ' HD3' ' A' ' 72' ' ' ARG . . . 95.27 -15.23 63.74 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 121.06 -0.591 . . . . 1.0 111.637 -176.674 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.529 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 3.3 t -79.58 -159.99 0.23 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.251 0.548 . . . . 1.0 109.746 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 36.1 t -128.14 175.06 8.71 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 109.189 -0.671 . . . . 1.0 109.189 -179.376 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.57 142.48 39.25 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.87 0.367 . . . . 1.0 111.29 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -62.79 143.62 57.33 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.663 -0.699 . . . . 1.0 112.557 -176.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.601 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 12.2 pt-20 -43.61 -42.32 5.1 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 114.383 -1.28 . . . . 1.0 113.748 178.697 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.673 ' O ' HG23 ' A' ' 61' ' ' VAL . 10.0 mtt-85 -70.16 -48.4 57.51 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 120.784 0.326 . . . . 1.0 110.462 -176.497 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.38 -31.49 70.89 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.224 -0.898 . . . . 1.0 110.298 -177.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.73 -45.84 84.77 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.66 -0.496 . . . . 1.0 109.66 176.472 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.07 -39.93 98.62 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.708 -0.758 . . . . 1.0 111.489 178.129 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.673 HG23 ' O ' ' A' ' 57' ' ' ARG . 88.8 t -58.67 -59.16 4.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-O 121.233 0.54 . . . . 1.0 111.242 178.205 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.679 ' HB2' HG22 ' A' ' 69' ' ' THR . 96.6 mt -60.4 -50.09 74.99 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.939 -0.573 . . . . 1.0 111.54 -177.432 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 6.9 ptm85 -61.72 -27.56 68.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.723 -0.217 . . . . 1.0 111.008 -178.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.7 -34.14 76.3 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.453 0.644 . . . . 1.0 110.387 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -96.41 4.98 51.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.562 -0.744 . . . . 1.0 111.43 -178.343 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.15 11.48 64.78 Favored Glycine 0 C--N 1.329 0.188 0 C-N-CA 121.026 -0.607 . . . . 1.0 112.743 177.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -89.84 149.75 42.54 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-O 120.691 0.282 . . . . 1.0 110.773 -179.062 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.456 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 37.6 Cg_endo -67.91 156.14 67.05 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.285 1.99 . . . . 1.0 110.878 177.685 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.679 HG22 ' HB2' ' A' ' 62' ' ' LEU . 80.4 p -130.85 14.24 5.3 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 120.191 -0.604 . . . . 1.0 111.032 -176.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -77.2 132.66 38.86 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.513 -0.767 . . . . 1.0 109.856 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.461 ' HB2' ' HE2' ' A' ' 23' ' ' LYS . 54.4 t60 -172.17 148.0 2.11 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.038 0.447 . . . . 1.0 110.797 -177.437 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.805 ' HD3' ' HA2' ' A' ' 51' ' ' GLY . 5.3 tmm_? -131.41 108.45 9.62 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 107.153 -1.425 . . . . 1.0 107.153 176.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 49' ' ' HIS . . . -58.73 139.99 55.44 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.071 -0.968 . . . . 1.0 112.474 -174.744 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.558 ' HA ' HG23 ' A' ' 50' ' ' VAL . . . -134.58 147.16 50.18 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.707 -0.678 . . . . 1.0 110.113 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.43 ' HB2' ' HB3' ' A' ' 47' ' ' ASN . 49.0 tt0 -83.79 153.56 24.03 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 110.116 -0.327 . . . . 1.0 110.116 176.763 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.597 HG11 HD23 ' A' ' 97' ' ' LEU . 82.0 t -63.56 112.56 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.033 -0.531 . . . . 1.0 110.909 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.432 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -122.4 -171.79 13.94 Favored Glycine 0 N--CA 1.442 -0.915 0 N-CA-C 111.055 -0.818 . . . . 1.0 111.055 178.511 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 90.8 m -57.88 -44.19 86.52 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.707 0.289 . . . . 1.0 110.935 -179.397 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -58.97 -29.99 67.6 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.186 -0.461 . . . . 1.0 111.641 178.123 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.578 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 79.7 m80 -78.66 -39.62 36.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.821 0.343 . . . . 1.0 110.169 179.145 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.712 ' HA ' HD21 ' A' ' 86' ' ' LEU . 16.2 mt -69.49 -15.19 63.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.112 0.482 . . . . 1.0 110.101 177.116 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.37 -5.83 59.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.323 -0.399 . . . . 1.0 110.543 -179.224 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.509 ' HB1' ' O ' ' A' ' 6' ' ' HIS . . . -63.35 154.36 32.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.906 -0.588 . . . . 1.0 110.976 179.155 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.408 ' HA ' HH11 ' A' ' 106' ' ' ARG . 21.2 t70 -80.9 -14.78 57.69 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 109.871 -0.418 . . . . 1.0 109.871 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.756 HD12 ' CE3' ' A' ' 152' ' ' TRP . 0.9 OUTLIER -152.72 113.51 4.13 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.484 -0.78 . . . . 1.0 109.73 -177.43 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.712 HD21 ' HA ' ' A' ' 81' ' ' LEU . 5.5 mp -105.72 87.65 2.64 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.534 -0.757 . . . . 1.0 110.951 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.607 HG23 HD22 ' A' ' 85' ' ' LEU . 54.6 t -66.36 92.88 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 113.806 -1.543 . . . . 1.0 112.237 -178.663 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.06 145.54 32.4 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.393 -1.276 . . . . 1.0 109.917 177.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.413 HD13 ' HA ' ' A' ' 89' ' ' LEU . 4.0 mm? -98.57 -8.53 26.32 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.955 0.407 . . . . 1.0 110.094 179.374 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.417 ' CG ' ' H ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -152.03 153.81 34.74 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.694 -0.685 . . . . 1.0 111.066 179.945 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -55.3 -27.67 48.35 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.251 -0.886 . . . . 1.0 113.104 -178.468 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.581 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 91.6 m-20 -75.51 -49.97 17.09 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.734 0.302 . . . . 1.0 110.504 -177.199 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.628 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 18.2 m170 -53.94 -46.02 71.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.428 179.046 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.91 -43.94 91.17 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.941 0.4 . . . . 1.0 110.735 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 16.6 ttm180 -61.3 -39.84 91.96 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.722 -0.672 . . . . 1.0 111.602 178.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.581 ' HG ' ' O ' ' A' ' 92' ' ' ASN . 43.9 mt -67.06 -50.74 60.87 Favored 'General case' 0 C--O 1.217 -0.645 0 CA-C-N 116.43 -0.35 . . . . 1.0 110.416 -178.21 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.634 HD13 ' HB3' ' A' ' 86' ' ' LEU . 29.2 mt -52.0 -57.45 9.44 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.971 -0.559 . . . . 1.0 111.387 -177.493 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.714 ' CA ' HG12 ' A' ' 102' ' ' VAL . 9.5 ptt180 -59.75 -44.12 93.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.659 -0.7 . . . . 1.0 112.439 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.546 ' HG3' ' O ' ' A' ' 96' ' ' LEU . 0.9 OUTLIER -67.66 -25.24 65.61 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.394 -0.522 . . . . 1.0 109.895 -179.972 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.494 HD13 ' O ' ' A' ' 96' ' ' LEU . 5.9 mp -77.68 -20.7 53.25 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 116.096 -0.502 . . . . 1.0 111.592 177.411 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 152.87 -21.15 0.78 Allowed Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 119.477 -1.344 . . . . 1.0 114.216 -178.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.714 HG12 ' CA ' ' A' ' 98' ' ' ARG . 0.3 OUTLIER -76.05 -162.35 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 118.048 0.924 . . . . 1.0 110.313 -179.51 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.741 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 10.7 pt-20 -159.34 160.6 35.23 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 107.753 -1.203 . . . . 1.0 107.753 -177.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.721 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -62.2 -25.1 67.6 Favored 'General case' 0 C--N 1.316 -0.876 0 O-C-N 123.465 0.478 . . . . 1.0 111.274 -175.331 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.41 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . . . -59.04 -30.2 67.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.011 0.434 . . . . 1.0 110.546 175.604 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.741 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 11.5 mtt-85 -105.41 -43.16 5.04 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 115.531 -0.759 . . . . 1.0 111.464 -177.666 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.721 HG12 ' HA ' ' A' ' 104' ' ' ALA . 11.3 p -78.38 117.93 24.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.497 -0.557 . . . . 1.0 109.497 -174.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.601 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 8.5 mmm180 -139.24 149.79 44.74 Favored 'General case' 0 C--N 1.322 -0.597 0 O-C-N 121.604 -0.685 . . . . 1.0 110.59 -176.59 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 87.7 mmm -80.39 131.49 35.62 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.079 -0.51 . . . . 1.0 111.26 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.53 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 2.8 tm? -53.54 -50.54 65.27 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 123.402 0.439 . . . . 1.0 111.028 179.684 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 43.7 ttt-85 -71.07 -16.67 62.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.308 -0.406 . . . . 1.0 110.956 -176.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 46.8 t -79.81 -2.31 42.75 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 120.706 -0.398 . . . . 1.0 111.034 -179.325 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.739 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 87.8 m-85 -92.74 -16.61 25.24 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-O 120.914 0.388 . . . . 1.0 109.972 175.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 22.1 t0 . . . . . 0 C--N 1.326 -0.421 0 CA-C-N 115.727 -0.669 . . . . 1.0 111.291 -178.261 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 . . . . . 0 N--CA 1.453 -0.295 0 CA-C-O 120.875 0.369 . . . . 1.0 110.248 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.561 ' O ' HG23 ' A' ' 141' ' ' VAL . 11.7 tp10 -62.76 -48.77 77.75 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.289 0.566 . . . . 1.0 110.048 178.348 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.679 ' HA ' HG23 ' A' ' 141' ' ' VAL . 73.5 t -61.51 -40.37 86.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.36 -0.836 . . . . 1.0 110.044 177.557 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.535 ' HB2' HG11 ' A' ' 61' ' ' VAL . 35.7 t80 -53.65 -42.12 67.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.129 -0.942 . . . . 1.0 109.204 175.642 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.637 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -67.18 -38.17 84.94 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.343 -0.844 . . . . 1.0 110.599 177.657 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.679 HG23 ' HA ' ' A' ' 138' ' ' VAL . 13.2 t -56.6 -53.58 39.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.58 0.705 . . . . 1.0 109.986 176.352 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.594 HD13 ' HB3' ' A' ' 20' ' ' MET . 6.0 mt -62.9 -50.43 79.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 114.883 -1.053 . . . . 1.0 111.842 -178.514 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.637 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 8.3 pt-20 -55.54 -33.33 63.72 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.628 0.252 . . . . 1.0 110.396 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 2.0 t -74.18 -28.53 61.33 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-O 121.064 0.459 . . . . 1.0 110.327 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.45 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -86.41 -23.3 26.14 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 116.329 -0.396 . . . . 1.0 111.851 179.228 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.702 HD13 ' HB3' ' A' ' 25' ' ' PHE . 11.9 mt -55.45 -38.31 66.5 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 112.37 0.507 . . . . 1.0 112.37 -179.063 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.621 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 58.0 Cg_endo -70.81 -10.13 27.12 Favored 'Trans proline' 0 C--N 1.359 1.107 0 C-N-CA 122.56 2.173 . . . . 1.0 112.211 178.122 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.739 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -105.12 -33.44 3.71 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 110.442 -1.063 . . . . 1.0 110.442 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.634 HD23 ' CE2' ' A' ' 25' ' ' PHE . 13.0 tp -73.86 -37.41 64.79 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.451 -1.314 . . . . 1.0 107.451 177.341 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' HIS . . . . . 0.451 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 0.2 OUTLIER -54.24 -51.5 64.29 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 114.549 -1.205 . . . . 1.0 109.57 174.195 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -59.16 -46.65 87.84 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.963 -1.017 . . . . 1.0 111.342 -176.412 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' TRP . . . . . 0.813 ' HZ3' HD21 ' A' ' 5' ' ' LEU . 28.7 t90 -63.0 -52.17 64.0 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.49 -0.777 . . . . 1.0 111.056 -178.161 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.473 HG13 ' O ' ' A' ' 149' ' ' LEU . 12.3 m -61.01 -39.39 82.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 120.545 -0.462 . . . . 1.0 109.919 -179.416 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.401 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 0.4 OUTLIER -61.11 -51.54 68.7 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 116.417 -0.356 . . . . 1.0 111.076 177.413 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.544 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 4.8 pt-20 -60.18 -39.34 86.12 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.256 0.55 . . . . 1.0 110.235 -178.017 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.558 ' HG3' ' CH2' ' A' ' 152' ' ' TRP . 17.3 mmt85 -72.11 -46.24 57.44 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.369 -0.832 . . . . 1.0 111.437 -176.133 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 4.3 pp . . . . . 0 C--N 1.327 -0.39 0 N-CA-C 109.317 -0.623 . . . . 1.0 109.317 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.595 ' HB2' ' HG2' ' A' ' 39' ' ' ARG . 11.1 Cg_endo . . . . . 0 C--O 1.236 0.389 0 N-CA-C 114.803 1.039 . . . . 1.0 114.803 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.71 HD21 ' HZ3' ' A' ' 152' ' ' TRP . 0.7 OUTLIER -70.79 -174.14 0.88 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 114.006 -1.452 . . . . 1.0 110.118 179.949 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.669 ' HA ' ' O ' ' A' ' 39' ' ' ARG . 1.4 t-160 -157.54 93.3 1.28 Allowed 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.493 -0.483 . . . . 1.0 111.159 -178.487 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.719 HG13 HD13 ' A' ' 85' ' ' LEU . 2.5 t -98.27 108.63 22.33 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.454 0 N-CA-C 109.916 -0.402 . . . . 1.0 109.916 177.535 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.533 ' HA ' ' O ' ' A' ' 41' ' ' THR . 14.7 t -109.88 116.88 32.44 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.143 0.497 . . . . 1.0 110.937 -179.692 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.561 ' CE2' ' HA ' ' A' ' 22' ' ' GLU . 0.4 OUTLIER -86.95 129.43 34.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.902 0.382 . . . . 1.0 110.653 -179.166 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.674 HG21 HD21 ' A' ' 97' ' ' LEU . 41.2 t -114.14 116.59 53.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.914 -0.585 . . . . 1.0 111.782 -176.206 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.514 ' HA ' ' CE1' ' A' ' 93' ' ' HIS . 45.1 t -145.32 151.9 39.05 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.409 178.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.34 99.71 2.99 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.285 0.564 . . . . 1.0 110.423 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.558 ' O ' HG12 ' A' ' 15' ' ' ILE . . . 140.02 -32.85 2.16 Favored Glycine 0 C--O 1.217 -0.951 0 CA-C-N 115.555 -0.748 . . . . 1.0 111.488 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.579 ' OD1' ' HB1' ' A' ' 73' ' ' ALA . 34.3 p30 48.7 20.98 0.38 Allowed 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 125.268 1.427 . . . . 1.0 113.901 179.198 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.558 HG12 ' O ' ' A' ' 13' ' ' GLY . 5.3 pt -139.46 10.26 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 122.233 -0.292 . . . . 1.0 111.362 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.419 ' O ' ' HG2' ' A' ' 20' ' ' MET . 47.9 t -125.1 -87.34 0.61 Allowed 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.263 -0.575 . . . . 1.0 112.131 -178.251 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 35.8 mtt180 -71.21 -39.47 71.72 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.23 0.456 . . . . 1.0 112.23 -174.124 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.938 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 16.5 m -58.29 -58.59 17.8 Favored Pre-proline 0 CA--C 1.543 0.677 0 N-CA-C 111.753 0.279 . . . . 1.0 111.753 179.155 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.639 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 38.1 Cg_endo -63.71 -23.94 69.31 Favored 'Trans proline' 0 C--N 1.358 1.042 0 C-N-CA 122.341 2.027 . . . . 1.0 112.431 178.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.678 ' HB3' HD13 ' A' ' 142' ' ' ILE . 49.0 mmm -59.74 -55.47 33.97 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.228 -0.286 . . . . 1.0 110.228 179.284 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.454 ' HA ' ' HB2' ' A' ' 24' ' ' MET . . . -75.36 -26.19 58.32 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.238 -0.585 . . . . 1.0 110.522 -179.425 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.625 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 11.8 tt0 -52.44 -54.3 34.01 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 115.377 -0.828 . . . . 1.0 110.008 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.722 ' HE3' ' HB2' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -84.78 -23.44 29.19 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.362 -0.836 . . . . 1.0 110.576 -175.844 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.671 ' HB3' HD11 ' A' ' 146' ' ' LEU . 5.2 mmm -62.82 -75.74 0.07 Allowed 'General case' 0 C--O 1.237 0.442 0 N-CA-C 112.679 0.622 . . . . 1.0 112.679 -178.427 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.774 ' HB3' HD22 ' A' ' 146' ' ' LEU . 18.6 p90 -79.06 -28.92 43.22 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 119.848 -0.741 . . . . 1.0 111.251 -174.694 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.69 ' HB2' HG21 ' A' ' 40' ' ' VAL . . . -64.06 -37.15 86.38 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 119.486 -0.886 . . . . 1.0 110.661 179.391 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.607 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -64.54 -38.69 91.87 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.676 -0.861 . . . . 1.0 108.676 176.507 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.555 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 77.8 mt-30 -60.63 -41.56 95.12 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.619 -0.718 . . . . 1.0 110.426 176.07 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.653 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 88.2 mt -57.01 -58.97 5.84 Favored 'General case' 0 C--O 1.225 -0.201 0 CA-C-N 115.774 -0.648 . . . . 1.0 110.89 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.531 ' HD3' ' HA ' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -59.31 -35.37 73.67 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.204 -0.598 . . . . 1.0 111.163 178.654 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -63.33 -26.29 68.7 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.244 0.461 . . . . 1.0 112.244 177.51 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.653 ' HG2' ' O ' ' A' ' 29' ' ' LEU . 4.0 ptm85 -96.21 -23.37 16.75 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 119.775 -0.77 . . . . 1.0 109.954 178.86 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 113.47 34.65 1.71 Allowed Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.174 -0.921 . . . . 1.0 112.433 177.245 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 25.8 mt -129.37 5.08 5.19 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.853 -0.425 . . . . 1.0 109.853 -178.33 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.452 ' HA3' ' HB3' ' A' ' 30' ' ' ARG . . . -59.39 -31.6 70.54 Favored Glycine 0 C--N 1.332 0.308 0 CA-C-N 115.819 -0.628 . . . . 1.0 112.967 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -88.17 -20.85 25.03 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.864 0.364 . . . . 1.0 110.186 176.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.02 -25.05 40.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.814 -0.63 . . . . 1.0 111.299 -178.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.644 HG13 ' HB3' ' A' ' 5' ' ' LEU . 5.9 t -130.13 126.29 61.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 121.106 -0.238 . . . . 1.0 110.604 -178.337 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.669 ' O ' ' HA ' ' A' ' 6' ' ' HIS . 24.2 mmt180 -99.61 98.89 9.7 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.185 0.517 . . . . 1.0 110.876 177.708 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.69 HG21 ' HB2' ' A' ' 26' ' ' ALA . 1.5 m -88.45 136.75 22.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 CA-C-N 115.703 -0.68 . . . . 1.0 109.299 178.228 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.533 ' O ' ' HA ' ' A' ' 8' ' ' THR . 28.9 p -146.59 -179.8 7.02 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.117 -0.947 . . . . 1.0 109.756 -175.816 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.938 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 95.1 p -158.19 161.4 37.83 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.382 -0.527 . . . . 1.0 110.936 -178.744 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.502 ' HB2' ' CD2' ' A' ' 80' ' ' HIS . . . -165.09 168.37 17.36 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.309 0.576 . . . . 1.0 111.415 -179.201 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -124.68 132.15 8.08 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 110.805 -0.918 . . . . 1.0 110.805 177.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.591 HG23 ' CG1' ' A' ' 10' ' ' VAL . 20.2 p -66.72 -28.82 68.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.948 0.404 . . . . 1.0 111.446 -176.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -101.64 7.13 55.49 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.653 -0.784 . . . . 1.0 113.059 -176.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 42.85 39.39 1.7 Allowed 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 113.46 0.911 . . . . 1.0 113.46 178.37 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -47.18 -79.64 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.635 0.731 . . . . 1.0 112.533 178.7 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -103.79 42.11 1.21 Allowed 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.992 -1.004 . . . . 1.0 111.095 -178.496 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.411 HG23 ' HA ' ' A' ' 74' ' ' ALA . 9.4 p -60.53 125.63 17.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.797 -0.638 . . . . 1.0 110.408 178.469 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.33 -12.76 64.99 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.703 -0.76 . . . . 1.0 111.834 -177.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.33 -161.06 0.38 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.728 -0.471 . . . . 1.0 109.728 178.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 71' ' ' HIS . 30.0 t -127.34 169.45 13.56 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.512 -0.921 . . . . 1.0 108.512 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -51.14 138.96 19.2 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.921 0.391 . . . . 1.0 111.707 -179.062 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.748 ' OD1' ' HG2' ' A' ' 57' ' ' ARG . 12.1 t70 -62.62 140.97 58.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.585 -0.734 . . . . 1.0 111.05 -176.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -51.06 -33.62 26.45 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.793 1.035 . . . . 1.0 113.793 -178.256 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.748 ' HG2' ' OD1' ' A' ' 55' ' ' ASP . 9.9 ptm180 -72.63 -41.16 65.81 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 118.958 0.799 . . . . 1.0 110.619 -178.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.15 -38.89 75.57 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.134 0.493 . . . . 1.0 109.955 179.221 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.13 -42.8 99.2 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.517 -0.765 . . . . 1.0 109.909 178.298 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.414 ' O ' ' HG2' ' A' ' 63' ' ' ARG . . . -57.82 -45.92 92.97 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.903 -0.665 . . . . 1.0 113.224 178.288 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 5.8 m -72.88 -39.75 59.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 117.585 0.692 . . . . 1.0 111.414 -178.391 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.632 ' HB2' HG22 ' A' ' 69' ' ' THR . 94.8 mt -60.92 -55.2 35.81 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 120.774 0.321 . . . . 1.0 110.5 179.063 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.414 ' HG2' ' O ' ' A' ' 60' ' ' GLY . 11.7 ptm180 -58.59 -33.16 69.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.75 -0.659 . . . . 1.0 110.729 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.95 -34.48 78.08 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.081 0.467 . . . . 1.0 110.932 179.196 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -95.62 5.68 50.86 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.891 -0.595 . . . . 1.0 111.409 -178.224 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.91 12.4 66.23 Favored Glycine 0 N--CA 1.452 -0.267 0 CA-C-N 115.589 -0.732 . . . . 1.0 112.575 176.487 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.406 ' CD1' ' HG2' ' A' ' 27' ' ' GLN . 65.6 m-85 -91.5 147.88 36.24 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-O 120.625 0.25 . . . . 1.0 110.827 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.547 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 38.1 Cg_endo -69.0 154.85 70.05 Favored 'Trans proline' 0 CA--C 1.508 -0.799 0 C-N-CA 122.529 2.152 . . . . 1.0 110.544 177.106 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.632 HG22 ' HB2' ' A' ' 62' ' ' LEU . 27.9 p -127.85 14.85 6.92 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.226 0.536 . . . . 1.0 110.428 -178.054 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -84.03 119.03 24.45 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.32 -0.855 . . . . 1.0 109.839 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.722 ' HB2' ' HE3' ' A' ' 23' ' ' LYS . 3.5 t60 -162.18 142.58 10.14 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.334 -176.56 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 -113.69 115.52 27.99 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 107.887 -1.153 . . . . 1.0 107.887 177.194 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.579 ' HB1' ' OD1' ' A' ' 14' ' ' ASN . . . -60.02 138.44 57.86 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 112.28 0.474 . . . . 1.0 112.28 -177.461 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.411 ' HA ' HG23 ' A' ' 50' ' ' VAL . . . -134.74 158.02 45.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.228 178.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -94.09 155.43 17.09 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.385 -0.598 . . . . 1.0 109.385 177.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.473 HG11 ' CD2' ' A' ' 97' ' ' LEU . 5.0 t -69.63 113.31 5.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.559 -0.534 . . . . 1.0 109.559 178.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.506 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -125.31 -166.65 12.38 Favored Glycine 0 N--CA 1.44 -1.061 0 CA-C-N 115.44 -0.8 . . . . 1.0 111.353 -179.162 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 83.8 m -55.83 -53.31 58.26 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.967 0.413 . . . . 1.0 111.623 -178.487 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.505 ' CD ' ' H ' ' A' ' 79' ' ' GLU . 1.6 pm0 -56.14 -32.72 64.51 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.415 -0.811 . . . . 1.0 111.287 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.502 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 78.3 m80 -74.81 -39.73 61.52 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.048 -0.524 . . . . 1.0 109.727 179.154 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.608 ' HA ' HD21 ' A' ' 86' ' ' LEU . 29.5 mt -69.03 -20.76 64.13 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.89 -0.595 . . . . 1.0 110.997 177.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.41 -4.6 59.21 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.773 -177.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.55 ' HB1' ' O ' ' A' ' 6' ' ' HIS . . . -59.58 153.61 19.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.706 -0.679 . . . . 1.0 111.064 179.234 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -79.4 -16.82 55.58 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.162 0.506 . . . . 1.0 110.036 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.719 HD13 HG13 ' A' ' 7' ' ' VAL . 0.3 OUTLIER -152.91 114.12 4.2 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.403 -0.817 . . . . 1.0 109.088 -178.057 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.615 ' HB3' HD13 ' A' ' 97' ' ' LEU . 4.9 mp -104.32 106.48 17.0 Favored 'General case' 0 N--CA 1.424 -1.726 0 CA-C-N 115.322 -0.854 . . . . 1.0 109.724 178.124 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.679 HG11 HD23 ' A' ' 110' ' ' LEU . 53.9 t -86.67 94.98 4.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 114.926 -1.034 . . . . 1.0 111.242 -177.173 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.92 143.68 31.49 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.501 -0.772 . . . . 1.0 110.805 178.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.488 HD23 ' HB2' ' A' ' 11' ' ' CYS . 4.4 mm? -93.93 -16.29 24.12 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.758 -0.655 . . . . 1.0 109.535 178.293 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -141.49 152.48 44.22 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.504 -0.771 . . . . 1.0 110.514 -177.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.425 ' HG2' ' H ' ' A' ' 91' ' ' ARG . 9.2 ptt180 -61.15 -21.45 63.77 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.649 0.593 . . . . 1.0 111.238 177.162 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.689 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 95.4 m-20 -73.84 -50.6 19.61 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 109.644 -0.502 . . . . 1.0 109.644 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.66 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 8.5 m170 -60.16 -43.63 95.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.452 -0.795 . . . . 1.0 109.786 178.594 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.95 -44.68 94.26 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.164 0.507 . . . . 1.0 110.544 179.175 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.477 ' O ' ' HG2' ' A' ' 98' ' ' ARG . 0.3 OUTLIER -57.83 -44.07 86.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.38 -0.827 . . . . 1.0 111.225 178.173 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.744 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 50.8 mt -64.69 -49.87 69.21 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 116.279 -0.418 . . . . 1.0 110.49 -177.162 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.674 HD21 HG21 ' A' ' 10' ' ' VAL . 49.3 mt -51.97 -56.76 12.2 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.947 -0.57 . . . . 1.0 111.641 -178.586 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.477 ' HG2' ' O ' ' A' ' 95' ' ' ARG . 26.1 ptt85 -59.62 -45.57 91.56 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.138 -0.483 . . . . 1.0 111.729 -176.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.64 ' HG3' ' O ' ' A' ' 96' ' ' LEU . 1.2 pp0? -69.42 -21.55 63.74 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 120.967 0.413 . . . . 1.0 110.857 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.744 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 10.8 mt -78.72 -6.82 56.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.043 -0.526 . . . . 1.0 111.966 -178.393 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 144.1 -29.31 1.94 Allowed Glycine 0 CA--C 1.506 -0.479 0 C-N-CA 119.828 -1.177 . . . . 1.0 113.021 178.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.765 HG12 ' H ' ' A' ' 103' ' ' GLU . 1.6 t -74.85 -153.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-O 121.541 0.686 . . . . 1.0 110.814 -178.524 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.765 ' H ' HG12 ' A' ' 102' ' ' VAL . 12.6 pt-20 -163.59 159.45 21.83 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.895 -1.15 . . . . 1.0 107.895 -178.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.475 ' HA ' ' HB ' ' A' ' 107' ' ' VAL . . . -67.71 -17.28 64.51 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.665 -0.414 . . . . 1.0 112.031 -173.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.92 -37.17 76.06 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 173.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.633 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 2.5 mtp85 -94.73 -34.98 12.33 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 114.744 -1.116 . . . . 1.0 110.422 -178.61 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 103' ' ' GLU . 39.5 t -79.57 114.56 20.57 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.423 -179.106 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.475 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 15.1 mmt180 -135.42 147.37 48.95 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 120.212 -0.595 . . . . 1.0 110.403 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.657 ' HB2' ' HB2' ' A' ' 112' ' ' SER . 77.0 mmm -78.07 139.05 39.06 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.691 -0.686 . . . . 1.0 110.037 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.679 HD23 HG11 ' A' ' 87' ' ' VAL . 2.9 tm? -56.89 -50.18 73.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.602 0.239 . . . . 1.0 110.963 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.09 -12.08 61.04 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.082 0.468 . . . . 1.0 110.747 -177.465 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.657 ' HB2' ' HB2' ' A' ' 109' ' ' MET . 32.5 t -78.69 -4.86 51.22 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.978 -0.555 . . . . 1.0 111.011 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.581 ' HZ ' HD21 ' A' ' 85' ' ' LEU . 86.4 m-85 -91.8 -21.06 20.87 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.049 0.452 . . . . 1.0 109.873 175.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.6 t0 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 115.303 -0.862 . . . . 1.0 110.533 -179.956 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.431 ' HA ' ' HB3' ' A' ' 139' ' ' PHE . 20.4 mt-10 . . . . . 0 N--CA 1.453 -0.29 0 CA-C-O 120.64 0.257 . . . . 1.0 110.883 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.577 ' O ' HG23 ' A' ' 141' ' ' VAL . 23.5 tp10 -63.99 -49.98 70.36 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.994 -0.743 . . . . 1.0 108.994 175.225 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.405 ' O ' HD12 ' A' ' 142' ' ' ILE . 87.2 t -59.41 -42.91 89.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.323 -0.853 . . . . 1.0 108.889 175.832 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.431 ' HB3' ' HA ' ' A' ' 136' ' ' GLU . 45.6 t80 -53.9 -43.41 69.67 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.159 -1.382 . . . . 1.0 109.553 175.42 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.558 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -65.03 -40.86 95.43 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.583 -0.735 . . . . 1.0 110.913 179.012 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 137' ' ' GLU . 21.5 t -56.17 -48.63 78.95 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 CA-C-O 121.868 0.842 . . . . 1.0 109.537 177.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.678 HD13 ' HB3' ' A' ' 20' ' ' MET . 5.3 mt -65.62 -51.88 57.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 114.763 -1.108 . . . . 1.0 111.593 -179.346 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.558 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 8.8 pt-20 -56.09 -33.21 64.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.745 0.307 . . . . 1.0 110.506 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 72.7 m -72.37 -28.44 63.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.889 -0.596 . . . . 1.0 110.927 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.465 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -87.61 -23.86 24.15 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-N 115.838 -0.619 . . . . 1.0 111.801 179.208 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.774 HD22 ' HB3' ' A' ' 25' ' ' PHE . 13.6 mt -55.86 -37.97 63.02 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 120.562 -0.455 . . . . 1.0 112.033 -177.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.632 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 57.8 Cg_endo -69.73 -9.65 26.65 Favored 'Trans proline' 0 C--N 1.363 1.314 0 C-N-CA 122.666 2.244 . . . . 1.0 112.084 178.223 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.56 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -106.09 -32.28 3.83 Favored Glycine 0 N--CA 1.442 -0.934 0 N-CA-C 109.896 -1.282 . . . . 1.0 109.896 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.473 ' O ' HG13 ' A' ' 153' ' ' VAL . 0.4 OUTLIER -74.96 -39.83 61.11 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.448 -0.945 . . . . 1.0 108.448 178.507 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -54.52 -50.99 66.53 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.364 -0.835 . . . . 1.0 110.578 175.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -60.79 -45.76 93.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.367 -0.833 . . . . 1.0 111.611 -176.692 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' TRP . . . . . 0.71 ' HZ3' HD21 ' A' ' 5' ' ' LEU . 22.2 t90 -60.2 -55.24 36.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.136 -0.938 . . . . 1.0 110.695 -177.749 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.473 HG13 ' O ' ' A' ' 149' ' ' LEU . 5.3 m -61.19 -40.39 85.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.524 -0.307 . . . . 1.0 110.527 -178.047 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.454 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 0.5 OUTLIER -60.95 -53.92 51.32 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.085 0.469 . . . . 1.0 111.104 179.216 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.503 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 10.5 pt-20 -61.97 -36.47 81.57 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.698 -0.683 . . . . 1.0 110.654 -177.108 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.454 ' HG3' ' CH2' ' A' ' 152' ' ' TRP . 14.0 mmt180 -73.88 -44.54 55.05 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 116.084 -0.507 . . . . 1.0 111.122 -178.586 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 4.0 pp . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 120.993 0.425 . . . . 1.0 110.11 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.575 0 N-CA-C 111.653 -0.579 . . . . 1.0 111.653 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.7 mtm -88.89 81.21 6.95 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.607 -0.516 . . . . 1.0 109.607 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.769 ' HB3' ' HA3' ' A' ' 161' ' ' GLY . 26.9 p -80.96 117.25 21.42 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.941 -0.572 . . . . 1.0 110.316 -178.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.563 ' HB3' ' HD2' ' A' ' 4' ' ' PRO . 0.7 OUTLIER -65.27 159.81 63.06 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.124 -0.695 . . . . 1.0 109.124 177.306 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.563 ' HD2' ' HB3' ' A' ' 3' ' ' ASP . 56.9 Cg_endo -69.49 164.13 35.44 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.401 2.068 . . . . 1.0 113.642 -176.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.765 HD13 ' HB3' ' A' ' 84' ' ' ASP . 0.2 OUTLIER -68.44 -177.89 1.01 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.623 -1.171 . . . . 1.0 109.522 178.078 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.696 ' HA ' ' O ' ' A' ' 39' ' ' ARG . 2.4 t-160 -156.84 87.7 1.01 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.924 -0.398 . . . . 1.0 109.924 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.794 HG13 HD13 ' A' ' 85' ' ' LEU . 2.5 t -97.15 104.68 16.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.473 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.591 ' HA ' ' O ' ' A' ' 41' ' ' THR . 12.7 t -107.99 115.58 30.39 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.163 0.506 . . . . 1.0 110.453 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.533 ' HD1' ' HB ' ' A' ' 87' ' ' VAL . 0.7 OUTLIER -84.56 131.75 34.59 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.438 -178.009 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.588 HG21 HD11 ' A' ' 97' ' ' LEU . 43.6 t -116.19 112.58 40.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.223 0.535 . . . . 1.0 111.891 -176.11 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.661 ' HB2' HD23 ' A' ' 89' ' ' LEU . 17.7 t -141.65 165.8 26.49 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.934 -0.575 . . . . 1.0 109.689 177.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.59 HG23 ' NE2' ' A' ' 93' ' ' HIS . 1.2 p -73.47 101.6 3.56 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.959 0.409 . . . . 1.0 110.782 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.944 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 120.68 -43.34 1.55 Allowed Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.859 -0.686 . . . . 1.0 111.863 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.711 ' ND2' ' H ' ' A' ' 74' ' ' ALA . 59.0 t30 60.2 25.82 15.22 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 122.169 0.985 . . . . 1.0 110.883 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.6 pt -126.54 0.66 4.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 115.602 -0.726 . . . . 1.0 111.15 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 23.1 m -120.6 -88.79 0.62 Allowed 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.439 -0.504 . . . . 1.0 111.916 -176.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.898 HH22 ' HA ' ' A' ' 126' ' ' ASP . 38.1 ttm105 -71.94 -40.42 68.72 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.282 0.475 . . . . 1.0 112.282 -174.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.453 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 24.5 m -58.47 -58.34 19.79 Favored Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 111.846 0.313 . . . . 1.0 111.846 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.526 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 40.2 Cg_endo -64.49 -20.99 66.37 Favored 'Trans proline' 0 C--N 1.357 0.978 0 C-N-CA 122.035 1.823 . . . . 1.0 112.166 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.697 ' HB3' HD13 ' A' ' 142' ' ' ILE . 41.9 mmm -62.97 -54.45 38.14 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.625 -0.261 . . . . 1.0 110.499 177.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.475 ' HA ' HG21 ' A' ' 142' ' ' ILE . . . -71.84 -27.83 63.16 Favored 'General case' 0 CA--C 1.509 -0.624 0 C-N-CA 120.461 -0.496 . . . . 1.0 110.076 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.619 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 15.8 tt0 -50.47 -53.47 29.48 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-N 114.741 -1.118 . . . . 1.0 109.852 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.821 ' HB3' ' HG2' ' A' ' 68' ' ' PRO . 0.1 OUTLIER -82.78 -27.32 31.07 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.165 -0.925 . . . . 1.0 110.22 -175.958 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.785 ' HB3' HD11 ' A' ' 146' ' ' LEU . 7.9 mmm -62.87 -75.61 0.07 Allowed 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 112.993 0.738 . . . . 1.0 112.993 -176.013 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.833 ' HB3' HD22 ' A' ' 146' ' ' LEU . 19.8 p90 -78.04 -29.92 49.61 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 119.958 -0.697 . . . . 1.0 111.219 -175.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.649 ' HB2' HG11 ' A' ' 40' ' ' VAL . . . -63.37 -38.15 90.02 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 119.413 -0.915 . . . . 1.0 110.57 179.106 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.643 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -63.36 -40.75 98.13 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.94 -0.763 . . . . 1.0 108.94 177.098 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.582 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 79.4 mt-30 -59.83 -41.88 92.32 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-N 115.85 -0.613 . . . . 1.0 110.679 176.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.67 ' HG ' ' O ' ' A' ' 25' ' ' PHE . 80.2 mt -55.89 -61.41 2.39 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.682 -0.69 . . . . 1.0 110.257 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.555 ' HB3' ' HA3' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -59.07 -33.56 70.95 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.793 -0.363 . . . . 1.0 111.374 178.553 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -63.37 -25.54 68.34 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.21 0.448 . . . . 1.0 112.21 176.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.598 ' HG2' ' O ' ' A' ' 29' ' ' LEU . 8.3 ptm85 -98.6 -21.29 16.54 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 120.05 -0.66 . . . . 1.0 110.104 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.27 33.17 1.83 Allowed Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 114.991 -1.004 . . . . 1.0 112.437 177.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.574 ' HG ' ' HG3' ' A' ' 32' ' ' ARG . 36.1 mt -127.14 6.47 6.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.982 0.391 . . . . 1.0 110.709 -178.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.555 ' HA3' ' HB3' ' A' ' 30' ' ' ARG . . . -54.21 -35.84 55.87 Favored Glycine 0 CA--C 1.52 0.374 0 C-N-CA 121.27 -0.49 . . . . 1.0 113.573 -177.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.614 ' HA ' ' NH1' ' A' ' 39' ' ' ARG . 2.8 m-20 -92.29 -14.02 29.48 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.97 0.414 . . . . 1.0 110.925 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.83 -17.93 49.13 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.875 -0.602 . . . . 1.0 111.2 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.705 HG23 ' HB3' ' A' ' 5' ' ' LEU . 0.4 OUTLIER -144.64 124.3 7.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.39 0.614 . . . . 1.0 111.055 179.436 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.696 ' O ' ' HA ' ' A' ' 6' ' ' HIS . 25.8 mmt180 -95.66 101.45 13.15 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.634 -0.712 . . . . 1.0 110.948 -178.176 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.649 HG11 ' HB2' ' A' ' 26' ' ' ALA . 1.6 m -89.03 136.61 23.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 109.035 -0.728 . . . . 1.0 109.035 178.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.591 ' O ' ' HA ' ' A' ' 8' ' ' THR . 31.7 p -146.6 -176.11 5.05 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.045 -0.98 . . . . 1.0 109.742 -175.054 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.439 ' HB3' ' HD2' ' A' ' 9' ' ' PHE . 49.2 p -158.76 160.66 36.56 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.153 -0.619 . . . . 1.0 111.253 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.619 ' HB2' ' CD2' ' A' ' 80' ' ' HIS . . . -162.68 161.88 26.66 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.315 0.579 . . . . 1.0 111.582 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -124.33 138.53 11.31 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 111.096 -0.802 . . . . 1.0 111.096 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.445 HG21 HD12 ' A' ' 96' ' ' LEU . 33.7 p -74.36 -24.0 59.09 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 111.962 0.356 . . . . 1.0 111.962 -176.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.584 ' HA3' ' CZ3' ' A' ' 48' ' ' TRP . . . -110.76 9.39 29.97 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.533 -0.841 . . . . 1.0 113.083 -178.162 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 42.67 37.35 1.0 Allowed 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 113.885 1.068 . . . . 1.0 113.885 177.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.944 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 1.5 m-90 -44.81 -70.41 0.1 Allowed 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.559 0.695 . . . . 1.0 112.369 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.686 ' O ' ' HB2' ' A' ' 52' ' ' SER . 6.8 m-70 -109.65 43.73 1.28 Allowed 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.1 -0.954 . . . . 1.0 111.057 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.43 HG23 ' HA ' ' A' ' 74' ' ' ALA . 14.8 p -62.54 129.74 26.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 C-N-CA 120.425 -0.51 . . . . 1.0 110.169 178.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.14 -13.5 66.88 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 121.109 -0.567 . . . . 1.0 111.684 -176.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.686 ' HB2' ' O ' ' A' ' 49' ' ' HIS . 0.4 OUTLIER -80.0 -162.26 0.42 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.174 0.511 . . . . 1.0 110.669 179.58 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 33.7 t -126.45 175.94 7.52 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.291 -1.003 . . . . 1.0 108.291 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.06 141.06 47.21 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.955 0.407 . . . . 1.0 111.374 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.456 ' OD1' ' HG2' ' A' ' 57' ' ' ARG . 13.2 t70 -61.05 141.15 57.61 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.285 -0.87 . . . . 1.0 111.436 -177.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -46.24 -37.8 7.67 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.727 -1.124 . . . . 1.0 113.555 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.674 ' O ' HG23 ' A' ' 61' ' ' VAL . 14.9 ptp180 -69.95 -45.31 67.73 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 122.276 -0.265 . . . . 1.0 110.897 -176.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.0 -31.62 68.19 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.485 -178.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.64 -43.43 98.82 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.893 -0.594 . . . . 1.0 110.046 178.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.41 -42.4 97.65 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.786 -0.721 . . . . 1.0 111.486 177.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.674 HG23 ' O ' ' A' ' 57' ' ' ARG . 61.3 t -58.05 -58.53 6.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-O 120.975 0.417 . . . . 1.0 111.273 179.172 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.735 ' HB2' HG22 ' A' ' 69' ' ' THR . 90.1 mt -59.04 -51.21 71.02 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.061 -0.518 . . . . 1.0 111.662 -178.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -60.87 -29.27 69.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.482 -0.326 . . . . 1.0 110.894 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.19 -31.48 71.91 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.225 0.536 . . . . 1.0 110.546 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -99.42 1.89 44.63 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.492 -0.776 . . . . 1.0 111.505 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.97 16.26 56.41 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 121.045 -0.597 . . . . 1.0 113.213 177.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -92.08 149.58 38.96 Favored Pre-proline 0 C--N 1.322 -0.627 0 C-N-CA 122.083 0.153 . . . . 1.0 111.082 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.821 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 49.6 Cg_endo -68.89 158.23 58.72 Favored 'Trans proline' 0 CA--C 1.511 -0.634 0 C-N-CA 122.519 2.146 . . . . 1.0 110.36 176.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.735 HG22 ' HB2' ' A' ' 62' ' ' LEU . 58.1 p -134.53 3.53 3.31 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 119.562 -0.855 . . . . 1.0 112.65 -176.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -79.85 135.65 36.5 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.762 -0.375 . . . . 1.0 110.429 -179.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -175.58 153.99 1.54 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.698 -0.683 . . . . 1.0 109.251 -176.414 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -123.3 116.72 23.79 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.208 -1.034 . . . . 1.0 108.208 177.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' A' ' 49' ' ' HIS . . . -61.3 139.02 58.24 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.259 0.552 . . . . 1.0 111.895 -176.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.711 ' H ' ' ND2' ' A' ' 14' ' ' ASN . . . -130.88 161.23 32.3 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.427 -0.806 . . . . 1.0 109.942 178.325 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -98.1 161.41 13.73 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.943 -0.762 . . . . 1.0 108.943 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.548 HG11 HD23 ' A' ' 97' ' ' LEU . 94.0 t -67.44 102.72 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.398 0.618 . . . . 1.0 110.388 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.556 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -120.79 -170.87 14.23 Favored Glycine 0 N--CA 1.443 -0.882 0 CA-C-N 115.046 -0.979 . . . . 1.0 111.824 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 88.4 m -55.92 -54.12 48.52 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.758 0.651 . . . . 1.0 112.758 -178.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.533 ' HG2' ' N ' ' A' ' 80' ' ' HIS . 0.6 OUTLIER -56.43 -31.36 63.84 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.893 -0.594 . . . . 1.0 111.089 -178.167 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.619 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 79.1 m80 -76.32 -42.36 45.4 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.6 -0.727 . . . . 1.0 110.064 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.556 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 23.2 mt -66.21 -19.77 65.93 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.476 178.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -84.77 -5.33 59.32 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.871 -0.604 . . . . 1.0 110.998 -178.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.573 ' HB1' ' O ' ' A' ' 6' ' ' HIS . . . -60.8 157.85 14.14 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.071 -0.513 . . . . 1.0 111.644 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.765 ' HB3' HD13 ' A' ' 5' ' ' LEU . 29.9 t70 -82.69 -16.57 47.67 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 115.915 -0.584 . . . . 1.0 109.807 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.794 HD13 HG13 ' A' ' 7' ' ' VAL . 0.4 OUTLIER -154.61 115.82 4.05 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.334 -0.848 . . . . 1.0 109.059 -176.581 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.577 ' HG ' HG22 ' A' ' 8' ' ' THR . 5.4 mp -106.74 106.81 17.52 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-N 115.479 -0.782 . . . . 1.0 109.853 177.453 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.559 HG11 HD23 ' A' ' 110' ' ' LEU . 52.3 t -85.14 92.26 3.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 114.896 -1.047 . . . . 1.0 110.869 -176.038 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.27 147.54 32.49 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.514 -0.766 . . . . 1.0 110.98 179.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.661 HD23 ' HB2' ' A' ' 11' ' ' CYS . 2.9 mm? -103.73 -4.85 23.14 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.273 0.558 . . . . 1.0 110.49 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.419 ' CG ' ' H ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -155.37 153.37 30.35 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.71 -0.677 . . . . 1.0 111.223 178.538 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 25.4 ptt180 -50.19 -32.09 15.44 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 114.903 -1.044 . . . . 1.0 112.998 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.714 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 5.9 m-20 -76.3 -48.46 20.03 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.288 -0.264 . . . . 1.0 110.288 -176.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.651 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 14.2 m170 -55.14 -48.46 73.65 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.73 -0.47 . . . . 1.0 109.73 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.458 ' HA ' HG21 ' A' ' 107' ' ' VAL . . . -59.3 -43.45 92.6 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.028 0.442 . . . . 1.0 110.849 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 9.8 ttt-85 -59.67 -45.51 91.84 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 115.408 -0.815 . . . . 1.0 111.66 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.772 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 56.0 mt -63.86 -49.49 72.55 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 115.902 -0.59 . . . . 1.0 110.028 -175.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.651 ' HG ' ' O ' ' A' ' 93' ' ' HIS . 22.6 mt -52.77 -57.83 8.86 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.668 -0.696 . . . . 1.0 111.368 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.604 ' HA ' ' HB ' ' A' ' 102' ' ' VAL . 9.4 ptt180 -60.42 -43.21 96.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.11 -0.496 . . . . 1.0 111.878 -176.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.648 ' HG3' ' O ' ' A' ' 96' ' ' LEU . 1.3 pp0? -68.33 -23.31 64.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.911 0.386 . . . . 1.0 110.287 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.772 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 11.4 mt -79.2 -13.43 59.71 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.87 -0.605 . . . . 1.0 112.194 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 148.4 -22.87 1.37 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.067 -1.063 . . . . 1.0 112.773 -178.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.975 HG12 ' H ' ' A' ' 103' ' ' GLU . 3.3 t -75.6 -156.09 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.123 0.487 . . . . 1.0 110.119 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.975 ' H ' HG12 ' A' ' 102' ' ' VAL . 9.3 pt-20 -170.44 163.84 8.57 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.755 -1.202 . . . . 1.0 107.755 -177.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.738 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -65.83 -22.14 66.53 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.754 0.311 . . . . 1.0 111.213 -176.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.487 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . . . -58.52 -37.8 76.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.295 0.569 . . . . 1.0 109.947 174.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.698 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 10.5 mtt180 -96.21 -45.33 6.89 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 115.193 -0.912 . . . . 1.0 110.778 -177.036 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.738 HG12 ' HA ' ' A' ' 104' ' ' ALA . 8.2 p -79.07 124.8 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-O 121.289 0.566 . . . . 1.0 110.49 -176.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.532 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 10.6 mmm180 -140.85 147.92 39.71 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.285 -0.635 . . . . 1.0 109.285 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.479 ' HB2' ' HB2' ' A' ' 112' ' ' SER . 83.1 mmm -78.88 140.24 38.16 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.451 -0.34 . . . . 1.0 110.375 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.559 HD23 HG11 ' A' ' 87' ' ' VAL . 3.0 tm? -58.45 -51.69 68.77 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 122.973 0.171 . . . . 1.0 111.262 -179.161 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 46.1 ttm-85 -71.26 -14.51 62.25 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 120.278 -0.569 . . . . 1.0 110.442 -178.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.479 ' HB2' ' HB2' ' A' ' 109' ' ' MET . 42.2 t -73.62 -9.51 58.75 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.71 -0.396 . . . . 1.0 110.423 179.222 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.553 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 97.2 m-85 -91.02 -22.68 20.66 Favored 'General case' 0 C--N 1.341 0.213 0 N-CA-C 109.782 -0.451 . . . . 1.0 109.782 175.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -59.43 117.66 24.22 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.22 -0.9 . . . . 1.0 111.019 -178.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.503 ' HD2' ' O ' ' A' ' 144' ' ' SER . 47.9 Cg_endo -66.36 -23.54 51.25 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.917 2.412 . . . . 1.0 112.383 -179.266 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -91.93 1.0 57.46 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 116.6 -0.273 . . . . 1.0 111.492 -178.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 39.4 t -58.59 -51.31 70.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.245 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 87.91 -70.12 2.77 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.157 -1.021 . . . . 1.0 111.144 178.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.3 m -91.25 166.5 12.9 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.054 -0.721 . . . . 1.0 109.054 177.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 59.2 m170 -64.85 136.82 57.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.892 0.377 . . . . 1.0 110.208 178.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -106.75 89.91 3.16 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.686 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.448 ' HA ' ' HG3' ' A' ' 109' ' ' MET . 2.7 mm? -99.18 15.26 26.6 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.949 0.404 . . . . 1.0 110.155 178.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -168.49 130.09 1.33 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.722 -0.672 . . . . 1.0 109.421 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.451 ' HB ' ' O ' ' A' ' 89' ' ' LEU . 59.4 t -107.62 154.4 8.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.816 -0.629 . . . . 1.0 109.599 -179.152 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -64.67 -175.79 0.21 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.102 -0.499 . . . . 1.0 111.209 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.898 ' HA ' HH22 ' A' ' 17' ' ' ARG . 2.2 t70 -167.39 120.87 0.78 Allowed Pre-proline 0 C--N 1.324 -0.539 0 N-CA-C 108.55 -0.907 . . . . 1.0 108.55 178.318 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.967 ' HB2' ' HB3' ' A' ' 134' ' ' ASP . 68.8 Cg_endo -84.44 93.81 0.73 Allowed 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.988 2.459 . . . . 1.0 114.0 -173.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.78 -15.74 36.08 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 120.716 -0.394 . . . . 1.0 111.474 178.312 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -71.47 -36.18 71.1 Favored 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 117.841 -1.544 . . . . 1.0 110.283 -176.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.62 58.88 3.98 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 119.768 -1.206 . . . . 1.0 113.437 173.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -119.5 -175.72 3.0 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 107.967 -1.123 . . . . 1.0 107.967 176.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 6.0 t-160 -66.09 -36.08 82.24 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.568 -0.901 . . . . 1.0 108.568 178.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 15.2 m -60.97 -50.1 74.75 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.481 -0.781 . . . . 1.0 111.246 178.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.967 ' HB3' ' HB2' ' A' ' 127' ' ' PRO . 0.9 OUTLIER -50.92 -41.39 58.67 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 112.233 0.457 . . . . 1.0 112.233 -178.69 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.468 ' CE1' ' HD3' ' A' ' 57' ' ' ARG . 10.3 m-30 -72.16 -53.17 13.47 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.256 -0.429 . . . . 1.0 111.024 -174.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -66.76 -25.34 66.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.143 -0.481 . . . . 1.0 110.806 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.543 ' O ' HG23 ' A' ' 141' ' ' VAL . 16.9 tp10 -61.58 -51.56 68.04 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.659 -0.7 . . . . 1.0 110.126 178.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.641 ' HA ' HG23 ' A' ' 141' ' ' VAL . 71.9 t -59.85 -41.15 84.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.758 -0.655 . . . . 1.0 110.346 178.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.543 ' HB2' HG11 ' A' ' 61' ' ' VAL . 49.8 t80 -54.65 -43.6 72.51 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.185 -0.916 . . . . 1.0 109.418 176.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.53 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -63.94 -41.86 97.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.595 -0.729 . . . . 1.0 110.798 178.058 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.641 HG23 ' HA ' ' A' ' 138' ' ' VAL . 5.6 t -53.83 -53.1 29.22 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 CA-C-O 121.841 0.829 . . . . 1.0 110.031 177.58 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.697 HD13 ' HB3' ' A' ' 20' ' ' MET . 6.8 mt -64.97 -50.94 72.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 114.649 -1.16 . . . . 1.0 112.085 -177.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.53 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 10.3 pt-20 -57.33 -30.87 65.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.677 0.275 . . . . 1.0 110.533 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.503 ' O ' ' HD2' ' A' ' 115' ' ' PRO . 1.9 t -73.49 -29.62 62.62 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-O 121.2 0.524 . . . . 1.0 110.164 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.502 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -86.7 -24.12 25.31 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-N 116.018 -0.537 . . . . 1.0 112.128 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.833 HD22 ' HB3' ' A' ' 25' ' ' PHE . 14.4 mt -55.15 -36.42 45.14 Favored Pre-proline 0 CA--C 1.545 0.769 0 N-CA-C 112.745 0.646 . . . . 1.0 112.745 -177.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.632 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 56.9 Cg_endo -70.22 -10.59 28.53 Favored 'Trans proline' 0 C--N 1.363 1.299 0 C-N-CA 122.63 2.22 . . . . 1.0 112.09 176.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.553 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -106.07 -33.74 3.39 Favored Glycine 0 N--CA 1.449 -0.492 0 N-CA-C 110.372 -1.091 . . . . 1.0 110.372 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.468 ' O ' HG13 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -73.02 -39.23 66.17 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.0 -1.111 . . . . 1.0 108.0 178.369 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.517 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 0.2 OUTLIER -52.97 -58.4 7.11 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 114.801 -1.091 . . . . 1.0 110.834 175.293 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -56.92 -39.83 75.22 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.766 -1.106 . . . . 1.0 111.304 -174.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' TRP . . . . . 0.758 ' HZ3' HD11 ' A' ' 5' ' ' LEU . 22.3 t90 -65.18 -55.75 16.8 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.602 -0.726 . . . . 1.0 110.875 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.468 HG13 ' O ' ' A' ' 149' ' ' LEU . 6.5 m -61.35 -41.97 91.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.888 -0.412 . . . . 1.0 109.888 -178.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.438 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 3.3 m-20 -60.19 -51.26 70.35 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-O 120.96 0.41 . . . . 1.0 110.855 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 7.1 pt-20 -63.4 -38.35 90.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.95 -177.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.529 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 5.5 mmt85 -73.81 -43.02 60.08 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.701 -0.681 . . . . 1.0 110.802 -176.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 4.0 pp -68.06 -26.16 65.72 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.017 -0.538 . . . . 1.0 109.998 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -73.26 -49.37 28.07 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.745 -0.661 . . . . 1.0 110.764 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.431 ' HG2' ' O ' ' A' ' 155' ' ' GLU . 11.4 ptp180 -76.79 -16.55 59.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.776 -0.647 . . . . 1.0 112.228 -177.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -58.53 -46.91 85.81 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.721 -0.672 . . . . 1.0 111.599 -174.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.769 ' HA3' ' HB3' ' A' ' 2' ' ' SER . . . -121.64 145.39 16.87 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 119.72 -1.229 . . . . 1.0 112.357 176.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.463 ' HD3' ' HA2' ' A' ' 161' ' ' GLY . 6.3 Cg_endo -87.7 -149.89 0.04 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 123.647 2.898 . . . . 1.0 112.429 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.432 ' H ' ' HB2' ' A' ' 162' ' ' PRO . 21.5 t . . . . . 0 C--N 1.31 -1.119 0 CA-C-N 114.148 -1.387 . . . . 1.0 110.629 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.731 0 N-CA-C 111.96 -0.456 . . . . 1.0 111.96 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -82.93 23.66 0.82 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.138 0.494 . . . . 1.0 109.866 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.5 p -166.73 165.87 16.17 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.382 -0.827 . . . . 1.0 109.993 -177.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.851 ' HB2' ' HD2' ' A' ' 4' ' ' PRO . 4.0 p-10 -169.13 168.06 5.28 Favored Pre-proline 0 C--N 1.329 -0.319 0 N-CA-C 109.313 -0.625 . . . . 1.0 109.313 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.851 ' HD2' ' HB2' ' A' ' 3' ' ' ASP . 17.8 Cg_endo -61.35 164.61 14.72 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.744 2.296 . . . . 1.0 112.915 -178.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.818 ' HB3' HG23 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -65.38 175.92 1.57 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.599 -0.728 . . . . 1.0 109.684 179.67 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.803 ' H ' HD13 ' A' ' 5' ' ' LEU . 0.5 OUTLIER -153.75 100.28 2.37 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.883 -0.414 . . . . 1.0 109.883 179.175 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.705 HG13 HD13 ' A' ' 85' ' ' LEU . 1.8 t -103.6 116.84 48.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 107.983 -1.118 . . . . 1.0 107.983 178.225 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.621 ' CG2' ' HG ' ' A' ' 86' ' ' LEU . 15.1 t -119.77 114.31 21.95 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 120.589 -0.444 . . . . 1.0 110.81 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.759 ' HZ ' ' HE1' ' A' ' 25' ' ' PHE . 0.4 OUTLIER -84.35 131.41 34.7 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 120.398 -0.521 . . . . 1.0 110.177 -179.619 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.596 HG21 HD11 ' A' ' 97' ' ' LEU . 30.1 t -113.66 118.42 58.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 116.284 -0.416 . . . . 1.0 111.365 -176.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.44 ' HB2' HD23 ' A' ' 89' ' ' LEU . 46.2 t -148.65 146.8 28.34 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.996 -0.372 . . . . 1.0 109.996 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.54 93.27 1.19 Allowed 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 121.115 0.483 . . . . 1.0 110.394 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 148.08 -37.99 1.06 Allowed Glycine 0 N--CA 1.441 -1.01 0 CA-C-N 115.183 -0.917 . . . . 1.0 111.088 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.894 HD21 ' HA3' ' A' ' 44' ' ' GLY . 1.4 p30 48.47 24.43 0.74 Allowed 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.063 0.945 . . . . 1.0 112.864 178.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.446 HG12 ' HB2' ' A' ' 49' ' ' HIS . 1.3 pt -148.23 47.2 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.451 0 CA-C-N 115.574 -0.739 . . . . 1.0 110.625 178.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.45 ' HA ' ' OD1' ' A' ' 55' ' ' ASP . 53.2 t -161.68 -84.56 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.535 -0.757 . . . . 1.0 109.599 173.082 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.609 ' NH2' ' HA ' ' A' ' 126' ' ' ASP . 27.4 mmt85 -59.79 -57.16 14.12 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.795 -0.639 . . . . 1.0 112.002 -178.418 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . 1.067 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 6.2 m -52.11 -58.35 11.72 Favored Pre-proline 0 CA--C 1.546 0.825 0 CA-C-N 115.085 -0.961 . . . . 1.0 112.55 -177.005 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.673 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 37.3 Cg_endo -63.45 -27.82 70.71 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 121.985 1.79 . . . . 1.0 112.909 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.477 ' HB3' HD13 ' A' ' 142' ' ' ILE . 45.5 mmm -59.28 -57.31 13.58 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.295 -0.261 . . . . 1.0 110.295 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.541 ' O ' ' HD1' ' A' ' 25' ' ' PHE . . . -71.37 -32.16 68.16 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 115.885 -0.598 . . . . 1.0 110.507 -178.526 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.633 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 15.0 tt0 -49.79 -52.72 29.95 Favored 'General case' 0 C--O 1.216 -0.69 0 O-C-N 124.198 0.936 . . . . 1.0 109.917 -178.019 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.972 ' HE3' ' HB2' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -86.63 -22.33 26.24 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 119.592 -0.843 . . . . 1.0 110.9 -176.919 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.472 ' HB3' HD11 ' A' ' 146' ' ' LEU . 88.7 mtp -64.21 -75.16 0.09 Allowed 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.384 0.513 . . . . 1.0 112.384 -179.052 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.759 ' HE1' ' HZ ' ' A' ' 9' ' ' PHE . 0.8 OUTLIER -78.43 -28.29 46.72 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 119.754 -0.778 . . . . 1.0 111.613 -175.452 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.633 ' HB3' ' O ' ' A' ' 22' ' ' GLU . . . -64.54 -38.73 92.04 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 119.387 -0.925 . . . . 1.0 110.473 178.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.602 ' HG3' ' N ' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -64.75 -37.45 87.63 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.825 -0.806 . . . . 1.0 108.825 177.789 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.602 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 78.5 mt-30 -60.05 -43.01 95.68 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-N 115.967 -0.56 . . . . 1.0 109.897 175.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 25' ' ' PHE . 93.2 mt -56.02 -59.01 5.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.74 -0.664 . . . . 1.0 110.767 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.502 ' HG2' ' O ' ' A' ' 27' ' ' GLN . 0.2 OUTLIER -60.58 -34.27 73.94 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.372 -0.531 . . . . 1.0 111.349 178.463 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.8 m170 -59.42 -30.09 68.23 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 111.994 0.368 . . . . 1.0 111.994 176.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.459 ' HG2' ' O ' ' A' ' 28' ' ' GLN . 5.8 ptp180 -95.41 -19.25 20.05 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 119.501 -0.88 . . . . 1.0 110.261 179.165 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 107.42 38.44 2.09 Favored Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.238 -0.892 . . . . 1.0 112.339 177.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 25.2 mt -129.54 0.02 4.98 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 122.554 -0.38 . . . . 1.0 110.258 -178.065 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.474 ' H ' ' HA ' ' A' ' 30' ' ' ARG . . . -54.26 -28.41 42.72 Favored Glycine 0 CA--C 1.519 0.337 0 CA-C-N 116.028 -0.533 . . . . 1.0 113.837 -178.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.499 ' HA ' ' NH1' ' A' ' 39' ' ' ARG . 5.1 t70 -89.45 -24.88 21.75 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-O 121.54 0.686 . . . . 1.0 109.739 178.09 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -77.59 -19.38 55.7 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 114.716 -1.129 . . . . 1.0 111.438 -174.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.818 HG23 ' HB3' ' A' ' 5' ' ' LEU . 0.4 OUTLIER -145.05 124.24 6.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.964 -0.562 . . . . 1.0 109.889 179.81 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.499 ' NH1' ' HA ' ' A' ' 36' ' ' ASP . 29.1 mmt180 -90.16 137.44 32.34 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 109.291 -0.633 . . . . 1.0 109.291 -178.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 80.8 t -124.78 126.88 72.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 N-CA-C 109.425 -0.583 . . . . 1.0 109.425 -178.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' ' 8' ' ' THR . 31.5 p -139.51 -178.11 5.24 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.175 -0.921 . . . . 1.0 110.557 -174.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' SER . . . . . 1.067 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 87.9 p -159.01 159.61 34.97 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.987 -0.551 . . . . 1.0 109.987 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.457 ' HA ' ' O ' ' A' ' 74' ' ' ALA . . . -164.44 166.17 20.8 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 121.32 0.581 . . . . 1.0 111.462 -178.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.894 ' HA3' HD21 ' A' ' 14' ' ' ASN . . . -124.58 138.96 11.47 Favored Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 110.789 -0.924 . . . . 1.0 110.789 177.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.54 HG21 HD12 ' A' ' 96' ' ' LEU . 28.3 p -71.79 -21.9 61.65 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.96 0.409 . . . . 1.0 110.977 -178.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -107.17 2.2 35.16 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 120.789 -0.72 . . . . 1.0 113.217 -177.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.493 ' HB3' ' HB2' ' A' ' 75' ' ' GLN . 3.1 p-10 44.23 35.99 1.41 Allowed 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 113.324 0.861 . . . . 1.0 113.324 178.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -43.87 -74.65 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.715 0.769 . . . . 1.0 112.453 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.446 ' HB2' HG12 ' A' ' 15' ' ' ILE . 79.0 m-70 -106.25 42.57 1.25 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.043 -0.98 . . . . 1.0 110.686 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.435 HG23 ' HA ' ' A' ' 74' ' ' ALA . 14.5 p -60.32 134.94 25.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.429 178.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.55 -13.63 60.03 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.885 -0.674 . . . . 1.0 112.303 -178.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.8 t -79.79 -162.67 0.45 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.163 0.506 . . . . 1.0 109.928 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 15.5 t -119.56 174.91 6.11 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.931 -0.766 . . . . 1.0 108.931 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.409 ' HB2' ' HB3' ' A' ' 71' ' ' HIS . . . -62.71 147.02 50.89 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.34 0.59 . . . . 1.0 111.485 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.621 ' OD2' ' HG3' ' A' ' 57' ' ' ARG . 9.8 p-10 -60.79 138.91 58.07 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.958 -1.019 . . . . 1.0 112.885 -178.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -48.6 -36.52 15.86 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 114.704 -1.134 . . . . 1.0 112.596 178.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.621 ' HG3' ' OD2' ' A' ' 55' ' ' ASP . 8.2 ptt180 -70.65 -44.23 67.54 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 122.298 0.239 . . . . 1.0 111.095 -178.048 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.34 -38.59 78.22 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 109.222 -0.658 . . . . 1.0 109.222 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.06 -44.9 94.38 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.604 -0.725 . . . . 1.0 109.984 178.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.427 ' O ' ' HG2' ' A' ' 63' ' ' ARG . . . -58.06 -44.1 94.83 Favored Glycine 0 N--CA 1.443 -0.882 0 CA-C-N 115.618 -0.719 . . . . 1.0 113.198 178.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.3 m -75.6 -39.24 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-N 117.326 0.563 . . . . 1.0 111.383 -178.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.618 ' HB2' HG22 ' A' ' 69' ' ' THR . 96.6 mt -61.59 -52.14 65.64 Favored 'General case' 0 C--O 1.23 0.044 0 C-N-CA 120.892 -0.323 . . . . 1.0 110.299 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.427 ' HG2' ' O ' ' A' ' 60' ' ' GLY . 6.8 ptm180 -59.63 -30.79 68.96 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.723 -0.671 . . . . 1.0 110.947 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.6 -33.23 74.58 Favored 'General case' 0 C--O 1.226 -0.141 0 CA-C-N 116.354 -0.385 . . . . 1.0 111.297 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.491 ' HB2' ' HD2' ' A' ' 67' ' ' TYR . 98.5 m-70 -96.33 2.51 52.84 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.341 -0.39 . . . . 1.0 111.237 -178.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 90.18 14.34 59.1 Favored Glycine 0 C--N 1.329 0.145 0 CA-C-N 116.005 -0.543 . . . . 1.0 112.536 177.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.491 ' HD2' ' HB2' ' A' ' 65' ' ' HIS . 69.0 m-85 -91.39 149.56 39.78 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-O 120.551 0.215 . . . . 1.0 110.855 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.407 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 52.1 Cg_endo -69.05 153.71 71.76 Favored 'Trans proline' 0 CA--C 1.509 -0.742 0 C-N-CA 122.325 2.017 . . . . 1.0 110.666 177.015 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.618 HG22 ' HB2' ' A' ' 62' ' ' LEU . 42.3 p -124.74 15.68 8.71 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 121.552 0.691 . . . . 1.0 110.442 -177.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -84.2 120.11 25.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.056 -0.975 . . . . 1.0 110.154 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.972 ' HB2' ' HE3' ' A' ' 23' ' ' LYS . 32.3 t60 -159.11 147.72 18.17 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.761 -0.654 . . . . 1.0 110.587 -177.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.7 tpp180 -125.71 112.57 16.25 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 107.697 -1.223 . . . . 1.0 107.697 175.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.546 ' HB1' ' OD1' ' A' ' 14' ' ' ASN . . . -59.95 140.17 56.91 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.543 -0.753 . . . . 1.0 111.956 -176.337 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 43' ' ' ALA . . . -135.96 160.6 38.11 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.646 178.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.493 ' HB2' ' HB3' ' A' ' 47' ' ' ASN . 43.5 tt0 -98.68 155.82 17.14 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.767 -0.457 . . . . 1.0 109.767 178.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.487 HG11 HD23 ' A' ' 97' ' ' LEU . 36.5 t -66.48 111.32 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.365 0.603 . . . . 1.0 110.731 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -123.86 -168.3 12.93 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.049 -0.978 . . . . 1.0 111.034 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 80.6 m -55.73 -46.96 77.67 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.711 0.291 . . . . 1.0 111.377 -179.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -60.13 -29.57 68.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.407 -0.36 . . . . 1.0 111.553 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.424 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 77.1 m80 -78.1 -39.26 42.0 Favored 'General case' 0 C--O 1.222 -0.357 0 N-CA-C 109.858 -0.423 . . . . 1.0 109.858 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.664 ' O ' HG23 ' A' ' 102' ' ' VAL . 15.6 mt -70.36 -18.18 63.06 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.308 -0.405 . . . . 1.0 110.451 176.369 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -88.43 -7.73 56.12 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 120.77 0.319 . . . . 1.0 110.232 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.603 ' HA ' ' HB3' ' A' ' 6' ' ' HIS . . . -59.65 148.01 35.36 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.81 -0.632 . . . . 1.0 109.888 178.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.544 ' HB3' HD13 ' A' ' 5' ' ' LEU . 28.5 t70 -74.44 -16.1 60.88 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.218 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.705 HD13 HG13 ' A' ' 7' ' ' VAL . 0.6 OUTLIER -153.17 116.47 4.64 Favored 'General case' 0 CA--C 1.51 -0.596 0 N-CA-C 109.336 -0.616 . . . . 1.0 109.336 -176.836 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.716 ' HB3' HD13 ' A' ' 97' ' ' LEU . 5.0 mp -106.89 105.52 15.59 Favored 'General case' 0 N--CA 1.426 -1.654 0 CA-C-N 115.489 -0.778 . . . . 1.0 109.782 178.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.628 HG11 HD23 ' A' ' 110' ' ' LEU . 86.6 t -84.63 93.39 3.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 114.554 -1.203 . . . . 1.0 111.263 -175.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.17 145.34 31.06 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.594 -0.73 . . . . 1.0 111.249 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.44 HD23 ' HB2' ' A' ' 11' ' ' CYS . 4.2 mm? -96.53 -11.53 25.32 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.821 -0.627 . . . . 1.0 109.774 178.227 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.426 ' CG ' ' H ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -148.78 153.62 38.41 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.631 -0.713 . . . . 1.0 110.747 179.859 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -57.96 -26.19 61.97 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.274 -0.876 . . . . 1.0 112.935 -178.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.629 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 82.8 m-20 -77.41 -47.34 20.03 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 110.125 -0.324 . . . . 1.0 110.125 -178.125 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.656 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 20.6 m170 -53.87 -47.64 70.84 Favored 'General case' 0 CA--C 1.522 -0.106 0 CA-C-N 115.981 -0.554 . . . . 1.0 109.666 177.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.95 -44.42 91.44 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.909 -0.587 . . . . 1.0 110.61 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.655 ' O ' ' HG2' ' A' ' 99' ' ' GLN . 9.8 ttp180 -56.54 -46.13 80.81 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.603 -0.726 . . . . 1.0 111.129 178.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.629 ' HG ' ' O ' ' A' ' 92' ' ' ASN . 42.7 mt -63.39 -47.87 80.22 Favored 'General case' 0 C--O 1.216 -0.696 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.547 -175.12 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.716 HD13 ' HB3' ' A' ' 86' ' ' LEU . 29.5 mt -53.03 -58.8 5.76 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.784 -0.644 . . . . 1.0 111.413 -177.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.678 ' CA ' HG12 ' A' ' 102' ' ' VAL . 2.2 ptm180 -59.33 -45.25 91.85 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.844 0.683 . . . . 1.0 112.844 -179.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.655 ' HG2' ' O ' ' A' ' 95' ' ' ARG . 7.5 pt20 -68.24 -23.6 64.81 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.165 -0.614 . . . . 1.0 110.49 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.612 HD13 ' O ' ' A' ' 96' ' ' LEU . 6.7 mp -78.98 -17.5 55.29 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 116.267 -0.424 . . . . 1.0 111.817 178.12 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 152.66 -23.44 0.83 Allowed Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 119.579 -1.296 . . . . 1.0 113.749 -178.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.678 HG12 ' CA ' ' A' ' 98' ' ' ARG . 0.4 OUTLIER -78.45 -163.89 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-N 117.77 0.785 . . . . 1.0 110.166 179.801 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.677 ' N ' HG13 ' A' ' 102' ' ' VAL . 13.1 pt-20 -156.38 165.22 36.99 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 107.736 -1.209 . . . . 1.0 107.736 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.781 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -61.37 -27.11 68.29 Favored 'General case' 0 C--N 1.316 -0.881 0 O-C-N 123.466 0.479 . . . . 1.0 111.278 -175.383 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.431 ' HA ' ' NH2' ' A' ' 108' ' ' ARG . . . -58.22 -34.07 70.0 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 120.713 0.292 . . . . 1.0 110.578 177.084 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.43 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 3.9 mtp180 -97.59 -42.84 7.48 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.955 -0.566 . . . . 1.0 111.343 -178.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.781 HG12 ' HA ' ' A' ' 104' ' ' ALA . 12.6 p -77.88 119.08 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-O 120.95 0.405 . . . . 1.0 110.032 -174.362 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.529 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 26.8 mmt180 -137.96 149.82 46.48 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 121.695 -0.628 . . . . 1.0 110.583 -178.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.676 ' HB2' ' HB2' ' A' ' 112' ' ' SER . 80.9 mmm -79.06 138.19 37.87 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.015 -0.539 . . . . 1.0 110.214 178.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.628 HD23 HG11 ' A' ' 87' ' ' VAL . 2.9 tm? -57.29 -48.8 78.0 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.037 0.446 . . . . 1.0 111.036 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.722 ' HB2' HG22 ' A' ' 124' ' ' VAL . 6.5 ttt-85 -69.68 -14.61 62.89 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.637 -0.71 . . . . 1.0 110.07 -178.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.676 ' HB2' ' HB2' ' A' ' 109' ' ' MET . 43.9 t -79.12 -8.97 59.41 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.921 -0.581 . . . . 1.0 111.289 -178.413 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.577 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 91.4 m-85 -91.36 -19.04 23.35 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 120.812 0.339 . . . . 1.0 110.266 176.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.409 ' OD1' ' HG2' ' A' ' 116' ' ' ARG . 15.8 t0 -63.27 122.59 76.52 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.854 -0.612 . . . . 1.0 111.143 -177.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 114' ' ' ASP . 37.7 Cg_endo -64.88 -32.48 55.17 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 123.16 2.573 . . . . 1.0 112.919 -179.218 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.409 ' HG2' ' OD1' ' A' ' 114' ' ' ASP . 6.9 ptp85 -96.89 8.45 44.37 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.689 -0.687 . . . . 1.0 111.796 -175.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 48.0 p -54.84 -38.0 66.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.125 -0.489 . . . . 1.0 111.749 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 131.13 -52.65 0.82 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.84 -0.695 . . . . 1.0 111.901 178.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 90.7 m -157.54 -62.1 0.09 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.213 0.53 . . . . 1.0 110.471 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -161.0 150.83 17.28 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-N 115.669 -0.696 . . . . 1.0 109.958 -178.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.662 ' HB3' ' HB2' ' A' ' 112' ' ' SER . . . -97.64 170.78 8.77 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.231 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.638 HD13 ' O ' ' A' ' 121' ' ' ALA . 1.6 mm? -149.95 -26.56 0.26 Allowed 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 114.248 -1.342 . . . . 1.0 109.713 -177.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -171.16 138.33 1.24 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.038 -0.983 . . . . 1.0 109.006 -176.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.722 HG22 ' HB2' ' A' ' 111' ' ' ARG . 60.0 t -92.59 146.84 5.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.984 0.421 . . . . 1.0 110.403 -177.343 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -69.85 -163.83 0.06 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.657 -0.701 . . . . 1.0 111.821 -178.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.609 ' HA ' ' NH2' ' A' ' 17' ' ' ARG . 38.0 t70 -165.71 144.76 5.18 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.531 -0.759 . . . . 1.0 109.202 -176.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.645 ' HB3' ' HB3' ' A' ' 134' ' ' ASP . 25.5 Cg_exo -37.11 155.19 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 124.029 3.153 . . . . 1.0 113.777 177.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -93.92 -52.71 4.3 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.266 -0.879 . . . . 1.0 109.708 -177.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -109.85 -40.45 4.78 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.483 0.658 . . . . 1.0 109.505 179.385 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 102.78 66.33 0.75 Allowed Glycine 0 N--CA 1.442 -0.937 0 N-CA-C 110.418 -1.073 . . . . 1.0 110.418 -175.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.53 ' H ' ' HB2' ' A' ' 134' ' ' ASP . 1.6 p-10 -130.42 -171.42 2.54 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.851 -0.426 . . . . 1.0 109.851 -177.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 20.1 t-160 -58.14 -39.41 78.67 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.059 -0.518 . . . . 1.0 110.457 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 4.2 m -62.34 -54.79 35.44 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.609 -0.515 . . . . 1.0 109.609 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.645 ' HB3' ' HB3' ' A' ' 127' ' ' PRO . 28.1 m-20 -56.07 -36.12 67.72 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.728 0.64 . . . . 1.0 112.728 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 23.1 m-30 -68.75 -49.62 57.31 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.001 0.429 . . . . 1.0 110.813 -177.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.408 ' O ' ' HB3' ' A' ' 139' ' ' PHE . 6.8 mt-10 -76.76 -17.37 59.1 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.864 -178.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.512 ' O ' HG23 ' A' ' 141' ' ' VAL . 4.3 tp10 -62.79 -47.5 83.2 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.961 -0.755 . . . . 1.0 108.961 175.292 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.679 ' HA ' HG23 ' A' ' 141' ' ' VAL . 55.3 t -61.93 -39.91 85.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 114.662 -1.153 . . . . 1.0 109.815 176.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.408 ' HB3' ' O ' ' A' ' 136' ' ' GLU . 74.4 t80 -53.11 -43.45 66.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.965 -1.016 . . . . 1.0 108.912 175.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.676 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -65.14 -41.16 95.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.304 -0.862 . . . . 1.0 111.09 177.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.679 HG23 ' HA ' ' A' ' 138' ' ' VAL . 12.7 t -54.64 -52.55 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 121.841 0.829 . . . . 1.0 110.233 178.344 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.477 HD13 ' HB3' ' A' ' 20' ' ' MET . 7.1 mt -65.81 -50.62 69.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 114.817 -1.083 . . . . 1.0 111.769 -179.015 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.676 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 11.3 pt-20 -58.91 -29.4 67.03 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 120.812 -0.355 . . . . 1.0 110.349 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.412 ' HB2' ' O ' ' A' ' 140' ' ' ALA . 2.1 t -74.17 -27.58 60.89 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 121.114 0.483 . . . . 1.0 109.94 178.389 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.468 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -86.54 -24.72 25.38 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 115.882 -0.599 . . . . 1.0 111.597 178.371 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.759 HD22 ' HB3' ' A' ' 25' ' ' PHE . 17.9 mt -54.85 -36.84 49.25 Favored Pre-proline 0 CA--C 1.549 0.942 0 N-CA-C 112.636 0.606 . . . . 1.0 112.636 -178.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.615 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 56.2 Cg_endo -70.45 -12.28 31.33 Favored 'Trans proline' 0 C--N 1.368 1.578 0 C-N-CA 122.775 2.317 . . . . 1.0 112.022 177.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.577 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -104.13 -33.68 3.92 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 110.195 -1.162 . . . . 1.0 110.195 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.457 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -72.51 -39.15 67.82 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 108.267 -1.012 . . . . 1.0 108.267 178.446 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.507 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 0.2 OUTLIER -54.0 -58.86 5.75 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-N 114.52 -1.218 . . . . 1.0 110.845 175.994 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -55.15 -41.78 72.23 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 114.826 -1.079 . . . . 1.0 111.012 -174.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' TRP . . . . . 0.667 ' HZ3' HD11 ' A' ' 5' ' ' LEU . 18.6 t90 -63.35 -54.94 29.06 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.325 -0.852 . . . . 1.0 110.444 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.453 HG13 ' O ' ' A' ' 149' ' ' LEU . 6.2 m -64.82 -41.25 91.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 120.842 -0.343 . . . . 1.0 110.764 -178.018 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.447 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 15.3 m-20 -60.03 -49.46 77.59 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 121.269 0.557 . . . . 1.0 110.613 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.492 ' O ' ' HG3' ' A' ' 159' ' ' ARG . 5.7 pt-20 -65.31 -37.27 86.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.612 -0.722 . . . . 1.0 110.739 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.56 ' HD2' ' HD2' ' A' ' 159' ' ' ARG . 10.9 mmt180 -75.07 -39.3 60.95 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.186 -0.461 . . . . 1.0 111.565 -177.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 4.4 pp -68.09 -24.64 65.07 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.218 -0.66 . . . . 1.0 109.218 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -71.91 -49.66 35.93 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.072 -0.967 . . . . 1.0 110.432 178.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.56 ' HD2' ' HD2' ' A' ' 156' ' ' ARG . 0.0 OUTLIER -81.0 -10.06 59.76 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 112.57 0.581 . . . . 1.0 112.57 -178.984 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -62.31 -52.06 65.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.593 0.235 . . . . 1.0 110.748 -177.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -159.76 -167.79 20.85 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.034 -1.079 . . . . 1.0 112.02 178.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -80.61 29.38 0.52 Allowed 'Trans proline' 0 N--CA 1.475 0.403 0 C-N-CA 123.416 2.744 . . . . 1.0 113.028 -178.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 25.4 t . . . . . 0 C--N 1.297 -1.688 0 CA-C-N 114.756 -1.111 . . . . 1.0 110.435 -178.232 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.786 0 N-CA-C 112.049 -0.42 . . . . 1.0 112.049 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.7 mmt -75.95 -12.22 60.1 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 111.918 0.34 . . . . 1.0 111.918 -177.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.1 p -80.39 -64.65 1.14 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.148 0.499 . . . . 1.0 110.241 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -162.26 159.43 21.03 Favored Pre-proline 0 C--O 1.238 0.49 0 CA-C-N 115.505 -0.771 . . . . 1.0 111.671 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -73.34 168.21 25.35 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.566 2.844 . . . . 1.0 113.036 178.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.85 ' HB3' HG23 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -69.19 -179.36 1.55 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.659 -0.7 . . . . 1.0 109.831 177.973 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.674 ' H ' HD13 ' A' ' 5' ' ' LEU . 2.5 t-160 -158.45 89.73 0.99 Allowed 'General case' 0 C--N 1.326 -0.444 0 O-C-N 122.145 -0.347 . . . . 1.0 110.066 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.479 HG13 HD13 ' A' ' 85' ' ' LEU . 1.8 t -95.61 109.07 21.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.87 -0.419 . . . . 1.0 109.87 178.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.637 ' CG2' ' HG ' ' A' ' 86' ' ' LEU . 10.5 t -112.89 118.84 36.02 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 120.896 0.379 . . . . 1.0 110.043 177.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.576 ' HD1' ' HB ' ' A' ' 87' ' ' VAL . 1.3 m-85 -86.65 131.27 34.2 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 116.465 -0.334 . . . . 1.0 110.784 -178.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.567 HG21 HD11 ' A' ' 97' ' ' LEU . 21.3 t -115.49 109.61 28.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.852 -0.613 . . . . 1.0 110.964 -177.342 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.644 ' HB2' HD23 ' A' ' 89' ' ' LEU . 49.8 t -142.38 163.55 32.55 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.587 -0.523 . . . . 1.0 109.587 179.28 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.57 HG23 ' NE2' ' A' ' 93' ' ' HIS . 0.7 OUTLIER -75.13 100.6 4.3 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.017 0.437 . . . . 1.0 110.89 -179.054 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.857 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 125.0 -44.78 1.22 Allowed Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.935 -0.65 . . . . 1.0 111.831 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.449 HD21 ' CB ' ' A' ' 42' ' ' SER . 4.5 t-20 65.7 11.82 7.83 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.278 0.631 . . . . 1.0 111.348 179.188 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.447 ' HA ' ' HG3' ' A' ' 19' ' ' PRO . 10.0 pt -120.57 8.74 6.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 O-C-N 121.736 -0.603 . . . . 1.0 111.738 -177.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.54 ' O ' ' HG3' ' A' ' 20' ' ' MET . 6.8 p -126.1 -86.56 0.61 Allowed 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.034 0.383 . . . . 1.0 112.034 -178.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.684 ' HD3' HG13 ' A' ' 138' ' ' VAL . 16.6 tpp180 -66.31 -48.53 70.04 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.981 0.42 . . . . 1.0 111.554 -176.026 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.654 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 14.2 m -56.55 -57.06 25.86 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 115.667 -0.697 . . . . 1.0 112.8 -178.344 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.714 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 39.0 Cg_endo -64.26 -27.54 64.0 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 121.806 1.67 . . . . 1.0 112.355 -177.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.622 ' HA ' HD21 ' A' ' 62' ' ' LEU . 66.1 mtp -62.43 -53.53 53.5 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.316 -0.554 . . . . 1.0 110.55 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.462 ' HA ' ' HB2' ' A' ' 24' ' ' MET . . . -70.59 -30.44 67.12 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.588 -0.445 . . . . 1.0 110.526 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.672 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 14.7 tt0 -52.15 -51.79 55.79 Favored 'General case' 0 C--O 1.214 -0.777 0 CA-C-N 115.49 -0.777 . . . . 1.0 109.623 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.944 ' HE3' ' HB2' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -88.49 -21.28 24.25 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 119.674 -0.81 . . . . 1.0 111.228 -176.702 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.511 ' HB3' HD11 ' A' ' 146' ' ' LEU . 83.1 mtp -65.8 -74.47 0.11 Allowed 'General case' 0 C--O 1.237 0.418 0 N-CA-C 112.37 0.508 . . . . 1.0 112.37 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.687 ' HB3' HD22 ' A' ' 146' ' ' LEU . 17.0 p90 -76.17 -30.52 58.13 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 119.707 -0.797 . . . . 1.0 111.481 -175.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.672 ' HB3' ' O ' ' A' ' 22' ' ' GLU . . . -65.11 -35.8 82.26 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 119.17 -1.012 . . . . 1.0 110.893 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.725 ' HA ' ' HD3' ' A' ' 30' ' ' ARG . 0.1 OUTLIER -63.07 -39.34 94.42 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 108.454 -0.943 . . . . 1.0 108.454 177.21 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.616 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 78.9 mt-30 -58.68 -45.81 88.62 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.647 -0.706 . . . . 1.0 109.879 175.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' A' ' 25' ' ' PHE . 96.7 mt -55.42 -58.85 6.02 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.502 -0.772 . . . . 1.0 110.978 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.725 ' HD3' ' HA ' ' A' ' 27' ' ' GLN . 0.4 OUTLIER -59.24 -36.24 75.11 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.49 -0.484 . . . . 1.0 111.258 179.125 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -63.35 -26.12 68.61 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.581 0.586 . . . . 1.0 112.581 177.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.634 ' HG3' ' HG ' ' A' ' 34' ' ' LEU . 8.3 ptp180 -95.54 -16.9 21.85 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 119.568 -0.853 . . . . 1.0 109.805 177.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 105.56 23.36 7.59 Favored Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 114.99 -1.004 . . . . 1.0 112.053 176.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.634 ' HG ' ' HG3' ' A' ' 32' ' ' ARG . 24.5 mt -111.69 1.5 16.75 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.172 -0.307 . . . . 1.0 110.172 -177.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -54.55 -26.03 37.07 Favored Glycine 0 CA--C 1.522 0.472 0 C-N-CA 121.115 -0.564 . . . . 1.0 113.2 -178.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.598 ' HA ' ' NH1' ' A' ' 39' ' ' ARG . 0.5 OUTLIER -95.98 -22.83 17.15 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 109.467 -0.568 . . . . 1.0 109.467 177.533 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -76.97 -23.28 52.33 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.903 -1.044 . . . . 1.0 111.002 -175.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.85 HG23 ' HB3' ' A' ' 5' ' ' LEU . 0.2 OUTLIER -143.38 122.59 8.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.733 -0.667 . . . . 1.0 109.334 177.911 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.598 ' NH1' ' HA ' ' A' ' 36' ' ' ASP . 30.2 mmt180 -87.18 143.33 27.34 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 109.201 -0.666 . . . . 1.0 109.201 -178.438 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.427 HG11 ' HB2' ' A' ' 26' ' ' ALA . 54.2 t -131.82 131.53 61.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 109.497 -0.557 . . . . 1.0 109.497 -178.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.508 ' O ' ' HA ' ' A' ' 8' ' ' THR . 43.2 p -145.95 -175.74 4.87 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.344 -0.844 . . . . 1.0 109.972 -174.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.654 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 90.6 p -161.7 166.04 27.24 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.799 -0.36 . . . . 1.0 110.52 178.402 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.588 ' HB2' ' CD2' ' A' ' 80' ' ' HIS . . . -165.52 169.0 15.97 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.398 0.618 . . . . 1.0 111.543 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -127.24 132.3 7.51 Favored Glycine 0 N--CA 1.44 -1.09 0 CA-C-N 114.924 -1.034 . . . . 1.0 110.937 177.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.524 HG23 ' CG1' ' A' ' 10' ' ' VAL . 17.8 p -67.75 -26.86 66.34 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.912 0.386 . . . . 1.0 111.707 -177.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -107.25 9.47 39.02 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.847 -0.692 . . . . 1.0 113.207 -177.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 43.5 38.17 1.73 Allowed 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 113.719 1.007 . . . . 1.0 113.719 176.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.857 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 1.1 m-90 -47.07 -74.21 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.514 0.674 . . . . 1.0 112.438 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.557 ' HB3' ' HB3' ' A' ' 52' ' ' SER . 3.8 m-70 -105.54 39.84 1.67 Allowed 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.184 -0.916 . . . . 1.0 111.16 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.418 HG23 ' HA ' ' A' ' 74' ' ' ALA . 14.8 p -60.17 127.19 19.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 120.377 -0.529 . . . . 1.0 110.068 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.606 ' HA2' ' NE ' ' A' ' 72' ' ' ARG . . . 93.47 -14.28 65.64 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.913 -0.661 . . . . 1.0 111.961 -177.116 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.557 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 3.1 t -81.4 -158.18 0.21 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.232 0.539 . . . . 1.0 110.034 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 18.7 t -133.28 175.29 9.53 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 115.676 -0.693 . . . . 1.0 109.153 -178.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.96 141.93 43.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.25 0.548 . . . . 1.0 111.85 -178.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.468 ' OD1' ' HG3' ' A' ' 57' ' ' ARG . 56.6 t0 -56.06 129.82 41.47 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.019 -0.991 . . . . 1.0 110.06 178.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -51.51 -29.69 17.58 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.103 0.779 . . . . 1.0 113.103 -179.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.609 ' O ' HG23 ' A' ' 61' ' ' VAL . 0.2 OUTLIER -74.03 -41.89 61.13 Favored 'General case' 0 N--CA 1.461 0.122 0 C-N-CA 120.261 -0.576 . . . . 1.0 110.412 178.602 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.43 -32.41 70.0 Favored 'General case' 0 N--CA 1.46 0.07 0 CA-C-O 120.918 0.39 . . . . 1.0 110.051 178.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.37 -42.42 98.68 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.762 -0.653 . . . . 1.0 110.025 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.448 ' O ' ' HG2' ' A' ' 63' ' ' ARG . . . -64.27 -40.4 97.89 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.563 -0.827 . . . . 1.0 111.217 178.306 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 57' ' ' ARG . 59.0 t -57.38 -57.47 9.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.091 0.472 . . . . 1.0 110.762 177.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.622 HD21 ' HA ' ' A' ' 20' ' ' MET . 5.7 mp -59.28 -52.28 66.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.972 -0.558 . . . . 1.0 111.109 -178.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.448 ' HG2' ' O ' ' A' ' 60' ' ' GLY . 5.9 ptm180 -60.08 -26.91 66.55 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.729 -0.669 . . . . 1.0 111.338 -178.291 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.54 -36.54 73.74 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.124 0.488 . . . . 1.0 110.379 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -93.15 3.82 55.04 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.577 -0.738 . . . . 1.0 111.019 -178.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.35 13.69 63.19 Favored Glycine 0 C--N 1.329 0.178 0 CA-C-N 115.735 -0.666 . . . . 1.0 112.593 176.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.48 ' CD1' ' HA ' ' A' ' 24' ' ' MET . 60.5 m-85 -90.03 147.48 37.3 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 110.258 -0.275 . . . . 1.0 110.258 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.474 ' HG2' ' CB ' ' A' ' 23' ' ' LYS . 56.8 Cg_endo -69.44 159.87 51.99 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.45 2.1 . . . . 1.0 110.572 177.293 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.0 p -130.38 12.69 5.5 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.541 0.686 . . . . 1.0 109.928 -178.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -70.94 114.35 8.91 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 114.725 -1.125 . . . . 1.0 109.994 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.944 ' HB2' ' HE3' ' A' ' 23' ' ' LYS . 62.5 t60 -160.48 149.83 17.35 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.928 0.394 . . . . 1.0 111.202 -176.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.606 ' NE ' ' HA2' ' A' ' 51' ' ' GLY . 1.4 tmt_? -135.61 112.36 10.13 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.684 -1.228 . . . . 1.0 107.684 175.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.524 ' HB3' ' O ' ' A' ' 49' ' ' HIS . . . -59.71 138.98 57.6 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.895 -1.048 . . . . 1.0 112.724 -174.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.418 ' HA ' HG23 ' A' ' 50' ' ' VAL . . . -130.06 160.62 33.17 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.249 -0.887 . . . . 1.0 110.354 178.242 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -97.31 155.16 17.0 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.43 -0.952 . . . . 1.0 108.43 178.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.504 HG11 HD23 ' A' ' 97' ' ' LEU . 19.1 t -68.42 112.59 3.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 120.938 0.399 . . . . 1.0 110.607 -178.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.444 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -122.97 -170.23 13.46 Favored Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 115.373 -0.831 . . . . 1.0 111.5 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 98.2 m -56.45 -44.15 80.22 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 122.388 0.275 . . . . 1.0 111.214 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -59.23 -29.71 67.73 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.972 0.415 . . . . 1.0 111.227 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.588 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 80.1 m80 -78.21 -41.66 33.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.161 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.746 ' HA ' HD21 ' A' ' 86' ' ' LEU . 15.6 mt -68.39 -17.41 64.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.255 0.55 . . . . 1.0 110.669 177.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.61 -4.5 59.18 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 116.167 -0.47 . . . . 1.0 110.539 -178.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.563 ' HB1' ' O ' ' A' ' 6' ' ' HIS . . . -63.41 160.0 17.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.99 -0.55 . . . . 1.0 111.049 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.753 ' HB3' HD13 ' A' ' 5' ' ' LEU . 15.5 t70 -85.29 -13.16 50.56 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.517 -0.549 . . . . 1.0 109.517 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.741 HD12 ' CE3' ' A' ' 152' ' ' TRP . 1.1 tt -157.73 112.2 2.63 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.746 -0.661 . . . . 1.0 109.6 -177.345 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.746 HD21 ' HA ' ' A' ' 81' ' ' LEU . 5.6 mp -103.84 89.18 3.23 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-N 115.396 -0.82 . . . . 1.0 110.832 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.637 HG23 HD22 ' A' ' 85' ' ' LEU . 54.0 t -66.22 91.34 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 113.816 -1.538 . . . . 1.0 112.05 -179.096 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.06 147.74 31.34 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.245 -1.343 . . . . 1.0 109.693 177.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.644 HD23 ' HB2' ' A' ' 11' ' ' CYS . 3.7 mm? -100.86 -10.86 20.3 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.308 0.575 . . . . 1.0 109.618 177.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -141.56 151.52 43.28 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.214 -0.903 . . . . 1.0 110.087 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.551 ' HB3' ' O ' ' A' ' 122' ' ' LEU . 11.6 ptm180 -65.07 -17.35 64.38 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 123.477 0.485 . . . . 1.0 110.089 176.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.643 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 5.3 m-20 -77.83 -50.04 13.09 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.668 -0.697 . . . . 1.0 109.817 178.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.682 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 16.3 m170 -59.26 -42.95 92.39 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.561 -0.533 . . . . 1.0 109.561 178.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.68 -44.48 93.6 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.559 178.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.604 ' O ' ' HG2' ' A' ' 99' ' ' GLN . 0.5 OUTLIER -56.66 -45.26 81.77 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 115.818 -0.628 . . . . 1.0 111.015 178.356 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.694 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 50.9 mt -64.39 -48.3 75.97 Favored 'General case' 0 C--O 1.216 -0.68 0 CA-C-N 115.944 -0.571 . . . . 1.0 110.425 -175.047 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.682 ' HG ' ' O ' ' A' ' 93' ' ' HIS . 33.2 mt -53.0 -60.16 3.63 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.898 -0.592 . . . . 1.0 111.474 -178.415 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.72 ' N ' HG12 ' A' ' 102' ' ' VAL . 1.2 ptm180 -59.26 -45.16 91.96 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.843 -0.617 . . . . 1.0 112.381 -179.117 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.604 ' HG2' ' O ' ' A' ' 95' ' ' ARG . 6.2 pt20 -66.74 -24.69 66.25 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 119.956 -0.698 . . . . 1.0 110.194 178.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.694 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 10.1 mt -80.7 -18.84 46.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.031 -0.531 . . . . 1.0 111.592 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 151.99 -21.27 0.88 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 119.748 -1.215 . . . . 1.0 114.44 -178.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.72 HG12 ' N ' ' A' ' 98' ' ' ARG . 0.3 OUTLIER -76.82 -162.36 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 118.113 0.956 . . . . 1.0 110.662 -179.492 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.773 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 12.3 pt-20 -157.3 160.32 38.43 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 107.703 -1.221 . . . . 1.0 107.703 -179.02 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.775 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -61.04 -26.13 67.41 Favored 'General case' 0 C--N 1.322 -0.601 0 O-C-N 123.366 0.416 . . . . 1.0 111.32 -175.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.48 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . . . -57.06 -36.42 70.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.15 0.5 . . . . 1.0 110.533 175.523 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.773 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 7.9 mtt-85 -98.46 -42.37 7.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.237 -0.892 . . . . 1.0 111.194 -177.209 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.775 HG12 ' HA ' ' A' ' 104' ' ' ALA . 14.6 p -77.96 115.44 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 120.614 -0.435 . . . . 1.0 110.085 -175.068 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.624 ' HD2' ' O ' ' A' ' 107' ' ' VAL . 26.9 mmm180 -136.13 148.71 48.35 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 121.68 -0.637 . . . . 1.0 110.7 -178.283 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 83.2 mmm -78.92 137.52 37.67 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.615 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.597 HD23 HG11 ' A' ' 87' ' ' VAL . 2.8 tm? -56.02 -52.68 63.36 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 122.455 0.302 . . . . 1.0 111.532 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 111' ' ' ARG . 25.6 ttt85 -71.22 -16.83 62.52 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.586 -0.445 . . . . 1.0 111.222 -176.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 41.7 t -73.56 -7.63 52.68 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 120.585 -0.446 . . . . 1.0 110.703 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.652 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 83.3 m-85 -87.31 -21.74 25.55 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-O 120.664 0.269 . . . . 1.0 110.765 176.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -57.69 117.91 22.2 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.948 -0.569 . . . . 1.0 111.433 -177.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.71 -16.59 46.71 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.725 2.284 . . . . 1.0 111.24 178.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 37.8 mtp180 -86.06 -19.24 30.55 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.367 -0.833 . . . . 1.0 110.482 178.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 28.1 m -74.01 86.39 1.82 Allowed 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.419 -0.355 . . . . 1.0 111.467 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -57.26 -42.34 93.41 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.409 -0.9 . . . . 1.0 112.354 176.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.43 161.66 20.23 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.824 0.345 . . . . 1.0 110.415 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 38.7 m170 -77.38 131.85 38.26 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.47 -0.332 . . . . 1.0 110.409 178.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -101.64 90.57 4.08 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.034 -0.53 . . . . 1.0 111.038 -179.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.551 ' O ' ' HB3' ' A' ' 91' ' ' ARG . 2.7 mm? -96.69 13.02 29.79 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-N 116.523 -0.308 . . . . 1.0 110.933 178.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -169.1 143.09 2.94 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-O 121.215 0.531 . . . . 1.0 111.264 178.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 44.2 t -125.7 154.24 34.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 114.829 -1.078 . . . . 1.0 108.119 178.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.469 ' H ' ' HG3' ' A' ' 125' ' ' GLU . 0.4 OUTLIER -87.39 -163.18 0.89 Allowed 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.859 -0.61 . . . . 1.0 111.458 -177.455 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -162.55 98.97 1.1 Allowed Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 106.967 -1.494 . . . . 1.0 106.967 -178.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.541 ' HG2' ' CG2' ' A' ' 138' ' ' VAL . 23.2 Cg_exo -62.14 113.38 1.86 Allowed 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.881 2.387 . . . . 1.0 113.257 -174.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -99.99 -9.17 23.02 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.345 -0.843 . . . . 1.0 110.416 178.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.619 ' CD2' ' HB2' ' A' ' 134' ' ' ASP . 0.0 OUTLIER -69.68 -34.34 73.82 Favored 'General case' 0 CA--C 1.522 -0.121 0 N-CA-C 112.789 0.663 . . . . 1.0 112.789 -174.208 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 70.66 61.72 3.97 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.054 -1.069 . . . . 1.0 113.25 176.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.963 ' H ' ' HB3' ' A' ' 134' ' ' ASP . 21.9 t70 -121.95 169.47 10.78 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.204 -1.036 . . . . 1.0 108.204 176.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 18.9 t-160 -58.78 -43.28 90.37 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 108.678 -0.86 . . . . 1.0 108.678 174.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.466 ' O ' ' HB2' ' A' ' 137' ' ' GLU . 12.0 t -64.96 -36.74 85.36 Favored 'General case' 0 C--O 1.217 -0.63 0 CA-C-N 115.766 -0.652 . . . . 1.0 109.844 178.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.963 ' HB3' ' H ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -60.69 -43.6 97.54 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.063 -0.517 . . . . 1.0 111.382 -179.295 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.601 ' HD1' ' HE ' ' A' ' 57' ' ' ARG . 9.5 m-85 -69.7 -49.84 49.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.09 0.472 . . . . 1.0 110.634 -178.121 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -77.26 -15.04 59.63 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.013 -0.54 . . . . 1.0 111.277 -176.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.615 ' O ' HG23 ' A' ' 141' ' ' VAL . 11.1 tp10 -64.34 -48.3 76.08 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 108.073 -1.084 . . . . 1.0 108.073 174.154 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.684 HG13 ' HD3' ' A' ' 17' ' ' ARG . 57.4 t -56.52 -47.41 81.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 114.482 -1.235 . . . . 1.0 109.766 175.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.507 ' HB2' HG11 ' A' ' 61' ' ' VAL . 69.8 t80 -56.4 -44.12 79.98 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 113.858 -1.519 . . . . 1.0 110.147 178.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.71 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -63.42 -44.97 93.09 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.208 -0.451 . . . . 1.0 111.761 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 137' ' ' GLU . 36.3 t -55.43 -46.59 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.706 0.765 . . . . 1.0 110.005 178.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.455 ' CG2' ' HB2' ' A' ' 21' ' ' ALA . 7.0 mt -69.51 -51.13 44.88 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 115.04 -0.982 . . . . 1.0 111.785 -178.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.71 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 6.2 pt-20 -56.14 -33.88 65.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.537 0.208 . . . . 1.0 110.665 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.8 t -73.33 -27.98 61.81 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.238 0.542 . . . . 1.0 110.124 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.472 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -86.69 -23.99 25.39 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-N 115.869 -0.605 . . . . 1.0 111.823 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.687 HD22 ' HB3' ' A' ' 25' ' ' PHE . 11.9 mt -55.16 -37.89 61.65 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 112.654 0.613 . . . . 1.0 112.654 -178.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 61.5 Cg_endo -70.65 -13.2 32.23 Favored 'Trans proline' 0 C--N 1.359 1.116 0 C-N-CA 122.649 2.232 . . . . 1.0 111.939 177.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.652 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -102.72 -32.35 4.81 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 110.099 -1.2 . . . . 1.0 110.099 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.495 ' O ' HG13 ' A' ' 153' ' ' VAL . 0.4 OUTLIER -73.73 -40.69 63.35 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.396 -0.964 . . . . 1.0 108.396 177.604 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.448 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -55.53 -54.7 40.76 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 114.81 -1.086 . . . . 1.0 110.135 175.667 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -58.94 -42.52 89.96 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.333 -0.849 . . . . 1.0 110.961 -175.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' TRP . . . . . 0.845 ' HZ3' HD11 ' A' ' 5' ' ' LEU . 23.6 t90 -63.02 -55.28 26.99 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.46 -0.791 . . . . 1.0 110.465 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.495 HG13 ' O ' ' A' ' 149' ' ' LEU . 10.7 m -62.7 -40.69 89.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.816 -0.354 . . . . 1.0 110.587 -177.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.495 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 4.1 m-20 -60.79 -50.93 71.46 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-O 120.838 0.351 . . . . 1.0 110.727 178.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.543 ' O ' ' HG3' ' A' ' 159' ' ' ARG . 6.8 pt-20 -64.11 -36.86 85.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.861 -178.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.535 ' HD2' ' HD2' ' A' ' 159' ' ' ARG . 10.4 mmt180 -73.56 -42.61 61.42 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 116.185 -0.461 . . . . 1.0 111.394 -178.294 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 4.3 pp -65.79 -24.8 67.01 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 109.27 -0.641 . . . . 1.0 109.27 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -73.34 -53.86 9.77 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.065 -0.97 . . . . 1.0 110.261 178.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.543 ' HG3' ' O ' ' A' ' 155' ' ' GLU . 0.0 OUTLIER -74.77 -9.68 58.79 Favored 'General case' 0 N--CA 1.462 0.143 0 N-CA-C 112.714 0.635 . . . . 1.0 112.714 -177.732 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -83.89 43.19 0.9 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.462 0.649 . . . . 1.0 110.51 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -123.06 155.06 17.21 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.723 -0.751 . . . . 1.0 112.036 175.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -87.3 -157.84 0.08 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 122.969 2.446 . . . . 1.0 112.272 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 25.1 m . . . . . 0 C--O 1.248 1.019 0 CA-C-N 114.776 -1.102 . . . . 1.0 111.606 -179.818 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.753 0 N-CA-C 111.793 -0.523 . . . . 1.0 111.793 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 mmt -87.2 64.56 8.41 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.907 0.353 . . . . 1.0 110.575 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.2 m -83.13 111.46 18.92 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.189 -0.46 . . . . 1.0 110.724 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.814 ' HB3' ' HD2' ' A' ' 4' ' ' PRO . 9.4 m-20 -69.24 166.65 27.26 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-O 121.035 0.445 . . . . 1.0 110.487 178.181 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.918 ' HG3' ' HE ' ' A' ' 39' ' ' ARG . 60.0 Cg_endo -72.22 170.05 20.07 Favored 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 123.26 2.64 . . . . 1.0 114.298 -178.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.869 ' HB3' HG23 ' A' ' 38' ' ' VAL . 0.8 OUTLIER -74.8 -173.31 1.82 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.05 -0.977 . . . . 1.0 110.836 178.146 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.492 ' O ' ' HB1' ' A' ' 83' ' ' ALA . 0.2 OUTLIER -159.15 94.59 1.21 Allowed 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 121.087 -0.245 . . . . 1.0 111.448 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.79 HG13 HD13 ' A' ' 85' ' ' LEU . 2.2 t -95.94 113.48 30.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 108.893 -0.781 . . . . 1.0 108.893 175.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.624 ' CG2' ' HG ' ' A' ' 86' ' ' LEU . 14.5 t -114.15 115.26 27.22 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 120.992 0.425 . . . . 1.0 110.108 178.11 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.549 ' HD1' ' HB ' ' A' ' 87' ' ' VAL . 2.0 m-85 -81.81 146.77 29.72 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 109.56 -0.533 . . . . 1.0 109.56 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.603 HG21 HD11 ' A' ' 97' ' ' LEU . 42.5 t -130.42 114.0 27.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 121.059 0.457 . . . . 1.0 111.63 -177.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.615 ' SG ' ' HD2' ' A' ' 17' ' ' ARG . 47.9 t -143.93 161.25 39.19 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.821 -0.807 . . . . 1.0 108.821 177.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.88 97.07 3.23 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.269 0.556 . . . . 1.0 111.182 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.691 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 130.96 -44.74 1.18 Allowed Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.457 -0.792 . . . . 1.0 111.249 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.662 ' ND2' ' H ' ' A' ' 74' ' ' ALA . 58.6 t30 59.8 29.16 18.73 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.829 0.824 . . . . 1.0 111.179 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.3 pt -130.91 10.67 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.963 -0.562 . . . . 1.0 111.675 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.66 ' O ' ' HG3' ' A' ' 20' ' ' MET . 12.3 m -125.54 -89.64 0.57 Allowed 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.089 -0.644 . . . . 1.0 111.609 -178.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.846 HH22 ' HD3' ' A' ' 127' ' ' PRO . 1.9 ptp85 -74.27 -35.85 63.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.065 -0.516 . . . . 1.0 112.364 -176.226 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.554 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 16.5 m -58.99 -58.83 16.58 Favored Pre-proline 0 CA--C 1.541 0.602 0 C-N-CA 121.26 -0.176 . . . . 1.0 111.105 179.026 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.76 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 36.6 Cg_endo -61.93 -26.66 79.11 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.051 1.834 . . . . 1.0 111.937 178.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.66 ' HG3' ' O ' ' A' ' 16' ' ' CYS . 63.8 mtp -62.43 -54.57 38.22 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.847 -0.341 . . . . 1.0 111.106 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.1 -28.5 65.45 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 120.452 -0.499 . . . . 1.0 109.666 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.703 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 7.4 tt0 -54.32 -51.9 63.24 Favored 'General case' 0 C--O 1.216 -0.672 0 CA-C-N 115.029 -0.987 . . . . 1.0 109.236 178.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.775 ' HB3' ' HG2' ' A' ' 68' ' ' PRO . 0.0 OUTLIER -80.36 -29.9 37.95 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.758 -0.655 . . . . 1.0 110.212 -176.846 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.585 ' HB3' HD11 ' A' ' 146' ' ' LEU . 3.1 mmm -63.33 -76.12 0.07 Allowed 'General case' 0 C--O 1.238 0.458 0 N-CA-C 113.058 0.762 . . . . 1.0 113.058 -176.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.658 ' HB3' HD22 ' A' ' 146' ' ' LEU . 22.6 p90 -76.76 -29.72 56.22 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 119.859 -0.736 . . . . 1.0 111.268 -174.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.703 ' HB3' ' O ' ' A' ' 22' ' ' GLU . . . -65.25 -37.82 88.43 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 119.036 -1.066 . . . . 1.0 111.134 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.642 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -63.2 -40.04 96.34 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.56 -0.904 . . . . 1.0 108.56 177.854 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.571 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 79.1 mt-30 -57.49 -47.71 81.19 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 115.608 -0.724 . . . . 1.0 110.082 176.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.539 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 93.3 mt -53.09 -59.55 4.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.69 -0.686 . . . . 1.0 111.06 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.597 ' HD3' ' HA ' ' A' ' 27' ' ' GLN . 0.1 OUTLIER -59.5 -37.25 77.81 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.484 -0.486 . . . . 1.0 111.275 178.955 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -63.9 -21.32 66.41 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.873 0.694 . . . . 1.0 112.873 178.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.539 ' HG2' ' O ' ' A' ' 29' ' ' LEU . 7.6 ptp180 -99.29 -21.54 16.01 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 119.677 -0.809 . . . . 1.0 110.037 176.187 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 107.34 42.35 1.51 Allowed Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 115.202 -0.908 . . . . 1.0 111.99 178.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 23.8 mt -135.83 -5.11 2.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.704 0.288 . . . . 1.0 110.372 -178.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.455 ' H ' ' HA ' ' A' ' 30' ' ' ARG . . . -58.72 -25.19 58.4 Favored Glycine 0 C--N 1.329 0.168 0 C-N-CA 121.361 -0.447 . . . . 1.0 112.619 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.46 ' O ' ' HB3' ' A' ' 4' ' ' PRO . 49.3 m-20 -85.01 -28.92 25.4 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.28 0.562 . . . . 1.0 109.885 177.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.58 -18.56 51.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.09 -0.959 . . . . 1.0 112.015 -177.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.869 HG23 ' HB3' ' A' ' 5' ' ' LEU . 0.8 OUTLIER -144.85 122.85 5.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.255 0.55 . . . . 1.0 110.137 179.133 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.918 ' HE ' ' HG3' ' A' ' 4' ' ' PRO . 9.9 mmt180 -89.16 145.45 25.42 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.802 -0.636 . . . . 1.0 110.071 -178.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 77.5 t -132.55 118.88 36.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.439 0.638 . . . . 1.0 109.869 -178.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 8' ' ' THR . 36.7 p -132.87 -174.42 3.47 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 114.279 -1.328 . . . . 1.0 111.365 -175.42 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.554 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 63.9 p -159.63 161.22 34.99 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.509 -178.071 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.663 ' HB2' ' CD2' ' A' ' 80' ' ' HIS . . . -162.38 163.09 27.99 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.294 0.569 . . . . 1.0 111.627 -178.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.404 ' HA2' ' O ' ' A' ' 11' ' ' CYS . . . -123.73 131.77 8.17 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 110.863 -0.895 . . . . 1.0 110.863 178.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.587 HG23 ' CG1' ' A' ' 10' ' ' VAL . 18.0 p -67.72 -26.92 66.39 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.036 0.384 . . . . 1.0 112.036 -177.219 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -107.26 9.07 38.75 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.73 -0.748 . . . . 1.0 112.904 -177.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.401 ' HB3' ' HB2' ' A' ' 75' ' ' GLN . 3.8 p-10 41.02 41.93 1.41 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.834 0.854 . . . . 1.0 113.288 179.41 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.691 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 0.9 OUTLIER -50.34 -77.64 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.154 0.502 . . . . 1.0 112.013 179.009 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.422 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 15.8 m-70 -101.97 41.12 1.24 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.907 -0.588 . . . . 1.0 110.919 -179.148 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.2 p -61.56 127.43 21.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.13 0.491 . . . . 1.0 110.105 178.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.767 ' HA2' ' HD3' ' A' ' 72' ' ' ARG . . . 97.02 -15.43 62.56 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.679 -0.691 . . . . 1.0 112.107 -177.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.0 t -80.27 -159.02 0.2 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.367 0.603 . . . . 1.0 109.926 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 31.7 t -132.91 173.08 11.77 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.359 -0.837 . . . . 1.0 109.01 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.91 139.95 32.23 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.982 0.42 . . . . 1.0 111.3 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.614 ' OD1' ' HG2' ' A' ' 57' ' ' ARG . 11.7 t70 -60.9 139.14 58.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.425 -0.807 . . . . 1.0 110.374 -178.036 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -48.21 -33.95 9.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.409 -0.814 . . . . 1.0 112.861 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.728 ' HB2' ' CD2' ' A' ' 135' ' ' PHE . 18.8 ptp180 -70.96 -46.07 63.03 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 122.26 -0.275 . . . . 1.0 110.589 -177.032 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.47 -32.84 68.75 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 116.086 -0.506 . . . . 1.0 109.743 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.99 -46.88 88.96 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.191 -0.67 . . . . 1.0 109.191 176.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.477 ' HA2' ' HD3' ' A' ' 63' ' ' ARG . . . -61.05 -39.69 97.44 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.818 -0.706 . . . . 1.0 111.574 177.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 57' ' ' ARG . 93.3 t -60.55 -60.31 2.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.803 0.335 . . . . 1.0 111.214 177.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.779 ' HB2' HG22 ' A' ' 69' ' ' THR . 81.8 mt -58.17 -51.79 68.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.211 -0.45 . . . . 1.0 111.526 -176.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.477 ' HD3' ' HA2' ' A' ' 60' ' ' GLY . 6.9 ptm180 -59.17 -29.15 67.25 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.315 -0.402 . . . . 1.0 111.191 -179.207 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.57 -30.63 61.79 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.343 0.592 . . . . 1.0 110.904 -179.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -95.06 3.97 54.25 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.854 -0.612 . . . . 1.0 110.668 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.09 10.61 60.94 Favored Glycine 0 C--N 1.331 0.264 0 CA-C-N 115.694 -0.685 . . . . 1.0 113.312 175.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.425 ' CD1' ' HA ' ' A' ' 24' ' ' MET . 66.5 m-85 -92.08 152.33 42.63 Favored Pre-proline 0 C--N 1.316 -0.871 0 CA-C-O 120.61 0.243 . . . . 1.0 111.543 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.775 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 33.0 Cg_endo -68.07 156.94 63.92 Favored 'Trans proline' 0 CA--C 1.514 -0.496 0 C-N-CA 122.515 2.144 . . . . 1.0 110.737 175.01 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.779 HG22 ' HB2' ' A' ' 62' ' ' LEU . 63.3 p -132.55 7.89 4.19 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 120.102 -0.639 . . . . 1.0 112.485 -176.175 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -90.5 133.09 35.29 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.008 0.432 . . . . 1.0 110.851 -178.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.483 ' HB2' ' HE3' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -173.03 150.71 2.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.41 -0.814 . . . . 1.0 109.207 -176.749 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.767 ' HD3' ' HA2' ' A' ' 51' ' ' GLY . 4.1 tmm_? -120.79 115.33 23.07 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.169 -1.049 . . . . 1.0 108.169 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' A' ' 49' ' ' HIS . . . -58.03 137.08 57.16 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.462 0.648 . . . . 1.0 112.307 -175.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.662 ' H ' ' ND2' ' A' ' 14' ' ' ASN . . . -127.81 158.29 38.1 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.41 -0.813 . . . . 1.0 109.913 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.401 ' HB2' ' HB3' ' A' ' 47' ' ' ASN . 34.2 tt0 -94.89 155.92 16.57 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.916 -0.772 . . . . 1.0 108.916 177.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.506 HG11 ' CD2' ' A' ' 97' ' ' LEU . 22.0 t -67.46 112.56 2.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.236 0.541 . . . . 1.0 110.09 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.549 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -126.24 -167.19 12.39 Favored Glycine 0 N--CA 1.438 -1.178 0 CA-C-N 115.445 -0.798 . . . . 1.0 111.38 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 54.4 m -55.42 -51.68 66.08 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 122.574 0.35 . . . . 1.0 111.931 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.45 ' HG2' ' N ' ' A' ' 80' ' ' HIS . 1.1 pm0 -57.2 -31.92 65.94 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.655 -0.702 . . . . 1.0 111.008 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.663 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 78.3 m80 -76.74 -41.86 43.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.034 179.168 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 24.4 mt -67.41 -19.26 65.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.939 -0.573 . . . . 1.0 110.992 177.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -87.38 -6.09 58.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.933 -0.576 . . . . 1.0 111.209 -178.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.492 ' HB1' ' O ' ' A' ' 6' ' ' HIS . . . -59.93 152.96 22.26 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.852 -0.613 . . . . 1.0 111.275 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -76.86 -17.48 58.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.102 0.477 . . . . 1.0 109.965 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.79 HD13 HG13 ' A' ' 7' ' ' VAL . 0.3 OUTLIER -153.26 116.42 4.6 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-N 115.604 -0.725 . . . . 1.0 109.443 -176.722 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.624 ' HG ' ' CG2' ' A' ' 8' ' ' THR . 5.1 mp -106.72 107.3 18.25 Favored 'General case' 0 N--CA 1.422 -1.856 0 CA-C-N 115.774 -0.648 . . . . 1.0 110.01 177.126 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.549 ' HB ' ' HD1' ' A' ' 9' ' ' PHE . 51.5 t -85.49 93.3 3.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 114.994 -1.003 . . . . 1.0 110.934 -176.296 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.23 145.78 32.06 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.628 -0.714 . . . . 1.0 110.432 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.501 ' HG ' ' HD3' ' A' ' 17' ' ' ARG . 3.9 mm? -96.67 -12.44 23.84 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.208 0.528 . . . . 1.0 110.604 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.446 ' CG ' ' H ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -151.54 157.66 42.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.625 -0.716 . . . . 1.0 111.193 179.523 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -53.5 -29.68 37.44 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 113.467 0.914 . . . . 1.0 113.467 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.637 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 43.3 m-20 -76.59 -48.37 19.43 Favored 'General case' 0 CA--C 1.512 -0.486 0 C-N-CA 120.364 -0.534 . . . . 1.0 110.864 -177.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.705 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 15.7 m170 -56.04 -46.36 78.91 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.838 -0.43 . . . . 1.0 109.838 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.45 -43.13 93.24 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.803 0.335 . . . . 1.0 110.794 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.453 ' O ' ' HG2' ' A' ' 98' ' ' ARG . 13.1 ttt180 -59.76 -44.64 93.76 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 115.845 -0.616 . . . . 1.0 111.629 179.108 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.754 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 58.5 mt -64.03 -48.98 74.2 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.169 -0.468 . . . . 1.0 110.083 -176.17 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.705 ' HG ' ' O ' ' A' ' 93' ' ' HIS . 32.7 mt -52.7 -57.12 11.15 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.845 -0.616 . . . . 1.0 111.22 -179.094 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.556 ' HA ' ' HB ' ' A' ' 102' ' ' VAL . 12.9 ptt180 -61.26 -41.31 96.71 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.216 -0.447 . . . . 1.0 111.832 -176.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.665 ' HG3' ' O ' ' A' ' 96' ' ' LEU . 1.1 pp0? -69.12 -25.32 64.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.993 0.425 . . . . 1.0 110.359 178.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.754 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 14.2 mt -78.53 -13.65 59.73 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.987 -0.551 . . . . 1.0 112.315 -179.076 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 148.59 -22.73 1.34 Allowed Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 119.995 -1.097 . . . . 1.0 112.935 -178.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.951 HG12 ' H ' ' A' ' 103' ' ' GLU . 3.3 t -76.24 -156.98 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 109.687 -0.486 . . . . 1.0 109.687 178.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.951 ' H ' HG12 ' A' ' 102' ' ' VAL . 16.8 pt-20 -171.18 168.08 6.87 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 107.66 -1.237 . . . . 1.0 107.66 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.735 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -66.45 -23.93 66.36 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.992 -0.283 . . . . 1.0 111.572 -174.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.04 -37.78 72.25 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.246 0.546 . . . . 1.0 110.509 176.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.752 ' HD2' HG13 ' A' ' 102' ' ' VAL . 15.1 mtt180 -96.11 -45.17 6.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.778 -1.101 . . . . 1.0 110.935 -176.211 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.735 HG12 ' HA ' ' A' ' 104' ' ' ALA . 8.0 p -79.46 124.78 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-O 121.572 0.701 . . . . 1.0 110.702 -177.13 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.546 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 21.2 mmm180 -140.52 146.69 38.46 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 -179.271 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.63 ' HE3' HG23 ' A' ' 124' ' ' VAL . 82.1 mmm -78.86 137.84 37.86 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.762 -0.654 . . . . 1.0 110.369 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.503 HD23 HG11 ' A' ' 87' ' ' VAL . 3.1 tm? -56.31 -48.7 76.16 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.077 0.465 . . . . 1.0 111.268 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.9 ' HB2' HG13 ' A' ' 124' ' ' VAL . 65.0 ttt180 -69.6 -20.59 63.62 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.98 -0.554 . . . . 1.0 110.303 -177.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.542 ' HB2' ' HB2' ' A' ' 109' ' ' MET . 36.1 t -76.15 -5.41 46.56 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.62 -0.718 . . . . 1.0 110.913 -177.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.568 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 86.9 m-85 -90.68 -22.77 20.98 Favored 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 122.172 -0.33 . . . . 1.0 110.237 175.314 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -61.0 119.39 44.73 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.733 -0.667 . . . . 1.0 110.263 -177.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -67.57 -17.26 48.3 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.669 2.246 . . . . 1.0 112.162 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 10.3 mmm180 -90.51 -22.61 21.25 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.718 -0.674 . . . . 1.0 110.814 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 36.2 t -75.25 64.49 1.47 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.001 -0.545 . . . . 1.0 112.377 -175.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 57.04 -102.14 0.19 Allowed Glycine 0 CA--C 1.52 0.373 0 C-N-CA 121.433 -0.413 . . . . 1.0 113.494 179.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 19.7 m -143.36 -40.04 0.31 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.027 0.442 . . . . 1.0 110.517 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -147.49 146.24 29.43 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 121.075 0.464 . . . . 1.0 110.38 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.463 ' HB1' ' HD3' ' A' ' 111' ' ' ARG . . . -131.42 106.05 8.0 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.672 -0.695 . . . . 1.0 110.663 -175.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.411 HD22 ' N ' ' A' ' 122' ' ' LEU . 2.8 mm? -86.73 16.69 4.52 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.434 0.635 . . . . 1.0 110.61 177.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -169.06 136.69 1.89 Allowed 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 108.25 -1.019 . . . . 1.0 108.25 177.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.9 HG13 ' HB2' ' A' ' 111' ' ' ARG . 55.4 t -95.81 -86.92 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 113.392 0.886 . . . . 1.0 113.392 -173.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.548 ' OE1' HG22 ' A' ' 138' ' ' VAL . 9.8 pt-20 -137.59 172.78 12.45 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 115.051 -0.977 . . . . 1.0 111.363 -174.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 35.3 t70 178.03 121.98 0.19 Allowed Pre-proline 0 C--O 1.236 0.367 0 CA-C-N 115.216 -0.902 . . . . 1.0 109.086 177.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.846 ' HD3' HH22 ' A' ' 17' ' ' ARG . 19.7 Cg_endo -59.04 162.15 14.3 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 123.216 2.611 . . . . 1.0 113.216 -177.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.503 ' HD2' ' CD2' ' A' ' 129' ' ' TYR . 43.7 t80 -107.47 -28.3 9.9 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.948 -1.024 . . . . 1.0 110.174 -178.182 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.503 ' CD2' ' HD2' ' A' ' 128' ' ' TYR . 0.1 OUTLIER -142.19 -35.44 0.43 Allowed 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 111.98 0.363 . . . . 1.0 111.98 -179.705 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 94.18 68.3 1.06 Allowed Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.075 -1.06 . . . . 1.0 111.589 -178.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.736 ' H ' ' HB3' ' A' ' 134' ' ' ASP . 2.5 t70 -131.45 -170.68 2.43 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.471 -0.566 . . . . 1.0 109.471 -177.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.922 ' HA ' ' CZ ' ' A' ' 135' ' ' PHE . 4.4 t60 -58.63 -39.53 80.76 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 109.252 -0.647 . . . . 1.0 109.252 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 27.0 t -63.03 -33.51 75.59 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 114.994 -1.003 . . . . 1.0 111.066 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.736 ' HB3' ' H ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -65.16 -47.75 75.92 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 111.578 0.214 . . . . 1.0 111.578 -176.796 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.922 ' CZ ' ' HA ' ' A' ' 132' ' ' HIS . 6.7 p90 -75.98 -32.55 59.53 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 119.143 -1.023 . . . . 1.0 112.426 -175.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.443 ' HG3' ' CD2' ' A' ' 132' ' ' HIS . 1.6 mt-10 -77.06 -21.83 53.83 Favored 'General case' 0 C--N 1.312 -1.04 0 C-N-CA 120.144 -0.623 . . . . 1.0 109.853 175.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.489 ' O ' HG23 ' A' ' 141' ' ' VAL . 71.1 tt0 -67.8 -42.95 80.76 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 108.539 -0.911 . . . . 1.0 108.539 174.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.548 HG22 ' OE1' ' A' ' 125' ' ' GLU . 76.1 t -58.72 -44.34 89.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 114.514 -1.221 . . . . 1.0 109.583 176.19 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.554 ' HB2' ' HE1' ' A' ' 20' ' ' MET . 46.5 t80 -54.59 -43.41 72.11 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.444 -1.253 . . . . 1.0 110.257 177.178 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.451 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -63.9 -42.19 97.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.774 -0.648 . . . . 1.0 110.901 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 137' ' ' GLU . 31.2 t -57.7 -57.02 12.09 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 CA-C-O 121.384 0.611 . . . . 1.0 110.592 178.065 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.482 ' HA ' HD11 ' A' ' 110' ' ' LEU . 7.0 mt -57.7 -52.07 62.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.21 -0.904 . . . . 1.0 112.388 -177.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.498 ' HG3' ' N ' ' A' ' 144' ' ' SER . 2.2 pt-20 -56.34 -33.06 65.28 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.702 0.287 . . . . 1.0 110.536 -179.081 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.498 ' N ' ' HG3' ' A' ' 143' ' ' GLU . 4.0 t -73.52 -27.42 61.35 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.347 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.466 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -88.61 -22.34 23.54 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-N 115.914 -0.585 . . . . 1.0 111.86 179.152 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.658 HD22 ' HB3' ' A' ' 25' ' ' PHE . 12.5 mt -55.28 -37.31 55.37 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-O 119.212 -0.423 . . . . 1.0 112.117 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.626 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 43.3 Cg_endo -68.91 -12.17 33.74 Favored 'Trans proline' 0 C--N 1.365 1.409 0 C-N-CA 122.325 2.017 . . . . 1.0 111.943 176.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.568 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -104.51 -33.8 3.78 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 110.72 -0.952 . . . . 1.0 110.72 178.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.517 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -73.46 -39.62 64.79 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.348 -0.982 . . . . 1.0 108.348 178.93 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.511 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 0.2 OUTLIER -54.12 -55.01 31.76 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-N 115.136 -0.938 . . . . 1.0 110.628 175.347 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -56.29 -42.26 77.24 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.716 -1.129 . . . . 1.0 111.193 -175.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' TRP . . . . . 0.666 ' HZ3' HD21 ' A' ' 5' ' ' LEU . 22.1 t90 -64.97 -54.85 24.1 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.346 -0.843 . . . . 1.0 110.613 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.446 HG13 ' O ' ' A' ' 149' ' ' LEU . 6.4 m -62.21 -41.17 90.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 120.587 -0.445 . . . . 1.0 110.069 -178.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -60.19 -49.51 77.36 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-O 121.013 0.435 . . . . 1.0 110.792 178.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.543 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 11.8 pt-20 -63.61 -39.57 94.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.691 -0.686 . . . . 1.0 110.399 -178.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.527 ' HG3' ' CH2' ' A' ' 152' ' ' TRP . 15.6 mmt85 -74.59 -42.37 58.8 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.863 -0.608 . . . . 1.0 111.528 -175.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.409 ' C ' HD12 ' A' ' 157' ' ' LEU . 4.0 pp -67.45 -24.92 65.67 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.285 0.564 . . . . 1.0 109.576 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -73.42 -54.4 8.39 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.376 -0.829 . . . . 1.0 110.272 177.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 155' ' ' GLU . 0.1 OUTLIER -79.13 -1.15 34.71 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.902 -0.59 . . . . 1.0 111.907 -178.502 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -54.74 -45.17 74.1 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.828 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -164.34 -173.1 32.62 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 119.985 -1.103 . . . . 1.0 112.812 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -82.39 41.21 1.08 Allowed 'Trans proline' 0 N--CA 1.474 0.357 0 C-N-CA 124.002 3.134 . . . . 1.0 112.347 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 50.4 m . . . . . 0 C--N 1.314 -0.96 0 CA-C-N 114.292 -1.322 . . . . 1.0 110.016 -179.25 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.675 0 N-CA-C 111.615 -0.594 . . . . 1.0 111.615 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.2 mtt -82.16 131.39 35.24 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.934 0.367 . . . . 1.0 110.21 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.6 p -166.67 169.81 13.16 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.857 -0.611 . . . . 1.0 110.879 -178.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -163.32 149.7 10.12 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 115.343 -0.844 . . . . 1.0 109.415 176.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.643 ' HB2' ' HG2' ' A' ' 39' ' ' ARG . 18.9 Cg_endo -63.32 164.06 21.45 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 123.162 2.575 . . . . 1.0 113.886 -176.194 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.577 ' HB3' HG13 ' A' ' 38' ' ' VAL . 0.4 OUTLIER -71.1 -173.85 0.89 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.287 -1.324 . . . . 1.0 110.347 179.173 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.573 ' HB3' ' H ' ' A' ' 84' ' ' ASP . 1.5 t-160 -155.2 102.52 2.3 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 110.043 -0.355 . . . . 1.0 110.043 -178.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.699 HG13 HD13 ' A' ' 85' ' ' LEU . 2.1 t -106.53 112.48 39.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 108.125 -1.065 . . . . 1.0 108.125 177.479 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.55 HG22 ' HG ' ' A' ' 86' ' ' LEU . 9.0 t -114.58 114.11 25.29 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.033 0.444 . . . . 1.0 110.479 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.566 ' HD1' ' HB ' ' A' ' 87' ' ' VAL . 0.9 OUTLIER -83.87 134.83 34.68 Favored 'General case' 0 CA--C 1.511 -0.526 0 O-C-N 121.857 -0.527 . . . . 1.0 110.259 -179.541 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.577 HG21 HD11 ' A' ' 97' ' ' LEU . 48.8 t -119.69 115.61 48.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-O 121.227 0.537 . . . . 1.0 111.453 -177.545 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 37.4 t -140.49 163.15 33.6 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.527 -0.76 . . . . 1.0 109.297 178.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.15 84.94 3.63 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.167 0.508 . . . . 1.0 111.23 -177.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.708 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 141.84 -39.14 1.42 Allowed Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.443 -0.799 . . . . 1.0 111.952 179.064 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.407 HD21 ' CB ' ' A' ' 42' ' ' SER . 3.8 t-20 62.71 16.47 8.98 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.817 0.818 . . . . 1.0 111.347 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.418 ' O ' ' HB3' ' A' ' 55' ' ' ASP . 1.8 pt -131.44 32.87 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 O-C-N 121.827 -0.546 . . . . 1.0 110.553 -178.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.787 ' O ' ' HG3' ' A' ' 20' ' ' MET . 35.6 m -147.97 -88.21 0.09 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.915 -0.402 . . . . 1.0 109.915 175.378 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.41 -51.29 68.11 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.257 0.466 . . . . 1.0 112.257 -177.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.872 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 14.3 m -54.19 -58.99 11.21 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 115.99 -0.55 . . . . 1.0 112.369 -177.109 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.657 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 33.2 Cg_endo -61.62 -26.6 80.54 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 121.898 1.732 . . . . 1.0 112.705 -178.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.787 ' HG3' ' O ' ' A' ' 16' ' ' CYS . 72.9 mtp -60.43 -54.84 40.76 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.751 -0.38 . . . . 1.0 110.524 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.524 ' HA ' ' HB2' ' A' ' 24' ' ' MET . . . -74.75 -27.53 60.39 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.582 -0.447 . . . . 1.0 110.763 -178.201 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.601 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 18.1 tt0 -52.37 -53.36 45.82 Favored 'General case' 0 C--O 1.217 -0.634 0 O-C-N 124.064 0.852 . . . . 1.0 110.09 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.981 ' HE3' ' HB2' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -86.71 -22.35 26.08 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.43 -0.805 . . . . 1.0 110.69 -176.409 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.704 ' HB3' HD11 ' A' ' 146' ' ' LEU . 3.2 mmm -63.73 -76.66 0.06 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.216 0.45 . . . . 1.0 112.216 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.762 ' HB3' HD22 ' A' ' 146' ' ' LEU . 22.6 p90 -76.2 -29.76 57.74 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 119.697 -0.801 . . . . 1.0 111.68 -175.349 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.601 ' HB3' ' O ' ' A' ' 22' ' ' GLU . . . -63.35 -36.62 84.31 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 119.321 -0.952 . . . . 1.0 110.714 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.625 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -65.48 -39.32 91.8 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 108.801 -0.815 . . . . 1.0 108.801 177.218 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.616 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 59.8 mt-30 -60.47 -37.73 81.96 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 121.098 0.475 . . . . 1.0 110.395 177.181 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.582 HD13 ' HB ' ' A' ' 38' ' ' VAL . 95.9 mt -57.01 -62.63 1.61 Allowed 'General case' 0 C--O 1.223 -0.308 0 CA-C-N 115.724 -0.671 . . . . 1.0 110.555 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.485 ' HB3' ' HA3' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -59.3 -31.01 68.74 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.154 -0.618 . . . . 1.0 111.548 179.099 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -59.88 -33.73 72.22 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.929 0.395 . . . . 1.0 111.213 176.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.566 ' HG3' ' HG ' ' A' ' 34' ' ' LEU . 11.6 ptm180 -95.71 -20.68 18.71 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 120.142 -0.623 . . . . 1.0 109.827 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 109.6 36.22 2.11 Favored Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 115.008 -0.996 . . . . 1.0 112.459 177.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.566 ' HG ' ' HG3' ' A' ' 32' ' ' ARG . 38.9 mt -129.03 4.36 5.31 Favored 'General case' 0 C--N 1.331 -0.239 0 O-C-N 122.275 -0.544 . . . . 1.0 110.174 -179.042 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.485 ' HA3' ' HB3' ' A' ' 30' ' ' ARG . . . -59.0 -29.53 65.3 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 121.276 -0.488 . . . . 1.0 113.27 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.594 ' HA ' ' NH1' ' A' ' 39' ' ' ARG . 11.8 m-20 -92.71 -17.63 24.0 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.117 0.484 . . . . 1.0 110.254 177.438 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.89 -24.13 38.51 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.659 -0.701 . . . . 1.0 110.428 178.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.582 ' HB ' HD13 ' A' ' 29' ' ' LEU . 12.0 t -130.94 123.92 55.12 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.446 -179.534 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.643 ' HG2' ' HB2' ' A' ' 4' ' ' PRO . 22.8 mmt180 -93.82 130.56 39.8 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 109.058 -0.719 . . . . 1.0 109.058 175.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 64.0 t -122.68 117.84 53.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-O 121.528 0.68 . . . . 1.0 109.599 -175.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.507 ' O ' ' HA ' ' A' ' 8' ' ' THR . 57.9 p -130.99 -177.11 4.23 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.379 -1.282 . . . . 1.0 110.322 -175.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.872 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 90.9 p -160.56 165.71 30.32 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.842 -0.343 . . . . 1.0 110.339 179.027 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.624 ' HB2' ' CD2' ' A' ' 80' ' ' HIS . . . -164.0 166.92 21.07 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 121.365 0.603 . . . . 1.0 111.677 -179.247 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -124.55 131.92 8.03 Favored Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 110.682 -0.967 . . . . 1.0 110.682 176.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.568 HG23 ' CG1' ' A' ' 10' ' ' VAL . 36.3 p -66.62 -28.87 68.83 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.108 0.41 . . . . 1.0 112.108 -176.113 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.443 ' HA3' ' HZ3' ' A' ' 48' ' ' TRP . . . -106.53 10.82 42.48 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.618 -0.801 . . . . 1.0 113.598 -175.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 44.87 34.51 1.23 Allowed 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.559 0.948 . . . . 1.0 113.559 177.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.708 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 1.2 m-90 -45.09 -74.87 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.596 0.712 . . . . 1.0 111.984 179.375 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -107.39 41.17 1.54 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.822 -1.081 . . . . 1.0 111.132 -178.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.9 p -60.64 127.84 20.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.405 178.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.03 -12.62 68.9 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.962 -0.637 . . . . 1.0 112.378 -178.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 t -80.81 -160.19 0.3 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.907 0.384 . . . . 1.0 110.615 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 31.7 t -129.91 170.42 13.95 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.688 -0.486 . . . . 1.0 109.688 -178.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.83 143.2 38.11 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.242 0.544 . . . . 1.0 112.094 -178.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.682 ' OD2' ' HG3' ' A' ' 57' ' ' ARG . 12.8 p-10 -63.54 144.58 56.88 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.71 -1.132 . . . . 1.0 112.655 -177.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -48.69 -43.3 36.93 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.546 -1.206 . . . . 1.0 113.311 178.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.682 ' HG3' ' OD2' ' A' ' 55' ' ' ASP . 4.0 ptp180 -71.49 -40.73 70.04 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 121.135 -0.226 . . . . 1.0 111.471 -175.009 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.635 ' HB1' ' HG2' ' A' ' 20' ' ' MET . . . -71.04 -35.66 72.05 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.045 0.45 . . . . 1.0 109.834 178.015 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.85 -42.3 97.6 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.905 -0.589 . . . . 1.0 111.04 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -67.53 -34.73 85.05 Favored Glycine 0 CA--C 1.489 -1.546 0 N-CA-C 110.379 -1.089 . . . . 1.0 110.379 -178.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.491 HG23 ' CD1' ' A' ' 135' ' ' PHE . 1.1 t -63.07 -54.57 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 CA-C-N 113.557 -1.322 . . . . 1.0 110.882 176.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.711 HD13 ' HG3' ' A' ' 23' ' ' LYS . 89.5 mt -62.39 -51.86 65.88 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.772 0.32 . . . . 1.0 111.152 -177.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -64.83 -23.5 67.26 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.807 -0.633 . . . . 1.0 111.509 -177.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.68 -33.3 70.77 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.2 0.524 . . . . 1.0 110.589 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -96.12 1.46 52.45 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.713 -0.676 . . . . 1.0 111.063 -178.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 96.22 9.51 56.87 Favored Glycine 0 C--N 1.33 0.221 0 C-N-CA 120.886 -0.674 . . . . 1.0 113.112 176.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.511 ' CD1' ' HA ' ' A' ' 24' ' ' MET . 73.5 m-85 -88.99 149.37 43.21 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-O 120.413 0.149 . . . . 1.0 110.621 -179.305 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.475 ' HG2' ' CB ' ' A' ' 23' ' ' LYS . 40.9 Cg_endo -69.09 156.31 65.49 Favored 'Trans proline' 0 CA--C 1.51 -0.705 0 C-N-CA 122.252 1.968 . . . . 1.0 110.883 176.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.706 HG22 ' HB2' ' A' ' 62' ' ' LEU . 52.1 p -130.36 13.68 5.56 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.49 0.662 . . . . 1.0 110.443 -177.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -85.03 125.5 32.78 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.988 -1.006 . . . . 1.0 109.15 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.981 ' HB2' ' HE3' ' A' ' 23' ' ' LYS . 19.2 t60 -165.54 154.06 11.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.347 -0.388 . . . . 1.0 110.385 -175.001 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -133.95 113.85 12.63 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.628 -0.879 . . . . 1.0 108.628 176.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.63 140.27 56.53 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.171 -0.922 . . . . 1.0 112.558 -175.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.449 ' O ' ' HA ' ' A' ' 43' ' ' ALA . . . -134.18 150.74 51.1 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.257 -0.883 . . . . 1.0 109.81 178.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -86.62 155.33 20.48 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.615 -0.513 . . . . 1.0 109.615 176.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.591 HG11 ' CD2' ' A' ' 97' ' ' LEU . 8.8 t -67.41 112.62 2.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.123 0.487 . . . . 1.0 110.212 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.493 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -123.37 -166.92 12.72 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.58 -0.736 . . . . 1.0 111.437 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 44.3 m -57.11 -51.56 68.82 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.125 0.488 . . . . 1.0 111.687 -178.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.448 ' CD ' ' H ' ' A' ' 79' ' ' GLU . 1.4 pm0 -56.39 -31.57 63.97 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.3 -0.864 . . . . 1.0 111.114 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.624 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 80.1 m80 -75.28 -42.77 54.09 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 116.055 -0.52 . . . . 1.0 110.158 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.522 ' HA ' HD21 ' A' ' 86' ' ' LEU . 21.0 mt -67.69 -18.64 65.0 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.737 -0.665 . . . . 1.0 110.672 178.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.37 -2.9 58.82 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.852 -0.613 . . . . 1.0 110.853 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.555 ' HA ' ' HB3' ' A' ' 6' ' ' HIS . . . -60.23 155.14 18.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.827 -0.624 . . . . 1.0 111.498 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.709 ' HA ' ' NH1' ' A' ' 106' ' ' ARG . 25.0 t70 -79.5 -16.83 55.37 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.335 0.588 . . . . 1.0 109.883 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.699 HD13 HG13 ' A' ' 7' ' ' VAL . 0.5 OUTLIER -155.07 117.64 4.28 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.137 -0.938 . . . . 1.0 108.909 -177.405 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.586 HD12 ' N ' ' A' ' 86' ' ' LEU . 5.0 mp -105.52 104.11 13.77 Favored 'General case' 0 N--CA 1.425 -1.704 0 CA-C-N 115.518 -0.765 . . . . 1.0 109.744 178.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.575 ' HA ' ' O ' ' A' ' 108' ' ' ARG . 72.2 t -84.91 92.59 3.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.202 -0.908 . . . . 1.0 111.272 -176.158 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.02 146.03 30.86 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.18 -0.918 . . . . 1.0 110.785 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.469 ' O ' ' HB ' ' A' ' 124' ' ' VAL . 4.2 mm? -97.55 -7.63 30.9 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.37 0.605 . . . . 1.0 109.952 178.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.441 ' CG ' ' H ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -152.64 152.97 32.39 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.16 -0.927 . . . . 1.0 110.103 178.335 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.679 ' HB3' ' O ' ' A' ' 122' ' ' LEU . 18.7 ptt180 -64.3 -19.72 65.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.573 -0.74 . . . . 1.0 112.749 -176.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.637 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 78.3 m-20 -75.62 -48.73 20.97 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.397 -0.594 . . . . 1.0 109.397 178.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.744 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 17.8 m170 -56.29 -47.32 78.89 Favored 'General case' 0 C--N 1.333 -0.124 0 N-CA-C 109.619 -0.512 . . . . 1.0 109.619 177.134 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.466 ' HA ' HG21 ' A' ' 107' ' ' VAL . . . -58.55 -44.33 89.63 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.308 -0.406 . . . . 1.0 110.961 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.458 ' O ' ' HG2' ' A' ' 98' ' ' ARG . 2.0 ttt85 -59.64 -41.76 91.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.128 -0.487 . . . . 1.0 111.517 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.761 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 50.4 mt -63.91 -49.27 73.32 Favored 'General case' 0 C--O 1.219 -0.52 0 N-CA-C 109.744 -0.465 . . . . 1.0 109.744 -177.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.744 ' HG ' ' O ' ' A' ' 93' ' ' HIS . 27.5 mt -55.78 -55.59 30.58 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.316 -0.856 . . . . 1.0 111.67 -178.345 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.458 ' HG2' ' O ' ' A' ' 95' ' ' ARG . 20.2 ptt180 -60.97 -43.6 98.56 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.214 -0.448 . . . . 1.0 111.554 -176.553 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.647 ' HG3' ' O ' ' A' ' 96' ' ' LEU . 1.1 pp0? -69.0 -21.38 64.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.125 0.488 . . . . 1.0 110.239 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.761 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 9.8 mt -78.61 -7.81 57.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.595 -0.729 . . . . 1.0 111.962 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 147.66 -31.13 1.38 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.047 -1.073 . . . . 1.0 113.223 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.698 HG12 ' H ' ' A' ' 103' ' ' GLU . 1.4 t -75.15 -153.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.359 0.6 . . . . 1.0 111.238 -178.455 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.731 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 15.5 pt-20 -164.25 164.53 22.45 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.603 -0.888 . . . . 1.0 108.603 -178.125 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.811 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -67.69 -21.92 65.31 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.571 -0.286 . . . . 1.0 111.542 -175.405 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.61 -35.88 77.22 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.284 0.564 . . . . 1.0 110.371 175.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.731 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 0.6 OUTLIER -95.09 -44.84 7.48 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 115.201 -0.909 . . . . 1.0 110.364 -177.676 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.811 HG12 ' HA ' ' A' ' 104' ' ' ALA . 8.9 p -78.33 117.29 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-O 121.846 0.832 . . . . 1.0 109.595 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.575 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 29.1 mmm180 -134.43 148.62 50.66 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.662 -0.699 . . . . 1.0 109.915 -177.224 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.531 ' HG3' ' HA ' ' A' ' 122' ' ' LEU . 82.6 mmm -78.57 140.29 38.52 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.279 -0.873 . . . . 1.0 110.581 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.571 HD11 ' HA ' ' A' ' 142' ' ' ILE . 3.2 tm? -56.49 -50.47 71.66 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 123.085 0.241 . . . . 1.0 110.93 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 5.6 ttm-85 -70.96 -15.52 62.59 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.691 -0.404 . . . . 1.0 110.854 -178.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.433 ' HB2' ' HB2' ' A' ' 109' ' ' MET . 33.5 t -75.26 -2.7 29.33 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 120.97 -0.292 . . . . 1.0 110.31 -179.131 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.68 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 85.9 m-85 -96.08 -17.77 20.67 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 121.972 -0.455 . . . . 1.0 110.617 175.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -59.27 121.14 53.92 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.882 -0.599 . . . . 1.0 110.47 -178.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -62.56 -21.92 73.4 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.425 2.083 . . . . 1.0 111.846 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 116' ' ' ARG . 33.3 mtm180 -89.53 0.65 56.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.964 -0.562 . . . . 1.0 112.092 -178.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 88.0 p -63.27 95.52 0.09 Allowed 'General case' 0 C--O 1.238 0.474 0 CA-C-O 121.261 0.553 . . . . 1.0 111.139 -178.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -58.41 -47.46 89.65 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.413 -0.812 . . . . 1.0 111.63 178.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.4 m -104.07 163.63 12.26 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.981 -0.748 . . . . 1.0 108.981 177.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 40.9 m170 -67.0 131.93 46.87 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.862 -0.792 . . . . 1.0 108.862 175.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -95.7 86.93 4.53 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.517 -0.765 . . . . 1.0 110.59 -177.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.679 ' O ' ' HB3' ' A' ' 91' ' ' ARG . 2.4 mm? -95.95 15.98 19.04 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.965 -0.754 . . . . 1.0 108.965 176.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -168.69 137.83 2.24 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.013 -0.994 . . . . 1.0 109.415 -178.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.469 ' HB ' ' O ' ' A' ' 89' ' ' LEU . 92.3 t -105.96 147.27 11.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.672 -0.492 . . . . 1.0 109.672 -178.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -60.68 -178.1 0.09 Allowed 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.499 0.666 . . . . 1.0 112.11 -177.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -152.73 139.49 12.52 Favored Pre-proline 0 C--N 1.316 -0.891 0 CA-C-N 114.993 -1.003 . . . . 1.0 109.274 -174.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.649 ' HB3' ' HB3' ' A' ' 134' ' ' ASP . 97.6 Cg_exo -44.26 153.57 0.33 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 123.517 2.811 . . . . 1.0 113.315 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.1 -36.56 18.05 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.349 -0.841 . . . . 1.0 109.292 -178.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.26 -25.29 0.59 Allowed 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.288 -0.869 . . . . 1.0 111.463 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 91.37 60.93 1.27 Allowed Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.106 -1.045 . . . . 1.0 111.155 -179.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.414 ' H ' ' CG ' ' A' ' 134' ' ' ASP . 3.3 t70 -133.91 -163.21 1.33 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.702 -0.851 . . . . 1.0 108.702 -177.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.806 ' HA ' ' CZ ' ' A' ' 135' ' ' PHE . 17.2 t-80 -51.43 -48.19 62.8 Favored 'General case' 0 C--N 1.329 -0.283 0 O-C-N 123.209 0.318 . . . . 1.0 111.839 -178.433 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.8 p -62.44 -39.51 93.57 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.039 -0.528 . . . . 1.0 112.395 -177.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.649 ' HB3' ' HB3' ' A' ' 127' ' ' PRO . 1.0 OUTLIER -68.03 -42.36 80.73 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.272 -0.876 . . . . 1.0 112.05 -174.434 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.806 ' CZ ' ' HA ' ' A' ' 132' ' ' HIS . 7.3 p90 -74.99 -33.36 61.84 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 119.121 -1.032 . . . . 1.0 111.613 -175.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -73.26 -25.02 60.54 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.634 -0.506 . . . . 1.0 109.634 175.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -65.56 -45.5 83.12 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 109.643 -0.503 . . . . 1.0 109.643 176.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.842 ' HA ' HG12 ' A' ' 141' ' ' VAL . 24.4 t -63.74 -40.39 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-O 121.756 0.788 . . . . 1.0 109.043 177.534 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -55.94 -42.18 75.77 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.328 -0.851 . . . . 1.0 109.309 175.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.58 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -66.99 -47.96 69.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.489 -0.778 . . . . 1.0 111.711 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.842 HG12 ' HA ' ' A' ' 138' ' ' VAL . 3.6 p -59.54 -43.86 91.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.709 0.766 . . . . 1.0 111.214 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.611 HD12 HG12 ' A' ' 138' ' ' VAL . 13.5 mt -67.13 -51.08 57.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 115.206 -0.906 . . . . 1.0 111.504 178.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.58 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 7.6 pt-20 -56.11 -30.25 61.8 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 109.934 -0.395 . . . . 1.0 109.934 179.084 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 4.2 t -72.57 -30.32 64.3 Favored 'General case' 0 C--O 1.226 -0.179 0 CA-C-N 115.749 -0.66 . . . . 1.0 110.315 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.457 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -87.84 -22.62 24.35 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-N 116.024 -0.535 . . . . 1.0 111.723 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.762 HD22 ' HB3' ' A' ' 25' ' ' PHE . 9.9 mt -54.77 -38.77 70.54 Favored Pre-proline 0 CA--C 1.545 0.774 0 CA-C-O 119.163 -0.446 . . . . 1.0 112.048 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 61.7 Cg_endo -71.28 -11.01 28.17 Favored 'Trans proline' 0 C--N 1.365 1.429 0 C-N-CA 122.695 2.264 . . . . 1.0 112.113 177.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.68 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -103.86 -33.32 4.11 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.372 -1.091 . . . . 1.0 110.372 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.498 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -74.28 -40.38 62.33 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.378 -0.971 . . . . 1.0 108.378 178.372 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.484 ' O ' ' HB2' ' A' ' 154' ' ' ASP . 1.0 OUTLIER -55.71 -52.1 65.05 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 114.716 -1.129 . . . . 1.0 110.966 176.111 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -61.73 -42.35 98.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.755 -0.657 . . . . 1.0 110.962 -176.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' TRP . . . . . 0.577 ' CE3' HD12 ' A' ' 85' ' ' LEU . 28.0 t90 -60.98 -57.12 13.95 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.387 -0.824 . . . . 1.0 110.629 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.508 ' HB ' HD22 ' A' ' 5' ' ' LEU . 11.0 m -60.41 -38.49 78.0 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.279 0 N-CA-C 110.088 -0.338 . . . . 1.0 110.088 -178.164 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.525 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 0.5 OUTLIER -59.53 -56.19 25.07 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.403 0.62 . . . . 1.0 110.815 179.72 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.514 ' O ' ' HG3' ' A' ' 159' ' ' ARG . 5.4 pt-20 -61.44 -39.81 92.19 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.047 -0.978 . . . . 1.0 110.72 -177.225 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.43 ' HD3' ' HA ' ' A' ' 156' ' ' ARG . 11.4 mmt85 -72.07 -45.75 59.54 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 115.79 -0.641 . . . . 1.0 110.966 -176.263 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.525 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 3.6 pp -64.02 -28.82 70.06 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.789 -0.641 . . . . 1.0 109.372 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -73.6 -53.3 10.81 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.226 -0.897 . . . . 1.0 110.687 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.514 ' HG3' ' O ' ' A' ' 155' ' ' GLU . 0.0 OUTLIER -77.48 -8.84 58.4 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 112.664 0.616 . . . . 1.0 112.664 -176.497 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -59.35 -50.91 72.15 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 110.269 -0.271 . . . . 1.0 110.269 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 65.48 -151.28 51.76 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.812 -0.709 . . . . 1.0 111.972 179.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -80.2 -89.49 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.368 2.046 . . . . 1.0 111.631 177.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 25.8 m . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.24 -0.886 . . . . 1.0 109.257 177.07 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.722 0 N-CA-C 112.081 -0.407 . . . . 1.0 112.081 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ptt? -159.19 150.34 20.06 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.393 -0.595 . . . . 1.0 109.393 179.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.1 m -89.74 167.97 12.47 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.25 0.548 . . . . 1.0 112.091 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.866 ' HB2' ' HD2' ' A' ' 4' ' ' PRO . 1.3 p30 -170.98 167.82 3.98 Favored Pre-proline 0 N--CA 1.451 -0.424 0 N-CA-C 107.636 -1.246 . . . . 1.0 107.636 179.116 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.866 ' HD2' ' HB2' ' A' ' 3' ' ' ASP . 19.4 Cg_endo -58.59 165.35 7.95 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.37 2.047 . . . . 1.0 112.402 -177.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.794 ' HB3' HG23 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -65.04 177.17 1.05 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.667 -0.697 . . . . 1.0 109.304 -179.213 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.738 ' H ' HD13 ' A' ' 5' ' ' LEU . 0.1 OUTLIER -157.24 90.93 1.14 Allowed 'General case' 0 C--N 1.318 -0.797 0 O-C-N 121.878 -0.514 . . . . 1.0 111.036 -179.134 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.582 HG13 HD13 ' A' ' 85' ' ' LEU . 1.7 t -95.74 109.09 22.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.731 -0.668 . . . . 1.0 109.557 178.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.614 ' CG2' ' HG ' ' A' ' 86' ' ' LEU . 10.1 t -112.56 117.28 31.9 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 109.623 -0.51 . . . . 1.0 109.623 178.044 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.727 ' HZ ' ' HE1' ' A' ' 25' ' ' PHE . 1.0 OUTLIER -86.3 134.49 33.74 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 120.843 0.354 . . . . 1.0 110.234 -178.919 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.598 HG21 HD11 ' A' ' 97' ' ' LEU . 33.7 t -116.5 113.67 43.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 116.083 -0.508 . . . . 1.0 111.649 -176.337 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.638 ' HB2' HD23 ' A' ' 89' ' ' LEU . 38.3 t -143.86 160.61 40.47 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.145 -0.48 . . . . 1.0 109.837 178.46 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.423 HG23 ' NE2' ' A' ' 93' ' ' HIS . 0.6 OUTLIER -67.39 100.45 0.84 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.205 0.526 . . . . 1.0 111.18 -179.768 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 1.008 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 117.21 -40.01 2.48 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.513 -0.767 . . . . 1.0 112.18 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.706 ' ND2' ' H ' ' A' ' 74' ' ' ALA . 57.7 t30 60.61 25.72 15.43 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 122.449 1.119 . . . . 1.0 110.392 -177.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.578 ' O ' ' HB3' ' A' ' 55' ' ' ASP . 1.3 pt -134.76 39.02 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 114.908 -1.042 . . . . 1.0 109.658 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.763 ' O ' ' HG3' ' A' ' 20' ' ' MET . 6.9 p -151.38 -89.26 0.06 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.086 -0.507 . . . . 1.0 111.426 177.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.445 ' NH2' ' HA ' ' A' ' 126' ' ' ASP . 81.3 mtt180 -74.83 -45.1 45.56 Favored 'General case' 0 N--CA 1.464 0.249 0 O-C-N 122.004 -0.435 . . . . 1.0 111.543 -176.155 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.472 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 20.4 m -53.09 -56.32 24.96 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 116.117 -0.492 . . . . 1.0 111.364 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.472 ' HD3' ' HB2' ' A' ' 18' ' ' SER . 49.4 Cg_endo -67.28 -24.52 43.62 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 121.444 1.43 . . . . 1.0 112.909 -178.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.763 ' HG3' ' O ' ' A' ' 16' ' ' CYS . 63.4 mtp -59.15 -53.35 59.32 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 109.869 -0.419 . . . . 1.0 109.869 178.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.554 ' O ' ' HD1' ' A' ' 25' ' ' PHE . . . -72.77 -31.15 64.68 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 115.379 -0.828 . . . . 1.0 110.68 -177.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.636 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 17.5 tt0 -50.66 -53.46 30.85 Favored 'General case' 0 C--O 1.218 -0.554 0 O-C-N 124.167 0.917 . . . . 1.0 110.162 -178.006 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.675 ' HZ1' ' HB3' ' A' ' 71' ' ' HIS . 0.2 OUTLIER -84.9 -24.23 28.55 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.497 -0.774 . . . . 1.0 110.902 -176.618 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.431 ' HB3' HD11 ' A' ' 146' ' ' LEU . 85.4 mtp -63.61 -75.66 0.08 Allowed 'General case' 0 C--O 1.237 0.423 0 N-CA-C 112.621 0.6 . . . . 1.0 112.621 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.754 ' HB3' HD22 ' A' ' 146' ' ' LEU . 0.6 OUTLIER -78.62 -28.77 45.65 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.163 -0.615 . . . . 1.0 111.93 -174.885 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.636 ' HB3' ' O ' ' A' ' 22' ' ' GLU . . . -64.71 -38.07 89.75 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 119.346 -0.941 . . . . 1.0 110.389 178.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.635 ' HG3' ' N ' ' A' ' 28' ' ' GLN . 0.1 OUTLIER -62.92 -38.84 92.57 Favored 'General case' 0 CA--C 1.527 0.061 0 N-CA-C 108.406 -0.961 . . . . 1.0 108.406 177.046 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.635 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 79.4 mt-30 -59.89 -42.88 94.76 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 115.593 -0.73 . . . . 1.0 110.808 176.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 25' ' ' PHE . 96.5 mt -56.17 -60.05 4.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.104 -0.498 . . . . 1.0 111.322 -178.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.425 ' HA ' ' H ' ' A' ' 35' ' ' GLY . 0.1 OUTLIER -60.29 -34.91 74.42 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.144 -0.623 . . . . 1.0 111.178 178.904 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -60.76 -29.24 69.29 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 111.96 0.355 . . . . 1.0 111.96 177.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.603 ' HG2' ' O ' ' A' ' 28' ' ' GLN . 6.8 ptp180 -94.72 -21.1 18.98 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.098 -0.641 . . . . 1.0 110.275 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 107.43 40.38 1.78 Allowed Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.175 -0.921 . . . . 1.0 111.962 177.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 25.8 mt -132.32 0.32 3.71 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.965 -0.383 . . . . 1.0 109.965 -178.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.425 ' H ' ' HA ' ' A' ' 30' ' ' ARG . . . -57.7 -28.91 60.7 Favored Glycine 0 C--N 1.332 0.351 0 CA-C-N 116.035 -0.53 . . . . 1.0 112.855 -179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -83.35 -25.76 31.14 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.17 0.509 . . . . 1.0 110.321 177.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.41 -23.11 40.6 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.559 -0.746 . . . . 1.0 111.571 -177.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.794 HG23 ' HB3' ' A' ' 5' ' ' LEU . 0.4 OUTLIER -141.33 125.09 16.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.296 0.569 . . . . 1.0 111.241 -179.396 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.466 ' HG2' ' HB2' ' A' ' 4' ' ' PRO . 17.3 mmt180 -88.93 142.43 27.65 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.475 -0.784 . . . . 1.0 108.998 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 77.0 t -129.8 130.13 66.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 109.173 -0.676 . . . . 1.0 109.173 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.494 ' O ' ' HA ' ' A' ' 8' ' ' THR . 37.0 p -143.8 -174.17 4.18 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.782 -1.099 . . . . 1.0 110.487 -174.355 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.472 ' OG ' ' HE1' ' A' ' 71' ' ' HIS . 65.2 p -160.43 163.03 33.37 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.598 -0.274 . . . . 1.0 110.427 -179.072 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.657 ' HB2' ' CD2' ' A' ' 80' ' ' HIS . . . -163.34 161.98 24.81 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.278 0.561 . . . . 1.0 111.345 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -123.37 133.42 8.95 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.453 -0.794 . . . . 1.0 111.481 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.504 HG23 ' CG1' ' A' ' 10' ' ' VAL . 17.9 p -71.44 -20.83 62.05 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.688 0.28 . . . . 1.0 111.727 -178.128 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.46 ' HA3' ' CZ3' ' A' ' 48' ' ' TRP . . . -109.66 5.33 31.09 Favored Glycine 0 C--O 1.226 -0.377 0 C-N-CA 120.603 -0.808 . . . . 1.0 113.026 -178.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 42.92 34.54 0.62 Allowed 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 113.518 0.933 . . . . 1.0 113.518 178.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 1.008 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 0.9 OUTLIER -46.83 -72.99 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.298 0.571 . . . . 1.0 112.419 -178.983 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.545 ' HB3' ' HB3' ' A' ' 52' ' ' SER . 3.2 m-70 -106.5 42.66 1.24 Allowed 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.734 -0.666 . . . . 1.0 111.186 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.434 HG23 ' HA ' ' A' ' 74' ' ' ALA . 11.9 p -61.34 126.92 20.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 120.573 -0.451 . . . . 1.0 109.985 178.399 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.0 -12.59 69.63 Favored Glycine 0 CA--C 1.519 0.303 0 N-CA-C 111.794 -0.523 . . . . 1.0 111.794 -176.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.545 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 1.4 t -83.08 -159.58 0.35 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.149 0.5 . . . . 1.0 109.839 178.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.614 ' HA ' ' O ' ' A' ' 71' ' ' HIS . 25.0 t -131.17 170.38 14.64 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.955 -0.566 . . . . 1.0 109.573 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -50.74 145.7 6.65 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 123.758 0.661 . . . . 1.0 111.553 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.672 ' OD1' ' HA ' ' A' ' 16' ' ' CYS . 9.6 p-10 -61.47 144.94 53.35 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.434 -0.803 . . . . 1.0 112.388 -178.289 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -45.75 -36.32 4.97 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.214 -1.357 . . . . 1.0 113.221 175.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.611 ' O ' HG23 ' A' ' 61' ' ' VAL . 17.1 mtt-85 -71.22 -49.66 41.09 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.843 0.354 . . . . 1.0 111.013 -175.238 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.479 ' HB1' ' HG2' ' A' ' 20' ' ' MET . . . -69.65 -29.83 67.39 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.419 -0.81 . . . . 1.0 110.557 -178.391 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.401 ' O ' HG21 ' A' ' 69' ' ' THR . . . -61.65 -47.71 84.16 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.701 -0.481 . . . . 1.0 109.701 177.266 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.36 -38.09 95.7 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.962 -0.637 . . . . 1.0 112.101 178.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 57' ' ' ARG . 99.7 t -64.19 -58.87 5.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.25 0.548 . . . . 1.0 110.826 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.479 ' HB2' HG22 ' A' ' 69' ' ' THR . 8.6 mp -59.79 -48.65 80.84 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.686 -0.688 . . . . 1.0 111.54 -177.2 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.448 ' HB3' HG21 ' A' ' 69' ' ' THR . 9.9 ptm180 -60.59 -28.54 68.57 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.517 -0.31 . . . . 1.0 111.131 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.34 -33.88 75.1 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.417 0.627 . . . . 1.0 110.053 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -93.74 4.78 53.42 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.228 -0.896 . . . . 1.0 111.536 -178.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.89 16.18 65.98 Favored Glycine 0 N--CA 1.455 -0.093 0 C-N-CA 120.96 -0.638 . . . . 1.0 112.754 177.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -92.44 151.95 41.79 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 110.259 -0.274 . . . . 1.0 110.259 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.482 ' O ' ' HD2' ' A' ' 23' ' ' LYS . 27.8 Cg_endo -66.29 152.1 81.84 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 121.877 1.718 . . . . 1.0 110.155 176.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.479 HG22 ' HB2' ' A' ' 62' ' ' LEU . 66.7 p -131.28 25.61 4.85 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 120.266 -0.574 . . . . 1.0 112.041 -175.334 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -110.57 127.02 55.04 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.783 -0.451 . . . . 1.0 109.783 179.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.675 ' HB3' ' HZ1' ' A' ' 23' ' ' LYS . 0.2 OUTLIER -160.09 139.5 11.04 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.883 -179.61 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.526 ' HD3' ' O ' ' A' ' 52' ' ' SER . 5.1 tpp180 -102.72 114.98 29.67 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.969 -0.56 . . . . 1.0 110.132 178.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 49' ' ' HIS . . . -63.51 138.01 58.35 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.139 -0.482 . . . . 1.0 112.133 -178.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.706 ' H ' ' ND2' ' A' ' 14' ' ' ASN . . . -129.41 163.62 25.43 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.942 -0.572 . . . . 1.0 109.894 176.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -98.07 159.41 14.95 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.977 -0.749 . . . . 1.0 108.977 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.578 HG11 HD23 ' A' ' 97' ' ' LEU . 47.8 t -70.83 115.26 10.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.936 0.398 . . . . 1.0 110.252 177.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.567 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -128.31 -167.0 12.13 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.723 -0.671 . . . . 1.0 111.697 178.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 30.3 m -57.35 -51.83 67.81 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.973 0.416 . . . . 1.0 111.747 -179.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.472 ' CD ' ' H ' ' A' ' 79' ' ' GLU . 1.6 pm0 -56.21 -31.93 63.95 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.623 -0.717 . . . . 1.0 110.981 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.657 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 80.0 m80 -74.87 -41.16 60.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.967 -0.561 . . . . 1.0 109.955 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.735 ' HA ' HD21 ' A' ' 86' ' ' LEU . 15.6 mt -68.78 -16.34 63.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.973 0.416 . . . . 1.0 110.238 176.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -87.35 -8.32 56.78 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 120.932 0.396 . . . . 1.0 110.112 -179.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.475 ' HB1' ' O ' ' A' ' 6' ' ' HIS . . . -59.18 156.16 12.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.86 -0.609 . . . . 1.0 110.774 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.77 ' HA ' ' NH1' ' A' ' 106' ' ' ARG . 3.0 t70 -82.35 -12.47 57.93 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.902 0.382 . . . . 1.0 110.153 -178.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.735 HD12 ' CE3' ' A' ' 152' ' ' TRP . 1.1 tt -158.0 115.26 2.94 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.81 -0.632 . . . . 1.0 109.539 -178.257 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.735 HD21 ' HA ' ' A' ' 81' ' ' LEU . 5.2 mp -107.08 87.64 2.55 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 115.669 -0.696 . . . . 1.0 110.802 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.632 HG11 HD23 ' A' ' 110' ' ' LEU . 76.7 t -66.01 92.91 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 113.886 -1.507 . . . . 1.0 112.521 -178.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.69 149.86 31.08 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.993 -1.003 . . . . 1.0 111.093 177.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.645 ' O ' ' HB ' ' A' ' 124' ' ' VAL . 3.9 mm? -98.7 -5.69 31.04 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.971 179.119 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.9 p30 -159.09 166.43 31.62 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.506 0.67 . . . . 1.0 111.368 174.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.452 ' HG2' ' H ' ' A' ' 91' ' ' ARG . 9.1 ptt180 -62.63 -18.98 63.32 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.11 -1.404 . . . . 1.0 112.305 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.622 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 5.9 m-20 -78.48 -53.24 7.45 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.749 0.309 . . . . 1.0 110.623 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.669 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 14.1 m170 -58.84 -44.73 91.02 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.958 -0.565 . . . . 1.0 109.674 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.17 -42.78 91.62 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.002 0.429 . . . . 1.0 110.817 179.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 95' ' ' ARG . 4.3 ttm180 -57.99 -44.84 87.4 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.37 -0.832 . . . . 1.0 111.281 177.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.691 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 49.4 mt -64.85 -48.45 74.28 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.44 -175.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.669 ' HG ' ' O ' ' A' ' 93' ' ' HIS . 29.0 mt -53.57 -59.77 4.16 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.642 -0.708 . . . . 1.0 111.771 -177.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.714 ' N ' HG12 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -60.12 -44.33 94.98 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.47 0.545 . . . . 1.0 112.47 -179.308 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.539 ' HG3' ' O ' ' A' ' 96' ' ' LEU . 1.0 OUTLIER -66.56 -23.3 66.19 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.254 -0.578 . . . . 1.0 109.945 179.056 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.691 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 8.9 mt -80.98 -21.75 40.05 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.764 -0.653 . . . . 1.0 111.65 178.155 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 155.25 -22.72 0.58 Allowed Glycine 0 CA--C 1.521 0.453 0 C-N-CA 119.332 -1.413 . . . . 1.0 114.38 -177.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.714 HG12 ' N ' ' A' ' 98' ' ' ARG . 0.3 OUTLIER -76.82 -162.09 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 117.836 0.818 . . . . 1.0 110.431 -179.78 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.756 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 16.7 pt-20 -156.37 159.85 39.13 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 107.624 -1.25 . . . . 1.0 107.624 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.767 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -62.91 -23.65 67.46 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.692 0.282 . . . . 1.0 111.625 -174.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.77 -36.57 74.6 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.376 174.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.77 ' NH1' ' HA ' ' A' ' 84' ' ' ASP . 0.7 OUTLIER -97.25 -42.17 7.93 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 115.323 -0.853 . . . . 1.0 111.063 -177.382 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.767 HG12 ' HA ' ' A' ' 104' ' ' ALA . 14.2 p -79.18 114.69 20.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.113 0.482 . . . . 1.0 109.798 -175.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.631 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 27.3 mmm180 -133.32 148.6 51.91 Favored 'General case' 0 C--N 1.318 -0.777 0 O-C-N 121.521 -0.737 . . . . 1.0 110.314 -177.262 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.573 ' HB2' ' HB2' ' A' ' 112' ' ' SER . 74.8 mmm -78.91 138.16 37.97 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.454 -0.794 . . . . 1.0 110.526 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.632 HD23 HG11 ' A' ' 87' ' ' VAL . 3.2 tm? -57.66 -50.67 72.39 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 111.488 0.181 . . . . 1.0 111.488 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.437 ' O ' ' HG2' ' A' ' 111' ' ' ARG . 19.1 ttm180 -69.18 -17.99 63.87 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.661 -0.416 . . . . 1.0 110.227 -178.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.573 ' HB2' ' HB2' ' A' ' 109' ' ' MET . 39.3 t -73.48 -5.66 41.46 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.928 -0.309 . . . . 1.0 111.262 -178.293 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.66 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 88.6 m-85 -92.99 -18.07 23.15 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 121.073 0.463 . . . . 1.0 110.411 175.421 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.63 ' OD2' ' HG3' ' A' ' 116' ' ' ARG . 17.7 t0 -61.87 125.37 84.83 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.598 -0.728 . . . . 1.0 111.256 -177.211 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.401 ' HD2' ' OD1' ' A' ' 114' ' ' ASP . 35.9 Cg_endo -60.84 -31.72 91.99 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 123.5 2.8 . . . . 1.0 112.805 -178.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.63 ' HG3' ' OD2' ' A' ' 114' ' ' ASP . 1.0 OUTLIER -93.85 -1.57 54.66 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.828 -0.623 . . . . 1.0 111.809 -177.251 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.623 ' HB2' ' HB3' ' A' ' 114' ' ' ASP . 31.0 t -76.0 46.96 0.41 Allowed 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 111.47 0.174 . . . . 1.0 111.47 -178.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 50.57 -123.18 15.0 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 121.223 -0.513 . . . . 1.0 113.693 -177.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 15.8 m -100.27 -57.92 2.02 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.415 -0.392 . . . . 1.0 111.054 -179.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -134.18 154.62 51.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.964 0.412 . . . . 1.0 110.817 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -133.04 98.25 4.23 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.169 -0.923 . . . . 1.0 109.066 176.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.405 HD22 ' N ' ' A' ' 122' ' ' LEU . 1.8 mm? -96.05 19.26 11.9 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.343 -0.389 . . . . 1.0 110.524 -177.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -171.27 133.66 0.86 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.062 -0.517 . . . . 1.0 109.731 -177.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.645 ' HB ' ' O ' ' A' ' 89' ' ' LEU . 88.2 t -105.54 148.76 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.596 -0.52 . . . . 1.0 109.596 179.073 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.33 -177.08 0.12 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.879 0.847 . . . . 1.0 113.081 -177.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.528 ' CG ' ' HD2' ' A' ' 127' ' ' PRO . 9.9 t70 -147.61 150.13 35.87 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 107.619 -1.252 . . . . 1.0 107.619 -176.355 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.567 ' HB3' ' OD1' ' A' ' 134' ' ' ASP . 28.9 Cg_endo -59.41 161.13 17.84 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 121.865 1.71 . . . . 1.0 111.972 -179.305 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.535 ' HD2' ' CD2' ' A' ' 129' ' ' TYR . 59.3 t80 -104.37 -30.04 10.36 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.237 -0.585 . . . . 1.0 110.522 -179.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.54 ' HD1' ' H ' ' A' ' 130' ' ' GLY . 0.1 OUTLIER -143.73 -50.38 0.31 Allowed 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 122.097 -0.377 . . . . 1.0 110.651 -179.607 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.54 ' H ' ' HD1' ' A' ' 129' ' ' TYR . . . 110.79 75.97 0.83 Allowed Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.261 -0.971 . . . . 1.0 113.08 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -143.12 -176.69 5.02 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.327 -0.62 . . . . 1.0 109.327 177.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.543 ' CD2' ' HG3' ' A' ' 136' ' ' GLU . 3.8 t-160 -52.91 -42.9 65.81 Favored 'General case' 0 C--O 1.233 0.206 0 O-C-N 123.297 0.373 . . . . 1.0 110.911 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 4.6 m -64.27 -41.79 96.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.91 0.386 . . . . 1.0 110.605 -177.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.567 ' OD1' ' HB3' ' A' ' 127' ' ' PRO . 8.3 t0 -65.75 -40.21 91.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.407 -0.815 . . . . 1.0 110.546 -178.246 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.445 ' CE1' ' HD3' ' A' ' 57' ' ' ARG . 11.6 m-85 -68.72 -41.25 79.31 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.0 0.429 . . . . 1.0 110.742 -176.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.543 ' HG3' ' CD2' ' A' ' 132' ' ' HIS . 1.8 mt-10 -73.14 -21.56 60.69 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.44 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.57 ' O ' HG23 ' A' ' 141' ' ' VAL . 20.4 tp10 -65.08 -47.96 75.41 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.107 -0.701 . . . . 1.0 109.107 175.156 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.534 ' HA ' HG23 ' A' ' 141' ' ' VAL . 52.7 t -60.85 -42.41 92.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 115.833 -0.621 . . . . 1.0 109.545 176.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.473 ' HB2' HG11 ' A' ' 61' ' ' VAL . 70.0 t80 -54.56 -43.48 72.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.906 -1.043 . . . . 1.0 109.45 176.215 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.711 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -64.0 -38.53 91.41 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.516 -0.765 . . . . 1.0 110.737 177.325 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 137' ' ' GLU . 13.6 t -58.33 -51.9 65.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-O 121.558 0.694 . . . . 1.0 110.067 177.271 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.461 ' CG2' ' HB2' ' A' ' 21' ' ' ALA . 5.8 mt -65.44 -50.96 69.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.177 -0.92 . . . . 1.0 111.89 -179.06 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.711 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 6.8 pt-20 -55.09 -33.47 62.82 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 110.033 -0.358 . . . . 1.0 110.033 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.511 ' HB2' ' O ' ' A' ' 140' ' ' ALA . 1.0 OUTLIER -73.5 -27.69 61.51 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.841 -0.618 . . . . 1.0 110.384 -179.694 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.444 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -86.94 -23.91 24.95 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 116.107 -0.497 . . . . 1.0 111.407 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.754 HD22 ' HB3' ' A' ' 25' ' ' PHE . 16.0 mt -55.22 -37.92 62.01 Favored Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 112.276 0.473 . . . . 1.0 112.276 -178.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 60.8 Cg_endo -71.61 -9.75 25.55 Favored 'Trans proline' 0 C--N 1.362 1.288 0 C-N-CA 122.634 2.222 . . . . 1.0 112.147 177.321 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.66 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -105.14 -30.86 4.6 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 110.317 -1.113 . . . . 1.0 110.317 178.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.565 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -75.54 -42.12 53.27 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.3 -1.0 . . . . 1.0 108.3 177.424 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 9.9 m170 -54.34 -49.76 69.0 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.087 -0.961 . . . . 1.0 110.777 176.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -61.54 -45.98 91.86 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.584 -0.735 . . . . 1.0 110.764 -177.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' TRP . . . . . 0.735 ' CE3' HD12 ' A' ' 85' ' ' LEU . 27.8 t90 -59.15 -57.02 14.89 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.914 -1.039 . . . . 1.0 110.722 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 15.8 m -58.88 -38.09 70.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.834 -0.346 . . . . 1.0 110.567 -178.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.521 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 9.9 t70 -58.84 -57.38 13.3 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 122.062 0.934 . . . . 1.0 110.897 178.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 4.5 pt-20 -62.23 -36.9 83.4 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 113.928 -1.487 . . . . 1.0 110.733 -176.118 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.524 ' HG3' ' CH2' ' A' ' 152' ' ' TRP . 3.8 mmt180 -74.72 -44.72 48.52 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.754 -0.657 . . . . 1.0 111.35 -177.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 3.7 pp -64.03 -26.16 68.44 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.566 -0.531 . . . . 1.0 109.566 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -72.76 -52.06 16.6 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.495 -0.775 . . . . 1.0 110.236 177.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.42 -8.44 55.91 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 112.33 0.493 . . . . 1.0 112.33 -178.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -90.16 8.04 34.93 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.678 0.751 . . . . 1.0 109.82 178.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.475 ' HA2' ' HD3' ' A' ' 162' ' ' PRO . . . -114.67 130.6 9.32 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.344 -0.844 . . . . 1.0 111.719 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.475 ' HD3' ' HA2' ' A' ' 161' ' ' GLY . 2.9 Cg_exo -78.3 -44.71 0.15 Allowed 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 123.658 2.905 . . . . 1.0 112.573 -178.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 51.1 m . . . . . 0 C--O 1.247 0.934 0 CA-C-N 115.363 -0.835 . . . . 1.0 109.75 -178.984 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.831 0 N-CA-C 111.578 -0.609 . . . . 1.0 111.578 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.7 mtm -151.88 153.69 34.67 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.807 0.304 . . . . 1.0 110.192 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.67 -73.93 0.32 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.091 -0.504 . . . . 1.0 111.139 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.568 ' HB2' ' HD2' ' A' ' 4' ' ' PRO . 3.9 p-10 -165.2 159.64 14.35 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-O 121.012 0.434 . . . . 1.0 111.112 -178.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.568 ' HD2' ' HB2' ' A' ' 3' ' ' ASP . 49.5 Cg_endo -72.04 168.04 25.09 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 123.099 2.532 . . . . 1.0 113.174 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.851 ' HB3' HG23 ' A' ' 38' ' ' VAL . 0.9 OUTLIER -73.57 -173.71 1.52 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.411 -0.813 . . . . 1.0 110.879 179.574 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.58 ' O ' ' HB1' ' A' ' 83' ' ' ALA . 1.5 t-160 -158.09 93.93 1.27 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.462 -0.335 . . . . 1.0 111.027 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.79 HG13 HD13 ' A' ' 85' ' ' LEU . 2.3 t -94.28 109.31 21.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.037 -0.727 . . . . 1.0 109.037 176.308 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.698 ' CG2' ' HG ' ' A' ' 86' ' ' LEU . 12.8 t -112.32 112.98 24.95 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.116 0.484 . . . . 1.0 110.307 178.279 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.741 ' HZ ' ' HE1' ' A' ' 25' ' ' PHE . 0.9 OUTLIER -82.06 147.1 29.31 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 121.857 -0.527 . . . . 1.0 109.761 179.921 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.68 HG21 HD21 ' A' ' 97' ' ' LEU . 44.3 t -132.74 118.12 32.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.321 0.581 . . . . 1.0 111.634 -176.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.584 ' HB3' HD23 ' A' ' 89' ' ' LEU . 28.7 p -141.29 178.81 7.16 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.524 -0.762 . . . . 1.0 110.092 178.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.521 HG23 ' NE2' ' A' ' 93' ' ' HIS . 0.7 OUTLIER -86.36 86.64 7.34 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.988 0.423 . . . . 1.0 110.971 179.064 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.857 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 135.55 -37.6 1.89 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.656 -0.783 . . . . 1.0 112.077 178.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.516 HD21 ' CB ' ' A' ' 42' ' ' SER . 3.8 t-20 64.01 17.22 10.46 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.59 0.709 . . . . 1.0 111.103 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.0 pt -124.55 11.03 4.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 O-C-N 121.783 -0.573 . . . . 1.0 111.715 -177.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 7.5 p -127.45 -87.36 0.57 Allowed 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 112.112 0.412 . . . . 1.0 112.112 -177.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.68 -44.37 74.17 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 112.323 0.49 . . . . 1.0 112.323 -176.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.738 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 50.9 m -57.37 -58.03 20.92 Favored Pre-proline 0 CA--C 1.538 0.488 0 N-CA-C 112.378 0.51 . . . . 1.0 112.378 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.665 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 49.4 Cg_endo -64.96 -24.48 60.4 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 121.632 1.555 . . . . 1.0 112.071 -177.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.617 ' HB3' HD13 ' A' ' 142' ' ' ILE . 39.9 mmm -61.62 -54.39 43.54 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 121.13 -0.228 . . . . 1.0 110.767 178.153 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.539 ' O ' ' HD1' ' A' ' 25' ' ' PHE . . . -72.65 -32.02 65.53 Favored 'General case' 0 CA--C 1.507 -0.679 0 C-N-CA 120.615 -0.434 . . . . 1.0 110.124 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.651 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 11.3 tt0 -50.83 -51.79 47.56 Favored 'General case' 0 C--O 1.216 -0.708 0 O-C-N 124.399 1.062 . . . . 1.0 109.988 -178.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.904 ' HE3' ' HB2' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -79.45 -30.33 42.15 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.829 -0.623 . . . . 1.0 110.014 -176.906 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.587 ' HB3' HD11 ' A' ' 146' ' ' LEU . 3.2 mmm -62.39 -75.78 0.07 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.436 0.902 . . . . 1.0 113.436 -176.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.741 ' HE1' ' HZ ' ' A' ' 9' ' ' PHE . 0.8 OUTLIER -78.86 -27.81 44.16 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.011 -0.676 . . . . 1.0 111.543 -174.628 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.651 ' HB3' ' O ' ' A' ' 22' ' ' GLU . . . -64.62 -37.16 86.63 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 118.934 -1.106 . . . . 1.0 110.262 177.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.694 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -63.48 -39.44 94.46 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.76 -0.83 . . . . 1.0 108.76 177.417 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.562 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 77.6 mt-30 -59.67 -45.02 93.3 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.982 -0.554 . . . . 1.0 110.39 176.299 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.623 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 90.8 mt -54.46 -61.38 2.34 Favored 'General case' 0 N--CA 1.461 0.094 0 CA-C-N 115.751 -0.659 . . . . 1.0 111.078 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.6 ' HD3' ' HA ' ' A' ' 27' ' ' GLN . 3.2 ptm180 -58.53 -39.72 80.96 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.211 -0.449 . . . . 1.0 111.47 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -62.27 -22.52 66.07 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 112.176 0.435 . . . . 1.0 112.176 178.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.623 ' HG2' ' O ' ' A' ' 29' ' ' LEU . 5.7 ptm85 -99.89 -17.79 17.44 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 119.346 -0.941 . . . . 1.0 110.158 178.331 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.17 35.75 2.86 Favored Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 115.016 -0.993 . . . . 1.0 112.077 177.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.521 ' HG ' ' HG3' ' A' ' 32' ' ' ARG . 43.5 mt -126.88 -1.28 6.61 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.739 0.304 . . . . 1.0 110.346 -178.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.429 ' H ' ' HA ' ' A' ' 30' ' ' ARG . . . -56.32 -28.0 54.12 Favored Glycine 0 N--CA 1.46 0.288 0 CA-C-N 116.027 -0.533 . . . . 1.0 112.897 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.503 ' O ' ' HB3' ' A' ' 4' ' ' PRO . 4.9 m-20 -89.7 -22.36 22.26 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.666 0.27 . . . . 1.0 110.55 177.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.04 -26.33 39.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.033 -0.53 . . . . 1.0 111.497 -179.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.851 HG23 ' HB3' ' A' ' 5' ' ' LEU . 1.1 p -143.83 124.02 8.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.37 0.605 . . . . 1.0 110.198 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.453 ' HE ' ' HG3' ' A' ' 4' ' ' PRO . 17.7 mmt85 -90.17 147.42 23.59 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.287 -0.87 . . . . 1.0 109.704 -178.135 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 74.7 t -132.64 117.27 30.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.557 0.694 . . . . 1.0 110.584 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.498 ' O ' ' HA ' ' A' ' 8' ' ' THR . 69.8 p -132.23 -174.15 3.36 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.502 -1.226 . . . . 1.0 110.419 -177.025 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.738 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 93.2 p -160.98 168.91 23.62 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.806 -0.357 . . . . 1.0 110.58 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.464 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -163.96 167.44 20.55 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.186 0.517 . . . . 1.0 111.291 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -125.75 135.74 9.34 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 115.355 -0.839 . . . . 1.0 111.023 176.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.59 HG21 HD12 ' A' ' 96' ' ' LEU . 23.5 p -70.59 -26.47 63.53 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.315 0.487 . . . . 1.0 112.315 -177.044 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.461 ' HA3' ' CZ3' ' A' ' 48' ' ' TRP . . . -108.11 9.61 36.58 Favored Glycine 0 C--O 1.229 -0.179 0 C-N-CA 120.717 -0.754 . . . . 1.0 112.796 -177.425 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 42.97 38.87 1.55 Allowed 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.344 0.868 . . . . 1.0 113.344 178.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.857 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 1.1 m-90 -46.38 -75.34 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.326 0.584 . . . . 1.0 112.48 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.483 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 8.1 m-70 -106.42 41.31 1.45 Allowed 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.259 -0.882 . . . . 1.0 111.046 -179.059 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.531 HG23 ' HA ' ' A' ' 74' ' ' ALA . 15.0 p -61.27 125.01 16.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 120.471 -0.492 . . . . 1.0 110.281 178.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.42 -12.5 66.4 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.903 -0.665 . . . . 1.0 111.763 -177.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.45 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 2.8 t -81.15 -160.33 0.32 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.228 0.537 . . . . 1.0 110.08 178.263 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 34.9 t -129.87 171.45 12.72 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.465 -0.788 . . . . 1.0 109.325 -178.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.26 140.85 37.71 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.745 0.307 . . . . 1.0 111.464 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -59.47 141.35 54.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.605 -0.725 . . . . 1.0 111.52 -177.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -51.58 -28.89 15.36 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 113.378 0.881 . . . . 1.0 113.378 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.68 ' O ' HG23 ' A' ' 61' ' ' VAL . 18.9 mtp180 -68.46 -50.61 51.24 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 118.524 0.602 . . . . 1.0 109.506 178.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.21 -32.37 72.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.145 -0.934 . . . . 1.0 110.568 -176.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.85 -46.6 88.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.135 178.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.88 -37.81 95.51 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.667 -0.778 . . . . 1.0 111.843 177.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 57' ' ' ARG . 58.1 t -63.2 -58.95 5.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.21 0.529 . . . . 1.0 111.282 179.14 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.738 ' HB2' HG22 ' A' ' 69' ' ' THR . 92.3 mt -58.3 -53.16 61.38 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.745 -0.661 . . . . 1.0 111.356 -177.205 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -59.23 -29.71 67.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.44 -0.346 . . . . 1.0 111.083 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.79 -33.33 73.69 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.231 0.538 . . . . 1.0 111.03 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 73.1 m80 -98.8 6.37 46.92 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.065 -0.516 . . . . 1.0 111.216 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.23 13.81 63.23 Favored Glycine 0 C--N 1.332 0.323 0 CA-C-N 115.642 -0.708 . . . . 1.0 112.961 176.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.403 ' CD1' ' HA ' ' A' ' 24' ' ' MET . 64.8 m-85 -90.59 151.64 44.25 Favored Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 110.554 -0.165 . . . . 1.0 110.554 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.891 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 46.9 Cg_endo -70.2 160.07 50.87 Favored 'Trans proline' 0 CA--C 1.515 -0.428 0 C-N-CA 122.481 2.121 . . . . 1.0 111.111 176.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.738 HG22 ' HB2' ' A' ' 62' ' ' LEU . 65.8 p -134.1 4.11 3.47 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.419 -0.513 . . . . 1.0 111.697 -177.339 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -74.38 126.75 31.37 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.398 -0.364 . . . . 1.0 110.075 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.904 ' HB2' ' HE3' ' A' ' 23' ' ' LYS . 28.8 t60 -166.28 150.29 7.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.638 -0.256 . . . . 1.0 110.802 -176.359 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.408 ' HA ' ' O ' ' A' ' 52' ' ' SER . 2.0 tmt_? -131.03 110.22 11.07 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.905 -1.146 . . . . 1.0 107.905 177.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 49' ' ' HIS . . . -58.57 139.92 55.06 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.896 -1.047 . . . . 1.0 112.412 -174.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.531 ' HA ' HG23 ' A' ' 50' ' ' VAL . . . -130.81 165.55 22.75 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.789 -0.642 . . . . 1.0 110.478 178.12 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -101.52 159.31 15.4 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.017 -0.735 . . . . 1.0 109.017 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.537 HG11 HD23 ' A' ' 97' ' ' LEU . 96.5 t -66.87 110.56 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.903 0.383 . . . . 1.0 110.61 179.092 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.506 ' H ' ' CD2' ' A' ' 80' ' ' HIS . . . -127.52 -169.43 12.67 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.696 -0.684 . . . . 1.0 112.324 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 99.1 m -54.51 -52.03 63.26 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 123.457 0.703 . . . . 1.0 112.595 -178.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.565 ' HG2' ' N ' ' A' ' 80' ' ' HIS . 0.8 OUTLIER -58.19 -29.84 65.96 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.281 0.562 . . . . 1.0 110.523 -178.204 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.565 ' N ' ' HG2' ' A' ' 79' ' ' GLU . 84.6 m-70 -76.59 -42.77 41.34 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.535 -0.757 . . . . 1.0 110.014 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.648 ' O ' HG23 ' A' ' 102' ' ' VAL . 17.3 mt -67.71 -18.85 65.05 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.118 0.485 . . . . 1.0 110.681 177.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.69 -7.92 57.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.936 0.398 . . . . 1.0 110.494 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.58 ' HB1' ' O ' ' A' ' 6' ' ' HIS . . . -60.74 152.69 26.16 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.64 -0.709 . . . . 1.0 111.099 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.476 ' HB3' ' HG ' ' A' ' 5' ' ' LEU . 26.0 t70 -79.47 -15.13 58.3 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.991 -0.55 . . . . 1.0 109.775 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.79 HD13 HG13 ' A' ' 7' ' ' VAL . 0.4 OUTLIER -153.62 117.33 4.7 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 115.573 -0.74 . . . . 1.0 109.862 -177.16 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.698 ' HG ' ' CG2' ' A' ' 8' ' ' THR . 5.0 mp -109.45 105.98 15.55 Favored 'General case' 0 N--CA 1.427 -1.599 0 CA-C-N 115.42 -0.809 . . . . 1.0 109.865 177.437 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.661 ' HB ' ' HD1' ' A' ' 9' ' ' PHE . 64.7 t -85.43 91.8 3.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.014 -0.994 . . . . 1.0 111.389 -175.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.06 149.92 30.5 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.307 -0.861 . . . . 1.0 110.884 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.584 HD23 ' HB3' ' A' ' 11' ' ' CYS . 3.9 mm? -96.26 -10.55 27.67 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.844 -0.616 . . . . 1.0 110.674 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.7 ' HA ' ' HE1' ' A' ' 109' ' ' MET . 9.7 p30 -156.5 167.89 29.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.463 0.649 . . . . 1.0 111.85 175.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -57.3 -24.61 56.08 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.165 -1.38 . . . . 1.0 112.636 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.619 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 91.1 m-20 -76.43 -53.88 7.51 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.837 0.351 . . . . 1.0 110.656 -176.382 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.521 ' NE2' HG23 ' A' ' 12' ' ' THR . 13.2 m170 -58.94 -42.61 90.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.223 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.55 -43.5 97.18 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.999 0.428 . . . . 1.0 110.586 178.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.446 HH11 ' HD3' ' A' ' 95' ' ' ARG . 5.0 ttm-85 -57.9 -43.62 86.27 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 115.508 -0.769 . . . . 1.0 110.999 177.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.619 ' HG ' ' O ' ' A' ' 92' ' ' ASN . 55.6 mt -65.88 -50.51 64.24 Favored 'General case' 0 C--O 1.217 -0.633 0 CA-C-N 115.906 -0.588 . . . . 1.0 110.365 -176.025 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.68 HD21 HG21 ' A' ' 10' ' ' VAL . 30.5 mt -51.87 -56.1 16.1 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.055 -0.521 . . . . 1.0 111.135 -178.201 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.706 ' CA ' HG12 ' A' ' 102' ' ' VAL . 14.2 ptt85 -62.37 -43.1 99.61 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.546 0.573 . . . . 1.0 112.546 -178.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.556 ' HG3' ' O ' ' A' ' 96' ' ' LEU . 0.9 OUTLIER -67.36 -26.77 66.64 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.592 -0.443 . . . . 1.0 110.045 179.262 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.485 HD13 ' O ' ' A' ' 96' ' ' LEU . 5.4 mp -76.51 -20.26 57.12 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 116.088 -0.505 . . . . 1.0 111.818 178.266 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 153.2 -22.38 0.76 Allowed Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 119.465 -1.35 . . . . 1.0 113.927 -177.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.986 HG22 ' HD2' ' A' ' 106' ' ' ARG . 0.4 OUTLIER -76.42 -163.52 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-N 117.633 0.717 . . . . 1.0 110.33 -178.756 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.7 ' N ' HG13 ' A' ' 102' ' ' VAL . 12.7 pt-20 -159.05 162.64 36.66 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 107.369 -1.345 . . . . 1.0 107.369 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.745 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -62.14 -24.72 67.34 Favored 'General case' 0 C--N 1.322 -0.617 0 O-C-N 123.135 0.272 . . . . 1.0 111.421 -175.25 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.454 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . . . -56.57 -38.05 71.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.42 0.628 . . . . 1.0 110.06 175.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.986 ' HD2' HG22 ' A' ' 102' ' ' VAL . 20.4 mtt180 -97.65 -43.64 7.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.755 -1.111 . . . . 1.0 111.12 -176.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.745 HG12 ' HA ' ' A' ' 104' ' ' ALA . 10.7 p -79.62 118.79 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-O 121.037 0.446 . . . . 1.0 110.187 -174.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.666 ' HD2' ' O ' ' A' ' 107' ' ' VAL . 19.6 mmm180 -137.37 149.53 47.05 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.386 0.612 . . . . 1.0 111.076 -178.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.7 ' HE1' ' HA ' ' A' ' 90' ' ' ASP . 80.3 mmm -80.25 137.58 36.66 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.185 -0.916 . . . . 1.0 110.692 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.552 HD23 HG11 ' A' ' 87' ' ' VAL . 3.1 tm? -58.71 -49.26 78.26 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.868 0.366 . . . . 1.0 111.09 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.762 ' HB2' HG22 ' A' ' 124' ' ' VAL . 1.2 ttt180 -69.42 -16.7 63.55 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.171 -177.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.493 ' HB2' ' HB2' ' A' ' 109' ' ' MET . 37.4 t -78.38 -7.76 57.69 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 116.147 -0.478 . . . . 1.0 111.355 -178.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.522 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 92.4 m-85 -91.15 -21.58 21.1 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 109.821 -0.436 . . . . 1.0 109.821 175.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -63.99 124.13 84.22 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 115.766 -0.652 . . . . 1.0 110.556 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -72.05 -17.38 28.36 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.441 2.094 . . . . 1.0 112.242 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.458 HH11 ' HD3' ' A' ' 116' ' ' ARG . 47.5 mtt180 -93.05 -5.05 51.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.703 -0.68 . . . . 1.0 111.353 -177.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 68.2 p -58.98 -59.87 4.78 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.13 -0.486 . . . . 1.0 111.336 -177.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 151.79 -103.74 0.25 Allowed Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 111.291 -0.724 . . . . 1.0 111.291 178.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 26.7 m -109.69 -51.04 2.92 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.118 0.485 . . . . 1.0 109.852 177.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -150.55 147.75 27.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.902 -0.59 . . . . 1.0 110.012 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -126.92 99.31 5.68 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.379 -0.373 . . . . 1.0 110.179 177.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.42 ' HA ' ' HG3' ' A' ' 109' ' ' MET . 2.9 mm? -97.98 19.26 14.22 Favored 'General case' 0 CA--C 1.505 -0.759 0 CA-C-O 121.071 0.462 . . . . 1.0 110.691 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -170.63 144.79 2.41 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 115.24 -0.891 . . . . 1.0 109.852 178.18 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.762 HG22 ' HB2' ' A' ' 111' ' ' ARG . 70.0 t -104.65 145.79 12.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.934 -0.765 . . . . 1.0 108.934 178.404 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.67 -174.68 0.05 OUTLIER 'General case' 0 C--O 1.24 0.601 0 CA-C-O 122.073 0.94 . . . . 1.0 113.39 -176.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -143.35 143.77 25.55 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 114.379 -1.282 . . . . 1.0 108.574 -174.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.698 ' HB3' ' OD1' ' A' ' 134' ' ' ASP . 10.1 Cg_endo -50.45 152.86 8.19 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 123.096 2.531 . . . . 1.0 112.896 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -84.26 -33.83 23.95 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.29 -0.868 . . . . 1.0 109.593 -179.52 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -147.24 -38.98 0.2 Allowed 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.364 -0.835 . . . . 1.0 111.529 -179.069 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.466 ' HA2' ' OD2' ' A' ' 134' ' ' ASP . . . 103.98 65.87 0.7 Allowed Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.113 -0.795 . . . . 1.0 111.113 -177.296 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.612 ' H ' ' HB3' ' A' ' 134' ' ' ASP . 1.7 t70 -140.19 -172.54 3.44 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.104 -0.332 . . . . 1.0 110.104 -176.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -52.41 -47.32 66.38 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.915 0.339 . . . . 1.0 111.915 -176.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 33.1 t -62.57 -36.14 81.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.945 0.402 . . . . 1.0 110.638 -178.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.698 ' OD1' ' HB3' ' A' ' 127' ' ' PRO . 0.0 OUTLIER -68.77 -35.95 77.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.988 -0.551 . . . . 1.0 111.837 -178.303 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.452 ' HB3' ' CG2' ' A' ' 61' ' ' VAL . 5.7 m-85 -66.43 -45.93 78.18 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.917 -0.772 . . . . 1.0 108.917 -178.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -71.65 -25.89 62.32 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.834 -1.076 . . . . 1.0 110.959 -178.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.609 ' O ' HG23 ' A' ' 141' ' ' VAL . 8.5 tp10 -63.19 -50.94 68.32 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.77 -0.456 . . . . 1.0 109.77 177.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.64 ' HA ' HG23 ' A' ' 141' ' ' VAL . 96.1 t -61.27 -40.41 85.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.402 0.62 . . . . 1.0 109.979 178.501 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.487 ' HB2' HG11 ' A' ' 61' ' ' VAL . 22.9 t80 -53.49 -45.01 69.47 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.865 -1.061 . . . . 1.0 109.459 175.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.625 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -64.19 -40.16 95.5 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.393 -0.821 . . . . 1.0 110.543 177.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.64 HG23 ' HA ' ' A' ' 138' ' ' VAL . 13.9 t -55.44 -53.16 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-O 121.619 0.723 . . . . 1.0 109.908 177.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.617 HD13 ' HB3' ' A' ' 20' ' ' MET . 5.7 mt -63.99 -51.66 66.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 114.945 -1.025 . . . . 1.0 111.812 -178.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.625 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 8.0 pt-20 -57.89 -30.2 65.66 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.74 -0.384 . . . . 1.0 110.397 -179.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 2.4 t -74.87 -26.7 59.85 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 121.253 0.549 . . . . 1.0 110.001 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.473 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -85.88 -25.81 25.97 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-N 115.794 -0.639 . . . . 1.0 111.277 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.705 HD22 ' HB3' ' A' ' 25' ' ' PHE . 16.7 mt -56.17 -36.4 45.72 Favored Pre-proline 0 CA--C 1.547 0.851 0 N-CA-C 112.719 0.637 . . . . 1.0 112.719 -178.03 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.626 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 43.9 Cg_endo -68.02 -14.4 40.92 Favored 'Trans proline' 0 C--N 1.364 1.357 0 C-N-CA 122.59 2.193 . . . . 1.0 111.495 177.244 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.522 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -103.29 -33.62 4.18 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 114.577 -1.192 . . . . 1.0 110.375 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.492 ' O ' HG13 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -73.19 -41.8 63.43 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 108.416 -0.957 . . . . 1.0 108.416 178.855 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.591 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 0.2 OUTLIER -53.93 -55.87 23.0 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-N 115.067 -0.969 . . . . 1.0 110.506 175.217 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -56.78 -42.92 80.28 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.764 -1.107 . . . . 1.0 110.781 -174.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' TRP . . . . . 0.715 ' HZ3' HD21 ' A' ' 5' ' ' LEU . 26.2 t90 -62.84 -56.17 19.73 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.181 -0.918 . . . . 1.0 110.286 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.492 HG13 ' O ' ' A' ' 149' ' ' LEU . 9.7 m -60.35 -40.3 83.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.904 -0.318 . . . . 1.0 110.463 -178.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.435 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 1.4 m-20 -60.46 -51.88 67.57 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 123.425 0.453 . . . . 1.0 111.042 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 7.9 pt-20 -63.32 -37.82 88.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.789 -0.641 . . . . 1.0 110.6 -178.22 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.526 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 10.4 mmt85 -72.84 -46.45 52.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.834 -0.621 . . . . 1.0 111.115 -176.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 4.0 pp -63.9 -26.05 68.43 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.658 -0.701 . . . . 1.0 109.686 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -71.73 -50.39 30.58 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.188 177.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.426 ' C ' ' H ' ' A' ' 161' ' ' GLY . 0.2 OUTLIER -78.55 4.9 12.13 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.752 0.649 . . . . 1.0 112.752 -179.259 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -69.58 13.85 0.12 Allowed 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.21 0.528 . . . . 1.0 111.809 177.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.426 ' H ' ' C ' ' A' ' 159' ' ' ARG . . . 92.5 149.02 23.93 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.94 -0.647 . . . . 1.0 112.437 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.491 ' O ' ' HB2' ' A' ' 163' ' ' SER . 43.5 Cg_endo -92.29 14.29 1.75 Allowed 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.555 2.17 . . . . 1.0 113.786 -177.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.491 ' HB2' ' O ' ' A' ' 162' ' ' PRO . 6.5 t . . . . . 0 C--N 1.314 -0.976 0 CA-C-N 115.029 -0.987 . . . . 1.0 110.329 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.074 0 N-CA-C 112.072 -0.411 . . . . 1.0 112.072 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -77.83 142.03 38.81 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.209 0.528 . . . . 1.0 111.184 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.404 ' HB3' ' OD1' ' A' ' 160' ' ' ASN . 50.8 m -87.76 125.04 34.2 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.522 -0.763 . . . . 1.0 110.351 -179.059 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.816 ' HB3' ' HD2' ' A' ' 4' ' ' PRO . 4.1 m-20 -66.65 166.58 17.43 Favored Pre-proline 0 C--N 1.329 -0.324 0 C-N-CA 120.622 -0.431 . . . . 1.0 110.824 177.276 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.816 ' HD2' ' HB3' ' A' ' 3' ' ' ASP . 39.9 Cg_endo -70.01 169.55 18.96 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 123.457 2.771 . . . . 1.0 113.481 -178.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.822 ' HB3' HG23 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -66.51 177.84 1.43 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.016 -0.993 . . . . 1.0 109.688 178.417 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.573 ' O ' ' HB1' ' A' ' 83' ' ' ALA . 3.3 t-160 -156.17 90.08 1.18 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 121.98 -0.45 . . . . 1.0 110.493 -179.094 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.753 HG13 HD13 ' A' ' 85' ' ' LEU . 2.0 t -94.33 113.17 28.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 N-CA-C 109.321 -0.622 . . . . 1.0 109.321 177.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.597 HG22 ' HG ' ' A' ' 86' ' ' LEU . 8.5 t -115.31 114.24 24.91 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.03 0.443 . . . . 1.0 110.589 178.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.648 ' HD2' ' HB3' ' A' ' 42' ' ' SER . 1.5 m-85 -84.71 132.83 34.41 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 122.138 -0.351 . . . . 1.0 110.744 -178.112 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.728 HG21 HD21 ' A' ' 97' ' ' LEU . 32.9 t -118.18 115.64 48.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.293 0.568 . . . . 1.0 111.975 -176.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.617 ' SG ' ' HD2' ' A' ' 17' ' ' ARG . 52.5 t -144.79 159.38 42.96 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.731 -0.668 . . . . 1.0 109.578 178.188 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -72.02 97.92 1.98 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.939 0.4 . . . . 1.0 110.336 178.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.911 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 127.88 -43.27 1.35 Allowed Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.481 -0.782 . . . . 1.0 111.549 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.469 HD21 ' CB ' ' A' ' 42' ' ' SER . 3.8 t-20 64.66 11.98 7.19 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 121.361 0.6 . . . . 1.0 111.752 179.005 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.458 ' HA ' ' HG3' ' A' ' 19' ' ' PRO . 7.5 pt -119.61 11.54 6.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 O-C-N 121.69 -0.631 . . . . 1.0 111.395 -178.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.1 p -127.36 -88.31 0.56 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.208 -0.451 . . . . 1.0 112.015 -178.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.617 ' HD2' ' SG ' ' A' ' 11' ' ' CYS . 57.7 mtt85 -63.54 -52.33 61.6 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 120.95 0.405 . . . . 1.0 111.845 -176.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.726 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 14.1 m -53.16 -58.37 12.73 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 115.666 -0.697 . . . . 1.0 112.679 -178.204 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.524 ' HD3' ' HB2' ' A' ' 18' ' ' SER . 57.7 Cg_endo -67.92 -20.72 44.79 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 121.556 1.504 . . . . 1.0 112.51 -176.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.606 ' HA ' HD11 ' A' ' 62' ' ' LEU . 47.2 mmm -61.89 -54.09 46.75 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 110.221 -0.288 . . . . 1.0 110.221 177.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.468 ' HA ' ' HB2' ' A' ' 24' ' ' MET . . . -74.9 -26.1 59.4 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 116.134 -0.485 . . . . 1.0 110.401 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.61 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 16.3 tt0 -51.29 -54.56 24.8 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.028 -0.987 . . . . 1.0 109.992 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.656 ' O ' ' HB3' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -85.69 -22.98 27.61 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.267 -0.879 . . . . 1.0 110.383 -176.023 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.708 ' HB3' HD11 ' A' ' 146' ' ' LEU . 6.3 mmm -63.03 -76.12 0.07 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.381 0.61 . . . . 1.0 112.592 -178.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.717 ' HB3' HD22 ' A' ' 146' ' ' LEU . 24.9 p90 -77.13 -29.63 54.77 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 119.864 -0.734 . . . . 1.0 111.546 -175.302 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.61 ' HB3' ' O ' ' A' ' 22' ' ' GLU . . . -64.39 -38.2 90.19 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 119.493 -0.883 . . . . 1.0 110.817 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.962 ' HA ' ' HE ' ' A' ' 30' ' ' ARG . 0.1 OUTLIER -62.53 -39.68 94.34 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.906 -0.776 . . . . 1.0 108.906 177.03 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.6 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 79.2 mt-30 -59.06 -43.78 91.75 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.653 -0.703 . . . . 1.0 110.589 176.003 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 25' ' ' PHE . 92.5 mt -54.22 -62.68 1.5 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.942 -0.572 . . . . 1.0 111.207 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.962 ' HE ' ' HA ' ' A' ' 27' ' ' GLN . 0.1 OUTLIER -58.93 -34.04 71.27 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 120.559 -0.456 . . . . 1.0 111.466 178.683 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.0 m170 -62.12 -28.63 69.77 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.422 0.527 . . . . 1.0 112.422 177.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.525 ' HG2' ' O ' ' A' ' 28' ' ' GLN . 9.2 ptp180 -95.33 -20.29 19.26 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 119.535 -0.866 . . . . 1.0 110.101 178.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 108.17 39.32 1.84 Allowed Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.034 -0.985 . . . . 1.0 111.992 177.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 25.0 mt -131.03 2.21 4.31 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.567 -0.531 . . . . 1.0 109.567 -178.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.415 ' H ' ' HA ' ' A' ' 30' ' ' ARG . . . -53.75 -35.73 53.27 Favored Glycine 0 C--O 1.226 -0.364 0 CA-C-N 115.545 -0.752 . . . . 1.0 113.35 -178.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.473 ' HA ' ' NH1' ' A' ' 39' ' ' ARG . 0.3 OUTLIER -86.94 -19.17 29.19 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 122.489 -0.418 . . . . 1.0 110.138 -179.86 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.89 -22.13 43.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.878 -0.601 . . . . 1.0 111.373 -177.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.822 HG23 ' HB3' ' A' ' 5' ' ' LEU . 0.4 OUTLIER -143.09 123.62 10.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.064 0.459 . . . . 1.0 110.66 -179.727 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.473 ' NH1' ' HA ' ' A' ' 36' ' ' ASP . 29.0 mmt180 -89.05 144.56 26.06 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.011 -0.541 . . . . 1.0 109.65 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.483 HG11 ' HB2' ' A' ' 26' ' ' ALA . 48.9 t -132.04 122.58 49.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 121.838 0.828 . . . . 1.0 110.234 -177.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.506 ' O ' ' HA ' ' A' ' 8' ' ' THR . 76.8 p -137.13 -176.87 4.53 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.203 -1.362 . . . . 1.0 110.511 -174.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.726 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 88.2 p -160.81 166.35 28.73 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.866 -0.334 . . . . 1.0 110.235 179.043 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.585 ' HB2' ' CD2' ' A' ' 80' ' ' HIS . . . -164.65 168.15 18.38 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.271 0.557 . . . . 1.0 111.353 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -125.83 132.81 8.04 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.26 -0.882 . . . . 1.0 110.997 177.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.583 HG23 ' CG1' ' A' ' 10' ' ' VAL . 26.0 p -68.77 -22.74 64.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.795 0.331 . . . . 1.0 111.831 -177.336 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.422 ' HA3' ' HZ3' ' A' ' 48' ' ' TRP . . . -112.41 9.11 26.47 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.875 -0.679 . . . . 1.0 113.133 -177.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 43.83 37.34 1.63 Allowed 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 114.156 1.169 . . . . 1.0 114.156 177.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.911 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 1.2 m-90 -45.77 -73.66 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.454 0.645 . . . . 1.0 112.404 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.468 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 12.4 m-70 -106.06 40.84 1.51 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.248 -0.887 . . . . 1.0 111.063 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.403 HG23 ' HA ' ' A' ' 74' ' ' ALA . 14.0 p -60.18 129.37 22.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 120.65 -0.42 . . . . 1.0 110.375 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.25 -13.61 65.91 Favored Glycine 0 C--O 1.227 -0.33 0 C-N-CA 121.033 -0.603 . . . . 1.0 111.87 -177.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.5 t -80.58 -161.12 0.35 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.636 -0.505 . . . . 1.0 109.636 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 33.6 t -126.33 175.18 8.02 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.585 -0.894 . . . . 1.0 108.585 -178.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.14 141.08 47.44 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 123.098 0.248 . . . . 1.0 110.482 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.524 ' OD2' ' HG2' ' A' ' 57' ' ' ARG . 18.6 t70 -62.1 143.42 56.7 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.841 -177.224 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -46.69 -36.39 7.05 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.973 -1.012 . . . . 1.0 112.819 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.685 ' O ' HG23 ' A' ' 61' ' ' VAL . 19.3 ptp180 -69.69 -47.11 64.35 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 121.033 -0.267 . . . . 1.0 110.686 -176.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.408 ' HB1' ' SD ' ' A' ' 20' ' ' MET . . . -71.49 -31.96 67.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.097 0.475 . . . . 1.0 110.471 -177.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.14 -55.08 38.19 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.112 -0.699 . . . . 1.0 109.112 176.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -58.31 -39.69 93.0 Favored Glycine 0 N--CA 1.441 -1.009 0 CA-C-N 115.853 -0.612 . . . . 1.0 111.924 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.685 HG23 ' O ' ' A' ' 57' ' ' ARG . 98.7 t -58.98 -58.94 4.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.065 0.46 . . . . 1.0 110.992 177.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.611 HD13 ' HG3' ' A' ' 23' ' ' LYS . 87.7 mt -59.77 -52.46 65.36 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.881 -0.6 . . . . 1.0 111.61 -177.471 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.487 ' HB3' HG21 ' A' ' 69' ' ' THR . 0.0 OUTLIER -61.34 -33.31 73.41 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.727 -178.997 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.71 -32.93 74.13 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.212 0.53 . . . . 1.0 110.667 179.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -95.68 2.39 54.0 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.646 -0.706 . . . . 1.0 111.078 -178.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 94.12 9.51 59.35 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.978 -0.629 . . . . 1.0 113.531 176.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.41 ' CD1' ' HA ' ' A' ' 24' ' ' MET . 65.9 m-85 -90.68 152.15 44.62 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 110.061 -0.348 . . . . 1.0 110.061 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.583 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 36.0 Cg_endo -67.31 157.56 61.15 Favored 'Trans proline' 0 CA--C 1.512 -0.609 0 C-N-CA 122.189 1.926 . . . . 1.0 110.756 176.532 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.558 HG22 ' HB2' ' A' ' 62' ' ' LEU . 63.2 p -130.65 11.46 5.26 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 120.365 -0.534 . . . . 1.0 111.644 -176.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -80.87 133.51 35.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.77 -0.65 . . . . 1.0 110.087 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 51.7 t60 -169.22 152.24 4.93 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.892 0.377 . . . . 1.0 110.659 -176.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.436 ' HD3' ' HA ' ' A' ' 72' ' ' ARG . 9.4 tpp180 -133.93 110.86 10.0 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 108.084 -1.08 . . . . 1.0 108.084 175.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.468 ' HB3' ' O ' ' A' ' 49' ' ' HIS . . . -60.34 137.72 58.09 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.288 -0.869 . . . . 1.0 112.176 -175.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.403 ' HA ' HG23 ' A' ' 50' ' ' VAL . . . -130.96 160.25 35.08 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.437 -0.801 . . . . 1.0 110.013 178.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -97.43 154.82 17.23 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.026 -0.731 . . . . 1.0 109.026 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.527 HG11 HD23 ' A' ' 97' ' ' LEU . 14.5 t -67.35 113.19 3.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.053 0.454 . . . . 1.0 110.725 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.454 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -124.19 -169.59 13.12 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.128 -0.942 . . . . 1.0 111.538 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 97.9 m -58.51 -44.48 89.48 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 122.275 0.23 . . . . 1.0 111.548 -178.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -60.4 -28.48 68.26 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.937 0.399 . . . . 1.0 111.183 178.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.585 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 78.8 m80 -77.67 -41.43 38.2 Favored 'General case' 0 C--O 1.223 -0.297 0 N-CA-C 109.763 -0.458 . . . . 1.0 109.763 179.181 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.645 ' O ' HG23 ' A' ' 102' ' ' VAL . 15.6 mt -69.83 -14.42 62.75 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.6 177.287 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -88.49 -7.55 56.34 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 120.884 0.373 . . . . 1.0 110.618 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.573 ' HB1' ' O ' ' A' ' 6' ' ' HIS . . . -59.94 150.38 29.0 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.805 -0.634 . . . . 1.0 111.407 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.711 ' HB3' HD13 ' A' ' 5' ' ' LEU . 15.3 t70 -75.4 -15.19 60.48 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.941 -0.392 . . . . 1.0 109.941 178.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.753 HD13 HG13 ' A' ' 7' ' ' VAL . 0.5 OUTLIER -154.66 119.63 4.94 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 109.245 -0.65 . . . . 1.0 109.245 -177.787 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.689 ' HB3' HD13 ' A' ' 97' ' ' LEU . 5.1 mp -109.8 104.74 13.75 Favored 'General case' 0 N--CA 1.426 -1.652 0 CA-C-N 115.531 -0.759 . . . . 1.0 109.735 177.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.589 ' HA ' ' O ' ' A' ' 108' ' ' ARG . 53.6 t -83.79 91.54 2.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 114.924 -1.035 . . . . 1.0 111.115 -176.006 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.13 145.73 33.57 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.397 -0.82 . . . . 1.0 110.29 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.625 ' O ' ' HB ' ' A' ' 124' ' ' VAL . 3.9 mm? -99.35 -8.04 25.4 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.026 -0.534 . . . . 1.0 110.361 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.405 ' CG ' ' H ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -151.76 152.48 32.77 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.662 -0.699 . . . . 1.0 110.858 179.15 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.558 ' HB3' ' O ' ' A' ' 122' ' ' LEU . 11.4 ptm180 -58.16 -24.01 57.37 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.21 0.818 . . . . 1.0 113.21 -177.501 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.682 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 9.7 m120 -77.1 -48.07 18.76 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.933 -0.395 . . . . 1.0 109.933 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.56 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 11.7 m170 -56.6 -44.24 80.91 Favored 'General case' 0 N--CA 1.461 0.094 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.031 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.65 -45.17 92.81 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.952 178.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.6 ttt180 -59.26 -39.89 84.29 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.11 -0.496 . . . . 1.0 111.152 178.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.707 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 48.7 mt -66.16 -48.87 69.33 Favored 'General case' 0 C--O 1.218 -0.58 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.304 -176.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.728 HD21 HG21 ' A' ' 10' ' ' VAL . 36.2 mt -52.89 -58.39 7.07 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.086 -0.506 . . . . 1.0 111.374 -179.023 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.74 ' HA ' HG12 ' A' ' 102' ' ' VAL . 1.3 ptt180 -58.34 -44.69 88.83 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.801 -0.636 . . . . 1.0 111.811 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.653 ' HG3' ' O ' ' A' ' 96' ' ' LEU . 1.1 pp0? -67.8 -25.27 65.5 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.043 0.449 . . . . 1.0 109.948 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.707 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 13.2 mt -79.67 -12.6 59.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.668 -0.696 . . . . 1.0 111.612 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 145.99 -22.25 1.77 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 119.863 -1.16 . . . . 1.0 113.935 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.74 HG12 ' HA ' ' A' ' 98' ' ' ARG . 0.4 OUTLIER -75.93 -163.19 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 CA-C-N 117.419 0.609 . . . . 1.0 110.463 -178.813 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.752 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 12.4 pt-20 -155.87 163.11 40.21 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.702 -1.221 . . . . 1.0 107.702 -179.369 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.801 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -63.03 -24.98 68.17 Favored 'General case' 0 C--N 1.321 -0.664 0 O-C-N 123.186 0.304 . . . . 1.0 111.459 -175.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.2 -36.82 73.67 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.189 0.519 . . . . 1.0 110.042 175.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.752 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 5.5 mtt-85 -97.23 -42.42 7.82 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 115.368 -0.833 . . . . 1.0 111.6 -176.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.801 HG12 ' HA ' ' A' ' 104' ' ' ALA . 11.9 p -77.55 118.68 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 109.354 -0.61 . . . . 1.0 109.354 -175.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.589 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 16.1 mmm180 -138.64 147.31 42.73 Favored 'General case' 0 C--N 1.319 -0.755 0 O-C-N 121.623 -0.673 . . . . 1.0 110.764 -178.221 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.523 ' HB2' ' HB2' ' A' ' 112' ' ' SER . 77.1 mmm -79.76 137.54 37.03 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.523 -0.762 . . . . 1.0 110.639 179.506 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.526 HD23 HG11 ' A' ' 87' ' ' VAL . 3.1 tm? -57.5 -49.97 74.56 Favored 'General case' 0 N--CA 1.465 0.303 0 O-C-N 123.16 0.287 . . . . 1.0 111.221 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.438 ' CB ' HG22 ' A' ' 124' ' ' VAL . 46.1 ttt180 -70.29 -17.44 63.09 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.877 -0.329 . . . . 1.0 110.776 -177.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.523 ' HB2' ' HB2' ' A' ' 109' ' ' MET . 33.8 t -75.6 -4.58 40.81 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.984 -0.286 . . . . 1.0 110.969 -178.026 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.618 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 92.1 m-85 -92.26 -16.25 26.38 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 120.878 0.37 . . . . 1.0 110.196 175.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -65.57 122.5 80.75 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.0 -0.545 . . . . 1.0 110.712 -178.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -65.95 -20.82 57.57 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.778 2.318 . . . . 1.0 111.968 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 21.5 mtt-85 -90.72 -16.87 27.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.806 -0.634 . . . . 1.0 111.053 -177.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 25.7 m -75.54 65.28 1.75 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.46 0.541 . . . . 1.0 112.46 -177.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 52.86 -99.5 0.04 OUTLIER Glycine 0 C--N 1.333 0.41 0 C-N-CA 121.58 -0.343 . . . . 1.0 113.341 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 15.4 m -136.23 -45.92 0.63 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.192 0.52 . . . . 1.0 109.92 178.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 42.1 m80 -139.29 153.16 47.73 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.894 -0.593 . . . . 1.0 110.672 178.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -133.68 98.99 4.34 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.753 -0.658 . . . . 1.0 109.236 177.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.558 ' O ' ' HB3' ' A' ' 91' ' ' ARG . 2.9 mm? -87.76 11.45 15.35 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.374 -0.376 . . . . 1.0 111.323 -177.404 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.465 ' HA ' ' HE1' ' A' ' 109' ' ' MET . 32.4 t70 -169.48 136.63 1.71 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.021 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.625 ' HB ' ' O ' ' A' ' 89' ' ' LEU . 61.0 t -100.95 141.97 16.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 108.674 -0.862 . . . . 1.0 108.674 178.213 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -70.15 -170.83 0.39 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.447 0.641 . . . . 1.0 112.423 -175.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.481 ' HA ' HH21 ' A' ' 17' ' ' ARG . 12.6 t70 -141.5 143.84 31.35 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 108.141 -1.059 . . . . 1.0 108.141 -173.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.437 ' HB3' ' HB2' ' A' ' 134' ' ' ASP . 51.1 Cg_exo -48.62 162.39 0.36 Allowed 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.518 2.146 . . . . 1.0 112.523 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.445 ' HD2' ' CD2' ' A' ' 129' ' ' TYR . 64.0 t80 -102.4 -61.88 1.34 Allowed 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 120.252 -0.579 . . . . 1.0 111.923 -176.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.445 ' CD2' ' HD2' ' A' ' 128' ' ' TYR . 0.0 OUTLIER -92.73 -59.07 2.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.32 0.581 . . . . 1.0 110.965 -174.831 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 117.14 57.35 0.3 Allowed Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 109.464 -1.455 . . . . 1.0 109.464 -175.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.409 ' CG ' ' H ' ' A' ' 132' ' ' HIS . 9.2 t70 -140.87 -174.22 3.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.313 -0.443 . . . . 1.0 110.657 -174.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.506 ' HA ' ' CD2' ' A' ' 135' ' ' PHE . 12.5 t-80 -56.03 -37.27 68.99 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.957 -0.565 . . . . 1.0 111.35 -178.107 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 12.1 m -64.83 -39.36 93.46 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.08 -0.509 . . . . 1.0 111.058 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.437 ' HB2' ' HB3' ' A' ' 127' ' ' PRO . 0.0 OUTLIER -68.58 -32.79 72.94 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.376 -0.375 . . . . 1.0 110.958 -176.575 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.569 ' CD1' ' HD3' ' A' ' 57' ' ' ARG . 5.6 m-85 -68.96 -49.35 58.7 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.462 0.648 . . . . 1.0 109.929 -178.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -72.92 -18.9 61.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.413 -0.812 . . . . 1.0 110.908 -179.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.414 ' O ' HG23 ' A' ' 141' ' ' VAL . 5.6 tp10 -64.33 -50.73 66.62 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.62 0.724 . . . . 1.0 109.359 176.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.697 ' HA ' HG23 ' A' ' 141' ' ' VAL . 92.9 t -61.77 -38.7 81.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.01 -0.995 . . . . 1.0 109.992 177.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -53.52 -42.06 67.02 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.098 -0.955 . . . . 1.0 109.325 175.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.519 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -65.33 -41.3 94.1 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.301 -0.863 . . . . 1.0 110.187 177.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.697 HG23 ' HA ' ' A' ' 138' ' ' VAL . 11.9 t -55.52 -52.43 47.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 121.604 0.716 . . . . 1.0 110.139 177.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.597 HD13 ' HB3' ' A' ' 20' ' ' MET . 6.5 mt -63.99 -51.74 65.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 114.954 -1.021 . . . . 1.0 112.055 -178.221 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.519 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 11.3 pt-20 -56.43 -31.5 63.99 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.862 0.363 . . . . 1.0 110.373 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.4 t -74.5 -28.35 60.95 Favored 'General case' 0 C--O 1.225 -0.206 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.253 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.478 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -86.54 -24.12 25.6 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-N 115.889 -0.596 . . . . 1.0 111.545 179.149 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.717 HD22 ' HB3' ' A' ' 25' ' ' PHE . 11.8 mt -55.65 -36.9 51.05 Favored Pre-proline 0 CA--C 1.544 0.727 0 N-CA-C 112.577 0.584 . . . . 1.0 112.577 -178.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.622 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 55.8 Cg_endo -69.88 -11.6 31.01 Favored 'Trans proline' 0 C--N 1.363 1.332 0 C-N-CA 122.339 2.026 . . . . 1.0 111.854 177.041 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.618 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -104.85 -33.94 3.64 Favored Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 110.703 -0.959 . . . . 1.0 110.703 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.529 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -74.21 -41.12 61.89 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.43 -0.952 . . . . 1.0 108.43 178.729 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.5 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 1.2 m-70 -54.29 -55.14 31.23 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 114.933 -1.031 . . . . 1.0 109.926 174.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -57.32 -40.83 78.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.315 -0.857 . . . . 1.0 110.71 -175.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' TRP . . . . . 0.708 ' HZ3' HD11 ' A' ' 5' ' ' LEU . 27.0 t90 -63.54 -57.54 9.83 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.596 -0.729 . . . . 1.0 110.748 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 10.3 m -61.43 -41.17 88.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.803 -0.359 . . . . 1.0 110.195 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.424 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 1.8 m-20 -60.5 -50.72 72.44 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 120.897 0.38 . . . . 1.0 110.42 178.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.559 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 6.3 pt-20 -63.23 -38.13 89.94 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.123 0.487 . . . . 1.0 110.936 -178.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.527 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 4.7 mmt180 -72.58 -45.15 60.54 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.664 -177.031 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.426 ' HB3' HD23 ' A' ' 5' ' ' LEU . 3.9 pp -67.12 -23.8 65.86 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.716 -0.675 . . . . 1.0 109.762 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -74.47 -51.22 15.45 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.58 -0.737 . . . . 1.0 110.529 178.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.47 ' HG2' ' O ' ' A' ' 155' ' ' GLU . 14.2 ptp180 -75.3 -7.83 54.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.063 -0.517 . . . . 1.0 111.72 -178.509 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ASN . . . . . 0.452 ' HB2' ' O ' ' A' ' 156' ' ' ARG . 15.4 t-20 -78.24 21.49 0.35 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.285 0.564 . . . . 1.0 111.421 -176.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -65.67 141.87 42.91 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.819 -0.705 . . . . 1.0 112.079 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -81.56 25.53 0.65 Allowed 'Trans proline' 0 CA--C 1.515 -0.443 0 C-N-CA 123.707 2.938 . . . . 1.0 113.273 -176.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 58.9 m . . . . . 0 C--N 1.3 -1.586 0 CA-C-N 114.632 -1.167 . . . . 1.0 110.155 -179.622 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.738 0 N-CA-C 112.132 -0.387 . . . . 1.0 112.132 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.9 mtm -84.63 27.27 0.74 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.416 0.627 . . . . 1.0 110.989 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.7 m -158.61 146.41 18.07 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.884 -0.784 . . . . 1.0 108.884 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.571 ' HB2' ' HD2' ' A' ' 4' ' ' PRO . 0.5 OUTLIER -164.29 162.52 15.68 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 110.136 -0.32 . . . . 1.0 110.136 -178.742 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.571 ' HD2' ' HB2' ' A' ' 3' ' ' ASP . 27.6 Cg_endo -67.06 170.16 13.62 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.69 2.26 . . . . 1.0 112.834 -179.114 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.809 HD13 ' HB3' ' A' ' 84' ' ' ASP . 0.2 OUTLIER -67.13 177.82 1.65 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.532 -0.758 . . . . 1.0 109.384 178.749 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.64 ' O ' ' HB1' ' A' ' 83' ' ' ALA . 3.4 t-160 -157.55 89.32 1.03 Allowed 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.363 -0.606 . . . . 1.0 109.363 -179.186 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.808 HG13 HD13 ' A' ' 85' ' ' LEU . 2.4 t -95.95 107.38 19.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 109.759 -0.46 . . . . 1.0 109.759 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.619 ' CG2' ' HG ' ' A' ' 86' ' ' LEU . 11.8 t -108.25 114.97 29.26 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.084 0.469 . . . . 1.0 110.943 -179.179 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.542 ' HA ' ' O ' ' A' ' 87' ' ' VAL . 0.5 OUTLIER -85.76 134.55 33.94 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 122.203 -0.31 . . . . 1.0 110.262 -178.802 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.588 ' CG1' HG23 ' A' ' 45' ' ' THR . 42.4 t -120.66 119.87 60.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-O 121.385 0.612 . . . . 1.0 112.17 -175.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.483 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 15.4 p -143.68 167.63 21.81 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.214 -0.903 . . . . 1.0 109.453 177.09 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.98 93.54 3.82 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.417 0.627 . . . . 1.0 111.033 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.776 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 129.68 -37.03 2.24 Favored Glycine 0 N--CA 1.443 -0.855 0 CA-C-N 115.25 -0.886 . . . . 1.0 112.526 178.575 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.488 HD21 ' CB ' ' A' ' 42' ' ' SER . 3.6 t-20 64.49 19.1 11.69 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.924 0.868 . . . . 1.0 110.703 -179.133 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.469 ' O ' ' HB3' ' A' ' 55' ' ' ASP . 1.3 pt -135.95 47.38 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 CA-C-N 115.491 -0.777 . . . . 1.0 109.567 -178.145 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.691 ' O ' ' HG3' ' A' ' 20' ' ' MET . 4.4 p -157.23 -89.3 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.78 -1.1 . . . . 1.0 111.846 175.398 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.514 ' HD2' ' H ' ' A' ' 17' ' ' ARG . 0.1 OUTLIER -74.96 -43.1 55.95 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 121.908 -0.495 . . . . 1.0 111.817 -175.569 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.869 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 46.8 m -54.33 -56.6 24.76 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 116.425 -0.352 . . . . 1.0 111.505 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.683 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 49.0 Cg_endo -66.47 -24.22 49.57 Favored 'Trans proline' 0 C--N 1.357 0.995 0 C-N-CA 121.548 1.499 . . . . 1.0 112.387 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.691 ' HG3' ' O ' ' A' ' 16' ' ' CYS . 51.0 mtp -62.94 -56.54 16.31 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.672 -0.411 . . . . 1.0 110.646 177.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.63 -28.02 64.5 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 120.724 -0.39 . . . . 1.0 110.217 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.67 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 14.8 tt0 -51.85 -53.22 42.82 Favored 'General case' 0 C--O 1.214 -0.764 0 CA-C-N 114.74 -1.118 . . . . 1.0 109.614 178.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.946 ' HB3' ' HG2' ' A' ' 68' ' ' PRO . 0.1 OUTLIER -79.43 -32.39 42.81 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.36 -0.837 . . . . 1.0 110.235 -176.089 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.605 ' HB3' HD11 ' A' ' 146' ' ' LEU . 3.5 mmm -61.9 -75.61 0.07 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 113.173 0.805 . . . . 1.0 113.173 -175.313 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.749 ' HB3' HD22 ' A' ' 146' ' ' LEU . 14.0 p90 -78.44 -29.31 46.95 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 119.828 -0.749 . . . . 1.0 111.484 -174.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.707 ' HB2' HG21 ' A' ' 40' ' ' VAL . . . -64.12 -36.62 84.62 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 119.146 -1.021 . . . . 1.0 110.461 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.629 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -64.03 -39.32 93.84 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.614 -0.884 . . . . 1.0 108.614 177.062 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.555 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 77.1 mt-30 -60.38 -39.45 87.33 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-N 115.719 -0.673 . . . . 1.0 110.916 176.405 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.593 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 88.7 mt -59.81 -59.89 4.71 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.756 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.533 ' HA ' ' H ' ' A' ' 35' ' ' GLY . 0.1 OUTLIER -58.96 -36.87 75.54 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.375 -0.53 . . . . 1.0 111.254 178.518 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -65.02 -25.46 67.86 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.382 0.512 . . . . 1.0 112.382 177.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.593 ' HG2' ' O ' ' A' ' 29' ' ' LEU . 3.9 ptm180 -93.17 -19.46 21.44 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 119.461 -0.895 . . . . 1.0 109.465 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 110.4 35.02 2.17 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 114.955 -1.02 . . . . 1.0 111.926 177.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.563 HD12 ' HD3' ' A' ' 32' ' ' ARG . 46.9 mt -134.45 5.93 3.5 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 122.59 -0.359 . . . . 1.0 111.006 -177.385 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.533 ' H ' ' HA ' ' A' ' 30' ' ' ARG . . . -54.83 -29.62 50.75 Favored Glycine 0 C--N 1.33 0.24 0 C-N-CA 121.177 -0.535 . . . . 1.0 113.118 -178.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -94.92 -20.91 19.0 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.632 0.253 . . . . 1.0 110.985 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.48 -23.27 43.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.369 0.604 . . . . 1.0 111.342 -178.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.8 HG23 ' HB3' ' A' ' 5' ' ' LEU . 0.3 OUTLIER -142.44 119.5 6.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.53 -0.545 . . . . 1.0 109.53 178.001 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.41 ' HE ' ' HG3' ' A' ' 4' ' ' PRO . 16.9 mmt85 -91.13 148.42 22.39 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.618 -0.719 . . . . 1.0 109.295 -178.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.707 HG21 ' HB2' ' A' ' 26' ' ' ALA . 2.0 m -131.54 139.62 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.075 0 N-CA-C 108.391 -0.966 . . . . 1.0 108.391 178.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.503 ' O ' ' HA ' ' A' ' 8' ' ' THR . 21.7 p -146.36 -177.69 5.75 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.287 -0.87 . . . . 1.0 109.808 -175.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.869 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 93.4 p -159.32 163.96 35.23 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 120.613 -0.435 . . . . 1.0 109.982 178.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.557 ' HB2' ' CD2' ' A' ' 80' ' ' HIS . . . -164.38 164.96 22.0 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.452 0.644 . . . . 1.0 111.357 -179.211 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.483 ' HA2' ' O ' ' A' ' 11' ' ' CYS . . . -122.18 130.05 7.84 Favored Glycine 0 N--CA 1.439 -1.163 0 N-CA-C 110.41 -1.076 . . . . 1.0 110.41 177.233 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.588 HG23 ' CG1' ' A' ' 10' ' ' VAL . 18.8 p -65.25 -24.16 67.25 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 111.853 0.316 . . . . 1.0 111.853 -177.212 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -107.66 8.81 37.44 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.809 -0.71 . . . . 1.0 113.353 -177.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 42.96 37.77 1.22 Allowed 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.722 0.809 . . . . 1.0 113.078 179.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.776 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 0.7 OUTLIER -49.2 -76.66 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.524 0.565 . . . . 1.0 112.524 -179.59 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.458 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 36.1 m-70 -103.97 39.65 1.59 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.869 -0.605 . . . . 1.0 111.154 -178.388 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.506 HG23 ' HA ' ' A' ' 74' ' ' ALA . 11.0 p -59.4 126.31 16.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.019 0.438 . . . . 1.0 110.338 178.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.25 -14.76 62.12 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 121.037 -0.601 . . . . 1.0 111.942 -177.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.461 ' O ' ' HA ' ' A' ' 72' ' ' ARG . 3.8 t -81.61 -161.87 0.47 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.119 0.485 . . . . 1.0 110.138 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 30.2 t -120.84 178.59 4.65 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.737 -0.665 . . . . 1.0 109.289 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.21 146.91 53.71 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.224 0.535 . . . . 1.0 110.499 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.579 ' OD1' ' HA ' ' A' ' 16' ' ' CYS . 9.7 p-10 -64.46 150.69 46.04 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.889 -1.05 . . . . 1.0 113.588 -175.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.409 ' HG3' ' H ' ' A' ' 57' ' ' ARG . 1.7 pt-20 -44.8 -49.62 10.63 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 113.533 -1.667 . . . . 1.0 114.121 176.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.509 ' HG2' ' OD2' ' A' ' 55' ' ' ASP . 9.6 ptp180 -71.04 -37.38 72.56 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.856 -0.338 . . . . 1.0 111.647 -174.374 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.454 ' HB1' ' HG2' ' A' ' 20' ' ' MET . . . -70.73 -40.95 72.45 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.906 -0.405 . . . . 1.0 109.906 177.239 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.5 -47.08 85.54 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.87 -0.604 . . . . 1.0 109.836 179.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -60.17 -46.87 93.44 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.912 -0.661 . . . . 1.0 113.318 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.425 HG13 ' O ' ' A' ' 57' ' ' ARG . 13.3 m -71.85 -38.06 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 CA-C-N 117.8 0.8 . . . . 1.0 111.663 -178.201 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.586 HD23 ' HG3' ' A' ' 23' ' ' LYS . 4.6 mp -63.9 -52.7 58.71 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 120.489 -0.484 . . . . 1.0 110.361 178.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 63' ' ' ARG . 0.3 OUTLIER -62.44 -27.67 69.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.013 -0.539 . . . . 1.0 111.416 -179.298 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.64 -33.9 69.33 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 120.817 0.341 . . . . 1.0 110.812 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -94.68 3.01 55.58 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.776 -178.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 90.56 13.49 59.66 Favored Glycine 0 CA--C 1.517 0.206 0 CA-C-N 115.697 -0.683 . . . . 1.0 113.257 176.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -90.26 155.4 46.72 Favored Pre-proline 0 C--N 1.318 -0.776 0 CA-C-O 120.45 0.167 . . . . 1.0 110.716 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.946 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 74.5 Cg_endo -72.91 162.24 41.56 Favored 'Trans proline' 0 CA--C 1.512 -0.604 0 C-N-CA 122.43 2.087 . . . . 1.0 110.871 177.267 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 35.0 p -137.83 10.93 2.89 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 120.043 -0.663 . . . . 1.0 111.228 -178.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -72.53 116.84 13.48 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.666 178.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.853 ' HB2' ' HE3' ' A' ' 23' ' ' LYS . 50.1 t60 -157.85 149.74 21.97 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.918 0.39 . . . . 1.0 111.175 -177.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' A' ' 52' ' ' SER . 4.8 tpt180 -133.66 114.19 13.2 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.785 -1.191 . . . . 1.0 107.785 175.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.458 ' HB3' ' O ' ' A' ' 49' ' ' HIS . . . -59.32 137.81 57.85 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.088 -0.96 . . . . 1.0 112.774 -175.074 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.506 ' HA ' HG23 ' A' ' 50' ' ' VAL . . . -129.65 161.65 30.11 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.213 -0.903 . . . . 1.0 110.078 178.143 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -97.53 156.73 16.37 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 108.244 -1.021 . . . . 1.0 108.244 178.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.5 HG11 ' CD2' ' A' ' 97' ' ' LEU . 8.1 t -66.91 104.26 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.303 0.573 . . . . 1.0 109.781 178.179 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.412 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -113.89 -175.09 18.93 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 115.184 -0.917 . . . . 1.0 111.269 -178.173 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 94.1 m -56.37 -43.36 79.1 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.814 0.34 . . . . 1.0 111.259 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -60.88 -29.76 69.74 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.091 -0.504 . . . . 1.0 111.312 178.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.557 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 80.0 m80 -78.19 -39.73 39.8 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-O 120.98 0.419 . . . . 1.0 109.875 178.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.519 ' HA ' HD21 ' A' ' 86' ' ' LEU . 33.9 mt -68.65 -18.75 64.34 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.784 -0.644 . . . . 1.0 110.758 178.123 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.8 -4.8 59.22 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.861 -0.608 . . . . 1.0 110.844 -178.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.64 ' HB1' ' O ' ' A' ' 6' ' ' HIS . . . -59.98 154.22 19.49 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.979 -0.555 . . . . 1.0 111.665 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.809 ' HB3' HD13 ' A' ' 5' ' ' LEU . 10.6 t70 -80.4 -12.08 59.62 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.52 -0.548 . . . . 1.0 109.52 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.808 HD13 HG13 ' A' ' 7' ' ' VAL . 0.4 OUTLIER -156.98 118.09 3.68 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 115.65 -0.705 . . . . 1.0 109.22 -177.615 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.716 ' HB3' HD13 ' A' ' 97' ' ' LEU . 5.1 mp -107.52 105.99 16.16 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-N 115.815 -0.629 . . . . 1.0 109.709 177.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.597 HG11 HD23 ' A' ' 110' ' ' LEU . 48.1 t -86.51 94.88 4.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 114.823 -1.081 . . . . 1.0 111.066 -176.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -82.73 144.67 30.04 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 114.975 -1.012 . . . . 1.0 110.949 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.413 ' HA ' HD13 ' A' ' 89' ' ' LEU . 4.3 mm? -95.04 -13.65 25.01 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.254 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.409 ' CG ' ' H ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -148.74 153.67 38.51 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.724 -0.671 . . . . 1.0 111.542 -178.89 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.7 ptt180 -49.74 -32.2 13.1 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.666 1.186 . . . . 1.0 113.55 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.646 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 76.9 m-20 -77.36 -47.51 19.7 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.751 -0.38 . . . . 1.0 110.672 -177.229 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.724 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 13.5 m170 -54.52 -48.15 72.27 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.923 -0.399 . . . . 1.0 109.923 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.96 -43.03 91.24 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.073 0.463 . . . . 1.0 110.752 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.674 ' O ' ' HG2' ' A' ' 99' ' ' GLN . 11.5 ttp180 -58.32 -47.56 83.31 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.465 -0.789 . . . . 1.0 111.363 179.08 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.722 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 48.4 mt -62.16 -49.11 77.15 Favored 'General case' 0 C--O 1.219 -0.533 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.233 -175.297 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.724 ' HG ' ' O ' ' A' ' 93' ' ' HIS . 32.1 mt -53.42 -58.05 8.49 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.816 -0.629 . . . . 1.0 111.762 -177.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.526 ' HG2' ' O ' ' A' ' 95' ' ' ARG . 22.6 ptt180 -59.41 -44.83 92.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.451 . . . . 1.0 111.578 -176.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.674 ' HG2' ' O ' ' A' ' 95' ' ' ARG . 9.9 pt20 -70.89 -18.65 62.67 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.84 0.353 . . . . 1.0 111.227 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.722 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 5.5 mt -79.58 -8.1 58.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.068 -0.515 . . . . 1.0 111.706 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 146.87 -30.36 1.52 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.029 -1.082 . . . . 1.0 113.011 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.8 HG12 ' H ' ' A' ' 103' ' ' GLU . 2.0 t -73.32 -154.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 121.077 0.465 . . . . 1.0 110.868 -178.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.8 ' H ' HG12 ' A' ' 102' ' ' VAL . 15.6 pt-20 -164.61 165.14 21.31 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.977 -0.749 . . . . 1.0 108.977 -177.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.788 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -65.01 -24.87 67.63 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 123.409 0.443 . . . . 1.0 111.542 -176.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.5 -35.65 72.57 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.3 0.571 . . . . 1.0 110.254 175.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.716 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 4.7 mtt-85 -96.89 -42.71 7.81 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 115.2 -0.909 . . . . 1.0 111.029 -177.261 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.788 HG12 ' HA ' ' A' ' 104' ' ' ALA . 7.8 p -80.79 121.7 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-O 121.37 0.605 . . . . 1.0 109.981 -177.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.533 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 12.7 mmm180 -137.97 146.6 43.36 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.39 -0.596 . . . . 1.0 109.39 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.779 ' HE3' HG23 ' A' ' 124' ' ' VAL . 79.6 mmm -77.81 139.53 39.33 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.837 -0.619 . . . . 1.0 110.234 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.597 HD23 HG11 ' A' ' 87' ' ' VAL . 3.2 tm? -56.04 -48.29 76.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.517 0.198 . . . . 1.0 111.075 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.838 ' H ' HG22 ' A' ' 124' ' ' VAL . 20.7 ttt85 -71.35 -17.49 62.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.007 0.432 . . . . 1.0 110.498 -178.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.483 ' HB2' ' HB2' ' A' ' 109' ' ' MET . 30.5 t -70.67 -12.26 61.45 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.581 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.458 ' HZ ' HD21 ' A' ' 85' ' ' LEU . 97.6 m-85 -90.8 -25.38 19.96 Favored 'General case' 0 N--CA 1.456 -0.166 0 O-C-N 122.175 -0.328 . . . . 1.0 110.122 176.161 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -62.83 122.23 73.27 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.51 -0.768 . . . . 1.0 111.756 -177.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.73 -16.77 20.75 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.394 2.063 . . . . 1.0 111.867 177.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 2.2 mmt180 -88.08 -6.99 57.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.923 -0.58 . . . . 1.0 110.565 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 33.2 t -57.69 -54.29 48.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.571 -0.74 . . . . 1.0 110.332 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 116.15 -61.26 0.4 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.41 -0.9 . . . . 1.0 111.643 178.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.631 HG22 ' H ' ' A' ' 120' ' ' HIS . 0.6 OUTLIER -128.91 -170.91 2.35 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.004 -0.739 . . . . 1.0 109.004 178.581 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.631 ' H ' HG22 ' A' ' 119' ' ' THR . 0.1 OUTLIER -58.68 144.83 42.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.836 0.35 . . . . 1.0 110.67 177.746 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -120.46 99.86 6.81 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.512 -0.313 . . . . 1.0 111.282 -178.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -95.48 19.49 10.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 122.028 0.918 . . . . 1.0 108.839 175.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -165.93 131.2 2.4 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 113.804 -1.544 . . . . 1.0 107.374 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.838 HG22 ' H ' ' A' ' 111' ' ' ARG . 79.9 t -90.26 -81.71 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 112.457 0.54 . . . . 1.0 112.457 -174.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -137.09 175.23 9.81 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.185 -0.916 . . . . 1.0 112.285 -175.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.43 ' HA ' ' HD2' ' A' ' 127' ' ' PRO . 33.5 t70 -174.23 106.79 0.29 Allowed Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 114.108 -1.406 . . . . 1.0 108.526 175.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.459 ' HG3' ' NH2' ' A' ' 17' ' ' ARG . 17.7 Cg_endo -60.65 172.67 2.62 Favored 'Trans proline' 0 C--O 1.233 0.269 0 C-N-CA 123.103 2.536 . . . . 1.0 112.625 -178.218 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.546 ' HD2' ' CD2' ' A' ' 129' ' ' TYR . 66.6 t80 -110.22 -35.1 6.18 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 112.792 0.664 . . . . 1.0 112.792 -174.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.563 ' CE1' ' HB2' ' A' ' 134' ' ' ASP . 0.4 OUTLIER -141.25 -41.27 0.38 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.969 0.729 . . . . 1.0 112.969 -176.66 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.406 ' N ' ' HD1' ' A' ' 129' ' ' TYR . . . 101.46 66.48 0.79 Allowed Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.098 -1.048 . . . . 1.0 111.846 -176.292 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.68 ' H ' ' HB3' ' A' ' 134' ' ' ASP . 3.8 t70 -137.44 -175.38 4.04 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.675 -0.861 . . . . 1.0 108.675 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -52.81 -49.6 65.35 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.674 0.25 . . . . 1.0 111.674 -178.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 5.0 p -63.89 -36.49 84.11 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.311 0.577 . . . . 1.0 110.933 -179.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.68 ' HB3' ' H ' ' A' ' 131' ' ' ASP . 12.6 t70 -64.05 -39.96 95.24 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.911 -1.041 . . . . 1.0 110.722 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.439 ' CG ' ' HB2' ' A' ' 57' ' ' ARG . 9.8 m-30 -67.46 -46.59 72.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.897 -0.592 . . . . 1.0 110.605 -178.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.43 ' HA ' ' HB3' ' A' ' 139' ' ' PHE . 10.1 mt-10 -76.67 -15.43 59.8 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.951 -0.568 . . . . 1.0 111.237 -178.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.5 ' O ' HG23 ' A' ' 141' ' ' VAL . 20.0 tp10 -65.29 -46.76 79.12 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 108.187 -1.042 . . . . 1.0 108.187 174.215 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 72.3 t -60.08 -44.25 94.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 114.594 -1.185 . . . . 1.0 109.214 175.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.43 ' HB3' ' HA ' ' A' ' 136' ' ' GLU . 49.9 t80 -54.01 -42.79 69.47 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.453 -1.249 . . . . 1.0 109.828 176.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.52 ' HA ' ' OE2' ' A' ' 143' ' ' GLU . . . -64.26 -42.07 96.64 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.462 -0.79 . . . . 1.0 111.03 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 137' ' ' GLU . 16.9 t -56.96 -53.77 38.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.503 0.668 . . . . 1.0 110.235 178.258 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.475 ' HA ' HD11 ' A' ' 110' ' ' LEU . 4.7 mt -60.92 -52.27 63.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.376 -0.829 . . . . 1.0 112.289 -178.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.52 ' OE2' ' HA ' ' A' ' 140' ' ' ALA . 13.2 pt-20 -56.17 -32.18 64.09 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.932 0.396 . . . . 1.0 110.515 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 73.0 m -72.8 -28.9 62.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.574 -0.739 . . . . 1.0 110.939 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.459 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -87.18 -23.5 24.77 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-N 116.215 -0.448 . . . . 1.0 111.712 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.749 HD22 ' HB3' ' A' ' 25' ' ' PHE . 13.4 mt -56.01 -36.66 48.63 Favored Pre-proline 0 CA--C 1.548 0.874 0 N-CA-C 112.417 0.525 . . . . 1.0 112.417 -177.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.636 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 51.1 Cg_endo -69.7 -10.79 29.47 Favored 'Trans proline' 0 C--N 1.366 1.465 0 C-N-CA 122.733 2.288 . . . . 1.0 112.277 177.081 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.429 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -105.24 -32.6 3.95 Favored Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 110.465 -1.054 . . . . 1.0 110.465 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.464 HD11 HG21 ' A' ' 87' ' ' VAL . 0.4 OUTLIER -74.48 -41.02 61.45 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.664 -0.865 . . . . 1.0 108.664 178.937 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.403 ' O ' HG22 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -53.52 -55.38 25.96 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 114.814 -1.085 . . . . 1.0 110.921 175.657 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -60.75 -40.47 92.56 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.563 -0.744 . . . . 1.0 111.591 -176.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' TRP . . . . . 0.756 ' HZ3' HD11 ' A' ' 5' ' ' LEU . 29.0 t90 -63.36 -54.6 34.37 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.552 -0.749 . . . . 1.0 110.751 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.458 HG13 ' O ' ' A' ' 149' ' ' LEU . 11.1 m -60.11 -39.19 79.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 C-N-CA 120.84 -0.344 . . . . 1.0 110.075 -179.185 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.442 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 8.3 m-20 -59.68 -51.74 68.5 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.272 0.558 . . . . 1.0 110.966 178.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.524 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 5.1 pt-20 -63.46 -38.31 90.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.406 -0.815 . . . . 1.0 110.443 -178.015 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.525 ' HG3' ' CH2' ' A' ' 152' ' ' TRP . 10.9 mmt180 -74.89 -42.72 57.29 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.615 -0.72 . . . . 1.0 111.664 -177.031 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 4.2 pp -64.54 -24.77 67.72 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.157 0.503 . . . . 1.0 109.793 179.105 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -71.62 -47.63 53.34 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.549 -0.75 . . . . 1.0 110.033 177.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.94 -4.09 48.1 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.533 0.568 . . . . 1.0 112.533 179.203 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -106.3 4.61 28.88 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.747 0.308 . . . . 1.0 110.979 179.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -175.07 144.62 7.42 Favored Glycine 0 C--N 1.319 -0.362 0 C-N-CA 119.971 -1.109 . . . . 1.0 114.247 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -87.7 30.36 0.45 Allowed 'Trans proline' 0 CA--C 1.519 -0.26 0 C-N-CA 123.777 2.985 . . . . 1.0 112.152 178.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 36.0 t . . . . . 0 C--N 1.302 -1.49 0 CA-C-N 114.585 -1.189 . . . . 1.0 110.813 -178.031 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.885 0 N-CA-C 112.247 -0.341 . . . . 1.0 112.247 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -82.13 -3.43 54.83 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.019 0.377 . . . . 1.0 112.019 -178.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.7 t -80.27 -179.71 7.24 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 110.3 -0.259 . . . . 1.0 110.3 -178.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.602 ' HB2' ' HD2' ' A' ' 4' ' ' PRO . 1.3 p-10 -64.1 159.96 52.12 Favored Pre-proline 0 C--O 1.234 0.253 0 CA-C-O 121.033 0.444 . . . . 1.0 111.379 178.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.602 ' HD2' ' HB2' ' A' ' 3' ' ' ASP . 23.1 Cg_endo -62.4 167.39 11.34 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 123.477 2.785 . . . . 1.0 114.046 -175.606 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.844 ' HB3' HG23 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -66.11 177.66 1.34 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.635 -1.166 . . . . 1.0 109.578 178.084 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.575 ' H ' HD13 ' A' ' 5' ' ' LEU . 0.9 OUTLIER -155.51 99.0 2.0 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.763 -0.458 . . . . 1.0 109.763 179.617 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.637 HG13 HD13 ' A' ' 85' ' ' LEU . 2.3 t -104.09 118.27 50.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 108.147 -1.057 . . . . 1.0 108.147 177.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.643 HG22 ' HG ' ' A' ' 86' ' ' LEU . 11.7 t -119.75 113.59 20.86 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.302 0.572 . . . . 1.0 110.352 178.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.647 ' HD1' ' HB ' ' A' ' 87' ' ' VAL . 1.0 OUTLIER -84.51 133.21 34.47 Favored 'General case' 0 CA--C 1.512 -0.487 0 O-C-N 122.024 -0.423 . . . . 1.0 110.258 -178.18 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.57 ' CG1' HG23 ' A' ' 45' ' ' THR . 40.7 t -119.95 119.49 60.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.552 0.691 . . . . 1.0 112.042 -176.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.445 ' HA ' ' CE1' ' A' ' 93' ' ' HIS . 21.7 p -148.32 163.37 37.29 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.221 -0.9 . . . . 1.0 109.963 177.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.96 96.81 5.83 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 120.849 0.357 . . . . 1.0 110.39 177.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.513 ' O ' HG12 ' A' ' 15' ' ' ILE . . . 146.64 -36.62 1.24 Allowed Glycine 0 C--O 1.218 -0.89 0 CA-C-N 115.687 -0.688 . . . . 1.0 112.26 179.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.503 ' OD1' ' HB1' ' A' ' 73' ' ' ALA . 32.2 p30 49.27 18.54 0.26 Allowed 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 125.155 1.382 . . . . 1.0 114.115 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.513 HG12 ' O ' ' A' ' 13' ' ' GLY . 5.8 pt -136.44 2.6 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 112.13 0.419 . . . . 1.0 112.13 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.646 ' O ' ' HG3' ' A' ' 20' ' ' MET . 51.4 t -121.99 -86.79 0.65 Allowed 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.437 -0.505 . . . . 1.0 111.577 -178.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 54.1 mtt85 -59.2 -56.55 20.67 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.063 0.458 . . . . 1.0 112.103 -175.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.948 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 45.3 m -53.19 -59.0 10.21 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 115.552 -0.749 . . . . 1.0 112.497 -177.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.409 ' HD3' ' HB2' ' A' ' 18' ' ' SER . 41.2 Cg_endo -63.19 -25.34 72.52 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 121.954 1.769 . . . . 1.0 113.2 -178.108 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.646 ' HG3' ' O ' ' A' ' 16' ' ' CYS . 53.4 mtp -61.19 -53.34 58.14 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.778 -0.369 . . . . 1.0 110.3 178.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.468 ' HB2' ' CG2' ' A' ' 142' ' ' ILE . . . -72.2 -26.74 62.17 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.265 -0.574 . . . . 1.0 110.178 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.685 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 17.7 tt0 -53.83 -52.1 61.43 Favored 'General case' 0 C--O 1.212 -0.874 0 CA-C-N 115.135 -0.939 . . . . 1.0 109.431 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.618 ' HZ1' ' HB3' ' A' ' 71' ' ' HIS . 0.1 OUTLIER -86.65 -23.03 25.8 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 120.06 -0.656 . . . . 1.0 110.879 -176.431 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.503 ' HB3' HD11 ' A' ' 146' ' ' LEU . 86.0 mtp -64.57 -75.78 0.08 Allowed 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.001 0.429 . . . . 1.0 112.132 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.617 ' HB3' HD22 ' A' ' 146' ' ' LEU . 17.5 p90 -77.04 -30.31 55.59 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 119.883 -0.727 . . . . 1.0 111.51 -175.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.685 ' HB3' ' O ' ' A' ' 22' ' ' GLU . . . -64.39 -36.96 85.84 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 118.951 -1.099 . . . . 1.0 110.991 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.605 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.2 OUTLIER -63.56 -37.53 87.68 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 108.433 -0.951 . . . . 1.0 108.433 176.468 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.581 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 77.9 mt-30 -60.15 -41.07 91.96 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-N 116.022 -0.536 . . . . 1.0 110.187 175.146 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.559 ' HG ' ' O ' ' A' ' 25' ' ' PHE . 70.7 mt -57.71 -59.69 4.83 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.004 -0.544 . . . . 1.0 110.907 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.525 ' HD3' ' HA ' ' A' ' 27' ' ' GLN . 0.3 OUTLIER -59.37 -34.36 72.31 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.556 -0.457 . . . . 1.0 110.779 178.225 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -63.01 -27.41 69.4 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.693 0.627 . . . . 1.0 112.693 176.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.46 ' HG2' ' O ' ' A' ' 28' ' ' GLN . 6.9 ptp180 -95.9 -15.01 22.68 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.566 0.698 . . . . 1.0 110.109 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.86 39.69 3.07 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 114.913 -1.039 . . . . 1.0 111.49 177.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 31.3 mt -132.32 3.8 3.98 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.987 -0.375 . . . . 1.0 109.987 -178.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.423 ' H ' ' HA ' ' A' ' 30' ' ' ARG . . . -56.22 -26.93 51.41 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 121.037 -0.602 . . . . 1.0 112.507 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.645 ' HA ' ' NH1' ' A' ' 39' ' ' ARG . 11.9 m-20 -91.32 -21.69 20.91 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.623 0.249 . . . . 1.0 110.796 176.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -81.01 -23.55 38.57 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.338 -178.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.844 HG23 ' HB3' ' A' ' 5' ' ' LEU . 0.7 OUTLIER -142.68 123.91 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-O 121.269 0.557 . . . . 1.0 110.509 179.769 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.645 ' NH1' ' HA ' ' A' ' 36' ' ' ASP . 24.3 mmt180 -92.53 141.33 28.63 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 109.233 -0.655 . . . . 1.0 109.233 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.441 HG13 ' CZ ' ' A' ' 9' ' ' PHE . 34.2 t -129.13 125.34 62.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-O 121.445 0.64 . . . . 1.0 109.931 -177.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' A' ' 8' ' ' THR . 36.5 p -136.79 -177.69 4.85 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.165 -1.379 . . . . 1.0 110.298 -174.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.948 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 66.9 p -161.03 162.94 31.9 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.986 -0.376 . . . . 1.0 109.986 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.561 ' HB2' ' CD2' ' A' ' 80' ' ' HIS . . . -164.59 171.03 15.01 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.556 0.693 . . . . 1.0 111.922 -178.082 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -128.29 134.05 7.98 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 114.851 -1.068 . . . . 1.0 111.073 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.57 HG23 ' CG1' ' A' ' 10' ' ' VAL . 25.7 p -69.6 -18.13 63.59 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.045 0.45 . . . . 1.0 111.385 -178.216 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.509 ' HA3' ' CZ3' ' A' ' 48' ' ' TRP . . . -113.8 8.53 23.7 Favored Glycine 0 CA--C 1.521 0.436 0 C-N-CA 120.853 -0.689 . . . . 1.0 113.173 -179.205 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 44.01 39.19 2.6 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 113.821 1.045 . . . . 1.0 113.821 177.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.509 ' CZ3' ' HA3' ' A' ' 46' ' ' GLY . 1.2 m-90 -43.96 -77.32 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.534 0.683 . . . . 1.0 112.506 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.428 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 24.4 m-70 -106.0 40.53 1.57 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.023 -0.99 . . . . 1.0 111.314 -179.282 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.446 HG23 ' HA ' ' A' ' 74' ' ' ALA . 12.0 p -58.2 127.63 17.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.853 179.276 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.6 -14.94 64.16 Favored Glycine 0 C--N 1.329 0.184 0 C-N-CA 121.196 -0.525 . . . . 1.0 112.195 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.6 t -81.56 -162.4 0.51 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.42 0.629 . . . . 1.0 110.356 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 14.0 t -118.89 175.74 5.61 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.703 -0.851 . . . . 1.0 108.703 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.458 ' HB2' ' HZ1' ' A' ' 23' ' ' LYS . . . -60.66 147.43 42.05 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 123.331 0.394 . . . . 1.0 111.525 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.454 ' OD1' ' HG2' ' A' ' 57' ' ' ARG . 11.5 t70 -63.0 142.84 58.23 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.698 -0.683 . . . . 1.0 111.163 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.437 ' HG3' ' N ' ' A' ' 57' ' ' ARG . 5.4 pt-20 -50.02 -37.06 31.2 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 113.522 0.934 . . . . 1.0 113.522 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.454 ' HG2' ' OD1' ' A' ' 55' ' ' ASP . 11.3 ptp180 -71.16 -37.56 72.2 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.039 0.447 . . . . 1.0 110.624 -176.039 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.417 ' HB1' ' HG2' ' A' ' 20' ' ' MET . . . -70.52 -37.65 74.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.61 -0.723 . . . . 1.0 109.5 178.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.14 -42.97 99.77 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.743 -0.662 . . . . 1.0 109.281 176.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.416 ' O ' ' HG2' ' A' ' 63' ' ' ARG . . . -58.77 -45.5 94.8 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.566 -0.743 . . . . 1.0 113.359 178.542 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.481 HG12 ' HG2' ' A' ' 136' ' ' GLU . 35.0 m -73.28 -41.73 57.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 117.569 0.685 . . . . 1.0 111.863 -179.195 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.735 ' HB2' HG22 ' A' ' 69' ' ' THR . 96.2 mt -60.63 -52.22 66.05 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 120.828 -0.349 . . . . 1.0 110.194 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.416 ' HG2' ' O ' ' A' ' 60' ' ' GLY . 2.4 ptm180 -59.83 -32.48 70.7 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.101 -0.499 . . . . 1.0 111.079 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.5 -34.81 74.85 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 121.155 0.503 . . . . 1.0 110.877 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.405 ' HB2' ' HD2' ' A' ' 67' ' ' TYR . 60.6 m80 -93.33 4.49 53.89 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.897 -179.021 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.16 16.74 62.23 Favored Glycine 0 C--N 1.331 0.288 0 CA-C-N 115.832 -0.622 . . . . 1.0 112.964 176.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.448 ' HD1' ' HG2' ' A' ' 27' ' ' GLN . 55.3 m-85 -92.45 153.52 42.69 Favored Pre-proline 0 C--N 1.32 -0.686 0 N-CA-C 110.434 -0.21 . . . . 1.0 110.434 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.402 ' O ' ' HD2' ' A' ' 23' ' ' LYS . 35.5 Cg_endo -68.25 156.76 64.57 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.063 1.842 . . . . 1.0 110.509 175.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.735 HG22 ' HB2' ' A' ' 62' ' ' LEU . 72.2 p -130.83 27.73 4.9 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 120.222 -0.591 . . . . 1.0 111.342 -176.467 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -104.08 131.87 50.91 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.81 -0.632 . . . . 1.0 110.335 178.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.618 ' HB3' ' HZ1' ' A' ' 23' ' ' LYS . 3.2 t60 -167.42 148.82 5.62 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.621 -0.718 . . . . 1.0 109.398 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -121.28 113.04 19.37 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 107.972 -1.121 . . . . 1.0 107.972 176.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.503 ' HB1' ' OD1' ' A' ' 14' ' ' ASN . . . -57.84 139.56 53.84 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.557 -0.747 . . . . 1.0 112.272 -175.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.446 ' HA ' HG23 ' A' ' 50' ' ' VAL . . . -132.98 161.95 32.97 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.742 178.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -97.66 156.59 16.47 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 108.134 -1.062 . . . . 1.0 108.134 177.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.59 HG11 ' CD2' ' A' ' 97' ' ' LEU . 14.5 t -66.24 104.69 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.529 0.681 . . . . 1.0 110.232 178.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.409 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -117.57 -171.77 15.67 Favored Glycine 0 N--CA 1.442 -0.962 0 CA-C-N 114.633 -1.167 . . . . 1.0 111.12 -178.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 98.9 m -56.99 -44.42 82.7 Favored 'General case' 0 C--N 1.319 -0.72 0 O-C-N 123.628 0.252 . . . . 1.0 111.3 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -60.71 -29.39 69.31 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.762 0.315 . . . . 1.0 111.216 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.561 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 79.1 m80 -79.22 -42.15 26.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.422 -0.354 . . . . 1.0 110.179 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.499 ' HA ' HD21 ' A' ' 86' ' ' LEU . 21.4 mt -66.77 -21.43 66.06 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.132 -0.485 . . . . 1.0 110.967 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.25 -5.01 59.28 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.166 -0.47 . . . . 1.0 111.438 -178.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.541 ' HA ' ' HB3' ' A' ' 6' ' ' HIS . . . -59.04 151.58 21.91 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.219 -0.446 . . . . 1.0 111.686 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.719 ' HB3' HD13 ' A' ' 5' ' ' LEU . 28.4 t70 -75.8 -16.26 60.12 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.924 -0.58 . . . . 1.0 109.635 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.637 HD13 HG13 ' A' ' 7' ' ' VAL . 0.4 OUTLIER -156.21 116.56 3.68 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.53 -0.759 . . . . 1.0 109.155 -176.931 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.643 ' HG ' HG22 ' A' ' 8' ' ' THR . 5.4 mp -106.59 106.48 17.02 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-N 115.778 -0.646 . . . . 1.0 109.562 177.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.647 ' HB ' ' HD1' ' A' ' 9' ' ' PHE . 54.9 t -85.18 93.15 3.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.124 -0.944 . . . . 1.0 110.994 -176.307 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.47 145.45 30.73 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.612 -0.722 . . . . 1.0 110.673 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.404 ' O ' ' HB ' ' A' ' 124' ' ' VAL . 4.4 mm? -96.38 -6.79 36.72 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.845 -0.616 . . . . 1.0 109.973 179.102 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.427 ' CG ' ' H ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -154.49 151.0 28.41 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.585 -0.734 . . . . 1.0 110.86 179.749 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.481 ' HB3' ' O ' ' A' ' 122' ' ' LEU . 13.7 ptp180 -58.04 -24.08 56.95 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.151 -0.931 . . . . 1.0 112.737 -177.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.689 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 82.3 m-20 -77.01 -47.64 20.12 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.983 -0.377 . . . . 1.0 109.983 -178.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.789 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 15.4 m170 -55.78 -48.26 75.64 Favored 'General case' 0 C--N 1.333 -0.119 0 N-CA-C 109.475 -0.565 . . . . 1.0 109.475 176.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.584 ' HA ' HG21 ' A' ' 107' ' ' VAL . . . -57.68 -42.46 83.65 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.477 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.401 ' O ' ' HG2' ' A' ' 98' ' ' ARG . 10.2 ttp180 -58.76 -47.12 85.75 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 115.548 -0.751 . . . . 1.0 111.248 178.29 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.752 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 52.0 mt -62.89 -50.32 71.34 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.667 -0.697 . . . . 1.0 110.212 -175.251 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.789 ' HG ' ' O ' ' A' ' 93' ' ' HIS . 22.1 mt -54.71 -57.36 11.81 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.369 -0.832 . . . . 1.0 111.468 -178.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.697 ' HA ' ' HB ' ' A' ' 102' ' ' VAL . 15.9 ptt180 -60.63 -42.83 97.68 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.08 -0.509 . . . . 1.0 111.675 -175.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.607 ' HG3' ' O ' ' A' ' 96' ' ' LEU . 0.9 OUTLIER -67.82 -25.43 65.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.888 0.375 . . . . 1.0 110.191 179.222 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.752 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 11.6 mt -77.13 -12.46 59.95 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.609 0.596 . . . . 1.0 112.609 -178.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 151.52 -26.94 0.96 Allowed Glycine 0 N--CA 1.453 -0.18 0 C-N-CA 120.277 -0.963 . . . . 1.0 112.4 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.931 HG12 ' H ' ' A' ' 103' ' ' GLU . 2.7 t -73.97 -155.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 C-N-CA 123.122 0.569 . . . . 1.0 110.185 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.931 ' H ' HG12 ' A' ' 102' ' ' VAL . 15.4 pt-20 -170.48 164.32 8.54 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 107.883 -1.154 . . . . 1.0 107.883 -178.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.707 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -67.31 -21.69 65.66 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.771 0.319 . . . . 1.0 110.882 -176.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.499 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . . . -58.31 -38.21 76.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.924 -0.58 . . . . 1.0 109.869 174.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.716 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 31.7 mtt180 -95.36 -45.79 6.98 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 115.182 -0.917 . . . . 1.0 110.333 -177.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.707 HG12 ' HA ' ' A' ' 104' ' ' ALA . 8.9 p -79.6 119.83 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-O 121.634 0.731 . . . . 1.0 110.033 -177.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.562 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 22.4 mmm180 -134.77 145.71 48.66 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.414 -0.587 . . . . 1.0 109.414 -178.047 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.589 ' HE3' HG23 ' A' ' 124' ' ' VAL . 81.4 mmm -77.35 134.86 38.37 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.829 -0.623 . . . . 1.0 110.389 -178.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.538 HD23 HG11 ' A' ' 87' ' ' VAL . 3.0 tm? -55.33 -48.94 73.42 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.933 0.396 . . . . 1.0 111.066 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.643 ' HD2' ' HA ' ' A' ' 124' ' ' VAL . 37.8 ttt180 -69.98 -19.02 63.37 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.894 -0.594 . . . . 1.0 110.679 -177.292 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 41.7 t -77.31 -8.41 57.59 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.95 -178.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.587 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 90.4 m-85 -88.75 -17.62 29.47 Favored 'General case' 0 C--N 1.341 0.21 0 O-C-N 121.858 -0.526 . . . . 1.0 110.235 176.234 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -60.8 123.34 74.32 Favored Pre-proline 0 CA--C 1.521 -0.149 0 CA-C-N 115.993 -0.549 . . . . 1.0 110.908 -178.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -70.1 -18.67 35.25 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.312 2.008 . . . . 1.0 111.674 178.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -87.67 -3.17 58.98 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.673 -0.694 . . . . 1.0 111.55 -178.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 77.6 p -64.13 101.77 0.44 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.314 0.578 . . . . 1.0 111.996 -178.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -55.96 -33.04 59.95 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-N 115.122 -0.945 . . . . 1.0 113.574 178.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.6 m -131.17 168.04 18.14 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.307 -0.627 . . . . 1.0 109.307 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 52.7 m170 -61.37 137.68 58.24 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 109.373 -0.603 . . . . 1.0 109.373 176.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.414 ' C ' ' H ' ' A' ' 123' ' ' ASP . . . -100.82 84.95 2.79 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.101 0.476 . . . . 1.0 111.404 -177.329 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.481 ' O ' ' HB3' ' A' ' 91' ' ' ARG . 2.5 mm? -91.12 22.93 3.48 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 108.311 -0.996 . . . . 1.0 108.311 175.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.414 ' H ' ' C ' ' A' ' 121' ' ' ALA . 0.1 OUTLIER -171.97 140.98 1.29 Allowed 'General case' 0 N--CA 1.426 -1.663 0 CA-C-N 113.359 -1.746 . . . . 1.0 107.829 178.595 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.643 ' HA ' ' HD2' ' A' ' 111' ' ' ARG . 64.0 t -101.14 144.47 12.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 109.472 -0.566 . . . . 1.0 109.472 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -65.23 166.48 9.75 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.826 -0.805 . . . . 1.0 108.826 178.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.53 ' OD1' ' HD2' ' A' ' 127' ' ' PRO . 35.4 t70 -156.55 148.42 17.3 Favored Pre-proline 0 C--N 1.314 -0.977 0 C-N-CA 119.827 -0.749 . . . . 1.0 109.769 -172.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.53 ' HD2' ' OD1' ' A' ' 126' ' ' ASP . 10.7 Cg_endo -54.72 -176.33 0.04 OUTLIER 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 123.458 2.772 . . . . 1.0 112.426 176.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.514 ' HD2' ' CD2' ' A' ' 129' ' ' TYR . 68.7 t80 -131.45 -26.63 2.04 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 113.872 1.064 . . . . 1.0 113.872 -173.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.514 ' CD2' ' HD2' ' A' ' 128' ' ' TYR . 0.2 OUTLIER -140.7 -44.52 0.4 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 114.238 1.199 . . . . 1.0 114.238 -174.99 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 109.66 59.01 0.51 Allowed Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 119.972 -1.109 . . . . 1.0 111.7 -175.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.62 ' H ' ' CB ' ' A' ' 134' ' ' ASP . 11.2 m-20 -125.98 -168.78 1.9 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.067 -0.716 . . . . 1.0 109.067 178.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.628 ' HA ' ' CE2' ' A' ' 135' ' ' PHE . 4.4 t-160 -58.66 -54.36 47.96 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.959 0.409 . . . . 1.0 110.674 -178.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.4 p -62.41 -32.71 73.58 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.049 -0.523 . . . . 1.0 111.789 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.62 ' CB ' ' H ' ' A' ' 131' ' ' ASP . 15.1 t70 -61.53 -47.09 87.17 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 114.78 -1.1 . . . . 1.0 111.355 -176.492 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.628 ' CE2' ' HA ' ' A' ' 132' ' ' HIS . 7.0 p90 -76.24 -37.74 57.27 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 119.734 -0.786 . . . . 1.0 112.243 -177.368 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.481 ' HG2' HG12 ' A' ' 61' ' ' VAL . 32.3 mt-10 -69.79 -24.59 63.51 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.504 -0.478 . . . . 1.0 110.014 177.012 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.561 ' O ' HG23 ' A' ' 141' ' ' VAL . 8.3 tt0 -64.44 -45.05 89.17 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.583 -0.735 . . . . 1.0 109.885 178.16 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 40.6 t -58.22 -43.34 85.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.405 0.621 . . . . 1.0 110.07 177.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -54.35 -45.65 72.77 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.43 -1.259 . . . . 1.0 110.344 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.613 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -62.3 -41.36 98.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.954 -0.567 . . . . 1.0 111.334 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 137' ' ' GLU . 20.7 t -56.9 -52.58 53.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-O 121.637 0.732 . . . . 1.0 110.855 178.274 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.468 ' CG2' ' HB2' ' A' ' 21' ' ' ALA . 6.3 mt -64.11 -49.67 80.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 114.928 -1.033 . . . . 1.0 111.956 -177.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.613 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 7.2 pt-20 -56.99 -30.45 64.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.887 0.375 . . . . 1.0 110.272 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 2.8 t -72.21 -31.28 65.72 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-O 121.233 0.54 . . . . 1.0 110.265 179.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.473 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -86.24 -23.07 26.55 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-N 115.699 -0.682 . . . . 1.0 111.796 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.617 HD22 ' HB3' ' A' ' 25' ' ' PHE . 10.6 mt -54.54 -40.94 86.77 Favored Pre-proline 0 C--N 1.329 -0.305 0 N-CA-C 112.795 0.665 . . . . 1.0 112.795 -178.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.725 ' HA ' ' CD2' ' A' ' 150' ' ' HIS . 69.7 Cg_endo -69.07 -7.27 20.39 Favored 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 122.279 1.986 . . . . 1.0 112.182 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.587 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -108.09 -32.5 3.25 Favored Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 109.903 -1.279 . . . . 1.0 109.903 177.336 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.556 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -76.49 -53.33 8.25 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.689 -0.756 . . . . 1.0 109.91 -179.334 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.725 ' CD2' ' HA ' ' A' ' 147' ' ' PRO . 3.7 p80 -56.28 -45.38 80.18 Favored 'General case' 0 C--O 1.216 -0.67 0 CA-C-O 121.469 0.652 . . . . 1.0 110.682 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.407 ' N ' ' CG ' ' A' ' 150' ' ' HIS . 25.9 t70 -57.31 -42.79 82.48 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 114.458 -1.246 . . . . 1.0 110.279 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' TRP . . . . . 0.756 ' HZ3' HD11 ' A' ' 5' ' ' LEU . 18.1 t90 -62.45 -55.47 27.34 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 114.993 -1.003 . . . . 1.0 110.072 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.535 HG11 HG21 ' A' ' 7' ' ' VAL . 4.0 m -61.95 -40.28 86.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.453 -0.34 . . . . 1.0 110.143 -179.04 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.503 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 67.1 m-20 -59.47 -54.89 41.43 Favored 'General case' 0 C--N 1.338 0.105 0 CA-C-O 121.405 0.621 . . . . 1.0 110.287 178.128 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.506 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 5.5 pt-20 -60.4 -35.76 76.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.278 -0.874 . . . . 1.0 110.571 -178.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.403 ' HG3' ' CH2' ' A' ' 152' ' ' TRP . 10.3 mmt180 -74.79 -43.69 53.42 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 115.831 -0.622 . . . . 1.0 111.187 -178.416 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 4.4 pp -67.7 -21.44 65.32 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.498 0.666 . . . . 1.0 109.73 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -76.3 -56.96 4.16 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.334 -0.848 . . . . 1.0 110.186 176.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.445 ' C ' ' H ' ' A' ' 161' ' ' GLY . 0.0 OUTLIER -80.3 1.14 29.86 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.498 0.925 . . . . 1.0 113.498 -175.036 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -76.05 31.48 0.12 Allowed 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.524 0.678 . . . . 1.0 111.448 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' A' ' 159' ' ' ARG . . . -84.74 174.69 50.14 Favored Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.588 -0.733 . . . . 1.0 111.527 179.05 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -84.1 27.48 0.61 Allowed 'Trans proline' 0 N--CA 1.473 0.286 0 C-N-CA 123.055 2.503 . . . . 1.0 112.991 -178.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 29.5 p . . . . . 0 C--N 1.306 -1.321 0 CA-C-N 114.54 -1.209 . . . . 1.0 110.111 179.868 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 0' ' ' GLY . . . . . 0.415 ' O ' ' HB2' ' A' ' 1' ' ' MET . . . . . . . . 0 N--CA 1.485 1.9 0 N-CA-C 112.024 -0.43 . . . . 1.0 112.024 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.415 ' HB2' ' O ' ' A' ' 0' ' ' GLY . 64.5 mtt 74.72 32.79 0.84 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 122.082 0.944 . . . . 1.0 108.55 -179.089 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.3 p -155.0 170.12 22.51 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 113.901 -1.499 . . . . 1.0 108.525 -178.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.623 ' HB3' ' HD2' ' A' ' 4' ' ' PRO . 0.6 OUTLIER -66.32 159.8 69.8 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.404 0.621 . . . . 1.0 111.801 -178.412 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.623 ' HD2' ' HB3' ' A' ' 3' ' ' ASP . 37.3 Cg_endo -69.89 177.28 5.83 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 124.19 3.26 . . . . 1.0 113.601 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.813 ' HB3' HG23 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -66.56 177.61 1.51 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.472 -0.786 . . . . 1.0 109.432 177.868 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.743 ' H ' HD13 ' A' ' 5' ' ' LEU . 1.7 t-160 -156.0 90.57 1.22 Allowed 'General case' 0 C--N 1.321 -0.631 0 O-C-N 122.161 -0.337 . . . . 1.0 110.695 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.859 HG13 HD13 ' A' ' 85' ' ' LEU . 2.1 t -96.29 102.88 14.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.031 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.633 ' CG2' HD23 ' A' ' 86' ' ' LEU . 9.6 t -105.8 114.71 29.02 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 121.029 0.442 . . . . 1.0 111.143 -178.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.545 ' HD1' ' HB ' ' A' ' 87' ' ' VAL . 1.1 m-85 -83.42 131.15 35.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.834 0.35 . . . . 1.0 110.361 -179.122 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.689 HG21 HD11 ' A' ' 97' ' ' LEU . 37.3 t -117.59 113.68 43.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.07 -0.514 . . . . 1.0 111.848 -176.166 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.49 ' HA ' ' CD2' ' A' ' 93' ' ' HIS . 41.8 t -142.7 163.06 33.84 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.048 -0.723 . . . . 1.0 109.048 177.064 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.79 90.89 4.07 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.357 0.599 . . . . 1.0 110.94 -178.03 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.833 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 136.65 -44.0 1.19 Allowed Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.453 -0.794 . . . . 1.0 111.442 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.678 ' ND2' ' H ' ' A' ' 74' ' ' ALA . 59.3 t30 61.57 22.88 13.27 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.843 0.83 . . . . 1.0 111.998 177.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.9 pt -127.41 4.44 3.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 O-C-N 121.63 -0.669 . . . . 1.0 110.956 179.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.756 ' O ' ' HG3' ' A' ' 20' ' ' MET . 5.3 p -121.6 -87.77 0.63 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.91 -0.587 . . . . 1.0 112.429 -177.131 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.782 HH11 HG21 ' A' ' 138' ' ' VAL . 8.5 mmt180 -71.63 -44.89 63.55 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.297 -0.41 . . . . 1.0 111.52 -174.444 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.451 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 19.2 m -55.72 -56.18 32.75 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-N 116.163 -0.471 . . . . 1.0 112.192 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.547 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 55.6 Cg_endo -67.01 -19.07 52.14 Favored 'Trans proline' 0 C--N 1.357 1.026 0 C-N-CA 121.633 1.555 . . . . 1.0 112.245 -178.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.756 ' HG3' ' O ' ' A' ' 16' ' ' CYS . 61.3 mtp -62.7 -55.0 30.75 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 120.336 -0.545 . . . . 1.0 109.907 176.535 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.424 ' HA ' ' HB2' ' A' ' 24' ' ' MET . . . -71.73 -27.9 63.31 Favored 'General case' 0 CA--C 1.512 -0.505 0 C-N-CA 120.37 -0.532 . . . . 1.0 110.617 -179.265 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.672 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 13.2 tt0 -51.15 -54.08 28.55 Favored 'General case' 0 C--O 1.217 -0.626 0 O-C-N 124.334 1.021 . . . . 1.0 109.73 179.191 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.925 ' HB3' ' HG2' ' A' ' 68' ' ' PRO . 0.4 OUTLIER -81.7 -27.16 34.09 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.239 -0.891 . . . . 1.0 110.311 -176.093 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.7 ' HB3' HD11 ' A' ' 146' ' ' LEU . 6.0 mmm -62.4 -76.76 0.06 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.811 0.671 . . . . 1.0 112.811 -176.34 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.701 ' HB3' HD22 ' A' ' 146' ' ' LEU . 18.2 p90 -78.2 -28.58 48.08 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 119.945 -0.702 . . . . 1.0 111.051 -174.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.672 ' HB3' ' O ' ' A' ' 22' ' ' GLU . . . -65.18 -38.02 89.18 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 119.208 -0.997 . . . . 1.0 110.922 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.699 ' HA ' ' HD3' ' A' ' 30' ' ' ARG . 0.1 OUTLIER -63.2 -37.7 88.27 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 108.709 -0.849 . . . . 1.0 108.709 177.485 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.593 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 74.9 mt-30 -60.33 -45.37 93.66 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.688 -0.687 . . . . 1.0 110.259 175.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.582 ' HG ' ' O ' ' A' ' 25' ' ' PHE . 84.9 mt -54.95 -58.47 7.5 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.887 -0.597 . . . . 1.0 111.09 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.699 ' HD3' ' HA ' ' A' ' 27' ' ' GLN . 0.7 OUTLIER -58.93 -38.1 78.21 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.35 -0.386 . . . . 1.0 111.228 179.597 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -62.7 -26.32 68.61 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.543 0.571 . . . . 1.0 112.543 177.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.593 ' HG2' ' O ' ' A' ' 28' ' ' GLN . 7.0 ptp180 -95.26 -18.96 20.4 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 119.406 -0.917 . . . . 1.0 109.917 178.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 107.44 34.95 2.76 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.345 -0.843 . . . . 1.0 112.305 177.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 21.1 mt -126.41 2.36 6.98 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.924 -0.399 . . . . 1.0 109.924 -178.234 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -53.54 -31.04 43.56 Favored Glycine 0 CA--C 1.521 0.468 0 CA-C-N 116.014 -0.539 . . . . 1.0 113.262 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.662 ' HA ' ' NH1' ' A' ' 39' ' ' ARG . 15.0 m-20 -92.04 -17.85 24.46 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 122.648 -0.325 . . . . 1.0 110.65 177.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.55 -22.73 43.46 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.163 -0.471 . . . . 1.0 111.139 -177.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.813 HG23 ' HB3' ' A' ' 5' ' ' LEU . 0.3 OUTLIER -144.32 123.92 7.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.186 0.517 . . . . 1.0 110.922 -179.749 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.682 ' O ' ' HA ' ' A' ' 6' ' ' HIS . 15.0 mmt180 -95.33 104.82 16.72 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 115.698 -0.683 . . . . 1.0 111.153 -177.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.652 HG11 ' HB2' ' A' ' 26' ' ' ALA . 1.5 m -87.99 137.1 21.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 108.231 -1.026 . . . . 1.0 108.231 176.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.502 ' O ' ' HA ' ' A' ' 8' ' ' THR . 21.5 p -146.76 -177.75 5.82 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.354 -0.839 . . . . 1.0 109.819 -175.283 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.475 ' OG ' ' HE1' ' A' ' 71' ' ' HIS . 67.1 p -157.14 156.73 33.21 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 120.388 -0.525 . . . . 1.0 111.035 -177.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.534 ' O ' ' HA ' ' A' ' 10' ' ' VAL . . . -161.65 160.68 29.02 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 121.225 0.536 . . . . 1.0 111.061 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.427 ' HA2' ' O ' ' A' ' 11' ' ' CYS . . . -123.08 133.77 9.19 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 111.351 -0.7 . . . . 1.0 111.351 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.479 HG21 HD12 ' A' ' 96' ' ' LEU . 21.1 p -69.17 -22.57 63.91 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 111.931 0.345 . . . . 1.0 111.931 -177.387 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -110.46 7.1 30.2 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.866 -0.683 . . . . 1.0 113.111 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 42.87 35.98 0.81 Allowed 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 113.87 1.063 . . . . 1.0 113.87 178.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.833 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 1.0 OUTLIER -44.95 -70.29 0.11 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.422 0.629 . . . . 1.0 112.487 -178.315 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.475 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 24.3 m-70 -110.58 44.08 1.31 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.317 -0.856 . . . . 1.0 111.244 179.434 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.469 HG23 ' HA ' ' A' ' 74' ' ' ALA . 12.0 p -61.56 129.17 24.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.772 -0.455 . . . . 1.0 109.772 177.055 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.597 ' HA2' ' HD3' ' A' ' 72' ' ' ARG . . . 92.58 -12.15 70.43 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.977 -0.63 . . . . 1.0 111.838 -177.271 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.495 ' O ' ' HA ' ' A' ' 72' ' ' ARG . 2.4 t -81.45 -158.56 0.22 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.357 0.598 . . . . 1.0 109.97 179.397 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 36.8 t -134.18 170.52 15.56 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 108.719 -0.845 . . . . 1.0 108.719 -178.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.54 140.77 27.39 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.193 0.52 . . . . 1.0 111.816 -178.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -59.35 137.37 58.01 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 114.432 -1.258 . . . . 1.0 110.43 -178.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -51.33 -29.15 14.27 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.315 -0.857 . . . . 1.0 113.109 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.598 ' HD3' ' CE1' ' A' ' 135' ' ' PHE . 30.9 mtt180 -69.63 -50.96 39.27 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.136 0.494 . . . . 1.0 110.267 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.407 ' O ' ' HG ' ' A' ' 62' ' ' LEU . . . -69.43 -29.32 67.0 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.18 -0.918 . . . . 1.0 110.533 -177.197 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.27 -44.63 96.92 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.86 -0.609 . . . . 1.0 109.514 176.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.19 -39.67 96.27 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.715 -0.755 . . . . 1.0 111.667 178.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 57' ' ' ARG . 78.7 t -60.81 -56.28 18.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 CA-C-O 121.188 0.518 . . . . 1.0 110.957 178.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.788 HD13 ' HG3' ' A' ' 23' ' ' LYS . 70.5 mt -61.04 -50.95 71.24 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.936 -0.574 . . . . 1.0 111.366 -178.52 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -60.07 -28.24 67.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.419 -0.355 . . . . 1.0 110.675 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.65 -35.67 79.31 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 120.977 0.417 . . . . 1.0 110.818 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.435 ' HB2' ' HD2' ' A' ' 67' ' ' TYR . 76.0 m80 -96.64 4.05 52.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.871 -0.604 . . . . 1.0 111.329 -177.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 90.21 14.99 58.16 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 121.086 -0.578 . . . . 1.0 112.632 177.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.508 ' HD1' ' HG2' ' A' ' 27' ' ' GLN . 69.7 m-85 -89.9 151.05 44.87 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-O 120.44 0.162 . . . . 1.0 110.985 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.925 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 55.3 Cg_endo -68.9 160.58 49.22 Favored 'Trans proline' 0 CA--C 1.511 -0.67 0 C-N-CA 122.571 2.18 . . . . 1.0 110.125 175.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.709 HG22 ' HB2' ' A' ' 62' ' ' LEU . 47.5 p -135.62 -0.43 2.63 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 119.589 -0.844 . . . . 1.0 112.161 -177.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.49 ' O ' ' HE2' ' A' ' 23' ' ' LYS . 48.4 t0 -71.94 134.84 46.22 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.293 -0.632 . . . . 1.0 109.293 -179.222 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.659 ' HB2' ' HE2' ' A' ' 23' ' ' LYS . 32.7 t60 -169.05 154.81 6.28 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.971 0.415 . . . . 1.0 110.379 -174.334 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.597 ' HD3' ' HA2' ' A' ' 51' ' ' GLY . 5.0 tmm_? -136.4 108.37 7.15 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 107.468 -1.308 . . . . 1.0 107.468 176.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 49' ' ' HIS . . . -58.67 139.99 55.27 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.823 -1.081 . . . . 1.0 112.048 -175.173 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.678 ' H ' ' ND2' ' A' ' 14' ' ' ASN . . . -130.01 161.54 30.73 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.645 -0.707 . . . . 1.0 109.93 177.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -96.77 159.9 14.67 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.205 -0.665 . . . . 1.0 109.205 179.079 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.424 HG11 HD23 ' A' ' 97' ' ' LEU . 61.7 t -70.18 110.2 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.158 0.504 . . . . 1.0 110.316 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.575 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -123.95 -170.58 13.34 Favored Glycine 0 N--CA 1.441 -1.006 0 CA-C-N 115.397 -0.819 . . . . 1.0 111.564 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 43.3 m -58.63 -51.71 68.75 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.873 0.368 . . . . 1.0 111.647 -178.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.522 ' HG2' ' N ' ' A' ' 80' ' ' HIS . 0.7 OUTLIER -54.46 -32.74 58.27 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.563 -0.744 . . . . 1.0 111.007 179.789 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.53 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 79.4 m80 -76.87 -40.61 47.0 Favored 'General case' 0 C--O 1.223 -0.321 0 N-CA-C 109.659 -0.497 . . . . 1.0 109.659 178.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.575 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 54.4 mt -65.75 -18.4 65.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.248 0.547 . . . . 1.0 110.539 178.143 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.39 -4.04 59.03 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.872 -0.604 . . . . 1.0 110.697 -178.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.569 ' HB1' ' O ' ' A' ' 6' ' ' HIS . . . -64.13 149.33 47.93 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.807 -0.633 . . . . 1.0 111.4 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.563 ' HB3' HD13 ' A' ' 5' ' ' LEU . 24.7 t70 -73.23 -14.4 61.33 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.07 0.462 . . . . 1.0 109.871 178.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.859 HD13 HG13 ' A' ' 7' ' ' VAL . 0.9 OUTLIER -154.08 120.94 5.59 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.597 -0.729 . . . . 1.0 110.504 -177.735 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 1.037 HD11 HG11 ' A' ' 102' ' ' VAL . 0.3 OUTLIER -105.99 104.33 14.02 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.747 -0.835 . . . . 1.0 108.747 175.158 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.571 HG23 HD22 ' A' ' 85' ' ' LEU . 54.5 t -83.73 92.18 2.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 121.493 0.663 . . . . 1.0 110.551 -178.092 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.21 146.78 30.3 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.195 -0.912 . . . . 1.0 111.231 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.672 ' O ' ' HB ' ' A' ' 124' ' ' VAL . 4.2 mm? -98.18 -13.68 20.76 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 115.689 -0.687 . . . . 1.0 109.741 178.054 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -139.44 153.55 47.59 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.496 -0.774 . . . . 1.0 109.961 -177.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.626 ' HB3' ' HB2' ' A' ' 123' ' ' ASP . 15.5 ptp180 -62.78 -20.38 64.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.36 0.6 . . . . 1.0 109.819 176.655 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.632 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 95.1 m-20 -76.49 -51.93 10.78 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.935 -1.029 . . . . 1.0 110.319 -178.46 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.49 ' CD2' ' HA ' ' A' ' 11' ' ' CYS . 17.4 m-70 -58.3 -44.14 88.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.792 -0.64 . . . . 1.0 110.277 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.549 ' HA ' HD12 ' A' ' 97' ' ' LEU . . . -60.54 -42.77 97.19 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.026 0.441 . . . . 1.0 110.473 178.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 5.0 ttp-105 -58.59 -45.56 88.82 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 115.438 -0.801 . . . . 1.0 111.16 178.227 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.736 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 45.6 mt -63.69 -50.28 69.81 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.343 -176.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.689 HD11 HG21 ' A' ' 10' ' ' VAL . 14.0 mt -52.76 -58.52 6.61 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.936 -0.575 . . . . 1.0 111.835 -177.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 13.0 ptt180 -60.68 -44.8 96.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.281 -0.418 . . . . 1.0 111.922 -176.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.47 ' HG3' ' O ' ' A' ' 96' ' ' LEU . 1.2 pt20 -69.0 -20.18 64.15 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 121.01 0.433 . . . . 1.0 110.595 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.736 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 6.2 mt -79.22 -9.02 59.47 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.622 -0.717 . . . . 1.0 111.798 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 150.96 -32.89 0.96 Allowed Glycine 0 CA--C 1.505 -0.57 0 C-N-CA 119.842 -1.171 . . . . 1.0 113.352 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 1.037 HG11 HD11 ' A' ' 86' ' ' LEU . 0.8 OUTLIER -76.79 -151.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 121.716 0.769 . . . . 1.0 112.056 -176.697 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.639 ' H ' HG12 ' A' ' 102' ' ' VAL . 12.8 pt-20 -162.9 167.42 22.7 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.189 -0.914 . . . . 1.0 108.733 -178.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.763 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -67.23 -22.32 65.7 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.179 -0.464 . . . . 1.0 112.132 -174.4 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.24 -36.59 73.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.12 0.486 . . . . 1.0 110.687 176.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.591 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 1.0 OUTLIER -96.86 -40.36 8.96 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.207 -0.906 . . . . 1.0 110.805 -177.615 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.763 HG12 ' HA ' ' A' ' 104' ' ' ALA . 13.4 p -79.76 115.2 21.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.574 0.702 . . . . 1.0 110.352 -179.294 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.527 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 20.5 mmm180 -133.3 145.08 50.12 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.889 -0.596 . . . . 1.0 109.658 -177.483 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.509 ' HG3' ' HA ' ' A' ' 122' ' ' LEU . 84.6 mmm -77.52 137.52 38.67 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.947 -0.57 . . . . 1.0 110.543 -179.176 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.55 HD11 ' HA ' ' A' ' 142' ' ' ILE . 3.1 tm? -55.27 -49.81 71.11 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.802 0.334 . . . . 1.0 110.567 179.323 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.579 ' HB2' HG22 ' A' ' 124' ' ' VAL . 11.8 ttt-85 -72.94 -12.87 61.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.321 -0.4 . . . . 1.0 111.419 -176.363 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.518 ' HB2' ' O ' ' A' ' 121' ' ' ALA . 33.3 t -78.81 -8.97 59.28 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 121.15 -0.22 . . . . 1.0 110.855 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.627 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 82.6 m-85 -86.46 -18.27 32.11 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-O 120.975 0.417 . . . . 1.0 110.341 177.532 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -54.28 120.05 23.58 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.33 -0.85 . . . . 1.0 111.046 -179.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -67.1 -25.6 43.63 Favored 'Trans proline' 0 C--O 1.233 0.275 0 C-N-CA 122.736 2.291 . . . . 1.0 111.533 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 52.9 mtt180 -85.49 -1.22 56.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.393 -0.821 . . . . 1.0 111.181 -177.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 75.9 p -62.4 99.27 0.13 Allowed 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.174 0.511 . . . . 1.0 111.651 -178.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -66.19 -20.74 69.47 Favored Glycine 0 C--N 1.331 0.304 0 CA-C-N 115.658 -0.701 . . . . 1.0 112.09 177.061 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -131.94 164.03 27.04 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.975 -0.75 . . . . 1.0 108.975 178.305 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 36.6 m170 -70.83 138.39 50.26 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.961 0.41 . . . . 1.0 110.026 177.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.518 ' O ' ' HB2' ' A' ' 112' ' ' SER . . . -108.64 92.43 4.05 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.025 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.509 ' HA ' ' HG3' ' A' ' 109' ' ' MET . 2.2 mm? -96.49 9.02 42.67 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.21 -0.663 . . . . 1.0 109.21 179.074 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.626 ' HB2' ' HB3' ' A' ' 91' ' ' ARG . 34.8 t70 -168.35 144.86 3.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.662 -1.154 . . . . 1.0 108.05 -177.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.672 ' HB ' ' O ' ' A' ' 89' ' ' LEU . 92.9 t -102.56 148.43 7.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.051 0.453 . . . . 1.0 110.865 -176.052 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -66.44 -175.32 0.35 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.696 -0.684 . . . . 1.0 110.964 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -146.47 152.94 47.0 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 108.931 -0.766 . . . . 1.0 108.931 -175.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.4 ' HB3' ' OD1' ' A' ' 134' ' ' ASP . 19.0 Cg_endo -60.95 172.31 3.08 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.98 2.453 . . . . 1.0 113.684 -175.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -97.11 -39.94 9.06 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.404 -0.816 . . . . 1.0 111.178 -178.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.466 ' HD1' ' N ' ' A' ' 130' ' ' GLY . 0.1 OUTLIER -143.53 -24.24 0.59 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 113.731 1.012 . . . . 1.0 113.731 -178.334 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.466 ' N ' ' HD1' ' A' ' 129' ' ' TYR . . . 89.54 67.2 1.24 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 119.96 -1.114 . . . . 1.0 111.552 -177.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.666 ' H ' ' HB3' ' A' ' 134' ' ' ASP . 8.5 t70 -135.29 -167.37 1.99 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.89 -0.782 . . . . 1.0 108.89 -177.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -56.71 -41.2 77.0 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.7 0.286 . . . . 1.0 110.75 -178.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 8.0 m -61.86 -37.1 83.26 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.854 179.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.666 ' HB3' ' H ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -65.74 -38.61 89.59 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.991 -177.61 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.598 ' CE1' ' HD3' ' A' ' 57' ' ' ARG . 2.9 m-85 -69.71 -44.08 71.07 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.644 -0.502 . . . . 1.0 109.644 -176.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.437 ' HA ' ' HB3' ' A' ' 139' ' ' PHE . 36.7 mt-10 -74.25 -26.21 60.09 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.723 -0.671 . . . . 1.0 110.382 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.528 ' O ' HG23 ' A' ' 141' ' ' VAL . 32.7 tt0 -63.22 -50.22 71.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.029 -0.532 . . . . 1.0 109.878 178.169 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.782 HG21 HH11 ' A' ' 17' ' ' ARG . 53.4 t -62.74 -40.16 87.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.663 -0.699 . . . . 1.0 109.857 175.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.548 ' HB2' ' HE1' ' A' ' 20' ' ' MET . 18.3 t80 -54.5 -41.77 69.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.113 -0.949 . . . . 1.0 109.172 175.722 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.575 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -65.63 -42.37 91.6 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.604 -0.725 . . . . 1.0 110.544 176.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.661 HG23 ' HA ' ' A' ' 138' ' ' VAL . 13.8 t -54.15 -52.11 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-O 121.863 0.84 . . . . 1.0 109.715 177.537 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.55 ' HA ' HD11 ' A' ' 110' ' ' LEU . 7.2 mt -65.29 -51.32 66.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 114.597 -1.183 . . . . 1.0 112.084 -178.167 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.575 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 8.4 pt-20 -55.29 -34.37 64.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.825 0.345 . . . . 1.0 110.479 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 67.1 m -72.24 -28.96 63.48 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.738 -0.664 . . . . 1.0 110.743 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.458 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -88.48 -22.77 23.48 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.776 -0.647 . . . . 1.0 112.08 179.253 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.701 HD22 ' HB3' ' A' ' 25' ' ' PHE . 12.0 mt -55.65 -37.74 60.3 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 112.266 0.469 . . . . 1.0 112.266 -178.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.623 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 60.3 Cg_endo -70.53 -10.31 27.67 Favored 'Trans proline' 0 C--N 1.361 1.204 0 C-N-CA 122.493 2.129 . . . . 1.0 111.832 177.728 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.627 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -104.67 -32.41 4.18 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 110.572 -1.011 . . . . 1.0 110.572 178.289 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.459 ' O ' HG13 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -75.63 -41.89 53.03 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.687 -0.857 . . . . 1.0 108.687 179.474 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.432 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 0.5 OUTLIER -54.08 -56.85 14.18 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 114.791 -1.095 . . . . 1.0 110.736 176.787 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -58.55 -40.64 83.58 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.226 -0.897 . . . . 1.0 111.504 -175.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' TRP . . . . . 0.747 ' HZ3' HD11 ' A' ' 5' ' ' LEU . 31.0 t90 -63.22 -55.23 26.75 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.624 -0.716 . . . . 1.0 110.615 -179.346 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.474 HG11 HG21 ' A' ' 7' ' ' VAL . 7.2 m -61.65 -40.38 86.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 120.723 -0.391 . . . . 1.0 110.598 -178.51 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.435 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 13.3 m-20 -59.69 -52.0 67.4 Favored 'General case' 0 CA--C 1.523 -0.084 0 CA-C-O 120.994 0.426 . . . . 1.0 110.721 178.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.59 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 6.2 pt-20 -61.86 -38.84 89.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.586 -0.734 . . . . 1.0 110.296 -178.517 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.515 ' HG3' ' CH2' ' A' ' 152' ' ' TRP . 20.4 mmt180 -72.11 -46.62 55.97 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.805 -0.634 . . . . 1.0 111.057 -177.291 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 4.1 pp -65.56 -23.81 66.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.337 0.589 . . . . 1.0 109.591 -179.176 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -74.63 -55.05 6.31 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.274 -0.876 . . . . 1.0 110.162 177.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.519 ' HG3' ' O ' ' A' ' 155' ' ' GLU . 0.1 OUTLIER -80.9 3.05 24.07 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 112.653 0.612 . . . . 1.0 112.653 -177.3 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -45.02 -36.41 3.44 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 123.276 0.36 . . . . 1.0 111.56 178.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 78.57 164.0 24.92 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.92 -0.657 . . . . 1.0 114.089 176.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -99.14 20.91 0.3 Allowed 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 123.545 2.83 . . . . 1.0 112.48 178.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 45.9 t . . . . . 0 C--N 1.306 -1.284 0 CA-C-N 114.124 -1.398 . . . . 1.0 109.311 -178.713 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.72 0 N-CA-C 111.715 -0.554 . . . . 1.0 111.715 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.6 mtt -82.24 70.44 9.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.942 0.371 . . . . 1.0 110.844 -178.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.3 m -158.68 176.48 12.32 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.574 -0.528 . . . . 1.0 109.574 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.76 155.84 75.1 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.942 175.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.489 ' HB2' ' HG2' ' A' ' 39' ' ' ARG . 35.1 Cg_endo -64.24 161.94 32.05 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.387 2.725 . . . . 1.0 113.836 -175.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.77 ' HB3' HG23 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -66.17 178.42 1.16 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.75 -1.114 . . . . 1.0 109.319 177.547 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.704 ' H ' HD13 ' A' ' 5' ' ' LEU . 4.0 t-160 -156.8 98.23 1.76 Allowed 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.503 -0.555 . . . . 1.0 109.503 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.775 HG13 HD13 ' A' ' 85' ' ' LEU . 2.1 t -103.18 117.97 49.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 N-CA-C 107.722 -1.214 . . . . 1.0 107.722 177.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.592 HG22 ' HG ' ' A' ' 86' ' ' LEU . 8.3 t -118.54 114.38 22.73 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 120.931 0.396 . . . . 1.0 110.204 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.591 ' HD2' ' HB3' ' A' ' 42' ' ' SER . 2.2 m-85 -82.89 126.07 32.06 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.076 0.465 . . . . 1.0 110.215 -178.681 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.665 HG21 HD11 ' A' ' 97' ' ' LEU . 35.4 t -110.23 112.01 38.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 CA-C-N 115.74 -0.664 . . . . 1.0 111.631 -176.251 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.639 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 37.7 t -139.91 161.28 37.96 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.149 -1.056 . . . . 1.0 108.149 177.174 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -66.24 -39.89 89.86 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.217 0.532 . . . . 1.0 109.812 179.248 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.588 ' C ' ' H ' ' A' ' 15' ' ' ILE . . . -104.17 80.4 0.32 Allowed Glycine 0 N--CA 1.435 -1.432 0 CA-C-N 115.187 -0.915 . . . . 1.0 110.856 175.371 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.628 ' ND2' ' HB1' ' A' ' 73' ' ' ALA . 15.9 p-10 -59.5 17.72 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.74 1.616 . . . . 1.0 112.418 176.1 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.588 ' H ' ' C ' ' A' ' 13' ' ' GLY . 6.7 pt -121.59 -0.81 7.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.177 178.398 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 22.1 m -116.16 -87.09 0.61 Allowed 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.215 0.45 . . . . 1.0 112.215 -177.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.587 HH21 ' HB3' ' A' ' 89' ' ' LEU . 13.0 mtm-85 -72.38 -46.96 53.02 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 112.391 0.515 . . . . 1.0 112.391 -173.462 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.76 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 26.4 m -54.46 -58.72 12.71 Favored Pre-proline 0 CA--C 1.537 0.446 0 CA-C-N 116.306 -0.406 . . . . 1.0 111.333 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.451 ' HA ' ' HB2' ' A' ' 22' ' ' GLU . 39.3 Cg_endo -63.56 -22.9 70.66 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 121.763 1.642 . . . . 1.0 113.345 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.698 ' HB3' HD13 ' A' ' 142' ' ' ILE . 35.6 mmm -60.97 -53.62 55.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.635 0.255 . . . . 1.0 110.846 178.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.92 -25.63 60.09 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.168 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.632 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 17.9 tt0 -51.92 -54.09 33.47 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 114.761 -1.109 . . . . 1.0 109.819 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.647 ' O ' ' HB3' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -83.51 -26.99 29.7 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.378 -0.828 . . . . 1.0 110.838 -175.753 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.599 ' HB3' HD11 ' A' ' 146' ' ' LEU . 5.6 mmm -60.85 -75.61 0.06 Allowed 'General case' 0 C--O 1.239 0.542 0 CA-C-O 121.453 0.644 . . . . 1.0 112.504 -178.062 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.677 ' CE2' HD23 ' A' ' 149' ' ' LEU . 22.3 p90 -79.37 -28.83 41.94 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.088 -0.645 . . . . 1.0 111.674 -174.764 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.632 ' HB3' ' O ' ' A' ' 22' ' ' GLU . . . -64.8 -36.2 83.56 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 119.082 -1.047 . . . . 1.0 110.739 178.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.647 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -63.73 -38.56 91.55 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.666 -0.864 . . . . 1.0 108.666 176.595 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.673 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 78.7 mt-30 -59.24 -44.56 92.35 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 115.608 -0.724 . . . . 1.0 110.499 175.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 25' ' ' PHE . 90.0 mt -54.26 -59.62 4.43 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.887 -0.597 . . . . 1.0 111.239 -179.319 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.531 ' HD3' ' HA ' ' A' ' 27' ' ' GLN . 1.5 ptm180 -59.31 -34.55 72.45 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.714 -0.394 . . . . 1.0 111.155 178.586 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -62.27 -28.96 70.08 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.315 0.487 . . . . 1.0 112.315 177.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.673 ' HG2' ' O ' ' A' ' 28' ' ' GLN . 4.8 ptp180 -94.16 -16.0 24.12 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 119.915 -0.714 . . . . 1.0 110.429 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 102.72 38.75 2.89 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.403 -0.817 . . . . 1.0 111.48 177.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 27.3 mt -132.72 1.51 3.66 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 110.088 -0.338 . . . . 1.0 110.088 -178.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.462 ' H ' ' HA ' ' A' ' 30' ' ' ARG . . . -57.6 -27.29 58.48 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 121.05 -0.595 . . . . 1.0 112.343 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -82.55 -31.27 29.17 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.964 0.411 . . . . 1.0 109.928 177.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -78.94 -16.86 56.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.201 -0.909 . . . . 1.0 112.318 -174.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.77 HG23 ' HB3' ' A' ' 5' ' ' LEU . 0.3 OUTLIER -143.86 126.59 11.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 121.877 -0.515 . . . . 1.0 111.241 -179.998 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.489 ' HG2' ' HB2' ' A' ' 4' ' ' PRO . 7.7 mmt180 -90.46 132.62 35.55 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 108.636 -0.875 . . . . 1.0 108.636 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 68.3 t -124.9 119.41 55.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.264 -0.643 . . . . 1.0 109.264 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.436 ' O ' ' HA ' ' A' ' 8' ' ' THR . 78.0 p -132.49 -175.16 3.66 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.47 -1.241 . . . . 1.0 110.979 -174.638 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.76 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 87.8 p -158.58 163.39 37.04 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.682 -0.488 . . . . 1.0 109.682 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.54 ' HB2' ' CD2' ' A' ' 80' ' ' HIS . . . -164.93 168.78 17.23 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 121.219 0.533 . . . . 1.0 111.571 -178.447 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.639 ' HA2' ' O ' ' A' ' 11' ' ' CYS . . . -127.53 132.56 7.55 Favored Glycine 0 N--CA 1.438 -1.174 0 CA-C-N 115.078 -0.965 . . . . 1.0 111.462 178.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.499 HG23 ' CG1' ' A' ' 10' ' ' VAL . 26.9 p -69.47 -23.41 63.64 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.887 0.375 . . . . 1.0 111.325 -178.145 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.429 ' HA3' ' HZ3' ' A' ' 48' ' ' TRP . . . -112.92 9.1 25.41 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.858 -0.686 . . . . 1.0 112.304 -178.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.494 ' HB3' ' HB2' ' A' ' 75' ' ' GLN . 10.1 p30 43.64 39.11 2.23 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.991 0.916 . . . . 1.0 113.41 177.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.429 ' HZ3' ' HA3' ' A' ' 46' ' ' GLY . 1.2 m-90 -42.8 -72.54 0.06 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.294 0.568 . . . . 1.0 112.386 -178.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.418 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 75.9 m-70 -112.23 45.72 1.25 Allowed 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.283 -0.872 . . . . 1.0 111.243 178.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.446 HG23 ' HA ' ' A' ' 74' ' ' ALA . 11.6 p -61.78 129.93 25.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.622 -0.717 . . . . 1.0 110.135 177.563 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.607 ' HA2' ' HD3' ' A' ' 72' ' ' ARG . . . 93.66 -15.31 63.34 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.889 -0.672 . . . . 1.0 112.081 -177.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.4 t -80.06 -161.16 0.33 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.379 0.609 . . . . 1.0 109.914 179.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 35.5 t -127.98 170.62 12.66 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 115.288 -0.869 . . . . 1.0 108.932 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -52.06 136.13 29.99 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 123.338 0.398 . . . . 1.0 111.414 -178.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.698 ' OD1' ' HG2' ' A' ' 57' ' ' ARG . 12.5 t70 -57.17 140.27 50.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.389 -0.823 . . . . 1.0 111.309 -178.114 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -45.78 -37.93 6.57 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.99 -1.004 . . . . 1.0 113.519 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.698 ' HG2' ' OD1' ' A' ' 55' ' ' ASP . 15.3 ptp180 -70.12 -44.52 68.77 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 120.522 -0.471 . . . . 1.0 110.914 -177.466 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.24 -30.91 66.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.035 0.445 . . . . 1.0 110.384 -178.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.02 -45.82 90.54 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.082 177.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.2 -36.87 94.01 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.937 -0.649 . . . . 1.0 111.773 177.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 57' ' ' ARG . 86.9 t -62.06 -59.04 4.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.23 0.538 . . . . 1.0 110.851 178.163 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.682 ' HB2' HG22 ' A' ' 69' ' ' THR . 96.8 mt -60.16 -50.12 74.95 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.836 -0.62 . . . . 1.0 111.363 -177.062 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 -59.25 -30.62 68.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.47 -0.332 . . . . 1.0 111.061 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.28 -33.24 73.99 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 121.124 0.488 . . . . 1.0 111.136 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -97.59 5.34 49.61 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.859 -0.61 . . . . 1.0 111.437 -178.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.48 13.44 63.32 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.899 -0.667 . . . . 1.0 112.837 177.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -91.13 148.95 39.01 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-O 120.561 0.22 . . . . 1.0 110.944 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.614 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 48.9 Cg_endo -69.95 158.13 57.73 Favored 'Trans proline' 0 CA--C 1.513 -0.563 0 C-N-CA 122.243 1.962 . . . . 1.0 110.841 176.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.682 HG22 ' HB2' ' A' ' 62' ' ' LEU . 53.1 p -131.3 9.09 4.73 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.341 -0.543 . . . . 1.0 110.803 -178.059 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -73.6 123.77 24.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.463 -0.79 . . . . 1.0 109.536 -178.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.48 ' HB2' ' HE2' ' A' ' 23' ' ' LYS . 31.2 t60 -166.07 154.58 11.01 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.973 -175.381 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.607 ' HD3' ' HA2' ' A' ' 51' ' ' GLY . 2.3 tmm_? -135.8 110.1 8.42 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.048 -1.093 . . . . 1.0 108.048 175.638 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.628 ' HB1' ' ND2' ' A' ' 14' ' ' ASN . . . -55.7 136.68 50.59 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.621 -1.172 . . . . 1.0 112.527 -175.452 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.464 ' O ' ' HA ' ' A' ' 43' ' ' ALA . . . -129.45 160.4 33.26 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.822 -0.172 . . . . 1.0 110.743 178.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.494 ' HB2' ' HB3' ' A' ' 47' ' ' ASN . 8.9 tt0 -97.04 153.39 17.95 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.531 -0.914 . . . . 1.0 108.531 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.504 HG11 ' CD2' ' A' ' 97' ' ' LEU . 20.2 t -65.41 109.92 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.424 0.631 . . . . 1.0 110.748 179.306 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -120.92 -169.67 13.87 Favored Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 115.396 -0.82 . . . . 1.0 111.103 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 53.9 m -58.8 -42.89 90.18 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.52 0.2 . . . . 1.0 110.692 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -57.78 -31.96 67.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.944 0.402 . . . . 1.0 111.303 177.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.54 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 79.3 m80 -79.22 -41.27 28.66 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-N 116.522 -0.308 . . . . 1.0 110.943 -179.201 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.688 ' HA ' HD21 ' A' ' 86' ' ' LEU . 16.8 mt -67.95 -19.04 64.93 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.914 0.387 . . . . 1.0 110.127 177.51 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.13 -5.16 59.26 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.849 0.357 . . . . 1.0 110.388 -178.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.497 ' HA ' ' HB3' ' A' ' 6' ' ' HIS . . . -58.2 153.72 14.53 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.822 -0.626 . . . . 1.0 110.782 178.517 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.757 ' HB3' HD13 ' A' ' 5' ' ' LEU . 12.1 t70 -79.96 -14.57 58.5 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.902 -0.59 . . . . 1.0 109.546 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.775 HD13 HG13 ' A' ' 7' ' ' VAL . 0.4 OUTLIER -155.69 118.31 4.2 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.342 -0.845 . . . . 1.0 108.842 -178.11 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.688 HD21 ' HA ' ' A' ' 81' ' ' LEU . 5.2 mp -107.93 105.55 15.4 Favored 'General case' 0 N--CA 1.425 -1.683 0 CA-C-O 121.305 0.574 . . . . 1.0 109.806 178.273 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.593 ' HA ' ' O ' ' A' ' 108' ' ' ARG . 55.8 t -84.9 92.59 3.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 114.652 -1.158 . . . . 1.0 111.453 -175.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.79 146.56 33.71 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.566 -0.743 . . . . 1.0 110.758 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.597 ' O ' ' HB ' ' A' ' 124' ' ' VAL . 3.9 mm? -100.83 -7.57 23.47 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.459 179.156 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.426 ' CG ' ' H ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -153.97 156.38 37.35 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.994 -0.548 . . . . 1.0 111.282 178.594 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 6.0 ptm85 -55.72 -24.65 35.98 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.479 0.918 . . . . 1.0 113.479 -178.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.655 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 87.8 m-20 -76.79 -51.49 11.27 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 110.186 -0.301 . . . . 1.0 110.186 -178.515 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.668 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 13.5 m170 -55.27 -46.33 76.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.011 -0.541 . . . . 1.0 110.527 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.85 -43.12 94.83 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.069 0.462 . . . . 1.0 110.713 179.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.682 ' O ' ' HG2' ' A' ' 99' ' ' GLN . 5.9 ttm180 -58.44 -46.49 86.43 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 115.482 -0.781 . . . . 1.0 111.005 177.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.744 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 46.6 mt -62.51 -51.14 68.59 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-N 115.921 -0.581 . . . . 1.0 110.412 -175.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.668 ' HG ' ' O ' ' A' ' 93' ' ' HIS . 40.8 mt -51.22 -58.34 6.42 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.954 -0.566 . . . . 1.0 111.684 -177.276 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.663 ' CA ' HG12 ' A' ' 102' ' ' VAL . 13.3 ptt180 -58.91 -46.99 86.59 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.015 -0.539 . . . . 1.0 112.258 -179.16 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.682 ' HG2' ' O ' ' A' ' 95' ' ' ARG . 12.8 pt20 -69.24 -19.39 63.94 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.649 -0.421 . . . . 1.0 110.665 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.744 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 10.8 mt -81.43 -18.96 43.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.969 -0.56 . . . . 1.0 110.963 177.162 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 153.35 -25.15 0.77 Allowed Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 119.706 -1.235 . . . . 1.0 113.655 -178.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.7 HG13 ' N ' ' A' ' 103' ' ' GLU . 0.4 OUTLIER -76.49 -161.6 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 CA-C-N 117.493 0.646 . . . . 1.0 110.555 -178.44 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.761 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 15.5 pt-20 -159.25 161.89 36.08 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.604 -1.258 . . . . 1.0 107.604 -178.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.772 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -62.84 -24.51 67.82 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.725 0.298 . . . . 1.0 111.406 -175.387 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.434 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . . . -58.63 -36.05 73.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.01 -0.541 . . . . 1.0 110.171 174.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.761 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 1.6 mtt-85 -98.95 -41.37 7.62 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 115.604 -0.726 . . . . 1.0 111.366 -177.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.772 HG12 ' HA ' ' A' ' 104' ' ' ALA . 10.5 p -80.21 120.25 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-O 120.905 0.383 . . . . 1.0 110.015 -175.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.593 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 31.5 mmm180 -138.86 149.18 44.59 Favored 'General case' 0 C--N 1.318 -0.761 0 O-C-N 121.864 -0.522 . . . . 1.0 110.361 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.596 ' HB2' ' HB2' ' A' ' 112' ' ' SER . 83.3 mmm -78.73 136.21 37.35 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.848 -0.614 . . . . 1.0 110.41 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.524 HD23 HG11 ' A' ' 87' ' ' VAL . 2.8 tm? -53.57 -53.8 46.51 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.494 0.188 . . . . 1.0 110.853 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.524 ' O ' ' HB3' ' A' ' 114' ' ' ASP . 5.8 ttt85 -73.88 -9.92 59.14 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.082 -0.647 . . . . 1.0 111.323 -176.408 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.596 ' HB2' ' HB2' ' A' ' 109' ' ' MET . 41.5 t -75.5 -6.01 48.05 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.775 -0.454 . . . . 1.0 109.775 178.444 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.575 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 96.9 m-85 -94.74 -12.7 26.68 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.526 0.679 . . . . 1.0 109.402 175.171 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.524 ' HB3' ' O ' ' A' ' 111' ' ' ARG . 6.0 t0 -72.36 131.66 84.69 Favored Pre-proline 0 N--CA 1.466 0.368 0 CA-C-N 114.97 -1.014 . . . . 1.0 111.533 -177.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.452 ' HD2' ' O ' ' A' ' 144' ' ' SER . 58.8 Cg_endo -70.38 -15.24 34.74 Favored 'Trans proline' 0 CA--C 1.532 0.415 0 C-N-CA 122.862 2.375 . . . . 1.0 112.095 177.042 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -90.47 -8.66 49.88 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.195 -0.457 . . . . 1.0 111.109 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.402 ' HB2' ' HB2' ' A' ' 121' ' ' ALA . 96.5 p -73.46 31.75 0.07 Allowed 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.058 0.392 . . . . 1.0 112.058 -177.452 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 61.47 -75.03 0.02 OUTLIER Glycine 0 CA--C 1.522 0.501 0 C-N-CA 119.938 -1.125 . . . . 1.0 112.742 -173.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.412 ' H ' ' H ' ' A' ' 120' ' ' HIS . 30.6 m -158.0 -28.26 0.08 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.367 0.603 . . . . 1.0 109.632 -179.498 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.412 ' H ' ' H ' ' A' ' 119' ' ' THR . 0.3 OUTLIER -154.37 141.67 19.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.538 -0.756 . . . . 1.0 110.879 -178.262 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.402 ' HB2' ' HB2' ' A' ' 117' ' ' SER . . . -129.13 99.87 5.41 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.749 -0.66 . . . . 1.0 110.08 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -96.8 16.22 19.8 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.893 0.377 . . . . 1.0 110.831 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -169.33 124.09 0.83 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.042 -0.527 . . . . 1.0 109.738 -178.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.597 ' HB ' ' O ' ' A' ' 89' ' ' LEU . 94.1 t -101.55 146.11 10.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.777 -0.647 . . . . 1.0 109.953 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -68.44 -163.11 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.562 0.696 . . . . 1.0 112.34 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.766 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 8.6 p-10 -162.59 171.72 6.18 Favored Pre-proline 0 C--N 1.323 -0.572 0 N-CA-C 108.219 -1.03 . . . . 1.0 108.219 -178.318 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.766 ' HD2' ' HB2' ' A' ' 126' ' ' ASP . 18.6 Cg_endo -55.62 145.47 70.03 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 121.952 1.768 . . . . 1.0 112.087 -178.396 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.413 ' HD2' ' CD2' ' A' ' 129' ' ' TYR . 74.3 t80 -107.74 -49.46 3.23 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.138 -0.937 . . . . 1.0 111.601 -176.054 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.413 ' CD2' ' HD2' ' A' ' 128' ' ' TYR . 0.1 OUTLIER -104.05 -67.43 0.9 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.205 0.526 . . . . 1.0 111.137 -178.208 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 128.38 57.35 0.11 Allowed Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 109.302 -1.519 . . . . 1.0 109.302 -176.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -141.71 176.17 9.12 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.243 -0.479 . . . . 1.0 110.837 -174.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.51 ' HA ' ' CD2' ' A' ' 135' ' ' PHE . 22.4 t-160 -52.66 -33.46 47.24 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.415 -0.811 . . . . 1.0 110.554 176.39 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 42.8 t -65.21 -42.38 93.57 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.89 -0.595 . . . . 1.0 111.184 178.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.29 -34.57 78.65 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.845 -0.162 . . . . 1.0 111.143 -176.026 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.51 ' CD2' ' HA ' ' A' ' 132' ' ' HIS . 2.9 m-85 -68.44 -50.76 50.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.379 0.609 . . . . 1.0 110.027 -179.153 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.517 ' HA ' ' HB3' ' A' ' 139' ' ' PHE . 16.2 mt-10 -75.74 -17.95 59.73 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.368 -0.833 . . . . 1.0 111.496 -176.452 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.574 ' O ' HG23 ' A' ' 141' ' ' VAL . 23.4 tp10 -64.42 -47.21 80.0 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 108.54 -0.911 . . . . 1.0 108.54 174.214 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.642 ' HA ' HG23 ' A' ' 141' ' ' VAL . 95.3 t -61.85 -40.5 87.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.9 -0.591 . . . . 1.0 109.746 176.357 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.546 ' HB2' HG11 ' A' ' 61' ' ' VAL . 13.5 t80 -52.75 -47.2 67.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.03 -0.986 . . . . 1.0 109.244 174.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.518 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -59.79 -43.06 94.62 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 115.351 -0.841 . . . . 1.0 110.228 177.279 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.642 HG23 ' HA ' ' A' ' 138' ' ' VAL . 8.2 t -54.54 -51.35 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 121.581 0.705 . . . . 1.0 110.505 177.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.698 HD13 ' HB3' ' A' ' 20' ' ' MET . 6.1 mt -66.16 -50.48 68.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 114.99 -1.005 . . . . 1.0 112.07 -178.378 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.518 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 8.8 pt-20 -56.06 -33.74 65.27 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.926 -0.398 . . . . 1.0 109.926 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.452 ' O ' ' HD2' ' A' ' 115' ' ' PRO . 70.7 m -72.48 -28.65 63.04 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.758 -0.655 . . . . 1.0 110.514 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.419 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -87.27 -22.37 25.22 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.172 -0.467 . . . . 1.0 111.85 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.646 HD13 ' HB3' ' A' ' 25' ' ' PHE . 12.8 mt -57.44 -37.47 57.24 Favored Pre-proline 0 CA--C 1.546 0.82 0 N-CA-C 112.656 0.613 . . . . 1.0 112.656 -178.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.64 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 48.0 Cg_endo -68.27 -12.07 33.88 Favored 'Trans proline' 0 C--N 1.365 1.44 0 C-N-CA 122.79 2.326 . . . . 1.0 111.665 177.537 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.575 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -103.88 -34.93 3.61 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 114.903 -1.044 . . . . 1.0 110.927 178.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.677 HD23 ' CE2' ' A' ' 25' ' ' PHE . 13.4 tp -75.77 -41.0 54.29 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.872 -0.788 . . . . 1.0 108.872 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.571 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 0.2 OUTLIER -53.92 -53.37 53.66 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 115.233 -0.894 . . . . 1.0 110.001 174.845 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -57.68 -43.76 85.32 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.871 -1.059 . . . . 1.0 110.679 -176.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' TRP . . . . . 0.745 ' HZ3' HD11 ' A' ' 5' ' ' LEU . 20.6 t90 -62.26 -55.78 25.0 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.395 -0.821 . . . . 1.0 110.486 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.452 HG11 HG21 ' A' ' 7' ' ' VAL . 12.6 m -62.02 -43.94 98.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 C-N-CA 120.72 -0.392 . . . . 1.0 111.091 -177.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.421 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 2.9 m-20 -59.81 -49.95 75.72 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 121.149 0.499 . . . . 1.0 110.76 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.623 ' O ' ' HG2' ' A' ' 159' ' ' ARG . 7.0 pt-20 -62.81 -39.23 93.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.626 -0.715 . . . . 1.0 110.554 -178.175 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.571 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 6.3 mmt85 -73.13 -47.35 44.87 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.871 -0.604 . . . . 1.0 111.13 -175.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 4.2 pp -62.2 -25.69 67.94 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.7 -0.682 . . . . 1.0 109.985 -178.698 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -73.81 -57.03 4.26 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.38 -0.827 . . . . 1.0 110.349 178.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.623 ' HG2' ' O ' ' A' ' 155' ' ' GLU . 3.6 ptp85 -76.08 -12.32 60.1 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.701 1.0 . . . . 1.0 113.701 -174.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -55.83 -41.6 74.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.955 0.407 . . . . 1.0 110.888 -176.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -103.81 -161.22 24.81 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.51 -0.853 . . . . 1.0 112.583 178.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -78.61 37.62 0.66 Allowed 'Trans proline' 0 N--CA 1.477 0.527 0 C-N-CA 123.691 2.927 . . . . 1.0 113.33 -178.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 15.1 t . . . . . 0 C--N 1.301 -1.53 0 CA-C-N 115.145 -0.934 . . . . 1.0 109.886 178.932 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.894 0 CA-C-O 119.81 -0.439 . . . . 1.0 112.427 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.2 ptp 45.52 41.58 6.98 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.773 0.829 . . . . 1.0 111.472 -178.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.8 m -164.64 111.01 1.01 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.304 -0.999 . . . . 1.0 108.304 -178.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.76 143.43 96.62 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-O 121.749 0.785 . . . . 1.0 111.997 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.569 ' HB2' ' HG2' ' A' ' 39' ' ' ARG . 26.0 Cg_endo -71.03 163.87 37.72 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 123.308 2.672 . . . . 1.0 113.58 -179.297 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.813 ' HB3' HG13 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -68.06 179.4 1.53 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.845 -1.07 . . . . 1.0 109.422 176.087 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.597 ' O ' ' HB1' ' A' ' 83' ' ' ALA . 2.3 t-160 -156.07 87.73 1.07 Allowed 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.878 -0.416 . . . . 1.0 109.878 -179.26 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.818 HG13 HD13 ' A' ' 85' ' ' LEU . 2.2 t -93.12 108.99 21.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 109.4 -0.593 . . . . 1.0 109.4 178.236 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.679 ' CG2' HD23 ' A' ' 86' ' ' LEU . 10.0 t -110.76 111.44 22.62 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.949 0.404 . . . . 1.0 110.635 179.041 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.615 ' HD1' ' HB ' ' A' ' 87' ' ' VAL . 1.3 m-85 -82.22 136.71 35.05 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.705 -0.479 . . . . 1.0 109.705 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.674 HG21 HD21 ' A' ' 97' ' ' LEU . 47.8 t -124.57 115.29 44.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.018 0.437 . . . . 1.0 111.461 -177.215 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.554 ' HB2' HD23 ' A' ' 89' ' ' LEU . 44.7 t -146.52 153.14 40.05 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.957 -0.565 . . . . 1.0 110.091 178.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -71.31 98.45 1.76 Allowed 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.902 -0.407 . . . . 1.0 109.902 178.196 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 142.68 -40.59 1.25 Allowed Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 110.623 -0.991 . . . . 1.0 110.623 -178.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.853 HD21 ' HA3' ' A' ' 44' ' ' GLY . 0.7 OUTLIER 49.37 23.45 0.86 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.601 1.16 . . . . 1.0 113.228 177.983 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.7 pt -140.83 9.44 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.288 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.478 177.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.482 ' O ' ' HG2' ' A' ' 20' ' ' MET . 5.1 p -122.41 -87.57 0.63 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.719 -0.673 . . . . 1.0 111.782 -176.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.434 HH11 ' HD3' ' A' ' 17' ' ' ARG . 7.3 mmm-85 -67.2 -48.69 67.16 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 121.124 0.488 . . . . 1.0 111.25 -175.32 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.905 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 13.1 m -52.48 -58.28 12.36 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-N 115.063 -0.971 . . . . 1.0 112.396 -179.318 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.638 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 56.8 Cg_endo -67.06 -23.43 46.29 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 121.842 1.694 . . . . 1.0 112.914 -178.227 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.581 ' HB3' HD13 ' A' ' 142' ' ' ILE . 51.8 mmm -59.65 -57.11 14.36 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.906 -0.405 . . . . 1.0 109.906 178.605 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.438 ' HB2' ' CG2' ' A' ' 142' ' ' ILE . . . -73.5 -27.15 61.22 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.57 -0.741 . . . . 1.0 110.645 -179.176 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.65 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 13.0 tt0 -52.82 -52.84 55.4 Favored 'General case' 0 C--O 1.215 -0.737 0 O-C-N 123.907 0.755 . . . . 1.0 109.946 -179.221 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.997 ' HE3' ' HB2' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -85.09 -25.81 27.33 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.837 -0.619 . . . . 1.0 110.777 -176.462 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.532 ' HB3' HD11 ' A' ' 146' ' ' LEU . 88.1 mtp -63.33 -74.59 0.09 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.564 0.579 . . . . 1.0 112.564 -177.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.732 ' HB3' HD22 ' A' ' 146' ' ' LEU . 17.2 p90 -76.81 -30.7 56.51 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 119.64 -0.824 . . . . 1.0 111.711 -176.003 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.65 ' HB3' ' O ' ' A' ' 22' ' ' GLU . . . -64.61 -37.51 87.82 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 119.284 -0.966 . . . . 1.0 111.172 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.611 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -63.32 -39.09 93.6 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 108.367 -0.975 . . . . 1.0 108.367 176.461 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.567 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 79.7 mt-30 -59.61 -42.49 92.74 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.562 -0.745 . . . . 1.0 110.172 175.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.646 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 88.8 mt -56.34 -61.13 2.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.947 -0.569 . . . . 1.0 110.719 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.501 ' HB3' ' HA3' ' A' ' 35' ' ' GLY . 0.2 OUTLIER -58.92 -35.78 73.66 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.778 -0.369 . . . . 1.0 111.382 178.642 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 3.1 m170 -63.23 -24.89 68.07 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.26 0.467 . . . . 1.0 112.26 177.103 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.646 ' HG2' ' O ' ' A' ' 29' ' ' LEU . 5.9 ptm85 -100.05 -20.18 16.16 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.442 0.639 . . . . 1.0 110.299 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 110.98 35.02 2.06 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.196 -0.911 . . . . 1.0 112.277 177.034 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.472 ' HG ' ' HG3' ' A' ' 32' ' ' ARG . 21.6 mt -128.33 3.89 5.72 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.877 -0.416 . . . . 1.0 109.877 -179.322 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.501 ' HA3' ' HB3' ' A' ' 30' ' ' ARG . . . -59.17 -31.44 69.2 Favored Glycine 0 C--O 1.229 -0.217 0 CA-C-N 115.777 -0.647 . . . . 1.0 113.383 -178.248 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.441 ' O ' ' HB3' ' A' ' 4' ' ' PRO . 3.3 t0 -86.98 -26.05 24.0 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 109.072 -0.714 . . . . 1.0 109.072 177.331 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.11 -20.82 47.72 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 114.558 -1.201 . . . . 1.0 110.795 -175.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.813 HG13 ' HB3' ' A' ' 5' ' ' LEU . 37.9 t -133.1 122.68 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 CA-C-N 116.393 -0.367 . . . . 1.0 110.207 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.569 ' HG2' ' HB2' ' A' ' 4' ' ' PRO . 11.9 mmt180 -89.78 133.32 34.76 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.04 -1.096 . . . . 1.0 108.04 175.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.458 HG11 ' HB2' ' A' ' 26' ' ' ALA . 45.5 t -127.53 115.58 40.5 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-O 121.375 0.607 . . . . 1.0 109.985 -178.011 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' A' ' 8' ' ' THR . 67.3 p -130.53 -175.51 3.67 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.461 -1.245 . . . . 1.0 110.427 -175.216 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.905 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 85.4 p -159.86 165.08 32.98 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 110.004 -0.369 . . . . 1.0 110.004 178.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.545 ' O ' ' HA ' ' A' ' 10' ' ' VAL . . . -164.57 166.85 19.92 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 120.944 0.402 . . . . 1.0 110.775 -179.476 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.853 ' HA3' HD21 ' A' ' 14' ' ' ASN . . . -125.96 138.96 11.12 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 111.257 -0.737 . . . . 1.0 111.257 177.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.526 HG21 HD12 ' A' ' 96' ' ' LEU . 21.4 p -72.86 -25.21 61.02 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.722 0.296 . . . . 1.0 111.339 -178.249 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.465 ' HA3' ' HZ3' ' A' ' 48' ' ' TRP . . . -107.85 9.49 37.28 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.97 -0.633 . . . . 1.0 113.34 -177.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 45.43 36.25 2.32 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 113.719 1.007 . . . . 1.0 113.719 176.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.465 ' HZ3' ' HA3' ' A' ' 46' ' ' GLY . 1.2 m-90 -44.53 -78.82 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.592 0.711 . . . . 1.0 112.376 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.407 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 8.2 m-70 -104.87 41.1 1.38 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.06 -0.973 . . . . 1.0 111.325 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.421 HG23 ' HA ' ' A' ' 74' ' ' ALA . 14.0 p -59.77 128.05 20.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.538 -0.301 . . . . 1.0 110.473 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.73 -13.5 67.35 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 121.071 -0.585 . . . . 1.0 112.202 -178.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.8 t -80.77 -161.79 0.42 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.321 0.582 . . . . 1.0 110.015 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 20.2 t -122.87 176.29 6.08 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.103 -1.073 . . . . 1.0 108.103 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.28 140.54 55.91 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.752 0.31 . . . . 1.0 110.56 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.41 ' OD1' ' HG2' ' A' ' 57' ' ' ARG . 9.8 t70 -59.12 140.2 56.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.86 -0.609 . . . . 1.0 111.079 -176.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -47.56 -37.1 11.61 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.485 -0.779 . . . . 1.0 112.873 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.41 ' HG2' ' OD1' ' A' ' 55' ' ' ASP . 11.5 ptp180 -73.83 -39.52 63.98 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 122.06 -0.4 . . . . 1.0 111.159 -177.065 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.92 -37.35 72.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.196 0.522 . . . . 1.0 110.06 178.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.41 -41.47 98.73 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.684 -0.689 . . . . 1.0 109.617 177.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.92 -48.09 81.64 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 115.687 -0.688 . . . . 1.0 112.679 178.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 23.6 m -72.17 -37.28 59.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 117.469 0.635 . . . . 1.0 111.614 -178.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.495 ' CD2' ' HG3' ' A' ' 23' ' ' LYS . 1.3 mp -62.05 -54.87 35.38 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.877 -0.329 . . . . 1.0 110.185 178.094 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -60.31 -32.79 71.55 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.862 -0.608 . . . . 1.0 110.911 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.47 -32.25 72.96 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-O 121.144 0.497 . . . . 1.0 111.192 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -98.11 5.85 48.18 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.961 -0.563 . . . . 1.0 111.515 -178.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 90.71 11.98 61.34 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 115.977 -0.556 . . . . 1.0 113.429 175.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.444 ' HD1' ' HG2' ' A' ' 27' ' ' GLN . 54.7 m-85 -92.67 151.01 40.66 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-O 120.624 0.25 . . . . 1.0 111.157 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.661 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 44.6 Cg_endo -70.22 158.93 54.82 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.19 1.926 . . . . 1.0 110.528 175.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 30.6 p -129.98 8.46 5.22 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.728 0.775 . . . . 1.0 109.823 -177.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -73.0 120.2 18.31 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.661 -1.154 . . . . 1.0 110.076 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.997 ' HB2' ' HE3' ' A' ' 23' ' ' LYS . 31.9 t60 -164.81 150.95 10.31 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.433 -0.349 . . . . 1.0 110.596 -175.331 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -132.29 111.26 11.22 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 108.489 -0.93 . . . . 1.0 108.489 175.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.512 ' HB1' ' OD1' ' A' ' 14' ' ' ASN . . . -59.47 141.53 54.5 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.211 -0.904 . . . . 1.0 112.606 -175.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.421 ' HA ' HG23 ' A' ' 50' ' ' VAL . . . -134.52 165.73 24.53 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.8 -0.637 . . . . 1.0 109.845 177.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -101.64 160.79 14.15 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.156 -0.683 . . . . 1.0 109.156 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 86.5 t -65.45 106.07 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.073 0.463 . . . . 1.0 110.88 179.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.464 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -120.77 -175.08 15.21 Favored Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 115.588 -0.733 . . . . 1.0 111.772 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 77.2 m -57.09 -49.45 75.82 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 122.742 0.417 . . . . 1.0 111.826 -178.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.444 ' HG2' ' N ' ' A' ' 80' ' ' HIS . 3.2 pm0 -57.33 -31.06 65.32 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.11 0.481 . . . . 1.0 111.062 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.444 ' N ' ' HG2' ' A' ' 79' ' ' GLU . 80.3 m80 -76.07 -41.55 50.21 Favored 'General case' 0 C--O 1.222 -0.356 0 CA-C-N 115.871 -0.604 . . . . 1.0 109.824 178.656 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 40.8 mt -66.1 -19.77 65.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.848 178.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.75 -6.26 59.14 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.92 -178.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.597 ' HB1' ' O ' ' A' ' 6' ' ' HIS . . . -60.33 148.56 36.53 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.399 -0.819 . . . . 1.0 111.756 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.691 ' HB3' HD13 ' A' ' 5' ' ' LEU . 15.5 t70 -74.46 -13.5 60.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.886 -0.597 . . . . 1.0 109.996 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.818 HD13 HG13 ' A' ' 7' ' ' VAL . 0.9 OUTLIER -154.37 122.76 6.1 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.685 -0.689 . . . . 1.0 110.198 -178.525 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 1.066 HD11 HG11 ' A' ' 102' ' ' VAL . 0.2 OUTLIER -108.15 105.0 14.53 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.904 -0.776 . . . . 1.0 108.904 174.653 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.615 ' HB ' ' HD1' ' A' ' 9' ' ' PHE . 53.7 t -84.31 91.27 2.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.663 0.744 . . . . 1.0 110.803 -178.398 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.93 147.0 30.49 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.434 -0.803 . . . . 1.0 111.207 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.554 HD23 ' HB2' ' A' ' 11' ' ' CYS . 4.2 mm? -100.79 -5.53 26.17 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.546 -0.752 . . . . 1.0 109.558 178.55 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -148.04 145.24 28.39 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.068 -0.969 . . . . 1.0 110.277 -178.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.436 ' HB3' ' O ' ' A' ' 122' ' ' LEU . 13.2 ptt180 -55.6 -26.28 43.03 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.418 0.687 . . . . 1.0 111.191 177.456 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.685 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 80.3 m-20 -75.21 -49.28 19.89 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.719 -0.673 . . . . 1.0 109.911 -178.153 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.466 ' HB3' HG12 ' A' ' 10' ' ' VAL . 11.8 m170 -58.19 -43.48 87.56 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 115.808 -0.633 . . . . 1.0 109.369 179.32 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.473 ' HA ' HG21 ' A' ' 107' ' ' VAL . . . -59.67 -47.12 86.88 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.915 -0.584 . . . . 1.0 110.718 178.627 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 13.2 ttm180 -59.59 -39.53 84.48 Favored 'General case' 0 CA--C 1.521 -0.143 0 CA-C-N 115.792 -0.64 . . . . 1.0 111.405 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.746 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 55.6 mt -66.14 -50.68 63.12 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 116.499 -0.319 . . . . 1.0 110.359 -177.377 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.674 HD21 HG21 ' A' ' 10' ' ' VAL . 14.2 mt -53.51 -56.35 17.75 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.858 -0.61 . . . . 1.0 111.452 -179.013 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 13.3 ptt85 -62.46 -43.9 97.7 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.161 -0.472 . . . . 1.0 111.844 -177.264 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.589 ' HG3' ' O ' ' A' ' 96' ' ' LEU . 0.9 OUTLIER -66.35 -22.22 66.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.378 0.608 . . . . 1.0 110.103 179.536 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.746 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 10.0 mt -77.87 -13.21 59.96 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.348 -0.842 . . . . 1.0 111.761 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 154.62 -33.52 0.69 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.003 -1.094 . . . . 1.0 113.279 -179.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 1.066 HG11 HD11 ' A' ' 86' ' ' LEU . 0.8 OUTLIER -76.36 -152.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.697 0.761 . . . . 1.0 112.221 -176.969 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.636 ' H ' HG12 ' A' ' 102' ' ' VAL . 11.4 pt-20 -164.72 167.32 19.14 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.449 -0.796 . . . . 1.0 109.125 -177.091 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.808 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -67.18 -23.26 65.74 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.231 -0.441 . . . . 1.0 111.81 -175.176 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.12 -34.76 70.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.361 0.601 . . . . 1.0 110.578 176.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.544 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 8.0 mtp180 -98.83 -40.93 7.87 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 115.475 -0.784 . . . . 1.0 110.825 -178.551 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.808 HG12 ' HA ' ' A' ' 104' ' ' ALA . 9.3 p -80.2 121.62 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-O 121.719 0.771 . . . . 1.0 110.721 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.508 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 21.1 mmm180 -138.05 150.07 46.59 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.808 -0.633 . . . . 1.0 110.177 -178.554 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.586 ' HB2' ' HB2' ' A' ' 112' ' ' SER . 81.7 mmm -78.45 138.86 38.68 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.619 -0.719 . . . . 1.0 109.715 178.682 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.549 HD23 HG11 ' A' ' 87' ' ' VAL . 3.0 tm? -55.68 -49.03 74.05 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.621 0.248 . . . . 1.0 110.765 179.01 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 111' ' ' ARG . 18.4 ttt85 -71.46 -14.28 62.09 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.87 0.367 . . . . 1.0 110.662 -178.522 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.586 ' HB2' ' HB2' ' A' ' 109' ' ' MET . 26.4 t -70.88 -14.02 62.24 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.482 -0.326 . . . . 1.0 110.403 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.56 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 98.7 m-85 -90.39 -15.37 31.14 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 120.95 0.405 . . . . 1.0 110.44 177.56 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.405 ' HB3' ' HB2' ' A' ' 117' ' ' SER . 13.5 t0 -72.4 124.12 90.39 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.785 -0.643 . . . . 1.0 111.206 -177.045 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.62 -15.77 33.91 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 122.573 2.182 . . . . 1.0 112.45 178.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 -92.66 -13.11 29.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.156 -0.474 . . . . 1.0 110.613 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.405 ' HB2' ' HB3' ' A' ' 114' ' ' ASP . 46.3 t -71.79 60.5 0.37 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.898 -0.592 . . . . 1.0 112.109 -178.303 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 48.74 -98.55 0.02 OUTLIER Glycine 0 C--N 1.334 0.471 0 C-N-CA 121.307 -0.473 . . . . 1.0 113.108 -178.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 25.9 m -132.07 -40.97 1.02 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.108 0.48 . . . . 1.0 110.326 178.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -151.05 154.6 37.32 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.117 0.484 . . . . 1.0 111.237 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.523 ' O ' HD13 ' A' ' 122' ' ' LEU . . . -107.53 172.3 6.91 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 115.141 -0.936 . . . . 1.0 109.714 177.301 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.523 HD13 ' O ' ' A' ' 121' ' ' ALA . 0.6 OUTLIER -160.2 -17.29 0.06 Allowed 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.041 -1.436 . . . . 1.0 109.759 -175.796 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -167.12 134.94 2.52 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.169 -1.048 . . . . 1.0 108.169 -176.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 67.1 t -96.91 147.45 6.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 110.031 -0.359 . . . . 1.0 110.031 -177.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -63.82 179.57 0.49 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.412 0.625 . . . . 1.0 112.543 -177.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.418 ' OD1' ' HD2' ' A' ' 127' ' ' PRO . 6.3 t70 -152.51 138.43 11.71 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 114.723 -1.126 . . . . 1.0 108.102 -174.702 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.418 ' HD2' ' OD1' ' A' ' 126' ' ' ASP . 84.7 Cg_exo -42.4 150.34 0.27 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 123.099 2.533 . . . . 1.0 112.937 -178.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.414 ' HD2' ' HD2' ' A' ' 129' ' ' TYR . 62.3 t80 -98.22 -32.56 11.51 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.306 -0.861 . . . . 1.0 110.821 -174.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.414 ' HD2' ' HD2' ' A' ' 128' ' ' TYR . 0.8 OUTLIER -137.04 -23.16 1.16 Allowed 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 120.909 -0.316 . . . . 1.0 111.175 178.384 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 86.06 71.22 1.31 Allowed Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.257 -0.973 . . . . 1.0 111.611 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -139.92 -174.43 3.91 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.503 -0.555 . . . . 1.0 109.503 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -55.98 -41.06 74.2 Favored 'General case' 0 C--N 1.323 -0.58 0 O-C-N 123.524 0.515 . . . . 1.0 110.994 -178.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 49.4 m -63.35 -50.26 70.68 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.894 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -56.66 -33.53 66.46 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.149 0.426 . . . . 1.0 112.149 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 15.9 m-30 -70.29 -46.24 64.7 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.962 0.41 . . . . 1.0 110.49 -178.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -78.48 -20.11 51.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 1.0 111.34 -178.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.575 ' O ' HG23 ' A' ' 141' ' ' VAL . 11.1 tp10 -63.6 -48.37 77.64 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.588 -0.893 . . . . 1.0 108.588 175.499 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.663 ' HA ' HG23 ' A' ' 141' ' ' VAL . 54.6 t -60.85 -41.43 88.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.095 -0.957 . . . . 1.0 109.941 176.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -53.55 -42.17 67.23 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.912 -1.04 . . . . 1.0 109.203 176.221 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.76 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -66.95 -40.21 87.48 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.278 -0.874 . . . . 1.0 110.635 177.549 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.663 HG23 ' HA ' ' A' ' 138' ' ' VAL . 10.7 t -55.58 -49.96 70.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.65 0.738 . . . . 1.0 110.167 178.136 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.581 HD13 ' HB3' ' A' ' 20' ' ' MET . 6.2 mt -67.78 -49.79 66.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 114.996 -1.002 . . . . 1.0 111.825 -178.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.76 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 5.3 pt-20 -57.49 -28.3 63.3 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.905 0.383 . . . . 1.0 110.062 178.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.9 t -75.11 -28.19 60.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.06 177.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.469 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -86.52 -23.71 25.79 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-N 116.246 -0.434 . . . . 1.0 111.644 178.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.732 HD22 ' HB3' ' A' ' 25' ' ' PHE . 14.2 mt -56.83 -35.93 40.97 Favored Pre-proline 0 CA--C 1.546 0.798 0 CA-C-O 118.943 -0.551 . . . . 1.0 112.452 -178.157 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.635 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 37.6 Cg_endo -67.63 -12.75 36.66 Favored 'Trans proline' 0 C--N 1.365 1.402 0 C-N-CA 122.543 2.162 . . . . 1.0 111.494 177.028 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.56 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -104.52 -34.12 3.68 Favored Glycine 0 N--CA 1.44 -1.065 0 CA-C-N 114.995 -1.002 . . . . 1.0 110.611 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.558 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.4 OUTLIER -75.24 -40.9 58.53 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 108.9 -0.778 . . . . 1.0 108.9 179.318 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.434 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 1.1 m-70 -54.33 -52.87 60.17 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.187 -0.915 . . . . 1.0 110.244 175.137 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -60.01 -44.1 94.78 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.67 -0.695 . . . . 1.0 110.946 -176.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' TRP . . . . . 0.775 ' HZ3' HD11 ' A' ' 5' ' ' LEU . 26.4 t90 -60.56 -55.23 35.88 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.491 -0.777 . . . . 1.0 110.697 -178.665 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.411 HG13 ' O ' ' A' ' 149' ' ' LEU . 11.7 m -60.67 -39.71 82.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 121.071 -0.252 . . . . 1.0 110.772 -178.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.537 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 4.6 m-20 -59.49 -54.9 41.23 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.271 0.558 . . . . 1.0 110.975 178.692 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 6.6 pt-20 -62.28 -33.95 75.64 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.506 -0.77 . . . . 1.0 110.465 -178.237 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.745 ' O ' ' HG2' ' A' ' 159' ' ' ARG . 18.5 mmt-85 -74.38 -42.6 59.03 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.759 -0.655 . . . . 1.0 111.711 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 4.5 pp -67.89 -23.98 65.17 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.505 -0.554 . . . . 1.0 109.505 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -73.39 -42.28 62.33 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.29 -0.868 . . . . 1.0 110.273 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.745 ' HG2' ' O ' ' A' ' 156' ' ' ARG . 14.2 ptt-85 -71.64 -24.39 61.85 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 116.066 -0.516 . . . . 1.0 111.401 -178.629 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -62.85 -47.42 83.44 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 120.434 -0.506 . . . . 1.0 111.105 -172.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -87.52 160.56 31.7 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 118.557 -1.782 . . . . 1.0 112.609 174.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -92.58 27.86 0.36 Allowed 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 123.349 2.7 . . . . 1.0 113.383 -178.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 12.0 t . . . . . 0 C--N 1.301 -1.525 0 CA-C-N 115.132 -0.94 . . . . 1.0 109.979 -179.665 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.738 0 N-CA-C 111.369 -0.692 . . . . 1.0 111.369 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.7 ptp -80.89 34.35 0.34 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.009 0.433 . . . . 1.0 111.031 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.7 p -164.82 162.38 20.93 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.894 -0.593 . . . . 1.0 109.881 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -166.07 160.93 12.89 Favored Pre-proline 0 C--N 1.321 -0.671 0 N-CA-C 109.308 -0.627 . . . . 1.0 109.308 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.459 ' HB2' ' HG2' ' A' ' 39' ' ' ARG . 36.4 Cg_endo -66.02 165.49 23.78 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.754 2.303 . . . . 1.0 112.939 -178.058 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.785 ' HB3' HG23 ' A' ' 38' ' ' VAL . 0.6 OUTLIER -70.99 -174.18 0.91 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.322 -0.854 . . . . 1.0 110.989 -179.388 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.612 ' HB3' ' HA ' ' A' ' 83' ' ' ALA . 2.7 t-160 -156.51 104.83 2.21 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.468 -0.333 . . . . 1.0 110.659 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.671 HG13 HD13 ' A' ' 85' ' ' LEU . 2.8 t -105.16 119.47 54.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 107.32 -1.363 . . . . 1.0 107.32 175.018 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.591 HG22 ' HG ' ' A' ' 86' ' ' LEU . 8.2 t -121.74 114.01 20.51 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 120.44 -0.504 . . . . 1.0 110.484 179.276 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.677 ' HD2' ' HB3' ' A' ' 42' ' ' SER . 1.5 m-85 -83.15 127.35 33.53 Favored 'General case' 0 CA--C 1.512 -0.491 0 O-C-N 122.004 -0.435 . . . . 1.0 110.6 -179.144 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.643 HG21 HD21 ' A' ' 97' ' ' LEU . 23.8 t -111.39 111.76 37.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.008 0.432 . . . . 1.0 111.633 -176.194 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.569 ' HB2' HD23 ' A' ' 89' ' ' LEU . 42.2 t -141.24 155.98 45.95 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.331 179.227 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.42 92.59 0.61 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.103 0.478 . . . . 1.0 110.776 179.194 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.835 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 132.57 -41.92 1.44 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.791 -0.718 . . . . 1.0 111.869 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.464 HD21 ' CB ' ' A' ' 42' ' ' SER . 3.6 t-20 62.17 18.74 10.35 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.454 0.645 . . . . 1.0 111.766 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.2 pt -127.25 11.8 3.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 O-C-N 121.542 -0.724 . . . . 1.0 112.165 -176.263 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.719 ' O ' ' HG3' ' A' ' 20' ' ' MET . 80.5 m -126.6 -89.96 0.54 Allowed 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.122 -0.631 . . . . 1.0 111.852 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.446 ' H ' ' HG2' ' A' ' 17' ' ' ARG . 0.9 OUTLIER -74.4 -30.13 61.82 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.674 0.62 . . . . 1.0 112.674 -175.819 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.658 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 17.2 m -62.46 -58.91 14.58 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 121.04 -0.264 . . . . 1.0 110.841 178.356 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.745 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 35.2 Cg_endo -62.78 -25.79 74.82 Favored 'Trans proline' 0 C--N 1.357 0.978 0 C-N-CA 122.213 1.942 . . . . 1.0 111.983 179.429 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.719 ' HG3' ' O ' ' A' ' 16' ' ' CYS . 71.3 mtp -61.85 -52.85 62.44 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.849 -0.34 . . . . 1.0 110.809 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.424 ' HA ' ' HB2' ' A' ' 24' ' ' MET . . . -74.16 -27.17 60.7 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.577 -0.449 . . . . 1.0 110.108 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.687 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 7.9 tt0 -55.88 -49.78 72.44 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 115.159 -0.928 . . . . 1.0 109.302 179.254 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.916 ' HB3' ' HG2' ' A' ' 68' ' ' PRO . 0.0 OUTLIER -80.79 -32.15 35.46 Favored 'General case' 0 C--N 1.32 -0.691 0 O-C-N 121.825 -0.547 . . . . 1.0 110.002 -177.155 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.651 ' HB3' HD11 ' A' ' 146' ' ' LEU . 2.3 mmm -61.56 -76.15 0.06 Allowed 'General case' 0 C--O 1.236 0.362 0 N-CA-C 112.928 0.714 . . . . 1.0 112.928 -176.006 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.678 ' HB3' HD22 ' A' ' 146' ' ' LEU . 16.5 p90 -76.84 -30.36 56.28 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 119.645 -0.822 . . . . 1.0 111.749 -174.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.687 ' HB3' ' O ' ' A' ' 22' ' ' GLU . . . -63.87 -37.75 88.55 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 119.082 -1.047 . . . . 1.0 110.894 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.687 ' HA ' ' HD3' ' A' ' 30' ' ' ARG . 0.8 OUTLIER -65.82 -37.71 86.99 Favored 'General case' 0 C--N 1.333 -0.13 0 N-CA-C 108.955 -0.758 . . . . 1.0 108.955 177.836 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.546 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 79.3 mt-30 -58.8 -42.09 88.28 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.114 175.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.659 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 85.9 mt -56.02 -60.54 3.34 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.706 -0.679 . . . . 1.0 110.578 179.575 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.687 ' HD3' ' HA ' ' A' ' 27' ' ' GLN . 0.7 OUTLIER -58.94 -37.69 77.3 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.59 -0.277 . . . . 1.0 111.168 179.254 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -60.93 -25.31 66.69 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.252 0.464 . . . . 1.0 112.252 177.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.659 ' HG2' ' O ' ' A' ' 29' ' ' LEU . 3.6 ptm180 -100.71 -18.94 16.27 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 119.602 -0.839 . . . . 1.0 110.418 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 108.04 36.04 2.43 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.236 -0.893 . . . . 1.0 112.502 176.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 23.2 mt -130.08 -3.62 4.5 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 122.625 -0.338 . . . . 1.0 110.535 -178.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.415 ' H ' ' HA ' ' A' ' 30' ' ' ARG . . . -59.5 -25.93 61.41 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 121.126 -0.559 . . . . 1.0 112.488 -179.282 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -80.06 -32.08 39.4 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.511 0.672 . . . . 1.0 109.847 177.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.74 -18.36 51.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.814 -1.085 . . . . 1.0 112.759 -175.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.785 HG23 ' HB3' ' A' ' 5' ' ' LEU . 0.8 OUTLIER -145.02 128.97 12.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.107 0.479 . . . . 1.0 110.869 -178.837 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.459 ' HG2' ' HB2' ' A' ' 4' ' ' PRO . 9.3 mmm180 -94.12 140.75 29.36 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.639 -0.709 . . . . 1.0 110.168 -178.105 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.436 HG11 ' HB2' ' A' ' 26' ' ' ALA . 77.9 t -127.77 120.0 53.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-O 121.659 0.743 . . . . 1.0 109.633 -178.435 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.541 ' O ' ' HA ' ' A' ' 8' ' ' THR . 69.3 p -136.05 -174.54 3.7 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.135 -1.393 . . . . 1.0 109.933 -175.201 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.677 ' HB3' ' HD2' ' A' ' 9' ' ' PHE . 84.4 p -162.69 167.32 23.28 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 116.485 -0.325 . . . . 1.0 110.49 179.022 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.583 ' HB2' ' CD2' ' A' ' 80' ' ' HIS . . . -162.83 166.7 23.79 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.578 0.704 . . . . 1.0 111.727 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.456 ' HA2' ' O ' ' A' ' 11' ' ' CYS . . . -124.87 131.34 7.74 Favored Glycine 0 N--CA 1.443 -0.86 0 CA-C-N 114.785 -1.098 . . . . 1.0 111.252 178.491 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.521 HG21 HD12 ' A' ' 96' ' ' LEU . 40.9 p -70.11 -27.49 64.63 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.985 0.421 . . . . 1.0 111.108 -178.222 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -102.28 5.93 52.85 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 121.069 -0.586 . . . . 1.0 113.161 -176.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 44.19 34.6 1.03 Allowed 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 114.269 1.211 . . . . 1.0 114.269 176.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.835 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 0.9 OUTLIER -46.75 -72.62 0.05 Allowed 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.638 0.732 . . . . 1.0 112.494 -179.846 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -107.75 42.58 1.32 Allowed 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.045 -0.979 . . . . 1.0 111.016 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.2 p -62.84 128.48 24.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.098 0.475 . . . . 1.0 110.284 178.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.48 -13.56 67.28 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.761 -0.733 . . . . 1.0 111.828 -177.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.4 t -80.66 -158.74 0.2 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.063 0.459 . . . . 1.0 110.036 178.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 21.6 t -131.15 174.69 9.78 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.117 -1.068 . . . . 1.0 108.117 -179.014 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.2 137.31 47.4 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.713 0.292 . . . . 1.0 111.032 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.718 ' OD1' ' HG2' ' A' ' 57' ' ' ARG . 11.3 t70 -62.66 140.64 58.71 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 115.881 -0.599 . . . . 1.0 110.145 -177.565 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -51.53 -30.4 20.26 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 113.341 0.867 . . . . 1.0 113.341 -178.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.718 ' HG2' ' OD1' ' A' ' 55' ' ' ASP . 3.9 ptp180 -70.99 -44.4 66.02 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 118.351 0.523 . . . . 1.0 110.769 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.69 -35.82 70.38 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.739 -0.664 . . . . 1.0 109.583 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.84 -44.22 96.73 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.402 -0.817 . . . . 1.0 109.472 177.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.44 ' O ' ' HG2' ' A' ' 63' ' ' ARG . . . -56.75 -45.92 90.33 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.95 -0.643 . . . . 1.0 113.301 178.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.1 m -73.29 -38.62 54.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 117.793 0.797 . . . . 1.0 111.478 -178.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.667 HD21 ' HA ' ' A' ' 20' ' ' MET . 5.6 mp -62.17 -53.29 57.35 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.85 -0.34 . . . . 1.0 110.556 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.44 ' HG2' ' O ' ' A' ' 60' ' ' GLY . 11.6 ptm180 -59.98 -28.37 67.63 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.952 -0.567 . . . . 1.0 111.377 179.162 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.39 -30.27 65.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.22 0.533 . . . . 1.0 110.738 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -96.83 4.76 51.53 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.872 -0.604 . . . . 1.0 110.526 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.62 13.41 65.18 Favored Glycine 0 C--N 1.331 0.257 0 CA-C-N 115.681 -0.691 . . . . 1.0 113.087 176.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -92.06 150.84 41.18 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-O 120.498 0.19 . . . . 1.0 110.882 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.916 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 39.3 Cg_endo -67.8 155.79 68.51 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.395 2.063 . . . . 1.0 110.612 176.166 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 57.0 p -130.86 10.74 5.08 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 120.262 -0.575 . . . . 1.0 111.834 -176.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -97.32 136.5 37.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.915 0.388 . . . . 1.0 110.853 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.712 ' HB3' ' HE3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -178.98 162.55 1.26 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.523 -1.288 . . . . 1.0 107.523 177.729 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -121.56 120.82 35.93 Favored 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 119.548 -0.861 . . . . 1.0 108.871 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.03 140.67 56.66 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.763 -0.653 . . . . 1.0 111.288 -177.154 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.43 ' O ' ' HA ' ' A' ' 43' ' ' ALA . . . -134.65 151.07 50.77 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.907 -0.588 . . . . 1.0 110.132 179.401 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -87.57 153.31 21.5 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.644 -0.872 . . . . 1.0 108.644 177.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.567 HG11 HD23 ' A' ' 97' ' ' LEU . 21.7 t -63.91 114.2 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.217 0.532 . . . . 1.0 110.506 -179.166 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.447 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -125.27 -169.31 12.9 Favored Glycine 0 N--CA 1.442 -0.948 0 CA-C-N 115.129 -0.941 . . . . 1.0 111.279 179.299 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 51.9 m -59.86 -43.72 94.53 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.453 0.168 . . . . 1.0 111.196 -178.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -59.09 -31.34 68.81 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 120.952 0.406 . . . . 1.0 111.249 177.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.583 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 78.6 m80 -76.52 -40.69 49.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.497 -0.32 . . . . 1.0 110.276 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.724 ' HA ' HD21 ' A' ' 86' ' ' LEU . 14.6 mt -70.18 -17.09 63.15 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 120.774 0.321 . . . . 1.0 110.444 177.387 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.73 -7.09 58.99 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 120.777 0.322 . . . . 1.0 110.223 -179.11 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.612 ' HA ' ' HB3' ' A' ' 6' ' ' HIS . . . -58.45 149.23 25.62 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.961 -0.563 . . . . 1.0 110.922 178.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.555 ' HA ' ' HE ' ' A' ' 106' ' ' ARG . 32.1 t70 -75.49 -16.19 60.33 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.179 0.514 . . . . 1.0 109.739 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.671 HD13 HG13 ' A' ' 7' ' ' VAL . 0.6 OUTLIER -152.73 117.68 5.13 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.205 -0.907 . . . . 1.0 109.043 -177.688 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.724 HD21 ' HA ' ' A' ' 81' ' ' LEU . 4.9 mp -108.06 104.23 13.62 Favored 'General case' 0 N--CA 1.424 -1.758 0 CA-C-N 115.824 -0.625 . . . . 1.0 109.535 178.337 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.582 ' HB ' ' HD1' ' A' ' 9' ' ' PHE . 52.9 t -83.32 90.58 2.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.01 -0.996 . . . . 1.0 110.757 -175.817 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.63 146.06 34.31 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.484 -0.78 . . . . 1.0 110.441 179.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.569 HD23 ' HB2' ' A' ' 11' ' ' CYS . 4.1 mm? -95.33 -8.63 35.24 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.335 0.588 . . . . 1.0 109.592 178.08 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -151.18 154.61 37.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.451 -0.795 . . . . 1.0 111.18 178.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 13.5 ptt180 -61.63 -20.02 62.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.42 -0.809 . . . . 1.0 111.523 177.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.664 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 4.2 m-20 -75.2 -51.9 12.22 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.044 -0.725 . . . . 1.0 109.044 179.544 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.554 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 10.4 m170 -58.32 -44.68 88.76 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.073 -0.967 . . . . 1.0 109.792 178.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.506 ' HA ' HD12 ' A' ' 97' ' ' LEU . . . -60.23 -44.51 95.14 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 116.297 -0.41 . . . . 1.0 111.072 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.648 ' O ' ' HG2' ' A' ' 99' ' ' GLN . 2.4 ttt180 -57.23 -44.8 84.12 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 115.934 -0.575 . . . . 1.0 110.954 178.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.664 ' HG ' ' O ' ' A' ' 92' ' ' ASN . 49.3 mt -63.34 -45.41 91.38 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 116.121 -0.49 . . . . 1.0 110.515 -175.26 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.643 HD21 HG21 ' A' ' 10' ' ' VAL . 31.2 mt -54.52 -61.08 2.54 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.814 -0.63 . . . . 1.0 111.433 -178.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.729 ' N ' HG12 ' A' ' 102' ' ' VAL . 7.3 ptm180 -58.8 -45.19 90.47 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.73 0.641 . . . . 1.0 112.73 -179.108 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.648 ' HG2' ' O ' ' A' ' 95' ' ' ARG . 6.6 pt20 -66.57 -23.91 66.27 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 119.978 -0.689 . . . . 1.0 109.915 179.061 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.606 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 3.4 mt -81.68 -13.73 57.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.605 -0.725 . . . . 1.0 111.789 178.274 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 150.83 -26.16 1.04 Allowed Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 119.769 -1.205 . . . . 1.0 114.138 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.729 HG12 ' N ' ' A' ' 98' ' ' ARG . 0.3 OUTLIER -77.26 -161.64 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-N 118.026 0.913 . . . . 1.0 111.252 -177.967 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.688 ' N ' HG13 ' A' ' 102' ' ' VAL . 12.9 pt-20 -159.05 164.49 35.39 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.844 -1.169 . . . . 1.0 107.844 -178.489 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.835 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -63.48 -24.22 67.73 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 123.354 0.409 . . . . 1.0 111.379 -175.41 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.94 -34.42 71.73 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.206 176.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.645 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 1.2 mtp85 -102.16 -40.42 6.81 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.653 -0.703 . . . . 1.0 111.541 -177.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.835 HG12 ' HA ' ' A' ' 104' ' ' ALA . 8.6 p -77.13 120.7 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 N-CA-C 109.415 -0.587 . . . . 1.0 109.415 -175.497 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.575 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 12.0 mmm180 -139.75 145.57 38.43 Favored 'General case' 0 C--N 1.322 -0.604 0 O-C-N 121.762 -0.586 . . . . 1.0 110.358 -178.427 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.547 ' HB2' ' HB2' ' A' ' 112' ' ' SER . 73.5 mmm -78.67 138.78 38.46 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.917 -0.583 . . . . 1.0 110.56 178.682 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.523 HD23 HG11 ' A' ' 87' ' ' VAL . 3.0 tm? -57.37 -50.53 72.67 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.668 0.27 . . . . 1.0 111.472 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.557 ' HB2' HG22 ' A' ' 124' ' ' VAL . 14.2 ttt180 -70.06 -17.23 63.23 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.041 0.448 . . . . 1.0 110.624 -177.533 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.547 ' HB2' ' HB2' ' A' ' 109' ' ' MET . 32.5 t -75.2 -7.65 54.43 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.888 -178.455 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.57 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 92.4 m-85 -90.56 -17.89 26.19 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 110.287 -0.264 . . . . 1.0 110.287 176.211 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -68.0 118.11 55.21 Favored Pre-proline 0 N--CA 1.464 0.241 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.799 -178.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.82 -17.18 29.32 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 121.942 1.761 . . . . 1.0 111.822 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.869 ' HA ' ' HE ' ' A' ' 116' ' ' ARG . 0.0 OUTLIER -90.44 -14.04 33.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.918 -0.583 . . . . 1.0 111.473 -179.301 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 3.8 m -62.81 -67.69 0.4 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.515 -0.311 . . . . 1.0 111.757 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 172.74 -123.29 0.99 Allowed Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.419 -0.896 . . . . 1.0 111.484 177.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 24.0 m -96.18 -42.44 8.2 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.059 0.457 . . . . 1.0 109.982 178.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -160.4 148.12 16.27 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.91 -0.586 . . . . 1.0 110.458 179.082 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -127.54 103.3 7.26 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.679 -0.691 . . . . 1.0 109.834 -178.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.409 HD22 ' N ' ' A' ' 122' ' ' LEU . 2.8 mm? -91.04 14.84 12.89 Favored 'General case' 0 CA--C 1.501 -0.904 0 CA-C-N 116.683 -0.235 . . . . 1.0 111.302 -179.171 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.447 ' HA ' ' HE1' ' A' ' 109' ' ' MET . 4.5 p-10 -170.54 146.61 2.78 Favored 'General case' 0 N--CA 1.433 -1.319 0 C-N-CA 120.222 -0.591 . . . . 1.0 111.313 -178.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.557 HG22 ' HB2' ' A' ' 111' ' ' ARG . 62.2 t -111.69 147.52 15.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.343 -0.614 . . . . 1.0 109.343 178.06 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -74.86 -175.34 2.49 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.622 -0.431 . . . . 1.0 111.965 -177.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.517 ' OD1' ' HD2' ' A' ' 127' ' ' PRO . 37.8 t70 -148.91 146.82 22.43 Favored Pre-proline 0 C--N 1.321 -0.646 0 N-CA-C 108.513 -0.921 . . . . 1.0 108.513 -173.034 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.517 ' HD2' ' OD1' ' A' ' 126' ' ' ASP . 69.5 Cg_exo -41.94 147.58 0.44 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.865 2.376 . . . . 1.0 112.787 179.008 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.482 ' HD2' ' CD2' ' A' ' 129' ' ' TYR . 55.7 t80 -99.76 -54.41 2.92 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.271 -0.877 . . . . 1.0 110.593 -175.465 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.482 ' CD2' ' HD2' ' A' ' 128' ' ' TYR . 0.0 OUTLIER -103.56 -32.26 9.53 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.472 0.653 . . . . 1.0 109.401 179.928 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 90.69 61.33 1.3 Allowed Glycine 0 N--CA 1.443 -0.892 0 N-CA-C 110.658 -0.977 . . . . 1.0 110.658 -175.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -128.27 -178.88 4.73 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.374 -0.602 . . . . 1.0 109.374 -176.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.406 ' HA ' ' CD2' ' A' ' 135' ' ' PHE . 17.8 t-80 -55.5 -34.94 65.05 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.046 -0.525 . . . . 1.0 110.511 176.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 5.8 m -62.02 -53.11 60.16 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.826 -0.625 . . . . 1.0 110.408 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -54.78 -33.6 61.58 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 115.547 -0.751 . . . . 1.0 112.111 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.406 ' CD2' ' HA ' ' A' ' 132' ' ' HIS . 10.9 m-30 -70.28 -47.87 59.3 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.339 0.59 . . . . 1.0 109.847 -177.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -69.49 -24.0 63.7 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.402 -0.817 . . . . 1.0 111.337 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -63.42 -47.12 83.25 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 109.251 -0.648 . . . . 1.0 109.251 175.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.836 ' HA ' HG12 ' A' ' 141' ' ' VAL . 85.5 t -62.74 -39.83 86.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.576 0.703 . . . . 1.0 109.259 177.185 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -56.33 -42.22 77.31 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.584 -0.735 . . . . 1.0 109.481 175.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.5 ' O ' ' HG2' ' A' ' 143' ' ' GLU . . . -67.14 -49.14 65.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.047 -0.979 . . . . 1.0 111.32 179.376 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.836 HG12 ' HA ' ' A' ' 138' ' ' VAL . 2.9 p -58.37 -40.34 77.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.456 0.646 . . . . 1.0 110.779 -178.508 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.536 HD12 HG12 ' A' ' 138' ' ' VAL . 14.2 mt -70.26 -51.54 37.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 115.187 -0.915 . . . . 1.0 112.228 178.416 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.5 ' HG2' ' O ' ' A' ' 140' ' ' ALA . 11.6 pt-20 -55.46 -31.18 61.75 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.309 0.576 . . . . 1.0 110.287 179.414 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 65.9 m -74.97 -27.66 60.26 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.102 -0.954 . . . . 1.0 110.468 179.053 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.472 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -86.24 -24.68 25.92 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 115.99 -0.55 . . . . 1.0 111.725 178.193 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.678 HD22 ' HB3' ' A' ' 25' ' ' PHE . 12.7 mt -55.89 -37.28 55.38 Favored Pre-proline 0 CA--C 1.547 0.846 0 N-CA-C 112.468 0.544 . . . . 1.0 112.468 -178.11 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.646 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 38.3 Cg_endo -67.04 -14.04 42.09 Favored 'Trans proline' 0 C--N 1.363 1.311 0 C-N-CA 122.495 2.13 . . . . 1.0 111.908 177.307 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.57 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -104.19 -34.05 3.79 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.084 -0.962 . . . . 1.0 110.714 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.576 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -73.68 -40.93 63.31 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.889 -0.782 . . . . 1.0 108.889 179.543 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.548 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 0.2 OUTLIER -53.08 -57.04 11.76 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 115.103 -0.953 . . . . 1.0 110.837 175.672 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -57.01 -40.19 76.15 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.727 -1.124 . . . . 1.0 111.069 -174.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' TRP . . . . . 0.654 ' CE3' HD12 ' A' ' 85' ' ' LEU . 24.3 t90 -63.22 -58.01 8.59 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.173 -0.922 . . . . 1.0 110.614 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.425 HG13 ' O ' ' A' ' 149' ' ' LEU . 5.7 m -60.73 -40.55 85.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.81 -0.356 . . . . 1.0 110.303 -177.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.42 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 5.8 m-20 -61.17 -49.5 76.93 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.832 0.349 . . . . 1.0 110.904 178.648 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.528 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 9.3 pt-20 -63.51 -39.39 94.3 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.095 0.474 . . . . 1.0 110.548 -178.54 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.534 ' HG3' ' CH2' ' A' ' 152' ' ' TRP . 18.4 mmt85 -71.32 -46.73 59.95 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.516 -0.766 . . . . 1.0 110.837 -176.459 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 4.2 pp -63.85 -24.78 67.88 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.228 0.537 . . . . 1.0 109.941 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -74.48 -52.84 10.81 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.596 -0.729 . . . . 1.0 110.902 177.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.416 ' HG3' ' O ' ' A' ' 155' ' ' GLU . 0.0 OUTLIER -79.14 -18.65 52.78 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 113.278 0.844 . . . . 1.0 113.278 -176.083 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -90.71 47.06 1.38 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.579 0.704 . . . . 1.0 109.842 -177.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -76.92 -175.84 42.54 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.338 -0.847 . . . . 1.0 112.625 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -79.85 24.81 0.61 Allowed 'Trans proline' 0 N--CA 1.477 0.504 0 C-N-CA 123.642 2.895 . . . . 1.0 113.042 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 19.1 m . . . . . 0 C--N 1.294 -1.839 0 CA-C-N 114.481 -1.236 . . . . 1.0 110.797 -176.969 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.651 0 N-CA-C 112.234 -0.347 . . . . 1.0 112.234 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.8 mtt -148.56 134.89 19.46 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.114 0.483 . . . . 1.0 110.433 -178.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.8 p -90.71 118.56 30.24 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.552 -0.749 . . . . 1.0 110.15 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.696 ' HB2' ' HD2' ' A' ' 4' ' ' PRO . 5.1 p-10 -67.58 159.19 79.67 Favored Pre-proline 0 C--N 1.325 -0.481 0 C-N-CA 120.244 -0.582 . . . . 1.0 110.796 177.177 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.696 ' HD2' ' HB2' ' A' ' 3' ' ' ASP . 13.0 Cg_endo -57.98 166.89 4.9 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 123.568 2.845 . . . . 1.0 114.101 -175.052 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.844 ' HB3' HG23 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -65.19 178.51 0.87 Allowed 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.637 -1.165 . . . . 1.0 108.453 178.608 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.763 ' H ' HD13 ' A' ' 5' ' ' LEU . 0.4 OUTLIER -155.55 100.97 2.14 Favored 'General case' 0 C--N 1.318 -0.803 0 O-C-N 121.549 -0.72 . . . . 1.0 109.585 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.425 HG21 HG11 ' A' ' 153' ' ' VAL . 2.2 t -104.68 116.01 47.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 107.964 -1.125 . . . . 1.0 107.964 178.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.648 HG22 ' HG ' ' A' ' 86' ' ' LEU . 6.3 t -119.06 117.89 29.96 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 120.52 -0.472 . . . . 1.0 109.918 178.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.612 ' HD2' ' HB3' ' A' ' 42' ' ' SER . 1.6 m-85 -85.22 133.19 34.19 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.016 -178.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.612 HG21 HD11 ' A' ' 97' ' ' LEU . 22.5 t -118.04 113.42 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.775 0 CA-C-O 121.123 0.487 . . . . 1.0 111.383 -176.617 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.666 ' SG ' ' HD3' ' A' ' 17' ' ' ARG . 42.2 t -144.94 160.23 41.66 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.657 -0.701 . . . . 1.0 109.491 178.214 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.453 HG23 ' NE2' ' A' ' 93' ' ' HIS . 2.7 p -68.56 112.28 5.26 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 120.941 0.401 . . . . 1.0 110.226 178.511 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.978 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 110.57 -45.16 1.36 Allowed Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.651 -0.785 . . . . 1.0 112.286 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.64 HD22 ' H ' ' A' ' 74' ' ' ALA . 57.5 t30 59.66 35.25 22.36 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 122.016 0.912 . . . . 1.0 110.953 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.414 HD13 ' ND1' ' A' ' 49' ' ' HIS . 4.5 pt -130.32 -4.39 2.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 O-C-N 121.682 -0.636 . . . . 1.0 112.483 -179.425 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.715 ' O ' ' HG3' ' A' ' 20' ' ' MET . 32.7 m -115.43 -89.05 0.57 Allowed 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 119.671 -0.812 . . . . 1.0 111.881 -177.347 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.96 ' HG3' ' HG ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -70.76 -39.99 72.91 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.821 0.674 . . . . 1.0 112.821 -175.071 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.481 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 19.4 m -57.58 -57.4 25.59 Favored Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 111.518 0.192 . . . . 1.0 111.518 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.481 ' HD3' ' HB2' ' A' ' 18' ' ' SER . 40.0 Cg_endo -65.15 -23.93 59.68 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 121.886 1.724 . . . . 1.0 112.395 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.715 ' HG3' ' O ' ' A' ' 16' ' ' CYS . 78.0 mtp -61.78 -52.33 64.66 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.111 -0.329 . . . . 1.0 110.111 179.046 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.459 ' HA ' ' HB2' ' A' ' 24' ' ' MET . . . -72.37 -27.56 62.46 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-N 115.632 -0.713 . . . . 1.0 110.138 -178.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.646 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 17.2 tt0 -52.63 -51.99 57.59 Favored 'General case' 0 C--O 1.216 -0.664 0 CA-C-N 114.981 -1.009 . . . . 1.0 109.361 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.709 ' HE2' ' HB2' ' A' ' 71' ' ' HIS . 0.1 OUTLIER -88.14 -22.79 23.88 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.815 -1.084 . . . . 1.0 110.99 -175.974 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.547 ' HB3' HD11 ' A' ' 146' ' ' LEU . 89.2 mtp -65.39 -74.97 0.09 Allowed 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.101 0.476 . . . . 1.0 112.246 -179.559 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.697 ' HB3' HD22 ' A' ' 146' ' ' LEU . 17.9 p90 -75.48 -30.64 59.95 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.003 -0.679 . . . . 1.0 111.601 -175.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.646 ' HB3' ' O ' ' A' ' 22' ' ' GLU . . . -64.79 -35.79 82.24 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 119.305 -0.958 . . . . 1.0 110.905 179.332 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.682 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -63.79 -37.88 89.01 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.402 -0.962 . . . . 1.0 108.402 177.147 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.578 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 77.9 mt-30 -59.5 -45.54 91.39 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 115.519 -0.764 . . . . 1.0 110.351 175.634 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.523 HD13 HG13 ' A' ' 38' ' ' VAL . 81.8 mt -53.3 -62.48 1.63 Allowed 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 115.859 -0.61 . . . . 1.0 111.317 -179.179 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.482 ' HA ' ' H ' ' A' ' 35' ' ' GLY . 0.3 OUTLIER -58.77 -35.48 72.85 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 120.831 -0.348 . . . . 1.0 111.502 179.863 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -62.14 -28.62 69.77 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.139 0.422 . . . . 1.0 112.139 177.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.578 ' HG2' ' O ' ' A' ' 28' ' ' GLN . 7.3 ptp180 -94.71 -20.25 19.69 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 119.452 -0.899 . . . . 1.0 109.949 178.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 110.52 35.52 2.06 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.202 -0.908 . . . . 1.0 112.277 176.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.464 ' HG ' ' HG3' ' A' ' 32' ' ' ARG . 17.9 mt -126.16 1.43 7.16 Favored 'General case' 0 N--CA 1.452 -0.358 0 O-C-N 122.432 -0.452 . . . . 1.0 110.0 -178.655 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.482 ' H ' ' HA ' ' A' ' 30' ' ' ARG . . . -55.75 -30.2 56.03 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 121.094 -0.574 . . . . 1.0 112.709 -178.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -88.79 -20.77 24.29 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.924 0.392 . . . . 1.0 110.55 178.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.92 -21.54 40.44 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.73 -0.668 . . . . 1.0 111.802 -179.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.844 HG23 ' HB3' ' A' ' 5' ' ' LEU . 0.6 OUTLIER -144.21 125.8 9.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.283 0.563 . . . . 1.0 111.386 -179.727 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.457 ' HG2' ' HB2' ' A' ' 4' ' ' PRO . 11.8 mmt180 -88.33 135.01 33.66 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.693 -0.855 . . . . 1.0 108.693 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.448 HG11 ' HB2' ' A' ' 26' ' ' ALA . 53.9 t -124.76 123.25 65.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.546 0.689 . . . . 1.0 109.385 -178.307 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.553 ' O ' ' HA ' ' A' ' 8' ' ' THR . 42.8 p -138.54 -175.75 4.23 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.491 -1.231 . . . . 1.0 110.989 -174.322 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.612 ' HB3' ' HD2' ' A' ' 9' ' ' PHE . 59.6 p -160.13 162.6 34.01 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.397 -0.365 . . . . 1.0 110.135 -178.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.527 ' HA ' ' O ' ' A' ' 74' ' ' ALA . . . -162.88 163.19 26.5 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.36 0.6 . . . . 1.0 111.636 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.481 ' HA2' ' O ' ' A' ' 11' ' ' CYS . . . -123.23 131.64 8.25 Favored Glycine 0 N--CA 1.442 -0.909 0 N-CA-C 110.778 -0.929 . . . . 1.0 110.778 178.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.519 HG23 ' CG1' ' A' ' 10' ' ' VAL . 23.2 p -69.98 -25.36 63.58 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.805 0.336 . . . . 1.0 111.752 -177.572 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.526 ' HA3' ' HZ3' ' A' ' 48' ' ' TRP . . . -110.91 9.16 29.64 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 120.851 -0.69 . . . . 1.0 113.409 -176.652 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 41.98 41.81 2.08 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 114.25 1.204 . . . . 1.0 114.25 176.307 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.978 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 1.2 m-90 -49.1 -76.02 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.694 0.759 . . . . 1.0 111.903 177.19 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.414 ' ND1' HD13 ' A' ' 15' ' ' ILE . 9.1 m170 -102.39 39.19 1.54 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.178 -0.919 . . . . 1.0 111.04 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.9 p -60.05 128.41 21.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.147 0.499 . . . . 1.0 110.529 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.439 ' HA2' ' HD3' ' A' ' 72' ' ' ARG . . . 93.3 -14.22 65.78 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.944 -0.646 . . . . 1.0 111.99 -177.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.409 ' O ' ' HA ' ' A' ' 72' ' ' ARG . 4.1 t -80.63 -161.12 0.35 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.183 0.516 . . . . 1.0 110.004 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 71' ' ' HIS . 24.8 t -121.39 176.23 5.76 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 108.448 -0.945 . . . . 1.0 108.448 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.501 ' HB2' ' HZ1' ' A' ' 23' ' ' LYS . . . -59.63 143.68 49.86 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.313 -0.403 . . . . 1.0 111.273 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.482 ' OD1' ' HG3' ' A' ' 57' ' ' ARG . 51.6 t0 -49.58 123.93 8.62 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.898 -1.046 . . . . 1.0 110.115 178.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -44.57 -37.02 3.3 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.444 -0.798 . . . . 1.0 112.64 178.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.646 HH11 ' HD1' ' A' ' 135' ' ' PHE . 0.2 OUTLIER -73.27 -38.06 66.07 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.095 -0.642 . . . . 1.0 111.178 -179.102 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.11 -36.37 72.12 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.55 0.214 . . . . 1.0 110.472 177.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.417 ' O ' HG21 ' A' ' 69' ' ' THR . . . -61.47 -41.88 97.92 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.046 177.204 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.09 -42.3 99.74 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 111.084 -0.807 . . . . 1.0 111.084 176.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.607 HG23 ' O ' ' A' ' 57' ' ' ARG . 85.0 t -59.14 -57.36 11.74 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 CA-C-N 115.273 -0.464 . . . . 1.0 111.127 178.551 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.712 ' HB2' HG22 ' A' ' 69' ' ' THR . 85.7 mt -59.5 -50.36 74.22 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.227 -0.442 . . . . 1.0 111.504 -177.152 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.599 ' HB3' HG21 ' A' ' 69' ' ' THR . 2.2 ptt180 -63.25 -27.74 69.55 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.727 -0.67 . . . . 1.0 110.823 -178.162 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.86 -29.68 68.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.128 0.49 . . . . 1.0 110.702 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -98.81 4.31 47.58 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.837 -0.619 . . . . 1.0 111.452 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.39 12.39 63.1 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.712 -0.756 . . . . 1.0 112.691 177.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.527 ' HD1' ' HG2' ' A' ' 27' ' ' GLN . 62.3 m-85 -86.96 152.31 53.3 Favored Pre-proline 0 C--N 1.323 -0.574 0 O-C-N 122.756 -0.261 . . . . 1.0 110.409 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.652 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 17.8 Cg_endo -64.81 153.25 78.81 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.295 1.997 . . . . 1.0 110.417 175.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.712 HG22 ' HB2' ' A' ' 62' ' ' LEU . 61.5 p -135.35 28.84 3.36 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 120.232 -0.587 . . . . 1.0 112.336 -176.074 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -104.38 130.47 52.25 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.343 -0.614 . . . . 1.0 109.343 178.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.709 ' HB2' ' HE2' ' A' ' 23' ' ' LYS . 18.7 t60 -164.95 148.34 8.56 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.287 -177.466 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.439 ' HD3' ' HA2' ' A' ' 51' ' ' GLY . 6.3 tmm_? -127.41 111.31 13.71 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 107.493 -1.299 . . . . 1.0 107.493 177.342 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.58 134.25 55.97 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.1 -0.955 . . . . 1.0 111.918 -175.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.64 ' H ' HD22 ' A' ' 14' ' ' ASN . . . -128.8 147.98 50.84 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.725 -0.67 . . . . 1.0 109.791 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -87.09 155.83 19.97 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.747 -0.464 . . . . 1.0 109.747 176.112 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.505 HG11 HD23 ' A' ' 97' ' ' LEU . 12.9 t -64.11 112.58 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.488 0.661 . . . . 1.0 111.229 -179.374 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.64 ' H ' ' CD2' ' A' ' 80' ' ' HIS . . . -122.64 -171.75 13.86 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 114.937 -1.029 . . . . 1.0 111.748 179.033 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 96.6 m -56.41 -44.45 80.35 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 123.704 0.297 . . . . 1.0 111.212 -179.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -60.07 -27.83 67.3 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.873 0.368 . . . . 1.0 110.939 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.64 ' CD2' ' H ' ' A' ' 77' ' ' GLY . 90.8 m-70 -79.73 -41.56 26.44 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 116.421 -0.354 . . . . 1.0 110.389 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.649 ' O ' HG23 ' A' ' 102' ' ' VAL . 17.9 mt -67.61 -17.0 64.46 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.241 176.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.76 -8.28 57.5 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.395 -0.366 . . . . 1.0 110.848 -179.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.538 ' HA ' ' HB3' ' A' ' 6' ' ' HIS . . . -60.15 151.17 27.67 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.074 -0.512 . . . . 1.0 111.569 -179.488 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.753 ' HB3' HD13 ' A' ' 5' ' ' LEU . 9.9 t70 -76.13 -14.98 60.16 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.759 -0.655 . . . . 1.0 109.712 179.27 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.745 HD12 ' CE3' ' A' ' 152' ' ' TRP . 1.2 tt -157.48 116.53 3.28 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.89 -0.595 . . . . 1.0 109.572 -177.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.648 ' HG ' HG22 ' A' ' 8' ' ' THR . 5.3 mp -107.27 88.44 2.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 116.018 -0.537 . . . . 1.0 110.671 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.633 ' HA ' ' O ' ' A' ' 108' ' ' ARG . 70.3 t -66.18 91.02 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 113.801 -1.545 . . . . 1.0 112.363 -179.219 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.49 146.32 32.77 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.509 -1.223 . . . . 1.0 110.655 177.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.96 ' HG ' ' HG3' ' A' ' 17' ' ' ARG . 4.3 mm? -99.04 -8.47 25.27 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.253 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.429 ' OD1' ' HB2' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -153.32 155.22 36.07 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.08 -0.509 . . . . 1.0 111.142 -179.843 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.432 ' HB3' ' O ' ' A' ' 122' ' ' LEU . 0.5 OUTLIER -56.91 -27.02 60.25 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.24 -0.891 . . . . 1.0 113.31 -178.598 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.655 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 7.0 m-20 -75.58 -49.93 17.08 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.977 -0.379 . . . . 1.0 109.977 -178.061 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.672 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 9.9 m170 -55.28 -47.33 75.69 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.73 -0.668 . . . . 1.0 110.295 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.96 -43.96 91.41 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.09 0.471 . . . . 1.0 110.704 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.469 ' O ' ' HG2' ' A' ' 99' ' ' GLN . 17.1 ttt180 -59.4 -44.42 92.82 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.759 -0.655 . . . . 1.0 111.332 178.105 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.655 ' HG ' ' O ' ' A' ' 92' ' ' ASN . 60.2 mt -62.69 -47.32 84.16 Favored 'General case' 0 C--O 1.215 -0.737 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.425 -176.358 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.672 ' HG ' ' O ' ' A' ' 93' ' ' HIS . 29.5 mt -54.32 -59.46 4.64 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.636 -0.711 . . . . 1.0 111.417 -178.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.688 ' CA ' HG12 ' A' ' 102' ' ' VAL . 16.5 ptt85 -59.7 -44.71 93.56 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.305 0.483 . . . . 1.0 112.305 -178.45 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.469 ' HG2' ' O ' ' A' ' 95' ' ' ARG . 2.3 pt20 -68.06 -24.63 65.09 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.497 -0.481 . . . . 1.0 109.918 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.653 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 6.1 mt -81.48 -16.14 52.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.718 -0.674 . . . . 1.0 112.037 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 151.06 -23.44 0.99 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 119.873 -1.156 . . . . 1.0 114.184 -178.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.841 HG22 ' HD2' ' A' ' 106' ' ' ARG . 0.4 OUTLIER -76.62 -163.11 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 CA-C-N 117.958 0.879 . . . . 1.0 110.295 -179.091 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.705 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 14.2 pt-20 -158.11 161.4 37.94 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 107.702 -1.221 . . . . 1.0 107.702 -179.193 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.763 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -61.86 -25.02 67.28 Favored 'General case' 0 C--N 1.32 -0.717 0 O-C-N 123.285 0.366 . . . . 1.0 111.273 -175.354 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.476 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . . . -56.37 -39.31 72.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.318 0.58 . . . . 1.0 110.286 175.158 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.841 ' HD2' HG22 ' A' ' 102' ' ' VAL . 22.5 mtt180 -96.82 -42.51 7.93 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 115.036 -0.983 . . . . 1.0 111.13 -176.538 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.763 HG12 ' HA ' ' A' ' 104' ' ' ALA . 11.5 p -78.86 117.75 24.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 120.694 -0.402 . . . . 1.0 110.03 -174.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.633 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 0.1 OUTLIER -138.35 148.44 44.57 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 121.716 -0.615 . . . . 1.0 110.455 -178.97 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 83.9 mmm -80.86 140.53 35.33 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.977 -0.556 . . . . 1.0 111.006 -178.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.55 HD23 HG11 ' A' ' 87' ' ' VAL . 3.1 tm? -59.11 -48.71 80.62 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 111.552 0.204 . . . . 1.0 111.552 -179.398 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.408 ' CB ' HG22 ' A' ' 124' ' ' VAL . 7.7 ttm180 -69.26 -19.92 63.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.707 0.289 . . . . 1.0 110.528 -178.155 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 30.4 t -74.26 -7.0 51.2 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.464 -0.335 . . . . 1.0 111.177 -178.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.641 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 87.6 m-85 -92.93 -19.11 21.96 Favored 'General case' 0 C--N 1.34 0.181 0 O-C-N 121.834 -0.541 . . . . 1.0 110.65 177.022 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -60.27 121.82 62.46 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.885 -0.598 . . . . 1.0 111.041 -178.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -64.33 -16.8 57.05 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.844 2.363 . . . . 1.0 111.802 179.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 18.3 mtp180 -91.22 -5.68 54.5 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.647 -0.706 . . . . 1.0 111.122 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 14.8 t -71.57 81.97 0.82 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.823 0.344 . . . . 1.0 110.702 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -52.82 -39.19 55.29 Favored Glycine 0 C--N 1.335 0.475 0 CA-C-N 115.895 -0.593 . . . . 1.0 113.042 179.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.76 162.67 12.74 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.813 -0.44 . . . . 1.0 109.813 178.463 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 28.3 m170 -63.89 133.7 53.78 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.019 -0.734 . . . . 1.0 109.019 175.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -100.63 87.98 3.49 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 116.086 -0.506 . . . . 1.0 111.241 -178.182 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.432 ' O ' ' HB3' ' A' ' 91' ' ' ARG . 2.5 mm? -95.26 17.34 14.51 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.664 -0.865 . . . . 1.0 108.664 175.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -168.38 132.95 1.65 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.615 -1.175 . . . . 1.0 109.487 -176.652 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.427 ' HB ' ' O ' ' A' ' 89' ' ' LEU . 62.3 t -104.04 148.38 8.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.12 -0.696 . . . . 1.0 109.12 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -64.22 -173.81 0.1 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.612 0.72 . . . . 1.0 112.767 -178.129 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.457 ' OD1' ' HD2' ' A' ' 127' ' ' PRO . 32.1 t70 -165.82 144.71 5.07 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 114.552 -1.204 . . . . 1.0 108.498 -175.686 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.457 ' HD2' ' OD1' ' A' ' 126' ' ' ASP . 7.9 Cg_endo -49.15 168.81 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.673 2.915 . . . . 1.0 113.636 -178.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.484 ' HD2' ' CE2' ' A' ' 129' ' ' TYR . 30.3 t80 -113.48 -22.4 10.36 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.072 -0.967 . . . . 1.0 111.449 -177.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.484 ' CE2' ' HD2' ' A' ' 128' ' ' TYR . 0.0 OUTLIER -140.1 -60.3 0.53 Allowed 'General case' 0 C--N 1.332 -0.181 0 O-C-N 122.061 -0.399 . . . . 1.0 110.903 179.652 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 121.62 73.4 0.31 Allowed Glycine 0 N--CA 1.451 -0.354 0 N-CA-C 111.042 -0.823 . . . . 1.0 111.042 -177.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.747 ' H ' ' HB3' ' A' ' 134' ' ' ASP . 5.2 p-10 -143.98 -167.03 2.5 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.774 0.321 . . . . 1.0 110.488 -177.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -54.34 -42.52 70.31 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.863 -0.608 . . . . 1.0 111.005 178.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.7 m -61.89 -40.5 95.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.501 -0.318 . . . . 1.0 110.669 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.747 ' HB3' ' H ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -63.35 -39.92 95.85 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.472 -0.786 . . . . 1.0 111.579 -177.601 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.646 ' HD1' HH11 ' A' ' 57' ' ' ARG . 5.4 m-85 -68.98 -45.55 70.36 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.161 0.505 . . . . 1.0 110.466 -176.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -75.1 -24.66 58.14 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.926 -0.579 . . . . 1.0 111.182 -178.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.664 ' O ' HG23 ' A' ' 141' ' ' VAL . 2.8 tt0 -63.85 -49.4 72.93 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.794 -0.447 . . . . 1.0 109.794 177.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.45 HG12 HD12 ' A' ' 142' ' ' ILE . 84.3 t -59.05 -44.54 91.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.479 0.657 . . . . 1.0 109.692 177.244 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.428 ' HB2' HG11 ' A' ' 61' ' ' VAL . 67.6 t80 -56.7 -40.11 75.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.804 -1.089 . . . . 1.0 110.058 177.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.58 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -67.18 -41.94 85.07 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.246 -0.433 . . . . 1.0 110.746 178.457 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.664 HG23 ' O ' ' A' ' 137' ' ' GLU . 33.4 t -56.33 -51.06 68.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.645 0.736 . . . . 1.0 110.425 178.212 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.45 HD12 HG12 ' A' ' 138' ' ' VAL . 7.7 mt -65.96 -50.36 70.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 114.782 -1.099 . . . . 1.0 111.588 -178.253 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.58 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 12.7 pt-20 -57.49 -30.41 65.08 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 121.003 -0.279 . . . . 1.0 110.354 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 2.9 t -74.76 -28.85 60.92 Favored 'General case' 0 C--O 1.226 -0.167 0 CA-C-O 121.155 0.502 . . . . 1.0 110.384 178.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.459 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -86.98 -22.31 25.64 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 116.014 -0.539 . . . . 1.0 111.523 179.304 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.697 HD22 ' HB3' ' A' ' 25' ' ' PHE . 11.2 mt -55.57 -37.49 57.52 Favored Pre-proline 0 CA--C 1.54 0.569 0 N-CA-C 112.523 0.564 . . . . 1.0 112.523 -179.439 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.62 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 57.1 Cg_endo -70.59 -8.53 23.83 Favored 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 122.495 2.13 . . . . 1.0 112.255 177.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.641 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -108.73 -33.93 2.74 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.214 -1.154 . . . . 1.0 110.214 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.579 HD11 HG21 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -73.44 -43.63 59.93 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.163 -1.051 . . . . 1.0 108.163 178.509 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.658 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 0.2 OUTLIER -54.21 -52.52 61.01 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-N 114.768 -1.106 . . . . 1.0 110.227 174.865 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -57.59 -43.89 84.97 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.324 -1.307 . . . . 1.0 110.89 -175.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' TRP . . . . . 0.745 ' CE3' HD12 ' A' ' 85' ' ' LEU . 22.9 t90 -63.01 -57.05 12.01 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.095 -0.957 . . . . 1.0 110.414 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.437 HG13 ' O ' ' A' ' 149' ' ' LEU . 8.4 m -61.95 -42.09 93.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.776 -0.37 . . . . 1.0 110.566 -177.513 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -60.33 -51.22 70.45 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.907 0.384 . . . . 1.0 110.777 179.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.724 ' O ' ' HG2' ' A' ' 159' ' ' ARG . 13.8 pt-20 -62.66 -38.76 91.57 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.771 -0.65 . . . . 1.0 110.403 -178.466 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.499 ' HD3' ' HA ' ' A' ' 156' ' ' ARG . 1.8 mmt180 -72.65 -50.66 23.6 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.893 -0.594 . . . . 1.0 111.029 -177.083 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.1 pp -59.65 -27.45 66.38 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.069 -0.514 . . . . 1.0 109.885 -178.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -76.0 -50.96 13.41 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.586 -0.734 . . . . 1.0 111.355 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.724 ' HG2' ' O ' ' A' ' 155' ' ' GLU . 5.1 ptp180 -78.04 -25.29 47.76 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.896 0.702 . . . . 1.0 112.896 -174.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ASN . . . . . 0.459 ' N ' ' HG3' ' A' ' 159' ' ' ARG . 5.9 m-20 -56.12 -59.91 4.24 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 123.34 0.4 . . . . 1.0 111.385 -173.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 63.75 -177.62 7.86 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.255 -0.974 . . . . 1.0 113.867 178.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -84.34 28.06 0.59 Allowed 'Trans proline' 0 CA--C 1.515 -0.432 0 C-N-CA 123.292 2.661 . . . . 1.0 112.573 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 22.6 t . . . . . 0 C--N 1.297 -1.694 0 CA-C-N 114.329 -1.305 . . . . 1.0 110.156 -177.981 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.794 0 N-CA-C 111.811 -0.515 . . . . 1.0 111.811 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.9 mtt -87.92 173.48 8.89 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.688 0.28 . . . . 1.0 110.611 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.7 p -157.5 163.73 38.13 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.878 -0.416 . . . . 1.0 109.878 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.585 ' HB2' ' HD2' ' A' ' 4' ' ' PRO . 1.9 p-10 -67.72 157.31 86.74 Favored Pre-proline 0 C--O 1.236 0.375 0 CA-C-O 121.258 0.551 . . . . 1.0 111.646 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.59 ' HB3' ' O ' ' A' ' 36' ' ' ASP . 35.0 Cg_endo -64.55 169.22 11.61 Favored 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 123.478 2.785 . . . . 1.0 113.826 -176.629 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.846 ' HB3' HG23 ' A' ' 38' ' ' VAL . 0.5 OUTLIER -73.21 -172.49 1.12 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.694 -1.139 . . . . 1.0 110.711 -179.303 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.624 ' HB3' ' HA ' ' A' ' 83' ' ' ALA . 0.3 OUTLIER -157.38 94.41 1.38 Allowed 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.897 -0.321 . . . . 1.0 110.881 179.295 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.69 HG13 HD13 ' A' ' 85' ' ' LEU . 2.1 t -96.06 115.62 35.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.876 -0.786 . . . . 1.0 108.876 176.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.603 ' CG2' ' HG ' ' A' ' 86' ' ' LEU . 14.2 t -118.52 115.35 24.42 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 120.92 0.391 . . . . 1.0 110.585 178.524 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.578 ' HD1' ' HB ' ' A' ' 87' ' ' VAL . 1.0 OUTLIER -83.54 132.42 34.93 Favored 'General case' 0 CA--C 1.511 -0.55 0 O-C-N 122.162 -0.336 . . . . 1.0 110.472 -179.025 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.713 HG21 HD11 ' A' ' 97' ' ' LEU . 44.5 t -115.37 119.98 63.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.221 0.534 . . . . 1.0 111.803 -176.416 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.528 ' HA ' ' CE1' ' A' ' 93' ' ' HIS . 47.0 t -147.59 164.92 31.95 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.654 -0.703 . . . . 1.0 109.712 178.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.6 96.22 2.94 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.186 0.517 . . . . 1.0 110.66 179.097 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.983 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 125.04 -39.81 2.01 Favored Glycine 0 N--CA 1.441 -1.01 0 CA-C-N 115.486 -0.779 . . . . 1.0 111.972 179.117 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.528 HD21 ' CB ' ' A' ' 42' ' ' SER . 3.6 t-20 65.05 18.88 11.67 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 122.115 0.96 . . . . 1.0 110.078 -178.529 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.501 HG12 ' HB2' ' A' ' 49' ' ' HIS . 1.2 pt -134.58 48.43 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-N 115.078 -0.964 . . . . 1.0 110.103 -177.23 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.742 ' O ' ' HG3' ' A' ' 20' ' ' MET . 4.7 p -157.9 -90.12 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.285 -0.87 . . . . 1.0 111.495 174.309 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.647 HH11 ' HB3' ' A' ' 89' ' ' LEU . 1.2 mtt180 -70.73 -44.46 66.8 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.986 0.422 . . . . 1.0 111.187 -177.071 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.712 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 15.1 m -54.41 -58.13 15.39 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-N 115.756 -0.657 . . . . 1.0 111.838 -179.364 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.537 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 33.6 Cg_endo -64.1 -24.58 66.24 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 121.68 1.586 . . . . 1.0 112.627 -179.334 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.742 ' HG3' ' O ' ' A' ' 16' ' ' CYS . 57.6 mtp -62.01 -53.81 50.38 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.902 -0.319 . . . . 1.0 110.607 178.638 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.428 ' HA ' ' HB2' ' A' ' 24' ' ' MET . . . -74.91 -26.14 59.43 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.488 -178.022 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.631 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 12.5 tt0 -53.84 -51.28 64.06 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.274 -0.876 . . . . 1.0 109.528 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.821 ' HB3' ' HG2' ' A' ' 68' ' ' PRO . 0.2 OUTLIER -80.7 -31.14 36.27 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.549 -0.75 . . . . 1.0 110.451 -177.244 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.65 ' HB3' HD11 ' A' ' 146' ' ' LEU . 6.0 mmm -60.85 -75.49 0.06 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.902 0.704 . . . . 1.0 112.902 -175.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.686 ' HB3' HD22 ' A' ' 146' ' ' LEU . 19.0 p90 -77.94 -30.77 50.61 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 119.815 -0.754 . . . . 1.0 111.527 -175.054 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.631 ' HB3' ' O ' ' A' ' 22' ' ' GLU . . . -63.03 -38.23 90.37 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 119.06 -1.056 . . . . 1.0 110.648 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.672 ' HA ' ' HD3' ' A' ' 30' ' ' ARG . 0.1 OUTLIER -65.39 -40.13 93.1 Favored 'General case' 0 C--N 1.339 0.118 0 N-CA-C 108.936 -0.765 . . . . 1.0 108.936 177.504 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.652 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 49.2 mt-30 -61.59 -40.46 94.84 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.751 176.241 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.677 ' HG ' ' O ' ' A' ' 25' ' ' PHE . 83.9 mt -56.73 -57.65 11.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.638 178.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.672 ' HD3' ' HA ' ' A' ' 27' ' ' GLN . 1.6 ptm180 -59.9 -32.28 70.6 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.485 -0.486 . . . . 1.0 111.129 178.051 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -62.27 -32.93 73.7 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 111.967 0.358 . . . . 1.0 111.967 175.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.652 ' HG2' ' O ' ' A' ' 28' ' ' GLN . 4.8 ptp180 -91.94 -17.5 25.08 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.632 0.729 . . . . 1.0 109.706 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.22 33.64 5.1 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 114.911 -1.041 . . . . 1.0 111.435 177.089 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 33.2 mt -123.42 -0.75 8.69 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.566 -0.531 . . . . 1.0 109.566 -177.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.25 -27.52 60.45 Favored Glycine 0 C--O 1.227 -0.338 0 CA-C-N 115.889 -0.596 . . . . 1.0 112.486 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.59 ' O ' ' HB3' ' A' ' 4' ' ' PRO . 0.9 OUTLIER -86.34 -25.86 25.18 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 109.716 -0.475 . . . . 1.0 109.716 177.549 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -78.42 -21.69 48.85 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.137 -0.938 . . . . 1.0 111.341 -176.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.846 HG23 ' HB3' ' A' ' 5' ' ' LEU . 1.2 p -144.45 126.85 10.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.229 0.538 . . . . 1.0 110.378 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.487 ' HG2' ' HB2' ' A' ' 4' ' ' PRO . 11.0 mmt180 -90.0 144.59 25.78 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.462 -0.79 . . . . 1.0 109.585 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.415 HG11 ' HB2' ' A' ' 26' ' ' ALA . 77.8 t -129.68 127.73 64.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 121.382 0.611 . . . . 1.0 109.93 -178.339 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.534 ' O ' ' HA ' ' A' ' 8' ' ' THR . 40.0 p -143.89 -175.54 4.63 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.476 -1.238 . . . . 1.0 110.024 -175.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.712 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 86.4 p -161.27 167.03 26.72 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 110.006 -0.368 . . . . 1.0 110.006 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 10' ' ' VAL . . . -163.5 166.41 22.66 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.156 0.503 . . . . 1.0 111.695 -178.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.523 ' HA2' ' O ' ' A' ' 11' ' ' CYS . . . -125.15 137.71 10.56 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.302 -0.863 . . . . 1.0 111.398 178.699 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.618 HG21 HD12 ' A' ' 96' ' ' LEU . 22.1 p -74.17 -22.93 59.21 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.805 0.303 . . . . 1.0 111.747 -177.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.459 ' HA3' ' CZ3' ' A' ' 48' ' ' TRP . . . -111.31 8.31 28.73 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.668 -0.777 . . . . 1.0 113.03 -178.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.459 ' HB3' ' HB2' ' A' ' 75' ' ' GLN . 2.7 p-10 43.01 37.02 1.0 Allowed 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 113.875 1.065 . . . . 1.0 113.875 177.66 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.983 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 1.1 m-90 -46.8 -64.4 0.78 Allowed 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.325 0.583 . . . . 1.0 112.532 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.573 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 2.3 m-70 -111.99 39.25 2.44 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.753 -0.658 . . . . 1.0 111.281 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.51 HG23 ' HA ' ' A' ' 74' ' ' ALA . 14.9 p -59.87 126.87 18.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 C-N-CA 120.207 -0.597 . . . . 1.0 110.473 179.056 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.64 -14.17 65.62 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-N 116.032 -0.531 . . . . 1.0 111.948 -177.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.503 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 3.3 t -79.93 -160.72 0.29 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.45 0.643 . . . . 1.0 109.961 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 47.7 t -124.48 175.02 7.41 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 115.445 -0.798 . . . . 1.0 108.971 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.38 147.56 48.06 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.54 0.686 . . . . 1.0 111.49 -178.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.428 ' N ' ' OD1' ' A' ' 55' ' ' ASP . 9.0 p-10 -59.75 137.76 57.96 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.437 -1.256 . . . . 1.0 112.034 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -48.36 -35.25 12.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.672 -1.149 . . . . 1.0 112.785 179.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.484 ' H ' ' HG2' ' A' ' 57' ' ' ARG . 17.3 ptt180 -71.93 -43.69 64.86 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.377 0.132 . . . . 1.0 111.071 -177.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.461 ' HB1' ' HG2' ' A' ' 20' ' ' MET . . . -69.56 -39.13 77.59 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 109.378 -0.601 . . . . 1.0 109.378 178.644 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.4 -45.53 93.93 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.672 -0.695 . . . . 1.0 109.398 177.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.42 ' O ' ' HG2' ' A' ' 63' ' ' ARG . . . -57.83 -47.21 90.29 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 115.768 -0.651 . . . . 1.0 113.36 178.058 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.6 m -70.34 -39.99 77.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 117.699 0.749 . . . . 1.0 111.045 -178.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.718 HD13 ' HG3' ' A' ' 23' ' ' LYS . 96.0 mt -63.64 -52.56 60.26 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 120.605 -0.438 . . . . 1.0 110.653 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.42 ' HG2' ' O ' ' A' ' 60' ' ' GLY . 4.5 ptm180 -61.13 -30.26 70.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.554 -0.294 . . . . 1.0 110.997 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.99 -33.45 75.6 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 120.946 0.403 . . . . 1.0 110.735 179.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -96.68 3.35 52.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.839 -0.619 . . . . 1.0 110.873 -178.306 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.41 13.8 62.89 Favored Glycine 0 N--CA 1.452 -0.257 0 CA-C-N 115.962 -0.563 . . . . 1.0 112.906 177.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -89.48 152.8 47.81 Favored Pre-proline 0 C--N 1.322 -0.616 0 N-CA-C 110.571 -0.159 . . . . 1.0 110.571 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.821 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 45.7 Cg_endo -69.8 158.46 56.84 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.182 1.921 . . . . 1.0 110.713 176.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.62 HG22 ' HB2' ' A' ' 62' ' ' LEU . 36.4 p -133.32 4.04 3.68 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 119.856 -0.738 . . . . 1.0 111.807 -177.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.412 ' O ' ' HE2' ' A' ' 23' ' ' LYS . 24.4 t70 -67.74 127.09 31.5 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.976 -0.556 . . . . 1.0 110.099 178.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.567 ' HB2' ' HE2' ' A' ' 23' ' ' LYS . 59.0 t60 -165.39 149.67 8.61 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.951 0.405 . . . . 1.0 111.116 -176.286 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.459 ' HA ' ' O ' ' A' ' 52' ' ' SER . 0.9 OUTLIER -134.16 112.65 11.29 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.113 -1.069 . . . . 1.0 108.113 175.136 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.573 ' HB3' ' O ' ' A' ' 49' ' ' HIS . . . -61.42 142.53 56.91 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.656 -1.157 . . . . 1.0 112.294 -176.259 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.51 ' HA ' HG23 ' A' ' 50' ' ' VAL . . . -133.55 161.25 35.11 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.469 -0.787 . . . . 1.0 109.885 178.072 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.459 ' HB2' ' HB3' ' A' ' 47' ' ' ASN . 46.8 tt0 -97.57 160.04 14.56 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.611 -0.885 . . . . 1.0 108.611 178.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.474 HG11 HD23 ' A' ' 97' ' ' LEU . 93.8 t -64.97 102.82 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.353 0.597 . . . . 1.0 110.093 178.393 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.448 ' H ' ' CD2' ' A' ' 80' ' ' HIS . . . -119.57 -174.94 15.78 Favored Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 114.834 -1.075 . . . . 1.0 111.769 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 93.0 m -57.75 -45.75 85.44 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 111.616 0.228 . . . . 1.0 111.616 -177.311 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -59.12 -29.65 67.55 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.871 0.367 . . . . 1.0 111.305 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.448 ' CD2' ' H ' ' A' ' 77' ' ' GLY . 92.4 m-70 -78.39 -41.24 33.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.394 -0.366 . . . . 1.0 110.491 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.623 ' O ' HG23 ' A' ' 102' ' ' VAL . 18.2 mt -68.31 -17.28 64.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.404 177.727 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.87 -8.27 58.17 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.846 0.355 . . . . 1.0 110.487 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.624 ' HA ' ' HB3' ' A' ' 6' ' ' HIS . . . -58.91 151.85 20.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.664 -0.698 . . . . 1.0 111.427 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.602 ' HA ' ' NH1' ' A' ' 106' ' ' ARG . 27.0 t70 -78.73 -14.45 59.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.333 -0.394 . . . . 1.0 109.956 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.69 HD13 HG13 ' A' ' 7' ' ' VAL . 0.5 OUTLIER -155.36 117.33 4.11 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.65 -0.705 . . . . 1.0 109.311 -177.909 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.618 ' HB3' HD13 ' A' ' 97' ' ' LEU . 5.0 mp -107.67 105.94 16.04 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-N 115.622 -0.717 . . . . 1.0 109.897 177.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.578 ' HB ' ' HD1' ' A' ' 9' ' ' PHE . 56.0 t -84.5 92.94 3.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 114.803 -1.09 . . . . 1.0 111.002 -176.094 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.7 141.81 37.6 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.474 -0.785 . . . . 1.0 110.62 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.647 ' HB3' HH11 ' A' ' 17' ' ' ARG . 3.8 mm? -95.82 -8.77 33.32 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.261 0.553 . . . . 1.0 109.82 178.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.518 ' HA ' ' OD1' ' A' ' 123' ' ' ASP . 0.0 OUTLIER -149.73 151.55 33.83 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.249 -0.887 . . . . 1.0 110.786 -179.939 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.461 ' HG2' ' HB2' ' A' ' 123' ' ' ASP . 9.3 ptm180 -55.16 -29.86 58.67 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.262 -0.881 . . . . 1.0 112.92 -179.082 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.694 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 43.2 m-80 -75.06 -49.51 19.48 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.614 -0.513 . . . . 1.0 109.614 -176.537 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.565 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 16.7 m170 -52.44 -46.07 66.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.535 -0.757 . . . . 1.0 110.121 178.705 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.416 ' HA ' HG21 ' A' ' 107' ' ' VAL . . . -58.85 -46.44 87.74 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.42 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.1 ttm180 -61.47 -39.27 90.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.722 -0.672 . . . . 1.0 111.626 178.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.694 ' HG ' ' O ' ' A' ' 92' ' ' ASN . 36.1 mt -65.85 -47.19 75.77 Favored 'General case' 0 C--O 1.218 -0.594 0 N-CA-C 110.229 -0.285 . . . . 1.0 110.229 -177.757 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.713 HD11 HG21 ' A' ' 10' ' ' VAL . 31.6 mt -55.14 -58.78 6.27 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.145 -0.48 . . . . 1.0 111.655 -178.661 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.685 ' HD2' HG11 ' A' ' 107' ' ' VAL . 2.9 ptm180 -60.3 -41.52 93.59 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.826 -0.624 . . . . 1.0 112.473 -178.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.652 ' HG3' ' O ' ' A' ' 96' ' ' LEU . 1.0 OUTLIER -66.8 -27.76 67.83 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.361 -0.607 . . . . 1.0 109.361 178.536 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.667 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 11.1 mt -79.46 -13.44 59.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.537 -0.756 . . . . 1.0 111.769 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 149.36 -25.31 1.23 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 119.907 -1.14 . . . . 1.0 113.678 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.68 HG13 ' H ' ' A' ' 103' ' ' GLU . 0.4 OUTLIER -76.73 -163.02 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-N 117.437 0.619 . . . . 1.0 110.321 -178.615 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.68 ' H ' HG13 ' A' ' 102' ' ' VAL . 12.5 pt-20 -159.97 166.64 29.67 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 108.389 -0.967 . . . . 1.0 108.389 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.778 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -63.75 -25.23 68.1 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 123.304 0.378 . . . . 1.0 111.686 -174.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.41 -36.19 75.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.112 0.482 . . . . 1.0 110.142 175.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.623 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 0.8 OUTLIER -98.15 -42.82 7.27 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 115.525 -0.761 . . . . 1.0 111.293 -177.163 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.778 HG12 ' HA ' ' A' ' 104' ' ' ALA . 7.7 p -78.34 118.09 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 N-CA-C 109.266 -0.642 . . . . 1.0 109.266 -176.311 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.549 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 17.7 mmm180 -136.3 147.53 47.51 Favored 'General case' 0 C--N 1.32 -0.703 0 O-C-N 121.633 -0.667 . . . . 1.0 110.352 -178.042 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 83.0 mmm -78.09 137.45 38.23 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.889 -0.596 . . . . 1.0 110.382 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.529 HD23 HG11 ' A' ' 87' ' ' VAL . 3.1 tm? -56.06 -49.09 74.75 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 123.031 0.207 . . . . 1.0 111.239 179.607 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 21.0 ttt180 -71.87 -11.9 61.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.011 0.434 . . . . 1.0 111.007 -178.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.779 ' HB2' ' HB3' ' A' ' 121' ' ' ALA . 26.7 t -75.81 -9.67 58.79 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.944 -0.303 . . . . 1.0 110.705 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.574 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 97.3 m-85 -92.41 -19.81 21.68 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.237 0.542 . . . . 1.0 110.366 176.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -60.72 124.22 78.19 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 114.945 -1.025 . . . . 1.0 111.685 -177.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.504 ' HD2' ' O ' ' A' ' 144' ' ' SER . 59.5 Cg_endo -73.93 -16.72 22.98 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.441 2.094 . . . . 1.0 111.939 176.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 28.5 mmm180 -86.61 -4.17 59.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.957 -0.565 . . . . 1.0 110.991 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 79.5 p -62.86 100.11 0.19 Allowed 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.337 0.589 . . . . 1.0 111.982 -178.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -56.06 -46.09 85.68 Favored Glycine 0 C--N 1.333 0.391 0 CA-C-N 115.367 -0.833 . . . . 1.0 111.96 176.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.559 HG22 ' H ' ' A' ' 120' ' ' HIS . 1.3 m -112.35 173.61 6.29 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.125 -0.694 . . . . 1.0 109.125 176.077 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.559 ' H ' HG22 ' A' ' 119' ' ' THR . 24.6 m-70 -75.46 147.84 39.55 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 109.569 -0.53 . . . . 1.0 109.569 178.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.779 ' HB3' ' HB2' ' A' ' 112' ' ' SER . . . -79.53 151.88 30.48 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 115.358 -0.837 . . . . 1.0 110.04 178.294 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.577 HD13 ' O ' ' A' ' 121' ' ' ALA . 1.0 OUTLIER -152.01 -27.01 0.18 Allowed 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 113.275 -1.784 . . . . 1.0 108.434 -178.256 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.518 ' OD1' ' HA ' ' A' ' 90' ' ' ASP . 17.6 t0 -167.41 143.48 4.18 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.504 -1.225 . . . . 1.0 107.83 -178.643 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.449 ' HB ' ' O ' ' A' ' 89' ' ' LEU . 94.9 t -94.54 144.57 9.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 110.121 -0.326 . . . . 1.0 110.121 -178.11 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -73.23 -165.76 0.27 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.885 0.374 . . . . 1.0 110.733 -178.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -161.06 162.98 21.42 Favored Pre-proline 0 C--N 1.318 -0.773 0 C-N-CA 120.35 -0.54 . . . . 1.0 109.595 -174.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.604 ' HB3' ' HB3' ' A' ' 134' ' ' ASP . 99.1 Cg_exo -47.73 155.73 1.45 Allowed 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 123.175 2.584 . . . . 1.0 113.246 178.73 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.437 ' HD2' ' CD2' ' A' ' 129' ' ' TYR . 79.2 t80 -93.81 -46.97 6.97 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.579 -0.737 . . . . 1.0 109.457 -179.092 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.437 ' CD2' ' HD2' ' A' ' 128' ' ' TYR . 0.4 OUTLIER -123.15 -21.85 5.32 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.813 176.175 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 87.19 59.01 1.8 Allowed Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.213 -0.994 . . . . 1.0 111.975 178.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -113.13 -168.42 1.32 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.054 -1.091 . . . . 1.0 108.054 178.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -62.12 -38.48 89.06 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.633 -0.506 . . . . 1.0 109.633 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 7.6 m -60.7 -49.6 76.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.865 -0.607 . . . . 1.0 110.579 -179.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.604 ' HB3' ' HB3' ' A' ' 127' ' ' PRO . 1.2 m-20 -56.89 -34.24 67.68 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.168 -0.469 . . . . 1.0 112.188 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -70.22 -44.41 68.67 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.869 0.366 . . . . 1.0 110.423 -177.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -79.27 -17.42 54.75 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.607 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.552 ' O ' HG23 ' A' ' 141' ' ' VAL . 10.9 tp10 -64.31 -48.28 76.23 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.543 -0.91 . . . . 1.0 108.543 174.659 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.683 ' HA ' HG23 ' A' ' 141' ' ' VAL . 54.8 t -61.9 -39.74 84.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.225 -0.898 . . . . 1.0 109.648 176.006 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.446 ' HB2' ' HE1' ' A' ' 20' ' ' MET . 46.1 t80 -53.44 -41.4 66.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.203 -0.908 . . . . 1.0 109.107 175.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.694 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -68.28 -39.83 82.01 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.323 -0.853 . . . . 1.0 110.629 177.503 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.683 HG23 ' HA ' ' A' ' 138' ' ' VAL . 15.9 t -55.6 -51.43 58.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-O 121.932 0.872 . . . . 1.0 109.83 177.599 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.446 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 7.0 mt -65.51 -51.59 61.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 114.755 -1.111 . . . . 1.0 111.775 -178.641 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.694 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 8.1 pt-20 -55.12 -32.79 62.32 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.839 -0.344 . . . . 1.0 110.29 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.504 ' O ' ' HD2' ' A' ' 115' ' ' PRO . 2.3 t -73.64 -30.18 62.79 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.488 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.453 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -86.17 -22.63 26.9 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-N 116.006 -0.543 . . . . 1.0 111.636 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.686 HD22 ' HB3' ' A' ' 25' ' ' PHE . 11.0 mt -54.18 -41.72 90.05 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 112.744 0.646 . . . . 1.0 112.744 -178.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.715 ' HA ' ' CD2' ' A' ' 150' ' ' HIS . 60.3 Cg_endo -68.36 -7.68 20.84 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 122.371 2.048 . . . . 1.0 111.866 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.574 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -108.48 -33.55 2.88 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 110.234 -1.146 . . . . 1.0 110.234 178.388 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.538 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -75.14 -54.34 7.31 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.327 -0.62 . . . . 1.0 109.327 -179.797 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.715 ' CD2' ' HA ' ' A' ' 147' ' ' PRO . 2.0 p80 -56.16 -46.81 79.15 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 115.268 -0.878 . . . . 1.0 110.471 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.448 ' N ' ' CG ' ' A' ' 150' ' ' HIS . 2.0 t70 -59.62 -37.94 79.98 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.764 -1.107 . . . . 1.0 110.411 -178.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' TRP . . . . . 0.784 ' HZ3' HD21 ' A' ' 5' ' ' LEU . 28.2 t90 -64.52 -54.66 28.87 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 115.637 -0.71 . . . . 1.0 109.858 178.149 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.636 HG22 ' O ' ' A' ' 150' ' ' HIS . 3.5 m -58.77 -37.8 68.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.571 -0.529 . . . . 1.0 109.571 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.462 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 2.7 m-20 -59.44 -56.39 22.61 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 121.487 0.661 . . . . 1.0 110.765 177.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.609 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 6.3 pt-20 -60.63 -37.92 83.06 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 114.901 -1.045 . . . . 1.0 110.369 -177.35 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.477 ' HD3' ' HA ' ' A' ' 156' ' ' ARG . 1.0 OUTLIER -74.11 -48.67 27.97 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.571 -0.741 . . . . 1.0 111.361 -177.222 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 3.9 pp -60.82 -27.77 68.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.233 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -72.64 -52.11 16.72 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.842 -0.617 . . . . 1.0 110.802 178.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.429 HH11 ' HD3' ' A' ' 159' ' ' ARG . 0.0 OUTLIER -80.56 -3.49 50.46 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.546 0.572 . . . . 1.0 112.546 -178.181 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -78.3 40.95 0.37 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.592 0.71 . . . . 1.0 111.39 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -76.18 178.98 48.61 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.662 -0.699 . . . . 1.0 111.887 177.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -82.87 23.92 0.78 Allowed 'Trans proline' 0 CA--C 1.517 -0.336 0 C-N-CA 123.144 2.563 . . . . 1.0 112.825 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 53.6 m . . . . . 0 C--N 1.304 -1.412 0 CA-C-N 114.738 -1.119 . . . . 1.0 110.631 -179.525 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.683 0 N-CA-C 112.117 -0.393 . . . . 1.0 112.117 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt 69.83 32.68 3.1 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.642 0.735 . . . . 1.0 110.467 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.3 m -89.31 129.24 35.89 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.887 -1.051 . . . . 1.0 109.69 178.038 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.26 148.06 93.53 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.215 0.531 . . . . 1.0 110.723 178.436 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.579 ' HB2' ' HG2' ' A' ' 39' ' ' ARG . 25.3 Cg_endo -63.56 167.25 13.66 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 123.708 2.939 . . . . 1.0 115.253 -174.463 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.655 HD21 ' HZ3' ' A' ' 152' ' ' TRP . 0.4 OUTLIER -74.3 -173.35 1.67 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 113.487 -1.688 . . . . 1.0 110.024 178.273 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.63 ' HB3' ' H ' ' A' ' 84' ' ' ASP . 3.0 t-160 -156.48 92.14 1.29 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.578 -0.449 . . . . 1.0 110.878 -178.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.784 HG13 HD13 ' A' ' 85' ' ' LEU . 2.9 t -96.1 111.11 25.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.351 -0.611 . . . . 1.0 109.351 177.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.57 HG22 ' HG ' ' A' ' 86' ' ' LEU . 9.2 t -112.17 113.88 26.38 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.221 0.534 . . . . 1.0 110.291 179.152 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.548 ' CE2' ' HA ' ' A' ' 22' ' ' GLU . 1.0 OUTLIER -83.43 125.3 31.56 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 122.004 -0.435 . . . . 1.0 110.289 -178.564 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.492 ' CG1' HG23 ' A' ' 45' ' ' THR . 37.6 t -112.18 111.12 34.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.802 -0.635 . . . . 1.0 112.161 -176.357 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.596 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 48.3 t -135.73 160.0 39.89 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.043 -1.095 . . . . 1.0 108.043 176.131 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -64.21 -32.23 73.73 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.334 0.588 . . . . 1.0 109.79 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.538 ' C ' ' H ' ' A' ' 15' ' ' ILE . . . -111.27 84.66 0.37 Allowed Glycine 0 N--CA 1.436 -1.328 0 CA-C-N 115.149 -0.932 . . . . 1.0 110.868 174.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.604 ' ND2' ' HB1' ' A' ' 73' ' ' ALA . 10.5 p-10 -65.0 16.07 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.262 1.425 . . . . 1.0 112.105 178.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.538 ' H ' ' C ' ' A' ' 13' ' ' GLY . 6.9 pt -119.89 -3.34 9.42 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.045 177.447 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.433 ' HB2' ' H ' ' A' ' 17' ' ' ARG . 9.2 m -115.13 -87.08 0.59 Allowed 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.679 -0.408 . . . . 1.0 112.041 -176.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.677 ' HG2' ' HG ' ' A' ' 89' ' ' LEU . 15.7 tpp180 -67.45 -50.43 59.24 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.352 -0.385 . . . . 1.0 112.014 -174.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.605 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 33.8 m -54.39 -59.05 11.24 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-N 116.321 -0.4 . . . . 1.0 111.882 -178.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.472 ' HA ' ' HB2' ' A' ' 22' ' ' GLU . 40.6 Cg_endo -63.89 -20.87 68.84 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 121.933 1.755 . . . . 1.0 113.029 -179.087 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.559 ' HB3' HD13 ' A' ' 142' ' ' ILE . 39.5 mmm -61.54 -55.51 30.2 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 110.056 -0.35 . . . . 1.0 110.056 177.514 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.418 ' HB2' ' CG2' ' A' ' 142' ' ' ILE . . . -72.24 -26.67 62.1 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 115.81 -0.632 . . . . 1.0 110.416 -179.008 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.64 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 18.1 tt0 -50.7 -54.56 22.14 Favored 'General case' 0 C--O 1.216 -0.686 0 CA-C-N 114.776 -1.102 . . . . 1.0 109.811 179.096 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.753 ' HB3' ' HG2' ' A' ' 68' ' ' PRO . 0.0 OUTLIER -84.15 -26.3 28.97 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.443 -0.799 . . . . 1.0 110.729 -175.803 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.565 ' HB3' HD11 ' A' ' 146' ' ' LEU . 90.9 mtp -63.91 -75.52 0.08 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.644 0.609 . . . . 1.0 112.644 -176.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.749 ' HB3' HD22 ' A' ' 146' ' ' LEU . 18.2 p90 -76.99 -29.57 55.54 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 119.696 -0.801 . . . . 1.0 111.311 -175.503 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.708 ' HB2' HG21 ' A' ' 40' ' ' VAL . . . -63.86 -37.0 85.75 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 119.2 -1.0 . . . . 1.0 110.562 179.344 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.676 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -63.84 -38.42 91.03 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 108.801 -0.814 . . . . 1.0 108.801 177.363 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.513 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 60.7 mt-30 -58.83 -43.84 90.79 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-O 121.149 0.499 . . . . 1.0 110.107 175.759 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.681 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 95.6 mt -54.84 -61.5 2.27 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.425 -0.807 . . . . 1.0 110.984 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.653 ' HD3' ' HA ' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -59.54 -35.73 74.77 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.763 -0.375 . . . . 1.0 111.565 179.633 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 3.4 m170 -62.83 -27.96 69.68 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 111.934 0.346 . . . . 1.0 111.934 177.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.681 ' HG2' ' O ' ' A' ' 29' ' ' LEU . 4.7 ptm85 -97.13 -22.0 17.01 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 119.796 -0.762 . . . . 1.0 110.291 -179.105 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 112.34 36.16 1.66 Allowed Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.226 -0.897 . . . . 1.0 112.528 177.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 18.9 mt -131.74 7.48 4.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.158 0.504 . . . . 1.0 109.814 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.409 ' HA3' ' HB3' ' A' ' 30' ' ' ARG . . . -60.56 -32.25 77.47 Favored Glycine 0 C--N 1.332 0.321 0 CA-C-N 115.831 -0.622 . . . . 1.0 113.03 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.648 ' HA ' ' NH1' ' A' ' 39' ' ' ARG . 3.2 m-20 -90.29 -15.41 31.28 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.935 0.398 . . . . 1.0 110.179 177.115 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -81.16 -22.7 38.77 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.61 -0.723 . . . . 1.0 110.916 178.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.594 HG13 ' HB3' ' A' ' 5' ' ' LEU . 8.7 t -133.7 123.35 45.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.675 0.274 . . . . 1.0 110.932 -178.456 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.648 ' NH1' ' HA ' ' A' ' 36' ' ' ASP . 24.2 mmt180 -96.92 98.0 9.74 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.157 0.503 . . . . 1.0 110.757 178.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.708 HG21 ' HB2' ' A' ' 26' ' ' ALA . 0.8 OUTLIER -92.25 120.89 42.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-O 122.209 1.005 . . . . 1.0 110.699 179.652 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.486 ' O ' ' HA ' ' A' ' 8' ' ' THR . 82.3 p -131.41 -175.24 3.64 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 113.466 -1.697 . . . . 1.0 110.082 -177.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.605 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 78.3 p -157.82 161.46 38.37 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.797 -0.361 . . . . 1.0 110.57 -178.585 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.635 ' HA ' ' O ' ' A' ' 74' ' ' ALA . . . -163.48 165.71 23.46 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.283 0.564 . . . . 1.0 111.522 -178.632 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.596 ' HA2' ' O ' ' A' ' 11' ' ' CYS . . . -126.01 134.07 8.51 Favored Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 115.284 -0.871 . . . . 1.0 111.415 178.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.492 HG23 ' CG1' ' A' ' 10' ' ' VAL . 26.9 p -71.57 -26.39 62.6 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.827 0.313 . . . . 1.0 111.433 -178.151 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -107.88 7.8 36.09 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.892 -0.671 . . . . 1.0 112.545 -177.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 43.34 39.8 2.3 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 113.569 0.951 . . . . 1.0 113.569 178.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -44.67 -76.2 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.443 0.639 . . . . 1.0 112.063 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 52.6 m-70 -107.01 44.46 1.06 Allowed 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.278 -0.873 . . . . 1.0 111.162 178.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.0 p -60.06 129.04 22.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.915 -0.584 . . . . 1.0 110.809 178.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.84 -13.42 66.0 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.899 -0.667 . . . . 1.0 112.26 -178.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -82.29 -162.48 0.56 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.009 0.433 . . . . 1.0 109.864 179.058 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 38.4 t -119.36 173.48 6.93 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.239 -0.652 . . . . 1.0 109.239 -179.218 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.73 135.55 47.06 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.821 0.343 . . . . 1.0 111.61 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.79 ' OD1' ' HG3' ' A' ' 57' ' ' ARG . 15.6 t0 -51.54 134.62 29.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.139 -0.937 . . . . 1.0 111.191 -179.046 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -48.31 -32.1 6.91 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.159 -0.928 . . . . 1.0 113.04 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.79 ' HG3' ' OD1' ' A' ' 55' ' ' ASP . 6.5 mtt180 -68.56 -50.71 49.76 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.254 0.55 . . . . 1.0 109.625 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.5 -32.19 71.98 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.006 -0.997 . . . . 1.0 110.405 -176.401 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.09 -45.45 94.68 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 109.433 -0.581 . . . . 1.0 109.433 176.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.25 -44.59 95.33 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.927 -0.654 . . . . 1.0 111.76 176.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.627 HG23 ' O ' ' A' ' 57' ' ' ARG . 64.5 t -57.05 -56.51 14.37 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 CA-C-O 121.279 0.561 . . . . 1.0 111.152 178.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.763 ' HB2' HG22 ' A' ' 69' ' ' THR . 88.4 mt -60.13 -52.46 65.25 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.087 -0.506 . . . . 1.0 111.398 -179.271 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -60.59 -28.61 68.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.687 -0.233 . . . . 1.0 110.897 -178.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.49 -34.12 77.22 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-O 121.106 0.479 . . . . 1.0 110.333 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -95.55 4.95 52.68 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.859 -0.61 . . . . 1.0 111.178 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.58 21.52 61.83 Favored Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 116.002 -0.544 . . . . 1.0 112.308 178.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -91.84 150.91 41.58 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.771 -0.214 . . . . 1.0 110.444 178.105 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.753 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 37.8 Cg_endo -68.41 155.68 68.32 Favored 'Trans proline' 0 CA--C 1.51 -0.687 0 C-N-CA 122.334 2.023 . . . . 1.0 110.162 176.289 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.763 HG22 ' HB2' ' A' ' 62' ' ' LEU . 56.6 p -134.79 7.3 3.49 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 119.778 -0.769 . . . . 1.0 111.709 -177.446 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.434 ' O ' ' HE2' ' A' ' 23' ' ' LYS . 12.8 t70 -74.49 132.52 41.96 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 108.791 -0.818 . . . . 1.0 108.791 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.485 ' HB2' ' HE2' ' A' ' 23' ' ' LYS . 37.2 t60 -170.05 151.12 3.91 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.132 0.491 . . . . 1.0 110.585 -175.528 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.405 ' HD3' ' HA ' ' A' ' 72' ' ' ARG . 3.2 tpp85 -130.71 109.37 10.57 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 107.818 -1.178 . . . . 1.0 107.818 176.057 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.604 ' HB1' ' ND2' ' A' ' 14' ' ' ASN . . . -56.32 137.45 52.42 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.097 -0.956 . . . . 1.0 112.084 -176.151 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.635 ' O ' ' HA ' ' A' ' 43' ' ' ALA . . . -133.6 145.41 50.01 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.834 -0.621 . . . . 1.0 109.976 179.333 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -84.45 154.77 22.57 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.737 -0.468 . . . . 1.0 109.737 177.31 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.538 HG11 ' CD2' ' A' ' 97' ' ' LEU . 16.6 t -62.39 107.17 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.359 0.599 . . . . 1.0 110.528 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.456 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -115.67 -174.21 17.74 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 115.089 -0.96 . . . . 1.0 110.869 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 68.2 m -57.04 -43.23 81.76 Favored 'General case' 0 C--N 1.319 -0.75 0 O-C-N 123.681 0.283 . . . . 1.0 110.304 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -58.33 -31.26 67.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 1.0 111.536 178.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.554 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 80.2 m80 -79.5 -37.71 36.08 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.834 0.35 . . . . 1.0 110.251 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 41.4 mt -67.97 -19.11 64.92 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.783 -0.644 . . . . 1.0 110.782 177.408 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.44 -3.39 59.0 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.909 -0.587 . . . . 1.0 110.732 -178.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.542 ' HB1' ' O ' ' A' ' 6' ' ' HIS . . . -61.81 152.08 32.52 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.948 -0.569 . . . . 1.0 111.646 179.206 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.63 ' H ' ' HB3' ' A' ' 6' ' ' HIS . 11.4 t70 -79.79 -14.32 58.79 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.071 0.463 . . . . 1.0 109.872 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.784 HD13 HG13 ' A' ' 7' ' ' VAL . 0.3 OUTLIER -154.2 117.06 4.44 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 108.641 -0.874 . . . . 1.0 108.641 -176.818 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.615 ' HB3' HD13 ' A' ' 97' ' ' LEU . 5.3 mp -107.98 106.31 16.5 Favored 'General case' 0 N--CA 1.423 -1.805 0 CA-C-N 115.683 -0.689 . . . . 1.0 109.639 178.209 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.547 HG11 HD23 ' A' ' 110' ' ' LEU . 55.6 t -85.72 91.71 3.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.204 -0.907 . . . . 1.0 110.542 -176.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.7 149.69 29.63 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.332 -0.849 . . . . 1.0 110.85 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.677 ' HG ' ' HG2' ' A' ' 17' ' ' ARG . 3.7 mm? -106.3 1.18 25.68 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.851 -0.613 . . . . 1.0 109.754 178.157 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -154.0 146.98 24.48 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.464 -0.789 . . . . 1.0 110.519 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.406 ' HG2' ' H ' ' A' ' 91' ' ' ARG . 11.4 ptt180 -60.58 -20.65 61.12 Favored 'General case' 0 C--N 1.33 -0.247 0 O-C-N 123.983 0.802 . . . . 1.0 110.946 177.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.726 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 78.9 m-20 -77.63 -47.82 18.36 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.19 -0.67 . . . . 1.0 109.19 178.557 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.737 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 8.8 m170 -61.26 -47.05 87.8 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 109.508 -0.552 . . . . 1.0 109.508 179.002 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.489 ' HA ' HG21 ' A' ' 107' ' ' VAL . . . -58.12 -42.37 85.62 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.1 -0.5 . . . . 1.0 110.732 179.434 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.69 ' O ' ' HG2' ' A' ' 99' ' ' GLN . 16.9 ttm180 -60.27 -45.29 93.8 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 115.636 -0.711 . . . . 1.0 111.47 178.588 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.765 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 50.1 mt -63.23 -49.99 72.01 Favored 'General case' 0 C--O 1.22 -0.475 0 O-C-N 123.52 0.513 . . . . 1.0 109.979 -175.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.737 ' HG ' ' O ' ' A' ' 93' ' ' HIS . 27.3 mt -53.49 -57.74 9.61 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.771 -0.649 . . . . 1.0 111.467 -178.714 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.575 ' HA ' ' HB ' ' A' ' 102' ' ' VAL . 6.6 ptt180 -60.42 -44.82 95.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.042 -0.526 . . . . 1.0 111.778 -176.385 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.69 ' HG2' ' O ' ' A' ' 95' ' ' ARG . 8.4 pt20 -67.71 -20.82 65.31 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.068 0.461 . . . . 1.0 110.608 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.765 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 8.2 mt -80.08 -8.32 59.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.967 -0.56 . . . . 1.0 111.814 179.403 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 147.5 -28.75 1.48 Allowed Glycine 0 C--N 1.331 0.303 0 C-N-CA 119.786 -1.197 . . . . 1.0 112.955 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.816 HG12 ' H ' ' A' ' 103' ' ' GLU . 2.1 t -73.84 -154.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 C-N-CA 123.036 0.535 . . . . 1.0 110.949 -178.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.816 ' H ' HG12 ' A' ' 102' ' ' VAL . 12.5 pt-20 -168.02 165.7 13.45 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.646 -0.872 . . . . 1.0 108.646 -179.092 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.78 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -65.59 -24.02 66.97 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.676 0.274 . . . . 1.0 111.664 -176.277 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.7 -36.62 74.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.418 0.628 . . . . 1.0 109.983 175.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.653 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 7.7 mtt-85 -94.92 -45.16 7.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.039 -0.982 . . . . 1.0 110.704 -177.349 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.78 HG12 ' HA ' ' A' ' 104' ' ' ALA . 7.3 p -79.94 122.6 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-O 121.415 0.626 . . . . 1.0 110.092 -177.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.538 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 7.8 mmm180 -138.12 146.31 42.68 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.079 -0.712 . . . . 1.0 109.079 -178.216 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.438 ' HE3' HG23 ' A' ' 124' ' ' VAL . 86.5 mmm -79.22 134.95 36.66 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.024 -0.534 . . . . 1.0 110.378 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.547 HD23 HG11 ' A' ' 87' ' ' VAL . 3.2 tm? -56.97 -49.18 76.49 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.671 0.272 . . . . 1.0 111.108 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 16.6 ttm180 -69.52 -21.35 63.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.886 0.374 . . . . 1.0 110.53 -177.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.405 ' CB ' ' HB2' ' A' ' 109' ' ' MET . 32.6 t -77.04 -6.04 51.16 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.424 -0.353 . . . . 1.0 111.138 -178.454 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.571 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 85.6 m-85 -87.44 -19.97 27.28 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.952 -0.388 . . . . 1.0 109.952 175.235 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.519 ' HB3' ' HB2' ' A' ' 117' ' ' SER . 61.7 t0 -65.33 118.56 51.45 Favored Pre-proline 0 C--O 1.233 0.19 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.198 -178.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -66.75 -16.73 51.11 Favored 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 122.357 2.038 . . . . 1.0 111.849 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 30.8 mmm-85 -92.91 -21.5 19.79 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.726 -0.67 . . . . 1.0 110.655 -178.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.519 ' HB2' ' HB3' ' A' ' 114' ' ' ASP . 7.2 t -75.59 58.73 1.08 Allowed 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.135 -0.484 . . . . 1.0 111.579 -177.076 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 62.15 -99.17 0.22 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.895 -0.669 . . . . 1.0 112.946 -178.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 91.1 m -158.32 -36.16 0.07 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.503 0.668 . . . . 1.0 110.1 -178.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 26.4 m80 -133.32 134.57 44.0 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.486 178.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -132.24 95.42 3.65 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.087 -0.708 . . . . 1.0 109.087 177.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -94.41 24.05 4.78 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.222 -177.075 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -171.14 135.35 0.98 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.029 -0.532 . . . . 1.0 109.718 -178.018 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.562 ' HB ' ' O ' ' A' ' 89' ' ' LEU . 42.2 t -121.75 152.32 25.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.104 0.478 . . . . 1.0 109.964 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.525 ' HG3' ' NH2' ' A' ' 17' ' ' ARG . 4.2 pt-20 -63.94 179.63 0.5 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.265 -0.88 . . . . 1.0 112.854 -178.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -152.75 115.11 2.81 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 114.586 -1.188 . . . . 1.0 109.274 -179.216 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.654 ' HG3' HG21 ' A' ' 138' ' ' VAL . 73.6 Cg_endo -79.02 92.14 1.16 Allowed 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.389 2.059 . . . . 1.0 112.89 -177.264 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -92.52 -28.37 16.83 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 113.862 1.06 . . . . 1.0 113.862 179.407 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -69.24 -35.31 75.99 Favored 'General case' 0 CA--C 1.512 -0.514 0 C-N-CA 119.189 -1.004 . . . . 1.0 112.803 -173.592 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 77.2 52.82 5.47 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 118.887 -1.625 . . . . 1.0 112.589 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.558 ' H ' ' HB3' ' A' ' 134' ' ' ASP . 3.2 t0 -108.65 172.44 6.84 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 107.781 -1.192 . . . . 1.0 107.781 177.675 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -66.12 -39.19 89.73 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 108.693 -0.854 . . . . 1.0 108.693 176.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 10.7 m -63.44 -49.73 72.57 Favored 'General case' 0 C--O 1.222 -0.365 0 CA-C-N 115.1 -0.955 . . . . 1.0 109.382 177.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.558 ' HB3' ' H ' ' A' ' 131' ' ' ASP . 38.8 t70 -51.67 -37.14 49.25 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.192 -0.913 . . . . 1.0 111.833 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.489 ' CE1' ' HD3' ' A' ' 57' ' ' ARG . 15.3 m-30 -72.69 -52.6 14.59 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.497 0.665 . . . . 1.0 110.694 -178.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -71.38 -22.85 61.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.5 -0.773 . . . . 1.0 111.307 -176.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.62 ' O ' HG23 ' A' ' 141' ' ' VAL . 7.9 tp10 -61.22 -47.66 85.06 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 108.7 -0.852 . . . . 1.0 108.7 176.518 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.654 HG21 ' HG3' ' A' ' 127' ' ' PRO . 75.6 t -56.7 -47.54 82.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 114.419 -1.264 . . . . 1.0 110.084 176.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.518 ' HB2' HG11 ' A' ' 61' ' ' VAL . 52.7 t80 -55.58 -44.56 77.03 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.616 -1.174 . . . . 1.0 110.5 178.66 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.433 ' O ' ' HG2' ' A' ' 143' ' ' GLU . . . -62.83 -44.69 95.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.991 -0.55 . . . . 1.0 111.518 -179.241 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 137' ' ' GLU . 21.2 t -56.28 -48.03 80.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.338 0.59 . . . . 1.0 110.584 178.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.559 HD13 ' HB3' ' A' ' 20' ' ' MET . 5.8 mt -67.11 -49.56 71.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 115.413 -0.812 . . . . 1.0 112.127 -178.541 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.464 ' HA ' ' HG ' ' A' ' 146' ' ' LEU . 11.2 pt-20 -56.19 -32.7 64.61 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.98 0.419 . . . . 1.0 110.451 179.359 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 63.3 m -73.06 -27.4 61.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.902 -0.59 . . . . 1.0 110.612 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.477 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -86.44 -25.09 25.41 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 115.67 -0.696 . . . . 1.0 111.92 178.711 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.749 HD22 ' HB3' ' A' ' 25' ' ' PHE . 14.9 mt -55.49 -36.69 48.58 Favored Pre-proline 0 CA--C 1.546 0.814 0 N-CA-C 112.745 0.646 . . . . 1.0 112.745 -178.037 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.643 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 42.1 Cg_endo -68.58 -14.91 40.65 Favored 'Trans proline' 0 C--N 1.359 1.106 0 C-N-CA 122.317 2.011 . . . . 1.0 111.661 176.712 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.571 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -101.97 -34.12 4.42 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.133 -0.94 . . . . 1.0 110.941 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.501 HD11 HG21 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -72.49 -40.0 67.22 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.18 -1.044 . . . . 1.0 108.18 179.334 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.482 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 0.2 OUTLIER -54.54 -54.28 43.33 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 114.648 -1.16 . . . . 1.0 110.541 175.427 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -57.27 -42.32 81.38 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.125 -0.943 . . . . 1.0 111.445 -175.007 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' TRP . . . . . 0.655 ' HZ3' HD21 ' A' ' 5' ' ' LEU . 18.0 t90 -62.27 -57.91 9.67 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.415 -0.811 . . . . 1.0 110.084 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.506 ' HB ' HD22 ' A' ' 5' ' ' LEU . 7.8 m -60.65 -43.82 95.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.675 -177.437 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.42 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 8.7 m-20 -60.87 -49.55 77.01 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 121.208 0.527 . . . . 1.0 111.015 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 5.4 pt-20 -64.85 -36.26 83.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.977 -0.556 . . . . 1.0 110.656 -178.497 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.53 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 0.6 OUTLIER -74.13 -43.41 57.61 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 115.769 -0.65 . . . . 1.0 110.869 -176.985 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 4.2 pp -66.31 -22.18 66.28 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.124 0.487 . . . . 1.0 109.748 178.362 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -72.08 -51.37 21.9 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.847 -0.615 . . . . 1.0 109.559 175.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.7 3.34 11.9 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.974 0.416 . . . . 1.0 111.569 178.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -78.51 -1.94 36.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.373 0.606 . . . . 1.0 109.935 176.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -97.57 143.05 16.49 Favored Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.388 -0.824 . . . . 1.0 111.57 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -85.57 29.5 0.53 Allowed 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 123.516 2.811 . . . . 1.0 112.65 -178.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 9.4 t . . . . . 0 C--N 1.3 -1.548 0 CA-C-N 114.613 -1.176 . . . . 1.0 109.709 -179.506 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.801 0 N-CA-C 112.391 -0.284 . . . . 1.0 112.391 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ptt? -160.42 173.71 15.2 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.705 -0.48 . . . . 1.0 109.705 -179.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.1 m -84.48 -62.48 1.54 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.273 0.558 . . . . 1.0 110.016 178.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.418 ' HB3' ' HD2' ' A' ' 4' ' ' PRO . 0.2 OUTLIER -157.0 160.47 30.66 Favored Pre-proline 0 C--O 1.236 0.381 0 CA-C-N 115.071 -0.968 . . . . 1.0 108.404 -179.508 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.418 ' HD2' ' HB3' ' A' ' 3' ' ' ASP . 26.2 Cg_endo -69.96 170.04 17.76 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.649 2.232 . . . . 1.0 111.842 176.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.798 HD13 ' HB3' ' A' ' 84' ' ' ASP . 0.2 OUTLIER -67.02 178.46 1.4 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.456 -0.572 . . . . 1.0 109.456 178.101 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.664 ' HA ' ' O ' ' A' ' 39' ' ' ARG . 2.7 t-160 -156.06 89.48 1.15 Allowed 'General case' 0 C--N 1.321 -0.651 0 O-C-N 122.053 -0.404 . . . . 1.0 109.989 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.769 HG13 HD13 ' A' ' 85' ' ' LEU . 2.1 t -96.51 105.57 17.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.366 -0.379 . . . . 1.0 110.134 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.645 ' CG2' ' HG ' ' A' ' 86' ' ' LEU . 13.0 t -108.65 115.44 30.09 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.079 0.466 . . . . 1.0 110.199 -179.634 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.568 ' HD1' ' HB ' ' A' ' 87' ' ' VAL . 0.7 OUTLIER -83.74 129.89 34.95 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.793 -0.447 . . . . 1.0 109.793 -178.952 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.657 HG21 HD11 ' A' ' 97' ' ' LEU . 22.0 t -114.38 113.01 42.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.737 -0.665 . . . . 1.0 111.945 -174.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.516 ' HA ' ' CE1' ' A' ' 93' ' ' HIS . 49.2 t -142.78 155.26 44.81 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.359 -0.608 . . . . 1.0 109.359 178.048 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.1 88.66 2.44 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.393 0.616 . . . . 1.0 111.157 -178.392 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.775 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 140.59 -45.74 0.96 Allowed Glycine 0 N--CA 1.445 -0.754 0 CA-C-N 115.313 -0.858 . . . . 1.0 111.062 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.676 ' ND2' ' H ' ' A' ' 74' ' ' ALA . 61.0 t30 58.63 23.86 11.43 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.674 0.75 . . . . 1.0 112.202 178.262 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.4 pt -124.51 3.88 4.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 O-C-N 121.616 -0.678 . . . . 1.0 111.494 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.673 ' O ' ' HG3' ' A' ' 20' ' ' MET . 27.9 m -129.4 -84.19 0.56 Allowed 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.597 -0.441 . . . . 1.0 111.064 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.49 ' HD3' ' H ' ' A' ' 17' ' ' ARG . 1.5 mpt_? -61.56 -58.83 6.58 Favored 'General case' 0 C--O 1.243 0.728 0 CA-C-N 116.211 -0.449 . . . . 1.0 111.939 -175.524 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.408 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 38.0 m -51.49 -58.58 10.32 Favored Pre-proline 0 CA--C 1.54 0.587 0 N-CA-C 112.982 0.734 . . . . 1.0 112.982 -178.665 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.408 ' HD3' ' HB2' ' A' ' 18' ' ' SER . 51.7 Cg_endo -63.67 -23.57 69.77 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 121.636 1.557 . . . . 1.0 112.495 -177.196 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.673 ' HG3' ' O ' ' A' ' 16' ' ' CYS . 61.2 mtp -61.98 -51.65 67.21 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.674 -0.41 . . . . 1.0 110.349 179.32 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.441 ' HA ' ' HB2' ' A' ' 24' ' ' MET . . . -71.58 -29.42 64.69 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.15 -0.62 . . . . 1.0 110.672 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.632 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 22.1 tt0 -53.17 -53.25 53.26 Favored 'General case' 0 C--O 1.219 -0.514 0 O-C-N 124.166 0.916 . . . . 1.0 110.171 -179.367 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.723 ' O ' ' HB3' ' A' ' 27' ' ' GLN . 0.3 OUTLIER -84.8 -23.11 29.28 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.031 -0.986 . . . . 1.0 110.364 -175.493 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.513 ' HB3' HD11 ' A' ' 146' ' ' LEU . 2.2 mmm -65.22 -76.35 0.07 Allowed 'General case' 0 C--O 1.238 0.477 0 N-CA-C 113.076 0.769 . . . . 1.0 113.076 -179.215 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.759 ' HB3' HD22 ' A' ' 146' ' ' LEU . 18.0 p90 -76.37 -29.38 57.13 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 119.852 -0.739 . . . . 1.0 111.243 -174.774 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.673 ' HB2' HG21 ' A' ' 40' ' ' VAL . . . -64.38 -35.73 81.85 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 119.577 -0.849 . . . . 1.0 110.818 178.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.723 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -63.99 -38.82 92.46 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.63 -0.878 . . . . 1.0 108.63 177.175 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.569 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 71.1 mt-30 -61.04 -41.71 97.09 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 115.285 -0.87 . . . . 1.0 110.638 175.713 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.562 ' HG ' ' O ' ' A' ' 25' ' ' PHE . 90.1 mt -57.07 -62.01 2.05 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 115.956 -0.566 . . . . 1.0 111.172 -179.411 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.699 ' HE ' ' HA ' ' A' ' 27' ' ' GLN . 0.1 OUTLIER -58.06 -32.55 68.12 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 120.468 -0.493 . . . . 1.0 111.325 179.582 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -64.11 -28.07 69.52 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.15 0.426 . . . . 1.0 112.15 176.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.583 ' HG3' ' HG ' ' A' ' 34' ' ' LEU . 7.3 ptp180 -95.4 -20.54 19.01 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 121.843 0.83 . . . . 1.0 109.625 178.042 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 108.77 31.93 3.26 Favored Glycine 0 N--CA 1.441 -0.972 0 CA-C-N 114.833 -1.076 . . . . 1.0 112.101 176.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.583 ' HG ' ' HG3' ' A' ' 32' ' ' ARG . 22.7 mt -119.54 0.5 11.03 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 122.434 -0.451 . . . . 1.0 109.959 -178.63 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.419 ' H ' ' HA ' ' A' ' 30' ' ' ARG . . . -53.9 -32.13 48.11 Favored Glycine 0 C--N 1.331 0.295 0 CA-C-N 115.943 -0.572 . . . . 1.0 113.137 -179.099 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.774 ' HA ' ' NH1' ' A' ' 39' ' ' ARG . 0.1 OUTLIER -89.52 -20.63 23.59 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-O 121.273 0.559 . . . . 1.0 110.312 178.66 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.89 -25.09 40.73 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.568 -0.742 . . . . 1.0 111.127 -177.045 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.74 HG23 ' HB3' ' A' ' 5' ' ' LEU . 0.5 OUTLIER -141.16 124.77 16.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.219 0.533 . . . . 1.0 110.826 179.707 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.774 ' NH1' ' HA ' ' A' ' 36' ' ' ASP . 24.6 mmt180 -95.5 106.5 18.58 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.57 -0.741 . . . . 1.0 111.262 -178.58 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.673 HG21 ' HB2' ' A' ' 26' ' ' ALA . 1.5 m -90.49 137.64 21.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-N 115.884 -0.598 . . . . 1.0 109.396 178.327 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.517 ' O ' ' HA ' ' A' ' 8' ' ' THR . 24.6 p -146.25 -178.07 5.95 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.063 -0.971 . . . . 1.0 110.009 -175.434 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.3 p -158.01 157.18 32.49 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.296 -0.562 . . . . 1.0 110.866 -177.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.606 ' HB2' ' CD2' ' A' ' 80' ' ' HIS . . . -163.23 164.51 25.03 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 121.475 0.655 . . . . 1.0 111.64 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' A' ' 11' ' ' CYS . . . -122.63 133.92 9.4 Favored Glycine 0 N--CA 1.441 -0.984 0 CA-C-N 115.06 -0.973 . . . . 1.0 111.046 177.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.529 HG23 ' CG1' ' A' ' 10' ' ' VAL . 12.3 p -69.68 -23.47 63.45 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.834 0.349 . . . . 1.0 111.762 -177.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.439 ' HA3' ' CZ3' ' A' ' 48' ' ' TRP . . . -109.84 8.48 31.79 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.723 -0.751 . . . . 1.0 113.239 -178.315 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 42.11 38.68 1.16 Allowed 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 113.551 0.945 . . . . 1.0 113.551 178.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.775 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 1.2 m-90 -46.9 -74.29 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.347 0.594 . . . . 1.0 112.278 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.452 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 46.5 m-70 -107.07 42.45 1.3 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.314 -0.857 . . . . 1.0 111.349 -179.085 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.451 HG23 ' HA ' ' A' ' 74' ' ' ALA . 14.6 p -61.58 132.02 26.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.215 178.708 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.35 -14.53 63.52 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.921 -0.657 . . . . 1.0 112.186 -177.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.49 -158.84 0.28 Allowed 'General case' 0 C--O 1.236 0.391 0 CA-C-O 120.986 0.422 . . . . 1.0 109.959 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.3 t -133.55 173.36 11.59 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.494 -0.558 . . . . 1.0 109.494 -178.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.67 148.15 20.82 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.015 -0.539 . . . . 1.0 111.507 -178.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.406 ' OD1' ' HG2' ' A' ' 57' ' ' ARG . 15.6 t70 -68.41 145.8 53.79 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.371 -0.831 . . . . 1.0 111.417 -178.348 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.416 ' HG3' ' N ' ' A' ' 57' ' ' ARG . 6.4 pt-20 -47.58 -37.74 12.97 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.953 -1.021 . . . . 1.0 113.224 178.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.613 ' O ' HG23 ' A' ' 61' ' ' VAL . 19.9 ptp180 -70.68 -44.43 67.02 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 121.136 -0.226 . . . . 1.0 110.777 -176.071 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.404 ' O ' HD13 ' A' ' 62' ' ' LEU . . . -70.15 -30.86 68.13 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.689 -0.486 . . . . 1.0 109.689 -179.19 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.46 -46.75 84.8 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.635 -0.711 . . . . 1.0 109.504 176.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.458 ' O ' ' HG2' ' A' ' 63' ' ' ARG . . . -62.72 -41.98 99.76 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.843 -0.694 . . . . 1.0 111.927 178.249 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 57' ' ' ARG . 97.5 t -58.23 -59.35 3.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.429 0.633 . . . . 1.0 111.622 178.458 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.488 ' HB2' HG22 ' A' ' 69' ' ' THR . 10.0 mp -61.72 -48.05 82.51 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.754 -0.657 . . . . 1.0 111.048 -177.155 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.458 ' HG2' ' O ' ' A' ' 60' ' ' GLY . 22.1 ptt180 -58.74 -31.44 68.32 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.611 -0.268 . . . . 1.0 110.888 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.65 -34.24 76.55 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.223 0.535 . . . . 1.0 110.826 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.452 ' HB2' ' HD2' ' A' ' 67' ' ' TYR . 78.8 m80 -96.91 5.55 50.3 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.587 -0.733 . . . . 1.0 110.866 -178.408 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.85 17.38 63.53 Favored Glycine 0 C--N 1.33 0.236 0 CA-C-N 115.7 -0.682 . . . . 1.0 113.165 176.373 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.544 ' HD1' ' HG2' ' A' ' 27' ' ' GLN . 71.1 m-85 -88.68 154.89 50.78 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-O 120.501 0.191 . . . . 1.0 110.827 179.32 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.596 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 21.9 Cg_endo -67.46 151.81 79.54 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.354 2.036 . . . . 1.0 110.123 174.387 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.488 HG22 ' HB2' ' A' ' 62' ' ' LEU . 67.1 p -132.68 20.15 4.24 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 120.271 -0.572 . . . . 1.0 112.181 -175.457 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.41 ' C ' ' HZ3' ' A' ' 23' ' ' LYS . 31.3 t70 -113.8 128.2 56.31 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.965 -177.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.581 ' HB3' ' NZ ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -165.76 159.44 16.19 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.429 -0.805 . . . . 1.0 108.923 178.838 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -116.35 120.15 37.94 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.627 -0.879 . . . . 1.0 108.627 178.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 49' ' ' HIS . . . -61.03 136.89 58.22 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.833 0.349 . . . . 1.0 111.77 -178.187 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.676 ' H ' ' ND2' ' A' ' 14' ' ' ASN . . . -127.63 163.54 24.0 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.07 178.645 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -98.91 157.26 16.43 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.476 -0.935 . . . . 1.0 108.476 178.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.546 HG11 HD23 ' A' ' 97' ' ' LEU . 41.9 t -71.71 111.98 6.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.159 0.504 . . . . 1.0 110.271 179.229 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.46 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -124.43 -165.21 12.13 Favored Glycine 0 N--CA 1.437 -1.275 0 CA-C-N 115.497 -0.774 . . . . 1.0 111.324 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 83.5 m -56.17 -51.2 68.88 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 122.651 0.381 . . . . 1.0 111.877 -179.297 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.516 ' HG2' ' N ' ' A' ' 80' ' ' HIS . 0.7 OUTLIER -58.15 -29.76 65.83 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.844 -0.616 . . . . 1.0 110.704 -178.589 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.606 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 79.3 m80 -76.82 -41.61 43.63 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 115.793 -0.64 . . . . 1.0 110.349 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.64 ' O ' HG23 ' A' ' 102' ' ' VAL . 16.6 mt -68.83 -18.67 64.2 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.442 176.581 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.06 -5.51 59.2 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.185 -178.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.601 ' HB1' ' O ' ' A' ' 6' ' ' HIS . . . -61.34 153.23 27.27 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.534 -0.757 . . . . 1.0 110.764 179.084 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.798 ' HB3' HD13 ' A' ' 5' ' ' LEU . 12.2 t70 -82.46 -11.93 58.18 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.242 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.769 HD13 HG13 ' A' ' 7' ' ' VAL . 0.3 OUTLIER -156.61 114.19 3.2 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 109.283 -0.636 . . . . 1.0 109.283 -178.224 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.645 ' HG ' ' CG2' ' A' ' 8' ' ' THR . 5.1 mp -105.74 106.33 16.78 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 115.407 -0.815 . . . . 1.0 110.069 178.356 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.6 HG11 HD23 ' A' ' 110' ' ' LEU . 52.6 t -84.79 93.43 3.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 114.772 -1.104 . . . . 1.0 110.856 -176.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.54 143.98 34.34 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.193 -0.912 . . . . 1.0 110.562 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.556 ' O ' ' HB ' ' A' ' 124' ' ' VAL . 4.3 mm? -93.39 -19.24 21.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.494 0.664 . . . . 1.0 109.848 178.337 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -139.86 154.91 47.42 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.443 -0.799 . . . . 1.0 110.311 -178.191 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.592 ' HB3' ' O ' ' A' ' 122' ' ' LEU . 5.2 ptm180 -58.67 -22.32 56.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.889 -0.596 . . . . 1.0 111.619 178.08 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.642 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 94.5 m-20 -75.41 -52.08 11.59 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.861 -0.609 . . . . 1.0 110.278 -178.194 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.669 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 17.5 m170 -55.92 -45.24 78.77 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.38 -0.827 . . . . 1.0 110.814 -179.23 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.428 ' HA ' HD12 ' A' ' 97' ' ' LEU . . . -59.86 -44.07 94.33 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.107 0.48 . . . . 1.0 110.463 178.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 13.6 ttm180 -58.99 -42.65 90.54 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.317 -0.856 . . . . 1.0 111.522 178.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.675 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 34.9 mt -66.32 -47.16 74.43 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.599 -177.678 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.669 ' HG ' ' O ' ' A' ' 93' ' ' HIS . 33.1 mt -53.14 -59.84 4.05 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.189 -0.459 . . . . 1.0 111.725 -177.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.67 ' CA ' HG12 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -58.46 -44.25 89.2 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.406 0.521 . . . . 1.0 112.406 -179.66 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.605 ' HG3' ' O ' ' A' ' 96' ' ' LEU . 1.0 OUTLIER -67.25 -24.74 65.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.115 0.483 . . . . 1.0 109.814 179.599 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.675 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 12.5 mt -80.82 -19.46 44.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.456 -0.793 . . . . 1.0 111.896 178.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 152.71 -22.84 0.82 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 119.37 -1.395 . . . . 1.0 114.314 -177.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.687 HG13 ' N ' ' A' ' 103' ' ' GLU . 0.3 OUTLIER -76.05 -161.92 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-N 117.988 0.894 . . . . 1.0 110.502 -179.096 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.824 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 8.6 pt-20 -158.06 160.27 37.21 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 107.671 -1.233 . . . . 1.0 107.671 -177.665 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.775 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -60.86 -27.08 67.86 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 123.194 0.309 . . . . 1.0 111.183 -175.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.48 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . . . -57.4 -35.38 69.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.101 0.477 . . . . 1.0 110.706 176.327 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.824 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 9.4 mtt-85 -99.51 -39.68 8.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.508 -0.769 . . . . 1.0 111.551 -177.15 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.775 HG12 ' HA ' ' A' ' 104' ' ' ALA . 9.3 p -80.06 122.25 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 120.661 -0.416 . . . . 1.0 110.85 -174.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.497 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 14.3 mmm180 -141.56 150.54 42.22 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 121.846 -0.534 . . . . 1.0 111.057 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.556 ' HE3' HG23 ' A' ' 124' ' ' VAL . 85.7 mmm -80.92 140.0 35.55 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.726 -0.67 . . . . 1.0 110.525 178.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.6 HD23 HG11 ' A' ' 87' ' ' VAL . 3.0 tm? -58.31 -49.73 76.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.588 0.232 . . . . 1.0 111.245 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 47.7 ttt180 -72.03 -15.7 62.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.714 0.292 . . . . 1.0 111.031 -177.136 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.4 t -72.46 -10.62 60.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.659 -0.246 . . . . 1.0 110.636 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.533 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 95.8 m-85 -89.39 -20.1 24.38 Favored 'General case' 0 C--O 1.233 0.203 0 O-C-N 122.224 -0.297 . . . . 1.0 110.826 177.733 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -59.29 119.81 42.4 Favored Pre-proline 0 N--CA 1.466 0.325 0 CA-C-N 115.969 -0.559 . . . . 1.0 111.554 -177.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.74 -22.12 43.87 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.466 2.111 . . . . 1.0 111.869 179.194 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 27.3 mtm180 -86.65 -15.5 39.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.253 -0.43 . . . . 1.0 111.49 -179.072 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.0 m -68.97 93.34 0.56 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.88 0.371 . . . . 1.0 111.184 -178.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -52.23 -54.64 25.58 Favored Glycine 0 CA--C 1.52 0.383 0 CA-C-N 115.17 -0.923 . . . . 1.0 113.338 178.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.471 HG22 ' H ' ' A' ' 120' ' ' HIS . 0.7 OUTLIER -86.07 171.31 11.48 Favored 'General case' 0 C--N 1.32 -0.682 0 O-C-N 122.596 -0.356 . . . . 1.0 110.634 -179.548 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.471 ' H ' HG22 ' A' ' 119' ' ' THR . 36.6 m170 -75.86 133.62 40.54 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.817 -0.438 . . . . 1.0 109.817 177.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -103.19 87.11 2.81 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.066 -0.515 . . . . 1.0 110.933 179.042 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.592 ' O ' ' HB3' ' A' ' 91' ' ' ARG . 2.4 mm? -95.26 15.61 18.82 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.239 -1.022 . . . . 1.0 108.239 175.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -167.76 133.43 1.98 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.358 -1.292 . . . . 1.0 108.182 -177.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.556 ' HB ' ' O ' ' A' ' 89' ' ' LEU . 40.1 t -109.7 156.15 10.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.843 -0.428 . . . . 1.0 109.843 -177.575 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.432 ' H ' ' HG2' ' A' ' 125' ' ' GLU . 12.4 pt-20 -74.05 168.52 19.37 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.859 -0.422 . . . . 1.0 109.859 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.433 ' CG ' HH21 ' A' ' 17' ' ' ARG . 15.9 t70 -156.94 96.41 2.14 Favored Pre-proline 0 C--N 1.319 -0.751 0 N-CA-C 108.387 -0.968 . . . . 1.0 108.387 -175.585 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.714 ' HB2' ' OD1' ' A' ' 134' ' ' ASP . 31.2 Cg_exo -61.88 90.39 0.11 Allowed 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.381 2.054 . . . . 1.0 113.035 -178.234 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -94.25 41.47 1.09 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.18 0.514 . . . . 1.0 111.672 177.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.598 ' CE2' ' HB3' ' A' ' 127' ' ' PRO . 0.0 OUTLIER -111.95 -32.6 6.54 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.8 -0.815 . . . . 1.0 108.8 -179.446 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 68.86 55.92 10.23 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.06 -0.973 . . . . 1.0 113.244 177.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.638 ' H ' ' HB3' ' A' ' 134' ' ' ASP . 44.9 m-20 -124.2 178.5 5.31 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.107 -1.071 . . . . 1.0 108.107 178.247 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 12.0 t-160 -58.77 -36.3 74.16 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.29 -0.633 . . . . 1.0 109.29 179.1 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.5 p -61.55 -37.58 84.32 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.005 -0.998 . . . . 1.0 111.226 177.28 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.714 ' OD1' ' HB2' ' A' ' 127' ' ' PRO . 0.4 OUTLIER -60.31 -44.41 95.46 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 116.058 -0.519 . . . . 1.0 111.352 -177.577 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.533 ' CD1' ' HB2' ' A' ' 57' ' ' ARG . 0.5 OUTLIER -70.87 -48.96 50.98 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.135 0.493 . . . . 1.0 110.391 -175.516 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -70.45 -25.36 63.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.739 -0.664 . . . . 1.0 111.176 -177.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -63.76 -51.07 66.52 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.108 0.48 . . . . 1.0 109.823 177.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.788 ' HA ' HG12 ' A' ' 141' ' ' VAL . 21.3 t -63.11 -41.13 91.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.749 0.785 . . . . 1.0 109.335 177.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.494 ' HB2' HG11 ' A' ' 61' ' ' VAL . 66.8 t80 -56.31 -43.22 78.75 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.566 -0.743 . . . . 1.0 109.727 177.374 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.531 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -66.92 -49.88 64.16 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.389 -0.823 . . . . 1.0 111.871 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.788 HG12 ' HA ' ' A' ' 138' ' ' VAL . 5.6 p -57.2 -43.19 81.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 CA-C-O 121.565 0.698 . . . . 1.0 110.671 -178.565 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.633 HD12 HG12 ' A' ' 138' ' ' VAL . 16.4 mt -68.46 -53.83 25.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 115.031 -0.986 . . . . 1.0 111.934 178.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.536 ' HA ' ' HG ' ' A' ' 146' ' ' LEU . 8.3 pt-20 -57.56 -28.43 63.54 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.513 -0.312 . . . . 1.0 110.372 -179.016 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 3.1 t -73.78 -30.04 62.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.085 0.469 . . . . 1.0 110.265 177.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.468 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -86.57 -23.37 25.83 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 116.187 -0.461 . . . . 1.0 111.904 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.759 HD22 ' HB3' ' A' ' 25' ' ' PHE . 17.5 mt -54.9 -37.56 57.51 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 112.146 0.424 . . . . 1.0 112.146 -178.597 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.622 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 56.1 Cg_endo -69.58 -9.19 25.53 Favored 'Trans proline' 0 C--N 1.364 1.366 0 C-N-CA 122.413 2.076 . . . . 1.0 112.35 177.606 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.533 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -106.09 -33.27 3.51 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 110.257 -1.137 . . . . 1.0 110.257 178.596 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.466 HD11 HG21 ' A' ' 87' ' ' VAL . 0.3 OUTLIER -73.4 -41.66 63.05 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.814 -0.81 . . . . 1.0 108.814 178.934 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.447 ' O ' ' HB2' ' A' ' 154' ' ' ASP . 2.1 m-70 -54.56 -50.88 66.9 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.134 -0.939 . . . . 1.0 110.628 177.067 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -60.98 -46.28 91.39 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.493 -0.776 . . . . 1.0 111.389 -176.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' TRP . . . . . 0.767 ' HZ3' HD11 ' A' ' 5' ' ' LEU . 21.1 t90 -59.45 -55.5 33.88 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.164 -0.925 . . . . 1.0 111.033 -177.414 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.485 HG11 HG21 ' A' ' 7' ' ' VAL . 6.1 m -61.88 -40.15 86.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.44 -177.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.571 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 1.1 t70 -60.03 -56.23 24.19 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 121.562 0.696 . . . . 1.0 110.574 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.629 ' O ' ' HG3' ' A' ' 159' ' ' ARG . 6.2 pt-20 -63.25 -35.66 81.09 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.894 -1.048 . . . . 1.0 110.922 -176.568 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 19.5 mmt-85 -72.17 -45.74 59.22 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.743 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.571 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 4.0 pp -65.77 -24.21 66.89 Favored 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 109.417 -0.586 . . . . 1.0 109.417 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -74.99 -52.89 9.98 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.233 -0.894 . . . . 1.0 111.002 178.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.629 ' HG3' ' O ' ' A' ' 155' ' ' GLU . 0.0 OUTLIER -79.38 -9.39 59.58 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 113.273 0.842 . . . . 1.0 113.273 -175.951 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ASN . . . . . 0.443 ' HA ' HH11 ' A' ' 159' ' ' ARG . 64.9 t30 -63.02 -48.16 79.93 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.65 -0.42 . . . . 1.0 110.883 -177.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 71.49 -159.88 53.93 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.49 -0.862 . . . . 1.0 112.79 177.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -94.06 29.25 0.27 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 123.718 2.945 . . . . 1.0 112.949 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 1.7 t . . . . . 0 C--N 1.306 -1.325 0 CA-C-N 114.936 -1.029 . . . . 1.0 110.268 179.279 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.615 0 N-CA-C 111.945 -0.462 . . . . 1.0 111.945 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.9 mtt -100.42 -166.22 1.3 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 110.179 -0.304 . . . . 1.0 110.179 179.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 75.5 m -154.99 169.49 23.95 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 110.425 -0.213 . . . . 1.0 110.425 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.635 ' HB3' ' HD2' ' A' ' 4' ' ' PRO . 0.6 OUTLIER -67.97 162.41 59.4 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.404 179.397 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.774 ' HG3' ' HE ' ' A' ' 39' ' ' ARG . 49.0 Cg_endo -72.07 171.11 17.41 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 123.05 2.5 . . . . 1.0 113.541 -179.644 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.813 HD21 ' HZ3' ' A' ' 152' ' ' TRP . 0.6 OUTLIER -75.65 -172.58 1.91 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.155 -0.93 . . . . 1.0 110.662 178.219 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.509 ' O ' ' HB1' ' A' ' 83' ' ' ALA . 0.1 OUTLIER -157.11 92.8 1.28 Allowed 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 121.107 -0.237 . . . . 1.0 111.136 179.641 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.639 HG13 HD13 ' A' ' 85' ' ' LEU . 1.9 t -97.12 115.3 36.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 108.802 -0.814 . . . . 1.0 108.802 176.343 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.616 ' CG2' ' HG ' ' A' ' 86' ' ' LEU . 7.2 t -116.28 117.58 30.39 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 120.821 0.343 . . . . 1.0 110.239 178.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.627 ' HD2' ' HB3' ' A' ' 42' ' ' SER . 2.0 m-85 -85.52 133.89 34.06 Favored 'General case' 0 CA--C 1.518 -0.276 0 O-C-N 121.974 -0.454 . . . . 1.0 110.883 -179.08 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.633 HG21 HD11 ' A' ' 97' ' ' LEU . 28.8 t -118.07 118.69 59.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.204 0.526 . . . . 1.0 111.497 -177.594 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.502 ' HA ' ' CE1' ' A' ' 93' ' ' HIS . 33.9 t -146.54 170.82 16.11 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 178.599 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.623 HG23 ' NE2' ' A' ' 93' ' ' HIS . 0.9 OUTLIER -80.64 92.65 6.01 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.25 0.548 . . . . 1.0 110.856 179.959 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.967 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 129.35 -40.39 1.7 Allowed Glycine 0 N--CA 1.441 -0.97 0 C-N-CA 120.597 -0.811 . . . . 1.0 111.74 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.472 HD21 ' CB ' ' A' ' 42' ' ' SER . 4.2 t-20 64.33 14.62 8.89 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.843 0.83 . . . . 1.0 111.338 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.486 ' HA ' ' HG3' ' A' ' 19' ' ' PRO . 14.5 pt -121.54 4.21 6.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 O-C-N 121.705 -0.622 . . . . 1.0 112.074 -177.447 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 6.1 p -120.3 -87.55 0.64 Allowed 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.926 -0.309 . . . . 1.0 111.81 -177.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.445 HH21 ' HB ' ' A' ' 124' ' ' VAL . 12.6 mtp180 -72.21 -45.06 61.86 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.29 0.478 . . . . 1.0 112.29 -175.506 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.567 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 18.5 m -55.01 -56.72 24.82 Favored Pre-proline 0 CA--C 1.541 0.603 0 N-CA-C 112.099 0.407 . . . . 1.0 112.099 179.276 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.494 ' HD3' ' HB2' ' A' ' 18' ' ' SER . 57.6 Cg_endo -68.53 -21.59 39.78 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 121.765 1.644 . . . . 1.0 112.539 -177.798 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.594 ' HB3' HD13 ' A' ' 142' ' ' ILE . 34.0 mmm -60.82 -53.13 61.06 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.601 -0.272 . . . . 1.0 110.32 177.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.473 ' HA ' ' HB2' ' A' ' 24' ' ' MET . . . -75.26 -25.43 58.03 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.234 -0.586 . . . . 1.0 110.61 -179.155 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.615 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 17.8 tt0 -52.31 -53.58 42.5 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 115.489 -0.778 . . . . 1.0 109.94 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.586 ' O ' ' HB3' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -85.88 -23.58 27.0 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.209 -0.905 . . . . 1.0 110.758 -175.787 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.646 ' HB3' HD11 ' A' ' 146' ' ' LEU . 7.0 mmm -61.78 -75.55 0.07 Allowed 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.563 0.579 . . . . 1.0 112.563 -178.558 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.702 ' HB3' HD13 ' A' ' 146' ' ' LEU . 26.5 p90 -80.65 -28.72 36.79 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.179 -0.608 . . . . 1.0 111.573 -174.717 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' A' ' 22' ' ' GLU . . . -63.65 -38.97 93.11 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 119.237 -0.985 . . . . 1.0 110.261 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.612 ' HA ' ' HD3' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -64.88 -37.65 88.35 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 108.845 -0.798 . . . . 1.0 108.845 177.272 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.6 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 79.1 mt-30 -59.02 -47.59 84.66 Favored 'General case' 0 CA--C 1.522 -0.097 0 CA-C-N 116.433 -0.349 . . . . 1.0 110.413 175.628 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 25' ' ' PHE . 95.6 mt -52.07 -56.26 15.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.835 -0.62 . . . . 1.0 111.071 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.612 ' HD3' ' HA ' ' A' ' 27' ' ' GLN . 0.1 OUTLIER -61.67 -37.4 83.93 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.647 -0.421 . . . . 1.0 111.797 178.866 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 8.1 m170 -62.82 -23.39 67.24 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.391 0.515 . . . . 1.0 112.391 178.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.6 ' HG2' ' O ' ' A' ' 28' ' ' GLN . 7.9 ptp180 -98.49 -21.52 16.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.48 0.657 . . . . 1.0 110.185 178.024 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 108.03 39.85 1.78 Allowed Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 115.24 -0.891 . . . . 1.0 112.297 177.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 15.9 mt -137.46 -3.11 1.93 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.034 0.445 . . . . 1.0 109.9 -177.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.463 ' H ' ' HA ' ' A' ' 30' ' ' ARG . . . -62.82 -23.58 65.65 Favored Glycine 0 C--N 1.332 0.325 0 CA-C-N 115.856 -0.611 . . . . 1.0 112.585 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -83.75 -32.86 25.22 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.272 0.558 . . . . 1.0 109.537 176.284 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.49 -15.84 55.75 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.45 -0.796 . . . . 1.0 111.334 -178.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.427 HG13 ' HB3' ' A' ' 5' ' ' LEU . 35.5 t -130.58 121.61 51.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 110.237 -0.282 . . . . 1.0 110.237 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.774 ' HE ' ' HG3' ' A' ' 4' ' ' PRO . 7.2 mmt180 -93.24 134.83 35.04 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 109.873 -0.417 . . . . 1.0 109.873 177.664 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.43 HG11 ' HB2' ' A' ' 26' ' ' ALA . 55.1 t -129.85 119.72 48.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 121.699 0.761 . . . . 1.0 109.877 -177.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.494 ' O ' ' HA ' ' A' ' 8' ' ' THR . 48.0 p -133.65 -174.12 3.43 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 113.693 -1.594 . . . . 1.0 110.809 -175.277 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.627 ' HB3' ' HD2' ' A' ' 9' ' ' PHE . 81.8 p -161.82 166.9 25.73 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 120.931 -0.308 . . . . 1.0 110.47 179.136 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.578 ' HB2' ' CD2' ' A' ' 80' ' ' HIS . . . -164.54 169.61 16.88 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.447 0.642 . . . . 1.0 111.728 -179.32 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -127.85 140.9 12.15 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.266 -0.879 . . . . 1.0 111.028 178.501 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.475 HG21 HD12 ' A' ' 96' ' ' LEU . 39.9 p -76.7 -23.2 53.15 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.935 0.368 . . . . 1.0 111.829 -177.031 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.498 ' HA3' ' CZ3' ' A' ' 48' ' ' TRP . . . -112.03 11.91 26.91 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.511 -0.852 . . . . 1.0 113.156 -177.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.43 ' HB3' ' HB2' ' A' ' 75' ' ' GLN . 2.7 p-10 43.11 39.9 2.1 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 113.572 0.953 . . . . 1.0 113.572 178.165 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.967 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 1.3 m-90 -46.84 -77.0 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.531 0.682 . . . . 1.0 112.306 179.758 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.556 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 11.3 m-70 -105.45 41.77 1.32 Allowed 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.525 -0.761 . . . . 1.0 111.06 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.558 HG23 ' HA ' ' A' ' 74' ' ' ALA . 12.9 p -61.04 125.85 17.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.119 0.485 . . . . 1.0 110.181 178.655 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.805 ' HA2' ' HD3' ' A' ' 72' ' ' ARG . . . 95.27 -15.23 63.74 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 121.06 -0.591 . . . . 1.0 111.637 -176.674 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.529 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 3.3 t -79.58 -159.99 0.23 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.251 0.548 . . . . 1.0 109.746 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 36.1 t -128.14 175.06 8.71 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 109.189 -0.671 . . . . 1.0 109.189 -179.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.57 142.48 39.25 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.87 0.367 . . . . 1.0 111.29 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -62.79 143.62 57.33 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.663 -0.699 . . . . 1.0 112.557 -176.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.601 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 12.2 pt-20 -43.61 -42.32 5.1 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 114.383 -1.28 . . . . 1.0 113.748 178.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.673 ' O ' HG23 ' A' ' 61' ' ' VAL . 10.0 mtt-85 -70.16 -48.4 57.51 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 120.784 0.326 . . . . 1.0 110.462 -176.497 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.38 -31.49 70.89 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.224 -0.898 . . . . 1.0 110.298 -177.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.73 -45.84 84.77 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.66 -0.496 . . . . 1.0 109.66 176.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.07 -39.93 98.62 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.708 -0.758 . . . . 1.0 111.489 178.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.673 HG23 ' O ' ' A' ' 57' ' ' ARG . 88.8 t -58.67 -59.16 4.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-O 121.233 0.54 . . . . 1.0 111.242 178.205 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.679 ' HB2' HG22 ' A' ' 69' ' ' THR . 96.6 mt -60.4 -50.09 74.99 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.939 -0.573 . . . . 1.0 111.54 -177.432 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 6.9 ptm85 -61.72 -27.56 68.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.723 -0.217 . . . . 1.0 111.008 -178.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.7 -34.14 76.3 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.453 0.644 . . . . 1.0 110.387 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -96.41 4.98 51.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.562 -0.744 . . . . 1.0 111.43 -178.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.15 11.48 64.78 Favored Glycine 0 C--N 1.329 0.188 0 C-N-CA 121.026 -0.607 . . . . 1.0 112.743 177.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -89.84 149.75 42.54 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-O 120.691 0.282 . . . . 1.0 110.773 -179.062 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.456 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 37.6 Cg_endo -67.91 156.14 67.05 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.285 1.99 . . . . 1.0 110.878 177.685 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.679 HG22 ' HB2' ' A' ' 62' ' ' LEU . 80.4 p -130.85 14.24 5.3 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 120.191 -0.604 . . . . 1.0 111.032 -176.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -77.2 132.66 38.86 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.513 -0.767 . . . . 1.0 109.856 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.461 ' HB2' ' HE2' ' A' ' 23' ' ' LYS . 54.4 t60 -172.17 148.0 2.11 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.038 0.447 . . . . 1.0 110.797 -177.437 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.805 ' HD3' ' HA2' ' A' ' 51' ' ' GLY . 5.3 tmm_? -131.41 108.45 9.62 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 107.153 -1.425 . . . . 1.0 107.153 176.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 49' ' ' HIS . . . -58.73 139.99 55.44 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.071 -0.968 . . . . 1.0 112.474 -174.744 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.558 ' HA ' HG23 ' A' ' 50' ' ' VAL . . . -134.58 147.16 50.18 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.707 -0.678 . . . . 1.0 110.113 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.43 ' HB2' ' HB3' ' A' ' 47' ' ' ASN . 49.0 tt0 -83.79 153.56 24.03 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 110.116 -0.327 . . . . 1.0 110.116 176.763 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.597 HG11 HD23 ' A' ' 97' ' ' LEU . 82.0 t -63.56 112.56 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.033 -0.531 . . . . 1.0 110.909 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.432 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -122.4 -171.79 13.94 Favored Glycine 0 N--CA 1.442 -0.915 0 N-CA-C 111.055 -0.818 . . . . 1.0 111.055 178.511 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 90.8 m -57.88 -44.19 86.52 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.707 0.289 . . . . 1.0 110.935 -179.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -58.97 -29.99 67.6 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.186 -0.461 . . . . 1.0 111.641 178.123 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.578 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 79.7 m80 -78.66 -39.62 36.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.821 0.343 . . . . 1.0 110.169 179.145 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.712 ' HA ' HD21 ' A' ' 86' ' ' LEU . 16.2 mt -69.49 -15.19 63.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.112 0.482 . . . . 1.0 110.101 177.116 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.37 -5.83 59.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.323 -0.399 . . . . 1.0 110.543 -179.224 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.509 ' HB1' ' O ' ' A' ' 6' ' ' HIS . . . -63.35 154.36 32.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.906 -0.588 . . . . 1.0 110.976 179.155 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.408 ' HA ' HH11 ' A' ' 106' ' ' ARG . 21.2 t70 -80.9 -14.78 57.69 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 109.871 -0.418 . . . . 1.0 109.871 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.756 HD12 ' CE3' ' A' ' 152' ' ' TRP . 0.9 OUTLIER -152.72 113.51 4.13 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.484 -0.78 . . . . 1.0 109.73 -177.43 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.712 HD21 ' HA ' ' A' ' 81' ' ' LEU . 5.5 mp -105.72 87.65 2.64 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.534 -0.757 . . . . 1.0 110.951 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.607 HG23 HD22 ' A' ' 85' ' ' LEU . 54.6 t -66.36 92.88 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 113.806 -1.543 . . . . 1.0 112.237 -178.663 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.06 145.54 32.4 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.393 -1.276 . . . . 1.0 109.917 177.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.506 ' O ' ' HB ' ' A' ' 124' ' ' VAL . 4.0 mm? -98.57 -8.53 26.32 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.955 0.407 . . . . 1.0 110.094 179.374 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.417 ' CG ' ' H ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -152.03 153.81 34.74 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.694 -0.685 . . . . 1.0 111.066 179.945 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -55.3 -27.67 48.35 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.251 -0.886 . . . . 1.0 113.104 -178.468 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.581 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 91.6 m-20 -75.51 -49.97 17.09 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.734 0.302 . . . . 1.0 110.504 -177.199 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.628 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 18.2 m170 -53.94 -46.02 71.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.428 179.046 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.91 -43.94 91.17 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.941 0.4 . . . . 1.0 110.735 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 16.6 ttm180 -61.3 -39.84 91.96 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.722 -0.672 . . . . 1.0 111.602 178.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.581 ' HG ' ' O ' ' A' ' 92' ' ' ASN . 43.9 mt -67.06 -50.74 60.87 Favored 'General case' 0 C--O 1.217 -0.645 0 CA-C-N 116.43 -0.35 . . . . 1.0 110.416 -178.21 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.634 HD13 ' HB3' ' A' ' 86' ' ' LEU . 29.2 mt -52.0 -57.45 9.44 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.971 -0.559 . . . . 1.0 111.387 -177.493 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.714 ' CA ' HG12 ' A' ' 102' ' ' VAL . 9.5 ptt180 -59.75 -44.12 93.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.659 -0.7 . . . . 1.0 112.439 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.546 ' HG3' ' O ' ' A' ' 96' ' ' LEU . 0.9 OUTLIER -67.66 -25.24 65.61 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.394 -0.522 . . . . 1.0 109.895 -179.972 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.494 HD13 ' O ' ' A' ' 96' ' ' LEU . 5.9 mp -77.68 -20.7 53.25 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 116.096 -0.502 . . . . 1.0 111.592 177.411 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 152.87 -21.15 0.78 Allowed Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 119.477 -1.344 . . . . 1.0 114.216 -178.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.714 HG12 ' CA ' ' A' ' 98' ' ' ARG . 0.3 OUTLIER -76.05 -162.35 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 118.048 0.924 . . . . 1.0 110.313 -179.51 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.741 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 10.7 pt-20 -159.34 160.6 35.23 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 107.753 -1.203 . . . . 1.0 107.753 -177.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.721 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -62.2 -25.1 67.6 Favored 'General case' 0 C--N 1.316 -0.876 0 O-C-N 123.465 0.478 . . . . 1.0 111.274 -175.331 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.41 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . . . -59.04 -30.2 67.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.011 0.434 . . . . 1.0 110.546 175.604 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.741 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 11.5 mtt-85 -105.41 -43.16 5.04 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 115.531 -0.759 . . . . 1.0 111.464 -177.666 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.721 HG12 ' HA ' ' A' ' 104' ' ' ALA . 11.3 p -78.38 117.93 24.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.497 -0.557 . . . . 1.0 109.497 -174.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.601 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 8.5 mmm180 -139.24 149.79 44.74 Favored 'General case' 0 C--N 1.322 -0.597 0 O-C-N 121.604 -0.685 . . . . 1.0 110.59 -176.59 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.529 ' HE3' HG23 ' A' ' 124' ' ' VAL . 87.7 mmm -80.39 131.49 35.62 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.079 -0.51 . . . . 1.0 111.26 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.53 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 2.8 tm? -53.54 -50.54 65.27 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 123.402 0.439 . . . . 1.0 111.028 179.684 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.602 ' HB2' HG22 ' A' ' 124' ' ' VAL . 43.7 ttt-85 -71.07 -16.67 62.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.308 -0.406 . . . . 1.0 110.956 -176.638 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 46.8 t -79.81 -2.31 42.75 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 120.706 -0.398 . . . . 1.0 111.034 -179.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.739 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 87.8 m-85 -92.74 -16.61 25.24 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-O 120.914 0.388 . . . . 1.0 109.972 175.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.5 ' HB3' ' HB2' ' A' ' 117' ' ' SER . 22.1 t0 -61.29 116.95 22.22 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.727 -0.669 . . . . 1.0 111.291 -178.261 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.465 ' HD2' ' O ' ' A' ' 144' ' ' SER . 38.2 Cg_endo -66.65 -19.31 54.01 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.607 2.205 . . . . 1.0 111.487 178.418 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 17.6 mmm180 -85.2 -14.3 47.29 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.836 -0.62 . . . . 1.0 110.094 179.327 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.5 ' HB2' ' HB3' ' A' ' 114' ' ' ASP . 10.9 t -71.88 86.97 0.99 Allowed 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.017 -0.538 . . . . 1.0 110.713 -179.355 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -57.28 -41.69 93.1 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.87 -0.681 . . . . 1.0 111.799 177.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.27 153.72 21.25 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 110.228 -0.286 . . . . 1.0 110.228 177.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -73.57 137.54 44.37 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.789 -0.819 . . . . 1.0 108.789 177.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -105.91 89.24 3.02 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.25 -0.432 . . . . 1.0 111.236 -177.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -89.25 7.36 35.89 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.616 -0.883 . . . . 1.0 108.616 176.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -166.16 139.56 4.16 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 114.339 -1.3 . . . . 1.0 108.519 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.602 HG22 ' HB2' ' A' ' 111' ' ' ARG . 85.3 t -98.33 144.47 11.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 110.292 -0.262 . . . . 1.0 110.292 -177.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -64.59 -176.52 0.25 Allowed 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.116 -0.493 . . . . 1.0 111.547 -177.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -153.46 159.57 31.98 Favored Pre-proline 0 C--N 1.326 -0.429 0 N-CA-C 109.93 -0.396 . . . . 1.0 109.93 -174.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.605 ' HB3' ' HB3' ' A' ' 134' ' ' ASP . 77.2 Cg_exo -53.57 154.16 16.5 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.757 2.305 . . . . 1.0 112.389 177.3 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -94.55 -36.16 11.94 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.668 -0.696 . . . . 1.0 109.73 -178.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -134.25 -24.18 1.64 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.685 -0.689 . . . . 1.0 111.214 176.272 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 85.72 53.64 2.99 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.483 -0.865 . . . . 1.0 112.111 178.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -115.57 -167.92 1.33 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.344 -0.984 . . . . 1.0 108.344 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 15.2 t-80 -58.03 -39.28 77.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.632 0.253 . . . . 1.0 110.653 -179.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.3 p -62.17 -38.69 90.02 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.026 -0.533 . . . . 1.0 111.663 179.101 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.605 ' HB3' ' HB3' ' A' ' 127' ' ' PRO . 1.4 m-20 -69.62 -33.97 73.4 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.35 -0.841 . . . . 1.0 111.382 -177.16 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.44 ' CE1' ' HD3' ' A' ' 57' ' ' ARG . 8.5 m-85 -70.68 -45.39 65.14 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.312 0.577 . . . . 1.0 110.069 -177.435 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -70.82 -26.54 63.34 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.333 -0.848 . . . . 1.0 110.248 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.561 ' O ' HG23 ' A' ' 141' ' ' VAL . 11.7 tp10 -62.76 -48.77 77.75 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.289 0.566 . . . . 1.0 110.048 178.348 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.679 ' HA ' HG23 ' A' ' 141' ' ' VAL . 73.5 t -61.51 -40.37 86.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.36 -0.836 . . . . 1.0 110.044 177.557 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.535 ' HB2' HG11 ' A' ' 61' ' ' VAL . 35.7 t80 -53.65 -42.12 67.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.129 -0.942 . . . . 1.0 109.204 175.642 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.637 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -67.18 -38.17 84.94 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.343 -0.844 . . . . 1.0 110.599 177.657 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.679 HG23 ' HA ' ' A' ' 138' ' ' VAL . 13.2 t -56.6 -53.58 39.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.58 0.705 . . . . 1.0 109.986 176.352 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.594 HD13 ' HB3' ' A' ' 20' ' ' MET . 6.0 mt -62.9 -50.43 79.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 114.883 -1.053 . . . . 1.0 111.842 -178.514 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.637 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 8.3 pt-20 -55.54 -33.33 63.72 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.628 0.252 . . . . 1.0 110.396 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.465 ' O ' ' HD2' ' A' ' 115' ' ' PRO . 2.0 t -74.18 -28.53 61.33 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-O 121.064 0.459 . . . . 1.0 110.327 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.45 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -86.41 -23.3 26.14 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 116.329 -0.396 . . . . 1.0 111.851 179.228 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.702 HD13 ' HB3' ' A' ' 25' ' ' PHE . 11.9 mt -55.45 -38.31 66.5 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 112.37 0.507 . . . . 1.0 112.37 -179.063 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.621 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 58.0 Cg_endo -70.81 -10.13 27.12 Favored 'Trans proline' 0 C--N 1.359 1.107 0 C-N-CA 122.56 2.173 . . . . 1.0 112.211 178.122 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.739 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -105.12 -33.44 3.71 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 110.442 -1.063 . . . . 1.0 110.442 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.634 HD23 ' CE2' ' A' ' 25' ' ' PHE . 13.0 tp -73.86 -37.41 64.79 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.451 -1.314 . . . . 1.0 107.451 177.341 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.451 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 0.2 OUTLIER -54.24 -51.5 64.29 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 114.549 -1.205 . . . . 1.0 109.57 174.195 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -59.16 -46.65 87.84 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.963 -1.017 . . . . 1.0 111.342 -176.412 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' TRP . . . . . 0.813 ' HZ3' HD21 ' A' ' 5' ' ' LEU . 28.7 t90 -63.0 -52.17 64.0 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.49 -0.777 . . . . 1.0 111.056 -178.161 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.473 HG13 ' O ' ' A' ' 149' ' ' LEU . 12.3 m -61.01 -39.39 82.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 120.545 -0.462 . . . . 1.0 109.919 -179.416 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.401 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 0.4 OUTLIER -61.11 -51.54 68.7 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 116.417 -0.356 . . . . 1.0 111.076 177.413 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.544 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 4.8 pt-20 -60.18 -39.34 86.12 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.256 0.55 . . . . 1.0 110.235 -178.017 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.558 ' HG3' ' CH2' ' A' ' 152' ' ' TRP . 17.3 mmt85 -72.11 -46.24 57.44 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.369 -0.832 . . . . 1.0 111.437 -176.133 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 4.3 pp -67.14 -22.8 65.76 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.317 -0.623 . . . . 1.0 109.317 179.331 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -73.82 -51.21 17.08 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.544 -0.753 . . . . 1.0 110.195 178.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 1.4 ptp85 -77.67 0.8 21.97 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 112.429 0.529 . . . . 1.0 112.429 -179.254 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -71.81 -4.18 26.44 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.947 -0.39 . . . . 1.0 109.947 177.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 35.5 -144.47 0.08 OUTLIER Glycine 0 C--N 1.335 0.502 0 CA-C-N 114.787 -1.097 . . . . 1.0 114.639 -179.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -92.24 -9.72 2.44 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 123.029 2.486 . . . . 1.0 113.12 177.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 68.9 m . . . . . 0 C--O 1.25 1.097 0 CA-C-N 114.972 -1.013 . . . . 1.0 111.742 -178.194 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 0' ' ' GLY . . . . . 0.508 ' CA ' ' HA ' ' A' ' 163' ' ' SER . . . . . . . . 0 N--CA 1.484 1.835 0 N-CA-C 112.288 -0.325 . . . . 1.0 112.288 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.56 ' H ' ' HA ' ' A' ' 163' ' ' SER . 64.1 mtt 65.65 101.18 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.308 0.643 . . . . 1.0 110.947 -178.572 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 73.6 m -76.31 177.8 7.0 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-O 120.739 0.305 . . . . 1.0 110.913 178.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.87 150.81 97.52 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-O 121.348 0.594 . . . . 1.0 112.015 -179.439 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.595 ' HB2' ' HG2' ' A' ' 39' ' ' ARG . 11.1 Cg_endo -58.63 168.61 3.94 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 124.213 3.275 . . . . 1.0 114.803 -175.577 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.71 HD21 ' HZ3' ' A' ' 152' ' ' TRP . 0.7 OUTLIER -70.79 -174.14 0.88 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 114.006 -1.452 . . . . 1.0 110.118 179.949 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.669 ' HA ' ' O ' ' A' ' 39' ' ' ARG . 1.4 t-160 -157.54 93.3 1.28 Allowed 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.493 -0.483 . . . . 1.0 111.159 -178.487 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.719 HG13 HD13 ' A' ' 85' ' ' LEU . 2.5 t -98.27 108.63 22.33 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.454 0 N-CA-C 109.916 -0.402 . . . . 1.0 109.916 177.535 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.533 ' HA ' ' O ' ' A' ' 41' ' ' THR . 14.7 t -109.88 116.88 32.44 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.143 0.497 . . . . 1.0 110.937 -179.692 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.561 ' CE2' ' HA ' ' A' ' 22' ' ' GLU . 0.4 OUTLIER -86.95 129.43 34.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.902 0.382 . . . . 1.0 110.653 -179.166 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.674 HG21 HD21 ' A' ' 97' ' ' LEU . 41.2 t -114.14 116.59 53.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.914 -0.585 . . . . 1.0 111.782 -176.206 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.514 ' HA ' ' CE1' ' A' ' 93' ' ' HIS . 45.1 t -145.32 151.9 39.05 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.409 178.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.34 99.71 2.99 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.285 0.564 . . . . 1.0 110.423 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.558 ' O ' HG12 ' A' ' 15' ' ' ILE . . . 140.02 -32.85 2.16 Favored Glycine 0 C--O 1.217 -0.951 0 CA-C-N 115.555 -0.748 . . . . 1.0 111.488 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.579 ' OD1' ' HB1' ' A' ' 73' ' ' ALA . 34.3 p30 48.7 20.98 0.38 Allowed 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 125.268 1.427 . . . . 1.0 113.901 179.198 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.558 HG12 ' O ' ' A' ' 13' ' ' GLY . 5.3 pt -139.46 10.26 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 122.233 -0.292 . . . . 1.0 111.362 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.419 ' O ' ' HG2' ' A' ' 20' ' ' MET . 47.9 t -125.1 -87.34 0.61 Allowed 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.263 -0.575 . . . . 1.0 112.131 -178.251 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.924 HH22 ' HA ' ' A' ' 126' ' ' ASP . 35.8 mtt180 -71.21 -39.47 71.72 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.23 0.456 . . . . 1.0 112.23 -174.124 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.938 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 16.5 m -58.29 -58.59 17.8 Favored Pre-proline 0 CA--C 1.543 0.677 0 N-CA-C 111.753 0.279 . . . . 1.0 111.753 179.155 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.639 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 38.1 Cg_endo -63.71 -23.94 69.31 Favored 'Trans proline' 0 C--N 1.358 1.042 0 C-N-CA 122.341 2.027 . . . . 1.0 112.431 178.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.678 ' HB3' HD13 ' A' ' 142' ' ' ILE . 49.0 mmm -59.74 -55.47 33.97 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.228 -0.286 . . . . 1.0 110.228 179.284 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.454 ' HA ' ' HB2' ' A' ' 24' ' ' MET . . . -75.36 -26.19 58.32 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.238 -0.585 . . . . 1.0 110.522 -179.425 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.625 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 11.8 tt0 -52.44 -54.3 34.01 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 115.377 -0.828 . . . . 1.0 110.008 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.722 ' HE3' ' HB2' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -84.78 -23.44 29.19 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.362 -0.836 . . . . 1.0 110.576 -175.844 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.671 ' HB3' HD11 ' A' ' 146' ' ' LEU . 5.2 mmm -62.82 -75.74 0.07 Allowed 'General case' 0 C--O 1.237 0.442 0 N-CA-C 112.679 0.622 . . . . 1.0 112.679 -178.427 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.774 ' HB3' HD22 ' A' ' 146' ' ' LEU . 18.6 p90 -79.06 -28.92 43.22 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 119.848 -0.741 . . . . 1.0 111.251 -174.694 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.69 ' HB2' HG21 ' A' ' 40' ' ' VAL . . . -64.06 -37.15 86.38 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 119.486 -0.886 . . . . 1.0 110.661 179.391 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.607 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -64.54 -38.69 91.87 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.676 -0.861 . . . . 1.0 108.676 176.507 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.555 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 77.8 mt-30 -60.63 -41.56 95.12 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.619 -0.718 . . . . 1.0 110.426 176.07 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.653 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 88.2 mt -57.01 -58.97 5.84 Favored 'General case' 0 C--O 1.225 -0.201 0 CA-C-N 115.774 -0.648 . . . . 1.0 110.89 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.531 ' HD3' ' HA ' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -59.31 -35.37 73.67 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.204 -0.598 . . . . 1.0 111.163 178.654 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -63.33 -26.29 68.7 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.244 0.461 . . . . 1.0 112.244 177.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.653 ' HG2' ' O ' ' A' ' 29' ' ' LEU . 4.0 ptm85 -96.21 -23.37 16.75 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 119.775 -0.77 . . . . 1.0 109.954 178.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 113.47 34.65 1.71 Allowed Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.174 -0.921 . . . . 1.0 112.433 177.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 25.8 mt -129.37 5.08 5.19 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.853 -0.425 . . . . 1.0 109.853 -178.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.452 ' HA3' ' HB3' ' A' ' 30' ' ' ARG . . . -59.39 -31.6 70.54 Favored Glycine 0 C--N 1.332 0.308 0 CA-C-N 115.819 -0.628 . . . . 1.0 112.967 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -88.17 -20.85 25.03 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.864 0.364 . . . . 1.0 110.186 176.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.02 -25.05 40.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.814 -0.63 . . . . 1.0 111.299 -178.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.644 HG13 ' HB3' ' A' ' 5' ' ' LEU . 5.9 t -130.13 126.29 61.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 121.106 -0.238 . . . . 1.0 110.604 -178.337 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.669 ' O ' ' HA ' ' A' ' 6' ' ' HIS . 24.2 mmt180 -99.61 98.89 9.7 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.185 0.517 . . . . 1.0 110.876 177.708 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.69 HG21 ' HB2' ' A' ' 26' ' ' ALA . 1.5 m -88.45 136.75 22.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 CA-C-N 115.703 -0.68 . . . . 1.0 109.299 178.228 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.533 ' O ' ' HA ' ' A' ' 8' ' ' THR . 28.9 p -146.59 -179.8 7.02 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.117 -0.947 . . . . 1.0 109.756 -175.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.938 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 95.1 p -158.19 161.4 37.83 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.382 -0.527 . . . . 1.0 110.936 -178.744 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.502 ' HB2' ' CD2' ' A' ' 80' ' ' HIS . . . -165.09 168.37 17.36 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.309 0.576 . . . . 1.0 111.415 -179.201 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -124.68 132.15 8.08 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 110.805 -0.918 . . . . 1.0 110.805 177.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.591 HG23 ' CG1' ' A' ' 10' ' ' VAL . 20.2 p -66.72 -28.82 68.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.948 0.404 . . . . 1.0 111.446 -176.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -101.64 7.13 55.49 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.653 -0.784 . . . . 1.0 113.059 -176.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 42.85 39.39 1.7 Allowed 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 113.46 0.911 . . . . 1.0 113.46 178.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -47.18 -79.64 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.635 0.731 . . . . 1.0 112.533 178.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -103.79 42.11 1.21 Allowed 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.992 -1.004 . . . . 1.0 111.095 -178.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.411 HG23 ' HA ' ' A' ' 74' ' ' ALA . 9.4 p -60.53 125.63 17.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.797 -0.638 . . . . 1.0 110.408 178.469 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.33 -12.76 64.99 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.703 -0.76 . . . . 1.0 111.834 -177.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.33 -161.06 0.38 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.728 -0.471 . . . . 1.0 109.728 178.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 71' ' ' HIS . 30.0 t -127.34 169.45 13.56 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.512 -0.921 . . . . 1.0 108.512 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -51.14 138.96 19.2 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.921 0.391 . . . . 1.0 111.707 -179.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.748 ' OD1' ' HG2' ' A' ' 57' ' ' ARG . 12.1 t70 -62.62 140.97 58.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.585 -0.734 . . . . 1.0 111.05 -176.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -51.06 -33.62 26.45 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.793 1.035 . . . . 1.0 113.793 -178.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.748 ' HG2' ' OD1' ' A' ' 55' ' ' ASP . 9.9 ptm180 -72.63 -41.16 65.81 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 118.958 0.799 . . . . 1.0 110.619 -178.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.15 -38.89 75.57 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.134 0.493 . . . . 1.0 109.955 179.221 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.13 -42.8 99.2 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.517 -0.765 . . . . 1.0 109.909 178.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.414 ' O ' ' HG2' ' A' ' 63' ' ' ARG . . . -57.82 -45.92 92.97 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.903 -0.665 . . . . 1.0 113.224 178.288 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 5.8 m -72.88 -39.75 59.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 117.585 0.692 . . . . 1.0 111.414 -178.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.632 ' HB2' HG22 ' A' ' 69' ' ' THR . 94.8 mt -60.92 -55.2 35.81 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 120.774 0.321 . . . . 1.0 110.5 179.063 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.414 ' HG2' ' O ' ' A' ' 60' ' ' GLY . 11.7 ptm180 -58.59 -33.16 69.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.75 -0.659 . . . . 1.0 110.729 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.95 -34.48 78.08 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.081 0.467 . . . . 1.0 110.932 179.196 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -95.62 5.68 50.86 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.891 -0.595 . . . . 1.0 111.409 -178.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.91 12.4 66.23 Favored Glycine 0 N--CA 1.452 -0.267 0 CA-C-N 115.589 -0.732 . . . . 1.0 112.575 176.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.406 ' CD1' ' HG2' ' A' ' 27' ' ' GLN . 65.6 m-85 -91.5 147.88 36.24 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-O 120.625 0.25 . . . . 1.0 110.827 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.547 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 38.1 Cg_endo -69.0 154.85 70.05 Favored 'Trans proline' 0 CA--C 1.508 -0.799 0 C-N-CA 122.529 2.152 . . . . 1.0 110.544 177.106 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.632 HG22 ' HB2' ' A' ' 62' ' ' LEU . 27.9 p -127.85 14.85 6.92 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.226 0.536 . . . . 1.0 110.428 -178.054 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -84.03 119.03 24.45 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.32 -0.855 . . . . 1.0 109.839 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.722 ' HB2' ' HE3' ' A' ' 23' ' ' LYS . 3.5 t60 -162.18 142.58 10.14 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.334 -176.56 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 -113.69 115.52 27.99 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 107.887 -1.153 . . . . 1.0 107.887 177.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.579 ' HB1' ' OD1' ' A' ' 14' ' ' ASN . . . -60.02 138.44 57.86 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 112.28 0.474 . . . . 1.0 112.28 -177.461 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.411 ' HA ' HG23 ' A' ' 50' ' ' VAL . . . -134.74 158.02 45.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.228 178.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -94.09 155.43 17.09 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.385 -0.598 . . . . 1.0 109.385 177.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.473 HG11 ' CD2' ' A' ' 97' ' ' LEU . 5.0 t -69.63 113.31 5.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.559 -0.534 . . . . 1.0 109.559 178.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.506 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -125.31 -166.65 12.38 Favored Glycine 0 N--CA 1.44 -1.061 0 CA-C-N 115.44 -0.8 . . . . 1.0 111.353 -179.162 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 83.8 m -55.83 -53.31 58.26 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.967 0.413 . . . . 1.0 111.623 -178.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.505 ' CD ' ' H ' ' A' ' 79' ' ' GLU . 1.6 pm0 -56.14 -32.72 64.51 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.415 -0.811 . . . . 1.0 111.287 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.502 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 78.3 m80 -74.81 -39.73 61.52 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.048 -0.524 . . . . 1.0 109.727 179.154 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.608 ' HA ' HD21 ' A' ' 86' ' ' LEU . 29.5 mt -69.03 -20.76 64.13 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.89 -0.595 . . . . 1.0 110.997 177.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.41 -4.6 59.21 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.773 -177.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.55 ' HB1' ' O ' ' A' ' 6' ' ' HIS . . . -59.58 153.61 19.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.706 -0.679 . . . . 1.0 111.064 179.234 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -79.4 -16.82 55.58 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.162 0.506 . . . . 1.0 110.036 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.719 HD13 HG13 ' A' ' 7' ' ' VAL . 0.3 OUTLIER -152.91 114.12 4.2 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.403 -0.817 . . . . 1.0 109.088 -178.057 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.615 ' HB3' HD13 ' A' ' 97' ' ' LEU . 4.9 mp -104.32 106.48 17.0 Favored 'General case' 0 N--CA 1.424 -1.726 0 CA-C-N 115.322 -0.854 . . . . 1.0 109.724 178.124 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.679 HG11 HD23 ' A' ' 110' ' ' LEU . 53.9 t -86.67 94.98 4.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 114.926 -1.034 . . . . 1.0 111.242 -177.173 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.92 143.68 31.49 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.501 -0.772 . . . . 1.0 110.805 178.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.488 HD23 ' HB2' ' A' ' 11' ' ' CYS . 4.4 mm? -93.93 -16.29 24.12 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.758 -0.655 . . . . 1.0 109.535 178.293 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -141.49 152.48 44.22 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.504 -0.771 . . . . 1.0 110.514 -177.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.425 ' HG2' ' H ' ' A' ' 91' ' ' ARG . 9.2 ptt180 -61.15 -21.45 63.77 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.649 0.593 . . . . 1.0 111.238 177.162 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.689 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 95.4 m-20 -73.84 -50.6 19.61 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 109.644 -0.502 . . . . 1.0 109.644 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.66 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 8.5 m170 -60.16 -43.63 95.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.452 -0.795 . . . . 1.0 109.786 178.594 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.95 -44.68 94.26 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.164 0.507 . . . . 1.0 110.544 179.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.477 ' O ' ' HG2' ' A' ' 98' ' ' ARG . 0.3 OUTLIER -57.83 -44.07 86.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.38 -0.827 . . . . 1.0 111.225 178.173 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.744 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 50.8 mt -64.69 -49.87 69.21 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 116.279 -0.418 . . . . 1.0 110.49 -177.162 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.674 HD21 HG21 ' A' ' 10' ' ' VAL . 49.3 mt -51.97 -56.76 12.2 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.947 -0.57 . . . . 1.0 111.641 -178.586 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.477 ' HG2' ' O ' ' A' ' 95' ' ' ARG . 26.1 ptt85 -59.62 -45.57 91.56 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.138 -0.483 . . . . 1.0 111.729 -176.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.64 ' HG3' ' O ' ' A' ' 96' ' ' LEU . 1.2 pp0? -69.42 -21.55 63.74 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 120.967 0.413 . . . . 1.0 110.857 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.744 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 10.8 mt -78.72 -6.82 56.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.043 -0.526 . . . . 1.0 111.966 -178.393 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 144.1 -29.31 1.94 Allowed Glycine 0 CA--C 1.506 -0.479 0 C-N-CA 119.828 -1.177 . . . . 1.0 113.021 178.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.765 HG12 ' H ' ' A' ' 103' ' ' GLU . 1.6 t -74.85 -153.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-O 121.541 0.686 . . . . 1.0 110.814 -178.524 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.765 ' H ' HG12 ' A' ' 102' ' ' VAL . 12.6 pt-20 -163.59 159.45 21.83 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.895 -1.15 . . . . 1.0 107.895 -178.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.475 ' HA ' ' HB ' ' A' ' 107' ' ' VAL . . . -67.71 -17.28 64.51 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.665 -0.414 . . . . 1.0 112.031 -173.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.92 -37.17 76.06 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 173.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.633 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 2.5 mtp85 -94.73 -34.98 12.33 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 114.744 -1.116 . . . . 1.0 110.422 -178.61 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 103' ' ' GLU . 39.5 t -79.57 114.56 20.57 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.423 -179.106 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.475 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 15.1 mmt180 -135.42 147.37 48.95 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 120.212 -0.595 . . . . 1.0 110.403 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.657 ' HB2' ' HB2' ' A' ' 112' ' ' SER . 77.0 mmm -78.07 139.05 39.06 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.691 -0.686 . . . . 1.0 110.037 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.679 HD23 HG11 ' A' ' 87' ' ' VAL . 2.9 tm? -56.89 -50.18 73.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.602 0.239 . . . . 1.0 110.963 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.09 -12.08 61.04 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.082 0.468 . . . . 1.0 110.747 -177.465 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.805 ' HB2' ' HB3' ' A' ' 121' ' ' ALA . 32.5 t -78.69 -4.86 51.22 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.978 -0.555 . . . . 1.0 111.011 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.581 ' HZ ' HD21 ' A' ' 85' ' ' LEU . 86.4 m-85 -91.8 -21.06 20.87 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.049 0.452 . . . . 1.0 109.873 175.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -61.25 121.02 60.13 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.303 -0.862 . . . . 1.0 110.533 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -67.13 -17.86 50.83 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 122.723 2.282 . . . . 1.0 112.267 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.453 ' HA ' ' HD3' ' A' ' 116' ' ' ARG . 1.2 mmt180 -93.99 0.46 56.03 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.995 -0.548 . . . . 1.0 111.186 -179.034 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 31.7 t -60.4 -68.35 0.31 Allowed 'General case' 0 C--N 1.332 -0.154 0 O-C-N 123.322 0.389 . . . . 1.0 111.018 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 149.95 -102.52 0.23 Allowed Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.736 -0.745 . . . . 1.0 111.412 179.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 20.5 m -103.71 -56.22 2.25 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.126 0.489 . . . . 1.0 110.264 178.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 24.7 m-70 -150.87 150.97 31.56 Favored 'General case' 0 CA--C 1.5 -0.951 0 CA-C-N 115.853 -0.612 . . . . 1.0 110.712 178.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.805 ' HB3' ' HB2' ' A' ' 112' ' ' SER . . . -97.79 161.9 13.52 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 107.456 -1.313 . . . . 1.0 107.456 173.352 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.664 HD13 ' O ' ' A' ' 121' ' ' ALA . 2.4 mm? -137.25 -29.4 0.89 Allowed 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.377 -0.829 . . . . 1.0 110.352 -174.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.617 ' HA ' ' HE1' ' A' ' 109' ' ' MET . 0.7 OUTLIER -173.79 154.93 2.52 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.988 -177.362 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 74.5 t -98.61 141.7 15.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.883 -0.598 . . . . 1.0 109.765 178.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -162.02 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.276 -1.329 . . . . 1.0 112.802 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.924 ' HA ' HH22 ' A' ' 17' ' ' ARG . 5.3 p-10 -158.53 142.43 11.21 Favored Pre-proline 0 C--N 1.318 -0.775 0 CA-C-N 114.714 -1.13 . . . . 1.0 108.056 179.135 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.607 ' HB3' ' HB3' ' A' ' 134' ' ' ASP . 72.8 Cg_exo -44.47 154.86 0.29 Allowed 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.35 2.7 . . . . 1.0 113.028 -176.69 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.573 ' HD2' ' CD2' ' A' ' 129' ' ' TYR . 49.7 t80 -102.14 -35.87 8.75 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.478 -0.783 . . . . 1.0 111.641 -174.431 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.573 ' CD2' ' HD2' ' A' ' 128' ' ' TYR . 0.2 OUTLIER -139.0 -25.88 0.86 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 120.541 -0.463 . . . . 1.0 111.698 -179.736 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 93.82 77.45 1.37 Allowed Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.24 -0.981 . . . . 1.0 111.975 179.027 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -140.1 -172.6 3.44 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.77 -0.826 . . . . 1.0 108.77 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -61.08 -33.59 73.58 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.956 -0.387 . . . . 1.0 109.956 179.088 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 9.9 p -62.41 -53.65 51.79 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.707 -0.679 . . . . 1.0 110.342 178.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.607 ' HB3' ' HB3' ' A' ' 127' ' ' PRO . 1.8 m-20 -53.9 -35.77 61.99 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.966 0.413 . . . . 1.0 111.651 -178.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 14.4 m-30 -71.07 -53.1 15.85 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.391 -0.368 . . . . 1.0 110.561 -178.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.431 ' HA ' ' HB3' ' A' ' 139' ' ' PHE . 20.4 mt-10 -76.42 -16.25 59.74 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.883 -178.01 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.577 ' O ' HG23 ' A' ' 141' ' ' VAL . 23.5 tp10 -63.99 -49.98 70.36 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.994 -0.743 . . . . 1.0 108.994 175.225 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.405 ' O ' HD12 ' A' ' 142' ' ' ILE . 87.2 t -59.41 -42.91 89.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.323 -0.853 . . . . 1.0 108.889 175.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.431 ' HB3' ' HA ' ' A' ' 136' ' ' GLU . 45.6 t80 -53.9 -43.41 69.67 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.159 -1.382 . . . . 1.0 109.553 175.42 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.558 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -65.03 -40.86 95.43 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.583 -0.735 . . . . 1.0 110.913 179.012 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 137' ' ' GLU . 21.5 t -56.17 -48.63 78.95 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 CA-C-O 121.868 0.842 . . . . 1.0 109.537 177.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.678 HD13 ' HB3' ' A' ' 20' ' ' MET . 5.3 mt -65.62 -51.88 57.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 114.763 -1.108 . . . . 1.0 111.593 -179.346 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.558 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 8.8 pt-20 -56.09 -33.21 64.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.745 0.307 . . . . 1.0 110.506 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 72.7 m -72.37 -28.44 63.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.889 -0.596 . . . . 1.0 110.927 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.465 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -87.61 -23.86 24.15 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-N 115.838 -0.619 . . . . 1.0 111.801 179.208 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.774 HD22 ' HB3' ' A' ' 25' ' ' PHE . 13.6 mt -55.86 -37.97 63.02 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 120.562 -0.455 . . . . 1.0 112.033 -177.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.632 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 57.8 Cg_endo -69.73 -9.65 26.65 Favored 'Trans proline' 0 C--N 1.363 1.314 0 C-N-CA 122.666 2.244 . . . . 1.0 112.084 178.223 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.56 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -106.09 -32.28 3.83 Favored Glycine 0 N--CA 1.442 -0.934 0 N-CA-C 109.896 -1.282 . . . . 1.0 109.896 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.473 ' O ' HG13 ' A' ' 153' ' ' VAL . 0.4 OUTLIER -74.96 -39.83 61.11 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.448 -0.945 . . . . 1.0 108.448 178.507 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -54.52 -50.99 66.53 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.364 -0.835 . . . . 1.0 110.578 175.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -60.79 -45.76 93.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.367 -0.833 . . . . 1.0 111.611 -176.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' TRP . . . . . 0.71 ' HZ3' HD21 ' A' ' 5' ' ' LEU . 22.2 t90 -60.2 -55.24 36.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.136 -0.938 . . . . 1.0 110.695 -177.749 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.473 HG13 ' O ' ' A' ' 149' ' ' LEU . 5.3 m -61.19 -40.39 85.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.524 -0.307 . . . . 1.0 110.527 -178.047 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.454 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 0.5 OUTLIER -60.95 -53.92 51.32 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.085 0.469 . . . . 1.0 111.104 179.216 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.606 ' O ' ' HG2' ' A' ' 159' ' ' ARG . 10.5 pt-20 -61.97 -36.47 81.57 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.698 -0.683 . . . . 1.0 110.654 -177.108 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.458 ' O ' ' HG3' ' A' ' 159' ' ' ARG . 14.0 mmt180 -73.88 -44.54 55.05 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 116.084 -0.507 . . . . 1.0 111.122 -178.586 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 4.0 pp -67.12 -24.12 65.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.993 0.425 . . . . 1.0 110.11 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -70.99 -49.76 41.74 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.691 -0.686 . . . . 1.0 109.86 179.032 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.606 ' HG2' ' O ' ' A' ' 155' ' ' GLU . 1.4 ptp180 -79.35 -2.89 43.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.476 -0.784 . . . . 1.0 112.268 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -72.05 19.45 0.07 Allowed 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.236 0.541 . . . . 1.0 111.732 -178.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.482 ' H ' ' C ' ' A' ' 159' ' ' ARG . . . 76.75 139.16 0.96 Allowed Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.513 -0.767 . . . . 1.0 113.785 178.643 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -89.45 20.0 1.16 Allowed 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 123.114 2.542 . . . . 1.0 111.686 177.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.56 ' HA ' ' H ' ' A' ' 1' ' ' MET . 5.0 t . . . . . 0 C--N 1.306 -1.309 0 CA-C-N 114.265 -1.334 . . . . 1.0 109.825 -177.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.457 ' HB3' ' O ' ' A' ' 36' ' ' ASP . 56.9 Cg_endo . . . . . 0 N--CA 1.457 -0.64 0 CA-C-O 121.732 0.638 . . . . 1.0 113.642 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.765 HD13 ' HB3' ' A' ' 84' ' ' ASP . 0.2 OUTLIER -68.44 -177.89 1.01 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.623 -1.171 . . . . 1.0 109.522 178.078 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.696 ' HA ' ' O ' ' A' ' 39' ' ' ARG . 2.4 t-160 -156.84 87.7 1.01 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.924 -0.398 . . . . 1.0 109.924 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.794 HG13 HD13 ' A' ' 85' ' ' LEU . 2.5 t -97.15 104.68 16.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.473 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.591 ' HA ' ' O ' ' A' ' 41' ' ' THR . 12.7 t -107.99 115.58 30.39 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.163 0.506 . . . . 1.0 110.453 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.533 ' HD1' ' HB ' ' A' ' 87' ' ' VAL . 0.7 OUTLIER -84.56 131.75 34.59 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.438 -178.009 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.588 HG21 HD11 ' A' ' 97' ' ' LEU . 43.6 t -116.19 112.58 40.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.223 0.535 . . . . 1.0 111.891 -176.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.661 ' HB2' HD23 ' A' ' 89' ' ' LEU . 17.7 t -141.65 165.8 26.49 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.934 -0.575 . . . . 1.0 109.689 177.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.59 HG23 ' NE2' ' A' ' 93' ' ' HIS . 1.2 p -73.47 101.6 3.56 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.959 0.409 . . . . 1.0 110.782 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.944 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 120.68 -43.34 1.55 Allowed Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.859 -0.686 . . . . 1.0 111.863 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.711 ' ND2' ' H ' ' A' ' 74' ' ' ALA . 59.0 t30 60.2 25.82 15.22 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 122.169 0.985 . . . . 1.0 110.883 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.6 pt -126.54 0.66 4.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 115.602 -0.726 . . . . 1.0 111.15 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 23.1 m -120.6 -88.79 0.62 Allowed 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.439 -0.504 . . . . 1.0 111.916 -176.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.41 ' HG3' HD11 ' A' ' 142' ' ' ILE . 38.1 ttm105 -71.94 -40.42 68.72 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.282 0.475 . . . . 1.0 112.282 -174.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.453 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 24.5 m -58.47 -58.34 19.79 Favored Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 111.846 0.313 . . . . 1.0 111.846 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.526 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 40.2 Cg_endo -64.49 -20.99 66.37 Favored 'Trans proline' 0 C--N 1.357 0.978 0 C-N-CA 122.035 1.823 . . . . 1.0 112.166 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.697 ' HB3' HD13 ' A' ' 142' ' ' ILE . 41.9 mmm -62.97 -54.45 38.14 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.625 -0.261 . . . . 1.0 110.499 177.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.475 ' HA ' HG21 ' A' ' 142' ' ' ILE . . . -71.84 -27.83 63.16 Favored 'General case' 0 CA--C 1.509 -0.624 0 C-N-CA 120.461 -0.496 . . . . 1.0 110.076 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.619 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 15.8 tt0 -50.47 -53.47 29.48 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-N 114.741 -1.118 . . . . 1.0 109.852 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.821 ' HB3' ' HG2' ' A' ' 68' ' ' PRO . 0.1 OUTLIER -82.78 -27.32 31.07 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.165 -0.925 . . . . 1.0 110.22 -175.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.785 ' HB3' HD11 ' A' ' 146' ' ' LEU . 7.9 mmm -62.87 -75.61 0.07 Allowed 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 112.993 0.738 . . . . 1.0 112.993 -176.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.833 ' HB3' HD22 ' A' ' 146' ' ' LEU . 19.8 p90 -78.04 -29.92 49.61 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 119.958 -0.697 . . . . 1.0 111.219 -175.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.649 ' HB2' HG11 ' A' ' 40' ' ' VAL . . . -63.37 -38.15 90.02 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 119.413 -0.915 . . . . 1.0 110.57 179.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.643 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -63.36 -40.75 98.13 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.94 -0.763 . . . . 1.0 108.94 177.098 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.582 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 79.4 mt-30 -59.83 -41.88 92.32 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-N 115.85 -0.613 . . . . 1.0 110.679 176.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.67 ' HG ' ' O ' ' A' ' 25' ' ' PHE . 80.2 mt -55.89 -61.41 2.39 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.682 -0.69 . . . . 1.0 110.257 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.555 ' HB3' ' HA3' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -59.07 -33.56 70.95 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.793 -0.363 . . . . 1.0 111.374 178.553 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -63.37 -25.54 68.34 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.21 0.448 . . . . 1.0 112.21 176.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.598 ' HG2' ' O ' ' A' ' 29' ' ' LEU . 8.3 ptm85 -98.6 -21.29 16.54 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 120.05 -0.66 . . . . 1.0 110.104 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.27 33.17 1.83 Allowed Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 114.991 -1.004 . . . . 1.0 112.437 177.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.574 ' HG ' ' HG3' ' A' ' 32' ' ' ARG . 36.1 mt -127.14 6.47 6.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.982 0.391 . . . . 1.0 110.709 -178.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.555 ' HA3' ' HB3' ' A' ' 30' ' ' ARG . . . -54.21 -35.84 55.87 Favored Glycine 0 CA--C 1.52 0.374 0 C-N-CA 121.27 -0.49 . . . . 1.0 113.573 -177.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.614 ' HA ' ' NH1' ' A' ' 39' ' ' ARG . 2.8 m-20 -92.29 -14.02 29.48 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.97 0.414 . . . . 1.0 110.925 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.83 -17.93 49.13 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.875 -0.602 . . . . 1.0 111.2 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.705 HG23 ' HB3' ' A' ' 5' ' ' LEU . 0.4 OUTLIER -144.64 124.3 7.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.39 0.614 . . . . 1.0 111.055 179.436 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.696 ' O ' ' HA ' ' A' ' 6' ' ' HIS . 25.8 mmt180 -95.66 101.45 13.15 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.634 -0.712 . . . . 1.0 110.948 -178.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.649 HG11 ' HB2' ' A' ' 26' ' ' ALA . 1.6 m -89.03 136.61 23.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 109.035 -0.728 . . . . 1.0 109.035 178.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.591 ' O ' ' HA ' ' A' ' 8' ' ' THR . 31.7 p -146.6 -176.11 5.05 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.045 -0.98 . . . . 1.0 109.742 -175.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.439 ' HB3' ' HD2' ' A' ' 9' ' ' PHE . 49.2 p -158.76 160.66 36.56 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.153 -0.619 . . . . 1.0 111.253 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.619 ' HB2' ' CD2' ' A' ' 80' ' ' HIS . . . -162.68 161.88 26.66 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.315 0.579 . . . . 1.0 111.582 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -124.33 138.53 11.31 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 111.096 -0.802 . . . . 1.0 111.096 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.445 HG21 HD12 ' A' ' 96' ' ' LEU . 33.7 p -74.36 -24.0 59.09 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 111.962 0.356 . . . . 1.0 111.962 -176.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.584 ' HA3' ' CZ3' ' A' ' 48' ' ' TRP . . . -110.76 9.39 29.97 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.533 -0.841 . . . . 1.0 113.083 -178.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 42.67 37.35 1.0 Allowed 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 113.885 1.068 . . . . 1.0 113.885 177.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.944 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 1.5 m-90 -44.81 -70.41 0.1 Allowed 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.559 0.695 . . . . 1.0 112.369 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.686 ' O ' ' HB2' ' A' ' 52' ' ' SER . 6.8 m-70 -109.65 43.73 1.28 Allowed 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.1 -0.954 . . . . 1.0 111.057 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.43 HG23 ' HA ' ' A' ' 74' ' ' ALA . 14.8 p -62.54 129.74 26.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 C-N-CA 120.425 -0.51 . . . . 1.0 110.169 178.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.14 -13.5 66.88 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 121.109 -0.567 . . . . 1.0 111.684 -176.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.686 ' HB2' ' O ' ' A' ' 49' ' ' HIS . 0.4 OUTLIER -80.0 -162.26 0.42 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.174 0.511 . . . . 1.0 110.669 179.58 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 33.7 t -126.45 175.94 7.52 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.291 -1.003 . . . . 1.0 108.291 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.06 141.06 47.21 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.955 0.407 . . . . 1.0 111.374 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.456 ' OD1' ' HG2' ' A' ' 57' ' ' ARG . 13.2 t70 -61.05 141.15 57.61 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.285 -0.87 . . . . 1.0 111.436 -177.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -46.24 -37.8 7.67 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.727 -1.124 . . . . 1.0 113.555 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.674 ' O ' HG23 ' A' ' 61' ' ' VAL . 14.9 ptp180 -69.95 -45.31 67.73 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 122.276 -0.265 . . . . 1.0 110.897 -176.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.0 -31.62 68.19 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.485 -178.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.64 -43.43 98.82 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.893 -0.594 . . . . 1.0 110.046 178.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.41 -42.4 97.65 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.786 -0.721 . . . . 1.0 111.486 177.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.674 HG23 ' O ' ' A' ' 57' ' ' ARG . 61.3 t -58.05 -58.53 6.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-O 120.975 0.417 . . . . 1.0 111.273 179.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.735 ' HB2' HG22 ' A' ' 69' ' ' THR . 90.1 mt -59.04 -51.21 71.02 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.061 -0.518 . . . . 1.0 111.662 -178.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -60.87 -29.27 69.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.482 -0.326 . . . . 1.0 110.894 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.19 -31.48 71.91 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.225 0.536 . . . . 1.0 110.546 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -99.42 1.89 44.63 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.492 -0.776 . . . . 1.0 111.505 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.97 16.26 56.41 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 121.045 -0.597 . . . . 1.0 113.213 177.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -92.08 149.58 38.96 Favored Pre-proline 0 C--N 1.322 -0.627 0 C-N-CA 122.083 0.153 . . . . 1.0 111.082 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.821 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 49.6 Cg_endo -68.89 158.23 58.72 Favored 'Trans proline' 0 CA--C 1.511 -0.634 0 C-N-CA 122.519 2.146 . . . . 1.0 110.36 176.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.735 HG22 ' HB2' ' A' ' 62' ' ' LEU . 58.1 p -134.53 3.53 3.31 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 119.562 -0.855 . . . . 1.0 112.65 -176.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -79.85 135.65 36.5 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.762 -0.375 . . . . 1.0 110.429 -179.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -175.58 153.99 1.54 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.698 -0.683 . . . . 1.0 109.251 -176.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -123.3 116.72 23.79 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.208 -1.034 . . . . 1.0 108.208 177.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' A' ' 49' ' ' HIS . . . -61.3 139.02 58.24 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.259 0.552 . . . . 1.0 111.895 -176.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.711 ' H ' ' ND2' ' A' ' 14' ' ' ASN . . . -130.88 161.23 32.3 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.427 -0.806 . . . . 1.0 109.942 178.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -98.1 161.41 13.73 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.943 -0.762 . . . . 1.0 108.943 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.548 HG11 HD23 ' A' ' 97' ' ' LEU . 94.0 t -67.44 102.72 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.398 0.618 . . . . 1.0 110.388 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.556 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -120.79 -170.87 14.23 Favored Glycine 0 N--CA 1.443 -0.882 0 CA-C-N 115.046 -0.979 . . . . 1.0 111.824 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 88.4 m -55.92 -54.12 48.52 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.758 0.651 . . . . 1.0 112.758 -178.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.533 ' HG2' ' N ' ' A' ' 80' ' ' HIS . 0.6 OUTLIER -56.43 -31.36 63.84 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.893 -0.594 . . . . 1.0 111.089 -178.167 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.619 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 79.1 m80 -76.32 -42.36 45.4 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.6 -0.727 . . . . 1.0 110.064 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.556 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 23.2 mt -66.21 -19.77 65.93 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.476 178.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -84.77 -5.33 59.32 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.871 -0.604 . . . . 1.0 110.998 -178.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.573 ' HB1' ' O ' ' A' ' 6' ' ' HIS . . . -60.8 157.85 14.14 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.071 -0.513 . . . . 1.0 111.644 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.765 ' HB3' HD13 ' A' ' 5' ' ' LEU . 29.9 t70 -82.69 -16.57 47.67 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 115.915 -0.584 . . . . 1.0 109.807 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.794 HD13 HG13 ' A' ' 7' ' ' VAL . 0.4 OUTLIER -154.61 115.82 4.05 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.334 -0.848 . . . . 1.0 109.059 -176.581 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.577 ' HG ' HG22 ' A' ' 8' ' ' THR . 5.4 mp -106.74 106.81 17.52 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-N 115.479 -0.782 . . . . 1.0 109.853 177.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.559 HG11 HD23 ' A' ' 110' ' ' LEU . 52.3 t -85.14 92.26 3.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 114.896 -1.047 . . . . 1.0 110.869 -176.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.27 147.54 32.49 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.514 -0.766 . . . . 1.0 110.98 179.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.661 HD23 ' HB2' ' A' ' 11' ' ' CYS . 2.9 mm? -103.73 -4.85 23.14 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.273 0.558 . . . . 1.0 110.49 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.419 ' CG ' ' H ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -155.37 153.37 30.35 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.71 -0.677 . . . . 1.0 111.223 178.538 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 25.4 ptt180 -50.19 -32.09 15.44 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 114.903 -1.044 . . . . 1.0 112.998 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.714 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 5.9 m-20 -76.3 -48.46 20.03 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.288 -0.264 . . . . 1.0 110.288 -176.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.651 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 14.2 m170 -55.14 -48.46 73.65 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.73 -0.47 . . . . 1.0 109.73 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.458 ' HA ' HG21 ' A' ' 107' ' ' VAL . . . -59.3 -43.45 92.6 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.028 0.442 . . . . 1.0 110.849 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 9.8 ttt-85 -59.67 -45.51 91.84 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 115.408 -0.815 . . . . 1.0 111.66 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.772 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 56.0 mt -63.86 -49.49 72.55 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 115.902 -0.59 . . . . 1.0 110.028 -175.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.651 ' HG ' ' O ' ' A' ' 93' ' ' HIS . 22.6 mt -52.77 -57.83 8.86 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.668 -0.696 . . . . 1.0 111.368 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.604 ' HA ' ' HB ' ' A' ' 102' ' ' VAL . 9.4 ptt180 -60.42 -43.21 96.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.11 -0.496 . . . . 1.0 111.878 -176.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.648 ' HG3' ' O ' ' A' ' 96' ' ' LEU . 1.3 pp0? -68.33 -23.31 64.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.911 0.386 . . . . 1.0 110.287 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.772 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 11.4 mt -79.2 -13.43 59.71 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.87 -0.605 . . . . 1.0 112.194 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 148.4 -22.87 1.37 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.067 -1.063 . . . . 1.0 112.773 -178.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.975 HG12 ' H ' ' A' ' 103' ' ' GLU . 3.3 t -75.6 -156.09 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.123 0.487 . . . . 1.0 110.119 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.975 ' H ' HG12 ' A' ' 102' ' ' VAL . 9.3 pt-20 -170.44 163.84 8.57 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.755 -1.202 . . . . 1.0 107.755 -177.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.738 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -65.83 -22.14 66.53 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.754 0.311 . . . . 1.0 111.213 -176.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.487 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . . . -58.52 -37.8 76.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.295 0.569 . . . . 1.0 109.947 174.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.698 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 10.5 mtt180 -96.21 -45.33 6.89 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 115.193 -0.912 . . . . 1.0 110.778 -177.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.738 HG12 ' HA ' ' A' ' 104' ' ' ALA . 8.2 p -79.07 124.8 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-O 121.289 0.566 . . . . 1.0 110.49 -176.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.532 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 10.6 mmm180 -140.85 147.92 39.71 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.285 -0.635 . . . . 1.0 109.285 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.479 ' HB2' ' HB2' ' A' ' 112' ' ' SER . 83.1 mmm -78.88 140.24 38.16 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.451 -0.34 . . . . 1.0 110.375 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.559 HD23 HG11 ' A' ' 87' ' ' VAL . 3.0 tm? -58.45 -51.69 68.77 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 122.973 0.171 . . . . 1.0 111.262 -179.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 46.1 ttm-85 -71.26 -14.51 62.25 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 120.278 -0.569 . . . . 1.0 110.442 -178.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.479 ' HB2' ' HB2' ' A' ' 109' ' ' MET . 42.2 t -73.62 -9.51 58.75 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.71 -0.396 . . . . 1.0 110.423 179.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.553 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 97.2 m-85 -91.02 -22.68 20.66 Favored 'General case' 0 C--N 1.341 0.213 0 N-CA-C 109.782 -0.451 . . . . 1.0 109.782 175.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.5 t0 . . . . . 0 C--N 1.331 -0.237 0 CA-C-N 115.22 -0.9 . . . . 1.0 111.019 -178.435 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 . . . . . 0 C--O 1.233 0.204 0 CA-C-O 120.96 0.409 . . . . 1.0 110.806 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.543 ' O ' HG23 ' A' ' 141' ' ' VAL . 16.9 tp10 -61.58 -51.56 68.04 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.659 -0.7 . . . . 1.0 110.126 178.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.641 ' HA ' HG23 ' A' ' 141' ' ' VAL . 71.9 t -59.85 -41.15 84.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.758 -0.655 . . . . 1.0 110.346 178.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.543 ' HB2' HG11 ' A' ' 61' ' ' VAL . 49.8 t80 -54.65 -43.6 72.51 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.185 -0.916 . . . . 1.0 109.418 176.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.53 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -63.94 -41.86 97.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.595 -0.729 . . . . 1.0 110.798 178.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.641 HG23 ' HA ' ' A' ' 138' ' ' VAL . 5.6 t -53.83 -53.1 29.22 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 CA-C-O 121.841 0.829 . . . . 1.0 110.031 177.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.697 HD13 ' HB3' ' A' ' 20' ' ' MET . 6.8 mt -64.97 -50.94 72.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 114.649 -1.16 . . . . 1.0 112.085 -177.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.53 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 10.3 pt-20 -57.33 -30.87 65.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.677 0.275 . . . . 1.0 110.533 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.9 t -73.49 -29.62 62.62 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-O 121.2 0.524 . . . . 1.0 110.164 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.502 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -86.7 -24.12 25.31 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-N 116.018 -0.537 . . . . 1.0 112.128 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.833 HD22 ' HB3' ' A' ' 25' ' ' PHE . 14.4 mt -55.15 -36.42 45.14 Favored Pre-proline 0 CA--C 1.545 0.769 0 N-CA-C 112.745 0.646 . . . . 1.0 112.745 -177.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.632 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 56.9 Cg_endo -70.22 -10.59 28.53 Favored 'Trans proline' 0 C--N 1.363 1.299 0 C-N-CA 122.63 2.22 . . . . 1.0 112.09 176.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.553 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -106.07 -33.74 3.39 Favored Glycine 0 N--CA 1.449 -0.492 0 N-CA-C 110.372 -1.091 . . . . 1.0 110.372 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.468 ' O ' HG13 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -73.02 -39.23 66.17 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.0 -1.111 . . . . 1.0 108.0 178.369 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . 0.517 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 0.2 OUTLIER -52.97 -58.4 7.11 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 114.801 -1.091 . . . . 1.0 110.834 175.293 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -56.92 -39.83 75.22 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.766 -1.106 . . . . 1.0 111.304 -174.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . 0.758 ' HZ3' HD11 ' A' ' 5' ' ' LEU . 22.3 t90 -65.18 -55.75 16.8 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.602 -0.726 . . . . 1.0 110.875 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.468 HG13 ' O ' ' A' ' 149' ' ' LEU . 6.5 m -61.35 -41.97 91.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.888 -0.412 . . . . 1.0 109.888 -178.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.438 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 3.3 m-20 -60.19 -51.26 70.35 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-O 120.96 0.41 . . . . 1.0 110.855 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 7.1 pt-20 -63.4 -38.35 90.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.95 -177.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.529 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 5.5 mmt85 -73.81 -43.02 60.08 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.701 -0.681 . . . . 1.0 110.802 -176.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 4.0 pp . . . . . 0 C--N 1.322 -0.596 0 CA-C-N 116.017 -0.538 . . . . 1.0 109.998 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.447 ' HB2' ' HG2' ' A' ' 39' ' ' ARG . 17.8 Cg_endo . . . . . 0 N--CA 1.461 -0.385 0 CA-C-O 121.091 0.371 . . . . 1.0 112.915 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.818 ' HB3' HG23 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -65.38 175.92 1.57 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.599 -0.728 . . . . 1.0 109.684 179.67 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.803 ' H ' HD13 ' A' ' 5' ' ' LEU . 0.5 OUTLIER -153.75 100.28 2.37 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.883 -0.414 . . . . 1.0 109.883 179.175 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.705 HG13 HD13 ' A' ' 85' ' ' LEU . 1.8 t -103.6 116.84 48.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 107.983 -1.118 . . . . 1.0 107.983 178.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.621 ' CG2' ' HG ' ' A' ' 86' ' ' LEU . 15.1 t -119.77 114.31 21.95 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 120.589 -0.444 . . . . 1.0 110.81 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.759 ' HZ ' ' HE1' ' A' ' 25' ' ' PHE . 0.4 OUTLIER -84.35 131.41 34.7 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 120.398 -0.521 . . . . 1.0 110.177 -179.619 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.596 HG21 HD11 ' A' ' 97' ' ' LEU . 30.1 t -113.66 118.42 58.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 116.284 -0.416 . . . . 1.0 111.365 -176.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.44 ' HB2' HD23 ' A' ' 89' ' ' LEU . 46.2 t -148.65 146.8 28.34 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.996 -0.372 . . . . 1.0 109.996 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.54 93.27 1.19 Allowed 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 121.115 0.483 . . . . 1.0 110.394 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 148.08 -37.99 1.06 Allowed Glycine 0 N--CA 1.441 -1.01 0 CA-C-N 115.183 -0.917 . . . . 1.0 111.088 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 1.089 HD22 ' HB1' ' A' ' 73' ' ' ALA . 1.4 p-10 48.47 24.43 0.74 Allowed 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.063 0.945 . . . . 1.0 112.864 178.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.446 HG12 ' HB2' ' A' ' 49' ' ' HIS . 1.3 pt -148.23 47.2 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.451 0 CA-C-N 115.574 -0.739 . . . . 1.0 110.625 178.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.45 ' HA ' ' OD1' ' A' ' 55' ' ' ASP . 53.2 t -161.68 -84.56 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.535 -0.757 . . . . 1.0 109.599 173.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 27.4 mmt85 -59.79 -57.16 14.12 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.795 -0.639 . . . . 1.0 112.002 -178.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 1.067 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 6.2 m -52.11 -58.35 11.72 Favored Pre-proline 0 CA--C 1.546 0.825 0 CA-C-N 115.085 -0.961 . . . . 1.0 112.55 -177.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.673 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 37.3 Cg_endo -63.45 -27.82 70.71 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 121.985 1.79 . . . . 1.0 112.909 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.477 ' HB3' HD13 ' A' ' 142' ' ' ILE . 45.5 mmm -59.28 -57.31 13.58 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.295 -0.261 . . . . 1.0 110.295 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.541 ' O ' ' HD1' ' A' ' 25' ' ' PHE . . . -71.37 -32.16 68.16 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 115.885 -0.598 . . . . 1.0 110.507 -178.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.633 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 15.0 tt0 -49.79 -52.72 29.95 Favored 'General case' 0 C--O 1.216 -0.69 0 O-C-N 124.198 0.936 . . . . 1.0 109.917 -178.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.972 ' HE3' ' HB2' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -86.63 -22.33 26.24 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 119.592 -0.843 . . . . 1.0 110.9 -176.919 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.472 ' HB3' HD11 ' A' ' 146' ' ' LEU . 88.7 mtp -64.21 -75.16 0.09 Allowed 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.384 0.513 . . . . 1.0 112.384 -179.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.759 ' HE1' ' HZ ' ' A' ' 9' ' ' PHE . 0.8 OUTLIER -78.43 -28.29 46.72 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 119.754 -0.778 . . . . 1.0 111.613 -175.452 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.633 ' HB3' ' O ' ' A' ' 22' ' ' GLU . . . -64.54 -38.73 92.04 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 119.387 -0.925 . . . . 1.0 110.473 178.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.602 ' HG3' ' N ' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -64.75 -37.45 87.63 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.825 -0.806 . . . . 1.0 108.825 177.789 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.602 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 78.5 mt-30 -60.05 -43.01 95.68 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-N 115.967 -0.56 . . . . 1.0 109.897 175.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 25' ' ' PHE . 93.2 mt -56.02 -59.01 5.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.74 -0.664 . . . . 1.0 110.767 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.502 ' HG2' ' O ' ' A' ' 27' ' ' GLN . 0.2 OUTLIER -60.58 -34.27 73.94 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.372 -0.531 . . . . 1.0 111.349 178.463 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.8 m170 -59.42 -30.09 68.23 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 111.994 0.368 . . . . 1.0 111.994 176.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.459 ' HG2' ' O ' ' A' ' 28' ' ' GLN . 5.8 ptp180 -95.41 -19.25 20.05 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 119.501 -0.88 . . . . 1.0 110.261 179.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 107.42 38.44 2.09 Favored Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.238 -0.892 . . . . 1.0 112.339 177.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 25.2 mt -129.54 0.02 4.98 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 122.554 -0.38 . . . . 1.0 110.258 -178.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.474 ' H ' ' HA ' ' A' ' 30' ' ' ARG . . . -54.26 -28.41 42.72 Favored Glycine 0 CA--C 1.519 0.337 0 CA-C-N 116.028 -0.533 . . . . 1.0 113.837 -178.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.499 ' HA ' ' NH1' ' A' ' 39' ' ' ARG . 5.1 t70 -89.45 -24.88 21.75 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-O 121.54 0.686 . . . . 1.0 109.739 178.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -77.59 -19.38 55.7 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 114.716 -1.129 . . . . 1.0 111.438 -174.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.818 HG23 ' HB3' ' A' ' 5' ' ' LEU . 0.4 OUTLIER -145.05 124.24 6.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.964 -0.562 . . . . 1.0 109.889 179.81 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.499 ' NH1' ' HA ' ' A' ' 36' ' ' ASP . 29.1 mmt180 -90.16 137.44 32.34 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 109.291 -0.633 . . . . 1.0 109.291 -178.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 80.8 t -124.78 126.88 72.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 N-CA-C 109.425 -0.583 . . . . 1.0 109.425 -178.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' ' 8' ' ' THR . 31.5 p -139.51 -178.11 5.24 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.175 -0.921 . . . . 1.0 110.557 -174.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 1.067 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 87.9 p -159.01 159.61 34.97 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.987 -0.551 . . . . 1.0 109.987 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.457 ' HA ' ' O ' ' A' ' 74' ' ' ALA . . . -164.44 166.17 20.8 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 121.32 0.581 . . . . 1.0 111.462 -178.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -124.58 138.96 11.47 Favored Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 110.789 -0.924 . . . . 1.0 110.789 177.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.54 HG21 HD12 ' A' ' 96' ' ' LEU . 28.3 p -71.79 -21.9 61.65 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.96 0.409 . . . . 1.0 110.977 -178.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -107.17 2.2 35.16 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 120.789 -0.72 . . . . 1.0 113.217 -177.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.493 ' HB3' ' HB2' ' A' ' 75' ' ' GLN . 3.1 p-10 44.23 35.99 1.41 Allowed 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 113.324 0.861 . . . . 1.0 113.324 178.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -43.87 -74.65 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.715 0.769 . . . . 1.0 112.453 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.446 ' HB2' HG12 ' A' ' 15' ' ' ILE . 79.0 m-70 -106.25 42.57 1.25 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.043 -0.98 . . . . 1.0 110.686 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.435 HG23 ' HA ' ' A' ' 74' ' ' ALA . 14.5 p -60.32 134.94 25.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.429 178.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.55 -13.63 60.03 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.885 -0.674 . . . . 1.0 112.303 -178.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.8 t -79.79 -162.67 0.45 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.163 0.506 . . . . 1.0 109.928 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 15.5 t -119.56 174.91 6.11 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.931 -0.766 . . . . 1.0 108.931 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.409 ' HB2' ' HB3' ' A' ' 71' ' ' HIS . . . -62.71 147.02 50.89 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.34 0.59 . . . . 1.0 111.485 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.621 ' OD2' ' HG3' ' A' ' 57' ' ' ARG . 9.8 p-10 -60.79 138.91 58.07 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.958 -1.019 . . . . 1.0 112.885 -178.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -48.6 -36.52 15.86 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 114.704 -1.134 . . . . 1.0 112.596 178.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.621 ' HG3' ' OD2' ' A' ' 55' ' ' ASP . 8.2 ptt180 -70.65 -44.23 67.54 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 122.298 0.239 . . . . 1.0 111.095 -178.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.34 -38.59 78.22 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 109.222 -0.658 . . . . 1.0 109.222 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.06 -44.9 94.38 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.604 -0.725 . . . . 1.0 109.984 178.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.427 ' O ' ' HG2' ' A' ' 63' ' ' ARG . . . -58.06 -44.1 94.83 Favored Glycine 0 N--CA 1.443 -0.882 0 CA-C-N 115.618 -0.719 . . . . 1.0 113.198 178.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.3 m -75.6 -39.24 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-N 117.326 0.563 . . . . 1.0 111.383 -178.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.618 ' HB2' HG22 ' A' ' 69' ' ' THR . 96.6 mt -61.59 -52.14 65.64 Favored 'General case' 0 C--O 1.23 0.044 0 C-N-CA 120.892 -0.323 . . . . 1.0 110.299 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.427 ' HG2' ' O ' ' A' ' 60' ' ' GLY . 6.8 ptm180 -59.63 -30.79 68.96 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.723 -0.671 . . . . 1.0 110.947 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.6 -33.23 74.58 Favored 'General case' 0 C--O 1.226 -0.141 0 CA-C-N 116.354 -0.385 . . . . 1.0 111.297 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.491 ' HB2' ' HD2' ' A' ' 67' ' ' TYR . 98.5 m-70 -96.33 2.51 52.84 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.341 -0.39 . . . . 1.0 111.237 -178.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 90.18 14.34 59.1 Favored Glycine 0 C--N 1.329 0.145 0 CA-C-N 116.005 -0.543 . . . . 1.0 112.536 177.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.491 ' HD2' ' HB2' ' A' ' 65' ' ' HIS . 69.0 m-85 -91.39 149.56 39.78 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-O 120.551 0.215 . . . . 1.0 110.855 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.407 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 52.1 Cg_endo -69.05 153.71 71.76 Favored 'Trans proline' 0 CA--C 1.509 -0.742 0 C-N-CA 122.325 2.017 . . . . 1.0 110.666 177.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.618 HG22 ' HB2' ' A' ' 62' ' ' LEU . 42.3 p -124.74 15.68 8.71 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 121.552 0.691 . . . . 1.0 110.442 -177.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -84.2 120.11 25.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.056 -0.975 . . . . 1.0 110.154 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.972 ' HB2' ' HE3' ' A' ' 23' ' ' LYS . 32.3 t60 -159.11 147.72 18.17 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.761 -0.654 . . . . 1.0 110.587 -177.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.7 tpp180 -125.71 112.57 16.25 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 107.697 -1.223 . . . . 1.0 107.697 175.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 1.089 ' HB1' HD22 ' A' ' 14' ' ' ASN . . . -59.95 140.17 56.91 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.543 -0.753 . . . . 1.0 111.956 -176.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 43' ' ' ALA . . . -135.96 160.6 38.11 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.646 178.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.493 ' HB2' ' HB3' ' A' ' 47' ' ' ASN . 43.5 tt0 -98.68 155.82 17.14 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.767 -0.457 . . . . 1.0 109.767 178.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.487 HG11 HD23 ' A' ' 97' ' ' LEU . 36.5 t -66.48 111.32 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.365 0.603 . . . . 1.0 110.731 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -123.86 -168.3 12.93 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.049 -0.978 . . . . 1.0 111.034 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 80.6 m -55.73 -46.96 77.67 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.711 0.291 . . . . 1.0 111.377 -179.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -60.13 -29.57 68.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.407 -0.36 . . . . 1.0 111.553 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.424 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 77.1 m80 -78.1 -39.26 42.0 Favored 'General case' 0 C--O 1.222 -0.357 0 N-CA-C 109.858 -0.423 . . . . 1.0 109.858 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.664 ' O ' HG23 ' A' ' 102' ' ' VAL . 15.6 mt -70.36 -18.18 63.06 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.308 -0.405 . . . . 1.0 110.451 176.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -88.43 -7.73 56.12 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 120.77 0.319 . . . . 1.0 110.232 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.603 ' HA ' ' HB3' ' A' ' 6' ' ' HIS . . . -59.65 148.01 35.36 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.81 -0.632 . . . . 1.0 109.888 178.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.544 ' HB3' HD13 ' A' ' 5' ' ' LEU . 28.5 t70 -74.44 -16.1 60.88 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.218 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.705 HD13 HG13 ' A' ' 7' ' ' VAL . 0.6 OUTLIER -153.17 116.47 4.64 Favored 'General case' 0 CA--C 1.51 -0.596 0 N-CA-C 109.336 -0.616 . . . . 1.0 109.336 -176.836 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.716 ' HB3' HD13 ' A' ' 97' ' ' LEU . 5.0 mp -106.89 105.52 15.59 Favored 'General case' 0 N--CA 1.426 -1.654 0 CA-C-N 115.489 -0.778 . . . . 1.0 109.782 178.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.628 HG11 HD23 ' A' ' 110' ' ' LEU . 86.6 t -84.63 93.39 3.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 114.554 -1.203 . . . . 1.0 111.263 -175.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.17 145.34 31.06 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.594 -0.73 . . . . 1.0 111.249 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.44 HD23 ' HB2' ' A' ' 11' ' ' CYS . 4.2 mm? -96.53 -11.53 25.32 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.821 -0.627 . . . . 1.0 109.774 178.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.426 ' CG ' ' H ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -148.78 153.62 38.41 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.631 -0.713 . . . . 1.0 110.747 179.859 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -57.96 -26.19 61.97 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.274 -0.876 . . . . 1.0 112.935 -178.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.629 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 82.8 m-20 -77.41 -47.34 20.03 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 110.125 -0.324 . . . . 1.0 110.125 -178.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.656 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 20.6 m170 -53.87 -47.64 70.84 Favored 'General case' 0 CA--C 1.522 -0.106 0 CA-C-N 115.981 -0.554 . . . . 1.0 109.666 177.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.95 -44.42 91.44 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.909 -0.587 . . . . 1.0 110.61 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.655 ' O ' ' HG2' ' A' ' 99' ' ' GLN . 9.8 ttp180 -56.54 -46.13 80.81 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.603 -0.726 . . . . 1.0 111.129 178.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.629 ' HG ' ' O ' ' A' ' 92' ' ' ASN . 42.7 mt -63.39 -47.87 80.22 Favored 'General case' 0 C--O 1.216 -0.696 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.547 -175.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.716 HD13 ' HB3' ' A' ' 86' ' ' LEU . 29.5 mt -53.03 -58.8 5.76 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.784 -0.644 . . . . 1.0 111.413 -177.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.678 ' CA ' HG12 ' A' ' 102' ' ' VAL . 2.2 ptm180 -59.33 -45.25 91.85 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.844 0.683 . . . . 1.0 112.844 -179.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.655 ' HG2' ' O ' ' A' ' 95' ' ' ARG . 7.5 pt20 -68.24 -23.6 64.81 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.165 -0.614 . . . . 1.0 110.49 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.612 HD13 ' O ' ' A' ' 96' ' ' LEU . 6.7 mp -78.98 -17.5 55.29 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 116.267 -0.424 . . . . 1.0 111.817 178.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 152.66 -23.44 0.83 Allowed Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 119.579 -1.296 . . . . 1.0 113.749 -178.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.678 HG12 ' CA ' ' A' ' 98' ' ' ARG . 0.4 OUTLIER -78.45 -163.89 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-N 117.77 0.785 . . . . 1.0 110.166 179.801 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.677 ' N ' HG13 ' A' ' 102' ' ' VAL . 13.1 pt-20 -156.38 165.22 36.99 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 107.736 -1.209 . . . . 1.0 107.736 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.781 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -61.37 -27.11 68.29 Favored 'General case' 0 C--N 1.316 -0.881 0 O-C-N 123.466 0.479 . . . . 1.0 111.278 -175.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.431 ' HA ' ' NH2' ' A' ' 108' ' ' ARG . . . -58.22 -34.07 70.0 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 120.713 0.292 . . . . 1.0 110.578 177.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.43 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 3.9 mtp180 -97.59 -42.84 7.48 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.955 -0.566 . . . . 1.0 111.343 -178.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.781 HG12 ' HA ' ' A' ' 104' ' ' ALA . 12.6 p -77.88 119.08 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-O 120.95 0.405 . . . . 1.0 110.032 -174.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.529 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 26.8 mmt180 -137.96 149.82 46.48 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 121.695 -0.628 . . . . 1.0 110.583 -178.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.676 ' HB2' ' HB2' ' A' ' 112' ' ' SER . 80.9 mmm -79.06 138.19 37.87 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.015 -0.539 . . . . 1.0 110.214 178.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.628 HD23 HG11 ' A' ' 87' ' ' VAL . 2.9 tm? -57.29 -48.8 78.0 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.037 0.446 . . . . 1.0 111.036 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 6.5 ttt-85 -69.68 -14.61 62.89 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.637 -0.71 . . . . 1.0 110.07 -178.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.676 ' HB2' ' HB2' ' A' ' 109' ' ' MET . 43.9 t -79.12 -8.97 59.41 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.921 -0.581 . . . . 1.0 111.289 -178.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.577 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 91.4 m-85 -91.36 -19.04 23.35 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 120.812 0.339 . . . . 1.0 110.266 176.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 15.8 t0 . . . . . 0 C--N 1.325 -0.491 0 CA-C-N 115.854 -0.612 . . . . 1.0 111.143 -177.456 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.408 ' O ' ' HB3' ' A' ' 139' ' ' PHE . 6.8 mt-10 . . . . . 0 N--CA 1.454 -0.261 0 CA-C-O 120.791 0.329 . . . . 1.0 110.864 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.512 ' O ' HG23 ' A' ' 141' ' ' VAL . 4.3 tp10 -62.79 -47.5 83.2 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.961 -0.755 . . . . 1.0 108.961 175.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.679 ' HA ' HG23 ' A' ' 141' ' ' VAL . 55.3 t -61.93 -39.91 85.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 114.662 -1.153 . . . . 1.0 109.815 176.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.408 ' HB3' ' O ' ' A' ' 136' ' ' GLU . 74.4 t80 -53.11 -43.45 66.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.965 -1.016 . . . . 1.0 108.912 175.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.676 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -65.14 -41.16 95.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.304 -0.862 . . . . 1.0 111.09 177.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.679 HG23 ' HA ' ' A' ' 138' ' ' VAL . 12.7 t -54.64 -52.55 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 121.841 0.829 . . . . 1.0 110.233 178.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.477 HD13 ' HB3' ' A' ' 20' ' ' MET . 7.1 mt -65.81 -50.62 69.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 114.817 -1.083 . . . . 1.0 111.769 -179.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.676 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 11.3 pt-20 -58.91 -29.4 67.03 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 120.812 -0.355 . . . . 1.0 110.349 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . 0.412 ' HB2' ' O ' ' A' ' 140' ' ' ALA . 2.1 t -74.17 -27.58 60.89 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 121.114 0.483 . . . . 1.0 109.94 178.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.468 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -86.54 -24.72 25.38 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 115.882 -0.599 . . . . 1.0 111.597 178.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.759 HD22 ' HB3' ' A' ' 25' ' ' PHE . 17.9 mt -54.85 -36.84 49.25 Favored Pre-proline 0 CA--C 1.549 0.942 0 N-CA-C 112.636 0.606 . . . . 1.0 112.636 -178.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.615 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 56.2 Cg_endo -70.45 -12.28 31.33 Favored 'Trans proline' 0 C--N 1.368 1.578 0 C-N-CA 122.775 2.317 . . . . 1.0 112.022 177.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.577 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -104.13 -33.68 3.92 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 110.195 -1.162 . . . . 1.0 110.195 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.457 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -72.51 -39.15 67.82 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 108.267 -1.012 . . . . 1.0 108.267 178.446 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . 0.507 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 0.2 OUTLIER -54.0 -58.86 5.75 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-N 114.52 -1.218 . . . . 1.0 110.845 175.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -55.15 -41.78 72.23 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 114.826 -1.079 . . . . 1.0 111.012 -174.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . 0.667 ' HZ3' HD11 ' A' ' 5' ' ' LEU . 18.6 t90 -63.35 -54.94 29.06 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.325 -0.852 . . . . 1.0 110.444 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.453 HG13 ' O ' ' A' ' 149' ' ' LEU . 6.2 m -64.82 -41.25 91.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 120.842 -0.343 . . . . 1.0 110.764 -178.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.447 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 15.3 m-20 -60.03 -49.46 77.59 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 121.269 0.557 . . . . 1.0 110.613 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 5.7 pt-20 -65.31 -37.27 86.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.612 -0.722 . . . . 1.0 110.739 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.458 ' HG3' ' CH2' ' A' ' 152' ' ' TRP . 10.9 mmt180 -75.07 -39.3 60.95 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.186 -0.461 . . . . 1.0 111.565 -177.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 4.4 pp . . . . . 0 C--N 1.326 -0.43 0 N-CA-C 109.218 -0.66 . . . . 1.0 109.218 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo . . . . . 0 C--O 1.232 0.202 0 CA-C-O 121.145 0.394 . . . . 1.0 113.036 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.85 ' HB3' HG23 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -69.19 -179.36 1.55 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.659 -0.7 . . . . 1.0 109.831 177.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.674 ' H ' HD13 ' A' ' 5' ' ' LEU . 2.5 t-160 -158.45 89.73 0.99 Allowed 'General case' 0 C--N 1.326 -0.444 0 O-C-N 122.145 -0.347 . . . . 1.0 110.066 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.479 HG13 HD13 ' A' ' 85' ' ' LEU . 1.8 t -95.61 109.07 21.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.87 -0.419 . . . . 1.0 109.87 178.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.637 ' CG2' ' HG ' ' A' ' 86' ' ' LEU . 10.5 t -112.89 118.84 36.02 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 120.896 0.379 . . . . 1.0 110.043 177.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.576 ' HD1' ' HB ' ' A' ' 87' ' ' VAL . 1.3 m-85 -86.65 131.27 34.2 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 116.465 -0.334 . . . . 1.0 110.784 -178.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.567 HG21 HD11 ' A' ' 97' ' ' LEU . 21.3 t -115.49 109.61 28.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.852 -0.613 . . . . 1.0 110.964 -177.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.644 ' HB2' HD23 ' A' ' 89' ' ' LEU . 49.8 t -142.38 163.55 32.55 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.587 -0.523 . . . . 1.0 109.587 179.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.57 HG23 ' NE2' ' A' ' 93' ' ' HIS . 0.7 OUTLIER -75.13 100.6 4.3 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.017 0.437 . . . . 1.0 110.89 -179.054 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.857 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 125.0 -44.78 1.22 Allowed Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.935 -0.65 . . . . 1.0 111.831 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.449 HD21 ' CB ' ' A' ' 42' ' ' SER . 4.5 t-20 65.7 11.82 7.83 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.278 0.631 . . . . 1.0 111.348 179.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.447 ' HA ' ' HG3' ' A' ' 19' ' ' PRO . 10.0 pt -120.57 8.74 6.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 O-C-N 121.736 -0.603 . . . . 1.0 111.738 -177.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.54 ' O ' ' HG3' ' A' ' 20' ' ' MET . 6.8 p -126.1 -86.56 0.61 Allowed 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.034 0.383 . . . . 1.0 112.034 -178.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.684 ' HD3' HG13 ' A' ' 138' ' ' VAL . 16.6 tpp180 -66.31 -48.53 70.04 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.981 0.42 . . . . 1.0 111.554 -176.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.654 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 14.2 m -56.55 -57.06 25.86 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 115.667 -0.697 . . . . 1.0 112.8 -178.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.714 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 39.0 Cg_endo -64.26 -27.54 64.0 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 121.806 1.67 . . . . 1.0 112.355 -177.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.622 ' HA ' HD21 ' A' ' 62' ' ' LEU . 66.1 mtp -62.43 -53.53 53.5 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.316 -0.554 . . . . 1.0 110.55 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.462 ' HA ' ' HB2' ' A' ' 24' ' ' MET . . . -70.59 -30.44 67.12 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.588 -0.445 . . . . 1.0 110.526 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.672 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 14.7 tt0 -52.15 -51.79 55.79 Favored 'General case' 0 C--O 1.214 -0.777 0 CA-C-N 115.49 -0.777 . . . . 1.0 109.623 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.944 ' HE3' ' HB2' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -88.49 -21.28 24.25 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 119.674 -0.81 . . . . 1.0 111.228 -176.702 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.511 ' HB3' HD11 ' A' ' 146' ' ' LEU . 83.1 mtp -65.8 -74.47 0.11 Allowed 'General case' 0 C--O 1.237 0.418 0 N-CA-C 112.37 0.508 . . . . 1.0 112.37 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.687 ' HB3' HD22 ' A' ' 146' ' ' LEU . 17.0 p90 -76.17 -30.52 58.13 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 119.707 -0.797 . . . . 1.0 111.481 -175.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.672 ' HB3' ' O ' ' A' ' 22' ' ' GLU . . . -65.11 -35.8 82.26 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 119.17 -1.012 . . . . 1.0 110.893 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.725 ' HA ' ' HD3' ' A' ' 30' ' ' ARG . 0.1 OUTLIER -63.07 -39.34 94.42 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 108.454 -0.943 . . . . 1.0 108.454 177.21 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.616 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 78.9 mt-30 -58.68 -45.81 88.62 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.647 -0.706 . . . . 1.0 109.879 175.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' A' ' 25' ' ' PHE . 96.7 mt -55.42 -58.85 6.02 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.502 -0.772 . . . . 1.0 110.978 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.725 ' HD3' ' HA ' ' A' ' 27' ' ' GLN . 0.4 OUTLIER -59.24 -36.24 75.11 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.49 -0.484 . . . . 1.0 111.258 179.125 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -63.35 -26.12 68.61 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.581 0.586 . . . . 1.0 112.581 177.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.634 ' HG3' ' HG ' ' A' ' 34' ' ' LEU . 8.3 ptp180 -95.54 -16.9 21.85 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 119.568 -0.853 . . . . 1.0 109.805 177.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 105.56 23.36 7.59 Favored Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 114.99 -1.004 . . . . 1.0 112.053 176.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.634 ' HG ' ' HG3' ' A' ' 32' ' ' ARG . 24.5 mt -111.69 1.5 16.75 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.172 -0.307 . . . . 1.0 110.172 -177.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -54.55 -26.03 37.07 Favored Glycine 0 CA--C 1.522 0.472 0 C-N-CA 121.115 -0.564 . . . . 1.0 113.2 -178.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.598 ' HA ' ' NH1' ' A' ' 39' ' ' ARG . 0.5 OUTLIER -95.98 -22.83 17.15 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 109.467 -0.568 . . . . 1.0 109.467 177.533 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -76.97 -23.28 52.33 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.903 -1.044 . . . . 1.0 111.002 -175.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.85 HG23 ' HB3' ' A' ' 5' ' ' LEU . 0.2 OUTLIER -143.38 122.59 8.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.733 -0.667 . . . . 1.0 109.334 177.911 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.598 ' NH1' ' HA ' ' A' ' 36' ' ' ASP . 30.2 mmt180 -87.18 143.33 27.34 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 109.201 -0.666 . . . . 1.0 109.201 -178.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.427 HG11 ' HB2' ' A' ' 26' ' ' ALA . 54.2 t -131.82 131.53 61.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 109.497 -0.557 . . . . 1.0 109.497 -178.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.508 ' O ' ' HA ' ' A' ' 8' ' ' THR . 43.2 p -145.95 -175.74 4.87 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.344 -0.844 . . . . 1.0 109.972 -174.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.654 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 90.6 p -161.7 166.04 27.24 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.799 -0.36 . . . . 1.0 110.52 178.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.588 ' HB2' ' CD2' ' A' ' 80' ' ' HIS . . . -165.52 169.0 15.97 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.398 0.618 . . . . 1.0 111.543 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -127.24 132.3 7.51 Favored Glycine 0 N--CA 1.44 -1.09 0 CA-C-N 114.924 -1.034 . . . . 1.0 110.937 177.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.524 HG23 ' CG1' ' A' ' 10' ' ' VAL . 17.8 p -67.75 -26.86 66.34 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.912 0.386 . . . . 1.0 111.707 -177.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -107.25 9.47 39.02 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.847 -0.692 . . . . 1.0 113.207 -177.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 43.5 38.17 1.73 Allowed 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 113.719 1.007 . . . . 1.0 113.719 176.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.857 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 1.1 m-90 -47.07 -74.21 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.514 0.674 . . . . 1.0 112.438 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.557 ' HB3' ' HB3' ' A' ' 52' ' ' SER . 3.8 m-70 -105.54 39.84 1.67 Allowed 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.184 -0.916 . . . . 1.0 111.16 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.418 HG23 ' HA ' ' A' ' 74' ' ' ALA . 14.8 p -60.17 127.19 19.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 120.377 -0.529 . . . . 1.0 110.068 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.606 ' HA2' ' NE ' ' A' ' 72' ' ' ARG . . . 93.47 -14.28 65.64 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.913 -0.661 . . . . 1.0 111.961 -177.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.557 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 3.1 t -81.4 -158.18 0.21 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.232 0.539 . . . . 1.0 110.034 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 18.7 t -133.28 175.29 9.53 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 115.676 -0.693 . . . . 1.0 109.153 -178.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.96 141.93 43.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.25 0.548 . . . . 1.0 111.85 -178.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.468 ' CG ' ' HG3' ' A' ' 57' ' ' ARG . 56.6 t0 -56.06 129.82 41.47 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.019 -0.991 . . . . 1.0 110.06 178.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -51.51 -29.69 17.58 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.103 0.779 . . . . 1.0 113.103 -179.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.609 ' O ' HG23 ' A' ' 61' ' ' VAL . 0.2 OUTLIER -74.03 -41.89 61.13 Favored 'General case' 0 N--CA 1.461 0.122 0 C-N-CA 120.261 -0.576 . . . . 1.0 110.412 178.602 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.43 -32.41 70.0 Favored 'General case' 0 N--CA 1.46 0.07 0 CA-C-O 120.918 0.39 . . . . 1.0 110.051 178.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.37 -42.42 98.68 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.762 -0.653 . . . . 1.0 110.025 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.448 ' O ' ' HG2' ' A' ' 63' ' ' ARG . . . -64.27 -40.4 97.89 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.563 -0.827 . . . . 1.0 111.217 178.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 57' ' ' ARG . 59.0 t -57.38 -57.47 9.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.091 0.472 . . . . 1.0 110.762 177.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.622 HD21 ' HA ' ' A' ' 20' ' ' MET . 5.7 mp -59.28 -52.28 66.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.972 -0.558 . . . . 1.0 111.109 -178.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.448 ' HG2' ' O ' ' A' ' 60' ' ' GLY . 5.9 ptm180 -60.08 -26.91 66.55 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.729 -0.669 . . . . 1.0 111.338 -178.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.54 -36.54 73.74 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.124 0.488 . . . . 1.0 110.379 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -93.15 3.82 55.04 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.577 -0.738 . . . . 1.0 111.019 -178.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.35 13.69 63.19 Favored Glycine 0 C--N 1.329 0.178 0 CA-C-N 115.735 -0.666 . . . . 1.0 112.593 176.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.48 ' CD1' ' HA ' ' A' ' 24' ' ' MET . 60.5 m-85 -90.03 147.48 37.3 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 110.258 -0.275 . . . . 1.0 110.258 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.474 ' HG2' ' CB ' ' A' ' 23' ' ' LYS . 56.8 Cg_endo -69.44 159.87 51.99 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.45 2.1 . . . . 1.0 110.572 177.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.0 p -130.38 12.69 5.5 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.541 0.686 . . . . 1.0 109.928 -178.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -70.94 114.35 8.91 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 114.725 -1.125 . . . . 1.0 109.994 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.944 ' HB2' ' HE3' ' A' ' 23' ' ' LYS . 62.5 t60 -160.48 149.83 17.35 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.928 0.394 . . . . 1.0 111.202 -176.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.606 ' NE ' ' HA2' ' A' ' 51' ' ' GLY . 1.4 tmt_? -135.61 112.36 10.13 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.684 -1.228 . . . . 1.0 107.684 175.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.524 ' HB3' ' O ' ' A' ' 49' ' ' HIS . . . -59.71 138.98 57.6 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.895 -1.048 . . . . 1.0 112.724 -174.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.418 ' HA ' HG23 ' A' ' 50' ' ' VAL . . . -130.06 160.62 33.17 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.249 -0.887 . . . . 1.0 110.354 178.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -97.31 155.16 17.0 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.43 -0.952 . . . . 1.0 108.43 178.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.504 HG11 HD23 ' A' ' 97' ' ' LEU . 19.1 t -68.42 112.59 3.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 120.938 0.399 . . . . 1.0 110.607 -178.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.444 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -122.97 -170.23 13.46 Favored Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 115.373 -0.831 . . . . 1.0 111.5 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 98.2 m -56.45 -44.15 80.22 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 122.388 0.275 . . . . 1.0 111.214 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -59.23 -29.71 67.73 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.972 0.415 . . . . 1.0 111.227 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.588 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 80.1 m80 -78.21 -41.66 33.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.161 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.746 ' HA ' HD21 ' A' ' 86' ' ' LEU . 15.6 mt -68.39 -17.41 64.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.255 0.55 . . . . 1.0 110.669 177.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.61 -4.5 59.18 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 116.167 -0.47 . . . . 1.0 110.539 -178.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.563 ' HB1' ' O ' ' A' ' 6' ' ' HIS . . . -63.41 160.0 17.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.99 -0.55 . . . . 1.0 111.049 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.753 ' HB3' HD13 ' A' ' 5' ' ' LEU . 15.5 t70 -85.29 -13.16 50.56 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.517 -0.549 . . . . 1.0 109.517 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.741 HD12 ' CE3' ' A' ' 152' ' ' TRP . 1.1 tt -157.73 112.2 2.63 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.746 -0.661 . . . . 1.0 109.6 -177.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.746 HD21 ' HA ' ' A' ' 81' ' ' LEU . 5.6 mp -103.84 89.18 3.23 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-N 115.396 -0.82 . . . . 1.0 110.832 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.637 HG23 HD22 ' A' ' 85' ' ' LEU . 54.0 t -66.22 91.34 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 113.816 -1.538 . . . . 1.0 112.05 -179.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.06 147.74 31.34 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.245 -1.343 . . . . 1.0 109.693 177.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.644 HD23 ' HB2' ' A' ' 11' ' ' CYS . 3.7 mm? -100.86 -10.86 20.3 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.308 0.575 . . . . 1.0 109.618 177.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -141.56 151.52 43.28 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.214 -0.903 . . . . 1.0 110.087 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -65.07 -17.35 64.38 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 123.477 0.485 . . . . 1.0 110.089 176.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.643 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 5.3 m-20 -77.83 -50.04 13.09 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.668 -0.697 . . . . 1.0 109.817 178.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.682 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 16.3 m170 -59.26 -42.95 92.39 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.561 -0.533 . . . . 1.0 109.561 178.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.68 -44.48 93.6 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.559 178.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.604 ' O ' ' HG2' ' A' ' 99' ' ' GLN . 0.5 OUTLIER -56.66 -45.26 81.77 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 115.818 -0.628 . . . . 1.0 111.015 178.356 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.694 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 50.9 mt -64.39 -48.3 75.97 Favored 'General case' 0 C--O 1.216 -0.68 0 CA-C-N 115.944 -0.571 . . . . 1.0 110.425 -175.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.682 ' HG ' ' O ' ' A' ' 93' ' ' HIS . 33.2 mt -53.0 -60.16 3.63 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.898 -0.592 . . . . 1.0 111.474 -178.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.72 ' N ' HG12 ' A' ' 102' ' ' VAL . 1.2 ptm180 -59.26 -45.16 91.96 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.843 -0.617 . . . . 1.0 112.381 -179.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.604 ' HG2' ' O ' ' A' ' 95' ' ' ARG . 6.2 pt20 -66.74 -24.69 66.25 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 119.956 -0.698 . . . . 1.0 110.194 178.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.694 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 10.1 mt -80.7 -18.84 46.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.031 -0.531 . . . . 1.0 111.592 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 151.99 -21.27 0.88 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 119.748 -1.215 . . . . 1.0 114.44 -178.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.72 HG12 ' N ' ' A' ' 98' ' ' ARG . 0.3 OUTLIER -76.82 -162.36 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 118.113 0.956 . . . . 1.0 110.662 -179.492 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.773 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 12.3 pt-20 -157.3 160.32 38.43 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 107.703 -1.221 . . . . 1.0 107.703 -179.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.775 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -61.04 -26.13 67.41 Favored 'General case' 0 C--N 1.322 -0.601 0 O-C-N 123.366 0.416 . . . . 1.0 111.32 -175.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.48 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . . . -57.06 -36.42 70.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.15 0.5 . . . . 1.0 110.533 175.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.773 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 7.9 mtt-85 -98.46 -42.37 7.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.237 -0.892 . . . . 1.0 111.194 -177.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.775 HG12 ' HA ' ' A' ' 104' ' ' ALA . 14.6 p -77.96 115.44 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 120.614 -0.435 . . . . 1.0 110.085 -175.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.624 ' HD2' ' O ' ' A' ' 107' ' ' VAL . 26.9 mmm180 -136.13 148.71 48.35 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 121.68 -0.637 . . . . 1.0 110.7 -178.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 83.2 mmm -78.92 137.52 37.67 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.615 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.597 HD23 HG11 ' A' ' 87' ' ' VAL . 2.8 tm? -56.02 -52.68 63.36 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 122.455 0.302 . . . . 1.0 111.532 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 111' ' ' ARG . 25.6 ttt85 -71.22 -16.83 62.52 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.586 -0.445 . . . . 1.0 111.222 -176.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 41.7 t -73.56 -7.63 52.68 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 120.585 -0.446 . . . . 1.0 110.703 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.652 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 83.3 m-85 -87.31 -21.74 25.55 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-O 120.664 0.269 . . . . 1.0 110.765 176.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 16.8 t0 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 115.948 -0.569 . . . . 1.0 111.433 -177.647 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 . . . . . 0 N--CA 1.452 -0.348 0 CA-C-O 120.699 0.285 . . . . 1.0 111.277 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.615 ' O ' HG23 ' A' ' 141' ' ' VAL . 11.1 tp10 -64.34 -48.3 76.08 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 108.073 -1.084 . . . . 1.0 108.073 174.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.684 HG13 ' HD3' ' A' ' 17' ' ' ARG . 57.4 t -56.52 -47.41 81.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 114.482 -1.235 . . . . 1.0 109.766 175.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.507 ' HB2' HG11 ' A' ' 61' ' ' VAL . 69.8 t80 -56.4 -44.12 79.98 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 113.858 -1.519 . . . . 1.0 110.147 178.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.71 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -63.42 -44.97 93.09 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.208 -0.451 . . . . 1.0 111.761 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 137' ' ' GLU . 36.3 t -55.43 -46.59 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.706 0.765 . . . . 1.0 110.005 178.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.455 ' CG2' ' HB2' ' A' ' 21' ' ' ALA . 7.0 mt -69.51 -51.13 44.88 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 115.04 -0.982 . . . . 1.0 111.785 -178.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.71 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 6.2 pt-20 -56.14 -33.88 65.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.537 0.208 . . . . 1.0 110.665 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.8 t -73.33 -27.98 61.81 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.238 0.542 . . . . 1.0 110.124 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.472 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -86.69 -23.99 25.39 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-N 115.869 -0.605 . . . . 1.0 111.823 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.687 HD22 ' HB3' ' A' ' 25' ' ' PHE . 11.9 mt -55.16 -37.89 61.65 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 112.654 0.613 . . . . 1.0 112.654 -178.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 61.5 Cg_endo -70.65 -13.2 32.23 Favored 'Trans proline' 0 C--N 1.359 1.116 0 C-N-CA 122.649 2.232 . . . . 1.0 111.939 177.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.652 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -102.72 -32.35 4.81 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 110.099 -1.2 . . . . 1.0 110.099 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.495 ' O ' HG13 ' A' ' 153' ' ' VAL . 0.4 OUTLIER -73.73 -40.69 63.35 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.396 -0.964 . . . . 1.0 108.396 177.604 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . 0.448 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -55.53 -54.7 40.76 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 114.81 -1.086 . . . . 1.0 110.135 175.667 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -58.94 -42.52 89.96 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.333 -0.849 . . . . 1.0 110.961 -175.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . 0.845 ' HZ3' HD11 ' A' ' 5' ' ' LEU . 23.6 t90 -63.02 -55.28 26.99 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.46 -0.791 . . . . 1.0 110.465 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.495 HG13 ' O ' ' A' ' 149' ' ' LEU . 10.7 m -62.7 -40.69 89.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.816 -0.354 . . . . 1.0 110.587 -177.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.495 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 4.1 m-20 -60.79 -50.93 71.46 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-O 120.838 0.351 . . . . 1.0 110.727 178.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.486 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 6.8 pt-20 -64.11 -36.86 85.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.861 -178.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.485 ' HG3' ' CH2' ' A' ' 152' ' ' TRP . 10.4 mmt180 -73.56 -42.61 61.42 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 116.185 -0.461 . . . . 1.0 111.394 -178.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 4.3 pp . . . . . 0 C--O 1.236 0.356 0 N-CA-C 109.27 -0.641 . . . . 1.0 109.27 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.918 ' HG3' ' HE ' ' A' ' 39' ' ' ARG . 60.0 Cg_endo . . . . . 0 C--O 1.236 0.402 0 N-CA-C 114.298 0.846 . . . . 1.0 114.298 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.869 ' HB3' HG23 ' A' ' 38' ' ' VAL . 0.8 OUTLIER -74.8 -173.31 1.82 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.05 -0.977 . . . . 1.0 110.836 178.146 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.492 ' O ' ' HB1' ' A' ' 83' ' ' ALA . 0.2 OUTLIER -159.15 94.59 1.21 Allowed 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 121.087 -0.245 . . . . 1.0 111.448 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.79 HG13 HD13 ' A' ' 85' ' ' LEU . 2.2 t -95.94 113.48 30.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 108.893 -0.781 . . . . 1.0 108.893 175.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.624 ' CG2' ' HG ' ' A' ' 86' ' ' LEU . 14.5 t -114.15 115.26 27.22 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 120.992 0.425 . . . . 1.0 110.108 178.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.549 ' HD1' ' HB ' ' A' ' 87' ' ' VAL . 2.0 m-85 -81.81 146.77 29.72 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 109.56 -0.533 . . . . 1.0 109.56 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.603 HG21 HD11 ' A' ' 97' ' ' LEU . 42.5 t -130.42 114.0 27.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 121.059 0.457 . . . . 1.0 111.63 -177.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.615 ' SG ' ' HD2' ' A' ' 17' ' ' ARG . 47.9 t -143.93 161.25 39.19 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.821 -0.807 . . . . 1.0 108.821 177.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.88 97.07 3.23 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.269 0.556 . . . . 1.0 111.182 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.691 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 130.96 -44.74 1.18 Allowed Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.457 -0.792 . . . . 1.0 111.249 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.662 ' ND2' ' H ' ' A' ' 74' ' ' ALA . 58.6 t30 59.8 29.16 18.73 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.829 0.824 . . . . 1.0 111.179 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.3 pt -130.91 10.67 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.963 -0.562 . . . . 1.0 111.675 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.66 ' O ' ' HG3' ' A' ' 20' ' ' MET . 12.3 m -125.54 -89.64 0.57 Allowed 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.089 -0.644 . . . . 1.0 111.609 -178.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.615 ' HD2' ' SG ' ' A' ' 11' ' ' CYS . 1.9 ptp85 -74.27 -35.85 63.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.065 -0.516 . . . . 1.0 112.364 -176.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.554 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 16.5 m -58.99 -58.83 16.58 Favored Pre-proline 0 CA--C 1.541 0.602 0 C-N-CA 121.26 -0.176 . . . . 1.0 111.105 179.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.76 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 36.6 Cg_endo -61.93 -26.66 79.11 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.051 1.834 . . . . 1.0 111.937 178.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.66 ' HG3' ' O ' ' A' ' 16' ' ' CYS . 63.8 mtp -62.43 -54.57 38.22 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.847 -0.341 . . . . 1.0 111.106 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.1 -28.5 65.45 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 120.452 -0.499 . . . . 1.0 109.666 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.703 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 7.4 tt0 -54.32 -51.9 63.24 Favored 'General case' 0 C--O 1.216 -0.672 0 CA-C-N 115.029 -0.987 . . . . 1.0 109.236 178.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.775 ' HB3' ' HG2' ' A' ' 68' ' ' PRO . 0.0 OUTLIER -80.36 -29.9 37.95 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.758 -0.655 . . . . 1.0 110.212 -176.846 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.585 ' HB3' HD11 ' A' ' 146' ' ' LEU . 3.1 mmm -63.33 -76.12 0.07 Allowed 'General case' 0 C--O 1.238 0.458 0 N-CA-C 113.058 0.762 . . . . 1.0 113.058 -176.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.658 ' HB3' HD22 ' A' ' 146' ' ' LEU . 22.6 p90 -76.76 -29.72 56.22 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 119.859 -0.736 . . . . 1.0 111.268 -174.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.703 ' HB3' ' O ' ' A' ' 22' ' ' GLU . . . -65.25 -37.82 88.43 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 119.036 -1.066 . . . . 1.0 111.134 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.642 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -63.2 -40.04 96.34 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.56 -0.904 . . . . 1.0 108.56 177.854 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.571 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 79.1 mt-30 -57.49 -47.71 81.19 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 115.608 -0.724 . . . . 1.0 110.082 176.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.539 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 93.3 mt -53.09 -59.55 4.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.69 -0.686 . . . . 1.0 111.06 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.597 ' HD3' ' HA ' ' A' ' 27' ' ' GLN . 0.1 OUTLIER -59.5 -37.25 77.81 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.484 -0.486 . . . . 1.0 111.275 178.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -63.9 -21.32 66.41 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.873 0.694 . . . . 1.0 112.873 178.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.539 ' HG2' ' O ' ' A' ' 29' ' ' LEU . 7.6 ptp180 -99.29 -21.54 16.01 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 119.677 -0.809 . . . . 1.0 110.037 176.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 107.34 42.35 1.51 Allowed Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 115.202 -0.908 . . . . 1.0 111.99 178.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 23.8 mt -135.83 -5.11 2.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.704 0.288 . . . . 1.0 110.372 -178.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.455 ' H ' ' HA ' ' A' ' 30' ' ' ARG . . . -58.72 -25.19 58.4 Favored Glycine 0 C--N 1.329 0.168 0 C-N-CA 121.361 -0.447 . . . . 1.0 112.619 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.46 ' O ' ' HB3' ' A' ' 4' ' ' PRO . 49.3 m-20 -85.01 -28.92 25.4 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.28 0.562 . . . . 1.0 109.885 177.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.58 -18.56 51.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.09 -0.959 . . . . 1.0 112.015 -177.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.869 HG23 ' HB3' ' A' ' 5' ' ' LEU . 0.8 OUTLIER -144.85 122.85 5.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.255 0.55 . . . . 1.0 110.137 179.133 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.918 ' HE ' ' HG3' ' A' ' 4' ' ' PRO . 9.9 mmt180 -89.16 145.45 25.42 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.802 -0.636 . . . . 1.0 110.071 -178.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 77.5 t -132.55 118.88 36.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.439 0.638 . . . . 1.0 109.869 -178.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 8' ' ' THR . 36.7 p -132.87 -174.42 3.47 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 114.279 -1.328 . . . . 1.0 111.365 -175.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.554 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 63.9 p -159.63 161.22 34.99 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.509 -178.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.663 ' HB2' ' CD2' ' A' ' 80' ' ' HIS . . . -162.38 163.09 27.99 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.294 0.569 . . . . 1.0 111.627 -178.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.404 ' HA2' ' O ' ' A' ' 11' ' ' CYS . . . -123.73 131.77 8.17 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 110.863 -0.895 . . . . 1.0 110.863 178.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.587 HG23 ' CG1' ' A' ' 10' ' ' VAL . 18.0 p -67.72 -26.92 66.39 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.036 0.384 . . . . 1.0 112.036 -177.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -107.26 9.07 38.75 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.73 -0.748 . . . . 1.0 112.904 -177.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.401 ' HB3' ' HB2' ' A' ' 75' ' ' GLN . 3.8 p-10 41.02 41.93 1.41 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.834 0.854 . . . . 1.0 113.288 179.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.691 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 0.9 OUTLIER -50.34 -77.64 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.154 0.502 . . . . 1.0 112.013 179.009 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.422 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 15.8 m-70 -101.97 41.12 1.24 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.907 -0.588 . . . . 1.0 110.919 -179.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.2 p -61.56 127.43 21.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.13 0.491 . . . . 1.0 110.105 178.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.767 ' HA2' ' HD3' ' A' ' 72' ' ' ARG . . . 97.02 -15.43 62.56 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.679 -0.691 . . . . 1.0 112.107 -177.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.0 t -80.27 -159.02 0.2 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.367 0.603 . . . . 1.0 109.926 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 31.7 t -132.91 173.08 11.77 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.359 -0.837 . . . . 1.0 109.01 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.91 139.95 32.23 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.982 0.42 . . . . 1.0 111.3 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.614 ' OD1' ' HG2' ' A' ' 57' ' ' ARG . 11.7 t70 -60.9 139.14 58.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.425 -0.807 . . . . 1.0 110.374 -178.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -48.21 -33.95 9.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.409 -0.814 . . . . 1.0 112.861 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.614 ' HG2' ' OD1' ' A' ' 55' ' ' ASP . 18.8 ptp180 -70.96 -46.07 63.03 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 122.26 -0.275 . . . . 1.0 110.589 -177.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.47 -32.84 68.75 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 116.086 -0.506 . . . . 1.0 109.743 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.99 -46.88 88.96 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.191 -0.67 . . . . 1.0 109.191 176.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.477 ' HA2' ' HD3' ' A' ' 63' ' ' ARG . . . -61.05 -39.69 97.44 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.818 -0.706 . . . . 1.0 111.574 177.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 57' ' ' ARG . 93.3 t -60.55 -60.31 2.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.803 0.335 . . . . 1.0 111.214 177.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.779 ' HB2' HG22 ' A' ' 69' ' ' THR . 81.8 mt -58.17 -51.79 68.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.211 -0.45 . . . . 1.0 111.526 -176.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.477 ' HD3' ' HA2' ' A' ' 60' ' ' GLY . 6.9 ptm180 -59.17 -29.15 67.25 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.315 -0.402 . . . . 1.0 111.191 -179.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.57 -30.63 61.79 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.343 0.592 . . . . 1.0 110.904 -179.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -95.06 3.97 54.25 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.854 -0.612 . . . . 1.0 110.668 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.09 10.61 60.94 Favored Glycine 0 C--N 1.331 0.264 0 CA-C-N 115.694 -0.685 . . . . 1.0 113.312 175.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.425 ' CD1' ' HA ' ' A' ' 24' ' ' MET . 66.5 m-85 -92.08 152.33 42.63 Favored Pre-proline 0 C--N 1.316 -0.871 0 CA-C-O 120.61 0.243 . . . . 1.0 111.543 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.775 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 33.0 Cg_endo -68.07 156.94 63.92 Favored 'Trans proline' 0 CA--C 1.514 -0.496 0 C-N-CA 122.515 2.144 . . . . 1.0 110.737 175.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.779 HG22 ' HB2' ' A' ' 62' ' ' LEU . 63.3 p -132.55 7.89 4.19 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 120.102 -0.639 . . . . 1.0 112.485 -176.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -90.5 133.09 35.29 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.008 0.432 . . . . 1.0 110.851 -178.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.483 ' HB2' ' HE3' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -173.03 150.71 2.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.41 -0.814 . . . . 1.0 109.207 -176.749 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.767 ' HD3' ' HA2' ' A' ' 51' ' ' GLY . 4.1 tmm_? -120.79 115.33 23.07 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.169 -1.049 . . . . 1.0 108.169 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' A' ' 49' ' ' HIS . . . -58.03 137.08 57.16 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.462 0.648 . . . . 1.0 112.307 -175.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.662 ' H ' ' ND2' ' A' ' 14' ' ' ASN . . . -127.81 158.29 38.1 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.41 -0.813 . . . . 1.0 109.913 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.401 ' HB2' ' HB3' ' A' ' 47' ' ' ASN . 34.2 tt0 -94.89 155.92 16.57 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.916 -0.772 . . . . 1.0 108.916 177.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.506 HG11 ' CD2' ' A' ' 97' ' ' LEU . 22.0 t -67.46 112.56 2.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.236 0.541 . . . . 1.0 110.09 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.549 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -126.24 -167.19 12.39 Favored Glycine 0 N--CA 1.438 -1.178 0 CA-C-N 115.445 -0.798 . . . . 1.0 111.38 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 54.4 m -55.42 -51.68 66.08 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 122.574 0.35 . . . . 1.0 111.931 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.45 ' HG2' ' N ' ' A' ' 80' ' ' HIS . 1.1 pm0 -57.2 -31.92 65.94 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.655 -0.702 . . . . 1.0 111.008 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.663 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 78.3 m80 -76.74 -41.86 43.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.034 179.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 24.4 mt -67.41 -19.26 65.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.939 -0.573 . . . . 1.0 110.992 177.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -87.38 -6.09 58.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.933 -0.576 . . . . 1.0 111.209 -178.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.492 ' HB1' ' O ' ' A' ' 6' ' ' HIS . . . -59.93 152.96 22.26 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.852 -0.613 . . . . 1.0 111.275 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -76.86 -17.48 58.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.102 0.477 . . . . 1.0 109.965 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.79 HD13 HG13 ' A' ' 7' ' ' VAL . 0.3 OUTLIER -153.26 116.42 4.6 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-N 115.604 -0.725 . . . . 1.0 109.443 -176.722 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.624 ' HG ' ' CG2' ' A' ' 8' ' ' THR . 5.1 mp -106.72 107.3 18.25 Favored 'General case' 0 N--CA 1.422 -1.856 0 CA-C-N 115.774 -0.648 . . . . 1.0 110.01 177.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.549 ' HB ' ' HD1' ' A' ' 9' ' ' PHE . 51.5 t -85.49 93.3 3.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 114.994 -1.003 . . . . 1.0 110.934 -176.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.23 145.78 32.06 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.628 -0.714 . . . . 1.0 110.432 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.501 ' HG ' ' HD3' ' A' ' 17' ' ' ARG . 3.9 mm? -96.67 -12.44 23.84 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.208 0.528 . . . . 1.0 110.604 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.446 ' CG ' ' H ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -151.54 157.66 42.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.625 -0.716 . . . . 1.0 111.193 179.523 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -53.5 -29.68 37.44 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 113.467 0.914 . . . . 1.0 113.467 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.637 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 2.2 m120 -76.59 -48.37 19.43 Favored 'General case' 0 CA--C 1.512 -0.486 0 C-N-CA 120.364 -0.534 . . . . 1.0 110.864 -177.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.705 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 15.7 m170 -56.04 -46.36 78.91 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.838 -0.43 . . . . 1.0 109.838 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.45 -43.13 93.24 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.803 0.335 . . . . 1.0 110.794 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.453 ' O ' ' HG2' ' A' ' 98' ' ' ARG . 13.1 ttt180 -59.76 -44.64 93.76 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 115.845 -0.616 . . . . 1.0 111.629 179.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.754 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 58.5 mt -64.03 -48.98 74.2 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.169 -0.468 . . . . 1.0 110.083 -176.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.705 ' HG ' ' O ' ' A' ' 93' ' ' HIS . 32.7 mt -52.7 -57.12 11.15 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.845 -0.616 . . . . 1.0 111.22 -179.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.556 ' HA ' ' HB ' ' A' ' 102' ' ' VAL . 12.9 ptt180 -61.26 -41.31 96.71 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.216 -0.447 . . . . 1.0 111.832 -176.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.665 ' HG3' ' O ' ' A' ' 96' ' ' LEU . 1.1 pp0? -69.12 -25.32 64.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.993 0.425 . . . . 1.0 110.359 178.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.754 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 14.2 mt -78.53 -13.65 59.73 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.987 -0.551 . . . . 1.0 112.315 -179.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 148.59 -22.73 1.34 Allowed Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 119.995 -1.097 . . . . 1.0 112.935 -178.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.951 HG12 ' H ' ' A' ' 103' ' ' GLU . 3.3 t -76.24 -156.98 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 109.687 -0.486 . . . . 1.0 109.687 178.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.951 ' H ' HG12 ' A' ' 102' ' ' VAL . 16.8 pt-20 -171.18 168.08 6.87 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 107.66 -1.237 . . . . 1.0 107.66 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.735 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -66.45 -23.93 66.36 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.992 -0.283 . . . . 1.0 111.572 -174.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.04 -37.78 72.25 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.246 0.546 . . . . 1.0 110.509 176.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.752 ' HD2' HG13 ' A' ' 102' ' ' VAL . 15.1 mtt180 -96.11 -45.17 6.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.778 -1.101 . . . . 1.0 110.935 -176.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.735 HG12 ' HA ' ' A' ' 104' ' ' ALA . 8.0 p -79.46 124.78 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-O 121.572 0.701 . . . . 1.0 110.702 -177.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.546 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 21.2 mmm180 -140.52 146.69 38.46 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 -179.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.542 ' HB2' ' HB2' ' A' ' 112' ' ' SER . 82.1 mmm -78.86 137.84 37.86 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.762 -0.654 . . . . 1.0 110.369 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.503 HD23 HG11 ' A' ' 87' ' ' VAL . 3.1 tm? -56.31 -48.7 76.16 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.077 0.465 . . . . 1.0 111.268 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 65.0 ttt180 -69.6 -20.59 63.62 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.98 -0.554 . . . . 1.0 110.303 -177.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.542 ' HB2' ' HB2' ' A' ' 109' ' ' MET . 36.1 t -76.15 -5.41 46.56 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.62 -0.718 . . . . 1.0 110.913 -177.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.568 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 86.9 m-85 -90.68 -22.77 20.98 Favored 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 122.172 -0.33 . . . . 1.0 110.237 175.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 58.6 t0 . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 115.733 -0.667 . . . . 1.0 110.263 -177.767 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 . . . . . 0 N--CA 1.454 -0.229 0 CA-C-O 121.045 0.45 . . . . 1.0 109.853 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.489 ' O ' HG23 ' A' ' 141' ' ' VAL . 71.1 tt0 -67.8 -42.95 80.76 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 108.539 -0.911 . . . . 1.0 108.539 174.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.449 HG12 HD12 ' A' ' 142' ' ' ILE . 76.1 t -58.72 -44.34 89.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 114.514 -1.221 . . . . 1.0 109.583 176.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.554 ' HB2' ' HE1' ' A' ' 20' ' ' MET . 46.5 t80 -54.59 -43.41 72.11 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.444 -1.253 . . . . 1.0 110.257 177.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.451 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -63.9 -42.19 97.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.774 -0.648 . . . . 1.0 110.901 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 137' ' ' GLU . 31.2 t -57.7 -57.02 12.09 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 CA-C-O 121.384 0.611 . . . . 1.0 110.592 178.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.482 ' HA ' HD11 ' A' ' 110' ' ' LEU . 7.0 mt -57.7 -52.07 62.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.21 -0.904 . . . . 1.0 112.388 -177.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.498 ' HG3' ' N ' ' A' ' 144' ' ' SER . 2.2 pt-20 -56.34 -33.06 65.28 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.702 0.287 . . . . 1.0 110.536 -179.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . 0.498 ' N ' ' HG3' ' A' ' 143' ' ' GLU . 4.0 t -73.52 -27.42 61.35 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.347 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.466 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -88.61 -22.34 23.54 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-N 115.914 -0.585 . . . . 1.0 111.86 179.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.658 HD22 ' HB3' ' A' ' 25' ' ' PHE . 12.5 mt -55.28 -37.31 55.37 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-O 119.212 -0.423 . . . . 1.0 112.117 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.626 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 43.3 Cg_endo -68.91 -12.17 33.74 Favored 'Trans proline' 0 C--N 1.365 1.409 0 C-N-CA 122.325 2.017 . . . . 1.0 111.943 176.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.568 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -104.51 -33.8 3.78 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 110.72 -0.952 . . . . 1.0 110.72 178.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.517 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -73.46 -39.62 64.79 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.348 -0.982 . . . . 1.0 108.348 178.93 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . 0.511 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 0.2 OUTLIER -54.12 -55.01 31.76 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-N 115.136 -0.938 . . . . 1.0 110.628 175.347 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -56.29 -42.26 77.24 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.716 -1.129 . . . . 1.0 111.193 -175.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . 0.666 ' HZ3' HD21 ' A' ' 5' ' ' LEU . 22.1 t90 -64.97 -54.85 24.1 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.346 -0.843 . . . . 1.0 110.613 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.446 HG13 ' O ' ' A' ' 149' ' ' LEU . 6.4 m -62.21 -41.17 90.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 120.587 -0.445 . . . . 1.0 110.069 -178.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -60.19 -49.51 77.36 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-O 121.013 0.435 . . . . 1.0 110.792 178.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.543 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 11.8 pt-20 -63.61 -39.57 94.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.691 -0.686 . . . . 1.0 110.399 -178.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.527 ' HG3' ' CH2' ' A' ' 152' ' ' TRP . 15.6 mmt85 -74.59 -42.37 58.8 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.863 -0.608 . . . . 1.0 111.528 -175.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.409 HD12 ' C ' ' A' ' 157' ' ' LEU . 4.0 pp . . . . . 0 C--N 1.325 -0.487 0 CA-C-O 121.285 0.564 . . . . 1.0 109.576 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.643 ' HB2' ' HG2' ' A' ' 39' ' ' ARG . 18.9 Cg_endo . . . . . 0 N--CA 1.46 -0.443 0 N-CA-C 113.886 0.687 . . . . 1.0 113.886 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.577 ' HB3' HG13 ' A' ' 38' ' ' VAL . 0.4 OUTLIER -71.1 -173.85 0.89 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.287 -1.324 . . . . 1.0 110.347 179.173 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.573 ' HB3' ' H ' ' A' ' 84' ' ' ASP . 1.5 t-160 -155.2 102.52 2.3 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 110.043 -0.355 . . . . 1.0 110.043 -178.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.699 HG13 HD13 ' A' ' 85' ' ' LEU . 2.1 t -106.53 112.48 39.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 108.125 -1.065 . . . . 1.0 108.125 177.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.55 HG22 ' HG ' ' A' ' 86' ' ' LEU . 9.0 t -114.58 114.11 25.29 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.033 0.444 . . . . 1.0 110.479 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.566 ' HD1' ' HB ' ' A' ' 87' ' ' VAL . 0.9 OUTLIER -83.87 134.83 34.68 Favored 'General case' 0 CA--C 1.511 -0.526 0 O-C-N 121.857 -0.527 . . . . 1.0 110.259 -179.541 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.577 HG21 HD11 ' A' ' 97' ' ' LEU . 48.8 t -119.69 115.61 48.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-O 121.227 0.537 . . . . 1.0 111.453 -177.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 37.4 t -140.49 163.15 33.6 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.527 -0.76 . . . . 1.0 109.297 178.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.15 84.94 3.63 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.167 0.508 . . . . 1.0 111.23 -177.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.708 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 141.84 -39.14 1.42 Allowed Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.443 -0.799 . . . . 1.0 111.952 179.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.407 HD21 ' CB ' ' A' ' 42' ' ' SER . 3.8 t-20 62.71 16.47 8.98 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.817 0.818 . . . . 1.0 111.347 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.418 ' O ' ' HB3' ' A' ' 55' ' ' ASP . 1.8 pt -131.44 32.87 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 O-C-N 121.827 -0.546 . . . . 1.0 110.553 -178.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.787 ' O ' ' HG3' ' A' ' 20' ' ' MET . 35.6 m -147.97 -88.21 0.09 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.915 -0.402 . . . . 1.0 109.915 175.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.41 -51.29 68.11 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.257 0.466 . . . . 1.0 112.257 -177.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.872 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 14.3 m -54.19 -58.99 11.21 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 115.99 -0.55 . . . . 1.0 112.369 -177.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.657 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 33.2 Cg_endo -61.62 -26.6 80.54 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 121.898 1.732 . . . . 1.0 112.705 -178.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.787 ' HG3' ' O ' ' A' ' 16' ' ' CYS . 72.9 mtp -60.43 -54.84 40.76 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.751 -0.38 . . . . 1.0 110.524 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.524 ' HA ' ' HB2' ' A' ' 24' ' ' MET . . . -74.75 -27.53 60.39 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.582 -0.447 . . . . 1.0 110.763 -178.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.601 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 18.1 tt0 -52.37 -53.36 45.82 Favored 'General case' 0 C--O 1.217 -0.634 0 O-C-N 124.064 0.852 . . . . 1.0 110.09 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.981 ' HE3' ' HB2' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -86.71 -22.35 26.08 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.43 -0.805 . . . . 1.0 110.69 -176.409 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.704 ' HB3' HD11 ' A' ' 146' ' ' LEU . 3.2 mmm -63.73 -76.66 0.06 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.216 0.45 . . . . 1.0 112.216 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.762 ' HB3' HD22 ' A' ' 146' ' ' LEU . 22.6 p90 -76.2 -29.76 57.74 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 119.697 -0.801 . . . . 1.0 111.68 -175.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.601 ' HB3' ' O ' ' A' ' 22' ' ' GLU . . . -63.35 -36.62 84.31 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 119.321 -0.952 . . . . 1.0 110.714 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.625 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -65.48 -39.32 91.8 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 108.801 -0.815 . . . . 1.0 108.801 177.218 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.616 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 59.8 mt-30 -60.47 -37.73 81.96 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 121.098 0.475 . . . . 1.0 110.395 177.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.582 HD13 ' HB ' ' A' ' 38' ' ' VAL . 95.9 mt -57.01 -62.63 1.61 Allowed 'General case' 0 C--O 1.223 -0.308 0 CA-C-N 115.724 -0.671 . . . . 1.0 110.555 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.485 ' HB3' ' HA3' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -59.3 -31.01 68.74 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.154 -0.618 . . . . 1.0 111.548 179.099 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -59.88 -33.73 72.22 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.929 0.395 . . . . 1.0 111.213 176.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.566 ' HG3' ' HG ' ' A' ' 34' ' ' LEU . 11.6 ptm180 -95.71 -20.68 18.71 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 120.142 -0.623 . . . . 1.0 109.827 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 109.6 36.22 2.11 Favored Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 115.008 -0.996 . . . . 1.0 112.459 177.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.566 ' HG ' ' HG3' ' A' ' 32' ' ' ARG . 38.9 mt -129.03 4.36 5.31 Favored 'General case' 0 C--N 1.331 -0.239 0 O-C-N 122.275 -0.544 . . . . 1.0 110.174 -179.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.485 ' HA3' ' HB3' ' A' ' 30' ' ' ARG . . . -59.0 -29.53 65.3 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 121.276 -0.488 . . . . 1.0 113.27 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.594 ' HA ' ' NH1' ' A' ' 39' ' ' ARG . 11.8 m-20 -92.71 -17.63 24.0 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.117 0.484 . . . . 1.0 110.254 177.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.89 -24.13 38.51 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.659 -0.701 . . . . 1.0 110.428 178.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.582 ' HB ' HD13 ' A' ' 29' ' ' LEU . 12.0 t -130.94 123.92 55.12 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.446 -179.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.643 ' HG2' ' HB2' ' A' ' 4' ' ' PRO . 22.8 mmt180 -93.82 130.56 39.8 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 109.058 -0.719 . . . . 1.0 109.058 175.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 64.0 t -122.68 117.84 53.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-O 121.528 0.68 . . . . 1.0 109.599 -175.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.507 ' O ' ' HA ' ' A' ' 8' ' ' THR . 57.9 p -130.99 -177.11 4.23 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.379 -1.282 . . . . 1.0 110.322 -175.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.872 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 90.9 p -160.56 165.71 30.32 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.842 -0.343 . . . . 1.0 110.339 179.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.624 ' HB2' ' CD2' ' A' ' 80' ' ' HIS . . . -164.0 166.92 21.07 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 121.365 0.603 . . . . 1.0 111.677 -179.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -124.55 131.92 8.03 Favored Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 110.682 -0.967 . . . . 1.0 110.682 176.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.568 HG23 ' CG1' ' A' ' 10' ' ' VAL . 36.3 p -66.62 -28.87 68.83 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.108 0.41 . . . . 1.0 112.108 -176.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.443 ' HA3' ' HZ3' ' A' ' 48' ' ' TRP . . . -106.53 10.82 42.48 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.618 -0.801 . . . . 1.0 113.598 -175.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 44.87 34.51 1.23 Allowed 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.559 0.948 . . . . 1.0 113.559 177.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.708 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 1.2 m-90 -45.09 -74.87 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.596 0.712 . . . . 1.0 111.984 179.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -107.39 41.17 1.54 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.822 -1.081 . . . . 1.0 111.132 -178.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.9 p -60.64 127.84 20.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.405 178.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.03 -12.62 68.9 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.962 -0.637 . . . . 1.0 112.378 -178.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 t -80.81 -160.19 0.3 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.907 0.384 . . . . 1.0 110.615 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 31.7 t -129.91 170.42 13.95 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.688 -0.486 . . . . 1.0 109.688 -178.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.83 143.2 38.11 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.242 0.544 . . . . 1.0 112.094 -178.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.682 ' OD2' ' HG3' ' A' ' 57' ' ' ARG . 12.8 p-10 -63.54 144.58 56.88 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.71 -1.132 . . . . 1.0 112.655 -177.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -48.69 -43.3 36.93 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.546 -1.206 . . . . 1.0 113.311 178.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.682 ' HG3' ' OD2' ' A' ' 55' ' ' ASP . 4.0 ptp180 -71.49 -40.73 70.04 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 121.135 -0.226 . . . . 1.0 111.471 -175.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.635 ' HB1' ' HG2' ' A' ' 20' ' ' MET . . . -71.04 -35.66 72.05 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.045 0.45 . . . . 1.0 109.834 178.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.85 -42.3 97.6 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.905 -0.589 . . . . 1.0 111.04 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -67.53 -34.73 85.05 Favored Glycine 0 CA--C 1.489 -1.546 0 N-CA-C 110.379 -1.089 . . . . 1.0 110.379 -178.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.542 ' O ' ' HD2' ' A' ' 65' ' ' HIS . 1.1 t -63.07 -54.57 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 CA-C-N 113.557 -1.322 . . . . 1.0 110.882 176.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.711 HD13 ' HG3' ' A' ' 23' ' ' LYS . 89.5 mt -62.39 -51.86 65.88 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.772 0.32 . . . . 1.0 111.152 -177.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -64.83 -23.5 67.26 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.807 -0.633 . . . . 1.0 111.509 -177.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.68 -33.3 70.77 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.2 0.524 . . . . 1.0 110.589 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.542 ' HD2' ' O ' ' A' ' 61' ' ' VAL . 87.7 m-70 -96.12 1.46 52.45 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.713 -0.676 . . . . 1.0 111.063 -178.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 96.22 9.51 56.87 Favored Glycine 0 C--N 1.33 0.221 0 C-N-CA 120.886 -0.674 . . . . 1.0 113.112 176.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.511 ' CD1' ' HA ' ' A' ' 24' ' ' MET . 73.5 m-85 -88.99 149.37 43.21 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-O 120.413 0.149 . . . . 1.0 110.621 -179.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.475 ' HG2' ' CB ' ' A' ' 23' ' ' LYS . 40.9 Cg_endo -69.09 156.31 65.49 Favored 'Trans proline' 0 CA--C 1.51 -0.705 0 C-N-CA 122.252 1.968 . . . . 1.0 110.883 176.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.706 HG22 ' HB2' ' A' ' 62' ' ' LEU . 52.1 p -130.36 13.68 5.56 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.49 0.662 . . . . 1.0 110.443 -177.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -85.03 125.5 32.78 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.988 -1.006 . . . . 1.0 109.15 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.981 ' HB2' ' HE3' ' A' ' 23' ' ' LYS . 19.2 t60 -165.54 154.06 11.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.347 -0.388 . . . . 1.0 110.385 -175.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -133.95 113.85 12.63 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.628 -0.879 . . . . 1.0 108.628 176.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.63 140.27 56.53 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.171 -0.922 . . . . 1.0 112.558 -175.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.449 ' O ' ' HA ' ' A' ' 43' ' ' ALA . . . -134.18 150.74 51.1 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.257 -0.883 . . . . 1.0 109.81 178.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -86.62 155.33 20.48 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.615 -0.513 . . . . 1.0 109.615 176.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.591 HG11 ' CD2' ' A' ' 97' ' ' LEU . 8.8 t -67.41 112.62 2.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.123 0.487 . . . . 1.0 110.212 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.493 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -123.37 -166.92 12.72 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.58 -0.736 . . . . 1.0 111.437 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 44.3 m -57.11 -51.56 68.82 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.125 0.488 . . . . 1.0 111.687 -178.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.448 ' CD ' ' H ' ' A' ' 79' ' ' GLU . 1.4 pm0 -56.39 -31.57 63.97 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.3 -0.864 . . . . 1.0 111.114 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.624 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 80.1 m80 -75.28 -42.77 54.09 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 116.055 -0.52 . . . . 1.0 110.158 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.522 ' HA ' HD21 ' A' ' 86' ' ' LEU . 21.0 mt -67.69 -18.64 65.0 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.737 -0.665 . . . . 1.0 110.672 178.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.37 -2.9 58.82 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.852 -0.613 . . . . 1.0 110.853 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.555 ' HA ' ' HB3' ' A' ' 6' ' ' HIS . . . -60.23 155.14 18.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.827 -0.624 . . . . 1.0 111.498 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.709 ' HA ' ' NH1' ' A' ' 106' ' ' ARG . 25.0 t70 -79.5 -16.83 55.37 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.335 0.588 . . . . 1.0 109.883 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.699 HD13 HG13 ' A' ' 7' ' ' VAL . 0.5 OUTLIER -155.07 117.64 4.28 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.137 -0.938 . . . . 1.0 108.909 -177.405 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.586 ' N ' HD12 ' A' ' 86' ' ' LEU . 5.0 mp -105.52 104.11 13.77 Favored 'General case' 0 N--CA 1.425 -1.704 0 CA-C-N 115.518 -0.765 . . . . 1.0 109.744 178.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.575 ' HA ' ' O ' ' A' ' 108' ' ' ARG . 72.2 t -84.91 92.59 3.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.202 -0.908 . . . . 1.0 111.272 -176.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.02 146.03 30.86 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.18 -0.918 . . . . 1.0 110.785 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.403 HD13 ' HA ' ' A' ' 89' ' ' LEU . 4.2 mm? -97.55 -7.63 30.9 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.37 0.605 . . . . 1.0 109.952 178.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.441 ' CG ' ' H ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -152.64 152.97 32.39 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.16 -0.927 . . . . 1.0 110.103 178.335 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 18.7 ptt180 -64.3 -19.72 65.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.573 -0.74 . . . . 1.0 112.749 -176.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.637 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 7.1 m120 -75.62 -48.73 20.97 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.397 -0.594 . . . . 1.0 109.397 178.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.744 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 17.8 m170 -56.29 -47.32 78.89 Favored 'General case' 0 C--N 1.333 -0.124 0 N-CA-C 109.619 -0.512 . . . . 1.0 109.619 177.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.466 ' HA ' HG21 ' A' ' 107' ' ' VAL . . . -58.55 -44.33 89.63 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.308 -0.406 . . . . 1.0 110.961 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.458 ' O ' ' HG2' ' A' ' 98' ' ' ARG . 2.0 ttt85 -59.64 -41.76 91.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.128 -0.487 . . . . 1.0 111.517 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.761 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 50.4 mt -63.91 -49.27 73.32 Favored 'General case' 0 C--O 1.219 -0.52 0 N-CA-C 109.744 -0.465 . . . . 1.0 109.744 -177.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.744 ' HG ' ' O ' ' A' ' 93' ' ' HIS . 27.5 mt -55.78 -55.59 30.58 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.316 -0.856 . . . . 1.0 111.67 -178.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.458 ' HG2' ' O ' ' A' ' 95' ' ' ARG . 20.2 ptt180 -60.97 -43.6 98.56 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.214 -0.448 . . . . 1.0 111.554 -176.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.647 ' HG3' ' O ' ' A' ' 96' ' ' LEU . 1.1 pp0? -69.0 -21.38 64.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.125 0.488 . . . . 1.0 110.239 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.761 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 9.8 mt -78.61 -7.81 57.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.595 -0.729 . . . . 1.0 111.962 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 147.66 -31.13 1.38 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.047 -1.073 . . . . 1.0 113.223 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.698 HG12 ' H ' ' A' ' 103' ' ' GLU . 1.4 t -75.15 -153.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.359 0.6 . . . . 1.0 111.238 -178.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.731 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 15.5 pt-20 -164.25 164.53 22.45 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.603 -0.888 . . . . 1.0 108.603 -178.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.811 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -67.69 -21.92 65.31 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.571 -0.286 . . . . 1.0 111.542 -175.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.61 -35.88 77.22 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.284 0.564 . . . . 1.0 110.371 175.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.731 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 0.6 OUTLIER -95.09 -44.84 7.48 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 115.201 -0.909 . . . . 1.0 110.364 -177.676 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.811 HG12 ' HA ' ' A' ' 104' ' ' ALA . 8.9 p -78.33 117.29 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-O 121.846 0.832 . . . . 1.0 109.595 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.575 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 29.1 mmm180 -134.43 148.62 50.66 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.662 -0.699 . . . . 1.0 109.915 -177.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.433 ' HB2' ' HB2' ' A' ' 112' ' ' SER . 82.6 mmm -78.57 140.29 38.52 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.279 -0.873 . . . . 1.0 110.581 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.571 HD11 ' HA ' ' A' ' 142' ' ' ILE . 3.2 tm? -56.49 -50.47 71.66 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 123.085 0.241 . . . . 1.0 110.93 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 5.6 ttm-85 -70.96 -15.52 62.59 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.691 -0.404 . . . . 1.0 110.854 -178.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.433 ' HB2' ' HB2' ' A' ' 109' ' ' MET . 33.5 t -75.26 -2.7 29.33 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 120.97 -0.292 . . . . 1.0 110.31 -179.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.68 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 85.9 m-85 -96.08 -17.77 20.67 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 121.972 -0.455 . . . . 1.0 110.617 175.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.7 t0 . . . . . 0 C--N 1.326 -0.438 0 CA-C-N 115.882 -0.599 . . . . 1.0 110.47 -178.307 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 . . . . . 0 N--CA 1.452 -0.348 0 N-CA-C 109.634 -0.506 . . . . 1.0 109.634 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -65.56 -45.5 83.12 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 109.643 -0.503 . . . . 1.0 109.643 176.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.842 ' HA ' HG12 ' A' ' 141' ' ' VAL . 24.4 t -63.74 -40.39 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-O 121.756 0.788 . . . . 1.0 109.043 177.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -55.94 -42.18 75.77 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.328 -0.851 . . . . 1.0 109.309 175.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.58 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -66.99 -47.96 69.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.489 -0.778 . . . . 1.0 111.711 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.842 HG12 ' HA ' ' A' ' 138' ' ' VAL . 3.6 p -59.54 -43.86 91.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.709 0.766 . . . . 1.0 111.214 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.611 HD12 HG12 ' A' ' 138' ' ' VAL . 13.5 mt -67.13 -51.08 57.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 115.206 -0.906 . . . . 1.0 111.504 178.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.58 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 7.6 pt-20 -56.11 -30.25 61.8 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 109.934 -0.395 . . . . 1.0 109.934 179.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 4.2 t -72.57 -30.32 64.3 Favored 'General case' 0 C--O 1.226 -0.179 0 CA-C-N 115.749 -0.66 . . . . 1.0 110.315 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.457 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -87.84 -22.62 24.35 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-N 116.024 -0.535 . . . . 1.0 111.723 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.762 HD22 ' HB3' ' A' ' 25' ' ' PHE . 9.9 mt -54.77 -38.77 70.54 Favored Pre-proline 0 CA--C 1.545 0.774 0 CA-C-O 119.163 -0.446 . . . . 1.0 112.048 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 61.7 Cg_endo -71.28 -11.01 28.17 Favored 'Trans proline' 0 C--N 1.365 1.429 0 C-N-CA 122.695 2.264 . . . . 1.0 112.113 177.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.68 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -103.86 -33.32 4.11 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.372 -1.091 . . . . 1.0 110.372 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.498 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -74.28 -40.38 62.33 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.378 -0.971 . . . . 1.0 108.378 178.372 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . 0.484 ' O ' ' HB2' ' A' ' 154' ' ' ASP . 1.0 OUTLIER -55.71 -52.1 65.05 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 114.716 -1.129 . . . . 1.0 110.966 176.111 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -61.73 -42.35 98.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.755 -0.657 . . . . 1.0 110.962 -176.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . 0.577 ' CE3' HD12 ' A' ' 85' ' ' LEU . 28.0 t90 -60.98 -57.12 13.95 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.387 -0.824 . . . . 1.0 110.629 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.508 ' HB ' HD22 ' A' ' 5' ' ' LEU . 11.0 m -60.41 -38.49 78.0 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.279 0 N-CA-C 110.088 -0.338 . . . . 1.0 110.088 -178.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.525 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 0.5 OUTLIER -59.53 -56.19 25.07 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.403 0.62 . . . . 1.0 110.815 179.72 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -61.44 -39.81 92.19 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.047 -0.978 . . . . 1.0 110.72 -177.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.43 ' HD3' ' HA ' ' A' ' 156' ' ' ARG . 11.4 mmt85 -72.07 -45.75 59.54 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 115.79 -0.641 . . . . 1.0 110.966 -176.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.525 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 3.6 pp . . . . . 0 C--N 1.326 -0.439 0 CA-C-N 115.789 -0.641 . . . . 1.0 109.372 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.466 ' HB2' ' HG2' ' A' ' 39' ' ' ARG . 19.4 Cg_endo . . . . . 0 N--CA 1.458 -0.584 0 CA-C-O 121.112 0.38 . . . . 1.0 112.402 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.794 ' HB3' HG23 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -65.04 177.17 1.05 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.667 -0.697 . . . . 1.0 109.304 -179.213 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.738 ' H ' HD13 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -157.24 90.93 1.14 Allowed 'General case' 0 C--N 1.318 -0.797 0 O-C-N 121.878 -0.514 . . . . 1.0 111.036 -179.134 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.582 HG13 HD13 ' A' ' 85' ' ' LEU . 1.7 t -95.74 109.09 22.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.731 -0.668 . . . . 1.0 109.557 178.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.614 ' CG2' ' HG ' ' A' ' 86' ' ' LEU . 10.1 t -112.56 117.28 31.9 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 109.623 -0.51 . . . . 1.0 109.623 178.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.727 ' HZ ' ' HE1' ' A' ' 25' ' ' PHE . 1.0 OUTLIER -86.3 134.49 33.74 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 120.843 0.354 . . . . 1.0 110.234 -178.919 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.598 HG21 HD11 ' A' ' 97' ' ' LEU . 33.7 t -116.5 113.67 43.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 116.083 -0.508 . . . . 1.0 111.649 -176.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.638 ' HB2' HD23 ' A' ' 89' ' ' LEU . 38.3 t -143.86 160.61 40.47 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.145 -0.48 . . . . 1.0 109.837 178.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.423 HG23 ' NE2' ' A' ' 93' ' ' HIS . 0.6 OUTLIER -67.39 100.45 0.84 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.205 0.526 . . . . 1.0 111.18 -179.768 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 1.008 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 117.21 -40.01 2.48 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.513 -0.767 . . . . 1.0 112.18 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.706 ' ND2' ' H ' ' A' ' 74' ' ' ALA . 57.7 t30 60.61 25.72 15.43 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 122.449 1.119 . . . . 1.0 110.392 -177.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.578 ' O ' ' HB3' ' A' ' 55' ' ' ASP . 1.3 pt -134.76 39.02 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 114.908 -1.042 . . . . 1.0 109.658 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.763 ' O ' ' HG3' ' A' ' 20' ' ' MET . 6.9 p -151.38 -89.26 0.06 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.086 -0.507 . . . . 1.0 111.426 177.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 81.3 mtt180 -74.83 -45.1 45.56 Favored 'General case' 0 N--CA 1.464 0.249 0 O-C-N 122.004 -0.435 . . . . 1.0 111.543 -176.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.472 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 20.4 m -53.09 -56.32 24.96 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 116.117 -0.492 . . . . 1.0 111.364 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.472 ' HD3' ' HB2' ' A' ' 18' ' ' SER . 49.4 Cg_endo -67.28 -24.52 43.62 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 121.444 1.43 . . . . 1.0 112.909 -178.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.763 ' HG3' ' O ' ' A' ' 16' ' ' CYS . 63.4 mtp -59.15 -53.35 59.32 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 109.869 -0.419 . . . . 1.0 109.869 178.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.554 ' O ' ' HD1' ' A' ' 25' ' ' PHE . . . -72.77 -31.15 64.68 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 115.379 -0.828 . . . . 1.0 110.68 -177.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.636 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 17.5 tt0 -50.66 -53.46 30.85 Favored 'General case' 0 C--O 1.218 -0.554 0 O-C-N 124.167 0.917 . . . . 1.0 110.162 -178.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.675 ' HZ1' ' HB3' ' A' ' 71' ' ' HIS . 0.2 OUTLIER -84.9 -24.23 28.55 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.497 -0.774 . . . . 1.0 110.902 -176.618 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.431 ' HB3' HD11 ' A' ' 146' ' ' LEU . 85.4 mtp -63.61 -75.66 0.08 Allowed 'General case' 0 C--O 1.237 0.423 0 N-CA-C 112.621 0.6 . . . . 1.0 112.621 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.754 ' HB3' HD22 ' A' ' 146' ' ' LEU . 0.6 OUTLIER -78.62 -28.77 45.65 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.163 -0.615 . . . . 1.0 111.93 -174.885 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.636 ' HB3' ' O ' ' A' ' 22' ' ' GLU . . . -64.71 -38.07 89.75 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 119.346 -0.941 . . . . 1.0 110.389 178.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.635 ' HG3' ' N ' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -62.92 -38.84 92.57 Favored 'General case' 0 CA--C 1.527 0.061 0 N-CA-C 108.406 -0.961 . . . . 1.0 108.406 177.046 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.635 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 79.4 mt-30 -59.89 -42.88 94.76 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 115.593 -0.73 . . . . 1.0 110.808 176.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 25' ' ' PHE . 96.5 mt -56.17 -60.05 4.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.104 -0.498 . . . . 1.0 111.322 -178.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.425 ' HA ' ' H ' ' A' ' 35' ' ' GLY . 0.1 OUTLIER -60.29 -34.91 74.42 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.144 -0.623 . . . . 1.0 111.178 178.904 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -60.76 -29.24 69.29 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 111.96 0.355 . . . . 1.0 111.96 177.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.603 ' HG2' ' O ' ' A' ' 28' ' ' GLN . 6.8 ptp180 -94.72 -21.1 18.98 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.098 -0.641 . . . . 1.0 110.275 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 107.43 40.38 1.78 Allowed Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.175 -0.921 . . . . 1.0 111.962 177.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 25.8 mt -132.32 0.32 3.71 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.965 -0.383 . . . . 1.0 109.965 -178.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.425 ' H ' ' HA ' ' A' ' 30' ' ' ARG . . . -57.7 -28.91 60.7 Favored Glycine 0 C--N 1.332 0.351 0 CA-C-N 116.035 -0.53 . . . . 1.0 112.855 -179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -83.35 -25.76 31.14 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.17 0.509 . . . . 1.0 110.321 177.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.41 -23.11 40.6 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.559 -0.746 . . . . 1.0 111.571 -177.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.794 HG23 ' HB3' ' A' ' 5' ' ' LEU . 0.4 OUTLIER -141.33 125.09 16.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.296 0.569 . . . . 1.0 111.241 -179.396 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.466 ' HG2' ' HB2' ' A' ' 4' ' ' PRO . 17.3 mmt180 -88.93 142.43 27.65 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.475 -0.784 . . . . 1.0 108.998 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 77.0 t -129.8 130.13 66.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 109.173 -0.676 . . . . 1.0 109.173 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.494 ' O ' ' HA ' ' A' ' 8' ' ' THR . 37.0 p -143.8 -174.17 4.18 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.782 -1.099 . . . . 1.0 110.487 -174.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.472 ' OG ' ' HE1' ' A' ' 71' ' ' HIS . 65.2 p -160.43 163.03 33.37 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.598 -0.274 . . . . 1.0 110.427 -179.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.657 ' HB2' ' CD2' ' A' ' 80' ' ' HIS . . . -163.34 161.98 24.81 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.278 0.561 . . . . 1.0 111.345 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -123.37 133.42 8.95 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.453 -0.794 . . . . 1.0 111.481 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.504 HG23 ' CG1' ' A' ' 10' ' ' VAL . 17.9 p -71.44 -20.83 62.05 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.688 0.28 . . . . 1.0 111.727 -178.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.46 ' HA3' ' CZ3' ' A' ' 48' ' ' TRP . . . -109.66 5.33 31.09 Favored Glycine 0 C--O 1.226 -0.377 0 C-N-CA 120.603 -0.808 . . . . 1.0 113.026 -178.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.403 ' HB3' ' NE2' ' A' ' 75' ' ' GLN . 3.2 p-10 42.92 34.54 0.62 Allowed 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 113.518 0.933 . . . . 1.0 113.518 178.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 1.008 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 0.9 OUTLIER -46.83 -72.99 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.298 0.571 . . . . 1.0 112.419 -178.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.545 ' HB3' ' HB3' ' A' ' 52' ' ' SER . 3.2 m-70 -106.5 42.66 1.24 Allowed 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.734 -0.666 . . . . 1.0 111.186 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.434 HG23 ' HA ' ' A' ' 74' ' ' ALA . 11.9 p -61.34 126.92 20.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 120.573 -0.451 . . . . 1.0 109.985 178.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.0 -12.59 69.63 Favored Glycine 0 CA--C 1.519 0.303 0 N-CA-C 111.794 -0.523 . . . . 1.0 111.794 -176.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.545 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 1.4 t -83.08 -159.58 0.35 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.149 0.5 . . . . 1.0 109.839 178.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.614 ' HA ' ' O ' ' A' ' 71' ' ' HIS . 25.0 t -131.17 170.38 14.64 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.955 -0.566 . . . . 1.0 109.573 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -50.74 145.7 6.65 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 123.758 0.661 . . . . 1.0 111.553 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.672 ' OD1' ' HA ' ' A' ' 16' ' ' CYS . 9.6 p-10 -61.47 144.94 53.35 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.434 -0.803 . . . . 1.0 112.388 -178.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -45.75 -36.32 4.97 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.214 -1.357 . . . . 1.0 113.221 175.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.611 ' O ' HG23 ' A' ' 61' ' ' VAL . 17.1 mtt-85 -71.22 -49.66 41.09 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.843 0.354 . . . . 1.0 111.013 -175.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.479 ' HB1' ' HG2' ' A' ' 20' ' ' MET . . . -69.65 -29.83 67.39 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.419 -0.81 . . . . 1.0 110.557 -178.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.401 ' O ' HG21 ' A' ' 69' ' ' THR . . . -61.65 -47.71 84.16 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.701 -0.481 . . . . 1.0 109.701 177.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.36 -38.09 95.7 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.962 -0.637 . . . . 1.0 112.101 178.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 57' ' ' ARG . 99.7 t -64.19 -58.87 5.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.25 0.548 . . . . 1.0 110.826 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.479 ' HB2' HG22 ' A' ' 69' ' ' THR . 8.6 mp -59.79 -48.65 80.84 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.686 -0.688 . . . . 1.0 111.54 -177.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.448 ' HB3' HG21 ' A' ' 69' ' ' THR . 9.9 ptm180 -60.59 -28.54 68.57 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.517 -0.31 . . . . 1.0 111.131 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.34 -33.88 75.1 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.417 0.627 . . . . 1.0 110.053 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -93.74 4.78 53.42 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.228 -0.896 . . . . 1.0 111.536 -178.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.89 16.18 65.98 Favored Glycine 0 N--CA 1.455 -0.093 0 C-N-CA 120.96 -0.638 . . . . 1.0 112.754 177.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -92.44 151.95 41.79 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 110.259 -0.274 . . . . 1.0 110.259 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.482 ' O ' ' HD2' ' A' ' 23' ' ' LYS . 27.8 Cg_endo -66.29 152.1 81.84 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 121.877 1.718 . . . . 1.0 110.155 176.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.479 HG22 ' HB2' ' A' ' 62' ' ' LEU . 66.7 p -131.28 25.61 4.85 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 120.266 -0.574 . . . . 1.0 112.041 -175.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -110.57 127.02 55.04 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.783 -0.451 . . . . 1.0 109.783 179.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.675 ' HB3' ' HZ1' ' A' ' 23' ' ' LYS . 0.2 OUTLIER -160.09 139.5 11.04 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.883 -179.61 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.526 ' HD3' ' O ' ' A' ' 52' ' ' SER . 5.1 tpp180 -102.72 114.98 29.67 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.969 -0.56 . . . . 1.0 110.132 178.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 49' ' ' HIS . . . -63.51 138.01 58.35 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.139 -0.482 . . . . 1.0 112.133 -178.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.706 ' H ' ' ND2' ' A' ' 14' ' ' ASN . . . -129.41 163.62 25.43 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.942 -0.572 . . . . 1.0 109.894 176.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.403 ' NE2' ' HB3' ' A' ' 47' ' ' ASN . 16.0 tt0 -98.07 159.41 14.95 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.977 -0.749 . . . . 1.0 108.977 178.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.578 HG11 HD23 ' A' ' 97' ' ' LEU . 47.8 t -70.83 115.26 10.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.936 0.398 . . . . 1.0 110.252 177.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.567 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -128.31 -167.0 12.13 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.723 -0.671 . . . . 1.0 111.697 178.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 30.3 m -57.35 -51.83 67.81 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.973 0.416 . . . . 1.0 111.747 -179.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.472 ' CD ' ' H ' ' A' ' 79' ' ' GLU . 1.6 pm0 -56.21 -31.93 63.95 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.623 -0.717 . . . . 1.0 110.981 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.657 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 80.0 m80 -74.87 -41.16 60.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.967 -0.561 . . . . 1.0 109.955 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.735 ' HA ' HD21 ' A' ' 86' ' ' LEU . 15.6 mt -68.78 -16.34 63.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.973 0.416 . . . . 1.0 110.238 176.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -87.35 -8.32 56.78 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 120.932 0.396 . . . . 1.0 110.112 -179.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.475 ' HB1' ' O ' ' A' ' 6' ' ' HIS . . . -59.18 156.16 12.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.86 -0.609 . . . . 1.0 110.774 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.77 ' HA ' ' NH1' ' A' ' 106' ' ' ARG . 3.0 t70 -82.35 -12.47 57.93 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.902 0.382 . . . . 1.0 110.153 -178.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.735 HD12 ' CE3' ' A' ' 152' ' ' TRP . 1.1 tt -158.0 115.26 2.94 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.81 -0.632 . . . . 1.0 109.539 -178.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.735 HD21 ' HA ' ' A' ' 81' ' ' LEU . 5.2 mp -107.08 87.64 2.55 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 115.669 -0.696 . . . . 1.0 110.802 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.632 HG11 HD23 ' A' ' 110' ' ' LEU . 76.7 t -66.01 92.91 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 113.886 -1.507 . . . . 1.0 112.521 -178.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.69 149.86 31.08 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.993 -1.003 . . . . 1.0 111.093 177.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.638 HD23 ' HB2' ' A' ' 11' ' ' CYS . 3.9 mm? -98.7 -5.69 31.04 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.971 179.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.9 p30 -159.09 166.43 31.62 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.506 0.67 . . . . 1.0 111.368 174.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.452 ' H ' ' HG2' ' A' ' 91' ' ' ARG . 9.1 ptt180 -62.63 -18.98 63.32 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.11 -1.404 . . . . 1.0 112.305 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.622 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 5.9 m-20 -78.48 -53.24 7.45 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.749 0.309 . . . . 1.0 110.623 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.669 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 14.1 m170 -58.84 -44.73 91.02 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.958 -0.565 . . . . 1.0 109.674 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.17 -42.78 91.62 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.002 0.429 . . . . 1.0 110.817 179.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 95' ' ' ARG . 4.3 ttm180 -57.99 -44.84 87.4 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.37 -0.832 . . . . 1.0 111.281 177.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.691 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 49.4 mt -64.85 -48.45 74.28 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.44 -175.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.669 ' HG ' ' O ' ' A' ' 93' ' ' HIS . 29.0 mt -53.57 -59.77 4.16 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.642 -0.708 . . . . 1.0 111.771 -177.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.714 ' N ' HG12 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -60.12 -44.33 94.98 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.47 0.545 . . . . 1.0 112.47 -179.308 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.539 ' HG3' ' O ' ' A' ' 96' ' ' LEU . 1.0 OUTLIER -66.56 -23.3 66.19 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.254 -0.578 . . . . 1.0 109.945 179.056 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.691 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 8.9 mt -80.98 -21.75 40.05 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.764 -0.653 . . . . 1.0 111.65 178.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 155.25 -22.72 0.58 Allowed Glycine 0 CA--C 1.521 0.453 0 C-N-CA 119.332 -1.413 . . . . 1.0 114.38 -177.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.714 HG12 ' N ' ' A' ' 98' ' ' ARG . 0.3 OUTLIER -76.82 -162.09 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 117.836 0.818 . . . . 1.0 110.431 -179.78 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.756 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 16.7 pt-20 -156.37 159.85 39.13 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 107.624 -1.25 . . . . 1.0 107.624 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.767 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -62.91 -23.65 67.46 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.692 0.282 . . . . 1.0 111.625 -174.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.77 -36.57 74.6 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.376 174.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.77 ' NH1' ' HA ' ' A' ' 84' ' ' ASP . 0.7 OUTLIER -97.25 -42.17 7.93 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 115.323 -0.853 . . . . 1.0 111.063 -177.382 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.767 HG12 ' HA ' ' A' ' 104' ' ' ALA . 14.2 p -79.18 114.69 20.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.113 0.482 . . . . 1.0 109.798 -175.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.631 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 27.3 mmm180 -133.32 148.6 51.91 Favored 'General case' 0 C--N 1.318 -0.777 0 O-C-N 121.521 -0.737 . . . . 1.0 110.314 -177.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.573 ' HB2' ' HB2' ' A' ' 112' ' ' SER . 74.8 mmm -78.91 138.16 37.97 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.454 -0.794 . . . . 1.0 110.526 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.632 HD23 HG11 ' A' ' 87' ' ' VAL . 3.2 tm? -57.66 -50.67 72.39 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 111.488 0.181 . . . . 1.0 111.488 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.437 ' O ' ' HG2' ' A' ' 111' ' ' ARG . 19.1 ttm180 -69.18 -17.99 63.87 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.661 -0.416 . . . . 1.0 110.227 -178.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.573 ' HB2' ' HB2' ' A' ' 109' ' ' MET . 39.3 t -73.48 -5.66 41.46 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.928 -0.309 . . . . 1.0 111.262 -178.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.66 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 88.6 m-85 -92.99 -18.07 23.15 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 121.073 0.463 . . . . 1.0 110.411 175.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 17.7 t0 . . . . . 0 C--N 1.327 -0.401 0 CA-C-N 115.598 -0.728 . . . . 1.0 111.256 -177.211 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 . . . . . 0 N--CA 1.452 -0.349 0 CA-C-O 120.882 0.372 . . . . 1.0 110.44 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.57 ' O ' HG23 ' A' ' 141' ' ' VAL . 20.4 tp10 -65.08 -47.96 75.41 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.107 -0.701 . . . . 1.0 109.107 175.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.534 ' HA ' HG23 ' A' ' 141' ' ' VAL . 52.7 t -60.85 -42.41 92.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 115.833 -0.621 . . . . 1.0 109.545 176.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.473 ' HB2' HG11 ' A' ' 61' ' ' VAL . 70.0 t80 -54.56 -43.48 72.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.906 -1.043 . . . . 1.0 109.45 176.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.711 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -64.0 -38.53 91.41 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.516 -0.765 . . . . 1.0 110.737 177.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 137' ' ' GLU . 13.6 t -58.33 -51.9 65.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-O 121.558 0.694 . . . . 1.0 110.067 177.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.461 ' CG2' ' HB2' ' A' ' 21' ' ' ALA . 5.8 mt -65.44 -50.96 69.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.177 -0.92 . . . . 1.0 111.89 -179.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.711 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 6.8 pt-20 -55.09 -33.47 62.82 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 110.033 -0.358 . . . . 1.0 110.033 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . 0.511 ' HB2' ' O ' ' A' ' 140' ' ' ALA . 1.0 OUTLIER -73.5 -27.69 61.51 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.841 -0.618 . . . . 1.0 110.384 -179.694 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.444 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -86.94 -23.91 24.95 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 116.107 -0.497 . . . . 1.0 111.407 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.754 HD22 ' HB3' ' A' ' 25' ' ' PHE . 16.0 mt -55.22 -37.92 62.01 Favored Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 112.276 0.473 . . . . 1.0 112.276 -178.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 60.8 Cg_endo -71.61 -9.75 25.55 Favored 'Trans proline' 0 C--N 1.362 1.288 0 C-N-CA 122.634 2.222 . . . . 1.0 112.147 177.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.66 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -105.14 -30.86 4.6 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 110.317 -1.113 . . . . 1.0 110.317 178.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.565 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -75.54 -42.12 53.27 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.3 -1.0 . . . . 1.0 108.3 177.424 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 9.9 m170 -54.34 -49.76 69.0 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.087 -0.961 . . . . 1.0 110.777 176.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -61.54 -45.98 91.86 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.584 -0.735 . . . . 1.0 110.764 -177.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . 0.735 ' CE3' HD12 ' A' ' 85' ' ' LEU . 27.8 t90 -59.15 -57.02 14.89 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.914 -1.039 . . . . 1.0 110.722 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 15.8 m -58.88 -38.09 70.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.834 -0.346 . . . . 1.0 110.567 -178.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.521 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 9.9 t70 -58.84 -57.38 13.3 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 122.062 0.934 . . . . 1.0 110.897 178.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 4.5 pt-20 -62.23 -36.9 83.4 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 113.928 -1.487 . . . . 1.0 110.733 -176.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.524 ' HG3' ' CH2' ' A' ' 152' ' ' TRP . 3.8 mmt180 -74.72 -44.72 48.52 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.754 -0.657 . . . . 1.0 111.35 -177.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 3.7 pp . . . . . 0 C--N 1.327 -0.396 0 N-CA-C 109.566 -0.531 . . . . 1.0 109.566 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.503 ' HB3' ' O ' ' A' ' 36' ' ' ASP . 49.5 Cg_endo . . . . . 0 N--CA 1.46 -0.449 0 CA-C-O 121.25 0.437 . . . . 1.0 113.174 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.851 ' HB3' HG23 ' A' ' 38' ' ' VAL . 0.9 OUTLIER -73.57 -173.71 1.52 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.411 -0.813 . . . . 1.0 110.879 179.574 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.58 ' O ' ' HB1' ' A' ' 83' ' ' ALA . 1.5 t-160 -158.09 93.93 1.27 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.462 -0.335 . . . . 1.0 111.027 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.79 HG13 HD13 ' A' ' 85' ' ' LEU . 2.3 t -94.28 109.31 21.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.037 -0.727 . . . . 1.0 109.037 176.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.698 ' CG2' ' HG ' ' A' ' 86' ' ' LEU . 12.8 t -112.32 112.98 24.95 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.116 0.484 . . . . 1.0 110.307 178.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.741 ' HZ ' ' HE1' ' A' ' 25' ' ' PHE . 0.9 OUTLIER -82.06 147.1 29.31 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 121.857 -0.527 . . . . 1.0 109.761 179.921 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.68 HG21 HD21 ' A' ' 97' ' ' LEU . 44.3 t -132.74 118.12 32.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.321 0.581 . . . . 1.0 111.634 -176.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.584 ' HB3' HD23 ' A' ' 89' ' ' LEU . 28.7 p -141.29 178.81 7.16 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.524 -0.762 . . . . 1.0 110.092 178.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.521 HG23 ' NE2' ' A' ' 93' ' ' HIS . 0.7 OUTLIER -86.36 86.64 7.34 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.988 0.423 . . . . 1.0 110.971 179.064 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.857 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 135.55 -37.6 1.89 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.656 -0.783 . . . . 1.0 112.077 178.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.516 HD21 ' CB ' ' A' ' 42' ' ' SER . 3.8 t-20 64.01 17.22 10.46 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.59 0.709 . . . . 1.0 111.103 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.0 pt -124.55 11.03 4.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 O-C-N 121.783 -0.573 . . . . 1.0 111.715 -177.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 7.5 p -127.45 -87.36 0.57 Allowed 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 112.112 0.412 . . . . 1.0 112.112 -177.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.68 -44.37 74.17 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 112.323 0.49 . . . . 1.0 112.323 -176.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.738 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 50.9 m -57.37 -58.03 20.92 Favored Pre-proline 0 CA--C 1.538 0.488 0 N-CA-C 112.378 0.51 . . . . 1.0 112.378 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.665 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 49.4 Cg_endo -64.96 -24.48 60.4 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 121.632 1.555 . . . . 1.0 112.071 -177.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.617 ' HB3' HD13 ' A' ' 142' ' ' ILE . 39.9 mmm -61.62 -54.39 43.54 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 121.13 -0.228 . . . . 1.0 110.767 178.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.539 ' O ' ' HD1' ' A' ' 25' ' ' PHE . . . -72.65 -32.02 65.53 Favored 'General case' 0 CA--C 1.507 -0.679 0 C-N-CA 120.615 -0.434 . . . . 1.0 110.124 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.651 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 11.3 tt0 -50.83 -51.79 47.56 Favored 'General case' 0 C--O 1.216 -0.708 0 O-C-N 124.399 1.062 . . . . 1.0 109.988 -178.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.904 ' HE3' ' HB2' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -79.45 -30.33 42.15 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.829 -0.623 . . . . 1.0 110.014 -176.906 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.587 ' HB3' HD11 ' A' ' 146' ' ' LEU . 3.2 mmm -62.39 -75.78 0.07 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.436 0.902 . . . . 1.0 113.436 -176.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.741 ' HE1' ' HZ ' ' A' ' 9' ' ' PHE . 0.8 OUTLIER -78.86 -27.81 44.16 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.011 -0.676 . . . . 1.0 111.543 -174.628 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.651 ' HB3' ' O ' ' A' ' 22' ' ' GLU . . . -64.62 -37.16 86.63 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 118.934 -1.106 . . . . 1.0 110.262 177.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.694 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -63.48 -39.44 94.46 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.76 -0.83 . . . . 1.0 108.76 177.417 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.562 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 77.6 mt-30 -59.67 -45.02 93.3 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.982 -0.554 . . . . 1.0 110.39 176.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.623 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 90.8 mt -54.46 -61.38 2.34 Favored 'General case' 0 N--CA 1.461 0.094 0 CA-C-N 115.751 -0.659 . . . . 1.0 111.078 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.6 ' HD3' ' HA ' ' A' ' 27' ' ' GLN . 3.2 ptm180 -58.53 -39.72 80.96 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.211 -0.449 . . . . 1.0 111.47 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -62.27 -22.52 66.07 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 112.176 0.435 . . . . 1.0 112.176 178.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.623 ' HG2' ' O ' ' A' ' 29' ' ' LEU . 5.7 ptm85 -99.89 -17.79 17.44 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 119.346 -0.941 . . . . 1.0 110.158 178.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.17 35.75 2.86 Favored Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 115.016 -0.993 . . . . 1.0 112.077 177.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.521 ' HG ' ' HG3' ' A' ' 32' ' ' ARG . 43.5 mt -126.88 -1.28 6.61 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.739 0.304 . . . . 1.0 110.346 -178.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.429 ' H ' ' HA ' ' A' ' 30' ' ' ARG . . . -56.32 -28.0 54.12 Favored Glycine 0 N--CA 1.46 0.288 0 CA-C-N 116.027 -0.533 . . . . 1.0 112.897 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.503 ' O ' ' HB3' ' A' ' 4' ' ' PRO . 4.9 m-20 -89.7 -22.36 22.26 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.666 0.27 . . . . 1.0 110.55 177.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.04 -26.33 39.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.033 -0.53 . . . . 1.0 111.497 -179.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.851 HG23 ' HB3' ' A' ' 5' ' ' LEU . 1.1 p -143.83 124.02 8.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.37 0.605 . . . . 1.0 110.198 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.453 ' HE ' ' HG3' ' A' ' 4' ' ' PRO . 17.7 mmt85 -90.17 147.42 23.59 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.287 -0.87 . . . . 1.0 109.704 -178.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 74.7 t -132.64 117.27 30.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.557 0.694 . . . . 1.0 110.584 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.498 ' O ' ' HA ' ' A' ' 8' ' ' THR . 69.8 p -132.23 -174.15 3.36 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.502 -1.226 . . . . 1.0 110.419 -177.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.738 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 93.2 p -160.98 168.91 23.62 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.806 -0.357 . . . . 1.0 110.58 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.585 ' HB2' ' CD2' ' A' ' 80' ' ' HIS . . . -163.96 167.44 20.55 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.186 0.517 . . . . 1.0 111.291 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -125.75 135.74 9.34 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 115.355 -0.839 . . . . 1.0 111.023 176.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.59 HG21 HD12 ' A' ' 96' ' ' LEU . 23.5 p -70.59 -26.47 63.53 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.315 0.487 . . . . 1.0 112.315 -177.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.461 ' HA3' ' CZ3' ' A' ' 48' ' ' TRP . . . -108.11 9.61 36.58 Favored Glycine 0 C--O 1.229 -0.179 0 C-N-CA 120.717 -0.754 . . . . 1.0 112.796 -177.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 42.97 38.87 1.55 Allowed 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.344 0.868 . . . . 1.0 113.344 178.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.857 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 1.1 m-90 -46.38 -75.34 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.326 0.584 . . . . 1.0 112.48 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.483 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 8.1 m-70 -106.42 41.31 1.45 Allowed 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.259 -0.882 . . . . 1.0 111.046 -179.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.531 HG23 ' HA ' ' A' ' 74' ' ' ALA . 15.0 p -61.27 125.01 16.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 120.471 -0.492 . . . . 1.0 110.281 178.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.42 -12.5 66.4 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.903 -0.665 . . . . 1.0 111.763 -177.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.45 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 2.8 t -81.15 -160.33 0.32 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.228 0.537 . . . . 1.0 110.08 178.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 34.9 t -129.87 171.45 12.72 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.465 -0.788 . . . . 1.0 109.325 -178.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.26 140.85 37.71 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.745 0.307 . . . . 1.0 111.464 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -59.47 141.35 54.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.605 -0.725 . . . . 1.0 111.52 -177.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -51.58 -28.89 15.36 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 113.378 0.881 . . . . 1.0 113.378 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.68 ' O ' HG23 ' A' ' 61' ' ' VAL . 18.9 mtp180 -68.46 -50.61 51.24 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 118.524 0.602 . . . . 1.0 109.506 178.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.21 -32.37 72.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.145 -0.934 . . . . 1.0 110.568 -176.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.85 -46.6 88.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.135 178.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.88 -37.81 95.51 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.667 -0.778 . . . . 1.0 111.843 177.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 57' ' ' ARG . 58.1 t -63.2 -58.95 5.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.21 0.529 . . . . 1.0 111.282 179.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.738 ' HB2' HG22 ' A' ' 69' ' ' THR . 92.3 mt -58.3 -53.16 61.38 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.745 -0.661 . . . . 1.0 111.356 -177.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -59.23 -29.71 67.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.44 -0.346 . . . . 1.0 111.083 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.79 -33.33 73.69 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.231 0.538 . . . . 1.0 111.03 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -98.8 6.37 46.92 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.065 -0.516 . . . . 1.0 111.216 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.23 13.81 63.23 Favored Glycine 0 C--N 1.332 0.323 0 CA-C-N 115.642 -0.708 . . . . 1.0 112.961 176.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.403 ' CD1' ' HA ' ' A' ' 24' ' ' MET . 64.8 m-85 -90.59 151.64 44.25 Favored Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 110.554 -0.165 . . . . 1.0 110.554 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.891 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 46.9 Cg_endo -70.2 160.07 50.87 Favored 'Trans proline' 0 CA--C 1.515 -0.428 0 C-N-CA 122.481 2.121 . . . . 1.0 111.111 176.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.738 HG22 ' HB2' ' A' ' 62' ' ' LEU . 65.8 p -134.1 4.11 3.47 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.419 -0.513 . . . . 1.0 111.697 -177.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -74.38 126.75 31.37 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.398 -0.364 . . . . 1.0 110.075 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.904 ' HB2' ' HE3' ' A' ' 23' ' ' LYS . 28.8 t60 -166.28 150.29 7.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.638 -0.256 . . . . 1.0 110.802 -176.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.408 ' HA ' ' O ' ' A' ' 52' ' ' SER . 2.0 tmt_? -131.03 110.22 11.07 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.905 -1.146 . . . . 1.0 107.905 177.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 49' ' ' HIS . . . -58.57 139.92 55.06 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.896 -1.047 . . . . 1.0 112.412 -174.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.531 ' HA ' HG23 ' A' ' 50' ' ' VAL . . . -130.81 165.55 22.75 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.789 -0.642 . . . . 1.0 110.478 178.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -101.52 159.31 15.4 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.017 -0.735 . . . . 1.0 109.017 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.537 HG11 HD23 ' A' ' 97' ' ' LEU . 96.5 t -66.87 110.56 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.903 0.383 . . . . 1.0 110.61 179.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.475 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -127.52 -169.43 12.67 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.696 -0.684 . . . . 1.0 112.324 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 99.1 m -54.51 -52.03 63.26 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 123.457 0.703 . . . . 1.0 112.595 -178.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.565 ' HG2' ' N ' ' A' ' 80' ' ' HIS . 0.8 OUTLIER -58.19 -29.84 65.96 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.281 0.562 . . . . 1.0 110.523 -178.204 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.585 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 79.9 m80 -76.59 -42.77 41.34 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.535 -0.757 . . . . 1.0 110.014 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.648 ' O ' HG23 ' A' ' 102' ' ' VAL . 17.3 mt -67.71 -18.85 65.05 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.118 0.485 . . . . 1.0 110.681 177.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.69 -7.92 57.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.936 0.398 . . . . 1.0 110.494 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.58 ' HB1' ' O ' ' A' ' 6' ' ' HIS . . . -60.74 152.69 26.16 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.64 -0.709 . . . . 1.0 111.099 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.476 ' HB3' ' HG ' ' A' ' 5' ' ' LEU . 26.0 t70 -79.47 -15.13 58.3 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.991 -0.55 . . . . 1.0 109.775 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.79 HD13 HG13 ' A' ' 7' ' ' VAL . 0.4 OUTLIER -153.62 117.33 4.7 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 115.573 -0.74 . . . . 1.0 109.862 -177.16 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.698 ' HG ' ' CG2' ' A' ' 8' ' ' THR . 5.0 mp -109.45 105.98 15.55 Favored 'General case' 0 N--CA 1.427 -1.599 0 CA-C-N 115.42 -0.809 . . . . 1.0 109.865 177.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.661 ' HB ' ' HD1' ' A' ' 9' ' ' PHE . 64.7 t -85.43 91.8 3.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.014 -0.994 . . . . 1.0 111.389 -175.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.06 149.92 30.5 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.307 -0.861 . . . . 1.0 110.884 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.584 HD23 ' HB3' ' A' ' 11' ' ' CYS . 3.9 mm? -96.26 -10.55 27.67 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.844 -0.616 . . . . 1.0 110.674 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.608 ' HA ' ' HE1' ' A' ' 109' ' ' MET . 9.7 p30 -156.5 167.89 29.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.463 0.649 . . . . 1.0 111.85 175.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -57.3 -24.61 56.08 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.165 -1.38 . . . . 1.0 112.636 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.619 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 91.1 m-20 -76.43 -53.88 7.51 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.837 0.351 . . . . 1.0 110.656 -176.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.521 ' NE2' HG23 ' A' ' 12' ' ' THR . 13.2 m170 -58.94 -42.61 90.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.223 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.55 -43.5 97.18 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.999 0.428 . . . . 1.0 110.586 178.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.446 HH11 ' HD3' ' A' ' 95' ' ' ARG . 5.0 ttm-85 -57.9 -43.62 86.27 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 115.508 -0.769 . . . . 1.0 110.999 177.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.619 ' HG ' ' O ' ' A' ' 92' ' ' ASN . 55.6 mt -65.88 -50.51 64.24 Favored 'General case' 0 C--O 1.217 -0.633 0 CA-C-N 115.906 -0.588 . . . . 1.0 110.365 -176.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.68 HD21 HG21 ' A' ' 10' ' ' VAL . 30.5 mt -51.87 -56.1 16.1 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.055 -0.521 . . . . 1.0 111.135 -178.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.706 ' CA ' HG12 ' A' ' 102' ' ' VAL . 14.2 ptt85 -62.37 -43.1 99.61 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.546 0.573 . . . . 1.0 112.546 -178.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.556 ' HG3' ' O ' ' A' ' 96' ' ' LEU . 0.9 OUTLIER -67.36 -26.77 66.64 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.592 -0.443 . . . . 1.0 110.045 179.262 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.485 HD13 ' O ' ' A' ' 96' ' ' LEU . 5.4 mp -76.51 -20.26 57.12 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 116.088 -0.505 . . . . 1.0 111.818 178.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 153.2 -22.38 0.76 Allowed Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 119.465 -1.35 . . . . 1.0 113.927 -177.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.986 HG22 ' HD2' ' A' ' 106' ' ' ARG . 0.4 OUTLIER -76.42 -163.52 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-N 117.633 0.717 . . . . 1.0 110.33 -178.756 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.7 ' N ' HG13 ' A' ' 102' ' ' VAL . 12.7 pt-20 -159.05 162.64 36.66 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 107.369 -1.345 . . . . 1.0 107.369 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.745 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -62.14 -24.72 67.34 Favored 'General case' 0 C--N 1.322 -0.617 0 O-C-N 123.135 0.272 . . . . 1.0 111.421 -175.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.454 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . . . -56.57 -38.05 71.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.42 0.628 . . . . 1.0 110.06 175.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.986 ' HD2' HG22 ' A' ' 102' ' ' VAL . 20.4 mtt180 -97.65 -43.64 7.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.755 -1.111 . . . . 1.0 111.12 -176.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.745 HG12 ' HA ' ' A' ' 104' ' ' ALA . 10.7 p -79.62 118.79 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-O 121.037 0.446 . . . . 1.0 110.187 -174.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.666 ' HD2' ' O ' ' A' ' 107' ' ' VAL . 19.6 mmm180 -137.37 149.53 47.05 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.386 0.612 . . . . 1.0 111.076 -178.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.608 ' HE1' ' HA ' ' A' ' 90' ' ' ASP . 80.3 mmm -80.25 137.58 36.66 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.185 -0.916 . . . . 1.0 110.692 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.552 HD23 HG11 ' A' ' 87' ' ' VAL . 3.1 tm? -58.71 -49.26 78.26 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.868 0.366 . . . . 1.0 111.09 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -69.42 -16.7 63.55 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.171 -177.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.493 ' HB2' ' HB2' ' A' ' 109' ' ' MET . 37.4 t -78.38 -7.76 57.69 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 116.147 -0.478 . . . . 1.0 111.355 -178.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.522 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 92.4 m-85 -91.15 -21.58 21.1 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 109.821 -0.436 . . . . 1.0 109.821 175.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.7 t0 . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 115.766 -0.652 . . . . 1.0 110.556 -179.576 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 . . . . . 0 N--CA 1.453 -0.312 0 CA-C-O 120.518 0.199 . . . . 1.0 110.959 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.609 ' O ' HG23 ' A' ' 141' ' ' VAL . 8.5 tp10 -63.19 -50.94 68.32 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.77 -0.456 . . . . 1.0 109.77 177.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.64 ' HA ' HG23 ' A' ' 141' ' ' VAL . 96.1 t -61.27 -40.41 85.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.402 0.62 . . . . 1.0 109.979 178.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.487 ' HB2' HG11 ' A' ' 61' ' ' VAL . 22.9 t80 -53.49 -45.01 69.47 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.865 -1.061 . . . . 1.0 109.459 175.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.625 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -64.19 -40.16 95.5 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.393 -0.821 . . . . 1.0 110.543 177.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.64 HG23 ' HA ' ' A' ' 138' ' ' VAL . 13.9 t -55.44 -53.16 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-O 121.619 0.723 . . . . 1.0 109.908 177.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.617 HD13 ' HB3' ' A' ' 20' ' ' MET . 5.7 mt -63.99 -51.66 66.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 114.945 -1.025 . . . . 1.0 111.812 -178.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.625 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 8.0 pt-20 -57.89 -30.2 65.66 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.74 -0.384 . . . . 1.0 110.397 -179.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 2.4 t -74.87 -26.7 59.85 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 121.253 0.549 . . . . 1.0 110.001 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.473 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -85.88 -25.81 25.97 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-N 115.794 -0.639 . . . . 1.0 111.277 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.705 HD22 ' HB3' ' A' ' 25' ' ' PHE . 16.7 mt -56.17 -36.4 45.72 Favored Pre-proline 0 CA--C 1.547 0.851 0 N-CA-C 112.719 0.637 . . . . 1.0 112.719 -178.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.626 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 43.9 Cg_endo -68.02 -14.4 40.92 Favored 'Trans proline' 0 C--N 1.364 1.357 0 C-N-CA 122.59 2.193 . . . . 1.0 111.495 177.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.522 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -103.29 -33.62 4.18 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 114.577 -1.192 . . . . 1.0 110.375 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.492 ' O ' HG13 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -73.19 -41.8 63.43 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 108.416 -0.957 . . . . 1.0 108.416 178.855 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . 0.591 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 0.2 OUTLIER -53.93 -55.87 23.0 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-N 115.067 -0.969 . . . . 1.0 110.506 175.217 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -56.78 -42.92 80.28 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.764 -1.107 . . . . 1.0 110.781 -174.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . 0.715 ' HZ3' HD21 ' A' ' 5' ' ' LEU . 26.2 t90 -62.84 -56.17 19.73 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.181 -0.918 . . . . 1.0 110.286 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.492 HG13 ' O ' ' A' ' 149' ' ' LEU . 9.7 m -60.35 -40.3 83.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.904 -0.318 . . . . 1.0 110.463 -178.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.435 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 1.4 m-20 -60.46 -51.88 67.57 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 123.425 0.453 . . . . 1.0 111.042 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 7.9 pt-20 -63.32 -37.82 88.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.789 -0.641 . . . . 1.0 110.6 -178.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.526 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 10.4 mmt85 -72.84 -46.45 52.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.834 -0.621 . . . . 1.0 111.115 -176.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 4.0 pp . . . . . 0 C--N 1.325 -0.494 0 CA-C-N 115.658 -0.701 . . . . 1.0 109.686 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo . . . . . 0 C--O 1.234 0.306 0 N-CA-C 113.481 0.531 . . . . 1.0 113.481 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.822 ' HB3' HG23 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -66.51 177.84 1.43 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.016 -0.993 . . . . 1.0 109.688 178.417 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.573 ' O ' ' HB1' ' A' ' 83' ' ' ALA . 3.3 t-160 -156.17 90.08 1.18 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 121.98 -0.45 . . . . 1.0 110.493 -179.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.753 HG13 HD13 ' A' ' 85' ' ' LEU . 2.0 t -94.33 113.17 28.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 N-CA-C 109.321 -0.622 . . . . 1.0 109.321 177.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.597 HG22 ' HG ' ' A' ' 86' ' ' LEU . 8.5 t -115.31 114.24 24.91 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.03 0.443 . . . . 1.0 110.589 178.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.648 ' HD2' ' HB3' ' A' ' 42' ' ' SER . 1.5 m-85 -84.71 132.83 34.41 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 122.138 -0.351 . . . . 1.0 110.744 -178.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.728 HG21 HD21 ' A' ' 97' ' ' LEU . 32.9 t -118.18 115.64 48.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.293 0.568 . . . . 1.0 111.975 -176.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.617 ' SG ' ' HD2' ' A' ' 17' ' ' ARG . 52.5 t -144.79 159.38 42.96 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.731 -0.668 . . . . 1.0 109.578 178.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -72.02 97.92 1.98 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.939 0.4 . . . . 1.0 110.336 178.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.911 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 127.88 -43.27 1.35 Allowed Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.481 -0.782 . . . . 1.0 111.549 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.469 HD21 ' CB ' ' A' ' 42' ' ' SER . 3.8 t-20 64.66 11.98 7.19 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 121.361 0.6 . . . . 1.0 111.752 179.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.458 ' HA ' ' HG3' ' A' ' 19' ' ' PRO . 7.5 pt -119.61 11.54 6.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 O-C-N 121.69 -0.631 . . . . 1.0 111.395 -178.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.1 p -127.36 -88.31 0.56 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.208 -0.451 . . . . 1.0 112.015 -178.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.617 ' HD2' ' SG ' ' A' ' 11' ' ' CYS . 57.7 mtt85 -63.54 -52.33 61.6 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 120.95 0.405 . . . . 1.0 111.845 -176.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.726 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 14.1 m -53.16 -58.37 12.73 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 115.666 -0.697 . . . . 1.0 112.679 -178.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.524 ' HD3' ' HB2' ' A' ' 18' ' ' SER . 57.7 Cg_endo -67.92 -20.72 44.79 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 121.556 1.504 . . . . 1.0 112.51 -176.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.606 ' HA ' HD11 ' A' ' 62' ' ' LEU . 47.2 mmm -61.89 -54.09 46.75 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 110.221 -0.288 . . . . 1.0 110.221 177.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.468 ' HA ' ' HB2' ' A' ' 24' ' ' MET . . . -74.9 -26.1 59.4 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 116.134 -0.485 . . . . 1.0 110.401 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.61 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 16.3 tt0 -51.29 -54.56 24.8 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.028 -0.987 . . . . 1.0 109.992 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.656 ' O ' ' HB3' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -85.69 -22.98 27.61 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.267 -0.879 . . . . 1.0 110.383 -176.023 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.708 ' HB3' HD11 ' A' ' 146' ' ' LEU . 6.3 mmm -63.03 -76.12 0.07 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.381 0.61 . . . . 1.0 112.592 -178.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.717 ' HB3' HD22 ' A' ' 146' ' ' LEU . 24.9 p90 -77.13 -29.63 54.77 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 119.864 -0.734 . . . . 1.0 111.546 -175.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.61 ' HB3' ' O ' ' A' ' 22' ' ' GLU . . . -64.39 -38.2 90.19 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 119.493 -0.883 . . . . 1.0 110.817 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.962 ' HA ' ' HE ' ' A' ' 30' ' ' ARG . 0.1 OUTLIER -62.53 -39.68 94.34 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.906 -0.776 . . . . 1.0 108.906 177.03 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.6 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 79.2 mt-30 -59.06 -43.78 91.75 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.653 -0.703 . . . . 1.0 110.589 176.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 25' ' ' PHE . 92.5 mt -54.22 -62.68 1.5 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.942 -0.572 . . . . 1.0 111.207 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.962 ' HE ' ' HA ' ' A' ' 27' ' ' GLN . 0.1 OUTLIER -58.93 -34.04 71.27 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 120.559 -0.456 . . . . 1.0 111.466 178.683 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.0 m170 -62.12 -28.63 69.77 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.422 0.527 . . . . 1.0 112.422 177.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.525 ' HG2' ' O ' ' A' ' 28' ' ' GLN . 9.2 ptp180 -95.33 -20.29 19.26 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 119.535 -0.866 . . . . 1.0 110.101 178.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 108.17 39.32 1.84 Allowed Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.034 -0.985 . . . . 1.0 111.992 177.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 25.0 mt -131.03 2.21 4.31 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.567 -0.531 . . . . 1.0 109.567 -178.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.415 ' H ' ' HA ' ' A' ' 30' ' ' ARG . . . -53.75 -35.73 53.27 Favored Glycine 0 C--O 1.226 -0.364 0 CA-C-N 115.545 -0.752 . . . . 1.0 113.35 -178.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.473 ' HA ' ' NH1' ' A' ' 39' ' ' ARG . 0.3 OUTLIER -86.94 -19.17 29.19 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 122.489 -0.418 . . . . 1.0 110.138 -179.86 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.89 -22.13 43.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.878 -0.601 . . . . 1.0 111.373 -177.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.822 HG23 ' HB3' ' A' ' 5' ' ' LEU . 0.4 OUTLIER -143.09 123.62 10.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.064 0.459 . . . . 1.0 110.66 -179.727 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.473 ' NH1' ' HA ' ' A' ' 36' ' ' ASP . 29.0 mmt180 -89.05 144.56 26.06 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.011 -0.541 . . . . 1.0 109.65 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.483 HG11 ' HB2' ' A' ' 26' ' ' ALA . 48.9 t -132.04 122.58 49.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 121.838 0.828 . . . . 1.0 110.234 -177.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.506 ' O ' ' HA ' ' A' ' 8' ' ' THR . 76.8 p -137.13 -176.87 4.53 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.203 -1.362 . . . . 1.0 110.511 -174.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.726 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 88.2 p -160.81 166.35 28.73 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.866 -0.334 . . . . 1.0 110.235 179.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.585 ' HB2' ' CD2' ' A' ' 80' ' ' HIS . . . -164.65 168.15 18.38 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.271 0.557 . . . . 1.0 111.353 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -125.83 132.81 8.04 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.26 -0.882 . . . . 1.0 110.997 177.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.583 HG23 ' CG1' ' A' ' 10' ' ' VAL . 26.0 p -68.77 -22.74 64.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.795 0.331 . . . . 1.0 111.831 -177.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.422 ' HA3' ' HZ3' ' A' ' 48' ' ' TRP . . . -112.41 9.11 26.47 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.875 -0.679 . . . . 1.0 113.133 -177.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 43.83 37.34 1.63 Allowed 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 114.156 1.169 . . . . 1.0 114.156 177.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.911 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 1.2 m-90 -45.77 -73.66 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.454 0.645 . . . . 1.0 112.404 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.468 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 12.4 m-70 -106.06 40.84 1.51 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.248 -0.887 . . . . 1.0 111.063 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.403 HG23 ' HA ' ' A' ' 74' ' ' ALA . 14.0 p -60.18 129.37 22.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 120.65 -0.42 . . . . 1.0 110.375 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.25 -13.61 65.91 Favored Glycine 0 C--O 1.227 -0.33 0 C-N-CA 121.033 -0.603 . . . . 1.0 111.87 -177.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.5 t -80.58 -161.12 0.35 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.636 -0.505 . . . . 1.0 109.636 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 33.6 t -126.33 175.18 8.02 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.585 -0.894 . . . . 1.0 108.585 -178.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.14 141.08 47.44 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 123.098 0.248 . . . . 1.0 110.482 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.524 ' OD2' ' HG2' ' A' ' 57' ' ' ARG . 18.6 t70 -62.1 143.42 56.7 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.841 -177.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -46.69 -36.39 7.05 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.973 -1.012 . . . . 1.0 112.819 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.685 ' O ' HG23 ' A' ' 61' ' ' VAL . 19.3 ptp180 -69.69 -47.11 64.35 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 121.033 -0.267 . . . . 1.0 110.686 -176.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.408 ' HB1' ' SD ' ' A' ' 20' ' ' MET . . . -71.49 -31.96 67.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.097 0.475 . . . . 1.0 110.471 -177.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.14 -55.08 38.19 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.112 -0.699 . . . . 1.0 109.112 176.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -58.31 -39.69 93.0 Favored Glycine 0 N--CA 1.441 -1.009 0 CA-C-N 115.853 -0.612 . . . . 1.0 111.924 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.685 HG23 ' O ' ' A' ' 57' ' ' ARG . 98.7 t -58.98 -58.94 4.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.065 0.46 . . . . 1.0 110.992 177.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.611 HD13 ' HG3' ' A' ' 23' ' ' LYS . 87.7 mt -59.77 -52.46 65.36 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.881 -0.6 . . . . 1.0 111.61 -177.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.487 ' HB3' HG21 ' A' ' 69' ' ' THR . 0.0 OUTLIER -61.34 -33.31 73.41 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.727 -178.997 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.71 -32.93 74.13 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.212 0.53 . . . . 1.0 110.667 179.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -95.68 2.39 54.0 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.646 -0.706 . . . . 1.0 111.078 -178.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 94.12 9.51 59.35 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.978 -0.629 . . . . 1.0 113.531 176.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.41 ' CD1' ' HA ' ' A' ' 24' ' ' MET . 65.9 m-85 -90.68 152.15 44.62 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 110.061 -0.348 . . . . 1.0 110.061 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.583 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 36.0 Cg_endo -67.31 157.56 61.15 Favored 'Trans proline' 0 CA--C 1.512 -0.609 0 C-N-CA 122.189 1.926 . . . . 1.0 110.756 176.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.558 HG22 ' HB2' ' A' ' 62' ' ' LEU . 63.2 p -130.65 11.46 5.26 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 120.365 -0.534 . . . . 1.0 111.644 -176.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -80.87 133.51 35.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.77 -0.65 . . . . 1.0 110.087 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 51.7 t60 -169.22 152.24 4.93 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.892 0.377 . . . . 1.0 110.659 -176.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.436 ' HD3' ' HA ' ' A' ' 72' ' ' ARG . 9.4 tpp180 -133.93 110.86 10.0 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 108.084 -1.08 . . . . 1.0 108.084 175.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.468 ' HB3' ' O ' ' A' ' 49' ' ' HIS . . . -60.34 137.72 58.09 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.288 -0.869 . . . . 1.0 112.176 -175.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.403 ' HA ' HG23 ' A' ' 50' ' ' VAL . . . -130.96 160.25 35.08 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.437 -0.801 . . . . 1.0 110.013 178.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -97.43 154.82 17.23 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.026 -0.731 . . . . 1.0 109.026 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.527 HG11 HD23 ' A' ' 97' ' ' LEU . 14.5 t -67.35 113.19 3.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.053 0.454 . . . . 1.0 110.725 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.454 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -124.19 -169.59 13.12 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.128 -0.942 . . . . 1.0 111.538 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 97.9 m -58.51 -44.48 89.48 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 122.275 0.23 . . . . 1.0 111.548 -178.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -60.4 -28.48 68.26 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.937 0.399 . . . . 1.0 111.183 178.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.585 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 78.8 m80 -77.67 -41.43 38.2 Favored 'General case' 0 C--O 1.223 -0.297 0 N-CA-C 109.763 -0.458 . . . . 1.0 109.763 179.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.645 ' O ' HG23 ' A' ' 102' ' ' VAL . 15.6 mt -69.83 -14.42 62.75 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.6 177.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -88.49 -7.55 56.34 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 120.884 0.373 . . . . 1.0 110.618 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.573 ' HB1' ' O ' ' A' ' 6' ' ' HIS . . . -59.94 150.38 29.0 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.805 -0.634 . . . . 1.0 111.407 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.711 ' HB3' HD13 ' A' ' 5' ' ' LEU . 15.3 t70 -75.4 -15.19 60.48 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.941 -0.392 . . . . 1.0 109.941 178.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.753 HD13 HG13 ' A' ' 7' ' ' VAL . 0.5 OUTLIER -154.66 119.63 4.94 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 109.245 -0.65 . . . . 1.0 109.245 -177.787 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.689 ' HB3' HD13 ' A' ' 97' ' ' LEU . 5.1 mp -109.8 104.74 13.75 Favored 'General case' 0 N--CA 1.426 -1.652 0 CA-C-N 115.531 -0.759 . . . . 1.0 109.735 177.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.589 ' HA ' ' O ' ' A' ' 108' ' ' ARG . 53.6 t -83.79 91.54 2.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 114.924 -1.035 . . . . 1.0 111.115 -176.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.13 145.73 33.57 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.397 -0.82 . . . . 1.0 110.29 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.474 ' HG ' ' CB ' ' A' ' 17' ' ' ARG . 3.9 mm? -99.35 -8.04 25.4 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.026 -0.534 . . . . 1.0 110.361 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.405 ' CG ' ' H ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -151.76 152.48 32.77 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.662 -0.699 . . . . 1.0 110.858 179.15 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -58.16 -24.01 57.37 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.21 0.818 . . . . 1.0 113.21 -177.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.682 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 9.7 m120 -77.1 -48.07 18.76 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.933 -0.395 . . . . 1.0 109.933 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.56 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 11.7 m170 -56.6 -44.24 80.91 Favored 'General case' 0 N--CA 1.461 0.094 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.031 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.65 -45.17 92.81 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.952 178.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.6 ttt180 -59.26 -39.89 84.29 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.11 -0.496 . . . . 1.0 111.152 178.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.707 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 48.7 mt -66.16 -48.87 69.33 Favored 'General case' 0 C--O 1.218 -0.58 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.304 -176.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.728 HD21 HG21 ' A' ' 10' ' ' VAL . 36.2 mt -52.89 -58.39 7.07 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.086 -0.506 . . . . 1.0 111.374 -179.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.74 ' HA ' HG12 ' A' ' 102' ' ' VAL . 1.3 ptt180 -58.34 -44.69 88.83 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.801 -0.636 . . . . 1.0 111.811 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.653 ' HG3' ' O ' ' A' ' 96' ' ' LEU . 1.1 pp0? -67.8 -25.27 65.5 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.043 0.449 . . . . 1.0 109.948 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.707 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 13.2 mt -79.67 -12.6 59.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.668 -0.696 . . . . 1.0 111.612 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 145.99 -22.25 1.77 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 119.863 -1.16 . . . . 1.0 113.935 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.74 HG12 ' HA ' ' A' ' 98' ' ' ARG . 0.4 OUTLIER -75.93 -163.19 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 CA-C-N 117.419 0.609 . . . . 1.0 110.463 -178.813 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.752 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 12.4 pt-20 -155.87 163.11 40.21 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.702 -1.221 . . . . 1.0 107.702 -179.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.801 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -63.03 -24.98 68.17 Favored 'General case' 0 C--N 1.321 -0.664 0 O-C-N 123.186 0.304 . . . . 1.0 111.459 -175.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.2 -36.82 73.67 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.189 0.519 . . . . 1.0 110.042 175.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.752 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 5.5 mtt-85 -97.23 -42.42 7.82 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 115.368 -0.833 . . . . 1.0 111.6 -176.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.801 HG12 ' HA ' ' A' ' 104' ' ' ALA . 11.9 p -77.55 118.68 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 109.354 -0.61 . . . . 1.0 109.354 -175.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.589 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 16.1 mmm180 -138.64 147.31 42.73 Favored 'General case' 0 C--N 1.319 -0.755 0 O-C-N 121.623 -0.673 . . . . 1.0 110.764 -178.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.523 ' HB2' ' HB2' ' A' ' 112' ' ' SER . 77.1 mmm -79.76 137.54 37.03 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.523 -0.762 . . . . 1.0 110.639 179.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.526 HD23 HG11 ' A' ' 87' ' ' VAL . 3.1 tm? -57.5 -49.97 74.56 Favored 'General case' 0 N--CA 1.465 0.303 0 O-C-N 123.16 0.287 . . . . 1.0 111.221 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.403 ' O ' ' HG2' ' A' ' 111' ' ' ARG . 46.1 ttt180 -70.29 -17.44 63.09 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.877 -0.329 . . . . 1.0 110.776 -177.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.523 ' HB2' ' HB2' ' A' ' 109' ' ' MET . 33.8 t -75.6 -4.58 40.81 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.984 -0.286 . . . . 1.0 110.969 -178.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.618 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 92.1 m-85 -92.26 -16.25 26.38 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 120.878 0.37 . . . . 1.0 110.196 175.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 17.9 t0 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.0 -0.545 . . . . 1.0 110.712 -178.552 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 . . . . . 0 N--CA 1.454 -0.258 0 CA-C-O 120.758 0.313 . . . . 1.0 110.908 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.414 ' O ' HG23 ' A' ' 141' ' ' VAL . 5.6 tp10 -64.33 -50.73 66.62 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.62 0.724 . . . . 1.0 109.359 176.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.697 ' HA ' HG23 ' A' ' 141' ' ' VAL . 92.9 t -61.77 -38.7 81.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.01 -0.995 . . . . 1.0 109.992 177.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -53.52 -42.06 67.02 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.098 -0.955 . . . . 1.0 109.325 175.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.519 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -65.33 -41.3 94.1 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.301 -0.863 . . . . 1.0 110.187 177.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.697 HG23 ' HA ' ' A' ' 138' ' ' VAL . 11.9 t -55.52 -52.43 47.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 121.604 0.716 . . . . 1.0 110.139 177.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.597 HD13 ' HB3' ' A' ' 20' ' ' MET . 6.5 mt -63.99 -51.74 65.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 114.954 -1.021 . . . . 1.0 112.055 -178.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.519 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 11.3 pt-20 -56.43 -31.5 63.99 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.862 0.363 . . . . 1.0 110.373 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.4 t -74.5 -28.35 60.95 Favored 'General case' 0 C--O 1.225 -0.206 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.253 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.478 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -86.54 -24.12 25.6 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-N 115.889 -0.596 . . . . 1.0 111.545 179.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.717 HD22 ' HB3' ' A' ' 25' ' ' PHE . 11.8 mt -55.65 -36.9 51.05 Favored Pre-proline 0 CA--C 1.544 0.727 0 N-CA-C 112.577 0.584 . . . . 1.0 112.577 -178.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.622 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 55.8 Cg_endo -69.88 -11.6 31.01 Favored 'Trans proline' 0 C--N 1.363 1.332 0 C-N-CA 122.339 2.026 . . . . 1.0 111.854 177.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.618 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -104.85 -33.94 3.64 Favored Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 110.703 -0.959 . . . . 1.0 110.703 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.529 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -74.21 -41.12 61.89 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.43 -0.952 . . . . 1.0 108.43 178.729 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . 0.5 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 1.2 m-70 -54.29 -55.14 31.23 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 114.933 -1.031 . . . . 1.0 109.926 174.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -57.32 -40.83 78.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.315 -0.857 . . . . 1.0 110.71 -175.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . 0.708 ' HZ3' HD11 ' A' ' 5' ' ' LEU . 27.0 t90 -63.54 -57.54 9.83 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.596 -0.729 . . . . 1.0 110.748 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 10.3 m -61.43 -41.17 88.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.803 -0.359 . . . . 1.0 110.195 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.424 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 1.8 m-20 -60.5 -50.72 72.44 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 120.897 0.38 . . . . 1.0 110.42 178.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.559 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 6.3 pt-20 -63.23 -38.13 89.94 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.123 0.487 . . . . 1.0 110.936 -178.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.527 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 4.7 mmt180 -72.58 -45.15 60.54 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.664 -177.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.426 ' HB3' HD23 ' A' ' 5' ' ' LEU . 3.9 pp . . . . . 0 C--N 1.32 -0.704 0 CA-C-N 115.716 -0.675 . . . . 1.0 109.762 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.41 ' HG3' ' HE ' ' A' ' 39' ' ' ARG . 27.6 Cg_endo . . . . . 0 N--CA 1.46 -0.443 0 CA-C-O 121.002 0.334 . . . . 1.0 112.834 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.809 HD13 ' HB3' ' A' ' 84' ' ' ASP . 0.2 OUTLIER -67.13 177.82 1.65 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.532 -0.758 . . . . 1.0 109.384 178.749 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.64 ' O ' ' HB1' ' A' ' 83' ' ' ALA . 3.4 t-160 -157.55 89.32 1.03 Allowed 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.363 -0.606 . . . . 1.0 109.363 -179.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.808 HG13 HD13 ' A' ' 85' ' ' LEU . 2.4 t -95.95 107.38 19.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 109.759 -0.46 . . . . 1.0 109.759 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.619 ' CG2' ' HG ' ' A' ' 86' ' ' LEU . 11.8 t -108.25 114.97 29.26 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.084 0.469 . . . . 1.0 110.943 -179.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.542 ' HA ' ' O ' ' A' ' 87' ' ' VAL . 0.5 OUTLIER -85.76 134.55 33.94 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 122.203 -0.31 . . . . 1.0 110.262 -178.802 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.588 ' CG1' HG23 ' A' ' 45' ' ' THR . 42.4 t -120.66 119.87 60.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-O 121.385 0.612 . . . . 1.0 112.17 -175.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.483 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 15.4 p -143.68 167.63 21.81 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.214 -0.903 . . . . 1.0 109.453 177.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.98 93.54 3.82 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.417 0.627 . . . . 1.0 111.033 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.776 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 129.68 -37.03 2.24 Favored Glycine 0 N--CA 1.443 -0.855 0 CA-C-N 115.25 -0.886 . . . . 1.0 112.526 178.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.488 HD21 ' CB ' ' A' ' 42' ' ' SER . 3.6 t-20 64.49 19.1 11.69 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.924 0.868 . . . . 1.0 110.703 -179.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.469 ' O ' ' HB3' ' A' ' 55' ' ' ASP . 1.3 pt -135.95 47.38 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 CA-C-N 115.491 -0.777 . . . . 1.0 109.567 -178.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.691 ' O ' ' HG3' ' A' ' 20' ' ' MET . 4.4 p -157.23 -89.3 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.78 -1.1 . . . . 1.0 111.846 175.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.514 ' H ' ' HD2' ' A' ' 17' ' ' ARG . 0.1 OUTLIER -74.96 -43.1 55.95 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 121.908 -0.495 . . . . 1.0 111.817 -175.569 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.869 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 46.8 m -54.33 -56.6 24.76 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 116.425 -0.352 . . . . 1.0 111.505 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.683 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 49.0 Cg_endo -66.47 -24.22 49.57 Favored 'Trans proline' 0 C--N 1.357 0.995 0 C-N-CA 121.548 1.499 . . . . 1.0 112.387 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.691 ' HG3' ' O ' ' A' ' 16' ' ' CYS . 51.0 mtp -62.94 -56.54 16.31 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.672 -0.411 . . . . 1.0 110.646 177.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.63 -28.02 64.5 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 120.724 -0.39 . . . . 1.0 110.217 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.67 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 14.8 tt0 -51.85 -53.22 42.82 Favored 'General case' 0 C--O 1.214 -0.764 0 CA-C-N 114.74 -1.118 . . . . 1.0 109.614 178.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.946 ' HB3' ' HG2' ' A' ' 68' ' ' PRO . 0.1 OUTLIER -79.43 -32.39 42.81 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.36 -0.837 . . . . 1.0 110.235 -176.089 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.605 ' HB3' HD11 ' A' ' 146' ' ' LEU . 3.5 mmm -61.9 -75.61 0.07 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 113.173 0.805 . . . . 1.0 113.173 -175.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.749 ' HB3' HD22 ' A' ' 146' ' ' LEU . 14.0 p90 -78.44 -29.31 46.95 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 119.828 -0.749 . . . . 1.0 111.484 -174.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.707 ' HB2' HG21 ' A' ' 40' ' ' VAL . . . -64.12 -36.62 84.62 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 119.146 -1.021 . . . . 1.0 110.461 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.629 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -64.03 -39.32 93.84 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.614 -0.884 . . . . 1.0 108.614 177.062 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.555 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 77.1 mt-30 -60.38 -39.45 87.33 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-N 115.719 -0.673 . . . . 1.0 110.916 176.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.593 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 88.7 mt -59.81 -59.89 4.71 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.756 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.533 ' HA ' ' H ' ' A' ' 35' ' ' GLY . 0.1 OUTLIER -58.96 -36.87 75.54 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.375 -0.53 . . . . 1.0 111.254 178.518 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -65.02 -25.46 67.86 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.382 0.512 . . . . 1.0 112.382 177.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.593 ' HG2' ' O ' ' A' ' 29' ' ' LEU . 3.9 ptm180 -93.17 -19.46 21.44 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 119.461 -0.895 . . . . 1.0 109.465 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 110.4 35.02 2.17 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 114.955 -1.02 . . . . 1.0 111.926 177.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.563 HD12 ' HD3' ' A' ' 32' ' ' ARG . 46.9 mt -134.45 5.93 3.5 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 122.59 -0.359 . . . . 1.0 111.006 -177.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.533 ' H ' ' HA ' ' A' ' 30' ' ' ARG . . . -54.83 -29.62 50.75 Favored Glycine 0 C--N 1.33 0.24 0 C-N-CA 121.177 -0.535 . . . . 1.0 113.118 -178.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -94.92 -20.91 19.0 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.632 0.253 . . . . 1.0 110.985 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.48 -23.27 43.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.369 0.604 . . . . 1.0 111.342 -178.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.8 HG23 ' HB3' ' A' ' 5' ' ' LEU . 0.3 OUTLIER -142.44 119.5 6.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.53 -0.545 . . . . 1.0 109.53 178.001 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.41 ' HE ' ' HG3' ' A' ' 4' ' ' PRO . 16.9 mmt85 -91.13 148.42 22.39 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.618 -0.719 . . . . 1.0 109.295 -178.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.707 HG21 ' HB2' ' A' ' 26' ' ' ALA . 2.0 m -131.54 139.62 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.075 0 N-CA-C 108.391 -0.966 . . . . 1.0 108.391 178.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.503 ' O ' ' HA ' ' A' ' 8' ' ' THR . 21.7 p -146.36 -177.69 5.75 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.287 -0.87 . . . . 1.0 109.808 -175.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.869 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 93.4 p -159.32 163.96 35.23 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 120.613 -0.435 . . . . 1.0 109.982 178.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.557 ' HB2' ' CD2' ' A' ' 80' ' ' HIS . . . -164.38 164.96 22.0 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.452 0.644 . . . . 1.0 111.357 -179.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.483 ' HA2' ' O ' ' A' ' 11' ' ' CYS . . . -122.18 130.05 7.84 Favored Glycine 0 N--CA 1.439 -1.163 0 N-CA-C 110.41 -1.076 . . . . 1.0 110.41 177.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.588 HG23 ' CG1' ' A' ' 10' ' ' VAL . 18.8 p -65.25 -24.16 67.25 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 111.853 0.316 . . . . 1.0 111.853 -177.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -107.66 8.81 37.44 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.809 -0.71 . . . . 1.0 113.353 -177.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 42.96 37.77 1.22 Allowed 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.722 0.809 . . . . 1.0 113.078 179.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.776 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 0.7 OUTLIER -49.2 -76.66 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.524 0.565 . . . . 1.0 112.524 -179.59 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.458 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 36.1 m-70 -103.97 39.65 1.59 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.869 -0.605 . . . . 1.0 111.154 -178.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.506 HG23 ' HA ' ' A' ' 74' ' ' ALA . 11.0 p -59.4 126.31 16.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.019 0.438 . . . . 1.0 110.338 178.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.25 -14.76 62.12 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 121.037 -0.601 . . . . 1.0 111.942 -177.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.461 ' O ' ' HA ' ' A' ' 72' ' ' ARG . 3.8 t -81.61 -161.87 0.47 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.119 0.485 . . . . 1.0 110.138 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 30.2 t -120.84 178.59 4.65 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.737 -0.665 . . . . 1.0 109.289 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.21 146.91 53.71 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.224 0.535 . . . . 1.0 110.499 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.579 ' OD1' ' HA ' ' A' ' 16' ' ' CYS . 9.7 p-10 -64.46 150.69 46.04 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.889 -1.05 . . . . 1.0 113.588 -175.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.409 ' HG3' ' H ' ' A' ' 57' ' ' ARG . 1.7 pt-20 -44.8 -49.62 10.63 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 113.533 -1.667 . . . . 1.0 114.121 176.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.509 ' HG2' ' OD2' ' A' ' 55' ' ' ASP . 9.6 ptp180 -71.04 -37.38 72.56 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.856 -0.338 . . . . 1.0 111.647 -174.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.454 ' HB1' ' HG2' ' A' ' 20' ' ' MET . . . -70.73 -40.95 72.45 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.906 -0.405 . . . . 1.0 109.906 177.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.5 -47.08 85.54 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.87 -0.604 . . . . 1.0 109.836 179.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -60.17 -46.87 93.44 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.912 -0.661 . . . . 1.0 113.318 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.425 HG13 ' O ' ' A' ' 57' ' ' ARG . 13.3 m -71.85 -38.06 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 CA-C-N 117.8 0.8 . . . . 1.0 111.663 -178.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.586 HD23 ' HG3' ' A' ' 23' ' ' LYS . 4.6 mp -63.9 -52.7 58.71 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 120.489 -0.484 . . . . 1.0 110.361 178.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 63' ' ' ARG . 0.3 OUTLIER -62.44 -27.67 69.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.013 -0.539 . . . . 1.0 111.416 -179.298 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.64 -33.9 69.33 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 120.817 0.341 . . . . 1.0 110.812 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -94.68 3.01 55.58 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.776 -178.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 90.56 13.49 59.66 Favored Glycine 0 CA--C 1.517 0.206 0 CA-C-N 115.697 -0.683 . . . . 1.0 113.257 176.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -90.26 155.4 46.72 Favored Pre-proline 0 C--N 1.318 -0.776 0 CA-C-O 120.45 0.167 . . . . 1.0 110.716 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.946 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 74.5 Cg_endo -72.91 162.24 41.56 Favored 'Trans proline' 0 CA--C 1.512 -0.604 0 C-N-CA 122.43 2.087 . . . . 1.0 110.871 177.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 35.0 p -137.83 10.93 2.89 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 120.043 -0.663 . . . . 1.0 111.228 -178.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -72.53 116.84 13.48 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.666 178.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.853 ' HB2' ' HE3' ' A' ' 23' ' ' LYS . 50.1 t60 -157.85 149.74 21.97 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.918 0.39 . . . . 1.0 111.175 -177.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' A' ' 52' ' ' SER . 4.8 tpt180 -133.66 114.19 13.2 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.785 -1.191 . . . . 1.0 107.785 175.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.458 ' HB3' ' O ' ' A' ' 49' ' ' HIS . . . -59.32 137.81 57.85 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.088 -0.96 . . . . 1.0 112.774 -175.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.506 ' HA ' HG23 ' A' ' 50' ' ' VAL . . . -129.65 161.65 30.11 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.213 -0.903 . . . . 1.0 110.078 178.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -97.53 156.73 16.37 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 108.244 -1.021 . . . . 1.0 108.244 178.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.5 HG11 ' CD2' ' A' ' 97' ' ' LEU . 8.1 t -66.91 104.26 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.303 0.573 . . . . 1.0 109.781 178.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.412 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -113.89 -175.09 18.93 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 115.184 -0.917 . . . . 1.0 111.269 -178.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 94.1 m -56.37 -43.36 79.1 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.814 0.34 . . . . 1.0 111.259 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -60.88 -29.76 69.74 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.091 -0.504 . . . . 1.0 111.312 178.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.557 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 80.0 m80 -78.19 -39.73 39.8 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-O 120.98 0.419 . . . . 1.0 109.875 178.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.519 ' HA ' HD21 ' A' ' 86' ' ' LEU . 33.9 mt -68.65 -18.75 64.34 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.784 -0.644 . . . . 1.0 110.758 178.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.8 -4.8 59.22 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.861 -0.608 . . . . 1.0 110.844 -178.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.64 ' HB1' ' O ' ' A' ' 6' ' ' HIS . . . -59.98 154.22 19.49 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.979 -0.555 . . . . 1.0 111.665 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.809 ' HB3' HD13 ' A' ' 5' ' ' LEU . 10.6 t70 -80.4 -12.08 59.62 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.52 -0.548 . . . . 1.0 109.52 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.808 HD13 HG13 ' A' ' 7' ' ' VAL . 0.4 OUTLIER -156.98 118.09 3.68 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 115.65 -0.705 . . . . 1.0 109.22 -177.615 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.716 ' HB3' HD13 ' A' ' 97' ' ' LEU . 5.1 mp -107.52 105.99 16.16 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-N 115.815 -0.629 . . . . 1.0 109.709 177.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.597 HG11 HD23 ' A' ' 110' ' ' LEU . 48.1 t -86.51 94.88 4.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 114.823 -1.081 . . . . 1.0 111.066 -176.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -82.73 144.67 30.04 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 114.975 -1.012 . . . . 1.0 110.949 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.413 HD13 ' HA ' ' A' ' 89' ' ' LEU . 4.3 mm? -95.04 -13.65 25.01 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.254 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.409 ' CG ' ' H ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -148.74 153.67 38.51 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.724 -0.671 . . . . 1.0 111.542 -178.89 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.7 ptt180 -49.74 -32.2 13.1 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.666 1.186 . . . . 1.0 113.55 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.646 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 76.9 m-20 -77.36 -47.51 19.7 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.751 -0.38 . . . . 1.0 110.672 -177.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.724 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 13.5 m170 -54.52 -48.15 72.27 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.923 -0.399 . . . . 1.0 109.923 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.96 -43.03 91.24 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.073 0.463 . . . . 1.0 110.752 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.674 ' O ' ' HG2' ' A' ' 99' ' ' GLN . 11.5 ttp180 -58.32 -47.56 83.31 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.465 -0.789 . . . . 1.0 111.363 179.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.722 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 48.4 mt -62.16 -49.11 77.15 Favored 'General case' 0 C--O 1.219 -0.533 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.233 -175.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.724 ' HG ' ' O ' ' A' ' 93' ' ' HIS . 32.1 mt -53.42 -58.05 8.49 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.816 -0.629 . . . . 1.0 111.762 -177.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.526 ' HG2' ' O ' ' A' ' 95' ' ' ARG . 22.6 ptt180 -59.41 -44.83 92.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.451 . . . . 1.0 111.578 -176.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.674 ' HG2' ' O ' ' A' ' 95' ' ' ARG . 9.9 pt20 -70.89 -18.65 62.67 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.84 0.353 . . . . 1.0 111.227 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.722 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 5.5 mt -79.58 -8.1 58.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.068 -0.515 . . . . 1.0 111.706 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 146.87 -30.36 1.52 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.029 -1.082 . . . . 1.0 113.011 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.8 HG12 ' H ' ' A' ' 103' ' ' GLU . 2.0 t -73.32 -154.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 121.077 0.465 . . . . 1.0 110.868 -178.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.8 ' H ' HG12 ' A' ' 102' ' ' VAL . 15.6 pt-20 -164.61 165.14 21.31 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.977 -0.749 . . . . 1.0 108.977 -177.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.788 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -65.01 -24.87 67.63 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 123.409 0.443 . . . . 1.0 111.542 -176.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.5 -35.65 72.57 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.3 0.571 . . . . 1.0 110.254 175.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.716 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 4.7 mtt-85 -96.89 -42.71 7.81 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 115.2 -0.909 . . . . 1.0 111.029 -177.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.788 HG12 ' HA ' ' A' ' 104' ' ' ALA . 7.8 p -80.79 121.7 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-O 121.37 0.605 . . . . 1.0 109.981 -177.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.533 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 12.7 mmm180 -137.97 146.6 43.36 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.39 -0.596 . . . . 1.0 109.39 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.483 ' HB2' ' HB2' ' A' ' 112' ' ' SER . 79.6 mmm -77.81 139.53 39.33 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.837 -0.619 . . . . 1.0 110.234 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.597 HD23 HG11 ' A' ' 87' ' ' VAL . 3.2 tm? -56.04 -48.29 76.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.517 0.198 . . . . 1.0 111.075 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.407 ' O ' ' HG2' ' A' ' 111' ' ' ARG . 20.7 ttt85 -71.35 -17.49 62.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.007 0.432 . . . . 1.0 110.498 -178.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.483 ' HB2' ' HB2' ' A' ' 109' ' ' MET . 30.5 t -70.67 -12.26 61.45 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.581 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.458 ' HZ ' HD21 ' A' ' 85' ' ' LEU . 97.6 m-85 -90.8 -25.38 19.96 Favored 'General case' 0 N--CA 1.456 -0.166 0 O-C-N 122.175 -0.328 . . . . 1.0 110.122 176.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 13.1 t0 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 115.51 -0.768 . . . . 1.0 111.756 -177.432 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.43 ' HA ' ' HB3' ' A' ' 139' ' ' PHE . 10.1 mt-10 . . . . . 0 N--CA 1.45 -0.453 0 CA-C-O 120.528 0.204 . . . . 1.0 111.237 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.5 ' O ' HG23 ' A' ' 141' ' ' VAL . 20.0 tp10 -65.29 -46.76 79.12 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 108.187 -1.042 . . . . 1.0 108.187 174.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 72.3 t -60.08 -44.25 94.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 114.594 -1.185 . . . . 1.0 109.214 175.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.43 ' HB3' ' HA ' ' A' ' 136' ' ' GLU . 49.9 t80 -54.01 -42.79 69.47 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.453 -1.249 . . . . 1.0 109.828 176.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.52 ' HA ' ' OE2' ' A' ' 143' ' ' GLU . . . -64.26 -42.07 96.64 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.462 -0.79 . . . . 1.0 111.03 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 137' ' ' GLU . 16.9 t -56.96 -53.77 38.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.503 0.668 . . . . 1.0 110.235 178.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.475 ' HA ' HD11 ' A' ' 110' ' ' LEU . 4.7 mt -60.92 -52.27 63.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.376 -0.829 . . . . 1.0 112.289 -178.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.52 ' OE2' ' HA ' ' A' ' 140' ' ' ALA . 13.2 pt-20 -56.17 -32.18 64.09 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.932 0.396 . . . . 1.0 110.515 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 73.0 m -72.8 -28.9 62.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.574 -0.739 . . . . 1.0 110.939 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.459 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -87.18 -23.5 24.77 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-N 116.215 -0.448 . . . . 1.0 111.712 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.749 HD22 ' HB3' ' A' ' 25' ' ' PHE . 13.4 mt -56.01 -36.66 48.63 Favored Pre-proline 0 CA--C 1.548 0.874 0 N-CA-C 112.417 0.525 . . . . 1.0 112.417 -177.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.636 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 51.1 Cg_endo -69.7 -10.79 29.47 Favored 'Trans proline' 0 C--N 1.366 1.465 0 C-N-CA 122.733 2.288 . . . . 1.0 112.277 177.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.429 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -105.24 -32.6 3.95 Favored Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 110.465 -1.054 . . . . 1.0 110.465 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.464 HD11 HG21 ' A' ' 87' ' ' VAL . 0.4 OUTLIER -74.48 -41.02 61.45 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.664 -0.865 . . . . 1.0 108.664 178.937 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . 0.403 ' O ' HG22 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -53.52 -55.38 25.96 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 114.814 -1.085 . . . . 1.0 110.921 175.657 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -60.75 -40.47 92.56 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.563 -0.744 . . . . 1.0 111.591 -176.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . 0.756 ' HZ3' HD11 ' A' ' 5' ' ' LEU . 29.0 t90 -63.36 -54.6 34.37 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.552 -0.749 . . . . 1.0 110.751 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.458 HG13 ' O ' ' A' ' 149' ' ' LEU . 11.1 m -60.11 -39.19 79.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 C-N-CA 120.84 -0.344 . . . . 1.0 110.075 -179.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.442 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 8.3 m-20 -59.68 -51.74 68.5 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.272 0.558 . . . . 1.0 110.966 178.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.524 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 5.1 pt-20 -63.46 -38.31 90.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.406 -0.815 . . . . 1.0 110.443 -178.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.525 ' HG3' ' CH2' ' A' ' 152' ' ' TRP . 10.9 mmt180 -74.89 -42.72 57.29 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.615 -0.72 . . . . 1.0 111.664 -177.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 4.2 pp . . . . . 0 C--N 1.322 -0.599 0 CA-C-O 121.157 0.503 . . . . 1.0 109.793 179.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.589 ' HB3' ' O ' ' A' ' 36' ' ' ASP . 23.1 Cg_endo . . . . . 0 N--CA 1.464 -0.26 0 N-CA-C 114.046 0.748 . . . . 1.0 114.046 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.844 ' HB3' HG23 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -66.11 177.66 1.34 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.635 -1.166 . . . . 1.0 109.578 178.084 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.575 ' H ' HD13 ' A' ' 5' ' ' LEU . 0.9 OUTLIER -155.51 99.0 2.0 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.763 -0.458 . . . . 1.0 109.763 179.617 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.637 HG13 HD13 ' A' ' 85' ' ' LEU . 2.3 t -104.09 118.27 50.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 108.147 -1.057 . . . . 1.0 108.147 177.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.643 HG22 ' HG ' ' A' ' 86' ' ' LEU . 11.7 t -119.75 113.59 20.86 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.302 0.572 . . . . 1.0 110.352 178.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.647 ' HD1' ' HB ' ' A' ' 87' ' ' VAL . 1.0 OUTLIER -84.51 133.21 34.47 Favored 'General case' 0 CA--C 1.512 -0.487 0 O-C-N 122.024 -0.423 . . . . 1.0 110.258 -178.18 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.57 ' CG1' HG23 ' A' ' 45' ' ' THR . 40.7 t -119.95 119.49 60.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.552 0.691 . . . . 1.0 112.042 -176.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.445 ' HA ' ' CE1' ' A' ' 93' ' ' HIS . 21.7 p -148.32 163.37 37.29 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.221 -0.9 . . . . 1.0 109.963 177.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.96 96.81 5.83 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 120.849 0.357 . . . . 1.0 110.39 177.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.513 ' O ' HG12 ' A' ' 15' ' ' ILE . . . 146.64 -36.62 1.24 Allowed Glycine 0 C--O 1.218 -0.89 0 CA-C-N 115.687 -0.688 . . . . 1.0 112.26 179.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.503 ' OD1' ' HB1' ' A' ' 73' ' ' ALA . 32.2 p30 49.27 18.54 0.26 Allowed 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 125.155 1.382 . . . . 1.0 114.115 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.513 HG12 ' O ' ' A' ' 13' ' ' GLY . 5.8 pt -136.44 2.6 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 112.13 0.419 . . . . 1.0 112.13 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.646 ' O ' ' HG3' ' A' ' 20' ' ' MET . 51.4 t -121.99 -86.79 0.65 Allowed 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.437 -0.505 . . . . 1.0 111.577 -178.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 54.1 mtt85 -59.2 -56.55 20.67 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.063 0.458 . . . . 1.0 112.103 -175.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.948 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 45.3 m -53.19 -59.0 10.21 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 115.552 -0.749 . . . . 1.0 112.497 -177.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.409 ' HG3' ' HA ' ' A' ' 15' ' ' ILE . 41.2 Cg_endo -63.19 -25.34 72.52 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 121.954 1.769 . . . . 1.0 113.2 -178.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.646 ' HG3' ' O ' ' A' ' 16' ' ' CYS . 53.4 mtp -61.19 -53.34 58.14 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.778 -0.369 . . . . 1.0 110.3 178.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.468 ' HB2' ' CG2' ' A' ' 142' ' ' ILE . . . -72.2 -26.74 62.17 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.265 -0.574 . . . . 1.0 110.178 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.685 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 17.7 tt0 -53.83 -52.1 61.43 Favored 'General case' 0 C--O 1.212 -0.874 0 CA-C-N 115.135 -0.939 . . . . 1.0 109.431 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.618 ' HZ1' ' HB3' ' A' ' 71' ' ' HIS . 0.1 OUTLIER -86.65 -23.03 25.8 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 120.06 -0.656 . . . . 1.0 110.879 -176.431 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.503 ' HB3' HD11 ' A' ' 146' ' ' LEU . 86.0 mtp -64.57 -75.78 0.08 Allowed 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.001 0.429 . . . . 1.0 112.132 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.617 ' HB3' HD22 ' A' ' 146' ' ' LEU . 17.5 p90 -77.04 -30.31 55.59 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 119.883 -0.727 . . . . 1.0 111.51 -175.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.685 ' HB3' ' O ' ' A' ' 22' ' ' GLU . . . -64.39 -36.96 85.84 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 118.951 -1.099 . . . . 1.0 110.991 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.605 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -63.56 -37.53 87.68 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 108.433 -0.951 . . . . 1.0 108.433 176.468 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.581 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 77.9 mt-30 -60.15 -41.07 91.96 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-N 116.022 -0.536 . . . . 1.0 110.187 175.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.559 ' HG ' ' O ' ' A' ' 25' ' ' PHE . 70.7 mt -57.71 -59.69 4.83 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.004 -0.544 . . . . 1.0 110.907 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.525 ' HD3' ' HA ' ' A' ' 27' ' ' GLN . 0.3 OUTLIER -59.37 -34.36 72.31 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.556 -0.457 . . . . 1.0 110.779 178.225 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -63.01 -27.41 69.4 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.693 0.627 . . . . 1.0 112.693 176.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.46 ' HG2' ' O ' ' A' ' 28' ' ' GLN . 6.9 ptp180 -95.9 -15.01 22.68 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.566 0.698 . . . . 1.0 110.109 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.86 39.69 3.07 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 114.913 -1.039 . . . . 1.0 111.49 177.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 31.3 mt -132.32 3.8 3.98 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.987 -0.375 . . . . 1.0 109.987 -178.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.423 ' H ' ' HA ' ' A' ' 30' ' ' ARG . . . -56.22 -26.93 51.41 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 121.037 -0.602 . . . . 1.0 112.507 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.645 ' HA ' ' NH1' ' A' ' 39' ' ' ARG . 11.9 m-20 -91.32 -21.69 20.91 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.623 0.249 . . . . 1.0 110.796 176.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -81.01 -23.55 38.57 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.338 -178.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.844 HG23 ' HB3' ' A' ' 5' ' ' LEU . 0.7 OUTLIER -142.68 123.91 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-O 121.269 0.557 . . . . 1.0 110.509 179.769 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.645 ' NH1' ' HA ' ' A' ' 36' ' ' ASP . 24.3 mmt180 -92.53 141.33 28.63 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 109.233 -0.655 . . . . 1.0 109.233 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.441 HG13 ' CZ ' ' A' ' 9' ' ' PHE . 34.2 t -129.13 125.34 62.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-O 121.445 0.64 . . . . 1.0 109.931 -177.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' A' ' 8' ' ' THR . 36.5 p -136.79 -177.69 4.85 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.165 -1.379 . . . . 1.0 110.298 -174.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.948 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 66.9 p -161.03 162.94 31.9 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.986 -0.376 . . . . 1.0 109.986 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.561 ' HB2' ' CD2' ' A' ' 80' ' ' HIS . . . -164.59 171.03 15.01 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.556 0.693 . . . . 1.0 111.922 -178.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -128.29 134.05 7.98 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 114.851 -1.068 . . . . 1.0 111.073 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.57 HG23 ' CG1' ' A' ' 10' ' ' VAL . 25.7 p -69.6 -18.13 63.59 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.045 0.45 . . . . 1.0 111.385 -178.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.509 ' HA3' ' CZ3' ' A' ' 48' ' ' TRP . . . -113.8 8.53 23.7 Favored Glycine 0 CA--C 1.521 0.436 0 C-N-CA 120.853 -0.689 . . . . 1.0 113.173 -179.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 44.01 39.19 2.6 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 113.821 1.045 . . . . 1.0 113.821 177.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.509 ' CZ3' ' HA3' ' A' ' 46' ' ' GLY . 1.2 m-90 -43.96 -77.32 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.534 0.683 . . . . 1.0 112.506 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.428 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 24.4 m-70 -106.0 40.53 1.57 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.023 -0.99 . . . . 1.0 111.314 -179.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.446 HG23 ' HA ' ' A' ' 74' ' ' ALA . 12.0 p -58.2 127.63 17.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.853 179.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.6 -14.94 64.16 Favored Glycine 0 C--N 1.329 0.184 0 C-N-CA 121.196 -0.525 . . . . 1.0 112.195 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.6 t -81.56 -162.4 0.51 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.42 0.629 . . . . 1.0 110.356 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 14.0 t -118.89 175.74 5.61 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.703 -0.851 . . . . 1.0 108.703 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.458 ' HB2' ' HZ1' ' A' ' 23' ' ' LYS . . . -60.66 147.43 42.05 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 123.331 0.394 . . . . 1.0 111.525 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.454 ' OD1' ' HG2' ' A' ' 57' ' ' ARG . 11.5 t70 -63.0 142.84 58.23 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.698 -0.683 . . . . 1.0 111.163 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.437 ' HG3' ' N ' ' A' ' 57' ' ' ARG . 5.4 pt-20 -50.02 -37.06 31.2 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 113.522 0.934 . . . . 1.0 113.522 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.454 ' HG2' ' OD1' ' A' ' 55' ' ' ASP . 11.3 ptp180 -71.16 -37.56 72.2 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.039 0.447 . . . . 1.0 110.624 -176.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.417 ' HB1' ' HG2' ' A' ' 20' ' ' MET . . . -70.52 -37.65 74.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.61 -0.723 . . . . 1.0 109.5 178.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.14 -42.97 99.77 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.743 -0.662 . . . . 1.0 109.281 176.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.416 ' O ' ' HG2' ' A' ' 63' ' ' ARG . . . -58.77 -45.5 94.8 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.566 -0.743 . . . . 1.0 113.359 178.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.481 HG12 ' HG2' ' A' ' 136' ' ' GLU . 35.0 m -73.28 -41.73 57.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 117.569 0.685 . . . . 1.0 111.863 -179.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.735 ' HB2' HG22 ' A' ' 69' ' ' THR . 96.2 mt -60.63 -52.22 66.05 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 120.828 -0.349 . . . . 1.0 110.194 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.416 ' HG2' ' O ' ' A' ' 60' ' ' GLY . 2.4 ptm180 -59.83 -32.48 70.7 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.101 -0.499 . . . . 1.0 111.079 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.5 -34.81 74.85 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 121.155 0.503 . . . . 1.0 110.877 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.405 ' HB2' ' HD2' ' A' ' 67' ' ' TYR . 99.7 m-70 -93.33 4.49 53.89 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.897 -179.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.16 16.74 62.23 Favored Glycine 0 C--N 1.331 0.288 0 CA-C-N 115.832 -0.622 . . . . 1.0 112.964 176.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.448 ' HD1' ' HG2' ' A' ' 27' ' ' GLN . 55.3 m-85 -92.45 153.52 42.69 Favored Pre-proline 0 C--N 1.32 -0.686 0 N-CA-C 110.434 -0.21 . . . . 1.0 110.434 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.402 ' O ' ' HD2' ' A' ' 23' ' ' LYS . 35.5 Cg_endo -68.25 156.76 64.57 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.063 1.842 . . . . 1.0 110.509 175.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.735 HG22 ' HB2' ' A' ' 62' ' ' LEU . 72.2 p -130.83 27.73 4.9 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 120.222 -0.591 . . . . 1.0 111.342 -176.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -104.08 131.87 50.91 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.81 -0.632 . . . . 1.0 110.335 178.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.618 ' HB3' ' HZ1' ' A' ' 23' ' ' LYS . 3.2 t60 -167.42 148.82 5.62 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.621 -0.718 . . . . 1.0 109.398 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -121.28 113.04 19.37 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 107.972 -1.121 . . . . 1.0 107.972 176.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.503 ' HB1' ' OD1' ' A' ' 14' ' ' ASN . . . -57.84 139.56 53.84 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.557 -0.747 . . . . 1.0 112.272 -175.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.446 ' HA ' HG23 ' A' ' 50' ' ' VAL . . . -132.98 161.95 32.97 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.742 178.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -97.66 156.59 16.47 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 108.134 -1.062 . . . . 1.0 108.134 177.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.59 HG11 ' CD2' ' A' ' 97' ' ' LEU . 14.5 t -66.24 104.69 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.529 0.681 . . . . 1.0 110.232 178.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.409 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -117.57 -171.77 15.67 Favored Glycine 0 N--CA 1.442 -0.962 0 CA-C-N 114.633 -1.167 . . . . 1.0 111.12 -178.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 98.9 m -56.99 -44.42 82.7 Favored 'General case' 0 C--N 1.319 -0.72 0 O-C-N 123.628 0.252 . . . . 1.0 111.3 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -60.71 -29.39 69.31 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.762 0.315 . . . . 1.0 111.216 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.561 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 79.1 m80 -79.22 -42.15 26.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.422 -0.354 . . . . 1.0 110.179 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.499 ' HA ' HD21 ' A' ' 86' ' ' LEU . 21.4 mt -66.77 -21.43 66.06 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.132 -0.485 . . . . 1.0 110.967 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.25 -5.01 59.28 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.166 -0.47 . . . . 1.0 111.438 -178.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.541 ' HA ' ' HB3' ' A' ' 6' ' ' HIS . . . -59.04 151.58 21.91 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.219 -0.446 . . . . 1.0 111.686 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.719 ' HB3' HD13 ' A' ' 5' ' ' LEU . 28.4 t70 -75.8 -16.26 60.12 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.924 -0.58 . . . . 1.0 109.635 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.637 HD13 HG13 ' A' ' 7' ' ' VAL . 0.4 OUTLIER -156.21 116.56 3.68 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.53 -0.759 . . . . 1.0 109.155 -176.931 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.643 ' HG ' HG22 ' A' ' 8' ' ' THR . 5.4 mp -106.59 106.48 17.02 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-N 115.778 -0.646 . . . . 1.0 109.562 177.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.647 ' HB ' ' HD1' ' A' ' 9' ' ' PHE . 54.9 t -85.18 93.15 3.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.124 -0.944 . . . . 1.0 110.994 -176.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.47 145.45 30.73 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.612 -0.722 . . . . 1.0 110.673 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -96.38 -6.79 36.72 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.845 -0.616 . . . . 1.0 109.973 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.427 ' CG ' ' H ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -154.49 151.0 28.41 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.585 -0.734 . . . . 1.0 110.86 179.749 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 13.7 ptp180 -58.04 -24.08 56.95 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.151 -0.931 . . . . 1.0 112.737 -177.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.689 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 82.3 m-20 -77.01 -47.64 20.12 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.983 -0.377 . . . . 1.0 109.983 -178.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.789 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 15.4 m170 -55.78 -48.26 75.64 Favored 'General case' 0 C--N 1.333 -0.119 0 N-CA-C 109.475 -0.565 . . . . 1.0 109.475 176.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.584 ' HA ' HG21 ' A' ' 107' ' ' VAL . . . -57.68 -42.46 83.65 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.477 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.401 ' O ' ' HG2' ' A' ' 98' ' ' ARG . 10.2 ttp180 -58.76 -47.12 85.75 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 115.548 -0.751 . . . . 1.0 111.248 178.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.752 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 52.0 mt -62.89 -50.32 71.34 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.667 -0.697 . . . . 1.0 110.212 -175.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.789 ' HG ' ' O ' ' A' ' 93' ' ' HIS . 22.1 mt -54.71 -57.36 11.81 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.369 -0.832 . . . . 1.0 111.468 -178.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.697 ' HA ' ' HB ' ' A' ' 102' ' ' VAL . 15.9 ptt180 -60.63 -42.83 97.68 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.08 -0.509 . . . . 1.0 111.675 -175.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.607 ' HG3' ' O ' ' A' ' 96' ' ' LEU . 0.9 OUTLIER -67.82 -25.43 65.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.888 0.375 . . . . 1.0 110.191 179.222 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.752 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 11.6 mt -77.13 -12.46 59.95 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.609 0.596 . . . . 1.0 112.609 -178.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 151.52 -26.94 0.96 Allowed Glycine 0 N--CA 1.453 -0.18 0 C-N-CA 120.277 -0.963 . . . . 1.0 112.4 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.931 HG12 ' H ' ' A' ' 103' ' ' GLU . 2.7 t -73.97 -155.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 C-N-CA 123.122 0.569 . . . . 1.0 110.185 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.931 ' H ' HG12 ' A' ' 102' ' ' VAL . 15.4 pt-20 -170.48 164.32 8.54 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 107.883 -1.154 . . . . 1.0 107.883 -178.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.707 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -67.31 -21.69 65.66 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.771 0.319 . . . . 1.0 110.882 -176.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.499 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . . . -58.31 -38.21 76.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.924 -0.58 . . . . 1.0 109.869 174.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.716 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 31.7 mtt180 -95.36 -45.79 6.98 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 115.182 -0.917 . . . . 1.0 110.333 -177.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.707 HG12 ' HA ' ' A' ' 104' ' ' ALA . 8.9 p -79.6 119.83 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-O 121.634 0.731 . . . . 1.0 110.033 -177.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.562 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 22.4 mmm180 -134.77 145.71 48.66 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.414 -0.587 . . . . 1.0 109.414 -178.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 81.4 mmm -77.35 134.86 38.37 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.829 -0.623 . . . . 1.0 110.389 -178.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.538 HD23 HG11 ' A' ' 87' ' ' VAL . 3.0 tm? -55.33 -48.94 73.42 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.933 0.396 . . . . 1.0 111.066 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 37.8 ttt180 -69.98 -19.02 63.37 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.894 -0.594 . . . . 1.0 110.679 -177.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 41.7 t -77.31 -8.41 57.59 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.95 -178.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.587 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 90.4 m-85 -88.75 -17.62 29.47 Favored 'General case' 0 C--N 1.341 0.21 0 O-C-N 121.858 -0.526 . . . . 1.0 110.235 176.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.5 t0 . . . . . 0 CA--C 1.521 -0.149 0 CA-C-N 115.993 -0.549 . . . . 1.0 110.908 -178.651 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.481 ' HG2' HG12 ' A' ' 61' ' ' VAL . 32.3 mt-10 . . . . . 0 C--O 1.234 0.259 0 CA-C-O 120.871 0.367 . . . . 1.0 110.014 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.561 ' O ' HG23 ' A' ' 141' ' ' VAL . 8.3 tt0 -64.44 -45.05 89.17 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.583 -0.735 . . . . 1.0 109.885 178.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 40.6 t -58.22 -43.34 85.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.405 0.621 . . . . 1.0 110.07 177.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -54.35 -45.65 72.77 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.43 -1.259 . . . . 1.0 110.344 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.613 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -62.3 -41.36 98.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.954 -0.567 . . . . 1.0 111.334 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 137' ' ' GLU . 20.7 t -56.9 -52.58 53.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-O 121.637 0.732 . . . . 1.0 110.855 178.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.468 ' CG2' ' HB2' ' A' ' 21' ' ' ALA . 6.3 mt -64.11 -49.67 80.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 114.928 -1.033 . . . . 1.0 111.956 -177.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.613 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 7.2 pt-20 -56.99 -30.45 64.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.887 0.375 . . . . 1.0 110.272 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 2.8 t -72.21 -31.28 65.72 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-O 121.233 0.54 . . . . 1.0 110.265 179.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.473 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -86.24 -23.07 26.55 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-N 115.699 -0.682 . . . . 1.0 111.796 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.617 HD22 ' HB3' ' A' ' 25' ' ' PHE . 10.6 mt -54.54 -40.94 86.77 Favored Pre-proline 0 C--N 1.329 -0.305 0 N-CA-C 112.795 0.665 . . . . 1.0 112.795 -178.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.725 ' HA ' ' CD2' ' A' ' 150' ' ' HIS . 69.7 Cg_endo -69.07 -7.27 20.39 Favored 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 122.279 1.986 . . . . 1.0 112.182 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.587 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -108.09 -32.5 3.25 Favored Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 109.903 -1.279 . . . . 1.0 109.903 177.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.556 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -76.49 -53.33 8.25 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.689 -0.756 . . . . 1.0 109.91 -179.334 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . 0.725 ' CD2' ' HA ' ' A' ' 147' ' ' PRO . 3.7 p80 -56.28 -45.38 80.18 Favored 'General case' 0 C--O 1.216 -0.67 0 CA-C-O 121.469 0.652 . . . . 1.0 110.682 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.407 ' N ' ' CG ' ' A' ' 150' ' ' HIS . 25.9 t70 -57.31 -42.79 82.48 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 114.458 -1.246 . . . . 1.0 110.279 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . 0.756 ' HZ3' HD11 ' A' ' 5' ' ' LEU . 18.1 t90 -62.45 -55.47 27.34 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 114.993 -1.003 . . . . 1.0 110.072 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.535 HG11 HG21 ' A' ' 7' ' ' VAL . 4.0 m -61.95 -40.28 86.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.453 -0.34 . . . . 1.0 110.143 -179.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.503 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 67.1 m-20 -59.47 -54.89 41.43 Favored 'General case' 0 C--N 1.338 0.105 0 CA-C-O 121.405 0.621 . . . . 1.0 110.287 178.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.506 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 5.5 pt-20 -60.4 -35.76 76.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.278 -0.874 . . . . 1.0 110.571 -178.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.403 ' HG3' ' CH2' ' A' ' 152' ' ' TRP . 10.3 mmt180 -74.79 -43.69 53.42 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 115.831 -0.622 . . . . 1.0 111.187 -178.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 4.4 pp . . . . . 0 N--CA 1.464 0.264 0 CA-C-O 121.498 0.666 . . . . 1.0 109.73 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.493 ' HG2' ' HG2' ' A' ' 39' ' ' ARG . 37.3 Cg_endo . . . . . 0 C--O 1.233 0.245 0 N-CA-C 113.601 0.577 . . . . 1.0 113.601 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.813 ' HB3' HG23 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -66.56 177.61 1.51 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.472 -0.786 . . . . 1.0 109.432 177.868 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.743 ' H ' HD13 ' A' ' 5' ' ' LEU . 1.7 t-160 -156.0 90.57 1.22 Allowed 'General case' 0 C--N 1.321 -0.631 0 O-C-N 122.161 -0.337 . . . . 1.0 110.695 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.859 HG13 HD13 ' A' ' 85' ' ' LEU . 2.1 t -96.29 102.88 14.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.031 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.633 ' CG2' HD23 ' A' ' 86' ' ' LEU . 9.6 t -105.8 114.71 29.02 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 121.029 0.442 . . . . 1.0 111.143 -178.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.545 ' HD1' ' HB ' ' A' ' 87' ' ' VAL . 1.1 m-85 -83.42 131.15 35.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.834 0.35 . . . . 1.0 110.361 -179.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.689 HG21 HD11 ' A' ' 97' ' ' LEU . 37.3 t -117.59 113.68 43.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.07 -0.514 . . . . 1.0 111.848 -176.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.537 ' HA ' ' CE1' ' A' ' 93' ' ' HIS . 41.8 t -142.7 163.06 33.84 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.048 -0.723 . . . . 1.0 109.048 177.064 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.79 90.89 4.07 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.357 0.599 . . . . 1.0 110.94 -178.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.833 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 136.65 -44.0 1.19 Allowed Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.453 -0.794 . . . . 1.0 111.442 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.678 ' ND2' ' H ' ' A' ' 74' ' ' ALA . 59.3 t30 61.57 22.88 13.27 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.843 0.83 . . . . 1.0 111.998 177.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.9 pt -127.41 4.44 3.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 O-C-N 121.63 -0.669 . . . . 1.0 110.956 179.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.756 ' O ' ' HG3' ' A' ' 20' ' ' MET . 5.3 p -121.6 -87.77 0.63 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.91 -0.587 . . . . 1.0 112.429 -177.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.782 HH11 HG21 ' A' ' 138' ' ' VAL . 8.5 mmt180 -71.63 -44.89 63.55 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.297 -0.41 . . . . 1.0 111.52 -174.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.451 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 19.2 m -55.72 -56.18 32.75 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-N 116.163 -0.471 . . . . 1.0 112.192 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.547 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 55.6 Cg_endo -67.01 -19.07 52.14 Favored 'Trans proline' 0 C--N 1.357 1.026 0 C-N-CA 121.633 1.555 . . . . 1.0 112.245 -178.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.756 ' HG3' ' O ' ' A' ' 16' ' ' CYS . 61.3 mtp -62.7 -55.0 30.75 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 120.336 -0.545 . . . . 1.0 109.907 176.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.424 ' HA ' ' HB2' ' A' ' 24' ' ' MET . . . -71.73 -27.9 63.31 Favored 'General case' 0 CA--C 1.512 -0.505 0 C-N-CA 120.37 -0.532 . . . . 1.0 110.617 -179.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.672 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 13.2 tt0 -51.15 -54.08 28.55 Favored 'General case' 0 C--O 1.217 -0.626 0 O-C-N 124.334 1.021 . . . . 1.0 109.73 179.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.925 ' HB3' ' HG2' ' A' ' 68' ' ' PRO . 0.4 OUTLIER -81.7 -27.16 34.09 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.239 -0.891 . . . . 1.0 110.311 -176.093 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.7 ' HB3' HD11 ' A' ' 146' ' ' LEU . 6.0 mmm -62.4 -76.76 0.06 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.811 0.671 . . . . 1.0 112.811 -176.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.701 ' HB3' HD22 ' A' ' 146' ' ' LEU . 18.2 p90 -78.2 -28.58 48.08 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 119.945 -0.702 . . . . 1.0 111.051 -174.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.672 ' HB3' ' O ' ' A' ' 22' ' ' GLU . . . -65.18 -38.02 89.18 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 119.208 -0.997 . . . . 1.0 110.922 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.699 ' HA ' ' HD3' ' A' ' 30' ' ' ARG . 0.1 OUTLIER -63.2 -37.7 88.27 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 108.709 -0.849 . . . . 1.0 108.709 177.485 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.593 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 74.9 mt-30 -60.33 -45.37 93.66 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.688 -0.687 . . . . 1.0 110.259 175.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.582 ' HG ' ' O ' ' A' ' 25' ' ' PHE . 84.9 mt -54.95 -58.47 7.5 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.887 -0.597 . . . . 1.0 111.09 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.699 ' HD3' ' HA ' ' A' ' 27' ' ' GLN . 0.7 OUTLIER -58.93 -38.1 78.21 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.35 -0.386 . . . . 1.0 111.228 179.597 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -62.7 -26.32 68.61 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.543 0.571 . . . . 1.0 112.543 177.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.593 ' HG2' ' O ' ' A' ' 28' ' ' GLN . 7.0 ptp180 -95.26 -18.96 20.4 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 119.406 -0.917 . . . . 1.0 109.917 178.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 107.44 34.95 2.76 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.345 -0.843 . . . . 1.0 112.305 177.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 21.1 mt -126.41 2.36 6.98 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.924 -0.399 . . . . 1.0 109.924 -178.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -53.54 -31.04 43.56 Favored Glycine 0 CA--C 1.521 0.468 0 CA-C-N 116.014 -0.539 . . . . 1.0 113.262 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.662 ' HA ' ' NH1' ' A' ' 39' ' ' ARG . 15.0 m-20 -92.04 -17.85 24.46 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 122.648 -0.325 . . . . 1.0 110.65 177.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.55 -22.73 43.46 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.163 -0.471 . . . . 1.0 111.139 -177.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.813 HG23 ' HB3' ' A' ' 5' ' ' LEU . 0.3 OUTLIER -144.32 123.92 7.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.186 0.517 . . . . 1.0 110.922 -179.749 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.682 ' O ' ' HA ' ' A' ' 6' ' ' HIS . 15.0 mmt180 -95.33 104.82 16.72 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 115.698 -0.683 . . . . 1.0 111.153 -177.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.652 HG11 ' HB2' ' A' ' 26' ' ' ALA . 1.5 m -87.99 137.1 21.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 108.231 -1.026 . . . . 1.0 108.231 176.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.502 ' O ' ' HA ' ' A' ' 8' ' ' THR . 21.5 p -146.76 -177.75 5.82 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.354 -0.839 . . . . 1.0 109.819 -175.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.475 ' OG ' ' HE1' ' A' ' 71' ' ' HIS . 67.1 p -157.14 156.73 33.21 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 120.388 -0.525 . . . . 1.0 111.035 -177.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.534 ' O ' ' HA ' ' A' ' 10' ' ' VAL . . . -161.65 160.68 29.02 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 121.225 0.536 . . . . 1.0 111.061 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.427 ' HA2' ' O ' ' A' ' 11' ' ' CYS . . . -123.08 133.77 9.19 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 111.351 -0.7 . . . . 1.0 111.351 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.479 HG21 HD12 ' A' ' 96' ' ' LEU . 21.1 p -69.17 -22.57 63.91 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 111.931 0.345 . . . . 1.0 111.931 -177.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -110.46 7.1 30.2 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.866 -0.683 . . . . 1.0 113.111 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 42.87 35.98 0.81 Allowed 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 113.87 1.063 . . . . 1.0 113.87 178.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.833 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 1.0 OUTLIER -44.95 -70.29 0.11 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.422 0.629 . . . . 1.0 112.487 -178.315 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.475 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 24.3 m-70 -110.58 44.08 1.31 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.317 -0.856 . . . . 1.0 111.244 179.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.469 HG23 ' HA ' ' A' ' 74' ' ' ALA . 12.0 p -61.56 129.17 24.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.772 -0.455 . . . . 1.0 109.772 177.055 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.597 ' HA2' ' HD3' ' A' ' 72' ' ' ARG . . . 92.58 -12.15 70.43 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.977 -0.63 . . . . 1.0 111.838 -177.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.495 ' O ' ' HA ' ' A' ' 72' ' ' ARG . 2.4 t -81.45 -158.56 0.22 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.357 0.598 . . . . 1.0 109.97 179.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 36.8 t -134.18 170.52 15.56 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 108.719 -0.845 . . . . 1.0 108.719 -178.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.54 140.77 27.39 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.193 0.52 . . . . 1.0 111.816 -178.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -59.35 137.37 58.01 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 114.432 -1.258 . . . . 1.0 110.43 -178.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -51.33 -29.15 14.27 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.315 -0.857 . . . . 1.0 113.109 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.457 ' O ' HG23 ' A' ' 61' ' ' VAL . 30.9 mtt180 -69.63 -50.96 39.27 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.136 0.494 . . . . 1.0 110.267 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.407 ' O ' ' HG ' ' A' ' 62' ' ' LEU . . . -69.43 -29.32 67.0 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.18 -0.918 . . . . 1.0 110.533 -177.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.27 -44.63 96.92 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.86 -0.609 . . . . 1.0 109.514 176.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.19 -39.67 96.27 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.715 -0.755 . . . . 1.0 111.667 178.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.487 ' O ' ' HD2' ' A' ' 65' ' ' HIS . 78.7 t -60.81 -56.28 18.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 CA-C-O 121.188 0.518 . . . . 1.0 110.957 178.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.788 HD13 ' HG3' ' A' ' 23' ' ' LYS . 70.5 mt -61.04 -50.95 71.24 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.936 -0.574 . . . . 1.0 111.366 -178.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -60.07 -28.24 67.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.419 -0.355 . . . . 1.0 110.675 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.65 -35.67 79.31 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 120.977 0.417 . . . . 1.0 110.818 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.487 ' HD2' ' O ' ' A' ' 61' ' ' VAL . 88.8 m-70 -96.64 4.05 52.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.871 -0.604 . . . . 1.0 111.329 -177.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 90.21 14.99 58.16 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 121.086 -0.578 . . . . 1.0 112.632 177.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.508 ' HD1' ' HG2' ' A' ' 27' ' ' GLN . 69.7 m-85 -89.9 151.05 44.87 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-O 120.44 0.162 . . . . 1.0 110.985 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.925 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 55.3 Cg_endo -68.9 160.58 49.22 Favored 'Trans proline' 0 CA--C 1.511 -0.67 0 C-N-CA 122.571 2.18 . . . . 1.0 110.125 175.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.709 HG22 ' HB2' ' A' ' 62' ' ' LEU . 47.5 p -135.62 -0.43 2.63 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 119.589 -0.844 . . . . 1.0 112.161 -177.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.49 ' O ' ' HE2' ' A' ' 23' ' ' LYS . 48.4 t0 -71.94 134.84 46.22 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.293 -0.632 . . . . 1.0 109.293 -179.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.659 ' HB2' ' HE2' ' A' ' 23' ' ' LYS . 32.7 t60 -169.05 154.81 6.28 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.971 0.415 . . . . 1.0 110.379 -174.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.597 ' HD3' ' HA2' ' A' ' 51' ' ' GLY . 5.0 tmm_? -136.4 108.37 7.15 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 107.468 -1.308 . . . . 1.0 107.468 176.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 49' ' ' HIS . . . -58.67 139.99 55.27 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.823 -1.081 . . . . 1.0 112.048 -175.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.678 ' H ' ' ND2' ' A' ' 14' ' ' ASN . . . -130.01 161.54 30.73 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.645 -0.707 . . . . 1.0 109.93 177.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -96.77 159.9 14.67 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.205 -0.665 . . . . 1.0 109.205 179.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.424 HG11 HD23 ' A' ' 97' ' ' LEU . 61.7 t -70.18 110.2 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.158 0.504 . . . . 1.0 110.316 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.575 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -123.95 -170.58 13.34 Favored Glycine 0 N--CA 1.441 -1.006 0 CA-C-N 115.397 -0.819 . . . . 1.0 111.564 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 43.3 m -58.63 -51.71 68.75 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.873 0.368 . . . . 1.0 111.647 -178.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.522 ' HG2' ' N ' ' A' ' 80' ' ' HIS . 0.7 OUTLIER -54.46 -32.74 58.27 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.563 -0.744 . . . . 1.0 111.007 179.789 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.53 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 79.4 m80 -76.87 -40.61 47.0 Favored 'General case' 0 C--O 1.223 -0.321 0 N-CA-C 109.659 -0.497 . . . . 1.0 109.659 178.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.575 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 54.4 mt -65.75 -18.4 65.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.248 0.547 . . . . 1.0 110.539 178.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.39 -4.04 59.03 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.872 -0.604 . . . . 1.0 110.697 -178.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.569 ' HB1' ' O ' ' A' ' 6' ' ' HIS . . . -64.13 149.33 47.93 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.807 -0.633 . . . . 1.0 111.4 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.563 ' HB3' HD13 ' A' ' 5' ' ' LEU . 24.7 t70 -73.23 -14.4 61.33 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.07 0.462 . . . . 1.0 109.871 178.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.859 HD13 HG13 ' A' ' 7' ' ' VAL . 0.9 OUTLIER -154.08 120.94 5.59 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.597 -0.729 . . . . 1.0 110.504 -177.735 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 1.037 HD11 HG11 ' A' ' 102' ' ' VAL . 0.3 OUTLIER -105.99 104.33 14.02 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.747 -0.835 . . . . 1.0 108.747 175.158 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.571 HG23 HD22 ' A' ' 85' ' ' LEU . 54.5 t -83.73 92.18 2.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 121.493 0.663 . . . . 1.0 110.551 -178.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.21 146.78 30.3 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.195 -0.912 . . . . 1.0 111.231 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.467 HD23 ' HB2' ' A' ' 11' ' ' CYS . 4.2 mm? -98.18 -13.68 20.76 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 115.689 -0.687 . . . . 1.0 109.741 178.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -139.44 153.55 47.59 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.496 -0.774 . . . . 1.0 109.961 -177.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -62.78 -20.38 64.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.36 0.6 . . . . 1.0 109.819 176.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.632 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 95.1 m-20 -76.49 -51.93 10.78 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.935 -1.029 . . . . 1.0 110.319 -178.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.537 ' CE1' ' HA ' ' A' ' 11' ' ' CYS . 19.0 m170 -58.3 -44.14 88.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.792 -0.64 . . . . 1.0 110.277 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.549 ' HA ' HD12 ' A' ' 97' ' ' LEU . . . -60.54 -42.77 97.19 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.026 0.441 . . . . 1.0 110.473 178.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 5.0 ttp-105 -58.59 -45.56 88.82 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 115.438 -0.801 . . . . 1.0 111.16 178.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.736 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 45.6 mt -63.69 -50.28 69.81 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.343 -176.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.689 HD11 HG21 ' A' ' 10' ' ' VAL . 14.0 mt -52.76 -58.52 6.61 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.936 -0.575 . . . . 1.0 111.835 -177.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 13.0 ptt180 -60.68 -44.8 96.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.281 -0.418 . . . . 1.0 111.922 -176.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.47 ' HG3' ' O ' ' A' ' 96' ' ' LEU . 1.2 pt20 -69.0 -20.18 64.15 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 121.01 0.433 . . . . 1.0 110.595 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.736 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 6.2 mt -79.22 -9.02 59.47 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.622 -0.717 . . . . 1.0 111.798 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 150.96 -32.89 0.96 Allowed Glycine 0 CA--C 1.505 -0.57 0 C-N-CA 119.842 -1.171 . . . . 1.0 113.352 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 1.037 HG11 HD11 ' A' ' 86' ' ' LEU . 0.8 OUTLIER -76.79 -151.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 121.716 0.769 . . . . 1.0 112.056 -176.697 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.639 ' H ' HG12 ' A' ' 102' ' ' VAL . 12.8 pt-20 -162.9 167.42 22.7 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.189 -0.914 . . . . 1.0 108.733 -178.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.763 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -67.23 -22.32 65.7 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.179 -0.464 . . . . 1.0 112.132 -174.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.24 -36.59 73.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.12 0.486 . . . . 1.0 110.687 176.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.591 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 1.0 OUTLIER -96.86 -40.36 8.96 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.207 -0.906 . . . . 1.0 110.805 -177.615 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.763 HG12 ' HA ' ' A' ' 104' ' ' ALA . 13.4 p -79.76 115.2 21.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.574 0.702 . . . . 1.0 110.352 -179.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.527 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 20.5 mmm180 -133.3 145.08 50.12 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.889 -0.596 . . . . 1.0 109.658 -177.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 84.6 mmm -77.52 137.52 38.67 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.947 -0.57 . . . . 1.0 110.543 -179.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.55 HD11 ' HA ' ' A' ' 142' ' ' ILE . 3.1 tm? -55.27 -49.81 71.11 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.802 0.334 . . . . 1.0 110.567 179.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.482 HH11 ' HG2' ' A' ' 111' ' ' ARG . 11.8 ttt-85 -72.94 -12.87 61.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.321 -0.4 . . . . 1.0 111.419 -176.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 33.3 t -78.81 -8.97 59.28 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 121.15 -0.22 . . . . 1.0 110.855 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.627 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 82.6 m-85 -86.46 -18.27 32.11 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-O 120.975 0.417 . . . . 1.0 110.341 177.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.8 t0 . . . . . 0 C--N 1.327 -0.41 0 CA-C-N 115.33 -0.85 . . . . 1.0 111.046 -179.44 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.437 ' HA ' ' HB3' ' A' ' 139' ' ' PHE . 36.7 mt-10 . . . . . 0 N--CA 1.452 -0.345 0 CA-C-O 120.857 0.361 . . . . 1.0 110.382 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.528 ' O ' HG23 ' A' ' 141' ' ' VAL . 32.7 tt0 -63.22 -50.22 71.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.029 -0.532 . . . . 1.0 109.878 178.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.782 HG21 HH11 ' A' ' 17' ' ' ARG . 53.4 t -62.74 -40.16 87.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.663 -0.699 . . . . 1.0 109.857 175.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.548 ' HB2' ' HE1' ' A' ' 20' ' ' MET . 18.3 t80 -54.5 -41.77 69.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.113 -0.949 . . . . 1.0 109.172 175.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.575 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -65.63 -42.37 91.6 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.604 -0.725 . . . . 1.0 110.544 176.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.661 HG23 ' HA ' ' A' ' 138' ' ' VAL . 13.8 t -54.15 -52.11 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-O 121.863 0.84 . . . . 1.0 109.715 177.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.55 ' HA ' HD11 ' A' ' 110' ' ' LEU . 7.2 mt -65.29 -51.32 66.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 114.597 -1.183 . . . . 1.0 112.084 -178.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.575 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 8.4 pt-20 -55.29 -34.37 64.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.825 0.345 . . . . 1.0 110.479 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 67.1 m -72.24 -28.96 63.48 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.738 -0.664 . . . . 1.0 110.743 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.458 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -88.48 -22.77 23.48 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.776 -0.647 . . . . 1.0 112.08 179.253 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.701 HD22 ' HB3' ' A' ' 25' ' ' PHE . 12.0 mt -55.65 -37.74 60.3 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 112.266 0.469 . . . . 1.0 112.266 -178.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.623 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 60.3 Cg_endo -70.53 -10.31 27.67 Favored 'Trans proline' 0 C--N 1.361 1.204 0 C-N-CA 122.493 2.129 . . . . 1.0 111.832 177.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.627 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -104.67 -32.41 4.18 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 110.572 -1.011 . . . . 1.0 110.572 178.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.459 ' O ' HG13 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -75.63 -41.89 53.03 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.687 -0.857 . . . . 1.0 108.687 179.474 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . 0.432 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 0.5 OUTLIER -54.08 -56.85 14.18 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 114.791 -1.095 . . . . 1.0 110.736 176.787 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -58.55 -40.64 83.58 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.226 -0.897 . . . . 1.0 111.504 -175.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . 0.747 ' HZ3' HD11 ' A' ' 5' ' ' LEU . 31.0 t90 -63.22 -55.23 26.75 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.624 -0.716 . . . . 1.0 110.615 -179.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.474 HG11 HG21 ' A' ' 7' ' ' VAL . 7.2 m -61.65 -40.38 86.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 120.723 -0.391 . . . . 1.0 110.598 -178.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.435 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 13.3 m-20 -59.69 -52.0 67.4 Favored 'General case' 0 CA--C 1.523 -0.084 0 CA-C-O 120.994 0.426 . . . . 1.0 110.721 178.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.59 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 6.2 pt-20 -61.86 -38.84 89.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.586 -0.734 . . . . 1.0 110.296 -178.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.515 ' HG3' ' CH2' ' A' ' 152' ' ' TRP . 20.4 mmt180 -72.11 -46.62 55.97 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.805 -0.634 . . . . 1.0 111.057 -177.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 4.1 pp . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 121.337 0.589 . . . . 1.0 109.591 -179.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.489 ' HB2' ' HG2' ' A' ' 39' ' ' ARG . 35.1 Cg_endo . . . . . 0 C--O 1.235 0.327 0 N-CA-C 113.836 0.668 . . . . 1.0 113.836 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.77 ' HB3' HG23 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -66.17 178.42 1.16 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.75 -1.114 . . . . 1.0 109.319 177.547 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.704 ' H ' HD13 ' A' ' 5' ' ' LEU . 4.0 t-160 -156.8 98.23 1.76 Allowed 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.503 -0.555 . . . . 1.0 109.503 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.775 HG13 HD13 ' A' ' 85' ' ' LEU . 2.1 t -103.18 117.97 49.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 N-CA-C 107.722 -1.214 . . . . 1.0 107.722 177.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.592 HG22 ' HG ' ' A' ' 86' ' ' LEU . 8.3 t -118.54 114.38 22.73 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 120.931 0.396 . . . . 1.0 110.204 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.591 ' HD2' ' HB3' ' A' ' 42' ' ' SER . 2.2 m-85 -82.89 126.07 32.06 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.076 0.465 . . . . 1.0 110.215 -178.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.665 HG21 HD11 ' A' ' 97' ' ' LEU . 35.4 t -110.23 112.01 38.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 CA-C-N 115.74 -0.664 . . . . 1.0 111.631 -176.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.639 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 37.7 t -139.91 161.28 37.96 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.149 -1.056 . . . . 1.0 108.149 177.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -66.24 -39.89 89.86 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.217 0.532 . . . . 1.0 109.812 179.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.588 ' C ' ' H ' ' A' ' 15' ' ' ILE . . . -104.17 80.4 0.32 Allowed Glycine 0 N--CA 1.435 -1.432 0 CA-C-N 115.187 -0.915 . . . . 1.0 110.856 175.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.628 ' ND2' ' HB1' ' A' ' 73' ' ' ALA . 15.9 p-10 -59.5 17.72 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.74 1.616 . . . . 1.0 112.418 176.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.588 ' H ' ' C ' ' A' ' 13' ' ' GLY . 6.7 pt -121.59 -0.81 7.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.177 178.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 22.1 m -116.16 -87.09 0.61 Allowed 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.215 0.45 . . . . 1.0 112.215 -177.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.587 HH21 ' HB3' ' A' ' 89' ' ' LEU . 13.0 mtm-85 -72.38 -46.96 53.02 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 112.391 0.515 . . . . 1.0 112.391 -173.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.76 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 26.4 m -54.46 -58.72 12.71 Favored Pre-proline 0 CA--C 1.537 0.446 0 CA-C-N 116.306 -0.406 . . . . 1.0 111.333 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.451 ' HA ' ' HB2' ' A' ' 22' ' ' GLU . 39.3 Cg_endo -63.56 -22.9 70.66 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 121.763 1.642 . . . . 1.0 113.345 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.698 ' HB3' HD13 ' A' ' 142' ' ' ILE . 35.6 mmm -60.97 -53.62 55.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.635 0.255 . . . . 1.0 110.846 178.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.92 -25.63 60.09 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.168 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.632 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 17.9 tt0 -51.92 -54.09 33.47 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 114.761 -1.109 . . . . 1.0 109.819 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.647 ' O ' ' HB3' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -83.51 -26.99 29.7 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.378 -0.828 . . . . 1.0 110.838 -175.753 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.599 ' HB3' HD11 ' A' ' 146' ' ' LEU . 5.6 mmm -60.85 -75.61 0.06 Allowed 'General case' 0 C--O 1.239 0.542 0 CA-C-O 121.453 0.644 . . . . 1.0 112.504 -178.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.677 ' CE2' HD23 ' A' ' 149' ' ' LEU . 22.3 p90 -79.37 -28.83 41.94 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.088 -0.645 . . . . 1.0 111.674 -174.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.632 ' HB3' ' O ' ' A' ' 22' ' ' GLU . . . -64.8 -36.2 83.56 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 119.082 -1.047 . . . . 1.0 110.739 178.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.647 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -63.73 -38.56 91.55 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.666 -0.864 . . . . 1.0 108.666 176.595 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.673 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 78.7 mt-30 -59.24 -44.56 92.35 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 115.608 -0.724 . . . . 1.0 110.499 175.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 25' ' ' PHE . 90.0 mt -54.26 -59.62 4.43 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.887 -0.597 . . . . 1.0 111.239 -179.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.531 ' HD3' ' HA ' ' A' ' 27' ' ' GLN . 1.5 ptm180 -59.31 -34.55 72.45 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.714 -0.394 . . . . 1.0 111.155 178.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -62.27 -28.96 70.08 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.315 0.487 . . . . 1.0 112.315 177.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.673 ' HG2' ' O ' ' A' ' 28' ' ' GLN . 4.8 ptp180 -94.16 -16.0 24.12 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 119.915 -0.714 . . . . 1.0 110.429 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 102.72 38.75 2.89 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.403 -0.817 . . . . 1.0 111.48 177.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 27.3 mt -132.72 1.51 3.66 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 110.088 -0.338 . . . . 1.0 110.088 -178.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.462 ' H ' ' HA ' ' A' ' 30' ' ' ARG . . . -57.6 -27.29 58.48 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 121.05 -0.595 . . . . 1.0 112.343 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -82.55 -31.27 29.17 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.964 0.411 . . . . 1.0 109.928 177.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -78.94 -16.86 56.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.201 -0.909 . . . . 1.0 112.318 -174.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.77 HG23 ' HB3' ' A' ' 5' ' ' LEU . 0.3 OUTLIER -143.86 126.59 11.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 121.877 -0.515 . . . . 1.0 111.241 -179.998 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.489 ' HG2' ' HB2' ' A' ' 4' ' ' PRO . 7.7 mmt180 -90.46 132.62 35.55 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 108.636 -0.875 . . . . 1.0 108.636 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 68.3 t -124.9 119.41 55.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.264 -0.643 . . . . 1.0 109.264 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.436 ' O ' ' HA ' ' A' ' 8' ' ' THR . 78.0 p -132.49 -175.16 3.66 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.47 -1.241 . . . . 1.0 110.979 -174.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.76 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 87.8 p -158.58 163.39 37.04 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.682 -0.488 . . . . 1.0 109.682 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.54 ' HB2' ' CD2' ' A' ' 80' ' ' HIS . . . -164.93 168.78 17.23 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 121.219 0.533 . . . . 1.0 111.571 -178.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.639 ' HA2' ' O ' ' A' ' 11' ' ' CYS . . . -127.53 132.56 7.55 Favored Glycine 0 N--CA 1.438 -1.174 0 CA-C-N 115.078 -0.965 . . . . 1.0 111.462 178.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.499 HG23 ' CG1' ' A' ' 10' ' ' VAL . 26.9 p -69.47 -23.41 63.64 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.887 0.375 . . . . 1.0 111.325 -178.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.429 ' HA3' ' HZ3' ' A' ' 48' ' ' TRP . . . -112.92 9.1 25.41 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.858 -0.686 . . . . 1.0 112.304 -178.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.494 ' HB3' ' HB2' ' A' ' 75' ' ' GLN . 2.7 p-10 43.64 39.11 2.23 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.991 0.916 . . . . 1.0 113.41 177.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.429 ' HZ3' ' HA3' ' A' ' 46' ' ' GLY . 1.2 m-90 -42.8 -72.54 0.06 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.294 0.568 . . . . 1.0 112.386 -178.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.418 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 75.9 m-70 -112.23 45.72 1.25 Allowed 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.283 -0.872 . . . . 1.0 111.243 178.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.446 HG23 ' HA ' ' A' ' 74' ' ' ALA . 11.6 p -61.78 129.93 25.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.622 -0.717 . . . . 1.0 110.135 177.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.607 ' HA2' ' HD3' ' A' ' 72' ' ' ARG . . . 93.66 -15.31 63.34 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.889 -0.672 . . . . 1.0 112.081 -177.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.4 t -80.06 -161.16 0.33 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.379 0.609 . . . . 1.0 109.914 179.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 35.5 t -127.98 170.62 12.66 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 115.288 -0.869 . . . . 1.0 108.932 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -52.06 136.13 29.99 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 123.338 0.398 . . . . 1.0 111.414 -178.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.698 ' OD1' ' HG2' ' A' ' 57' ' ' ARG . 12.5 t70 -57.17 140.27 50.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.389 -0.823 . . . . 1.0 111.309 -178.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -45.78 -37.93 6.57 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.99 -1.004 . . . . 1.0 113.519 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.698 ' HG2' ' OD1' ' A' ' 55' ' ' ASP . 15.3 ptp180 -70.12 -44.52 68.77 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 120.522 -0.471 . . . . 1.0 110.914 -177.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.24 -30.91 66.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.035 0.445 . . . . 1.0 110.384 -178.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.02 -45.82 90.54 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.082 177.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.2 -36.87 94.01 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.937 -0.649 . . . . 1.0 111.773 177.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 57' ' ' ARG . 86.9 t -62.06 -59.04 4.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.23 0.538 . . . . 1.0 110.851 178.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.682 ' HB2' HG22 ' A' ' 69' ' ' THR . 96.8 mt -60.16 -50.12 74.95 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.836 -0.62 . . . . 1.0 111.363 -177.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 -59.25 -30.62 68.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.47 -0.332 . . . . 1.0 111.061 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.28 -33.24 73.99 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 121.124 0.488 . . . . 1.0 111.136 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -97.59 5.34 49.61 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.859 -0.61 . . . . 1.0 111.437 -178.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.48 13.44 63.32 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.899 -0.667 . . . . 1.0 112.837 177.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -91.13 148.95 39.01 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-O 120.561 0.22 . . . . 1.0 110.944 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.614 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 48.9 Cg_endo -69.95 158.13 57.73 Favored 'Trans proline' 0 CA--C 1.513 -0.563 0 C-N-CA 122.243 1.962 . . . . 1.0 110.841 176.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.682 HG22 ' HB2' ' A' ' 62' ' ' LEU . 53.1 p -131.3 9.09 4.73 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.341 -0.543 . . . . 1.0 110.803 -178.059 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -73.6 123.77 24.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.463 -0.79 . . . . 1.0 109.536 -178.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.48 ' HB2' ' HE2' ' A' ' 23' ' ' LYS . 31.2 t60 -166.07 154.58 11.01 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.973 -175.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.607 ' HD3' ' HA2' ' A' ' 51' ' ' GLY . 2.3 tmm_? -135.8 110.1 8.42 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.048 -1.093 . . . . 1.0 108.048 175.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.628 ' HB1' ' ND2' ' A' ' 14' ' ' ASN . . . -55.7 136.68 50.59 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.621 -1.172 . . . . 1.0 112.527 -175.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.464 ' O ' ' HA ' ' A' ' 43' ' ' ALA . . . -129.45 160.4 33.26 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.822 -0.172 . . . . 1.0 110.743 178.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.494 ' HB2' ' HB3' ' A' ' 47' ' ' ASN . 9.3 tt0 -97.04 153.39 17.95 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.531 -0.914 . . . . 1.0 108.531 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.504 HG11 ' CD2' ' A' ' 97' ' ' LEU . 20.2 t -65.41 109.92 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.424 0.631 . . . . 1.0 110.748 179.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -120.92 -169.67 13.87 Favored Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 115.396 -0.82 . . . . 1.0 111.103 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 53.9 m -58.8 -42.89 90.18 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.52 0.2 . . . . 1.0 110.692 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -57.78 -31.96 67.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.944 0.402 . . . . 1.0 111.303 177.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.54 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 79.3 m80 -79.22 -41.27 28.66 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-N 116.522 -0.308 . . . . 1.0 110.943 -179.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.688 ' HA ' HD21 ' A' ' 86' ' ' LEU . 16.8 mt -67.95 -19.04 64.93 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.914 0.387 . . . . 1.0 110.127 177.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.13 -5.16 59.26 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.849 0.357 . . . . 1.0 110.388 -178.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.497 ' HA ' ' HB3' ' A' ' 6' ' ' HIS . . . -58.2 153.72 14.53 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.822 -0.626 . . . . 1.0 110.782 178.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.757 ' HB3' HD13 ' A' ' 5' ' ' LEU . 12.1 t70 -79.96 -14.57 58.5 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.902 -0.59 . . . . 1.0 109.546 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.775 HD13 HG13 ' A' ' 7' ' ' VAL . 0.4 OUTLIER -155.69 118.31 4.2 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.342 -0.845 . . . . 1.0 108.842 -178.11 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.688 HD21 ' HA ' ' A' ' 81' ' ' LEU . 5.2 mp -107.93 105.55 15.4 Favored 'General case' 0 N--CA 1.425 -1.683 0 CA-C-O 121.305 0.574 . . . . 1.0 109.806 178.273 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.593 ' HA ' ' O ' ' A' ' 108' ' ' ARG . 55.8 t -84.9 92.59 3.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 114.652 -1.158 . . . . 1.0 111.453 -175.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.79 146.56 33.71 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.566 -0.743 . . . . 1.0 110.758 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.587 ' HB3' HH21 ' A' ' 17' ' ' ARG . 3.9 mm? -100.83 -7.57 23.47 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.459 179.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.426 ' CG ' ' H ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -153.97 156.38 37.35 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.994 -0.548 . . . . 1.0 111.282 178.594 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 6.0 ptm85 -55.72 -24.65 35.98 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.479 0.918 . . . . 1.0 113.479 -178.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.655 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 87.8 m-20 -76.79 -51.49 11.27 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 110.186 -0.301 . . . . 1.0 110.186 -178.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.668 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 13.5 m170 -55.27 -46.33 76.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.011 -0.541 . . . . 1.0 110.527 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.85 -43.12 94.83 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.069 0.462 . . . . 1.0 110.713 179.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.682 ' O ' ' HG2' ' A' ' 99' ' ' GLN . 5.9 ttm180 -58.44 -46.49 86.43 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 115.482 -0.781 . . . . 1.0 111.005 177.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.744 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 46.6 mt -62.51 -51.14 68.59 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-N 115.921 -0.581 . . . . 1.0 110.412 -175.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.668 ' HG ' ' O ' ' A' ' 93' ' ' HIS . 40.8 mt -51.22 -58.34 6.42 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.954 -0.566 . . . . 1.0 111.684 -177.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.663 ' CA ' HG12 ' A' ' 102' ' ' VAL . 13.3 ptt180 -58.91 -46.99 86.59 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.015 -0.539 . . . . 1.0 112.258 -179.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.682 ' HG2' ' O ' ' A' ' 95' ' ' ARG . 12.8 pt20 -69.24 -19.39 63.94 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.649 -0.421 . . . . 1.0 110.665 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.744 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 10.8 mt -81.43 -18.96 43.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.969 -0.56 . . . . 1.0 110.963 177.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 153.35 -25.15 0.77 Allowed Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 119.706 -1.235 . . . . 1.0 113.655 -178.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.7 HG13 ' N ' ' A' ' 103' ' ' GLU . 0.4 OUTLIER -76.49 -161.6 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 CA-C-N 117.493 0.646 . . . . 1.0 110.555 -178.44 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.761 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 15.5 pt-20 -159.25 161.89 36.08 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.604 -1.258 . . . . 1.0 107.604 -178.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.772 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -62.84 -24.51 67.82 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.725 0.298 . . . . 1.0 111.406 -175.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.434 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . . . -58.63 -36.05 73.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.01 -0.541 . . . . 1.0 110.171 174.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.761 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 1.6 mtt-85 -98.95 -41.37 7.62 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 115.604 -0.726 . . . . 1.0 111.366 -177.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.772 HG12 ' HA ' ' A' ' 104' ' ' ALA . 10.5 p -80.21 120.25 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-O 120.905 0.383 . . . . 1.0 110.015 -175.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.593 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 31.5 mmm180 -138.86 149.18 44.59 Favored 'General case' 0 C--N 1.318 -0.761 0 O-C-N 121.864 -0.522 . . . . 1.0 110.361 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.596 ' HB2' ' HB2' ' A' ' 112' ' ' SER . 83.3 mmm -78.73 136.21 37.35 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.848 -0.614 . . . . 1.0 110.41 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.524 HD23 HG11 ' A' ' 87' ' ' VAL . 2.8 tm? -53.57 -53.8 46.51 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.494 0.188 . . . . 1.0 110.853 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.524 ' O ' ' HB3' ' A' ' 114' ' ' ASP . 5.8 ttt85 -73.88 -9.92 59.14 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.082 -0.647 . . . . 1.0 111.323 -176.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.596 ' HB2' ' HB2' ' A' ' 109' ' ' MET . 41.5 t -75.5 -6.01 48.05 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.775 -0.454 . . . . 1.0 109.775 178.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.575 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 96.9 m-85 -94.74 -12.7 26.68 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.526 0.679 . . . . 1.0 109.402 175.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.524 ' HB3' ' O ' ' A' ' 111' ' ' ARG . 6.0 t0 . . . . . 0 N--CA 1.466 0.368 0 CA-C-N 114.97 -1.014 . . . . 1.0 111.533 -177.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.517 ' HA ' ' HB3' ' A' ' 139' ' ' PHE . 16.2 mt-10 . . . . . 0 N--CA 1.451 -0.398 0 N-CA-C 111.496 0.184 . . . . 1.0 111.496 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.574 ' O ' HG23 ' A' ' 141' ' ' VAL . 23.4 tp10 -64.42 -47.21 80.0 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 108.54 -0.911 . . . . 1.0 108.54 174.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.642 ' HA ' HG23 ' A' ' 141' ' ' VAL . 95.3 t -61.85 -40.5 87.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.9 -0.591 . . . . 1.0 109.746 176.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.546 ' HB2' HG11 ' A' ' 61' ' ' VAL . 13.5 t80 -52.75 -47.2 67.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.03 -0.986 . . . . 1.0 109.244 174.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.518 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -59.79 -43.06 94.62 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 115.351 -0.841 . . . . 1.0 110.228 177.279 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.642 HG23 ' HA ' ' A' ' 138' ' ' VAL . 8.2 t -54.54 -51.35 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 121.581 0.705 . . . . 1.0 110.505 177.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.698 HD13 ' HB3' ' A' ' 20' ' ' MET . 6.1 mt -66.16 -50.48 68.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 114.99 -1.005 . . . . 1.0 112.07 -178.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.518 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 8.8 pt-20 -56.06 -33.74 65.27 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.926 -0.398 . . . . 1.0 109.926 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . 0.426 ' HB3' ' OD1' ' A' ' 114' ' ' ASP . 70.7 m -72.48 -28.65 63.04 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.758 -0.655 . . . . 1.0 110.514 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.419 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -87.27 -22.37 25.22 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.172 -0.467 . . . . 1.0 111.85 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.646 HD13 ' HB3' ' A' ' 25' ' ' PHE . 12.8 mt -57.44 -37.47 57.24 Favored Pre-proline 0 CA--C 1.546 0.82 0 N-CA-C 112.656 0.613 . . . . 1.0 112.656 -178.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.64 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 48.0 Cg_endo -68.27 -12.07 33.88 Favored 'Trans proline' 0 C--N 1.365 1.44 0 C-N-CA 122.79 2.326 . . . . 1.0 111.665 177.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.575 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -103.88 -34.93 3.61 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 114.903 -1.044 . . . . 1.0 110.927 178.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.677 HD23 ' CE2' ' A' ' 25' ' ' PHE . 13.4 tp -75.77 -41.0 54.29 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.872 -0.788 . . . . 1.0 108.872 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . 0.571 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 0.2 OUTLIER -53.92 -53.37 53.66 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 115.233 -0.894 . . . . 1.0 110.001 174.845 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -57.68 -43.76 85.32 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.871 -1.059 . . . . 1.0 110.679 -176.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . 0.745 ' HZ3' HD11 ' A' ' 5' ' ' LEU . 20.6 t90 -62.26 -55.78 25.0 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.395 -0.821 . . . . 1.0 110.486 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.452 HG11 HG21 ' A' ' 7' ' ' VAL . 12.6 m -62.02 -43.94 98.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 C-N-CA 120.72 -0.392 . . . . 1.0 111.091 -177.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.421 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 2.9 m-20 -59.81 -49.95 75.72 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 121.149 0.499 . . . . 1.0 110.76 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.535 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 7.0 pt-20 -62.81 -39.23 93.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.626 -0.715 . . . . 1.0 110.554 -178.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.571 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 6.3 mmt85 -73.13 -47.35 44.87 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.871 -0.604 . . . . 1.0 111.13 -175.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 4.2 pp . . . . . 0 C--N 1.326 -0.449 0 CA-C-N 115.7 -0.682 . . . . 1.0 109.985 -178.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.569 ' HB2' ' HG2' ' A' ' 39' ' ' ARG . 26.0 Cg_endo . . . . . 0 N--CA 1.458 -0.592 0 N-CA-C 113.58 0.569 . . . . 1.0 113.58 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.813 ' HB3' HG13 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -68.06 179.4 1.53 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.845 -1.07 . . . . 1.0 109.422 176.087 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.597 ' O ' ' HB1' ' A' ' 83' ' ' ALA . 2.3 t-160 -156.07 87.73 1.07 Allowed 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.878 -0.416 . . . . 1.0 109.878 -179.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.818 HG13 HD13 ' A' ' 85' ' ' LEU . 2.2 t -93.12 108.99 21.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 109.4 -0.593 . . . . 1.0 109.4 178.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.679 ' CG2' HD23 ' A' ' 86' ' ' LEU . 10.0 t -110.76 111.44 22.62 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.949 0.404 . . . . 1.0 110.635 179.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.615 ' HD1' ' HB ' ' A' ' 87' ' ' VAL . 1.3 m-85 -82.22 136.71 35.05 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.705 -0.479 . . . . 1.0 109.705 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.674 HG21 HD21 ' A' ' 97' ' ' LEU . 47.8 t -124.57 115.29 44.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.018 0.437 . . . . 1.0 111.461 -177.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.554 ' HB2' HD23 ' A' ' 89' ' ' LEU . 44.7 t -146.52 153.14 40.05 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.957 -0.565 . . . . 1.0 110.091 178.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -71.31 98.45 1.76 Allowed 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.902 -0.407 . . . . 1.0 109.902 178.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 142.68 -40.59 1.25 Allowed Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 110.623 -0.991 . . . . 1.0 110.623 -178.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 1.026 HD22 ' HB1' ' A' ' 73' ' ' ALA . 1.1 p-10 49.37 23.45 0.86 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.601 1.16 . . . . 1.0 113.228 177.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.7 pt -140.83 9.44 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.288 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.478 177.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.482 ' O ' ' HG2' ' A' ' 20' ' ' MET . 5.1 p -122.41 -87.57 0.63 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.719 -0.673 . . . . 1.0 111.782 -176.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.434 HH11 ' HD3' ' A' ' 17' ' ' ARG . 7.3 mmm-85 -67.2 -48.69 67.16 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 121.124 0.488 . . . . 1.0 111.25 -175.32 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.905 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 13.1 m -52.48 -58.28 12.36 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-N 115.063 -0.971 . . . . 1.0 112.396 -179.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.638 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 56.8 Cg_endo -67.06 -23.43 46.29 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 121.842 1.694 . . . . 1.0 112.914 -178.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.581 ' HB3' HD13 ' A' ' 142' ' ' ILE . 51.8 mmm -59.65 -57.11 14.36 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.906 -0.405 . . . . 1.0 109.906 178.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.438 ' HB2' ' CG2' ' A' ' 142' ' ' ILE . . . -73.5 -27.15 61.22 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.57 -0.741 . . . . 1.0 110.645 -179.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.65 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 13.0 tt0 -52.82 -52.84 55.4 Favored 'General case' 0 C--O 1.215 -0.737 0 O-C-N 123.907 0.755 . . . . 1.0 109.946 -179.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.997 ' HE3' ' HB2' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -85.09 -25.81 27.33 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.837 -0.619 . . . . 1.0 110.777 -176.462 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.532 ' HB3' HD11 ' A' ' 146' ' ' LEU . 88.1 mtp -63.33 -74.59 0.09 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.564 0.579 . . . . 1.0 112.564 -177.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.732 ' HB3' HD22 ' A' ' 146' ' ' LEU . 17.2 p90 -76.81 -30.7 56.51 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 119.64 -0.824 . . . . 1.0 111.711 -176.003 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.65 ' HB3' ' O ' ' A' ' 22' ' ' GLU . . . -64.61 -37.51 87.82 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 119.284 -0.966 . . . . 1.0 111.172 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.611 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -63.32 -39.09 93.6 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 108.367 -0.975 . . . . 1.0 108.367 176.461 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.567 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 79.7 mt-30 -59.61 -42.49 92.74 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.562 -0.745 . . . . 1.0 110.172 175.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.646 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 88.8 mt -56.34 -61.13 2.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.947 -0.569 . . . . 1.0 110.719 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.501 ' HB3' ' HA3' ' A' ' 35' ' ' GLY . 0.2 OUTLIER -58.92 -35.78 73.66 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.778 -0.369 . . . . 1.0 111.382 178.642 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 3.1 m170 -63.23 -24.89 68.07 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.26 0.467 . . . . 1.0 112.26 177.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.646 ' HG2' ' O ' ' A' ' 29' ' ' LEU . 5.9 ptm85 -100.05 -20.18 16.16 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.442 0.639 . . . . 1.0 110.299 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 110.98 35.02 2.06 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.196 -0.911 . . . . 1.0 112.277 177.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.472 ' HG ' ' HG3' ' A' ' 32' ' ' ARG . 21.6 mt -128.33 3.89 5.72 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.877 -0.416 . . . . 1.0 109.877 -179.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.501 ' HA3' ' HB3' ' A' ' 30' ' ' ARG . . . -59.17 -31.44 69.2 Favored Glycine 0 C--O 1.229 -0.217 0 CA-C-N 115.777 -0.647 . . . . 1.0 113.383 -178.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.441 ' O ' ' HB3' ' A' ' 4' ' ' PRO . 3.3 t0 -86.98 -26.05 24.0 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 109.072 -0.714 . . . . 1.0 109.072 177.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.11 -20.82 47.72 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 114.558 -1.201 . . . . 1.0 110.795 -175.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.813 HG13 ' HB3' ' A' ' 5' ' ' LEU . 37.9 t -133.1 122.68 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 CA-C-N 116.393 -0.367 . . . . 1.0 110.207 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.569 ' HG2' ' HB2' ' A' ' 4' ' ' PRO . 11.9 mmt180 -89.78 133.32 34.76 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.04 -1.096 . . . . 1.0 108.04 175.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.458 HG11 ' HB2' ' A' ' 26' ' ' ALA . 45.5 t -127.53 115.58 40.5 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-O 121.375 0.607 . . . . 1.0 109.985 -178.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' A' ' 8' ' ' THR . 67.3 p -130.53 -175.51 3.67 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.461 -1.245 . . . . 1.0 110.427 -175.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.905 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 85.4 p -159.86 165.08 32.98 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 110.004 -0.369 . . . . 1.0 110.004 178.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.545 ' O ' ' HA ' ' A' ' 10' ' ' VAL . . . -164.57 166.85 19.92 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 120.944 0.402 . . . . 1.0 110.775 -179.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.443 ' HA3' ' OD1' ' A' ' 14' ' ' ASN . . . -125.96 138.96 11.12 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 111.257 -0.737 . . . . 1.0 111.257 177.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.526 HG21 HD12 ' A' ' 96' ' ' LEU . 21.4 p -72.86 -25.21 61.02 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.722 0.296 . . . . 1.0 111.339 -178.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.465 ' HA3' ' HZ3' ' A' ' 48' ' ' TRP . . . -107.85 9.49 37.28 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.97 -0.633 . . . . 1.0 113.34 -177.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 45.43 36.25 2.32 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 113.719 1.007 . . . . 1.0 113.719 176.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.465 ' HZ3' ' HA3' ' A' ' 46' ' ' GLY . 1.2 m-90 -44.53 -78.82 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.592 0.711 . . . . 1.0 112.376 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.407 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 8.2 m-70 -104.87 41.1 1.38 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.06 -0.973 . . . . 1.0 111.325 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.421 HG23 ' HA ' ' A' ' 74' ' ' ALA . 14.0 p -59.77 128.05 20.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.538 -0.301 . . . . 1.0 110.473 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.73 -13.5 67.35 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 121.071 -0.585 . . . . 1.0 112.202 -178.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.8 t -80.77 -161.79 0.42 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.321 0.582 . . . . 1.0 110.015 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 20.2 t -122.87 176.29 6.08 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.103 -1.073 . . . . 1.0 108.103 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.28 140.54 55.91 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.752 0.31 . . . . 1.0 110.56 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.41 ' OD1' ' HG2' ' A' ' 57' ' ' ARG . 9.8 t70 -59.12 140.2 56.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.86 -0.609 . . . . 1.0 111.079 -176.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -47.56 -37.1 11.61 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.485 -0.779 . . . . 1.0 112.873 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.41 ' HG2' ' OD1' ' A' ' 55' ' ' ASP . 11.5 ptp180 -73.83 -39.52 63.98 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 122.06 -0.4 . . . . 1.0 111.159 -177.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.92 -37.35 72.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.196 0.522 . . . . 1.0 110.06 178.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.41 -41.47 98.73 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.684 -0.689 . . . . 1.0 109.617 177.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.92 -48.09 81.64 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 115.687 -0.688 . . . . 1.0 112.679 178.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 23.6 m -72.17 -37.28 59.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 117.469 0.635 . . . . 1.0 111.614 -178.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.495 ' CD2' ' HG3' ' A' ' 23' ' ' LYS . 1.3 mp -62.05 -54.87 35.38 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.877 -0.329 . . . . 1.0 110.185 178.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -60.31 -32.79 71.55 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.862 -0.608 . . . . 1.0 110.911 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.47 -32.25 72.96 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-O 121.144 0.497 . . . . 1.0 111.192 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -98.11 5.85 48.18 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.961 -0.563 . . . . 1.0 111.515 -178.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 90.71 11.98 61.34 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 115.977 -0.556 . . . . 1.0 113.429 175.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.444 ' HD1' ' HG2' ' A' ' 27' ' ' GLN . 54.7 m-85 -92.67 151.01 40.66 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-O 120.624 0.25 . . . . 1.0 111.157 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.661 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 44.6 Cg_endo -70.22 158.93 54.82 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.19 1.926 . . . . 1.0 110.528 175.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 30.6 p -129.98 8.46 5.22 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.728 0.775 . . . . 1.0 109.823 -177.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -73.0 120.2 18.31 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.661 -1.154 . . . . 1.0 110.076 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.997 ' HB2' ' HE3' ' A' ' 23' ' ' LYS . 31.9 t60 -164.81 150.95 10.31 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.433 -0.349 . . . . 1.0 110.596 -175.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -132.29 111.26 11.22 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 108.489 -0.93 . . . . 1.0 108.489 175.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 1.026 ' HB1' HD22 ' A' ' 14' ' ' ASN . . . -59.47 141.53 54.5 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.211 -0.904 . . . . 1.0 112.606 -175.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.421 ' HA ' HG23 ' A' ' 50' ' ' VAL . . . -134.52 165.73 24.53 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.8 -0.637 . . . . 1.0 109.845 177.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -101.64 160.79 14.15 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.156 -0.683 . . . . 1.0 109.156 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 86.5 t -65.45 106.07 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.073 0.463 . . . . 1.0 110.88 179.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.464 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -120.77 -175.08 15.21 Favored Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 115.588 -0.733 . . . . 1.0 111.772 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 77.2 m -57.09 -49.45 75.82 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 122.742 0.417 . . . . 1.0 111.826 -178.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.444 ' HG2' ' N ' ' A' ' 80' ' ' HIS . 3.2 pm0 -57.33 -31.06 65.32 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.11 0.481 . . . . 1.0 111.062 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.444 ' N ' ' HG2' ' A' ' 79' ' ' GLU . 80.3 m80 -76.07 -41.55 50.21 Favored 'General case' 0 C--O 1.222 -0.356 0 CA-C-N 115.871 -0.604 . . . . 1.0 109.824 178.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 40.8 mt -66.1 -19.77 65.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.848 178.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.75 -6.26 59.14 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.92 -178.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.597 ' HB1' ' O ' ' A' ' 6' ' ' HIS . . . -60.33 148.56 36.53 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.399 -0.819 . . . . 1.0 111.756 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.691 ' HB3' HD13 ' A' ' 5' ' ' LEU . 15.5 t70 -74.46 -13.5 60.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.886 -0.597 . . . . 1.0 109.996 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.818 HD13 HG13 ' A' ' 7' ' ' VAL . 0.9 OUTLIER -154.37 122.76 6.1 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.685 -0.689 . . . . 1.0 110.198 -178.525 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 1.066 HD11 HG11 ' A' ' 102' ' ' VAL . 0.2 OUTLIER -108.15 105.0 14.53 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.904 -0.776 . . . . 1.0 108.904 174.653 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.615 ' HB ' ' HD1' ' A' ' 9' ' ' PHE . 53.7 t -84.31 91.27 2.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.663 0.744 . . . . 1.0 110.803 -178.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.93 147.0 30.49 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.434 -0.803 . . . . 1.0 111.207 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.554 HD23 ' HB2' ' A' ' 11' ' ' CYS . 4.2 mm? -100.79 -5.53 26.17 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.546 -0.752 . . . . 1.0 109.558 178.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -148.04 145.24 28.39 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.068 -0.969 . . . . 1.0 110.277 -178.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -55.6 -26.28 43.03 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.418 0.687 . . . . 1.0 111.191 177.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.685 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 80.3 m-20 -75.21 -49.28 19.89 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.719 -0.673 . . . . 1.0 109.911 -178.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.466 ' HB3' HG12 ' A' ' 10' ' ' VAL . 11.8 m170 -58.19 -43.48 87.56 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 115.808 -0.633 . . . . 1.0 109.369 179.32 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.473 ' HA ' HG21 ' A' ' 107' ' ' VAL . . . -59.67 -47.12 86.88 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.915 -0.584 . . . . 1.0 110.718 178.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 13.2 ttm180 -59.59 -39.53 84.48 Favored 'General case' 0 CA--C 1.521 -0.143 0 CA-C-N 115.792 -0.64 . . . . 1.0 111.405 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.746 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 55.6 mt -66.14 -50.68 63.12 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 116.499 -0.319 . . . . 1.0 110.359 -177.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.674 HD21 HG21 ' A' ' 10' ' ' VAL . 14.2 mt -53.51 -56.35 17.75 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.858 -0.61 . . . . 1.0 111.452 -179.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 13.3 ptt85 -62.46 -43.9 97.7 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.161 -0.472 . . . . 1.0 111.844 -177.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.589 ' HG3' ' O ' ' A' ' 96' ' ' LEU . 0.9 OUTLIER -66.35 -22.22 66.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.378 0.608 . . . . 1.0 110.103 179.536 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.746 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 10.0 mt -77.87 -13.21 59.96 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.348 -0.842 . . . . 1.0 111.761 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 154.62 -33.52 0.69 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.003 -1.094 . . . . 1.0 113.279 -179.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 1.066 HG11 HD11 ' A' ' 86' ' ' LEU . 0.8 OUTLIER -76.36 -152.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.697 0.761 . . . . 1.0 112.221 -176.969 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.636 ' H ' HG12 ' A' ' 102' ' ' VAL . 11.4 pt-20 -164.72 167.32 19.14 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.449 -0.796 . . . . 1.0 109.125 -177.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.808 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -67.18 -23.26 65.74 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.231 -0.441 . . . . 1.0 111.81 -175.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.12 -34.76 70.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.361 0.601 . . . . 1.0 110.578 176.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.544 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 8.0 mtp180 -98.83 -40.93 7.87 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 115.475 -0.784 . . . . 1.0 110.825 -178.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.808 HG12 ' HA ' ' A' ' 104' ' ' ALA . 9.3 p -80.2 121.62 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-O 121.719 0.771 . . . . 1.0 110.721 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.508 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 21.1 mmm180 -138.05 150.07 46.59 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.808 -0.633 . . . . 1.0 110.177 -178.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.586 ' HB2' ' HB2' ' A' ' 112' ' ' SER . 81.7 mmm -78.45 138.86 38.68 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.619 -0.719 . . . . 1.0 109.715 178.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.549 HD23 HG11 ' A' ' 87' ' ' VAL . 3.0 tm? -55.68 -49.03 74.05 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.621 0.248 . . . . 1.0 110.765 179.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 111' ' ' ARG . 18.4 ttt85 -71.46 -14.28 62.09 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.87 0.367 . . . . 1.0 110.662 -178.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.586 ' HB2' ' HB2' ' A' ' 109' ' ' MET . 26.4 t -70.88 -14.02 62.24 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.482 -0.326 . . . . 1.0 110.403 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.56 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 98.7 m-85 -90.39 -15.37 31.14 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 120.95 0.405 . . . . 1.0 110.44 177.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 13.5 t0 . . . . . 0 C--N 1.327 -0.382 0 CA-C-N 115.785 -0.643 . . . . 1.0 111.206 -177.045 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 . . . . . 0 N--CA 1.456 -0.168 0 CA-C-O 120.56 0.219 . . . . 1.0 111.34 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.575 ' O ' HG23 ' A' ' 141' ' ' VAL . 11.1 tp10 -63.6 -48.37 77.64 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.588 -0.893 . . . . 1.0 108.588 175.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.663 ' HA ' HG23 ' A' ' 141' ' ' VAL . 54.6 t -60.85 -41.43 88.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.095 -0.957 . . . . 1.0 109.941 176.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -53.55 -42.17 67.23 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.912 -1.04 . . . . 1.0 109.203 176.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.76 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -66.95 -40.21 87.48 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.278 -0.874 . . . . 1.0 110.635 177.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.663 HG23 ' HA ' ' A' ' 138' ' ' VAL . 10.7 t -55.58 -49.96 70.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.65 0.738 . . . . 1.0 110.167 178.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.581 HD13 ' HB3' ' A' ' 20' ' ' MET . 6.2 mt -67.78 -49.79 66.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 114.996 -1.002 . . . . 1.0 111.825 -178.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.76 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 5.3 pt-20 -57.49 -28.3 63.3 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.905 0.383 . . . . 1.0 110.062 178.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.9 t -75.11 -28.19 60.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.06 177.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.469 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -86.52 -23.71 25.79 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-N 116.246 -0.434 . . . . 1.0 111.644 178.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.732 HD22 ' HB3' ' A' ' 25' ' ' PHE . 14.2 mt -56.83 -35.93 40.97 Favored Pre-proline 0 CA--C 1.546 0.798 0 CA-C-O 118.943 -0.551 . . . . 1.0 112.452 -178.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.635 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 37.6 Cg_endo -67.63 -12.75 36.66 Favored 'Trans proline' 0 C--N 1.365 1.402 0 C-N-CA 122.543 2.162 . . . . 1.0 111.494 177.028 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.56 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -104.52 -34.12 3.68 Favored Glycine 0 N--CA 1.44 -1.065 0 CA-C-N 114.995 -1.002 . . . . 1.0 110.611 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.558 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.4 OUTLIER -75.24 -40.9 58.53 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 108.9 -0.778 . . . . 1.0 108.9 179.318 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . 0.434 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 1.1 m-70 -54.33 -52.87 60.17 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.187 -0.915 . . . . 1.0 110.244 175.137 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -60.01 -44.1 94.78 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.67 -0.695 . . . . 1.0 110.946 -176.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . 0.775 ' HZ3' HD11 ' A' ' 5' ' ' LEU . 26.4 t90 -60.56 -55.23 35.88 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.491 -0.777 . . . . 1.0 110.697 -178.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.411 HG13 ' O ' ' A' ' 149' ' ' LEU . 11.7 m -60.67 -39.71 82.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 121.071 -0.252 . . . . 1.0 110.772 -178.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.537 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 4.6 m-20 -59.49 -54.9 41.23 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.271 0.558 . . . . 1.0 110.975 178.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 6.6 pt-20 -62.28 -33.95 75.64 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.506 -0.77 . . . . 1.0 110.465 -178.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.574 ' HG3' ' CH2' ' A' ' 152' ' ' TRP . 18.5 mmt-85 -74.38 -42.6 59.03 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.759 -0.655 . . . . 1.0 111.711 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 4.5 pp . . . . . 0 C--N 1.323 -0.552 0 N-CA-C 109.505 -0.554 . . . . 1.0 109.505 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.459 ' HB2' ' HG2' ' A' ' 39' ' ' ARG . 36.4 Cg_endo . . . . . 0 C--O 1.233 0.272 0 CA-C-O 121.396 0.498 . . . . 1.0 112.939 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.785 ' HB3' HG23 ' A' ' 38' ' ' VAL . 0.6 OUTLIER -70.99 -174.18 0.91 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.322 -0.854 . . . . 1.0 110.989 -179.388 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.612 ' HB3' ' HA ' ' A' ' 83' ' ' ALA . 2.7 t-160 -156.51 104.83 2.21 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.468 -0.333 . . . . 1.0 110.659 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.671 HG13 HD13 ' A' ' 85' ' ' LEU . 2.8 t -105.16 119.47 54.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 107.32 -1.363 . . . . 1.0 107.32 175.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.591 HG22 ' HG ' ' A' ' 86' ' ' LEU . 8.2 t -121.74 114.01 20.51 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 120.44 -0.504 . . . . 1.0 110.484 179.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.677 ' HD2' ' HB3' ' A' ' 42' ' ' SER . 1.5 m-85 -83.15 127.35 33.53 Favored 'General case' 0 CA--C 1.512 -0.491 0 O-C-N 122.004 -0.435 . . . . 1.0 110.6 -179.144 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.643 HG21 HD21 ' A' ' 97' ' ' LEU . 23.8 t -111.39 111.76 37.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.008 0.432 . . . . 1.0 111.633 -176.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.569 ' HB2' HD23 ' A' ' 89' ' ' LEU . 42.2 t -141.24 155.98 45.95 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.331 179.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.42 92.59 0.61 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.103 0.478 . . . . 1.0 110.776 179.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.835 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 132.57 -41.92 1.44 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.791 -0.718 . . . . 1.0 111.869 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.464 HD21 ' CB ' ' A' ' 42' ' ' SER . 3.6 t-20 62.17 18.74 10.35 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.454 0.645 . . . . 1.0 111.766 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.2 pt -127.25 11.8 3.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 O-C-N 121.542 -0.724 . . . . 1.0 112.165 -176.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.719 ' O ' ' HG3' ' A' ' 20' ' ' MET . 80.5 m -126.6 -89.96 0.54 Allowed 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.122 -0.631 . . . . 1.0 111.852 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.446 ' H ' ' HG2' ' A' ' 17' ' ' ARG . 0.9 OUTLIER -74.4 -30.13 61.82 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.674 0.62 . . . . 1.0 112.674 -175.819 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.658 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 17.2 m -62.46 -58.91 14.58 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 121.04 -0.264 . . . . 1.0 110.841 178.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.745 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 35.2 Cg_endo -62.78 -25.79 74.82 Favored 'Trans proline' 0 C--N 1.357 0.978 0 C-N-CA 122.213 1.942 . . . . 1.0 111.983 179.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.719 ' HG3' ' O ' ' A' ' 16' ' ' CYS . 71.3 mtp -61.85 -52.85 62.44 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.849 -0.34 . . . . 1.0 110.809 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.424 ' HA ' ' HB2' ' A' ' 24' ' ' MET . . . -74.16 -27.17 60.7 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.577 -0.449 . . . . 1.0 110.108 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.687 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 7.9 tt0 -55.88 -49.78 72.44 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 115.159 -0.928 . . . . 1.0 109.302 179.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.916 ' HB3' ' HG2' ' A' ' 68' ' ' PRO . 0.0 OUTLIER -80.79 -32.15 35.46 Favored 'General case' 0 C--N 1.32 -0.691 0 O-C-N 121.825 -0.547 . . . . 1.0 110.002 -177.155 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.651 ' HB3' HD11 ' A' ' 146' ' ' LEU . 2.3 mmm -61.56 -76.15 0.06 Allowed 'General case' 0 C--O 1.236 0.362 0 N-CA-C 112.928 0.714 . . . . 1.0 112.928 -176.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.678 ' HB3' HD22 ' A' ' 146' ' ' LEU . 16.5 p90 -76.84 -30.36 56.28 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 119.645 -0.822 . . . . 1.0 111.749 -174.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.687 ' HB3' ' O ' ' A' ' 22' ' ' GLU . . . -63.87 -37.75 88.55 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 119.082 -1.047 . . . . 1.0 110.894 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.687 ' HA ' ' HD3' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -65.82 -37.71 86.99 Favored 'General case' 0 C--N 1.333 -0.13 0 N-CA-C 108.955 -0.758 . . . . 1.0 108.955 177.836 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.546 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 79.3 mt-30 -58.8 -42.09 88.28 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.114 175.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.659 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 85.9 mt -56.02 -60.54 3.34 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.706 -0.679 . . . . 1.0 110.578 179.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.687 ' HD3' ' HA ' ' A' ' 27' ' ' GLN . 0.7 OUTLIER -58.94 -37.69 77.3 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.59 -0.277 . . . . 1.0 111.168 179.254 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -60.93 -25.31 66.69 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.252 0.464 . . . . 1.0 112.252 177.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.659 ' HG2' ' O ' ' A' ' 29' ' ' LEU . 3.6 ptm180 -100.71 -18.94 16.27 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 119.602 -0.839 . . . . 1.0 110.418 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 108.04 36.04 2.43 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.236 -0.893 . . . . 1.0 112.502 176.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 23.2 mt -130.08 -3.62 4.5 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 122.625 -0.338 . . . . 1.0 110.535 -178.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.415 ' H ' ' HA ' ' A' ' 30' ' ' ARG . . . -59.5 -25.93 61.41 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 121.126 -0.559 . . . . 1.0 112.488 -179.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -80.06 -32.08 39.4 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.511 0.672 . . . . 1.0 109.847 177.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.74 -18.36 51.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.814 -1.085 . . . . 1.0 112.759 -175.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.785 HG23 ' HB3' ' A' ' 5' ' ' LEU . 0.8 OUTLIER -145.02 128.97 12.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.107 0.479 . . . . 1.0 110.869 -178.837 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.459 ' HG2' ' HB2' ' A' ' 4' ' ' PRO . 9.3 mmm180 -94.12 140.75 29.36 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.639 -0.709 . . . . 1.0 110.168 -178.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.436 HG11 ' HB2' ' A' ' 26' ' ' ALA . 77.9 t -127.77 120.0 53.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-O 121.659 0.743 . . . . 1.0 109.633 -178.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.541 ' O ' ' HA ' ' A' ' 8' ' ' THR . 69.3 p -136.05 -174.54 3.7 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.135 -1.393 . . . . 1.0 109.933 -175.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.677 ' HB3' ' HD2' ' A' ' 9' ' ' PHE . 84.4 p -162.69 167.32 23.28 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 116.485 -0.325 . . . . 1.0 110.49 179.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.583 ' HB2' ' CD2' ' A' ' 80' ' ' HIS . . . -162.83 166.7 23.79 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.578 0.704 . . . . 1.0 111.727 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.456 ' HA2' ' O ' ' A' ' 11' ' ' CYS . . . -124.87 131.34 7.74 Favored Glycine 0 N--CA 1.443 -0.86 0 CA-C-N 114.785 -1.098 . . . . 1.0 111.252 178.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.521 HG21 HD12 ' A' ' 96' ' ' LEU . 40.9 p -70.11 -27.49 64.63 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.985 0.421 . . . . 1.0 111.108 -178.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -102.28 5.93 52.85 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 121.069 -0.586 . . . . 1.0 113.161 -176.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 44.19 34.6 1.03 Allowed 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 114.269 1.211 . . . . 1.0 114.269 176.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.835 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 0.9 OUTLIER -46.75 -72.62 0.05 Allowed 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.638 0.732 . . . . 1.0 112.494 -179.846 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -107.75 42.58 1.32 Allowed 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.045 -0.979 . . . . 1.0 111.016 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.2 p -62.84 128.48 24.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.098 0.475 . . . . 1.0 110.284 178.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.48 -13.56 67.28 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.761 -0.733 . . . . 1.0 111.828 -177.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.4 t -80.66 -158.74 0.2 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.063 0.459 . . . . 1.0 110.036 178.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 21.6 t -131.15 174.69 9.78 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.117 -1.068 . . . . 1.0 108.117 -179.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.2 137.31 47.4 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.713 0.292 . . . . 1.0 111.032 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.718 ' OD1' ' HG2' ' A' ' 57' ' ' ARG . 11.3 t70 -62.66 140.64 58.71 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 115.881 -0.599 . . . . 1.0 110.145 -177.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -51.53 -30.4 20.26 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 113.341 0.867 . . . . 1.0 113.341 -178.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.718 ' HG2' ' OD1' ' A' ' 55' ' ' ASP . 3.9 ptp180 -70.99 -44.4 66.02 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 118.351 0.523 . . . . 1.0 110.769 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.69 -35.82 70.38 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.739 -0.664 . . . . 1.0 109.583 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.84 -44.22 96.73 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.402 -0.817 . . . . 1.0 109.472 177.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.44 ' O ' ' HG2' ' A' ' 63' ' ' ARG . . . -56.75 -45.92 90.33 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.95 -0.643 . . . . 1.0 113.301 178.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.1 m -73.29 -38.62 54.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 117.793 0.797 . . . . 1.0 111.478 -178.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.667 HD21 ' HA ' ' A' ' 20' ' ' MET . 5.6 mp -62.17 -53.29 57.35 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.85 -0.34 . . . . 1.0 110.556 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.44 ' HG2' ' O ' ' A' ' 60' ' ' GLY . 11.6 ptm180 -59.98 -28.37 67.63 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.952 -0.567 . . . . 1.0 111.377 179.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.39 -30.27 65.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.22 0.533 . . . . 1.0 110.738 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -96.83 4.76 51.53 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.872 -0.604 . . . . 1.0 110.526 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.62 13.41 65.18 Favored Glycine 0 C--N 1.331 0.257 0 CA-C-N 115.681 -0.691 . . . . 1.0 113.087 176.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -92.06 150.84 41.18 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-O 120.498 0.19 . . . . 1.0 110.882 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.916 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 39.3 Cg_endo -67.8 155.79 68.51 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.395 2.063 . . . . 1.0 110.612 176.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 57.0 p -130.86 10.74 5.08 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 120.262 -0.575 . . . . 1.0 111.834 -176.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -97.32 136.5 37.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.915 0.388 . . . . 1.0 110.853 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.712 ' HB3' ' HE3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -178.98 162.55 1.26 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.523 -1.288 . . . . 1.0 107.523 177.729 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -121.56 120.82 35.93 Favored 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 119.548 -0.861 . . . . 1.0 108.871 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.03 140.67 56.66 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.763 -0.653 . . . . 1.0 111.288 -177.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.43 ' O ' ' HA ' ' A' ' 43' ' ' ALA . . . -134.65 151.07 50.77 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.907 -0.588 . . . . 1.0 110.132 179.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -87.57 153.31 21.5 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.644 -0.872 . . . . 1.0 108.644 177.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.567 HG11 HD23 ' A' ' 97' ' ' LEU . 21.7 t -63.91 114.2 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.217 0.532 . . . . 1.0 110.506 -179.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.447 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -125.27 -169.31 12.9 Favored Glycine 0 N--CA 1.442 -0.948 0 CA-C-N 115.129 -0.941 . . . . 1.0 111.279 179.299 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 51.9 m -59.86 -43.72 94.53 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.453 0.168 . . . . 1.0 111.196 -178.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -59.09 -31.34 68.81 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 120.952 0.406 . . . . 1.0 111.249 177.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.583 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 78.6 m80 -76.52 -40.69 49.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.497 -0.32 . . . . 1.0 110.276 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.724 ' HA ' HD21 ' A' ' 86' ' ' LEU . 14.6 mt -70.18 -17.09 63.15 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 120.774 0.321 . . . . 1.0 110.444 177.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.73 -7.09 58.99 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 120.777 0.322 . . . . 1.0 110.223 -179.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.612 ' HA ' ' HB3' ' A' ' 6' ' ' HIS . . . -58.45 149.23 25.62 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.961 -0.563 . . . . 1.0 110.922 178.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.555 ' HA ' ' HE ' ' A' ' 106' ' ' ARG . 32.1 t70 -75.49 -16.19 60.33 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.179 0.514 . . . . 1.0 109.739 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.671 HD13 HG13 ' A' ' 7' ' ' VAL . 0.6 OUTLIER -152.73 117.68 5.13 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.205 -0.907 . . . . 1.0 109.043 -177.688 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.724 HD21 ' HA ' ' A' ' 81' ' ' LEU . 4.9 mp -108.06 104.23 13.62 Favored 'General case' 0 N--CA 1.424 -1.758 0 CA-C-N 115.824 -0.625 . . . . 1.0 109.535 178.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.582 ' HB ' ' HD1' ' A' ' 9' ' ' PHE . 52.9 t -83.32 90.58 2.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.01 -0.996 . . . . 1.0 110.757 -175.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.63 146.06 34.31 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.484 -0.78 . . . . 1.0 110.441 179.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.569 HD23 ' HB2' ' A' ' 11' ' ' CYS . 4.1 mm? -95.33 -8.63 35.24 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.335 0.588 . . . . 1.0 109.592 178.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -151.18 154.61 37.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.451 -0.795 . . . . 1.0 111.18 178.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 13.5 ptt180 -61.63 -20.02 62.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.42 -0.809 . . . . 1.0 111.523 177.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.664 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 4.2 m-20 -75.2 -51.9 12.22 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.044 -0.725 . . . . 1.0 109.044 179.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.554 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 10.4 m170 -58.32 -44.68 88.76 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.073 -0.967 . . . . 1.0 109.792 178.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.506 ' HA ' HD12 ' A' ' 97' ' ' LEU . . . -60.23 -44.51 95.14 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 116.297 -0.41 . . . . 1.0 111.072 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.648 ' O ' ' HG2' ' A' ' 99' ' ' GLN . 2.4 ttt180 -57.23 -44.8 84.12 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 115.934 -0.575 . . . . 1.0 110.954 178.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.664 ' HG ' ' O ' ' A' ' 92' ' ' ASN . 49.3 mt -63.34 -45.41 91.38 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 116.121 -0.49 . . . . 1.0 110.515 -175.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.643 HD21 HG21 ' A' ' 10' ' ' VAL . 31.2 mt -54.52 -61.08 2.54 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.814 -0.63 . . . . 1.0 111.433 -178.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.729 ' N ' HG12 ' A' ' 102' ' ' VAL . 7.3 ptm180 -58.8 -45.19 90.47 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.73 0.641 . . . . 1.0 112.73 -179.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.648 ' HG2' ' O ' ' A' ' 95' ' ' ARG . 6.6 pt20 -66.57 -23.91 66.27 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 119.978 -0.689 . . . . 1.0 109.915 179.061 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.606 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 3.4 mt -81.68 -13.73 57.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.605 -0.725 . . . . 1.0 111.789 178.274 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 150.83 -26.16 1.04 Allowed Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 119.769 -1.205 . . . . 1.0 114.138 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.729 HG12 ' N ' ' A' ' 98' ' ' ARG . 0.3 OUTLIER -77.26 -161.64 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-N 118.026 0.913 . . . . 1.0 111.252 -177.967 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.688 ' N ' HG13 ' A' ' 102' ' ' VAL . 12.9 pt-20 -159.05 164.49 35.39 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.844 -1.169 . . . . 1.0 107.844 -178.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.835 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -63.48 -24.22 67.73 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 123.354 0.409 . . . . 1.0 111.379 -175.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.94 -34.42 71.73 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.206 176.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.645 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 1.2 mtp85 -102.16 -40.42 6.81 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.653 -0.703 . . . . 1.0 111.541 -177.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.835 HG12 ' HA ' ' A' ' 104' ' ' ALA . 8.6 p -77.13 120.7 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 N-CA-C 109.415 -0.587 . . . . 1.0 109.415 -175.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.575 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 12.0 mmm180 -139.75 145.57 38.43 Favored 'General case' 0 C--N 1.322 -0.604 0 O-C-N 121.762 -0.586 . . . . 1.0 110.358 -178.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.547 ' HB2' ' HB2' ' A' ' 112' ' ' SER . 73.5 mmm -78.67 138.78 38.46 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.917 -0.583 . . . . 1.0 110.56 178.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.523 HD23 HG11 ' A' ' 87' ' ' VAL . 3.0 tm? -57.37 -50.53 72.67 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.668 0.27 . . . . 1.0 111.472 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 14.2 ttt180 -70.06 -17.23 63.23 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.041 0.448 . . . . 1.0 110.624 -177.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.547 ' HB2' ' HB2' ' A' ' 109' ' ' MET . 32.5 t -75.2 -7.65 54.43 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.888 -178.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.57 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 92.4 m-85 -90.56 -17.89 26.19 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 110.287 -0.264 . . . . 1.0 110.287 176.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 27.4 t0 . . . . . 0 N--CA 1.464 0.241 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.799 -178.53 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 . . . . . 0 N--CA 1.456 -0.141 0 CA-C-O 120.594 0.235 . . . . 1.0 111.337 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -63.42 -47.12 83.25 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 109.251 -0.648 . . . . 1.0 109.251 175.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.836 ' HA ' HG12 ' A' ' 141' ' ' VAL . 85.5 t -62.74 -39.83 86.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.576 0.703 . . . . 1.0 109.259 177.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -56.33 -42.22 77.31 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.584 -0.735 . . . . 1.0 109.481 175.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.5 ' O ' ' HG2' ' A' ' 143' ' ' GLU . . . -67.14 -49.14 65.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.047 -0.979 . . . . 1.0 111.32 179.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.836 HG12 ' HA ' ' A' ' 138' ' ' VAL . 2.9 p -58.37 -40.34 77.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.456 0.646 . . . . 1.0 110.779 -178.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.536 HD12 HG12 ' A' ' 138' ' ' VAL . 14.2 mt -70.26 -51.54 37.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 115.187 -0.915 . . . . 1.0 112.228 178.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.5 ' HG2' ' O ' ' A' ' 140' ' ' ALA . 11.6 pt-20 -55.46 -31.18 61.75 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.309 0.576 . . . . 1.0 110.287 179.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 65.9 m -74.97 -27.66 60.26 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.102 -0.954 . . . . 1.0 110.468 179.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.472 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -86.24 -24.68 25.92 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 115.99 -0.55 . . . . 1.0 111.725 178.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.678 HD22 ' HB3' ' A' ' 25' ' ' PHE . 12.7 mt -55.89 -37.28 55.38 Favored Pre-proline 0 CA--C 1.547 0.846 0 N-CA-C 112.468 0.544 . . . . 1.0 112.468 -178.11 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.646 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 38.3 Cg_endo -67.04 -14.04 42.09 Favored 'Trans proline' 0 C--N 1.363 1.311 0 C-N-CA 122.495 2.13 . . . . 1.0 111.908 177.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.57 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -104.19 -34.05 3.79 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.084 -0.962 . . . . 1.0 110.714 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.576 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -73.68 -40.93 63.31 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.889 -0.782 . . . . 1.0 108.889 179.543 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . 0.548 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 0.2 OUTLIER -53.08 -57.04 11.76 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 115.103 -0.953 . . . . 1.0 110.837 175.672 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -57.01 -40.19 76.15 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.727 -1.124 . . . . 1.0 111.069 -174.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . 0.654 ' CE3' HD12 ' A' ' 85' ' ' LEU . 24.3 t90 -63.22 -58.01 8.59 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.173 -0.922 . . . . 1.0 110.614 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.425 HG13 ' O ' ' A' ' 149' ' ' LEU . 5.7 m -60.73 -40.55 85.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.81 -0.356 . . . . 1.0 110.303 -177.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.42 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 5.8 m-20 -61.17 -49.5 76.93 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.832 0.349 . . . . 1.0 110.904 178.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.528 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 9.3 pt-20 -63.51 -39.39 94.3 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.095 0.474 . . . . 1.0 110.548 -178.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.534 ' HG3' ' CH2' ' A' ' 152' ' ' TRP . 18.4 mmt85 -71.32 -46.73 59.95 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.516 -0.766 . . . . 1.0 110.837 -176.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 4.2 pp . . . . . 0 C--N 1.326 -0.453 0 CA-C-O 121.228 0.537 . . . . 1.0 109.941 -179.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.457 ' HB2' ' HG2' ' A' ' 39' ' ' ARG . 13.0 Cg_endo . . . . . 0 N--CA 1.461 -0.386 0 N-CA-C 114.101 0.769 . . . . 1.0 114.101 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.844 ' HB3' HG23 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -65.19 178.51 0.87 Allowed 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.637 -1.165 . . . . 1.0 108.453 178.608 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.763 ' H ' HD13 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -155.55 100.97 2.14 Favored 'General case' 0 C--N 1.318 -0.803 0 O-C-N 121.549 -0.72 . . . . 1.0 109.585 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.425 HG21 HG11 ' A' ' 153' ' ' VAL . 2.2 t -104.68 116.01 47.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 107.964 -1.125 . . . . 1.0 107.964 178.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.648 HG22 ' HG ' ' A' ' 86' ' ' LEU . 6.3 t -119.06 117.89 29.96 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 120.52 -0.472 . . . . 1.0 109.918 178.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.612 ' HD2' ' HB3' ' A' ' 42' ' ' SER . 1.6 m-85 -85.22 133.19 34.19 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.016 -178.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.612 HG21 HD11 ' A' ' 97' ' ' LEU . 22.5 t -118.04 113.42 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.775 0 CA-C-O 121.123 0.487 . . . . 1.0 111.383 -176.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.666 ' SG ' ' HD3' ' A' ' 17' ' ' ARG . 42.2 t -144.94 160.23 41.66 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.657 -0.701 . . . . 1.0 109.491 178.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.453 HG23 ' NE2' ' A' ' 93' ' ' HIS . 2.7 p -68.56 112.28 5.26 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 120.941 0.401 . . . . 1.0 110.226 178.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.978 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 110.57 -45.16 1.36 Allowed Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.651 -0.785 . . . . 1.0 112.286 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.64 HD22 ' H ' ' A' ' 74' ' ' ALA . 57.5 t30 59.66 35.25 22.36 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 122.016 0.912 . . . . 1.0 110.953 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.414 HD13 ' ND1' ' A' ' 49' ' ' HIS . 4.5 pt -130.32 -4.39 2.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 O-C-N 121.682 -0.636 . . . . 1.0 112.483 -179.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.715 ' O ' ' HG3' ' A' ' 20' ' ' MET . 32.7 m -115.43 -89.05 0.57 Allowed 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 119.671 -0.812 . . . . 1.0 111.881 -177.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.96 ' HG3' ' HG ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -70.76 -39.99 72.91 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.821 0.674 . . . . 1.0 112.821 -175.071 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.481 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 19.4 m -57.58 -57.4 25.59 Favored Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 111.518 0.192 . . . . 1.0 111.518 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.481 ' HD3' ' HB2' ' A' ' 18' ' ' SER . 40.0 Cg_endo -65.15 -23.93 59.68 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 121.886 1.724 . . . . 1.0 112.395 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.715 ' HG3' ' O ' ' A' ' 16' ' ' CYS . 78.0 mtp -61.78 -52.33 64.66 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.111 -0.329 . . . . 1.0 110.111 179.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.459 ' HA ' ' HB2' ' A' ' 24' ' ' MET . . . -72.37 -27.56 62.46 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-N 115.632 -0.713 . . . . 1.0 110.138 -178.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.646 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 17.2 tt0 -52.63 -51.99 57.59 Favored 'General case' 0 C--O 1.216 -0.664 0 CA-C-N 114.981 -1.009 . . . . 1.0 109.361 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.709 ' HE2' ' HB2' ' A' ' 71' ' ' HIS . 0.1 OUTLIER -88.14 -22.79 23.88 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.815 -1.084 . . . . 1.0 110.99 -175.974 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.547 ' HB3' HD11 ' A' ' 146' ' ' LEU . 89.2 mtp -65.39 -74.97 0.09 Allowed 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.101 0.476 . . . . 1.0 112.246 -179.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.697 ' HB3' HD22 ' A' ' 146' ' ' LEU . 17.9 p90 -75.48 -30.64 59.95 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.003 -0.679 . . . . 1.0 111.601 -175.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.646 ' HB3' ' O ' ' A' ' 22' ' ' GLU . . . -64.79 -35.79 82.24 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 119.305 -0.958 . . . . 1.0 110.905 179.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.682 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -63.79 -37.88 89.01 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.402 -0.962 . . . . 1.0 108.402 177.147 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.578 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 77.9 mt-30 -59.5 -45.54 91.39 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 115.519 -0.764 . . . . 1.0 110.351 175.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.523 HD13 HG13 ' A' ' 38' ' ' VAL . 81.8 mt -53.3 -62.48 1.63 Allowed 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 115.859 -0.61 . . . . 1.0 111.317 -179.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.482 ' HA ' ' H ' ' A' ' 35' ' ' GLY . 0.3 OUTLIER -58.77 -35.48 72.85 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 120.831 -0.348 . . . . 1.0 111.502 179.863 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -62.14 -28.62 69.77 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.139 0.422 . . . . 1.0 112.139 177.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.578 ' HG2' ' O ' ' A' ' 28' ' ' GLN . 7.3 ptp180 -94.71 -20.25 19.69 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 119.452 -0.899 . . . . 1.0 109.949 178.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 110.52 35.52 2.06 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.202 -0.908 . . . . 1.0 112.277 176.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.464 ' HG ' ' HG3' ' A' ' 32' ' ' ARG . 17.9 mt -126.16 1.43 7.16 Favored 'General case' 0 N--CA 1.452 -0.358 0 O-C-N 122.432 -0.452 . . . . 1.0 110.0 -178.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.482 ' H ' ' HA ' ' A' ' 30' ' ' ARG . . . -55.75 -30.2 56.03 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 121.094 -0.574 . . . . 1.0 112.709 -178.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -88.79 -20.77 24.29 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.924 0.392 . . . . 1.0 110.55 178.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.92 -21.54 40.44 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.73 -0.668 . . . . 1.0 111.802 -179.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.844 HG23 ' HB3' ' A' ' 5' ' ' LEU . 0.6 OUTLIER -144.21 125.8 9.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.283 0.563 . . . . 1.0 111.386 -179.727 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.457 ' HG2' ' HB2' ' A' ' 4' ' ' PRO . 11.8 mmt180 -88.33 135.01 33.66 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.693 -0.855 . . . . 1.0 108.693 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.448 HG11 ' HB2' ' A' ' 26' ' ' ALA . 53.9 t -124.76 123.25 65.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.546 0.689 . . . . 1.0 109.385 -178.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.553 ' O ' ' HA ' ' A' ' 8' ' ' THR . 42.8 p -138.54 -175.75 4.23 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.491 -1.231 . . . . 1.0 110.989 -174.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.612 ' HB3' ' HD2' ' A' ' 9' ' ' PHE . 59.6 p -160.13 162.6 34.01 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.397 -0.365 . . . . 1.0 110.135 -178.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.619 ' HB2' ' CD2' ' A' ' 80' ' ' HIS . . . -162.88 163.19 26.5 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.36 0.6 . . . . 1.0 111.636 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.481 ' HA2' ' O ' ' A' ' 11' ' ' CYS . . . -123.23 131.64 8.25 Favored Glycine 0 N--CA 1.442 -0.909 0 N-CA-C 110.778 -0.929 . . . . 1.0 110.778 178.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.519 HG23 ' CG1' ' A' ' 10' ' ' VAL . 23.2 p -69.98 -25.36 63.58 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.805 0.336 . . . . 1.0 111.752 -177.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.526 ' HA3' ' HZ3' ' A' ' 48' ' ' TRP . . . -110.91 9.16 29.64 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 120.851 -0.69 . . . . 1.0 113.409 -176.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 41.98 41.81 2.08 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 114.25 1.204 . . . . 1.0 114.25 176.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.978 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 1.2 m-90 -49.1 -76.02 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.694 0.759 . . . . 1.0 111.903 177.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.414 ' ND1' HD13 ' A' ' 15' ' ' ILE . 9.1 m170 -102.39 39.19 1.54 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.178 -0.919 . . . . 1.0 111.04 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.9 p -60.05 128.41 21.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.147 0.499 . . . . 1.0 110.529 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.439 ' HA2' ' HD3' ' A' ' 72' ' ' ARG . . . 93.3 -14.22 65.78 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.944 -0.646 . . . . 1.0 111.99 -177.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.409 ' O ' ' HA ' ' A' ' 72' ' ' ARG . 4.1 t -80.63 -161.12 0.35 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.183 0.516 . . . . 1.0 110.004 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 71' ' ' HIS . 24.8 t -121.39 176.23 5.76 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 108.448 -0.945 . . . . 1.0 108.448 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.501 ' HB2' ' HZ1' ' A' ' 23' ' ' LYS . . . -59.63 143.68 49.86 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.313 -0.403 . . . . 1.0 111.273 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.482 ' OD1' ' HG3' ' A' ' 57' ' ' ARG . 51.6 t0 -49.58 123.93 8.62 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.898 -1.046 . . . . 1.0 110.115 178.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -44.57 -37.02 3.3 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.444 -0.798 . . . . 1.0 112.64 178.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.607 ' O ' HG23 ' A' ' 61' ' ' VAL . 0.2 OUTLIER -73.27 -38.06 66.07 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.095 -0.642 . . . . 1.0 111.178 -179.102 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.11 -36.37 72.12 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.55 0.214 . . . . 1.0 110.472 177.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.417 ' O ' HG21 ' A' ' 69' ' ' THR . . . -61.47 -41.88 97.92 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.046 177.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.09 -42.3 99.74 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 111.084 -0.807 . . . . 1.0 111.084 176.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.607 HG23 ' O ' ' A' ' 57' ' ' ARG . 85.0 t -59.14 -57.36 11.74 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 CA-C-N 115.273 -0.464 . . . . 1.0 111.127 178.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.712 ' HB2' HG22 ' A' ' 69' ' ' THR . 85.7 mt -59.5 -50.36 74.22 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.227 -0.442 . . . . 1.0 111.504 -177.152 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.599 ' HB3' HG21 ' A' ' 69' ' ' THR . 2.2 ptt180 -63.25 -27.74 69.55 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.727 -0.67 . . . . 1.0 110.823 -178.162 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.86 -29.68 68.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.128 0.49 . . . . 1.0 110.702 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -98.81 4.31 47.58 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.837 -0.619 . . . . 1.0 111.452 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.39 12.39 63.1 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.712 -0.756 . . . . 1.0 112.691 177.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.527 ' HD1' ' HG2' ' A' ' 27' ' ' GLN . 62.3 m-85 -86.96 152.31 53.3 Favored Pre-proline 0 C--N 1.323 -0.574 0 O-C-N 122.756 -0.261 . . . . 1.0 110.409 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.652 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 17.8 Cg_endo -64.81 153.25 78.81 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.295 1.997 . . . . 1.0 110.417 175.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.712 HG22 ' HB2' ' A' ' 62' ' ' LEU . 61.5 p -135.35 28.84 3.36 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 120.232 -0.587 . . . . 1.0 112.336 -176.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -104.38 130.47 52.25 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.343 -0.614 . . . . 1.0 109.343 178.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.709 ' HB2' ' HE2' ' A' ' 23' ' ' LYS . 18.7 t60 -164.95 148.34 8.56 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.287 -177.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.439 ' HD3' ' HA2' ' A' ' 51' ' ' GLY . 6.3 tmm_? -127.41 111.31 13.71 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 107.493 -1.299 . . . . 1.0 107.493 177.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.58 134.25 55.97 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.1 -0.955 . . . . 1.0 111.918 -175.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.64 ' H ' HD22 ' A' ' 14' ' ' ASN . . . -128.8 147.98 50.84 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.725 -0.67 . . . . 1.0 109.791 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -87.09 155.83 19.97 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.747 -0.464 . . . . 1.0 109.747 176.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.505 HG11 HD23 ' A' ' 97' ' ' LEU . 12.9 t -64.11 112.58 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.488 0.661 . . . . 1.0 111.229 -179.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -122.64 -171.75 13.86 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 114.937 -1.029 . . . . 1.0 111.748 179.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 96.6 m -56.41 -44.45 80.35 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 123.704 0.297 . . . . 1.0 111.212 -179.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -60.07 -27.83 67.3 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.873 0.368 . . . . 1.0 110.939 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.619 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 79.6 m80 -79.73 -41.56 26.44 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 116.421 -0.354 . . . . 1.0 110.389 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.649 ' O ' HG23 ' A' ' 102' ' ' VAL . 17.9 mt -67.61 -17.0 64.46 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.241 176.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.76 -8.28 57.5 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.395 -0.366 . . . . 1.0 110.848 -179.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.538 ' HA ' ' HB3' ' A' ' 6' ' ' HIS . . . -60.15 151.17 27.67 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.074 -0.512 . . . . 1.0 111.569 -179.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.753 ' HB3' HD13 ' A' ' 5' ' ' LEU . 9.9 t70 -76.13 -14.98 60.16 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.759 -0.655 . . . . 1.0 109.712 179.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.745 HD12 ' CE3' ' A' ' 152' ' ' TRP . 1.2 tt -157.48 116.53 3.28 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.89 -0.595 . . . . 1.0 109.572 -177.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.648 ' HG ' HG22 ' A' ' 8' ' ' THR . 5.3 mp -107.27 88.44 2.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 116.018 -0.537 . . . . 1.0 110.671 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.633 ' HA ' ' O ' ' A' ' 108' ' ' ARG . 70.3 t -66.18 91.02 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 113.801 -1.545 . . . . 1.0 112.363 -179.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.49 146.32 32.77 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.509 -1.223 . . . . 1.0 110.655 177.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.96 ' HG ' ' HG3' ' A' ' 17' ' ' ARG . 4.3 mm? -99.04 -8.47 25.27 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.253 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.429 ' OD1' ' HB2' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -153.32 155.22 36.07 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.08 -0.509 . . . . 1.0 111.142 -179.843 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -56.91 -27.02 60.25 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.24 -0.891 . . . . 1.0 113.31 -178.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.655 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 7.0 m-20 -75.58 -49.93 17.08 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.977 -0.379 . . . . 1.0 109.977 -178.061 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.672 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 9.9 m170 -55.28 -47.33 75.69 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.73 -0.668 . . . . 1.0 110.295 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.96 -43.96 91.41 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.09 0.471 . . . . 1.0 110.704 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.469 ' O ' ' HG2' ' A' ' 99' ' ' GLN . 17.1 ttt180 -59.4 -44.42 92.82 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.759 -0.655 . . . . 1.0 111.332 178.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.655 ' HG ' ' O ' ' A' ' 92' ' ' ASN . 60.2 mt -62.69 -47.32 84.16 Favored 'General case' 0 C--O 1.215 -0.737 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.425 -176.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.672 ' HG ' ' O ' ' A' ' 93' ' ' HIS . 29.5 mt -54.32 -59.46 4.64 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.636 -0.711 . . . . 1.0 111.417 -178.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.688 ' CA ' HG12 ' A' ' 102' ' ' VAL . 16.5 ptt85 -59.7 -44.71 93.56 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.305 0.483 . . . . 1.0 112.305 -178.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.469 ' HG2' ' O ' ' A' ' 95' ' ' ARG . 2.3 pt20 -68.06 -24.63 65.09 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.497 -0.481 . . . . 1.0 109.918 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.653 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 6.1 mt -81.48 -16.14 52.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.718 -0.674 . . . . 1.0 112.037 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 151.06 -23.44 0.99 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 119.873 -1.156 . . . . 1.0 114.184 -178.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.841 HG22 ' HD2' ' A' ' 106' ' ' ARG . 0.4 OUTLIER -76.62 -163.11 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 CA-C-N 117.958 0.879 . . . . 1.0 110.295 -179.091 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.705 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 14.2 pt-20 -158.11 161.4 37.94 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 107.702 -1.221 . . . . 1.0 107.702 -179.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.763 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -61.86 -25.02 67.28 Favored 'General case' 0 C--N 1.32 -0.717 0 O-C-N 123.285 0.366 . . . . 1.0 111.273 -175.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.476 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . . . -56.37 -39.31 72.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.318 0.58 . . . . 1.0 110.286 175.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.841 ' HD2' HG22 ' A' ' 102' ' ' VAL . 22.5 mtt180 -96.82 -42.51 7.93 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 115.036 -0.983 . . . . 1.0 111.13 -176.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.763 HG12 ' HA ' ' A' ' 104' ' ' ALA . 11.5 p -78.86 117.75 24.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 120.694 -0.402 . . . . 1.0 110.03 -174.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.633 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 0.1 OUTLIER -138.35 148.44 44.57 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 121.716 -0.615 . . . . 1.0 110.455 -178.97 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 83.9 mmm -80.86 140.53 35.33 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.977 -0.556 . . . . 1.0 111.006 -178.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.55 HD23 HG11 ' A' ' 87' ' ' VAL . 3.1 tm? -59.11 -48.71 80.62 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 111.552 0.204 . . . . 1.0 111.552 -179.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 7.7 ttm180 -69.26 -19.92 63.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.707 0.289 . . . . 1.0 110.528 -178.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 30.4 t -74.26 -7.0 51.2 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.464 -0.335 . . . . 1.0 111.177 -178.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.641 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 87.6 m-85 -92.93 -19.11 21.96 Favored 'General case' 0 C--N 1.34 0.181 0 O-C-N 121.834 -0.541 . . . . 1.0 110.65 177.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 13.6 t0 . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 115.885 -0.598 . . . . 1.0 111.041 -178.58 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 . . . . . 0 N--CA 1.451 -0.384 0 CA-C-O 120.427 0.156 . . . . 1.0 111.182 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.664 ' O ' HG23 ' A' ' 141' ' ' VAL . 2.8 tt0 -63.85 -49.4 72.93 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.794 -0.447 . . . . 1.0 109.794 177.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.45 HG12 HD12 ' A' ' 142' ' ' ILE . 84.3 t -59.05 -44.54 91.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.479 0.657 . . . . 1.0 109.692 177.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.428 ' HB2' HG11 ' A' ' 61' ' ' VAL . 67.6 t80 -56.7 -40.11 75.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.804 -1.089 . . . . 1.0 110.058 177.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.58 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -67.18 -41.94 85.07 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.246 -0.433 . . . . 1.0 110.746 178.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.664 HG23 ' O ' ' A' ' 137' ' ' GLU . 33.4 t -56.33 -51.06 68.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.645 0.736 . . . . 1.0 110.425 178.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.45 HD12 HG12 ' A' ' 138' ' ' VAL . 7.7 mt -65.96 -50.36 70.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 114.782 -1.099 . . . . 1.0 111.588 -178.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.58 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 12.7 pt-20 -57.49 -30.41 65.08 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 121.003 -0.279 . . . . 1.0 110.354 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 2.9 t -74.76 -28.85 60.92 Favored 'General case' 0 C--O 1.226 -0.167 0 CA-C-O 121.155 0.502 . . . . 1.0 110.384 178.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.459 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -86.98 -22.31 25.64 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 116.014 -0.539 . . . . 1.0 111.523 179.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.697 HD22 ' HB3' ' A' ' 25' ' ' PHE . 11.2 mt -55.57 -37.49 57.52 Favored Pre-proline 0 CA--C 1.54 0.569 0 N-CA-C 112.523 0.564 . . . . 1.0 112.523 -179.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.62 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 57.1 Cg_endo -70.59 -8.53 23.83 Favored 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 122.495 2.13 . . . . 1.0 112.255 177.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.641 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -108.73 -33.93 2.74 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.214 -1.154 . . . . 1.0 110.214 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.579 HD11 HG21 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -73.44 -43.63 59.93 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.163 -1.051 . . . . 1.0 108.163 178.509 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . 0.658 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 0.2 OUTLIER -54.21 -52.52 61.01 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-N 114.768 -1.106 . . . . 1.0 110.227 174.865 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -57.59 -43.89 84.97 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.324 -1.307 . . . . 1.0 110.89 -175.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . 0.745 ' CE3' HD12 ' A' ' 85' ' ' LEU . 22.9 t90 -63.01 -57.05 12.01 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.095 -0.957 . . . . 1.0 110.414 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.437 HG13 ' O ' ' A' ' 149' ' ' LEU . 8.4 m -61.95 -42.09 93.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.776 -0.37 . . . . 1.0 110.566 -177.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -60.33 -51.22 70.45 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.907 0.384 . . . . 1.0 110.777 179.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.534 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 13.8 pt-20 -62.66 -38.76 91.57 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.771 -0.65 . . . . 1.0 110.403 -178.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.499 ' HA ' ' HD3' ' A' ' 156' ' ' ARG . 1.8 mmt180 -72.65 -50.66 23.6 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.893 -0.594 . . . . 1.0 111.029 -177.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.1 pp . . . . . 0 C--N 1.322 -0.601 0 CA-C-N 116.069 -0.514 . . . . 1.0 109.885 -178.941 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.59 ' HB3' ' O ' ' A' ' 36' ' ' ASP . 35.0 Cg_endo . . . . . 0 N--CA 1.463 -0.292 0 N-CA-C 113.826 0.664 . . . . 1.0 113.826 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.846 ' HB3' HG23 ' A' ' 38' ' ' VAL . 0.5 OUTLIER -73.21 -172.49 1.12 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.694 -1.139 . . . . 1.0 110.711 -179.303 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.624 ' HB3' ' HA ' ' A' ' 83' ' ' ALA . 0.3 OUTLIER -157.38 94.41 1.38 Allowed 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.897 -0.321 . . . . 1.0 110.881 179.295 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.69 HG13 HD13 ' A' ' 85' ' ' LEU . 2.1 t -96.06 115.62 35.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.876 -0.786 . . . . 1.0 108.876 176.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.603 ' CG2' ' HG ' ' A' ' 86' ' ' LEU . 14.2 t -118.52 115.35 24.42 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 120.92 0.391 . . . . 1.0 110.585 178.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.578 ' HD1' ' HB ' ' A' ' 87' ' ' VAL . 1.0 OUTLIER -83.54 132.42 34.93 Favored 'General case' 0 CA--C 1.511 -0.55 0 O-C-N 122.162 -0.336 . . . . 1.0 110.472 -179.025 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.713 HG21 HD11 ' A' ' 97' ' ' LEU . 44.5 t -115.37 119.98 63.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.221 0.534 . . . . 1.0 111.803 -176.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.528 ' HA ' ' CE1' ' A' ' 93' ' ' HIS . 47.0 t -147.59 164.92 31.95 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.654 -0.703 . . . . 1.0 109.712 178.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.6 96.22 2.94 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.186 0.517 . . . . 1.0 110.66 179.097 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.983 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 125.04 -39.81 2.01 Favored Glycine 0 N--CA 1.441 -1.01 0 CA-C-N 115.486 -0.779 . . . . 1.0 111.972 179.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.528 HD21 ' CB ' ' A' ' 42' ' ' SER . 3.6 t-20 65.05 18.88 11.67 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 122.115 0.96 . . . . 1.0 110.078 -178.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.501 HG12 ' HB2' ' A' ' 49' ' ' HIS . 1.2 pt -134.58 48.43 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-N 115.078 -0.964 . . . . 1.0 110.103 -177.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.742 ' O ' ' HG3' ' A' ' 20' ' ' MET . 4.7 p -157.9 -90.12 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.285 -0.87 . . . . 1.0 111.495 174.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.647 HH11 ' HB3' ' A' ' 89' ' ' LEU . 1.2 mtt180 -70.73 -44.46 66.8 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.986 0.422 . . . . 1.0 111.187 -177.071 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.712 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 15.1 m -54.41 -58.13 15.39 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-N 115.756 -0.657 . . . . 1.0 111.838 -179.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.537 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 33.6 Cg_endo -64.1 -24.58 66.24 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 121.68 1.586 . . . . 1.0 112.627 -179.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.742 ' HG3' ' O ' ' A' ' 16' ' ' CYS . 57.6 mtp -62.01 -53.81 50.38 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.902 -0.319 . . . . 1.0 110.607 178.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.428 ' HA ' ' HB2' ' A' ' 24' ' ' MET . . . -74.91 -26.14 59.43 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.488 -178.022 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.631 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 12.5 tt0 -53.84 -51.28 64.06 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.274 -0.876 . . . . 1.0 109.528 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.821 ' HB3' ' HG2' ' A' ' 68' ' ' PRO . 0.2 OUTLIER -80.7 -31.14 36.27 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.549 -0.75 . . . . 1.0 110.451 -177.244 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.65 ' HB3' HD11 ' A' ' 146' ' ' LEU . 6.0 mmm -60.85 -75.49 0.06 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.902 0.704 . . . . 1.0 112.902 -175.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.686 ' HB3' HD22 ' A' ' 146' ' ' LEU . 19.0 p90 -77.94 -30.77 50.61 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 119.815 -0.754 . . . . 1.0 111.527 -175.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.631 ' HB3' ' O ' ' A' ' 22' ' ' GLU . . . -63.03 -38.23 90.37 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 119.06 -1.056 . . . . 1.0 110.648 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.672 ' HA ' ' HD3' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -65.39 -40.13 93.1 Favored 'General case' 0 C--N 1.339 0.118 0 N-CA-C 108.936 -0.765 . . . . 1.0 108.936 177.504 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.652 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 50.7 mt-30 -61.59 -40.46 94.84 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.751 176.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.677 ' HG ' ' O ' ' A' ' 25' ' ' PHE . 83.9 mt -56.73 -57.65 11.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.638 178.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.672 ' HD3' ' HA ' ' A' ' 27' ' ' GLN . 1.6 ptm180 -59.9 -32.28 70.6 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.485 -0.486 . . . . 1.0 111.129 178.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -62.27 -32.93 73.7 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 111.967 0.358 . . . . 1.0 111.967 175.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.652 ' HG2' ' O ' ' A' ' 28' ' ' GLN . 4.8 ptp180 -91.94 -17.5 25.08 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.632 0.729 . . . . 1.0 109.706 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.22 33.64 5.1 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 114.911 -1.041 . . . . 1.0 111.435 177.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 33.2 mt -123.42 -0.75 8.69 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.566 -0.531 . . . . 1.0 109.566 -177.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.25 -27.52 60.45 Favored Glycine 0 C--O 1.227 -0.338 0 CA-C-N 115.889 -0.596 . . . . 1.0 112.486 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.59 ' O ' ' HB3' ' A' ' 4' ' ' PRO . 0.9 OUTLIER -86.34 -25.86 25.18 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 109.716 -0.475 . . . . 1.0 109.716 177.549 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -78.42 -21.69 48.85 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.137 -0.938 . . . . 1.0 111.341 -176.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.846 HG23 ' HB3' ' A' ' 5' ' ' LEU . 1.2 p -144.45 126.85 10.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.229 0.538 . . . . 1.0 110.378 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.487 ' HG2' ' HB2' ' A' ' 4' ' ' PRO . 11.0 mmt180 -90.0 144.59 25.78 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.462 -0.79 . . . . 1.0 109.585 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.415 HG11 ' HB2' ' A' ' 26' ' ' ALA . 77.8 t -129.68 127.73 64.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 121.382 0.611 . . . . 1.0 109.93 -178.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.534 ' O ' ' HA ' ' A' ' 8' ' ' THR . 40.0 p -143.89 -175.54 4.63 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.476 -1.238 . . . . 1.0 110.024 -175.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.712 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 86.4 p -161.27 167.03 26.72 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 110.006 -0.368 . . . . 1.0 110.006 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.593 ' HB2' ' CD2' ' A' ' 80' ' ' HIS . . . -163.5 166.41 22.66 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.156 0.503 . . . . 1.0 111.695 -178.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.523 ' HA2' ' O ' ' A' ' 11' ' ' CYS . . . -125.15 137.71 10.56 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.302 -0.863 . . . . 1.0 111.398 178.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.618 HG21 HD12 ' A' ' 96' ' ' LEU . 22.1 p -74.17 -22.93 59.21 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.805 0.303 . . . . 1.0 111.747 -177.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.459 ' HA3' ' CZ3' ' A' ' 48' ' ' TRP . . . -111.31 8.31 28.73 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.668 -0.777 . . . . 1.0 113.03 -178.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.459 ' HB3' ' HB2' ' A' ' 75' ' ' GLN . 2.7 p-10 43.01 37.02 1.0 Allowed 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 113.875 1.065 . . . . 1.0 113.875 177.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.983 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 1.1 m-90 -46.8 -64.4 0.78 Allowed 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.325 0.583 . . . . 1.0 112.532 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.573 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 2.3 m-70 -111.99 39.25 2.44 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.753 -0.658 . . . . 1.0 111.281 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.51 HG23 ' HA ' ' A' ' 74' ' ' ALA . 14.9 p -59.87 126.87 18.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 C-N-CA 120.207 -0.597 . . . . 1.0 110.473 179.056 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.64 -14.17 65.62 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-N 116.032 -0.531 . . . . 1.0 111.948 -177.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.503 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 3.3 t -79.93 -160.72 0.29 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.45 0.643 . . . . 1.0 109.961 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 47.7 t -124.48 175.02 7.41 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 115.445 -0.798 . . . . 1.0 108.971 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.38 147.56 48.06 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.54 0.686 . . . . 1.0 111.49 -178.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.428 ' N ' ' OD1' ' A' ' 55' ' ' ASP . 9.0 p-10 -59.75 137.76 57.96 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.437 -1.256 . . . . 1.0 112.034 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -48.36 -35.25 12.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.672 -1.149 . . . . 1.0 112.785 179.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.484 ' H ' ' HG2' ' A' ' 57' ' ' ARG . 17.3 ptt180 -71.93 -43.69 64.86 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.377 0.132 . . . . 1.0 111.071 -177.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.461 ' HB1' ' HG2' ' A' ' 20' ' ' MET . . . -69.56 -39.13 77.59 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 109.378 -0.601 . . . . 1.0 109.378 178.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.4 -45.53 93.93 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.672 -0.695 . . . . 1.0 109.398 177.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.42 ' O ' ' HG2' ' A' ' 63' ' ' ARG . . . -57.83 -47.21 90.29 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 115.768 -0.651 . . . . 1.0 113.36 178.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.6 m -70.34 -39.99 77.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 117.699 0.749 . . . . 1.0 111.045 -178.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.718 HD13 ' HG3' ' A' ' 23' ' ' LYS . 96.0 mt -63.64 -52.56 60.26 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 120.605 -0.438 . . . . 1.0 110.653 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.42 ' HG2' ' O ' ' A' ' 60' ' ' GLY . 4.5 ptm180 -61.13 -30.26 70.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.554 -0.294 . . . . 1.0 110.997 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.99 -33.45 75.6 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 120.946 0.403 . . . . 1.0 110.735 179.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -96.68 3.35 52.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.839 -0.619 . . . . 1.0 110.873 -178.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.41 13.8 62.89 Favored Glycine 0 N--CA 1.452 -0.257 0 CA-C-N 115.962 -0.563 . . . . 1.0 112.906 177.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -89.48 152.8 47.81 Favored Pre-proline 0 C--N 1.322 -0.616 0 N-CA-C 110.571 -0.159 . . . . 1.0 110.571 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.821 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 45.7 Cg_endo -69.8 158.46 56.84 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.182 1.921 . . . . 1.0 110.713 176.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.62 HG22 ' HB2' ' A' ' 62' ' ' LEU . 36.4 p -133.32 4.04 3.68 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 119.856 -0.738 . . . . 1.0 111.807 -177.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.412 ' O ' ' HE2' ' A' ' 23' ' ' LYS . 24.4 t70 -67.74 127.09 31.5 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.976 -0.556 . . . . 1.0 110.099 178.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.567 ' HB2' ' HE2' ' A' ' 23' ' ' LYS . 59.0 t60 -165.39 149.67 8.61 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.951 0.405 . . . . 1.0 111.116 -176.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.459 ' HA ' ' O ' ' A' ' 52' ' ' SER . 0.9 OUTLIER -134.16 112.65 11.29 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.113 -1.069 . . . . 1.0 108.113 175.136 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.573 ' HB3' ' O ' ' A' ' 49' ' ' HIS . . . -61.42 142.53 56.91 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.656 -1.157 . . . . 1.0 112.294 -176.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.51 ' HA ' HG23 ' A' ' 50' ' ' VAL . . . -133.55 161.25 35.11 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.469 -0.787 . . . . 1.0 109.885 178.072 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.459 ' HB2' ' HB3' ' A' ' 47' ' ' ASN . 46.8 tt0 -97.57 160.04 14.56 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.611 -0.885 . . . . 1.0 108.611 178.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.474 HG11 HD23 ' A' ' 97' ' ' LEU . 93.8 t -64.97 102.82 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.353 0.597 . . . . 1.0 110.093 178.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -119.57 -174.94 15.78 Favored Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 114.834 -1.075 . . . . 1.0 111.769 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 93.0 m -57.75 -45.75 85.44 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 111.616 0.228 . . . . 1.0 111.616 -177.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -59.12 -29.65 67.55 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.871 0.367 . . . . 1.0 111.305 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.593 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 78.2 m80 -78.39 -41.24 33.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.394 -0.366 . . . . 1.0 110.491 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.623 ' O ' HG23 ' A' ' 102' ' ' VAL . 18.2 mt -68.31 -17.28 64.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.404 177.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.87 -8.27 58.17 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.846 0.355 . . . . 1.0 110.487 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.624 ' HA ' ' HB3' ' A' ' 6' ' ' HIS . . . -58.91 151.85 20.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.664 -0.698 . . . . 1.0 111.427 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.602 ' HA ' ' NH1' ' A' ' 106' ' ' ARG . 27.0 t70 -78.73 -14.45 59.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.333 -0.394 . . . . 1.0 109.956 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.69 HD13 HG13 ' A' ' 7' ' ' VAL . 0.5 OUTLIER -155.36 117.33 4.11 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.65 -0.705 . . . . 1.0 109.311 -177.909 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.618 ' HB3' HD13 ' A' ' 97' ' ' LEU . 5.0 mp -107.67 105.94 16.04 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-N 115.622 -0.717 . . . . 1.0 109.897 177.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.578 ' HB ' ' HD1' ' A' ' 9' ' ' PHE . 56.0 t -84.5 92.94 3.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 114.803 -1.09 . . . . 1.0 111.002 -176.094 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.7 141.81 37.6 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.474 -0.785 . . . . 1.0 110.62 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.647 ' HB3' HH11 ' A' ' 17' ' ' ARG . 3.8 mm? -95.82 -8.77 33.32 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.261 0.553 . . . . 1.0 109.82 178.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.454 ' OD2' ' HB2' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -149.73 151.55 33.83 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.249 -0.887 . . . . 1.0 110.786 -179.939 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -55.16 -29.86 58.67 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.262 -0.881 . . . . 1.0 112.92 -179.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.694 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 43.2 m-80 -75.06 -49.51 19.48 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.614 -0.513 . . . . 1.0 109.614 -176.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.565 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 16.7 m170 -52.44 -46.07 66.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.535 -0.757 . . . . 1.0 110.121 178.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.416 ' HA ' HG21 ' A' ' 107' ' ' VAL . . . -58.85 -46.44 87.74 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.42 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.1 ttm180 -61.47 -39.27 90.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.722 -0.672 . . . . 1.0 111.626 178.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.694 ' HG ' ' O ' ' A' ' 92' ' ' ASN . 36.1 mt -65.85 -47.19 75.77 Favored 'General case' 0 C--O 1.218 -0.594 0 N-CA-C 110.229 -0.285 . . . . 1.0 110.229 -177.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.713 HD11 HG21 ' A' ' 10' ' ' VAL . 31.6 mt -55.14 -58.78 6.27 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.145 -0.48 . . . . 1.0 111.655 -178.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.685 ' HD2' HG11 ' A' ' 107' ' ' VAL . 2.9 ptm180 -60.3 -41.52 93.59 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.826 -0.624 . . . . 1.0 112.473 -178.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.652 ' HG3' ' O ' ' A' ' 96' ' ' LEU . 1.0 OUTLIER -66.8 -27.76 67.83 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.361 -0.607 . . . . 1.0 109.361 178.536 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.667 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 11.1 mt -79.46 -13.44 59.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.537 -0.756 . . . . 1.0 111.769 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 149.36 -25.31 1.23 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 119.907 -1.14 . . . . 1.0 113.678 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.68 HG13 ' H ' ' A' ' 103' ' ' GLU . 0.4 OUTLIER -76.73 -163.02 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-N 117.437 0.619 . . . . 1.0 110.321 -178.615 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.68 ' H ' HG13 ' A' ' 102' ' ' VAL . 12.5 pt-20 -159.97 166.64 29.67 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 108.389 -0.967 . . . . 1.0 108.389 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.778 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -63.75 -25.23 68.1 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 123.304 0.378 . . . . 1.0 111.686 -174.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.41 -36.19 75.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.112 0.482 . . . . 1.0 110.142 175.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.623 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 0.8 OUTLIER -98.15 -42.82 7.27 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 115.525 -0.761 . . . . 1.0 111.293 -177.163 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.778 HG12 ' HA ' ' A' ' 104' ' ' ALA . 7.7 p -78.34 118.09 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 N-CA-C 109.266 -0.642 . . . . 1.0 109.266 -176.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.549 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 17.7 mmm180 -136.3 147.53 47.51 Favored 'General case' 0 C--N 1.32 -0.703 0 O-C-N 121.633 -0.667 . . . . 1.0 110.352 -178.042 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 83.0 mmm -78.09 137.45 38.23 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.889 -0.596 . . . . 1.0 110.382 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.529 HD23 HG11 ' A' ' 87' ' ' VAL . 3.1 tm? -56.06 -49.09 74.75 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 123.031 0.207 . . . . 1.0 111.239 179.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 21.0 ttt180 -71.87 -11.9 61.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.011 0.434 . . . . 1.0 111.007 -178.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 26.7 t -75.81 -9.67 58.79 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.944 -0.303 . . . . 1.0 110.705 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.574 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 97.3 m-85 -92.41 -19.81 21.68 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.237 0.542 . . . . 1.0 110.366 176.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 20.7 t0 . . . . . 0 C--N 1.325 -0.481 0 CA-C-N 114.945 -1.025 . . . . 1.0 111.685 -177.116 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 . . . . . 0 N--CA 1.454 -0.233 0 CA-C-O 120.862 0.363 . . . . 1.0 110.607 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.552 ' O ' HG23 ' A' ' 141' ' ' VAL . 10.9 tp10 -64.31 -48.28 76.23 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.543 -0.91 . . . . 1.0 108.543 174.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.683 ' HA ' HG23 ' A' ' 141' ' ' VAL . 54.8 t -61.9 -39.74 84.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.225 -0.898 . . . . 1.0 109.648 176.006 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.446 ' HB2' ' HE1' ' A' ' 20' ' ' MET . 46.1 t80 -53.44 -41.4 66.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.203 -0.908 . . . . 1.0 109.107 175.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.694 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -68.28 -39.83 82.01 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.323 -0.853 . . . . 1.0 110.629 177.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.683 HG23 ' HA ' ' A' ' 138' ' ' VAL . 15.9 t -55.6 -51.43 58.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-O 121.932 0.872 . . . . 1.0 109.83 177.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.446 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 7.0 mt -65.51 -51.59 61.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 114.755 -1.111 . . . . 1.0 111.775 -178.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.694 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 8.1 pt-20 -55.12 -32.79 62.32 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.839 -0.344 . . . . 1.0 110.29 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 2.3 t -73.64 -30.18 62.79 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.488 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.453 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -86.17 -22.63 26.9 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-N 116.006 -0.543 . . . . 1.0 111.636 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.686 HD22 ' HB3' ' A' ' 25' ' ' PHE . 11.0 mt -54.18 -41.72 90.05 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 112.744 0.646 . . . . 1.0 112.744 -178.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.715 ' HA ' ' CD2' ' A' ' 150' ' ' HIS . 60.3 Cg_endo -68.36 -7.68 20.84 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 122.371 2.048 . . . . 1.0 111.866 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.574 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -108.48 -33.55 2.88 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 110.234 -1.146 . . . . 1.0 110.234 178.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.538 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -75.14 -54.34 7.31 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.327 -0.62 . . . . 1.0 109.327 -179.797 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . 0.715 ' CD2' ' HA ' ' A' ' 147' ' ' PRO . 2.0 p80 -56.16 -46.81 79.15 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 115.268 -0.878 . . . . 1.0 110.471 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.448 ' N ' ' CG ' ' A' ' 150' ' ' HIS . 2.0 t70 -59.62 -37.94 79.98 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.764 -1.107 . . . . 1.0 110.411 -178.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . 0.784 ' HZ3' HD21 ' A' ' 5' ' ' LEU . 28.2 t90 -64.52 -54.66 28.87 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 115.637 -0.71 . . . . 1.0 109.858 178.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.636 HG22 ' O ' ' A' ' 150' ' ' HIS . 3.5 m -58.77 -37.8 68.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.571 -0.529 . . . . 1.0 109.571 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.462 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 2.7 m-20 -59.44 -56.39 22.61 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 121.487 0.661 . . . . 1.0 110.765 177.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.609 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 6.3 pt-20 -60.63 -37.92 83.06 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 114.901 -1.045 . . . . 1.0 110.369 -177.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.477 ' HA ' ' HD3' ' A' ' 156' ' ' ARG . 1.0 OUTLIER -74.11 -48.67 27.97 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.571 -0.741 . . . . 1.0 111.361 -177.222 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 3.9 pp . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.233 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.579 ' HB2' ' HG2' ' A' ' 39' ' ' ARG . 25.3 Cg_endo . . . . . 0 C--O 1.235 0.338 0 N-CA-C 115.253 1.213 . . . . 1.0 115.253 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.655 HD21 ' HZ3' ' A' ' 152' ' ' TRP . 0.4 OUTLIER -74.3 -173.35 1.67 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 113.487 -1.688 . . . . 1.0 110.024 178.273 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.63 ' HB3' ' H ' ' A' ' 84' ' ' ASP . 3.0 t-160 -156.48 92.14 1.29 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.578 -0.449 . . . . 1.0 110.878 -178.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.784 HG13 HD13 ' A' ' 85' ' ' LEU . 2.9 t -96.1 111.11 25.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.351 -0.611 . . . . 1.0 109.351 177.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.57 HG22 ' HG ' ' A' ' 86' ' ' LEU . 9.2 t -112.17 113.88 26.38 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.221 0.534 . . . . 1.0 110.291 179.152 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.548 ' CE2' ' HA ' ' A' ' 22' ' ' GLU . 1.0 OUTLIER -83.43 125.3 31.56 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 122.004 -0.435 . . . . 1.0 110.289 -178.564 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.492 ' CG1' HG23 ' A' ' 45' ' ' THR . 37.6 t -112.18 111.12 34.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.802 -0.635 . . . . 1.0 112.161 -176.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.596 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 48.3 t -135.73 160.0 39.89 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.043 -1.095 . . . . 1.0 108.043 176.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -64.21 -32.23 73.73 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.334 0.588 . . . . 1.0 109.79 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.538 ' C ' ' H ' ' A' ' 15' ' ' ILE . . . -111.27 84.66 0.37 Allowed Glycine 0 N--CA 1.436 -1.328 0 CA-C-N 115.149 -0.932 . . . . 1.0 110.868 174.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.604 ' ND2' ' HB1' ' A' ' 73' ' ' ALA . 10.5 p-10 -65.0 16.07 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.262 1.425 . . . . 1.0 112.105 178.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.538 ' H ' ' C ' ' A' ' 13' ' ' GLY . 6.9 pt -119.89 -3.34 9.42 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.045 177.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.433 ' HB2' ' H ' ' A' ' 17' ' ' ARG . 9.2 m -115.13 -87.08 0.59 Allowed 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.679 -0.408 . . . . 1.0 112.041 -176.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.677 ' HG2' ' HG ' ' A' ' 89' ' ' LEU . 15.7 tpp180 -67.45 -50.43 59.24 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.352 -0.385 . . . . 1.0 112.014 -174.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.605 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 33.8 m -54.39 -59.05 11.24 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-N 116.321 -0.4 . . . . 1.0 111.882 -178.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.472 ' HA ' ' HB2' ' A' ' 22' ' ' GLU . 40.6 Cg_endo -63.89 -20.87 68.84 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 121.933 1.755 . . . . 1.0 113.029 -179.087 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.559 ' HB3' HD13 ' A' ' 142' ' ' ILE . 39.5 mmm -61.54 -55.51 30.2 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 110.056 -0.35 . . . . 1.0 110.056 177.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.418 ' HB2' ' CG2' ' A' ' 142' ' ' ILE . . . -72.24 -26.67 62.1 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 115.81 -0.632 . . . . 1.0 110.416 -179.008 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.64 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 18.1 tt0 -50.7 -54.56 22.14 Favored 'General case' 0 C--O 1.216 -0.686 0 CA-C-N 114.776 -1.102 . . . . 1.0 109.811 179.096 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.753 ' HB3' ' HG2' ' A' ' 68' ' ' PRO . 0.0 OUTLIER -84.15 -26.3 28.97 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.443 -0.799 . . . . 1.0 110.729 -175.803 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.565 ' HB3' HD11 ' A' ' 146' ' ' LEU . 90.9 mtp -63.91 -75.52 0.08 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.644 0.609 . . . . 1.0 112.644 -176.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.749 ' HB3' HD22 ' A' ' 146' ' ' LEU . 18.2 p90 -76.99 -29.57 55.54 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 119.696 -0.801 . . . . 1.0 111.311 -175.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.708 ' HB2' HG21 ' A' ' 40' ' ' VAL . . . -63.86 -37.0 85.75 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 119.2 -1.0 . . . . 1.0 110.562 179.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.676 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -63.84 -38.42 91.03 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 108.801 -0.814 . . . . 1.0 108.801 177.363 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.513 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 60.7 mt-30 -58.83 -43.84 90.79 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-O 121.149 0.499 . . . . 1.0 110.107 175.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.681 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 95.6 mt -54.84 -61.5 2.27 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.425 -0.807 . . . . 1.0 110.984 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.653 ' HD3' ' HA ' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -59.54 -35.73 74.77 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.763 -0.375 . . . . 1.0 111.565 179.633 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 3.4 m170 -62.83 -27.96 69.68 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 111.934 0.346 . . . . 1.0 111.934 177.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.681 ' HG2' ' O ' ' A' ' 29' ' ' LEU . 4.7 ptm85 -97.13 -22.0 17.01 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 119.796 -0.762 . . . . 1.0 110.291 -179.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 112.34 36.16 1.66 Allowed Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.226 -0.897 . . . . 1.0 112.528 177.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 18.9 mt -131.74 7.48 4.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.158 0.504 . . . . 1.0 109.814 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.409 ' HA3' ' HB3' ' A' ' 30' ' ' ARG . . . -60.56 -32.25 77.47 Favored Glycine 0 C--N 1.332 0.321 0 CA-C-N 115.831 -0.622 . . . . 1.0 113.03 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.648 ' HA ' ' NH1' ' A' ' 39' ' ' ARG . 3.2 m-20 -90.29 -15.41 31.28 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.935 0.398 . . . . 1.0 110.179 177.115 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -81.16 -22.7 38.77 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.61 -0.723 . . . . 1.0 110.916 178.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.594 HG13 ' HB3' ' A' ' 5' ' ' LEU . 8.7 t -133.7 123.35 45.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.675 0.274 . . . . 1.0 110.932 -178.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.648 ' NH1' ' HA ' ' A' ' 36' ' ' ASP . 24.2 mmt180 -96.92 98.0 9.74 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.157 0.503 . . . . 1.0 110.757 178.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.708 HG21 ' HB2' ' A' ' 26' ' ' ALA . 0.8 OUTLIER -92.25 120.89 42.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-O 122.209 1.005 . . . . 1.0 110.699 179.652 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.486 ' O ' ' HA ' ' A' ' 8' ' ' THR . 82.3 p -131.41 -175.24 3.64 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 113.466 -1.697 . . . . 1.0 110.082 -177.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.605 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 78.3 p -157.82 161.46 38.37 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.797 -0.361 . . . . 1.0 110.57 -178.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.635 ' HA ' ' O ' ' A' ' 74' ' ' ALA . . . -163.48 165.71 23.46 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.283 0.564 . . . . 1.0 111.522 -178.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.596 ' HA2' ' O ' ' A' ' 11' ' ' CYS . . . -126.01 134.07 8.51 Favored Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 115.284 -0.871 . . . . 1.0 111.415 178.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.492 HG23 ' CG1' ' A' ' 10' ' ' VAL . 26.9 p -71.57 -26.39 62.6 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.827 0.313 . . . . 1.0 111.433 -178.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -107.88 7.8 36.09 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.892 -0.671 . . . . 1.0 112.545 -177.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 43.34 39.8 2.3 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 113.569 0.951 . . . . 1.0 113.569 178.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -44.67 -76.2 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.443 0.639 . . . . 1.0 112.063 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 52.6 m-70 -107.01 44.46 1.06 Allowed 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.278 -0.873 . . . . 1.0 111.162 178.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.0 p -60.06 129.04 22.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.915 -0.584 . . . . 1.0 110.809 178.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.84 -13.42 66.0 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.899 -0.667 . . . . 1.0 112.26 -178.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -82.29 -162.48 0.56 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.009 0.433 . . . . 1.0 109.864 179.058 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 38.4 t -119.36 173.48 6.93 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.239 -0.652 . . . . 1.0 109.239 -179.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.73 135.55 47.06 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.821 0.343 . . . . 1.0 111.61 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.79 ' OD1' ' HG3' ' A' ' 57' ' ' ARG . 15.6 t0 -51.54 134.62 29.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.139 -0.937 . . . . 1.0 111.191 -179.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -48.31 -32.1 6.91 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.159 -0.928 . . . . 1.0 113.04 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.79 ' HG3' ' OD1' ' A' ' 55' ' ' ASP . 6.5 mtt180 -68.56 -50.71 49.76 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.254 0.55 . . . . 1.0 109.625 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.5 -32.19 71.98 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.006 -0.997 . . . . 1.0 110.405 -176.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.09 -45.45 94.68 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 109.433 -0.581 . . . . 1.0 109.433 176.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.25 -44.59 95.33 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.927 -0.654 . . . . 1.0 111.76 176.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.627 HG23 ' O ' ' A' ' 57' ' ' ARG . 64.5 t -57.05 -56.51 14.37 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 CA-C-O 121.279 0.561 . . . . 1.0 111.152 178.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.763 ' HB2' HG22 ' A' ' 69' ' ' THR . 88.4 mt -60.13 -52.46 65.25 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.087 -0.506 . . . . 1.0 111.398 -179.271 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -60.59 -28.61 68.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.687 -0.233 . . . . 1.0 110.897 -178.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.49 -34.12 77.22 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-O 121.106 0.479 . . . . 1.0 110.333 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -95.55 4.95 52.68 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.859 -0.61 . . . . 1.0 111.178 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.58 21.52 61.83 Favored Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 116.002 -0.544 . . . . 1.0 112.308 178.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -91.84 150.91 41.58 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.771 -0.214 . . . . 1.0 110.444 178.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.753 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 37.8 Cg_endo -68.41 155.68 68.32 Favored 'Trans proline' 0 CA--C 1.51 -0.687 0 C-N-CA 122.334 2.023 . . . . 1.0 110.162 176.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.763 HG22 ' HB2' ' A' ' 62' ' ' LEU . 56.6 p -134.79 7.3 3.49 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 119.778 -0.769 . . . . 1.0 111.709 -177.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.434 ' O ' ' HE2' ' A' ' 23' ' ' LYS . 12.8 t70 -74.49 132.52 41.96 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 108.791 -0.818 . . . . 1.0 108.791 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.485 ' HB2' ' HE2' ' A' ' 23' ' ' LYS . 37.2 t60 -170.05 151.12 3.91 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.132 0.491 . . . . 1.0 110.585 -175.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.405 ' HA ' ' HD3' ' A' ' 72' ' ' ARG . 3.2 tpp85 -130.71 109.37 10.57 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 107.818 -1.178 . . . . 1.0 107.818 176.057 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.604 ' HB1' ' ND2' ' A' ' 14' ' ' ASN . . . -56.32 137.45 52.42 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.097 -0.956 . . . . 1.0 112.084 -176.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.635 ' O ' ' HA ' ' A' ' 43' ' ' ALA . . . -133.6 145.41 50.01 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.834 -0.621 . . . . 1.0 109.976 179.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -84.45 154.77 22.57 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.737 -0.468 . . . . 1.0 109.737 177.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.538 HG11 ' CD2' ' A' ' 97' ' ' LEU . 16.6 t -62.39 107.17 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.359 0.599 . . . . 1.0 110.528 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.456 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -115.67 -174.21 17.74 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 115.089 -0.96 . . . . 1.0 110.869 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 68.2 m -57.04 -43.23 81.76 Favored 'General case' 0 C--N 1.319 -0.75 0 O-C-N 123.681 0.283 . . . . 1.0 110.304 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -58.33 -31.26 67.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 1.0 111.536 178.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.554 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 80.2 m80 -79.5 -37.71 36.08 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.834 0.35 . . . . 1.0 110.251 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 41.4 mt -67.97 -19.11 64.92 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.783 -0.644 . . . . 1.0 110.782 177.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.44 -3.39 59.0 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.909 -0.587 . . . . 1.0 110.732 -178.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.542 ' HB1' ' O ' ' A' ' 6' ' ' HIS . . . -61.81 152.08 32.52 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.948 -0.569 . . . . 1.0 111.646 179.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.63 ' H ' ' HB3' ' A' ' 6' ' ' HIS . 11.4 t70 -79.79 -14.32 58.79 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.071 0.463 . . . . 1.0 109.872 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.784 HD13 HG13 ' A' ' 7' ' ' VAL . 0.3 OUTLIER -154.2 117.06 4.44 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 108.641 -0.874 . . . . 1.0 108.641 -176.818 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.615 ' HB3' HD13 ' A' ' 97' ' ' LEU . 5.3 mp -107.98 106.31 16.5 Favored 'General case' 0 N--CA 1.423 -1.805 0 CA-C-N 115.683 -0.689 . . . . 1.0 109.639 178.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.547 HG11 HD23 ' A' ' 110' ' ' LEU . 55.6 t -85.72 91.71 3.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.204 -0.907 . . . . 1.0 110.542 -176.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.7 149.69 29.63 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.332 -0.849 . . . . 1.0 110.85 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.677 ' HG ' ' HG2' ' A' ' 17' ' ' ARG . 3.7 mm? -106.3 1.18 25.68 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.851 -0.613 . . . . 1.0 109.754 178.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -154.0 146.98 24.48 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.464 -0.789 . . . . 1.0 110.519 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.406 ' H ' ' HG2' ' A' ' 91' ' ' ARG . 11.4 ptt180 -60.58 -20.65 61.12 Favored 'General case' 0 C--N 1.33 -0.247 0 O-C-N 123.983 0.802 . . . . 1.0 110.946 177.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.726 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 78.9 m-20 -77.63 -47.82 18.36 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.19 -0.67 . . . . 1.0 109.19 178.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.737 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 8.8 m170 -61.26 -47.05 87.8 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 109.508 -0.552 . . . . 1.0 109.508 179.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.489 ' HA ' HG21 ' A' ' 107' ' ' VAL . . . -58.12 -42.37 85.62 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.1 -0.5 . . . . 1.0 110.732 179.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.69 ' O ' ' HG2' ' A' ' 99' ' ' GLN . 16.9 ttm180 -60.27 -45.29 93.8 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 115.636 -0.711 . . . . 1.0 111.47 178.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.765 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 50.1 mt -63.23 -49.99 72.01 Favored 'General case' 0 C--O 1.22 -0.475 0 O-C-N 123.52 0.513 . . . . 1.0 109.979 -175.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.737 ' HG ' ' O ' ' A' ' 93' ' ' HIS . 27.3 mt -53.49 -57.74 9.61 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.771 -0.649 . . . . 1.0 111.467 -178.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.575 ' HA ' ' HB ' ' A' ' 102' ' ' VAL . 6.6 ptt180 -60.42 -44.82 95.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.042 -0.526 . . . . 1.0 111.778 -176.385 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.69 ' HG2' ' O ' ' A' ' 95' ' ' ARG . 8.4 pt20 -67.71 -20.82 65.31 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.068 0.461 . . . . 1.0 110.608 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.765 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 8.2 mt -80.08 -8.32 59.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.967 -0.56 . . . . 1.0 111.814 179.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 147.5 -28.75 1.48 Allowed Glycine 0 C--N 1.331 0.303 0 C-N-CA 119.786 -1.197 . . . . 1.0 112.955 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.816 HG12 ' H ' ' A' ' 103' ' ' GLU . 2.1 t -73.84 -154.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 C-N-CA 123.036 0.535 . . . . 1.0 110.949 -178.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.816 ' H ' HG12 ' A' ' 102' ' ' VAL . 12.5 pt-20 -168.02 165.7 13.45 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.646 -0.872 . . . . 1.0 108.646 -179.092 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.78 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -65.59 -24.02 66.97 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.676 0.274 . . . . 1.0 111.664 -176.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.7 -36.62 74.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.418 0.628 . . . . 1.0 109.983 175.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.653 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 7.7 mtt-85 -94.92 -45.16 7.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.039 -0.982 . . . . 1.0 110.704 -177.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.78 HG12 ' HA ' ' A' ' 104' ' ' ALA . 7.3 p -79.94 122.6 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-O 121.415 0.626 . . . . 1.0 110.092 -177.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.538 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 7.8 mmm180 -138.12 146.31 42.68 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.079 -0.712 . . . . 1.0 109.079 -178.216 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.405 ' HB2' ' CB ' ' A' ' 112' ' ' SER . 86.5 mmm -79.22 134.95 36.66 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.024 -0.534 . . . . 1.0 110.378 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.547 HD23 HG11 ' A' ' 87' ' ' VAL . 3.2 tm? -56.97 -49.18 76.49 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.671 0.272 . . . . 1.0 111.108 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 16.6 ttm180 -69.52 -21.35 63.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.886 0.374 . . . . 1.0 110.53 -177.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.405 ' CB ' ' HB2' ' A' ' 109' ' ' MET . 32.6 t -77.04 -6.04 51.16 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.424 -0.353 . . . . 1.0 111.138 -178.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.571 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 85.6 m-85 -87.44 -19.97 27.28 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.952 -0.388 . . . . 1.0 109.952 175.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 61.7 t0 . . . . . 0 C--O 1.233 0.19 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.198 -178.836 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 . . . . . 0 CA--C 1.522 -0.128 0 CA-C-O 120.657 0.265 . . . . 1.0 111.307 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.62 ' O ' HG23 ' A' ' 141' ' ' VAL . 7.9 tp10 -61.22 -47.66 85.06 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 108.7 -0.852 . . . . 1.0 108.7 176.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.645 HG13 ' HD3' ' A' ' 17' ' ' ARG . 75.6 t -56.7 -47.54 82.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 114.419 -1.264 . . . . 1.0 110.084 176.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.518 ' HB2' HG11 ' A' ' 61' ' ' VAL . 52.7 t80 -55.58 -44.56 77.03 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.616 -1.174 . . . . 1.0 110.5 178.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.433 ' O ' ' HG2' ' A' ' 143' ' ' GLU . . . -62.83 -44.69 95.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.991 -0.55 . . . . 1.0 111.518 -179.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 137' ' ' GLU . 21.2 t -56.28 -48.03 80.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.338 0.59 . . . . 1.0 110.584 178.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.559 HD13 ' HB3' ' A' ' 20' ' ' MET . 5.8 mt -67.11 -49.56 71.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 115.413 -0.812 . . . . 1.0 112.127 -178.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.464 ' HA ' ' HG ' ' A' ' 146' ' ' LEU . 11.2 pt-20 -56.19 -32.7 64.61 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.98 0.419 . . . . 1.0 110.451 179.359 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 63.3 m -73.06 -27.4 61.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.902 -0.59 . . . . 1.0 110.612 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.477 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -86.44 -25.09 25.41 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 115.67 -0.696 . . . . 1.0 111.92 178.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.749 HD22 ' HB3' ' A' ' 25' ' ' PHE . 14.9 mt -55.49 -36.69 48.58 Favored Pre-proline 0 CA--C 1.546 0.814 0 N-CA-C 112.745 0.646 . . . . 1.0 112.745 -178.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.643 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 42.1 Cg_endo -68.58 -14.91 40.65 Favored 'Trans proline' 0 C--N 1.359 1.106 0 C-N-CA 122.317 2.011 . . . . 1.0 111.661 176.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.571 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -101.97 -34.12 4.42 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.133 -0.94 . . . . 1.0 110.941 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.501 HD11 HG21 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -72.49 -40.0 67.22 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.18 -1.044 . . . . 1.0 108.18 179.334 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . 0.482 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 0.2 OUTLIER -54.54 -54.28 43.33 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 114.648 -1.16 . . . . 1.0 110.541 175.427 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -57.27 -42.32 81.38 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.125 -0.943 . . . . 1.0 111.445 -175.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . 0.655 ' HZ3' HD21 ' A' ' 5' ' ' LEU . 18.0 t90 -62.27 -57.91 9.67 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.415 -0.811 . . . . 1.0 110.084 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.506 ' HB ' HD22 ' A' ' 5' ' ' LEU . 7.8 m -60.65 -43.82 95.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.675 -177.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.42 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 8.7 m-20 -60.87 -49.55 77.01 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 121.208 0.527 . . . . 1.0 111.015 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 5.4 pt-20 -64.85 -36.26 83.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.977 -0.556 . . . . 1.0 110.656 -178.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.53 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 0.6 OUTLIER -74.13 -43.41 57.61 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 115.769 -0.65 . . . . 1.0 110.869 -176.985 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 4.2 pp . . . . . 0 C--N 1.324 -0.5 0 CA-C-O 121.124 0.487 . . . . 1.0 109.748 178.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo . . . . . 0 N--CA 1.462 -0.325 0 CA-C-O 120.843 0.268 . . . . 1.0 111.842 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.798 HD13 ' HB3' ' A' ' 84' ' ' ASP . 0.2 OUTLIER -67.02 178.46 1.4 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.456 -0.572 . . . . 1.0 109.456 178.101 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.664 ' HA ' ' O ' ' A' ' 39' ' ' ARG . 2.7 t-160 -156.06 89.48 1.15 Allowed 'General case' 0 C--N 1.321 -0.651 0 O-C-N 122.053 -0.404 . . . . 1.0 109.989 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.769 HG13 HD13 ' A' ' 85' ' ' LEU . 2.1 t -96.51 105.57 17.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.366 -0.379 . . . . 1.0 110.134 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.645 ' CG2' ' HG ' ' A' ' 86' ' ' LEU . 13.0 t -108.65 115.44 30.09 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.079 0.466 . . . . 1.0 110.199 -179.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.568 ' HD1' ' HB ' ' A' ' 87' ' ' VAL . 0.7 OUTLIER -83.74 129.89 34.95 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.793 -0.447 . . . . 1.0 109.793 -178.952 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.657 HG21 HD11 ' A' ' 97' ' ' LEU . 22.0 t -114.38 113.01 42.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.737 -0.665 . . . . 1.0 111.945 -174.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.516 ' HA ' ' CE1' ' A' ' 93' ' ' HIS . 49.2 t -142.78 155.26 44.81 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.359 -0.608 . . . . 1.0 109.359 178.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.1 88.66 2.44 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.393 0.616 . . . . 1.0 111.157 -178.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.775 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 140.59 -45.74 0.96 Allowed Glycine 0 N--CA 1.445 -0.754 0 CA-C-N 115.313 -0.858 . . . . 1.0 111.062 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.676 ' ND2' ' H ' ' A' ' 74' ' ' ALA . 61.0 t30 58.63 23.86 11.43 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.674 0.75 . . . . 1.0 112.202 178.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.4 pt -124.51 3.88 4.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 O-C-N 121.616 -0.678 . . . . 1.0 111.494 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.673 ' O ' ' HG3' ' A' ' 20' ' ' MET . 27.9 m -129.4 -84.19 0.56 Allowed 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.597 -0.441 . . . . 1.0 111.064 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.49 ' H ' ' HD3' ' A' ' 17' ' ' ARG . 1.5 mpt_? -61.56 -58.83 6.58 Favored 'General case' 0 C--O 1.243 0.728 0 CA-C-N 116.211 -0.449 . . . . 1.0 111.939 -175.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.408 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 38.0 m -51.49 -58.58 10.32 Favored Pre-proline 0 CA--C 1.54 0.587 0 N-CA-C 112.982 0.734 . . . . 1.0 112.982 -178.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.408 ' HD3' ' HB2' ' A' ' 18' ' ' SER . 51.7 Cg_endo -63.67 -23.57 69.77 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 121.636 1.557 . . . . 1.0 112.495 -177.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.673 ' HG3' ' O ' ' A' ' 16' ' ' CYS . 61.2 mtp -61.98 -51.65 67.21 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.674 -0.41 . . . . 1.0 110.349 179.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.441 ' HA ' ' HB2' ' A' ' 24' ' ' MET . . . -71.58 -29.42 64.69 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.15 -0.62 . . . . 1.0 110.672 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.632 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 22.1 tt0 -53.17 -53.25 53.26 Favored 'General case' 0 C--O 1.219 -0.514 0 O-C-N 124.166 0.916 . . . . 1.0 110.171 -179.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.723 ' O ' ' HB3' ' A' ' 27' ' ' GLN . 0.3 OUTLIER -84.8 -23.11 29.28 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.031 -0.986 . . . . 1.0 110.364 -175.493 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.513 ' HB3' HD11 ' A' ' 146' ' ' LEU . 2.2 mmm -65.22 -76.35 0.07 Allowed 'General case' 0 C--O 1.238 0.477 0 N-CA-C 113.076 0.769 . . . . 1.0 113.076 -179.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.759 ' HB3' HD22 ' A' ' 146' ' ' LEU . 18.0 p90 -76.37 -29.38 57.13 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 119.852 -0.739 . . . . 1.0 111.243 -174.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.673 ' HB2' HG21 ' A' ' 40' ' ' VAL . . . -64.38 -35.73 81.85 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 119.577 -0.849 . . . . 1.0 110.818 178.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.723 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -63.99 -38.82 92.46 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.63 -0.878 . . . . 1.0 108.63 177.175 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.569 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 71.1 mt-30 -61.04 -41.71 97.09 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 115.285 -0.87 . . . . 1.0 110.638 175.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.562 ' HG ' ' O ' ' A' ' 25' ' ' PHE . 90.1 mt -57.07 -62.01 2.05 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 115.956 -0.566 . . . . 1.0 111.172 -179.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.699 ' HE ' ' HA ' ' A' ' 27' ' ' GLN . 0.1 OUTLIER -58.06 -32.55 68.12 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 120.468 -0.493 . . . . 1.0 111.325 179.582 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -64.11 -28.07 69.52 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.15 0.426 . . . . 1.0 112.15 176.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.583 ' HG3' ' HG ' ' A' ' 34' ' ' LEU . 7.3 ptp180 -95.4 -20.54 19.01 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 121.843 0.83 . . . . 1.0 109.625 178.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 108.77 31.93 3.26 Favored Glycine 0 N--CA 1.441 -0.972 0 CA-C-N 114.833 -1.076 . . . . 1.0 112.101 176.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.583 ' HG ' ' HG3' ' A' ' 32' ' ' ARG . 22.7 mt -119.54 0.5 11.03 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 122.434 -0.451 . . . . 1.0 109.959 -178.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.419 ' H ' ' HA ' ' A' ' 30' ' ' ARG . . . -53.9 -32.13 48.11 Favored Glycine 0 C--N 1.331 0.295 0 CA-C-N 115.943 -0.572 . . . . 1.0 113.137 -179.099 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.774 ' HA ' ' NH1' ' A' ' 39' ' ' ARG . 0.1 OUTLIER -89.52 -20.63 23.59 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-O 121.273 0.559 . . . . 1.0 110.312 178.66 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.89 -25.09 40.73 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.568 -0.742 . . . . 1.0 111.127 -177.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.74 HG23 ' HB3' ' A' ' 5' ' ' LEU . 0.5 OUTLIER -141.16 124.77 16.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.219 0.533 . . . . 1.0 110.826 179.707 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.774 ' NH1' ' HA ' ' A' ' 36' ' ' ASP . 24.6 mmt180 -95.5 106.5 18.58 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.57 -0.741 . . . . 1.0 111.262 -178.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.673 HG21 ' HB2' ' A' ' 26' ' ' ALA . 1.5 m -90.49 137.64 21.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-N 115.884 -0.598 . . . . 1.0 109.396 178.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.517 ' O ' ' HA ' ' A' ' 8' ' ' THR . 24.6 p -146.25 -178.07 5.95 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.063 -0.971 . . . . 1.0 110.009 -175.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.3 p -158.01 157.18 32.49 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.296 -0.562 . . . . 1.0 110.866 -177.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.606 ' HB2' ' CD2' ' A' ' 80' ' ' HIS . . . -163.23 164.51 25.03 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 121.475 0.655 . . . . 1.0 111.64 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' A' ' 11' ' ' CYS . . . -122.63 133.92 9.4 Favored Glycine 0 N--CA 1.441 -0.984 0 CA-C-N 115.06 -0.973 . . . . 1.0 111.046 177.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.529 HG23 ' CG1' ' A' ' 10' ' ' VAL . 12.3 p -69.68 -23.47 63.45 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.834 0.349 . . . . 1.0 111.762 -177.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.439 ' HA3' ' CZ3' ' A' ' 48' ' ' TRP . . . -109.84 8.48 31.79 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.723 -0.751 . . . . 1.0 113.239 -178.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 42.11 38.68 1.16 Allowed 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 113.551 0.945 . . . . 1.0 113.551 178.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.775 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 1.2 m-90 -46.9 -74.29 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.347 0.594 . . . . 1.0 112.278 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.452 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 46.5 m-70 -107.07 42.45 1.3 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.314 -0.857 . . . . 1.0 111.349 -179.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.451 HG23 ' HA ' ' A' ' 74' ' ' ALA . 14.6 p -61.58 132.02 26.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.215 178.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.35 -14.53 63.52 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.921 -0.657 . . . . 1.0 112.186 -177.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.49 -158.84 0.28 Allowed 'General case' 0 C--O 1.236 0.391 0 CA-C-O 120.986 0.422 . . . . 1.0 109.959 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.3 t -133.55 173.36 11.59 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.494 -0.558 . . . . 1.0 109.494 -178.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.67 148.15 20.82 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.015 -0.539 . . . . 1.0 111.507 -178.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.406 ' OD1' ' HG2' ' A' ' 57' ' ' ARG . 15.6 t70 -68.41 145.8 53.79 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.371 -0.831 . . . . 1.0 111.417 -178.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.416 ' HG3' ' N ' ' A' ' 57' ' ' ARG . 6.4 pt-20 -47.58 -37.74 12.97 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.953 -1.021 . . . . 1.0 113.224 178.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.613 ' O ' HG23 ' A' ' 61' ' ' VAL . 19.9 ptp180 -70.68 -44.43 67.02 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 121.136 -0.226 . . . . 1.0 110.777 -176.071 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.404 ' O ' HD13 ' A' ' 62' ' ' LEU . . . -70.15 -30.86 68.13 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.689 -0.486 . . . . 1.0 109.689 -179.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.46 -46.75 84.8 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.635 -0.711 . . . . 1.0 109.504 176.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.458 ' O ' ' HG2' ' A' ' 63' ' ' ARG . . . -62.72 -41.98 99.76 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.843 -0.694 . . . . 1.0 111.927 178.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 57' ' ' ARG . 97.5 t -58.23 -59.35 3.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.429 0.633 . . . . 1.0 111.622 178.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.488 ' HB2' HG22 ' A' ' 69' ' ' THR . 10.0 mp -61.72 -48.05 82.51 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.754 -0.657 . . . . 1.0 111.048 -177.155 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.458 ' HG2' ' O ' ' A' ' 60' ' ' GLY . 22.1 ptt180 -58.74 -31.44 68.32 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.611 -0.268 . . . . 1.0 110.888 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.65 -34.24 76.55 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.223 0.535 . . . . 1.0 110.826 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.461 ' HD2' ' O ' ' A' ' 61' ' ' VAL . 90.1 m-70 -96.91 5.55 50.3 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.587 -0.733 . . . . 1.0 110.866 -178.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.85 17.38 63.53 Favored Glycine 0 C--N 1.33 0.236 0 CA-C-N 115.7 -0.682 . . . . 1.0 113.165 176.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.544 ' HD1' ' HG2' ' A' ' 27' ' ' GLN . 71.1 m-85 -88.68 154.89 50.78 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-O 120.501 0.191 . . . . 1.0 110.827 179.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.596 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 21.9 Cg_endo -67.46 151.81 79.54 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.354 2.036 . . . . 1.0 110.123 174.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.488 HG22 ' HB2' ' A' ' 62' ' ' LEU . 67.1 p -132.68 20.15 4.24 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 120.271 -0.572 . . . . 1.0 112.181 -175.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.41 ' C ' ' HZ3' ' A' ' 23' ' ' LYS . 31.3 t70 -113.8 128.2 56.31 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.965 -177.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.581 ' HB3' ' NZ ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -165.76 159.44 16.19 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.429 -0.805 . . . . 1.0 108.923 178.838 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -116.35 120.15 37.94 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.627 -0.879 . . . . 1.0 108.627 178.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 49' ' ' HIS . . . -61.03 136.89 58.22 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.833 0.349 . . . . 1.0 111.77 -178.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.676 ' H ' ' ND2' ' A' ' 14' ' ' ASN . . . -127.63 163.54 24.0 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.07 178.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -98.91 157.26 16.43 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.476 -0.935 . . . . 1.0 108.476 178.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.546 HG11 HD23 ' A' ' 97' ' ' LEU . 41.9 t -71.71 111.98 6.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.159 0.504 . . . . 1.0 110.271 179.229 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.46 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -124.43 -165.21 12.13 Favored Glycine 0 N--CA 1.437 -1.275 0 CA-C-N 115.497 -0.774 . . . . 1.0 111.324 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 83.5 m -56.17 -51.2 68.88 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 122.651 0.381 . . . . 1.0 111.877 -179.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.516 ' HG2' ' N ' ' A' ' 80' ' ' HIS . 0.7 OUTLIER -58.15 -29.76 65.83 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.844 -0.616 . . . . 1.0 110.704 -178.589 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.606 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 79.3 m80 -76.82 -41.61 43.63 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 115.793 -0.64 . . . . 1.0 110.349 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.64 ' O ' HG23 ' A' ' 102' ' ' VAL . 16.6 mt -68.83 -18.67 64.2 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.442 176.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.06 -5.51 59.2 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.185 -178.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.601 ' HB1' ' O ' ' A' ' 6' ' ' HIS . . . -61.34 153.23 27.27 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.534 -0.757 . . . . 1.0 110.764 179.084 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.798 ' HB3' HD13 ' A' ' 5' ' ' LEU . 12.2 t70 -82.46 -11.93 58.18 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.242 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.769 HD13 HG13 ' A' ' 7' ' ' VAL . 0.3 OUTLIER -156.61 114.19 3.2 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 109.283 -0.636 . . . . 1.0 109.283 -178.224 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.645 ' HG ' ' CG2' ' A' ' 8' ' ' THR . 5.1 mp -105.74 106.33 16.78 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 115.407 -0.815 . . . . 1.0 110.069 178.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.6 HG11 HD23 ' A' ' 110' ' ' LEU . 52.6 t -84.79 93.43 3.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 114.772 -1.104 . . . . 1.0 110.856 -176.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.54 143.98 34.34 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.193 -0.912 . . . . 1.0 110.562 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.424 HD23 ' HB2' ' A' ' 11' ' ' CYS . 4.3 mm? -93.39 -19.24 21.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.494 0.664 . . . . 1.0 109.848 178.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -139.86 154.91 47.42 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.443 -0.799 . . . . 1.0 110.311 -178.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.402 ' HG2' ' H ' ' A' ' 91' ' ' ARG . 5.2 ptm180 -58.67 -22.32 56.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.889 -0.596 . . . . 1.0 111.619 178.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.642 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 94.5 m-20 -75.41 -52.08 11.59 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.861 -0.609 . . . . 1.0 110.278 -178.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.669 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 17.5 m170 -55.92 -45.24 78.77 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.38 -0.827 . . . . 1.0 110.814 -179.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.428 ' HA ' HD12 ' A' ' 97' ' ' LEU . . . -59.86 -44.07 94.33 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.107 0.48 . . . . 1.0 110.463 178.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 13.6 ttm180 -58.99 -42.65 90.54 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.317 -0.856 . . . . 1.0 111.522 178.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.675 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 34.9 mt -66.32 -47.16 74.43 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.599 -177.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.669 ' HG ' ' O ' ' A' ' 93' ' ' HIS . 33.1 mt -53.14 -59.84 4.05 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.189 -0.459 . . . . 1.0 111.725 -177.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.67 ' CA ' HG12 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -58.46 -44.25 89.2 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.406 0.521 . . . . 1.0 112.406 -179.66 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.605 ' HG3' ' O ' ' A' ' 96' ' ' LEU . 1.0 OUTLIER -67.25 -24.74 65.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.115 0.483 . . . . 1.0 109.814 179.599 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.675 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 12.5 mt -80.82 -19.46 44.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.456 -0.793 . . . . 1.0 111.896 178.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 152.71 -22.84 0.82 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 119.37 -1.395 . . . . 1.0 114.314 -177.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.687 HG13 ' N ' ' A' ' 103' ' ' GLU . 0.3 OUTLIER -76.05 -161.92 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-N 117.988 0.894 . . . . 1.0 110.502 -179.096 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.824 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 8.6 pt-20 -158.06 160.27 37.21 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 107.671 -1.233 . . . . 1.0 107.671 -177.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.775 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -60.86 -27.08 67.86 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 123.194 0.309 . . . . 1.0 111.183 -175.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.48 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . . . -57.4 -35.38 69.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.101 0.477 . . . . 1.0 110.706 176.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.824 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 9.4 mtt-85 -99.51 -39.68 8.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.508 -0.769 . . . . 1.0 111.551 -177.15 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.775 HG12 ' HA ' ' A' ' 104' ' ' ALA . 9.3 p -80.06 122.25 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 120.661 -0.416 . . . . 1.0 110.85 -174.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.497 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 14.3 mmm180 -141.56 150.54 42.22 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 121.846 -0.534 . . . . 1.0 111.057 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 85.7 mmm -80.92 140.0 35.55 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.726 -0.67 . . . . 1.0 110.525 178.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.6 HD23 HG11 ' A' ' 87' ' ' VAL . 3.0 tm? -58.31 -49.73 76.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.588 0.232 . . . . 1.0 111.245 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 47.7 ttt180 -72.03 -15.7 62.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.714 0.292 . . . . 1.0 111.031 -177.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.4 t -72.46 -10.62 60.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.659 -0.246 . . . . 1.0 110.636 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.533 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 95.8 m-85 -89.39 -20.1 24.38 Favored 'General case' 0 C--O 1.233 0.203 0 O-C-N 122.224 -0.297 . . . . 1.0 110.826 177.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 19.8 t0 . . . . . 0 N--CA 1.466 0.325 0 CA-C-N 115.969 -0.559 . . . . 1.0 111.554 -177.133 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 . . . . . 0 N--CA 1.455 -0.183 0 CA-C-O 120.467 0.175 . . . . 1.0 111.176 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -63.76 -51.07 66.52 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.108 0.48 . . . . 1.0 109.823 177.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.788 ' HA ' HG12 ' A' ' 141' ' ' VAL . 21.3 t -63.11 -41.13 91.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.749 0.785 . . . . 1.0 109.335 177.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.494 ' HB2' HG11 ' A' ' 61' ' ' VAL . 66.8 t80 -56.31 -43.22 78.75 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.566 -0.743 . . . . 1.0 109.727 177.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.531 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -66.92 -49.88 64.16 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.389 -0.823 . . . . 1.0 111.871 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.788 HG12 ' HA ' ' A' ' 138' ' ' VAL . 5.6 p -57.2 -43.19 81.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 CA-C-O 121.565 0.698 . . . . 1.0 110.671 -178.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.633 HD12 HG12 ' A' ' 138' ' ' VAL . 16.4 mt -68.46 -53.83 25.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 115.031 -0.986 . . . . 1.0 111.934 178.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.536 ' HA ' ' HG ' ' A' ' 146' ' ' LEU . 8.3 pt-20 -57.56 -28.43 63.54 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.513 -0.312 . . . . 1.0 110.372 -179.016 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 3.1 t -73.78 -30.04 62.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.085 0.469 . . . . 1.0 110.265 177.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.468 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -86.57 -23.37 25.83 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 116.187 -0.461 . . . . 1.0 111.904 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.759 HD22 ' HB3' ' A' ' 25' ' ' PHE . 17.5 mt -54.9 -37.56 57.51 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 112.146 0.424 . . . . 1.0 112.146 -178.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.622 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 56.1 Cg_endo -69.58 -9.19 25.53 Favored 'Trans proline' 0 C--N 1.364 1.366 0 C-N-CA 122.413 2.076 . . . . 1.0 112.35 177.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.533 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -106.09 -33.27 3.51 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 110.257 -1.137 . . . . 1.0 110.257 178.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.466 HD11 HG21 ' A' ' 87' ' ' VAL . 0.3 OUTLIER -73.4 -41.66 63.05 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.814 -0.81 . . . . 1.0 108.814 178.934 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . 0.447 ' O ' ' HB2' ' A' ' 154' ' ' ASP . 2.1 m-70 -54.56 -50.88 66.9 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.134 -0.939 . . . . 1.0 110.628 177.067 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -60.98 -46.28 91.39 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.493 -0.776 . . . . 1.0 111.389 -176.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . 0.767 ' HZ3' HD11 ' A' ' 5' ' ' LEU . 21.1 t90 -59.45 -55.5 33.88 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.164 -0.925 . . . . 1.0 111.033 -177.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.485 HG11 HG21 ' A' ' 7' ' ' VAL . 6.1 m -61.88 -40.15 86.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.44 -177.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.571 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 1.1 t70 -60.03 -56.23 24.19 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 121.562 0.696 . . . . 1.0 110.574 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -63.25 -35.66 81.09 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.894 -1.048 . . . . 1.0 110.922 -176.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 19.5 mmt-85 -72.17 -45.74 59.22 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.743 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.571 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 4.0 pp . . . . . 0 CA--C 1.52 -0.184 0 N-CA-C 109.417 -0.586 . . . . 1.0 109.417 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.774 ' HG3' ' HE ' ' A' ' 39' ' ' ARG . 49.0 Cg_endo . . . . . 0 N--CA 1.462 -0.348 0 N-CA-C 113.541 0.554 . . . . 1.0 113.541 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.813 HD21 ' HZ3' ' A' ' 152' ' ' TRP . 0.6 OUTLIER -75.65 -172.58 1.91 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.155 -0.93 . . . . 1.0 110.662 178.219 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.509 ' O ' ' HB1' ' A' ' 83' ' ' ALA . 0.1 OUTLIER -157.11 92.8 1.28 Allowed 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 121.107 -0.237 . . . . 1.0 111.136 179.641 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.639 HG13 HD13 ' A' ' 85' ' ' LEU . 1.9 t -97.12 115.3 36.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 108.802 -0.814 . . . . 1.0 108.802 176.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.616 ' CG2' ' HG ' ' A' ' 86' ' ' LEU . 7.2 t -116.28 117.58 30.39 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 120.821 0.343 . . . . 1.0 110.239 178.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.627 ' HD2' ' HB3' ' A' ' 42' ' ' SER . 2.0 m-85 -85.52 133.89 34.06 Favored 'General case' 0 CA--C 1.518 -0.276 0 O-C-N 121.974 -0.454 . . . . 1.0 110.883 -179.08 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.633 HG21 HD11 ' A' ' 97' ' ' LEU . 28.8 t -118.07 118.69 59.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.204 0.526 . . . . 1.0 111.497 -177.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.502 ' HA ' ' CE1' ' A' ' 93' ' ' HIS . 33.9 t -146.54 170.82 16.11 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 178.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.623 HG23 ' NE2' ' A' ' 93' ' ' HIS . 0.9 OUTLIER -80.64 92.65 6.01 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.25 0.548 . . . . 1.0 110.856 179.959 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.967 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 129.35 -40.39 1.7 Allowed Glycine 0 N--CA 1.441 -0.97 0 C-N-CA 120.597 -0.811 . . . . 1.0 111.74 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.472 HD21 ' CB ' ' A' ' 42' ' ' SER . 4.2 t-20 64.33 14.62 8.89 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.843 0.83 . . . . 1.0 111.338 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.486 ' HA ' ' HG3' ' A' ' 19' ' ' PRO . 14.5 pt -121.54 4.21 6.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 O-C-N 121.705 -0.622 . . . . 1.0 112.074 -177.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 6.1 p -120.3 -87.55 0.64 Allowed 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.926 -0.309 . . . . 1.0 111.81 -177.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 12.6 mtp180 -72.21 -45.06 61.86 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.29 0.478 . . . . 1.0 112.29 -175.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.567 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 18.5 m -55.01 -56.72 24.82 Favored Pre-proline 0 CA--C 1.541 0.603 0 N-CA-C 112.099 0.407 . . . . 1.0 112.099 179.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.494 ' HD3' ' HB2' ' A' ' 18' ' ' SER . 57.6 Cg_endo -68.53 -21.59 39.78 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 121.765 1.644 . . . . 1.0 112.539 -177.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.594 ' HB3' HD13 ' A' ' 142' ' ' ILE . 34.0 mmm -60.82 -53.13 61.06 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.601 -0.272 . . . . 1.0 110.32 177.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.473 ' HA ' ' HB2' ' A' ' 24' ' ' MET . . . -75.26 -25.43 58.03 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.234 -0.586 . . . . 1.0 110.61 -179.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.615 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 17.8 tt0 -52.31 -53.58 42.5 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 115.489 -0.778 . . . . 1.0 109.94 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.586 ' O ' ' HB3' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -85.88 -23.58 27.0 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.209 -0.905 . . . . 1.0 110.758 -175.787 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.646 ' HB3' HD11 ' A' ' 146' ' ' LEU . 7.0 mmm -61.78 -75.55 0.07 Allowed 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.563 0.579 . . . . 1.0 112.563 -178.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.702 ' HB3' HD13 ' A' ' 146' ' ' LEU . 26.5 p90 -80.65 -28.72 36.79 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.179 -0.608 . . . . 1.0 111.573 -174.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' A' ' 22' ' ' GLU . . . -63.65 -38.97 93.11 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 119.237 -0.985 . . . . 1.0 110.261 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.612 ' HA ' ' HD3' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -64.88 -37.65 88.35 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 108.845 -0.798 . . . . 1.0 108.845 177.272 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.6 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 79.1 mt-30 -59.02 -47.59 84.66 Favored 'General case' 0 CA--C 1.522 -0.097 0 CA-C-N 116.433 -0.349 . . . . 1.0 110.413 175.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 25' ' ' PHE . 95.6 mt -52.07 -56.26 15.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.835 -0.62 . . . . 1.0 111.071 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.612 ' HD3' ' HA ' ' A' ' 27' ' ' GLN . 0.1 OUTLIER -61.67 -37.4 83.93 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.647 -0.421 . . . . 1.0 111.797 178.866 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 8.1 m170 -62.82 -23.39 67.24 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.391 0.515 . . . . 1.0 112.391 178.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.6 ' HG2' ' O ' ' A' ' 28' ' ' GLN . 7.9 ptp180 -98.49 -21.52 16.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.48 0.657 . . . . 1.0 110.185 178.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 108.03 39.85 1.78 Allowed Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 115.24 -0.891 . . . . 1.0 112.297 177.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 15.9 mt -137.46 -3.11 1.93 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.034 0.445 . . . . 1.0 109.9 -177.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.463 ' H ' ' HA ' ' A' ' 30' ' ' ARG . . . -62.82 -23.58 65.65 Favored Glycine 0 C--N 1.332 0.325 0 CA-C-N 115.856 -0.611 . . . . 1.0 112.585 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -83.75 -32.86 25.22 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.272 0.558 . . . . 1.0 109.537 176.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.49 -15.84 55.75 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.45 -0.796 . . . . 1.0 111.334 -178.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.427 HG13 ' HB3' ' A' ' 5' ' ' LEU . 35.5 t -130.58 121.61 51.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 110.237 -0.282 . . . . 1.0 110.237 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.774 ' HE ' ' HG3' ' A' ' 4' ' ' PRO . 7.2 mmt180 -93.24 134.83 35.04 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 109.873 -0.417 . . . . 1.0 109.873 177.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.43 HG11 ' HB2' ' A' ' 26' ' ' ALA . 55.1 t -129.85 119.72 48.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 121.699 0.761 . . . . 1.0 109.877 -177.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.494 ' O ' ' HA ' ' A' ' 8' ' ' THR . 48.0 p -133.65 -174.12 3.43 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 113.693 -1.594 . . . . 1.0 110.809 -175.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.627 ' HB3' ' HD2' ' A' ' 9' ' ' PHE . 81.8 p -161.82 166.9 25.73 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 120.931 -0.308 . . . . 1.0 110.47 179.136 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.578 ' HB2' ' CD2' ' A' ' 80' ' ' HIS . . . -164.54 169.61 16.88 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.447 0.642 . . . . 1.0 111.728 -179.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -127.85 140.9 12.15 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.266 -0.879 . . . . 1.0 111.028 178.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.475 HG21 HD12 ' A' ' 96' ' ' LEU . 39.9 p -76.7 -23.2 53.15 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.935 0.368 . . . . 1.0 111.829 -177.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.498 ' HA3' ' CZ3' ' A' ' 48' ' ' TRP . . . -112.03 11.91 26.91 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.511 -0.852 . . . . 1.0 113.156 -177.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.43 ' HB3' ' HB2' ' A' ' 75' ' ' GLN . 2.7 p-10 43.11 39.9 2.1 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 113.572 0.953 . . . . 1.0 113.572 178.165 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.967 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 1.3 m-90 -46.84 -77.0 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.531 0.682 . . . . 1.0 112.306 179.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.556 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 11.3 m-70 -105.45 41.77 1.32 Allowed 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.525 -0.761 . . . . 1.0 111.06 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.558 HG23 ' HA ' ' A' ' 74' ' ' ALA . 12.9 p -61.04 125.85 17.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.119 0.485 . . . . 1.0 110.181 178.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.805 ' HA2' ' HD3' ' A' ' 72' ' ' ARG . . . 95.27 -15.23 63.74 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 121.06 -0.591 . . . . 1.0 111.637 -176.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.529 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 3.3 t -79.58 -159.99 0.23 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.251 0.548 . . . . 1.0 109.746 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 36.1 t -128.14 175.06 8.71 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 109.189 -0.671 . . . . 1.0 109.189 -179.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.57 142.48 39.25 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.87 0.367 . . . . 1.0 111.29 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -62.79 143.62 57.33 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.663 -0.699 . . . . 1.0 112.557 -176.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.601 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 12.2 pt-20 -43.61 -42.32 5.1 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 114.383 -1.28 . . . . 1.0 113.748 178.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.673 ' O ' HG23 ' A' ' 61' ' ' VAL . 10.0 mtt-85 -70.16 -48.4 57.51 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 120.784 0.326 . . . . 1.0 110.462 -176.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.38 -31.49 70.89 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.224 -0.898 . . . . 1.0 110.298 -177.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.73 -45.84 84.77 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.66 -0.496 . . . . 1.0 109.66 176.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.07 -39.93 98.62 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.708 -0.758 . . . . 1.0 111.489 178.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.673 HG23 ' O ' ' A' ' 57' ' ' ARG . 88.8 t -58.67 -59.16 4.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-O 121.233 0.54 . . . . 1.0 111.242 178.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.679 ' HB2' HG22 ' A' ' 69' ' ' THR . 96.6 mt -60.4 -50.09 74.99 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.939 -0.573 . . . . 1.0 111.54 -177.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 6.9 ptm85 -61.72 -27.56 68.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.723 -0.217 . . . . 1.0 111.008 -178.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.7 -34.14 76.3 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.453 0.644 . . . . 1.0 110.387 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.42 ' HD2' ' O ' ' A' ' 61' ' ' VAL . 94.1 m-70 -96.41 4.98 51.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.562 -0.744 . . . . 1.0 111.43 -178.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.15 11.48 64.78 Favored Glycine 0 C--N 1.329 0.188 0 C-N-CA 121.026 -0.607 . . . . 1.0 112.743 177.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -89.84 149.75 42.54 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-O 120.691 0.282 . . . . 1.0 110.773 -179.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.456 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 37.6 Cg_endo -67.91 156.14 67.05 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.285 1.99 . . . . 1.0 110.878 177.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.679 HG22 ' HB2' ' A' ' 62' ' ' LEU . 80.4 p -130.85 14.24 5.3 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 120.191 -0.604 . . . . 1.0 111.032 -176.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -77.2 132.66 38.86 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.513 -0.767 . . . . 1.0 109.856 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.461 ' HB2' ' HE2' ' A' ' 23' ' ' LYS . 54.4 t60 -172.17 148.0 2.11 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.038 0.447 . . . . 1.0 110.797 -177.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.805 ' HD3' ' HA2' ' A' ' 51' ' ' GLY . 5.3 tmm_? -131.41 108.45 9.62 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 107.153 -1.425 . . . . 1.0 107.153 176.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 49' ' ' HIS . . . -58.73 139.99 55.44 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.071 -0.968 . . . . 1.0 112.474 -174.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.558 ' HA ' HG23 ' A' ' 50' ' ' VAL . . . -134.58 147.16 50.18 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.707 -0.678 . . . . 1.0 110.113 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.43 ' HB2' ' HB3' ' A' ' 47' ' ' ASN . 49.0 tt0 -83.79 153.56 24.03 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 110.116 -0.327 . . . . 1.0 110.116 176.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.597 HG11 HD23 ' A' ' 97' ' ' LEU . 82.0 t -63.56 112.56 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.033 -0.531 . . . . 1.0 110.909 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.432 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -122.4 -171.79 13.94 Favored Glycine 0 N--CA 1.442 -0.915 0 N-CA-C 111.055 -0.818 . . . . 1.0 111.055 178.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 90.8 m -57.88 -44.19 86.52 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.707 0.289 . . . . 1.0 110.935 -179.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -58.97 -29.99 67.6 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.186 -0.461 . . . . 1.0 111.641 178.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.578 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 79.7 m80 -78.66 -39.62 36.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.821 0.343 . . . . 1.0 110.169 179.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.712 ' HA ' HD21 ' A' ' 86' ' ' LEU . 16.2 mt -69.49 -15.19 63.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.112 0.482 . . . . 1.0 110.101 177.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.37 -5.83 59.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.323 -0.399 . . . . 1.0 110.543 -179.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.509 ' HB1' ' O ' ' A' ' 6' ' ' HIS . . . -63.35 154.36 32.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.906 -0.588 . . . . 1.0 110.976 179.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.408 ' HA ' HH11 ' A' ' 106' ' ' ARG . 21.2 t70 -80.9 -14.78 57.69 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 109.871 -0.418 . . . . 1.0 109.871 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.756 HD12 ' CE3' ' A' ' 152' ' ' TRP . 0.9 OUTLIER -152.72 113.51 4.13 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.484 -0.78 . . . . 1.0 109.73 -177.43 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.712 HD21 ' HA ' ' A' ' 81' ' ' LEU . 5.5 mp -105.72 87.65 2.64 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.534 -0.757 . . . . 1.0 110.951 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.607 HG23 HD22 ' A' ' 85' ' ' LEU . 54.6 t -66.36 92.88 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 113.806 -1.543 . . . . 1.0 112.237 -178.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.06 145.54 32.4 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.393 -1.276 . . . . 1.0 109.917 177.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.413 HD13 ' HA ' ' A' ' 89' ' ' LEU . 4.0 mm? -98.57 -8.53 26.32 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.955 0.407 . . . . 1.0 110.094 179.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.417 ' CG ' ' H ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -152.03 153.81 34.74 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.694 -0.685 . . . . 1.0 111.066 179.945 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -55.3 -27.67 48.35 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.251 -0.886 . . . . 1.0 113.104 -178.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.581 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 91.6 m-20 -75.51 -49.97 17.09 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.734 0.302 . . . . 1.0 110.504 -177.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.628 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 18.2 m170 -53.94 -46.02 71.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.428 179.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.91 -43.94 91.17 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.941 0.4 . . . . 1.0 110.735 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 16.6 ttm180 -61.3 -39.84 91.96 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.722 -0.672 . . . . 1.0 111.602 178.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.581 ' HG ' ' O ' ' A' ' 92' ' ' ASN . 43.9 mt -67.06 -50.74 60.87 Favored 'General case' 0 C--O 1.217 -0.645 0 CA-C-N 116.43 -0.35 . . . . 1.0 110.416 -178.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.634 HD13 ' HB3' ' A' ' 86' ' ' LEU . 29.2 mt -52.0 -57.45 9.44 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.971 -0.559 . . . . 1.0 111.387 -177.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.714 ' CA ' HG12 ' A' ' 102' ' ' VAL . 9.5 ptt180 -59.75 -44.12 93.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.659 -0.7 . . . . 1.0 112.439 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.546 ' HG3' ' O ' ' A' ' 96' ' ' LEU . 0.9 OUTLIER -67.66 -25.24 65.61 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.394 -0.522 . . . . 1.0 109.895 -179.972 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.494 HD13 ' O ' ' A' ' 96' ' ' LEU . 5.9 mp -77.68 -20.7 53.25 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 116.096 -0.502 . . . . 1.0 111.592 177.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 152.87 -21.15 0.78 Allowed Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 119.477 -1.344 . . . . 1.0 114.216 -178.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.714 HG12 ' CA ' ' A' ' 98' ' ' ARG . 0.3 OUTLIER -76.05 -162.35 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 118.048 0.924 . . . . 1.0 110.313 -179.51 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.741 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 10.7 pt-20 -159.34 160.6 35.23 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 107.753 -1.203 . . . . 1.0 107.753 -177.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.721 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -62.2 -25.1 67.6 Favored 'General case' 0 C--N 1.316 -0.876 0 O-C-N 123.465 0.478 . . . . 1.0 111.274 -175.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.41 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . . . -59.04 -30.2 67.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.011 0.434 . . . . 1.0 110.546 175.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.741 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 11.5 mtt-85 -105.41 -43.16 5.04 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 115.531 -0.759 . . . . 1.0 111.464 -177.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.721 HG12 ' HA ' ' A' ' 104' ' ' ALA . 11.3 p -78.38 117.93 24.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.497 -0.557 . . . . 1.0 109.497 -174.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.601 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 8.5 mmm180 -139.24 149.79 44.74 Favored 'General case' 0 C--N 1.322 -0.597 0 O-C-N 121.604 -0.685 . . . . 1.0 110.59 -176.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 87.7 mmm -80.39 131.49 35.62 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.079 -0.51 . . . . 1.0 111.26 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.53 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 2.8 tm? -53.54 -50.54 65.27 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 123.402 0.439 . . . . 1.0 111.028 179.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 43.7 ttt-85 -71.07 -16.67 62.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.308 -0.406 . . . . 1.0 110.956 -176.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 46.8 t -79.81 -2.31 42.75 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 120.706 -0.398 . . . . 1.0 111.034 -179.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.739 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 87.8 m-85 -92.74 -16.61 25.24 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-O 120.914 0.388 . . . . 1.0 109.972 175.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 22.1 t0 . . . . . 0 C--N 1.326 -0.421 0 CA-C-N 115.727 -0.669 . . . . 1.0 111.291 -178.261 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 . . . . . 0 N--CA 1.453 -0.295 0 CA-C-O 120.875 0.369 . . . . 1.0 110.248 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.561 ' O ' HG23 ' A' ' 141' ' ' VAL . 11.7 tp10 -62.76 -48.77 77.75 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.289 0.566 . . . . 1.0 110.048 178.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.679 ' HA ' HG23 ' A' ' 141' ' ' VAL . 73.5 t -61.51 -40.37 86.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.36 -0.836 . . . . 1.0 110.044 177.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.535 ' HB2' HG11 ' A' ' 61' ' ' VAL . 35.7 t80 -53.65 -42.12 67.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.129 -0.942 . . . . 1.0 109.204 175.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.637 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -67.18 -38.17 84.94 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.343 -0.844 . . . . 1.0 110.599 177.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.679 HG23 ' HA ' ' A' ' 138' ' ' VAL . 13.2 t -56.6 -53.58 39.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.58 0.705 . . . . 1.0 109.986 176.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.594 HD13 ' HB3' ' A' ' 20' ' ' MET . 6.0 mt -62.9 -50.43 79.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 114.883 -1.053 . . . . 1.0 111.842 -178.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.637 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 8.3 pt-20 -55.54 -33.33 63.72 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.628 0.252 . . . . 1.0 110.396 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 2.0 t -74.18 -28.53 61.33 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-O 121.064 0.459 . . . . 1.0 110.327 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.45 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -86.41 -23.3 26.14 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 116.329 -0.396 . . . . 1.0 111.851 179.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.702 HD13 ' HB3' ' A' ' 25' ' ' PHE . 11.9 mt -55.45 -38.31 66.5 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 112.37 0.507 . . . . 1.0 112.37 -179.063 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.621 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 58.0 Cg_endo -70.81 -10.13 27.12 Favored 'Trans proline' 0 C--N 1.359 1.107 0 C-N-CA 122.56 2.173 . . . . 1.0 112.211 178.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.739 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -105.12 -33.44 3.71 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 110.442 -1.063 . . . . 1.0 110.442 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.634 HD23 ' CE2' ' A' ' 25' ' ' PHE . 13.0 tp -73.86 -37.41 64.79 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.451 -1.314 . . . . 1.0 107.451 177.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . 0.451 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 0.2 OUTLIER -54.24 -51.5 64.29 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 114.549 -1.205 . . . . 1.0 109.57 174.195 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -59.16 -46.65 87.84 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.963 -1.017 . . . . 1.0 111.342 -176.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . 0.813 ' HZ3' HD21 ' A' ' 5' ' ' LEU . 28.7 t90 -63.0 -52.17 64.0 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.49 -0.777 . . . . 1.0 111.056 -178.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.473 HG13 ' O ' ' A' ' 149' ' ' LEU . 12.3 m -61.01 -39.39 82.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 120.545 -0.462 . . . . 1.0 109.919 -179.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.401 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 0.4 OUTLIER -61.11 -51.54 68.7 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 116.417 -0.356 . . . . 1.0 111.076 177.413 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.544 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 4.8 pt-20 -60.18 -39.34 86.12 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.256 0.55 . . . . 1.0 110.235 -178.017 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.558 ' HG3' ' CH2' ' A' ' 152' ' ' TRP . 17.3 mmt85 -72.11 -46.24 57.44 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.369 -0.832 . . . . 1.0 111.437 -176.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 4.3 pp . . . . . 0 C--N 1.327 -0.39 0 N-CA-C 109.317 -0.623 . . . . 1.0 109.317 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.595 ' HB2' ' HG2' ' A' ' 39' ' ' ARG . 11.1 Cg_endo . . . . . 0 C--O 1.236 0.389 0 N-CA-C 114.803 1.039 . . . . 1.0 114.803 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.71 HD21 ' HZ3' ' A' ' 152' ' ' TRP . 0.7 OUTLIER -70.79 -174.14 0.88 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 114.006 -1.452 . . . . 1.0 110.118 179.949 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.669 ' HA ' ' O ' ' A' ' 39' ' ' ARG . 1.4 t-160 -157.54 93.3 1.28 Allowed 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.493 -0.483 . . . . 1.0 111.159 -178.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.719 HG13 HD13 ' A' ' 85' ' ' LEU . 2.5 t -98.27 108.63 22.33 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.454 0 N-CA-C 109.916 -0.402 . . . . 1.0 109.916 177.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.533 ' HA ' ' O ' ' A' ' 41' ' ' THR . 14.7 t -109.88 116.88 32.44 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.143 0.497 . . . . 1.0 110.937 -179.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.561 ' CE2' ' HA ' ' A' ' 22' ' ' GLU . 0.4 OUTLIER -86.95 129.43 34.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.902 0.382 . . . . 1.0 110.653 -179.166 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.674 HG21 HD21 ' A' ' 97' ' ' LEU . 41.2 t -114.14 116.59 53.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.914 -0.585 . . . . 1.0 111.782 -176.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.514 ' HA ' ' CE1' ' A' ' 93' ' ' HIS . 45.1 t -145.32 151.9 39.05 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.409 178.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.34 99.71 2.99 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.285 0.564 . . . . 1.0 110.423 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.558 ' O ' HG12 ' A' ' 15' ' ' ILE . . . 140.02 -32.85 2.16 Favored Glycine 0 C--O 1.217 -0.951 0 CA-C-N 115.555 -0.748 . . . . 1.0 111.488 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.579 ' OD1' ' HB1' ' A' ' 73' ' ' ALA . 34.3 p30 48.7 20.98 0.38 Allowed 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 125.268 1.427 . . . . 1.0 113.901 179.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.558 HG12 ' O ' ' A' ' 13' ' ' GLY . 5.3 pt -139.46 10.26 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 122.233 -0.292 . . . . 1.0 111.362 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.419 ' O ' ' HG2' ' A' ' 20' ' ' MET . 47.9 t -125.1 -87.34 0.61 Allowed 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.263 -0.575 . . . . 1.0 112.131 -178.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 35.8 mtt180 -71.21 -39.47 71.72 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.23 0.456 . . . . 1.0 112.23 -174.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.938 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 16.5 m -58.29 -58.59 17.8 Favored Pre-proline 0 CA--C 1.543 0.677 0 N-CA-C 111.753 0.279 . . . . 1.0 111.753 179.155 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.639 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 38.1 Cg_endo -63.71 -23.94 69.31 Favored 'Trans proline' 0 C--N 1.358 1.042 0 C-N-CA 122.341 2.027 . . . . 1.0 112.431 178.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.678 ' HB3' HD13 ' A' ' 142' ' ' ILE . 49.0 mmm -59.74 -55.47 33.97 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.228 -0.286 . . . . 1.0 110.228 179.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.454 ' HA ' ' HB2' ' A' ' 24' ' ' MET . . . -75.36 -26.19 58.32 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.238 -0.585 . . . . 1.0 110.522 -179.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.625 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 11.8 tt0 -52.44 -54.3 34.01 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 115.377 -0.828 . . . . 1.0 110.008 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.722 ' HE3' ' HB2' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -84.78 -23.44 29.19 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.362 -0.836 . . . . 1.0 110.576 -175.844 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.671 ' HB3' HD11 ' A' ' 146' ' ' LEU . 5.2 mmm -62.82 -75.74 0.07 Allowed 'General case' 0 C--O 1.237 0.442 0 N-CA-C 112.679 0.622 . . . . 1.0 112.679 -178.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.774 ' HB3' HD22 ' A' ' 146' ' ' LEU . 18.6 p90 -79.06 -28.92 43.22 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 119.848 -0.741 . . . . 1.0 111.251 -174.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.69 ' HB2' HG21 ' A' ' 40' ' ' VAL . . . -64.06 -37.15 86.38 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 119.486 -0.886 . . . . 1.0 110.661 179.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.607 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -64.54 -38.69 91.87 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.676 -0.861 . . . . 1.0 108.676 176.507 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.555 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 77.8 mt-30 -60.63 -41.56 95.12 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.619 -0.718 . . . . 1.0 110.426 176.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.653 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 88.2 mt -57.01 -58.97 5.84 Favored 'General case' 0 C--O 1.225 -0.201 0 CA-C-N 115.774 -0.648 . . . . 1.0 110.89 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.531 ' HD3' ' HA ' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -59.31 -35.37 73.67 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.204 -0.598 . . . . 1.0 111.163 178.654 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -63.33 -26.29 68.7 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.244 0.461 . . . . 1.0 112.244 177.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.653 ' HG2' ' O ' ' A' ' 29' ' ' LEU . 4.0 ptm85 -96.21 -23.37 16.75 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 119.775 -0.77 . . . . 1.0 109.954 178.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 113.47 34.65 1.71 Allowed Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.174 -0.921 . . . . 1.0 112.433 177.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 25.8 mt -129.37 5.08 5.19 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.853 -0.425 . . . . 1.0 109.853 -178.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.452 ' HA3' ' HB3' ' A' ' 30' ' ' ARG . . . -59.39 -31.6 70.54 Favored Glycine 0 C--N 1.332 0.308 0 CA-C-N 115.819 -0.628 . . . . 1.0 112.967 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -88.17 -20.85 25.03 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.864 0.364 . . . . 1.0 110.186 176.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.02 -25.05 40.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.814 -0.63 . . . . 1.0 111.299 -178.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.644 HG13 ' HB3' ' A' ' 5' ' ' LEU . 5.9 t -130.13 126.29 61.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 121.106 -0.238 . . . . 1.0 110.604 -178.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.669 ' O ' ' HA ' ' A' ' 6' ' ' HIS . 24.2 mmt180 -99.61 98.89 9.7 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.185 0.517 . . . . 1.0 110.876 177.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.69 HG21 ' HB2' ' A' ' 26' ' ' ALA . 1.5 m -88.45 136.75 22.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 CA-C-N 115.703 -0.68 . . . . 1.0 109.299 178.228 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.533 ' O ' ' HA ' ' A' ' 8' ' ' THR . 28.9 p -146.59 -179.8 7.02 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.117 -0.947 . . . . 1.0 109.756 -175.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.938 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 95.1 p -158.19 161.4 37.83 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.382 -0.527 . . . . 1.0 110.936 -178.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.502 ' HB2' ' CD2' ' A' ' 80' ' ' HIS . . . -165.09 168.37 17.36 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.309 0.576 . . . . 1.0 111.415 -179.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -124.68 132.15 8.08 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 110.805 -0.918 . . . . 1.0 110.805 177.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.591 HG23 ' CG1' ' A' ' 10' ' ' VAL . 20.2 p -66.72 -28.82 68.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.948 0.404 . . . . 1.0 111.446 -176.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -101.64 7.13 55.49 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.653 -0.784 . . . . 1.0 113.059 -176.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 42.85 39.39 1.7 Allowed 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 113.46 0.911 . . . . 1.0 113.46 178.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -47.18 -79.64 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.635 0.731 . . . . 1.0 112.533 178.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -103.79 42.11 1.21 Allowed 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.992 -1.004 . . . . 1.0 111.095 -178.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.411 HG23 ' HA ' ' A' ' 74' ' ' ALA . 9.4 p -60.53 125.63 17.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.797 -0.638 . . . . 1.0 110.408 178.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.33 -12.76 64.99 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.703 -0.76 . . . . 1.0 111.834 -177.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.33 -161.06 0.38 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.728 -0.471 . . . . 1.0 109.728 178.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 71' ' ' HIS . 30.0 t -127.34 169.45 13.56 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.512 -0.921 . . . . 1.0 108.512 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -51.14 138.96 19.2 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.921 0.391 . . . . 1.0 111.707 -179.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.748 ' OD1' ' HG2' ' A' ' 57' ' ' ARG . 12.1 t70 -62.62 140.97 58.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.585 -0.734 . . . . 1.0 111.05 -176.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -51.06 -33.62 26.45 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.793 1.035 . . . . 1.0 113.793 -178.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.748 ' HG2' ' OD1' ' A' ' 55' ' ' ASP . 9.9 ptm180 -72.63 -41.16 65.81 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 118.958 0.799 . . . . 1.0 110.619 -178.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.15 -38.89 75.57 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.134 0.493 . . . . 1.0 109.955 179.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.13 -42.8 99.2 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.517 -0.765 . . . . 1.0 109.909 178.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.414 ' O ' ' HG2' ' A' ' 63' ' ' ARG . . . -57.82 -45.92 92.97 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.903 -0.665 . . . . 1.0 113.224 178.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 5.8 m -72.88 -39.75 59.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 117.585 0.692 . . . . 1.0 111.414 -178.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.632 ' HB2' HG22 ' A' ' 69' ' ' THR . 94.8 mt -60.92 -55.2 35.81 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 120.774 0.321 . . . . 1.0 110.5 179.063 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.414 ' HG2' ' O ' ' A' ' 60' ' ' GLY . 11.7 ptm180 -58.59 -33.16 69.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.75 -0.659 . . . . 1.0 110.729 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.95 -34.48 78.08 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.081 0.467 . . . . 1.0 110.932 179.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -95.62 5.68 50.86 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.891 -0.595 . . . . 1.0 111.409 -178.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.91 12.4 66.23 Favored Glycine 0 N--CA 1.452 -0.267 0 CA-C-N 115.589 -0.732 . . . . 1.0 112.575 176.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.406 ' CD1' ' HG2' ' A' ' 27' ' ' GLN . 65.6 m-85 -91.5 147.88 36.24 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-O 120.625 0.25 . . . . 1.0 110.827 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.547 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 38.1 Cg_endo -69.0 154.85 70.05 Favored 'Trans proline' 0 CA--C 1.508 -0.799 0 C-N-CA 122.529 2.152 . . . . 1.0 110.544 177.106 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.632 HG22 ' HB2' ' A' ' 62' ' ' LEU . 27.9 p -127.85 14.85 6.92 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.226 0.536 . . . . 1.0 110.428 -178.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -84.03 119.03 24.45 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.32 -0.855 . . . . 1.0 109.839 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.722 ' HB2' ' HE3' ' A' ' 23' ' ' LYS . 3.5 t60 -162.18 142.58 10.14 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.334 -176.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 -113.69 115.52 27.99 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 107.887 -1.153 . . . . 1.0 107.887 177.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.579 ' HB1' ' OD1' ' A' ' 14' ' ' ASN . . . -60.02 138.44 57.86 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 112.28 0.474 . . . . 1.0 112.28 -177.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.411 ' HA ' HG23 ' A' ' 50' ' ' VAL . . . -134.74 158.02 45.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.228 178.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -94.09 155.43 17.09 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.385 -0.598 . . . . 1.0 109.385 177.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.473 HG11 ' CD2' ' A' ' 97' ' ' LEU . 5.0 t -69.63 113.31 5.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.559 -0.534 . . . . 1.0 109.559 178.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.506 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -125.31 -166.65 12.38 Favored Glycine 0 N--CA 1.44 -1.061 0 CA-C-N 115.44 -0.8 . . . . 1.0 111.353 -179.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 83.8 m -55.83 -53.31 58.26 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.967 0.413 . . . . 1.0 111.623 -178.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.505 ' CD ' ' H ' ' A' ' 79' ' ' GLU . 1.6 pm0 -56.14 -32.72 64.51 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.415 -0.811 . . . . 1.0 111.287 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.502 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 78.3 m80 -74.81 -39.73 61.52 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.048 -0.524 . . . . 1.0 109.727 179.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.608 ' HA ' HD21 ' A' ' 86' ' ' LEU . 29.5 mt -69.03 -20.76 64.13 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.89 -0.595 . . . . 1.0 110.997 177.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.41 -4.6 59.21 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.773 -177.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.55 ' HB1' ' O ' ' A' ' 6' ' ' HIS . . . -59.58 153.61 19.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.706 -0.679 . . . . 1.0 111.064 179.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -79.4 -16.82 55.58 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.162 0.506 . . . . 1.0 110.036 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.719 HD13 HG13 ' A' ' 7' ' ' VAL . 0.3 OUTLIER -152.91 114.12 4.2 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.403 -0.817 . . . . 1.0 109.088 -178.057 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.615 ' HB3' HD13 ' A' ' 97' ' ' LEU . 4.9 mp -104.32 106.48 17.0 Favored 'General case' 0 N--CA 1.424 -1.726 0 CA-C-N 115.322 -0.854 . . . . 1.0 109.724 178.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.679 HG11 HD23 ' A' ' 110' ' ' LEU . 53.9 t -86.67 94.98 4.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 114.926 -1.034 . . . . 1.0 111.242 -177.173 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.92 143.68 31.49 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.501 -0.772 . . . . 1.0 110.805 178.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.488 HD23 ' HB2' ' A' ' 11' ' ' CYS . 4.4 mm? -93.93 -16.29 24.12 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.758 -0.655 . . . . 1.0 109.535 178.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -141.49 152.48 44.22 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.504 -0.771 . . . . 1.0 110.514 -177.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.425 ' HG2' ' H ' ' A' ' 91' ' ' ARG . 9.2 ptt180 -61.15 -21.45 63.77 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.649 0.593 . . . . 1.0 111.238 177.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.689 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 95.4 m-20 -73.84 -50.6 19.61 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 109.644 -0.502 . . . . 1.0 109.644 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.66 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 8.5 m170 -60.16 -43.63 95.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.452 -0.795 . . . . 1.0 109.786 178.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.95 -44.68 94.26 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.164 0.507 . . . . 1.0 110.544 179.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.477 ' O ' ' HG2' ' A' ' 98' ' ' ARG . 0.3 OUTLIER -57.83 -44.07 86.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.38 -0.827 . . . . 1.0 111.225 178.173 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.744 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 50.8 mt -64.69 -49.87 69.21 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 116.279 -0.418 . . . . 1.0 110.49 -177.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.674 HD21 HG21 ' A' ' 10' ' ' VAL . 49.3 mt -51.97 -56.76 12.2 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.947 -0.57 . . . . 1.0 111.641 -178.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.477 ' HG2' ' O ' ' A' ' 95' ' ' ARG . 26.1 ptt85 -59.62 -45.57 91.56 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.138 -0.483 . . . . 1.0 111.729 -176.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.64 ' HG3' ' O ' ' A' ' 96' ' ' LEU . 1.2 pp0? -69.42 -21.55 63.74 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 120.967 0.413 . . . . 1.0 110.857 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.744 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 10.8 mt -78.72 -6.82 56.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.043 -0.526 . . . . 1.0 111.966 -178.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 144.1 -29.31 1.94 Allowed Glycine 0 CA--C 1.506 -0.479 0 C-N-CA 119.828 -1.177 . . . . 1.0 113.021 178.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.765 HG12 ' H ' ' A' ' 103' ' ' GLU . 1.6 t -74.85 -153.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-O 121.541 0.686 . . . . 1.0 110.814 -178.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.765 ' H ' HG12 ' A' ' 102' ' ' VAL . 12.6 pt-20 -163.59 159.45 21.83 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.895 -1.15 . . . . 1.0 107.895 -178.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.475 ' HA ' ' HB ' ' A' ' 107' ' ' VAL . . . -67.71 -17.28 64.51 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.665 -0.414 . . . . 1.0 112.031 -173.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.92 -37.17 76.06 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 173.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.633 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 2.5 mtp85 -94.73 -34.98 12.33 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 114.744 -1.116 . . . . 1.0 110.422 -178.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 103' ' ' GLU . 39.5 t -79.57 114.56 20.57 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.423 -179.106 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.475 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 15.1 mmt180 -135.42 147.37 48.95 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 120.212 -0.595 . . . . 1.0 110.403 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.657 ' HB2' ' HB2' ' A' ' 112' ' ' SER . 77.0 mmm -78.07 139.05 39.06 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.691 -0.686 . . . . 1.0 110.037 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.679 HD23 HG11 ' A' ' 87' ' ' VAL . 2.9 tm? -56.89 -50.18 73.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.602 0.239 . . . . 1.0 110.963 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.09 -12.08 61.04 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.082 0.468 . . . . 1.0 110.747 -177.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.657 ' HB2' ' HB2' ' A' ' 109' ' ' MET . 32.5 t -78.69 -4.86 51.22 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.978 -0.555 . . . . 1.0 111.011 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.581 ' HZ ' HD21 ' A' ' 85' ' ' LEU . 86.4 m-85 -91.8 -21.06 20.87 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.049 0.452 . . . . 1.0 109.873 175.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.6 t0 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 115.303 -0.862 . . . . 1.0 110.533 -179.956 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.431 ' HA ' ' HB3' ' A' ' 139' ' ' PHE . 20.4 mt-10 . . . . . 0 N--CA 1.453 -0.29 0 CA-C-O 120.64 0.257 . . . . 1.0 110.883 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.577 ' O ' HG23 ' A' ' 141' ' ' VAL . 23.5 tp10 -63.99 -49.98 70.36 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.994 -0.743 . . . . 1.0 108.994 175.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.405 ' O ' HD12 ' A' ' 142' ' ' ILE . 87.2 t -59.41 -42.91 89.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.323 -0.853 . . . . 1.0 108.889 175.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.431 ' HB3' ' HA ' ' A' ' 136' ' ' GLU . 45.6 t80 -53.9 -43.41 69.67 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.159 -1.382 . . . . 1.0 109.553 175.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.558 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -65.03 -40.86 95.43 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.583 -0.735 . . . . 1.0 110.913 179.012 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 137' ' ' GLU . 21.5 t -56.17 -48.63 78.95 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 CA-C-O 121.868 0.842 . . . . 1.0 109.537 177.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.678 HD13 ' HB3' ' A' ' 20' ' ' MET . 5.3 mt -65.62 -51.88 57.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 114.763 -1.108 . . . . 1.0 111.593 -179.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.558 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 8.8 pt-20 -56.09 -33.21 64.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.745 0.307 . . . . 1.0 110.506 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 72.7 m -72.37 -28.44 63.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.889 -0.596 . . . . 1.0 110.927 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.465 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -87.61 -23.86 24.15 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-N 115.838 -0.619 . . . . 1.0 111.801 179.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.774 HD22 ' HB3' ' A' ' 25' ' ' PHE . 13.6 mt -55.86 -37.97 63.02 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 120.562 -0.455 . . . . 1.0 112.033 -177.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.632 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 57.8 Cg_endo -69.73 -9.65 26.65 Favored 'Trans proline' 0 C--N 1.363 1.314 0 C-N-CA 122.666 2.244 . . . . 1.0 112.084 178.223 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.56 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -106.09 -32.28 3.83 Favored Glycine 0 N--CA 1.442 -0.934 0 N-CA-C 109.896 -1.282 . . . . 1.0 109.896 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.473 ' O ' HG13 ' A' ' 153' ' ' VAL . 0.4 OUTLIER -74.96 -39.83 61.11 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.448 -0.945 . . . . 1.0 108.448 178.507 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -54.52 -50.99 66.53 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.364 -0.835 . . . . 1.0 110.578 175.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -60.79 -45.76 93.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.367 -0.833 . . . . 1.0 111.611 -176.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . 0.71 ' HZ3' HD21 ' A' ' 5' ' ' LEU . 22.2 t90 -60.2 -55.24 36.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.136 -0.938 . . . . 1.0 110.695 -177.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.473 HG13 ' O ' ' A' ' 149' ' ' LEU . 5.3 m -61.19 -40.39 85.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.524 -0.307 . . . . 1.0 110.527 -178.047 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.454 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 0.5 OUTLIER -60.95 -53.92 51.32 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.085 0.469 . . . . 1.0 111.104 179.216 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.503 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 10.5 pt-20 -61.97 -36.47 81.57 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.698 -0.683 . . . . 1.0 110.654 -177.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.454 ' HG3' ' CH2' ' A' ' 152' ' ' TRP . 14.0 mmt180 -73.88 -44.54 55.05 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 116.084 -0.507 . . . . 1.0 111.122 -178.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 4.0 pp . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 120.993 0.425 . . . . 1.0 110.11 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.575 0 N-CA-C 111.653 -0.579 . . . . 1.0 111.653 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.7 mtm -88.89 81.21 6.95 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.607 -0.516 . . . . 1.0 109.607 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.769 ' HB3' ' HA3' ' A' ' 161' ' ' GLY . 26.9 p -80.96 117.25 21.42 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.941 -0.572 . . . . 1.0 110.316 -178.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.563 ' HB3' ' HD2' ' A' ' 4' ' ' PRO . 0.7 OUTLIER -65.27 159.81 63.06 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.124 -0.695 . . . . 1.0 109.124 177.306 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.563 ' HD2' ' HB3' ' A' ' 3' ' ' ASP . 56.9 Cg_endo -69.49 164.13 35.44 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.401 2.068 . . . . 1.0 113.642 -176.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.765 HD13 ' HB3' ' A' ' 84' ' ' ASP . 0.2 OUTLIER -68.44 -177.89 1.01 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.623 -1.171 . . . . 1.0 109.522 178.078 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.696 ' HA ' ' O ' ' A' ' 39' ' ' ARG . 2.4 t-160 -156.84 87.7 1.01 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.924 -0.398 . . . . 1.0 109.924 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.794 HG13 HD13 ' A' ' 85' ' ' LEU . 2.5 t -97.15 104.68 16.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.473 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.591 ' HA ' ' O ' ' A' ' 41' ' ' THR . 12.7 t -107.99 115.58 30.39 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.163 0.506 . . . . 1.0 110.453 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.533 ' HD1' ' HB ' ' A' ' 87' ' ' VAL . 0.7 OUTLIER -84.56 131.75 34.59 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.438 -178.009 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.588 HG21 HD11 ' A' ' 97' ' ' LEU . 43.6 t -116.19 112.58 40.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.223 0.535 . . . . 1.0 111.891 -176.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.661 ' HB2' HD23 ' A' ' 89' ' ' LEU . 17.7 t -141.65 165.8 26.49 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.934 -0.575 . . . . 1.0 109.689 177.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.59 HG23 ' NE2' ' A' ' 93' ' ' HIS . 1.2 p -73.47 101.6 3.56 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.959 0.409 . . . . 1.0 110.782 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.944 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 120.68 -43.34 1.55 Allowed Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.859 -0.686 . . . . 1.0 111.863 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.711 ' ND2' ' H ' ' A' ' 74' ' ' ALA . 59.0 t30 60.2 25.82 15.22 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 122.169 0.985 . . . . 1.0 110.883 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.6 pt -126.54 0.66 4.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 115.602 -0.726 . . . . 1.0 111.15 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 23.1 m -120.6 -88.79 0.62 Allowed 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.439 -0.504 . . . . 1.0 111.916 -176.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.898 HH22 ' HA ' ' A' ' 126' ' ' ASP . 38.1 ttm105 -71.94 -40.42 68.72 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.282 0.475 . . . . 1.0 112.282 -174.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.453 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 24.5 m -58.47 -58.34 19.79 Favored Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 111.846 0.313 . . . . 1.0 111.846 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.526 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 40.2 Cg_endo -64.49 -20.99 66.37 Favored 'Trans proline' 0 C--N 1.357 0.978 0 C-N-CA 122.035 1.823 . . . . 1.0 112.166 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.697 ' HB3' HD13 ' A' ' 142' ' ' ILE . 41.9 mmm -62.97 -54.45 38.14 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.625 -0.261 . . . . 1.0 110.499 177.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.475 ' HA ' HG21 ' A' ' 142' ' ' ILE . . . -71.84 -27.83 63.16 Favored 'General case' 0 CA--C 1.509 -0.624 0 C-N-CA 120.461 -0.496 . . . . 1.0 110.076 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.619 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 15.8 tt0 -50.47 -53.47 29.48 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-N 114.741 -1.118 . . . . 1.0 109.852 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.821 ' HB3' ' HG2' ' A' ' 68' ' ' PRO . 0.1 OUTLIER -82.78 -27.32 31.07 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.165 -0.925 . . . . 1.0 110.22 -175.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.785 ' HB3' HD11 ' A' ' 146' ' ' LEU . 7.9 mmm -62.87 -75.61 0.07 Allowed 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 112.993 0.738 . . . . 1.0 112.993 -176.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.833 ' HB3' HD22 ' A' ' 146' ' ' LEU . 19.8 p90 -78.04 -29.92 49.61 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 119.958 -0.697 . . . . 1.0 111.219 -175.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.649 ' HB2' HG11 ' A' ' 40' ' ' VAL . . . -63.37 -38.15 90.02 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 119.413 -0.915 . . . . 1.0 110.57 179.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.643 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -63.36 -40.75 98.13 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.94 -0.763 . . . . 1.0 108.94 177.098 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.582 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 79.4 mt-30 -59.83 -41.88 92.32 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-N 115.85 -0.613 . . . . 1.0 110.679 176.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.67 ' HG ' ' O ' ' A' ' 25' ' ' PHE . 80.2 mt -55.89 -61.41 2.39 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.682 -0.69 . . . . 1.0 110.257 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.555 ' HB3' ' HA3' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -59.07 -33.56 70.95 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.793 -0.363 . . . . 1.0 111.374 178.553 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -63.37 -25.54 68.34 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.21 0.448 . . . . 1.0 112.21 176.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.598 ' HG2' ' O ' ' A' ' 29' ' ' LEU . 8.3 ptm85 -98.6 -21.29 16.54 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 120.05 -0.66 . . . . 1.0 110.104 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.27 33.17 1.83 Allowed Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 114.991 -1.004 . . . . 1.0 112.437 177.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.574 ' HG ' ' HG3' ' A' ' 32' ' ' ARG . 36.1 mt -127.14 6.47 6.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.982 0.391 . . . . 1.0 110.709 -178.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.555 ' HA3' ' HB3' ' A' ' 30' ' ' ARG . . . -54.21 -35.84 55.87 Favored Glycine 0 CA--C 1.52 0.374 0 C-N-CA 121.27 -0.49 . . . . 1.0 113.573 -177.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.614 ' HA ' ' NH1' ' A' ' 39' ' ' ARG . 2.8 m-20 -92.29 -14.02 29.48 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.97 0.414 . . . . 1.0 110.925 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.83 -17.93 49.13 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.875 -0.602 . . . . 1.0 111.2 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.705 HG23 ' HB3' ' A' ' 5' ' ' LEU . 0.4 OUTLIER -144.64 124.3 7.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.39 0.614 . . . . 1.0 111.055 179.436 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.696 ' O ' ' HA ' ' A' ' 6' ' ' HIS . 25.8 mmt180 -95.66 101.45 13.15 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.634 -0.712 . . . . 1.0 110.948 -178.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.649 HG11 ' HB2' ' A' ' 26' ' ' ALA . 1.6 m -89.03 136.61 23.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 109.035 -0.728 . . . . 1.0 109.035 178.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.591 ' O ' ' HA ' ' A' ' 8' ' ' THR . 31.7 p -146.6 -176.11 5.05 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.045 -0.98 . . . . 1.0 109.742 -175.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.439 ' HB3' ' HD2' ' A' ' 9' ' ' PHE . 49.2 p -158.76 160.66 36.56 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.153 -0.619 . . . . 1.0 111.253 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.619 ' HB2' ' CD2' ' A' ' 80' ' ' HIS . . . -162.68 161.88 26.66 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.315 0.579 . . . . 1.0 111.582 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -124.33 138.53 11.31 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 111.096 -0.802 . . . . 1.0 111.096 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.445 HG21 HD12 ' A' ' 96' ' ' LEU . 33.7 p -74.36 -24.0 59.09 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 111.962 0.356 . . . . 1.0 111.962 -176.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.584 ' HA3' ' CZ3' ' A' ' 48' ' ' TRP . . . -110.76 9.39 29.97 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.533 -0.841 . . . . 1.0 113.083 -178.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 42.67 37.35 1.0 Allowed 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 113.885 1.068 . . . . 1.0 113.885 177.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.944 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 1.5 m-90 -44.81 -70.41 0.1 Allowed 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.559 0.695 . . . . 1.0 112.369 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.686 ' O ' ' HB2' ' A' ' 52' ' ' SER . 6.8 m-70 -109.65 43.73 1.28 Allowed 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.1 -0.954 . . . . 1.0 111.057 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.43 HG23 ' HA ' ' A' ' 74' ' ' ALA . 14.8 p -62.54 129.74 26.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 C-N-CA 120.425 -0.51 . . . . 1.0 110.169 178.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.14 -13.5 66.88 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 121.109 -0.567 . . . . 1.0 111.684 -176.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.686 ' HB2' ' O ' ' A' ' 49' ' ' HIS . 0.4 OUTLIER -80.0 -162.26 0.42 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.174 0.511 . . . . 1.0 110.669 179.58 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 33.7 t -126.45 175.94 7.52 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.291 -1.003 . . . . 1.0 108.291 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.06 141.06 47.21 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.955 0.407 . . . . 1.0 111.374 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.456 ' OD1' ' HG2' ' A' ' 57' ' ' ARG . 13.2 t70 -61.05 141.15 57.61 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.285 -0.87 . . . . 1.0 111.436 -177.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -46.24 -37.8 7.67 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.727 -1.124 . . . . 1.0 113.555 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.674 ' O ' HG23 ' A' ' 61' ' ' VAL . 14.9 ptp180 -69.95 -45.31 67.73 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 122.276 -0.265 . . . . 1.0 110.897 -176.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.0 -31.62 68.19 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.485 -178.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.64 -43.43 98.82 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.893 -0.594 . . . . 1.0 110.046 178.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.41 -42.4 97.65 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.786 -0.721 . . . . 1.0 111.486 177.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.674 HG23 ' O ' ' A' ' 57' ' ' ARG . 61.3 t -58.05 -58.53 6.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-O 120.975 0.417 . . . . 1.0 111.273 179.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.735 ' HB2' HG22 ' A' ' 69' ' ' THR . 90.1 mt -59.04 -51.21 71.02 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.061 -0.518 . . . . 1.0 111.662 -178.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -60.87 -29.27 69.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.482 -0.326 . . . . 1.0 110.894 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.19 -31.48 71.91 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.225 0.536 . . . . 1.0 110.546 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -99.42 1.89 44.63 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.492 -0.776 . . . . 1.0 111.505 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.97 16.26 56.41 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 121.045 -0.597 . . . . 1.0 113.213 177.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -92.08 149.58 38.96 Favored Pre-proline 0 C--N 1.322 -0.627 0 C-N-CA 122.083 0.153 . . . . 1.0 111.082 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.821 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 49.6 Cg_endo -68.89 158.23 58.72 Favored 'Trans proline' 0 CA--C 1.511 -0.634 0 C-N-CA 122.519 2.146 . . . . 1.0 110.36 176.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.735 HG22 ' HB2' ' A' ' 62' ' ' LEU . 58.1 p -134.53 3.53 3.31 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 119.562 -0.855 . . . . 1.0 112.65 -176.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -79.85 135.65 36.5 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.762 -0.375 . . . . 1.0 110.429 -179.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -175.58 153.99 1.54 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.698 -0.683 . . . . 1.0 109.251 -176.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -123.3 116.72 23.79 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.208 -1.034 . . . . 1.0 108.208 177.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' A' ' 49' ' ' HIS . . . -61.3 139.02 58.24 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.259 0.552 . . . . 1.0 111.895 -176.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.711 ' H ' ' ND2' ' A' ' 14' ' ' ASN . . . -130.88 161.23 32.3 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.427 -0.806 . . . . 1.0 109.942 178.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -98.1 161.41 13.73 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.943 -0.762 . . . . 1.0 108.943 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.548 HG11 HD23 ' A' ' 97' ' ' LEU . 94.0 t -67.44 102.72 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.398 0.618 . . . . 1.0 110.388 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.556 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -120.79 -170.87 14.23 Favored Glycine 0 N--CA 1.443 -0.882 0 CA-C-N 115.046 -0.979 . . . . 1.0 111.824 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 88.4 m -55.92 -54.12 48.52 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.758 0.651 . . . . 1.0 112.758 -178.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.533 ' HG2' ' N ' ' A' ' 80' ' ' HIS . 0.6 OUTLIER -56.43 -31.36 63.84 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.893 -0.594 . . . . 1.0 111.089 -178.167 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.619 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 79.1 m80 -76.32 -42.36 45.4 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.6 -0.727 . . . . 1.0 110.064 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.556 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 23.2 mt -66.21 -19.77 65.93 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.476 178.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -84.77 -5.33 59.32 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.871 -0.604 . . . . 1.0 110.998 -178.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.573 ' HB1' ' O ' ' A' ' 6' ' ' HIS . . . -60.8 157.85 14.14 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.071 -0.513 . . . . 1.0 111.644 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.765 ' HB3' HD13 ' A' ' 5' ' ' LEU . 29.9 t70 -82.69 -16.57 47.67 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 115.915 -0.584 . . . . 1.0 109.807 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.794 HD13 HG13 ' A' ' 7' ' ' VAL . 0.4 OUTLIER -154.61 115.82 4.05 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.334 -0.848 . . . . 1.0 109.059 -176.581 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.577 ' HG ' HG22 ' A' ' 8' ' ' THR . 5.4 mp -106.74 106.81 17.52 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-N 115.479 -0.782 . . . . 1.0 109.853 177.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.559 HG11 HD23 ' A' ' 110' ' ' LEU . 52.3 t -85.14 92.26 3.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 114.896 -1.047 . . . . 1.0 110.869 -176.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.27 147.54 32.49 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.514 -0.766 . . . . 1.0 110.98 179.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.661 HD23 ' HB2' ' A' ' 11' ' ' CYS . 2.9 mm? -103.73 -4.85 23.14 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.273 0.558 . . . . 1.0 110.49 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.419 ' CG ' ' H ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -155.37 153.37 30.35 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.71 -0.677 . . . . 1.0 111.223 178.538 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 25.4 ptt180 -50.19 -32.09 15.44 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 114.903 -1.044 . . . . 1.0 112.998 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.714 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 5.9 m-20 -76.3 -48.46 20.03 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.288 -0.264 . . . . 1.0 110.288 -176.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.651 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 14.2 m170 -55.14 -48.46 73.65 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.73 -0.47 . . . . 1.0 109.73 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.458 ' HA ' HG21 ' A' ' 107' ' ' VAL . . . -59.3 -43.45 92.6 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.028 0.442 . . . . 1.0 110.849 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 9.8 ttt-85 -59.67 -45.51 91.84 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 115.408 -0.815 . . . . 1.0 111.66 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.772 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 56.0 mt -63.86 -49.49 72.55 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 115.902 -0.59 . . . . 1.0 110.028 -175.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.651 ' HG ' ' O ' ' A' ' 93' ' ' HIS . 22.6 mt -52.77 -57.83 8.86 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.668 -0.696 . . . . 1.0 111.368 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.604 ' HA ' ' HB ' ' A' ' 102' ' ' VAL . 9.4 ptt180 -60.42 -43.21 96.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.11 -0.496 . . . . 1.0 111.878 -176.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.648 ' HG3' ' O ' ' A' ' 96' ' ' LEU . 1.3 pp0? -68.33 -23.31 64.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.911 0.386 . . . . 1.0 110.287 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.772 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 11.4 mt -79.2 -13.43 59.71 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.87 -0.605 . . . . 1.0 112.194 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 148.4 -22.87 1.37 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.067 -1.063 . . . . 1.0 112.773 -178.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.975 HG12 ' H ' ' A' ' 103' ' ' GLU . 3.3 t -75.6 -156.09 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.123 0.487 . . . . 1.0 110.119 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.975 ' H ' HG12 ' A' ' 102' ' ' VAL . 9.3 pt-20 -170.44 163.84 8.57 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.755 -1.202 . . . . 1.0 107.755 -177.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.738 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -65.83 -22.14 66.53 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.754 0.311 . . . . 1.0 111.213 -176.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.487 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . . . -58.52 -37.8 76.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.295 0.569 . . . . 1.0 109.947 174.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.698 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 10.5 mtt180 -96.21 -45.33 6.89 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 115.193 -0.912 . . . . 1.0 110.778 -177.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.738 HG12 ' HA ' ' A' ' 104' ' ' ALA . 8.2 p -79.07 124.8 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-O 121.289 0.566 . . . . 1.0 110.49 -176.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.532 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 10.6 mmm180 -140.85 147.92 39.71 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.285 -0.635 . . . . 1.0 109.285 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.479 ' HB2' ' HB2' ' A' ' 112' ' ' SER . 83.1 mmm -78.88 140.24 38.16 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.451 -0.34 . . . . 1.0 110.375 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.559 HD23 HG11 ' A' ' 87' ' ' VAL . 3.0 tm? -58.45 -51.69 68.77 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 122.973 0.171 . . . . 1.0 111.262 -179.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 46.1 ttm-85 -71.26 -14.51 62.25 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 120.278 -0.569 . . . . 1.0 110.442 -178.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.479 ' HB2' ' HB2' ' A' ' 109' ' ' MET . 42.2 t -73.62 -9.51 58.75 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.71 -0.396 . . . . 1.0 110.423 179.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.553 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 97.2 m-85 -91.02 -22.68 20.66 Favored 'General case' 0 C--N 1.341 0.213 0 N-CA-C 109.782 -0.451 . . . . 1.0 109.782 175.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -59.43 117.66 24.22 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.22 -0.9 . . . . 1.0 111.019 -178.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.503 ' HD2' ' O ' ' A' ' 144' ' ' SER . 47.9 Cg_endo -66.36 -23.54 51.25 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.917 2.412 . . . . 1.0 112.383 -179.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -91.93 1.0 57.46 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 116.6 -0.273 . . . . 1.0 111.492 -178.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 39.4 t -58.59 -51.31 70.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.245 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 87.91 -70.12 2.77 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.157 -1.021 . . . . 1.0 111.144 178.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.3 m -91.25 166.5 12.9 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.054 -0.721 . . . . 1.0 109.054 177.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 59.2 m170 -64.85 136.82 57.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.892 0.377 . . . . 1.0 110.208 178.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -106.75 89.91 3.16 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.686 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.448 ' HA ' ' HG3' ' A' ' 109' ' ' MET . 2.7 mm? -99.18 15.26 26.6 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.949 0.404 . . . . 1.0 110.155 178.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -168.49 130.09 1.33 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.722 -0.672 . . . . 1.0 109.421 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.451 ' HB ' ' O ' ' A' ' 89' ' ' LEU . 59.4 t -107.62 154.4 8.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.816 -0.629 . . . . 1.0 109.599 -179.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -64.67 -175.79 0.21 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.102 -0.499 . . . . 1.0 111.209 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.898 ' HA ' HH22 ' A' ' 17' ' ' ARG . 2.2 t70 -167.39 120.87 0.78 Allowed Pre-proline 0 C--N 1.324 -0.539 0 N-CA-C 108.55 -0.907 . . . . 1.0 108.55 178.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.967 ' HB2' ' HB3' ' A' ' 134' ' ' ASP . 68.8 Cg_endo -84.44 93.81 0.73 Allowed 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.988 2.459 . . . . 1.0 114.0 -173.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.78 -15.74 36.08 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 120.716 -0.394 . . . . 1.0 111.474 178.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -71.47 -36.18 71.1 Favored 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 117.841 -1.544 . . . . 1.0 110.283 -176.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.62 58.88 3.98 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 119.768 -1.206 . . . . 1.0 113.437 173.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -119.5 -175.72 3.0 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 107.967 -1.123 . . . . 1.0 107.967 176.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 6.0 t-160 -66.09 -36.08 82.24 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.568 -0.901 . . . . 1.0 108.568 178.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 15.2 m -60.97 -50.1 74.75 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.481 -0.781 . . . . 1.0 111.246 178.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.967 ' HB3' ' HB2' ' A' ' 127' ' ' PRO . 0.9 OUTLIER -50.92 -41.39 58.67 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 112.233 0.457 . . . . 1.0 112.233 -178.69 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.468 ' CE1' ' HD3' ' A' ' 57' ' ' ARG . 10.3 m-30 -72.16 -53.17 13.47 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.256 -0.429 . . . . 1.0 111.024 -174.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -66.76 -25.34 66.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.143 -0.481 . . . . 1.0 110.806 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.543 ' O ' HG23 ' A' ' 141' ' ' VAL . 16.9 tp10 -61.58 -51.56 68.04 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.659 -0.7 . . . . 1.0 110.126 178.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.641 ' HA ' HG23 ' A' ' 141' ' ' VAL . 71.9 t -59.85 -41.15 84.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.758 -0.655 . . . . 1.0 110.346 178.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.543 ' HB2' HG11 ' A' ' 61' ' ' VAL . 49.8 t80 -54.65 -43.6 72.51 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.185 -0.916 . . . . 1.0 109.418 176.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.53 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -63.94 -41.86 97.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.595 -0.729 . . . . 1.0 110.798 178.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.641 HG23 ' HA ' ' A' ' 138' ' ' VAL . 5.6 t -53.83 -53.1 29.22 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 CA-C-O 121.841 0.829 . . . . 1.0 110.031 177.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.697 HD13 ' HB3' ' A' ' 20' ' ' MET . 6.8 mt -64.97 -50.94 72.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 114.649 -1.16 . . . . 1.0 112.085 -177.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.53 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 10.3 pt-20 -57.33 -30.87 65.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.677 0.275 . . . . 1.0 110.533 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.503 ' O ' ' HD2' ' A' ' 115' ' ' PRO . 1.9 t -73.49 -29.62 62.62 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-O 121.2 0.524 . . . . 1.0 110.164 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.502 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -86.7 -24.12 25.31 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-N 116.018 -0.537 . . . . 1.0 112.128 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.833 HD22 ' HB3' ' A' ' 25' ' ' PHE . 14.4 mt -55.15 -36.42 45.14 Favored Pre-proline 0 CA--C 1.545 0.769 0 N-CA-C 112.745 0.646 . . . . 1.0 112.745 -177.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.632 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 56.9 Cg_endo -70.22 -10.59 28.53 Favored 'Trans proline' 0 C--N 1.363 1.299 0 C-N-CA 122.63 2.22 . . . . 1.0 112.09 176.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.553 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -106.07 -33.74 3.39 Favored Glycine 0 N--CA 1.449 -0.492 0 N-CA-C 110.372 -1.091 . . . . 1.0 110.372 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.468 ' O ' HG13 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -73.02 -39.23 66.17 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.0 -1.111 . . . . 1.0 108.0 178.369 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.517 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 0.2 OUTLIER -52.97 -58.4 7.11 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 114.801 -1.091 . . . . 1.0 110.834 175.293 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -56.92 -39.83 75.22 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.766 -1.106 . . . . 1.0 111.304 -174.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . 0.758 ' HZ3' HD11 ' A' ' 5' ' ' LEU . 22.3 t90 -65.18 -55.75 16.8 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.602 -0.726 . . . . 1.0 110.875 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.468 HG13 ' O ' ' A' ' 149' ' ' LEU . 6.5 m -61.35 -41.97 91.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.888 -0.412 . . . . 1.0 109.888 -178.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.438 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 3.3 m-20 -60.19 -51.26 70.35 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-O 120.96 0.41 . . . . 1.0 110.855 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 7.1 pt-20 -63.4 -38.35 90.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.95 -177.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.529 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 5.5 mmt85 -73.81 -43.02 60.08 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.701 -0.681 . . . . 1.0 110.802 -176.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 4.0 pp -68.06 -26.16 65.72 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.017 -0.538 . . . . 1.0 109.998 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -73.26 -49.37 28.07 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.745 -0.661 . . . . 1.0 110.764 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.431 ' HG2' ' O ' ' A' ' 155' ' ' GLU . 11.4 ptp180 -76.79 -16.55 59.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.776 -0.647 . . . . 1.0 112.228 -177.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -58.53 -46.91 85.81 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.721 -0.672 . . . . 1.0 111.599 -174.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.769 ' HA3' ' HB3' ' A' ' 2' ' ' SER . . . -121.64 145.39 16.87 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 119.72 -1.229 . . . . 1.0 112.357 176.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.463 ' HD3' ' HA2' ' A' ' 161' ' ' GLY . 6.3 Cg_endo -87.7 -149.89 0.04 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 123.647 2.898 . . . . 1.0 112.429 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.432 ' H ' ' HB2' ' A' ' 162' ' ' PRO . 21.5 t . . . . . 0 C--N 1.31 -1.119 0 CA-C-N 114.148 -1.387 . . . . 1.0 110.629 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.731 0 N-CA-C 111.96 -0.456 . . . . 1.0 111.96 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -82.93 23.66 0.82 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.138 0.494 . . . . 1.0 109.866 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.5 p -166.73 165.87 16.17 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.382 -0.827 . . . . 1.0 109.993 -177.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.851 ' HB2' ' HD2' ' A' ' 4' ' ' PRO . 4.0 p-10 -169.13 168.06 5.28 Favored Pre-proline 0 C--N 1.329 -0.319 0 N-CA-C 109.313 -0.625 . . . . 1.0 109.313 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.851 ' HD2' ' HB2' ' A' ' 3' ' ' ASP . 17.8 Cg_endo -61.35 164.61 14.72 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.744 2.296 . . . . 1.0 112.915 -178.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.818 ' HB3' HG23 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -65.38 175.92 1.57 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.599 -0.728 . . . . 1.0 109.684 179.67 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.803 ' H ' HD13 ' A' ' 5' ' ' LEU . 0.5 OUTLIER -153.75 100.28 2.37 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.883 -0.414 . . . . 1.0 109.883 179.175 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.705 HG13 HD13 ' A' ' 85' ' ' LEU . 1.8 t -103.6 116.84 48.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 107.983 -1.118 . . . . 1.0 107.983 178.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.621 ' CG2' ' HG ' ' A' ' 86' ' ' LEU . 15.1 t -119.77 114.31 21.95 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 120.589 -0.444 . . . . 1.0 110.81 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.759 ' HZ ' ' HE1' ' A' ' 25' ' ' PHE . 0.4 OUTLIER -84.35 131.41 34.7 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 120.398 -0.521 . . . . 1.0 110.177 -179.619 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.596 HG21 HD11 ' A' ' 97' ' ' LEU . 30.1 t -113.66 118.42 58.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 116.284 -0.416 . . . . 1.0 111.365 -176.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.44 ' HB2' HD23 ' A' ' 89' ' ' LEU . 46.2 t -148.65 146.8 28.34 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.996 -0.372 . . . . 1.0 109.996 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.54 93.27 1.19 Allowed 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 121.115 0.483 . . . . 1.0 110.394 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 148.08 -37.99 1.06 Allowed Glycine 0 N--CA 1.441 -1.01 0 CA-C-N 115.183 -0.917 . . . . 1.0 111.088 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 1.089 HD22 ' HB1' ' A' ' 73' ' ' ALA . 1.4 p-10 48.47 24.43 0.74 Allowed 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.063 0.945 . . . . 1.0 112.864 178.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.446 HG12 ' HB2' ' A' ' 49' ' ' HIS . 1.3 pt -148.23 47.2 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.451 0 CA-C-N 115.574 -0.739 . . . . 1.0 110.625 178.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.45 ' HA ' ' OD1' ' A' ' 55' ' ' ASP . 53.2 t -161.68 -84.56 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.535 -0.757 . . . . 1.0 109.599 173.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.609 ' NH2' ' HA ' ' A' ' 126' ' ' ASP . 27.4 mmt85 -59.79 -57.16 14.12 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.795 -0.639 . . . . 1.0 112.002 -178.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 1.067 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 6.2 m -52.11 -58.35 11.72 Favored Pre-proline 0 CA--C 1.546 0.825 0 CA-C-N 115.085 -0.961 . . . . 1.0 112.55 -177.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.673 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 37.3 Cg_endo -63.45 -27.82 70.71 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 121.985 1.79 . . . . 1.0 112.909 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.477 ' HB3' HD13 ' A' ' 142' ' ' ILE . 45.5 mmm -59.28 -57.31 13.58 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.295 -0.261 . . . . 1.0 110.295 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.541 ' O ' ' HD1' ' A' ' 25' ' ' PHE . . . -71.37 -32.16 68.16 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 115.885 -0.598 . . . . 1.0 110.507 -178.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.633 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 15.0 tt0 -49.79 -52.72 29.95 Favored 'General case' 0 C--O 1.216 -0.69 0 O-C-N 124.198 0.936 . . . . 1.0 109.917 -178.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.972 ' HE3' ' HB2' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -86.63 -22.33 26.24 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 119.592 -0.843 . . . . 1.0 110.9 -176.919 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.472 ' HB3' HD11 ' A' ' 146' ' ' LEU . 88.7 mtp -64.21 -75.16 0.09 Allowed 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.384 0.513 . . . . 1.0 112.384 -179.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.759 ' HE1' ' HZ ' ' A' ' 9' ' ' PHE . 0.8 OUTLIER -78.43 -28.29 46.72 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 119.754 -0.778 . . . . 1.0 111.613 -175.452 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.633 ' HB3' ' O ' ' A' ' 22' ' ' GLU . . . -64.54 -38.73 92.04 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 119.387 -0.925 . . . . 1.0 110.473 178.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.602 ' HG3' ' N ' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -64.75 -37.45 87.63 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.825 -0.806 . . . . 1.0 108.825 177.789 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.602 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 78.5 mt-30 -60.05 -43.01 95.68 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-N 115.967 -0.56 . . . . 1.0 109.897 175.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 25' ' ' PHE . 93.2 mt -56.02 -59.01 5.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.74 -0.664 . . . . 1.0 110.767 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.502 ' HG2' ' O ' ' A' ' 27' ' ' GLN . 0.2 OUTLIER -60.58 -34.27 73.94 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.372 -0.531 . . . . 1.0 111.349 178.463 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.8 m170 -59.42 -30.09 68.23 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 111.994 0.368 . . . . 1.0 111.994 176.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.459 ' HG2' ' O ' ' A' ' 28' ' ' GLN . 5.8 ptp180 -95.41 -19.25 20.05 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 119.501 -0.88 . . . . 1.0 110.261 179.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 107.42 38.44 2.09 Favored Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.238 -0.892 . . . . 1.0 112.339 177.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 25.2 mt -129.54 0.02 4.98 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 122.554 -0.38 . . . . 1.0 110.258 -178.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.474 ' H ' ' HA ' ' A' ' 30' ' ' ARG . . . -54.26 -28.41 42.72 Favored Glycine 0 CA--C 1.519 0.337 0 CA-C-N 116.028 -0.533 . . . . 1.0 113.837 -178.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.499 ' HA ' ' NH1' ' A' ' 39' ' ' ARG . 5.1 t70 -89.45 -24.88 21.75 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-O 121.54 0.686 . . . . 1.0 109.739 178.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -77.59 -19.38 55.7 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 114.716 -1.129 . . . . 1.0 111.438 -174.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.818 HG23 ' HB3' ' A' ' 5' ' ' LEU . 0.4 OUTLIER -145.05 124.24 6.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.964 -0.562 . . . . 1.0 109.889 179.81 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.499 ' NH1' ' HA ' ' A' ' 36' ' ' ASP . 29.1 mmt180 -90.16 137.44 32.34 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 109.291 -0.633 . . . . 1.0 109.291 -178.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 80.8 t -124.78 126.88 72.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 N-CA-C 109.425 -0.583 . . . . 1.0 109.425 -178.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' ' 8' ' ' THR . 31.5 p -139.51 -178.11 5.24 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.175 -0.921 . . . . 1.0 110.557 -174.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 1.067 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 87.9 p -159.01 159.61 34.97 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.987 -0.551 . . . . 1.0 109.987 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.457 ' HA ' ' O ' ' A' ' 74' ' ' ALA . . . -164.44 166.17 20.8 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 121.32 0.581 . . . . 1.0 111.462 -178.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -124.58 138.96 11.47 Favored Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 110.789 -0.924 . . . . 1.0 110.789 177.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.54 HG21 HD12 ' A' ' 96' ' ' LEU . 28.3 p -71.79 -21.9 61.65 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.96 0.409 . . . . 1.0 110.977 -178.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -107.17 2.2 35.16 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 120.789 -0.72 . . . . 1.0 113.217 -177.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.493 ' HB3' ' HB2' ' A' ' 75' ' ' GLN . 3.1 p-10 44.23 35.99 1.41 Allowed 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 113.324 0.861 . . . . 1.0 113.324 178.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -43.87 -74.65 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.715 0.769 . . . . 1.0 112.453 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.446 ' HB2' HG12 ' A' ' 15' ' ' ILE . 79.0 m-70 -106.25 42.57 1.25 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.043 -0.98 . . . . 1.0 110.686 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.435 HG23 ' HA ' ' A' ' 74' ' ' ALA . 14.5 p -60.32 134.94 25.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.429 178.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.55 -13.63 60.03 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.885 -0.674 . . . . 1.0 112.303 -178.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.8 t -79.79 -162.67 0.45 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.163 0.506 . . . . 1.0 109.928 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 15.5 t -119.56 174.91 6.11 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.931 -0.766 . . . . 1.0 108.931 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.409 ' HB2' ' HB3' ' A' ' 71' ' ' HIS . . . -62.71 147.02 50.89 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.34 0.59 . . . . 1.0 111.485 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.621 ' OD2' ' HG3' ' A' ' 57' ' ' ARG . 9.8 p-10 -60.79 138.91 58.07 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.958 -1.019 . . . . 1.0 112.885 -178.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -48.6 -36.52 15.86 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 114.704 -1.134 . . . . 1.0 112.596 178.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.621 ' HG3' ' OD2' ' A' ' 55' ' ' ASP . 8.2 ptt180 -70.65 -44.23 67.54 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 122.298 0.239 . . . . 1.0 111.095 -178.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.34 -38.59 78.22 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 109.222 -0.658 . . . . 1.0 109.222 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.06 -44.9 94.38 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.604 -0.725 . . . . 1.0 109.984 178.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.427 ' O ' ' HG2' ' A' ' 63' ' ' ARG . . . -58.06 -44.1 94.83 Favored Glycine 0 N--CA 1.443 -0.882 0 CA-C-N 115.618 -0.719 . . . . 1.0 113.198 178.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.3 m -75.6 -39.24 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-N 117.326 0.563 . . . . 1.0 111.383 -178.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.618 ' HB2' HG22 ' A' ' 69' ' ' THR . 96.6 mt -61.59 -52.14 65.64 Favored 'General case' 0 C--O 1.23 0.044 0 C-N-CA 120.892 -0.323 . . . . 1.0 110.299 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.427 ' HG2' ' O ' ' A' ' 60' ' ' GLY . 6.8 ptm180 -59.63 -30.79 68.96 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.723 -0.671 . . . . 1.0 110.947 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.6 -33.23 74.58 Favored 'General case' 0 C--O 1.226 -0.141 0 CA-C-N 116.354 -0.385 . . . . 1.0 111.297 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.491 ' HB2' ' HD2' ' A' ' 67' ' ' TYR . 98.5 m-70 -96.33 2.51 52.84 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.341 -0.39 . . . . 1.0 111.237 -178.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 90.18 14.34 59.1 Favored Glycine 0 C--N 1.329 0.145 0 CA-C-N 116.005 -0.543 . . . . 1.0 112.536 177.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.491 ' HD2' ' HB2' ' A' ' 65' ' ' HIS . 69.0 m-85 -91.39 149.56 39.78 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-O 120.551 0.215 . . . . 1.0 110.855 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.407 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 52.1 Cg_endo -69.05 153.71 71.76 Favored 'Trans proline' 0 CA--C 1.509 -0.742 0 C-N-CA 122.325 2.017 . . . . 1.0 110.666 177.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.618 HG22 ' HB2' ' A' ' 62' ' ' LEU . 42.3 p -124.74 15.68 8.71 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 121.552 0.691 . . . . 1.0 110.442 -177.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -84.2 120.11 25.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.056 -0.975 . . . . 1.0 110.154 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.972 ' HB2' ' HE3' ' A' ' 23' ' ' LYS . 32.3 t60 -159.11 147.72 18.17 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.761 -0.654 . . . . 1.0 110.587 -177.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.7 tpp180 -125.71 112.57 16.25 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 107.697 -1.223 . . . . 1.0 107.697 175.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 1.089 ' HB1' HD22 ' A' ' 14' ' ' ASN . . . -59.95 140.17 56.91 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.543 -0.753 . . . . 1.0 111.956 -176.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 43' ' ' ALA . . . -135.96 160.6 38.11 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.646 178.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.493 ' HB2' ' HB3' ' A' ' 47' ' ' ASN . 43.5 tt0 -98.68 155.82 17.14 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.767 -0.457 . . . . 1.0 109.767 178.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.487 HG11 HD23 ' A' ' 97' ' ' LEU . 36.5 t -66.48 111.32 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.365 0.603 . . . . 1.0 110.731 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -123.86 -168.3 12.93 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.049 -0.978 . . . . 1.0 111.034 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 80.6 m -55.73 -46.96 77.67 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.711 0.291 . . . . 1.0 111.377 -179.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -60.13 -29.57 68.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.407 -0.36 . . . . 1.0 111.553 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.424 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 77.1 m80 -78.1 -39.26 42.0 Favored 'General case' 0 C--O 1.222 -0.357 0 N-CA-C 109.858 -0.423 . . . . 1.0 109.858 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.664 ' O ' HG23 ' A' ' 102' ' ' VAL . 15.6 mt -70.36 -18.18 63.06 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.308 -0.405 . . . . 1.0 110.451 176.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -88.43 -7.73 56.12 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 120.77 0.319 . . . . 1.0 110.232 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.603 ' HA ' ' HB3' ' A' ' 6' ' ' HIS . . . -59.65 148.01 35.36 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.81 -0.632 . . . . 1.0 109.888 178.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.544 ' HB3' HD13 ' A' ' 5' ' ' LEU . 28.5 t70 -74.44 -16.1 60.88 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.218 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.705 HD13 HG13 ' A' ' 7' ' ' VAL . 0.6 OUTLIER -153.17 116.47 4.64 Favored 'General case' 0 CA--C 1.51 -0.596 0 N-CA-C 109.336 -0.616 . . . . 1.0 109.336 -176.836 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.716 ' HB3' HD13 ' A' ' 97' ' ' LEU . 5.0 mp -106.89 105.52 15.59 Favored 'General case' 0 N--CA 1.426 -1.654 0 CA-C-N 115.489 -0.778 . . . . 1.0 109.782 178.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.628 HG11 HD23 ' A' ' 110' ' ' LEU . 86.6 t -84.63 93.39 3.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 114.554 -1.203 . . . . 1.0 111.263 -175.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.17 145.34 31.06 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.594 -0.73 . . . . 1.0 111.249 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.44 HD23 ' HB2' ' A' ' 11' ' ' CYS . 4.2 mm? -96.53 -11.53 25.32 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.821 -0.627 . . . . 1.0 109.774 178.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.426 ' CG ' ' H ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -148.78 153.62 38.41 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.631 -0.713 . . . . 1.0 110.747 179.859 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -57.96 -26.19 61.97 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.274 -0.876 . . . . 1.0 112.935 -178.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.629 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 82.8 m-20 -77.41 -47.34 20.03 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 110.125 -0.324 . . . . 1.0 110.125 -178.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.656 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 20.6 m170 -53.87 -47.64 70.84 Favored 'General case' 0 CA--C 1.522 -0.106 0 CA-C-N 115.981 -0.554 . . . . 1.0 109.666 177.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.95 -44.42 91.44 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.909 -0.587 . . . . 1.0 110.61 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.655 ' O ' ' HG2' ' A' ' 99' ' ' GLN . 9.8 ttp180 -56.54 -46.13 80.81 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.603 -0.726 . . . . 1.0 111.129 178.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.629 ' HG ' ' O ' ' A' ' 92' ' ' ASN . 42.7 mt -63.39 -47.87 80.22 Favored 'General case' 0 C--O 1.216 -0.696 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.547 -175.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.716 HD13 ' HB3' ' A' ' 86' ' ' LEU . 29.5 mt -53.03 -58.8 5.76 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.784 -0.644 . . . . 1.0 111.413 -177.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.678 ' CA ' HG12 ' A' ' 102' ' ' VAL . 2.2 ptm180 -59.33 -45.25 91.85 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.844 0.683 . . . . 1.0 112.844 -179.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.655 ' HG2' ' O ' ' A' ' 95' ' ' ARG . 7.5 pt20 -68.24 -23.6 64.81 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.165 -0.614 . . . . 1.0 110.49 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.612 HD13 ' O ' ' A' ' 96' ' ' LEU . 6.7 mp -78.98 -17.5 55.29 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 116.267 -0.424 . . . . 1.0 111.817 178.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 152.66 -23.44 0.83 Allowed Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 119.579 -1.296 . . . . 1.0 113.749 -178.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.678 HG12 ' CA ' ' A' ' 98' ' ' ARG . 0.4 OUTLIER -78.45 -163.89 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-N 117.77 0.785 . . . . 1.0 110.166 179.801 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.677 ' N ' HG13 ' A' ' 102' ' ' VAL . 13.1 pt-20 -156.38 165.22 36.99 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 107.736 -1.209 . . . . 1.0 107.736 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.781 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -61.37 -27.11 68.29 Favored 'General case' 0 C--N 1.316 -0.881 0 O-C-N 123.466 0.479 . . . . 1.0 111.278 -175.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.431 ' HA ' ' NH2' ' A' ' 108' ' ' ARG . . . -58.22 -34.07 70.0 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 120.713 0.292 . . . . 1.0 110.578 177.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.43 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 3.9 mtp180 -97.59 -42.84 7.48 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.955 -0.566 . . . . 1.0 111.343 -178.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.781 HG12 ' HA ' ' A' ' 104' ' ' ALA . 12.6 p -77.88 119.08 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-O 120.95 0.405 . . . . 1.0 110.032 -174.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.529 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 26.8 mmt180 -137.96 149.82 46.48 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 121.695 -0.628 . . . . 1.0 110.583 -178.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.676 ' HB2' ' HB2' ' A' ' 112' ' ' SER . 80.9 mmm -79.06 138.19 37.87 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.015 -0.539 . . . . 1.0 110.214 178.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.628 HD23 HG11 ' A' ' 87' ' ' VAL . 2.9 tm? -57.29 -48.8 78.0 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.037 0.446 . . . . 1.0 111.036 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.722 ' HB2' HG22 ' A' ' 124' ' ' VAL . 6.5 ttt-85 -69.68 -14.61 62.89 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.637 -0.71 . . . . 1.0 110.07 -178.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.676 ' HB2' ' HB2' ' A' ' 109' ' ' MET . 43.9 t -79.12 -8.97 59.41 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.921 -0.581 . . . . 1.0 111.289 -178.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.577 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 91.4 m-85 -91.36 -19.04 23.35 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 120.812 0.339 . . . . 1.0 110.266 176.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.409 ' OD1' ' HG2' ' A' ' 116' ' ' ARG . 15.8 t0 -63.27 122.59 76.52 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.854 -0.612 . . . . 1.0 111.143 -177.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 114' ' ' ASP . 37.7 Cg_endo -64.88 -32.48 55.17 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 123.16 2.573 . . . . 1.0 112.919 -179.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.409 ' HG2' ' OD1' ' A' ' 114' ' ' ASP . 6.9 ptp85 -96.89 8.45 44.37 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.689 -0.687 . . . . 1.0 111.796 -175.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 48.0 p -54.84 -38.0 66.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.125 -0.489 . . . . 1.0 111.749 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 131.13 -52.65 0.82 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.84 -0.695 . . . . 1.0 111.901 178.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 90.7 m -157.54 -62.1 0.09 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.213 0.53 . . . . 1.0 110.471 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -161.0 150.83 17.28 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-N 115.669 -0.696 . . . . 1.0 109.958 -178.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.662 ' HB3' ' HB2' ' A' ' 112' ' ' SER . . . -97.64 170.78 8.77 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.231 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.638 HD13 ' O ' ' A' ' 121' ' ' ALA . 1.6 mm? -149.95 -26.56 0.26 Allowed 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 114.248 -1.342 . . . . 1.0 109.713 -177.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -171.16 138.33 1.24 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.038 -0.983 . . . . 1.0 109.006 -176.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.722 HG22 ' HB2' ' A' ' 111' ' ' ARG . 60.0 t -92.59 146.84 5.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.984 0.421 . . . . 1.0 110.403 -177.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -69.85 -163.83 0.06 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.657 -0.701 . . . . 1.0 111.821 -178.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.609 ' HA ' ' NH2' ' A' ' 17' ' ' ARG . 38.0 t70 -165.71 144.76 5.18 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.531 -0.759 . . . . 1.0 109.202 -176.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.645 ' HB3' ' HB3' ' A' ' 134' ' ' ASP . 25.5 Cg_exo -37.11 155.19 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 124.029 3.153 . . . . 1.0 113.777 177.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -93.92 -52.71 4.3 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.266 -0.879 . . . . 1.0 109.708 -177.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -109.85 -40.45 4.78 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.483 0.658 . . . . 1.0 109.505 179.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 102.78 66.33 0.75 Allowed Glycine 0 N--CA 1.442 -0.937 0 N-CA-C 110.418 -1.073 . . . . 1.0 110.418 -175.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.53 ' H ' ' HB2' ' A' ' 134' ' ' ASP . 1.6 p-10 -130.42 -171.42 2.54 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.851 -0.426 . . . . 1.0 109.851 -177.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 20.1 t-160 -58.14 -39.41 78.67 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.059 -0.518 . . . . 1.0 110.457 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 4.2 m -62.34 -54.79 35.44 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.609 -0.515 . . . . 1.0 109.609 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.645 ' HB3' ' HB3' ' A' ' 127' ' ' PRO . 28.1 m-20 -56.07 -36.12 67.72 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.728 0.64 . . . . 1.0 112.728 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 23.1 m-30 -68.75 -49.62 57.31 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.001 0.429 . . . . 1.0 110.813 -177.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.408 ' O ' ' HB3' ' A' ' 139' ' ' PHE . 6.8 mt-10 -76.76 -17.37 59.1 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.864 -178.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.512 ' O ' HG23 ' A' ' 141' ' ' VAL . 4.3 tp10 -62.79 -47.5 83.2 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.961 -0.755 . . . . 1.0 108.961 175.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.679 ' HA ' HG23 ' A' ' 141' ' ' VAL . 55.3 t -61.93 -39.91 85.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 114.662 -1.153 . . . . 1.0 109.815 176.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.408 ' HB3' ' O ' ' A' ' 136' ' ' GLU . 74.4 t80 -53.11 -43.45 66.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.965 -1.016 . . . . 1.0 108.912 175.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.676 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -65.14 -41.16 95.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.304 -0.862 . . . . 1.0 111.09 177.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.679 HG23 ' HA ' ' A' ' 138' ' ' VAL . 12.7 t -54.64 -52.55 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 121.841 0.829 . . . . 1.0 110.233 178.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.477 HD13 ' HB3' ' A' ' 20' ' ' MET . 7.1 mt -65.81 -50.62 69.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 114.817 -1.083 . . . . 1.0 111.769 -179.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.676 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 11.3 pt-20 -58.91 -29.4 67.03 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 120.812 -0.355 . . . . 1.0 110.349 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.412 ' HB2' ' O ' ' A' ' 140' ' ' ALA . 2.1 t -74.17 -27.58 60.89 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 121.114 0.483 . . . . 1.0 109.94 178.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.468 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -86.54 -24.72 25.38 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 115.882 -0.599 . . . . 1.0 111.597 178.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.759 HD22 ' HB3' ' A' ' 25' ' ' PHE . 17.9 mt -54.85 -36.84 49.25 Favored Pre-proline 0 CA--C 1.549 0.942 0 N-CA-C 112.636 0.606 . . . . 1.0 112.636 -178.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.615 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 56.2 Cg_endo -70.45 -12.28 31.33 Favored 'Trans proline' 0 C--N 1.368 1.578 0 C-N-CA 122.775 2.317 . . . . 1.0 112.022 177.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.577 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -104.13 -33.68 3.92 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 110.195 -1.162 . . . . 1.0 110.195 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.457 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -72.51 -39.15 67.82 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 108.267 -1.012 . . . . 1.0 108.267 178.446 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.507 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 0.2 OUTLIER -54.0 -58.86 5.75 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-N 114.52 -1.218 . . . . 1.0 110.845 175.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -55.15 -41.78 72.23 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 114.826 -1.079 . . . . 1.0 111.012 -174.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . 0.667 ' HZ3' HD11 ' A' ' 5' ' ' LEU . 18.6 t90 -63.35 -54.94 29.06 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.325 -0.852 . . . . 1.0 110.444 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.453 HG13 ' O ' ' A' ' 149' ' ' LEU . 6.2 m -64.82 -41.25 91.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 120.842 -0.343 . . . . 1.0 110.764 -178.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.447 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 15.3 m-20 -60.03 -49.46 77.59 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 121.269 0.557 . . . . 1.0 110.613 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.492 ' O ' ' HG3' ' A' ' 159' ' ' ARG . 5.7 pt-20 -65.31 -37.27 86.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.612 -0.722 . . . . 1.0 110.739 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.56 ' HD2' ' HD2' ' A' ' 159' ' ' ARG . 10.9 mmt180 -75.07 -39.3 60.95 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.186 -0.461 . . . . 1.0 111.565 -177.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 4.4 pp -68.09 -24.64 65.07 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.218 -0.66 . . . . 1.0 109.218 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -71.91 -49.66 35.93 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.072 -0.967 . . . . 1.0 110.432 178.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.56 ' HD2' ' HD2' ' A' ' 156' ' ' ARG . 0.0 OUTLIER -81.0 -10.06 59.76 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 112.57 0.581 . . . . 1.0 112.57 -178.984 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -62.31 -52.06 65.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.593 0.235 . . . . 1.0 110.748 -177.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -159.76 -167.79 20.85 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.034 -1.079 . . . . 1.0 112.02 178.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -80.61 29.38 0.52 Allowed 'Trans proline' 0 N--CA 1.475 0.403 0 C-N-CA 123.416 2.744 . . . . 1.0 113.028 -178.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 25.4 t . . . . . 0 C--N 1.297 -1.688 0 CA-C-N 114.756 -1.111 . . . . 1.0 110.435 -178.232 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.786 0 N-CA-C 112.049 -0.42 . . . . 1.0 112.049 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.7 mmt -75.95 -12.22 60.1 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 111.918 0.34 . . . . 1.0 111.918 -177.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.1 p -80.39 -64.65 1.14 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.148 0.499 . . . . 1.0 110.241 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -162.26 159.43 21.03 Favored Pre-proline 0 C--O 1.238 0.49 0 CA-C-N 115.505 -0.771 . . . . 1.0 111.671 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -73.34 168.21 25.35 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.566 2.844 . . . . 1.0 113.036 178.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.85 ' HB3' HG23 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -69.19 -179.36 1.55 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.659 -0.7 . . . . 1.0 109.831 177.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.674 ' H ' HD13 ' A' ' 5' ' ' LEU . 2.5 t-160 -158.45 89.73 0.99 Allowed 'General case' 0 C--N 1.326 -0.444 0 O-C-N 122.145 -0.347 . . . . 1.0 110.066 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.479 HG13 HD13 ' A' ' 85' ' ' LEU . 1.8 t -95.61 109.07 21.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.87 -0.419 . . . . 1.0 109.87 178.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.637 ' CG2' ' HG ' ' A' ' 86' ' ' LEU . 10.5 t -112.89 118.84 36.02 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 120.896 0.379 . . . . 1.0 110.043 177.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.576 ' HD1' ' HB ' ' A' ' 87' ' ' VAL . 1.3 m-85 -86.65 131.27 34.2 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 116.465 -0.334 . . . . 1.0 110.784 -178.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.567 HG21 HD11 ' A' ' 97' ' ' LEU . 21.3 t -115.49 109.61 28.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.852 -0.613 . . . . 1.0 110.964 -177.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.644 ' HB2' HD23 ' A' ' 89' ' ' LEU . 49.8 t -142.38 163.55 32.55 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.587 -0.523 . . . . 1.0 109.587 179.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.57 HG23 ' NE2' ' A' ' 93' ' ' HIS . 0.7 OUTLIER -75.13 100.6 4.3 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.017 0.437 . . . . 1.0 110.89 -179.054 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.857 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 125.0 -44.78 1.22 Allowed Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.935 -0.65 . . . . 1.0 111.831 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.449 HD21 ' CB ' ' A' ' 42' ' ' SER . 4.5 t-20 65.7 11.82 7.83 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.278 0.631 . . . . 1.0 111.348 179.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.447 ' HA ' ' HG3' ' A' ' 19' ' ' PRO . 10.0 pt -120.57 8.74 6.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 O-C-N 121.736 -0.603 . . . . 1.0 111.738 -177.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.54 ' O ' ' HG3' ' A' ' 20' ' ' MET . 6.8 p -126.1 -86.56 0.61 Allowed 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.034 0.383 . . . . 1.0 112.034 -178.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.684 ' HD3' HG13 ' A' ' 138' ' ' VAL . 16.6 tpp180 -66.31 -48.53 70.04 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.981 0.42 . . . . 1.0 111.554 -176.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.654 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 14.2 m -56.55 -57.06 25.86 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 115.667 -0.697 . . . . 1.0 112.8 -178.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.714 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 39.0 Cg_endo -64.26 -27.54 64.0 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 121.806 1.67 . . . . 1.0 112.355 -177.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.622 ' HA ' HD21 ' A' ' 62' ' ' LEU . 66.1 mtp -62.43 -53.53 53.5 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.316 -0.554 . . . . 1.0 110.55 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.462 ' HA ' ' HB2' ' A' ' 24' ' ' MET . . . -70.59 -30.44 67.12 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.588 -0.445 . . . . 1.0 110.526 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.672 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 14.7 tt0 -52.15 -51.79 55.79 Favored 'General case' 0 C--O 1.214 -0.777 0 CA-C-N 115.49 -0.777 . . . . 1.0 109.623 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.944 ' HE3' ' HB2' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -88.49 -21.28 24.25 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 119.674 -0.81 . . . . 1.0 111.228 -176.702 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.511 ' HB3' HD11 ' A' ' 146' ' ' LEU . 83.1 mtp -65.8 -74.47 0.11 Allowed 'General case' 0 C--O 1.237 0.418 0 N-CA-C 112.37 0.508 . . . . 1.0 112.37 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.687 ' HB3' HD22 ' A' ' 146' ' ' LEU . 17.0 p90 -76.17 -30.52 58.13 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 119.707 -0.797 . . . . 1.0 111.481 -175.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.672 ' HB3' ' O ' ' A' ' 22' ' ' GLU . . . -65.11 -35.8 82.26 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 119.17 -1.012 . . . . 1.0 110.893 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.725 ' HA ' ' HD3' ' A' ' 30' ' ' ARG . 0.1 OUTLIER -63.07 -39.34 94.42 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 108.454 -0.943 . . . . 1.0 108.454 177.21 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.616 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 78.9 mt-30 -58.68 -45.81 88.62 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.647 -0.706 . . . . 1.0 109.879 175.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' A' ' 25' ' ' PHE . 96.7 mt -55.42 -58.85 6.02 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.502 -0.772 . . . . 1.0 110.978 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.725 ' HD3' ' HA ' ' A' ' 27' ' ' GLN . 0.4 OUTLIER -59.24 -36.24 75.11 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.49 -0.484 . . . . 1.0 111.258 179.125 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -63.35 -26.12 68.61 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.581 0.586 . . . . 1.0 112.581 177.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.634 ' HG3' ' HG ' ' A' ' 34' ' ' LEU . 8.3 ptp180 -95.54 -16.9 21.85 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 119.568 -0.853 . . . . 1.0 109.805 177.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 105.56 23.36 7.59 Favored Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 114.99 -1.004 . . . . 1.0 112.053 176.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.634 ' HG ' ' HG3' ' A' ' 32' ' ' ARG . 24.5 mt -111.69 1.5 16.75 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.172 -0.307 . . . . 1.0 110.172 -177.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -54.55 -26.03 37.07 Favored Glycine 0 CA--C 1.522 0.472 0 C-N-CA 121.115 -0.564 . . . . 1.0 113.2 -178.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.598 ' HA ' ' NH1' ' A' ' 39' ' ' ARG . 0.5 OUTLIER -95.98 -22.83 17.15 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 109.467 -0.568 . . . . 1.0 109.467 177.533 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -76.97 -23.28 52.33 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.903 -1.044 . . . . 1.0 111.002 -175.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.85 HG23 ' HB3' ' A' ' 5' ' ' LEU . 0.2 OUTLIER -143.38 122.59 8.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.733 -0.667 . . . . 1.0 109.334 177.911 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.598 ' NH1' ' HA ' ' A' ' 36' ' ' ASP . 30.2 mmt180 -87.18 143.33 27.34 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 109.201 -0.666 . . . . 1.0 109.201 -178.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.427 HG11 ' HB2' ' A' ' 26' ' ' ALA . 54.2 t -131.82 131.53 61.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 109.497 -0.557 . . . . 1.0 109.497 -178.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.508 ' O ' ' HA ' ' A' ' 8' ' ' THR . 43.2 p -145.95 -175.74 4.87 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.344 -0.844 . . . . 1.0 109.972 -174.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.654 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 90.6 p -161.7 166.04 27.24 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.799 -0.36 . . . . 1.0 110.52 178.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.588 ' HB2' ' CD2' ' A' ' 80' ' ' HIS . . . -165.52 169.0 15.97 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.398 0.618 . . . . 1.0 111.543 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -127.24 132.3 7.51 Favored Glycine 0 N--CA 1.44 -1.09 0 CA-C-N 114.924 -1.034 . . . . 1.0 110.937 177.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.524 HG23 ' CG1' ' A' ' 10' ' ' VAL . 17.8 p -67.75 -26.86 66.34 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.912 0.386 . . . . 1.0 111.707 -177.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -107.25 9.47 39.02 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.847 -0.692 . . . . 1.0 113.207 -177.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 43.5 38.17 1.73 Allowed 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 113.719 1.007 . . . . 1.0 113.719 176.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.857 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 1.1 m-90 -47.07 -74.21 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.514 0.674 . . . . 1.0 112.438 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.557 ' HB3' ' HB3' ' A' ' 52' ' ' SER . 3.8 m-70 -105.54 39.84 1.67 Allowed 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.184 -0.916 . . . . 1.0 111.16 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.418 HG23 ' HA ' ' A' ' 74' ' ' ALA . 14.8 p -60.17 127.19 19.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 120.377 -0.529 . . . . 1.0 110.068 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.606 ' HA2' ' NE ' ' A' ' 72' ' ' ARG . . . 93.47 -14.28 65.64 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.913 -0.661 . . . . 1.0 111.961 -177.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.557 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 3.1 t -81.4 -158.18 0.21 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.232 0.539 . . . . 1.0 110.034 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 18.7 t -133.28 175.29 9.53 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 115.676 -0.693 . . . . 1.0 109.153 -178.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.96 141.93 43.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.25 0.548 . . . . 1.0 111.85 -178.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.468 ' CG ' ' HG3' ' A' ' 57' ' ' ARG . 56.6 t0 -56.06 129.82 41.47 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.019 -0.991 . . . . 1.0 110.06 178.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -51.51 -29.69 17.58 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.103 0.779 . . . . 1.0 113.103 -179.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.609 ' O ' HG23 ' A' ' 61' ' ' VAL . 0.2 OUTLIER -74.03 -41.89 61.13 Favored 'General case' 0 N--CA 1.461 0.122 0 C-N-CA 120.261 -0.576 . . . . 1.0 110.412 178.602 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.43 -32.41 70.0 Favored 'General case' 0 N--CA 1.46 0.07 0 CA-C-O 120.918 0.39 . . . . 1.0 110.051 178.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.37 -42.42 98.68 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.762 -0.653 . . . . 1.0 110.025 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.448 ' O ' ' HG2' ' A' ' 63' ' ' ARG . . . -64.27 -40.4 97.89 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.563 -0.827 . . . . 1.0 111.217 178.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 57' ' ' ARG . 59.0 t -57.38 -57.47 9.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.091 0.472 . . . . 1.0 110.762 177.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.622 HD21 ' HA ' ' A' ' 20' ' ' MET . 5.7 mp -59.28 -52.28 66.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.972 -0.558 . . . . 1.0 111.109 -178.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.448 ' HG2' ' O ' ' A' ' 60' ' ' GLY . 5.9 ptm180 -60.08 -26.91 66.55 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.729 -0.669 . . . . 1.0 111.338 -178.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.54 -36.54 73.74 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.124 0.488 . . . . 1.0 110.379 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -93.15 3.82 55.04 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.577 -0.738 . . . . 1.0 111.019 -178.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.35 13.69 63.19 Favored Glycine 0 C--N 1.329 0.178 0 CA-C-N 115.735 -0.666 . . . . 1.0 112.593 176.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.48 ' CD1' ' HA ' ' A' ' 24' ' ' MET . 60.5 m-85 -90.03 147.48 37.3 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 110.258 -0.275 . . . . 1.0 110.258 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.474 ' HG2' ' CB ' ' A' ' 23' ' ' LYS . 56.8 Cg_endo -69.44 159.87 51.99 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.45 2.1 . . . . 1.0 110.572 177.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.0 p -130.38 12.69 5.5 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.541 0.686 . . . . 1.0 109.928 -178.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -70.94 114.35 8.91 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 114.725 -1.125 . . . . 1.0 109.994 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.944 ' HB2' ' HE3' ' A' ' 23' ' ' LYS . 62.5 t60 -160.48 149.83 17.35 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.928 0.394 . . . . 1.0 111.202 -176.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.606 ' NE ' ' HA2' ' A' ' 51' ' ' GLY . 1.4 tmt_? -135.61 112.36 10.13 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.684 -1.228 . . . . 1.0 107.684 175.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.524 ' HB3' ' O ' ' A' ' 49' ' ' HIS . . . -59.71 138.98 57.6 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.895 -1.048 . . . . 1.0 112.724 -174.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.418 ' HA ' HG23 ' A' ' 50' ' ' VAL . . . -130.06 160.62 33.17 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.249 -0.887 . . . . 1.0 110.354 178.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -97.31 155.16 17.0 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.43 -0.952 . . . . 1.0 108.43 178.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.504 HG11 HD23 ' A' ' 97' ' ' LEU . 19.1 t -68.42 112.59 3.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 120.938 0.399 . . . . 1.0 110.607 -178.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.444 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -122.97 -170.23 13.46 Favored Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 115.373 -0.831 . . . . 1.0 111.5 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 98.2 m -56.45 -44.15 80.22 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 122.388 0.275 . . . . 1.0 111.214 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -59.23 -29.71 67.73 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.972 0.415 . . . . 1.0 111.227 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.588 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 80.1 m80 -78.21 -41.66 33.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.161 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.746 ' HA ' HD21 ' A' ' 86' ' ' LEU . 15.6 mt -68.39 -17.41 64.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.255 0.55 . . . . 1.0 110.669 177.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.61 -4.5 59.18 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 116.167 -0.47 . . . . 1.0 110.539 -178.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.563 ' HB1' ' O ' ' A' ' 6' ' ' HIS . . . -63.41 160.0 17.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.99 -0.55 . . . . 1.0 111.049 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.753 ' HB3' HD13 ' A' ' 5' ' ' LEU . 15.5 t70 -85.29 -13.16 50.56 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.517 -0.549 . . . . 1.0 109.517 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.741 HD12 ' CE3' ' A' ' 152' ' ' TRP . 1.1 tt -157.73 112.2 2.63 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.746 -0.661 . . . . 1.0 109.6 -177.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.746 HD21 ' HA ' ' A' ' 81' ' ' LEU . 5.6 mp -103.84 89.18 3.23 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-N 115.396 -0.82 . . . . 1.0 110.832 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.637 HG23 HD22 ' A' ' 85' ' ' LEU . 54.0 t -66.22 91.34 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 113.816 -1.538 . . . . 1.0 112.05 -179.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.06 147.74 31.34 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.245 -1.343 . . . . 1.0 109.693 177.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.644 HD23 ' HB2' ' A' ' 11' ' ' CYS . 3.7 mm? -100.86 -10.86 20.3 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.308 0.575 . . . . 1.0 109.618 177.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -141.56 151.52 43.28 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.214 -0.903 . . . . 1.0 110.087 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.551 ' HB3' ' O ' ' A' ' 122' ' ' LEU . 11.6 ptm180 -65.07 -17.35 64.38 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 123.477 0.485 . . . . 1.0 110.089 176.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.643 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 5.3 m-20 -77.83 -50.04 13.09 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.668 -0.697 . . . . 1.0 109.817 178.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.682 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 16.3 m170 -59.26 -42.95 92.39 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.561 -0.533 . . . . 1.0 109.561 178.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.68 -44.48 93.6 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.559 178.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.604 ' O ' ' HG2' ' A' ' 99' ' ' GLN . 0.5 OUTLIER -56.66 -45.26 81.77 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 115.818 -0.628 . . . . 1.0 111.015 178.356 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.694 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 50.9 mt -64.39 -48.3 75.97 Favored 'General case' 0 C--O 1.216 -0.68 0 CA-C-N 115.944 -0.571 . . . . 1.0 110.425 -175.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.682 ' HG ' ' O ' ' A' ' 93' ' ' HIS . 33.2 mt -53.0 -60.16 3.63 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.898 -0.592 . . . . 1.0 111.474 -178.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.72 ' N ' HG12 ' A' ' 102' ' ' VAL . 1.2 ptm180 -59.26 -45.16 91.96 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.843 -0.617 . . . . 1.0 112.381 -179.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.604 ' HG2' ' O ' ' A' ' 95' ' ' ARG . 6.2 pt20 -66.74 -24.69 66.25 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 119.956 -0.698 . . . . 1.0 110.194 178.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.694 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 10.1 mt -80.7 -18.84 46.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.031 -0.531 . . . . 1.0 111.592 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 151.99 -21.27 0.88 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 119.748 -1.215 . . . . 1.0 114.44 -178.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.72 HG12 ' N ' ' A' ' 98' ' ' ARG . 0.3 OUTLIER -76.82 -162.36 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 118.113 0.956 . . . . 1.0 110.662 -179.492 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.773 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 12.3 pt-20 -157.3 160.32 38.43 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 107.703 -1.221 . . . . 1.0 107.703 -179.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.775 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -61.04 -26.13 67.41 Favored 'General case' 0 C--N 1.322 -0.601 0 O-C-N 123.366 0.416 . . . . 1.0 111.32 -175.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.48 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . . . -57.06 -36.42 70.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.15 0.5 . . . . 1.0 110.533 175.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.773 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 7.9 mtt-85 -98.46 -42.37 7.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.237 -0.892 . . . . 1.0 111.194 -177.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.775 HG12 ' HA ' ' A' ' 104' ' ' ALA . 14.6 p -77.96 115.44 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 120.614 -0.435 . . . . 1.0 110.085 -175.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.624 ' HD2' ' O ' ' A' ' 107' ' ' VAL . 26.9 mmm180 -136.13 148.71 48.35 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 121.68 -0.637 . . . . 1.0 110.7 -178.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 83.2 mmm -78.92 137.52 37.67 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.615 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.597 HD23 HG11 ' A' ' 87' ' ' VAL . 2.8 tm? -56.02 -52.68 63.36 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 122.455 0.302 . . . . 1.0 111.532 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 111' ' ' ARG . 25.6 ttt85 -71.22 -16.83 62.52 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.586 -0.445 . . . . 1.0 111.222 -176.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 41.7 t -73.56 -7.63 52.68 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 120.585 -0.446 . . . . 1.0 110.703 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.652 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 83.3 m-85 -87.31 -21.74 25.55 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-O 120.664 0.269 . . . . 1.0 110.765 176.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -57.69 117.91 22.2 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.948 -0.569 . . . . 1.0 111.433 -177.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.71 -16.59 46.71 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.725 2.284 . . . . 1.0 111.24 178.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 37.8 mtp180 -86.06 -19.24 30.55 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.367 -0.833 . . . . 1.0 110.482 178.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 28.1 m -74.01 86.39 1.82 Allowed 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.419 -0.355 . . . . 1.0 111.467 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -57.26 -42.34 93.41 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.409 -0.9 . . . . 1.0 112.354 176.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.43 161.66 20.23 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.824 0.345 . . . . 1.0 110.415 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 38.7 m170 -77.38 131.85 38.26 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.47 -0.332 . . . . 1.0 110.409 178.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -101.64 90.57 4.08 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.034 -0.53 . . . . 1.0 111.038 -179.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.551 ' O ' ' HB3' ' A' ' 91' ' ' ARG . 2.7 mm? -96.69 13.02 29.79 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-N 116.523 -0.308 . . . . 1.0 110.933 178.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -169.1 143.09 2.94 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-O 121.215 0.531 . . . . 1.0 111.264 178.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 44.2 t -125.7 154.24 34.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 114.829 -1.078 . . . . 1.0 108.119 178.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.469 ' H ' ' HG3' ' A' ' 125' ' ' GLU . 0.4 OUTLIER -87.39 -163.18 0.89 Allowed 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.859 -0.61 . . . . 1.0 111.458 -177.455 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -162.55 98.97 1.1 Allowed Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 106.967 -1.494 . . . . 1.0 106.967 -178.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.541 ' HG2' ' CG2' ' A' ' 138' ' ' VAL . 23.2 Cg_exo -62.14 113.38 1.86 Allowed 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.881 2.387 . . . . 1.0 113.257 -174.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -99.99 -9.17 23.02 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.345 -0.843 . . . . 1.0 110.416 178.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.619 ' CD2' ' HB2' ' A' ' 134' ' ' ASP . 0.0 OUTLIER -69.68 -34.34 73.82 Favored 'General case' 0 CA--C 1.522 -0.121 0 N-CA-C 112.789 0.663 . . . . 1.0 112.789 -174.208 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 70.66 61.72 3.97 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.054 -1.069 . . . . 1.0 113.25 176.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.963 ' H ' ' HB3' ' A' ' 134' ' ' ASP . 21.9 t70 -121.95 169.47 10.78 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.204 -1.036 . . . . 1.0 108.204 176.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 18.9 t-160 -58.78 -43.28 90.37 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 108.678 -0.86 . . . . 1.0 108.678 174.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.466 ' O ' ' HB2' ' A' ' 137' ' ' GLU . 12.0 t -64.96 -36.74 85.36 Favored 'General case' 0 C--O 1.217 -0.63 0 CA-C-N 115.766 -0.652 . . . . 1.0 109.844 178.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.963 ' HB3' ' H ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -60.69 -43.6 97.54 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.063 -0.517 . . . . 1.0 111.382 -179.295 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.601 ' HD1' ' HE ' ' A' ' 57' ' ' ARG . 9.5 m-85 -69.7 -49.84 49.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.09 0.472 . . . . 1.0 110.634 -178.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -77.26 -15.04 59.63 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.013 -0.54 . . . . 1.0 111.277 -176.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.615 ' O ' HG23 ' A' ' 141' ' ' VAL . 11.1 tp10 -64.34 -48.3 76.08 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 108.073 -1.084 . . . . 1.0 108.073 174.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.684 HG13 ' HD3' ' A' ' 17' ' ' ARG . 57.4 t -56.52 -47.41 81.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 114.482 -1.235 . . . . 1.0 109.766 175.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.507 ' HB2' HG11 ' A' ' 61' ' ' VAL . 69.8 t80 -56.4 -44.12 79.98 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 113.858 -1.519 . . . . 1.0 110.147 178.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.71 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -63.42 -44.97 93.09 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.208 -0.451 . . . . 1.0 111.761 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 137' ' ' GLU . 36.3 t -55.43 -46.59 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.706 0.765 . . . . 1.0 110.005 178.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.455 ' CG2' ' HB2' ' A' ' 21' ' ' ALA . 7.0 mt -69.51 -51.13 44.88 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 115.04 -0.982 . . . . 1.0 111.785 -178.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.71 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 6.2 pt-20 -56.14 -33.88 65.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.537 0.208 . . . . 1.0 110.665 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.8 t -73.33 -27.98 61.81 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.238 0.542 . . . . 1.0 110.124 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.472 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -86.69 -23.99 25.39 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-N 115.869 -0.605 . . . . 1.0 111.823 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.687 HD22 ' HB3' ' A' ' 25' ' ' PHE . 11.9 mt -55.16 -37.89 61.65 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 112.654 0.613 . . . . 1.0 112.654 -178.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 61.5 Cg_endo -70.65 -13.2 32.23 Favored 'Trans proline' 0 C--N 1.359 1.116 0 C-N-CA 122.649 2.232 . . . . 1.0 111.939 177.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.652 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -102.72 -32.35 4.81 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 110.099 -1.2 . . . . 1.0 110.099 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.495 ' O ' HG13 ' A' ' 153' ' ' VAL . 0.4 OUTLIER -73.73 -40.69 63.35 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.396 -0.964 . . . . 1.0 108.396 177.604 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.448 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -55.53 -54.7 40.76 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 114.81 -1.086 . . . . 1.0 110.135 175.667 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -58.94 -42.52 89.96 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.333 -0.849 . . . . 1.0 110.961 -175.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . 0.845 ' HZ3' HD11 ' A' ' 5' ' ' LEU . 23.6 t90 -63.02 -55.28 26.99 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.46 -0.791 . . . . 1.0 110.465 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.495 HG13 ' O ' ' A' ' 149' ' ' LEU . 10.7 m -62.7 -40.69 89.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.816 -0.354 . . . . 1.0 110.587 -177.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.495 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 4.1 m-20 -60.79 -50.93 71.46 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-O 120.838 0.351 . . . . 1.0 110.727 178.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.543 ' O ' ' HG3' ' A' ' 159' ' ' ARG . 6.8 pt-20 -64.11 -36.86 85.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.861 -178.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.535 ' HD2' ' HD2' ' A' ' 159' ' ' ARG . 10.4 mmt180 -73.56 -42.61 61.42 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 116.185 -0.461 . . . . 1.0 111.394 -178.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 4.3 pp -65.79 -24.8 67.01 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 109.27 -0.641 . . . . 1.0 109.27 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -73.34 -53.86 9.77 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.065 -0.97 . . . . 1.0 110.261 178.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.543 ' HG3' ' O ' ' A' ' 155' ' ' GLU . 0.0 OUTLIER -74.77 -9.68 58.79 Favored 'General case' 0 N--CA 1.462 0.143 0 N-CA-C 112.714 0.635 . . . . 1.0 112.714 -177.732 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -83.89 43.19 0.9 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.462 0.649 . . . . 1.0 110.51 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -123.06 155.06 17.21 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.723 -0.751 . . . . 1.0 112.036 175.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -87.3 -157.84 0.08 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 122.969 2.446 . . . . 1.0 112.272 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 25.1 m . . . . . 0 C--O 1.248 1.019 0 CA-C-N 114.776 -1.102 . . . . 1.0 111.606 -179.818 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.753 0 N-CA-C 111.793 -0.523 . . . . 1.0 111.793 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 mmt -87.2 64.56 8.41 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.907 0.353 . . . . 1.0 110.575 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.2 m -83.13 111.46 18.92 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.189 -0.46 . . . . 1.0 110.724 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.814 ' HB3' ' HD2' ' A' ' 4' ' ' PRO . 9.4 m-20 -69.24 166.65 27.26 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-O 121.035 0.445 . . . . 1.0 110.487 178.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.918 ' HG3' ' HE ' ' A' ' 39' ' ' ARG . 60.0 Cg_endo -72.22 170.05 20.07 Favored 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 123.26 2.64 . . . . 1.0 114.298 -178.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.869 ' HB3' HG23 ' A' ' 38' ' ' VAL . 0.8 OUTLIER -74.8 -173.31 1.82 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.05 -0.977 . . . . 1.0 110.836 178.146 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.492 ' O ' ' HB1' ' A' ' 83' ' ' ALA . 0.2 OUTLIER -159.15 94.59 1.21 Allowed 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 121.087 -0.245 . . . . 1.0 111.448 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.79 HG13 HD13 ' A' ' 85' ' ' LEU . 2.2 t -95.94 113.48 30.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 108.893 -0.781 . . . . 1.0 108.893 175.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.624 ' CG2' ' HG ' ' A' ' 86' ' ' LEU . 14.5 t -114.15 115.26 27.22 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 120.992 0.425 . . . . 1.0 110.108 178.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.549 ' HD1' ' HB ' ' A' ' 87' ' ' VAL . 2.0 m-85 -81.81 146.77 29.72 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 109.56 -0.533 . . . . 1.0 109.56 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.603 HG21 HD11 ' A' ' 97' ' ' LEU . 42.5 t -130.42 114.0 27.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 121.059 0.457 . . . . 1.0 111.63 -177.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.615 ' SG ' ' HD2' ' A' ' 17' ' ' ARG . 47.9 t -143.93 161.25 39.19 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.821 -0.807 . . . . 1.0 108.821 177.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.88 97.07 3.23 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.269 0.556 . . . . 1.0 111.182 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.691 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 130.96 -44.74 1.18 Allowed Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.457 -0.792 . . . . 1.0 111.249 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.662 ' ND2' ' H ' ' A' ' 74' ' ' ALA . 58.6 t30 59.8 29.16 18.73 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.829 0.824 . . . . 1.0 111.179 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.3 pt -130.91 10.67 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.963 -0.562 . . . . 1.0 111.675 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.66 ' O ' ' HG3' ' A' ' 20' ' ' MET . 12.3 m -125.54 -89.64 0.57 Allowed 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.089 -0.644 . . . . 1.0 111.609 -178.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.846 HH22 ' HD3' ' A' ' 127' ' ' PRO . 1.9 ptp85 -74.27 -35.85 63.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.065 -0.516 . . . . 1.0 112.364 -176.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.554 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 16.5 m -58.99 -58.83 16.58 Favored Pre-proline 0 CA--C 1.541 0.602 0 C-N-CA 121.26 -0.176 . . . . 1.0 111.105 179.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.76 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 36.6 Cg_endo -61.93 -26.66 79.11 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.051 1.834 . . . . 1.0 111.937 178.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.66 ' HG3' ' O ' ' A' ' 16' ' ' CYS . 63.8 mtp -62.43 -54.57 38.22 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.847 -0.341 . . . . 1.0 111.106 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.1 -28.5 65.45 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 120.452 -0.499 . . . . 1.0 109.666 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.703 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 7.4 tt0 -54.32 -51.9 63.24 Favored 'General case' 0 C--O 1.216 -0.672 0 CA-C-N 115.029 -0.987 . . . . 1.0 109.236 178.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.775 ' HB3' ' HG2' ' A' ' 68' ' ' PRO . 0.0 OUTLIER -80.36 -29.9 37.95 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.758 -0.655 . . . . 1.0 110.212 -176.846 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.585 ' HB3' HD11 ' A' ' 146' ' ' LEU . 3.1 mmm -63.33 -76.12 0.07 Allowed 'General case' 0 C--O 1.238 0.458 0 N-CA-C 113.058 0.762 . . . . 1.0 113.058 -176.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.658 ' HB3' HD22 ' A' ' 146' ' ' LEU . 22.6 p90 -76.76 -29.72 56.22 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 119.859 -0.736 . . . . 1.0 111.268 -174.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.703 ' HB3' ' O ' ' A' ' 22' ' ' GLU . . . -65.25 -37.82 88.43 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 119.036 -1.066 . . . . 1.0 111.134 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.642 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -63.2 -40.04 96.34 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.56 -0.904 . . . . 1.0 108.56 177.854 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.571 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 79.1 mt-30 -57.49 -47.71 81.19 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 115.608 -0.724 . . . . 1.0 110.082 176.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.539 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 93.3 mt -53.09 -59.55 4.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.69 -0.686 . . . . 1.0 111.06 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.597 ' HD3' ' HA ' ' A' ' 27' ' ' GLN . 0.1 OUTLIER -59.5 -37.25 77.81 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.484 -0.486 . . . . 1.0 111.275 178.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -63.9 -21.32 66.41 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.873 0.694 . . . . 1.0 112.873 178.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.539 ' HG2' ' O ' ' A' ' 29' ' ' LEU . 7.6 ptp180 -99.29 -21.54 16.01 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 119.677 -0.809 . . . . 1.0 110.037 176.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 107.34 42.35 1.51 Allowed Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 115.202 -0.908 . . . . 1.0 111.99 178.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 23.8 mt -135.83 -5.11 2.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.704 0.288 . . . . 1.0 110.372 -178.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.455 ' H ' ' HA ' ' A' ' 30' ' ' ARG . . . -58.72 -25.19 58.4 Favored Glycine 0 C--N 1.329 0.168 0 C-N-CA 121.361 -0.447 . . . . 1.0 112.619 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.46 ' O ' ' HB3' ' A' ' 4' ' ' PRO . 49.3 m-20 -85.01 -28.92 25.4 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.28 0.562 . . . . 1.0 109.885 177.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.58 -18.56 51.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.09 -0.959 . . . . 1.0 112.015 -177.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.869 HG23 ' HB3' ' A' ' 5' ' ' LEU . 0.8 OUTLIER -144.85 122.85 5.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.255 0.55 . . . . 1.0 110.137 179.133 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.918 ' HE ' ' HG3' ' A' ' 4' ' ' PRO . 9.9 mmt180 -89.16 145.45 25.42 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.802 -0.636 . . . . 1.0 110.071 -178.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 77.5 t -132.55 118.88 36.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.439 0.638 . . . . 1.0 109.869 -178.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 8' ' ' THR . 36.7 p -132.87 -174.42 3.47 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 114.279 -1.328 . . . . 1.0 111.365 -175.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.554 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 63.9 p -159.63 161.22 34.99 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.509 -178.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.663 ' HB2' ' CD2' ' A' ' 80' ' ' HIS . . . -162.38 163.09 27.99 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.294 0.569 . . . . 1.0 111.627 -178.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.404 ' HA2' ' O ' ' A' ' 11' ' ' CYS . . . -123.73 131.77 8.17 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 110.863 -0.895 . . . . 1.0 110.863 178.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.587 HG23 ' CG1' ' A' ' 10' ' ' VAL . 18.0 p -67.72 -26.92 66.39 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.036 0.384 . . . . 1.0 112.036 -177.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -107.26 9.07 38.75 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.73 -0.748 . . . . 1.0 112.904 -177.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.401 ' HB3' ' HB2' ' A' ' 75' ' ' GLN . 3.8 p-10 41.02 41.93 1.41 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.834 0.854 . . . . 1.0 113.288 179.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.691 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 0.9 OUTLIER -50.34 -77.64 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.154 0.502 . . . . 1.0 112.013 179.009 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.422 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 15.8 m-70 -101.97 41.12 1.24 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.907 -0.588 . . . . 1.0 110.919 -179.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.2 p -61.56 127.43 21.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.13 0.491 . . . . 1.0 110.105 178.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.767 ' HA2' ' HD3' ' A' ' 72' ' ' ARG . . . 97.02 -15.43 62.56 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.679 -0.691 . . . . 1.0 112.107 -177.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.0 t -80.27 -159.02 0.2 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.367 0.603 . . . . 1.0 109.926 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 31.7 t -132.91 173.08 11.77 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.359 -0.837 . . . . 1.0 109.01 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.91 139.95 32.23 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.982 0.42 . . . . 1.0 111.3 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.614 ' OD1' ' HG2' ' A' ' 57' ' ' ARG . 11.7 t70 -60.9 139.14 58.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.425 -0.807 . . . . 1.0 110.374 -178.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -48.21 -33.95 9.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.409 -0.814 . . . . 1.0 112.861 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.728 ' HB2' ' CD2' ' A' ' 135' ' ' PHE . 18.8 ptp180 -70.96 -46.07 63.03 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 122.26 -0.275 . . . . 1.0 110.589 -177.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.47 -32.84 68.75 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 116.086 -0.506 . . . . 1.0 109.743 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.99 -46.88 88.96 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.191 -0.67 . . . . 1.0 109.191 176.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.477 ' HA2' ' HD3' ' A' ' 63' ' ' ARG . . . -61.05 -39.69 97.44 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.818 -0.706 . . . . 1.0 111.574 177.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 57' ' ' ARG . 93.3 t -60.55 -60.31 2.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.803 0.335 . . . . 1.0 111.214 177.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.779 ' HB2' HG22 ' A' ' 69' ' ' THR . 81.8 mt -58.17 -51.79 68.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.211 -0.45 . . . . 1.0 111.526 -176.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.477 ' HD3' ' HA2' ' A' ' 60' ' ' GLY . 6.9 ptm180 -59.17 -29.15 67.25 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.315 -0.402 . . . . 1.0 111.191 -179.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.57 -30.63 61.79 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.343 0.592 . . . . 1.0 110.904 -179.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -95.06 3.97 54.25 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.854 -0.612 . . . . 1.0 110.668 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.09 10.61 60.94 Favored Glycine 0 C--N 1.331 0.264 0 CA-C-N 115.694 -0.685 . . . . 1.0 113.312 175.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.425 ' CD1' ' HA ' ' A' ' 24' ' ' MET . 66.5 m-85 -92.08 152.33 42.63 Favored Pre-proline 0 C--N 1.316 -0.871 0 CA-C-O 120.61 0.243 . . . . 1.0 111.543 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.775 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 33.0 Cg_endo -68.07 156.94 63.92 Favored 'Trans proline' 0 CA--C 1.514 -0.496 0 C-N-CA 122.515 2.144 . . . . 1.0 110.737 175.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.779 HG22 ' HB2' ' A' ' 62' ' ' LEU . 63.3 p -132.55 7.89 4.19 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 120.102 -0.639 . . . . 1.0 112.485 -176.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -90.5 133.09 35.29 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.008 0.432 . . . . 1.0 110.851 -178.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.483 ' HB2' ' HE3' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -173.03 150.71 2.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.41 -0.814 . . . . 1.0 109.207 -176.749 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.767 ' HD3' ' HA2' ' A' ' 51' ' ' GLY . 4.1 tmm_? -120.79 115.33 23.07 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.169 -1.049 . . . . 1.0 108.169 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' A' ' 49' ' ' HIS . . . -58.03 137.08 57.16 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.462 0.648 . . . . 1.0 112.307 -175.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.662 ' H ' ' ND2' ' A' ' 14' ' ' ASN . . . -127.81 158.29 38.1 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.41 -0.813 . . . . 1.0 109.913 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.401 ' HB2' ' HB3' ' A' ' 47' ' ' ASN . 34.2 tt0 -94.89 155.92 16.57 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.916 -0.772 . . . . 1.0 108.916 177.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.506 HG11 ' CD2' ' A' ' 97' ' ' LEU . 22.0 t -67.46 112.56 2.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.236 0.541 . . . . 1.0 110.09 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.549 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -126.24 -167.19 12.39 Favored Glycine 0 N--CA 1.438 -1.178 0 CA-C-N 115.445 -0.798 . . . . 1.0 111.38 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 54.4 m -55.42 -51.68 66.08 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 122.574 0.35 . . . . 1.0 111.931 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.45 ' HG2' ' N ' ' A' ' 80' ' ' HIS . 1.1 pm0 -57.2 -31.92 65.94 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.655 -0.702 . . . . 1.0 111.008 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.663 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 78.3 m80 -76.74 -41.86 43.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.034 179.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 24.4 mt -67.41 -19.26 65.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.939 -0.573 . . . . 1.0 110.992 177.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -87.38 -6.09 58.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.933 -0.576 . . . . 1.0 111.209 -178.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.492 ' HB1' ' O ' ' A' ' 6' ' ' HIS . . . -59.93 152.96 22.26 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.852 -0.613 . . . . 1.0 111.275 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -76.86 -17.48 58.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.102 0.477 . . . . 1.0 109.965 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.79 HD13 HG13 ' A' ' 7' ' ' VAL . 0.3 OUTLIER -153.26 116.42 4.6 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-N 115.604 -0.725 . . . . 1.0 109.443 -176.722 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.624 ' HG ' ' CG2' ' A' ' 8' ' ' THR . 5.1 mp -106.72 107.3 18.25 Favored 'General case' 0 N--CA 1.422 -1.856 0 CA-C-N 115.774 -0.648 . . . . 1.0 110.01 177.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.549 ' HB ' ' HD1' ' A' ' 9' ' ' PHE . 51.5 t -85.49 93.3 3.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 114.994 -1.003 . . . . 1.0 110.934 -176.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.23 145.78 32.06 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.628 -0.714 . . . . 1.0 110.432 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.501 ' HG ' ' HD3' ' A' ' 17' ' ' ARG . 3.9 mm? -96.67 -12.44 23.84 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.208 0.528 . . . . 1.0 110.604 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.446 ' CG ' ' H ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -151.54 157.66 42.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.625 -0.716 . . . . 1.0 111.193 179.523 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -53.5 -29.68 37.44 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 113.467 0.914 . . . . 1.0 113.467 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.637 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 2.2 m120 -76.59 -48.37 19.43 Favored 'General case' 0 CA--C 1.512 -0.486 0 C-N-CA 120.364 -0.534 . . . . 1.0 110.864 -177.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.705 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 15.7 m170 -56.04 -46.36 78.91 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.838 -0.43 . . . . 1.0 109.838 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.45 -43.13 93.24 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.803 0.335 . . . . 1.0 110.794 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.453 ' O ' ' HG2' ' A' ' 98' ' ' ARG . 13.1 ttt180 -59.76 -44.64 93.76 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 115.845 -0.616 . . . . 1.0 111.629 179.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.754 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 58.5 mt -64.03 -48.98 74.2 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.169 -0.468 . . . . 1.0 110.083 -176.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.705 ' HG ' ' O ' ' A' ' 93' ' ' HIS . 32.7 mt -52.7 -57.12 11.15 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.845 -0.616 . . . . 1.0 111.22 -179.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.556 ' HA ' ' HB ' ' A' ' 102' ' ' VAL . 12.9 ptt180 -61.26 -41.31 96.71 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.216 -0.447 . . . . 1.0 111.832 -176.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.665 ' HG3' ' O ' ' A' ' 96' ' ' LEU . 1.1 pp0? -69.12 -25.32 64.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.993 0.425 . . . . 1.0 110.359 178.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.754 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 14.2 mt -78.53 -13.65 59.73 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.987 -0.551 . . . . 1.0 112.315 -179.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 148.59 -22.73 1.34 Allowed Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 119.995 -1.097 . . . . 1.0 112.935 -178.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.951 HG12 ' H ' ' A' ' 103' ' ' GLU . 3.3 t -76.24 -156.98 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 109.687 -0.486 . . . . 1.0 109.687 178.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.951 ' H ' HG12 ' A' ' 102' ' ' VAL . 16.8 pt-20 -171.18 168.08 6.87 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 107.66 -1.237 . . . . 1.0 107.66 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.735 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -66.45 -23.93 66.36 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.992 -0.283 . . . . 1.0 111.572 -174.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.04 -37.78 72.25 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.246 0.546 . . . . 1.0 110.509 176.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.752 ' HD2' HG13 ' A' ' 102' ' ' VAL . 15.1 mtt180 -96.11 -45.17 6.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.778 -1.101 . . . . 1.0 110.935 -176.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.735 HG12 ' HA ' ' A' ' 104' ' ' ALA . 8.0 p -79.46 124.78 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-O 121.572 0.701 . . . . 1.0 110.702 -177.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.546 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 21.2 mmm180 -140.52 146.69 38.46 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 -179.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.63 ' HE3' HG23 ' A' ' 124' ' ' VAL . 82.1 mmm -78.86 137.84 37.86 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.762 -0.654 . . . . 1.0 110.369 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.503 HD23 HG11 ' A' ' 87' ' ' VAL . 3.1 tm? -56.31 -48.7 76.16 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.077 0.465 . . . . 1.0 111.268 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.9 ' HB2' HG13 ' A' ' 124' ' ' VAL . 65.0 ttt180 -69.6 -20.59 63.62 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.98 -0.554 . . . . 1.0 110.303 -177.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.542 ' HB2' ' HB2' ' A' ' 109' ' ' MET . 36.1 t -76.15 -5.41 46.56 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.62 -0.718 . . . . 1.0 110.913 -177.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.568 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 86.9 m-85 -90.68 -22.77 20.98 Favored 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 122.172 -0.33 . . . . 1.0 110.237 175.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -61.0 119.39 44.73 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.733 -0.667 . . . . 1.0 110.263 -177.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -67.57 -17.26 48.3 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.669 2.246 . . . . 1.0 112.162 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 10.3 mmm180 -90.51 -22.61 21.25 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.718 -0.674 . . . . 1.0 110.814 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 36.2 t -75.25 64.49 1.47 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.001 -0.545 . . . . 1.0 112.377 -175.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 57.04 -102.14 0.19 Allowed Glycine 0 CA--C 1.52 0.373 0 C-N-CA 121.433 -0.413 . . . . 1.0 113.494 179.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 19.7 m -143.36 -40.04 0.31 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.027 0.442 . . . . 1.0 110.517 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -147.49 146.24 29.43 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 121.075 0.464 . . . . 1.0 110.38 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.463 ' HB1' ' HD3' ' A' ' 111' ' ' ARG . . . -131.42 106.05 8.0 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.672 -0.695 . . . . 1.0 110.663 -175.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.411 HD22 ' N ' ' A' ' 122' ' ' LEU . 2.8 mm? -86.73 16.69 4.52 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.434 0.635 . . . . 1.0 110.61 177.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -169.06 136.69 1.89 Allowed 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 108.25 -1.019 . . . . 1.0 108.25 177.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.9 HG13 ' HB2' ' A' ' 111' ' ' ARG . 55.4 t -95.81 -86.92 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 113.392 0.886 . . . . 1.0 113.392 -173.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.548 ' OE1' HG22 ' A' ' 138' ' ' VAL . 9.8 pt-20 -137.59 172.78 12.45 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 115.051 -0.977 . . . . 1.0 111.363 -174.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 35.3 t70 178.03 121.98 0.19 Allowed Pre-proline 0 C--O 1.236 0.367 0 CA-C-N 115.216 -0.902 . . . . 1.0 109.086 177.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.846 ' HD3' HH22 ' A' ' 17' ' ' ARG . 19.7 Cg_endo -59.04 162.15 14.3 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 123.216 2.611 . . . . 1.0 113.216 -177.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.503 ' HD2' ' CD2' ' A' ' 129' ' ' TYR . 43.7 t80 -107.47 -28.3 9.9 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.948 -1.024 . . . . 1.0 110.174 -178.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.503 ' CD2' ' HD2' ' A' ' 128' ' ' TYR . 0.1 OUTLIER -142.19 -35.44 0.43 Allowed 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 111.98 0.363 . . . . 1.0 111.98 -179.705 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 94.18 68.3 1.06 Allowed Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.075 -1.06 . . . . 1.0 111.589 -178.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.736 ' H ' ' HB3' ' A' ' 134' ' ' ASP . 2.5 t70 -131.45 -170.68 2.43 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.471 -0.566 . . . . 1.0 109.471 -177.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.922 ' HA ' ' CZ ' ' A' ' 135' ' ' PHE . 4.4 t60 -58.63 -39.53 80.76 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 109.252 -0.647 . . . . 1.0 109.252 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 27.0 t -63.03 -33.51 75.59 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 114.994 -1.003 . . . . 1.0 111.066 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.736 ' HB3' ' H ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -65.16 -47.75 75.92 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 111.578 0.214 . . . . 1.0 111.578 -176.796 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.922 ' CZ ' ' HA ' ' A' ' 132' ' ' HIS . 6.7 p90 -75.98 -32.55 59.53 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 119.143 -1.023 . . . . 1.0 112.426 -175.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.443 ' HG3' ' CD2' ' A' ' 132' ' ' HIS . 1.6 mt-10 -77.06 -21.83 53.83 Favored 'General case' 0 C--N 1.312 -1.04 0 C-N-CA 120.144 -0.623 . . . . 1.0 109.853 175.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.489 ' O ' HG23 ' A' ' 141' ' ' VAL . 71.1 tt0 -67.8 -42.95 80.76 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 108.539 -0.911 . . . . 1.0 108.539 174.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.548 HG22 ' OE1' ' A' ' 125' ' ' GLU . 76.1 t -58.72 -44.34 89.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 114.514 -1.221 . . . . 1.0 109.583 176.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.554 ' HB2' ' HE1' ' A' ' 20' ' ' MET . 46.5 t80 -54.59 -43.41 72.11 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.444 -1.253 . . . . 1.0 110.257 177.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.451 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -63.9 -42.19 97.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.774 -0.648 . . . . 1.0 110.901 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 137' ' ' GLU . 31.2 t -57.7 -57.02 12.09 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 CA-C-O 121.384 0.611 . . . . 1.0 110.592 178.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.482 ' HA ' HD11 ' A' ' 110' ' ' LEU . 7.0 mt -57.7 -52.07 62.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.21 -0.904 . . . . 1.0 112.388 -177.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.498 ' HG3' ' N ' ' A' ' 144' ' ' SER . 2.2 pt-20 -56.34 -33.06 65.28 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.702 0.287 . . . . 1.0 110.536 -179.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.498 ' N ' ' HG3' ' A' ' 143' ' ' GLU . 4.0 t -73.52 -27.42 61.35 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.347 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.466 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -88.61 -22.34 23.54 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-N 115.914 -0.585 . . . . 1.0 111.86 179.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.658 HD22 ' HB3' ' A' ' 25' ' ' PHE . 12.5 mt -55.28 -37.31 55.37 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-O 119.212 -0.423 . . . . 1.0 112.117 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.626 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 43.3 Cg_endo -68.91 -12.17 33.74 Favored 'Trans proline' 0 C--N 1.365 1.409 0 C-N-CA 122.325 2.017 . . . . 1.0 111.943 176.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.568 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -104.51 -33.8 3.78 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 110.72 -0.952 . . . . 1.0 110.72 178.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.517 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -73.46 -39.62 64.79 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.348 -0.982 . . . . 1.0 108.348 178.93 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.511 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 0.2 OUTLIER -54.12 -55.01 31.76 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-N 115.136 -0.938 . . . . 1.0 110.628 175.347 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -56.29 -42.26 77.24 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.716 -1.129 . . . . 1.0 111.193 -175.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . 0.666 ' HZ3' HD21 ' A' ' 5' ' ' LEU . 22.1 t90 -64.97 -54.85 24.1 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.346 -0.843 . . . . 1.0 110.613 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.446 HG13 ' O ' ' A' ' 149' ' ' LEU . 6.4 m -62.21 -41.17 90.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 120.587 -0.445 . . . . 1.0 110.069 -178.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -60.19 -49.51 77.36 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-O 121.013 0.435 . . . . 1.0 110.792 178.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.543 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 11.8 pt-20 -63.61 -39.57 94.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.691 -0.686 . . . . 1.0 110.399 -178.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.527 ' HG3' ' CH2' ' A' ' 152' ' ' TRP . 15.6 mmt85 -74.59 -42.37 58.8 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.863 -0.608 . . . . 1.0 111.528 -175.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.409 HD12 ' C ' ' A' ' 157' ' ' LEU . 4.0 pp -67.45 -24.92 65.67 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.285 0.564 . . . . 1.0 109.576 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -73.42 -54.4 8.39 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.376 -0.829 . . . . 1.0 110.272 177.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 155' ' ' GLU . 0.1 OUTLIER -79.13 -1.15 34.71 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.902 -0.59 . . . . 1.0 111.907 -178.502 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -54.74 -45.17 74.1 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.828 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -164.34 -173.1 32.62 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 119.985 -1.103 . . . . 1.0 112.812 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -82.39 41.21 1.08 Allowed 'Trans proline' 0 N--CA 1.474 0.357 0 C-N-CA 124.002 3.134 . . . . 1.0 112.347 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 50.4 m . . . . . 0 C--N 1.314 -0.96 0 CA-C-N 114.292 -1.322 . . . . 1.0 110.016 -179.25 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.675 0 N-CA-C 111.615 -0.594 . . . . 1.0 111.615 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.2 mtt -82.16 131.39 35.24 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.934 0.367 . . . . 1.0 110.21 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.6 p -166.67 169.81 13.16 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.857 -0.611 . . . . 1.0 110.879 -178.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -163.32 149.7 10.12 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 115.343 -0.844 . . . . 1.0 109.415 176.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.643 ' HB2' ' HG2' ' A' ' 39' ' ' ARG . 18.9 Cg_endo -63.32 164.06 21.45 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 123.162 2.575 . . . . 1.0 113.886 -176.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.577 ' HB3' HG13 ' A' ' 38' ' ' VAL . 0.4 OUTLIER -71.1 -173.85 0.89 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.287 -1.324 . . . . 1.0 110.347 179.173 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.573 ' HB3' ' H ' ' A' ' 84' ' ' ASP . 1.5 t-160 -155.2 102.52 2.3 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 110.043 -0.355 . . . . 1.0 110.043 -178.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.699 HG13 HD13 ' A' ' 85' ' ' LEU . 2.1 t -106.53 112.48 39.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 108.125 -1.065 . . . . 1.0 108.125 177.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.55 HG22 ' HG ' ' A' ' 86' ' ' LEU . 9.0 t -114.58 114.11 25.29 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.033 0.444 . . . . 1.0 110.479 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.566 ' HD1' ' HB ' ' A' ' 87' ' ' VAL . 0.9 OUTLIER -83.87 134.83 34.68 Favored 'General case' 0 CA--C 1.511 -0.526 0 O-C-N 121.857 -0.527 . . . . 1.0 110.259 -179.541 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.577 HG21 HD11 ' A' ' 97' ' ' LEU . 48.8 t -119.69 115.61 48.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-O 121.227 0.537 . . . . 1.0 111.453 -177.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 37.4 t -140.49 163.15 33.6 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.527 -0.76 . . . . 1.0 109.297 178.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.15 84.94 3.63 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.167 0.508 . . . . 1.0 111.23 -177.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.708 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 141.84 -39.14 1.42 Allowed Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.443 -0.799 . . . . 1.0 111.952 179.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.407 HD21 ' CB ' ' A' ' 42' ' ' SER . 3.8 t-20 62.71 16.47 8.98 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.817 0.818 . . . . 1.0 111.347 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.418 ' O ' ' HB3' ' A' ' 55' ' ' ASP . 1.8 pt -131.44 32.87 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 O-C-N 121.827 -0.546 . . . . 1.0 110.553 -178.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.787 ' O ' ' HG3' ' A' ' 20' ' ' MET . 35.6 m -147.97 -88.21 0.09 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.915 -0.402 . . . . 1.0 109.915 175.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.41 -51.29 68.11 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.257 0.466 . . . . 1.0 112.257 -177.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.872 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 14.3 m -54.19 -58.99 11.21 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 115.99 -0.55 . . . . 1.0 112.369 -177.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.657 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 33.2 Cg_endo -61.62 -26.6 80.54 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 121.898 1.732 . . . . 1.0 112.705 -178.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.787 ' HG3' ' O ' ' A' ' 16' ' ' CYS . 72.9 mtp -60.43 -54.84 40.76 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.751 -0.38 . . . . 1.0 110.524 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.524 ' HA ' ' HB2' ' A' ' 24' ' ' MET . . . -74.75 -27.53 60.39 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.582 -0.447 . . . . 1.0 110.763 -178.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.601 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 18.1 tt0 -52.37 -53.36 45.82 Favored 'General case' 0 C--O 1.217 -0.634 0 O-C-N 124.064 0.852 . . . . 1.0 110.09 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.981 ' HE3' ' HB2' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -86.71 -22.35 26.08 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.43 -0.805 . . . . 1.0 110.69 -176.409 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.704 ' HB3' HD11 ' A' ' 146' ' ' LEU . 3.2 mmm -63.73 -76.66 0.06 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.216 0.45 . . . . 1.0 112.216 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.762 ' HB3' HD22 ' A' ' 146' ' ' LEU . 22.6 p90 -76.2 -29.76 57.74 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 119.697 -0.801 . . . . 1.0 111.68 -175.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.601 ' HB3' ' O ' ' A' ' 22' ' ' GLU . . . -63.35 -36.62 84.31 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 119.321 -0.952 . . . . 1.0 110.714 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.625 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -65.48 -39.32 91.8 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 108.801 -0.815 . . . . 1.0 108.801 177.218 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.616 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 59.8 mt-30 -60.47 -37.73 81.96 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 121.098 0.475 . . . . 1.0 110.395 177.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.582 HD13 ' HB ' ' A' ' 38' ' ' VAL . 95.9 mt -57.01 -62.63 1.61 Allowed 'General case' 0 C--O 1.223 -0.308 0 CA-C-N 115.724 -0.671 . . . . 1.0 110.555 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.485 ' HB3' ' HA3' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -59.3 -31.01 68.74 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.154 -0.618 . . . . 1.0 111.548 179.099 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -59.88 -33.73 72.22 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.929 0.395 . . . . 1.0 111.213 176.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.566 ' HG3' ' HG ' ' A' ' 34' ' ' LEU . 11.6 ptm180 -95.71 -20.68 18.71 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 120.142 -0.623 . . . . 1.0 109.827 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 109.6 36.22 2.11 Favored Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 115.008 -0.996 . . . . 1.0 112.459 177.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.566 ' HG ' ' HG3' ' A' ' 32' ' ' ARG . 38.9 mt -129.03 4.36 5.31 Favored 'General case' 0 C--N 1.331 -0.239 0 O-C-N 122.275 -0.544 . . . . 1.0 110.174 -179.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.485 ' HA3' ' HB3' ' A' ' 30' ' ' ARG . . . -59.0 -29.53 65.3 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 121.276 -0.488 . . . . 1.0 113.27 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.594 ' HA ' ' NH1' ' A' ' 39' ' ' ARG . 11.8 m-20 -92.71 -17.63 24.0 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.117 0.484 . . . . 1.0 110.254 177.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.89 -24.13 38.51 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.659 -0.701 . . . . 1.0 110.428 178.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.582 ' HB ' HD13 ' A' ' 29' ' ' LEU . 12.0 t -130.94 123.92 55.12 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.446 -179.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.643 ' HG2' ' HB2' ' A' ' 4' ' ' PRO . 22.8 mmt180 -93.82 130.56 39.8 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 109.058 -0.719 . . . . 1.0 109.058 175.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 64.0 t -122.68 117.84 53.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-O 121.528 0.68 . . . . 1.0 109.599 -175.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.507 ' O ' ' HA ' ' A' ' 8' ' ' THR . 57.9 p -130.99 -177.11 4.23 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.379 -1.282 . . . . 1.0 110.322 -175.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.872 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 90.9 p -160.56 165.71 30.32 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.842 -0.343 . . . . 1.0 110.339 179.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.624 ' HB2' ' CD2' ' A' ' 80' ' ' HIS . . . -164.0 166.92 21.07 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 121.365 0.603 . . . . 1.0 111.677 -179.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -124.55 131.92 8.03 Favored Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 110.682 -0.967 . . . . 1.0 110.682 176.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.568 HG23 ' CG1' ' A' ' 10' ' ' VAL . 36.3 p -66.62 -28.87 68.83 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.108 0.41 . . . . 1.0 112.108 -176.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.443 ' HA3' ' HZ3' ' A' ' 48' ' ' TRP . . . -106.53 10.82 42.48 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.618 -0.801 . . . . 1.0 113.598 -175.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 44.87 34.51 1.23 Allowed 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.559 0.948 . . . . 1.0 113.559 177.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.708 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 1.2 m-90 -45.09 -74.87 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.596 0.712 . . . . 1.0 111.984 179.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -107.39 41.17 1.54 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.822 -1.081 . . . . 1.0 111.132 -178.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.9 p -60.64 127.84 20.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.405 178.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.03 -12.62 68.9 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.962 -0.637 . . . . 1.0 112.378 -178.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 t -80.81 -160.19 0.3 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.907 0.384 . . . . 1.0 110.615 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 31.7 t -129.91 170.42 13.95 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.688 -0.486 . . . . 1.0 109.688 -178.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.83 143.2 38.11 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.242 0.544 . . . . 1.0 112.094 -178.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.682 ' OD2' ' HG3' ' A' ' 57' ' ' ARG . 12.8 p-10 -63.54 144.58 56.88 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.71 -1.132 . . . . 1.0 112.655 -177.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -48.69 -43.3 36.93 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.546 -1.206 . . . . 1.0 113.311 178.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.682 ' HG3' ' OD2' ' A' ' 55' ' ' ASP . 4.0 ptp180 -71.49 -40.73 70.04 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 121.135 -0.226 . . . . 1.0 111.471 -175.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.635 ' HB1' ' HG2' ' A' ' 20' ' ' MET . . . -71.04 -35.66 72.05 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.045 0.45 . . . . 1.0 109.834 178.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.85 -42.3 97.6 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.905 -0.589 . . . . 1.0 111.04 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -67.53 -34.73 85.05 Favored Glycine 0 CA--C 1.489 -1.546 0 N-CA-C 110.379 -1.089 . . . . 1.0 110.379 -178.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.542 ' O ' ' HD2' ' A' ' 65' ' ' HIS . 1.1 t -63.07 -54.57 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 CA-C-N 113.557 -1.322 . . . . 1.0 110.882 176.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.711 HD13 ' HG3' ' A' ' 23' ' ' LYS . 89.5 mt -62.39 -51.86 65.88 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.772 0.32 . . . . 1.0 111.152 -177.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -64.83 -23.5 67.26 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.807 -0.633 . . . . 1.0 111.509 -177.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.68 -33.3 70.77 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.2 0.524 . . . . 1.0 110.589 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.542 ' HD2' ' O ' ' A' ' 61' ' ' VAL . 87.7 m-70 -96.12 1.46 52.45 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.713 -0.676 . . . . 1.0 111.063 -178.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 96.22 9.51 56.87 Favored Glycine 0 C--N 1.33 0.221 0 C-N-CA 120.886 -0.674 . . . . 1.0 113.112 176.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.511 ' CD1' ' HA ' ' A' ' 24' ' ' MET . 73.5 m-85 -88.99 149.37 43.21 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-O 120.413 0.149 . . . . 1.0 110.621 -179.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.475 ' HG2' ' CB ' ' A' ' 23' ' ' LYS . 40.9 Cg_endo -69.09 156.31 65.49 Favored 'Trans proline' 0 CA--C 1.51 -0.705 0 C-N-CA 122.252 1.968 . . . . 1.0 110.883 176.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.706 HG22 ' HB2' ' A' ' 62' ' ' LEU . 52.1 p -130.36 13.68 5.56 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.49 0.662 . . . . 1.0 110.443 -177.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -85.03 125.5 32.78 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.988 -1.006 . . . . 1.0 109.15 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.981 ' HB2' ' HE3' ' A' ' 23' ' ' LYS . 19.2 t60 -165.54 154.06 11.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.347 -0.388 . . . . 1.0 110.385 -175.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -133.95 113.85 12.63 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.628 -0.879 . . . . 1.0 108.628 176.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.63 140.27 56.53 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.171 -0.922 . . . . 1.0 112.558 -175.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.449 ' O ' ' HA ' ' A' ' 43' ' ' ALA . . . -134.18 150.74 51.1 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.257 -0.883 . . . . 1.0 109.81 178.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -86.62 155.33 20.48 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.615 -0.513 . . . . 1.0 109.615 176.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.591 HG11 ' CD2' ' A' ' 97' ' ' LEU . 8.8 t -67.41 112.62 2.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.123 0.487 . . . . 1.0 110.212 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.493 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -123.37 -166.92 12.72 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.58 -0.736 . . . . 1.0 111.437 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 44.3 m -57.11 -51.56 68.82 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.125 0.488 . . . . 1.0 111.687 -178.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.448 ' CD ' ' H ' ' A' ' 79' ' ' GLU . 1.4 pm0 -56.39 -31.57 63.97 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.3 -0.864 . . . . 1.0 111.114 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.624 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 80.1 m80 -75.28 -42.77 54.09 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 116.055 -0.52 . . . . 1.0 110.158 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.522 ' HA ' HD21 ' A' ' 86' ' ' LEU . 21.0 mt -67.69 -18.64 65.0 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.737 -0.665 . . . . 1.0 110.672 178.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.37 -2.9 58.82 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.852 -0.613 . . . . 1.0 110.853 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.555 ' HA ' ' HB3' ' A' ' 6' ' ' HIS . . . -60.23 155.14 18.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.827 -0.624 . . . . 1.0 111.498 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.709 ' HA ' ' NH1' ' A' ' 106' ' ' ARG . 25.0 t70 -79.5 -16.83 55.37 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.335 0.588 . . . . 1.0 109.883 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.699 HD13 HG13 ' A' ' 7' ' ' VAL . 0.5 OUTLIER -155.07 117.64 4.28 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.137 -0.938 . . . . 1.0 108.909 -177.405 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.586 ' N ' HD12 ' A' ' 86' ' ' LEU . 5.0 mp -105.52 104.11 13.77 Favored 'General case' 0 N--CA 1.425 -1.704 0 CA-C-N 115.518 -0.765 . . . . 1.0 109.744 178.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.575 ' HA ' ' O ' ' A' ' 108' ' ' ARG . 72.2 t -84.91 92.59 3.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.202 -0.908 . . . . 1.0 111.272 -176.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.02 146.03 30.86 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.18 -0.918 . . . . 1.0 110.785 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.469 ' O ' ' HB ' ' A' ' 124' ' ' VAL . 4.2 mm? -97.55 -7.63 30.9 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.37 0.605 . . . . 1.0 109.952 178.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.441 ' CG ' ' H ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -152.64 152.97 32.39 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.16 -0.927 . . . . 1.0 110.103 178.335 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.679 ' HB3' ' O ' ' A' ' 122' ' ' LEU . 18.7 ptt180 -64.3 -19.72 65.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.573 -0.74 . . . . 1.0 112.749 -176.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.637 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 7.1 m120 -75.62 -48.73 20.97 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.397 -0.594 . . . . 1.0 109.397 178.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.744 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 17.8 m170 -56.29 -47.32 78.89 Favored 'General case' 0 C--N 1.333 -0.124 0 N-CA-C 109.619 -0.512 . . . . 1.0 109.619 177.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.466 ' HA ' HG21 ' A' ' 107' ' ' VAL . . . -58.55 -44.33 89.63 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.308 -0.406 . . . . 1.0 110.961 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.458 ' O ' ' HG2' ' A' ' 98' ' ' ARG . 2.0 ttt85 -59.64 -41.76 91.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.128 -0.487 . . . . 1.0 111.517 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.761 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 50.4 mt -63.91 -49.27 73.32 Favored 'General case' 0 C--O 1.219 -0.52 0 N-CA-C 109.744 -0.465 . . . . 1.0 109.744 -177.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.744 ' HG ' ' O ' ' A' ' 93' ' ' HIS . 27.5 mt -55.78 -55.59 30.58 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.316 -0.856 . . . . 1.0 111.67 -178.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.458 ' HG2' ' O ' ' A' ' 95' ' ' ARG . 20.2 ptt180 -60.97 -43.6 98.56 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.214 -0.448 . . . . 1.0 111.554 -176.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.647 ' HG3' ' O ' ' A' ' 96' ' ' LEU . 1.1 pp0? -69.0 -21.38 64.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.125 0.488 . . . . 1.0 110.239 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.761 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 9.8 mt -78.61 -7.81 57.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.595 -0.729 . . . . 1.0 111.962 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 147.66 -31.13 1.38 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.047 -1.073 . . . . 1.0 113.223 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.698 HG12 ' H ' ' A' ' 103' ' ' GLU . 1.4 t -75.15 -153.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.359 0.6 . . . . 1.0 111.238 -178.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.731 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 15.5 pt-20 -164.25 164.53 22.45 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.603 -0.888 . . . . 1.0 108.603 -178.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.811 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -67.69 -21.92 65.31 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.571 -0.286 . . . . 1.0 111.542 -175.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.61 -35.88 77.22 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.284 0.564 . . . . 1.0 110.371 175.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.731 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 0.6 OUTLIER -95.09 -44.84 7.48 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 115.201 -0.909 . . . . 1.0 110.364 -177.676 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.811 HG12 ' HA ' ' A' ' 104' ' ' ALA . 8.9 p -78.33 117.29 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-O 121.846 0.832 . . . . 1.0 109.595 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.575 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 29.1 mmm180 -134.43 148.62 50.66 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.662 -0.699 . . . . 1.0 109.915 -177.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.531 ' HG3' ' HA ' ' A' ' 122' ' ' LEU . 82.6 mmm -78.57 140.29 38.52 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.279 -0.873 . . . . 1.0 110.581 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.571 HD11 ' HA ' ' A' ' 142' ' ' ILE . 3.2 tm? -56.49 -50.47 71.66 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 123.085 0.241 . . . . 1.0 110.93 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 5.6 ttm-85 -70.96 -15.52 62.59 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.691 -0.404 . . . . 1.0 110.854 -178.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.433 ' HB2' ' HB2' ' A' ' 109' ' ' MET . 33.5 t -75.26 -2.7 29.33 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 120.97 -0.292 . . . . 1.0 110.31 -179.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.68 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 85.9 m-85 -96.08 -17.77 20.67 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 121.972 -0.455 . . . . 1.0 110.617 175.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -59.27 121.14 53.92 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.882 -0.599 . . . . 1.0 110.47 -178.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -62.56 -21.92 73.4 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.425 2.083 . . . . 1.0 111.846 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 116' ' ' ARG . 33.3 mtm180 -89.53 0.65 56.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.964 -0.562 . . . . 1.0 112.092 -178.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 88.0 p -63.27 95.52 0.09 Allowed 'General case' 0 C--O 1.238 0.474 0 CA-C-O 121.261 0.553 . . . . 1.0 111.139 -178.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -58.41 -47.46 89.65 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.413 -0.812 . . . . 1.0 111.63 178.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.4 m -104.07 163.63 12.26 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.981 -0.748 . . . . 1.0 108.981 177.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 40.9 m170 -67.0 131.93 46.87 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.862 -0.792 . . . . 1.0 108.862 175.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -95.7 86.93 4.53 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.517 -0.765 . . . . 1.0 110.59 -177.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.679 ' O ' ' HB3' ' A' ' 91' ' ' ARG . 2.4 mm? -95.95 15.98 19.04 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.965 -0.754 . . . . 1.0 108.965 176.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -168.69 137.83 2.24 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.013 -0.994 . . . . 1.0 109.415 -178.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.469 ' HB ' ' O ' ' A' ' 89' ' ' LEU . 92.3 t -105.96 147.27 11.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.672 -0.492 . . . . 1.0 109.672 -178.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -60.68 -178.1 0.09 Allowed 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.499 0.666 . . . . 1.0 112.11 -177.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -152.73 139.49 12.52 Favored Pre-proline 0 C--N 1.316 -0.891 0 CA-C-N 114.993 -1.003 . . . . 1.0 109.274 -174.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.649 ' HB3' ' HB3' ' A' ' 134' ' ' ASP . 97.6 Cg_exo -44.26 153.57 0.33 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 123.517 2.811 . . . . 1.0 113.315 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.1 -36.56 18.05 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.349 -0.841 . . . . 1.0 109.292 -178.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.26 -25.29 0.59 Allowed 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.288 -0.869 . . . . 1.0 111.463 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 91.37 60.93 1.27 Allowed Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.106 -1.045 . . . . 1.0 111.155 -179.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.414 ' H ' ' CG ' ' A' ' 134' ' ' ASP . 3.3 t70 -133.91 -163.21 1.33 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.702 -0.851 . . . . 1.0 108.702 -177.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.806 ' HA ' ' CZ ' ' A' ' 135' ' ' PHE . 17.2 t-80 -51.43 -48.19 62.8 Favored 'General case' 0 C--N 1.329 -0.283 0 O-C-N 123.209 0.318 . . . . 1.0 111.839 -178.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.8 p -62.44 -39.51 93.57 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.039 -0.528 . . . . 1.0 112.395 -177.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.649 ' HB3' ' HB3' ' A' ' 127' ' ' PRO . 1.0 OUTLIER -68.03 -42.36 80.73 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.272 -0.876 . . . . 1.0 112.05 -174.434 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.806 ' CZ ' ' HA ' ' A' ' 132' ' ' HIS . 7.3 p90 -74.99 -33.36 61.84 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 119.121 -1.032 . . . . 1.0 111.613 -175.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -73.26 -25.02 60.54 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.634 -0.506 . . . . 1.0 109.634 175.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -65.56 -45.5 83.12 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 109.643 -0.503 . . . . 1.0 109.643 176.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.842 ' HA ' HG12 ' A' ' 141' ' ' VAL . 24.4 t -63.74 -40.39 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-O 121.756 0.788 . . . . 1.0 109.043 177.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -55.94 -42.18 75.77 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.328 -0.851 . . . . 1.0 109.309 175.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.58 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -66.99 -47.96 69.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.489 -0.778 . . . . 1.0 111.711 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.842 HG12 ' HA ' ' A' ' 138' ' ' VAL . 3.6 p -59.54 -43.86 91.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.709 0.766 . . . . 1.0 111.214 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.611 HD12 HG12 ' A' ' 138' ' ' VAL . 13.5 mt -67.13 -51.08 57.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 115.206 -0.906 . . . . 1.0 111.504 178.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.58 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 7.6 pt-20 -56.11 -30.25 61.8 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 109.934 -0.395 . . . . 1.0 109.934 179.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 4.2 t -72.57 -30.32 64.3 Favored 'General case' 0 C--O 1.226 -0.179 0 CA-C-N 115.749 -0.66 . . . . 1.0 110.315 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.457 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -87.84 -22.62 24.35 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-N 116.024 -0.535 . . . . 1.0 111.723 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.762 HD22 ' HB3' ' A' ' 25' ' ' PHE . 9.9 mt -54.77 -38.77 70.54 Favored Pre-proline 0 CA--C 1.545 0.774 0 CA-C-O 119.163 -0.446 . . . . 1.0 112.048 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 61.7 Cg_endo -71.28 -11.01 28.17 Favored 'Trans proline' 0 C--N 1.365 1.429 0 C-N-CA 122.695 2.264 . . . . 1.0 112.113 177.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.68 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -103.86 -33.32 4.11 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.372 -1.091 . . . . 1.0 110.372 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.498 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -74.28 -40.38 62.33 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.378 -0.971 . . . . 1.0 108.378 178.372 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.484 ' O ' ' HB2' ' A' ' 154' ' ' ASP . 1.0 OUTLIER -55.71 -52.1 65.05 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 114.716 -1.129 . . . . 1.0 110.966 176.111 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -61.73 -42.35 98.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.755 -0.657 . . . . 1.0 110.962 -176.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . 0.577 ' CE3' HD12 ' A' ' 85' ' ' LEU . 28.0 t90 -60.98 -57.12 13.95 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.387 -0.824 . . . . 1.0 110.629 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.508 ' HB ' HD22 ' A' ' 5' ' ' LEU . 11.0 m -60.41 -38.49 78.0 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.279 0 N-CA-C 110.088 -0.338 . . . . 1.0 110.088 -178.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.525 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 0.5 OUTLIER -59.53 -56.19 25.07 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.403 0.62 . . . . 1.0 110.815 179.72 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.514 ' O ' ' HG3' ' A' ' 159' ' ' ARG . 5.4 pt-20 -61.44 -39.81 92.19 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.047 -0.978 . . . . 1.0 110.72 -177.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.43 ' HD3' ' HA ' ' A' ' 156' ' ' ARG . 11.4 mmt85 -72.07 -45.75 59.54 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 115.79 -0.641 . . . . 1.0 110.966 -176.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.525 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 3.6 pp -64.02 -28.82 70.06 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.789 -0.641 . . . . 1.0 109.372 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -73.6 -53.3 10.81 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.226 -0.897 . . . . 1.0 110.687 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.514 ' HG3' ' O ' ' A' ' 155' ' ' GLU . 0.0 OUTLIER -77.48 -8.84 58.4 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 112.664 0.616 . . . . 1.0 112.664 -176.497 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -59.35 -50.91 72.15 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 110.269 -0.271 . . . . 1.0 110.269 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 65.48 -151.28 51.76 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.812 -0.709 . . . . 1.0 111.972 179.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -80.2 -89.49 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.368 2.046 . . . . 1.0 111.631 177.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 25.8 m . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.24 -0.886 . . . . 1.0 109.257 177.07 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.722 0 N-CA-C 112.081 -0.407 . . . . 1.0 112.081 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ptt? -159.19 150.34 20.06 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.393 -0.595 . . . . 1.0 109.393 179.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.1 m -89.74 167.97 12.47 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.25 0.548 . . . . 1.0 112.091 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.866 ' HB2' ' HD2' ' A' ' 4' ' ' PRO . 1.3 p30 -170.98 167.82 3.98 Favored Pre-proline 0 N--CA 1.451 -0.424 0 N-CA-C 107.636 -1.246 . . . . 1.0 107.636 179.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.866 ' HD2' ' HB2' ' A' ' 3' ' ' ASP . 19.4 Cg_endo -58.59 165.35 7.95 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.37 2.047 . . . . 1.0 112.402 -177.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.794 ' HB3' HG23 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -65.04 177.17 1.05 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.667 -0.697 . . . . 1.0 109.304 -179.213 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.738 ' H ' HD13 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -157.24 90.93 1.14 Allowed 'General case' 0 C--N 1.318 -0.797 0 O-C-N 121.878 -0.514 . . . . 1.0 111.036 -179.134 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.582 HG13 HD13 ' A' ' 85' ' ' LEU . 1.7 t -95.74 109.09 22.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.731 -0.668 . . . . 1.0 109.557 178.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.614 ' CG2' ' HG ' ' A' ' 86' ' ' LEU . 10.1 t -112.56 117.28 31.9 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 109.623 -0.51 . . . . 1.0 109.623 178.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.727 ' HZ ' ' HE1' ' A' ' 25' ' ' PHE . 1.0 OUTLIER -86.3 134.49 33.74 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 120.843 0.354 . . . . 1.0 110.234 -178.919 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.598 HG21 HD11 ' A' ' 97' ' ' LEU . 33.7 t -116.5 113.67 43.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 116.083 -0.508 . . . . 1.0 111.649 -176.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.638 ' HB2' HD23 ' A' ' 89' ' ' LEU . 38.3 t -143.86 160.61 40.47 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.145 -0.48 . . . . 1.0 109.837 178.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.423 HG23 ' NE2' ' A' ' 93' ' ' HIS . 0.6 OUTLIER -67.39 100.45 0.84 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.205 0.526 . . . . 1.0 111.18 -179.768 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 1.008 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 117.21 -40.01 2.48 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.513 -0.767 . . . . 1.0 112.18 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.706 ' ND2' ' H ' ' A' ' 74' ' ' ALA . 57.7 t30 60.61 25.72 15.43 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 122.449 1.119 . . . . 1.0 110.392 -177.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.578 ' O ' ' HB3' ' A' ' 55' ' ' ASP . 1.3 pt -134.76 39.02 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 114.908 -1.042 . . . . 1.0 109.658 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.763 ' O ' ' HG3' ' A' ' 20' ' ' MET . 6.9 p -151.38 -89.26 0.06 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.086 -0.507 . . . . 1.0 111.426 177.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.445 ' NH2' ' HA ' ' A' ' 126' ' ' ASP . 81.3 mtt180 -74.83 -45.1 45.56 Favored 'General case' 0 N--CA 1.464 0.249 0 O-C-N 122.004 -0.435 . . . . 1.0 111.543 -176.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.472 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 20.4 m -53.09 -56.32 24.96 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 116.117 -0.492 . . . . 1.0 111.364 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.472 ' HD3' ' HB2' ' A' ' 18' ' ' SER . 49.4 Cg_endo -67.28 -24.52 43.62 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 121.444 1.43 . . . . 1.0 112.909 -178.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.763 ' HG3' ' O ' ' A' ' 16' ' ' CYS . 63.4 mtp -59.15 -53.35 59.32 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 109.869 -0.419 . . . . 1.0 109.869 178.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.554 ' O ' ' HD1' ' A' ' 25' ' ' PHE . . . -72.77 -31.15 64.68 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 115.379 -0.828 . . . . 1.0 110.68 -177.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.636 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 17.5 tt0 -50.66 -53.46 30.85 Favored 'General case' 0 C--O 1.218 -0.554 0 O-C-N 124.167 0.917 . . . . 1.0 110.162 -178.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.675 ' HZ1' ' HB3' ' A' ' 71' ' ' HIS . 0.2 OUTLIER -84.9 -24.23 28.55 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.497 -0.774 . . . . 1.0 110.902 -176.618 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.431 ' HB3' HD11 ' A' ' 146' ' ' LEU . 85.4 mtp -63.61 -75.66 0.08 Allowed 'General case' 0 C--O 1.237 0.423 0 N-CA-C 112.621 0.6 . . . . 1.0 112.621 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.754 ' HB3' HD22 ' A' ' 146' ' ' LEU . 0.6 OUTLIER -78.62 -28.77 45.65 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.163 -0.615 . . . . 1.0 111.93 -174.885 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.636 ' HB3' ' O ' ' A' ' 22' ' ' GLU . . . -64.71 -38.07 89.75 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 119.346 -0.941 . . . . 1.0 110.389 178.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.635 ' HG3' ' N ' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -62.92 -38.84 92.57 Favored 'General case' 0 CA--C 1.527 0.061 0 N-CA-C 108.406 -0.961 . . . . 1.0 108.406 177.046 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.635 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 79.4 mt-30 -59.89 -42.88 94.76 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 115.593 -0.73 . . . . 1.0 110.808 176.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 25' ' ' PHE . 96.5 mt -56.17 -60.05 4.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.104 -0.498 . . . . 1.0 111.322 -178.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.425 ' HA ' ' H ' ' A' ' 35' ' ' GLY . 0.1 OUTLIER -60.29 -34.91 74.42 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.144 -0.623 . . . . 1.0 111.178 178.904 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -60.76 -29.24 69.29 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 111.96 0.355 . . . . 1.0 111.96 177.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.603 ' HG2' ' O ' ' A' ' 28' ' ' GLN . 6.8 ptp180 -94.72 -21.1 18.98 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.098 -0.641 . . . . 1.0 110.275 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 107.43 40.38 1.78 Allowed Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.175 -0.921 . . . . 1.0 111.962 177.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 25.8 mt -132.32 0.32 3.71 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.965 -0.383 . . . . 1.0 109.965 -178.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.425 ' H ' ' HA ' ' A' ' 30' ' ' ARG . . . -57.7 -28.91 60.7 Favored Glycine 0 C--N 1.332 0.351 0 CA-C-N 116.035 -0.53 . . . . 1.0 112.855 -179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -83.35 -25.76 31.14 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.17 0.509 . . . . 1.0 110.321 177.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.41 -23.11 40.6 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.559 -0.746 . . . . 1.0 111.571 -177.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.794 HG23 ' HB3' ' A' ' 5' ' ' LEU . 0.4 OUTLIER -141.33 125.09 16.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.296 0.569 . . . . 1.0 111.241 -179.396 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.466 ' HG2' ' HB2' ' A' ' 4' ' ' PRO . 17.3 mmt180 -88.93 142.43 27.65 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.475 -0.784 . . . . 1.0 108.998 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 77.0 t -129.8 130.13 66.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 109.173 -0.676 . . . . 1.0 109.173 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.494 ' O ' ' HA ' ' A' ' 8' ' ' THR . 37.0 p -143.8 -174.17 4.18 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.782 -1.099 . . . . 1.0 110.487 -174.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.472 ' OG ' ' HE1' ' A' ' 71' ' ' HIS . 65.2 p -160.43 163.03 33.37 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.598 -0.274 . . . . 1.0 110.427 -179.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.657 ' HB2' ' CD2' ' A' ' 80' ' ' HIS . . . -163.34 161.98 24.81 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.278 0.561 . . . . 1.0 111.345 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -123.37 133.42 8.95 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.453 -0.794 . . . . 1.0 111.481 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.504 HG23 ' CG1' ' A' ' 10' ' ' VAL . 17.9 p -71.44 -20.83 62.05 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.688 0.28 . . . . 1.0 111.727 -178.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.46 ' HA3' ' CZ3' ' A' ' 48' ' ' TRP . . . -109.66 5.33 31.09 Favored Glycine 0 C--O 1.226 -0.377 0 C-N-CA 120.603 -0.808 . . . . 1.0 113.026 -178.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.403 ' HB3' ' NE2' ' A' ' 75' ' ' GLN . 3.2 p-10 42.92 34.54 0.62 Allowed 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 113.518 0.933 . . . . 1.0 113.518 178.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 1.008 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 0.9 OUTLIER -46.83 -72.99 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.298 0.571 . . . . 1.0 112.419 -178.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.545 ' HB3' ' HB3' ' A' ' 52' ' ' SER . 3.2 m-70 -106.5 42.66 1.24 Allowed 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.734 -0.666 . . . . 1.0 111.186 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.434 HG23 ' HA ' ' A' ' 74' ' ' ALA . 11.9 p -61.34 126.92 20.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 120.573 -0.451 . . . . 1.0 109.985 178.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.0 -12.59 69.63 Favored Glycine 0 CA--C 1.519 0.303 0 N-CA-C 111.794 -0.523 . . . . 1.0 111.794 -176.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.545 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 1.4 t -83.08 -159.58 0.35 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.149 0.5 . . . . 1.0 109.839 178.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.614 ' HA ' ' O ' ' A' ' 71' ' ' HIS . 25.0 t -131.17 170.38 14.64 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.955 -0.566 . . . . 1.0 109.573 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -50.74 145.7 6.65 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 123.758 0.661 . . . . 1.0 111.553 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.672 ' OD1' ' HA ' ' A' ' 16' ' ' CYS . 9.6 p-10 -61.47 144.94 53.35 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.434 -0.803 . . . . 1.0 112.388 -178.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -45.75 -36.32 4.97 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.214 -1.357 . . . . 1.0 113.221 175.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.611 ' O ' HG23 ' A' ' 61' ' ' VAL . 17.1 mtt-85 -71.22 -49.66 41.09 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.843 0.354 . . . . 1.0 111.013 -175.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.479 ' HB1' ' HG2' ' A' ' 20' ' ' MET . . . -69.65 -29.83 67.39 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.419 -0.81 . . . . 1.0 110.557 -178.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.401 ' O ' HG21 ' A' ' 69' ' ' THR . . . -61.65 -47.71 84.16 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.701 -0.481 . . . . 1.0 109.701 177.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.36 -38.09 95.7 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.962 -0.637 . . . . 1.0 112.101 178.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 57' ' ' ARG . 99.7 t -64.19 -58.87 5.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.25 0.548 . . . . 1.0 110.826 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.479 ' HB2' HG22 ' A' ' 69' ' ' THR . 8.6 mp -59.79 -48.65 80.84 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.686 -0.688 . . . . 1.0 111.54 -177.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.448 ' HB3' HG21 ' A' ' 69' ' ' THR . 9.9 ptm180 -60.59 -28.54 68.57 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.517 -0.31 . . . . 1.0 111.131 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.34 -33.88 75.1 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.417 0.627 . . . . 1.0 110.053 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -93.74 4.78 53.42 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.228 -0.896 . . . . 1.0 111.536 -178.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.89 16.18 65.98 Favored Glycine 0 N--CA 1.455 -0.093 0 C-N-CA 120.96 -0.638 . . . . 1.0 112.754 177.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -92.44 151.95 41.79 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 110.259 -0.274 . . . . 1.0 110.259 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.482 ' O ' ' HD2' ' A' ' 23' ' ' LYS . 27.8 Cg_endo -66.29 152.1 81.84 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 121.877 1.718 . . . . 1.0 110.155 176.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.479 HG22 ' HB2' ' A' ' 62' ' ' LEU . 66.7 p -131.28 25.61 4.85 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 120.266 -0.574 . . . . 1.0 112.041 -175.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -110.57 127.02 55.04 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.783 -0.451 . . . . 1.0 109.783 179.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.675 ' HB3' ' HZ1' ' A' ' 23' ' ' LYS . 0.2 OUTLIER -160.09 139.5 11.04 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.883 -179.61 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.526 ' HD3' ' O ' ' A' ' 52' ' ' SER . 5.1 tpp180 -102.72 114.98 29.67 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.969 -0.56 . . . . 1.0 110.132 178.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 49' ' ' HIS . . . -63.51 138.01 58.35 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.139 -0.482 . . . . 1.0 112.133 -178.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.706 ' H ' ' ND2' ' A' ' 14' ' ' ASN . . . -129.41 163.62 25.43 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.942 -0.572 . . . . 1.0 109.894 176.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.403 ' NE2' ' HB3' ' A' ' 47' ' ' ASN . 16.0 tt0 -98.07 159.41 14.95 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.977 -0.749 . . . . 1.0 108.977 178.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.578 HG11 HD23 ' A' ' 97' ' ' LEU . 47.8 t -70.83 115.26 10.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.936 0.398 . . . . 1.0 110.252 177.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.567 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -128.31 -167.0 12.13 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.723 -0.671 . . . . 1.0 111.697 178.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 30.3 m -57.35 -51.83 67.81 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.973 0.416 . . . . 1.0 111.747 -179.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.472 ' CD ' ' H ' ' A' ' 79' ' ' GLU . 1.6 pm0 -56.21 -31.93 63.95 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.623 -0.717 . . . . 1.0 110.981 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.657 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 80.0 m80 -74.87 -41.16 60.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.967 -0.561 . . . . 1.0 109.955 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.735 ' HA ' HD21 ' A' ' 86' ' ' LEU . 15.6 mt -68.78 -16.34 63.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.973 0.416 . . . . 1.0 110.238 176.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -87.35 -8.32 56.78 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 120.932 0.396 . . . . 1.0 110.112 -179.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.475 ' HB1' ' O ' ' A' ' 6' ' ' HIS . . . -59.18 156.16 12.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.86 -0.609 . . . . 1.0 110.774 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.77 ' HA ' ' NH1' ' A' ' 106' ' ' ARG . 3.0 t70 -82.35 -12.47 57.93 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.902 0.382 . . . . 1.0 110.153 -178.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.735 HD12 ' CE3' ' A' ' 152' ' ' TRP . 1.1 tt -158.0 115.26 2.94 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.81 -0.632 . . . . 1.0 109.539 -178.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.735 HD21 ' HA ' ' A' ' 81' ' ' LEU . 5.2 mp -107.08 87.64 2.55 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 115.669 -0.696 . . . . 1.0 110.802 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.632 HG11 HD23 ' A' ' 110' ' ' LEU . 76.7 t -66.01 92.91 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 113.886 -1.507 . . . . 1.0 112.521 -178.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.69 149.86 31.08 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.993 -1.003 . . . . 1.0 111.093 177.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.645 ' O ' ' HB ' ' A' ' 124' ' ' VAL . 3.9 mm? -98.7 -5.69 31.04 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.971 179.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.9 p30 -159.09 166.43 31.62 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.506 0.67 . . . . 1.0 111.368 174.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.452 ' H ' ' HG2' ' A' ' 91' ' ' ARG . 9.1 ptt180 -62.63 -18.98 63.32 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.11 -1.404 . . . . 1.0 112.305 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.622 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 5.9 m-20 -78.48 -53.24 7.45 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.749 0.309 . . . . 1.0 110.623 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.669 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 14.1 m170 -58.84 -44.73 91.02 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.958 -0.565 . . . . 1.0 109.674 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.17 -42.78 91.62 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.002 0.429 . . . . 1.0 110.817 179.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 95' ' ' ARG . 4.3 ttm180 -57.99 -44.84 87.4 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.37 -0.832 . . . . 1.0 111.281 177.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.691 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 49.4 mt -64.85 -48.45 74.28 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.44 -175.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.669 ' HG ' ' O ' ' A' ' 93' ' ' HIS . 29.0 mt -53.57 -59.77 4.16 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.642 -0.708 . . . . 1.0 111.771 -177.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.714 ' N ' HG12 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -60.12 -44.33 94.98 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.47 0.545 . . . . 1.0 112.47 -179.308 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.539 ' HG3' ' O ' ' A' ' 96' ' ' LEU . 1.0 OUTLIER -66.56 -23.3 66.19 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.254 -0.578 . . . . 1.0 109.945 179.056 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.691 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 8.9 mt -80.98 -21.75 40.05 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.764 -0.653 . . . . 1.0 111.65 178.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 155.25 -22.72 0.58 Allowed Glycine 0 CA--C 1.521 0.453 0 C-N-CA 119.332 -1.413 . . . . 1.0 114.38 -177.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.714 HG12 ' N ' ' A' ' 98' ' ' ARG . 0.3 OUTLIER -76.82 -162.09 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 117.836 0.818 . . . . 1.0 110.431 -179.78 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.756 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 16.7 pt-20 -156.37 159.85 39.13 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 107.624 -1.25 . . . . 1.0 107.624 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.767 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -62.91 -23.65 67.46 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.692 0.282 . . . . 1.0 111.625 -174.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.77 -36.57 74.6 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.376 174.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.77 ' NH1' ' HA ' ' A' ' 84' ' ' ASP . 0.7 OUTLIER -97.25 -42.17 7.93 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 115.323 -0.853 . . . . 1.0 111.063 -177.382 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.767 HG12 ' HA ' ' A' ' 104' ' ' ALA . 14.2 p -79.18 114.69 20.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.113 0.482 . . . . 1.0 109.798 -175.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.631 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 27.3 mmm180 -133.32 148.6 51.91 Favored 'General case' 0 C--N 1.318 -0.777 0 O-C-N 121.521 -0.737 . . . . 1.0 110.314 -177.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.573 ' HB2' ' HB2' ' A' ' 112' ' ' SER . 74.8 mmm -78.91 138.16 37.97 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.454 -0.794 . . . . 1.0 110.526 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.632 HD23 HG11 ' A' ' 87' ' ' VAL . 3.2 tm? -57.66 -50.67 72.39 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 111.488 0.181 . . . . 1.0 111.488 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.437 ' O ' ' HG2' ' A' ' 111' ' ' ARG . 19.1 ttm180 -69.18 -17.99 63.87 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.661 -0.416 . . . . 1.0 110.227 -178.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.573 ' HB2' ' HB2' ' A' ' 109' ' ' MET . 39.3 t -73.48 -5.66 41.46 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.928 -0.309 . . . . 1.0 111.262 -178.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.66 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 88.6 m-85 -92.99 -18.07 23.15 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 121.073 0.463 . . . . 1.0 110.411 175.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.63 ' OD2' ' HG3' ' A' ' 116' ' ' ARG . 17.7 t0 -61.87 125.37 84.83 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.598 -0.728 . . . . 1.0 111.256 -177.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.401 ' HD2' ' OD1' ' A' ' 114' ' ' ASP . 35.9 Cg_endo -60.84 -31.72 91.99 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 123.5 2.8 . . . . 1.0 112.805 -178.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.63 ' HG3' ' OD2' ' A' ' 114' ' ' ASP . 1.0 OUTLIER -93.85 -1.57 54.66 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.828 -0.623 . . . . 1.0 111.809 -177.251 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.623 ' HB2' ' HB3' ' A' ' 114' ' ' ASP . 31.0 t -76.0 46.96 0.41 Allowed 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 111.47 0.174 . . . . 1.0 111.47 -178.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 50.57 -123.18 15.0 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 121.223 -0.513 . . . . 1.0 113.693 -177.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 15.8 m -100.27 -57.92 2.02 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.415 -0.392 . . . . 1.0 111.054 -179.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 5.6 m170 -134.18 154.62 51.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.964 0.412 . . . . 1.0 110.817 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -133.04 98.25 4.23 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.169 -0.923 . . . . 1.0 109.066 176.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.405 HD22 ' N ' ' A' ' 122' ' ' LEU . 1.8 mm? -96.05 19.26 11.9 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.343 -0.389 . . . . 1.0 110.524 -177.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -171.27 133.66 0.86 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.062 -0.517 . . . . 1.0 109.731 -177.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.645 ' HB ' ' O ' ' A' ' 89' ' ' LEU . 88.2 t -105.54 148.76 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.596 -0.52 . . . . 1.0 109.596 179.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.33 -177.08 0.12 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.879 0.847 . . . . 1.0 113.081 -177.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.528 ' CG ' ' HD2' ' A' ' 127' ' ' PRO . 9.9 t70 -147.61 150.13 35.87 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 107.619 -1.252 . . . . 1.0 107.619 -176.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.567 ' HB3' ' OD1' ' A' ' 134' ' ' ASP . 28.9 Cg_endo -59.41 161.13 17.84 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 121.865 1.71 . . . . 1.0 111.972 -179.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.535 ' HD2' ' CD2' ' A' ' 129' ' ' TYR . 59.3 t80 -104.37 -30.04 10.36 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.237 -0.585 . . . . 1.0 110.522 -179.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.54 ' HD1' ' H ' ' A' ' 130' ' ' GLY . 0.1 OUTLIER -143.73 -50.38 0.31 Allowed 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 122.097 -0.377 . . . . 1.0 110.651 -179.607 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.54 ' H ' ' HD1' ' A' ' 129' ' ' TYR . . . 110.79 75.97 0.83 Allowed Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.261 -0.971 . . . . 1.0 113.08 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -143.12 -176.69 5.02 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.327 -0.62 . . . . 1.0 109.327 177.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.543 ' CD2' ' HG3' ' A' ' 136' ' ' GLU . 3.8 t-160 -52.91 -42.9 65.81 Favored 'General case' 0 C--O 1.233 0.206 0 O-C-N 123.297 0.373 . . . . 1.0 110.911 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 4.6 m -64.27 -41.79 96.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.91 0.386 . . . . 1.0 110.605 -177.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.567 ' OD1' ' HB3' ' A' ' 127' ' ' PRO . 8.3 t0 -65.75 -40.21 91.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.407 -0.815 . . . . 1.0 110.546 -178.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.445 ' CE1' ' HD3' ' A' ' 57' ' ' ARG . 11.6 m-85 -68.72 -41.25 79.31 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.0 0.429 . . . . 1.0 110.742 -176.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.543 ' HG3' ' CD2' ' A' ' 132' ' ' HIS . 1.8 mt-10 -73.14 -21.56 60.69 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.44 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.57 ' O ' HG23 ' A' ' 141' ' ' VAL . 20.4 tp10 -65.08 -47.96 75.41 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.107 -0.701 . . . . 1.0 109.107 175.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.534 ' HA ' HG23 ' A' ' 141' ' ' VAL . 52.7 t -60.85 -42.41 92.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 115.833 -0.621 . . . . 1.0 109.545 176.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.473 ' HB2' HG11 ' A' ' 61' ' ' VAL . 70.0 t80 -54.56 -43.48 72.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.906 -1.043 . . . . 1.0 109.45 176.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.711 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -64.0 -38.53 91.41 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.516 -0.765 . . . . 1.0 110.737 177.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 137' ' ' GLU . 13.6 t -58.33 -51.9 65.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-O 121.558 0.694 . . . . 1.0 110.067 177.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.461 ' CG2' ' HB2' ' A' ' 21' ' ' ALA . 5.8 mt -65.44 -50.96 69.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.177 -0.92 . . . . 1.0 111.89 -179.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.711 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 6.8 pt-20 -55.09 -33.47 62.82 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 110.033 -0.358 . . . . 1.0 110.033 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.511 ' HB2' ' O ' ' A' ' 140' ' ' ALA . 1.0 OUTLIER -73.5 -27.69 61.51 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.841 -0.618 . . . . 1.0 110.384 -179.694 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.444 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -86.94 -23.91 24.95 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 116.107 -0.497 . . . . 1.0 111.407 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.754 HD22 ' HB3' ' A' ' 25' ' ' PHE . 16.0 mt -55.22 -37.92 62.01 Favored Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 112.276 0.473 . . . . 1.0 112.276 -178.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 60.8 Cg_endo -71.61 -9.75 25.55 Favored 'Trans proline' 0 C--N 1.362 1.288 0 C-N-CA 122.634 2.222 . . . . 1.0 112.147 177.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.66 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -105.14 -30.86 4.6 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 110.317 -1.113 . . . . 1.0 110.317 178.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.565 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -75.54 -42.12 53.27 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.3 -1.0 . . . . 1.0 108.3 177.424 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 9.9 m170 -54.34 -49.76 69.0 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.087 -0.961 . . . . 1.0 110.777 176.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -61.54 -45.98 91.86 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.584 -0.735 . . . . 1.0 110.764 -177.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . 0.735 ' CE3' HD12 ' A' ' 85' ' ' LEU . 27.8 t90 -59.15 -57.02 14.89 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.914 -1.039 . . . . 1.0 110.722 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 15.8 m -58.88 -38.09 70.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.834 -0.346 . . . . 1.0 110.567 -178.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.521 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 9.9 t70 -58.84 -57.38 13.3 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 122.062 0.934 . . . . 1.0 110.897 178.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 4.5 pt-20 -62.23 -36.9 83.4 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 113.928 -1.487 . . . . 1.0 110.733 -176.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.524 ' HG3' ' CH2' ' A' ' 152' ' ' TRP . 3.8 mmt180 -74.72 -44.72 48.52 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.754 -0.657 . . . . 1.0 111.35 -177.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 3.7 pp -64.03 -26.16 68.44 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.566 -0.531 . . . . 1.0 109.566 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -72.76 -52.06 16.6 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.495 -0.775 . . . . 1.0 110.236 177.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.42 -8.44 55.91 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 112.33 0.493 . . . . 1.0 112.33 -178.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -90.16 8.04 34.93 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.678 0.751 . . . . 1.0 109.82 178.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.475 ' HA2' ' HD3' ' A' ' 162' ' ' PRO . . . -114.67 130.6 9.32 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.344 -0.844 . . . . 1.0 111.719 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.475 ' HD3' ' HA2' ' A' ' 161' ' ' GLY . 2.9 Cg_exo -78.3 -44.71 0.15 Allowed 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 123.658 2.905 . . . . 1.0 112.573 -178.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 51.1 m . . . . . 0 C--O 1.247 0.934 0 CA-C-N 115.363 -0.835 . . . . 1.0 109.75 -178.984 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.831 0 N-CA-C 111.578 -0.609 . . . . 1.0 111.578 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.7 mtm -151.88 153.69 34.67 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.807 0.304 . . . . 1.0 110.192 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.67 -73.93 0.32 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.091 -0.504 . . . . 1.0 111.139 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.568 ' HB2' ' HD2' ' A' ' 4' ' ' PRO . 3.9 p-10 -165.2 159.64 14.35 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-O 121.012 0.434 . . . . 1.0 111.112 -178.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.568 ' HD2' ' HB2' ' A' ' 3' ' ' ASP . 49.5 Cg_endo -72.04 168.04 25.09 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 123.099 2.532 . . . . 1.0 113.174 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.851 ' HB3' HG23 ' A' ' 38' ' ' VAL . 0.9 OUTLIER -73.57 -173.71 1.52 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.411 -0.813 . . . . 1.0 110.879 179.574 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.58 ' O ' ' HB1' ' A' ' 83' ' ' ALA . 1.5 t-160 -158.09 93.93 1.27 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.462 -0.335 . . . . 1.0 111.027 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.79 HG13 HD13 ' A' ' 85' ' ' LEU . 2.3 t -94.28 109.31 21.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.037 -0.727 . . . . 1.0 109.037 176.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.698 ' CG2' ' HG ' ' A' ' 86' ' ' LEU . 12.8 t -112.32 112.98 24.95 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.116 0.484 . . . . 1.0 110.307 178.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.741 ' HZ ' ' HE1' ' A' ' 25' ' ' PHE . 0.9 OUTLIER -82.06 147.1 29.31 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 121.857 -0.527 . . . . 1.0 109.761 179.921 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.68 HG21 HD21 ' A' ' 97' ' ' LEU . 44.3 t -132.74 118.12 32.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.321 0.581 . . . . 1.0 111.634 -176.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.584 ' HB3' HD23 ' A' ' 89' ' ' LEU . 28.7 p -141.29 178.81 7.16 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.524 -0.762 . . . . 1.0 110.092 178.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.521 HG23 ' NE2' ' A' ' 93' ' ' HIS . 0.7 OUTLIER -86.36 86.64 7.34 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.988 0.423 . . . . 1.0 110.971 179.064 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.857 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 135.55 -37.6 1.89 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.656 -0.783 . . . . 1.0 112.077 178.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.516 HD21 ' CB ' ' A' ' 42' ' ' SER . 3.8 t-20 64.01 17.22 10.46 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.59 0.709 . . . . 1.0 111.103 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.0 pt -124.55 11.03 4.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 O-C-N 121.783 -0.573 . . . . 1.0 111.715 -177.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 7.5 p -127.45 -87.36 0.57 Allowed 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 112.112 0.412 . . . . 1.0 112.112 -177.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.68 -44.37 74.17 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 112.323 0.49 . . . . 1.0 112.323 -176.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.738 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 50.9 m -57.37 -58.03 20.92 Favored Pre-proline 0 CA--C 1.538 0.488 0 N-CA-C 112.378 0.51 . . . . 1.0 112.378 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.665 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 49.4 Cg_endo -64.96 -24.48 60.4 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 121.632 1.555 . . . . 1.0 112.071 -177.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.617 ' HB3' HD13 ' A' ' 142' ' ' ILE . 39.9 mmm -61.62 -54.39 43.54 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 121.13 -0.228 . . . . 1.0 110.767 178.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.539 ' O ' ' HD1' ' A' ' 25' ' ' PHE . . . -72.65 -32.02 65.53 Favored 'General case' 0 CA--C 1.507 -0.679 0 C-N-CA 120.615 -0.434 . . . . 1.0 110.124 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.651 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 11.3 tt0 -50.83 -51.79 47.56 Favored 'General case' 0 C--O 1.216 -0.708 0 O-C-N 124.399 1.062 . . . . 1.0 109.988 -178.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.904 ' HE3' ' HB2' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -79.45 -30.33 42.15 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.829 -0.623 . . . . 1.0 110.014 -176.906 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.587 ' HB3' HD11 ' A' ' 146' ' ' LEU . 3.2 mmm -62.39 -75.78 0.07 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.436 0.902 . . . . 1.0 113.436 -176.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.741 ' HE1' ' HZ ' ' A' ' 9' ' ' PHE . 0.8 OUTLIER -78.86 -27.81 44.16 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.011 -0.676 . . . . 1.0 111.543 -174.628 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.651 ' HB3' ' O ' ' A' ' 22' ' ' GLU . . . -64.62 -37.16 86.63 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 118.934 -1.106 . . . . 1.0 110.262 177.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.694 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -63.48 -39.44 94.46 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.76 -0.83 . . . . 1.0 108.76 177.417 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.562 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 77.6 mt-30 -59.67 -45.02 93.3 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.982 -0.554 . . . . 1.0 110.39 176.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.623 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 90.8 mt -54.46 -61.38 2.34 Favored 'General case' 0 N--CA 1.461 0.094 0 CA-C-N 115.751 -0.659 . . . . 1.0 111.078 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.6 ' HD3' ' HA ' ' A' ' 27' ' ' GLN . 3.2 ptm180 -58.53 -39.72 80.96 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.211 -0.449 . . . . 1.0 111.47 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -62.27 -22.52 66.07 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 112.176 0.435 . . . . 1.0 112.176 178.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.623 ' HG2' ' O ' ' A' ' 29' ' ' LEU . 5.7 ptm85 -99.89 -17.79 17.44 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 119.346 -0.941 . . . . 1.0 110.158 178.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.17 35.75 2.86 Favored Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 115.016 -0.993 . . . . 1.0 112.077 177.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.521 ' HG ' ' HG3' ' A' ' 32' ' ' ARG . 43.5 mt -126.88 -1.28 6.61 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.739 0.304 . . . . 1.0 110.346 -178.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.429 ' H ' ' HA ' ' A' ' 30' ' ' ARG . . . -56.32 -28.0 54.12 Favored Glycine 0 N--CA 1.46 0.288 0 CA-C-N 116.027 -0.533 . . . . 1.0 112.897 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.503 ' O ' ' HB3' ' A' ' 4' ' ' PRO . 4.9 m-20 -89.7 -22.36 22.26 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.666 0.27 . . . . 1.0 110.55 177.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.04 -26.33 39.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.033 -0.53 . . . . 1.0 111.497 -179.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.851 HG23 ' HB3' ' A' ' 5' ' ' LEU . 1.1 p -143.83 124.02 8.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.37 0.605 . . . . 1.0 110.198 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.453 ' HE ' ' HG3' ' A' ' 4' ' ' PRO . 17.7 mmt85 -90.17 147.42 23.59 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.287 -0.87 . . . . 1.0 109.704 -178.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 74.7 t -132.64 117.27 30.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.557 0.694 . . . . 1.0 110.584 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.498 ' O ' ' HA ' ' A' ' 8' ' ' THR . 69.8 p -132.23 -174.15 3.36 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.502 -1.226 . . . . 1.0 110.419 -177.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.738 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 93.2 p -160.98 168.91 23.62 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.806 -0.357 . . . . 1.0 110.58 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.585 ' HB2' ' CD2' ' A' ' 80' ' ' HIS . . . -163.96 167.44 20.55 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.186 0.517 . . . . 1.0 111.291 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -125.75 135.74 9.34 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 115.355 -0.839 . . . . 1.0 111.023 176.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.59 HG21 HD12 ' A' ' 96' ' ' LEU . 23.5 p -70.59 -26.47 63.53 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.315 0.487 . . . . 1.0 112.315 -177.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.461 ' HA3' ' CZ3' ' A' ' 48' ' ' TRP . . . -108.11 9.61 36.58 Favored Glycine 0 C--O 1.229 -0.179 0 C-N-CA 120.717 -0.754 . . . . 1.0 112.796 -177.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 42.97 38.87 1.55 Allowed 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.344 0.868 . . . . 1.0 113.344 178.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.857 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 1.1 m-90 -46.38 -75.34 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.326 0.584 . . . . 1.0 112.48 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.483 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 8.1 m-70 -106.42 41.31 1.45 Allowed 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.259 -0.882 . . . . 1.0 111.046 -179.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.531 HG23 ' HA ' ' A' ' 74' ' ' ALA . 15.0 p -61.27 125.01 16.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 120.471 -0.492 . . . . 1.0 110.281 178.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.42 -12.5 66.4 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.903 -0.665 . . . . 1.0 111.763 -177.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.45 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 2.8 t -81.15 -160.33 0.32 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.228 0.537 . . . . 1.0 110.08 178.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 34.9 t -129.87 171.45 12.72 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.465 -0.788 . . . . 1.0 109.325 -178.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.26 140.85 37.71 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.745 0.307 . . . . 1.0 111.464 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -59.47 141.35 54.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.605 -0.725 . . . . 1.0 111.52 -177.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -51.58 -28.89 15.36 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 113.378 0.881 . . . . 1.0 113.378 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.68 ' O ' HG23 ' A' ' 61' ' ' VAL . 18.9 mtp180 -68.46 -50.61 51.24 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 118.524 0.602 . . . . 1.0 109.506 178.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.21 -32.37 72.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.145 -0.934 . . . . 1.0 110.568 -176.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.85 -46.6 88.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.135 178.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.88 -37.81 95.51 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.667 -0.778 . . . . 1.0 111.843 177.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 57' ' ' ARG . 58.1 t -63.2 -58.95 5.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.21 0.529 . . . . 1.0 111.282 179.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.738 ' HB2' HG22 ' A' ' 69' ' ' THR . 92.3 mt -58.3 -53.16 61.38 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.745 -0.661 . . . . 1.0 111.356 -177.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -59.23 -29.71 67.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.44 -0.346 . . . . 1.0 111.083 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.79 -33.33 73.69 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.231 0.538 . . . . 1.0 111.03 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -98.8 6.37 46.92 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.065 -0.516 . . . . 1.0 111.216 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.23 13.81 63.23 Favored Glycine 0 C--N 1.332 0.323 0 CA-C-N 115.642 -0.708 . . . . 1.0 112.961 176.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.403 ' CD1' ' HA ' ' A' ' 24' ' ' MET . 64.8 m-85 -90.59 151.64 44.25 Favored Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 110.554 -0.165 . . . . 1.0 110.554 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.891 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 46.9 Cg_endo -70.2 160.07 50.87 Favored 'Trans proline' 0 CA--C 1.515 -0.428 0 C-N-CA 122.481 2.121 . . . . 1.0 111.111 176.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.738 HG22 ' HB2' ' A' ' 62' ' ' LEU . 65.8 p -134.1 4.11 3.47 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.419 -0.513 . . . . 1.0 111.697 -177.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -74.38 126.75 31.37 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.398 -0.364 . . . . 1.0 110.075 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.904 ' HB2' ' HE3' ' A' ' 23' ' ' LYS . 28.8 t60 -166.28 150.29 7.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.638 -0.256 . . . . 1.0 110.802 -176.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.408 ' HA ' ' O ' ' A' ' 52' ' ' SER . 2.0 tmt_? -131.03 110.22 11.07 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.905 -1.146 . . . . 1.0 107.905 177.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 49' ' ' HIS . . . -58.57 139.92 55.06 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.896 -1.047 . . . . 1.0 112.412 -174.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.531 ' HA ' HG23 ' A' ' 50' ' ' VAL . . . -130.81 165.55 22.75 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.789 -0.642 . . . . 1.0 110.478 178.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -101.52 159.31 15.4 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.017 -0.735 . . . . 1.0 109.017 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.537 HG11 HD23 ' A' ' 97' ' ' LEU . 96.5 t -66.87 110.56 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.903 0.383 . . . . 1.0 110.61 179.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.475 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -127.52 -169.43 12.67 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.696 -0.684 . . . . 1.0 112.324 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 99.1 m -54.51 -52.03 63.26 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 123.457 0.703 . . . . 1.0 112.595 -178.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.565 ' HG2' ' N ' ' A' ' 80' ' ' HIS . 0.8 OUTLIER -58.19 -29.84 65.96 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.281 0.562 . . . . 1.0 110.523 -178.204 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.585 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 79.9 m80 -76.59 -42.77 41.34 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.535 -0.757 . . . . 1.0 110.014 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.648 ' O ' HG23 ' A' ' 102' ' ' VAL . 17.3 mt -67.71 -18.85 65.05 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.118 0.485 . . . . 1.0 110.681 177.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.69 -7.92 57.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.936 0.398 . . . . 1.0 110.494 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.58 ' HB1' ' O ' ' A' ' 6' ' ' HIS . . . -60.74 152.69 26.16 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.64 -0.709 . . . . 1.0 111.099 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.476 ' HB3' ' HG ' ' A' ' 5' ' ' LEU . 26.0 t70 -79.47 -15.13 58.3 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.991 -0.55 . . . . 1.0 109.775 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.79 HD13 HG13 ' A' ' 7' ' ' VAL . 0.4 OUTLIER -153.62 117.33 4.7 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 115.573 -0.74 . . . . 1.0 109.862 -177.16 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.698 ' HG ' ' CG2' ' A' ' 8' ' ' THR . 5.0 mp -109.45 105.98 15.55 Favored 'General case' 0 N--CA 1.427 -1.599 0 CA-C-N 115.42 -0.809 . . . . 1.0 109.865 177.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.661 ' HB ' ' HD1' ' A' ' 9' ' ' PHE . 64.7 t -85.43 91.8 3.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.014 -0.994 . . . . 1.0 111.389 -175.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.06 149.92 30.5 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.307 -0.861 . . . . 1.0 110.884 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.584 HD23 ' HB3' ' A' ' 11' ' ' CYS . 3.9 mm? -96.26 -10.55 27.67 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.844 -0.616 . . . . 1.0 110.674 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.7 ' HA ' ' HE1' ' A' ' 109' ' ' MET . 9.7 p30 -156.5 167.89 29.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.463 0.649 . . . . 1.0 111.85 175.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -57.3 -24.61 56.08 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.165 -1.38 . . . . 1.0 112.636 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.619 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 91.1 m-20 -76.43 -53.88 7.51 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.837 0.351 . . . . 1.0 110.656 -176.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.521 ' NE2' HG23 ' A' ' 12' ' ' THR . 13.2 m170 -58.94 -42.61 90.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.223 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.55 -43.5 97.18 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.999 0.428 . . . . 1.0 110.586 178.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.446 HH11 ' HD3' ' A' ' 95' ' ' ARG . 5.0 ttm-85 -57.9 -43.62 86.27 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 115.508 -0.769 . . . . 1.0 110.999 177.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.619 ' HG ' ' O ' ' A' ' 92' ' ' ASN . 55.6 mt -65.88 -50.51 64.24 Favored 'General case' 0 C--O 1.217 -0.633 0 CA-C-N 115.906 -0.588 . . . . 1.0 110.365 -176.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.68 HD21 HG21 ' A' ' 10' ' ' VAL . 30.5 mt -51.87 -56.1 16.1 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.055 -0.521 . . . . 1.0 111.135 -178.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.706 ' CA ' HG12 ' A' ' 102' ' ' VAL . 14.2 ptt85 -62.37 -43.1 99.61 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.546 0.573 . . . . 1.0 112.546 -178.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.556 ' HG3' ' O ' ' A' ' 96' ' ' LEU . 0.9 OUTLIER -67.36 -26.77 66.64 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.592 -0.443 . . . . 1.0 110.045 179.262 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.485 HD13 ' O ' ' A' ' 96' ' ' LEU . 5.4 mp -76.51 -20.26 57.12 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 116.088 -0.505 . . . . 1.0 111.818 178.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 153.2 -22.38 0.76 Allowed Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 119.465 -1.35 . . . . 1.0 113.927 -177.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.986 HG22 ' HD2' ' A' ' 106' ' ' ARG . 0.4 OUTLIER -76.42 -163.52 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-N 117.633 0.717 . . . . 1.0 110.33 -178.756 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.7 ' N ' HG13 ' A' ' 102' ' ' VAL . 12.7 pt-20 -159.05 162.64 36.66 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 107.369 -1.345 . . . . 1.0 107.369 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.745 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -62.14 -24.72 67.34 Favored 'General case' 0 C--N 1.322 -0.617 0 O-C-N 123.135 0.272 . . . . 1.0 111.421 -175.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.454 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . . . -56.57 -38.05 71.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.42 0.628 . . . . 1.0 110.06 175.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.986 ' HD2' HG22 ' A' ' 102' ' ' VAL . 20.4 mtt180 -97.65 -43.64 7.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.755 -1.111 . . . . 1.0 111.12 -176.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.745 HG12 ' HA ' ' A' ' 104' ' ' ALA . 10.7 p -79.62 118.79 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-O 121.037 0.446 . . . . 1.0 110.187 -174.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.666 ' HD2' ' O ' ' A' ' 107' ' ' VAL . 19.6 mmm180 -137.37 149.53 47.05 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.386 0.612 . . . . 1.0 111.076 -178.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.7 ' HE1' ' HA ' ' A' ' 90' ' ' ASP . 80.3 mmm -80.25 137.58 36.66 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.185 -0.916 . . . . 1.0 110.692 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.552 HD23 HG11 ' A' ' 87' ' ' VAL . 3.1 tm? -58.71 -49.26 78.26 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.868 0.366 . . . . 1.0 111.09 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.762 ' HB2' HG22 ' A' ' 124' ' ' VAL . 1.2 ttt180 -69.42 -16.7 63.55 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.171 -177.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.493 ' HB2' ' HB2' ' A' ' 109' ' ' MET . 37.4 t -78.38 -7.76 57.69 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 116.147 -0.478 . . . . 1.0 111.355 -178.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.522 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 92.4 m-85 -91.15 -21.58 21.1 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 109.821 -0.436 . . . . 1.0 109.821 175.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -63.99 124.13 84.22 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 115.766 -0.652 . . . . 1.0 110.556 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -72.05 -17.38 28.36 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.441 2.094 . . . . 1.0 112.242 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.458 HH11 ' HD3' ' A' ' 116' ' ' ARG . 47.5 mtt180 -93.05 -5.05 51.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.703 -0.68 . . . . 1.0 111.353 -177.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 68.2 p -58.98 -59.87 4.78 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.13 -0.486 . . . . 1.0 111.336 -177.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 151.79 -103.74 0.25 Allowed Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 111.291 -0.724 . . . . 1.0 111.291 178.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 26.7 m -109.69 -51.04 2.92 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.118 0.485 . . . . 1.0 109.852 177.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -150.55 147.75 27.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.902 -0.59 . . . . 1.0 110.012 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -126.92 99.31 5.68 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.379 -0.373 . . . . 1.0 110.179 177.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.42 ' HA ' ' HG3' ' A' ' 109' ' ' MET . 2.9 mm? -97.98 19.26 14.22 Favored 'General case' 0 CA--C 1.505 -0.759 0 CA-C-O 121.071 0.462 . . . . 1.0 110.691 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -170.63 144.79 2.41 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 115.24 -0.891 . . . . 1.0 109.852 178.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.762 HG22 ' HB2' ' A' ' 111' ' ' ARG . 70.0 t -104.65 145.79 12.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.934 -0.765 . . . . 1.0 108.934 178.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.67 -174.68 0.05 OUTLIER 'General case' 0 C--O 1.24 0.601 0 CA-C-O 122.073 0.94 . . . . 1.0 113.39 -176.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -143.35 143.77 25.55 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 114.379 -1.282 . . . . 1.0 108.574 -174.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.698 ' HB3' ' OD1' ' A' ' 134' ' ' ASP . 10.1 Cg_endo -50.45 152.86 8.19 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 123.096 2.531 . . . . 1.0 112.896 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -84.26 -33.83 23.95 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.29 -0.868 . . . . 1.0 109.593 -179.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -147.24 -38.98 0.2 Allowed 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.364 -0.835 . . . . 1.0 111.529 -179.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.466 ' HA2' ' OD2' ' A' ' 134' ' ' ASP . . . 103.98 65.87 0.7 Allowed Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.113 -0.795 . . . . 1.0 111.113 -177.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.612 ' H ' ' HB3' ' A' ' 134' ' ' ASP . 1.7 t70 -140.19 -172.54 3.44 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.104 -0.332 . . . . 1.0 110.104 -176.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -52.41 -47.32 66.38 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.915 0.339 . . . . 1.0 111.915 -176.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 33.1 t -62.57 -36.14 81.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.945 0.402 . . . . 1.0 110.638 -178.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.698 ' OD1' ' HB3' ' A' ' 127' ' ' PRO . 0.0 OUTLIER -68.77 -35.95 77.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.988 -0.551 . . . . 1.0 111.837 -178.303 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.452 ' HB3' ' CG2' ' A' ' 61' ' ' VAL . 5.7 m-85 -66.43 -45.93 78.18 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.917 -0.772 . . . . 1.0 108.917 -178.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -71.65 -25.89 62.32 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.834 -1.076 . . . . 1.0 110.959 -178.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.609 ' O ' HG23 ' A' ' 141' ' ' VAL . 8.5 tp10 -63.19 -50.94 68.32 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.77 -0.456 . . . . 1.0 109.77 177.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.64 ' HA ' HG23 ' A' ' 141' ' ' VAL . 96.1 t -61.27 -40.41 85.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.402 0.62 . . . . 1.0 109.979 178.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.487 ' HB2' HG11 ' A' ' 61' ' ' VAL . 22.9 t80 -53.49 -45.01 69.47 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.865 -1.061 . . . . 1.0 109.459 175.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.625 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -64.19 -40.16 95.5 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.393 -0.821 . . . . 1.0 110.543 177.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.64 HG23 ' HA ' ' A' ' 138' ' ' VAL . 13.9 t -55.44 -53.16 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-O 121.619 0.723 . . . . 1.0 109.908 177.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.617 HD13 ' HB3' ' A' ' 20' ' ' MET . 5.7 mt -63.99 -51.66 66.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 114.945 -1.025 . . . . 1.0 111.812 -178.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.625 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 8.0 pt-20 -57.89 -30.2 65.66 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.74 -0.384 . . . . 1.0 110.397 -179.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 2.4 t -74.87 -26.7 59.85 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 121.253 0.549 . . . . 1.0 110.001 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.473 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -85.88 -25.81 25.97 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-N 115.794 -0.639 . . . . 1.0 111.277 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.705 HD22 ' HB3' ' A' ' 25' ' ' PHE . 16.7 mt -56.17 -36.4 45.72 Favored Pre-proline 0 CA--C 1.547 0.851 0 N-CA-C 112.719 0.637 . . . . 1.0 112.719 -178.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.626 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 43.9 Cg_endo -68.02 -14.4 40.92 Favored 'Trans proline' 0 C--N 1.364 1.357 0 C-N-CA 122.59 2.193 . . . . 1.0 111.495 177.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.522 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -103.29 -33.62 4.18 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 114.577 -1.192 . . . . 1.0 110.375 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.492 ' O ' HG13 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -73.19 -41.8 63.43 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 108.416 -0.957 . . . . 1.0 108.416 178.855 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.591 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 0.2 OUTLIER -53.93 -55.87 23.0 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-N 115.067 -0.969 . . . . 1.0 110.506 175.217 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -56.78 -42.92 80.28 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.764 -1.107 . . . . 1.0 110.781 -174.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . 0.715 ' HZ3' HD21 ' A' ' 5' ' ' LEU . 26.2 t90 -62.84 -56.17 19.73 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.181 -0.918 . . . . 1.0 110.286 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.492 HG13 ' O ' ' A' ' 149' ' ' LEU . 9.7 m -60.35 -40.3 83.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.904 -0.318 . . . . 1.0 110.463 -178.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.435 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 1.4 m-20 -60.46 -51.88 67.57 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 123.425 0.453 . . . . 1.0 111.042 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 7.9 pt-20 -63.32 -37.82 88.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.789 -0.641 . . . . 1.0 110.6 -178.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.526 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 10.4 mmt85 -72.84 -46.45 52.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.834 -0.621 . . . . 1.0 111.115 -176.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 4.0 pp -63.9 -26.05 68.43 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.658 -0.701 . . . . 1.0 109.686 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -71.73 -50.39 30.58 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.188 177.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.426 ' C ' ' H ' ' A' ' 161' ' ' GLY . 0.2 OUTLIER -78.55 4.9 12.13 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.752 0.649 . . . . 1.0 112.752 -179.259 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -69.58 13.85 0.12 Allowed 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.21 0.528 . . . . 1.0 111.809 177.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.426 ' H ' ' C ' ' A' ' 159' ' ' ARG . . . 92.5 149.02 23.93 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.94 -0.647 . . . . 1.0 112.437 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.491 ' O ' ' HB2' ' A' ' 163' ' ' SER . 43.5 Cg_endo -92.29 14.29 1.75 Allowed 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.555 2.17 . . . . 1.0 113.786 -177.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.491 ' HB2' ' O ' ' A' ' 162' ' ' PRO . 6.5 t . . . . . 0 C--N 1.314 -0.976 0 CA-C-N 115.029 -0.987 . . . . 1.0 110.329 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.074 0 N-CA-C 112.072 -0.411 . . . . 1.0 112.072 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -77.83 142.03 38.81 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.209 0.528 . . . . 1.0 111.184 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.404 ' HB3' ' OD1' ' A' ' 160' ' ' ASN . 50.8 m -87.76 125.04 34.2 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.522 -0.763 . . . . 1.0 110.351 -179.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.816 ' HB3' ' HD2' ' A' ' 4' ' ' PRO . 4.1 m-20 -66.65 166.58 17.43 Favored Pre-proline 0 C--N 1.329 -0.324 0 C-N-CA 120.622 -0.431 . . . . 1.0 110.824 177.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.816 ' HD2' ' HB3' ' A' ' 3' ' ' ASP . 39.9 Cg_endo -70.01 169.55 18.96 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 123.457 2.771 . . . . 1.0 113.481 -178.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.822 ' HB3' HG23 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -66.51 177.84 1.43 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.016 -0.993 . . . . 1.0 109.688 178.417 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.573 ' O ' ' HB1' ' A' ' 83' ' ' ALA . 3.3 t-160 -156.17 90.08 1.18 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 121.98 -0.45 . . . . 1.0 110.493 -179.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.753 HG13 HD13 ' A' ' 85' ' ' LEU . 2.0 t -94.33 113.17 28.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 N-CA-C 109.321 -0.622 . . . . 1.0 109.321 177.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.597 HG22 ' HG ' ' A' ' 86' ' ' LEU . 8.5 t -115.31 114.24 24.91 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.03 0.443 . . . . 1.0 110.589 178.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.648 ' HD2' ' HB3' ' A' ' 42' ' ' SER . 1.5 m-85 -84.71 132.83 34.41 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 122.138 -0.351 . . . . 1.0 110.744 -178.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.728 HG21 HD21 ' A' ' 97' ' ' LEU . 32.9 t -118.18 115.64 48.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.293 0.568 . . . . 1.0 111.975 -176.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.617 ' SG ' ' HD2' ' A' ' 17' ' ' ARG . 52.5 t -144.79 159.38 42.96 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.731 -0.668 . . . . 1.0 109.578 178.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -72.02 97.92 1.98 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.939 0.4 . . . . 1.0 110.336 178.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.911 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 127.88 -43.27 1.35 Allowed Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.481 -0.782 . . . . 1.0 111.549 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.469 HD21 ' CB ' ' A' ' 42' ' ' SER . 3.8 t-20 64.66 11.98 7.19 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 121.361 0.6 . . . . 1.0 111.752 179.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.458 ' HA ' ' HG3' ' A' ' 19' ' ' PRO . 7.5 pt -119.61 11.54 6.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 O-C-N 121.69 -0.631 . . . . 1.0 111.395 -178.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.1 p -127.36 -88.31 0.56 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.208 -0.451 . . . . 1.0 112.015 -178.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.617 ' HD2' ' SG ' ' A' ' 11' ' ' CYS . 57.7 mtt85 -63.54 -52.33 61.6 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 120.95 0.405 . . . . 1.0 111.845 -176.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.726 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 14.1 m -53.16 -58.37 12.73 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 115.666 -0.697 . . . . 1.0 112.679 -178.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.524 ' HD3' ' HB2' ' A' ' 18' ' ' SER . 57.7 Cg_endo -67.92 -20.72 44.79 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 121.556 1.504 . . . . 1.0 112.51 -176.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.606 ' HA ' HD11 ' A' ' 62' ' ' LEU . 47.2 mmm -61.89 -54.09 46.75 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 110.221 -0.288 . . . . 1.0 110.221 177.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.468 ' HA ' ' HB2' ' A' ' 24' ' ' MET . . . -74.9 -26.1 59.4 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 116.134 -0.485 . . . . 1.0 110.401 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.61 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 16.3 tt0 -51.29 -54.56 24.8 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.028 -0.987 . . . . 1.0 109.992 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.656 ' O ' ' HB3' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -85.69 -22.98 27.61 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.267 -0.879 . . . . 1.0 110.383 -176.023 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.708 ' HB3' HD11 ' A' ' 146' ' ' LEU . 6.3 mmm -63.03 -76.12 0.07 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.381 0.61 . . . . 1.0 112.592 -178.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.717 ' HB3' HD22 ' A' ' 146' ' ' LEU . 24.9 p90 -77.13 -29.63 54.77 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 119.864 -0.734 . . . . 1.0 111.546 -175.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.61 ' HB3' ' O ' ' A' ' 22' ' ' GLU . . . -64.39 -38.2 90.19 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 119.493 -0.883 . . . . 1.0 110.817 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.962 ' HA ' ' HE ' ' A' ' 30' ' ' ARG . 0.1 OUTLIER -62.53 -39.68 94.34 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.906 -0.776 . . . . 1.0 108.906 177.03 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.6 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 79.2 mt-30 -59.06 -43.78 91.75 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.653 -0.703 . . . . 1.0 110.589 176.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 25' ' ' PHE . 92.5 mt -54.22 -62.68 1.5 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.942 -0.572 . . . . 1.0 111.207 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.962 ' HE ' ' HA ' ' A' ' 27' ' ' GLN . 0.1 OUTLIER -58.93 -34.04 71.27 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 120.559 -0.456 . . . . 1.0 111.466 178.683 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.0 m170 -62.12 -28.63 69.77 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.422 0.527 . . . . 1.0 112.422 177.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.525 ' HG2' ' O ' ' A' ' 28' ' ' GLN . 9.2 ptp180 -95.33 -20.29 19.26 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 119.535 -0.866 . . . . 1.0 110.101 178.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 108.17 39.32 1.84 Allowed Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.034 -0.985 . . . . 1.0 111.992 177.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 25.0 mt -131.03 2.21 4.31 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.567 -0.531 . . . . 1.0 109.567 -178.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.415 ' H ' ' HA ' ' A' ' 30' ' ' ARG . . . -53.75 -35.73 53.27 Favored Glycine 0 C--O 1.226 -0.364 0 CA-C-N 115.545 -0.752 . . . . 1.0 113.35 -178.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.473 ' HA ' ' NH1' ' A' ' 39' ' ' ARG . 0.3 OUTLIER -86.94 -19.17 29.19 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 122.489 -0.418 . . . . 1.0 110.138 -179.86 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.89 -22.13 43.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.878 -0.601 . . . . 1.0 111.373 -177.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.822 HG23 ' HB3' ' A' ' 5' ' ' LEU . 0.4 OUTLIER -143.09 123.62 10.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.064 0.459 . . . . 1.0 110.66 -179.727 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.473 ' NH1' ' HA ' ' A' ' 36' ' ' ASP . 29.0 mmt180 -89.05 144.56 26.06 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.011 -0.541 . . . . 1.0 109.65 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.483 HG11 ' HB2' ' A' ' 26' ' ' ALA . 48.9 t -132.04 122.58 49.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 121.838 0.828 . . . . 1.0 110.234 -177.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.506 ' O ' ' HA ' ' A' ' 8' ' ' THR . 76.8 p -137.13 -176.87 4.53 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.203 -1.362 . . . . 1.0 110.511 -174.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.726 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 88.2 p -160.81 166.35 28.73 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.866 -0.334 . . . . 1.0 110.235 179.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.585 ' HB2' ' CD2' ' A' ' 80' ' ' HIS . . . -164.65 168.15 18.38 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.271 0.557 . . . . 1.0 111.353 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -125.83 132.81 8.04 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.26 -0.882 . . . . 1.0 110.997 177.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.583 HG23 ' CG1' ' A' ' 10' ' ' VAL . 26.0 p -68.77 -22.74 64.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.795 0.331 . . . . 1.0 111.831 -177.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.422 ' HA3' ' HZ3' ' A' ' 48' ' ' TRP . . . -112.41 9.11 26.47 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.875 -0.679 . . . . 1.0 113.133 -177.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 43.83 37.34 1.63 Allowed 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 114.156 1.169 . . . . 1.0 114.156 177.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.911 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 1.2 m-90 -45.77 -73.66 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.454 0.645 . . . . 1.0 112.404 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.468 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 12.4 m-70 -106.06 40.84 1.51 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.248 -0.887 . . . . 1.0 111.063 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.403 HG23 ' HA ' ' A' ' 74' ' ' ALA . 14.0 p -60.18 129.37 22.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 120.65 -0.42 . . . . 1.0 110.375 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.25 -13.61 65.91 Favored Glycine 0 C--O 1.227 -0.33 0 C-N-CA 121.033 -0.603 . . . . 1.0 111.87 -177.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.5 t -80.58 -161.12 0.35 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.636 -0.505 . . . . 1.0 109.636 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 33.6 t -126.33 175.18 8.02 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.585 -0.894 . . . . 1.0 108.585 -178.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.14 141.08 47.44 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 123.098 0.248 . . . . 1.0 110.482 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.524 ' OD2' ' HG2' ' A' ' 57' ' ' ARG . 18.6 t70 -62.1 143.42 56.7 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.841 -177.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -46.69 -36.39 7.05 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.973 -1.012 . . . . 1.0 112.819 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.685 ' O ' HG23 ' A' ' 61' ' ' VAL . 19.3 ptp180 -69.69 -47.11 64.35 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 121.033 -0.267 . . . . 1.0 110.686 -176.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.408 ' HB1' ' SD ' ' A' ' 20' ' ' MET . . . -71.49 -31.96 67.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.097 0.475 . . . . 1.0 110.471 -177.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.14 -55.08 38.19 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.112 -0.699 . . . . 1.0 109.112 176.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -58.31 -39.69 93.0 Favored Glycine 0 N--CA 1.441 -1.009 0 CA-C-N 115.853 -0.612 . . . . 1.0 111.924 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.685 HG23 ' O ' ' A' ' 57' ' ' ARG . 98.7 t -58.98 -58.94 4.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.065 0.46 . . . . 1.0 110.992 177.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.611 HD13 ' HG3' ' A' ' 23' ' ' LYS . 87.7 mt -59.77 -52.46 65.36 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.881 -0.6 . . . . 1.0 111.61 -177.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.487 ' HB3' HG21 ' A' ' 69' ' ' THR . 0.0 OUTLIER -61.34 -33.31 73.41 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.727 -178.997 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.71 -32.93 74.13 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.212 0.53 . . . . 1.0 110.667 179.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -95.68 2.39 54.0 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.646 -0.706 . . . . 1.0 111.078 -178.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 94.12 9.51 59.35 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.978 -0.629 . . . . 1.0 113.531 176.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.41 ' CD1' ' HA ' ' A' ' 24' ' ' MET . 65.9 m-85 -90.68 152.15 44.62 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 110.061 -0.348 . . . . 1.0 110.061 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.583 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 36.0 Cg_endo -67.31 157.56 61.15 Favored 'Trans proline' 0 CA--C 1.512 -0.609 0 C-N-CA 122.189 1.926 . . . . 1.0 110.756 176.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.558 HG22 ' HB2' ' A' ' 62' ' ' LEU . 63.2 p -130.65 11.46 5.26 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 120.365 -0.534 . . . . 1.0 111.644 -176.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -80.87 133.51 35.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.77 -0.65 . . . . 1.0 110.087 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 51.7 t60 -169.22 152.24 4.93 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.892 0.377 . . . . 1.0 110.659 -176.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.436 ' HD3' ' HA ' ' A' ' 72' ' ' ARG . 9.4 tpp180 -133.93 110.86 10.0 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 108.084 -1.08 . . . . 1.0 108.084 175.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.468 ' HB3' ' O ' ' A' ' 49' ' ' HIS . . . -60.34 137.72 58.09 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.288 -0.869 . . . . 1.0 112.176 -175.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.403 ' HA ' HG23 ' A' ' 50' ' ' VAL . . . -130.96 160.25 35.08 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.437 -0.801 . . . . 1.0 110.013 178.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -97.43 154.82 17.23 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.026 -0.731 . . . . 1.0 109.026 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.527 HG11 HD23 ' A' ' 97' ' ' LEU . 14.5 t -67.35 113.19 3.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.053 0.454 . . . . 1.0 110.725 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.454 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -124.19 -169.59 13.12 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.128 -0.942 . . . . 1.0 111.538 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 97.9 m -58.51 -44.48 89.48 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 122.275 0.23 . . . . 1.0 111.548 -178.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -60.4 -28.48 68.26 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.937 0.399 . . . . 1.0 111.183 178.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.585 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 78.8 m80 -77.67 -41.43 38.2 Favored 'General case' 0 C--O 1.223 -0.297 0 N-CA-C 109.763 -0.458 . . . . 1.0 109.763 179.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.645 ' O ' HG23 ' A' ' 102' ' ' VAL . 15.6 mt -69.83 -14.42 62.75 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.6 177.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -88.49 -7.55 56.34 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 120.884 0.373 . . . . 1.0 110.618 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.573 ' HB1' ' O ' ' A' ' 6' ' ' HIS . . . -59.94 150.38 29.0 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.805 -0.634 . . . . 1.0 111.407 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.711 ' HB3' HD13 ' A' ' 5' ' ' LEU . 15.3 t70 -75.4 -15.19 60.48 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.941 -0.392 . . . . 1.0 109.941 178.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.753 HD13 HG13 ' A' ' 7' ' ' VAL . 0.5 OUTLIER -154.66 119.63 4.94 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 109.245 -0.65 . . . . 1.0 109.245 -177.787 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.689 ' HB3' HD13 ' A' ' 97' ' ' LEU . 5.1 mp -109.8 104.74 13.75 Favored 'General case' 0 N--CA 1.426 -1.652 0 CA-C-N 115.531 -0.759 . . . . 1.0 109.735 177.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.589 ' HA ' ' O ' ' A' ' 108' ' ' ARG . 53.6 t -83.79 91.54 2.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 114.924 -1.035 . . . . 1.0 111.115 -176.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.13 145.73 33.57 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.397 -0.82 . . . . 1.0 110.29 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.625 ' O ' ' HB ' ' A' ' 124' ' ' VAL . 3.9 mm? -99.35 -8.04 25.4 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.026 -0.534 . . . . 1.0 110.361 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.405 ' CG ' ' H ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -151.76 152.48 32.77 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.662 -0.699 . . . . 1.0 110.858 179.15 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.558 ' HB3' ' O ' ' A' ' 122' ' ' LEU . 11.4 ptm180 -58.16 -24.01 57.37 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.21 0.818 . . . . 1.0 113.21 -177.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.682 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 9.7 m120 -77.1 -48.07 18.76 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.933 -0.395 . . . . 1.0 109.933 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.56 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 11.7 m170 -56.6 -44.24 80.91 Favored 'General case' 0 N--CA 1.461 0.094 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.031 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.65 -45.17 92.81 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.952 178.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.6 ttt180 -59.26 -39.89 84.29 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.11 -0.496 . . . . 1.0 111.152 178.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.707 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 48.7 mt -66.16 -48.87 69.33 Favored 'General case' 0 C--O 1.218 -0.58 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.304 -176.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.728 HD21 HG21 ' A' ' 10' ' ' VAL . 36.2 mt -52.89 -58.39 7.07 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.086 -0.506 . . . . 1.0 111.374 -179.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.74 ' HA ' HG12 ' A' ' 102' ' ' VAL . 1.3 ptt180 -58.34 -44.69 88.83 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.801 -0.636 . . . . 1.0 111.811 -179.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.653 ' HG3' ' O ' ' A' ' 96' ' ' LEU . 1.1 pp0? -67.8 -25.27 65.5 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.043 0.449 . . . . 1.0 109.948 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.707 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 13.2 mt -79.67 -12.6 59.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.668 -0.696 . . . . 1.0 111.612 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 145.99 -22.25 1.77 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 119.863 -1.16 . . . . 1.0 113.935 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.74 HG12 ' HA ' ' A' ' 98' ' ' ARG . 0.4 OUTLIER -75.93 -163.19 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 CA-C-N 117.419 0.609 . . . . 1.0 110.463 -178.813 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.752 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 12.4 pt-20 -155.87 163.11 40.21 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.702 -1.221 . . . . 1.0 107.702 -179.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.801 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -63.03 -24.98 68.17 Favored 'General case' 0 C--N 1.321 -0.664 0 O-C-N 123.186 0.304 . . . . 1.0 111.459 -175.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.2 -36.82 73.67 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.189 0.519 . . . . 1.0 110.042 175.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.752 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 5.5 mtt-85 -97.23 -42.42 7.82 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 115.368 -0.833 . . . . 1.0 111.6 -176.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.801 HG12 ' HA ' ' A' ' 104' ' ' ALA . 11.9 p -77.55 118.68 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 109.354 -0.61 . . . . 1.0 109.354 -175.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.589 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 16.1 mmm180 -138.64 147.31 42.73 Favored 'General case' 0 C--N 1.319 -0.755 0 O-C-N 121.623 -0.673 . . . . 1.0 110.764 -178.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.523 ' HB2' ' HB2' ' A' ' 112' ' ' SER . 77.1 mmm -79.76 137.54 37.03 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.523 -0.762 . . . . 1.0 110.639 179.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.526 HD23 HG11 ' A' ' 87' ' ' VAL . 3.1 tm? -57.5 -49.97 74.56 Favored 'General case' 0 N--CA 1.465 0.303 0 O-C-N 123.16 0.287 . . . . 1.0 111.221 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.438 ' CB ' HG22 ' A' ' 124' ' ' VAL . 46.1 ttt180 -70.29 -17.44 63.09 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.877 -0.329 . . . . 1.0 110.776 -177.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.523 ' HB2' ' HB2' ' A' ' 109' ' ' MET . 33.8 t -75.6 -4.58 40.81 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.984 -0.286 . . . . 1.0 110.969 -178.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.618 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 92.1 m-85 -92.26 -16.25 26.38 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 120.878 0.37 . . . . 1.0 110.196 175.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -65.57 122.5 80.75 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.0 -0.545 . . . . 1.0 110.712 -178.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -65.95 -20.82 57.57 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.778 2.318 . . . . 1.0 111.968 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 21.5 mtt-85 -90.72 -16.87 27.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.806 -0.634 . . . . 1.0 111.053 -177.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 25.7 m -75.54 65.28 1.75 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.46 0.541 . . . . 1.0 112.46 -177.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 52.86 -99.5 0.04 OUTLIER Glycine 0 C--N 1.333 0.41 0 C-N-CA 121.58 -0.343 . . . . 1.0 113.341 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 15.4 m -136.23 -45.92 0.63 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.192 0.52 . . . . 1.0 109.92 178.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 42.1 m80 -139.29 153.16 47.73 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.894 -0.593 . . . . 1.0 110.672 178.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -133.68 98.99 4.34 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.753 -0.658 . . . . 1.0 109.236 177.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.558 ' O ' ' HB3' ' A' ' 91' ' ' ARG . 2.9 mm? -87.76 11.45 15.35 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.374 -0.376 . . . . 1.0 111.323 -177.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.465 ' HA ' ' HE1' ' A' ' 109' ' ' MET . 32.4 t70 -169.48 136.63 1.71 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.021 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.625 ' HB ' ' O ' ' A' ' 89' ' ' LEU . 61.0 t -100.95 141.97 16.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 108.674 -0.862 . . . . 1.0 108.674 178.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -70.15 -170.83 0.39 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.447 0.641 . . . . 1.0 112.423 -175.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.481 ' HA ' HH21 ' A' ' 17' ' ' ARG . 12.6 t70 -141.5 143.84 31.35 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 108.141 -1.059 . . . . 1.0 108.141 -173.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.437 ' HB3' ' HB2' ' A' ' 134' ' ' ASP . 51.1 Cg_exo -48.62 162.39 0.36 Allowed 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.518 2.146 . . . . 1.0 112.523 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.445 ' HD2' ' CD2' ' A' ' 129' ' ' TYR . 64.0 t80 -102.4 -61.88 1.34 Allowed 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 120.252 -0.579 . . . . 1.0 111.923 -176.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.445 ' CD2' ' HD2' ' A' ' 128' ' ' TYR . 0.0 OUTLIER -92.73 -59.07 2.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.32 0.581 . . . . 1.0 110.965 -174.831 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 117.14 57.35 0.3 Allowed Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 109.464 -1.455 . . . . 1.0 109.464 -175.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.409 ' CG ' ' H ' ' A' ' 132' ' ' HIS . 9.2 t70 -140.87 -174.22 3.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.313 -0.443 . . . . 1.0 110.657 -174.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.506 ' HA ' ' CD2' ' A' ' 135' ' ' PHE . 12.5 t-80 -56.03 -37.27 68.99 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.957 -0.565 . . . . 1.0 111.35 -178.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 12.1 m -64.83 -39.36 93.46 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.08 -0.509 . . . . 1.0 111.058 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.437 ' HB2' ' HB3' ' A' ' 127' ' ' PRO . 0.0 OUTLIER -68.58 -32.79 72.94 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.376 -0.375 . . . . 1.0 110.958 -176.575 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.569 ' CD1' ' HD3' ' A' ' 57' ' ' ARG . 5.6 m-85 -68.96 -49.35 58.7 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.462 0.648 . . . . 1.0 109.929 -178.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -72.92 -18.9 61.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.413 -0.812 . . . . 1.0 110.908 -179.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.414 ' O ' HG23 ' A' ' 141' ' ' VAL . 5.6 tp10 -64.33 -50.73 66.62 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.62 0.724 . . . . 1.0 109.359 176.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.697 ' HA ' HG23 ' A' ' 141' ' ' VAL . 92.9 t -61.77 -38.7 81.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.01 -0.995 . . . . 1.0 109.992 177.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -53.52 -42.06 67.02 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.098 -0.955 . . . . 1.0 109.325 175.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.519 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -65.33 -41.3 94.1 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.301 -0.863 . . . . 1.0 110.187 177.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.697 HG23 ' HA ' ' A' ' 138' ' ' VAL . 11.9 t -55.52 -52.43 47.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 121.604 0.716 . . . . 1.0 110.139 177.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.597 HD13 ' HB3' ' A' ' 20' ' ' MET . 6.5 mt -63.99 -51.74 65.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 114.954 -1.021 . . . . 1.0 112.055 -178.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.519 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 11.3 pt-20 -56.43 -31.5 63.99 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.862 0.363 . . . . 1.0 110.373 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.4 t -74.5 -28.35 60.95 Favored 'General case' 0 C--O 1.225 -0.206 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.253 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.478 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -86.54 -24.12 25.6 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-N 115.889 -0.596 . . . . 1.0 111.545 179.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.717 HD22 ' HB3' ' A' ' 25' ' ' PHE . 11.8 mt -55.65 -36.9 51.05 Favored Pre-proline 0 CA--C 1.544 0.727 0 N-CA-C 112.577 0.584 . . . . 1.0 112.577 -178.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.622 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 55.8 Cg_endo -69.88 -11.6 31.01 Favored 'Trans proline' 0 C--N 1.363 1.332 0 C-N-CA 122.339 2.026 . . . . 1.0 111.854 177.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.618 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -104.85 -33.94 3.64 Favored Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 110.703 -0.959 . . . . 1.0 110.703 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.529 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -74.21 -41.12 61.89 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.43 -0.952 . . . . 1.0 108.43 178.729 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.5 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 1.2 m-70 -54.29 -55.14 31.23 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 114.933 -1.031 . . . . 1.0 109.926 174.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -57.32 -40.83 78.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.315 -0.857 . . . . 1.0 110.71 -175.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . 0.708 ' HZ3' HD11 ' A' ' 5' ' ' LEU . 27.0 t90 -63.54 -57.54 9.83 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.596 -0.729 . . . . 1.0 110.748 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 10.3 m -61.43 -41.17 88.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.803 -0.359 . . . . 1.0 110.195 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.424 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 1.8 m-20 -60.5 -50.72 72.44 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 120.897 0.38 . . . . 1.0 110.42 178.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.559 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 6.3 pt-20 -63.23 -38.13 89.94 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.123 0.487 . . . . 1.0 110.936 -178.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.527 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 4.7 mmt180 -72.58 -45.15 60.54 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.664 -177.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.426 ' HB3' HD23 ' A' ' 5' ' ' LEU . 3.9 pp -67.12 -23.8 65.86 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.716 -0.675 . . . . 1.0 109.762 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -74.47 -51.22 15.45 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.58 -0.737 . . . . 1.0 110.529 178.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.47 ' HG2' ' O ' ' A' ' 155' ' ' GLU . 14.2 ptp180 -75.3 -7.83 54.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.063 -0.517 . . . . 1.0 111.72 -178.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . 0.452 ' HB2' ' O ' ' A' ' 156' ' ' ARG . 15.4 t-20 -78.24 21.49 0.35 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.285 0.564 . . . . 1.0 111.421 -176.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -65.67 141.87 42.91 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.819 -0.705 . . . . 1.0 112.079 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -81.56 25.53 0.65 Allowed 'Trans proline' 0 CA--C 1.515 -0.443 0 C-N-CA 123.707 2.938 . . . . 1.0 113.273 -176.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 58.9 m . . . . . 0 C--N 1.3 -1.586 0 CA-C-N 114.632 -1.167 . . . . 1.0 110.155 -179.622 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.738 0 N-CA-C 112.132 -0.387 . . . . 1.0 112.132 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.9 mtm -84.63 27.27 0.74 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.416 0.627 . . . . 1.0 110.989 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.7 m -158.61 146.41 18.07 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.884 -0.784 . . . . 1.0 108.884 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.571 ' HB2' ' HD2' ' A' ' 4' ' ' PRO . 0.5 OUTLIER -164.29 162.52 15.68 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 110.136 -0.32 . . . . 1.0 110.136 -178.742 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.571 ' HD2' ' HB2' ' A' ' 3' ' ' ASP . 27.6 Cg_endo -67.06 170.16 13.62 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.69 2.26 . . . . 1.0 112.834 -179.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.809 HD13 ' HB3' ' A' ' 84' ' ' ASP . 0.2 OUTLIER -67.13 177.82 1.65 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.532 -0.758 . . . . 1.0 109.384 178.749 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.64 ' O ' ' HB1' ' A' ' 83' ' ' ALA . 3.4 t-160 -157.55 89.32 1.03 Allowed 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.363 -0.606 . . . . 1.0 109.363 -179.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.808 HG13 HD13 ' A' ' 85' ' ' LEU . 2.4 t -95.95 107.38 19.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 109.759 -0.46 . . . . 1.0 109.759 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.619 ' CG2' ' HG ' ' A' ' 86' ' ' LEU . 11.8 t -108.25 114.97 29.26 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.084 0.469 . . . . 1.0 110.943 -179.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.542 ' HA ' ' O ' ' A' ' 87' ' ' VAL . 0.5 OUTLIER -85.76 134.55 33.94 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 122.203 -0.31 . . . . 1.0 110.262 -178.802 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.588 ' CG1' HG23 ' A' ' 45' ' ' THR . 42.4 t -120.66 119.87 60.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-O 121.385 0.612 . . . . 1.0 112.17 -175.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.483 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 15.4 p -143.68 167.63 21.81 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.214 -0.903 . . . . 1.0 109.453 177.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.98 93.54 3.82 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.417 0.627 . . . . 1.0 111.033 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.776 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 129.68 -37.03 2.24 Favored Glycine 0 N--CA 1.443 -0.855 0 CA-C-N 115.25 -0.886 . . . . 1.0 112.526 178.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.488 HD21 ' CB ' ' A' ' 42' ' ' SER . 3.6 t-20 64.49 19.1 11.69 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.924 0.868 . . . . 1.0 110.703 -179.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.469 ' O ' ' HB3' ' A' ' 55' ' ' ASP . 1.3 pt -135.95 47.38 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 CA-C-N 115.491 -0.777 . . . . 1.0 109.567 -178.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.691 ' O ' ' HG3' ' A' ' 20' ' ' MET . 4.4 p -157.23 -89.3 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.78 -1.1 . . . . 1.0 111.846 175.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.514 ' H ' ' HD2' ' A' ' 17' ' ' ARG . 0.1 OUTLIER -74.96 -43.1 55.95 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 121.908 -0.495 . . . . 1.0 111.817 -175.569 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.869 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 46.8 m -54.33 -56.6 24.76 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 116.425 -0.352 . . . . 1.0 111.505 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.683 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 49.0 Cg_endo -66.47 -24.22 49.57 Favored 'Trans proline' 0 C--N 1.357 0.995 0 C-N-CA 121.548 1.499 . . . . 1.0 112.387 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.691 ' HG3' ' O ' ' A' ' 16' ' ' CYS . 51.0 mtp -62.94 -56.54 16.31 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.672 -0.411 . . . . 1.0 110.646 177.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.63 -28.02 64.5 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 120.724 -0.39 . . . . 1.0 110.217 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.67 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 14.8 tt0 -51.85 -53.22 42.82 Favored 'General case' 0 C--O 1.214 -0.764 0 CA-C-N 114.74 -1.118 . . . . 1.0 109.614 178.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.946 ' HB3' ' HG2' ' A' ' 68' ' ' PRO . 0.1 OUTLIER -79.43 -32.39 42.81 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.36 -0.837 . . . . 1.0 110.235 -176.089 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.605 ' HB3' HD11 ' A' ' 146' ' ' LEU . 3.5 mmm -61.9 -75.61 0.07 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 113.173 0.805 . . . . 1.0 113.173 -175.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.749 ' HB3' HD22 ' A' ' 146' ' ' LEU . 14.0 p90 -78.44 -29.31 46.95 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 119.828 -0.749 . . . . 1.0 111.484 -174.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.707 ' HB2' HG21 ' A' ' 40' ' ' VAL . . . -64.12 -36.62 84.62 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 119.146 -1.021 . . . . 1.0 110.461 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.629 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -64.03 -39.32 93.84 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.614 -0.884 . . . . 1.0 108.614 177.062 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.555 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 77.1 mt-30 -60.38 -39.45 87.33 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-N 115.719 -0.673 . . . . 1.0 110.916 176.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.593 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 88.7 mt -59.81 -59.89 4.71 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.756 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.533 ' HA ' ' H ' ' A' ' 35' ' ' GLY . 0.1 OUTLIER -58.96 -36.87 75.54 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.375 -0.53 . . . . 1.0 111.254 178.518 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -65.02 -25.46 67.86 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.382 0.512 . . . . 1.0 112.382 177.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.593 ' HG2' ' O ' ' A' ' 29' ' ' LEU . 3.9 ptm180 -93.17 -19.46 21.44 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 119.461 -0.895 . . . . 1.0 109.465 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 110.4 35.02 2.17 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 114.955 -1.02 . . . . 1.0 111.926 177.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.563 HD12 ' HD3' ' A' ' 32' ' ' ARG . 46.9 mt -134.45 5.93 3.5 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 122.59 -0.359 . . . . 1.0 111.006 -177.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.533 ' H ' ' HA ' ' A' ' 30' ' ' ARG . . . -54.83 -29.62 50.75 Favored Glycine 0 C--N 1.33 0.24 0 C-N-CA 121.177 -0.535 . . . . 1.0 113.118 -178.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -94.92 -20.91 19.0 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.632 0.253 . . . . 1.0 110.985 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.48 -23.27 43.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.369 0.604 . . . . 1.0 111.342 -178.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.8 HG23 ' HB3' ' A' ' 5' ' ' LEU . 0.3 OUTLIER -142.44 119.5 6.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.53 -0.545 . . . . 1.0 109.53 178.001 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.41 ' HE ' ' HG3' ' A' ' 4' ' ' PRO . 16.9 mmt85 -91.13 148.42 22.39 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.618 -0.719 . . . . 1.0 109.295 -178.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.707 HG21 ' HB2' ' A' ' 26' ' ' ALA . 2.0 m -131.54 139.62 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.075 0 N-CA-C 108.391 -0.966 . . . . 1.0 108.391 178.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.503 ' O ' ' HA ' ' A' ' 8' ' ' THR . 21.7 p -146.36 -177.69 5.75 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.287 -0.87 . . . . 1.0 109.808 -175.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.869 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 93.4 p -159.32 163.96 35.23 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 120.613 -0.435 . . . . 1.0 109.982 178.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.557 ' HB2' ' CD2' ' A' ' 80' ' ' HIS . . . -164.38 164.96 22.0 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.452 0.644 . . . . 1.0 111.357 -179.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.483 ' HA2' ' O ' ' A' ' 11' ' ' CYS . . . -122.18 130.05 7.84 Favored Glycine 0 N--CA 1.439 -1.163 0 N-CA-C 110.41 -1.076 . . . . 1.0 110.41 177.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.588 HG23 ' CG1' ' A' ' 10' ' ' VAL . 18.8 p -65.25 -24.16 67.25 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 111.853 0.316 . . . . 1.0 111.853 -177.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -107.66 8.81 37.44 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.809 -0.71 . . . . 1.0 113.353 -177.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 42.96 37.77 1.22 Allowed 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.722 0.809 . . . . 1.0 113.078 179.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.776 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 0.7 OUTLIER -49.2 -76.66 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.524 0.565 . . . . 1.0 112.524 -179.59 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.458 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 36.1 m-70 -103.97 39.65 1.59 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.869 -0.605 . . . . 1.0 111.154 -178.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.506 HG23 ' HA ' ' A' ' 74' ' ' ALA . 11.0 p -59.4 126.31 16.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.019 0.438 . . . . 1.0 110.338 178.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.25 -14.76 62.12 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 121.037 -0.601 . . . . 1.0 111.942 -177.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.461 ' O ' ' HA ' ' A' ' 72' ' ' ARG . 3.8 t -81.61 -161.87 0.47 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.119 0.485 . . . . 1.0 110.138 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 30.2 t -120.84 178.59 4.65 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.737 -0.665 . . . . 1.0 109.289 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.21 146.91 53.71 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.224 0.535 . . . . 1.0 110.499 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.579 ' OD1' ' HA ' ' A' ' 16' ' ' CYS . 9.7 p-10 -64.46 150.69 46.04 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.889 -1.05 . . . . 1.0 113.588 -175.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.409 ' HG3' ' H ' ' A' ' 57' ' ' ARG . 1.7 pt-20 -44.8 -49.62 10.63 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 113.533 -1.667 . . . . 1.0 114.121 176.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.509 ' HG2' ' OD2' ' A' ' 55' ' ' ASP . 9.6 ptp180 -71.04 -37.38 72.56 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.856 -0.338 . . . . 1.0 111.647 -174.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.454 ' HB1' ' HG2' ' A' ' 20' ' ' MET . . . -70.73 -40.95 72.45 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.906 -0.405 . . . . 1.0 109.906 177.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.5 -47.08 85.54 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.87 -0.604 . . . . 1.0 109.836 179.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -60.17 -46.87 93.44 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.912 -0.661 . . . . 1.0 113.318 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.425 HG13 ' O ' ' A' ' 57' ' ' ARG . 13.3 m -71.85 -38.06 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 CA-C-N 117.8 0.8 . . . . 1.0 111.663 -178.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.586 HD23 ' HG3' ' A' ' 23' ' ' LYS . 4.6 mp -63.9 -52.7 58.71 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 120.489 -0.484 . . . . 1.0 110.361 178.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 63' ' ' ARG . 0.3 OUTLIER -62.44 -27.67 69.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.013 -0.539 . . . . 1.0 111.416 -179.298 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.64 -33.9 69.33 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 120.817 0.341 . . . . 1.0 110.812 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -94.68 3.01 55.58 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.776 -178.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 90.56 13.49 59.66 Favored Glycine 0 CA--C 1.517 0.206 0 CA-C-N 115.697 -0.683 . . . . 1.0 113.257 176.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -90.26 155.4 46.72 Favored Pre-proline 0 C--N 1.318 -0.776 0 CA-C-O 120.45 0.167 . . . . 1.0 110.716 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.946 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 74.5 Cg_endo -72.91 162.24 41.56 Favored 'Trans proline' 0 CA--C 1.512 -0.604 0 C-N-CA 122.43 2.087 . . . . 1.0 110.871 177.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 35.0 p -137.83 10.93 2.89 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 120.043 -0.663 . . . . 1.0 111.228 -178.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -72.53 116.84 13.48 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.666 178.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.853 ' HB2' ' HE3' ' A' ' 23' ' ' LYS . 50.1 t60 -157.85 149.74 21.97 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.918 0.39 . . . . 1.0 111.175 -177.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' A' ' 52' ' ' SER . 4.8 tpt180 -133.66 114.19 13.2 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.785 -1.191 . . . . 1.0 107.785 175.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.458 ' HB3' ' O ' ' A' ' 49' ' ' HIS . . . -59.32 137.81 57.85 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.088 -0.96 . . . . 1.0 112.774 -175.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.506 ' HA ' HG23 ' A' ' 50' ' ' VAL . . . -129.65 161.65 30.11 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.213 -0.903 . . . . 1.0 110.078 178.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -97.53 156.73 16.37 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 108.244 -1.021 . . . . 1.0 108.244 178.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.5 HG11 ' CD2' ' A' ' 97' ' ' LEU . 8.1 t -66.91 104.26 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.303 0.573 . . . . 1.0 109.781 178.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.412 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -113.89 -175.09 18.93 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 115.184 -0.917 . . . . 1.0 111.269 -178.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 94.1 m -56.37 -43.36 79.1 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.814 0.34 . . . . 1.0 111.259 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -60.88 -29.76 69.74 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.091 -0.504 . . . . 1.0 111.312 178.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.557 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 80.0 m80 -78.19 -39.73 39.8 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-O 120.98 0.419 . . . . 1.0 109.875 178.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.519 ' HA ' HD21 ' A' ' 86' ' ' LEU . 33.9 mt -68.65 -18.75 64.34 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.784 -0.644 . . . . 1.0 110.758 178.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.8 -4.8 59.22 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.861 -0.608 . . . . 1.0 110.844 -178.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.64 ' HB1' ' O ' ' A' ' 6' ' ' HIS . . . -59.98 154.22 19.49 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.979 -0.555 . . . . 1.0 111.665 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.809 ' HB3' HD13 ' A' ' 5' ' ' LEU . 10.6 t70 -80.4 -12.08 59.62 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.52 -0.548 . . . . 1.0 109.52 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.808 HD13 HG13 ' A' ' 7' ' ' VAL . 0.4 OUTLIER -156.98 118.09 3.68 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 115.65 -0.705 . . . . 1.0 109.22 -177.615 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.716 ' HB3' HD13 ' A' ' 97' ' ' LEU . 5.1 mp -107.52 105.99 16.16 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-N 115.815 -0.629 . . . . 1.0 109.709 177.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.597 HG11 HD23 ' A' ' 110' ' ' LEU . 48.1 t -86.51 94.88 4.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 114.823 -1.081 . . . . 1.0 111.066 -176.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -82.73 144.67 30.04 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 114.975 -1.012 . . . . 1.0 110.949 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.413 HD13 ' HA ' ' A' ' 89' ' ' LEU . 4.3 mm? -95.04 -13.65 25.01 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.254 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.409 ' CG ' ' H ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -148.74 153.67 38.51 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.724 -0.671 . . . . 1.0 111.542 -178.89 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.7 ptt180 -49.74 -32.2 13.1 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.666 1.186 . . . . 1.0 113.55 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.646 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 76.9 m-20 -77.36 -47.51 19.7 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.751 -0.38 . . . . 1.0 110.672 -177.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.724 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 13.5 m170 -54.52 -48.15 72.27 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.923 -0.399 . . . . 1.0 109.923 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.96 -43.03 91.24 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.073 0.463 . . . . 1.0 110.752 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.674 ' O ' ' HG2' ' A' ' 99' ' ' GLN . 11.5 ttp180 -58.32 -47.56 83.31 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.465 -0.789 . . . . 1.0 111.363 179.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.722 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 48.4 mt -62.16 -49.11 77.15 Favored 'General case' 0 C--O 1.219 -0.533 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.233 -175.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.724 ' HG ' ' O ' ' A' ' 93' ' ' HIS . 32.1 mt -53.42 -58.05 8.49 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.816 -0.629 . . . . 1.0 111.762 -177.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.526 ' HG2' ' O ' ' A' ' 95' ' ' ARG . 22.6 ptt180 -59.41 -44.83 92.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.451 . . . . 1.0 111.578 -176.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.674 ' HG2' ' O ' ' A' ' 95' ' ' ARG . 9.9 pt20 -70.89 -18.65 62.67 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.84 0.353 . . . . 1.0 111.227 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.722 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 5.5 mt -79.58 -8.1 58.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.068 -0.515 . . . . 1.0 111.706 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 146.87 -30.36 1.52 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.029 -1.082 . . . . 1.0 113.011 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.8 HG12 ' H ' ' A' ' 103' ' ' GLU . 2.0 t -73.32 -154.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 121.077 0.465 . . . . 1.0 110.868 -178.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.8 ' H ' HG12 ' A' ' 102' ' ' VAL . 15.6 pt-20 -164.61 165.14 21.31 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.977 -0.749 . . . . 1.0 108.977 -177.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.788 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -65.01 -24.87 67.63 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 123.409 0.443 . . . . 1.0 111.542 -176.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.5 -35.65 72.57 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.3 0.571 . . . . 1.0 110.254 175.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.716 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 4.7 mtt-85 -96.89 -42.71 7.81 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 115.2 -0.909 . . . . 1.0 111.029 -177.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.788 HG12 ' HA ' ' A' ' 104' ' ' ALA . 7.8 p -80.79 121.7 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-O 121.37 0.605 . . . . 1.0 109.981 -177.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.533 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 12.7 mmm180 -137.97 146.6 43.36 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.39 -0.596 . . . . 1.0 109.39 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.779 ' HE3' HG23 ' A' ' 124' ' ' VAL . 79.6 mmm -77.81 139.53 39.33 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.837 -0.619 . . . . 1.0 110.234 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.597 HD23 HG11 ' A' ' 87' ' ' VAL . 3.2 tm? -56.04 -48.29 76.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.517 0.198 . . . . 1.0 111.075 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.838 ' H ' HG22 ' A' ' 124' ' ' VAL . 20.7 ttt85 -71.35 -17.49 62.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.007 0.432 . . . . 1.0 110.498 -178.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.483 ' HB2' ' HB2' ' A' ' 109' ' ' MET . 30.5 t -70.67 -12.26 61.45 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.581 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.458 ' HZ ' HD21 ' A' ' 85' ' ' LEU . 97.6 m-85 -90.8 -25.38 19.96 Favored 'General case' 0 N--CA 1.456 -0.166 0 O-C-N 122.175 -0.328 . . . . 1.0 110.122 176.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -62.83 122.23 73.27 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.51 -0.768 . . . . 1.0 111.756 -177.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.73 -16.77 20.75 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.394 2.063 . . . . 1.0 111.867 177.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 2.2 mmt180 -88.08 -6.99 57.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.923 -0.58 . . . . 1.0 110.565 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 33.2 t -57.69 -54.29 48.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.571 -0.74 . . . . 1.0 110.332 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 116.15 -61.26 0.4 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.41 -0.9 . . . . 1.0 111.643 178.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.631 HG22 ' H ' ' A' ' 120' ' ' HIS . 0.6 OUTLIER -128.91 -170.91 2.35 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.004 -0.739 . . . . 1.0 109.004 178.581 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.631 ' H ' HG22 ' A' ' 119' ' ' THR . 0.9 OUTLIER -58.68 144.83 42.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.836 0.35 . . . . 1.0 110.67 177.746 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -120.46 99.86 6.81 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.512 -0.313 . . . . 1.0 111.282 -178.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -95.48 19.49 10.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 122.028 0.918 . . . . 1.0 108.839 175.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -165.93 131.2 2.4 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 113.804 -1.544 . . . . 1.0 107.374 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.838 HG22 ' H ' ' A' ' 111' ' ' ARG . 79.9 t -90.26 -81.71 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 112.457 0.54 . . . . 1.0 112.457 -174.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -137.09 175.23 9.81 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.185 -0.916 . . . . 1.0 112.285 -175.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.43 ' HA ' ' HD2' ' A' ' 127' ' ' PRO . 33.5 t70 -174.23 106.79 0.29 Allowed Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 114.108 -1.406 . . . . 1.0 108.526 175.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.459 ' HG3' ' NH2' ' A' ' 17' ' ' ARG . 17.7 Cg_endo -60.65 172.67 2.62 Favored 'Trans proline' 0 C--O 1.233 0.269 0 C-N-CA 123.103 2.536 . . . . 1.0 112.625 -178.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.546 ' HD2' ' CD2' ' A' ' 129' ' ' TYR . 66.6 t80 -110.22 -35.1 6.18 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 112.792 0.664 . . . . 1.0 112.792 -174.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.563 ' CE1' ' HB2' ' A' ' 134' ' ' ASP . 0.4 OUTLIER -141.25 -41.27 0.38 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.969 0.729 . . . . 1.0 112.969 -176.66 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.406 ' N ' ' HD1' ' A' ' 129' ' ' TYR . . . 101.46 66.48 0.79 Allowed Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.098 -1.048 . . . . 1.0 111.846 -176.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.68 ' H ' ' HB3' ' A' ' 134' ' ' ASP . 3.8 t70 -137.44 -175.38 4.04 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.675 -0.861 . . . . 1.0 108.675 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -52.81 -49.6 65.35 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.674 0.25 . . . . 1.0 111.674 -178.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 5.0 p -63.89 -36.49 84.11 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.311 0.577 . . . . 1.0 110.933 -179.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.68 ' HB3' ' H ' ' A' ' 131' ' ' ASP . 12.6 t70 -64.05 -39.96 95.24 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.911 -1.041 . . . . 1.0 110.722 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.439 ' CG ' ' HB2' ' A' ' 57' ' ' ARG . 9.8 m-30 -67.46 -46.59 72.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.897 -0.592 . . . . 1.0 110.605 -178.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.43 ' HA ' ' HB3' ' A' ' 139' ' ' PHE . 10.1 mt-10 -76.67 -15.43 59.8 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.951 -0.568 . . . . 1.0 111.237 -178.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.5 ' O ' HG23 ' A' ' 141' ' ' VAL . 20.0 tp10 -65.29 -46.76 79.12 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 108.187 -1.042 . . . . 1.0 108.187 174.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 72.3 t -60.08 -44.25 94.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 114.594 -1.185 . . . . 1.0 109.214 175.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.43 ' HB3' ' HA ' ' A' ' 136' ' ' GLU . 49.9 t80 -54.01 -42.79 69.47 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.453 -1.249 . . . . 1.0 109.828 176.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.52 ' HA ' ' OE2' ' A' ' 143' ' ' GLU . . . -64.26 -42.07 96.64 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.462 -0.79 . . . . 1.0 111.03 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 137' ' ' GLU . 16.9 t -56.96 -53.77 38.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.503 0.668 . . . . 1.0 110.235 178.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.475 ' HA ' HD11 ' A' ' 110' ' ' LEU . 4.7 mt -60.92 -52.27 63.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.376 -0.829 . . . . 1.0 112.289 -178.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.52 ' OE2' ' HA ' ' A' ' 140' ' ' ALA . 13.2 pt-20 -56.17 -32.18 64.09 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.932 0.396 . . . . 1.0 110.515 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 73.0 m -72.8 -28.9 62.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.574 -0.739 . . . . 1.0 110.939 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.459 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -87.18 -23.5 24.77 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-N 116.215 -0.448 . . . . 1.0 111.712 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.749 HD22 ' HB3' ' A' ' 25' ' ' PHE . 13.4 mt -56.01 -36.66 48.63 Favored Pre-proline 0 CA--C 1.548 0.874 0 N-CA-C 112.417 0.525 . . . . 1.0 112.417 -177.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.636 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 51.1 Cg_endo -69.7 -10.79 29.47 Favored 'Trans proline' 0 C--N 1.366 1.465 0 C-N-CA 122.733 2.288 . . . . 1.0 112.277 177.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.429 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -105.24 -32.6 3.95 Favored Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 110.465 -1.054 . . . . 1.0 110.465 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.464 HD11 HG21 ' A' ' 87' ' ' VAL . 0.4 OUTLIER -74.48 -41.02 61.45 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.664 -0.865 . . . . 1.0 108.664 178.937 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.403 ' O ' HG22 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -53.52 -55.38 25.96 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 114.814 -1.085 . . . . 1.0 110.921 175.657 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -60.75 -40.47 92.56 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.563 -0.744 . . . . 1.0 111.591 -176.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . 0.756 ' HZ3' HD11 ' A' ' 5' ' ' LEU . 29.0 t90 -63.36 -54.6 34.37 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.552 -0.749 . . . . 1.0 110.751 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.458 HG13 ' O ' ' A' ' 149' ' ' LEU . 11.1 m -60.11 -39.19 79.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 C-N-CA 120.84 -0.344 . . . . 1.0 110.075 -179.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.442 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 8.3 m-20 -59.68 -51.74 68.5 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.272 0.558 . . . . 1.0 110.966 178.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.524 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 5.1 pt-20 -63.46 -38.31 90.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.406 -0.815 . . . . 1.0 110.443 -178.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.525 ' HG3' ' CH2' ' A' ' 152' ' ' TRP . 10.9 mmt180 -74.89 -42.72 57.29 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.615 -0.72 . . . . 1.0 111.664 -177.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 4.2 pp -64.54 -24.77 67.72 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.157 0.503 . . . . 1.0 109.793 179.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -71.62 -47.63 53.34 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.549 -0.75 . . . . 1.0 110.033 177.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.94 -4.09 48.1 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.533 0.568 . . . . 1.0 112.533 179.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -106.3 4.61 28.88 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.747 0.308 . . . . 1.0 110.979 179.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -175.07 144.62 7.42 Favored Glycine 0 C--N 1.319 -0.362 0 C-N-CA 119.971 -1.109 . . . . 1.0 114.247 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -87.7 30.36 0.45 Allowed 'Trans proline' 0 CA--C 1.519 -0.26 0 C-N-CA 123.777 2.985 . . . . 1.0 112.152 178.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 36.0 t . . . . . 0 C--N 1.302 -1.49 0 CA-C-N 114.585 -1.189 . . . . 1.0 110.813 -178.031 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.885 0 N-CA-C 112.247 -0.341 . . . . 1.0 112.247 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -82.13 -3.43 54.83 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.019 0.377 . . . . 1.0 112.019 -178.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.7 t -80.27 -179.71 7.24 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 110.3 -0.259 . . . . 1.0 110.3 -178.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.602 ' HB2' ' HD2' ' A' ' 4' ' ' PRO . 1.3 p-10 -64.1 159.96 52.12 Favored Pre-proline 0 C--O 1.234 0.253 0 CA-C-O 121.033 0.444 . . . . 1.0 111.379 178.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.602 ' HD2' ' HB2' ' A' ' 3' ' ' ASP . 23.1 Cg_endo -62.4 167.39 11.34 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 123.477 2.785 . . . . 1.0 114.046 -175.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.844 ' HB3' HG23 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -66.11 177.66 1.34 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.635 -1.166 . . . . 1.0 109.578 178.084 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.575 ' H ' HD13 ' A' ' 5' ' ' LEU . 0.9 OUTLIER -155.51 99.0 2.0 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.763 -0.458 . . . . 1.0 109.763 179.617 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.637 HG13 HD13 ' A' ' 85' ' ' LEU . 2.3 t -104.09 118.27 50.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 108.147 -1.057 . . . . 1.0 108.147 177.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.643 HG22 ' HG ' ' A' ' 86' ' ' LEU . 11.7 t -119.75 113.59 20.86 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.302 0.572 . . . . 1.0 110.352 178.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.647 ' HD1' ' HB ' ' A' ' 87' ' ' VAL . 1.0 OUTLIER -84.51 133.21 34.47 Favored 'General case' 0 CA--C 1.512 -0.487 0 O-C-N 122.024 -0.423 . . . . 1.0 110.258 -178.18 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.57 ' CG1' HG23 ' A' ' 45' ' ' THR . 40.7 t -119.95 119.49 60.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.552 0.691 . . . . 1.0 112.042 -176.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.445 ' HA ' ' CE1' ' A' ' 93' ' ' HIS . 21.7 p -148.32 163.37 37.29 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.221 -0.9 . . . . 1.0 109.963 177.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.96 96.81 5.83 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 120.849 0.357 . . . . 1.0 110.39 177.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.513 ' O ' HG12 ' A' ' 15' ' ' ILE . . . 146.64 -36.62 1.24 Allowed Glycine 0 C--O 1.218 -0.89 0 CA-C-N 115.687 -0.688 . . . . 1.0 112.26 179.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.503 ' OD1' ' HB1' ' A' ' 73' ' ' ALA . 32.2 p30 49.27 18.54 0.26 Allowed 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 125.155 1.382 . . . . 1.0 114.115 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.513 HG12 ' O ' ' A' ' 13' ' ' GLY . 5.8 pt -136.44 2.6 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 112.13 0.419 . . . . 1.0 112.13 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.646 ' O ' ' HG3' ' A' ' 20' ' ' MET . 51.4 t -121.99 -86.79 0.65 Allowed 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.437 -0.505 . . . . 1.0 111.577 -178.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 54.1 mtt85 -59.2 -56.55 20.67 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.063 0.458 . . . . 1.0 112.103 -175.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.948 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 45.3 m -53.19 -59.0 10.21 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 115.552 -0.749 . . . . 1.0 112.497 -177.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.409 ' HG3' ' HA ' ' A' ' 15' ' ' ILE . 41.2 Cg_endo -63.19 -25.34 72.52 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 121.954 1.769 . . . . 1.0 113.2 -178.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.646 ' HG3' ' O ' ' A' ' 16' ' ' CYS . 53.4 mtp -61.19 -53.34 58.14 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.778 -0.369 . . . . 1.0 110.3 178.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.468 ' HB2' ' CG2' ' A' ' 142' ' ' ILE . . . -72.2 -26.74 62.17 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.265 -0.574 . . . . 1.0 110.178 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.685 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 17.7 tt0 -53.83 -52.1 61.43 Favored 'General case' 0 C--O 1.212 -0.874 0 CA-C-N 115.135 -0.939 . . . . 1.0 109.431 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.618 ' HZ1' ' HB3' ' A' ' 71' ' ' HIS . 0.1 OUTLIER -86.65 -23.03 25.8 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 120.06 -0.656 . . . . 1.0 110.879 -176.431 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.503 ' HB3' HD11 ' A' ' 146' ' ' LEU . 86.0 mtp -64.57 -75.78 0.08 Allowed 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.001 0.429 . . . . 1.0 112.132 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.617 ' HB3' HD22 ' A' ' 146' ' ' LEU . 17.5 p90 -77.04 -30.31 55.59 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 119.883 -0.727 . . . . 1.0 111.51 -175.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.685 ' HB3' ' O ' ' A' ' 22' ' ' GLU . . . -64.39 -36.96 85.84 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 118.951 -1.099 . . . . 1.0 110.991 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.605 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -63.56 -37.53 87.68 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 108.433 -0.951 . . . . 1.0 108.433 176.468 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.581 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 77.9 mt-30 -60.15 -41.07 91.96 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-N 116.022 -0.536 . . . . 1.0 110.187 175.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.559 ' HG ' ' O ' ' A' ' 25' ' ' PHE . 70.7 mt -57.71 -59.69 4.83 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.004 -0.544 . . . . 1.0 110.907 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.525 ' HD3' ' HA ' ' A' ' 27' ' ' GLN . 0.3 OUTLIER -59.37 -34.36 72.31 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.556 -0.457 . . . . 1.0 110.779 178.225 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -63.01 -27.41 69.4 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.693 0.627 . . . . 1.0 112.693 176.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.46 ' HG2' ' O ' ' A' ' 28' ' ' GLN . 6.9 ptp180 -95.9 -15.01 22.68 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.566 0.698 . . . . 1.0 110.109 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.86 39.69 3.07 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 114.913 -1.039 . . . . 1.0 111.49 177.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 31.3 mt -132.32 3.8 3.98 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.987 -0.375 . . . . 1.0 109.987 -178.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.423 ' H ' ' HA ' ' A' ' 30' ' ' ARG . . . -56.22 -26.93 51.41 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 121.037 -0.602 . . . . 1.0 112.507 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.645 ' HA ' ' NH1' ' A' ' 39' ' ' ARG . 11.9 m-20 -91.32 -21.69 20.91 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.623 0.249 . . . . 1.0 110.796 176.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -81.01 -23.55 38.57 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.338 -178.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.844 HG23 ' HB3' ' A' ' 5' ' ' LEU . 0.7 OUTLIER -142.68 123.91 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-O 121.269 0.557 . . . . 1.0 110.509 179.769 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.645 ' NH1' ' HA ' ' A' ' 36' ' ' ASP . 24.3 mmt180 -92.53 141.33 28.63 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 109.233 -0.655 . . . . 1.0 109.233 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.441 HG13 ' CZ ' ' A' ' 9' ' ' PHE . 34.2 t -129.13 125.34 62.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-O 121.445 0.64 . . . . 1.0 109.931 -177.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' A' ' 8' ' ' THR . 36.5 p -136.79 -177.69 4.85 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.165 -1.379 . . . . 1.0 110.298 -174.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.948 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 66.9 p -161.03 162.94 31.9 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.986 -0.376 . . . . 1.0 109.986 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.561 ' HB2' ' CD2' ' A' ' 80' ' ' HIS . . . -164.59 171.03 15.01 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.556 0.693 . . . . 1.0 111.922 -178.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -128.29 134.05 7.98 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 114.851 -1.068 . . . . 1.0 111.073 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.57 HG23 ' CG1' ' A' ' 10' ' ' VAL . 25.7 p -69.6 -18.13 63.59 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.045 0.45 . . . . 1.0 111.385 -178.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.509 ' HA3' ' CZ3' ' A' ' 48' ' ' TRP . . . -113.8 8.53 23.7 Favored Glycine 0 CA--C 1.521 0.436 0 C-N-CA 120.853 -0.689 . . . . 1.0 113.173 -179.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 44.01 39.19 2.6 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 113.821 1.045 . . . . 1.0 113.821 177.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.509 ' CZ3' ' HA3' ' A' ' 46' ' ' GLY . 1.2 m-90 -43.96 -77.32 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.534 0.683 . . . . 1.0 112.506 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.428 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 24.4 m-70 -106.0 40.53 1.57 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.023 -0.99 . . . . 1.0 111.314 -179.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.446 HG23 ' HA ' ' A' ' 74' ' ' ALA . 12.0 p -58.2 127.63 17.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.853 179.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.6 -14.94 64.16 Favored Glycine 0 C--N 1.329 0.184 0 C-N-CA 121.196 -0.525 . . . . 1.0 112.195 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.6 t -81.56 -162.4 0.51 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.42 0.629 . . . . 1.0 110.356 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 14.0 t -118.89 175.74 5.61 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.703 -0.851 . . . . 1.0 108.703 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.458 ' HB2' ' HZ1' ' A' ' 23' ' ' LYS . . . -60.66 147.43 42.05 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 123.331 0.394 . . . . 1.0 111.525 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.454 ' OD1' ' HG2' ' A' ' 57' ' ' ARG . 11.5 t70 -63.0 142.84 58.23 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.698 -0.683 . . . . 1.0 111.163 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.437 ' HG3' ' N ' ' A' ' 57' ' ' ARG . 5.4 pt-20 -50.02 -37.06 31.2 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 113.522 0.934 . . . . 1.0 113.522 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.454 ' HG2' ' OD1' ' A' ' 55' ' ' ASP . 11.3 ptp180 -71.16 -37.56 72.2 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.039 0.447 . . . . 1.0 110.624 -176.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.417 ' HB1' ' HG2' ' A' ' 20' ' ' MET . . . -70.52 -37.65 74.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.61 -0.723 . . . . 1.0 109.5 178.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.14 -42.97 99.77 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.743 -0.662 . . . . 1.0 109.281 176.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.416 ' O ' ' HG2' ' A' ' 63' ' ' ARG . . . -58.77 -45.5 94.8 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.566 -0.743 . . . . 1.0 113.359 178.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.481 HG12 ' HG2' ' A' ' 136' ' ' GLU . 35.0 m -73.28 -41.73 57.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 117.569 0.685 . . . . 1.0 111.863 -179.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.735 ' HB2' HG22 ' A' ' 69' ' ' THR . 96.2 mt -60.63 -52.22 66.05 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 120.828 -0.349 . . . . 1.0 110.194 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.416 ' HG2' ' O ' ' A' ' 60' ' ' GLY . 2.4 ptm180 -59.83 -32.48 70.7 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.101 -0.499 . . . . 1.0 111.079 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.5 -34.81 74.85 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 121.155 0.503 . . . . 1.0 110.877 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.405 ' HB2' ' HD2' ' A' ' 67' ' ' TYR . 99.7 m-70 -93.33 4.49 53.89 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.897 -179.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.16 16.74 62.23 Favored Glycine 0 C--N 1.331 0.288 0 CA-C-N 115.832 -0.622 . . . . 1.0 112.964 176.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.448 ' HD1' ' HG2' ' A' ' 27' ' ' GLN . 55.3 m-85 -92.45 153.52 42.69 Favored Pre-proline 0 C--N 1.32 -0.686 0 N-CA-C 110.434 -0.21 . . . . 1.0 110.434 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.402 ' O ' ' HD2' ' A' ' 23' ' ' LYS . 35.5 Cg_endo -68.25 156.76 64.57 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.063 1.842 . . . . 1.0 110.509 175.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.735 HG22 ' HB2' ' A' ' 62' ' ' LEU . 72.2 p -130.83 27.73 4.9 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 120.222 -0.591 . . . . 1.0 111.342 -176.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -104.08 131.87 50.91 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.81 -0.632 . . . . 1.0 110.335 178.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.618 ' HB3' ' HZ1' ' A' ' 23' ' ' LYS . 3.2 t60 -167.42 148.82 5.62 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.621 -0.718 . . . . 1.0 109.398 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -121.28 113.04 19.37 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 107.972 -1.121 . . . . 1.0 107.972 176.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.503 ' HB1' ' OD1' ' A' ' 14' ' ' ASN . . . -57.84 139.56 53.84 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.557 -0.747 . . . . 1.0 112.272 -175.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.446 ' HA ' HG23 ' A' ' 50' ' ' VAL . . . -132.98 161.95 32.97 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.742 178.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -97.66 156.59 16.47 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 108.134 -1.062 . . . . 1.0 108.134 177.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.59 HG11 ' CD2' ' A' ' 97' ' ' LEU . 14.5 t -66.24 104.69 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.529 0.681 . . . . 1.0 110.232 178.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.409 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -117.57 -171.77 15.67 Favored Glycine 0 N--CA 1.442 -0.962 0 CA-C-N 114.633 -1.167 . . . . 1.0 111.12 -178.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 98.9 m -56.99 -44.42 82.7 Favored 'General case' 0 C--N 1.319 -0.72 0 O-C-N 123.628 0.252 . . . . 1.0 111.3 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -60.71 -29.39 69.31 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.762 0.315 . . . . 1.0 111.216 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.561 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 79.1 m80 -79.22 -42.15 26.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.422 -0.354 . . . . 1.0 110.179 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.499 ' HA ' HD21 ' A' ' 86' ' ' LEU . 21.4 mt -66.77 -21.43 66.06 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.132 -0.485 . . . . 1.0 110.967 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.25 -5.01 59.28 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.166 -0.47 . . . . 1.0 111.438 -178.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.541 ' HA ' ' HB3' ' A' ' 6' ' ' HIS . . . -59.04 151.58 21.91 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.219 -0.446 . . . . 1.0 111.686 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.719 ' HB3' HD13 ' A' ' 5' ' ' LEU . 28.4 t70 -75.8 -16.26 60.12 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.924 -0.58 . . . . 1.0 109.635 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.637 HD13 HG13 ' A' ' 7' ' ' VAL . 0.4 OUTLIER -156.21 116.56 3.68 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.53 -0.759 . . . . 1.0 109.155 -176.931 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.643 ' HG ' HG22 ' A' ' 8' ' ' THR . 5.4 mp -106.59 106.48 17.02 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-N 115.778 -0.646 . . . . 1.0 109.562 177.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.647 ' HB ' ' HD1' ' A' ' 9' ' ' PHE . 54.9 t -85.18 93.15 3.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.124 -0.944 . . . . 1.0 110.994 -176.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.47 145.45 30.73 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.612 -0.722 . . . . 1.0 110.673 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.404 ' O ' ' HB ' ' A' ' 124' ' ' VAL . 4.4 mm? -96.38 -6.79 36.72 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.845 -0.616 . . . . 1.0 109.973 179.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.427 ' CG ' ' H ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -154.49 151.0 28.41 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.585 -0.734 . . . . 1.0 110.86 179.749 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.481 ' HB3' ' O ' ' A' ' 122' ' ' LEU . 13.7 ptp180 -58.04 -24.08 56.95 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.151 -0.931 . . . . 1.0 112.737 -177.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.689 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 82.3 m-20 -77.01 -47.64 20.12 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.983 -0.377 . . . . 1.0 109.983 -178.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.789 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 15.4 m170 -55.78 -48.26 75.64 Favored 'General case' 0 C--N 1.333 -0.119 0 N-CA-C 109.475 -0.565 . . . . 1.0 109.475 176.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.584 ' HA ' HG21 ' A' ' 107' ' ' VAL . . . -57.68 -42.46 83.65 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.477 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.401 ' O ' ' HG2' ' A' ' 98' ' ' ARG . 10.2 ttp180 -58.76 -47.12 85.75 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 115.548 -0.751 . . . . 1.0 111.248 178.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.752 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 52.0 mt -62.89 -50.32 71.34 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.667 -0.697 . . . . 1.0 110.212 -175.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.789 ' HG ' ' O ' ' A' ' 93' ' ' HIS . 22.1 mt -54.71 -57.36 11.81 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.369 -0.832 . . . . 1.0 111.468 -178.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.697 ' HA ' ' HB ' ' A' ' 102' ' ' VAL . 15.9 ptt180 -60.63 -42.83 97.68 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.08 -0.509 . . . . 1.0 111.675 -175.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.607 ' HG3' ' O ' ' A' ' 96' ' ' LEU . 0.9 OUTLIER -67.82 -25.43 65.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.888 0.375 . . . . 1.0 110.191 179.222 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.752 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 11.6 mt -77.13 -12.46 59.95 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.609 0.596 . . . . 1.0 112.609 -178.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 151.52 -26.94 0.96 Allowed Glycine 0 N--CA 1.453 -0.18 0 C-N-CA 120.277 -0.963 . . . . 1.0 112.4 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.931 HG12 ' H ' ' A' ' 103' ' ' GLU . 2.7 t -73.97 -155.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 C-N-CA 123.122 0.569 . . . . 1.0 110.185 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.931 ' H ' HG12 ' A' ' 102' ' ' VAL . 15.4 pt-20 -170.48 164.32 8.54 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 107.883 -1.154 . . . . 1.0 107.883 -178.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.707 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -67.31 -21.69 65.66 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.771 0.319 . . . . 1.0 110.882 -176.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.499 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . . . -58.31 -38.21 76.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.924 -0.58 . . . . 1.0 109.869 174.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.716 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 31.7 mtt180 -95.36 -45.79 6.98 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 115.182 -0.917 . . . . 1.0 110.333 -177.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.707 HG12 ' HA ' ' A' ' 104' ' ' ALA . 8.9 p -79.6 119.83 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-O 121.634 0.731 . . . . 1.0 110.033 -177.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.562 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 22.4 mmm180 -134.77 145.71 48.66 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.414 -0.587 . . . . 1.0 109.414 -178.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.589 ' HE3' HG23 ' A' ' 124' ' ' VAL . 81.4 mmm -77.35 134.86 38.37 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.829 -0.623 . . . . 1.0 110.389 -178.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.538 HD23 HG11 ' A' ' 87' ' ' VAL . 3.0 tm? -55.33 -48.94 73.42 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.933 0.396 . . . . 1.0 111.066 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.643 ' HD2' ' HA ' ' A' ' 124' ' ' VAL . 37.8 ttt180 -69.98 -19.02 63.37 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.894 -0.594 . . . . 1.0 110.679 -177.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 41.7 t -77.31 -8.41 57.59 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.95 -178.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.587 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 90.4 m-85 -88.75 -17.62 29.47 Favored 'General case' 0 C--N 1.341 0.21 0 O-C-N 121.858 -0.526 . . . . 1.0 110.235 176.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -60.8 123.34 74.32 Favored Pre-proline 0 CA--C 1.521 -0.149 0 CA-C-N 115.993 -0.549 . . . . 1.0 110.908 -178.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -70.1 -18.67 35.25 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.312 2.008 . . . . 1.0 111.674 178.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -87.67 -3.17 58.98 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.673 -0.694 . . . . 1.0 111.55 -178.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 77.6 p -64.13 101.77 0.44 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.314 0.578 . . . . 1.0 111.996 -178.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -55.96 -33.04 59.95 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-N 115.122 -0.945 . . . . 1.0 113.574 178.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.6 m -131.17 168.04 18.14 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.307 -0.627 . . . . 1.0 109.307 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 52.7 m170 -61.37 137.68 58.24 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 109.373 -0.603 . . . . 1.0 109.373 176.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.414 ' C ' ' H ' ' A' ' 123' ' ' ASP . . . -100.82 84.95 2.79 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.101 0.476 . . . . 1.0 111.404 -177.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.481 ' O ' ' HB3' ' A' ' 91' ' ' ARG . 2.5 mm? -91.12 22.93 3.48 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 108.311 -0.996 . . . . 1.0 108.311 175.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.414 ' H ' ' C ' ' A' ' 121' ' ' ALA . 0.1 OUTLIER -171.97 140.98 1.29 Allowed 'General case' 0 N--CA 1.426 -1.663 0 CA-C-N 113.359 -1.746 . . . . 1.0 107.829 178.595 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.643 ' HA ' ' HD2' ' A' ' 111' ' ' ARG . 64.0 t -101.14 144.47 12.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 109.472 -0.566 . . . . 1.0 109.472 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -65.23 166.48 9.75 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.826 -0.805 . . . . 1.0 108.826 178.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.53 ' OD1' ' HD2' ' A' ' 127' ' ' PRO . 35.4 t70 -156.55 148.42 17.3 Favored Pre-proline 0 C--N 1.314 -0.977 0 C-N-CA 119.827 -0.749 . . . . 1.0 109.769 -172.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.53 ' HD2' ' OD1' ' A' ' 126' ' ' ASP . 10.7 Cg_endo -54.72 -176.33 0.04 OUTLIER 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 123.458 2.772 . . . . 1.0 112.426 176.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.514 ' HD2' ' CD2' ' A' ' 129' ' ' TYR . 68.7 t80 -131.45 -26.63 2.04 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 113.872 1.064 . . . . 1.0 113.872 -173.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.514 ' CD2' ' HD2' ' A' ' 128' ' ' TYR . 0.2 OUTLIER -140.7 -44.52 0.4 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 114.238 1.199 . . . . 1.0 114.238 -174.99 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 109.66 59.01 0.51 Allowed Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 119.972 -1.109 . . . . 1.0 111.7 -175.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.62 ' H ' ' CB ' ' A' ' 134' ' ' ASP . 11.2 m-20 -125.98 -168.78 1.9 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.067 -0.716 . . . . 1.0 109.067 178.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.628 ' HA ' ' CE2' ' A' ' 135' ' ' PHE . 4.4 t-160 -58.66 -54.36 47.96 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.959 0.409 . . . . 1.0 110.674 -178.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.4 p -62.41 -32.71 73.58 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.049 -0.523 . . . . 1.0 111.789 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.62 ' CB ' ' H ' ' A' ' 131' ' ' ASP . 15.1 t70 -61.53 -47.09 87.17 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 114.78 -1.1 . . . . 1.0 111.355 -176.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.628 ' CE2' ' HA ' ' A' ' 132' ' ' HIS . 7.0 p90 -76.24 -37.74 57.27 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 119.734 -0.786 . . . . 1.0 112.243 -177.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.481 ' HG2' HG12 ' A' ' 61' ' ' VAL . 32.3 mt-10 -69.79 -24.59 63.51 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.504 -0.478 . . . . 1.0 110.014 177.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.561 ' O ' HG23 ' A' ' 141' ' ' VAL . 8.3 tt0 -64.44 -45.05 89.17 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.583 -0.735 . . . . 1.0 109.885 178.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 40.6 t -58.22 -43.34 85.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.405 0.621 . . . . 1.0 110.07 177.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -54.35 -45.65 72.77 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.43 -1.259 . . . . 1.0 110.344 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.613 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -62.3 -41.36 98.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.954 -0.567 . . . . 1.0 111.334 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 137' ' ' GLU . 20.7 t -56.9 -52.58 53.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-O 121.637 0.732 . . . . 1.0 110.855 178.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.468 ' CG2' ' HB2' ' A' ' 21' ' ' ALA . 6.3 mt -64.11 -49.67 80.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 114.928 -1.033 . . . . 1.0 111.956 -177.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.613 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 7.2 pt-20 -56.99 -30.45 64.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.887 0.375 . . . . 1.0 110.272 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 2.8 t -72.21 -31.28 65.72 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-O 121.233 0.54 . . . . 1.0 110.265 179.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.473 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -86.24 -23.07 26.55 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-N 115.699 -0.682 . . . . 1.0 111.796 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.617 HD22 ' HB3' ' A' ' 25' ' ' PHE . 10.6 mt -54.54 -40.94 86.77 Favored Pre-proline 0 C--N 1.329 -0.305 0 N-CA-C 112.795 0.665 . . . . 1.0 112.795 -178.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.725 ' HA ' ' CD2' ' A' ' 150' ' ' HIS . 69.7 Cg_endo -69.07 -7.27 20.39 Favored 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 122.279 1.986 . . . . 1.0 112.182 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.587 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -108.09 -32.5 3.25 Favored Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 109.903 -1.279 . . . . 1.0 109.903 177.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.556 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -76.49 -53.33 8.25 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.689 -0.756 . . . . 1.0 109.91 -179.334 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.725 ' CD2' ' HA ' ' A' ' 147' ' ' PRO . 3.7 p80 -56.28 -45.38 80.18 Favored 'General case' 0 C--O 1.216 -0.67 0 CA-C-O 121.469 0.652 . . . . 1.0 110.682 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.407 ' N ' ' CG ' ' A' ' 150' ' ' HIS . 25.9 t70 -57.31 -42.79 82.48 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 114.458 -1.246 . . . . 1.0 110.279 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . 0.756 ' HZ3' HD11 ' A' ' 5' ' ' LEU . 18.1 t90 -62.45 -55.47 27.34 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 114.993 -1.003 . . . . 1.0 110.072 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.535 HG11 HG21 ' A' ' 7' ' ' VAL . 4.0 m -61.95 -40.28 86.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.453 -0.34 . . . . 1.0 110.143 -179.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.503 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 67.1 m-20 -59.47 -54.89 41.43 Favored 'General case' 0 C--N 1.338 0.105 0 CA-C-O 121.405 0.621 . . . . 1.0 110.287 178.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.506 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 5.5 pt-20 -60.4 -35.76 76.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.278 -0.874 . . . . 1.0 110.571 -178.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.403 ' HG3' ' CH2' ' A' ' 152' ' ' TRP . 10.3 mmt180 -74.79 -43.69 53.42 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 115.831 -0.622 . . . . 1.0 111.187 -178.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 4.4 pp -67.7 -21.44 65.32 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.498 0.666 . . . . 1.0 109.73 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -76.3 -56.96 4.16 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.334 -0.848 . . . . 1.0 110.186 176.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.445 ' C ' ' H ' ' A' ' 161' ' ' GLY . 0.0 OUTLIER -80.3 1.14 29.86 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.498 0.925 . . . . 1.0 113.498 -175.036 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -76.05 31.48 0.12 Allowed 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.524 0.678 . . . . 1.0 111.448 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' A' ' 159' ' ' ARG . . . -84.74 174.69 50.14 Favored Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.588 -0.733 . . . . 1.0 111.527 179.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -84.1 27.48 0.61 Allowed 'Trans proline' 0 N--CA 1.473 0.286 0 C-N-CA 123.055 2.503 . . . . 1.0 112.991 -178.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 29.5 p . . . . . 0 C--N 1.306 -1.321 0 CA-C-N 114.54 -1.209 . . . . 1.0 110.111 179.868 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . 0.415 ' O ' ' HB2' ' A' ' 1' ' ' MET . . . . . . . . 0 N--CA 1.485 1.9 0 N-CA-C 112.024 -0.43 . . . . 1.0 112.024 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.415 ' HB2' ' O ' ' A' ' 0' ' ' GLY . 64.5 mtt 74.72 32.79 0.84 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 122.082 0.944 . . . . 1.0 108.55 -179.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.3 p -155.0 170.12 22.51 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 113.901 -1.499 . . . . 1.0 108.525 -178.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.623 ' HB3' ' HD2' ' A' ' 4' ' ' PRO . 0.6 OUTLIER -66.32 159.8 69.8 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.404 0.621 . . . . 1.0 111.801 -178.412 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.623 ' HD2' ' HB3' ' A' ' 3' ' ' ASP . 37.3 Cg_endo -69.89 177.28 5.83 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 124.19 3.26 . . . . 1.0 113.601 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.813 ' HB3' HG23 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -66.56 177.61 1.51 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.472 -0.786 . . . . 1.0 109.432 177.868 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.743 ' H ' HD13 ' A' ' 5' ' ' LEU . 1.7 t-160 -156.0 90.57 1.22 Allowed 'General case' 0 C--N 1.321 -0.631 0 O-C-N 122.161 -0.337 . . . . 1.0 110.695 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.859 HG13 HD13 ' A' ' 85' ' ' LEU . 2.1 t -96.29 102.88 14.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.031 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.633 ' CG2' HD23 ' A' ' 86' ' ' LEU . 9.6 t -105.8 114.71 29.02 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 121.029 0.442 . . . . 1.0 111.143 -178.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.545 ' HD1' ' HB ' ' A' ' 87' ' ' VAL . 1.1 m-85 -83.42 131.15 35.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.834 0.35 . . . . 1.0 110.361 -179.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.689 HG21 HD11 ' A' ' 97' ' ' LEU . 37.3 t -117.59 113.68 43.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.07 -0.514 . . . . 1.0 111.848 -176.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.537 ' HA ' ' CE1' ' A' ' 93' ' ' HIS . 41.8 t -142.7 163.06 33.84 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.048 -0.723 . . . . 1.0 109.048 177.064 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.79 90.89 4.07 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.357 0.599 . . . . 1.0 110.94 -178.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.833 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 136.65 -44.0 1.19 Allowed Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.453 -0.794 . . . . 1.0 111.442 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.678 ' ND2' ' H ' ' A' ' 74' ' ' ALA . 59.3 t30 61.57 22.88 13.27 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.843 0.83 . . . . 1.0 111.998 177.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.9 pt -127.41 4.44 3.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 O-C-N 121.63 -0.669 . . . . 1.0 110.956 179.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.756 ' O ' ' HG3' ' A' ' 20' ' ' MET . 5.3 p -121.6 -87.77 0.63 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.91 -0.587 . . . . 1.0 112.429 -177.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.782 HH11 HG21 ' A' ' 138' ' ' VAL . 8.5 mmt180 -71.63 -44.89 63.55 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.297 -0.41 . . . . 1.0 111.52 -174.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.451 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 19.2 m -55.72 -56.18 32.75 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-N 116.163 -0.471 . . . . 1.0 112.192 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.547 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 55.6 Cg_endo -67.01 -19.07 52.14 Favored 'Trans proline' 0 C--N 1.357 1.026 0 C-N-CA 121.633 1.555 . . . . 1.0 112.245 -178.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.756 ' HG3' ' O ' ' A' ' 16' ' ' CYS . 61.3 mtp -62.7 -55.0 30.75 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 120.336 -0.545 . . . . 1.0 109.907 176.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.424 ' HA ' ' HB2' ' A' ' 24' ' ' MET . . . -71.73 -27.9 63.31 Favored 'General case' 0 CA--C 1.512 -0.505 0 C-N-CA 120.37 -0.532 . . . . 1.0 110.617 -179.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.672 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 13.2 tt0 -51.15 -54.08 28.55 Favored 'General case' 0 C--O 1.217 -0.626 0 O-C-N 124.334 1.021 . . . . 1.0 109.73 179.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.925 ' HB3' ' HG2' ' A' ' 68' ' ' PRO . 0.4 OUTLIER -81.7 -27.16 34.09 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.239 -0.891 . . . . 1.0 110.311 -176.093 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.7 ' HB3' HD11 ' A' ' 146' ' ' LEU . 6.0 mmm -62.4 -76.76 0.06 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.811 0.671 . . . . 1.0 112.811 -176.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.701 ' HB3' HD22 ' A' ' 146' ' ' LEU . 18.2 p90 -78.2 -28.58 48.08 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 119.945 -0.702 . . . . 1.0 111.051 -174.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.672 ' HB3' ' O ' ' A' ' 22' ' ' GLU . . . -65.18 -38.02 89.18 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 119.208 -0.997 . . . . 1.0 110.922 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.699 ' HA ' ' HD3' ' A' ' 30' ' ' ARG . 0.1 OUTLIER -63.2 -37.7 88.27 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 108.709 -0.849 . . . . 1.0 108.709 177.485 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.593 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 74.9 mt-30 -60.33 -45.37 93.66 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.688 -0.687 . . . . 1.0 110.259 175.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.582 ' HG ' ' O ' ' A' ' 25' ' ' PHE . 84.9 mt -54.95 -58.47 7.5 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.887 -0.597 . . . . 1.0 111.09 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.699 ' HD3' ' HA ' ' A' ' 27' ' ' GLN . 0.7 OUTLIER -58.93 -38.1 78.21 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.35 -0.386 . . . . 1.0 111.228 179.597 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -62.7 -26.32 68.61 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.543 0.571 . . . . 1.0 112.543 177.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.593 ' HG2' ' O ' ' A' ' 28' ' ' GLN . 7.0 ptp180 -95.26 -18.96 20.4 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 119.406 -0.917 . . . . 1.0 109.917 178.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 107.44 34.95 2.76 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.345 -0.843 . . . . 1.0 112.305 177.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 21.1 mt -126.41 2.36 6.98 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.924 -0.399 . . . . 1.0 109.924 -178.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -53.54 -31.04 43.56 Favored Glycine 0 CA--C 1.521 0.468 0 CA-C-N 116.014 -0.539 . . . . 1.0 113.262 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.662 ' HA ' ' NH1' ' A' ' 39' ' ' ARG . 15.0 m-20 -92.04 -17.85 24.46 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 122.648 -0.325 . . . . 1.0 110.65 177.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.55 -22.73 43.46 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.163 -0.471 . . . . 1.0 111.139 -177.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.813 HG23 ' HB3' ' A' ' 5' ' ' LEU . 0.3 OUTLIER -144.32 123.92 7.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.186 0.517 . . . . 1.0 110.922 -179.749 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.682 ' O ' ' HA ' ' A' ' 6' ' ' HIS . 15.0 mmt180 -95.33 104.82 16.72 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 115.698 -0.683 . . . . 1.0 111.153 -177.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.652 HG11 ' HB2' ' A' ' 26' ' ' ALA . 1.5 m -87.99 137.1 21.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 108.231 -1.026 . . . . 1.0 108.231 176.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.502 ' O ' ' HA ' ' A' ' 8' ' ' THR . 21.5 p -146.76 -177.75 5.82 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.354 -0.839 . . . . 1.0 109.819 -175.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.475 ' OG ' ' HE1' ' A' ' 71' ' ' HIS . 67.1 p -157.14 156.73 33.21 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 120.388 -0.525 . . . . 1.0 111.035 -177.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.534 ' O ' ' HA ' ' A' ' 10' ' ' VAL . . . -161.65 160.68 29.02 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 121.225 0.536 . . . . 1.0 111.061 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.427 ' HA2' ' O ' ' A' ' 11' ' ' CYS . . . -123.08 133.77 9.19 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 111.351 -0.7 . . . . 1.0 111.351 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.479 HG21 HD12 ' A' ' 96' ' ' LEU . 21.1 p -69.17 -22.57 63.91 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 111.931 0.345 . . . . 1.0 111.931 -177.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -110.46 7.1 30.2 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.866 -0.683 . . . . 1.0 113.111 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 42.87 35.98 0.81 Allowed 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 113.87 1.063 . . . . 1.0 113.87 178.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.833 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 1.0 OUTLIER -44.95 -70.29 0.11 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.422 0.629 . . . . 1.0 112.487 -178.315 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.475 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 24.3 m-70 -110.58 44.08 1.31 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.317 -0.856 . . . . 1.0 111.244 179.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.469 HG23 ' HA ' ' A' ' 74' ' ' ALA . 12.0 p -61.56 129.17 24.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.772 -0.455 . . . . 1.0 109.772 177.055 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.597 ' HA2' ' HD3' ' A' ' 72' ' ' ARG . . . 92.58 -12.15 70.43 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.977 -0.63 . . . . 1.0 111.838 -177.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.495 ' O ' ' HA ' ' A' ' 72' ' ' ARG . 2.4 t -81.45 -158.56 0.22 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.357 0.598 . . . . 1.0 109.97 179.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 36.8 t -134.18 170.52 15.56 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 108.719 -0.845 . . . . 1.0 108.719 -178.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.54 140.77 27.39 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.193 0.52 . . . . 1.0 111.816 -178.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -59.35 137.37 58.01 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 114.432 -1.258 . . . . 1.0 110.43 -178.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -51.33 -29.15 14.27 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.315 -0.857 . . . . 1.0 113.109 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.598 ' HD3' ' CE1' ' A' ' 135' ' ' PHE . 30.9 mtt180 -69.63 -50.96 39.27 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.136 0.494 . . . . 1.0 110.267 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.407 ' O ' ' HG ' ' A' ' 62' ' ' LEU . . . -69.43 -29.32 67.0 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.18 -0.918 . . . . 1.0 110.533 -177.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.27 -44.63 96.92 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.86 -0.609 . . . . 1.0 109.514 176.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.19 -39.67 96.27 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.715 -0.755 . . . . 1.0 111.667 178.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.487 ' O ' ' HD2' ' A' ' 65' ' ' HIS . 78.7 t -60.81 -56.28 18.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 CA-C-O 121.188 0.518 . . . . 1.0 110.957 178.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.788 HD13 ' HG3' ' A' ' 23' ' ' LYS . 70.5 mt -61.04 -50.95 71.24 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.936 -0.574 . . . . 1.0 111.366 -178.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -60.07 -28.24 67.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.419 -0.355 . . . . 1.0 110.675 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.65 -35.67 79.31 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 120.977 0.417 . . . . 1.0 110.818 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.487 ' HD2' ' O ' ' A' ' 61' ' ' VAL . 88.8 m-70 -96.64 4.05 52.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.871 -0.604 . . . . 1.0 111.329 -177.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 90.21 14.99 58.16 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 121.086 -0.578 . . . . 1.0 112.632 177.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.508 ' HD1' ' HG2' ' A' ' 27' ' ' GLN . 69.7 m-85 -89.9 151.05 44.87 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-O 120.44 0.162 . . . . 1.0 110.985 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.925 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 55.3 Cg_endo -68.9 160.58 49.22 Favored 'Trans proline' 0 CA--C 1.511 -0.67 0 C-N-CA 122.571 2.18 . . . . 1.0 110.125 175.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.709 HG22 ' HB2' ' A' ' 62' ' ' LEU . 47.5 p -135.62 -0.43 2.63 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 119.589 -0.844 . . . . 1.0 112.161 -177.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.49 ' O ' ' HE2' ' A' ' 23' ' ' LYS . 48.4 t0 -71.94 134.84 46.22 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.293 -0.632 . . . . 1.0 109.293 -179.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.659 ' HB2' ' HE2' ' A' ' 23' ' ' LYS . 32.7 t60 -169.05 154.81 6.28 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.971 0.415 . . . . 1.0 110.379 -174.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.597 ' HD3' ' HA2' ' A' ' 51' ' ' GLY . 5.0 tmm_? -136.4 108.37 7.15 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 107.468 -1.308 . . . . 1.0 107.468 176.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 49' ' ' HIS . . . -58.67 139.99 55.27 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.823 -1.081 . . . . 1.0 112.048 -175.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.678 ' H ' ' ND2' ' A' ' 14' ' ' ASN . . . -130.01 161.54 30.73 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.645 -0.707 . . . . 1.0 109.93 177.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -96.77 159.9 14.67 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.205 -0.665 . . . . 1.0 109.205 179.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.424 HG11 HD23 ' A' ' 97' ' ' LEU . 61.7 t -70.18 110.2 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.158 0.504 . . . . 1.0 110.316 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.575 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -123.95 -170.58 13.34 Favored Glycine 0 N--CA 1.441 -1.006 0 CA-C-N 115.397 -0.819 . . . . 1.0 111.564 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 43.3 m -58.63 -51.71 68.75 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.873 0.368 . . . . 1.0 111.647 -178.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.522 ' HG2' ' N ' ' A' ' 80' ' ' HIS . 0.7 OUTLIER -54.46 -32.74 58.27 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.563 -0.744 . . . . 1.0 111.007 179.789 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.53 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 79.4 m80 -76.87 -40.61 47.0 Favored 'General case' 0 C--O 1.223 -0.321 0 N-CA-C 109.659 -0.497 . . . . 1.0 109.659 178.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.575 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 54.4 mt -65.75 -18.4 65.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.248 0.547 . . . . 1.0 110.539 178.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.39 -4.04 59.03 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.872 -0.604 . . . . 1.0 110.697 -178.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.569 ' HB1' ' O ' ' A' ' 6' ' ' HIS . . . -64.13 149.33 47.93 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.807 -0.633 . . . . 1.0 111.4 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.563 ' HB3' HD13 ' A' ' 5' ' ' LEU . 24.7 t70 -73.23 -14.4 61.33 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.07 0.462 . . . . 1.0 109.871 178.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.859 HD13 HG13 ' A' ' 7' ' ' VAL . 0.9 OUTLIER -154.08 120.94 5.59 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.597 -0.729 . . . . 1.0 110.504 -177.735 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 1.037 HD11 HG11 ' A' ' 102' ' ' VAL . 0.3 OUTLIER -105.99 104.33 14.02 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.747 -0.835 . . . . 1.0 108.747 175.158 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.571 HG23 HD22 ' A' ' 85' ' ' LEU . 54.5 t -83.73 92.18 2.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 121.493 0.663 . . . . 1.0 110.551 -178.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.21 146.78 30.3 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.195 -0.912 . . . . 1.0 111.231 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.672 ' O ' ' HB ' ' A' ' 124' ' ' VAL . 4.2 mm? -98.18 -13.68 20.76 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 115.689 -0.687 . . . . 1.0 109.741 178.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -139.44 153.55 47.59 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.496 -0.774 . . . . 1.0 109.961 -177.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.626 ' HB3' ' HB2' ' A' ' 123' ' ' ASP . 15.5 ptp180 -62.78 -20.38 64.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.36 0.6 . . . . 1.0 109.819 176.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.632 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 95.1 m-20 -76.49 -51.93 10.78 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.935 -1.029 . . . . 1.0 110.319 -178.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.537 ' CE1' ' HA ' ' A' ' 11' ' ' CYS . 19.0 m170 -58.3 -44.14 88.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.792 -0.64 . . . . 1.0 110.277 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.549 ' HA ' HD12 ' A' ' 97' ' ' LEU . . . -60.54 -42.77 97.19 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.026 0.441 . . . . 1.0 110.473 178.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 5.0 ttp-105 -58.59 -45.56 88.82 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 115.438 -0.801 . . . . 1.0 111.16 178.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.736 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 45.6 mt -63.69 -50.28 69.81 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.343 -176.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.689 HD11 HG21 ' A' ' 10' ' ' VAL . 14.0 mt -52.76 -58.52 6.61 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.936 -0.575 . . . . 1.0 111.835 -177.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 13.0 ptt180 -60.68 -44.8 96.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.281 -0.418 . . . . 1.0 111.922 -176.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.47 ' HG3' ' O ' ' A' ' 96' ' ' LEU . 1.2 pt20 -69.0 -20.18 64.15 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 121.01 0.433 . . . . 1.0 110.595 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.736 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 6.2 mt -79.22 -9.02 59.47 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.622 -0.717 . . . . 1.0 111.798 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 150.96 -32.89 0.96 Allowed Glycine 0 CA--C 1.505 -0.57 0 C-N-CA 119.842 -1.171 . . . . 1.0 113.352 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 1.037 HG11 HD11 ' A' ' 86' ' ' LEU . 0.8 OUTLIER -76.79 -151.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 121.716 0.769 . . . . 1.0 112.056 -176.697 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.639 ' H ' HG12 ' A' ' 102' ' ' VAL . 12.8 pt-20 -162.9 167.42 22.7 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.189 -0.914 . . . . 1.0 108.733 -178.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.763 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -67.23 -22.32 65.7 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.179 -0.464 . . . . 1.0 112.132 -174.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.24 -36.59 73.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.12 0.486 . . . . 1.0 110.687 176.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.591 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 1.0 OUTLIER -96.86 -40.36 8.96 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.207 -0.906 . . . . 1.0 110.805 -177.615 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.763 HG12 ' HA ' ' A' ' 104' ' ' ALA . 13.4 p -79.76 115.2 21.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.574 0.702 . . . . 1.0 110.352 -179.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.527 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 20.5 mmm180 -133.3 145.08 50.12 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.889 -0.596 . . . . 1.0 109.658 -177.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.509 ' HG3' ' HA ' ' A' ' 122' ' ' LEU . 84.6 mmm -77.52 137.52 38.67 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.947 -0.57 . . . . 1.0 110.543 -179.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.55 HD11 ' HA ' ' A' ' 142' ' ' ILE . 3.1 tm? -55.27 -49.81 71.11 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.802 0.334 . . . . 1.0 110.567 179.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.579 ' HB2' HG22 ' A' ' 124' ' ' VAL . 11.8 ttt-85 -72.94 -12.87 61.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.321 -0.4 . . . . 1.0 111.419 -176.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.518 ' HB2' ' O ' ' A' ' 121' ' ' ALA . 33.3 t -78.81 -8.97 59.28 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 121.15 -0.22 . . . . 1.0 110.855 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.627 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 82.6 m-85 -86.46 -18.27 32.11 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-O 120.975 0.417 . . . . 1.0 110.341 177.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -54.28 120.05 23.58 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.33 -0.85 . . . . 1.0 111.046 -179.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -67.1 -25.6 43.63 Favored 'Trans proline' 0 C--O 1.233 0.275 0 C-N-CA 122.736 2.291 . . . . 1.0 111.533 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 52.9 mtt180 -85.49 -1.22 56.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.393 -0.821 . . . . 1.0 111.181 -177.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 75.9 p -62.4 99.27 0.13 Allowed 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.174 0.511 . . . . 1.0 111.651 -178.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -66.19 -20.74 69.47 Favored Glycine 0 C--N 1.331 0.304 0 CA-C-N 115.658 -0.701 . . . . 1.0 112.09 177.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -131.94 164.03 27.04 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.975 -0.75 . . . . 1.0 108.975 178.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 36.6 m170 -70.83 138.39 50.26 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.961 0.41 . . . . 1.0 110.026 177.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.518 ' O ' ' HB2' ' A' ' 112' ' ' SER . . . -108.64 92.43 4.05 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.025 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.509 ' HA ' ' HG3' ' A' ' 109' ' ' MET . 2.2 mm? -96.49 9.02 42.67 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.21 -0.663 . . . . 1.0 109.21 179.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.626 ' HB2' ' HB3' ' A' ' 91' ' ' ARG . 34.8 t70 -168.35 144.86 3.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.662 -1.154 . . . . 1.0 108.05 -177.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.672 ' HB ' ' O ' ' A' ' 89' ' ' LEU . 92.9 t -102.56 148.43 7.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.051 0.453 . . . . 1.0 110.865 -176.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -66.44 -175.32 0.35 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.696 -0.684 . . . . 1.0 110.964 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -146.47 152.94 47.0 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 108.931 -0.766 . . . . 1.0 108.931 -175.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.4 ' HB3' ' OD1' ' A' ' 134' ' ' ASP . 19.0 Cg_endo -60.95 172.31 3.08 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.98 2.453 . . . . 1.0 113.684 -175.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -97.11 -39.94 9.06 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.404 -0.816 . . . . 1.0 111.178 -178.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.466 ' HD1' ' N ' ' A' ' 130' ' ' GLY . 0.1 OUTLIER -143.53 -24.24 0.59 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 113.731 1.012 . . . . 1.0 113.731 -178.334 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.466 ' N ' ' HD1' ' A' ' 129' ' ' TYR . . . 89.54 67.2 1.24 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 119.96 -1.114 . . . . 1.0 111.552 -177.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.666 ' H ' ' HB3' ' A' ' 134' ' ' ASP . 8.5 t70 -135.29 -167.37 1.99 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.89 -0.782 . . . . 1.0 108.89 -177.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -56.71 -41.2 77.0 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.7 0.286 . . . . 1.0 110.75 -178.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 8.0 m -61.86 -37.1 83.26 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.854 179.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.666 ' HB3' ' H ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -65.74 -38.61 89.59 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.991 -177.61 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.598 ' CE1' ' HD3' ' A' ' 57' ' ' ARG . 2.9 m-85 -69.71 -44.08 71.07 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.644 -0.502 . . . . 1.0 109.644 -176.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.437 ' HA ' ' HB3' ' A' ' 139' ' ' PHE . 36.7 mt-10 -74.25 -26.21 60.09 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.723 -0.671 . . . . 1.0 110.382 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.528 ' O ' HG23 ' A' ' 141' ' ' VAL . 32.7 tt0 -63.22 -50.22 71.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.029 -0.532 . . . . 1.0 109.878 178.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.782 HG21 HH11 ' A' ' 17' ' ' ARG . 53.4 t -62.74 -40.16 87.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.663 -0.699 . . . . 1.0 109.857 175.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.548 ' HB2' ' HE1' ' A' ' 20' ' ' MET . 18.3 t80 -54.5 -41.77 69.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.113 -0.949 . . . . 1.0 109.172 175.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.575 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -65.63 -42.37 91.6 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.604 -0.725 . . . . 1.0 110.544 176.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.661 HG23 ' HA ' ' A' ' 138' ' ' VAL . 13.8 t -54.15 -52.11 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-O 121.863 0.84 . . . . 1.0 109.715 177.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.55 ' HA ' HD11 ' A' ' 110' ' ' LEU . 7.2 mt -65.29 -51.32 66.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 114.597 -1.183 . . . . 1.0 112.084 -178.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.575 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 8.4 pt-20 -55.29 -34.37 64.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.825 0.345 . . . . 1.0 110.479 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 67.1 m -72.24 -28.96 63.48 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.738 -0.664 . . . . 1.0 110.743 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.458 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -88.48 -22.77 23.48 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.776 -0.647 . . . . 1.0 112.08 179.253 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.701 HD22 ' HB3' ' A' ' 25' ' ' PHE . 12.0 mt -55.65 -37.74 60.3 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 112.266 0.469 . . . . 1.0 112.266 -178.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.623 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 60.3 Cg_endo -70.53 -10.31 27.67 Favored 'Trans proline' 0 C--N 1.361 1.204 0 C-N-CA 122.493 2.129 . . . . 1.0 111.832 177.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.627 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -104.67 -32.41 4.18 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 110.572 -1.011 . . . . 1.0 110.572 178.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.459 ' O ' HG13 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -75.63 -41.89 53.03 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.687 -0.857 . . . . 1.0 108.687 179.474 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.432 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 0.5 OUTLIER -54.08 -56.85 14.18 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 114.791 -1.095 . . . . 1.0 110.736 176.787 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -58.55 -40.64 83.58 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.226 -0.897 . . . . 1.0 111.504 -175.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . 0.747 ' HZ3' HD11 ' A' ' 5' ' ' LEU . 31.0 t90 -63.22 -55.23 26.75 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.624 -0.716 . . . . 1.0 110.615 -179.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.474 HG11 HG21 ' A' ' 7' ' ' VAL . 7.2 m -61.65 -40.38 86.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 120.723 -0.391 . . . . 1.0 110.598 -178.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.435 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 13.3 m-20 -59.69 -52.0 67.4 Favored 'General case' 0 CA--C 1.523 -0.084 0 CA-C-O 120.994 0.426 . . . . 1.0 110.721 178.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.59 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 6.2 pt-20 -61.86 -38.84 89.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.586 -0.734 . . . . 1.0 110.296 -178.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.515 ' HG3' ' CH2' ' A' ' 152' ' ' TRP . 20.4 mmt180 -72.11 -46.62 55.97 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.805 -0.634 . . . . 1.0 111.057 -177.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 4.1 pp -65.56 -23.81 66.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.337 0.589 . . . . 1.0 109.591 -179.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -74.63 -55.05 6.31 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.274 -0.876 . . . . 1.0 110.162 177.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.519 ' HG3' ' O ' ' A' ' 155' ' ' GLU . 0.1 OUTLIER -80.9 3.05 24.07 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 112.653 0.612 . . . . 1.0 112.653 -177.3 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -45.02 -36.41 3.44 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 123.276 0.36 . . . . 1.0 111.56 178.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 78.57 164.0 24.92 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.92 -0.657 . . . . 1.0 114.089 176.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -99.14 20.91 0.3 Allowed 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 123.545 2.83 . . . . 1.0 112.48 178.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 45.9 t . . . . . 0 C--N 1.306 -1.284 0 CA-C-N 114.124 -1.398 . . . . 1.0 109.311 -178.713 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.72 0 N-CA-C 111.715 -0.554 . . . . 1.0 111.715 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.6 mtt -82.24 70.44 9.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.942 0.371 . . . . 1.0 110.844 -178.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.3 m -158.68 176.48 12.32 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.574 -0.528 . . . . 1.0 109.574 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.76 155.84 75.1 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.942 175.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.489 ' HB2' ' HG2' ' A' ' 39' ' ' ARG . 35.1 Cg_endo -64.24 161.94 32.05 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.387 2.725 . . . . 1.0 113.836 -175.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.77 ' HB3' HG23 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -66.17 178.42 1.16 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.75 -1.114 . . . . 1.0 109.319 177.547 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.704 ' H ' HD13 ' A' ' 5' ' ' LEU . 4.0 t-160 -156.8 98.23 1.76 Allowed 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.503 -0.555 . . . . 1.0 109.503 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.775 HG13 HD13 ' A' ' 85' ' ' LEU . 2.1 t -103.18 117.97 49.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 N-CA-C 107.722 -1.214 . . . . 1.0 107.722 177.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.592 HG22 ' HG ' ' A' ' 86' ' ' LEU . 8.3 t -118.54 114.38 22.73 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 120.931 0.396 . . . . 1.0 110.204 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.591 ' HD2' ' HB3' ' A' ' 42' ' ' SER . 2.2 m-85 -82.89 126.07 32.06 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.076 0.465 . . . . 1.0 110.215 -178.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.665 HG21 HD11 ' A' ' 97' ' ' LEU . 35.4 t -110.23 112.01 38.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 CA-C-N 115.74 -0.664 . . . . 1.0 111.631 -176.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.639 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 37.7 t -139.91 161.28 37.96 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.149 -1.056 . . . . 1.0 108.149 177.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -66.24 -39.89 89.86 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.217 0.532 . . . . 1.0 109.812 179.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.588 ' C ' ' H ' ' A' ' 15' ' ' ILE . . . -104.17 80.4 0.32 Allowed Glycine 0 N--CA 1.435 -1.432 0 CA-C-N 115.187 -0.915 . . . . 1.0 110.856 175.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.628 ' ND2' ' HB1' ' A' ' 73' ' ' ALA . 15.9 p-10 -59.5 17.72 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.74 1.616 . . . . 1.0 112.418 176.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.588 ' H ' ' C ' ' A' ' 13' ' ' GLY . 6.7 pt -121.59 -0.81 7.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.177 178.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 22.1 m -116.16 -87.09 0.61 Allowed 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.215 0.45 . . . . 1.0 112.215 -177.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.587 HH21 ' HB3' ' A' ' 89' ' ' LEU . 13.0 mtm-85 -72.38 -46.96 53.02 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 112.391 0.515 . . . . 1.0 112.391 -173.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.76 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 26.4 m -54.46 -58.72 12.71 Favored Pre-proline 0 CA--C 1.537 0.446 0 CA-C-N 116.306 -0.406 . . . . 1.0 111.333 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.451 ' HA ' ' HB2' ' A' ' 22' ' ' GLU . 39.3 Cg_endo -63.56 -22.9 70.66 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 121.763 1.642 . . . . 1.0 113.345 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.698 ' HB3' HD13 ' A' ' 142' ' ' ILE . 35.6 mmm -60.97 -53.62 55.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.635 0.255 . . . . 1.0 110.846 178.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.92 -25.63 60.09 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.168 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.632 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 17.9 tt0 -51.92 -54.09 33.47 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 114.761 -1.109 . . . . 1.0 109.819 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.647 ' O ' ' HB3' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -83.51 -26.99 29.7 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.378 -0.828 . . . . 1.0 110.838 -175.753 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.599 ' HB3' HD11 ' A' ' 146' ' ' LEU . 5.6 mmm -60.85 -75.61 0.06 Allowed 'General case' 0 C--O 1.239 0.542 0 CA-C-O 121.453 0.644 . . . . 1.0 112.504 -178.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.677 ' CE2' HD23 ' A' ' 149' ' ' LEU . 22.3 p90 -79.37 -28.83 41.94 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.088 -0.645 . . . . 1.0 111.674 -174.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.632 ' HB3' ' O ' ' A' ' 22' ' ' GLU . . . -64.8 -36.2 83.56 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 119.082 -1.047 . . . . 1.0 110.739 178.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.647 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -63.73 -38.56 91.55 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.666 -0.864 . . . . 1.0 108.666 176.595 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.673 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 78.7 mt-30 -59.24 -44.56 92.35 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 115.608 -0.724 . . . . 1.0 110.499 175.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 25' ' ' PHE . 90.0 mt -54.26 -59.62 4.43 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.887 -0.597 . . . . 1.0 111.239 -179.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.531 ' HD3' ' HA ' ' A' ' 27' ' ' GLN . 1.5 ptm180 -59.31 -34.55 72.45 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.714 -0.394 . . . . 1.0 111.155 178.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -62.27 -28.96 70.08 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.315 0.487 . . . . 1.0 112.315 177.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.673 ' HG2' ' O ' ' A' ' 28' ' ' GLN . 4.8 ptp180 -94.16 -16.0 24.12 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 119.915 -0.714 . . . . 1.0 110.429 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 102.72 38.75 2.89 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.403 -0.817 . . . . 1.0 111.48 177.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 27.3 mt -132.72 1.51 3.66 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 110.088 -0.338 . . . . 1.0 110.088 -178.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.462 ' H ' ' HA ' ' A' ' 30' ' ' ARG . . . -57.6 -27.29 58.48 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 121.05 -0.595 . . . . 1.0 112.343 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -82.55 -31.27 29.17 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.964 0.411 . . . . 1.0 109.928 177.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -78.94 -16.86 56.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.201 -0.909 . . . . 1.0 112.318 -174.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.77 HG23 ' HB3' ' A' ' 5' ' ' LEU . 0.3 OUTLIER -143.86 126.59 11.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 121.877 -0.515 . . . . 1.0 111.241 -179.998 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.489 ' HG2' ' HB2' ' A' ' 4' ' ' PRO . 7.7 mmt180 -90.46 132.62 35.55 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 108.636 -0.875 . . . . 1.0 108.636 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 68.3 t -124.9 119.41 55.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.264 -0.643 . . . . 1.0 109.264 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.436 ' O ' ' HA ' ' A' ' 8' ' ' THR . 78.0 p -132.49 -175.16 3.66 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.47 -1.241 . . . . 1.0 110.979 -174.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.76 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 87.8 p -158.58 163.39 37.04 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.682 -0.488 . . . . 1.0 109.682 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.54 ' HB2' ' CD2' ' A' ' 80' ' ' HIS . . . -164.93 168.78 17.23 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 121.219 0.533 . . . . 1.0 111.571 -178.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.639 ' HA2' ' O ' ' A' ' 11' ' ' CYS . . . -127.53 132.56 7.55 Favored Glycine 0 N--CA 1.438 -1.174 0 CA-C-N 115.078 -0.965 . . . . 1.0 111.462 178.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.499 HG23 ' CG1' ' A' ' 10' ' ' VAL . 26.9 p -69.47 -23.41 63.64 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.887 0.375 . . . . 1.0 111.325 -178.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.429 ' HA3' ' HZ3' ' A' ' 48' ' ' TRP . . . -112.92 9.1 25.41 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.858 -0.686 . . . . 1.0 112.304 -178.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.494 ' HB3' ' HB2' ' A' ' 75' ' ' GLN . 2.7 p-10 43.64 39.11 2.23 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.991 0.916 . . . . 1.0 113.41 177.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.429 ' HZ3' ' HA3' ' A' ' 46' ' ' GLY . 1.2 m-90 -42.8 -72.54 0.06 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.294 0.568 . . . . 1.0 112.386 -178.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.418 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 75.9 m-70 -112.23 45.72 1.25 Allowed 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.283 -0.872 . . . . 1.0 111.243 178.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.446 HG23 ' HA ' ' A' ' 74' ' ' ALA . 11.6 p -61.78 129.93 25.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.622 -0.717 . . . . 1.0 110.135 177.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.607 ' HA2' ' HD3' ' A' ' 72' ' ' ARG . . . 93.66 -15.31 63.34 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.889 -0.672 . . . . 1.0 112.081 -177.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.4 t -80.06 -161.16 0.33 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.379 0.609 . . . . 1.0 109.914 179.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 35.5 t -127.98 170.62 12.66 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 115.288 -0.869 . . . . 1.0 108.932 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -52.06 136.13 29.99 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 123.338 0.398 . . . . 1.0 111.414 -178.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.698 ' OD1' ' HG2' ' A' ' 57' ' ' ARG . 12.5 t70 -57.17 140.27 50.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.389 -0.823 . . . . 1.0 111.309 -178.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -45.78 -37.93 6.57 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.99 -1.004 . . . . 1.0 113.519 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.698 ' HG2' ' OD1' ' A' ' 55' ' ' ASP . 15.3 ptp180 -70.12 -44.52 68.77 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 120.522 -0.471 . . . . 1.0 110.914 -177.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.24 -30.91 66.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.035 0.445 . . . . 1.0 110.384 -178.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.02 -45.82 90.54 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.082 177.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.2 -36.87 94.01 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.937 -0.649 . . . . 1.0 111.773 177.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 57' ' ' ARG . 86.9 t -62.06 -59.04 4.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.23 0.538 . . . . 1.0 110.851 178.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.682 ' HB2' HG22 ' A' ' 69' ' ' THR . 96.8 mt -60.16 -50.12 74.95 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.836 -0.62 . . . . 1.0 111.363 -177.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 -59.25 -30.62 68.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.47 -0.332 . . . . 1.0 111.061 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.28 -33.24 73.99 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 121.124 0.488 . . . . 1.0 111.136 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -97.59 5.34 49.61 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.859 -0.61 . . . . 1.0 111.437 -178.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.48 13.44 63.32 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.899 -0.667 . . . . 1.0 112.837 177.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -91.13 148.95 39.01 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-O 120.561 0.22 . . . . 1.0 110.944 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.614 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 48.9 Cg_endo -69.95 158.13 57.73 Favored 'Trans proline' 0 CA--C 1.513 -0.563 0 C-N-CA 122.243 1.962 . . . . 1.0 110.841 176.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.682 HG22 ' HB2' ' A' ' 62' ' ' LEU . 53.1 p -131.3 9.09 4.73 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.341 -0.543 . . . . 1.0 110.803 -178.059 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -73.6 123.77 24.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.463 -0.79 . . . . 1.0 109.536 -178.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.48 ' HB2' ' HE2' ' A' ' 23' ' ' LYS . 31.2 t60 -166.07 154.58 11.01 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.973 -175.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.607 ' HD3' ' HA2' ' A' ' 51' ' ' GLY . 2.3 tmm_? -135.8 110.1 8.42 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.048 -1.093 . . . . 1.0 108.048 175.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.628 ' HB1' ' ND2' ' A' ' 14' ' ' ASN . . . -55.7 136.68 50.59 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.621 -1.172 . . . . 1.0 112.527 -175.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.464 ' O ' ' HA ' ' A' ' 43' ' ' ALA . . . -129.45 160.4 33.26 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.822 -0.172 . . . . 1.0 110.743 178.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.494 ' HB2' ' HB3' ' A' ' 47' ' ' ASN . 9.3 tt0 -97.04 153.39 17.95 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.531 -0.914 . . . . 1.0 108.531 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.504 HG11 ' CD2' ' A' ' 97' ' ' LEU . 20.2 t -65.41 109.92 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.424 0.631 . . . . 1.0 110.748 179.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -120.92 -169.67 13.87 Favored Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 115.396 -0.82 . . . . 1.0 111.103 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 53.9 m -58.8 -42.89 90.18 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.52 0.2 . . . . 1.0 110.692 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -57.78 -31.96 67.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.944 0.402 . . . . 1.0 111.303 177.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.54 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 79.3 m80 -79.22 -41.27 28.66 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-N 116.522 -0.308 . . . . 1.0 110.943 -179.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.688 ' HA ' HD21 ' A' ' 86' ' ' LEU . 16.8 mt -67.95 -19.04 64.93 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.914 0.387 . . . . 1.0 110.127 177.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.13 -5.16 59.26 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.849 0.357 . . . . 1.0 110.388 -178.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.497 ' HA ' ' HB3' ' A' ' 6' ' ' HIS . . . -58.2 153.72 14.53 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.822 -0.626 . . . . 1.0 110.782 178.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.757 ' HB3' HD13 ' A' ' 5' ' ' LEU . 12.1 t70 -79.96 -14.57 58.5 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.902 -0.59 . . . . 1.0 109.546 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.775 HD13 HG13 ' A' ' 7' ' ' VAL . 0.4 OUTLIER -155.69 118.31 4.2 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.342 -0.845 . . . . 1.0 108.842 -178.11 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.688 HD21 ' HA ' ' A' ' 81' ' ' LEU . 5.2 mp -107.93 105.55 15.4 Favored 'General case' 0 N--CA 1.425 -1.683 0 CA-C-O 121.305 0.574 . . . . 1.0 109.806 178.273 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.593 ' HA ' ' O ' ' A' ' 108' ' ' ARG . 55.8 t -84.9 92.59 3.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 114.652 -1.158 . . . . 1.0 111.453 -175.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.79 146.56 33.71 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.566 -0.743 . . . . 1.0 110.758 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.597 ' O ' ' HB ' ' A' ' 124' ' ' VAL . 3.9 mm? -100.83 -7.57 23.47 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.459 179.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.426 ' CG ' ' H ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -153.97 156.38 37.35 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.994 -0.548 . . . . 1.0 111.282 178.594 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 6.0 ptm85 -55.72 -24.65 35.98 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.479 0.918 . . . . 1.0 113.479 -178.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.655 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 87.8 m-20 -76.79 -51.49 11.27 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 110.186 -0.301 . . . . 1.0 110.186 -178.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.668 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 13.5 m170 -55.27 -46.33 76.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.011 -0.541 . . . . 1.0 110.527 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.85 -43.12 94.83 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.069 0.462 . . . . 1.0 110.713 179.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.682 ' O ' ' HG2' ' A' ' 99' ' ' GLN . 5.9 ttm180 -58.44 -46.49 86.43 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 115.482 -0.781 . . . . 1.0 111.005 177.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.744 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 46.6 mt -62.51 -51.14 68.59 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-N 115.921 -0.581 . . . . 1.0 110.412 -175.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.668 ' HG ' ' O ' ' A' ' 93' ' ' HIS . 40.8 mt -51.22 -58.34 6.42 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.954 -0.566 . . . . 1.0 111.684 -177.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.663 ' CA ' HG12 ' A' ' 102' ' ' VAL . 13.3 ptt180 -58.91 -46.99 86.59 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.015 -0.539 . . . . 1.0 112.258 -179.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.682 ' HG2' ' O ' ' A' ' 95' ' ' ARG . 12.8 pt20 -69.24 -19.39 63.94 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.649 -0.421 . . . . 1.0 110.665 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.744 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 10.8 mt -81.43 -18.96 43.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.969 -0.56 . . . . 1.0 110.963 177.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 153.35 -25.15 0.77 Allowed Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 119.706 -1.235 . . . . 1.0 113.655 -178.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.7 HG13 ' N ' ' A' ' 103' ' ' GLU . 0.4 OUTLIER -76.49 -161.6 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 CA-C-N 117.493 0.646 . . . . 1.0 110.555 -178.44 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.761 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 15.5 pt-20 -159.25 161.89 36.08 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.604 -1.258 . . . . 1.0 107.604 -178.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.772 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -62.84 -24.51 67.82 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.725 0.298 . . . . 1.0 111.406 -175.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.434 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . . . -58.63 -36.05 73.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.01 -0.541 . . . . 1.0 110.171 174.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.761 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 1.6 mtt-85 -98.95 -41.37 7.62 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 115.604 -0.726 . . . . 1.0 111.366 -177.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.772 HG12 ' HA ' ' A' ' 104' ' ' ALA . 10.5 p -80.21 120.25 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-O 120.905 0.383 . . . . 1.0 110.015 -175.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.593 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 31.5 mmm180 -138.86 149.18 44.59 Favored 'General case' 0 C--N 1.318 -0.761 0 O-C-N 121.864 -0.522 . . . . 1.0 110.361 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.596 ' HB2' ' HB2' ' A' ' 112' ' ' SER . 83.3 mmm -78.73 136.21 37.35 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.848 -0.614 . . . . 1.0 110.41 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.524 HD23 HG11 ' A' ' 87' ' ' VAL . 2.8 tm? -53.57 -53.8 46.51 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.494 0.188 . . . . 1.0 110.853 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.524 ' O ' ' HB3' ' A' ' 114' ' ' ASP . 5.8 ttt85 -73.88 -9.92 59.14 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.082 -0.647 . . . . 1.0 111.323 -176.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.596 ' HB2' ' HB2' ' A' ' 109' ' ' MET . 41.5 t -75.5 -6.01 48.05 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.775 -0.454 . . . . 1.0 109.775 178.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.575 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 96.9 m-85 -94.74 -12.7 26.68 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.526 0.679 . . . . 1.0 109.402 175.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.524 ' HB3' ' O ' ' A' ' 111' ' ' ARG . 6.0 t0 -72.36 131.66 84.69 Favored Pre-proline 0 N--CA 1.466 0.368 0 CA-C-N 114.97 -1.014 . . . . 1.0 111.533 -177.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.452 ' HD2' ' O ' ' A' ' 144' ' ' SER . 58.8 Cg_endo -70.38 -15.24 34.74 Favored 'Trans proline' 0 CA--C 1.532 0.415 0 C-N-CA 122.862 2.375 . . . . 1.0 112.095 177.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -90.47 -8.66 49.88 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.195 -0.457 . . . . 1.0 111.109 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.402 ' HB2' ' HB2' ' A' ' 121' ' ' ALA . 96.5 p -73.46 31.75 0.07 Allowed 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.058 0.392 . . . . 1.0 112.058 -177.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 61.47 -75.03 0.02 OUTLIER Glycine 0 CA--C 1.522 0.501 0 C-N-CA 119.938 -1.125 . . . . 1.0 112.742 -173.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.412 ' H ' ' H ' ' A' ' 120' ' ' HIS . 30.6 m -158.0 -28.26 0.08 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.367 0.603 . . . . 1.0 109.632 -179.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.412 ' H ' ' H ' ' A' ' 119' ' ' THR . 0.3 OUTLIER -154.37 141.67 19.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.538 -0.756 . . . . 1.0 110.879 -178.262 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.402 ' HB2' ' HB2' ' A' ' 117' ' ' SER . . . -129.13 99.87 5.41 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.749 -0.66 . . . . 1.0 110.08 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -96.8 16.22 19.8 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.893 0.377 . . . . 1.0 110.831 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -169.33 124.09 0.83 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.042 -0.527 . . . . 1.0 109.738 -178.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.597 ' HB ' ' O ' ' A' ' 89' ' ' LEU . 94.1 t -101.55 146.11 10.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.777 -0.647 . . . . 1.0 109.953 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -68.44 -163.11 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.562 0.696 . . . . 1.0 112.34 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.766 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 8.6 p-10 -162.59 171.72 6.18 Favored Pre-proline 0 C--N 1.323 -0.572 0 N-CA-C 108.219 -1.03 . . . . 1.0 108.219 -178.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.766 ' HD2' ' HB2' ' A' ' 126' ' ' ASP . 18.6 Cg_endo -55.62 145.47 70.03 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 121.952 1.768 . . . . 1.0 112.087 -178.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.413 ' HD2' ' CD2' ' A' ' 129' ' ' TYR . 74.3 t80 -107.74 -49.46 3.23 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.138 -0.937 . . . . 1.0 111.601 -176.054 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.413 ' CD2' ' HD2' ' A' ' 128' ' ' TYR . 0.1 OUTLIER -104.05 -67.43 0.9 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.205 0.526 . . . . 1.0 111.137 -178.208 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 128.38 57.35 0.11 Allowed Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 109.302 -1.519 . . . . 1.0 109.302 -176.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -141.71 176.17 9.12 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.243 -0.479 . . . . 1.0 110.837 -174.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.51 ' HA ' ' CD2' ' A' ' 135' ' ' PHE . 22.4 t-160 -52.66 -33.46 47.24 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.415 -0.811 . . . . 1.0 110.554 176.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 42.8 t -65.21 -42.38 93.57 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.89 -0.595 . . . . 1.0 111.184 178.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.29 -34.57 78.65 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.845 -0.162 . . . . 1.0 111.143 -176.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.51 ' CD2' ' HA ' ' A' ' 132' ' ' HIS . 2.9 m-85 -68.44 -50.76 50.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.379 0.609 . . . . 1.0 110.027 -179.153 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.517 ' HA ' ' HB3' ' A' ' 139' ' ' PHE . 16.2 mt-10 -75.74 -17.95 59.73 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.368 -0.833 . . . . 1.0 111.496 -176.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.574 ' O ' HG23 ' A' ' 141' ' ' VAL . 23.4 tp10 -64.42 -47.21 80.0 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 108.54 -0.911 . . . . 1.0 108.54 174.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.642 ' HA ' HG23 ' A' ' 141' ' ' VAL . 95.3 t -61.85 -40.5 87.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.9 -0.591 . . . . 1.0 109.746 176.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.546 ' HB2' HG11 ' A' ' 61' ' ' VAL . 13.5 t80 -52.75 -47.2 67.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.03 -0.986 . . . . 1.0 109.244 174.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.518 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -59.79 -43.06 94.62 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 115.351 -0.841 . . . . 1.0 110.228 177.279 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.642 HG23 ' HA ' ' A' ' 138' ' ' VAL . 8.2 t -54.54 -51.35 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 121.581 0.705 . . . . 1.0 110.505 177.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.698 HD13 ' HB3' ' A' ' 20' ' ' MET . 6.1 mt -66.16 -50.48 68.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 114.99 -1.005 . . . . 1.0 112.07 -178.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.518 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 8.8 pt-20 -56.06 -33.74 65.27 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.926 -0.398 . . . . 1.0 109.926 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.452 ' O ' ' HD2' ' A' ' 115' ' ' PRO . 70.7 m -72.48 -28.65 63.04 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.758 -0.655 . . . . 1.0 110.514 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.419 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -87.27 -22.37 25.22 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.172 -0.467 . . . . 1.0 111.85 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.646 HD13 ' HB3' ' A' ' 25' ' ' PHE . 12.8 mt -57.44 -37.47 57.24 Favored Pre-proline 0 CA--C 1.546 0.82 0 N-CA-C 112.656 0.613 . . . . 1.0 112.656 -178.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.64 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 48.0 Cg_endo -68.27 -12.07 33.88 Favored 'Trans proline' 0 C--N 1.365 1.44 0 C-N-CA 122.79 2.326 . . . . 1.0 111.665 177.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.575 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -103.88 -34.93 3.61 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 114.903 -1.044 . . . . 1.0 110.927 178.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.677 HD23 ' CE2' ' A' ' 25' ' ' PHE . 13.4 tp -75.77 -41.0 54.29 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.872 -0.788 . . . . 1.0 108.872 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.571 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 0.2 OUTLIER -53.92 -53.37 53.66 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 115.233 -0.894 . . . . 1.0 110.001 174.845 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -57.68 -43.76 85.32 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.871 -1.059 . . . . 1.0 110.679 -176.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . 0.745 ' HZ3' HD11 ' A' ' 5' ' ' LEU . 20.6 t90 -62.26 -55.78 25.0 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.395 -0.821 . . . . 1.0 110.486 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.452 HG11 HG21 ' A' ' 7' ' ' VAL . 12.6 m -62.02 -43.94 98.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 C-N-CA 120.72 -0.392 . . . . 1.0 111.091 -177.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.421 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 2.9 m-20 -59.81 -49.95 75.72 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 121.149 0.499 . . . . 1.0 110.76 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.623 ' O ' ' HG2' ' A' ' 159' ' ' ARG . 7.0 pt-20 -62.81 -39.23 93.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.626 -0.715 . . . . 1.0 110.554 -178.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.571 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 6.3 mmt85 -73.13 -47.35 44.87 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.871 -0.604 . . . . 1.0 111.13 -175.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 4.2 pp -62.2 -25.69 67.94 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.7 -0.682 . . . . 1.0 109.985 -178.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -73.81 -57.03 4.26 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.38 -0.827 . . . . 1.0 110.349 178.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.623 ' HG2' ' O ' ' A' ' 155' ' ' GLU . 3.6 ptp85 -76.08 -12.32 60.1 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.701 1.0 . . . . 1.0 113.701 -174.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -55.83 -41.6 74.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.955 0.407 . . . . 1.0 110.888 -176.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -103.81 -161.22 24.81 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.51 -0.853 . . . . 1.0 112.583 178.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -78.61 37.62 0.66 Allowed 'Trans proline' 0 N--CA 1.477 0.527 0 C-N-CA 123.691 2.927 . . . . 1.0 113.33 -178.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 15.1 t . . . . . 0 C--N 1.301 -1.53 0 CA-C-N 115.145 -0.934 . . . . 1.0 109.886 178.932 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.894 0 CA-C-O 119.81 -0.439 . . . . 1.0 112.427 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.2 ptp 45.52 41.58 6.98 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.773 0.829 . . . . 1.0 111.472 -178.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.8 m -164.64 111.01 1.01 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.304 -0.999 . . . . 1.0 108.304 -178.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.76 143.43 96.62 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-O 121.749 0.785 . . . . 1.0 111.997 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.569 ' HB2' ' HG2' ' A' ' 39' ' ' ARG . 26.0 Cg_endo -71.03 163.87 37.72 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 123.308 2.672 . . . . 1.0 113.58 -179.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.813 ' HB3' HG13 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -68.06 179.4 1.53 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.845 -1.07 . . . . 1.0 109.422 176.087 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.597 ' O ' ' HB1' ' A' ' 83' ' ' ALA . 2.3 t-160 -156.07 87.73 1.07 Allowed 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.878 -0.416 . . . . 1.0 109.878 -179.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.818 HG13 HD13 ' A' ' 85' ' ' LEU . 2.2 t -93.12 108.99 21.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 109.4 -0.593 . . . . 1.0 109.4 178.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.679 ' CG2' HD23 ' A' ' 86' ' ' LEU . 10.0 t -110.76 111.44 22.62 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.949 0.404 . . . . 1.0 110.635 179.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.615 ' HD1' ' HB ' ' A' ' 87' ' ' VAL . 1.3 m-85 -82.22 136.71 35.05 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.705 -0.479 . . . . 1.0 109.705 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.674 HG21 HD21 ' A' ' 97' ' ' LEU . 47.8 t -124.57 115.29 44.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.018 0.437 . . . . 1.0 111.461 -177.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.554 ' HB2' HD23 ' A' ' 89' ' ' LEU . 44.7 t -146.52 153.14 40.05 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.957 -0.565 . . . . 1.0 110.091 178.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -71.31 98.45 1.76 Allowed 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.902 -0.407 . . . . 1.0 109.902 178.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 142.68 -40.59 1.25 Allowed Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 110.623 -0.991 . . . . 1.0 110.623 -178.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 1.026 HD22 ' HB1' ' A' ' 73' ' ' ALA . 1.1 p-10 49.37 23.45 0.86 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.601 1.16 . . . . 1.0 113.228 177.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.7 pt -140.83 9.44 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.288 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.478 177.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.482 ' O ' ' HG2' ' A' ' 20' ' ' MET . 5.1 p -122.41 -87.57 0.63 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.719 -0.673 . . . . 1.0 111.782 -176.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.434 HH11 ' HD3' ' A' ' 17' ' ' ARG . 7.3 mmm-85 -67.2 -48.69 67.16 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 121.124 0.488 . . . . 1.0 111.25 -175.32 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.905 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 13.1 m -52.48 -58.28 12.36 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-N 115.063 -0.971 . . . . 1.0 112.396 -179.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.638 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 56.8 Cg_endo -67.06 -23.43 46.29 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 121.842 1.694 . . . . 1.0 112.914 -178.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.581 ' HB3' HD13 ' A' ' 142' ' ' ILE . 51.8 mmm -59.65 -57.11 14.36 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.906 -0.405 . . . . 1.0 109.906 178.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.438 ' HB2' ' CG2' ' A' ' 142' ' ' ILE . . . -73.5 -27.15 61.22 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.57 -0.741 . . . . 1.0 110.645 -179.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.65 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 13.0 tt0 -52.82 -52.84 55.4 Favored 'General case' 0 C--O 1.215 -0.737 0 O-C-N 123.907 0.755 . . . . 1.0 109.946 -179.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.997 ' HE3' ' HB2' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -85.09 -25.81 27.33 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.837 -0.619 . . . . 1.0 110.777 -176.462 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.532 ' HB3' HD11 ' A' ' 146' ' ' LEU . 88.1 mtp -63.33 -74.59 0.09 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.564 0.579 . . . . 1.0 112.564 -177.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.732 ' HB3' HD22 ' A' ' 146' ' ' LEU . 17.2 p90 -76.81 -30.7 56.51 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 119.64 -0.824 . . . . 1.0 111.711 -176.003 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.65 ' HB3' ' O ' ' A' ' 22' ' ' GLU . . . -64.61 -37.51 87.82 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 119.284 -0.966 . . . . 1.0 111.172 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.611 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -63.32 -39.09 93.6 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 108.367 -0.975 . . . . 1.0 108.367 176.461 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.567 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 79.7 mt-30 -59.61 -42.49 92.74 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.562 -0.745 . . . . 1.0 110.172 175.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.646 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 88.8 mt -56.34 -61.13 2.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.947 -0.569 . . . . 1.0 110.719 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.501 ' HB3' ' HA3' ' A' ' 35' ' ' GLY . 0.2 OUTLIER -58.92 -35.78 73.66 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.778 -0.369 . . . . 1.0 111.382 178.642 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 3.1 m170 -63.23 -24.89 68.07 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.26 0.467 . . . . 1.0 112.26 177.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.646 ' HG2' ' O ' ' A' ' 29' ' ' LEU . 5.9 ptm85 -100.05 -20.18 16.16 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.442 0.639 . . . . 1.0 110.299 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 110.98 35.02 2.06 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.196 -0.911 . . . . 1.0 112.277 177.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.472 ' HG ' ' HG3' ' A' ' 32' ' ' ARG . 21.6 mt -128.33 3.89 5.72 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.877 -0.416 . . . . 1.0 109.877 -179.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.501 ' HA3' ' HB3' ' A' ' 30' ' ' ARG . . . -59.17 -31.44 69.2 Favored Glycine 0 C--O 1.229 -0.217 0 CA-C-N 115.777 -0.647 . . . . 1.0 113.383 -178.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.441 ' O ' ' HB3' ' A' ' 4' ' ' PRO . 3.3 t0 -86.98 -26.05 24.0 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 109.072 -0.714 . . . . 1.0 109.072 177.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.11 -20.82 47.72 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 114.558 -1.201 . . . . 1.0 110.795 -175.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.813 HG13 ' HB3' ' A' ' 5' ' ' LEU . 37.9 t -133.1 122.68 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 CA-C-N 116.393 -0.367 . . . . 1.0 110.207 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.569 ' HG2' ' HB2' ' A' ' 4' ' ' PRO . 11.9 mmt180 -89.78 133.32 34.76 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.04 -1.096 . . . . 1.0 108.04 175.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.458 HG11 ' HB2' ' A' ' 26' ' ' ALA . 45.5 t -127.53 115.58 40.5 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-O 121.375 0.607 . . . . 1.0 109.985 -178.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' A' ' 8' ' ' THR . 67.3 p -130.53 -175.51 3.67 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.461 -1.245 . . . . 1.0 110.427 -175.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.905 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 85.4 p -159.86 165.08 32.98 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 110.004 -0.369 . . . . 1.0 110.004 178.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.545 ' O ' ' HA ' ' A' ' 10' ' ' VAL . . . -164.57 166.85 19.92 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 120.944 0.402 . . . . 1.0 110.775 -179.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.443 ' HA3' ' OD1' ' A' ' 14' ' ' ASN . . . -125.96 138.96 11.12 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 111.257 -0.737 . . . . 1.0 111.257 177.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.526 HG21 HD12 ' A' ' 96' ' ' LEU . 21.4 p -72.86 -25.21 61.02 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.722 0.296 . . . . 1.0 111.339 -178.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.465 ' HA3' ' HZ3' ' A' ' 48' ' ' TRP . . . -107.85 9.49 37.28 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.97 -0.633 . . . . 1.0 113.34 -177.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 45.43 36.25 2.32 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 113.719 1.007 . . . . 1.0 113.719 176.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.465 ' HZ3' ' HA3' ' A' ' 46' ' ' GLY . 1.2 m-90 -44.53 -78.82 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.592 0.711 . . . . 1.0 112.376 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.407 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 8.2 m-70 -104.87 41.1 1.38 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.06 -0.973 . . . . 1.0 111.325 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.421 HG23 ' HA ' ' A' ' 74' ' ' ALA . 14.0 p -59.77 128.05 20.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.538 -0.301 . . . . 1.0 110.473 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.73 -13.5 67.35 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 121.071 -0.585 . . . . 1.0 112.202 -178.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.8 t -80.77 -161.79 0.42 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.321 0.582 . . . . 1.0 110.015 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 20.2 t -122.87 176.29 6.08 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.103 -1.073 . . . . 1.0 108.103 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.28 140.54 55.91 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.752 0.31 . . . . 1.0 110.56 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.41 ' OD1' ' HG2' ' A' ' 57' ' ' ARG . 9.8 t70 -59.12 140.2 56.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.86 -0.609 . . . . 1.0 111.079 -176.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -47.56 -37.1 11.61 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.485 -0.779 . . . . 1.0 112.873 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.41 ' HG2' ' OD1' ' A' ' 55' ' ' ASP . 11.5 ptp180 -73.83 -39.52 63.98 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 122.06 -0.4 . . . . 1.0 111.159 -177.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.92 -37.35 72.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.196 0.522 . . . . 1.0 110.06 178.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.41 -41.47 98.73 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.684 -0.689 . . . . 1.0 109.617 177.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.92 -48.09 81.64 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 115.687 -0.688 . . . . 1.0 112.679 178.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 23.6 m -72.17 -37.28 59.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 117.469 0.635 . . . . 1.0 111.614 -178.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.495 ' CD2' ' HG3' ' A' ' 23' ' ' LYS . 1.3 mp -62.05 -54.87 35.38 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.877 -0.329 . . . . 1.0 110.185 178.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -60.31 -32.79 71.55 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.862 -0.608 . . . . 1.0 110.911 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.47 -32.25 72.96 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-O 121.144 0.497 . . . . 1.0 111.192 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -98.11 5.85 48.18 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.961 -0.563 . . . . 1.0 111.515 -178.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 90.71 11.98 61.34 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 115.977 -0.556 . . . . 1.0 113.429 175.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.444 ' HD1' ' HG2' ' A' ' 27' ' ' GLN . 54.7 m-85 -92.67 151.01 40.66 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-O 120.624 0.25 . . . . 1.0 111.157 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.661 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 44.6 Cg_endo -70.22 158.93 54.82 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.19 1.926 . . . . 1.0 110.528 175.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 30.6 p -129.98 8.46 5.22 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.728 0.775 . . . . 1.0 109.823 -177.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -73.0 120.2 18.31 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.661 -1.154 . . . . 1.0 110.076 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.997 ' HB2' ' HE3' ' A' ' 23' ' ' LYS . 31.9 t60 -164.81 150.95 10.31 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.433 -0.349 . . . . 1.0 110.596 -175.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -132.29 111.26 11.22 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 108.489 -0.93 . . . . 1.0 108.489 175.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 1.026 ' HB1' HD22 ' A' ' 14' ' ' ASN . . . -59.47 141.53 54.5 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.211 -0.904 . . . . 1.0 112.606 -175.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.421 ' HA ' HG23 ' A' ' 50' ' ' VAL . . . -134.52 165.73 24.53 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.8 -0.637 . . . . 1.0 109.845 177.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -101.64 160.79 14.15 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.156 -0.683 . . . . 1.0 109.156 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 86.5 t -65.45 106.07 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.073 0.463 . . . . 1.0 110.88 179.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.464 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -120.77 -175.08 15.21 Favored Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 115.588 -0.733 . . . . 1.0 111.772 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 77.2 m -57.09 -49.45 75.82 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 122.742 0.417 . . . . 1.0 111.826 -178.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.444 ' HG2' ' N ' ' A' ' 80' ' ' HIS . 3.2 pm0 -57.33 -31.06 65.32 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.11 0.481 . . . . 1.0 111.062 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.444 ' N ' ' HG2' ' A' ' 79' ' ' GLU . 80.3 m80 -76.07 -41.55 50.21 Favored 'General case' 0 C--O 1.222 -0.356 0 CA-C-N 115.871 -0.604 . . . . 1.0 109.824 178.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 40.8 mt -66.1 -19.77 65.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.848 178.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.75 -6.26 59.14 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.92 -178.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.597 ' HB1' ' O ' ' A' ' 6' ' ' HIS . . . -60.33 148.56 36.53 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.399 -0.819 . . . . 1.0 111.756 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.691 ' HB3' HD13 ' A' ' 5' ' ' LEU . 15.5 t70 -74.46 -13.5 60.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.886 -0.597 . . . . 1.0 109.996 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.818 HD13 HG13 ' A' ' 7' ' ' VAL . 0.9 OUTLIER -154.37 122.76 6.1 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.685 -0.689 . . . . 1.0 110.198 -178.525 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 1.066 HD11 HG11 ' A' ' 102' ' ' VAL . 0.2 OUTLIER -108.15 105.0 14.53 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.904 -0.776 . . . . 1.0 108.904 174.653 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.615 ' HB ' ' HD1' ' A' ' 9' ' ' PHE . 53.7 t -84.31 91.27 2.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.663 0.744 . . . . 1.0 110.803 -178.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.93 147.0 30.49 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.434 -0.803 . . . . 1.0 111.207 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.554 HD23 ' HB2' ' A' ' 11' ' ' CYS . 4.2 mm? -100.79 -5.53 26.17 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.546 -0.752 . . . . 1.0 109.558 178.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -148.04 145.24 28.39 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.068 -0.969 . . . . 1.0 110.277 -178.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.436 ' HB3' ' O ' ' A' ' 122' ' ' LEU . 13.2 ptt180 -55.6 -26.28 43.03 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.418 0.687 . . . . 1.0 111.191 177.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.685 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 80.3 m-20 -75.21 -49.28 19.89 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.719 -0.673 . . . . 1.0 109.911 -178.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.466 ' HB3' HG12 ' A' ' 10' ' ' VAL . 11.8 m170 -58.19 -43.48 87.56 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 115.808 -0.633 . . . . 1.0 109.369 179.32 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.473 ' HA ' HG21 ' A' ' 107' ' ' VAL . . . -59.67 -47.12 86.88 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.915 -0.584 . . . . 1.0 110.718 178.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 13.2 ttm180 -59.59 -39.53 84.48 Favored 'General case' 0 CA--C 1.521 -0.143 0 CA-C-N 115.792 -0.64 . . . . 1.0 111.405 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.746 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 55.6 mt -66.14 -50.68 63.12 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 116.499 -0.319 . . . . 1.0 110.359 -177.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.674 HD21 HG21 ' A' ' 10' ' ' VAL . 14.2 mt -53.51 -56.35 17.75 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.858 -0.61 . . . . 1.0 111.452 -179.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 13.3 ptt85 -62.46 -43.9 97.7 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.161 -0.472 . . . . 1.0 111.844 -177.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.589 ' HG3' ' O ' ' A' ' 96' ' ' LEU . 0.9 OUTLIER -66.35 -22.22 66.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.378 0.608 . . . . 1.0 110.103 179.536 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.746 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 10.0 mt -77.87 -13.21 59.96 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.348 -0.842 . . . . 1.0 111.761 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 154.62 -33.52 0.69 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.003 -1.094 . . . . 1.0 113.279 -179.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 1.066 HG11 HD11 ' A' ' 86' ' ' LEU . 0.8 OUTLIER -76.36 -152.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.697 0.761 . . . . 1.0 112.221 -176.969 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.636 ' H ' HG12 ' A' ' 102' ' ' VAL . 11.4 pt-20 -164.72 167.32 19.14 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.449 -0.796 . . . . 1.0 109.125 -177.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.808 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -67.18 -23.26 65.74 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.231 -0.441 . . . . 1.0 111.81 -175.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.12 -34.76 70.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.361 0.601 . . . . 1.0 110.578 176.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.544 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 8.0 mtp180 -98.83 -40.93 7.87 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 115.475 -0.784 . . . . 1.0 110.825 -178.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.808 HG12 ' HA ' ' A' ' 104' ' ' ALA . 9.3 p -80.2 121.62 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-O 121.719 0.771 . . . . 1.0 110.721 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.508 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 21.1 mmm180 -138.05 150.07 46.59 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.808 -0.633 . . . . 1.0 110.177 -178.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.586 ' HB2' ' HB2' ' A' ' 112' ' ' SER . 81.7 mmm -78.45 138.86 38.68 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.619 -0.719 . . . . 1.0 109.715 178.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.549 HD23 HG11 ' A' ' 87' ' ' VAL . 3.0 tm? -55.68 -49.03 74.05 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.621 0.248 . . . . 1.0 110.765 179.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 111' ' ' ARG . 18.4 ttt85 -71.46 -14.28 62.09 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.87 0.367 . . . . 1.0 110.662 -178.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.586 ' HB2' ' HB2' ' A' ' 109' ' ' MET . 26.4 t -70.88 -14.02 62.24 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.482 -0.326 . . . . 1.0 110.403 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.56 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 98.7 m-85 -90.39 -15.37 31.14 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 120.95 0.405 . . . . 1.0 110.44 177.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.405 ' HB3' ' HB2' ' A' ' 117' ' ' SER . 13.5 t0 -72.4 124.12 90.39 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.785 -0.643 . . . . 1.0 111.206 -177.045 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.62 -15.77 33.91 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 122.573 2.182 . . . . 1.0 112.45 178.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 -92.66 -13.11 29.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.156 -0.474 . . . . 1.0 110.613 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.405 ' HB2' ' HB3' ' A' ' 114' ' ' ASP . 46.3 t -71.79 60.5 0.37 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.898 -0.592 . . . . 1.0 112.109 -178.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 48.74 -98.55 0.02 OUTLIER Glycine 0 C--N 1.334 0.471 0 C-N-CA 121.307 -0.473 . . . . 1.0 113.108 -178.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 25.9 m -132.07 -40.97 1.02 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.108 0.48 . . . . 1.0 110.326 178.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -151.05 154.6 37.32 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.117 0.484 . . . . 1.0 111.237 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.523 ' O ' HD13 ' A' ' 122' ' ' LEU . . . -107.53 172.3 6.91 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 115.141 -0.936 . . . . 1.0 109.714 177.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.523 HD13 ' O ' ' A' ' 121' ' ' ALA . 0.6 OUTLIER -160.2 -17.29 0.06 Allowed 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.041 -1.436 . . . . 1.0 109.759 -175.796 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -167.12 134.94 2.52 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.169 -1.048 . . . . 1.0 108.169 -176.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 67.1 t -96.91 147.45 6.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 110.031 -0.359 . . . . 1.0 110.031 -177.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -63.82 179.57 0.49 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.412 0.625 . . . . 1.0 112.543 -177.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.418 ' OD1' ' HD2' ' A' ' 127' ' ' PRO . 6.3 t70 -152.51 138.43 11.71 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 114.723 -1.126 . . . . 1.0 108.102 -174.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.418 ' HD2' ' OD1' ' A' ' 126' ' ' ASP . 84.7 Cg_exo -42.4 150.34 0.27 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 123.099 2.533 . . . . 1.0 112.937 -178.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.414 ' HD2' ' HD2' ' A' ' 129' ' ' TYR . 62.3 t80 -98.22 -32.56 11.51 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.306 -0.861 . . . . 1.0 110.821 -174.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.414 ' HD2' ' HD2' ' A' ' 128' ' ' TYR . 0.8 OUTLIER -137.04 -23.16 1.16 Allowed 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 120.909 -0.316 . . . . 1.0 111.175 178.384 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 86.06 71.22 1.31 Allowed Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.257 -0.973 . . . . 1.0 111.611 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -139.92 -174.43 3.91 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.503 -0.555 . . . . 1.0 109.503 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -55.98 -41.06 74.2 Favored 'General case' 0 C--N 1.323 -0.58 0 O-C-N 123.524 0.515 . . . . 1.0 110.994 -178.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 49.4 m -63.35 -50.26 70.68 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.894 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -56.66 -33.53 66.46 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.149 0.426 . . . . 1.0 112.149 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 15.9 m-30 -70.29 -46.24 64.7 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.962 0.41 . . . . 1.0 110.49 -178.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -78.48 -20.11 51.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 1.0 111.34 -178.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.575 ' O ' HG23 ' A' ' 141' ' ' VAL . 11.1 tp10 -63.6 -48.37 77.64 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.588 -0.893 . . . . 1.0 108.588 175.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.663 ' HA ' HG23 ' A' ' 141' ' ' VAL . 54.6 t -60.85 -41.43 88.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.095 -0.957 . . . . 1.0 109.941 176.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -53.55 -42.17 67.23 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.912 -1.04 . . . . 1.0 109.203 176.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.76 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -66.95 -40.21 87.48 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.278 -0.874 . . . . 1.0 110.635 177.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.663 HG23 ' HA ' ' A' ' 138' ' ' VAL . 10.7 t -55.58 -49.96 70.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.65 0.738 . . . . 1.0 110.167 178.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.581 HD13 ' HB3' ' A' ' 20' ' ' MET . 6.2 mt -67.78 -49.79 66.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 114.996 -1.002 . . . . 1.0 111.825 -178.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.76 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 5.3 pt-20 -57.49 -28.3 63.3 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.905 0.383 . . . . 1.0 110.062 178.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.9 t -75.11 -28.19 60.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.06 177.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.469 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -86.52 -23.71 25.79 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-N 116.246 -0.434 . . . . 1.0 111.644 178.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.732 HD22 ' HB3' ' A' ' 25' ' ' PHE . 14.2 mt -56.83 -35.93 40.97 Favored Pre-proline 0 CA--C 1.546 0.798 0 CA-C-O 118.943 -0.551 . . . . 1.0 112.452 -178.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.635 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 37.6 Cg_endo -67.63 -12.75 36.66 Favored 'Trans proline' 0 C--N 1.365 1.402 0 C-N-CA 122.543 2.162 . . . . 1.0 111.494 177.028 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.56 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -104.52 -34.12 3.68 Favored Glycine 0 N--CA 1.44 -1.065 0 CA-C-N 114.995 -1.002 . . . . 1.0 110.611 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.558 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.4 OUTLIER -75.24 -40.9 58.53 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 108.9 -0.778 . . . . 1.0 108.9 179.318 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.434 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 1.1 m-70 -54.33 -52.87 60.17 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.187 -0.915 . . . . 1.0 110.244 175.137 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -60.01 -44.1 94.78 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.67 -0.695 . . . . 1.0 110.946 -176.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . 0.775 ' HZ3' HD11 ' A' ' 5' ' ' LEU . 26.4 t90 -60.56 -55.23 35.88 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.491 -0.777 . . . . 1.0 110.697 -178.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.411 HG13 ' O ' ' A' ' 149' ' ' LEU . 11.7 m -60.67 -39.71 82.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 121.071 -0.252 . . . . 1.0 110.772 -178.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.537 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 4.6 m-20 -59.49 -54.9 41.23 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.271 0.558 . . . . 1.0 110.975 178.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 6.6 pt-20 -62.28 -33.95 75.64 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.506 -0.77 . . . . 1.0 110.465 -178.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.745 ' O ' ' HG2' ' A' ' 159' ' ' ARG . 18.5 mmt-85 -74.38 -42.6 59.03 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.759 -0.655 . . . . 1.0 111.711 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 4.5 pp -67.89 -23.98 65.17 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.505 -0.554 . . . . 1.0 109.505 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -73.39 -42.28 62.33 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.29 -0.868 . . . . 1.0 110.273 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.745 ' HG2' ' O ' ' A' ' 156' ' ' ARG . 14.2 ptt-85 -71.64 -24.39 61.85 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 116.066 -0.516 . . . . 1.0 111.401 -178.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -62.85 -47.42 83.44 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 120.434 -0.506 . . . . 1.0 111.105 -172.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -87.52 160.56 31.7 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 118.557 -1.782 . . . . 1.0 112.609 174.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -92.58 27.86 0.36 Allowed 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 123.349 2.7 . . . . 1.0 113.383 -178.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 12.0 t . . . . . 0 C--N 1.301 -1.525 0 CA-C-N 115.132 -0.94 . . . . 1.0 109.979 -179.665 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.738 0 N-CA-C 111.369 -0.692 . . . . 1.0 111.369 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.7 ptp -80.89 34.35 0.34 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.009 0.433 . . . . 1.0 111.031 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.7 p -164.82 162.38 20.93 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.894 -0.593 . . . . 1.0 109.881 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -166.07 160.93 12.89 Favored Pre-proline 0 C--N 1.321 -0.671 0 N-CA-C 109.308 -0.627 . . . . 1.0 109.308 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.459 ' HB2' ' HG2' ' A' ' 39' ' ' ARG . 36.4 Cg_endo -66.02 165.49 23.78 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.754 2.303 . . . . 1.0 112.939 -178.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.785 ' HB3' HG23 ' A' ' 38' ' ' VAL . 0.6 OUTLIER -70.99 -174.18 0.91 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.322 -0.854 . . . . 1.0 110.989 -179.388 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.612 ' HB3' ' HA ' ' A' ' 83' ' ' ALA . 2.7 t-160 -156.51 104.83 2.21 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.468 -0.333 . . . . 1.0 110.659 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.671 HG13 HD13 ' A' ' 85' ' ' LEU . 2.8 t -105.16 119.47 54.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 107.32 -1.363 . . . . 1.0 107.32 175.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.591 HG22 ' HG ' ' A' ' 86' ' ' LEU . 8.2 t -121.74 114.01 20.51 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 120.44 -0.504 . . . . 1.0 110.484 179.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.677 ' HD2' ' HB3' ' A' ' 42' ' ' SER . 1.5 m-85 -83.15 127.35 33.53 Favored 'General case' 0 CA--C 1.512 -0.491 0 O-C-N 122.004 -0.435 . . . . 1.0 110.6 -179.144 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.643 HG21 HD21 ' A' ' 97' ' ' LEU . 23.8 t -111.39 111.76 37.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.008 0.432 . . . . 1.0 111.633 -176.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.569 ' HB2' HD23 ' A' ' 89' ' ' LEU . 42.2 t -141.24 155.98 45.95 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.331 179.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.42 92.59 0.61 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.103 0.478 . . . . 1.0 110.776 179.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.835 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 132.57 -41.92 1.44 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.791 -0.718 . . . . 1.0 111.869 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.464 HD21 ' CB ' ' A' ' 42' ' ' SER . 3.6 t-20 62.17 18.74 10.35 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.454 0.645 . . . . 1.0 111.766 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.2 pt -127.25 11.8 3.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 O-C-N 121.542 -0.724 . . . . 1.0 112.165 -176.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.719 ' O ' ' HG3' ' A' ' 20' ' ' MET . 80.5 m -126.6 -89.96 0.54 Allowed 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.122 -0.631 . . . . 1.0 111.852 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.446 ' H ' ' HG2' ' A' ' 17' ' ' ARG . 0.9 OUTLIER -74.4 -30.13 61.82 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.674 0.62 . . . . 1.0 112.674 -175.819 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.658 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 17.2 m -62.46 -58.91 14.58 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 121.04 -0.264 . . . . 1.0 110.841 178.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.745 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 35.2 Cg_endo -62.78 -25.79 74.82 Favored 'Trans proline' 0 C--N 1.357 0.978 0 C-N-CA 122.213 1.942 . . . . 1.0 111.983 179.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.719 ' HG3' ' O ' ' A' ' 16' ' ' CYS . 71.3 mtp -61.85 -52.85 62.44 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.849 -0.34 . . . . 1.0 110.809 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.424 ' HA ' ' HB2' ' A' ' 24' ' ' MET . . . -74.16 -27.17 60.7 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.577 -0.449 . . . . 1.0 110.108 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.687 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 7.9 tt0 -55.88 -49.78 72.44 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 115.159 -0.928 . . . . 1.0 109.302 179.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.916 ' HB3' ' HG2' ' A' ' 68' ' ' PRO . 0.0 OUTLIER -80.79 -32.15 35.46 Favored 'General case' 0 C--N 1.32 -0.691 0 O-C-N 121.825 -0.547 . . . . 1.0 110.002 -177.155 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.651 ' HB3' HD11 ' A' ' 146' ' ' LEU . 2.3 mmm -61.56 -76.15 0.06 Allowed 'General case' 0 C--O 1.236 0.362 0 N-CA-C 112.928 0.714 . . . . 1.0 112.928 -176.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.678 ' HB3' HD22 ' A' ' 146' ' ' LEU . 16.5 p90 -76.84 -30.36 56.28 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 119.645 -0.822 . . . . 1.0 111.749 -174.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.687 ' HB3' ' O ' ' A' ' 22' ' ' GLU . . . -63.87 -37.75 88.55 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 119.082 -1.047 . . . . 1.0 110.894 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.687 ' HA ' ' HD3' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -65.82 -37.71 86.99 Favored 'General case' 0 C--N 1.333 -0.13 0 N-CA-C 108.955 -0.758 . . . . 1.0 108.955 177.836 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.546 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 79.3 mt-30 -58.8 -42.09 88.28 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.114 175.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.659 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 85.9 mt -56.02 -60.54 3.34 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.706 -0.679 . . . . 1.0 110.578 179.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.687 ' HD3' ' HA ' ' A' ' 27' ' ' GLN . 0.7 OUTLIER -58.94 -37.69 77.3 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.59 -0.277 . . . . 1.0 111.168 179.254 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -60.93 -25.31 66.69 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.252 0.464 . . . . 1.0 112.252 177.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.659 ' HG2' ' O ' ' A' ' 29' ' ' LEU . 3.6 ptm180 -100.71 -18.94 16.27 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 119.602 -0.839 . . . . 1.0 110.418 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 108.04 36.04 2.43 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.236 -0.893 . . . . 1.0 112.502 176.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 23.2 mt -130.08 -3.62 4.5 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 122.625 -0.338 . . . . 1.0 110.535 -178.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.415 ' H ' ' HA ' ' A' ' 30' ' ' ARG . . . -59.5 -25.93 61.41 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 121.126 -0.559 . . . . 1.0 112.488 -179.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -80.06 -32.08 39.4 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.511 0.672 . . . . 1.0 109.847 177.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.74 -18.36 51.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.814 -1.085 . . . . 1.0 112.759 -175.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.785 HG23 ' HB3' ' A' ' 5' ' ' LEU . 0.8 OUTLIER -145.02 128.97 12.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.107 0.479 . . . . 1.0 110.869 -178.837 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.459 ' HG2' ' HB2' ' A' ' 4' ' ' PRO . 9.3 mmm180 -94.12 140.75 29.36 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.639 -0.709 . . . . 1.0 110.168 -178.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.436 HG11 ' HB2' ' A' ' 26' ' ' ALA . 77.9 t -127.77 120.0 53.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-O 121.659 0.743 . . . . 1.0 109.633 -178.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.541 ' O ' ' HA ' ' A' ' 8' ' ' THR . 69.3 p -136.05 -174.54 3.7 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.135 -1.393 . . . . 1.0 109.933 -175.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.677 ' HB3' ' HD2' ' A' ' 9' ' ' PHE . 84.4 p -162.69 167.32 23.28 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 116.485 -0.325 . . . . 1.0 110.49 179.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.583 ' HB2' ' CD2' ' A' ' 80' ' ' HIS . . . -162.83 166.7 23.79 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.578 0.704 . . . . 1.0 111.727 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.456 ' HA2' ' O ' ' A' ' 11' ' ' CYS . . . -124.87 131.34 7.74 Favored Glycine 0 N--CA 1.443 -0.86 0 CA-C-N 114.785 -1.098 . . . . 1.0 111.252 178.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.521 HG21 HD12 ' A' ' 96' ' ' LEU . 40.9 p -70.11 -27.49 64.63 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.985 0.421 . . . . 1.0 111.108 -178.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -102.28 5.93 52.85 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 121.069 -0.586 . . . . 1.0 113.161 -176.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 44.19 34.6 1.03 Allowed 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 114.269 1.211 . . . . 1.0 114.269 176.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.835 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 0.9 OUTLIER -46.75 -72.62 0.05 Allowed 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.638 0.732 . . . . 1.0 112.494 -179.846 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -107.75 42.58 1.32 Allowed 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.045 -0.979 . . . . 1.0 111.016 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.2 p -62.84 128.48 24.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.098 0.475 . . . . 1.0 110.284 178.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.48 -13.56 67.28 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.761 -0.733 . . . . 1.0 111.828 -177.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.4 t -80.66 -158.74 0.2 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.063 0.459 . . . . 1.0 110.036 178.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 21.6 t -131.15 174.69 9.78 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.117 -1.068 . . . . 1.0 108.117 -179.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.2 137.31 47.4 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.713 0.292 . . . . 1.0 111.032 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.718 ' OD1' ' HG2' ' A' ' 57' ' ' ARG . 11.3 t70 -62.66 140.64 58.71 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 115.881 -0.599 . . . . 1.0 110.145 -177.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -51.53 -30.4 20.26 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 113.341 0.867 . . . . 1.0 113.341 -178.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.718 ' HG2' ' OD1' ' A' ' 55' ' ' ASP . 3.9 ptp180 -70.99 -44.4 66.02 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 118.351 0.523 . . . . 1.0 110.769 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.69 -35.82 70.38 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.739 -0.664 . . . . 1.0 109.583 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.84 -44.22 96.73 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.402 -0.817 . . . . 1.0 109.472 177.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.44 ' O ' ' HG2' ' A' ' 63' ' ' ARG . . . -56.75 -45.92 90.33 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.95 -0.643 . . . . 1.0 113.301 178.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.1 m -73.29 -38.62 54.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 117.793 0.797 . . . . 1.0 111.478 -178.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.667 HD21 ' HA ' ' A' ' 20' ' ' MET . 5.6 mp -62.17 -53.29 57.35 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.85 -0.34 . . . . 1.0 110.556 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.44 ' HG2' ' O ' ' A' ' 60' ' ' GLY . 11.6 ptm180 -59.98 -28.37 67.63 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.952 -0.567 . . . . 1.0 111.377 179.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.39 -30.27 65.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.22 0.533 . . . . 1.0 110.738 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -96.83 4.76 51.53 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.872 -0.604 . . . . 1.0 110.526 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.62 13.41 65.18 Favored Glycine 0 C--N 1.331 0.257 0 CA-C-N 115.681 -0.691 . . . . 1.0 113.087 176.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -92.06 150.84 41.18 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-O 120.498 0.19 . . . . 1.0 110.882 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.916 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 39.3 Cg_endo -67.8 155.79 68.51 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.395 2.063 . . . . 1.0 110.612 176.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 57.0 p -130.86 10.74 5.08 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 120.262 -0.575 . . . . 1.0 111.834 -176.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -97.32 136.5 37.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.915 0.388 . . . . 1.0 110.853 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.712 ' HB3' ' HE3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -178.98 162.55 1.26 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.523 -1.288 . . . . 1.0 107.523 177.729 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -121.56 120.82 35.93 Favored 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 119.548 -0.861 . . . . 1.0 108.871 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.03 140.67 56.66 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.763 -0.653 . . . . 1.0 111.288 -177.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.43 ' O ' ' HA ' ' A' ' 43' ' ' ALA . . . -134.65 151.07 50.77 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.907 -0.588 . . . . 1.0 110.132 179.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -87.57 153.31 21.5 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.644 -0.872 . . . . 1.0 108.644 177.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.567 HG11 HD23 ' A' ' 97' ' ' LEU . 21.7 t -63.91 114.2 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.217 0.532 . . . . 1.0 110.506 -179.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.447 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -125.27 -169.31 12.9 Favored Glycine 0 N--CA 1.442 -0.948 0 CA-C-N 115.129 -0.941 . . . . 1.0 111.279 179.299 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 51.9 m -59.86 -43.72 94.53 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.453 0.168 . . . . 1.0 111.196 -178.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -59.09 -31.34 68.81 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 120.952 0.406 . . . . 1.0 111.249 177.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.583 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 78.6 m80 -76.52 -40.69 49.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.497 -0.32 . . . . 1.0 110.276 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.724 ' HA ' HD21 ' A' ' 86' ' ' LEU . 14.6 mt -70.18 -17.09 63.15 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 120.774 0.321 . . . . 1.0 110.444 177.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.73 -7.09 58.99 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 120.777 0.322 . . . . 1.0 110.223 -179.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.612 ' HA ' ' HB3' ' A' ' 6' ' ' HIS . . . -58.45 149.23 25.62 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.961 -0.563 . . . . 1.0 110.922 178.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.555 ' HA ' ' HE ' ' A' ' 106' ' ' ARG . 32.1 t70 -75.49 -16.19 60.33 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.179 0.514 . . . . 1.0 109.739 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.671 HD13 HG13 ' A' ' 7' ' ' VAL . 0.6 OUTLIER -152.73 117.68 5.13 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.205 -0.907 . . . . 1.0 109.043 -177.688 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.724 HD21 ' HA ' ' A' ' 81' ' ' LEU . 4.9 mp -108.06 104.23 13.62 Favored 'General case' 0 N--CA 1.424 -1.758 0 CA-C-N 115.824 -0.625 . . . . 1.0 109.535 178.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.582 ' HB ' ' HD1' ' A' ' 9' ' ' PHE . 52.9 t -83.32 90.58 2.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.01 -0.996 . . . . 1.0 110.757 -175.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.63 146.06 34.31 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.484 -0.78 . . . . 1.0 110.441 179.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.569 HD23 ' HB2' ' A' ' 11' ' ' CYS . 4.1 mm? -95.33 -8.63 35.24 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.335 0.588 . . . . 1.0 109.592 178.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -151.18 154.61 37.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.451 -0.795 . . . . 1.0 111.18 178.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 13.5 ptt180 -61.63 -20.02 62.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.42 -0.809 . . . . 1.0 111.523 177.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.664 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 4.2 m-20 -75.2 -51.9 12.22 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.044 -0.725 . . . . 1.0 109.044 179.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.554 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 10.4 m170 -58.32 -44.68 88.76 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.073 -0.967 . . . . 1.0 109.792 178.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.506 ' HA ' HD12 ' A' ' 97' ' ' LEU . . . -60.23 -44.51 95.14 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 116.297 -0.41 . . . . 1.0 111.072 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.648 ' O ' ' HG2' ' A' ' 99' ' ' GLN . 2.4 ttt180 -57.23 -44.8 84.12 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 115.934 -0.575 . . . . 1.0 110.954 178.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.664 ' HG ' ' O ' ' A' ' 92' ' ' ASN . 49.3 mt -63.34 -45.41 91.38 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 116.121 -0.49 . . . . 1.0 110.515 -175.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.643 HD21 HG21 ' A' ' 10' ' ' VAL . 31.2 mt -54.52 -61.08 2.54 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.814 -0.63 . . . . 1.0 111.433 -178.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.729 ' N ' HG12 ' A' ' 102' ' ' VAL . 7.3 ptm180 -58.8 -45.19 90.47 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.73 0.641 . . . . 1.0 112.73 -179.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.648 ' HG2' ' O ' ' A' ' 95' ' ' ARG . 6.6 pt20 -66.57 -23.91 66.27 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 119.978 -0.689 . . . . 1.0 109.915 179.061 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.606 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 3.4 mt -81.68 -13.73 57.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.605 -0.725 . . . . 1.0 111.789 178.274 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 150.83 -26.16 1.04 Allowed Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 119.769 -1.205 . . . . 1.0 114.138 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.729 HG12 ' N ' ' A' ' 98' ' ' ARG . 0.3 OUTLIER -77.26 -161.64 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-N 118.026 0.913 . . . . 1.0 111.252 -177.967 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.688 ' N ' HG13 ' A' ' 102' ' ' VAL . 12.9 pt-20 -159.05 164.49 35.39 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.844 -1.169 . . . . 1.0 107.844 -178.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.835 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -63.48 -24.22 67.73 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 123.354 0.409 . . . . 1.0 111.379 -175.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.94 -34.42 71.73 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.206 176.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.645 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 1.2 mtp85 -102.16 -40.42 6.81 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.653 -0.703 . . . . 1.0 111.541 -177.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.835 HG12 ' HA ' ' A' ' 104' ' ' ALA . 8.6 p -77.13 120.7 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 N-CA-C 109.415 -0.587 . . . . 1.0 109.415 -175.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.575 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 12.0 mmm180 -139.75 145.57 38.43 Favored 'General case' 0 C--N 1.322 -0.604 0 O-C-N 121.762 -0.586 . . . . 1.0 110.358 -178.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.547 ' HB2' ' HB2' ' A' ' 112' ' ' SER . 73.5 mmm -78.67 138.78 38.46 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.917 -0.583 . . . . 1.0 110.56 178.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.523 HD23 HG11 ' A' ' 87' ' ' VAL . 3.0 tm? -57.37 -50.53 72.67 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.668 0.27 . . . . 1.0 111.472 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.557 ' HB2' HG22 ' A' ' 124' ' ' VAL . 14.2 ttt180 -70.06 -17.23 63.23 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.041 0.448 . . . . 1.0 110.624 -177.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.547 ' HB2' ' HB2' ' A' ' 109' ' ' MET . 32.5 t -75.2 -7.65 54.43 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.888 -178.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.57 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 92.4 m-85 -90.56 -17.89 26.19 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 110.287 -0.264 . . . . 1.0 110.287 176.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -68.0 118.11 55.21 Favored Pre-proline 0 N--CA 1.464 0.241 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.799 -178.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.82 -17.18 29.32 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 121.942 1.761 . . . . 1.0 111.822 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.869 ' HA ' ' HE ' ' A' ' 116' ' ' ARG . 0.0 OUTLIER -90.44 -14.04 33.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.918 -0.583 . . . . 1.0 111.473 -179.301 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 3.8 m -62.81 -67.69 0.4 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.515 -0.311 . . . . 1.0 111.757 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 172.74 -123.29 0.99 Allowed Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.419 -0.896 . . . . 1.0 111.484 177.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 24.0 m -96.18 -42.44 8.2 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.059 0.457 . . . . 1.0 109.982 178.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -160.4 148.12 16.27 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.91 -0.586 . . . . 1.0 110.458 179.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -127.54 103.3 7.26 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.679 -0.691 . . . . 1.0 109.834 -178.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.409 HD22 ' N ' ' A' ' 122' ' ' LEU . 2.8 mm? -91.04 14.84 12.89 Favored 'General case' 0 CA--C 1.501 -0.904 0 CA-C-N 116.683 -0.235 . . . . 1.0 111.302 -179.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.447 ' HA ' ' HE1' ' A' ' 109' ' ' MET . 4.5 p-10 -170.54 146.61 2.78 Favored 'General case' 0 N--CA 1.433 -1.319 0 C-N-CA 120.222 -0.591 . . . . 1.0 111.313 -178.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.557 HG22 ' HB2' ' A' ' 111' ' ' ARG . 62.2 t -111.69 147.52 15.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.343 -0.614 . . . . 1.0 109.343 178.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -74.86 -175.34 2.49 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.622 -0.431 . . . . 1.0 111.965 -177.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.517 ' OD1' ' HD2' ' A' ' 127' ' ' PRO . 37.8 t70 -148.91 146.82 22.43 Favored Pre-proline 0 C--N 1.321 -0.646 0 N-CA-C 108.513 -0.921 . . . . 1.0 108.513 -173.034 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.517 ' HD2' ' OD1' ' A' ' 126' ' ' ASP . 69.5 Cg_exo -41.94 147.58 0.44 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.865 2.376 . . . . 1.0 112.787 179.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.482 ' HD2' ' CD2' ' A' ' 129' ' ' TYR . 55.7 t80 -99.76 -54.41 2.92 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.271 -0.877 . . . . 1.0 110.593 -175.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.482 ' CD2' ' HD2' ' A' ' 128' ' ' TYR . 0.0 OUTLIER -103.56 -32.26 9.53 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.472 0.653 . . . . 1.0 109.401 179.928 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 90.69 61.33 1.3 Allowed Glycine 0 N--CA 1.443 -0.892 0 N-CA-C 110.658 -0.977 . . . . 1.0 110.658 -175.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -128.27 -178.88 4.73 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.374 -0.602 . . . . 1.0 109.374 -176.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.406 ' HA ' ' CD2' ' A' ' 135' ' ' PHE . 17.8 t-80 -55.5 -34.94 65.05 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.046 -0.525 . . . . 1.0 110.511 176.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 5.8 m -62.02 -53.11 60.16 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.826 -0.625 . . . . 1.0 110.408 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -54.78 -33.6 61.58 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 115.547 -0.751 . . . . 1.0 112.111 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.406 ' CD2' ' HA ' ' A' ' 132' ' ' HIS . 10.9 m-30 -70.28 -47.87 59.3 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.339 0.59 . . . . 1.0 109.847 -177.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -69.49 -24.0 63.7 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.402 -0.817 . . . . 1.0 111.337 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -63.42 -47.12 83.25 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 109.251 -0.648 . . . . 1.0 109.251 175.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.836 ' HA ' HG12 ' A' ' 141' ' ' VAL . 85.5 t -62.74 -39.83 86.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.576 0.703 . . . . 1.0 109.259 177.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -56.33 -42.22 77.31 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.584 -0.735 . . . . 1.0 109.481 175.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.5 ' O ' ' HG2' ' A' ' 143' ' ' GLU . . . -67.14 -49.14 65.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.047 -0.979 . . . . 1.0 111.32 179.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.836 HG12 ' HA ' ' A' ' 138' ' ' VAL . 2.9 p -58.37 -40.34 77.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.456 0.646 . . . . 1.0 110.779 -178.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.536 HD12 HG12 ' A' ' 138' ' ' VAL . 14.2 mt -70.26 -51.54 37.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 115.187 -0.915 . . . . 1.0 112.228 178.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.5 ' HG2' ' O ' ' A' ' 140' ' ' ALA . 11.6 pt-20 -55.46 -31.18 61.75 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.309 0.576 . . . . 1.0 110.287 179.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 65.9 m -74.97 -27.66 60.26 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.102 -0.954 . . . . 1.0 110.468 179.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.472 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -86.24 -24.68 25.92 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 115.99 -0.55 . . . . 1.0 111.725 178.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.678 HD22 ' HB3' ' A' ' 25' ' ' PHE . 12.7 mt -55.89 -37.28 55.38 Favored Pre-proline 0 CA--C 1.547 0.846 0 N-CA-C 112.468 0.544 . . . . 1.0 112.468 -178.11 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.646 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 38.3 Cg_endo -67.04 -14.04 42.09 Favored 'Trans proline' 0 C--N 1.363 1.311 0 C-N-CA 122.495 2.13 . . . . 1.0 111.908 177.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.57 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -104.19 -34.05 3.79 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.084 -0.962 . . . . 1.0 110.714 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.576 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -73.68 -40.93 63.31 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.889 -0.782 . . . . 1.0 108.889 179.543 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.548 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 0.2 OUTLIER -53.08 -57.04 11.76 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 115.103 -0.953 . . . . 1.0 110.837 175.672 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -57.01 -40.19 76.15 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.727 -1.124 . . . . 1.0 111.069 -174.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . 0.654 ' CE3' HD12 ' A' ' 85' ' ' LEU . 24.3 t90 -63.22 -58.01 8.59 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.173 -0.922 . . . . 1.0 110.614 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.425 HG13 ' O ' ' A' ' 149' ' ' LEU . 5.7 m -60.73 -40.55 85.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.81 -0.356 . . . . 1.0 110.303 -177.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.42 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 5.8 m-20 -61.17 -49.5 76.93 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.832 0.349 . . . . 1.0 110.904 178.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.528 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 9.3 pt-20 -63.51 -39.39 94.3 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.095 0.474 . . . . 1.0 110.548 -178.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.534 ' HG3' ' CH2' ' A' ' 152' ' ' TRP . 18.4 mmt85 -71.32 -46.73 59.95 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.516 -0.766 . . . . 1.0 110.837 -176.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 4.2 pp -63.85 -24.78 67.88 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.228 0.537 . . . . 1.0 109.941 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -74.48 -52.84 10.81 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.596 -0.729 . . . . 1.0 110.902 177.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.416 ' HG3' ' O ' ' A' ' 155' ' ' GLU . 0.0 OUTLIER -79.14 -18.65 52.78 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 113.278 0.844 . . . . 1.0 113.278 -176.083 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -90.71 47.06 1.38 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.579 0.704 . . . . 1.0 109.842 -177.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -76.92 -175.84 42.54 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.338 -0.847 . . . . 1.0 112.625 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -79.85 24.81 0.61 Allowed 'Trans proline' 0 N--CA 1.477 0.504 0 C-N-CA 123.642 2.895 . . . . 1.0 113.042 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 19.1 m . . . . . 0 C--N 1.294 -1.839 0 CA-C-N 114.481 -1.236 . . . . 1.0 110.797 -176.969 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.651 0 N-CA-C 112.234 -0.347 . . . . 1.0 112.234 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.8 mtt -148.56 134.89 19.46 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.114 0.483 . . . . 1.0 110.433 -178.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.8 p -90.71 118.56 30.24 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.552 -0.749 . . . . 1.0 110.15 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.696 ' HB2' ' HD2' ' A' ' 4' ' ' PRO . 5.1 p-10 -67.58 159.19 79.67 Favored Pre-proline 0 C--N 1.325 -0.481 0 C-N-CA 120.244 -0.582 . . . . 1.0 110.796 177.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.696 ' HD2' ' HB2' ' A' ' 3' ' ' ASP . 13.0 Cg_endo -57.98 166.89 4.9 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 123.568 2.845 . . . . 1.0 114.101 -175.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.844 ' HB3' HG23 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -65.19 178.51 0.87 Allowed 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.637 -1.165 . . . . 1.0 108.453 178.608 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.763 ' H ' HD13 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -155.55 100.97 2.14 Favored 'General case' 0 C--N 1.318 -0.803 0 O-C-N 121.549 -0.72 . . . . 1.0 109.585 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.425 HG21 HG11 ' A' ' 153' ' ' VAL . 2.2 t -104.68 116.01 47.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 107.964 -1.125 . . . . 1.0 107.964 178.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.648 HG22 ' HG ' ' A' ' 86' ' ' LEU . 6.3 t -119.06 117.89 29.96 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 120.52 -0.472 . . . . 1.0 109.918 178.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.612 ' HD2' ' HB3' ' A' ' 42' ' ' SER . 1.6 m-85 -85.22 133.19 34.19 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.016 -178.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.612 HG21 HD11 ' A' ' 97' ' ' LEU . 22.5 t -118.04 113.42 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.775 0 CA-C-O 121.123 0.487 . . . . 1.0 111.383 -176.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.666 ' SG ' ' HD3' ' A' ' 17' ' ' ARG . 42.2 t -144.94 160.23 41.66 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.657 -0.701 . . . . 1.0 109.491 178.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.453 HG23 ' NE2' ' A' ' 93' ' ' HIS . 2.7 p -68.56 112.28 5.26 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 120.941 0.401 . . . . 1.0 110.226 178.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.978 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 110.57 -45.16 1.36 Allowed Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.651 -0.785 . . . . 1.0 112.286 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.64 HD22 ' H ' ' A' ' 74' ' ' ALA . 57.5 t30 59.66 35.25 22.36 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 122.016 0.912 . . . . 1.0 110.953 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.414 HD13 ' ND1' ' A' ' 49' ' ' HIS . 4.5 pt -130.32 -4.39 2.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 O-C-N 121.682 -0.636 . . . . 1.0 112.483 -179.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.715 ' O ' ' HG3' ' A' ' 20' ' ' MET . 32.7 m -115.43 -89.05 0.57 Allowed 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 119.671 -0.812 . . . . 1.0 111.881 -177.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.96 ' HG3' ' HG ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -70.76 -39.99 72.91 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.821 0.674 . . . . 1.0 112.821 -175.071 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.481 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 19.4 m -57.58 -57.4 25.59 Favored Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 111.518 0.192 . . . . 1.0 111.518 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.481 ' HD3' ' HB2' ' A' ' 18' ' ' SER . 40.0 Cg_endo -65.15 -23.93 59.68 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 121.886 1.724 . . . . 1.0 112.395 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.715 ' HG3' ' O ' ' A' ' 16' ' ' CYS . 78.0 mtp -61.78 -52.33 64.66 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.111 -0.329 . . . . 1.0 110.111 179.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.459 ' HA ' ' HB2' ' A' ' 24' ' ' MET . . . -72.37 -27.56 62.46 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-N 115.632 -0.713 . . . . 1.0 110.138 -178.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.646 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 17.2 tt0 -52.63 -51.99 57.59 Favored 'General case' 0 C--O 1.216 -0.664 0 CA-C-N 114.981 -1.009 . . . . 1.0 109.361 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.709 ' HE2' ' HB2' ' A' ' 71' ' ' HIS . 0.1 OUTLIER -88.14 -22.79 23.88 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.815 -1.084 . . . . 1.0 110.99 -175.974 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.547 ' HB3' HD11 ' A' ' 146' ' ' LEU . 89.2 mtp -65.39 -74.97 0.09 Allowed 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.101 0.476 . . . . 1.0 112.246 -179.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.697 ' HB3' HD22 ' A' ' 146' ' ' LEU . 17.9 p90 -75.48 -30.64 59.95 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.003 -0.679 . . . . 1.0 111.601 -175.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.646 ' HB3' ' O ' ' A' ' 22' ' ' GLU . . . -64.79 -35.79 82.24 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 119.305 -0.958 . . . . 1.0 110.905 179.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.682 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -63.79 -37.88 89.01 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.402 -0.962 . . . . 1.0 108.402 177.147 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.578 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 77.9 mt-30 -59.5 -45.54 91.39 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 115.519 -0.764 . . . . 1.0 110.351 175.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.523 HD13 HG13 ' A' ' 38' ' ' VAL . 81.8 mt -53.3 -62.48 1.63 Allowed 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 115.859 -0.61 . . . . 1.0 111.317 -179.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.482 ' HA ' ' H ' ' A' ' 35' ' ' GLY . 0.3 OUTLIER -58.77 -35.48 72.85 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 120.831 -0.348 . . . . 1.0 111.502 179.863 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -62.14 -28.62 69.77 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.139 0.422 . . . . 1.0 112.139 177.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.578 ' HG2' ' O ' ' A' ' 28' ' ' GLN . 7.3 ptp180 -94.71 -20.25 19.69 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 119.452 -0.899 . . . . 1.0 109.949 178.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 110.52 35.52 2.06 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.202 -0.908 . . . . 1.0 112.277 176.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.464 ' HG ' ' HG3' ' A' ' 32' ' ' ARG . 17.9 mt -126.16 1.43 7.16 Favored 'General case' 0 N--CA 1.452 -0.358 0 O-C-N 122.432 -0.452 . . . . 1.0 110.0 -178.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.482 ' H ' ' HA ' ' A' ' 30' ' ' ARG . . . -55.75 -30.2 56.03 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 121.094 -0.574 . . . . 1.0 112.709 -178.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -88.79 -20.77 24.29 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.924 0.392 . . . . 1.0 110.55 178.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.92 -21.54 40.44 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.73 -0.668 . . . . 1.0 111.802 -179.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.844 HG23 ' HB3' ' A' ' 5' ' ' LEU . 0.6 OUTLIER -144.21 125.8 9.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.283 0.563 . . . . 1.0 111.386 -179.727 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.457 ' HG2' ' HB2' ' A' ' 4' ' ' PRO . 11.8 mmt180 -88.33 135.01 33.66 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.693 -0.855 . . . . 1.0 108.693 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.448 HG11 ' HB2' ' A' ' 26' ' ' ALA . 53.9 t -124.76 123.25 65.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.546 0.689 . . . . 1.0 109.385 -178.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.553 ' O ' ' HA ' ' A' ' 8' ' ' THR . 42.8 p -138.54 -175.75 4.23 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.491 -1.231 . . . . 1.0 110.989 -174.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.612 ' HB3' ' HD2' ' A' ' 9' ' ' PHE . 59.6 p -160.13 162.6 34.01 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.397 -0.365 . . . . 1.0 110.135 -178.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.619 ' HB2' ' CD2' ' A' ' 80' ' ' HIS . . . -162.88 163.19 26.5 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.36 0.6 . . . . 1.0 111.636 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.481 ' HA2' ' O ' ' A' ' 11' ' ' CYS . . . -123.23 131.64 8.25 Favored Glycine 0 N--CA 1.442 -0.909 0 N-CA-C 110.778 -0.929 . . . . 1.0 110.778 178.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.519 HG23 ' CG1' ' A' ' 10' ' ' VAL . 23.2 p -69.98 -25.36 63.58 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.805 0.336 . . . . 1.0 111.752 -177.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.526 ' HA3' ' HZ3' ' A' ' 48' ' ' TRP . . . -110.91 9.16 29.64 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 120.851 -0.69 . . . . 1.0 113.409 -176.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 41.98 41.81 2.08 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 114.25 1.204 . . . . 1.0 114.25 176.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.978 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 1.2 m-90 -49.1 -76.02 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.694 0.759 . . . . 1.0 111.903 177.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.414 ' ND1' HD13 ' A' ' 15' ' ' ILE . 9.1 m170 -102.39 39.19 1.54 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.178 -0.919 . . . . 1.0 111.04 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.9 p -60.05 128.41 21.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.147 0.499 . . . . 1.0 110.529 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.439 ' HA2' ' HD3' ' A' ' 72' ' ' ARG . . . 93.3 -14.22 65.78 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.944 -0.646 . . . . 1.0 111.99 -177.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.409 ' O ' ' HA ' ' A' ' 72' ' ' ARG . 4.1 t -80.63 -161.12 0.35 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.183 0.516 . . . . 1.0 110.004 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 71' ' ' HIS . 24.8 t -121.39 176.23 5.76 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 108.448 -0.945 . . . . 1.0 108.448 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.501 ' HB2' ' HZ1' ' A' ' 23' ' ' LYS . . . -59.63 143.68 49.86 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.313 -0.403 . . . . 1.0 111.273 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.482 ' OD1' ' HG3' ' A' ' 57' ' ' ARG . 51.6 t0 -49.58 123.93 8.62 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.898 -1.046 . . . . 1.0 110.115 178.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -44.57 -37.02 3.3 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.444 -0.798 . . . . 1.0 112.64 178.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.646 HH11 ' HD1' ' A' ' 135' ' ' PHE . 0.2 OUTLIER -73.27 -38.06 66.07 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.095 -0.642 . . . . 1.0 111.178 -179.102 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.11 -36.37 72.12 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.55 0.214 . . . . 1.0 110.472 177.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.417 ' O ' HG21 ' A' ' 69' ' ' THR . . . -61.47 -41.88 97.92 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.046 177.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.09 -42.3 99.74 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 111.084 -0.807 . . . . 1.0 111.084 176.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.607 HG23 ' O ' ' A' ' 57' ' ' ARG . 85.0 t -59.14 -57.36 11.74 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 CA-C-N 115.273 -0.464 . . . . 1.0 111.127 178.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.712 ' HB2' HG22 ' A' ' 69' ' ' THR . 85.7 mt -59.5 -50.36 74.22 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.227 -0.442 . . . . 1.0 111.504 -177.152 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.599 ' HB3' HG21 ' A' ' 69' ' ' THR . 2.2 ptt180 -63.25 -27.74 69.55 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.727 -0.67 . . . . 1.0 110.823 -178.162 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.86 -29.68 68.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.128 0.49 . . . . 1.0 110.702 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -98.81 4.31 47.58 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.837 -0.619 . . . . 1.0 111.452 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.39 12.39 63.1 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.712 -0.756 . . . . 1.0 112.691 177.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.527 ' HD1' ' HG2' ' A' ' 27' ' ' GLN . 62.3 m-85 -86.96 152.31 53.3 Favored Pre-proline 0 C--N 1.323 -0.574 0 O-C-N 122.756 -0.261 . . . . 1.0 110.409 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.652 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 17.8 Cg_endo -64.81 153.25 78.81 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.295 1.997 . . . . 1.0 110.417 175.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.712 HG22 ' HB2' ' A' ' 62' ' ' LEU . 61.5 p -135.35 28.84 3.36 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 120.232 -0.587 . . . . 1.0 112.336 -176.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -104.38 130.47 52.25 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.343 -0.614 . . . . 1.0 109.343 178.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.709 ' HB2' ' HE2' ' A' ' 23' ' ' LYS . 18.7 t60 -164.95 148.34 8.56 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.287 -177.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.439 ' HD3' ' HA2' ' A' ' 51' ' ' GLY . 6.3 tmm_? -127.41 111.31 13.71 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 107.493 -1.299 . . . . 1.0 107.493 177.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.58 134.25 55.97 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.1 -0.955 . . . . 1.0 111.918 -175.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.64 ' H ' HD22 ' A' ' 14' ' ' ASN . . . -128.8 147.98 50.84 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.725 -0.67 . . . . 1.0 109.791 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -87.09 155.83 19.97 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.747 -0.464 . . . . 1.0 109.747 176.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.505 HG11 HD23 ' A' ' 97' ' ' LEU . 12.9 t -64.11 112.58 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.488 0.661 . . . . 1.0 111.229 -179.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -122.64 -171.75 13.86 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 114.937 -1.029 . . . . 1.0 111.748 179.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 96.6 m -56.41 -44.45 80.35 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 123.704 0.297 . . . . 1.0 111.212 -179.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -60.07 -27.83 67.3 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.873 0.368 . . . . 1.0 110.939 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.619 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 79.6 m80 -79.73 -41.56 26.44 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 116.421 -0.354 . . . . 1.0 110.389 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.649 ' O ' HG23 ' A' ' 102' ' ' VAL . 17.9 mt -67.61 -17.0 64.46 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.241 176.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.76 -8.28 57.5 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.395 -0.366 . . . . 1.0 110.848 -179.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.538 ' HA ' ' HB3' ' A' ' 6' ' ' HIS . . . -60.15 151.17 27.67 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.074 -0.512 . . . . 1.0 111.569 -179.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.753 ' HB3' HD13 ' A' ' 5' ' ' LEU . 9.9 t70 -76.13 -14.98 60.16 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.759 -0.655 . . . . 1.0 109.712 179.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.745 HD12 ' CE3' ' A' ' 152' ' ' TRP . 1.2 tt -157.48 116.53 3.28 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.89 -0.595 . . . . 1.0 109.572 -177.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.648 ' HG ' HG22 ' A' ' 8' ' ' THR . 5.3 mp -107.27 88.44 2.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 116.018 -0.537 . . . . 1.0 110.671 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.633 ' HA ' ' O ' ' A' ' 108' ' ' ARG . 70.3 t -66.18 91.02 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 113.801 -1.545 . . . . 1.0 112.363 -179.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.49 146.32 32.77 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.509 -1.223 . . . . 1.0 110.655 177.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.96 ' HG ' ' HG3' ' A' ' 17' ' ' ARG . 4.3 mm? -99.04 -8.47 25.27 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.253 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.429 ' OD1' ' HB2' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -153.32 155.22 36.07 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.08 -0.509 . . . . 1.0 111.142 -179.843 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.432 ' HB3' ' O ' ' A' ' 122' ' ' LEU . 0.5 OUTLIER -56.91 -27.02 60.25 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.24 -0.891 . . . . 1.0 113.31 -178.598 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.655 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 7.0 m-20 -75.58 -49.93 17.08 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.977 -0.379 . . . . 1.0 109.977 -178.061 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.672 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 9.9 m170 -55.28 -47.33 75.69 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.73 -0.668 . . . . 1.0 110.295 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.96 -43.96 91.41 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.09 0.471 . . . . 1.0 110.704 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.469 ' O ' ' HG2' ' A' ' 99' ' ' GLN . 17.1 ttt180 -59.4 -44.42 92.82 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.759 -0.655 . . . . 1.0 111.332 178.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.655 ' HG ' ' O ' ' A' ' 92' ' ' ASN . 60.2 mt -62.69 -47.32 84.16 Favored 'General case' 0 C--O 1.215 -0.737 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.425 -176.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.672 ' HG ' ' O ' ' A' ' 93' ' ' HIS . 29.5 mt -54.32 -59.46 4.64 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.636 -0.711 . . . . 1.0 111.417 -178.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.688 ' CA ' HG12 ' A' ' 102' ' ' VAL . 16.5 ptt85 -59.7 -44.71 93.56 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.305 0.483 . . . . 1.0 112.305 -178.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.469 ' HG2' ' O ' ' A' ' 95' ' ' ARG . 2.3 pt20 -68.06 -24.63 65.09 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.497 -0.481 . . . . 1.0 109.918 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.653 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 6.1 mt -81.48 -16.14 52.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.718 -0.674 . . . . 1.0 112.037 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 151.06 -23.44 0.99 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 119.873 -1.156 . . . . 1.0 114.184 -178.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.841 HG22 ' HD2' ' A' ' 106' ' ' ARG . 0.4 OUTLIER -76.62 -163.11 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 CA-C-N 117.958 0.879 . . . . 1.0 110.295 -179.091 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.705 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 14.2 pt-20 -158.11 161.4 37.94 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 107.702 -1.221 . . . . 1.0 107.702 -179.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.763 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -61.86 -25.02 67.28 Favored 'General case' 0 C--N 1.32 -0.717 0 O-C-N 123.285 0.366 . . . . 1.0 111.273 -175.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.476 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . . . -56.37 -39.31 72.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.318 0.58 . . . . 1.0 110.286 175.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.841 ' HD2' HG22 ' A' ' 102' ' ' VAL . 22.5 mtt180 -96.82 -42.51 7.93 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 115.036 -0.983 . . . . 1.0 111.13 -176.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.763 HG12 ' HA ' ' A' ' 104' ' ' ALA . 11.5 p -78.86 117.75 24.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 120.694 -0.402 . . . . 1.0 110.03 -174.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.633 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 0.1 OUTLIER -138.35 148.44 44.57 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 121.716 -0.615 . . . . 1.0 110.455 -178.97 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 83.9 mmm -80.86 140.53 35.33 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.977 -0.556 . . . . 1.0 111.006 -178.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.55 HD23 HG11 ' A' ' 87' ' ' VAL . 3.1 tm? -59.11 -48.71 80.62 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 111.552 0.204 . . . . 1.0 111.552 -179.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.408 ' CB ' HG22 ' A' ' 124' ' ' VAL . 7.7 ttm180 -69.26 -19.92 63.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.707 0.289 . . . . 1.0 110.528 -178.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 30.4 t -74.26 -7.0 51.2 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.464 -0.335 . . . . 1.0 111.177 -178.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.641 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 87.6 m-85 -92.93 -19.11 21.96 Favored 'General case' 0 C--N 1.34 0.181 0 O-C-N 121.834 -0.541 . . . . 1.0 110.65 177.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -60.27 121.82 62.46 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.885 -0.598 . . . . 1.0 111.041 -178.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -64.33 -16.8 57.05 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.844 2.363 . . . . 1.0 111.802 179.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 18.3 mtp180 -91.22 -5.68 54.5 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.647 -0.706 . . . . 1.0 111.122 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 14.8 t -71.57 81.97 0.82 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.823 0.344 . . . . 1.0 110.702 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -52.82 -39.19 55.29 Favored Glycine 0 C--N 1.335 0.475 0 CA-C-N 115.895 -0.593 . . . . 1.0 113.042 179.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.76 162.67 12.74 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.813 -0.44 . . . . 1.0 109.813 178.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 28.3 m170 -63.89 133.7 53.78 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.019 -0.734 . . . . 1.0 109.019 175.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -100.63 87.98 3.49 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 116.086 -0.506 . . . . 1.0 111.241 -178.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.432 ' O ' ' HB3' ' A' ' 91' ' ' ARG . 2.5 mm? -95.26 17.34 14.51 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.664 -0.865 . . . . 1.0 108.664 175.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -168.38 132.95 1.65 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.615 -1.175 . . . . 1.0 109.487 -176.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.427 ' HB ' ' O ' ' A' ' 89' ' ' LEU . 62.3 t -104.04 148.38 8.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.12 -0.696 . . . . 1.0 109.12 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -64.22 -173.81 0.1 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.612 0.72 . . . . 1.0 112.767 -178.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.457 ' OD1' ' HD2' ' A' ' 127' ' ' PRO . 32.1 t70 -165.82 144.71 5.07 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 114.552 -1.204 . . . . 1.0 108.498 -175.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.457 ' HD2' ' OD1' ' A' ' 126' ' ' ASP . 7.9 Cg_endo -49.15 168.81 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.673 2.915 . . . . 1.0 113.636 -178.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.484 ' HD2' ' CE2' ' A' ' 129' ' ' TYR . 30.3 t80 -113.48 -22.4 10.36 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.072 -0.967 . . . . 1.0 111.449 -177.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.484 ' CE2' ' HD2' ' A' ' 128' ' ' TYR . 0.0 OUTLIER -140.1 -60.3 0.53 Allowed 'General case' 0 C--N 1.332 -0.181 0 O-C-N 122.061 -0.399 . . . . 1.0 110.903 179.652 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 121.62 73.4 0.31 Allowed Glycine 0 N--CA 1.451 -0.354 0 N-CA-C 111.042 -0.823 . . . . 1.0 111.042 -177.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.747 ' H ' ' HB3' ' A' ' 134' ' ' ASP . 5.2 p-10 -143.98 -167.03 2.5 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.774 0.321 . . . . 1.0 110.488 -177.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -54.34 -42.52 70.31 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.863 -0.608 . . . . 1.0 111.005 178.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.7 m -61.89 -40.5 95.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.501 -0.318 . . . . 1.0 110.669 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.747 ' HB3' ' H ' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -63.35 -39.92 95.85 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.472 -0.786 . . . . 1.0 111.579 -177.601 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.646 ' HD1' HH11 ' A' ' 57' ' ' ARG . 5.4 m-85 -68.98 -45.55 70.36 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.161 0.505 . . . . 1.0 110.466 -176.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -75.1 -24.66 58.14 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.926 -0.579 . . . . 1.0 111.182 -178.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.664 ' O ' HG23 ' A' ' 141' ' ' VAL . 2.8 tt0 -63.85 -49.4 72.93 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.794 -0.447 . . . . 1.0 109.794 177.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.45 HG12 HD12 ' A' ' 142' ' ' ILE . 84.3 t -59.05 -44.54 91.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.479 0.657 . . . . 1.0 109.692 177.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.428 ' HB2' HG11 ' A' ' 61' ' ' VAL . 67.6 t80 -56.7 -40.11 75.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.804 -1.089 . . . . 1.0 110.058 177.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.58 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -67.18 -41.94 85.07 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.246 -0.433 . . . . 1.0 110.746 178.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.664 HG23 ' O ' ' A' ' 137' ' ' GLU . 33.4 t -56.33 -51.06 68.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.645 0.736 . . . . 1.0 110.425 178.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.45 HD12 HG12 ' A' ' 138' ' ' VAL . 7.7 mt -65.96 -50.36 70.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 114.782 -1.099 . . . . 1.0 111.588 -178.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.58 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 12.7 pt-20 -57.49 -30.41 65.08 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 121.003 -0.279 . . . . 1.0 110.354 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 2.9 t -74.76 -28.85 60.92 Favored 'General case' 0 C--O 1.226 -0.167 0 CA-C-O 121.155 0.502 . . . . 1.0 110.384 178.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.459 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -86.98 -22.31 25.64 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 116.014 -0.539 . . . . 1.0 111.523 179.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.697 HD22 ' HB3' ' A' ' 25' ' ' PHE . 11.2 mt -55.57 -37.49 57.52 Favored Pre-proline 0 CA--C 1.54 0.569 0 N-CA-C 112.523 0.564 . . . . 1.0 112.523 -179.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.62 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 57.1 Cg_endo -70.59 -8.53 23.83 Favored 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 122.495 2.13 . . . . 1.0 112.255 177.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.641 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -108.73 -33.93 2.74 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.214 -1.154 . . . . 1.0 110.214 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.579 HD11 HG21 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -73.44 -43.63 59.93 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.163 -1.051 . . . . 1.0 108.163 178.509 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.658 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 0.2 OUTLIER -54.21 -52.52 61.01 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-N 114.768 -1.106 . . . . 1.0 110.227 174.865 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -57.59 -43.89 84.97 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.324 -1.307 . . . . 1.0 110.89 -175.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . 0.745 ' CE3' HD12 ' A' ' 85' ' ' LEU . 22.9 t90 -63.01 -57.05 12.01 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.095 -0.957 . . . . 1.0 110.414 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.437 HG13 ' O ' ' A' ' 149' ' ' LEU . 8.4 m -61.95 -42.09 93.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.776 -0.37 . . . . 1.0 110.566 -177.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -60.33 -51.22 70.45 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.907 0.384 . . . . 1.0 110.777 179.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.724 ' O ' ' HG2' ' A' ' 159' ' ' ARG . 13.8 pt-20 -62.66 -38.76 91.57 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.771 -0.65 . . . . 1.0 110.403 -178.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.499 ' HA ' ' HD3' ' A' ' 156' ' ' ARG . 1.8 mmt180 -72.65 -50.66 23.6 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.893 -0.594 . . . . 1.0 111.029 -177.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.1 pp -59.65 -27.45 66.38 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.069 -0.514 . . . . 1.0 109.885 -178.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -76.0 -50.96 13.41 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.586 -0.734 . . . . 1.0 111.355 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.724 ' HG2' ' O ' ' A' ' 155' ' ' GLU . 5.1 ptp180 -78.04 -25.29 47.76 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.896 0.702 . . . . 1.0 112.896 -174.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . 0.459 ' N ' ' HG3' ' A' ' 159' ' ' ARG . 5.9 m-20 -56.12 -59.91 4.24 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 123.34 0.4 . . . . 1.0 111.385 -173.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 63.75 -177.62 7.86 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.255 -0.974 . . . . 1.0 113.867 178.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -84.34 28.06 0.59 Allowed 'Trans proline' 0 CA--C 1.515 -0.432 0 C-N-CA 123.292 2.661 . . . . 1.0 112.573 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 22.6 t . . . . . 0 C--N 1.297 -1.694 0 CA-C-N 114.329 -1.305 . . . . 1.0 110.156 -177.981 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.794 0 N-CA-C 111.811 -0.515 . . . . 1.0 111.811 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.9 mtt -87.92 173.48 8.89 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.688 0.28 . . . . 1.0 110.611 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.7 p -157.5 163.73 38.13 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.878 -0.416 . . . . 1.0 109.878 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.585 ' HB2' ' HD2' ' A' ' 4' ' ' PRO . 1.9 p-10 -67.72 157.31 86.74 Favored Pre-proline 0 C--O 1.236 0.375 0 CA-C-O 121.258 0.551 . . . . 1.0 111.646 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.59 ' HB3' ' O ' ' A' ' 36' ' ' ASP . 35.0 Cg_endo -64.55 169.22 11.61 Favored 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 123.478 2.785 . . . . 1.0 113.826 -176.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.846 ' HB3' HG23 ' A' ' 38' ' ' VAL . 0.5 OUTLIER -73.21 -172.49 1.12 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.694 -1.139 . . . . 1.0 110.711 -179.303 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.624 ' HB3' ' HA ' ' A' ' 83' ' ' ALA . 0.3 OUTLIER -157.38 94.41 1.38 Allowed 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.897 -0.321 . . . . 1.0 110.881 179.295 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.69 HG13 HD13 ' A' ' 85' ' ' LEU . 2.1 t -96.06 115.62 35.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 108.876 -0.786 . . . . 1.0 108.876 176.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.603 ' CG2' ' HG ' ' A' ' 86' ' ' LEU . 14.2 t -118.52 115.35 24.42 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 120.92 0.391 . . . . 1.0 110.585 178.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.578 ' HD1' ' HB ' ' A' ' 87' ' ' VAL . 1.0 OUTLIER -83.54 132.42 34.93 Favored 'General case' 0 CA--C 1.511 -0.55 0 O-C-N 122.162 -0.336 . . . . 1.0 110.472 -179.025 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.713 HG21 HD11 ' A' ' 97' ' ' LEU . 44.5 t -115.37 119.98 63.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.221 0.534 . . . . 1.0 111.803 -176.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.528 ' HA ' ' CE1' ' A' ' 93' ' ' HIS . 47.0 t -147.59 164.92 31.95 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.654 -0.703 . . . . 1.0 109.712 178.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.6 96.22 2.94 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.186 0.517 . . . . 1.0 110.66 179.097 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.983 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 125.04 -39.81 2.01 Favored Glycine 0 N--CA 1.441 -1.01 0 CA-C-N 115.486 -0.779 . . . . 1.0 111.972 179.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.528 HD21 ' CB ' ' A' ' 42' ' ' SER . 3.6 t-20 65.05 18.88 11.67 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 122.115 0.96 . . . . 1.0 110.078 -178.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.501 HG12 ' HB2' ' A' ' 49' ' ' HIS . 1.2 pt -134.58 48.43 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-N 115.078 -0.964 . . . . 1.0 110.103 -177.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.742 ' O ' ' HG3' ' A' ' 20' ' ' MET . 4.7 p -157.9 -90.12 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.285 -0.87 . . . . 1.0 111.495 174.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.647 HH11 ' HB3' ' A' ' 89' ' ' LEU . 1.2 mtt180 -70.73 -44.46 66.8 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.986 0.422 . . . . 1.0 111.187 -177.071 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.712 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 15.1 m -54.41 -58.13 15.39 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-N 115.756 -0.657 . . . . 1.0 111.838 -179.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.537 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 33.6 Cg_endo -64.1 -24.58 66.24 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 121.68 1.586 . . . . 1.0 112.627 -179.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.742 ' HG3' ' O ' ' A' ' 16' ' ' CYS . 57.6 mtp -62.01 -53.81 50.38 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.902 -0.319 . . . . 1.0 110.607 178.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.428 ' HA ' ' HB2' ' A' ' 24' ' ' MET . . . -74.91 -26.14 59.43 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.488 -178.022 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.631 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 12.5 tt0 -53.84 -51.28 64.06 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.274 -0.876 . . . . 1.0 109.528 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.821 ' HB3' ' HG2' ' A' ' 68' ' ' PRO . 0.2 OUTLIER -80.7 -31.14 36.27 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.549 -0.75 . . . . 1.0 110.451 -177.244 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.65 ' HB3' HD11 ' A' ' 146' ' ' LEU . 6.0 mmm -60.85 -75.49 0.06 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.902 0.704 . . . . 1.0 112.902 -175.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.686 ' HB3' HD22 ' A' ' 146' ' ' LEU . 19.0 p90 -77.94 -30.77 50.61 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 119.815 -0.754 . . . . 1.0 111.527 -175.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.631 ' HB3' ' O ' ' A' ' 22' ' ' GLU . . . -63.03 -38.23 90.37 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 119.06 -1.056 . . . . 1.0 110.648 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.672 ' HA ' ' HD3' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -65.39 -40.13 93.1 Favored 'General case' 0 C--N 1.339 0.118 0 N-CA-C 108.936 -0.765 . . . . 1.0 108.936 177.504 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.652 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 50.7 mt-30 -61.59 -40.46 94.84 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.751 176.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.677 ' HG ' ' O ' ' A' ' 25' ' ' PHE . 83.9 mt -56.73 -57.65 11.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.638 178.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.672 ' HD3' ' HA ' ' A' ' 27' ' ' GLN . 1.6 ptm180 -59.9 -32.28 70.6 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.485 -0.486 . . . . 1.0 111.129 178.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -62.27 -32.93 73.7 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 111.967 0.358 . . . . 1.0 111.967 175.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.652 ' HG2' ' O ' ' A' ' 28' ' ' GLN . 4.8 ptp180 -91.94 -17.5 25.08 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.632 0.729 . . . . 1.0 109.706 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.22 33.64 5.1 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 114.911 -1.041 . . . . 1.0 111.435 177.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 33.2 mt -123.42 -0.75 8.69 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.566 -0.531 . . . . 1.0 109.566 -177.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.25 -27.52 60.45 Favored Glycine 0 C--O 1.227 -0.338 0 CA-C-N 115.889 -0.596 . . . . 1.0 112.486 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.59 ' O ' ' HB3' ' A' ' 4' ' ' PRO . 0.9 OUTLIER -86.34 -25.86 25.18 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 109.716 -0.475 . . . . 1.0 109.716 177.549 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -78.42 -21.69 48.85 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.137 -0.938 . . . . 1.0 111.341 -176.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.846 HG23 ' HB3' ' A' ' 5' ' ' LEU . 1.2 p -144.45 126.85 10.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.229 0.538 . . . . 1.0 110.378 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.487 ' HG2' ' HB2' ' A' ' 4' ' ' PRO . 11.0 mmt180 -90.0 144.59 25.78 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.462 -0.79 . . . . 1.0 109.585 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.415 HG11 ' HB2' ' A' ' 26' ' ' ALA . 77.8 t -129.68 127.73 64.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 121.382 0.611 . . . . 1.0 109.93 -178.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.534 ' O ' ' HA ' ' A' ' 8' ' ' THR . 40.0 p -143.89 -175.54 4.63 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.476 -1.238 . . . . 1.0 110.024 -175.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.712 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 86.4 p -161.27 167.03 26.72 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 110.006 -0.368 . . . . 1.0 110.006 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.593 ' HB2' ' CD2' ' A' ' 80' ' ' HIS . . . -163.5 166.41 22.66 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.156 0.503 . . . . 1.0 111.695 -178.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.523 ' HA2' ' O ' ' A' ' 11' ' ' CYS . . . -125.15 137.71 10.56 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.302 -0.863 . . . . 1.0 111.398 178.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.618 HG21 HD12 ' A' ' 96' ' ' LEU . 22.1 p -74.17 -22.93 59.21 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.805 0.303 . . . . 1.0 111.747 -177.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.459 ' HA3' ' CZ3' ' A' ' 48' ' ' TRP . . . -111.31 8.31 28.73 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.668 -0.777 . . . . 1.0 113.03 -178.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.459 ' HB3' ' HB2' ' A' ' 75' ' ' GLN . 2.7 p-10 43.01 37.02 1.0 Allowed 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 113.875 1.065 . . . . 1.0 113.875 177.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.983 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 1.1 m-90 -46.8 -64.4 0.78 Allowed 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.325 0.583 . . . . 1.0 112.532 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.573 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 2.3 m-70 -111.99 39.25 2.44 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.753 -0.658 . . . . 1.0 111.281 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.51 HG23 ' HA ' ' A' ' 74' ' ' ALA . 14.9 p -59.87 126.87 18.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 C-N-CA 120.207 -0.597 . . . . 1.0 110.473 179.056 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.64 -14.17 65.62 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-N 116.032 -0.531 . . . . 1.0 111.948 -177.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.503 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 3.3 t -79.93 -160.72 0.29 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.45 0.643 . . . . 1.0 109.961 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 47.7 t -124.48 175.02 7.41 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 115.445 -0.798 . . . . 1.0 108.971 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.38 147.56 48.06 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.54 0.686 . . . . 1.0 111.49 -178.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.428 ' N ' ' OD1' ' A' ' 55' ' ' ASP . 9.0 p-10 -59.75 137.76 57.96 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.437 -1.256 . . . . 1.0 112.034 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -48.36 -35.25 12.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.672 -1.149 . . . . 1.0 112.785 179.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.484 ' H ' ' HG2' ' A' ' 57' ' ' ARG . 17.3 ptt180 -71.93 -43.69 64.86 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.377 0.132 . . . . 1.0 111.071 -177.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.461 ' HB1' ' HG2' ' A' ' 20' ' ' MET . . . -69.56 -39.13 77.59 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 109.378 -0.601 . . . . 1.0 109.378 178.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.4 -45.53 93.93 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.672 -0.695 . . . . 1.0 109.398 177.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.42 ' O ' ' HG2' ' A' ' 63' ' ' ARG . . . -57.83 -47.21 90.29 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 115.768 -0.651 . . . . 1.0 113.36 178.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.6 m -70.34 -39.99 77.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 117.699 0.749 . . . . 1.0 111.045 -178.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.718 HD13 ' HG3' ' A' ' 23' ' ' LYS . 96.0 mt -63.64 -52.56 60.26 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 120.605 -0.438 . . . . 1.0 110.653 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.42 ' HG2' ' O ' ' A' ' 60' ' ' GLY . 4.5 ptm180 -61.13 -30.26 70.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.554 -0.294 . . . . 1.0 110.997 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.99 -33.45 75.6 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 120.946 0.403 . . . . 1.0 110.735 179.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -96.68 3.35 52.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.839 -0.619 . . . . 1.0 110.873 -178.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.41 13.8 62.89 Favored Glycine 0 N--CA 1.452 -0.257 0 CA-C-N 115.962 -0.563 . . . . 1.0 112.906 177.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -89.48 152.8 47.81 Favored Pre-proline 0 C--N 1.322 -0.616 0 N-CA-C 110.571 -0.159 . . . . 1.0 110.571 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.821 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 45.7 Cg_endo -69.8 158.46 56.84 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.182 1.921 . . . . 1.0 110.713 176.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.62 HG22 ' HB2' ' A' ' 62' ' ' LEU . 36.4 p -133.32 4.04 3.68 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 119.856 -0.738 . . . . 1.0 111.807 -177.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.412 ' O ' ' HE2' ' A' ' 23' ' ' LYS . 24.4 t70 -67.74 127.09 31.5 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.976 -0.556 . . . . 1.0 110.099 178.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.567 ' HB2' ' HE2' ' A' ' 23' ' ' LYS . 59.0 t60 -165.39 149.67 8.61 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.951 0.405 . . . . 1.0 111.116 -176.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.459 ' HA ' ' O ' ' A' ' 52' ' ' SER . 0.9 OUTLIER -134.16 112.65 11.29 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.113 -1.069 . . . . 1.0 108.113 175.136 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.573 ' HB3' ' O ' ' A' ' 49' ' ' HIS . . . -61.42 142.53 56.91 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.656 -1.157 . . . . 1.0 112.294 -176.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.51 ' HA ' HG23 ' A' ' 50' ' ' VAL . . . -133.55 161.25 35.11 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.469 -0.787 . . . . 1.0 109.885 178.072 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.459 ' HB2' ' HB3' ' A' ' 47' ' ' ASN . 46.8 tt0 -97.57 160.04 14.56 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.611 -0.885 . . . . 1.0 108.611 178.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.474 HG11 HD23 ' A' ' 97' ' ' LEU . 93.8 t -64.97 102.82 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.353 0.597 . . . . 1.0 110.093 178.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -119.57 -174.94 15.78 Favored Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 114.834 -1.075 . . . . 1.0 111.769 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 93.0 m -57.75 -45.75 85.44 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 111.616 0.228 . . . . 1.0 111.616 -177.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -59.12 -29.65 67.55 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.871 0.367 . . . . 1.0 111.305 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.593 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 78.2 m80 -78.39 -41.24 33.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.394 -0.366 . . . . 1.0 110.491 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.623 ' O ' HG23 ' A' ' 102' ' ' VAL . 18.2 mt -68.31 -17.28 64.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.404 177.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.87 -8.27 58.17 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.846 0.355 . . . . 1.0 110.487 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.624 ' HA ' ' HB3' ' A' ' 6' ' ' HIS . . . -58.91 151.85 20.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.664 -0.698 . . . . 1.0 111.427 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.602 ' HA ' ' NH1' ' A' ' 106' ' ' ARG . 27.0 t70 -78.73 -14.45 59.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.333 -0.394 . . . . 1.0 109.956 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.69 HD13 HG13 ' A' ' 7' ' ' VAL . 0.5 OUTLIER -155.36 117.33 4.11 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.65 -0.705 . . . . 1.0 109.311 -177.909 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.618 ' HB3' HD13 ' A' ' 97' ' ' LEU . 5.0 mp -107.67 105.94 16.04 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-N 115.622 -0.717 . . . . 1.0 109.897 177.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.578 ' HB ' ' HD1' ' A' ' 9' ' ' PHE . 56.0 t -84.5 92.94 3.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 114.803 -1.09 . . . . 1.0 111.002 -176.094 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.7 141.81 37.6 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.474 -0.785 . . . . 1.0 110.62 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.647 ' HB3' HH11 ' A' ' 17' ' ' ARG . 3.8 mm? -95.82 -8.77 33.32 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.261 0.553 . . . . 1.0 109.82 178.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.518 ' HA ' ' OD1' ' A' ' 123' ' ' ASP . 0.0 OUTLIER -149.73 151.55 33.83 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.249 -0.887 . . . . 1.0 110.786 -179.939 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.461 ' HG2' ' HB2' ' A' ' 123' ' ' ASP . 9.3 ptm180 -55.16 -29.86 58.67 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.262 -0.881 . . . . 1.0 112.92 -179.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.694 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 43.2 m-80 -75.06 -49.51 19.48 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.614 -0.513 . . . . 1.0 109.614 -176.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.565 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 16.7 m170 -52.44 -46.07 66.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.535 -0.757 . . . . 1.0 110.121 178.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.416 ' HA ' HG21 ' A' ' 107' ' ' VAL . . . -58.85 -46.44 87.74 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.42 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.1 ttm180 -61.47 -39.27 90.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.722 -0.672 . . . . 1.0 111.626 178.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.694 ' HG ' ' O ' ' A' ' 92' ' ' ASN . 36.1 mt -65.85 -47.19 75.77 Favored 'General case' 0 C--O 1.218 -0.594 0 N-CA-C 110.229 -0.285 . . . . 1.0 110.229 -177.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.713 HD11 HG21 ' A' ' 10' ' ' VAL . 31.6 mt -55.14 -58.78 6.27 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.145 -0.48 . . . . 1.0 111.655 -178.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.685 ' HD2' HG11 ' A' ' 107' ' ' VAL . 2.9 ptm180 -60.3 -41.52 93.59 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.826 -0.624 . . . . 1.0 112.473 -178.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.652 ' HG3' ' O ' ' A' ' 96' ' ' LEU . 1.0 OUTLIER -66.8 -27.76 67.83 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.361 -0.607 . . . . 1.0 109.361 178.536 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.667 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 11.1 mt -79.46 -13.44 59.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.537 -0.756 . . . . 1.0 111.769 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 149.36 -25.31 1.23 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 119.907 -1.14 . . . . 1.0 113.678 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.68 HG13 ' H ' ' A' ' 103' ' ' GLU . 0.4 OUTLIER -76.73 -163.02 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-N 117.437 0.619 . . . . 1.0 110.321 -178.615 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.68 ' H ' HG13 ' A' ' 102' ' ' VAL . 12.5 pt-20 -159.97 166.64 29.67 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 108.389 -0.967 . . . . 1.0 108.389 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.778 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -63.75 -25.23 68.1 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 123.304 0.378 . . . . 1.0 111.686 -174.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.41 -36.19 75.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.112 0.482 . . . . 1.0 110.142 175.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.623 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 0.8 OUTLIER -98.15 -42.82 7.27 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 115.525 -0.761 . . . . 1.0 111.293 -177.163 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.778 HG12 ' HA ' ' A' ' 104' ' ' ALA . 7.7 p -78.34 118.09 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 N-CA-C 109.266 -0.642 . . . . 1.0 109.266 -176.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.549 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 17.7 mmm180 -136.3 147.53 47.51 Favored 'General case' 0 C--N 1.32 -0.703 0 O-C-N 121.633 -0.667 . . . . 1.0 110.352 -178.042 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 83.0 mmm -78.09 137.45 38.23 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.889 -0.596 . . . . 1.0 110.382 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.529 HD23 HG11 ' A' ' 87' ' ' VAL . 3.1 tm? -56.06 -49.09 74.75 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 123.031 0.207 . . . . 1.0 111.239 179.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 21.0 ttt180 -71.87 -11.9 61.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.011 0.434 . . . . 1.0 111.007 -178.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.779 ' HB2' ' HB3' ' A' ' 121' ' ' ALA . 26.7 t -75.81 -9.67 58.79 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.944 -0.303 . . . . 1.0 110.705 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.574 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 97.3 m-85 -92.41 -19.81 21.68 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.237 0.542 . . . . 1.0 110.366 176.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -60.72 124.22 78.19 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 114.945 -1.025 . . . . 1.0 111.685 -177.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.504 ' HD2' ' O ' ' A' ' 144' ' ' SER . 59.5 Cg_endo -73.93 -16.72 22.98 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.441 2.094 . . . . 1.0 111.939 176.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 28.5 mmm180 -86.61 -4.17 59.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.957 -0.565 . . . . 1.0 110.991 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 79.5 p -62.86 100.11 0.19 Allowed 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.337 0.589 . . . . 1.0 111.982 -178.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -56.06 -46.09 85.68 Favored Glycine 0 C--N 1.333 0.391 0 CA-C-N 115.367 -0.833 . . . . 1.0 111.96 176.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.559 HG22 ' H ' ' A' ' 120' ' ' HIS . 1.3 m -112.35 173.61 6.29 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.125 -0.694 . . . . 1.0 109.125 176.077 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.559 ' H ' HG22 ' A' ' 119' ' ' THR . 24.6 m-70 -75.46 147.84 39.55 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 109.569 -0.53 . . . . 1.0 109.569 178.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.779 ' HB3' ' HB2' ' A' ' 112' ' ' SER . . . -79.53 151.88 30.48 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 115.358 -0.837 . . . . 1.0 110.04 178.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.577 HD13 ' O ' ' A' ' 121' ' ' ALA . 1.0 OUTLIER -152.01 -27.01 0.18 Allowed 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 113.275 -1.784 . . . . 1.0 108.434 -178.256 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.518 ' OD1' ' HA ' ' A' ' 90' ' ' ASP . 17.6 t0 -167.41 143.48 4.18 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.504 -1.225 . . . . 1.0 107.83 -178.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.449 ' HB ' ' O ' ' A' ' 89' ' ' LEU . 94.9 t -94.54 144.57 9.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 110.121 -0.326 . . . . 1.0 110.121 -178.11 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -73.23 -165.76 0.27 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.885 0.374 . . . . 1.0 110.733 -178.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -161.06 162.98 21.42 Favored Pre-proline 0 C--N 1.318 -0.773 0 C-N-CA 120.35 -0.54 . . . . 1.0 109.595 -174.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.604 ' HB3' ' HB3' ' A' ' 134' ' ' ASP . 99.1 Cg_exo -47.73 155.73 1.45 Allowed 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 123.175 2.584 . . . . 1.0 113.246 178.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.437 ' HD2' ' CD2' ' A' ' 129' ' ' TYR . 79.2 t80 -93.81 -46.97 6.97 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.579 -0.737 . . . . 1.0 109.457 -179.092 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.437 ' CD2' ' HD2' ' A' ' 128' ' ' TYR . 0.4 OUTLIER -123.15 -21.85 5.32 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.813 176.175 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 87.19 59.01 1.8 Allowed Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.213 -0.994 . . . . 1.0 111.975 178.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -113.13 -168.42 1.32 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.054 -1.091 . . . . 1.0 108.054 178.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -62.12 -38.48 89.06 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.633 -0.506 . . . . 1.0 109.633 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 7.6 m -60.7 -49.6 76.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.865 -0.607 . . . . 1.0 110.579 -179.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.604 ' HB3' ' HB3' ' A' ' 127' ' ' PRO . 1.2 m-20 -56.89 -34.24 67.68 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.168 -0.469 . . . . 1.0 112.188 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -70.22 -44.41 68.67 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.869 0.366 . . . . 1.0 110.423 -177.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -79.27 -17.42 54.75 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.607 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.552 ' O ' HG23 ' A' ' 141' ' ' VAL . 10.9 tp10 -64.31 -48.28 76.23 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.543 -0.91 . . . . 1.0 108.543 174.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.683 ' HA ' HG23 ' A' ' 141' ' ' VAL . 54.8 t -61.9 -39.74 84.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.225 -0.898 . . . . 1.0 109.648 176.006 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.446 ' HB2' ' HE1' ' A' ' 20' ' ' MET . 46.1 t80 -53.44 -41.4 66.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.203 -0.908 . . . . 1.0 109.107 175.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.694 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -68.28 -39.83 82.01 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.323 -0.853 . . . . 1.0 110.629 177.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.683 HG23 ' HA ' ' A' ' 138' ' ' VAL . 15.9 t -55.6 -51.43 58.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-O 121.932 0.872 . . . . 1.0 109.83 177.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.446 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 7.0 mt -65.51 -51.59 61.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 114.755 -1.111 . . . . 1.0 111.775 -178.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.694 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 8.1 pt-20 -55.12 -32.79 62.32 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.839 -0.344 . . . . 1.0 110.29 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.504 ' O ' ' HD2' ' A' ' 115' ' ' PRO . 2.3 t -73.64 -30.18 62.79 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.488 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.453 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -86.17 -22.63 26.9 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-N 116.006 -0.543 . . . . 1.0 111.636 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.686 HD22 ' HB3' ' A' ' 25' ' ' PHE . 11.0 mt -54.18 -41.72 90.05 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 112.744 0.646 . . . . 1.0 112.744 -178.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.715 ' HA ' ' CD2' ' A' ' 150' ' ' HIS . 60.3 Cg_endo -68.36 -7.68 20.84 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 122.371 2.048 . . . . 1.0 111.866 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.574 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -108.48 -33.55 2.88 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 110.234 -1.146 . . . . 1.0 110.234 178.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.538 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -75.14 -54.34 7.31 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.327 -0.62 . . . . 1.0 109.327 -179.797 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.715 ' CD2' ' HA ' ' A' ' 147' ' ' PRO . 2.0 p80 -56.16 -46.81 79.15 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 115.268 -0.878 . . . . 1.0 110.471 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.448 ' N ' ' CG ' ' A' ' 150' ' ' HIS . 2.0 t70 -59.62 -37.94 79.98 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.764 -1.107 . . . . 1.0 110.411 -178.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . 0.784 ' HZ3' HD21 ' A' ' 5' ' ' LEU . 28.2 t90 -64.52 -54.66 28.87 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 115.637 -0.71 . . . . 1.0 109.858 178.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.636 HG22 ' O ' ' A' ' 150' ' ' HIS . 3.5 m -58.77 -37.8 68.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.571 -0.529 . . . . 1.0 109.571 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.462 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 2.7 m-20 -59.44 -56.39 22.61 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 121.487 0.661 . . . . 1.0 110.765 177.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.609 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 6.3 pt-20 -60.63 -37.92 83.06 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 114.901 -1.045 . . . . 1.0 110.369 -177.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.477 ' HA ' ' HD3' ' A' ' 156' ' ' ARG . 1.0 OUTLIER -74.11 -48.67 27.97 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.571 -0.741 . . . . 1.0 111.361 -177.222 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 3.9 pp -60.82 -27.77 68.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.233 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -72.64 -52.11 16.72 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.842 -0.617 . . . . 1.0 110.802 178.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.429 HH11 ' HD3' ' A' ' 159' ' ' ARG . 0.0 OUTLIER -80.56 -3.49 50.46 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.546 0.572 . . . . 1.0 112.546 -178.181 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -78.3 40.95 0.37 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.592 0.71 . . . . 1.0 111.39 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -76.18 178.98 48.61 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.662 -0.699 . . . . 1.0 111.887 177.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -82.87 23.92 0.78 Allowed 'Trans proline' 0 CA--C 1.517 -0.336 0 C-N-CA 123.144 2.563 . . . . 1.0 112.825 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 53.6 m . . . . . 0 C--N 1.304 -1.412 0 CA-C-N 114.738 -1.119 . . . . 1.0 110.631 -179.525 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.683 0 N-CA-C 112.117 -0.393 . . . . 1.0 112.117 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt 69.83 32.68 3.1 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.642 0.735 . . . . 1.0 110.467 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.3 m -89.31 129.24 35.89 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.887 -1.051 . . . . 1.0 109.69 178.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.26 148.06 93.53 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.215 0.531 . . . . 1.0 110.723 178.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.579 ' HB2' ' HG2' ' A' ' 39' ' ' ARG . 25.3 Cg_endo -63.56 167.25 13.66 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 123.708 2.939 . . . . 1.0 115.253 -174.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.655 HD21 ' HZ3' ' A' ' 152' ' ' TRP . 0.4 OUTLIER -74.3 -173.35 1.67 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 113.487 -1.688 . . . . 1.0 110.024 178.273 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.63 ' HB3' ' H ' ' A' ' 84' ' ' ASP . 3.0 t-160 -156.48 92.14 1.29 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.578 -0.449 . . . . 1.0 110.878 -178.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.784 HG13 HD13 ' A' ' 85' ' ' LEU . 2.9 t -96.1 111.11 25.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.351 -0.611 . . . . 1.0 109.351 177.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.57 HG22 ' HG ' ' A' ' 86' ' ' LEU . 9.2 t -112.17 113.88 26.38 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.221 0.534 . . . . 1.0 110.291 179.152 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.548 ' CE2' ' HA ' ' A' ' 22' ' ' GLU . 1.0 OUTLIER -83.43 125.3 31.56 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 122.004 -0.435 . . . . 1.0 110.289 -178.564 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.492 ' CG1' HG23 ' A' ' 45' ' ' THR . 37.6 t -112.18 111.12 34.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.802 -0.635 . . . . 1.0 112.161 -176.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.596 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 48.3 t -135.73 160.0 39.89 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.043 -1.095 . . . . 1.0 108.043 176.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -64.21 -32.23 73.73 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.334 0.588 . . . . 1.0 109.79 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.538 ' C ' ' H ' ' A' ' 15' ' ' ILE . . . -111.27 84.66 0.37 Allowed Glycine 0 N--CA 1.436 -1.328 0 CA-C-N 115.149 -0.932 . . . . 1.0 110.868 174.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.604 ' ND2' ' HB1' ' A' ' 73' ' ' ALA . 10.5 p-10 -65.0 16.07 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.262 1.425 . . . . 1.0 112.105 178.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.538 ' H ' ' C ' ' A' ' 13' ' ' GLY . 6.9 pt -119.89 -3.34 9.42 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.045 177.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.433 ' HB2' ' H ' ' A' ' 17' ' ' ARG . 9.2 m -115.13 -87.08 0.59 Allowed 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.679 -0.408 . . . . 1.0 112.041 -176.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.677 ' HG2' ' HG ' ' A' ' 89' ' ' LEU . 15.7 tpp180 -67.45 -50.43 59.24 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.352 -0.385 . . . . 1.0 112.014 -174.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.605 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 33.8 m -54.39 -59.05 11.24 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-N 116.321 -0.4 . . . . 1.0 111.882 -178.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.472 ' HA ' ' HB2' ' A' ' 22' ' ' GLU . 40.6 Cg_endo -63.89 -20.87 68.84 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 121.933 1.755 . . . . 1.0 113.029 -179.087 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.559 ' HB3' HD13 ' A' ' 142' ' ' ILE . 39.5 mmm -61.54 -55.51 30.2 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 110.056 -0.35 . . . . 1.0 110.056 177.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.418 ' HB2' ' CG2' ' A' ' 142' ' ' ILE . . . -72.24 -26.67 62.1 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 115.81 -0.632 . . . . 1.0 110.416 -179.008 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.64 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 18.1 tt0 -50.7 -54.56 22.14 Favored 'General case' 0 C--O 1.216 -0.686 0 CA-C-N 114.776 -1.102 . . . . 1.0 109.811 179.096 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.753 ' HB3' ' HG2' ' A' ' 68' ' ' PRO . 0.0 OUTLIER -84.15 -26.3 28.97 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.443 -0.799 . . . . 1.0 110.729 -175.803 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.565 ' HB3' HD11 ' A' ' 146' ' ' LEU . 90.9 mtp -63.91 -75.52 0.08 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.644 0.609 . . . . 1.0 112.644 -176.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.749 ' HB3' HD22 ' A' ' 146' ' ' LEU . 18.2 p90 -76.99 -29.57 55.54 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 119.696 -0.801 . . . . 1.0 111.311 -175.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.708 ' HB2' HG21 ' A' ' 40' ' ' VAL . . . -63.86 -37.0 85.75 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 119.2 -1.0 . . . . 1.0 110.562 179.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.676 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -63.84 -38.42 91.03 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 108.801 -0.814 . . . . 1.0 108.801 177.363 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.513 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 60.7 mt-30 -58.83 -43.84 90.79 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-O 121.149 0.499 . . . . 1.0 110.107 175.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.681 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 95.6 mt -54.84 -61.5 2.27 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.425 -0.807 . . . . 1.0 110.984 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.653 ' HD3' ' HA ' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -59.54 -35.73 74.77 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.763 -0.375 . . . . 1.0 111.565 179.633 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 3.4 m170 -62.83 -27.96 69.68 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 111.934 0.346 . . . . 1.0 111.934 177.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.681 ' HG2' ' O ' ' A' ' 29' ' ' LEU . 4.7 ptm85 -97.13 -22.0 17.01 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 119.796 -0.762 . . . . 1.0 110.291 -179.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 112.34 36.16 1.66 Allowed Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.226 -0.897 . . . . 1.0 112.528 177.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 18.9 mt -131.74 7.48 4.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.158 0.504 . . . . 1.0 109.814 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.409 ' HA3' ' HB3' ' A' ' 30' ' ' ARG . . . -60.56 -32.25 77.47 Favored Glycine 0 C--N 1.332 0.321 0 CA-C-N 115.831 -0.622 . . . . 1.0 113.03 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.648 ' HA ' ' NH1' ' A' ' 39' ' ' ARG . 3.2 m-20 -90.29 -15.41 31.28 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.935 0.398 . . . . 1.0 110.179 177.115 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -81.16 -22.7 38.77 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.61 -0.723 . . . . 1.0 110.916 178.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.594 HG13 ' HB3' ' A' ' 5' ' ' LEU . 8.7 t -133.7 123.35 45.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.675 0.274 . . . . 1.0 110.932 -178.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.648 ' NH1' ' HA ' ' A' ' 36' ' ' ASP . 24.2 mmt180 -96.92 98.0 9.74 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.157 0.503 . . . . 1.0 110.757 178.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.708 HG21 ' HB2' ' A' ' 26' ' ' ALA . 0.8 OUTLIER -92.25 120.89 42.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-O 122.209 1.005 . . . . 1.0 110.699 179.652 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.486 ' O ' ' HA ' ' A' ' 8' ' ' THR . 82.3 p -131.41 -175.24 3.64 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 113.466 -1.697 . . . . 1.0 110.082 -177.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.605 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 78.3 p -157.82 161.46 38.37 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.797 -0.361 . . . . 1.0 110.57 -178.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.635 ' HA ' ' O ' ' A' ' 74' ' ' ALA . . . -163.48 165.71 23.46 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.283 0.564 . . . . 1.0 111.522 -178.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.596 ' HA2' ' O ' ' A' ' 11' ' ' CYS . . . -126.01 134.07 8.51 Favored Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 115.284 -0.871 . . . . 1.0 111.415 178.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.492 HG23 ' CG1' ' A' ' 10' ' ' VAL . 26.9 p -71.57 -26.39 62.6 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.827 0.313 . . . . 1.0 111.433 -178.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -107.88 7.8 36.09 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.892 -0.671 . . . . 1.0 112.545 -177.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 43.34 39.8 2.3 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 113.569 0.951 . . . . 1.0 113.569 178.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -44.67 -76.2 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.443 0.639 . . . . 1.0 112.063 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 52.6 m-70 -107.01 44.46 1.06 Allowed 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.278 -0.873 . . . . 1.0 111.162 178.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.0 p -60.06 129.04 22.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.915 -0.584 . . . . 1.0 110.809 178.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.84 -13.42 66.0 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.899 -0.667 . . . . 1.0 112.26 -178.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -82.29 -162.48 0.56 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.009 0.433 . . . . 1.0 109.864 179.058 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 38.4 t -119.36 173.48 6.93 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.239 -0.652 . . . . 1.0 109.239 -179.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.73 135.55 47.06 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.821 0.343 . . . . 1.0 111.61 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.79 ' OD1' ' HG3' ' A' ' 57' ' ' ARG . 15.6 t0 -51.54 134.62 29.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.139 -0.937 . . . . 1.0 111.191 -179.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -48.31 -32.1 6.91 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.159 -0.928 . . . . 1.0 113.04 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.79 ' HG3' ' OD1' ' A' ' 55' ' ' ASP . 6.5 mtt180 -68.56 -50.71 49.76 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.254 0.55 . . . . 1.0 109.625 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.5 -32.19 71.98 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.006 -0.997 . . . . 1.0 110.405 -176.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.09 -45.45 94.68 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 109.433 -0.581 . . . . 1.0 109.433 176.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.25 -44.59 95.33 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.927 -0.654 . . . . 1.0 111.76 176.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.627 HG23 ' O ' ' A' ' 57' ' ' ARG . 64.5 t -57.05 -56.51 14.37 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 CA-C-O 121.279 0.561 . . . . 1.0 111.152 178.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.763 ' HB2' HG22 ' A' ' 69' ' ' THR . 88.4 mt -60.13 -52.46 65.25 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.087 -0.506 . . . . 1.0 111.398 -179.271 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -60.59 -28.61 68.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.687 -0.233 . . . . 1.0 110.897 -178.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.49 -34.12 77.22 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-O 121.106 0.479 . . . . 1.0 110.333 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -95.55 4.95 52.68 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.859 -0.61 . . . . 1.0 111.178 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.58 21.52 61.83 Favored Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 116.002 -0.544 . . . . 1.0 112.308 178.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -91.84 150.91 41.58 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.771 -0.214 . . . . 1.0 110.444 178.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.753 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 37.8 Cg_endo -68.41 155.68 68.32 Favored 'Trans proline' 0 CA--C 1.51 -0.687 0 C-N-CA 122.334 2.023 . . . . 1.0 110.162 176.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.763 HG22 ' HB2' ' A' ' 62' ' ' LEU . 56.6 p -134.79 7.3 3.49 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 119.778 -0.769 . . . . 1.0 111.709 -177.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.434 ' O ' ' HE2' ' A' ' 23' ' ' LYS . 12.8 t70 -74.49 132.52 41.96 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 108.791 -0.818 . . . . 1.0 108.791 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.485 ' HB2' ' HE2' ' A' ' 23' ' ' LYS . 37.2 t60 -170.05 151.12 3.91 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.132 0.491 . . . . 1.0 110.585 -175.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.405 ' HA ' ' HD3' ' A' ' 72' ' ' ARG . 3.2 tpp85 -130.71 109.37 10.57 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 107.818 -1.178 . . . . 1.0 107.818 176.057 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.604 ' HB1' ' ND2' ' A' ' 14' ' ' ASN . . . -56.32 137.45 52.42 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.097 -0.956 . . . . 1.0 112.084 -176.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.635 ' O ' ' HA ' ' A' ' 43' ' ' ALA . . . -133.6 145.41 50.01 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.834 -0.621 . . . . 1.0 109.976 179.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -84.45 154.77 22.57 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.737 -0.468 . . . . 1.0 109.737 177.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.538 HG11 ' CD2' ' A' ' 97' ' ' LEU . 16.6 t -62.39 107.17 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.359 0.599 . . . . 1.0 110.528 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.456 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -115.67 -174.21 17.74 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 115.089 -0.96 . . . . 1.0 110.869 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 68.2 m -57.04 -43.23 81.76 Favored 'General case' 0 C--N 1.319 -0.75 0 O-C-N 123.681 0.283 . . . . 1.0 110.304 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -58.33 -31.26 67.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 1.0 111.536 178.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.554 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 80.2 m80 -79.5 -37.71 36.08 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.834 0.35 . . . . 1.0 110.251 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 77' ' ' GLY . 41.4 mt -67.97 -19.11 64.92 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.783 -0.644 . . . . 1.0 110.782 177.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.44 -3.39 59.0 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.909 -0.587 . . . . 1.0 110.732 -178.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.542 ' HB1' ' O ' ' A' ' 6' ' ' HIS . . . -61.81 152.08 32.52 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.948 -0.569 . . . . 1.0 111.646 179.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.63 ' H ' ' HB3' ' A' ' 6' ' ' HIS . 11.4 t70 -79.79 -14.32 58.79 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.071 0.463 . . . . 1.0 109.872 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.784 HD13 HG13 ' A' ' 7' ' ' VAL . 0.3 OUTLIER -154.2 117.06 4.44 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 108.641 -0.874 . . . . 1.0 108.641 -176.818 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.615 ' HB3' HD13 ' A' ' 97' ' ' LEU . 5.3 mp -107.98 106.31 16.5 Favored 'General case' 0 N--CA 1.423 -1.805 0 CA-C-N 115.683 -0.689 . . . . 1.0 109.639 178.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.547 HG11 HD23 ' A' ' 110' ' ' LEU . 55.6 t -85.72 91.71 3.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.204 -0.907 . . . . 1.0 110.542 -176.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.7 149.69 29.63 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.332 -0.849 . . . . 1.0 110.85 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.677 ' HG ' ' HG2' ' A' ' 17' ' ' ARG . 3.7 mm? -106.3 1.18 25.68 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.851 -0.613 . . . . 1.0 109.754 178.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -154.0 146.98 24.48 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.464 -0.789 . . . . 1.0 110.519 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.406 ' H ' ' HG2' ' A' ' 91' ' ' ARG . 11.4 ptt180 -60.58 -20.65 61.12 Favored 'General case' 0 C--N 1.33 -0.247 0 O-C-N 123.983 0.802 . . . . 1.0 110.946 177.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.726 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 78.9 m-20 -77.63 -47.82 18.36 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.19 -0.67 . . . . 1.0 109.19 178.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.737 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 8.8 m170 -61.26 -47.05 87.8 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 109.508 -0.552 . . . . 1.0 109.508 179.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.489 ' HA ' HG21 ' A' ' 107' ' ' VAL . . . -58.12 -42.37 85.62 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.1 -0.5 . . . . 1.0 110.732 179.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.69 ' O ' ' HG2' ' A' ' 99' ' ' GLN . 16.9 ttm180 -60.27 -45.29 93.8 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 115.636 -0.711 . . . . 1.0 111.47 178.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.765 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 50.1 mt -63.23 -49.99 72.01 Favored 'General case' 0 C--O 1.22 -0.475 0 O-C-N 123.52 0.513 . . . . 1.0 109.979 -175.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.737 ' HG ' ' O ' ' A' ' 93' ' ' HIS . 27.3 mt -53.49 -57.74 9.61 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.771 -0.649 . . . . 1.0 111.467 -178.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.575 ' HA ' ' HB ' ' A' ' 102' ' ' VAL . 6.6 ptt180 -60.42 -44.82 95.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.042 -0.526 . . . . 1.0 111.778 -176.385 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.69 ' HG2' ' O ' ' A' ' 95' ' ' ARG . 8.4 pt20 -67.71 -20.82 65.31 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.068 0.461 . . . . 1.0 110.608 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.765 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 8.2 mt -80.08 -8.32 59.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.967 -0.56 . . . . 1.0 111.814 179.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 147.5 -28.75 1.48 Allowed Glycine 0 C--N 1.331 0.303 0 C-N-CA 119.786 -1.197 . . . . 1.0 112.955 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.816 HG12 ' H ' ' A' ' 103' ' ' GLU . 2.1 t -73.84 -154.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 C-N-CA 123.036 0.535 . . . . 1.0 110.949 -178.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.816 ' H ' HG12 ' A' ' 102' ' ' VAL . 12.5 pt-20 -168.02 165.7 13.45 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.646 -0.872 . . . . 1.0 108.646 -179.092 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.78 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -65.59 -24.02 66.97 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.676 0.274 . . . . 1.0 111.664 -176.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.7 -36.62 74.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.418 0.628 . . . . 1.0 109.983 175.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.653 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 7.7 mtt-85 -94.92 -45.16 7.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.039 -0.982 . . . . 1.0 110.704 -177.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.78 HG12 ' HA ' ' A' ' 104' ' ' ALA . 7.3 p -79.94 122.6 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-O 121.415 0.626 . . . . 1.0 110.092 -177.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.538 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 7.8 mmm180 -138.12 146.31 42.68 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.079 -0.712 . . . . 1.0 109.079 -178.216 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.438 ' HE3' HG23 ' A' ' 124' ' ' VAL . 86.5 mmm -79.22 134.95 36.66 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.024 -0.534 . . . . 1.0 110.378 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.547 HD23 HG11 ' A' ' 87' ' ' VAL . 3.2 tm? -56.97 -49.18 76.49 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.671 0.272 . . . . 1.0 111.108 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 16.6 ttm180 -69.52 -21.35 63.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.886 0.374 . . . . 1.0 110.53 -177.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.405 ' CB ' ' HB2' ' A' ' 109' ' ' MET . 32.6 t -77.04 -6.04 51.16 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.424 -0.353 . . . . 1.0 111.138 -178.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.571 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 85.6 m-85 -87.44 -19.97 27.28 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.952 -0.388 . . . . 1.0 109.952 175.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.519 ' HB3' ' HB2' ' A' ' 117' ' ' SER . 61.7 t0 -65.33 118.56 51.45 Favored Pre-proline 0 C--O 1.233 0.19 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.198 -178.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -66.75 -16.73 51.11 Favored 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 122.357 2.038 . . . . 1.0 111.849 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 30.8 mmm-85 -92.91 -21.5 19.79 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.726 -0.67 . . . . 1.0 110.655 -178.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.519 ' HB2' ' HB3' ' A' ' 114' ' ' ASP . 7.2 t -75.59 58.73 1.08 Allowed 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.135 -0.484 . . . . 1.0 111.579 -177.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 62.15 -99.17 0.22 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.895 -0.669 . . . . 1.0 112.946 -178.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 91.1 m -158.32 -36.16 0.07 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.503 0.668 . . . . 1.0 110.1 -178.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 26.4 m80 -133.32 134.57 44.0 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.486 178.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -132.24 95.42 3.65 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.087 -0.708 . . . . 1.0 109.087 177.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -94.41 24.05 4.78 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.222 -177.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -171.14 135.35 0.98 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.029 -0.532 . . . . 1.0 109.718 -178.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.562 ' HB ' ' O ' ' A' ' 89' ' ' LEU . 42.2 t -121.75 152.32 25.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.104 0.478 . . . . 1.0 109.964 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.525 ' HG3' ' NH2' ' A' ' 17' ' ' ARG . 4.2 pt-20 -63.94 179.63 0.5 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.265 -0.88 . . . . 1.0 112.854 -178.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -152.75 115.11 2.81 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 114.586 -1.188 . . . . 1.0 109.274 -179.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.654 ' HG3' HG21 ' A' ' 138' ' ' VAL . 73.6 Cg_endo -79.02 92.14 1.16 Allowed 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.389 2.059 . . . . 1.0 112.89 -177.264 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -92.52 -28.37 16.83 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 113.862 1.06 . . . . 1.0 113.862 179.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -69.24 -35.31 75.99 Favored 'General case' 0 CA--C 1.512 -0.514 0 C-N-CA 119.189 -1.004 . . . . 1.0 112.803 -173.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 77.2 52.82 5.47 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 118.887 -1.625 . . . . 1.0 112.589 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.558 ' H ' ' HB3' ' A' ' 134' ' ' ASP . 3.2 t0 -108.65 172.44 6.84 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 107.781 -1.192 . . . . 1.0 107.781 177.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -66.12 -39.19 89.73 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 108.693 -0.854 . . . . 1.0 108.693 176.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 10.7 m -63.44 -49.73 72.57 Favored 'General case' 0 C--O 1.222 -0.365 0 CA-C-N 115.1 -0.955 . . . . 1.0 109.382 177.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.558 ' HB3' ' H ' ' A' ' 131' ' ' ASP . 38.8 t70 -51.67 -37.14 49.25 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.192 -0.913 . . . . 1.0 111.833 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.489 ' CE1' ' HD3' ' A' ' 57' ' ' ARG . 15.3 m-30 -72.69 -52.6 14.59 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.497 0.665 . . . . 1.0 110.694 -178.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -71.38 -22.85 61.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.5 -0.773 . . . . 1.0 111.307 -176.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.62 ' O ' HG23 ' A' ' 141' ' ' VAL . 7.9 tp10 -61.22 -47.66 85.06 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 108.7 -0.852 . . . . 1.0 108.7 176.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.654 HG21 ' HG3' ' A' ' 127' ' ' PRO . 75.6 t -56.7 -47.54 82.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 114.419 -1.264 . . . . 1.0 110.084 176.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.518 ' HB2' HG11 ' A' ' 61' ' ' VAL . 52.7 t80 -55.58 -44.56 77.03 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.616 -1.174 . . . . 1.0 110.5 178.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.433 ' O ' ' HG2' ' A' ' 143' ' ' GLU . . . -62.83 -44.69 95.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.991 -0.55 . . . . 1.0 111.518 -179.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 137' ' ' GLU . 21.2 t -56.28 -48.03 80.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.338 0.59 . . . . 1.0 110.584 178.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.559 HD13 ' HB3' ' A' ' 20' ' ' MET . 5.8 mt -67.11 -49.56 71.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 115.413 -0.812 . . . . 1.0 112.127 -178.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.464 ' HA ' ' HG ' ' A' ' 146' ' ' LEU . 11.2 pt-20 -56.19 -32.7 64.61 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.98 0.419 . . . . 1.0 110.451 179.359 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 63.3 m -73.06 -27.4 61.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.902 -0.59 . . . . 1.0 110.612 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.477 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -86.44 -25.09 25.41 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 115.67 -0.696 . . . . 1.0 111.92 178.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.749 HD22 ' HB3' ' A' ' 25' ' ' PHE . 14.9 mt -55.49 -36.69 48.58 Favored Pre-proline 0 CA--C 1.546 0.814 0 N-CA-C 112.745 0.646 . . . . 1.0 112.745 -178.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.643 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 42.1 Cg_endo -68.58 -14.91 40.65 Favored 'Trans proline' 0 C--N 1.359 1.106 0 C-N-CA 122.317 2.011 . . . . 1.0 111.661 176.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.571 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -101.97 -34.12 4.42 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.133 -0.94 . . . . 1.0 110.941 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.501 HD11 HG21 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -72.49 -40.0 67.22 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.18 -1.044 . . . . 1.0 108.18 179.334 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.482 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 0.2 OUTLIER -54.54 -54.28 43.33 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 114.648 -1.16 . . . . 1.0 110.541 175.427 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -57.27 -42.32 81.38 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.125 -0.943 . . . . 1.0 111.445 -175.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . 0.655 ' HZ3' HD21 ' A' ' 5' ' ' LEU . 18.0 t90 -62.27 -57.91 9.67 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.415 -0.811 . . . . 1.0 110.084 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.506 ' HB ' HD22 ' A' ' 5' ' ' LEU . 7.8 m -60.65 -43.82 95.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.675 -177.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.42 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 8.7 m-20 -60.87 -49.55 77.01 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 121.208 0.527 . . . . 1.0 111.015 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 5.4 pt-20 -64.85 -36.26 83.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.977 -0.556 . . . . 1.0 110.656 -178.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.53 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 0.6 OUTLIER -74.13 -43.41 57.61 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 115.769 -0.65 . . . . 1.0 110.869 -176.985 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 4.2 pp -66.31 -22.18 66.28 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.124 0.487 . . . . 1.0 109.748 178.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -72.08 -51.37 21.9 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.847 -0.615 . . . . 1.0 109.559 175.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.7 3.34 11.9 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.974 0.416 . . . . 1.0 111.569 178.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -78.51 -1.94 36.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.373 0.606 . . . . 1.0 109.935 176.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -97.57 143.05 16.49 Favored Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.388 -0.824 . . . . 1.0 111.57 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -85.57 29.5 0.53 Allowed 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 123.516 2.811 . . . . 1.0 112.65 -178.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 9.4 t . . . . . 0 C--N 1.3 -1.548 0 CA-C-N 114.613 -1.176 . . . . 1.0 109.709 -179.506 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.801 0 N-CA-C 112.391 -0.284 . . . . 1.0 112.391 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ptt? -160.42 173.71 15.2 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.705 -0.48 . . . . 1.0 109.705 -179.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.1 m -84.48 -62.48 1.54 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.273 0.558 . . . . 1.0 110.016 178.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.418 ' HB3' ' HD2' ' A' ' 4' ' ' PRO . 0.2 OUTLIER -157.0 160.47 30.66 Favored Pre-proline 0 C--O 1.236 0.381 0 CA-C-N 115.071 -0.968 . . . . 1.0 108.404 -179.508 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.418 ' HD2' ' HB3' ' A' ' 3' ' ' ASP . 26.2 Cg_endo -69.96 170.04 17.76 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.649 2.232 . . . . 1.0 111.842 176.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.798 HD13 ' HB3' ' A' ' 84' ' ' ASP . 0.2 OUTLIER -67.02 178.46 1.4 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.456 -0.572 . . . . 1.0 109.456 178.101 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.664 ' HA ' ' O ' ' A' ' 39' ' ' ARG . 2.7 t-160 -156.06 89.48 1.15 Allowed 'General case' 0 C--N 1.321 -0.651 0 O-C-N 122.053 -0.404 . . . . 1.0 109.989 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.769 HG13 HD13 ' A' ' 85' ' ' LEU . 2.1 t -96.51 105.57 17.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.366 -0.379 . . . . 1.0 110.134 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.645 ' CG2' ' HG ' ' A' ' 86' ' ' LEU . 13.0 t -108.65 115.44 30.09 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.079 0.466 . . . . 1.0 110.199 -179.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.568 ' HD1' ' HB ' ' A' ' 87' ' ' VAL . 0.7 OUTLIER -83.74 129.89 34.95 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.793 -0.447 . . . . 1.0 109.793 -178.952 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.657 HG21 HD11 ' A' ' 97' ' ' LEU . 22.0 t -114.38 113.01 42.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.737 -0.665 . . . . 1.0 111.945 -174.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.516 ' HA ' ' CE1' ' A' ' 93' ' ' HIS . 49.2 t -142.78 155.26 44.81 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.359 -0.608 . . . . 1.0 109.359 178.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.1 88.66 2.44 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.393 0.616 . . . . 1.0 111.157 -178.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.775 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 140.59 -45.74 0.96 Allowed Glycine 0 N--CA 1.445 -0.754 0 CA-C-N 115.313 -0.858 . . . . 1.0 111.062 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.676 ' ND2' ' H ' ' A' ' 74' ' ' ALA . 61.0 t30 58.63 23.86 11.43 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.674 0.75 . . . . 1.0 112.202 178.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.4 pt -124.51 3.88 4.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 O-C-N 121.616 -0.678 . . . . 1.0 111.494 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.673 ' O ' ' HG3' ' A' ' 20' ' ' MET . 27.9 m -129.4 -84.19 0.56 Allowed 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.597 -0.441 . . . . 1.0 111.064 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.49 ' H ' ' HD3' ' A' ' 17' ' ' ARG . 1.5 mpt_? -61.56 -58.83 6.58 Favored 'General case' 0 C--O 1.243 0.728 0 CA-C-N 116.211 -0.449 . . . . 1.0 111.939 -175.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.408 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 38.0 m -51.49 -58.58 10.32 Favored Pre-proline 0 CA--C 1.54 0.587 0 N-CA-C 112.982 0.734 . . . . 1.0 112.982 -178.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.408 ' HD3' ' HB2' ' A' ' 18' ' ' SER . 51.7 Cg_endo -63.67 -23.57 69.77 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 121.636 1.557 . . . . 1.0 112.495 -177.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.673 ' HG3' ' O ' ' A' ' 16' ' ' CYS . 61.2 mtp -61.98 -51.65 67.21 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.674 -0.41 . . . . 1.0 110.349 179.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.441 ' HA ' ' HB2' ' A' ' 24' ' ' MET . . . -71.58 -29.42 64.69 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.15 -0.62 . . . . 1.0 110.672 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.632 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 22.1 tt0 -53.17 -53.25 53.26 Favored 'General case' 0 C--O 1.219 -0.514 0 O-C-N 124.166 0.916 . . . . 1.0 110.171 -179.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.723 ' O ' ' HB3' ' A' ' 27' ' ' GLN . 0.3 OUTLIER -84.8 -23.11 29.28 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.031 -0.986 . . . . 1.0 110.364 -175.493 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.513 ' HB3' HD11 ' A' ' 146' ' ' LEU . 2.2 mmm -65.22 -76.35 0.07 Allowed 'General case' 0 C--O 1.238 0.477 0 N-CA-C 113.076 0.769 . . . . 1.0 113.076 -179.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.759 ' HB3' HD22 ' A' ' 146' ' ' LEU . 18.0 p90 -76.37 -29.38 57.13 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 119.852 -0.739 . . . . 1.0 111.243 -174.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.673 ' HB2' HG21 ' A' ' 40' ' ' VAL . . . -64.38 -35.73 81.85 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 119.577 -0.849 . . . . 1.0 110.818 178.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.723 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -63.99 -38.82 92.46 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.63 -0.878 . . . . 1.0 108.63 177.175 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.569 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 71.1 mt-30 -61.04 -41.71 97.09 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 115.285 -0.87 . . . . 1.0 110.638 175.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.562 ' HG ' ' O ' ' A' ' 25' ' ' PHE . 90.1 mt -57.07 -62.01 2.05 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 115.956 -0.566 . . . . 1.0 111.172 -179.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.699 ' HE ' ' HA ' ' A' ' 27' ' ' GLN . 0.1 OUTLIER -58.06 -32.55 68.12 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 120.468 -0.493 . . . . 1.0 111.325 179.582 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -64.11 -28.07 69.52 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.15 0.426 . . . . 1.0 112.15 176.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.583 ' HG3' ' HG ' ' A' ' 34' ' ' LEU . 7.3 ptp180 -95.4 -20.54 19.01 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 121.843 0.83 . . . . 1.0 109.625 178.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 108.77 31.93 3.26 Favored Glycine 0 N--CA 1.441 -0.972 0 CA-C-N 114.833 -1.076 . . . . 1.0 112.101 176.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.583 ' HG ' ' HG3' ' A' ' 32' ' ' ARG . 22.7 mt -119.54 0.5 11.03 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 122.434 -0.451 . . . . 1.0 109.959 -178.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.419 ' H ' ' HA ' ' A' ' 30' ' ' ARG . . . -53.9 -32.13 48.11 Favored Glycine 0 C--N 1.331 0.295 0 CA-C-N 115.943 -0.572 . . . . 1.0 113.137 -179.099 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.774 ' HA ' ' NH1' ' A' ' 39' ' ' ARG . 0.1 OUTLIER -89.52 -20.63 23.59 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-O 121.273 0.559 . . . . 1.0 110.312 178.66 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.89 -25.09 40.73 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.568 -0.742 . . . . 1.0 111.127 -177.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.74 HG23 ' HB3' ' A' ' 5' ' ' LEU . 0.5 OUTLIER -141.16 124.77 16.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.219 0.533 . . . . 1.0 110.826 179.707 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.774 ' NH1' ' HA ' ' A' ' 36' ' ' ASP . 24.6 mmt180 -95.5 106.5 18.58 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.57 -0.741 . . . . 1.0 111.262 -178.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.673 HG21 ' HB2' ' A' ' 26' ' ' ALA . 1.5 m -90.49 137.64 21.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-N 115.884 -0.598 . . . . 1.0 109.396 178.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.517 ' O ' ' HA ' ' A' ' 8' ' ' THR . 24.6 p -146.25 -178.07 5.95 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.063 -0.971 . . . . 1.0 110.009 -175.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.3 p -158.01 157.18 32.49 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.296 -0.562 . . . . 1.0 110.866 -177.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.606 ' HB2' ' CD2' ' A' ' 80' ' ' HIS . . . -163.23 164.51 25.03 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 121.475 0.655 . . . . 1.0 111.64 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' A' ' 11' ' ' CYS . . . -122.63 133.92 9.4 Favored Glycine 0 N--CA 1.441 -0.984 0 CA-C-N 115.06 -0.973 . . . . 1.0 111.046 177.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.529 HG23 ' CG1' ' A' ' 10' ' ' VAL . 12.3 p -69.68 -23.47 63.45 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.834 0.349 . . . . 1.0 111.762 -177.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.439 ' HA3' ' CZ3' ' A' ' 48' ' ' TRP . . . -109.84 8.48 31.79 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.723 -0.751 . . . . 1.0 113.239 -178.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 42.11 38.68 1.16 Allowed 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 113.551 0.945 . . . . 1.0 113.551 178.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.775 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 1.2 m-90 -46.9 -74.29 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.347 0.594 . . . . 1.0 112.278 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.452 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 46.5 m-70 -107.07 42.45 1.3 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.314 -0.857 . . . . 1.0 111.349 -179.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.451 HG23 ' HA ' ' A' ' 74' ' ' ALA . 14.6 p -61.58 132.02 26.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.215 178.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.35 -14.53 63.52 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.921 -0.657 . . . . 1.0 112.186 -177.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.49 -158.84 0.28 Allowed 'General case' 0 C--O 1.236 0.391 0 CA-C-O 120.986 0.422 . . . . 1.0 109.959 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 26.3 t -133.55 173.36 11.59 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.494 -0.558 . . . . 1.0 109.494 -178.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.67 148.15 20.82 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.015 -0.539 . . . . 1.0 111.507 -178.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.406 ' OD1' ' HG2' ' A' ' 57' ' ' ARG . 15.6 t70 -68.41 145.8 53.79 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.371 -0.831 . . . . 1.0 111.417 -178.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.416 ' HG3' ' N ' ' A' ' 57' ' ' ARG . 6.4 pt-20 -47.58 -37.74 12.97 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.953 -1.021 . . . . 1.0 113.224 178.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.613 ' O ' HG23 ' A' ' 61' ' ' VAL . 19.9 ptp180 -70.68 -44.43 67.02 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 121.136 -0.226 . . . . 1.0 110.777 -176.071 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.404 ' O ' HD13 ' A' ' 62' ' ' LEU . . . -70.15 -30.86 68.13 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.689 -0.486 . . . . 1.0 109.689 -179.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.46 -46.75 84.8 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.635 -0.711 . . . . 1.0 109.504 176.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.458 ' O ' ' HG2' ' A' ' 63' ' ' ARG . . . -62.72 -41.98 99.76 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.843 -0.694 . . . . 1.0 111.927 178.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 57' ' ' ARG . 97.5 t -58.23 -59.35 3.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.429 0.633 . . . . 1.0 111.622 178.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.488 ' HB2' HG22 ' A' ' 69' ' ' THR . 10.0 mp -61.72 -48.05 82.51 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.754 -0.657 . . . . 1.0 111.048 -177.155 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.458 ' HG2' ' O ' ' A' ' 60' ' ' GLY . 22.1 ptt180 -58.74 -31.44 68.32 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.611 -0.268 . . . . 1.0 110.888 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.65 -34.24 76.55 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.223 0.535 . . . . 1.0 110.826 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.461 ' HD2' ' O ' ' A' ' 61' ' ' VAL . 90.1 m-70 -96.91 5.55 50.3 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.587 -0.733 . . . . 1.0 110.866 -178.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.85 17.38 63.53 Favored Glycine 0 C--N 1.33 0.236 0 CA-C-N 115.7 -0.682 . . . . 1.0 113.165 176.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.544 ' HD1' ' HG2' ' A' ' 27' ' ' GLN . 71.1 m-85 -88.68 154.89 50.78 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-O 120.501 0.191 . . . . 1.0 110.827 179.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.596 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 21.9 Cg_endo -67.46 151.81 79.54 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.354 2.036 . . . . 1.0 110.123 174.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.488 HG22 ' HB2' ' A' ' 62' ' ' LEU . 67.1 p -132.68 20.15 4.24 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 120.271 -0.572 . . . . 1.0 112.181 -175.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.41 ' C ' ' HZ3' ' A' ' 23' ' ' LYS . 31.3 t70 -113.8 128.2 56.31 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.965 -177.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.581 ' HB3' ' NZ ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -165.76 159.44 16.19 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.429 -0.805 . . . . 1.0 108.923 178.838 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -116.35 120.15 37.94 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.627 -0.879 . . . . 1.0 108.627 178.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 49' ' ' HIS . . . -61.03 136.89 58.22 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.833 0.349 . . . . 1.0 111.77 -178.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.676 ' H ' ' ND2' ' A' ' 14' ' ' ASN . . . -127.63 163.54 24.0 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.07 178.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -98.91 157.26 16.43 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.476 -0.935 . . . . 1.0 108.476 178.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.546 HG11 HD23 ' A' ' 97' ' ' LEU . 41.9 t -71.71 111.98 6.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.159 0.504 . . . . 1.0 110.271 179.229 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.46 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -124.43 -165.21 12.13 Favored Glycine 0 N--CA 1.437 -1.275 0 CA-C-N 115.497 -0.774 . . . . 1.0 111.324 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 83.5 m -56.17 -51.2 68.88 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 122.651 0.381 . . . . 1.0 111.877 -179.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.516 ' HG2' ' N ' ' A' ' 80' ' ' HIS . 0.7 OUTLIER -58.15 -29.76 65.83 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.844 -0.616 . . . . 1.0 110.704 -178.589 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.606 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 79.3 m80 -76.82 -41.61 43.63 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 115.793 -0.64 . . . . 1.0 110.349 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.64 ' O ' HG23 ' A' ' 102' ' ' VAL . 16.6 mt -68.83 -18.67 64.2 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.442 176.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.06 -5.51 59.2 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.185 -178.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.601 ' HB1' ' O ' ' A' ' 6' ' ' HIS . . . -61.34 153.23 27.27 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.534 -0.757 . . . . 1.0 110.764 179.084 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.798 ' HB3' HD13 ' A' ' 5' ' ' LEU . 12.2 t70 -82.46 -11.93 58.18 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.242 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.769 HD13 HG13 ' A' ' 7' ' ' VAL . 0.3 OUTLIER -156.61 114.19 3.2 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 109.283 -0.636 . . . . 1.0 109.283 -178.224 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.645 ' HG ' ' CG2' ' A' ' 8' ' ' THR . 5.1 mp -105.74 106.33 16.78 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 115.407 -0.815 . . . . 1.0 110.069 178.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.6 HG11 HD23 ' A' ' 110' ' ' LEU . 52.6 t -84.79 93.43 3.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 114.772 -1.104 . . . . 1.0 110.856 -176.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.54 143.98 34.34 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.193 -0.912 . . . . 1.0 110.562 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.556 ' O ' ' HB ' ' A' ' 124' ' ' VAL . 4.3 mm? -93.39 -19.24 21.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.494 0.664 . . . . 1.0 109.848 178.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -139.86 154.91 47.42 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.443 -0.799 . . . . 1.0 110.311 -178.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.592 ' HB3' ' O ' ' A' ' 122' ' ' LEU . 5.2 ptm180 -58.67 -22.32 56.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.889 -0.596 . . . . 1.0 111.619 178.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.642 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 94.5 m-20 -75.41 -52.08 11.59 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.861 -0.609 . . . . 1.0 110.278 -178.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.669 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 17.5 m170 -55.92 -45.24 78.77 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.38 -0.827 . . . . 1.0 110.814 -179.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.428 ' HA ' HD12 ' A' ' 97' ' ' LEU . . . -59.86 -44.07 94.33 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.107 0.48 . . . . 1.0 110.463 178.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 13.6 ttm180 -58.99 -42.65 90.54 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.317 -0.856 . . . . 1.0 111.522 178.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.675 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 34.9 mt -66.32 -47.16 74.43 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.599 -177.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.669 ' HG ' ' O ' ' A' ' 93' ' ' HIS . 33.1 mt -53.14 -59.84 4.05 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.189 -0.459 . . . . 1.0 111.725 -177.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.67 ' CA ' HG12 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -58.46 -44.25 89.2 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.406 0.521 . . . . 1.0 112.406 -179.66 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.605 ' HG3' ' O ' ' A' ' 96' ' ' LEU . 1.0 OUTLIER -67.25 -24.74 65.84 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.115 0.483 . . . . 1.0 109.814 179.599 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.675 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 12.5 mt -80.82 -19.46 44.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.456 -0.793 . . . . 1.0 111.896 178.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 152.71 -22.84 0.82 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 119.37 -1.395 . . . . 1.0 114.314 -177.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.687 HG13 ' N ' ' A' ' 103' ' ' GLU . 0.3 OUTLIER -76.05 -161.92 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-N 117.988 0.894 . . . . 1.0 110.502 -179.096 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.824 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 8.6 pt-20 -158.06 160.27 37.21 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 107.671 -1.233 . . . . 1.0 107.671 -177.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.775 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -60.86 -27.08 67.86 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 123.194 0.309 . . . . 1.0 111.183 -175.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.48 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . . . -57.4 -35.38 69.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.101 0.477 . . . . 1.0 110.706 176.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.824 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 9.4 mtt-85 -99.51 -39.68 8.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.508 -0.769 . . . . 1.0 111.551 -177.15 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.775 HG12 ' HA ' ' A' ' 104' ' ' ALA . 9.3 p -80.06 122.25 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 120.661 -0.416 . . . . 1.0 110.85 -174.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.497 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 14.3 mmm180 -141.56 150.54 42.22 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 121.846 -0.534 . . . . 1.0 111.057 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.556 ' HE3' HG23 ' A' ' 124' ' ' VAL . 85.7 mmm -80.92 140.0 35.55 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.726 -0.67 . . . . 1.0 110.525 178.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.6 HD23 HG11 ' A' ' 87' ' ' VAL . 3.0 tm? -58.31 -49.73 76.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.588 0.232 . . . . 1.0 111.245 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 47.7 ttt180 -72.03 -15.7 62.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.714 0.292 . . . . 1.0 111.031 -177.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.4 t -72.46 -10.62 60.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.659 -0.246 . . . . 1.0 110.636 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.533 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 95.8 m-85 -89.39 -20.1 24.38 Favored 'General case' 0 C--O 1.233 0.203 0 O-C-N 122.224 -0.297 . . . . 1.0 110.826 177.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -59.29 119.81 42.4 Favored Pre-proline 0 N--CA 1.466 0.325 0 CA-C-N 115.969 -0.559 . . . . 1.0 111.554 -177.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.74 -22.12 43.87 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.466 2.111 . . . . 1.0 111.869 179.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 27.3 mtm180 -86.65 -15.5 39.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.253 -0.43 . . . . 1.0 111.49 -179.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.0 m -68.97 93.34 0.56 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.88 0.371 . . . . 1.0 111.184 -178.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -52.23 -54.64 25.58 Favored Glycine 0 CA--C 1.52 0.383 0 CA-C-N 115.17 -0.923 . . . . 1.0 113.338 178.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.471 HG22 ' H ' ' A' ' 120' ' ' HIS . 0.7 OUTLIER -86.07 171.31 11.48 Favored 'General case' 0 C--N 1.32 -0.682 0 O-C-N 122.596 -0.356 . . . . 1.0 110.634 -179.548 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.471 ' H ' HG22 ' A' ' 119' ' ' THR . 36.6 m170 -75.86 133.62 40.54 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.817 -0.438 . . . . 1.0 109.817 177.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -103.19 87.11 2.81 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.066 -0.515 . . . . 1.0 110.933 179.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.592 ' O ' ' HB3' ' A' ' 91' ' ' ARG . 2.4 mm? -95.26 15.61 18.82 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.239 -1.022 . . . . 1.0 108.239 175.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -167.76 133.43 1.98 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.358 -1.292 . . . . 1.0 108.182 -177.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.556 HG23 ' HE3' ' A' ' 109' ' ' MET . 40.1 t -109.7 156.15 10.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.843 -0.428 . . . . 1.0 109.843 -177.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.432 ' H ' ' HG2' ' A' ' 125' ' ' GLU . 12.4 pt-20 -74.05 168.52 19.37 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.859 -0.422 . . . . 1.0 109.859 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.433 ' CG ' HH21 ' A' ' 17' ' ' ARG . 15.9 t70 -156.94 96.41 2.14 Favored Pre-proline 0 C--N 1.319 -0.751 0 N-CA-C 108.387 -0.968 . . . . 1.0 108.387 -175.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.714 ' HB2' ' OD1' ' A' ' 134' ' ' ASP . 31.2 Cg_exo -61.88 90.39 0.11 Allowed 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.381 2.054 . . . . 1.0 113.035 -178.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -94.25 41.47 1.09 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.18 0.514 . . . . 1.0 111.672 177.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.598 ' CE2' ' HB3' ' A' ' 127' ' ' PRO . 0.0 OUTLIER -111.95 -32.6 6.54 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.8 -0.815 . . . . 1.0 108.8 -179.446 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 68.86 55.92 10.23 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.06 -0.973 . . . . 1.0 113.244 177.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.638 ' H ' ' HB3' ' A' ' 134' ' ' ASP . 44.9 m-20 -124.2 178.5 5.31 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.107 -1.071 . . . . 1.0 108.107 178.247 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 12.0 t-160 -58.77 -36.3 74.16 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.29 -0.633 . . . . 1.0 109.29 179.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.5 p -61.55 -37.58 84.32 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.005 -0.998 . . . . 1.0 111.226 177.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.714 ' OD1' ' HB2' ' A' ' 127' ' ' PRO . 0.4 OUTLIER -60.31 -44.41 95.46 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 116.058 -0.519 . . . . 1.0 111.352 -177.577 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.533 ' CD1' ' HB2' ' A' ' 57' ' ' ARG . 0.5 OUTLIER -70.87 -48.96 50.98 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.135 0.493 . . . . 1.0 110.391 -175.516 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -70.45 -25.36 63.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.739 -0.664 . . . . 1.0 111.176 -177.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -63.76 -51.07 66.52 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.108 0.48 . . . . 1.0 109.823 177.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.788 ' HA ' HG12 ' A' ' 141' ' ' VAL . 21.3 t -63.11 -41.13 91.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.749 0.785 . . . . 1.0 109.335 177.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.494 ' HB2' HG11 ' A' ' 61' ' ' VAL . 66.8 t80 -56.31 -43.22 78.75 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.566 -0.743 . . . . 1.0 109.727 177.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.531 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -66.92 -49.88 64.16 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.389 -0.823 . . . . 1.0 111.871 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.788 HG12 ' HA ' ' A' ' 138' ' ' VAL . 5.6 p -57.2 -43.19 81.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 CA-C-O 121.565 0.698 . . . . 1.0 110.671 -178.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.633 HD12 HG12 ' A' ' 138' ' ' VAL . 16.4 mt -68.46 -53.83 25.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 115.031 -0.986 . . . . 1.0 111.934 178.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.536 ' HA ' ' HG ' ' A' ' 146' ' ' LEU . 8.3 pt-20 -57.56 -28.43 63.54 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.513 -0.312 . . . . 1.0 110.372 -179.016 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 3.1 t -73.78 -30.04 62.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.085 0.469 . . . . 1.0 110.265 177.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.468 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -86.57 -23.37 25.83 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 116.187 -0.461 . . . . 1.0 111.904 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.759 HD22 ' HB3' ' A' ' 25' ' ' PHE . 17.5 mt -54.9 -37.56 57.51 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 112.146 0.424 . . . . 1.0 112.146 -178.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.622 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 56.1 Cg_endo -69.58 -9.19 25.53 Favored 'Trans proline' 0 C--N 1.364 1.366 0 C-N-CA 122.413 2.076 . . . . 1.0 112.35 177.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.533 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -106.09 -33.27 3.51 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 110.257 -1.137 . . . . 1.0 110.257 178.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.466 HD11 HG21 ' A' ' 87' ' ' VAL . 0.3 OUTLIER -73.4 -41.66 63.05 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.814 -0.81 . . . . 1.0 108.814 178.934 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.447 ' O ' ' HB2' ' A' ' 154' ' ' ASP . 2.1 m-70 -54.56 -50.88 66.9 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.134 -0.939 . . . . 1.0 110.628 177.067 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -60.98 -46.28 91.39 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.493 -0.776 . . . . 1.0 111.389 -176.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . 0.767 ' HZ3' HD11 ' A' ' 5' ' ' LEU . 21.1 t90 -59.45 -55.5 33.88 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.164 -0.925 . . . . 1.0 111.033 -177.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.485 HG11 HG21 ' A' ' 7' ' ' VAL . 6.1 m -61.88 -40.15 86.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.44 -177.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.571 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 1.1 t70 -60.03 -56.23 24.19 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 121.562 0.696 . . . . 1.0 110.574 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.629 ' O ' ' HG3' ' A' ' 159' ' ' ARG . 6.2 pt-20 -63.25 -35.66 81.09 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.894 -1.048 . . . . 1.0 110.922 -176.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 19.5 mmt-85 -72.17 -45.74 59.22 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.743 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.571 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 4.0 pp -65.77 -24.21 66.89 Favored 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 109.417 -0.586 . . . . 1.0 109.417 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -74.99 -52.89 9.98 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.233 -0.894 . . . . 1.0 111.002 178.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.629 ' HG3' ' O ' ' A' ' 155' ' ' GLU . 0.0 OUTLIER -79.38 -9.39 59.58 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 113.273 0.842 . . . . 1.0 113.273 -175.951 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . 0.443 ' HA ' HH11 ' A' ' 159' ' ' ARG . 64.9 t30 -63.02 -48.16 79.93 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.65 -0.42 . . . . 1.0 110.883 -177.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 71.49 -159.88 53.93 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.49 -0.862 . . . . 1.0 112.79 177.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -94.06 29.25 0.27 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 123.718 2.945 . . . . 1.0 112.949 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 1.7 t . . . . . 0 C--N 1.306 -1.325 0 CA-C-N 114.936 -1.029 . . . . 1.0 110.268 179.279 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.615 0 N-CA-C 111.945 -0.462 . . . . 1.0 111.945 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.9 mtt -100.42 -166.22 1.3 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 110.179 -0.304 . . . . 1.0 110.179 179.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 75.5 m -154.99 169.49 23.95 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 110.425 -0.213 . . . . 1.0 110.425 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.635 ' HB3' ' HD2' ' A' ' 4' ' ' PRO . 0.6 OUTLIER -67.97 162.41 59.4 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.404 179.397 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.774 ' HG3' ' HE ' ' A' ' 39' ' ' ARG . 49.0 Cg_endo -72.07 171.11 17.41 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 123.05 2.5 . . . . 1.0 113.541 -179.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.813 HD21 ' HZ3' ' A' ' 152' ' ' TRP . 0.6 OUTLIER -75.65 -172.58 1.91 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.155 -0.93 . . . . 1.0 110.662 178.219 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.509 ' O ' ' HB1' ' A' ' 83' ' ' ALA . 0.1 OUTLIER -157.11 92.8 1.28 Allowed 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 121.107 -0.237 . . . . 1.0 111.136 179.641 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.639 HG13 HD13 ' A' ' 85' ' ' LEU . 1.9 t -97.12 115.3 36.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 108.802 -0.814 . . . . 1.0 108.802 176.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.616 ' CG2' ' HG ' ' A' ' 86' ' ' LEU . 7.2 t -116.28 117.58 30.39 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 120.821 0.343 . . . . 1.0 110.239 178.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.627 ' HD2' ' HB3' ' A' ' 42' ' ' SER . 2.0 m-85 -85.52 133.89 34.06 Favored 'General case' 0 CA--C 1.518 -0.276 0 O-C-N 121.974 -0.454 . . . . 1.0 110.883 -179.08 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.633 HG21 HD11 ' A' ' 97' ' ' LEU . 28.8 t -118.07 118.69 59.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.204 0.526 . . . . 1.0 111.497 -177.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.502 ' HA ' ' CE1' ' A' ' 93' ' ' HIS . 33.9 t -146.54 170.82 16.11 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 178.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.623 HG23 ' NE2' ' A' ' 93' ' ' HIS . 0.9 OUTLIER -80.64 92.65 6.01 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.25 0.548 . . . . 1.0 110.856 179.959 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.967 ' HA2' ' HB2' ' A' ' 48' ' ' TRP . . . 129.35 -40.39 1.7 Allowed Glycine 0 N--CA 1.441 -0.97 0 C-N-CA 120.597 -0.811 . . . . 1.0 111.74 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.472 HD21 ' CB ' ' A' ' 42' ' ' SER . 4.2 t-20 64.33 14.62 8.89 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.843 0.83 . . . . 1.0 111.338 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.486 ' HA ' ' HG3' ' A' ' 19' ' ' PRO . 14.5 pt -121.54 4.21 6.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 O-C-N 121.705 -0.622 . . . . 1.0 112.074 -177.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 6.1 p -120.3 -87.55 0.64 Allowed 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.926 -0.309 . . . . 1.0 111.81 -177.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.445 HH21 ' HB ' ' A' ' 124' ' ' VAL . 12.6 mtp180 -72.21 -45.06 61.86 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.29 0.478 . . . . 1.0 112.29 -175.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.567 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 18.5 m -55.01 -56.72 24.82 Favored Pre-proline 0 CA--C 1.541 0.603 0 N-CA-C 112.099 0.407 . . . . 1.0 112.099 179.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.494 ' HD3' ' HB2' ' A' ' 18' ' ' SER . 57.6 Cg_endo -68.53 -21.59 39.78 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 121.765 1.644 . . . . 1.0 112.539 -177.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.594 ' HB3' HD13 ' A' ' 142' ' ' ILE . 34.0 mmm -60.82 -53.13 61.06 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.601 -0.272 . . . . 1.0 110.32 177.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.473 ' HA ' ' HB2' ' A' ' 24' ' ' MET . . . -75.26 -25.43 58.03 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.234 -0.586 . . . . 1.0 110.61 -179.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.615 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 17.8 tt0 -52.31 -53.58 42.5 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 115.489 -0.778 . . . . 1.0 109.94 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.586 ' O ' ' HB3' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -85.88 -23.58 27.0 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.209 -0.905 . . . . 1.0 110.758 -175.787 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.646 ' HB3' HD11 ' A' ' 146' ' ' LEU . 7.0 mmm -61.78 -75.55 0.07 Allowed 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.563 0.579 . . . . 1.0 112.563 -178.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.702 ' HB3' HD13 ' A' ' 146' ' ' LEU . 26.5 p90 -80.65 -28.72 36.79 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.179 -0.608 . . . . 1.0 111.573 -174.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' A' ' 22' ' ' GLU . . . -63.65 -38.97 93.11 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 119.237 -0.985 . . . . 1.0 110.261 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.612 ' HA ' ' HD3' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -64.88 -37.65 88.35 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 108.845 -0.798 . . . . 1.0 108.845 177.272 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.6 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 79.1 mt-30 -59.02 -47.59 84.66 Favored 'General case' 0 CA--C 1.522 -0.097 0 CA-C-N 116.433 -0.349 . . . . 1.0 110.413 175.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 25' ' ' PHE . 95.6 mt -52.07 -56.26 15.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.835 -0.62 . . . . 1.0 111.071 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.612 ' HD3' ' HA ' ' A' ' 27' ' ' GLN . 0.1 OUTLIER -61.67 -37.4 83.93 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.647 -0.421 . . . . 1.0 111.797 178.866 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 8.1 m170 -62.82 -23.39 67.24 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.391 0.515 . . . . 1.0 112.391 178.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.6 ' HG2' ' O ' ' A' ' 28' ' ' GLN . 7.9 ptp180 -98.49 -21.52 16.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.48 0.657 . . . . 1.0 110.185 178.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 108.03 39.85 1.78 Allowed Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 115.24 -0.891 . . . . 1.0 112.297 177.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 15.9 mt -137.46 -3.11 1.93 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.034 0.445 . . . . 1.0 109.9 -177.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.463 ' H ' ' HA ' ' A' ' 30' ' ' ARG . . . -62.82 -23.58 65.65 Favored Glycine 0 C--N 1.332 0.325 0 CA-C-N 115.856 -0.611 . . . . 1.0 112.585 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -83.75 -32.86 25.22 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.272 0.558 . . . . 1.0 109.537 176.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.49 -15.84 55.75 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.45 -0.796 . . . . 1.0 111.334 -178.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.427 HG13 ' HB3' ' A' ' 5' ' ' LEU . 35.5 t -130.58 121.61 51.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 110.237 -0.282 . . . . 1.0 110.237 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.774 ' HE ' ' HG3' ' A' ' 4' ' ' PRO . 7.2 mmt180 -93.24 134.83 35.04 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 109.873 -0.417 . . . . 1.0 109.873 177.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.43 HG11 ' HB2' ' A' ' 26' ' ' ALA . 55.1 t -129.85 119.72 48.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 121.699 0.761 . . . . 1.0 109.877 -177.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.494 ' O ' ' HA ' ' A' ' 8' ' ' THR . 48.0 p -133.65 -174.12 3.43 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 113.693 -1.594 . . . . 1.0 110.809 -175.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.627 ' HB3' ' HD2' ' A' ' 9' ' ' PHE . 81.8 p -161.82 166.9 25.73 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 120.931 -0.308 . . . . 1.0 110.47 179.136 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.578 ' HB2' ' CD2' ' A' ' 80' ' ' HIS . . . -164.54 169.61 16.88 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.447 0.642 . . . . 1.0 111.728 -179.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -127.85 140.9 12.15 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.266 -0.879 . . . . 1.0 111.028 178.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.475 HG21 HD12 ' A' ' 96' ' ' LEU . 39.9 p -76.7 -23.2 53.15 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.935 0.368 . . . . 1.0 111.829 -177.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.498 ' HA3' ' CZ3' ' A' ' 48' ' ' TRP . . . -112.03 11.91 26.91 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.511 -0.852 . . . . 1.0 113.156 -177.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.43 ' HB3' ' HB2' ' A' ' 75' ' ' GLN . 2.7 p-10 43.11 39.9 2.1 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 113.572 0.953 . . . . 1.0 113.572 178.165 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.967 ' HB2' ' HA2' ' A' ' 13' ' ' GLY . 1.3 m-90 -46.84 -77.0 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.531 0.682 . . . . 1.0 112.306 179.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.556 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 11.3 m-70 -105.45 41.77 1.32 Allowed 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.525 -0.761 . . . . 1.0 111.06 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.558 HG23 ' HA ' ' A' ' 74' ' ' ALA . 12.9 p -61.04 125.85 17.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.119 0.485 . . . . 1.0 110.181 178.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.805 ' HA2' ' HD3' ' A' ' 72' ' ' ARG . . . 95.27 -15.23 63.74 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 121.06 -0.591 . . . . 1.0 111.637 -176.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.529 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 3.3 t -79.58 -159.99 0.23 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.251 0.548 . . . . 1.0 109.746 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 36.1 t -128.14 175.06 8.71 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 109.189 -0.671 . . . . 1.0 109.189 -179.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.57 142.48 39.25 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.87 0.367 . . . . 1.0 111.29 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -62.79 143.62 57.33 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.663 -0.699 . . . . 1.0 112.557 -176.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.601 ' HG3' ' HG3' ' A' ' 57' ' ' ARG . 12.2 pt-20 -43.61 -42.32 5.1 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 114.383 -1.28 . . . . 1.0 113.748 178.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.673 ' O ' HG23 ' A' ' 61' ' ' VAL . 10.0 mtt-85 -70.16 -48.4 57.51 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 120.784 0.326 . . . . 1.0 110.462 -176.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.38 -31.49 70.89 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.224 -0.898 . . . . 1.0 110.298 -177.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.73 -45.84 84.77 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.66 -0.496 . . . . 1.0 109.66 176.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.07 -39.93 98.62 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.708 -0.758 . . . . 1.0 111.489 178.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.673 HG23 ' O ' ' A' ' 57' ' ' ARG . 88.8 t -58.67 -59.16 4.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-O 121.233 0.54 . . . . 1.0 111.242 178.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.679 ' HB2' HG22 ' A' ' 69' ' ' THR . 96.6 mt -60.4 -50.09 74.99 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.939 -0.573 . . . . 1.0 111.54 -177.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 6.9 ptm85 -61.72 -27.56 68.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.723 -0.217 . . . . 1.0 111.008 -178.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.7 -34.14 76.3 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.453 0.644 . . . . 1.0 110.387 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.42 ' HD2' ' O ' ' A' ' 61' ' ' VAL . 94.1 m-70 -96.41 4.98 51.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.562 -0.744 . . . . 1.0 111.43 -178.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.15 11.48 64.78 Favored Glycine 0 C--N 1.329 0.188 0 C-N-CA 121.026 -0.607 . . . . 1.0 112.743 177.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -89.84 149.75 42.54 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-O 120.691 0.282 . . . . 1.0 110.773 -179.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.456 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 37.6 Cg_endo -67.91 156.14 67.05 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.285 1.99 . . . . 1.0 110.878 177.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.679 HG22 ' HB2' ' A' ' 62' ' ' LEU . 80.4 p -130.85 14.24 5.3 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 120.191 -0.604 . . . . 1.0 111.032 -176.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -77.2 132.66 38.86 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.513 -0.767 . . . . 1.0 109.856 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.461 ' HB2' ' HE2' ' A' ' 23' ' ' LYS . 54.4 t60 -172.17 148.0 2.11 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.038 0.447 . . . . 1.0 110.797 -177.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.805 ' HD3' ' HA2' ' A' ' 51' ' ' GLY . 5.3 tmm_? -131.41 108.45 9.62 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 107.153 -1.425 . . . . 1.0 107.153 176.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 49' ' ' HIS . . . -58.73 139.99 55.44 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.071 -0.968 . . . . 1.0 112.474 -174.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.558 ' HA ' HG23 ' A' ' 50' ' ' VAL . . . -134.58 147.16 50.18 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.707 -0.678 . . . . 1.0 110.113 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.43 ' HB2' ' HB3' ' A' ' 47' ' ' ASN . 49.0 tt0 -83.79 153.56 24.03 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 110.116 -0.327 . . . . 1.0 110.116 176.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.597 HG11 HD23 ' A' ' 97' ' ' LEU . 82.0 t -63.56 112.56 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.033 -0.531 . . . . 1.0 110.909 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.432 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -122.4 -171.79 13.94 Favored Glycine 0 N--CA 1.442 -0.915 0 N-CA-C 111.055 -0.818 . . . . 1.0 111.055 178.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 90.8 m -57.88 -44.19 86.52 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.707 0.289 . . . . 1.0 110.935 -179.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -58.97 -29.99 67.6 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.186 -0.461 . . . . 1.0 111.641 178.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.578 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 79.7 m80 -78.66 -39.62 36.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.821 0.343 . . . . 1.0 110.169 179.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.712 ' HA ' HD21 ' A' ' 86' ' ' LEU . 16.2 mt -69.49 -15.19 63.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.112 0.482 . . . . 1.0 110.101 177.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.37 -5.83 59.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.323 -0.399 . . . . 1.0 110.543 -179.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.509 ' HB1' ' O ' ' A' ' 6' ' ' HIS . . . -63.35 154.36 32.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.906 -0.588 . . . . 1.0 110.976 179.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.408 ' HA ' HH11 ' A' ' 106' ' ' ARG . 21.2 t70 -80.9 -14.78 57.69 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 109.871 -0.418 . . . . 1.0 109.871 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.756 HD12 ' CE3' ' A' ' 152' ' ' TRP . 0.9 OUTLIER -152.72 113.51 4.13 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.484 -0.78 . . . . 1.0 109.73 -177.43 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.712 HD21 ' HA ' ' A' ' 81' ' ' LEU . 5.5 mp -105.72 87.65 2.64 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.534 -0.757 . . . . 1.0 110.951 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.607 HG23 HD22 ' A' ' 85' ' ' LEU . 54.6 t -66.36 92.88 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 113.806 -1.543 . . . . 1.0 112.237 -178.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.06 145.54 32.4 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.393 -1.276 . . . . 1.0 109.917 177.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.506 ' O ' ' HB ' ' A' ' 124' ' ' VAL . 4.0 mm? -98.57 -8.53 26.32 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.955 0.407 . . . . 1.0 110.094 179.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.417 ' CG ' ' H ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -152.03 153.81 34.74 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.694 -0.685 . . . . 1.0 111.066 179.945 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -55.3 -27.67 48.35 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.251 -0.886 . . . . 1.0 113.104 -178.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.581 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 91.6 m-20 -75.51 -49.97 17.09 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.734 0.302 . . . . 1.0 110.504 -177.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.628 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 18.2 m170 -53.94 -46.02 71.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.428 179.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.91 -43.94 91.17 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.941 0.4 . . . . 1.0 110.735 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 16.6 ttm180 -61.3 -39.84 91.96 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.722 -0.672 . . . . 1.0 111.602 178.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.581 ' HG ' ' O ' ' A' ' 92' ' ' ASN . 43.9 mt -67.06 -50.74 60.87 Favored 'General case' 0 C--O 1.217 -0.645 0 CA-C-N 116.43 -0.35 . . . . 1.0 110.416 -178.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.634 HD13 ' HB3' ' A' ' 86' ' ' LEU . 29.2 mt -52.0 -57.45 9.44 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.971 -0.559 . . . . 1.0 111.387 -177.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.714 ' CA ' HG12 ' A' ' 102' ' ' VAL . 9.5 ptt180 -59.75 -44.12 93.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.659 -0.7 . . . . 1.0 112.439 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.546 ' HG3' ' O ' ' A' ' 96' ' ' LEU . 0.9 OUTLIER -67.66 -25.24 65.61 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.394 -0.522 . . . . 1.0 109.895 -179.972 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.494 HD13 ' O ' ' A' ' 96' ' ' LEU . 5.9 mp -77.68 -20.7 53.25 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 116.096 -0.502 . . . . 1.0 111.592 177.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 152.87 -21.15 0.78 Allowed Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 119.477 -1.344 . . . . 1.0 114.216 -178.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.714 HG12 ' CA ' ' A' ' 98' ' ' ARG . 0.3 OUTLIER -76.05 -162.35 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 118.048 0.924 . . . . 1.0 110.313 -179.51 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.741 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 10.7 pt-20 -159.34 160.6 35.23 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 107.753 -1.203 . . . . 1.0 107.753 -177.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.721 ' HA ' HG12 ' A' ' 107' ' ' VAL . . . -62.2 -25.1 67.6 Favored 'General case' 0 C--N 1.316 -0.876 0 O-C-N 123.465 0.478 . . . . 1.0 111.274 -175.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.41 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . . . -59.04 -30.2 67.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.011 0.434 . . . . 1.0 110.546 175.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.741 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 11.5 mtt-85 -105.41 -43.16 5.04 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 115.531 -0.759 . . . . 1.0 111.464 -177.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.721 HG12 ' HA ' ' A' ' 104' ' ' ALA . 11.3 p -78.38 117.93 24.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.497 -0.557 . . . . 1.0 109.497 -174.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.601 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 8.5 mmm180 -139.24 149.79 44.74 Favored 'General case' 0 C--N 1.322 -0.597 0 O-C-N 121.604 -0.685 . . . . 1.0 110.59 -176.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.529 ' HE3' HG23 ' A' ' 124' ' ' VAL . 87.7 mmm -80.39 131.49 35.62 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.079 -0.51 . . . . 1.0 111.26 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.53 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 2.8 tm? -53.54 -50.54 65.27 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 123.402 0.439 . . . . 1.0 111.028 179.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.602 ' HB2' HG22 ' A' ' 124' ' ' VAL . 43.7 ttt-85 -71.07 -16.67 62.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.308 -0.406 . . . . 1.0 110.956 -176.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 46.8 t -79.81 -2.31 42.75 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 120.706 -0.398 . . . . 1.0 111.034 -179.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.739 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 87.8 m-85 -92.74 -16.61 25.24 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-O 120.914 0.388 . . . . 1.0 109.972 175.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.5 ' HB3' ' HB2' ' A' ' 117' ' ' SER . 22.1 t0 -61.29 116.95 22.22 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.727 -0.669 . . . . 1.0 111.291 -178.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.465 ' HD2' ' O ' ' A' ' 144' ' ' SER . 38.2 Cg_endo -66.65 -19.31 54.01 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.607 2.205 . . . . 1.0 111.487 178.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 17.6 mmm180 -85.2 -14.3 47.29 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.836 -0.62 . . . . 1.0 110.094 179.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.5 ' HB2' ' HB3' ' A' ' 114' ' ' ASP . 10.9 t -71.88 86.97 0.99 Allowed 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.017 -0.538 . . . . 1.0 110.713 -179.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -57.28 -41.69 93.1 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.87 -0.681 . . . . 1.0 111.799 177.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.27 153.72 21.25 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 110.228 -0.286 . . . . 1.0 110.228 177.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -73.57 137.54 44.37 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.789 -0.819 . . . . 1.0 108.789 177.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -105.91 89.24 3.02 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.25 -0.432 . . . . 1.0 111.236 -177.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -89.25 7.36 35.89 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.616 -0.883 . . . . 1.0 108.616 176.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -166.16 139.56 4.16 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 114.339 -1.3 . . . . 1.0 108.519 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.602 HG22 ' HB2' ' A' ' 111' ' ' ARG . 85.3 t -98.33 144.47 11.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 110.292 -0.262 . . . . 1.0 110.292 -177.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -64.59 -176.52 0.25 Allowed 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.116 -0.493 . . . . 1.0 111.547 -177.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -153.46 159.57 31.98 Favored Pre-proline 0 C--N 1.326 -0.429 0 N-CA-C 109.93 -0.396 . . . . 1.0 109.93 -174.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.605 ' HB3' ' HB3' ' A' ' 134' ' ' ASP . 77.2 Cg_exo -53.57 154.16 16.5 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.757 2.305 . . . . 1.0 112.389 177.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -94.55 -36.16 11.94 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.668 -0.696 . . . . 1.0 109.73 -178.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -134.25 -24.18 1.64 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.685 -0.689 . . . . 1.0 111.214 176.272 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 85.72 53.64 2.99 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.483 -0.865 . . . . 1.0 112.111 178.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -115.57 -167.92 1.33 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.344 -0.984 . . . . 1.0 108.344 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 15.2 t-80 -58.03 -39.28 77.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.632 0.253 . . . . 1.0 110.653 -179.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.3 p -62.17 -38.69 90.02 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.026 -0.533 . . . . 1.0 111.663 179.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.605 ' HB3' ' HB3' ' A' ' 127' ' ' PRO . 1.4 m-20 -69.62 -33.97 73.4 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.35 -0.841 . . . . 1.0 111.382 -177.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.44 ' CE1' ' HD3' ' A' ' 57' ' ' ARG . 8.5 m-85 -70.68 -45.39 65.14 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.312 0.577 . . . . 1.0 110.069 -177.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -70.82 -26.54 63.34 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.333 -0.848 . . . . 1.0 110.248 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.561 ' O ' HG23 ' A' ' 141' ' ' VAL . 11.7 tp10 -62.76 -48.77 77.75 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.289 0.566 . . . . 1.0 110.048 178.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.679 ' HA ' HG23 ' A' ' 141' ' ' VAL . 73.5 t -61.51 -40.37 86.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.36 -0.836 . . . . 1.0 110.044 177.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.535 ' HB2' HG11 ' A' ' 61' ' ' VAL . 35.7 t80 -53.65 -42.12 67.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.129 -0.942 . . . . 1.0 109.204 175.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.637 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -67.18 -38.17 84.94 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.343 -0.844 . . . . 1.0 110.599 177.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.679 HG23 ' HA ' ' A' ' 138' ' ' VAL . 13.2 t -56.6 -53.58 39.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.58 0.705 . . . . 1.0 109.986 176.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.594 HD13 ' HB3' ' A' ' 20' ' ' MET . 6.0 mt -62.9 -50.43 79.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 114.883 -1.053 . . . . 1.0 111.842 -178.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.637 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 8.3 pt-20 -55.54 -33.33 63.72 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.628 0.252 . . . . 1.0 110.396 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.465 ' O ' ' HD2' ' A' ' 115' ' ' PRO . 2.0 t -74.18 -28.53 61.33 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-O 121.064 0.459 . . . . 1.0 110.327 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.45 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -86.41 -23.3 26.14 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 116.329 -0.396 . . . . 1.0 111.851 179.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.702 HD13 ' HB3' ' A' ' 25' ' ' PHE . 11.9 mt -55.45 -38.31 66.5 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 112.37 0.507 . . . . 1.0 112.37 -179.063 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.621 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 58.0 Cg_endo -70.81 -10.13 27.12 Favored 'Trans proline' 0 C--N 1.359 1.107 0 C-N-CA 122.56 2.173 . . . . 1.0 112.211 178.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.739 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -105.12 -33.44 3.71 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 110.442 -1.063 . . . . 1.0 110.442 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.634 HD23 ' CE2' ' A' ' 25' ' ' PHE . 13.0 tp -73.86 -37.41 64.79 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.451 -1.314 . . . . 1.0 107.451 177.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.451 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 0.2 OUTLIER -54.24 -51.5 64.29 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 114.549 -1.205 . . . . 1.0 109.57 174.195 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -59.16 -46.65 87.84 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.963 -1.017 . . . . 1.0 111.342 -176.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . 0.813 ' HZ3' HD21 ' A' ' 5' ' ' LEU . 28.7 t90 -63.0 -52.17 64.0 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.49 -0.777 . . . . 1.0 111.056 -178.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.473 HG13 ' O ' ' A' ' 149' ' ' LEU . 12.3 m -61.01 -39.39 82.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 120.545 -0.462 . . . . 1.0 109.919 -179.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.401 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 0.4 OUTLIER -61.11 -51.54 68.7 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 116.417 -0.356 . . . . 1.0 111.076 177.413 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.544 ' HG2' ' O ' ' A' ' 152' ' ' TRP . 4.8 pt-20 -60.18 -39.34 86.12 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.256 0.55 . . . . 1.0 110.235 -178.017 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.558 ' HG3' ' CH2' ' A' ' 152' ' ' TRP . 17.3 mmt85 -72.11 -46.24 57.44 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.369 -0.832 . . . . 1.0 111.437 -176.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 4.3 pp -67.14 -22.8 65.76 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.317 -0.623 . . . . 1.0 109.317 179.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -73.82 -51.21 17.08 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.544 -0.753 . . . . 1.0 110.195 178.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 1.4 ptp85 -77.67 0.8 21.97 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 112.429 0.529 . . . . 1.0 112.429 -179.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -71.81 -4.18 26.44 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.947 -0.39 . . . . 1.0 109.947 177.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 35.5 -144.47 0.08 OUTLIER Glycine 0 C--N 1.335 0.502 0 CA-C-N 114.787 -1.097 . . . . 1.0 114.639 -179.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -92.24 -9.72 2.44 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 123.029 2.486 . . . . 1.0 113.12 177.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 68.9 m . . . . . 0 C--O 1.25 1.097 0 CA-C-N 114.972 -1.013 . . . . 1.0 111.742 -178.194 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . 0.508 ' CA ' ' HA ' ' A' ' 163' ' ' SER . . . . . . . . 0 N--CA 1.484 1.835 0 N-CA-C 112.288 -0.325 . . . . 1.0 112.288 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.56 ' H ' ' HA ' ' A' ' 163' ' ' SER . 64.1 mtt 65.65 101.18 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.308 0.643 . . . . 1.0 110.947 -178.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 73.6 m -76.31 177.8 7.0 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-O 120.739 0.305 . . . . 1.0 110.913 178.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.87 150.81 97.52 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-O 121.348 0.594 . . . . 1.0 112.015 -179.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.595 ' HB2' ' HG2' ' A' ' 39' ' ' ARG . 11.1 Cg_endo -58.63 168.61 3.94 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 124.213 3.275 . . . . 1.0 114.803 -175.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.71 HD21 ' HZ3' ' A' ' 152' ' ' TRP . 0.7 OUTLIER -70.79 -174.14 0.88 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 114.006 -1.452 . . . . 1.0 110.118 179.949 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.669 ' HA ' ' O ' ' A' ' 39' ' ' ARG . 1.4 t-160 -157.54 93.3 1.28 Allowed 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.493 -0.483 . . . . 1.0 111.159 -178.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.719 HG13 HD13 ' A' ' 85' ' ' LEU . 2.5 t -98.27 108.63 22.33 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.454 0 N-CA-C 109.916 -0.402 . . . . 1.0 109.916 177.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.533 ' HA ' ' O ' ' A' ' 41' ' ' THR . 14.7 t -109.88 116.88 32.44 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.143 0.497 . . . . 1.0 110.937 -179.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.561 ' CE2' ' HA ' ' A' ' 22' ' ' GLU . 0.4 OUTLIER -86.95 129.43 34.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.902 0.382 . . . . 1.0 110.653 -179.166 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.674 HG21 HD21 ' A' ' 97' ' ' LEU . 41.2 t -114.14 116.59 53.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.914 -0.585 . . . . 1.0 111.782 -176.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.514 ' HA ' ' CE1' ' A' ' 93' ' ' HIS . 45.1 t -145.32 151.9 39.05 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.409 178.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.34 99.71 2.99 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.285 0.564 . . . . 1.0 110.423 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.558 ' O ' HG12 ' A' ' 15' ' ' ILE . . . 140.02 -32.85 2.16 Favored Glycine 0 C--O 1.217 -0.951 0 CA-C-N 115.555 -0.748 . . . . 1.0 111.488 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.579 ' OD1' ' HB1' ' A' ' 73' ' ' ALA . 34.3 p30 48.7 20.98 0.38 Allowed 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 125.268 1.427 . . . . 1.0 113.901 179.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.558 HG12 ' O ' ' A' ' 13' ' ' GLY . 5.3 pt -139.46 10.26 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 122.233 -0.292 . . . . 1.0 111.362 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.419 ' O ' ' HG2' ' A' ' 20' ' ' MET . 47.9 t -125.1 -87.34 0.61 Allowed 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.263 -0.575 . . . . 1.0 112.131 -178.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.924 HH22 ' HA ' ' A' ' 126' ' ' ASP . 35.8 mtt180 -71.21 -39.47 71.72 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.23 0.456 . . . . 1.0 112.23 -174.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.938 ' HB3' ' HB2' ' A' ' 42' ' ' SER . 16.5 m -58.29 -58.59 17.8 Favored Pre-proline 0 CA--C 1.543 0.677 0 N-CA-C 111.753 0.279 . . . . 1.0 111.753 179.155 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.639 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 38.1 Cg_endo -63.71 -23.94 69.31 Favored 'Trans proline' 0 C--N 1.358 1.042 0 C-N-CA 122.341 2.027 . . . . 1.0 112.431 178.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.678 ' HB3' HD13 ' A' ' 142' ' ' ILE . 49.0 mmm -59.74 -55.47 33.97 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.228 -0.286 . . . . 1.0 110.228 179.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.454 ' HA ' ' HB2' ' A' ' 24' ' ' MET . . . -75.36 -26.19 58.32 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.238 -0.585 . . . . 1.0 110.522 -179.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.625 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 11.8 tt0 -52.44 -54.3 34.01 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 115.377 -0.828 . . . . 1.0 110.008 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.722 ' HE3' ' HB2' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -84.78 -23.44 29.19 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.362 -0.836 . . . . 1.0 110.576 -175.844 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.671 ' HB3' HD11 ' A' ' 146' ' ' LEU . 5.2 mmm -62.82 -75.74 0.07 Allowed 'General case' 0 C--O 1.237 0.442 0 N-CA-C 112.679 0.622 . . . . 1.0 112.679 -178.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.774 ' HB3' HD22 ' A' ' 146' ' ' LEU . 18.6 p90 -79.06 -28.92 43.22 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 119.848 -0.741 . . . . 1.0 111.251 -174.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.69 ' HB2' HG21 ' A' ' 40' ' ' VAL . . . -64.06 -37.15 86.38 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 119.486 -0.886 . . . . 1.0 110.661 179.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.607 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -64.54 -38.69 91.87 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.676 -0.861 . . . . 1.0 108.676 176.507 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.555 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 77.8 mt-30 -60.63 -41.56 95.12 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.619 -0.718 . . . . 1.0 110.426 176.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.653 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 88.2 mt -57.01 -58.97 5.84 Favored 'General case' 0 C--O 1.225 -0.201 0 CA-C-N 115.774 -0.648 . . . . 1.0 110.89 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.531 ' HD3' ' HA ' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -59.31 -35.37 73.67 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.204 -0.598 . . . . 1.0 111.163 178.654 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -63.33 -26.29 68.7 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.244 0.461 . . . . 1.0 112.244 177.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.653 ' HG2' ' O ' ' A' ' 29' ' ' LEU . 4.0 ptm85 -96.21 -23.37 16.75 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 119.775 -0.77 . . . . 1.0 109.954 178.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 113.47 34.65 1.71 Allowed Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.174 -0.921 . . . . 1.0 112.433 177.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 25.8 mt -129.37 5.08 5.19 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.853 -0.425 . . . . 1.0 109.853 -178.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.452 ' HA3' ' HB3' ' A' ' 30' ' ' ARG . . . -59.39 -31.6 70.54 Favored Glycine 0 C--N 1.332 0.308 0 CA-C-N 115.819 -0.628 . . . . 1.0 112.967 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -88.17 -20.85 25.03 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.864 0.364 . . . . 1.0 110.186 176.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.02 -25.05 40.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.814 -0.63 . . . . 1.0 111.299 -178.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.644 HG13 ' HB3' ' A' ' 5' ' ' LEU . 5.9 t -130.13 126.29 61.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 121.106 -0.238 . . . . 1.0 110.604 -178.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.669 ' O ' ' HA ' ' A' ' 6' ' ' HIS . 24.2 mmt180 -99.61 98.89 9.7 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.185 0.517 . . . . 1.0 110.876 177.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.69 HG21 ' HB2' ' A' ' 26' ' ' ALA . 1.5 m -88.45 136.75 22.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 CA-C-N 115.703 -0.68 . . . . 1.0 109.299 178.228 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.533 ' O ' ' HA ' ' A' ' 8' ' ' THR . 28.9 p -146.59 -179.8 7.02 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.117 -0.947 . . . . 1.0 109.756 -175.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.938 ' HB2' ' HB3' ' A' ' 18' ' ' SER . 95.1 p -158.19 161.4 37.83 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.382 -0.527 . . . . 1.0 110.936 -178.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.502 ' HB2' ' CD2' ' A' ' 80' ' ' HIS . . . -165.09 168.37 17.36 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.309 0.576 . . . . 1.0 111.415 -179.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -124.68 132.15 8.08 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 110.805 -0.918 . . . . 1.0 110.805 177.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.591 HG23 ' CG1' ' A' ' 10' ' ' VAL . 20.2 p -66.72 -28.82 68.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.948 0.404 . . . . 1.0 111.446 -176.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -101.64 7.13 55.49 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.653 -0.784 . . . . 1.0 113.059 -176.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 42.85 39.39 1.7 Allowed 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 113.46 0.911 . . . . 1.0 113.46 178.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -47.18 -79.64 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.635 0.731 . . . . 1.0 112.533 178.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -103.79 42.11 1.21 Allowed 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.992 -1.004 . . . . 1.0 111.095 -178.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.411 HG23 ' HA ' ' A' ' 74' ' ' ALA . 9.4 p -60.53 125.63 17.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.797 -0.638 . . . . 1.0 110.408 178.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.33 -12.76 64.99 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.703 -0.76 . . . . 1.0 111.834 -177.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.33 -161.06 0.38 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.728 -0.471 . . . . 1.0 109.728 178.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 71' ' ' HIS . 30.0 t -127.34 169.45 13.56 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.512 -0.921 . . . . 1.0 108.512 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -51.14 138.96 19.2 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.921 0.391 . . . . 1.0 111.707 -179.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.748 ' OD1' ' HG2' ' A' ' 57' ' ' ARG . 12.1 t70 -62.62 140.97 58.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.585 -0.734 . . . . 1.0 111.05 -176.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -51.06 -33.62 26.45 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.793 1.035 . . . . 1.0 113.793 -178.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.748 ' HG2' ' OD1' ' A' ' 55' ' ' ASP . 9.9 ptm180 -72.63 -41.16 65.81 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 118.958 0.799 . . . . 1.0 110.619 -178.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.15 -38.89 75.57 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.134 0.493 . . . . 1.0 109.955 179.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.13 -42.8 99.2 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.517 -0.765 . . . . 1.0 109.909 178.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.414 ' O ' ' HG2' ' A' ' 63' ' ' ARG . . . -57.82 -45.92 92.97 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.903 -0.665 . . . . 1.0 113.224 178.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 5.8 m -72.88 -39.75 59.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 117.585 0.692 . . . . 1.0 111.414 -178.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.632 ' HB2' HG22 ' A' ' 69' ' ' THR . 94.8 mt -60.92 -55.2 35.81 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 120.774 0.321 . . . . 1.0 110.5 179.063 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.414 ' HG2' ' O ' ' A' ' 60' ' ' GLY . 11.7 ptm180 -58.59 -33.16 69.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.75 -0.659 . . . . 1.0 110.729 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.95 -34.48 78.08 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.081 0.467 . . . . 1.0 110.932 179.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -95.62 5.68 50.86 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.891 -0.595 . . . . 1.0 111.409 -178.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.91 12.4 66.23 Favored Glycine 0 N--CA 1.452 -0.267 0 CA-C-N 115.589 -0.732 . . . . 1.0 112.575 176.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.406 ' CD1' ' HG2' ' A' ' 27' ' ' GLN . 65.6 m-85 -91.5 147.88 36.24 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-O 120.625 0.25 . . . . 1.0 110.827 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.547 ' HG2' ' HB3' ' A' ' 23' ' ' LYS . 38.1 Cg_endo -69.0 154.85 70.05 Favored 'Trans proline' 0 CA--C 1.508 -0.799 0 C-N-CA 122.529 2.152 . . . . 1.0 110.544 177.106 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.632 HG22 ' HB2' ' A' ' 62' ' ' LEU . 27.9 p -127.85 14.85 6.92 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.226 0.536 . . . . 1.0 110.428 -178.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -84.03 119.03 24.45 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.32 -0.855 . . . . 1.0 109.839 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.722 ' HB2' ' HE3' ' A' ' 23' ' ' LYS . 3.5 t60 -162.18 142.58 10.14 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.334 -176.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 -113.69 115.52 27.99 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 107.887 -1.153 . . . . 1.0 107.887 177.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.579 ' HB1' ' OD1' ' A' ' 14' ' ' ASN . . . -60.02 138.44 57.86 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 112.28 0.474 . . . . 1.0 112.28 -177.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.411 ' HA ' HG23 ' A' ' 50' ' ' VAL . . . -134.74 158.02 45.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.228 178.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -94.09 155.43 17.09 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.385 -0.598 . . . . 1.0 109.385 177.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.473 HG11 ' CD2' ' A' ' 97' ' ' LEU . 5.0 t -69.63 113.31 5.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.559 -0.534 . . . . 1.0 109.559 178.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.506 ' O ' ' HG ' ' A' ' 81' ' ' LEU . . . -125.31 -166.65 12.38 Favored Glycine 0 N--CA 1.44 -1.061 0 CA-C-N 115.44 -0.8 . . . . 1.0 111.353 -179.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 83.8 m -55.83 -53.31 58.26 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.967 0.413 . . . . 1.0 111.623 -178.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.505 ' CD ' ' H ' ' A' ' 79' ' ' GLU . 1.6 pm0 -56.14 -32.72 64.51 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.415 -0.811 . . . . 1.0 111.287 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.502 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 78.3 m80 -74.81 -39.73 61.52 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.048 -0.524 . . . . 1.0 109.727 179.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.608 ' HA ' HD21 ' A' ' 86' ' ' LEU . 29.5 mt -69.03 -20.76 64.13 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.89 -0.595 . . . . 1.0 110.997 177.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.41 -4.6 59.21 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.773 -177.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.55 ' HB1' ' O ' ' A' ' 6' ' ' HIS . . . -59.58 153.61 19.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.706 -0.679 . . . . 1.0 111.064 179.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -79.4 -16.82 55.58 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.162 0.506 . . . . 1.0 110.036 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.719 HD13 HG13 ' A' ' 7' ' ' VAL . 0.3 OUTLIER -152.91 114.12 4.2 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.403 -0.817 . . . . 1.0 109.088 -178.057 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.615 ' HB3' HD13 ' A' ' 97' ' ' LEU . 4.9 mp -104.32 106.48 17.0 Favored 'General case' 0 N--CA 1.424 -1.726 0 CA-C-N 115.322 -0.854 . . . . 1.0 109.724 178.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.679 HG11 HD23 ' A' ' 110' ' ' LEU . 53.9 t -86.67 94.98 4.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 114.926 -1.034 . . . . 1.0 111.242 -177.173 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -81.92 143.68 31.49 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.501 -0.772 . . . . 1.0 110.805 178.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.488 HD23 ' HB2' ' A' ' 11' ' ' CYS . 4.4 mm? -93.93 -16.29 24.12 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.758 -0.655 . . . . 1.0 109.535 178.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -141.49 152.48 44.22 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.504 -0.771 . . . . 1.0 110.514 -177.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.425 ' HG2' ' H ' ' A' ' 91' ' ' ARG . 9.2 ptt180 -61.15 -21.45 63.77 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.649 0.593 . . . . 1.0 111.238 177.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.689 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 95.4 m-20 -73.84 -50.6 19.61 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 109.644 -0.502 . . . . 1.0 109.644 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.66 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 8.5 m170 -60.16 -43.63 95.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.452 -0.795 . . . . 1.0 109.786 178.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.95 -44.68 94.26 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.164 0.507 . . . . 1.0 110.544 179.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.477 ' O ' ' HG2' ' A' ' 98' ' ' ARG . 0.3 OUTLIER -57.83 -44.07 86.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.38 -0.827 . . . . 1.0 111.225 178.173 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.744 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 50.8 mt -64.69 -49.87 69.21 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 116.279 -0.418 . . . . 1.0 110.49 -177.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.674 HD21 HG21 ' A' ' 10' ' ' VAL . 49.3 mt -51.97 -56.76 12.2 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.947 -0.57 . . . . 1.0 111.641 -178.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.477 ' HG2' ' O ' ' A' ' 95' ' ' ARG . 26.1 ptt85 -59.62 -45.57 91.56 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.138 -0.483 . . . . 1.0 111.729 -176.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.64 ' HG3' ' O ' ' A' ' 96' ' ' LEU . 1.2 pp0? -69.42 -21.55 63.74 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 120.967 0.413 . . . . 1.0 110.857 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.744 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 10.8 mt -78.72 -6.82 56.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.043 -0.526 . . . . 1.0 111.966 -178.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 144.1 -29.31 1.94 Allowed Glycine 0 CA--C 1.506 -0.479 0 C-N-CA 119.828 -1.177 . . . . 1.0 113.021 178.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.765 HG12 ' H ' ' A' ' 103' ' ' GLU . 1.6 t -74.85 -153.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-O 121.541 0.686 . . . . 1.0 110.814 -178.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.765 ' H ' HG12 ' A' ' 102' ' ' VAL . 12.6 pt-20 -163.59 159.45 21.83 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.895 -1.15 . . . . 1.0 107.895 -178.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.475 ' HA ' ' HB ' ' A' ' 107' ' ' VAL . . . -67.71 -17.28 64.51 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.665 -0.414 . . . . 1.0 112.031 -173.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.92 -37.17 76.06 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 173.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.633 ' HG3' ' HG2' ' A' ' 103' ' ' GLU . 2.5 mtp85 -94.73 -34.98 12.33 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 114.744 -1.116 . . . . 1.0 110.422 -178.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 103' ' ' GLU . 39.5 t -79.57 114.56 20.57 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.423 -179.106 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.475 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 15.1 mmt180 -135.42 147.37 48.95 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 120.212 -0.595 . . . . 1.0 110.403 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.657 ' HB2' ' HB2' ' A' ' 112' ' ' SER . 77.0 mmm -78.07 139.05 39.06 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.691 -0.686 . . . . 1.0 110.037 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.679 HD23 HG11 ' A' ' 87' ' ' VAL . 2.9 tm? -56.89 -50.18 73.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.602 0.239 . . . . 1.0 110.963 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.09 -12.08 61.04 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.082 0.468 . . . . 1.0 110.747 -177.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.805 ' HB2' ' HB3' ' A' ' 121' ' ' ALA . 32.5 t -78.69 -4.86 51.22 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.978 -0.555 . . . . 1.0 111.011 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.581 ' HZ ' HD21 ' A' ' 85' ' ' LEU . 86.4 m-85 -91.8 -21.06 20.87 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.049 0.452 . . . . 1.0 109.873 175.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -61.25 121.02 60.13 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.303 -0.862 . . . . 1.0 110.533 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -67.13 -17.86 50.83 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 122.723 2.282 . . . . 1.0 112.267 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.453 ' HA ' ' HD3' ' A' ' 116' ' ' ARG . 1.2 mmt180 -93.99 0.46 56.03 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.995 -0.548 . . . . 1.0 111.186 -179.034 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 31.7 t -60.4 -68.35 0.31 Allowed 'General case' 0 C--N 1.332 -0.154 0 O-C-N 123.322 0.389 . . . . 1.0 111.018 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 149.95 -102.52 0.23 Allowed Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.736 -0.745 . . . . 1.0 111.412 179.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 20.5 m -103.71 -56.22 2.25 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.126 0.489 . . . . 1.0 110.264 178.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 24.7 m-70 -150.87 150.97 31.56 Favored 'General case' 0 CA--C 1.5 -0.951 0 CA-C-N 115.853 -0.612 . . . . 1.0 110.712 178.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.805 ' HB3' ' HB2' ' A' ' 112' ' ' SER . . . -97.79 161.9 13.52 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 107.456 -1.313 . . . . 1.0 107.456 173.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.664 HD13 ' O ' ' A' ' 121' ' ' ALA . 2.4 mm? -137.25 -29.4 0.89 Allowed 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.377 -0.829 . . . . 1.0 110.352 -174.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.617 ' HA ' ' HE1' ' A' ' 109' ' ' MET . 0.7 OUTLIER -173.79 154.93 2.52 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.988 -177.362 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 74.5 t -98.61 141.7 15.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.883 -0.598 . . . . 1.0 109.765 178.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -162.02 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.276 -1.329 . . . . 1.0 112.802 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.924 ' HA ' HH22 ' A' ' 17' ' ' ARG . 5.3 p-10 -158.53 142.43 11.21 Favored Pre-proline 0 C--N 1.318 -0.775 0 CA-C-N 114.714 -1.13 . . . . 1.0 108.056 179.135 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.607 ' HB3' ' HB3' ' A' ' 134' ' ' ASP . 72.8 Cg_exo -44.47 154.86 0.29 Allowed 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.35 2.7 . . . . 1.0 113.028 -176.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.573 ' HD2' ' CD2' ' A' ' 129' ' ' TYR . 49.7 t80 -102.14 -35.87 8.75 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.478 -0.783 . . . . 1.0 111.641 -174.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.573 ' CD2' ' HD2' ' A' ' 128' ' ' TYR . 0.2 OUTLIER -139.0 -25.88 0.86 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 120.541 -0.463 . . . . 1.0 111.698 -179.736 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 93.82 77.45 1.37 Allowed Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.24 -0.981 . . . . 1.0 111.975 179.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -140.1 -172.6 3.44 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.77 -0.826 . . . . 1.0 108.77 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -61.08 -33.59 73.58 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.956 -0.387 . . . . 1.0 109.956 179.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 9.9 p -62.41 -53.65 51.79 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.707 -0.679 . . . . 1.0 110.342 178.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.607 ' HB3' ' HB3' ' A' ' 127' ' ' PRO . 1.8 m-20 -53.9 -35.77 61.99 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.966 0.413 . . . . 1.0 111.651 -178.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 14.4 m-30 -71.07 -53.1 15.85 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.391 -0.368 . . . . 1.0 110.561 -178.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.431 ' HA ' ' HB3' ' A' ' 139' ' ' PHE . 20.4 mt-10 -76.42 -16.25 59.74 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.883 -178.01 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.577 ' O ' HG23 ' A' ' 141' ' ' VAL . 23.5 tp10 -63.99 -49.98 70.36 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.994 -0.743 . . . . 1.0 108.994 175.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.405 ' O ' HD12 ' A' ' 142' ' ' ILE . 87.2 t -59.41 -42.91 89.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.323 -0.853 . . . . 1.0 108.889 175.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.431 ' HB3' ' HA ' ' A' ' 136' ' ' GLU . 45.6 t80 -53.9 -43.41 69.67 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.159 -1.382 . . . . 1.0 109.553 175.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.558 ' HA ' ' HG2' ' A' ' 143' ' ' GLU . . . -65.03 -40.86 95.43 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.583 -0.735 . . . . 1.0 110.913 179.012 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 137' ' ' GLU . 21.5 t -56.17 -48.63 78.95 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 CA-C-O 121.868 0.842 . . . . 1.0 109.537 177.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.678 HD13 ' HB3' ' A' ' 20' ' ' MET . 5.3 mt -65.62 -51.88 57.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 114.763 -1.108 . . . . 1.0 111.593 -179.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.558 ' HG2' ' HA ' ' A' ' 140' ' ' ALA . 8.8 pt-20 -56.09 -33.21 64.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.745 0.307 . . . . 1.0 110.506 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 72.7 m -72.37 -28.44 63.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.889 -0.596 . . . . 1.0 110.927 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.465 ' C ' ' HD2' ' A' ' 147' ' ' PRO . . . -87.61 -23.86 24.15 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-N 115.838 -0.619 . . . . 1.0 111.801 179.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.774 HD22 ' HB3' ' A' ' 25' ' ' PHE . 13.6 mt -55.86 -37.97 63.02 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 120.562 -0.455 . . . . 1.0 112.033 -177.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.632 ' HD2' ' N ' ' A' ' 146' ' ' LEU . 57.8 Cg_endo -69.73 -9.65 26.65 Favored 'Trans proline' 0 C--N 1.363 1.314 0 C-N-CA 122.666 2.244 . . . . 1.0 112.084 178.223 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.56 ' HA3' ' O ' ' A' ' 113' ' ' PHE . . . -106.09 -32.28 3.83 Favored Glycine 0 N--CA 1.442 -0.934 0 N-CA-C 109.896 -1.282 . . . . 1.0 109.896 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.473 ' O ' HG13 ' A' ' 153' ' ' VAL . 0.4 OUTLIER -74.96 -39.83 61.11 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.448 -0.945 . . . . 1.0 108.448 178.507 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -54.52 -50.99 66.53 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.364 -0.835 . . . . 1.0 110.578 175.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -60.79 -45.76 93.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.367 -0.833 . . . . 1.0 111.611 -176.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . 0.71 ' HZ3' HD21 ' A' ' 5' ' ' LEU . 22.2 t90 -60.2 -55.24 36.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.136 -0.938 . . . . 1.0 110.695 -177.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.473 HG13 ' O ' ' A' ' 149' ' ' LEU . 5.3 m -61.19 -40.39 85.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.524 -0.307 . . . . 1.0 110.527 -178.047 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.454 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 0.5 OUTLIER -60.95 -53.92 51.32 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.085 0.469 . . . . 1.0 111.104 179.216 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.606 ' O ' ' HG2' ' A' ' 159' ' ' ARG . 10.5 pt-20 -61.97 -36.47 81.57 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.698 -0.683 . . . . 1.0 110.654 -177.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.458 ' O ' ' HG3' ' A' ' 159' ' ' ARG . 14.0 mmt180 -73.88 -44.54 55.05 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 116.084 -0.507 . . . . 1.0 111.122 -178.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' A' ' 154' ' ' ASP . 4.0 pp -67.12 -24.12 65.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.993 0.425 . . . . 1.0 110.11 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -70.99 -49.76 41.74 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.691 -0.686 . . . . 1.0 109.86 179.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.606 ' HG2' ' O ' ' A' ' 155' ' ' GLU . 1.4 ptp180 -79.35 -2.89 43.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.476 -0.784 . . . . 1.0 112.268 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -72.05 19.45 0.07 Allowed 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.236 0.541 . . . . 1.0 111.732 -178.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.482 ' H ' ' C ' ' A' ' 159' ' ' ARG . . . 76.75 139.16 0.96 Allowed Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.513 -0.767 . . . . 1.0 113.785 178.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -89.45 20.0 1.16 Allowed 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 123.114 2.542 . . . . 1.0 111.686 177.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.56 ' HA ' ' H ' ' A' ' 1' ' ' MET . 5.0 t . . . . . 0 C--N 1.306 -1.309 0 CA-C-N 114.265 -1.334 . . . . 1.0 109.825 -177.109 . . . . . . . . 1 1 . 1 stop_ save_